Citrus Sinensis ID: 043292

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------56
Protein Sequence
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR
Secondary Structure (PSIPRED)
cEEcccccEEEEEEEccccEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccHHHHHHHHHccccEEEEEEcccccccccEEEEcccccccccccccccccccEEEEEEccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHccccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEccccccEEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEccccEEEEEEEEcccccEEEEEEccccccccccccccccccccccccccccccccccccccccccEEccccEccccccccEEEEccccccccccHEEEcccccHHHHHHHHHHcccEEEEEEEcccccccEEEEEcccHEcHHHHcccccccccEEEEEEEccHHccccccccccccHHHEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccEcHHHHHHHHHcHHHHEEEEccEEEEEEEEcccEEEEEEEEccccccHHHHHHHHHHHHccccccEccEHccccccccEEEEEEEcccccHHHHHEcccccccccHHHHHHHHHHHHHHHHHHHHHcccEEEcccccHHHEEEcccccEEEccccccEEccccccEEEEEEEEccccccHHHccccEEEcccHEHHEEEEEEEEcccccccccccccccccHHHHHHHHHHccccHHHccHHHccccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHccccccccccccccEcccccccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
mrlwpdghlrVYEWQRMWIVVADLLMSdlwdcdyplvcgkygicsrgqcscpatyfkllddrqpalgcsqitslsceasqdhrfvelNDVAYfafsssssditntdsetcKQACLKNCSCKAALFQYglnssagdcylpseIFSMMnneketthynstayikvqnlpmpgaspggketshRKRIMGFILESFFGLLVLIGILIFFFrkkngadeieedyldqvpglpkrfsfEELKVMTDNFRKmlgkggfgsvfegtqtdgTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVyeympngsldrwLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIlhldikpqnilldgnfnakvadfglsklidqdqSQVVTtmrgtpgylapewlSSIITEKVDIYSFGVVMLEILCgrkvfdrsqpeeeDMYLLSIFKKKAEEDKLSDLvdkhsndmqsNGEEVVNMMKVAAWCLesdfakrpsmSMVVRVLEGVTEFEHNLHYNLVHLPITAAlanvdhreendkpttqllpsvlsgpr
Flexible Loop (DISEMBL)
mrlwpdghLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEdyldqvpglpkrFSFEELKVMTDNFRKMLGKGgfgsvfegtqtdgTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRkvfdrsqpeEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANVDHREendkpttqllpsvlsgpr
Low Complexity Region (SEG)
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFsssssDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESffgllvligilifffRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR
Disordered region (IsUnstruct)
***WPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFS**********SETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNN***TTHYNSTAYIKV*******************RIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDR*******MYLLSIF**************************VVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANV**********************
Disordered Region (DISOPRED)
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDD*QP**GCS*ITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNE*****YNSTAYI**********************IMGFILESFFGLLVLIGILIFFFRKK***************GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVF******EE*MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNL***************************SVLSGP*
Disordered Region (DISEMBL)
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPG*********HRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR
Disordered Region (DISPRO)
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPG*KETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEE****QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHL*****************PTTQLLPSVLSG**
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	558	2.2.26 [Sep-21-2011]
Q8RWZ5	821	G-type lectin S-receptor-	yes	no	0.845	0.574	0.424	1e-101
O64477	828	G-type lectin S-receptor-	no	no	0.844	0.568	0.383	6e-86
Q9XID3	829	G-type lectin S-receptor-	no	no	0.917	0.617	0.356	3e-85
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.881	0.564	0.369	3e-83
O65238	872	G-type lectin S-receptor-	no	no	0.845	0.541	0.345	7e-76
Q94C25	452	Probable receptor-like pr	no	no	0.559	0.690	0.458	2e-72
P17801	817	Putative receptor protein	N/A	no	0.881	0.602	0.335	3e-71
Q39203	797	G-type lectin S-receptor-	no	no	0.507	0.355	0.479	2e-70
Q39202	832	G-type lectin S-receptor-	no	no	0.826	0.554	0.341	2e-67
Q96285	661	L-type lectin-domain cont	no	no	0.621	0.524	0.387	2e-63

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  370 bits (949), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 213/502 (42%), Positives = 306/502 (60%), Gaps = 30/502 (5%)

Query: 27  SDLWDCDYPLVCGKYGICSRGQ-CSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFV 85
           SDL  C  P  CG Y +CS  + C C +   +   D      C    +  C+ ++D+  +
Sbjct: 281 SDL--CGTPEPCGPYYVCSGSKVCGCVSGLSRARSD------CKTGITSPCKKTKDNATL 332

Query: 86  EL------NDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLP 139
            L      + V YFA   +      TD ++CK+ C  NCSC    FQ    +S+G+C+L 
Sbjct: 333 PLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQ----NSSGNCFLF 388

Query: 140 SEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLI 199
             I S   +    + +   +YIK+ +    G   G  +  H   ++  ++ + F + VLI
Sbjct: 389 DYIGSFKTSGNGGSGF--VSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLI 446

Query: 200 GILIFFFRKKNGADEI------EEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGS 253
            +     ++K    E       E+++L+ + G+P RF++++L+  T+NF   LG+GGFGS
Sbjct: 447 FVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGS 506

Query: 254 VFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE 313
           V+EGT  DG+++AVK+LEGIG+  K F AEV  IGSIHH +LVRL GFCAE +H LL YE
Sbjct: 507 VYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYE 566

Query: 314 YMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
           ++  GSL+RW+F++ D + +LDW  R  I L  AKGL YLHEDC  +I+H DIKP+NILL
Sbjct: 567 FLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILL 626

Query: 373 DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLE 431
           D NFNAKV+DFGL+KL+ ++QS V TTMRGT GYLAPEW+++  I+EK D+YS+G+V+LE
Sbjct: 627 DDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686

Query: 432 ILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW 491
           ++ GRK +D S+  E+  +  S   KK EE KL D+VD    ++    E V   MK A W
Sbjct: 687 LIGGRKNYDPSETSEK-CHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALW 745

Query: 492 CLESDFAKRPSMSMVVRVLEGV 513
           C++ D   RPSMS VV++LEGV
Sbjct: 746 CIQEDMQTRPSMSKVVQMLEGV 767

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  318 bits (816), Expect = 6e-86,   Method: Compositional matrix adjust.
 Identities = 190/495 (38%), Positives = 275/495 (55%), Gaps = 24/495 (4%)

Query: 32  CDYPLVCGKYGICSRGQ---CSCPATYFKL----LDDRQPALGCSQITSLSCEASQDHRF 84
           C     CG +GICS      C CP  +  +     D +  + GC + T L C     ++F
Sbjct: 290 CQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQF 349

Query: 85  VELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPS-EIF 143
             L ++     + +S  +T T    C  AC  +CSCKA    Y  +  +  C + S ++ 
Sbjct: 350 FRLPNMK---LADNSEVLTRTSLSICASACQGDCSCKA----YAYDEGSSKCLVWSKDVL 402

Query: 144 SMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILI 203
           ++   E E +  N   Y+++    +P     GK  +      G I  +  G L +I +++
Sbjct: 403 NLQQLEDENSEGN-IFYLRLAASDVPNVGASGKSNNK-----GLIFGAVLGSLGVIVLVL 456

Query: 204 FFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGT 263
                       +    ++  G    FS+ EL+  T NF   LG GGFGSVF+G   D +
Sbjct: 457 LVVILILRYRRRKRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSS 516

Query: 264 KVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW 323
            +AVKRLEGI +  K F  EV TIG+I H NLVRL GFC+E S  LLVY+YMPNGSLD  
Sbjct: 517 DIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSH 576

Query: 324 LF--QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA 381
           LF  Q  ++ +L W+ R +I L  A+GL YLH++CR  I+H DIKP+NILLD  F  KVA
Sbjct: 577 LFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVA 636

Query: 382 DFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFD 440
           DFGL+KL+ +D S+V+TTMRGT GYLAPEW+S + IT K D+YS+G+++ E++ GR+  +
Sbjct: 637 DFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE 696

Query: 441 RSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR 500
           +S+ E+   +         ++  +  LVD        + EEV    KVA WC++ + + R
Sbjct: 697 QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHR 756

Query: 501 PSMSMVVRVLEGVTE 515
           P+MS VV++LEGV E
Sbjct: 757 PAMSQVVQILEGVLE 771

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  316 bits (810), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 192/538 (35%), Positives = 301/538 (55%), Gaps = 26/538 (4%)

Query: 1   MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQ----CSCPATYF 56
           ++L  DG+LR+Y          +   S +  C     CG +GICS       CSCP+  F
Sbjct: 237 LKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLVYGYCGNFGICSYNDTNPICSCPSRNF 296

Query: 57  KLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSS-SSDITNTDSETCKQACL 115
             +D      GC +   LS + S +   ++L     F +    +S+     S  C+  CL
Sbjct: 297 DFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCL 355

Query: 116 KNCSCKAALFQYGLNSSAGDCYL--PSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGA-- 171
            +  C A++    ++  +G+C+   P   F+      +     ST+Y+KV    +     
Sbjct: 356 SSVLCLASV---SMSDGSGNCWQKHPGSFFTGY----QWPSVPSTSYVKVCGPVVANTLE 408

Query: 172 -SPGGKETSHRKRIMGFILESFFGLLVLIGILIFFF----RKKNGADEIEEDY--LDQVP 224
            +  G + + +  +    +    GLL L+ + I  +    RK      +   Y  L+   
Sbjct: 409 RATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYAS 468

Query: 225 GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEV 284
           G P +F+++EL+  T +F++ LG GGFG+V+ G  T+ T VAVK+LEGI +  K F  EV
Sbjct: 469 GAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEV 528

Query: 285 KTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
            TI S HH NLVRLIGFC++  H LLVYE+M NGSLD +LF       L W+ R  I L 
Sbjct: 529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGT 403
            AKG+TYLHE+CR  I+H DIKP+NIL+D NF AKV+DFGL+KL++ +D    ++++RGT
Sbjct: 589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648

Query: 404 PGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            GYLAPEWL+++ IT K D+YS+G+V+LE++ G++ FD S+      + +  +++  + +
Sbjct: 649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
             + L  + S D   + E+V+ M+K + WC++    +RP+M  VV++LEG+TE ++ L
Sbjct: 709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPL 766

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  309 bits (792), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 201/544 (36%), Positives = 298/544 (54%), Gaps = 52/544 (9%)

Query: 6   DGHLRVYEWQRMWIVVADLLMSDLW---------DCDYPLVCGKYGICS------RGQCS 50
           +G+LR+Y W        D+  S  W          CD   +CG  G+C+         C 
Sbjct: 281 NGNLRLYRWDN------DMNGSSQWVPEWAAVSNPCDIAGICGN-GVCNLDRTKKNADCL 333

Query: 51  CPATYFKLLDDRQPALGCSQITSL--SCEASQDH----RFVELNDVAYFAFSSSS----- 99
           C     KL D     L CS  +SL   CE++ +     +   + +  Y+ FS  S     
Sbjct: 334 CLPGSVKLPDQENAKL-CSDNSSLVQECESNINRNGSFKISTVQETNYY-FSERSVIENI 391

Query: 100 SDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCY-LPSEIFSMMNNEKETTHYNST 158
           SDI+N     C + CL +C C A++  YGL+     C+ L S  F    +   T    + 
Sbjct: 392 SDISNV--RKCGEMCLSDCKCVASV--YGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTR 447

Query: 159 AYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLI---GILIFF-FRKKNGADE 214
           A     +      S   K    R++++  ++    G+LVL+   G+L+++   +K     
Sbjct: 448 ANESYPSNSNNNDSKSRKSHGLRQKVL--VIPIVVGMLVLVALLGMLLYYNLDRKRTLKR 505

Query: 215 IEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLE-GI 273
             ++ L      P  F++ +L+  T+NF ++LG GGFG+V++GT    T VAVKRL+  +
Sbjct: 506 AAKNSLILCDS-PVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRAL 564

Query: 274 GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF-M 332
               + F+ EV TIGS+HH NLVRL G+C+E SH LLVYEYM NGSLD+W+F       +
Sbjct: 565 SHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANL 624

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           LDW+ R +I +  A+G+ Y HE CR +I+H DIKP+NILLD NF  KV+DFGL+K++ ++
Sbjct: 625 LDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGRE 684

Query: 393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL 451
            S VVT +RGT GYLAPEW+S+  IT K D+YS+G+++LEI+ GR+  D S   E+  Y 
Sbjct: 685 HSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYP 744

Query: 452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
              +K+      L   VDK    +    EEVV  +KVA WC++ + + RPSM  VV++LE
Sbjct: 745 GWAYKELTNGTSLK-AVDKRLQGVAEE-EEVVKALKVAFWCIQDEVSMRPSMGEVVKLLE 802

Query: 512 GVTE 515
           G ++
Sbjct: 803 GTSD 806

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  285 bits (729), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 183/530 (34%), Positives = 282/530 (53%), Gaps = 58/530 (10%)

Query: 31  DCDYPLVCGKYGICS------RGQCSCPATYFKLLDDRQPALGCSQITSL--SCEASQDH 82
            C  P VCGK G+C+         CSCP    ++   +   +  SQ  SL  SCEA ++ 
Sbjct: 286 SCQIPFVCGKLGLCNLDNASENQSCSCPDE-MRMDAGKGVCVPVSQSLSLPVSCEA-RNI 343

Query: 83  RFVELN-DVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSE 141
            ++EL   V+YF+   +           C   C KNCSC    ++    +++  CYL  +
Sbjct: 344 SYLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYE----NTSRSCYLVKD 399

Query: 142 IF---SMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRK-RIMGFILESFFGLLV 197
            F   S++ N  E  +++   Y+K+         PG          ++  +L    G  +
Sbjct: 400 SFGSLSLVKNSPE--NHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFL 457

Query: 198 LIGILIFFFRK---------------KNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNF 242
           LI + + ++R+               + G+ E  +     +PGLP++F FEEL+  T+NF
Sbjct: 458 LIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENF 517

Query: 243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +  +G GGFGSV++GT  D T +AVK++   G    + F  E+  IG+I H NLV+L GF
Sbjct: 518 KMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGF 577

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           CA     LLVYEYM +GSL++ LF  +   +L+WQ+R  I L  A+GL YLH  C QKI+
Sbjct: 578 CARGRQLLLVYEYMNHGSLEKTLFSGNGP-VLEWQERFDIALGTARGLAYLHSGCDQKII 636

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H D+KP+NILL  +F  K++DFGLSKL++Q++S + TTMRGT GYLAPEW++ + I+EK 
Sbjct: 637 HCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKA 696

Query: 421 DIYSFGVVMLEILCGRK---VFDRSQPEEED---------------MYLLSIFKKKAEED 462
           D+YS+G+V+LE++ GRK      RS    ED               +Y         E+ 
Sbjct: 697 DVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQG 756

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG 512
           +  +L D    + +   +E   ++++A  C+  + A RP+M+ VV + EG
Sbjct: 757 RYMELADPRL-EGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEG 805

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1

 Score =  274 bits (700), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 150/327 (45%), Positives = 212/327 (64%), Gaps = 15/327 (4%)

Query: 201 ILIFFFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT 260
           +L+  F  +     IE  +L +V G+P +F  E+L+  TD FR ++GKGG GSVF+G   
Sbjct: 64  LLVSRFASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLK 123

Query: 261 DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN---LLVYEYMPN 317
           DG++VAVKR+EG  +  + F +EV  I S+ H+NLVRL G+ +  S N    LVY+Y+ N
Sbjct: 124 DGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVN 183

Query: 318 GSLDRWLF------QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNIL 371
            SLD W+F       RS    L W+QR ++ +D+AK L YLH DCR KILHLD+KP+NIL
Sbjct: 184 SSLDIWIFPDRGNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENIL 243

Query: 372 LDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVML 430
           LD NF A V DFGLSKLI +D+S+V+T +RGT GYLAPEW L   I+EK D+YS+G+V+L
Sbjct: 244 LDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLL 303

Query: 431 EILCGRKVFDRSQPEEEDM----YLLSIFKKKAEEDKLSDLVDKH-SNDMQSNGEEVVNM 485
           E++ GR+   R + +E       Y   I  +K  E K+ ++VD+      + + EEV+ +
Sbjct: 304 EMIGGRRSISRVEVKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKL 363

Query: 486 MKVAAWCLESDFAKRPSMSMVVRVLEG 512
           + VA WC++    KRP M+MV+ +LEG
Sbjct: 364 VCVALWCIQEKSKKRPDMTMVIEMLEG 390

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  269 bits (688), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 187/558 (33%), Positives = 270/558 (48%), Gaps = 66/558 (11%)

Query: 5   PDGHLRVYEWQRM---WIVVADLLMSDLWDCDYPLVCGKYGICSRG---QCSCPATYFKL 58
           PDG+LR+Y        W V    +++    C+   +CG  GIC       CSCP  Y   
Sbjct: 269 PDGNLRLYSMNDSDGSWSVS---MVAMTQPCNIHGLCGPNGICHYSPTPTCSCPPGYAT- 324

Query: 59  LDDRQPA---LGCSQITSLSCEA--SQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQA 113
              R P     GC  I + +C+    +  RFV L +  ++   S    + +    TC+  
Sbjct: 325 ---RNPGNWTEGCMAIVNTTCDRYDKRSMRFVRLPNTDFWG--SDQQHLLSVSLRTCRDI 379

Query: 114 CLKNCSCKAALFQYGLNSSAGDCYLPSEIFS---MMNNEKETTHYNSTAYIKVQNL---- 166
           C+ +C+CK   +Q G     G CY  + +FS      ++  T +      + V N     
Sbjct: 380 CISDCTCKGFQYQEG----TGSCYPKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPR 435

Query: 167 ----------------------PMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIF 204
                                 P P     G   S      GFI   F   +  I    F
Sbjct: 436 SDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWF 495

Query: 205 FFRKKN-GADEI---EEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT 260
           F  K+     E+   E+ Y        +R+S+ EL   T  F+  LG+G  G+V++G   
Sbjct: 496 FVLKRELRPSELWASEKGYKAMTSNF-RRYSYRELVKATRKFKVELGRGESGTVYKGVLE 554

Query: 261 DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL 320
           D   VAVK+LE + +  + F AE+  IG I+H NLVR+ GFC+E SH LLV EY+ NGSL
Sbjct: 555 DDRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSL 614

Query: 321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV 380
              LF      +LDW+ R  I L +AKGL YLH +C + ++H D+KP+NILLD  F  K+
Sbjct: 615 ANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKI 674

Query: 381 ADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKV 438
            DFGL KL+++  S Q V+ +RGT GY+APEW+SS+ IT KVD+YS+GVV+LE+L G +V
Sbjct: 675 TDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRV 734

Query: 439 FDRSQPEEEDMYLLSIF------KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWC 492
            +     +E   +L         K + EE    D       +   N  +   ++K+A  C
Sbjct: 735 SELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSC 794

Query: 493 LESDFAKRPSMSMVVRVL 510
           LE D +KRP+M   V+ L
Sbjct: 795 LEEDRSKRPTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  266 bits (681), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 141/294 (47%), Positives = 189/294 (64%), Gaps = 11/294 (3%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKT 286
           K FSF+EL+  T+ F   +G GGFG+VF+GT     T VAVKRLE  G     F AEV T
Sbjct: 449 KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCT 508

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           IG+I H NLVRL GFC+E  H LLVY+YMP GSL  +L  R+   +L W+ R +I L  A
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWETRFRIALGTA 567

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           KG+ YLHE CR  I+H DIKP+NILLD ++NAKV+DFGL+KL+ +D S+V+ TMRGT GY
Sbjct: 568 KGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGY 627

Query: 407 LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRK-------VFDRSQPEEEDMYLLSIFKKK 458
           +APEW+S + IT K D+YSFG+ +LE++ GR+            + E E  +      ++
Sbjct: 628 VAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAARE 687

Query: 459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG 512
             +  +  +VD   N  + N EEV  M  VA WC++ +   RP+M  VV++LEG
Sbjct: 688 IIQGNVDSVVDSRLNG-EYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  256 bits (655), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 175/512 (34%), Positives = 268/512 (52%), Gaps = 51/512 (9%)

Query: 36  LVCGKYGICS-----RGQCSCPATYFKLLDDRQPALGC-SQITSLSCEASQDHRFVELND 89
           + CG   ICS     R +C CP   F L D       C       +C         ++N 
Sbjct: 312 MACGYNNICSLGNNKRPKCECPER-FVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNL 370

Query: 90  VAYFAFSSSS------SDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIF 143
             +     ++          N D E CK +CL +C C A +F  G N    D     + F
Sbjct: 371 YEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIF--GTNR---DLKCWKKKF 425

Query: 144 SMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILI 203
            + + E+ +   +S  +IKV+N  +      G    +R + + +++ +   LL     +I
Sbjct: 426 PLSHGER-SPRGDSDTFIKVRNRSIADVPVTG----NRAKKLDWLIIACSVLLGTSAFVI 480

Query: 204 F----FFRK--------KNGADEIEEDYLDQVPG-LPKR-FSFEELKVMTDNFRKMLGKG 249
           F     +RK        KN A +I           L  R F++ EL   T +F + LG+G
Sbjct: 481 FDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRG 540

Query: 250 GFGSVFEG----TQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCAE 304
            FG V++G           VAVK+L+ +   N K F  EVK IG IHH+NLVRLIGFC E
Sbjct: 541 AFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNE 600

Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
               ++VYE++P G+L  +LF+R       W+ RK I + IA+G+ YLHE+C ++I+H D
Sbjct: 601 GQSQMIVYEFLPQGTLANFLFRRPRP---SWEDRKNIAVAIARGILYLHEECSEQIIHCD 657

Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVDIY 423
           IKPQNILLD  +  +++DFGL+KL+  +Q+  +T +RGT GY+APEW  +S IT KVD+Y
Sbjct: 658 IKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVY 717

Query: 424 SFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVV 483
           S+GV++LEI+C +K  D     E+++ L++       + +L DL +  S  M ++ E V 
Sbjct: 718 SYGVMLLEIVCCKKAVDL----EDNVILINWAYDCFRQGRLEDLTEDDSEAM-NDMETVE 772

Query: 484 NMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
             +K+A WC++ +   RP+M  V ++LEGV +
Sbjct: 773 RYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQ 804

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96285|LRK55_ARATH L-type lectin-domain containing receptor kinase V.5 OS=Arabidopsis thaliana GN=LECRK55 PE=1 SV=1

 Score =  243 bits (621), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 142/366 (38%), Positives = 220/366 (60%), Gaps = 19/366 (5%)

Query: 166 LPMPGASPGGKETSHR-KRIMGFILE-SFFGLLVLIGILIFFFRKKNGADEIEEDYLDQV 223
           L +P   P  K+TS+R K ++   L  S F   V   I   F+ +     E+ E++  ++
Sbjct: 262 LSIPVLPPYPKKTSNRTKTVLAVCLTVSVFAAFVASWIGFVFYLRHKKVKEVLEEW--EI 319

Query: 224 PGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRL-----EGIGE 275
              P RF+++EL   T  F+  ++LGKGGFG V++GT      ++AVKR      +G+ E
Sbjct: 320 QYGPHRFAYKELFNATKGFKEKQLLGKGGFGQVYKGTLPGSDAEIAVKRTSHDSRQGMSE 379

Query: 276 INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDW 335
               FLAE+ TIG + H NLVRL+G+C  K +  LVY+YMPNGSLD++L +  ++  L W
Sbjct: 380 ----FLAEISTIGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLTW 435

Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
           +QR +II D+A  L +LH++  Q I+H DIKP N+L+D   NA++ DFGL+KL DQ    
Sbjct: 436 EQRFRIIKDVATALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFDP 495

Query: 396 VVTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
             + + GT GY+APE+L +   T   D+Y+FG+VMLE++CGR++ +R   E E+ YL+  
Sbjct: 496 ETSKVAGTFGYIAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEE-YLVDW 554

Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
             +  E  K+ D  ++     Q+ G +V  ++K+   C     + RP+MS+V+R+L GV+
Sbjct: 555 ILELWENGKIFDAAEESIRQEQNRG-QVELVLKLGVLCSHQAASIRPAMSVVMRILNGVS 613

Query: 515 EFEHNL 520
           +   NL
Sbjct: 614 QLPDNL 619

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	558
255569833	837	serine-threonine protein kinase, plant-t	0.973	0.648	0.638	0.0
359485463	848	PREDICTED: G-type lectin S-receptor-like	0.992	0.653	0.620	0.0
338190111	830	lectin-domain receptor-like kinase [Nico	0.971	0.653	0.596	0.0
359479303	832	PREDICTED: G-type lectin S-receptor-like	0.987	0.662	0.594	0.0
255569825	870	serine-threonine protein kinase, plant-t	0.962	0.617	0.595	0.0
359485467	1044	PREDICTED: G-type lectin S-receptor-like	0.974	0.521	0.576	0.0
225446699	846	PREDICTED: G-type lectin S-receptor-like	0.980	0.646	0.574	0.0
359485461	842	PREDICTED: G-type lectin S-receptor-like	0.973	0.644	0.574	0.0
359485465	868	PREDICTED: G-type lectin S-receptor-like	0.983	0.632	0.572	1e-179
359485477	834	PREDICTED: G-type lectin S-receptor-like	0.969	0.648	0.552	1e-170

>gi|255569833|ref|XP_002525880.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223534794|gb|EEF36484.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  728 bits (1880), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/567 (63%), Positives = 442/567 (77%), Gaps = 24/567 (4%)

Query: 2   RLWPDGHLRVYEW-QRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPAT-YFKLL 59
           R + DGHLRVYEW    W VVADLL S  ++C YP VCG YGICS  QCSCP+T YFK +
Sbjct: 285 RFFADGHLRVYEWGTNGWTVVADLLSSPGYECFYPTVCGNYGICSDRQCSCPSTAYFKQI 344

Query: 60  DDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCS 119
            DRQP LGCS I  LSC AS++H F+EL D  Y +F +   D+ N DSE+CK AC KNCS
Sbjct: 345 TDRQPNLGCSAIIPLSCGASKNHSFLELKDTTYSSFQT---DLENVDSESCKMACSKNCS 401

Query: 120 CKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPGG---- 175
           CKAA+FQYG +S++G CY+P+EIFS++NN+KE TH+NST Y+KVQ++P+   +P      
Sbjct: 402 CKAAIFQYGSDSASGFCYMPNEIFSLINNDKEKTHFNSTVYLKVQDVPVVQNAPTTEALL 461

Query: 176 ---KETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFSF 232
              K+ S    I+   L S  GLL++IGIL     KK+  D  EED+LDQVPG+P RFS+
Sbjct: 462 PQRKKKSRTATILWSSLGSLSGLLLVIGILASLAWKKSDNDGYEEDFLDQVPGMPTRFSY 521

Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH 292
           E+LK +T+NF KMLG+GGFGSVFEGT  +GTK+AVKRL G+G++ KSFLAEV++IGSIHH
Sbjct: 522 EDLKSLTENFSKMLGEGGFGSVFEGTLINGTKIAVKRLNGLGQVKKSFLAEVESIGSIHH 581

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            NLVRL+GFCA+KSH LLVYE+M  GSL++W+F +S EF+LDW+QRKKIILDIAKGL YL
Sbjct: 582 MNLVRLLGFCADKSHRLLVYEFMSRGSLEKWIFHQSLEFVLDWRQRKKIILDIAKGLAYL 641

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           HEDC QKI+HLDIKPQNILLD  F+AK++DFGLSKL+D+DQS+VVT MRGTPGYLAPEWL
Sbjct: 642 HEDCTQKIIHLDIKPQNILLDQKFSAKISDFGLSKLMDRDQSKVVTAMRGTPGYLAPEWL 701

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS 472
           SSIITEK DIYSFGVVMLE+LCGR+  D SQPEE+ M+LL++F+K A+EDKL DLVD   
Sbjct: 702 SSIITEKADIYSFGVVMLEMLCGRRNVDHSQPEEQ-MHLLTLFEKAAQEDKLKDLVDNFC 760

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVH-LPITA 531
            DMQ +  E+VNMMKVAAWCL+ D+AKRPSMS+VV+VLEGVTE EHNL YN+ +   ITA
Sbjct: 761 EDMQLHMAEIVNMMKVAAWCLQKDYAKRPSMSVVVKVLEGVTEVEHNLDYNISNPTSITA 820

Query: 532 ALANVDHREENDKPTTQLLPSVLSGPR 558
              N          +TQ+ PSVLSGPR
Sbjct: 821 VATN----------STQMFPSVLSGPR 837

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485463|ref|XP_003633280.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  706 bits (1822), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/574 (62%), Positives = 433/574 (75%), Gaps = 20/574 (3%)

Query: 1   MRLWPDGHLRVYEWQRM-WIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCP------A 53
           M+L PDGHLRVYEW+   W  VADLL ++  +C+YPL CGKYGICS  QCSCP      A
Sbjct: 279 MKLDPDGHLRVYEWRESEWKEVADLLQTNEGNCEYPLSCGKYGICSDEQCSCPGDSSNAA 338

Query: 54  TYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQA 113
            YF+ +DDR P LGCS+ITS+SC +SQ +  +EL++  Y  F     D   TD E CKQA
Sbjct: 339 KYFRPVDDRLPNLGCSEITSISCLSSQYYSLMELDNYRYSTFRE---DTVYTDMENCKQA 395

Query: 114 CLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNN--EKETTHYNSTAYIKVQNLPMPG- 170
           CLKNCSCK A F Y  NSS G+CYL SE+FS++ N  + E T+ NST  +KV + P+   
Sbjct: 396 CLKNCSCKGARFLYDWNSSNGNCYLLSEVFSLIRNYGKHEETYVNSTVLLKVVDSPIENN 455

Query: 171 ----ASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGL 226
                S  GK+T H   I+G  L +FFG+L+LI   +F FRKKN   E+EEDYLDQV G+
Sbjct: 456 TEQVGSKAGKKTGHVPIIIGSSLGAFFGVLILIVTCLFLFRKKNNTMEVEEDYLDQVSGM 515

Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKT 286
           P RFS+  LK  T+NF + LG+GGFGSV+EGT  +G KVAVK LEG+ ++ KSFLAEV+T
Sbjct: 516 PTRFSYGGLKAATENFSRKLGEGGFGSVYEGTLGNGVKVAVKLLEGLAQVKKSFLAEVET 575

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           IGSIHH NLV LIGFCAEKSH LLVYEYM NGSLDRW+F ++ +  L WQ R+KIILDIA
Sbjct: 576 IGSIHHVNLVILIGFCAEKSHRLLVYEYMCNGSLDRWIFHKNQDLALGWQSRRKIILDIA 635

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           KGL+YLHE+C +KI HLDIKPQNILLD +FNAKV+DFGLSKLID+DQSQVVTTMRGTPGY
Sbjct: 636 KGLSYLHEECTKKIFHLDIKPQNILLDEHFNAKVSDFGLSKLIDRDQSQVVTTMRGTPGY 695

Query: 407 LAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           LAPEWLS++ITEKVD+YSFGVV+LEILCGRK  DRS+P EEDM+LLSIFK+KA+E++L D
Sbjct: 696 LAPEWLSAVITEKVDVYSFGVVVLEILCGRKNIDRSRP-EEDMHLLSIFKRKAQEEQLLD 754

Query: 467 LVDKH-SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLV 525
           +VDKH + +MQ +G EVV MM+V AWCL+SDFAKRP MSMVV+ LEG+ + + NL Y+  
Sbjct: 755 MVDKHRTEEMQLHGTEVVKMMRVGAWCLQSDFAKRPYMSMVVKALEGLVDVDENLDYSFS 814

Query: 526 HLPITAALANVDHREE-NDKPTTQLLPSVLSGPR 558
            LP+  +L  V  +E      TT LL SVLSGPR
Sbjct: 815 PLPLPGSLTVVGPKEGVASSSTTPLLASVLSGPR 848

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|338190111|gb|AEI84329.1| lectin-domain receptor-like kinase [Nicotiana attenuata]

 Score =  694 bits (1790), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/567 (59%), Positives = 423/567 (74%), Gaps = 25/567 (4%)

Query: 1   MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCP------AT 54
           M+L  DGHL+VYEWQ  W  V DLL     +C YP++CG+YGICSRGQCSCP       +
Sbjct: 280 MKLESDGHLKVYEWQSRWNEVNDLLTGFNGECYYPMICGRYGICSRGQCSCPKSSSNSTS 339

Query: 55  YFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQAC 114
           YF+ +DDRQ  LGC+++T L+C A  +HRF+EL DV YF F++   DI NTD   CK AC
Sbjct: 340 YFRQIDDRQGNLGCAEVTRLTCNALNNHRFLELQDVDYFTFTA---DIKNTDMNACKDAC 396

Query: 115 LKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASPG 174
           L+NCSCKAALF+ GLNSS GDCYLPSEI+S+ NNEKE T YNS A++KVQ    P A+  
Sbjct: 397 LRNCSCKAALFRSGLNSSTGDCYLPSEIYSLANNEKEKTRYNSYAFVKVQVEAEPAAA-- 454

Query: 175 GKETSHRKRIMGFILESFFGLLVL---IGILIFFFRKKNGADEIEEDYLDQVPGLPKRFS 231
                 +KR+ G +L S  GL +L   I I +F   KK  A+E EE+YLD VPG+P RFS
Sbjct: 455 ----KEKKRVSGVVLGSVIGLAILGILIAIAVFIIWKKRKANEDEENYLDHVPGMPTRFS 510

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
           +++LK  T+NF K LG+GGFGSVFEG   DGTK+AVK L+G+G++ KSFLAEV+TIGSIH
Sbjct: 511 YDDLKAATENFTKKLGRGGFGSVFEGCLEDGTKIAVKCLDGVGQVKKSFLAEVETIGSIH 570

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H NLV+LIGFCAEKSH LLVYE+M NGSL++W++    E  LDW  R+KII DIAKGL Y
Sbjct: 571 HVNLVQLIGFCAEKSHRLLVYEFMSNGSLEKWIYHGKQELTLDWNCRRKIIQDIAKGLAY 630

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           LHE+CRQKILHLDIKP NILLD   NAK++DFGL+KLID++QSQV+T MRGTPGYLAPEW
Sbjct: 631 LHEECRQKILHLDIKPPNILLDEKHNAKLSDFGLAKLIDRNQSQVMTMMRGTPGYLAPEW 690

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
           LS  ITEKVD+YSFG+V+LEIL GR+ F+ S+ EE+ + +L++FKKKAEE +L DL+DKH
Sbjct: 691 LSGAITEKVDVYSFGIVILEILSGRRHFEASESEEQQV-MLNLFKKKAEEGQLVDLIDKH 749

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITA 531
           S DMQ   EEV+  M++AAWCL+ D+ KRPSMSMVV+ +EGV + E +L Y+  +    +
Sbjct: 750 SEDMQLYKEEVIKTMQIAAWCLQRDYTKRPSMSMVVKAMEGVLDVEKSLDYSF-NPQTVS 808

Query: 532 ALANVDHREENDKPTTQLLPSVLSGPR 558
            + N+         +T LLPSVLSGPR
Sbjct: 809 VIPNITFAH-----STPLLPSVLSGPR 830

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359479303|ref|XP_003632253.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  685 bits (1768), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/567 (59%), Positives = 427/567 (75%), Gaps = 16/567 (2%)

Query: 1   MRLWPDGHLRVYEWQRM-WIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPAT----- 54
           MRL  DGHLRV++WQ   W    DL    L +CDYPL CGKYGICS GQC+CP       
Sbjct: 273 MRLGSDGHLRVFQWQETGWQEAVDLTDEFLTECDYPLACGKYGICSAGQCTCPGASDNGT 332

Query: 55  -YFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQA 113
            YF+ +++RQ  LGCS IT +SC+ SQ H  +EL + +Y  F     D+ +TD E CKQ 
Sbjct: 333 IYFRPINERQTNLGCSAITPISCQLSQYHSLLELQNTSYSTFQV---DMQSTDVEICKQT 389

Query: 114 CLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNE--KETTHYNSTAYIKVQNLPMPGA 171
           CLKNCSCKAALF++  N S+GDC L S++F++ N E    T +++++ ++KV+N P    
Sbjct: 390 CLKNCSCKAALFRHPSNHSSGDCCLLSDVFTLQNMETLNPTDYFSTSLFLKVENSPTENV 449

Query: 172 SPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPGLPKRFS 231
               K+  + + I+G  L + FG+L+LIG  IF F K+  + E EED+LD +PG+P RFS
Sbjct: 450 VE--KKAGNARIILGSSLGALFGVLILIGAFIFLFWKRRDSKEAEEDHLDCIPGMPTRFS 507

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
           FE+LK +T+NF   LG+GGFGSVF+GT ++G KVAVK+LEG+G++ KSFLAEV+TIGS+H
Sbjct: 508 FEDLKAITENFSCKLGEGGFGSVFQGTLSNGIKVAVKQLEGLGQVKKSFLAEVETIGSVH 567

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H NLVRLIGFCAEKSH LLVYE M NGSLD+W+F  + +  L WQ R+KIILDIAKGL+Y
Sbjct: 568 HVNLVRLIGFCAEKSHRLLVYECMCNGSLDKWIFHGNRDLALGWQSRRKIILDIAKGLSY 627

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           LHEDCRQKI HLDIKPQNILLD +FNAKV+DFGLSKLID+DQSQVVT MRGTPGYLAPEW
Sbjct: 628 LHEDCRQKIFHLDIKPQNILLDEDFNAKVSDFGLSKLIDKDQSQVVTRMRGTPGYLAPEW 687

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
           L+SIITEKVD+YSFGVV+LEILCGRK  DRSQ  EEDM+LL IFK+KAEE++L+D++DK 
Sbjct: 688 LTSIITEKVDVYSFGVVVLEILCGRKNLDRSQ-TEEDMHLLGIFKRKAEENRLADIIDKC 746

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLPITA 531
           S DMQ +G +VV MMKV  WCL+SDFA+RPSMS+VV+VLEG+ + E NL Y+  + P   
Sbjct: 747 SEDMQLHGADVVEMMKVGGWCLQSDFARRPSMSVVVKVLEGLVDIEDNLEYSFSYSPRPP 806

Query: 532 ALANVDHREENDKPTTQLLPSVLSGPR 558
            +A + ++   D  T + +PS LSGPR
Sbjct: 807 KIAGMGNKAA-DAATAEPIPSALSGPR 832

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255569825|ref|XP_002525876.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223534790|gb|EEF36480.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  664 bits (1713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/569 (59%), Positives = 425/569 (74%), Gaps = 32/569 (5%)

Query: 1   MRLWPDGHLRVYEWQRM---WIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPA---- 53
           +R    G LR+YEW      W +V D+       C YP VCG YGICS+GQCSCPA    
Sbjct: 290 LRFGATGQLRLYEWNTQGAAWRIVTDVTSVTGGVCFYPTVCGNYGICSKGQCSCPASDSG 349

Query: 54  --TYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCK 111
             TYF+ ++DR+P LGCS+ TSLSCE S+ H F+EL D  YF+F +   D+ N DS+ CK
Sbjct: 350 RTTYFRHVNDREPNLGCSETTSLSCEVSEYHNFLELTDTTYFSFRT---DLENVDSKRCK 406

Query: 112 QACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGA 171
           +ACL+NCSCKAA+F+YG + + G C+LP++I S++NNE E T YNST ++KVQN  +   
Sbjct: 407 EACLQNCSCKAAIFRYGSDHANGSCHLPNQILSLINNEPEATDYNSTVFVKVQNNSIDKV 466

Query: 172 SPGGKETSHRKR------IMGFILESFFGLLVLIGILIFF-FRKKNGADEIEEDYLDQVP 224
                 T+ RK       I+G  L SFFGLL+L+GI +   ++++NG  E EEDYLDQVP
Sbjct: 467 E-NNSTTARRKAKNRVAVILGSSLGSFFGLLLLVGIFVLLVWKERNG--EAEEDYLDQVP 523

Query: 225 GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEV 284
           G+P RFSFE+LK +T+NFRK+LG+GGFG+ FEGT  DGTK+AVKRL G+ ++ KSFLAEV
Sbjct: 524 GMPTRFSFEDLKAITENFRKVLGEGGFGTAFEGTTADGTKIAVKRLNGLDQVKKSFLAEV 583

Query: 285 KTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
           ++IGS+HH NLVRL+GFCAEKSH LLVYE+M NGSLD+W+F +S EF+LDW+QRKKIILD
Sbjct: 584 ESIGSLHHMNLVRLLGFCAEKSHRLLVYEFMSNGSLDKWIFHQSREFVLDWKQRKKIILD 643

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           IAKGLTYLHE+C QK++HLDIKPQNILLD  FNAK+ DFGLSKLI +DQS+VVTTMRGTP
Sbjct: 644 IAKGLTYLHEECSQKVIHLDIKPQNILLDNQFNAKICDFGLSKLIHRDQSKVVTTMRGTP 703

Query: 405 GYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           GYLAPEWLSS+ITEKVDIYSFG+V+LE+LCGR+  D SQPEE  M+LLSIF+KK EE++L
Sbjct: 704 GYLAPEWLSSVITEKVDIYSFGIVVLEMLCGRRNIDPSQPEEL-MHLLSIFEKKVEENRL 762

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNL 524
            DLVD    D+    EEV+N+M++AAWCL+ D  +RPSMSMVV+VLEGV E E +L YNL
Sbjct: 763 VDLVDSCIEDIHR--EEVMNLMRLAAWCLQRDHTRRPSMSMVVKVLEGVAEVEDDLDYNL 820

Query: 525 VHLPITAALANVDHREENDKPTTQLLPSV 553
            +       A          P  Q+L SV
Sbjct: 821 PNPASNRTFAEA-------SPLNQVLTSV 842

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485467|ref|XP_002277954.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  662 bits (1708), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/572 (57%), Positives = 414/572 (72%), Gaps = 28/572 (4%)

Query: 1   MRLWPDGHLRVYEWQRMWIVVADLL---------MSDLWDCDYPLVCGKYGICSRGQCSC 51
           ++L PDGHLR Y W+      ADLL         +SD+ DC YPLVCGKYGICS  QCSC
Sbjct: 281 IKLGPDGHLRAYGWKNNSWEAADLLTDWLSFPNHLSDVDDCQYPLVCGKYGICSERQCSC 340

Query: 52  P------ATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNT 105
           P        YF+ +DD  P+ GC     ++C +SQ H  +EL  V YFAFSS   DI++T
Sbjct: 341 PPPSANGTNYFRPVDDNLPSHGCYTTKPIACGSSQYHHLLELQHVGYFAFSS---DISST 397

Query: 106 DSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQN 165
           + E CKQACL NCSCKAALFQY  +   GDC L SE+FS+M  ++      S+ ++KV  
Sbjct: 398 NVENCKQACLNNCSCKAALFQYTDDPLDGDCCLLSEVFSLMTTDRGDI--KSSTFLKVAI 455

Query: 166 LPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPG 225
            P+   +   K+  H + I+   L +FFG+ + +    F FRKK  + E EEDYLDQV G
Sbjct: 456 SPIDIGNM--KKKGHARVILVSSLAAFFGVFIFMTTCFFLFRKKKDSIEFEEDYLDQVSG 513

Query: 226 LPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVK 285
           +P RFSF++LK  T NF   LG+GGFGSV+EGT ++G KVAVK LEG+ ++ KSF AEV+
Sbjct: 514 MPTRFSFQDLKSTTQNFSCKLGEGGFGSVYEGTLSNGVKVAVKHLEGLAQVKKSFSAEVE 573

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           TIGSIHH NLVRLIGFCAEKSH LLVYEYM NGSLD+W+F ++    L W+ R+KIILDI
Sbjct: 574 TIGSIHHVNLVRLIGFCAEKSHRLLVYEYMCNGSLDKWIFHKNQHLSLGWESRRKIILDI 633

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           AKGL YLHE+CRQKI HLDIKPQNILLD + NAKV+DFGLSKLID+DQSQVVTTMRGTPG
Sbjct: 634 AKGLAYLHEECRQKIFHLDIKPQNILLDEHLNAKVSDFGLSKLIDKDQSQVVTTMRGTPG 693

Query: 406 YLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           YLAPEWLSS+ITEKVD+YSFGVV+LEILCGR+  DRSQP EEDM+LL IF++KA E ++ 
Sbjct: 694 YLAPEWLSSVITEKVDVYSFGVVLLEILCGRRNVDRSQP-EEDMHLLGIFRRKANEGQVL 752

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLV 525
           D+VDK+S DMQ +G EV+ +MKVAAWCL++D+A+RPSMS+VV+ LEG+ + E +L YN  
Sbjct: 753 DMVDKNSEDMQRHGAEVMELMKVAAWCLQNDYARRPSMSVVVKALEGLVDIEDDLIYNFS 812

Query: 526 HLPITAALANVDHREENDKPTTQLLPSVLSGP 557
           + P+   +A+     +     T ++PS LSGP
Sbjct: 813 YSPLPRGIAH-----KVAAAATPIMPSALSGP 839

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225446699|ref|XP_002277643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  660 bits (1704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/573 (57%), Positives = 413/573 (72%), Gaps = 26/573 (4%)

Query: 1   MRLWPDGHLRVYEWQRMWIVVADLL---------MSDLWDCDYPLVCGKYGICSRGQCSC 51
           ++L PDGHLR Y W+     VADLL         +SD+ DC YPLVCGKYGIC   +CSC
Sbjct: 285 IKLGPDGHLRAYGWKESDWEVADLLTDWLSFPNHLSDVDDCQYPLVCGKYGICEERRCSC 344

Query: 52  P------ATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNT 105
           P        YF+ +DD  P+ GC     ++C +SQ H+ +EL  V YFAFSS   DI++T
Sbjct: 345 PPPSPDGTNYFRSVDDNLPSHGCYATKPIACGSSQYHQLLELQHVGYFAFSS---DISST 401

Query: 106 DSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQN 165
           + E CKQACL NCSCKAALFQY  +   GDC L SE+FS+M  ++      S  ++KV  
Sbjct: 402 NVENCKQACLNNCSCKAALFQYTDDPLHGDCCLLSEVFSLMTTDRGDI--KSFTFLKVAI 459

Query: 166 LPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPG 225
            P+   +   K+  H + I+   L +FFG+ + +    F FRKK  + E EEDYLDQV G
Sbjct: 460 SPIDIGNTIQKKKGHARVILVSSLAAFFGVFIFMTTCFFLFRKKKDSIEFEEDYLDQVSG 519

Query: 226 LPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVK 285
           +P RFSF++LK  T NF   +G+GGFGSV+EGT  +G KVAVK LEG+ ++ KSF AEV+
Sbjct: 520 MPTRFSFQDLKSTTQNFSCKIGEGGFGSVYEGTLGNGVKVAVKHLEGLAQVKKSFSAEVE 579

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           TIGSIHH NLVRLIGFCAEKSH LLVYEYM NGSLD+W+F ++    L W+ R+KIILDI
Sbjct: 580 TIGSIHHVNLVRLIGFCAEKSHRLLVYEYMCNGSLDKWIFHKNQHLSLGWESRRKIILDI 639

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           AKGL YLHE+CRQKI HLDIKPQNILLD + NAKV+DFGLSKLID+DQSQVVTTMRGTPG
Sbjct: 640 AKGLAYLHEECRQKIFHLDIKPQNILLDEHLNAKVSDFGLSKLIDKDQSQVVTTMRGTPG 699

Query: 406 YLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           YLAPEWLSS+ITEKVD+YSFGVV+LEILCGR+  DRSQP EEDM+LL IF++KA E ++ 
Sbjct: 700 YLAPEWLSSVITEKVDVYSFGVVLLEILCGRRNVDRSQP-EEDMHLLGIFRRKANEGQVL 758

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLV 525
           D+VDK+S DMQ +G +V+ +MKVAAWCL++D+AKRPSMS+VV+ LEG+ + E +L YN  
Sbjct: 759 DMVDKNSEDMQRHGADVLELMKVAAWCLQNDYAKRPSMSVVVKALEGLVDIEGDLDYNFS 818

Query: 526 HLPITAALANVDHREENDKPTTQLLPSVLSGPR 558
             P+   +A+     +     T ++PS LSGPR
Sbjct: 819 FSPLARGIAH-----KVAAAATPIMPSALSGPR 846

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485461|ref|XP_002277755.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  658 bits (1697), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/573 (57%), Positives = 413/573 (72%), Gaps = 30/573 (5%)

Query: 1   MRLWPDGHLRVYEWQRMWIVVADLL---------MSDLWDCDYPLVCGKYGICSRGQCSC 51
           ++L PDGHLR Y W+      ADLL         +SD+ DC YPLVCGKYGICS  QCSC
Sbjct: 285 IKLGPDGHLRAYGWKDYDWEAADLLTDWLSFPNHLSDVDDCQYPLVCGKYGICSERQCSC 344

Query: 52  P------ATYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNT 105
           P        YF+ +DD  P+ GC     ++C +SQ H  +EL  V YFAFSS   DI++T
Sbjct: 345 PPPSPDGTNYFRPVDDNLPSHGCYATKPIACGSSQYHHLLELQHVCYFAFSS---DISST 401

Query: 106 DSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQN 165
           + E CKQACL NCSCKAA+F+Y  +   GDC L SE+FS+M  +++    NS  ++KV  
Sbjct: 402 NVENCKQACLNNCSCKAAVFKYTDDPLHGDCCLLSEVFSLMTADRDDI--NSFTFLKVAV 459

Query: 166 LPMPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPG 225
            P+       K+  H + I+   L +FFG+ + +    F FRKK  + E EEDYLDQV G
Sbjct: 460 SPIDIQ----KKKGHARVILVSSLAAFFGVFIFMTTCFFLFRKKKDSIEFEEDYLDQVSG 515

Query: 226 LPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVK 285
           +P RFSF++LK  T NF   LG+GGFGSV+EGT ++G KVAVK LEG+ ++ KSF AEV+
Sbjct: 516 MPTRFSFQDLKSTTQNFSCKLGEGGFGSVYEGTLSNGAKVAVKHLEGLAQVKKSFSAEVE 575

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           TIGSIHH NLVRLIGFCAEKSH LLVYEYM NGSLD+W+F ++    L W+ R+KIILDI
Sbjct: 576 TIGSIHHVNLVRLIGFCAEKSHRLLVYEYMCNGSLDKWIFHKNQHLSLGWESRRKIILDI 635

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           AKGL YLHE+CRQKI HLDIKPQNILLD + NAKV+DFGLSKLID+DQSQVVTTMRGTPG
Sbjct: 636 AKGLAYLHEECRQKIFHLDIKPQNILLDEHLNAKVSDFGLSKLIDKDQSQVVTTMRGTPG 695

Query: 406 YLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           YLAPEWLSS+ITEKVD+YSFGVV+LEILCGR+  DRSQP EED++LL IF++KA E ++ 
Sbjct: 696 YLAPEWLSSVITEKVDVYSFGVVLLEILCGRRNVDRSQP-EEDLHLLGIFRRKANEGQVL 754

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLV 525
           D+VDK+S DMQ +G EV+ +MKVAAWCL++D+A RPSMS+VV+ LEG+ + E +L YN  
Sbjct: 755 DMVDKNSEDMQGHGAEVMELMKVAAWCLQNDYATRPSMSVVVKALEGLVDIEGDLDYNFS 814

Query: 526 HLPITAALANVDHREENDKPTTQLLPSVLSGPR 558
             P+   +A+     +     T ++PS LSGPR
Sbjct: 815 FSPLARGIAH-----KVAAAATPIMPSALSGPR 842

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485465|ref|XP_002277928.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  633 bits (1632), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 330/576 (57%), Positives = 403/576 (69%), Gaps = 27/576 (4%)

Query: 1   MRLWPDGHLRVYEW-QRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCP------A 53
           ++L P G LR YEW +  W  +   L+ DL DC YP+ CGKYGICS GQCSCP       
Sbjct: 302 IKLEPTGQLRFYEWIKNSWRALLFPLLRDL-DCLYPMTCGKYGICSNGQCSCPKPADGET 360

Query: 54  TYFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQA 113
           +YF+ +   +P LGCS+IT LS EAS  H  +EL +   F+F+       +TD E+CK+A
Sbjct: 361 SYFRQISYNEPHLGCSEITPLSREASHYHSLLELKETTSFSFAPELD--ASTDIESCKRA 418

Query: 114 CLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLP------ 167
           CLKN SCKAA+F    ++    CYLPSEIFS+MN E  +T  NST ++KVQN+P      
Sbjct: 419 CLKNYSCKAAVFLTAADNRL--CYLPSEIFSLMNIEVYSTLLNSTTFLKVQNVPKIESPP 476

Query: 168 -----MPGASPGGKETSHRKRIMGFILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQ 222
                +P + P  K+ S    I+   LE+F  L + +    F       A E EEDYL Q
Sbjct: 477 AVTDLIPDSPPPSKKIS---VILLLSLEAFLCLFLAVMACYFLSLGFKDAKEDEEDYLHQ 533

Query: 223 VPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA 282
           VPG+P RFS E L V T NF + LGKGGFGSVF+G  +DGTKVAVK L+   +   SFLA
Sbjct: 534 VPGMPTRFSHEILVVATKNFSQKLGKGGFGSVFKGILSDGTKVAVKCLDVFCQAKNSFLA 593

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV+TIG IHH NLVRL+G+C +KS  LLVYEYM NGSLD+W+F RS    LDWQ R+KII
Sbjct: 594 EVETIGGIHHMNLVRLVGYCVKKSKRLLVYEYMYNGSLDKWIFDRSSGLALDWQTRRKII 653

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
           L+IA+GL YLHE+C++KI+HLDIKPQNILLD NFNAKV+DFGLSKLID+DQSQVVTT+RG
Sbjct: 654 LNIARGLAYLHEECQKKIVHLDIKPQNILLDENFNAKVSDFGLSKLIDRDQSQVVTTLRG 713

Query: 403 TPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           T GYLAPEW SS ITEKVD+YSFGVV LEILCGRK  DRSQP E D +LL +FK++AEED
Sbjct: 714 TLGYLAPEWFSSAITEKVDVYSFGVVTLEILCGRKNLDRSQP-EGDTHLLCLFKQRAEED 772

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHY 522
           +L DLVDK+S DMQ++G EVV MM++AAWCL+ +  KRPSMS+VV+VLEGV   E NL Y
Sbjct: 773 QLLDLVDKNSEDMQAHGAEVVEMMRLAAWCLQGEVTKRPSMSVVVKVLEGVINVEGNLEY 832

Query: 523 NLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR 558
           N  +  +      V HRE N    + LLPSVLSGPR
Sbjct: 833 NFFYPAVPIGTEAVGHRENNVIIASPLLPSVLSGPR 868

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485477|ref|XP_002278230.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera]

 Score =  605 bits (1559), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 318/576 (55%), Positives = 400/576 (69%), Gaps = 35/576 (6%)

Query: 1   MRLWPDGHLRVYEW-QRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQCSCPAT----- 54
           M+L P G+L  Y +   +W V+ + L+ D ++C YP++CGKYG+CS  QC CP       
Sbjct: 276 MKLEPKGYLTFYGFFNDIWKVLFNPLLGD-FNCAYPMICGKYGVCSEQQCFCPGPTAGET 334

Query: 55  -YFKLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQA 113
            YF  ++D +P LGC +IT LSC AS     + L       F+   SDI     E+CKQA
Sbjct: 335 RYFTPVNDEEPDLGCKEITPLSCNASHYQSLLMLRSTI---FNKKESDI-----ESCKQA 386

Query: 114 CLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKVQNLPMPGASP 173
           CL NCSCKAA+F     SS G CYL SEIFS+M   K+      T +IKVQN+  PG  P
Sbjct: 387 CLSNCSCKAAVFW----SSHGACYLLSEIFSLM---KDAHPPGLTTFIKVQNISNPGDPP 439

Query: 174 ------GGKETSHRKRIMGFILESFFGLLVLIGILI-----FFFRKKNGADEIEEDYLDQ 222
                 G + +S  + I+  +L  F   + L+ I+I        + K+  ++ E+  L Q
Sbjct: 440 SSSNPEGPQSSSSPETIISQLLSPFGAFVGLVFIVIMIGRYLILKGKDVKEDGEDKDLLQ 499

Query: 223 VPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA 282
           VPG+P RFS E L V T+NF + LGKGGFGSVFEG  TDGTKVAVK + G+ +    FLA
Sbjct: 500 VPGMPTRFSHEILIVATENFSRELGKGGFGSVFEGILTDGTKVAVKCINGLSQTKDYFLA 559

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV+TIG IHH NLVRL+G+CA KS+  LVYEYM NGSLD+W+F R+ E  LDWQ R+KII
Sbjct: 560 EVETIGGIHHLNLVRLVGYCANKSNRCLVYEYMFNGSLDKWIFHRNKELALDWQTRRKII 619

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
           LDIAKGL+YLHE+CRQKI+HLDIKPQNILLD +FNAKV+DFGLSKL+D+DQSQVVTT+RG
Sbjct: 620 LDIAKGLSYLHEECRQKIIHLDIKPQNILLDESFNAKVSDFGLSKLMDRDQSQVVTTLRG 679

Query: 403 TPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           TPGY+APEWL S ITEKVD+YSFG+V LEILCGR+  D SQP EED YLLS+FK+KAEED
Sbjct: 680 TPGYMAPEWLISAITEKVDVYSFGIVTLEILCGRRNLDHSQP-EEDKYLLSLFKRKAEED 738

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHY 522
           ++ DLVDK+S DMQ +GEE V +M++AAWCL++D  +RPSMSMV++VLEGV + E NL Y
Sbjct: 739 QMLDLVDKYSEDMQLHGEEAVELMRLAAWCLQNDNGRRPSMSMVIKVLEGVIDVEDNLDY 798

Query: 523 NLVHLPITAALANVDHREENDKPTTQLLPSVLSGPR 558
           N  +     A   V  RE N    + +LPS+LSGPR
Sbjct: 799 NFFNSSGLGATEAVHRREINVGFASPVLPSILSGPR 834

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	558
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.854	0.580	0.428	2.5e-97
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.844	0.568	0.383	5.8e-82
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.917	0.617	0.351	1.8e-78
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.383	0.245	0.525	1e-76
TAIR|locus:2147635	452	AT5G20050 [Arabidopsis thalian	0.534	0.659	0.472	1.1e-71
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.471	0.335	0.397	3.2e-62
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.514	0.340	0.391	1.1e-61
TAIR|locus:2097493	661	HLECRK "lectin-receptor kinase	0.629	0.531	0.383	5e-60
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.543	0.479	0.428	1.3e-59
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.505	0.332	0.382	1.5e-59

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
 Identities = 213/497 (42%), Positives = 296/497 (59%)

Query:    27 SDLWDCDYPLVCGKYGICSRGQ-CSCPATYFKLLDDRQPALGCSQITSLSCEASQDHRFV 85
             SDL  C  P  CG Y +CS  + C C +   +   D +  +  S        A+   + V
Sbjct:   281 SDL--CGTPEPCGPYYVCSGSKVCGCVSGLSRARSDCKTGI-TSPCKKTKDNATLPLQLV 337

Query:    86 ELND-VAYFAFXXXXXDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFS 144
                D V YFA          TD ++CK+ C  NCSC    FQ   NSS G+C+L   I S
Sbjct:   338 SAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQ---NSS-GNCFLFDYIGS 393

Query:   145 MMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESXXXXXXXXXXXXX 204
                +    + + S  YIK+ +    G   G  +  H   ++  ++ +             
Sbjct:   394 FKTSGNGGSGFVS--YIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIFVAFR 451

Query:   205 XXRKKN-----GADEIEED-YLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT 258
               ++K        +  EED +L+ + G+P RF++++L+  T+NF   LG+GGFGSV+EGT
Sbjct:   452 IHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGT 511

Query:   259 QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG 318
               DG+++AVK+LEGIG+  K F AEV  IGSIHH +LVRL GFCAE +H LL YE++  G
Sbjct:   512 LPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKG 571

Query:   319 SLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN 377
             SL+RW+F++ D + +LDW  R  I L  AKGL YLHEDC  +I+H DIKP+NILLD NFN
Sbjct:   572 SLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFN 631

Query:   378 AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGR 436
             AKV+DFGL+KL+ ++QS V TTMRGT GYLAPEW+++  I+EK D+YS+G+V+LE++ GR
Sbjct:   632 AKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGR 691

Query:   437 KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESD 496
             K +D S+  E+  +  S   KK EE KL D+VD    ++    E V   MK A WC++ D
Sbjct:   692 KNYDPSETSEK-CHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQED 750

Query:   497 FAKRPSMSMVVRVLEGV 513
                RPSMS VV++LEGV
Sbjct:   751 MQTRPSMSKVVQMLEGV 767

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 822 (294.4 bits), Expect = 5.8e-82, P = 5.8e-82
 Identities = 190/495 (38%), Positives = 274/495 (55%)

Query:    32 CDYPLVCGKYGICS-RGQ--CSCPATYFKLL----DDRQPALGCSQITSLSCEASQDHRF 84
             C     CG +GICS + +  C CP  +  +     D +  + GC + T L C     ++F
Sbjct:   290 CQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQF 349

Query:    85 VELNDVAYFAFXXXXXDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPS-EIF 143
               L ++           +T T    C  AC  +CSCKA    Y  +  +  C + S ++ 
Sbjct:   350 FRLPNMK---LADNSEVLTRTSLSICASACQGDCSCKA----YAYDEGSSKCLVWSKDVL 402

Query:   144 SMMNNEKETTHYNSTAYIKVQNLPMPGASPGGKETSHRKRIMGFILESXXXXXXXXXXXX 203
             ++   E E +  N   Y+++    +P     GK ++++  I G +L S            
Sbjct:   403 NLQQLEDENSEGN-IFYLRLAASDVPNVGASGK-SNNKGLIFGAVLGSLGVIVLVLLVVI 460

Query:   204 XXXRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGT 263
                R +     +  +  D   G    FS+ EL+  T NF   LG GGFGSVF+G   D +
Sbjct:   461 LILRYRR-RKRMRGEKGD---GTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSS 516

Query:   264 KVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW 323
              +AVKRLEGI +  K F  EV TIG+I H NLVRL GFC+E S  LLVY+YMPNGSLD  
Sbjct:   517 DIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSH 576

Query:   324 LF--QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA 381
             LF  Q  ++ +L W+ R +I L  A+GL YLH++CR  I+H DIKP+NILLD  F  KVA
Sbjct:   577 LFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVA 636

Query:   382 DFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFD 440
             DFGL+KL+ +D S+V+TTMRGT GYLAPEW+S + IT K D+YS+G+++ E++ GR+  +
Sbjct:   637 DFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE 696

Query:   441 RSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR 500
             +S+ E+   +         ++  +  LVD        + EEV    KVA WC++ + + R
Sbjct:   697 QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHR 756

Query:   501 PSMSMVVRVLEGVTE 515
             P+MS VV++LEGV E
Sbjct:   757 PAMSQVVQILEGVLE 771

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
 Identities = 189/538 (35%), Positives = 293/538 (54%)

Query:     1 MRLWPDGHLRVYEWQRMWIVVADLLMSDLWDCDYPLVCGKYGICSRGQ----CSCPATYF 56
             ++L  DG+LR+Y          +   S +  C     CG +GICS       CSCP+  F
Sbjct:   237 LKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLVYGYCGNFGICSYNDTNPICSCPSRNF 296

Query:    57 KLLDDRQPALGCSQITSLSCEASQDHRFVELNDVAYFAFXXX-XXDITNTDSETCKQACL 115
               +D      GC +   LS + S +   ++L     F +      +     S  C+  CL
Sbjct:   297 DFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCL 355

Query:   116 KNCSCKAALFQYGLNSSAGDCYL--PSEIFSMMNNEKETTHYNSTAYIKVQNLPMPG--- 170
              +  C A++    ++  +G+C+   P   F+      +     ST+Y+KV    +     
Sbjct:   356 SSVLCLASV---SMSDGSGNCWQKHPGSFFTGY----QWPSVPSTSYVKVCGPVVANTLE 408

Query:   171 -ASPGGKETS--HRKRIMGFILESXXXXXXXXXXXXXXXRKKNGA-DEIEEDY--LDQVP 224
              A+ G    S  H   +   ++                  +KN     +   Y  L+   
Sbjct:   409 RATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYAS 468

Query:   225 GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEV 284
             G P +F+++EL+  T +F++ LG GGFG+V+ G  T+ T VAVK+LEGI +  K F  EV
Sbjct:   469 GAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEV 528

Query:   285 KTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
              TI S HH NLVRLIGFC++  H LLVYE+M NGSLD +LF       L W+ R  I L 
Sbjct:   529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588

Query:   345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGT 403
              AKG+TYLHE+CR  I+H DIKP+NIL+D NF AKV+DFGL+KL++ +D    ++++RGT
Sbjct:   589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648

Query:   404 PGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
              GYLAPEWL+++ IT K D+YS+G+V+LE++ G++ FD S+      + +  +++  + +
Sbjct:   649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708

Query:   463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
               + L  + S D   + E+V+ M+K + WC++    +RP+M  VV++LEG+TE ++ L
Sbjct:   709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPL 766

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 606 (218.4 bits), Expect = 1.0e-76, Sum P(3) = 1.0e-76
 Identities = 114/217 (52%), Positives = 159/217 (73%)

Query:   223 VPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-EINKSFL 281
             +PGLP++F FEEL+  T+NF+  +G GGFGSV++GT  D T +AVK++   G    + F 
Sbjct:   498 IPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFC 557

Query:   282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
              E+  IG+I H NLV+L GFCA     LLVYEYM +GSL++ LF  +   +L+WQ+R  I
Sbjct:   558 TEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGP-VLEWQERFDI 616

Query:   342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              L  A+GL YLH  C QKI+H D+KP+NILL  +F  K++DFGLSKL++Q++S + TTMR
Sbjct:   617 ALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMR 676

Query:   402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRK 437
             GT GYLAPEW+++  I+EK D+YS+G+V+LE++ GRK
Sbjct:   677 GTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRK 713

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)]

 Score = 725 (260.3 bits), Expect = 1.1e-71, P = 1.1e-71
 Identities = 148/313 (47%), Positives = 208/313 (66%)

Query:   215 IEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG 274
             IE  +L +V G+P +F  E+L+  TD FR ++GKGG GSVF+G   DG++VAVKR+EG  
Sbjct:    78 IEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEE 137

Query:   275 EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN---LLVYEYMPNGSLDRWLFQ----- 326
             +  + F +EV  I S+ H+NLVRL G+ +  S N    LVY+Y+ N SLD W+F      
Sbjct:   138 KGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNR 197

Query:   327 -RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL 385
              RS    L W+QR ++ +D+AK L YLH DCR KILHLD+KP+NILLD NF A V DFGL
Sbjct:   198 GRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGL 257

Query:   386 SKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
             SKLI +D+S+V+T +RGT GYLAPEWL    I+EK D+YS+G+V+LE++ GR+   R + 
Sbjct:   258 SKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEV 317

Query:   445 EEEDM----YLLSIFKKKAEEDKLSDLVDKHSNDMQS-NGEEVVNMMKVAAWCLESDFAK 499
             +E       Y   I  +K  E K+ ++VD+   ++   + EEV+ ++ VA WC++    K
Sbjct:   318 KETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCVALWCIQEKSKK 377

Query:   500 RPSMSMVVRVLEG 512
             RP M+MV+ +LEG
Sbjct:   378 RPDMTMVIEMLEG 390

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 3.2e-62, Sum P(2) = 3.2e-62
 Identities = 107/269 (39%), Positives = 176/269 (65%)

Query:   246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCAE 304
             LG+GGFG V++GT   G +VAVKRL        + F  E+K I  + H+NLV+++G+C +
Sbjct:   471 LGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVD 530

Query:   305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
             +   +L+YEY PN SLD ++F +     LDW +R +II  IA+G+ YLHED R +I+H D
Sbjct:   531 EEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRD 590

Query:   365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT-MRGTPGYLAPEW-LSSIITEKVDI 422
             +K  N+LLD + NAK++DFGL++ +  D+++  TT + GT GY++PE+ +    + K D+
Sbjct:   591 LKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDV 650

Query:   423 YSFGVVMLEILCGRKVFDRS-QPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
             +SFGV++LEI+ GR+  +R  + EE  + LL    ++  EDK  +++D+  N+  ++  E
Sbjct:   651 FSFGVLVLEIVSGRR--NRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISE 708

Query:   482 VVNMMKVAAWCLESDFAKRPSMSMVVRVL 510
             V+ ++ +   C++ D   RP+MS+VV +L
Sbjct:   709 VLRVIHIGLLCVQQDPKDRPNMSVVVLML 737

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 533 (192.7 bits), Expect = 1.1e-61, Sum P(2) = 1.1e-61
 Identities = 119/304 (39%), Positives = 184/304 (60%)

Query:   221 DQV--PGLPKRFSFEELKVMTDNFRK--MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI 276
             DQV  P LP  FSF+ +   T +F +   LG+GGFG+V++G  ++G ++AVKRL G  + 
Sbjct:   503 DQVDTPDLPI-FSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561

Query:   277 N-KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDW 335
               + F  E+  I  + H+NLVRL+G C E +  +L+YEYMPN SLDR+LF  S +  LDW
Sbjct:   562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621

Query:   336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID--QDQ 393
             ++R ++I  IA+GL YLH D R KI+H D+K  NILLD   N K++DFG++++ +  QD 
Sbjct:   622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDH 681

Query:   394 SQVVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM--Y 450
             +  +  + GT GY+APE+ +  I +EK D+YSFGV++LEI+ GRK       +   +  Y
Sbjct:   682 ANTIRVV-GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGY 740

Query:   451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL 510
                ++ +   ++ +  +V K + D+     E +  + V   C +     RP+M  V+ +L
Sbjct:   741 AWHLWSQGKTKEMIDPIV-KDTRDVT----EAMRCIHVGMLCTQDSVIHRPNMGSVLLML 795

Query:   511 EGVT 514
             E  T
Sbjct:   796 ESQT 799

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2097493 HLECRK "lectin-receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 5.0e-60, P = 5.0e-60
 Identities = 139/362 (38%), Positives = 212/362 (58%)

Query:   166 LPMPGASPGGKETSHR-KRIMGFILE-SXXXXXXXXXXXXXXXRKKNGADEIEEDYLDQV 223
             L +P   P  K+TS+R K ++   L  S                +     E+ E++  Q 
Sbjct:   262 LSIPVLPPYPKKTSNRTKTVLAVCLTVSVFAAFVASWIGFVFYLRHKKVKEVLEEWEIQY 321

Query:   224 PGLPKRFSFEELKVMTDNFRK--MLGKGGFGSVFEGTQTDG-TKVAVKRLEGIGEINKS- 279
              G P RF+++EL   T  F++  +LGKGGFG V++GT      ++AVKR         S 
Sbjct:   322 -G-PHRFAYKELFNATKGFKEKQLLGKGGFGQVYKGTLPGSDAEIAVKRTSHDSRQGMSE 379

Query:   280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
             FLAE+ TIG + H NLVRL+G+C  K +  LVY+YMPNGSLD++L +  ++  L W+QR 
Sbjct:   380 FLAEISTIGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLTWEQRF 439

Query:   340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
             +II D+A  L +LH++  Q I+H DIKP N+L+D   NA++ DFGL+KL DQ      + 
Sbjct:   440 RIIKDVATALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFDPETSK 499

Query:   400 MRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
             + GT GY+APE+L +   T   D+Y+FG+VMLE++CGR++ +R   E E+ YL+    + 
Sbjct:   500 VAGTFGYIAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEE-YLVDWILEL 558

Query:   459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH 518
              E  K+ D  ++     Q+ G+ V  ++K+   C     + RP+MS+V+R+L GV++   
Sbjct:   559 WENGKIFDAAEESIRQEQNRGQ-VELVLKLGVLCSHQAASIRPAMSVVMRILNGVSQLPD 617

Query:   519 NL 520
             NL
Sbjct:   618 NL 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0090333 "regulation of stomatal closure" evidence=IMP

GO:1900425 "negative regulation of defense response to bacterium" evidence=IMP

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
 Identities = 135/315 (42%), Positives = 197/315 (62%)

Query:   207 RKKNGADEIEEDYLDQVP-GLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGT 263
             R K    ++ E Y  +V  G  KR++F+EL+  T++F  + +LG+GG+G V++G   DGT
Sbjct:   265 RNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGT 324

Query:   264 KVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS 319
              VAVKRL+      GE+   F  EV+TI    H+NL+RL GFC+     +LVY YMPNGS
Sbjct:   325 LVAVKRLKDCNIAGGEVQ--FQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGS 382

Query:   320 LDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA 378
             +   L      E  LDW +RKKI +  A+GL YLHE C  KI+H D+K  NILLD +F A
Sbjct:   383 VASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEA 442

Query:   379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRK 437
              V DFGL+KL+D   S V T +RGT G++APE+LS+   +EK D++ FG+++LE++ G+K
Sbjct:   443 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query:   438 VFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDF 497
               D  +   +   +L   KK  +E KL  L+DK  ND + +  E+  +++VA  C + + 
Sbjct:   503 ALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLND-KFDRVELEEIVQVALLCTQFNP 561

Query:   498 AKRPSMSMVVRVLEG 512
             + RP MS V+++LEG
Sbjct:   562 SHRPKMSEVMKMLEG 576

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 1.5e-59, Sum P(2) = 1.5e-59
 Identities = 111/290 (38%), Positives = 174/290 (60%)

Query:   230 FSFEELKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRLEG-IGEINKSFLAEVKT 286
             FS   + + T++F K   LG+GGFG V++G   DG ++AVKRL G  G+    F  E+  
Sbjct:   517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIIL 576

Query:   287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
             I  + H+NLVRL+G C E    +LVYEYMPN SLD +LF  + + ++DW+ R  II  IA
Sbjct:   577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIA 636

Query:   347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT-MRGTPG 405
             +GL YLH D R +I+H D+K  N+LLD   N K++DFG++++   +Q++  T  + GT G
Sbjct:   637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696

Query:   406 YLAPEW-LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
             Y++PE+ +  + + K D+YSFGV++LEI+ G++  + S    E   L+          + 
Sbjct:   697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR--NTSLRSSEHGSLIGYAWYLYTHGRS 754

Query:   465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
              +LVD     +  +  E +  + VA  C++   A+RP+M+ V+ +LE  T
Sbjct:   755 EELVDPKIR-VTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDT 803

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00018801001 SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (848 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	558
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-57
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-54
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-30
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-28
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-19
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-17
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-13
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-05
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	0.002
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  190 bits (485), Expect = 9e-57
 Identities = 89/268 (33%), Positives = 133/268 (49%), Gaps = 25/268 (9%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRL--EGIGE-INKSFLAEVKTIGSIHHQNLVRLIGF 301
           LG G FG+V++   +  G  VAVK L         +++   E++ +  + H N+VRLI  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
             +K H  LV EY   G L  +L +      L   + KKI L I +GL YLH      I+
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSR---GGPLSEDEAKKIALQILRGLEYLHS---NGII 120

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSIITEK 419
           H D+KP+NILLD N   K+ADFGL+K + +  S  +TT  GTP Y+APE L   +    K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG 479
           VD++S GV++ E+L G+  F  S     D   L + ++        D     S       
Sbjct: 180 VDVWSLGVILYELLTGKPPF--SGENILDQ--LQLIRRILGPPLEFDEPKWSSGS--EEA 233

Query: 480 EEVVNMMKVAAWCLESDFAKRPSMSMVV 507
           ++++        CL  D +KRP+   ++
Sbjct: 234 KDLIK------KCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  183 bits (466), Expect = 5e-54
 Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 27/263 (10%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G FG V+       G  VA+K  + + I +  +  L E+K +  + H N+VRL  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              ++    LV EY   G L   L ++      D  + +  +  I   L YLH    + I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSED--EARFYLRQILSALEYLHS---KGI 118

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEK 419
           +H D+KP+NILLD + + K+ADFGL++ +D  +   +TT  GTP Y+APE L      + 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG 479
           VDI+S GV++ E+L G+  F       E      +FKK  +                   
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPKPPFP------PPEWDIS 224

Query: 480 EEVVNMMKVAAWCLESDFAKRPS 502
            E  ++++     L  D  KR +
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (461), Expect = 8e-54
 Identities = 77/193 (39%), Positives = 115/193 (59%), Gaps = 12/193 (6%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+GGFG+V+    +  G KVA+K +  E    + +  L E++ +  ++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            +++H  LV EY   GSL   L +   +  L   +  +I+L I +GL YLH      I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 363 LDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI--ITEK 419
            D+KP+NILLD  N   K+ADFGLSKL+  D+S  + T+ GTP Y+APE L      +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 420 VDIYSFGVVMLEI 432
            DI+S GV++ E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (433), Expect = 4e-49
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 31/278 (11%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQN 294
             K LG+G FG V++GT          +VAVK L  +   +  + FL E + +  + H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L+G C E+   ++V EYMP G L  +L +++    L         L IA+G+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLS 413
              +  +H D+  +N L+  N   K++DFGLS+ +  D    V   +    ++APE    
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
              T K D++SFGV++ EI      F   +     M            + L  L   +  
Sbjct: 179 GKFTSKSDVWSFGVLLWEI------FTLGEEPYPGMSN---------AEVLEYLKKGYRL 223

Query: 474 DMQSNG-EEVVNMMKVAAWCLESDFAKRPSMSMVVRVL 510
               N   E+  +M     C   D   RP+ S +V +L
Sbjct: 224 PKPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  168 bits (429), Expect = 1e-48
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 32/278 (11%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQN 294
             K LG+G FG V++G           +VAVK L  +   +  + FL E + +  + H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L+G C E+    +V EYM  G L  +L +   +  L         L IA+G+ YL  
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE- 119

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLS 413
              +  +H D+  +N L+  N   K++DFGLS+ +  D        +    ++APE    
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
              T K D++SFGV++ EI      F   +     M    +         L  L + +  
Sbjct: 178 GKFTSKSDVWSFGVLLWEI------FTLGEQPYPGMSNEEV---------LEYLKNGYRL 222

Query: 474 DMQSNG-EEVVNMMKVAAWCLESDFAKRPSMSMVVRVL 510
               N   E+ ++M     C   D   RP+ S +V +L
Sbjct: 223 PQPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  167 bits (425), Expect = 5e-48
 Identities = 87/284 (30%), Positives = 130/284 (45%), Gaps = 43/284 (15%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINK-SFLAEVKTIGSIHHQN 294
             K LG+G FG V++GT     +   TKVAVK L EG  E  +  FL E   +  + H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +VRL+G C +     +V EYMP G L  +L +  ++  L  +   ++ L IAKG+ YL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLES 120

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE-WL 412
              +  +H D+  +N L+  N   K++DFGLS+ I +D           P  ++APE   
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 413 SSIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEE-----EDMYLLSIFKKKAEEDKLSD 466
               T K D++SFGV++ EI   G + +     EE     ED Y L              
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------------ 225

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL 510
                    ++  +E+  +M     C   D   RP+ S +V  L
Sbjct: 226 --------PENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  159 bits (404), Expect = 6e-45
 Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 18/217 (8%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLI 299
           ++LG+G FGSV+     D G  +AVK +E  G+  +   +   E++ + S+ H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 300 GFCAEKSHN-LLVY-EYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           G   ++  N L ++ EY+  GSL   L  F +  E ++     +K    I +GL YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTRQILEGLAYLH-- 118

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-TMRGTPGYLAPEWLS- 413
               I+H DIK  NIL+D +   K+ADFG +K +   ++   T ++RGTP ++APE +  
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
                  DI+S G  ++E+  G+  +         +Y
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (397), Expect = 6e-44
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 244 KMLGKGGFGSVFEGTQTDG----TKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVR 297
           K LG+G FG V++G         T+VAVK L+        K FL E + +  + H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------LDWQQRKKIILDIAKGLTY 351
           L+G C E+    LV EYM  G L  +L +    F       L  +      + IAKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE 410
           L     +K +H D+  +N L+  +   K++DFGLS+ +  D      T    P  ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 411 WLSS-IITEKVDIYSFGVVMLEI 432
            L   I T K D++SFGV++ EI
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  144 bits (364), Expect = 2e-38
 Identities = 82/279 (29%), Positives = 127/279 (45%), Gaps = 26/279 (9%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL----EGIGEINKSFLAEVKTIGSI-HHQNL 295
              + LG+G FG V+     D   VA+K L    E   +  + FL E++ + S+ H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L  F  ++    LV EY+  GSL+  L +   +  L   +   I+  I   L YLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS- 119

Query: 356 CRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQS-----QVVTTMRGTPGYLAP 409
             + I+H DIKP+NILLD +    K+ DFGL+KL+    S      + +T  GTPGY+AP
Sbjct: 120 --KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 410 EWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           E L  +     +   DI+S G+ + E+L G   F+  +        L I  +       S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
            L   +   +     +++  +      L  D   R S S
Sbjct: 238 PLSPSNPELISKAASDLLKKL------LAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  135 bits (343), Expect = 3e-36
 Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 46/276 (16%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKR--LEGIGEINKSF-LAEVKTIGSIHHQNLVRLI 299
           K +GKG FG V+   +  DG    +K   L  + E  +   L EVK +  ++H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQR-------SDEFMLDWQQRKKIILDIAKGLTYL 352
               EK    +V EY   G L + + ++        +E +LDW       + +   L YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCLALKYL 119

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H    +KILH DIKPQNI L  N   K+ DFG+SK++      +  T+ GTP YL+PE  
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKTVVGTPYYLSPELC 175

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFD-RSQPEEEDMYLLSIFKK--KAEEDKLSDLV 468
            +     K DI+S G V+ E+   +  F+  +  E        +  K  K +   +    
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--------LALKILKGQYPPIP--- 224

Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
            ++S++++     +V+ +      L+ D  +RPS++
Sbjct: 225 SQYSSELR----NLVSSL------LQKDPEERPSIA 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 1e-34
 Identities = 65/192 (33%), Positives = 103/192 (53%), Gaps = 10/192 (5%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
               +GKG FG V  G    G KVAVK L+      ++FLAE   + ++ H NLV+L+G 
Sbjct: 10  LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
             + +   +V EYM  GSL  +L  R    ++   Q+    LD+ +G+ YL E   +  +
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEE---KNFV 124

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H D+  +N+L+  +  AKV+DFGL+K    + SQ   + +    + APE L     + K 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 421 DIYSFGVVMLEI 432
           D++SFG+++ EI
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (316), Expect = 1e-32
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 46/272 (16%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           + +GKGGFG V++      G +VA+K +     E  +  + E++ +    H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG- 64

Query: 302 CAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              K   L +V E+   GSL   L   +        Q   +  ++ KGL YLH      I
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL--TESQIAYVCKELLKGLEYLHS---NGI 119

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII---- 416
           +H DIK  NILL  +   K+ DFGLS       ++   TM GTP ++APE    +I    
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPE----VINGKP 173

Query: 417 -TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI-----FKKKAEEDKLSDLVDK 470
              K DI+S G+  +E+  G+  +    P +  ++ ++       +             K
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIATNGPPGLRNPE----------K 222

Query: 471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
            S       +E  + +K    CL+ +  KRP+
Sbjct: 223 WS-------DEFKDFLKK---CLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 4e-30
 Identities = 66/199 (33%), Positives = 105/199 (52%), Gaps = 18/199 (9%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKR--LEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G FG V++G     G  VA+K+  LE I E   KS + E+  + ++ H N+V+ IG 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQK 359
                   ++ EY  NGSL + + ++   F   L        +  + +GL YLHE   Q 
Sbjct: 68  IETSDSLYIILEYAENGSLRQ-IIKKFGPFPESL----VAVYVYQVLQGLAYLHE---QG 119

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS-SIIT 417
           ++H DIK  NIL   +   K+ADFG++ KL D  +     ++ GTP ++APE +  S  +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGAS 177

Query: 418 EKVDIYSFGVVMLEILCGR 436
              DI+S G  ++E+L G 
Sbjct: 178 TASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 7e-30
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G +G V++   +  G  VA+K++    E      + + E+K +  + H N+VRL   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 302 CAEKSHN--LLVYEYMP---NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
              K      +V+EYM     G LD    + ++       Q K  +  + +GL YLH   
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTE------SQIKCYMKQLLEGLQYLH--- 117

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SS 414
              ILH DIK  NIL++ +   K+ADFGL++   +  S   T    T  Y  PE L  ++
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 415 IITEKVDIYSFGVVMLEILCGRKVF 439
               +VD++S G ++ E+  G+ +F
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (297), Expect = 9e-30
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 22/216 (10%)

Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGT---QTDGT--KVAVKRLEGIGEINKS--FLA 282
           F    LK +     K LG+G FG V         D T  +VAVK L   GE      F  
Sbjct: 1   FEKRHLKFI-----KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER 55

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
           E++ + ++ H+N+V+  G C +       L+ EY+P+GSL  +L +  D+  ++ ++   
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLL 113

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVTT 399
               I KG+ YL     Q+ +H D+  +NIL++     K++DFGL+K++ +D+    V  
Sbjct: 114 FSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 400 MRGTPG-YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              +P  + APE L  S  +   D++SFGV + E+ 
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 24/213 (11%)

Query: 242 FRKMLGKGGFGSVFEGTQT---DGTK--VAVKRL--EGIGEINKSFLAEVKTIGSIHHQN 294
             K+LG G FG+V++G      +  K  VA+K L  E   + NK  L E   + S+ H +
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIILDIAKGLT 350
           +VRL+G C       L+ + MP G L  ++    D      +L+W       + IAKG++
Sbjct: 71  VVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMS 123

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAP 409
           YL E   ++++H D+  +N+L+    + K+ DFGL+KL+D D+ +        P  ++A 
Sbjct: 124 YLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 410 EWLS-SIITEKVDIYSFGVVMLEILC-GRKVFD 440
           E +   I T K D++S+GV + E++  G K ++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  113 bits (285), Expect = 4e-28
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 23/221 (10%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G+G  G VF+   +  G  VA+K++       GI       L E+K + +  H  +V+L
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           +      S  +LV EYMP   L   L            Q K  +  + KG+ Y+H +   
Sbjct: 65  LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE--AQVKSYMRMLLKGVAYMHAN--- 118

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSII 416
            I+H D+KP N+L+  +   K+ADFGL++L  +++ ++ +    T  Y APE L  +   
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFK 456
              VD+++ G +  E+L G  +F    P E D+  L  +F+
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLF----PGENDIEQLAIVFR 215

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 15/199 (7%)

Query: 244 KMLGKGGFGSVFEGTQTDGTK----VAVKRLE-GIGEINKS-FLAEVKTIGSIHHQNLVR 297
           K++G G FG V  G      K    VA+K L+ G  +  +  FL E   +G   H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G   +    +++ EYM NGSLD++L +   +F     Q   ++  IA G+ YL E   
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLSEMN- 126

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG-TP-GYLAPEWLS-S 414
              +H D+  +NIL++ N   KV+DFGLS+ ++ D     TT  G  P  + APE ++  
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 415 IITEKVDIYSFGVVMLEIL 433
             T   D++SFG+VM E++
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  110 bits (276), Expect = 4e-27
 Identities = 87/280 (31%), Positives = 139/280 (49%), Gaps = 35/280 (12%)

Query: 243 RKMLGKGGFGSVFEGT-QTDGTK---VAVKRLE-GIGEINKS-FLAEVKTIGSIHHQNLV 296
           +K++G G FG VF G  +  G K   VA+K L+ G  E  +  FL+E   +G   H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           RL G   +    +++ EYM NG+LD++L     EF     Q   ++  IA G+ YL +  
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS--YQLVGMLRGIAAGMKYLSD-- 125

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT-P-GYLAPEWLS- 413
               +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G  P  + APE ++ 
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 414 SIITEKVDIYSFGVVMLEILC--GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
              T   D++SFG+VM E++    R  +D S  E        + K   +  +L   +D  
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------VMKAINDGFRLPAPMDCP 236

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           S   Q        M++    C + D A+RP    +V +L+
Sbjct: 237 SAVYQL-------MLQ----CWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 5e-27
 Identities = 67/191 (35%), Positives = 101/191 (52%), Gaps = 7/191 (3%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           + LG G FG V+ GT    TKVAVK L+      ++FL E + +  + H  LV+L   C+
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           E+    +V EYM  GSL  +L  +S E   L   Q   +   IA+G+ YL     +  +H
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW-LSSIITEKVD 421
            D+  +NIL+  N   K+ADFGL++LI+ D+       +    + APE       T K D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 422 IYSFGVVMLEI 432
           ++SFG+++ EI
Sbjct: 187 VWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (276), Expect = 8e-27
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 32/268 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
              + +G+G  G V++ T    G +VA+K++    +  +  + E+  +    H N+V   
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
                     +V EYM  GSL   + Q +   M +  Q   +  ++ +GL YLH    Q 
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQ-NFVRMNE-PQIAYVCREVLQGLEYLH---SQN 136

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT-- 417
           ++H DIK  NILL  + + K+ADFG +  + +++S+   ++ GTP ++APE    +I   
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPE----VIKRK 191

Query: 418 ---EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
               KVDI+S G++ +E+  G   + R  P    ++L++          +  L  K+   
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITT-------KGIPPL--KNPEK 241

Query: 475 MQSNGEEVVNMMKVAAWCLESDFAKRPS 502
                ++ +N       CL  D  KRPS
Sbjct: 242 WSPEFKDFLN------KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 39/223 (17%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----------LAEVKTIGSIHHQN 294
           LGKG FG V    + D G   A+K       + K            L E   +  I+H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMK------VLKKKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 295 LVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +V+L    A   +    LV EY P G L       S E     ++ +    +I   L YL
Sbjct: 55  IVKL--HYAFQTEEKLYLVLEYAPGGEL---FSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      I++ D+KP+NILLD + + K+ DFGL+K +  + S+   T  GTP YLAPE  
Sbjct: 110 H---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFCGTPEYLAPE-- 163

Query: 413 SSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
             ++  K     VD +S GV++ E+L G+  F     + +++Y
Sbjct: 164 --VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY--AEDRKEIY 202

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 59/191 (30%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           +GKG FG V++G     T+VAVK  R     ++ + FL E + +    H N+V+LIG C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           +K    +V E +P GSL  +L ++ +   L  ++  ++ LD A G+ YL        +H 
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITEKVD 421
           D+  +N L+  N   K++DFG+S+  +     V   ++  P  + APE L+    T + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 422 IYSFGVVMLEI 432
           ++S+G+++ E 
Sbjct: 178 VWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 2e-26
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 42/291 (14%)

Query: 244 KMLGKGGFGSVFEGT--QTDGT--KVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNL 295
           K+LG+G FGSV EG   Q DG+  KVAVK ++       EI + FL+E   +    H N+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-EEFLSEAACMKDFDHPNV 63

Query: 296 VRLIGFCAEKSHN------LLVYEYMPNGSLDRWLFQRSDE---FMLDWQQRKKIILDIA 346
           ++LIG C E S        +++  +M +G L  +L           L  Q   K ++DIA
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-G 405
            G+ YL     +  +H D+  +N +L  +    VADFGLSK I          +   P  
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 406 YLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK 463
           ++A E L+  + T K D+++FGV M EI   G+  +   +  E   YL    + K  ED 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240

Query: 464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
           L +L D                  +   C  +D   RP+ + +  VLE + 
Sbjct: 241 LDELYD------------------LMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 4e-26
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 5/193 (2%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             + LG G FG V+EG   + T VAVK L+      K FLAE + +  + H  L++L   
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C  +    +V E M  GSL  +L Q      L   Q   +   +A G+ YL     Q  +
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW-LSSIITEKV 420
           H D+  +N+L+  N   KVADFGL+++I +D  +     +    + APE  L +  + K 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 421 DIYSFGVVMLEIL 433
           D++SFG+++ EI+
Sbjct: 186 DVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 5e-26
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           LG+G +G V++   +  G  VA+K++    E   I  + L E+  +  + H N+V+L+  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
              +    LV+EY     +D   +       L     K I+  + +GL Y H     +IL
Sbjct: 67  IHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRIL 120

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL--SSI 415
           H D+KPQNIL++ +   K+ADFGL++     +     +VV     T  Y APE L  S  
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILLGSKH 175

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            +  VDI+S G +  E++ G+ +F      E D  L  IF+
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLF-PGD-SEIDQ-LFKIFQ 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (265), Expect = 2e-25
 Identities = 91/310 (29%), Positives = 145/310 (46%), Gaps = 59/310 (19%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLE-GIGEINKSFLAEV 284
           FEE  +    F + LGKG FGSV E  + D      G  VAVK+L+    E  + F  E+
Sbjct: 1   FEERHLK---FIQQLGKGNFGSV-ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREI 56

Query: 285 KTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           + + S+ H N+V+  G C  A + +  LV EY+P GSL  +L +  +         +K++
Sbjct: 57  EILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-----DHRKLL 111

Query: 343 L---DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
           L    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+      
Sbjct: 112 LYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168

Query: 400 MRGTPG-----YLAPEWLS-SIITEKVDIYSFGVVMLEIL--CGRKVFDRSQPEEEDMYL 451
               PG     + APE L+ S  +   D++SFGVV+ E+     +     S P E     
Sbjct: 169 ---EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK---SCSPPAE----- 217

Query: 452 LSIFKKKAEEDKLSDLVDKHSNDMQSNG----------EEVVNMMKVAAWCLESDFAKRP 501
              F +    DK   ++  H  ++  N            E+  +MK    C  +D ++RP
Sbjct: 218 ---FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKE---CWNNDPSQRP 271

Query: 502 SMSMVVRVLE 511
           S S +   +E
Sbjct: 272 SFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 72/250 (28%), Positives = 126/250 (50%), Gaps = 35/250 (14%)

Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLE-----------GIGEINKSFLAEVKTIGSIH 291
           +++GKG +G V+     T G  +AVK++E              ++ K+  +E++T+  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 292 HQNLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           H N+V+ +GF  E +   L    EY+P GS+     +    F  + Q  +     + +GL
Sbjct: 67  HLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGS-CLRTYGRF--EEQLVRFFTEQVLEGL 121

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK----LIDQDQSQVVTTMRGTPG 405
            YLH    + ILH D+K  N+L+D +   K++DFG+SK    + D DQ+    +M+G+  
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVF 175

Query: 406 YLAPEWLSSI---ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           ++APE + S     + KVDI+S G V+LE+  GR+ +     EE    +  +  K++   
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD---EEAIAAMFKLGNKRSAPP 232

Query: 463 KLSDLVDKHS 472
              D+    S
Sbjct: 233 IPPDVSMNLS 242

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 39/215 (18%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSF--------LAEVKTIGSI-HHQ 293
           K LG G FGSV+    +  G  VA+K++       K F        L EVK++  +  H 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR-------KKIILDIA 346
           N+V+L     E      V+EYM     +  L+Q     M D + +       + II  I 
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-----EGNLYQ----LMKDRKGKPFSESVIRSIIYQIL 109

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           +GL ++H   +    H D+KP+N+L+ G    K+ADFGL++ I        T    T  Y
Sbjct: 110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWY 164

Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            APE L  S+  +  VDI++ G +M E+   R +F
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (260), Expect = 6e-25
 Identities = 84/271 (30%), Positives = 122/271 (45%), Gaps = 35/271 (12%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +   LG G  G V +   +  G  +AVK  RLE    I K  L E+  +   +   +V  
Sbjct: 5   YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWL---FQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
            G         +  EYM  GSLD+ L     R  E +L      KI + + KGLTYLHE 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL-----GKIAVAVLKGLTYLHEK 119

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
              KI+H D+KP NIL++     K+ DFG+S +L++     +  T  GT  Y+APE +  
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPERIQG 173

Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDLVDKH 471
              + K DI+S G+ ++E+  GR  F      +    +  + +    E   +L     K 
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKF 229

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           S D Q      VN+      CL  D  +RPS
Sbjct: 230 SPDFQD----FVNL------CLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (260), Expect = 7e-25
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           K+LG+G  G V++   +  G   A+K++   G+    K  L E+KT+ S     +V+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 301 -FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F  E   ++ V EYM  GSL      +    + +      I   I KGL YLH    + 
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLAD--LLKKVGKIPE-PVLAYIARQILKGLDYLHTK--RH 120

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK 419
           I+H DIKP N+L++     K+ADFG+SK+++        T  GT  Y++PE +     E 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFVGTVTYMSPERIQG---ES 176

Query: 420 ----VDIYSFGVVMLEILCGR 436
                DI+S G+ +LE   G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  103 bits (259), Expect = 9e-25
 Identities = 79/269 (29%), Positives = 126/269 (46%), Gaps = 33/269 (12%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRL--EGIGEINKSFL-AEVKTIGSIHHQNLVRLIGF 301
           +GKG FG+V +  + +DG  +  K +    + E  K  L +EV  +  + H N+VR    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 302 CAEKSHNLL--VYEYMPNGSLDRWLFQRS--DEFMLDWQQRKKIILDIAKGLTYLH--ED 355
             ++S+  L  V EY   G L + L Q+   +   ++ +   +I+  +   L   H   D
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               +LH D+KP NI LD N N K+ DFGL+K++  D S    T  GTP Y++PE L+ +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPYYMSPEQLNHM 185

Query: 416 -ITEKVDIYSFGVVMLEILCGRKVFD-RSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
              EK DI+S G ++ E+      F  R+Q +            K +E K   +  ++S+
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---------LASKIKEGKFRRIPYRYSS 236

Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           ++            V    L  D  KRPS
Sbjct: 237 ELNE----------VIKSMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (260), Expect = 9e-25
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 62/271 (22%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI---------- 290
           F K++G+G F +V     +    + A+K L      +K  L + K +  +          
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKIL------DKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 291 -HHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
             H  +++L  +  +   NL  V EY PNG L +++ +      LD +  +    +I   
Sbjct: 59  NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLA 114

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR------- 401
           L YLH    + I+H D+KP+NILLD + + K+ DFG +K++D + S              
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 402 ------------GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGR---------KVF 439
                       GT  Y++PE L+     +  D+++ G ++ ++L G+           F
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231

Query: 440 DRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
            +    E        F   A      DL++K
Sbjct: 232 QKILKLEYSF--PPNFPPDA-----KDLIEK 255

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (257), Expect = 1e-24
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 60/281 (21%)

Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINK----SFLAEVKTIGSIHHQNLVR- 297
           K LGKG +GSV++  + +D    A+K ++ +G +++      + E++ + S++H N++  
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 298 ----LIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRK--------KIIL 343
               L G       N L  V EY P G L + + +R        ++RK        +I +
Sbjct: 65  KEAFLDG-------NKLCIVMEYAPFGDLSKAISKRK-------KKRKLIPEQEIWRIFI 110

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
            + +GL  LHE   QKILH D+K  NILL  N   K+ D G+SK++ ++ ++      GT
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GT 164

Query: 404 PGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           P Y+APE W     + K DI+S G ++ E+      F     E   M  L     K +  
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-----EARSMQDLRY---KVQRG 216

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
           K   +   +S D+Q                L+     RP+ 
Sbjct: 217 KYPPIPPIYSQDLQ----------NFIRSMLQVKPKLRPNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  102 bits (257), Expect = 1e-24
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 29/203 (14%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG+G +GSV++    + G  VA+K +  + E  +  + E+  +       +V+  G   +
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
            +   +V EY   GS+   +  +     L  ++   I+    KGL YLH     K +H D
Sbjct: 70  NTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRD 124

Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR------GTPGYLAPEWLSSIITE 418
           IK  NILL+    AK+ADFG+S        Q+  TM       GTP ++APE    +I E
Sbjct: 125 IKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPE----VIQE 173

Query: 419 -----KVDIYSFGVVMLEILCGR 436
                K DI+S G+  +E+  G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 28/205 (13%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE-------INKSFLAEVKTIGSIHHQNL 295
           K LG+G +  V++      G  VA+K+++ +GE       IN + L E+K +  + H N+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIK-LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 296 VRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           + L+  F  + + NL V+E+M    L++ +  +S          K  +L   +GL YLH 
Sbjct: 65  IGLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTP--ADIKSYMLMTLRGLEYLH- 119

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGYLAPE 410
                ILH D+KP N+L+  +   K+ADFGL++           QVVT       Y APE
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPE 172

Query: 411 WL--SSIITEKVDIYSFGVVMLEIL 433
            L  +      VD++S G +  E+L
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (254), Expect = 3e-24
 Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 50/282 (17%)

Query: 243 RKMLGKGGFGSVFEGTQTD-GTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
              +G G FG V+     D G  +AVK +   +   +  K    E+K +  + H NLV+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLF--QRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            G    +    +  EY   G+L+  L   +  DE ++     +   L + +GL YLH   
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI-----RVYTLQLLEGLAYLHS-- 117

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV----VTTMRGTPGYLAPEWL 412
              I+H DIKP NI LD N   K+ DFG +  + ++ +      V ++ GTP Y+APE  
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPE-- 173

Query: 413 SSIITEK--------VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA--EED 462
             +IT           DI+S G V+LE+  G++ +     E + M+ +    K    +  
Sbjct: 174 --VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           +LS                          CLESD  KRP+ S
Sbjct: 232 QLSPEG-----------------KDFLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  101 bits (252), Expect = 4e-24
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 8/203 (3%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           +G G FG V+ G   +  KVA+K +       + F+ E + +  + H  LV+L G C E+
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
           S   LV+E+M +G L  +L  R+       +    + LD+ +G+ YL       ++H D+
Sbjct: 72  SPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
             +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K D++S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 425 FGVVMLEILC-GRKVFD-RSQPE 445
           FGV+M E+   G+  ++ RS  E
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 5e-24
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 245 MLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIG 300
           ++G+G +G V +      G  VA+K+ +   +   + K+ L EVK +  + H+N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
               K    LV+EY+    L+  L + S    L     +  I  + + + Y H      I
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE--LLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNI 121

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
           +H DIKP+NIL+  +   K+ DFG ++ +    +  +T    T  Y APE L   +   +
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 419 KVDIYSFGVVMLEILCGRKVF 439
            VD+++ G +M E+L G  +F
Sbjct: 182 PVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 8e-24
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 45/216 (20%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRL----------EGIGEINKSFLAEVKTIGSIHH 292
           ++LG G FGSV+EG   D G   AVK +          E + ++ +    E+  +  + H
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ----EIALLSKLQH 61

Query: 293 QNLVRLIGFCAEKSHNLLVY-EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
            N+V+ +G    +  NL ++ E +P GSL + L ++   F       +     I  GL Y
Sbjct: 62  PNIVQYLG-TEREEDNLYIFLELVPGGSLAK-LLKKYGSF--PEPVIRLYTRQILLGLEY 117

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-----TMRGTPGY 406
           LH+   +  +H DIK  NIL+D N   K+ADFG++K       QVV      + +G+P +
Sbjct: 118 LHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYW 167

Query: 407 LAPEWLSSIITEK------VDIYSFGVVMLEILCGR 436
           +APE    +I ++       DI+S G  +LE+  G+
Sbjct: 168 MAPE----VIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 24/272 (8%)

Query: 241 NFRKMLGKGGFGSVFEGTQTD-GTKVAVKR--LEGIGEINKSFLAEVKTIGSIHHQNLVR 297
              +++G G    V+         KVA+KR  LE           EV+ +   +H N+V+
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
                       LV  Y+  GSL   +        LD      ++ ++ KGL YLH    
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD---QSQVVTTMRGTPGYLAPEWLSS 414
              +H DIK  NILL  + + K+ADFG+S  +        +V  T  GTP ++APE +  
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 415 I--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS 472
           +     K DI+SFG+  +E+  G   + +  P +  M  L       E            
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA--------- 231

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
            D +   +    M+ +   CL+ D +KRP+  
Sbjct: 232 -DYKKYSKSFRKMISL---CLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQ 293
            ++ LG+G FG VF G       + D   VAVK L+     +  K F  E + + +  H+
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-----------FQRSDEFMLDWQQRKKII 342
           N+V+  G C E    ++V+EYM +G L+++L              S    L   Q  +I 
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVV-TTM 400
           + IA G+ YL     Q  +H D+  +N L+  +   K+ DFG+S+ +   D  +V   TM
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 401 RGTPGYLAPEWLS--SII----TEKVDIYSFGVVMLEI 432
                 L   W+   SI+    T + D++SFGVV+ EI
Sbjct: 186 ------LPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           F K LG G FG V  G       VA+K +         F+ E K +  + H NLV+L G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL----DIAKGLTYLHEDCR 357
           C ++    +V EYM NG L  +L +R  +         + +L    D+ + + YL  +  
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKL------GTEWLLDMCSDVCEAMEYLESNG- 120

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
              +H D+  +N L+  +   KV+DFGL++ +  DQ       +    +  PE    S  
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 417 TEKVDIYSFGVVMLEIL-CGRKVFDR 441
           + K D++SFGV+M E+   G+  ++R
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 30/231 (12%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINK----------SFLAEVKTIGSI 290
             +++GKG FG V    + D  K+ A+K       +NK          + L E + +  +
Sbjct: 4   LLRVIGKGAFGKVCIVQKRDTKKMFAMK------YMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 291 HHQNLVRL-IGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           +H  LV L   F  E+  N+ LV + +  G L R+   +  +F    +Q K  I +I   
Sbjct: 58  NHPFLVNLWYSFQDEE--NMYLVVDLLLGGDL-RYHLSQKVKF--SEEQVKFWICEIVLA 112

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L YLH    + I+H DIKP NILLD   +  + DF ++  +  D   + T+  GTPGY+A
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMA 167

Query: 409 PEWLSSIITEK-VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
           PE L        VD +S GV   E L G++ +        D          
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (260), Expect = 3e-23
 Identities = 83/341 (24%), Positives = 159/341 (46%), Gaps = 33/341 (9%)

Query: 187 FILESFFGLLVLIGILIFFFRKKNGADEIEEDYLDQVPG----------LPKRFSFEELK 236
           F +    G  +++ ++ F F    G + +E   ++   G          + K  +  ++ 
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI- 688

Query: 237 VMTDNFRKMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL 295
           + +     ++ +G  G+ ++G +  +G +  VK +  +  I  S +A+   +G + H N+
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNI 745

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+LIG C  +    L++EY+   +L   L        L W++R+KI + IAK L +LH  
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCR 799

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
           C   ++  ++ P+ I++DG     +    L  L+  D    +++      Y+APE   + 
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETK 853

Query: 416 -ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL-VDKH-S 472
            ITEK DIY FG++++E+L G+   D    E      +  + +    D   D+ +D    
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
            D+  N  E+V +M +A  C  +D   RP  + V++ LE  
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 99.5 bits (249), Expect = 3e-23
 Identities = 72/217 (33%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS-----FLAEVKTIGSIHHQN 294
            F K LG G FG V         K  A+K L    +I K       L E + + SI H  
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ--RKKIILDIAKGLTYL 352
           LV L G   + S+  LV EY+P G L   L ++S  F     +    +++L     L YL
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVL----ALEYL 117

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      I++ D+KP+N+LLD +   K+ DFG +K +         T+ GTP YLAPE  
Sbjct: 118 H---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLAPE-- 168

Query: 413 SSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQP 444
             II  K     VD ++ G+++ E+L G   F    P
Sbjct: 169 --IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G+G +G V++   +  G  VA+K++      EGI +     L E+K +  ++H N+++L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           +     K    LV+E+M     D +   +  +  L     K  +  + +GL + H     
Sbjct: 64  LDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS----QVVTTMRGTPGYLAPEWL-- 412
            ILH D+KP+N+L++     K+ADFGL++            VVT       Y APE L  
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLG 172

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVF 439
               +  VDI+S G +  E+L  R +F
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLV 296
           LG+G FG V+EG           T+VA+K +     + E  + FL E   +   +  ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-FQRSDEFMLDWQQ---RKKII---LDIAKGL 349
           RL+G  +     L+V E M  G L  +L  +R +            +K I    +IA G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLA 408
            YL     +K +H D+  +N ++  +   K+ DFG+++ I +            P  ++A
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 409 PEWLSS-IITEKVDIYSFGVVMLEIL 433
           PE L   + T K D++SFGVV+ E+ 
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 16/200 (8%)

Query: 244 KMLGKGGFGSVFEG-TQTDGTK---VAVKRLEGIGEINKS---FLAEVKTIGSIHHQNLV 296
           K++G G FG V  G  +  G +   VA+K L+  G   K    FL+E   +G   H N++
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L G   +    ++V EYM NGSLD +L +   +F +   Q   ++  IA G+ YL +  
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSD-- 124

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT-P-GYLAPEWLS- 413
               +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G  P  + APE ++ 
Sbjct: 125 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 414 SIITEKVDIYSFGVVMLEIL 433
              T   D++S+G+VM E++
Sbjct: 184 RKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 74/235 (31%), Positives = 126/235 (53%), Gaps = 39/235 (16%)

Query: 241 NFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRL-----EG-----IGEINKSFLAEVKTI 287
           NF+++  LG+G + +V++G  +T G  VA+K +     EG     I EI  S + E+K  
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI--SLMKELK-- 56

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
               H+N+VRL      ++  +LV+EYM +  L +++        LD    K     + K
Sbjct: 57  ----HENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGT 403
           G+ + HE+   ++LH D+KPQN+L++     K+ADFGL++     ++   ++VVT     
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW--- 165

Query: 404 PGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
             Y AP+ L  S   +  +DI+S G +M E++ GR +F  +  E++   LL IF+
Sbjct: 166 --YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 66/191 (34%), Positives = 106/191 (55%), Gaps = 16/191 (8%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           +G+G FG+V +G  T G KVAVK ++      ++FL E   +  +HH+NLVRL+G     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-- 69

Query: 306 SHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
            HN L  V E M  G+L  +L  R    ++   Q  +  LD+A+G+ YL     +K++H 
Sbjct: 70  -HNGLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           D+  +NIL+  +  AKV+DFGL+++     S  V   +    + APE L     + K D+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180

Query: 423 YSFGVVMLEIL 433
           +S+GV++ E+ 
Sbjct: 181 WSYGVLLWEVF 191

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 25/217 (11%)

Query: 246 LGKGGFGSVF--EGTQTDGTKVAVK---RLEGIGEI-NKSFLAEVKTIGSIHHQNLVRLI 299
           + KG +G VF  +   T G   A+K   + + I +      L E   +       +V+L 
Sbjct: 1   ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 300 -GFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
             F  +   NL LV EY+P G L   L    +   LD    +  I +I   L YLH    
Sbjct: 60  YSFQGK--KNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLH---S 111

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQDQSQVVTTMR-----GTPGYLAPE 410
             I+H D+KP NIL+D N + K+ DFGLSK  L+ +  +            GTP Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 411 -WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
             L    ++ VD +S G ++ E L G   F    PEE
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 64/192 (33%), Positives = 106/192 (55%), Gaps = 10/192 (5%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           ++LGKG FG VF+GT  D T VAVK  + +   E+   FL+E + +    H N+V+LIG 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C ++    +V E +P G    +L ++ DE  L  +Q  K  LD A G+ YL     +  +
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITEK 419
           H D+  +N L+  N   K++DFG+S+  D D     + ++  P  + APE L+    + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 420 VDIYSFGVVMLE 431
            D++S+G+++ E
Sbjct: 175 SDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.9 bits (236), Expect = 7e-22
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 6/189 (3%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
           +    ++ E+M  G+L  +L +  +   ++      +   I+  + YL    ++  +H D
Sbjct: 74  EPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIY 423
           +  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + K D++
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189

Query: 424 SFGVVMLEI 432
           +FGV++ EI
Sbjct: 190 AFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.8 bits (236), Expect = 8e-22
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGF 301
            + LG G FG V+EG   +  +VA+K L+    +  + F  EV+ +  + H++L+ L   
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C+      ++ E M  GSL  +L +  +  +L       +   +A+G+ YL E   Q  +
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSI 126

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITEK 419
           H D+  +NIL+  +   KVADFGL++LI +D    +++ +  P  + APE  S    + K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 420 VDIYSFGVVMLEI 432
            D++SFG+++ E+
Sbjct: 185 SDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 43/284 (15%)

Query: 241 NFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTI-------GSI 290
           N+R  K+LG+G FG V+     D G ++AVK++      +     EV  +        ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALECEIQLLKNL 61

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            H+ +V+  G   +     +  EYMP GS+   L        L     +K    I +G+ 
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVE 118

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYL 407
           YLH      I+H DIK  NIL D   N K+ DFG SK +    S   T M+   GTP ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS-GTGMKSVTGTPYWM 174

Query: 408 APEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK--KKAEEDKL 464
           +PE +S      K D++S G  ++E+L  +  +   +       + +IFK   +    +L
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNPQL 228

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
              V   + +                     +  KRPS   ++R
Sbjct: 229 PSHVSPDARNFLRR-------------TFVENAKKRPSAEELLR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLV 296
           + +GKG FG V++   +     VA+K +      + I +I +    E++ +       + 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ----EIQFLSQCRSPYIT 62

Query: 297 RLIGFCAEKSHNL-LVYEYMPNGS-LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +  G    K   L ++ EY   GS LD     + DE          I+ ++  GL YLHE
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-----TYIAFILREVLLGLEYLHE 116

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
              +  +H DIK  NILL    + K+ADFG+S  +    S+   T  GTP ++APE    
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPE---- 168

Query: 415 IIT-----EKVDIYSFGVVMLEILCG 435
           +I      EK DI+S G+  +E+  G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 40/274 (14%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK----SFLAEVKTIGSIHHQNLVRLIGF 301
           +GKG FG VF+  +    +V   +   + ++N+      + E + +  +    ++R    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
             +K    +V EY  NG L + L  +    + +  Q  +  + I  GL +LH    +KIL
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLH---SKKIL 123

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKV 420
           H DIK  N+ LD   N K+ D G++KL+  D +    T+ GTP YL+PE        EK 
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 421 DIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE------EDKLSDLVDKHSND 474
           D+++ GVV+ E   G+  FD      +   +L I +            +L+ L+D+    
Sbjct: 183 DVWALGVVLYECCTGKHPFD---ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ---- 235

Query: 475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                            CL  D+ +RP    ++R
Sbjct: 236 -----------------CLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 83/286 (29%), Positives = 132/286 (46%), Gaps = 64/286 (22%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGI-----------GEINKSFLAEVKTIGSIHHQN 294
           LG+G  GSV        TK  +K    I            ++ K  L E++   S     
Sbjct: 9   LGEGAGGSV--------TKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 295 LVRLIG-FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQR--KKIILDIA---- 346
           +V+  G F  E S ++ +  EY   GSLD  ++++    +     R  +K++  IA    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK----VKKRGGRIGEKVLGKIAESVL 115

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPG 405
           KGL+YLH    +KI+H DIKP NILL      K+ DFG+S +L+    + +  T  GT  
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSF 168

Query: 406 YLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVF--DRSQ---PEEEDMYLLSIFK 456
           Y+APE +     SI     D++S G+ +LE+   R  F  +      P E   Y++++  
Sbjct: 169 YMAPERIQGKPYSI---TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225

Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
            +        L D+  N ++ + EE  + +K    CLE D  +RP+
Sbjct: 226 PE--------LKDEPGNGIKWS-EEFKDFIKQ---CLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 71/257 (27%), Positives = 111/257 (43%), Gaps = 58/257 (22%)

Query: 241 NFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF---------LAEVKTIGSI 290
              K +G G +G V        G KVA+K+      I+  F         L E+K +  +
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKK------ISNVFDDLIDAKRILREIKLLRHL 56

Query: 291 HHQNLVRLIG-FCAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            H+N++ L+         +     +V E M    L + +        L     +  +  I
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFLYQI 112

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-------VVT 398
            +GL YLH      ++H D+KP NIL++ N + K+ DFGL++ +D D+ +       VVT
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169

Query: 399 TMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF---DRSQ---------- 443
             R    Y APE L  SS  T+ +DI+S G +  E+L  + +F   D             
Sbjct: 170 --R---WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224

Query: 444 -PEEEDMYLLSIFKKKA 459
            P EED+    I  +KA
Sbjct: 225 TPSEEDL--KFITSEKA 239

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 43/291 (14%)

Query: 245 MLGKGGFGSVFEGTQTD-GTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           ++G+G +G V +    + G  VA+K+    E    + K  + E++ +  + H+NLV LI 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
               K    LV+E++ +  LD           LD  + +K +  I +G+ + H      I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT--E 418
           +H DIKP+NIL+  +   K+ DFG ++ +     +V T    T  Y APE L        
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGR 180

Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN 478
            VDI++ G ++ E+L G  +F    P + D+  L    K      L +L+ +H    Q N
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLF----PGDSDIDQLYHIIK-----CLGNLIPRHQEIFQKN 231

Query: 479 ----------GEEVVNMMK-----------VAAWCLESDFAKRPSMSMVVR 508
                      +E+  + K           +A  CL  D   RPS S ++ 
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 27/238 (11%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     +  L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 74  P-IYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 425 FGVVMLEI----------LCGRKVFDRSQ-----------PEEEDMYLLSIFKKKAEE 461
           FG+++ E+          +  R+V D+ +           PE     +   ++K+ EE
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 246

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 8/192 (4%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           K LG G FG V+ G     TKVA+K L +G     ++FLAE   +  + H  LVRL    
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
             +    ++ EYM NGSL  +L +  +   L   +   +   IA+G+ ++    R+  +H
Sbjct: 71  T-QEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVD 421
            D++  NIL+      K+ADFGL++LI+ ++       +    + APE ++    T K D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 422 IYSFGVVMLEIL 433
           ++SFG+++ EI+
Sbjct: 186 VWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 92.6 bits (230), Expect = 5e-21
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 24/205 (11%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVR 297
           +++G G FG V  G  +  G +   VA+K L+     +  + FL+E   +G   H N++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G   +    +++ E+M NG+LD +L Q   +F +   Q   ++  IA G+ YL E   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE--- 124

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT--------MRGTPGYLAP 409
              +H D+  +NIL++ N   KV+DFGLS+ ++ D S    T        +R T    AP
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT----AP 180

Query: 410 EWLS-SIITEKVDIYSFGVVMLEIL 433
           E ++    T   D++S+G+VM E++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 21/204 (10%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+ G   + TKVAVK L+      ++FL E   + ++ H  LVRL     
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--------DIAKGLTYLHED 355
           ++    ++ EYM  GSL  +L  +SDE         K++L         IA+G+ Y+   
Sbjct: 72  KEEPIYIITEYMAKGSLLDFL--KSDE-------GGKVLLPKLIDFSAQIAEGMAYIE-- 120

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-S 414
            R+  +H D++  N+L+  +   K+ADFGL+++I+ ++       +    + APE ++  
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 415 IITEKVDIYSFGVVMLEILCGRKV 438
             T K D++SFG+++ EI+   K+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKI 203

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 244 KMLGKGGFGSVFEGTQTD----GT---KVAVKRLE--GIGEINKSFLAEVKTIGSIHHQN 294
             LG G FG V+EGT TD    G+   +VAVK L      +  K FL E   + + +H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWL----FQRSDEFMLDWQQRKKIILDIAKGLT 350
           +V+L+G C       ++ E M  G L  +L     +R    +L  ++   I LD+AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 351 YLHEDCRQKILHLDIKPQNILL-----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP- 404
           YL    +   +H D+  +N L+     D +   K+ DFGL++ I +            P 
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 405 GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            ++APE L     T + D++SFGV+M EIL
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 45/283 (15%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLE-------GIGEINKSFLAEVKTIGSIHHQNLV 296
           ++LGKG +G+V+ G    G  +AVK++E          +  +    EV  + S+ H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           + +G C + +   +  E++P GS+   L +        + +  K ILD   G+ YLH +C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNNC 122

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-----DQDQSQVVTTMRGTPGYLAPEW 411
              ++H DIK  N++L  N   K+ DFG ++ +         S ++ +M GTP ++APE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE- 178

Query: 412 LSSIITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS-IFKKKAEEDKLS 465
              +I E     K DI+S G  + E+  G       +P    M  L+ +F   A    + 
Sbjct: 179 ---VINESGYGRKSDIWSIGCTVFEMATG-------KPPLASMDRLAAMFYIGAHRGLMP 228

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
            L D  S    +   + V        CL  D  +RPS   ++R
Sbjct: 229 RLPDSFS----AAAIDFVTS------CLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 7/202 (3%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           F K LG G FG V  G       VA+K ++        F+ E K +  + H+ LV+L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C ++    +V EYM NG L  +L  R         Q  ++  D+ +G+ YL     ++ +
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKV 420
           H D+  +N L+D     KV+DFGLS+ +  D+       +    +  PE  L S  + K 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 421 DIYSFGVVMLEILC-GRKVFDR 441
           D+++FGV+M E+   G+  ++R
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH 292
           +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  + H
Sbjct: 6   KELKLL-----QTIGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQAFLAEASVMTQLRH 58

Query: 293 QNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
            NLV+L+G   E+   L +V EYM  GSL  +L  R    +L      K  LD+ + + Y
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 117

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           L  +     +H D+  +N+L+  +  AKV+DFGL+K    + S    T +    + APE 
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA 170

Query: 412 L-SSIITEKVDIYSFGVVMLEI 432
           L     + K D++SFG+++ EI
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 30/211 (14%)

Query: 244 KMLGKGGFGSVFEGT----QTDGTK--VAVKRLEGI--GEINKSFLAEVKTIGSIHHQNL 295
           + LG G FG V+EG       D  +  VAVK L      +    FL E   +   +HQN+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ----RSDEFMLDWQQRKKIILDIAKGLTY 351
           VRLIG   E+    ++ E M  G L  +L +          L  +       D+AKG  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 352 LHEDCRQKILHLDIKPQNILLD----GNFNAKVADFGLSKLIDQDQ-----SQVVTTMRG 402
           L E+     +H DI  +N LL     G   AK+ADFG+++ I +        + +  ++ 
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRV-AKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 403 TPGYLAPE-WLSSIITEKVDIYSFGVVMLEI 432
            P    PE +L  I T K D++SFGV++ EI
Sbjct: 188 MP----PEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 72/207 (34%), Positives = 107/207 (51%), Gaps = 22/207 (10%)

Query: 244 KMLGKGGFGSVFEG--TQTDGT-KVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           K LG+G FGSV EG   Q D   KVAVK ++ I    +S    FL+E   +    H N++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMK-IAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 297 RLIGFCAEKSHN------LLVYEYMPNGSLDRWL-FQRSDE--FMLDWQQRKKIILDIAK 347
           RLIG C +   +      +++  +M +G L  +L + R  +    L  Q   K + DIA 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPGY 406
           G+ YL     +  +H D+  +N +L+ N N  VADFGLSK I + D  +     +    +
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 407 LAPEWLSS-IITEKVDIYSFGVVMLEI 432
           +A E L+  + T K D++SFGV M EI
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 244 KMLGKGGFGSVFEGTQTD--GTK--VAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V++G        K  VAVK  +      + + FL E   +    H ++V+
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E +   +V E  P G L  +L        LD          ++  L YL     
Sbjct: 72  LIGVITE-NPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAYLES--- 125

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-- 415
           ++ +H DI  +N+L+      K+ DFGLS+ ++ +     +  +    ++APE   SI  
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINF 182

Query: 416 --ITEKVDIYSFGVVMLEILC-GRKVF 439
              T   D++ FGV M EIL  G K F
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 64/270 (23%), Positives = 126/270 (46%), Gaps = 30/270 (11%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK----SFLAEVKTIGSIHHQNLVRLI 299
           +++G+G FG V    +    K+ + +   + ++ K    +   E + +  + H N++   
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
               E    ++V EY P G+L  ++ +R +  +        I+    + L  LH    + 
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLL----DEDTILHFFVQILLALHHVHTKL 121

Query: 360 ILHLDIKPQNILLDGNFN-AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IIT 417
           ILH D+K QNILLD +    K+ DFG+SK++         T+ GTP Y++PE        
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYN 179

Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS 477
           +K DI++ G V+ E+   ++ F+ +         L     K      + + D++S D++ 
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSGTFAPISDRYSPDLR- 230

Query: 478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVV 507
             + +++M+ +       D +KRP +S ++
Sbjct: 231 --QLILSMLNL-------DPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 44/283 (15%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDG-TKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
             R +LGKG +G V+         ++A+K + E      +    E+     + H+N+V+ 
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 299 IGFCAEKSHNLLVYEYMPNGSLD-----RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +G  +E     +  E +P GSL      +W   + +E  + +  ++     I +GL YLH
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH 125

Query: 354 EDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           +    +I+H DIK  N+L++      K++DFG SK +    +    T  GT  Y+APE  
Sbjct: 126 D---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPE-- 179

Query: 413 SSIITEKV-------DIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
             +I +         DI+S G  ++E+  G+  F      +  M+ + +FK         
Sbjct: 180 --VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------- 228

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                H    +S   E  N +     C E D  KR S   +++
Sbjct: 229 ----IHPEIPESLSAEAKNFILR---CFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 6/196 (3%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+ GT    TKVAVK L+      +SFL E + +  + H  LV+L    +
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           E+    +V EYM  GSL  +L +  +   L       +   +A G+ Y+    R   +H 
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDI 422
           D++  NIL+      K+ADFGL++LI+ ++       +    + APE  L    T K D+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 423 YSFGVVMLEILCGRKV 438
           +SFG+++ E++   +V
Sbjct: 187 WSFGILLTELVTKGRV 202

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-----QNLVR 297
           K + KG FGSV+   + + G   A+K L+    I K+ +  VK   +I         + +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L      K +  LV EY+  G     L +       DW   K+ I ++  G+  LH+   
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWA--KQYIAEVVLGVEDLHQR-- 116

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-I 416
             I+H DIKP+N+L+D   + K+ DFGLS+   +++  V     GTP YLAPE +  +  
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGD 170

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            +  D +S G V+ E L G   F    P+ 
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)

Query: 245 MLGKGGFGSVFEGTQT-DGTKVAVKRLE--GIGEINK--------SFLAEVKTIGSIHHQ 293
           ++G G FGSV+ G     G  +AVK++E   +   +K        +   E+  +  + H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS--DEFMLDWQQRKKIILDIAKGLTY 351
           N+V+ +G   +  H  +  EY+P GS+   L      +E ++     +  +  I KGL Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV-----RNFVRQILKGLNY 121

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-----TMRGTPGY 406
           LH    + I+H DIK  NIL+D     K++DFG+SK ++ +     T     +++G+  +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 407 LAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +APE +  +  T K DI+S G +++E+L G+  F
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 246 LGKGGFGSVFEGT-QTDGTK---VAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LG G FGSV +G       K   VAVK L  E I    K FL E   +  + H  +VRLI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G C  +   +LV E  P G L ++L +R +  + D    K++   +A G+ YL     + 
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLES---KH 115

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWLS-SII 416
            +H D+  +N+LL     AK++DFG+S+ +    D  +  T  R    + APE ++    
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 417 TEKVDIYSFGVVMLEIL 433
           + K D++S+GV + E  
Sbjct: 176 SSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 32/215 (14%)

Query: 244 KMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIG-EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G      +T    VA+K L E  G + N  F+ E   + S+ H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L V + MP+G L  ++ +  D    + +L+W       + IAKG+ YL
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
            E   ++++H D+  +N+L+    + K+ DFGL++L++ D+ +         G +  +W+
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE----YNADGGKMPIKWM 178

Query: 413 S------SIITEKVDIYSFGVVMLEILC-GRKVFD 440
           +         T + D++S+GV + E++  G K +D
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.0 bits (220), Expect = 9e-20
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    TKVA+K L+    + ++FL E + +  + H  LV L    +E+
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V E+M  GSL  +L +  D   L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 74  P-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   K+ADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 425 FGVVMLEILCGRKV 438
           FG+++ E++   +V
Sbjct: 189 FGILLTELVTKGRV 202

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 244 KMLGKGGFGSVFEGTQTDG----TKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           +++GKG FG V+ GT  D        AVK L  I ++ +   FL E   +    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 298 LIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           L+G C     + L+V  YM +G L    F RS+      +      L +AKG+ YL    
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW--LSS 414
            +K +H D+  +N +LD +F  KVADFGL++ I   +   V    G    L  +W  L S
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG--AKLPVKWMALES 173

Query: 415 I----ITEKVDIYSFGVVMLEIL 433
           +     T K D++SFGV++ E++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 34/218 (15%)

Query: 242 FRKMLGKGGFGSVFEG------TQTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQ 293
           F + LG+G FG V++G       +   T VA+K L      ++ + F  E + +  + H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS----------DEFM---LDWQQRKK 340
           N+V L+G C ++    +++EY+ +G L  +L + S          DE +   LD      
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQD----QSQ 395
           I + IA G+ YL        +H D+  +N L+      K++DFGLS+ I   D    QS+
Sbjct: 129 IAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 396 VVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVMLEI 432
            +  +R    ++ PE  L    T + DI+SFGVV+ EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)

Query: 244 KMLGKGGFGSVFEGTQTDGT----KVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V  G  +        VAVK L  + + +I   FL E   + S+ H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFML----DWQQRKKIILDIAKGLTYL 352
           L G        ++V E  P GSL DR        F++    D+       + IA G+ YL
Sbjct: 61  LYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYA------VQIANGMRYL 113

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM-RGTP-GYLAPE 410
                ++ +H D+  +NILL  +   K+ DFGL + + Q++   V       P  + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 411 WLSSI-ITEKVDIYSFGVVMLEI 432
            L +   +   D++ FGV + E+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 75/251 (29%), Positives = 116/251 (46%), Gaps = 34/251 (13%)

Query: 244 KMLGKGGFGSVFEG--TQTDGT--KVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQN 294
           +MLGKG FGSV E      DG+  KVAVK L+   +I  S     FL E   +    H N
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA--DIFSSSDIEEFLREAACMKEFDHPN 62

Query: 295 LVRLIGFCAEKSHN------LLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDI 345
           +++LIG              +++  +M +G L  +L       + F L  Q   + ++DI
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL     +  +H D+  +N +L+ N    VADFGLSK I           +G   
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCAS 175

Query: 406 YLAPEWLS------SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKK 458
            L  +WL+      ++ T   D+++FGV M EI+  G+  +   +  E   YL+   + K
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235

Query: 459 AEEDKLSDLVD 469
              D L D+ +
Sbjct: 236 QPPDCLEDVYE 246

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 64/213 (30%), Positives = 114/213 (53%), Gaps = 27/213 (12%)

Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKV--AVKRLEGIG--EINKSFLAEVKTIGSI-HHQNL 295
           F+ ++G+G FG V +   + DG ++  A+KR++     + ++ F  E++ +  + HH N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRKKII 342
           + L+G C  + +  L  EY P+G+L  +L                S    L  QQ     
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            D+A+G+ YL +   ++ +H D+  +NIL+  N+ AK+ADFGLS+     +  V  TM  
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184

Query: 403 TP-GYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            P  ++A E L+ S+ T   D++S+GV++ EI+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           F K LG G FG V  G      KVA+K +       + F+ E K +  + H  LV+L G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL----DIAKGLTYLHEDCR 357
           C ++    +V E+M NG L  +L QR  +        K ++L    D+ +G+ YL    R
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKL------SKDMLLSMCQDVCEGMEYLE---R 118

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
              +H D+  +N L+      KV+DFG+++ +  D+    +  +    +  PE +  S  
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 417 TEKVDIYSFGVVMLEILC-GRKVFDRS 442
           + K D++SFGV+M E+   G+  F++ 
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKK 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 72/287 (25%), Positives = 133/287 (46%), Gaps = 42/287 (14%)

Query: 239 TDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEI-----NKSFLAEVKTIGSI 290
             NF+  K +GKG F  V++     DG  VA+K+++ I E+      +  L E+  +  +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQL 59

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ-RSDEFMLDWQQRKKIILDIAKGL 349
            H N+++ +    E +   +V E    G L R +   +  + ++  +   K  + +   L
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            ++H    ++I+H DIKP N+ +      K+ D GL +     ++    ++ GTP Y++P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175

Query: 410 EWLSSIITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK--KAEED 462
           E     I E     K DI+S G ++ E+   +  F       + M L S+ KK  K +  
Sbjct: 176 E----RIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEKCDYP 226

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
            L    D +S +++    ++V+       C+  D  KRP +S V++V
Sbjct: 227 PLPA--DHYSEELR----DLVSR------CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 65/215 (30%), Positives = 114/215 (53%), Gaps = 32/215 (14%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTK----VAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G K    VA+K L      + NK  L E   + S+ + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   S   L+ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 73  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW- 411
            E   ++++H D+  +N+L+    + K+ DFGL+KL+  D+ +         G +  +W 
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWM 178

Query: 412 -LSSII----TEKVDIYSFGVVMLEILC-GRKVFD 440
            L SI+    T + D++S+GV + E++  G K +D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 86.9 bits (215), Expect = 6e-19
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 244 KMLGKGGFGSVFEG---TQTDGTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVRL 298
             +G G FG V  G         +V VK L      ++   FL EV+    ++H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL----DIAKGLTYLHE 354
           +G C E    LLV E+ P G L  +L  RS+  M+    +K ++     ++A GL +LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS 413
             +   +H D+  +N  L  + + K+ D+GL+     +   +       P  +LAPE + 
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 414 SI--------ITEKVDIYSFGVVMLEI 432
                      T+K +I+S GV M E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)

Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKV--AVKRLEGIGEIN--KSFLAEVKTIGSI-HHQNL 295
           F  ++G+G FG V     + DG K+  A+K L+     N  + F  E++ +  + HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-----------FQRS--DEFMLDWQQRKKII 342
           + L+G C  + +  +  EY P G+L  +L           F +       L  QQ  +  
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            D+A G+ YL E   ++ +H D+  +N+L+  N  +K+ADFGLS+    ++  V  TM  
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 403 TP-GYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            P  ++A E L+ S+ T K D++SFGV++ EI+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 48/224 (21%)

Query: 246 LGKGGFGSVFEGTQ------TDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G FG VF+            T VAVK L  E   ++   F  E   +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS-------------------DEFMLDWQQR 338
           L+G CA      L++EYM  G L+ +L  RS                   +   L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI------DQD 392
             I   +A G+ YL E   +K +H D+  +N L+  N   K+ADFGLS+ I         
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 393 QSQVVTTMRGTPGYLAPEWLSSII----TEKVDIYSFGVVMLEI 432
           ++  +  +R  P    PE   SI     T + D++++GVV+ EI
Sbjct: 190 ENDAI-PIRWMP----PE---SIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 9e-19
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 246 LGKGGFGSVFE-GTQTDGTKVAVKRL--EGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           LG GGFG V     ++     A+K +    I E    +   +E + +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              +K +  ++ EY   G L  W   R D  + D    +  I  +     YLH    + I
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL--WTILR-DRGLFDEYTARFYIACVVLAFEYLH---NRGI 114

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-TMRGTPGYLAPEWLSSIITEK 419
           ++ D+KP+N+LLD N   K+ DFG +K +   +S   T T  GTP Y+APE    II  K
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPE----IILNK 167

Query: 420 -----VDIYSFGVVMLEILCGRKVFDRSQPEEEDM 449
                VD +S G+++ E+L GR  F   + +E+ M
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPF--GEDDEDPM 200

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 36/291 (12%)

Query: 244 KMLGKGGFGSV----FEGTQTD-GTKVAVKRLE-GIGEINKS-FLAEVKTIGSIHHQNLV 296
           ++LG+G FG V    ++      G  VAVK L+   G+ N S +  E+  + +++H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 297 RLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTY 351
           +  G C+E+      L+ EY+P GSL  +L +      + +L  QQ       I +G+ Y
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-------ICEGMAY 122

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG-TPGY-LAP 409
           LH    Q  +H D+  +N+LLD +   K+ DFGL+K + +          G +P +  A 
Sbjct: 123 LHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 410 EWLSSI-ITEKVDIYSFGVVMLEIL--CGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           E L     +   D++SFGV + E+L  C  K     + EE    ++   + +    +L +
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE----MIGPKQGQMTVVRLIE 235

Query: 467 LVDKHSNDMQSNG--EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
           L+++           +EV  +MK    C E++   RP+   ++ +L+ +  
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKN---CWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 39/211 (18%)

Query: 244 KMLGKGGFGSVFEGT---QTDGTK--VAVKRLE------GIGEINKSFLAEVKTIGSIHH 292
           K+LG G FG+V +G    + D  K  VA+K ++         EI    LA    +GS+ H
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA----MGSLDH 68

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKG 348
             +VRL+G C   S  L V +  P GSL   + Q  D    + +L+W       + IAKG
Sbjct: 69  AYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKG 121

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL E     ++H ++  +NILL  +   ++ADFG++ L+  D  +   +   TP    
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP---- 174

Query: 409 PEW--LSSII----TEKVDIYSFGVVMLEIL 433
            +W  L SI+    T + D++S+GV + E++
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 70/250 (28%), Positives = 98/250 (39%), Gaps = 60/250 (24%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSF--------LAEVKTIGSIHHQNLV 296
           LG+G FG V++  Q   G  VA+K++     +  +         L E+K +  + H N+V
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKI-----LMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 297 RLIGFCAEKSHNLL-----VYEYMP------NGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            LI    E+          VY   P      +G L+      +    L   Q K  +L +
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKLTESQIKCYMLQL 124

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--------- 396
            +G+ YLHE     ILH DIK  NIL+D     K+ADFGL++  D               
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 397 -VTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVF----DRSQ------ 443
             T +  T  Y  PE L      T  VDI+  G V  E+   R +     D  Q      
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241

Query: 444 ----PEEEDM 449
               P EE  
Sbjct: 242 LCGTPTEETW 251

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 61/194 (31%), Positives = 105/194 (54%), Gaps = 12/194 (6%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+  T    TKVAVK ++      ++FLAE   + ++ H  LV+L     
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII---LDIAKGLTYLHEDCRQKI 360
            K    ++ E+M  GSL  +L  +SDE     Q   K+I     IA+G+ ++    ++  
Sbjct: 72  -KEPIYIITEFMAKGSLLDFL--KSDEG--SKQPLPKLIDFSAQIAEGMAFIE---QRNY 123

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D++  NIL+  +   K+ADFGL+++I+ ++       +    + APE ++    T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 420 VDIYSFGVVMLEIL 433
            D++SFG++++EI+
Sbjct: 184 SDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 74/219 (33%), Positives = 114/219 (52%), Gaps = 28/219 (12%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVF------EGTQTDGTKVAVKRL--EGIGEINKS 279
           KRF    LK + D     LG+G FG V       EG  T G +VAVK L  E  G     
Sbjct: 3   KRF----LKRIRD-----LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIAD 52

Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
              E++ + +++H+N+V+  G C E   N   L+ E++P+GSL  +L +  ++  L  +Q
Sbjct: 53  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQ 110

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QV 396
           + K  + I KG+ YL    RQ + H D+  +N+L++     K+ DFGL+K I+ D+    
Sbjct: 111 QLKYAVQICKGMDYLGS--RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167

Query: 397 VTTMRGTPGY-LAPEWL-SSIITEKVDIYSFGVVMLEIL 433
           V     +P +  APE L  S      D++SFGV + E+L
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLE-GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++   +  G   A K ++    E  + F+ E+  +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
            ++   ++ E+   G+LD  + +   E  L   Q + +   + + L +LH     K++H 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHR 127

Query: 364 DIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE---- 418
           D+K  NILL  + + K+ADFG+S K     Q +   T  GTP ++APE    +  E    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPE---VVACETFKD 182

Query: 419 -----KVDIYSFGVVMLEI 432
                K DI+S G+ ++E+
Sbjct: 183 NPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 50/280 (17%)

Query: 244 KMLGKGGFGS-VFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQ 293
           ++LGKG FG         D + V  K      E+N + L+         E+  +  + H 
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWK------EVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N++       + +  L+  EY   G+L   + ++  + + + +     +  I   ++Y+H
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-LFEEEMVLWYLFQIVSAVSYIH 118

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +     ILH DIK  NI L      K+ DFG+SK++  + S   T + GTP Y++PE   
Sbjct: 119 K---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQ 174

Query: 414 SI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS 472
            +    K DI++ G V+ E+L  ++ FD + P                     +LV K  
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------------------LNLVVK-- 212

Query: 473 NDMQSNGEEVVN-----MMKVAAWCLESDFAKRPSMSMVV 507
             +Q N   VV+     ++ +    L+ D  KRP+   V+
Sbjct: 213 -IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 25/219 (11%)

Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE--INKSFLAE 283
               S  EL    +   + +G G  G+V++      G   A+K + G  E  + +    E
Sbjct: 68  SAAKSLSEL----ERVNR-IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122

Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
           ++ +  ++H N+V+            ++ E+M  GSL+          + D Q    +  
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVAR 175

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
            I  G+ YLH   R+ I+H DIKP N+L++   N K+ADFG+S+++ Q      +++ GT
Sbjct: 176 QILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GT 231

Query: 404 PGYLAPEWLSSIITEKV------DIYSFGVVMLEILCGR 436
             Y++PE +++ +          DI+S GV +LE   GR
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 41/283 (14%)

Query: 233 EELKVMTDNFRKMLGKGGFGSV--FEGTQTDGTKVAVK--RLEGIGEINKSFLAEVKTIG 288
           E+L+ ++D     LG G  GSV   +   T GT +A K   +     + K  L E++ + 
Sbjct: 5   EDLETISD-----LGAGNGGSVSKVKHIPT-GTVMAKKVVHIGAKSSVRKQILRELQIMH 58

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
                 +V   G    +++  +  E+M  GSLDR ++++     ++     KI + + +G
Sbjct: 59  ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEIL--GKIAVAVVEG 115

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYL 407
           LTYL+   R  I+H DIKP NIL++     K+ DFG+S +LI+     +  T  GT  Y+
Sbjct: 116 LTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----SIADTFVGTSTYM 169

Query: 408 APEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL--LSIFKKKAEEDKL 464
           +PE +     T K D++S G+ ++E+  G+  F  S   ++D     + I       D L
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS-NIDDDGQDDPMGIL------DLL 222

Query: 465 SDLVDKH-----SNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
             +V +      S+D   +  + V+       CL  D  +RP+
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDA------CLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 46/241 (19%)

Query: 241 NFRKMLGKGGFGSVF------------EGTQTDGTK-----VAVKRLEGIGEIN--KSFL 281
           NF + LG+G FG V             +    +        VAVK L      N  + FL
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE--------FML 333
            EVK +  +   N+ RL+G C       ++ EYM NG L+++L +   E          L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQD 392
            +     +   IA G+ YL        +H D+  +N L+  N+  K+ADFG+S+ L   D
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 393 QSQVVTTMRGTPGYLAPEWLS--SII----TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
             +V    +G    L   W++  S++    T K D+++FGV + EIL       R QP E
Sbjct: 185 YYRV----QGRA-PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL----TLCREQPYE 235

Query: 447 E 447
            
Sbjct: 236 H 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 32/245 (13%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G +G VF+    + G  VA+K+    E    I K  L E++ +  + H NLV LI  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM--LDWQQRKKIILDIAKGLTYLHEDCRQK 359
              K    LV+EY      D  +    ++    +     KKII    + + + H   +  
Sbjct: 69  FRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHN 120

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYLAPEWL--SS 414
            +H D+KP+NIL+      K+ DFG ++++     D +  V T      Y APE L   +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR----WYRAPELLVGDT 176

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
                VD+++ G V  E+L G+ ++    P + D+  L + +K      L DL+ +H   
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLW----PGKSDVDQLYLIRK-----TLGDLIPRHQQI 227

Query: 475 MQSNG 479
             +N 
Sbjct: 228 FSTNQ 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 41/221 (18%)

Query: 244 KMLGKGGFGSVFEGT------QTDGTKVAVKRLEG----------IGEINKSFLAEVKTI 287
           K LG+G FG V +          + + VAVK L+           + E+       +K I
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEM-----EMMKMI 72

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-----SDEFMLDWQQRKKII 342
           G   H+N++ L+G C ++    +V EY  +G+L  +L  R                + + 
Sbjct: 73  GK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 343 L--------DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQ 393
                     +A+G+ +L     +K +H D+  +N+L+  +   K+ADFGL++ I   D 
Sbjct: 131 QKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEIL 433
            +  T  R    ++APE L   + T + D++SFGV++ EI 
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 80/300 (26%), Positives = 134/300 (44%), Gaps = 53/300 (17%)

Query: 244 KMLGKGGFGSVFEGTQTD------GTKVAVKRL-EGIGEIN-KSFLAEVKTIGSIHHQNL 295
           K LG+G FG V + T          T VAVK L E       +  L+E   +  ++H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD---EFMLDWQQRKKIILD-------- 344
           ++L G C++    LL+ EY   GSL  +L +       ++     R    LD        
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 345 ----------IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
                     I++G+ YL E    K++H D+  +N+L+      K++DFGLS+ + ++ S
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 395 QVVTTMRGTP-GYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYL 451
            V  +    P  ++A E L   I T + D++SFGV++ EI+  G   +    PE     L
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER----L 238

Query: 452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
            ++ K     ++  +             EE+ N+M    W  E D  KRP+ + + + LE
Sbjct: 239 FNLLKTGYRMERPENC-----------SEEMYNLML-TCWKQEPD--KRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 27/210 (12%)

Query: 245 MLGKGGFGSVFEGT-QTDGTKV--AVKRLEGIGEIN--KSFLAEVKTIGSI-HHQNLVRL 298
           ++G+G FG V +   + DG ++  A+KR++     +  + F  E++ +  + HH N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWL-----------FQRS--DEFMLDWQQRKKIILDI 345
           +G C  + +  L  EY P+G+L  +L           F  +      L  QQ      D+
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP- 404
           A+G+ YL +   ++ +H D+  +NIL+  N+ AK+ADFGLS+     +  V  TM   P 
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 405 GYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            ++A E L+ S+ T   D++S+GV++ EI+
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 34/207 (16%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRL------EGIGEINKSFLAEV---KTIGSIHHQNL 295
           +G+G +G+V++      G  VA+K++      EGI     S L E+   K + S  H N+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI---PLSTLREIALLKQLESFEHPNI 63

Query: 296 VRLIGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           VRL+  C       +    LV+E++ +  L  +L  +  +  L  +  K ++  + +G+ 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ---SQVVTTMRGTPGYL 407
           +LH      I+H D+KPQNIL+  +   K+ADFGL+++   +    S VVT       Y 
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW-----YR 173

Query: 408 APEWL--SSIITEKVDIYSFGVVMLEI 432
           APE L  SS  T  VD++S G +  E+
Sbjct: 174 APEVLLQSSYAT-PVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 38/213 (17%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEG---------IGEINKSFLAEVKTIGSIHHQ 293
           +G+G +G V++   +  G  VA+K  RLE          I EI  S L E+      +H 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI--SLLKEL------NHP 58

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLD-RWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N+VRL+     ++   LV+E++    LD +     S    LD    K  +  + +G+ Y 
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KPQN+L+D     K+ADFGL++     +     +VVT       Y A
Sbjct: 116 HS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW-----YRA 167

Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           PE L  S   +  VDI+S G +  E++  R +F
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 73/228 (32%), Positives = 112/228 (49%), Gaps = 31/228 (13%)

Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSIHHQN-LVR------ 297
           +GKG FG V++  + D  ++ A+K L       K  +A+ +   +I  +N LVR      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS-----KKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 298 --LIG--FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTY 351
             ++G  F  +   +L LV +YM  G L  W  Q+   F    + R K  I ++   L +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFS---EDRAKFYIAELVLALEH 111

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           LH+     I++ D+KP+NILLD   +  + DFGLSK  +   ++   T  GT  YLAPE 
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEV 167

Query: 412 L--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           L      T+ VD +S GV++ E+ CG   F     + + MY    F K
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGK 213

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 57/191 (29%), Positives = 96/191 (50%), Gaps = 10/191 (5%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G FG VF G  + D T VAVK  R     ++   FL E + +    H N+VRLIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            +K    +V E +  G  D   F R++   L  ++  +++ + A G+ YL        +H
Sbjct: 63  TQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITEKV 420
            D+  +N L+      K++DFG+S+  +         M+  P  + APE L+    + + 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 421 DIYSFGVVMLE 431
           D++SFG+++ E
Sbjct: 178 DVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 33/282 (11%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           F K LG G FG V E T     ++D   KVAVK L+     +  ++ ++E+K +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +N+V L+G C      L++ EY   G L  +L +R  E  L  +        +AKG+ +L
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 353 -HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE 410
             ++C    +H D+  +N+LL      K+ DFGL++ I  D + VV      P  ++APE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD 469
            + + + T + D++S+G+++ EI      F         M + S F K   ++       
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEI------FSLGSNPYPGMPVDSKFYKLI-KEGYRMAQP 266

Query: 470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +H+        E+ ++MK    C ++D  KRP+   +V+++ 
Sbjct: 267 EHAPA------EIYDIMKT---CWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 53/285 (18%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGF 301
           +++G+G +G V++      G  VA+K ++ I +  +    E   +    +H N+    G 
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 302 CAEKSHNL------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK------IILDIAKGL 349
             +K+         LV E    GS+   L +     +    +R K      I+ +  +GL
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTD-LVKG----LRKKGKRLKEEWIAYILRETLRGL 126

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            YLHE+   K++H DIK QNILL  N   K+ DFG+S  +D    +  T + GTP ++AP
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182

Query: 410 EWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKA 459
           E ++           + D++S G+  +E+  G       +P   DM+    L  I +   
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADG-------KPPLCDMHPMRALFKIPRNPP 235

Query: 460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
              K  +   K  ND               + CL  ++ +RP M 
Sbjct: 236 PTLKSPENWSKKFNDF-------------ISECLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 14/217 (6%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G +G V++G  +  G  VA+K  RLE   E +  + + E+  +  + H N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
             ++S   L++E++ +  L ++L        +D +  K  +  I +G+ + H    +++L
Sbjct: 68  LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSIITEK 419
           H D+KPQN+L+D     K+ADFGL++       +V T    T  Y APE L  S   +  
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182

Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           VDI+S G +  E+   + +F     + E   L  IF+
Sbjct: 183 VDIWSIGTIFAEMATKKPLF---HGDSEIDQLFRIFR 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 35/217 (16%)

Query: 243 RKMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----------IGEINKSFLAEVKTIGSI 290
            + LGKG +G V++         VA+K++               EI   FL E+      
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREI--MFLQELG----- 64

Query: 291 HHQNLVRLIG-FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
            H N+V+L+    AE   ++ LV+EYM     D     R++  +L+   ++ I+  + K 
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMET---DLHAVIRAN--ILEDVHKRYIMYQLLKA 119

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ----DQSQVVTTMRGTP 404
           L Y+H      ++H D+KP NILL+ +   K+ADFGL++ + +     ++ V+T    T 
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 405 GYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            Y APE L  S+  T+ VD++S G ++ E+L G+ +F
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRL-------------EGIGE--INKSFLAEVKTI 287
             LG+G +G V +   T  G  VA+K++             + +G   I+ + L E+K +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
             I H+N++ L+    E     LV + M    L + +     +  L   Q K I+L I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILN 130

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS----------KLIDQDQSQVV 397
           GL  LH   +   +H D+ P NI ++     K+ADFGL+           L   +  Q  
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 398 TTMRG---TPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
             M     T  Y APE L  +      VD++S G +  E+L G+ +F
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 244 KMLGKGGFGSVFEGTQTDG---TKVAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRL 298
           K +G G FG V  G    G    +V VK L     +     FL E +   S+ H NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWL-FQRSDEFML-DWQQRKKIILDIAKGLTYLHEDC 356
           +G C E +  LLV E+ P G L  +L   R  E M  D    +++  +IA GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLSSI 415
           +   +H D+  +N LL  +   K+ D+GLS    ++   V       P  ++APE +  +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 416 --------ITEKVDIYSFGVVMLEIL 433
                    T++ +++S GV + E+ 
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 37/231 (16%)

Query: 234 ELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTK----VAVK--RLEGIGEINKSFLAEVKT 286
           ELK +     K+LG G FG+V++G    DG      VA+K  R     + NK  L E   
Sbjct: 8   ELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 62

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKII 342
           +  +    + RL+G C   +  L V + MP G L  ++ +  D    + +L+W       
Sbjct: 63  MAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------C 115

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
           + IAKG++YL E    +++H D+  +N+L+    + K+ DFGL++L+D D+    T    
Sbjct: 116 VQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHA 168

Query: 403 TPGYLAPEW--LSSII----TEKVDIYSFGVVMLEILC-GRKVFDRSQPEE 446
             G +  +W  L SI+    T + D++S+GV + E++  G K +D     E
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 24/214 (11%)

Query: 240 DNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQNLVR 297
           DNF K +G+G  G V   T  + G +VAVK+++   +  +  L  EV  +    H N+V 
Sbjct: 22  DNFVK-IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQ-RSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +           +V E++  G+L   +   R +E     +Q   + L + K L++LH   
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLAVLKALSFLHA-- 133

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFG----LSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
            Q ++H DIK  +ILL  +   K++DFG    +SK + + +S V     GTP ++APE +
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVI 187

Query: 413 SSII--TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
           S +   TE VDI+S G++++E++ G   +    P
Sbjct: 188 SRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 29/229 (12%)

Query: 244 KMLGKGGFGSVF--EGTQTD---GTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVR 297
           K+LGKG FG V   E   TD     KV  K +    +  +  + E + +  +  H  L +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L      K     V EY+  G L  +  QRS  F  D  + +    +I  GL +LHE   
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDL-MFHIQRSGRF--DEPRARFYAAEIVLGLQFLHE--- 114

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
           + I++ D+K  N+LLD   + K+ADFG+ K  ++    +   +T  GTP Y+APE    I
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE----I 167

Query: 416 ITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA 459
           ++ +     VD ++ GV++ E+L G+  F+    ++ED    SI + + 
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILEDEV 213

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 37/215 (17%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLE-------GIGEINKSFLAEVKTIGSIHHQNL 295
           + LG G F S ++      GT +AVK++           E+ ++   E++ +  ++H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-----FQRSDEFMLDWQQRKKIILDIAKGLT 350
           +R++G   E SH  L  E+M  GS+   L     F+ +                + +GL+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII--------NYTEQLLRGLS 117

Query: 351 YLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQD-------QSQVVTTMRG 402
           YLHE+   +I+H D+K  N+L+D      ++ADFG +  +          Q Q++    G
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL----G 170

Query: 403 TPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGR 436
           T  ++APE L         D++S G V++E+   +
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)

Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEIN--KSFL 281
           F    L+ +T      LG+G FG VF         +   T V VK L+   + N    F 
Sbjct: 2   FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF--QRSDEFM----LDW 335
            E+     + H+N+VRL+G C E   + ++ EY   G L ++L   +  DE +    L  
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-- 393
           +Q+  +   IA G+ +L      + +H D+  +N L+      KV+   LSK +   +  
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 394 --SQVVTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEI 432
                +  +R    +LAPE +     + K D++SFGV+M E+
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G G FG V+  T   DG +VA+K++  + +     K    E+K +    H N++  +  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL-- 65

Query: 302 CAEKSHNLLVYEYMPNGSLD--RWLFQRSDEFMLDW------QQR------KKIILDIAK 347
                      + +    +D    ++  ++    D        Q       K  +  I +
Sbjct: 66  -----------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           GL YLH      ILH DIKP N+L++ N   K+ DFGL+++ + D+S+ +T    T  Y 
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171

Query: 408 APEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
           APE L  S   T  VDI+S G +  E+L  R +F    P
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 234 ELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEG--IGEINKSFLAEVKTI 287
           EL   +    ++LG G FG +  G     +K    VA+  L      +  + FLAE  T+
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
           G   H N+VRL G     +  ++V EYM NG+LD +L  R  E  L   Q   ++  +A 
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLAS 118

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTMRGTPGY 406
           G+ YL E      +H  +    +L++ +   K++ F     + +D+S+ + TTM G    
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172

Query: 407 L--APEWLS-SIITEKVDIYSFGVVMLEIL 433
           L  APE +     +   D++SFG+VM E++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 22/226 (9%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+G + +V++G ++     VA+K  RLE       + + EV  +  + H N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             +    LV+EY     LD+ L Q  D+    ++    K  +  + +GL Y H   R+K+
Sbjct: 74  HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPEWL--SSI 415
           LH D+KPQN+L++     K+ADFGL++   +  +  S  V T+     Y  P+ L  S+ 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL----WYRPPDILLGSTD 181

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
            + ++D++  G +  E+  GR +F  S  EE+  ++  I     EE
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 29/196 (14%)

Query: 262 GTKVAVKRL-----EGIGEINKSFLAEVKTIGSIHHQNLVRLI--GFCAEKSHNLL--VY 312
           G +VA+K L     E   +    F  E      ++H N+V L+  G        LL  V+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEAPP---GLLFAVF 58

Query: 313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
           EY+P  +L   L   + +  L   +  +++L +   L   H    Q I+H D+KPQNI++
Sbjct: 59  EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112

Query: 373 ---DGNFNAKVADFGLSKL------IDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVDI 422
                  +AKV DFG+  L       D       T + GTP Y APE L    +T   D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 423 YSFGVVMLEILCGRKV 438
           Y++G++ LE L G++V
Sbjct: 173 YAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 12/200 (6%)

Query: 244 KMLGKGGFGSVF-EGTQTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIHHQNLVRLI 299
           K +G+G FG ++    ++D     +K ++      K   A   EV  +  + H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
               E     +V EY   G L + +  R    +    Q     + I+ GL ++H+   +K
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD---RK 121

Query: 360 ILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IIT 417
           ILH DIK QNI L  N   AK+ DFG+++ ++ D  ++  T  GTP YL+PE   +    
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 418 EKVDIYSFGVVMLEILCGRK 437
            K DI+S G V+ E LC  K
Sbjct: 181 NKTDIWSLGCVLYE-LCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 77/274 (28%), Positives = 117/274 (42%), Gaps = 48/274 (17%)

Query: 246 LGKGGFGSVFEG--TQTDGTKVAVKRL-----EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G G +G V++     T G  VA+K +     +    I +    E+  +    H N+V  
Sbjct: 11  IGSGTYGDVYKARDIAT-GELVAIKVIKLEPGDDFEIIQQ----EISMLKECRHPNIVAY 65

Query: 299 IGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            G  +    + L  V EY   GSL   ++Q +    L   Q   +  +  KGL YLHE  
Sbjct: 66  FG--SYLRRDKLWIVMEYCGGGSLQD-IYQVTRG-PLSELQIAYVCRETLKGLAYLHE-- 119

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS--- 413
             KI H DIK  NILL  + + K+ADFG+S  +    ++   +  GTP ++APE  +   
Sbjct: 120 TGKI-HRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-RKSFIGTPYWMAPEVAAVER 177

Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKAEEDKLSDLV 468
                 K DI++ G+  +E+          QP   D++    L  I K      KL D  
Sbjct: 178 KGGYDGKCDIWALGITAIELAEL-------QPPMFDLHPMRALFLISKSNFPPPKLKD-K 229

Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           +K S           + +K    CL  D  KRP+
Sbjct: 230 EKWSPVFH-------DFIKK---CLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 241 NFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQN 294
            F K+  +G+G +G V+    T  G  VA+K++    E   I  S L E+  + ++ H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 295 LVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +V L      K  +   LV EY     L   L      F     Q K ++L + +GL YL
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE--SQVKCLMLQLLRGLQYL 124

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAP 409
           HE+    I+H D+K  N+LL      K+ADFGL++   L  +  +  V T+     Y AP
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL----WYRAP 177

Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L   +  T  +D+++ G ++ E+L  + + 
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 26/209 (12%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQT-DGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQN 294
           D+F K+  LG G  G V +      G  +A K   LE    I    + E+K +   H  N
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECN 57

Query: 295 LVRLIGFCAEKSHN---LLVYEYMPNGSLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGL 349
              ++GF      +    +  E+M  GSLD+ L +  R  E +L      KI + + +GL
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGL 112

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID   +  V    GT  Y++
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMS 166

Query: 409 PEWLS-SIITEKVDIYSFGVVMLEILCGR 436
           PE L  +  T + DI+S G+ ++E+  GR
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 30/211 (14%)

Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-----EVKTIGSIHHQNLVRLI 299
           +G+G +G V   T    G KVA+K++                 E+K +    H+N++ + 
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFKHENIIGI- 68

Query: 300 GFCAEKSHNL-------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
                +  +        +V E M    L + +  ++    L     +  +  I +GL Y+
Sbjct: 69  -LDIIRPPSFESFNDVYIVQELMET-DLYKLI--KTQ--HLSNDHIQYFLYQILRGLKYI 122

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMRGTPGYLAPE 410
           H      +LH D+KP N+LL+ N + K+ DFGL+++ D   D +  +T    T  Y APE
Sbjct: 123 HS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            +  S   T+ +DI+S G ++ E+L  R +F
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 61/274 (22%)

Query: 247 GKGGFGSVFEG---TQTDGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLI 299
           G+G +G V++       DG + A+K+ +G  E    I++S   E+  +  + H+N+V L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 300 GFCAEKSHNL--LVYEYMPNGSLDRWL---FQRS------DEFMLDWQQRKKIILDIAKG 348
               E +     L+++Y      D W    F R          M+     K ++  I  G
Sbjct: 69  EVFLEHADKSVYLLFDY---AEHDLWQIIKFHRQAKRVSIPPSMV-----KSLLWQILNG 120

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNA----KVADFGLSKLIDQ------DQSQVVT 398
           + YLH      +LH D+KP NIL+ G        K+ D GL++L +       D   VV 
Sbjct: 121 VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 399 TMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY------ 450
           T+     Y APE L  +   T+ +DI++ G +  E+L    +F   +  E  +       
Sbjct: 178 TI----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF---KGREAKIKKSNPFQ 230

Query: 451 ---LLSIFKKKA--EEDKLSDLVD--KHSNDMQS 477
              L  IF+      E    D+    ++   M+ 
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD 264

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 22/226 (9%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+G + +VF+G ++     VA+K  RLE       + + EV  +  + H N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
                  LV+EY     LD+ L Q  D+   ++     K  +  I +GL Y H   R+K+
Sbjct: 74  HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPEWL--SSI 415
           LH D+KPQN+L++     K+ADFGL++   +  +  S  V T+     Y  P+ L  SS 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL----WYRPPDVLLGSSE 181

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
            + ++D++  G +  E+  GR +F  S  E+E   +  +     EE
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 62/229 (27%), Positives = 115/229 (50%), Gaps = 27/229 (11%)

Query: 241 NFRKM--LGKGGFGSVFEG-TQTDGTKVAVKR--LEGIGE-INKSFLAEVKTIGSIHHQN 294
            + K+  +G+G +G+VF+   +     VA+KR  L+   E +  S L E+  +  + H+N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +VRL           LV+EY  +  L ++    + +  +D +  K  +  + KGL + H 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHS 117

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPE 410
                +LH D+KPQN+L++ N   K+ADFGL++     +    ++VVT       Y  P+
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-----YRPPD 169

Query: 411 WL--SSIITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFK 456
            L  + + +  +D++S G +  E+   GR +F  +  +++   L  IF+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFR 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 64/202 (31%), Positives = 91/202 (45%), Gaps = 13/202 (6%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRL 298
           K+LGKG FG V    +    K  A+K L+    I K  +A    E + + +  H  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                       V EY   G L    F  S E +    + +    +I   L YLH     
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLH---SC 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIIT 417
            +++ D+K +N++LD + + K+ DFGL K         + T  GTP YLAPE L  +   
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VD +  GVVM E++CGR  F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 21/220 (9%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEG----IGEINKSFLAEVKTIG-SIHHQNLVR 297
           K+LGKG FG V         +  A+K L+       +  +  + E + +  +  H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 298 LIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L  FC    K H   V EY+  G L   +F        D  + +    +I  GL +LH  
Sbjct: 61  L--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH-- 113

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SS 414
            ++ I++ D+K  N+LLD + + K+ADFG+ K  + +     +T  GTP Y+APE L   
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
              E VD +SFGV++ E+L G+  F     E+ED    SI
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFDSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKR-----LEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           +G+GG+G VF   + D G  VA+KR     L  + E+    L E   + +   + LV+L+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKSEWLVKLL 67

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
               +  +  L  EY+P G     L   ++  +L     +  + ++ + +  LH      
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALH---ELG 121

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK 419
            +H D+KP+N L+D + + K+ DFGLSK I    + VV    G+P Y+APE L     + 
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRG---KG 174

Query: 420 ----VDIYSFGVVMLEILCGRKVFDRSQPEE 446
               VD +S G ++ E LCG   F  S P E
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 34/214 (15%)

Query: 246 LGKGGFGSVFEGT------QTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRL 298
           LG+G FG VF         + D   VAVK L+   E   + F  E + +  + HQ++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRS-DEFMLDWQQRK-----------KIILDIA 346
            G C E    L+V+EYM +G L+R+L     D  +L   +              I   IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPG 405
            G+ YL        +H D+  +N L+      K+ DFG+S+ I   D  +V     G   
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV-----GGRT 184

Query: 406 YLAPEWL--SSII----TEKVDIYSFGVVMLEIL 433
            L   W+   SI+    T + DI+SFGVV+ EI 
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 49/231 (21%)

Query: 242 FRKMLGKGGFGSVF----EG---------TQTDGTK--VAVKRLEGIGEINKS----FLA 282
            ++ LG+G FG V     EG          + DG    VAVK L    ++ K+    FL 
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA--DVTKTARNDFLK 66

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML--------- 333
           E+K +  + + N++RL+G C       ++ EYM NG L+++L QR  E            
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQD 392
                  + + IA G+ YL        +H D+  +N L+  ++  K+ADFG+S+ L   D
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 393 ----QSQVVTTMRGTPGYLAPEWLSSII---TEKVDIYSFGVVMLEI--LC 434
               Q + V  +R    ++A  W S ++   T   D+++FGV + E+  LC
Sbjct: 184 YYRIQGRAVLPIR----WMA--WESILLGKFTTASDVWAFGVTLWEMFTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 73/251 (29%), Positives = 117/251 (46%), Gaps = 30/251 (11%)

Query: 241 NFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRL-------EGIGEINKSFLAEVKTIGSI 290
           N+R  K+LG+G FG V+     D G ++AVK++       E   E+N +   E++ + ++
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN-ALECEIQLLKNL 61

Query: 291 HHQNLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
            H+ +V+  G   +     L    E+MP GS+     Q      L     +K    I +G
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENVTRKYTRQILEG 118

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD--QSQVVTTMRGTPGY 406
           ++YLH +    I+H DIK  NIL D   N K+ DFG SK +         + ++ GTP +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 407 LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK--KKAEEDK 463
           ++PE +S      K DI+S G  ++E+L  +       P  E   + +IFK   +     
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKP------PWAEFEAMAAIFKIATQPTNPV 229

Query: 464 LSDLVDKHSND 474
           L   V  H  D
Sbjct: 230 LPPHVSDHCRD 240

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQN 294
            ++ LG+G FG VF         + D   VAVK L+   +   K F  E + + ++ H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM----------LDWQQRKKIILD 344
           +V+  G C E    ++V+EYM +G L+++L     + +          L   Q   I   
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           IA G+ YL     Q  +H D+  +N L+  N   K+ DFG+S+ +       V      P
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 405 -GYLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
             ++ PE  +    T + D++S GVV+ EI 
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 26/226 (11%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLE---GIGEINKSFLA---EVKTIGSIHHQNLV 296
           K+LG+G FG V+     D G ++A K+++      E +K   A   E++ + ++ H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 297 RLIGFCAEKSHNLLV--YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +  G   +++   L    EYMP GS+     Q      L     +K    I +G++YLH 
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKD---QLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPEW 411
           +    I+H DIK  NIL D   N K+ DFG SK + Q      T +R   GTP +++PE 
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEV 180

Query: 412 LSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           +S      K D++S G  ++E+L  +       P  E   + +IFK
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKP------PWAEYEAMAAIFK 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQN 294
            ++ LG+G FG VF           D   VAVK L+       K F  E + + ++ H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML--DWQQRKK-----------I 341
           +V+  G C +    ++V+EYM +G L+++L     + M+  D Q R+            I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTM 400
              IA G+ YL     Q  +H D+  +N L+  N   K+ DFG+S+ +   D  +V    
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV---- 181

Query: 401 RGTPGYLAPEWL--SSIITEKV----DIYSFGVVMLEIL 433
            G    L   W+   SI+  K     D++SFGV++ EI 
Sbjct: 182 -GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 63/225 (28%), Positives = 114/225 (50%), Gaps = 22/225 (9%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         D+F K +G+G  G V   T+   G +VAVK+++   +  +  L 
Sbjct: 17  PGDPREY--------LDSFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF 67

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +   HH+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 68  NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAT 122

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+YLH    Q ++H DIK  +ILL  +   K++DFG    + ++  +   ++
Sbjct: 123 VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178

Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 43/288 (14%)

Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGS 289
           +E++V+ +     LGKG +GSV++   +  G  +A+K  RLE         + E+  +  
Sbjct: 1   DEIEVLDE-----LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK 55

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
                +V   G    +    +  EYM  GSLD+          +     ++I   + KGL
Sbjct: 56  AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            +L E+    I+H D+KP N+L++GN   K+ DFG+S       + +  T  G   Y+AP
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAP 170

Query: 410 EWLSS-------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           E + S         T + D++S G+ +LE+  GR  +    PE       +IF       
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY---PPETYA----NIFA------ 217

Query: 463 KLSDLVD----KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           +LS +VD       +    + ++ V        CL     +RP+ + +
Sbjct: 218 QLSAIVDGDPPTLPSGYSDDAQDFVAK------CLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 12/211 (5%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+VF       G +VA+K++    +  K  +  E+  +  + + N+V  +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIHR 139

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  N+LL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KVDI
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 423 YSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           +S G++ +E++ G   +    P    +YL++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRA-LYLIA 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 241 NFRKMLGKGGFGSV--FEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNL 295
           + + ++G+G FG V       T G   A+K ++    + +   SF  E + I SI +   
Sbjct: 4   DVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 296 VRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +  + +  +   NL LV EY P G L   L +  D+F  D  Q    + ++   +  +H+
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF--YLAELVLAIHSVHQ 120

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
                 +H DIKP+N+L+D   + K+ADFG +  +  ++        GTP Y+APE L++
Sbjct: 121 ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 415 IITE-------KVDIYSFGVVMLEILCGRKVF 439
           +  +       + D +S GV+  E++ GR  F
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 76.7 bits (188), Expect = 3e-15
 Identities = 68/202 (33%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRL 298
           K+LGKG FG V     +  G   A+K L+    I K      L E + + +  H  L  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                 K     V EY+  G L    F  S E +    + +    +I   L YLH     
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIIT 417
           KI++ D+K +N++LD + + K+ DFGL K    D +  + T  GTP YLAPE L  +   
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VD +  GVVM E++CGR  F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 20/217 (9%)

Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEI-----NKSFLAEVK---TIGSIH 291
               +LG+G FG V     +  G   A+K L+  G+I      +S + E +   T  S  
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKK-GDIIARDEVESLMCEKRIFETANSER 60

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H  LV L      + H   V EY   G L           +    +       +  GL Y
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDL-MMHIHTD---VFSEPRAVFYAACVVLGLQY 116

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           LHE+   KI++ D+K  N+LLD     K+ADFGL K          +T  GTP +LAPE 
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAPEV 172

Query: 412 LS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
           L+ +  T  VD +  GV++ E+L G   F     EEE
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPF-PGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 71/237 (29%), Positives = 119/237 (50%), Gaps = 24/237 (10%)

Query: 234 ELKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEV-KTIGSI 290
           ELK   D+F K+  LG G  G VF+ +      +  ++L  + EI  +   ++ + +  +
Sbjct: 1   ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVL 57

Query: 291 HHQNLVRLIGFCA---EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
           H  N   ++GF           +  E+M  GSLD+ L +      +  Q   K+ + + K
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIK 114

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGY 406
           GLTYL E  + KI+H D+KP NIL++     K+ DFG+S +LID   +  V    GT  Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSY 168

Query: 407 LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           ++PE L     + + DI+S G+ ++E+  GR  +    P+ +++ L  +F    E D
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR--YPIPPPDAKELEL--MFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 34/212 (16%)

Query: 242 FRK--MLGKGGFGSVFEGTQT-DGTKVAVKRL------EGIGEINK--SFLAEVKTIGSI 290
           +++  ++G+G +G+V+ G     G  VA+K +      + + +I +  + L++++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP- 61

Query: 291 HHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
              N+ +  G    K   L ++ EY   GS+ R L +      +  +    II ++   L
Sbjct: 62  --PNITKYYG-SYLKGPRLWIIMEYAEGGSV-RTLMKAGP---IAEKYISVIIREVLVAL 114

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            Y+H+     ++H DIK  NIL+    N K+ DFG++ L++Q+ S+  +T  GTP ++AP
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAP 170

Query: 410 EWLSSIITE------KVDIYSFGVVMLEILCG 435
           E    +ITE      K DI+S G+ + E+  G
Sbjct: 171 E----VITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +GKG FG VF+G      +V A+K +   E   EI +    E+  +       + +  G 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGS 70

Query: 302 CAEKSHNLLVYEYMPNGS-LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             + +   ++ EY+  GS LD       DEF     Q   ++ +I KGL YLH    +K 
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEF-----QIATMLKEILKGLDYLHS---EKK 122

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           +H DIK  N+LL    + K+ADFG++  +   Q +   T  GTP ++APE +  S    K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIQQSAYDSK 181

Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
            DI+S G+  +E+  G       +P   DM+ + + 
Sbjct: 182 ADIWSLGITAIELAKG-------EPPNSDMHPMRVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 30/227 (13%)

Query: 227 PKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAE 283
                 E L   TD +   + +GKG +G V++ T + DG+  AVK L+ I ++++   AE
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE 68

Query: 284 VKTIGSI-HHQNLVRLIGFCAEKSHNL-----LVYEYMPNGSLDRWLF------QRSDEF 331
              + S+ +H N+V+  G   +    +     LV E    GS+   +       QR DE 
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 332 MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ 391
           M+ +     I+     GL +LH +   +I+H D+K  NILL      K+ DFG+S  +  
Sbjct: 129 MISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 392 DQSQVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEI 432
            + +  T++ GTP ++APE ++           + D++S G+  +E+
Sbjct: 181 TRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 28/208 (13%)

Query: 246 LGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQ-RSDEFMLDWQQR---KKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L   R +      Q     KK+I    +IA G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186

Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 28/213 (13%)

Query: 241 NFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHH 292
              + LG+G FG V+EG   D       T+VAVK +     + +   FL E   +     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ-RSD------EFMLDWQQRKKIILDI 345
            ++VRL+G  ++    L+V E M +G L  +L   R +            Q+  ++  +I
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 181

Query: 406 YLAPEWLSS------IITEKVDIYSFGVVMLEI 432
            L   W++       + T   D++SFGVV+ EI
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 32/233 (13%)

Query: 241 NFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRL-------EGIGEINKSFLAEVKTIGSI 290
           N+R  K+LG+G FG V+     D G ++AVK++       E   E+N +   E++ + ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN-ALECEIQLLKNL 61

Query: 291 HHQNLVRLIGFC----AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
            H  +V+  G C     EK  ++ V EYMP GS+     Q      L     ++    I 
Sbjct: 62  RHDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKD---QLKAYGALTENVTRRYTRQIL 116

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMRGTP 404
           +G++YLH +    I+H DIK  NIL D   N K+ DFG SK I         + ++ GTP
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 405 GYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            +++PE +S      K D++S    ++E+L  +       P  E   + +IFK
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP------PWAEYEAMAAIFK 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 243 RKMLGKGGFGSVFEGTQTDGTK----VAVKRLE--GIGEINKSFL---AEVKTIGSIHHQ 293
            K+LGKGG+G VF+  +  G       A+K L+   I    K      AE   + ++ H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
            +V LI          L+ EY+  G L   L +R   FM D       + +I+  L +LH
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMED--TACFYLSEISLALEHLH 117

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
              +Q I++ D+KP+NILLD   + K+ DFGL K    +   V  T  GT  Y+APE L 
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPEILM 173

Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            S   + VD +S G +M ++L G   F
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 44/235 (18%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKT----IGSIHHQNL 295
              K++G+G FG V+     D  +V A+K L     I ++ +A V+     +       +
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 296 VRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           V+L  + +  ++ H  LV EYMP G L   L  R D F  +    +  I ++   L  +H
Sbjct: 64  VKL--YYSFQDEEHLYLVMEYMPGGDLMNLLI-RKDVFPEETA--RFYIAELVLALDSVH 118

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMR----------- 401
              +   +H DIKP NIL+D + + K+ADFGL  K+      +                 
Sbjct: 119 ---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 402 ----------------GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
                           GTP Y+APE L       + D +S GV++ E+L G   F
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 71/248 (28%), Positives = 116/248 (46%), Gaps = 36/248 (14%)

Query: 208 KKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGT--KV 265
           KK  +D  +E      P    +  +E+      NF + LG G FG V   T  +     V
Sbjct: 11  KKKDSDSTKE------PKRKNKMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPV 59

Query: 266 AVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD 321
           A+KR E    I +       +E K +  I+H   V L G   ++S+  LV E++  G   
Sbjct: 60  AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119

Query: 322 RWLFQRSDEFMLD----WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN 377
            +L +R+  F  D    +  +  +I +  + L          I++ D+KP+N+LLD +  
Sbjct: 120 TFL-RRNKRFPNDVGCFYAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGF 169

Query: 378 AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYSFGVVMLEILCGR 436
            K+ DFG +K++D        T+ GTP Y+APE L ++   K  D ++ G+ + EIL G 
Sbjct: 170 IKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225

Query: 437 KVFDRSQP 444
             F  ++P
Sbjct: 226 PPFYANEP 233

Length = 340

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI-------NKSFLA--EVKTIGSIHHQ 293
           ++ LGKG FG+V+     D   VA +RL+ + EI       N++  A  E + +  + H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ-RSDEFMLDWQQRKKIILDIAKGLTYL 352
            +V+      E+    ++ EY     LD  L + +     L   Q  +  + +  G+ Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H+   ++ILH D+K +NI L  N   K+ DFG+S+L+      + TT  GTP Y++PE L
Sbjct: 123 HQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEAL 177

Query: 413 SSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
                  K DI+S G ++ E+ C    F+           LS+  +  E    S L + +
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTPS-LPETY 229

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
           S  + S    ++  M      L  D + RPS + ++R
Sbjct: 230 SRQLNS----IMQSM------LNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.5 bits (183), Expect = 9e-15
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGIGEINKSF---LAEVKTIGSIHHQNL 295
           LGKGGFG V    Q   T       K+  KRL+      K +   + E + +  +H + +
Sbjct: 1   LGKGGFGEVS-ACQMRATGKLYACKKLNKKRLKK----RKGYEGAMVEKRILAKVHSRFI 55

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLH 353
           V L      K+   LV   M  G L R+     DE    + + +       I  GL +LH
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDL-RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +   ++I++ D+KP+N+LLD + N +++D GL+  +   QS+      GTPG++APE L 
Sbjct: 115 Q---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQ 170

Query: 414 SIITE-KVDIYSFGVVMLEILCGRKVFDR 441
               +  VD ++ GV + E++  R  F  
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 62/228 (27%), Positives = 115/228 (50%), Gaps = 23/228 (10%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKV-AVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           ++++LG G  G+V++       ++ AVK   L+   E+ K  ++E++ +       ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
            G    ++   +  E+M  GSLD  ++++  E +L      +I + + KGLTYL      
Sbjct: 65  YGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---L 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS----S 414
           KILH D+KP N+L++     K+ DFG+S    Q  + +  T  GT  Y+APE +S     
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           I +   D++S G+  +E+  GR  + + Q  +  +  L + +   +ED
Sbjct: 172 IHS---DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 44/278 (15%)

Query: 246 LGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCA 303
           +GKG +G VF+   + +G+K AVK L+ I +I++   AE   + ++  H N+V+  G   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 304 EKSHN-----LLVYEYMPNGS---LDRWLFQRSD---EFMLDWQQRKKIILDIAKGLTYL 352
           +K         LV E    GS   L +   +R +   E ++ +     I+ +   GL +L
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQHL 140

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-- 410
           H +   K +H D+K  NILL      K+ DFG+S  +   + +  T++ GTP ++APE  
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196

Query: 411 ----WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                L S    + D++S G+  +E+  G        P      L  I +         +
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFKIPRNPPPTLHQPE 253

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           L     ND                 CL  D+ KRP++S
Sbjct: 254 LWSNEFNDFIRK-------------CLTKDYEKRPTVS 278

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 22/225 (9%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 15  PGDPRTY--------LDNFIK-IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF 65

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 120

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + K L+ LH    Q ++H DIK  +ILL  +   K++DFG    + + +     ++
Sbjct: 121 VCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSL 176

Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 18/224 (8%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+G + +VF+G ++     VA+K  RLE       + + EV  + ++ H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
             +    LV+EY+ +  L ++L    +  ++     K  +  + +GL+Y H   ++KILH
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 363 LDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPEWL--SSIIT 417
            D+KPQN+L++     K+ADFGL++   +  +  S  V T+     Y  P+ L  S+  +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL----WYRPPDVLLGSTEYS 182

Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
             +D++  G ++ E+  GR +F  S  +EE   +  +     EE
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 19/219 (8%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEG----IGEINKSFLAEVKTIGSIHHQN--LV 296
           K+LGKG FG V     +  G   AVK L+     I +  +  + E K + ++  +N  L 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVE-KRVLALAWENPFLT 59

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L      K H   V E++  G L   +F   D+   D  +      +I  GL +LH   
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-- 114

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI- 415
            + I++ D+K  N++LD + + K+ADFG+ K      ++  +T  GTP Y+APE L  + 
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLK 172

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
            T  VD +SFGV++ E+L G+  F     ++ED    SI
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPF---HGDDEDELFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 44/278 (15%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGEINKSFLAEVKTI-GSIHHQNLVRLIGF 301
           +G+G FG+V +      GT +AVK  R     +  K  L ++  +  S     +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 302 CAEKSHNLLVYEYMPNGSLDRW-------LFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              +    +  E M + SLD++       L     E +L      KI +   K L YL E
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +   KI+H D+KP NILLD N N K+ DFG+S +L+D   S   T   G   Y+APE + 
Sbjct: 126 EL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERID 180

Query: 414 SIITEKVDI----YSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD 469
               +  D+    +S G+ + E+  G+  + +           S+F      D+L+ +V 
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPK---------WNSVF------DQLTQVVK 225

Query: 470 KHSNDMQSNGEEVVN--MMKVAAWCLESDFAKRPSMSM 505
                + ++ E   +   +     CL  D +KRP    
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 69/204 (33%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRL 298
           K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 299 IGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
               A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH   
Sbjct: 61  K--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS-- 113

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ DIK +N++LD + + K+ DFGL K    D +  + T  GTP YLAPE L  + 
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDND 171

Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 47/270 (17%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA+K++    +  K  +  E+  +    H N+V  +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK---- 419
           DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE    ++T K    
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPE----VVTRKAYGP 194

Query: 420 -VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK--AEEDKLS----DLVDKHS 472
            VDI+S G++ +E++ G   +    P    +YL++          +KLS    D +++  
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRDFLNR-- 251

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
                              CLE D  KR S
Sbjct: 252 -------------------CLEMDVEKRGS 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 16/202 (7%)

Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRL 298
           LGKGGFG V         K+ A K+L+        GE  +  L E K +  +  + +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE--QMALNEKKILEKVSSRFIVSL 58

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                 K    LV   M  G L   ++    E      +       I  GL +LH   ++
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QR 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIIT 417
           +I++ D+KP+N+LLD + N +++D GL+  ++    + +    GTPGY+APE L   +  
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VD ++ G  + E++ GR  F
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 28/217 (12%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRL--- 298
           +G+G +G V++    D G  VA+K  RL+   E    + + E+K +  ++H+N+V L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 299 -------IGFCAEKSHNLLVYEYMPN---GSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
                  + F  +K    LV+EYM +   G L+  L   S++        K  +  + +G
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED------HIKSFMKQLLEG 128

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L Y H   ++  LH DIK  NILL+     K+ADFGL++L + ++S+  T    T  Y  
Sbjct: 129 LNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           PE L         +D++S G ++ E+   + +F  +Q
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 246 LGKGGFGSVFEGT---QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ----NLVRL 298
           LG G FG V +G    +     VA+K L+   E  KS   E+     I HQ     +VR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           IG C E    +LV E    G L+++L  + DE  +      +++  ++ G+ YL     +
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEG---K 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT-P-GYLAPEWLS-SI 415
             +H D+  +N+LL     AK++DFGLSK +  D S       G  P  + APE ++   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 416 ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEE 446
            + + D++S+G+ M E    G+K + + +  E
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 45/287 (15%)

Query: 246 LGKGGFGSVFEGT--QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G +G VF+    +  G  VA+KR+      EG+       +A ++ + +  H N+VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 298 LIGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           L   C       ++   LV+E++ +  L  +L  +  E  +  +  K ++  + +GL +L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL--IDQDQSQVVTTMRGTPGYLAPE 410
           H     +++H D+KPQNIL+  +   K+ADFGL+++       + VV T+     Y APE
Sbjct: 127 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL----WYRAPE 179

Query: 411 -WLSSIITEKVDIYSFGVVMLEILCGRKVF----DRSQ----------PEEEDMYLLSIF 455
             L S     VD++S G +  E+   + +F    D  Q          P EED       
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239

Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
            ++A   K +  ++K   D+   G+++  ++K    CL  + AKR S
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDL--LLK----CLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 32/213 (15%)

Query: 244 KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQ 293
           K +G+G FG ++   ++ DG +  +K      EIN S ++         EV  + ++ H 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIK------EINISKMSPKEREESRKEVAVLSNMKHP 59

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-----SDEFMLDWQQRKKIILDIAKG 348
           N+V+      E  +  +V +Y   G L + +  +      ++ +LDW       + I   
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLA 113

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L ++H+   +KILH DIK QNI L  +   K+ DFG++++++    ++  T  GTP YL+
Sbjct: 114 LKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLS 169

Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVFD 440
           PE   +     K DI++ G V+ E+   +  F+
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 16/202 (7%)

Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           LGKGGFG V    Q   T       K+  KRL+      K  L E + +  ++   +V L
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSG-EKMALLEKEILEKVNSPFIVNL 58

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                 K+H  LV   M  G L   ++    E  L+ ++       I  G+ +LH     
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIIT 417
            I++ D+KP+N+LLD   N +++D GL+  ++    + +T   GT GY+APE L     +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VD ++ G  + E++ GR  F
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 25/207 (12%)

Query: 246 LGKGGFGSVFEGTQ--TDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIG 300
           +G+G +G V++     T+ T +A+K  RLE   E +  + + E+  +  + H N+VRL  
Sbjct: 10  IGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 301 FCAEKSHNLLVYEYMPNGSLD-RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
               +    LV+EY+    LD +     S +F  + +  K  +  I +G+ Y H     +
Sbjct: 69  VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HR 122

Query: 360 ILHLDIKPQNILLDGNFNA-KVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL-- 412
           +LH D+KPQN+L+D   NA K+ADFGL++     +     +VVT       Y APE L  
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW-----YRAPEILLG 177

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVF 439
           S   +  VDI+S G +  E++  + +F
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 54/241 (22%)

Query: 242 FRKMLGKGGFGSV-----------------FEGTQTDGTKVAVKRLEGIGEIN--KSFLA 282
           F++ LG+G FG V                  + +      VAVK L      N    FL 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--------FQRSDEFMLD 334
           E+K +  +   N++RL+  C       ++ EYM NG L+++L         +++D   + 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQD- 392
           +     +   IA G+ YL        +H D+  +N L+  N+  K+ADFG+S+ L   D 
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 393 ---QSQVVTTMRGTPGYLAPEWLS--SII----TEKVDIYSFGVVMLEILCGRKVFDRSQ 443
              Q + V  +R         W+S  SI+    T   D+++FGV + EIL       + Q
Sbjct: 186 YRIQGRAVLPIR---------WMSWESILLGKFTTASDVWAFGVTLWEIL----TLCKEQ 232

Query: 444 P 444
           P
Sbjct: 233 P 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 73/232 (31%), Positives = 114/232 (49%), Gaps = 34/232 (14%)

Query: 243 RKMLGKGGFGSVF---EGTQTD-GTKVAVKRLEGIGEINKSFLA---------EVKTIGS 289
            K+LG+G FG VF   + T  D G   A+K L+      K+ L          E   +  
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK------KATLKVRDRVRTKMERDILAE 54

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKG 348
           ++H  +V+L      +    L+ +++  G L    F R S E M   +  K  + ++A  
Sbjct: 55  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA 110

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPGYL 407
           L +LH      I++ D+KP+NILLD   + K+ DFGLSK  ID ++     +  GT  Y+
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYM 165

Query: 408 APEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
           APE ++    T+  D +SFGV+M E+L G   F + +  +E M +  I K K
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRKETMTM--ILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 16/195 (8%)

Query: 246 LGKGGFGSVFEG---TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLI 299
           LG G FG+V +G    +     VAVK L+       +    L E   +  + +  +VR+I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G C E    +LV E    G L+++L +      +  +   +++  ++ G+ YL E     
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEE---TN 115

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--QVVTTMRGTPGYLAPEWLSSI-I 416
            +H D+  +N+LL     AK++DFGLSK +  D++  +  T  +    + APE ++    
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 417 TEKVDIYSFGVVMLE 431
           + K D++SFGV+M E
Sbjct: 176 SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)

Query: 244 KMLGKGGFGSVF----EGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVR 297
           KMLGKG FG VF    +GT Q    K   K +  + +  +  + E + +  +  H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L      K +   V EY+  G L   +F        D  +      +I  GL +LH    
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS--- 114

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQDQSQVVTTMRGTPGYLAPE-WLSS 414
           + I++ D+K  NILLD + + K+ADFG+ K  ++   ++    T  GTP Y+APE  L  
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQ 171

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
                VD +SFGV++ E+L G+  F     EEE
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG VF+G      KV   ++  + E     +    E+  +       + +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            + +   ++ EY+  GS    L    +   LD  Q   I+ +I KGL YLH    +K +H
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 124

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVD 421
            DIK  N+LL  +   K+ADFG++  +   Q +   T  GTP ++APE +  S    K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDSKAD 183

Query: 422 IYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           I+S G+  +E+        + +P   +++ + + 
Sbjct: 184 IWSLGITAIELA-------KGEPPHSELHPMKVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 66/238 (27%), Positives = 112/238 (47%), Gaps = 33/238 (13%)

Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQ 293
           D + K+  +G+G +G V++   +  G  VA+K  RLE   E I  + L E+  +  +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 294 N-LVRLIGFCAEKSHN-----LLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDI 345
             +VRL+     +  N      LV+EY+ +  L +++    R     L  +  K  +  +
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKL----IDQDQSQVVTTM 400
            KG+ + H   +  ++H D+KPQN+L+D      K+AD GL +     +     ++VT  
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 401 RGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
                Y APE L  S+  +  VDI+S G +  E+   + +F     + E   LL IFK
Sbjct: 177 -----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF---PGDSELQQLLHIFK 226

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 5e-14
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGF 301
           +++G G +G V++G     G   A+K ++  G+  +    E+  +    HH+N+    G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 302 CAEKS------HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
             +K+         LV E+   GS+   L + +    L  +    I  +I +GL++LH+ 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 129

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-- 413
              K++H DIK QN+LL  N   K+ DFG+S  +D+   +   T  GTP ++APE ++  
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACD 186

Query: 414 ----SIITEKVDIYSFGVVMLEILCG 435
               +    K D++S G+  +E+  G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 27/222 (12%)

Query: 234 ELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS---FLAEVKTI 287
           +L++  ++F   K++G+G FG V         +V A+K L     I +S   F  E + I
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 288 GSIHHQN---LVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
             + H N   +V+L    A  +  +  +V EYMP G L   +   + +    W +     
Sbjct: 97  --MAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARF--YT 148

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            ++   L  +H       +H D+KP N+LLD + + K+ADFG    +D +      T  G
Sbjct: 149 AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205

Query: 403 TPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVF 439
           TP Y++PE L S         + D +S GV + E+L G   F
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 23/203 (11%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLE---GIGEINKSFLAEVKTIGSIHHQNLVRLIG- 300
           +G G FG V     Q  G  VA+K++        + K    E+K +  + H+N++ L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
           F +       V E +    L R L  R     L+ Q  +  +  I +GL Y+H      +
Sbjct: 78  FISPLEDIYFVTELLGT-DLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHS---AGV 129

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WLSSII 416
           +H D+KP NIL++ N + K+ DFGL+++ D   +  V+T      Y APE    W     
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----YRAPEIMLTWQK--Y 183

Query: 417 TEKVDIYSFGVVMLEILCGRKVF 439
             +VDI+S G +  E+L G+ +F
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 36/282 (12%)

Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQ 293
           NFR  K +G+G F  V+  T   DG  VA+K+++       +     + E+  +  ++H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLD---WQQRKKIILDIAKG 348
           N+++      E +   +V E    G L R +  F++    + +   W    K  + +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSA 118

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L ++H    ++++H DIKP N+ +      K+ D GL +     ++    ++ GTP Y++
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174

Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           PE +  +    K DI+S G ++ E+   +  F       + M L S+ KK  + D     
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCDYPPLP 229

Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
            D +S +++    ++VNM      C+  D  KRP ++ V  V
Sbjct: 230 SDHYSEELR----QLVNM------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.7 bits (179), Expect = 7e-14
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 34/211 (16%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +G V     T  G KVA+K+L    +      K    E++ +  + H+N++ L+ 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 301 -FCAEKSHN-----LLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYL 352
            F    S        LV   M    L+  +  +  SD+        + ++  I +GL Y+
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD------HIQFLVYQILRGLKYI 134

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-- 410
           H      I+H D+KP NI ++ +   K+ DFGL++  D + +  V T      Y APE  
Sbjct: 135 HS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIM 187

Query: 411 --WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
             W+     + VDI+S G +M E+L G+ +F
Sbjct: 188 LNWMH--YNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRLIG 300
           +G+G FG VF+   +     VA+K++    E  + F    L E+K +  + H+N+V LI 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 78

Query: 301 FCAEKSHN--------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            C  K+           LV+E+  +  L   L  ++ +F L   + KK++  +  GL Y+
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL--SEIKKVMKMLLNGLYYI 135

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ---DQSQVVTTMRGTPGYLAP 409
           H   R KILH D+K  NIL+  +   K+ADFGL++        +    T    T  Y  P
Sbjct: 136 H---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 410 EWLSSIITEK-----VDIYSFGVVMLE 431
           E L   + E+     +D++  G +M E
Sbjct: 193 ELL---LGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 33/218 (15%)

Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL-EGIGEINKSFLAE----VKTIGSI 290
           K LG+G FG V   E    D  K      VAVK L +   E + S L      +K IG  
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 79

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQ 337
            H+N++ L+G C +     ++ EY   G+L  +L               R  +  + ++ 
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQV 396
                  +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ ++  D  + 
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 397 VTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            T  R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G FG+V+          VA+K++   G    E  +  + EV+ +  + H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 301 FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA-------KGLTYL 352
            C  + H   LV EY    + D          +L+  ++    ++IA       +GL YL
Sbjct: 83  -CYLREHTAWLVMEYCLGSASD----------ILEVHKKPLQEVEIAAICHGALQGLAYL 131

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H   R   +H DIK  NILL      K+ADFG + L+    S V     GTP ++APE +
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183

Query: 413 SSI----ITEKVDIYSFGVVMLEILCGRK 437
            ++       KVD++S G+  +E L  RK
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 17/212 (8%)

Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRLIG 300
           +GKG FG V +  + D  ++ A+K +     +++S     LAE   +  ++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
                    LV  ++  G L   L QR   F  D  + +    ++   L  LH+     +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL-QREGRF--DLSRARFYTAELLCALENLHK---FNV 114

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEK 419
           ++ D+KP+NILLD   +  + DFGL KL +        T  GTP YLAPE L     T+ 
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 420 VDIYSFGVVMLEILCGRKVF-DRSQPEEEDMY 450
           VD ++ GV++ E+L G   F D +  E   MY
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNE---MY 202

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 68/203 (33%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGS--------IHHQN 294
           K++GKG FG V     + DG   AVK L+    + K    E K I +        + H  
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPF 57

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLH 353
           LV L            V +Y+  G L   L QR   F    + R +    +IA  L YLH
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFP---EPRARFYAAEIASALGYLH 113

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                 I++ D+KP+NILLD   +  + DFGL K    + S+  +T  GTP YLAPE L 
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 414 SIITEK-VDIYSFGVVMLEILCG 435
               ++ VD +  G V+ E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF---------LAEVKTIGSIHHQ 293
           K +G+G +G V     ++   KVA+K+      I  +F         L E+K +  + H+
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKK------IANAFDNRIDAKRTLREIKLLRHLDHE 64

Query: 294 NLVRLIGFCAEKSHN-----LLVYEYMPNGSLDRWLFQ--RSDEFMLDWQQRKKIILDIA 346
           N++ +                +VYE M     D  L Q  RS + + D    +  +  + 
Sbjct: 65  NVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSD-DHCQYFLYQLL 118

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           +GL Y+H      +LH D+KP N+LL+ N + K+ DFGL++    ++   +T    T  Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWY 174

Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRK 437
            APE L   S  T  +D++S G +  E+L GRK
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 19/234 (8%)

Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL----EG 272
           +++L++   + ++    ++K    +  K++G+G FG V         KV   +L    E 
Sbjct: 22  DNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM 81

Query: 273 IGEINKSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDE 330
           I   + +F  E + I +  +   V  + FCA  +  +  +V EYMP G L   +      
Sbjct: 82  IKRSDSAFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLM----SN 136

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           + +  +  K    ++   L  +H      ++H D+KP N+LLD + + K+ADFG    +D
Sbjct: 137 YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193

Query: 391 QDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVF 439
           +       T  GTP Y++PE L S         + D +S GV + E+L G   F
Sbjct: 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)

Query: 241 NFRKM--LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQN 294
           NF+K+  +G+G +G V++   +  G  VA+K  RL+   E +  + + E+  +  ++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPE 410
               ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y APE
Sbjct: 119 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPE 170

Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            L      +  VDI+S G +  E++  R +F
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRL 298
           K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                       V EY   G L    F  S E +    + +    +I   L YLH +  +
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 115

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIIT 417
            +++ D+K +N++LD + + K+ DFGL K   +D +  + T  GTP YLAPE L  +   
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYG 174

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VD +  GVVM E++CGR  F
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN----KSFLAEVKTI-GSIHHQNLVR 297
           K++GKG FG V    +  DG   AVK L+    +N    K  +AE   +  ++ H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 298 LIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           L  +  + +  L  V +++  G L    F    E      + +    +IA  L YLH   
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
              I++ D+KP+NILLD   +  + DFGL K     QS   TT  GTP YLAPE +    
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 417 TEK-VDIYSFGVVMLEILCGRKVF 439
            +  VD +  G V+ E+L G   F
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRL----EGIGEINKSFLAEVKTIGSI-HHQNLVRLI 299
           +G+G F  V +      G   A+K +    + + ++N   L E++ +  +  H N++RLI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 300 GFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFM------LDWQQRKKIILDIAKGLTY 351
               ++      LV+E M     D  L+    E +      L  ++ K  +  + K L +
Sbjct: 65  EVLFDRKTGRLALVFELM-----DMNLY----ELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           +H   R  I H DIKP+NIL+  +   K+ADFG  + I        T    T  Y APE 
Sbjct: 116 MH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPEC 169

Query: 412 L--SSIITEKVDIYSFGVVMLEIL 433
           L        K+DI++ G V  EIL
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 50/304 (16%)

Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEINK-----SFLAEVKTIGSI 290
           K LG+G FG V   E    D       TKVAVK L+            S +  +K IG  
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 82

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------------LDWQQ 337
            H+N++ L+G C +     ++ EY   G+L  +L  R    M             L ++ 
Sbjct: 83  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQV 396
                  +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  + 
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 397 VTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
            T  R    ++APE L   I T + D++SFGV++ EI           P EE   L  + 
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLL 255

Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
           K+    DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +  
Sbjct: 256 KEGHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRILA 301

Query: 516 FEHN 519
              N
Sbjct: 302 LTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGF 301
           +++G G +G V++G     G   A+K ++   +  +    E+  +    HH+N+    G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 302 CAEKS---HN---LLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
             +KS   H+    LV E+   GS+ D     + +    DW     I  +I +GL +LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS- 413
               K++H DIK QN+LL  N   K+ DFG+S  +D+   +   T  GTP ++APE ++ 
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIAC 195

Query: 414 -----SIITEKVDIYSFGVVMLEILCG 435
                +    + DI+S G+  +E+  G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 42/227 (18%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI-----------NKSFLAEVKT 286
           D+    K +G G FG V              ++  I E+            K  L EV  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS- 59

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKI 341
                H  ++RL  F  E     L  + EY+P G L  +L      S+   L +      
Sbjct: 60  -----HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS---- 108

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTM 400
             +I   L YLH    ++I++ D+KP+NILLD   + K+ DFG +K L D+       T+
Sbjct: 109 --EIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTL 158

Query: 401 RGTPGYLAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVFDRSQPEE 446
            GTP YLAPE + S    K VD ++ G+++ E+L G   F    P  
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 53/280 (18%)

Query: 246 LGKGGFGSVFEGTQTDGTK-VAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G FG+V+  T +   + VAVK++   G    E  +  + EVK +  + H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 301 FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA-------KGLTYL 352
            C  K H   LV EY    + D          +L+  ++    ++IA       +GL YL
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASD----------LLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      ++H DIK  NILL      K+ADFG +       S V     GTP ++APE +
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189

Query: 413 SSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV 468
            ++       KVD++S G+  +E L  RK      P   +M  +S     A+ D      
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIE-LAERK------PPLFNMNAMSALYHIAQND------ 236

Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
              S  +QSN E   +      +CL+    +RP+ + ++R
Sbjct: 237 ---SPTLQSN-EWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 22/199 (11%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + G   A K +E   E   + ++ E++ + + +H  +V+L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 ++ E+ P G++D  + +   +  L   Q + I   + + L YLH     KI+H 
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 364 DIKPQNILLDGNFNAKVADFGLS----KLIDQDQSQVVTTMRGTPGYLAPEWL------S 413
           D+K  N+LL  + + K+ADFG+S    K + +  S +     GTP ++APE +       
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKD 189

Query: 414 SIITEKVDIYSFGVVMLEI 432
           +    K DI+S G+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 12/211 (5%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA+K++    +  K  +  E+  +    + N+V  +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIHR 139

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KVDI
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 423 YSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           +S G++ +E++ G   +    P    +YL++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRA-LYLIA 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 69/206 (33%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKS----FLAEVKTI-GSIHHQNLVR 297
           K++GKG FG V     ++DG+  AVK L+    + K      +AE   +  ++ H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 298 L-IGF-CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLHE 354
           L   F  AEK +   V +Y+  G L   L QR   F+   + R +    ++A  + YLH 
Sbjct: 61  LHYSFQTAEKLY--FVLDYVNGGELFFHL-QRERCFL---EPRARFYAAEVASAIGYLHS 114

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
                I++ D+KP+NILLD   +  + DFGL K    +  +  +T  GTP YLAPE L  
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 415 IITEK-VDIYSFGVVMLEILCGRKVF 439
              ++ VD +  G V+ E+L G   F
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 244 KMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSFLA--EVKTIGSIHHQNLVRLIG 300
           + LG+G + +V++G ++ +G  VA+K +    E    F A  E   +  + H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
               K     V+EYM +  L +++ Q      L     +  +  + +GL Y+H    Q I
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIH---GQHI 124

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPEWL--SSI 415
           LH D+KPQN+L+      K+ADFGL++   +  Q  S  V T+     Y  P+ L  ++ 
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL----WYRPPDVLLGATD 180

Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
            +  +DI+  G + +E+L G+  F
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 67/261 (25%), Positives = 111/261 (42%), Gaps = 39/261 (14%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G  G VF    +D   +VAVK++      + K  L E+K I  + H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 304 EKSHNL--------------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
               +L              +V EYM    L   L Q      L  +  +  +  + +GL
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGP----LSEEHARLFMYQLLRGL 127

Query: 350 TYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQ-------VVTTMR 401
            Y+H      +LH D+KP N+ ++  +   K+ DFGL++++D   S        +VT   
Sbjct: 128 KYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183

Query: 402 GTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA 459
               Y +P  L S    T+ +D+++ G +  E+L G+ +F  +   E+   +L       
Sbjct: 184 ----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239

Query: 460 EEDKLSDLVDKHSNDMQSNGE 480
           EED+   L    S      GE
Sbjct: 240 EEDRNELLNVIPSFVRNDGGE 260

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 64.4 bits (157), Expect = 4e-13
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 11/93 (11%)

Query: 72  TSLSCE-ASQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLN 130
           T L+C        F++L DV     +S+   IT    E C++ACL NCSC A    Y  N
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDNASA---ITAISLEECREACLSNCSCTA----YAYN 53

Query: 131 SSAGDCYLPSEIFSMMNNEKETTHYNSTAYIKV 163
           + +G C L + + + +   +  +    T Y+++
Sbjct: 54  NGSGGCLLWNGLLNNL---RSLSSGGGTLYLRL 83

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 16/196 (8%)

Query: 246 LGKGGFGSVFEGTQTDGTKV--AVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG G FG V++  Q   T V  A K ++   E   + ++ E+  + S  H N+V+L+   
Sbjct: 13  LGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
             +++  ++ E+   G++D  + +   E  L   Q + +     + L YLHE+   KI+H
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE---- 418
            D+K  NIL   + + K+ADFG+S   +    Q   +  GTP ++APE +    ++    
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 419 --KVDIYSFGVVMLEI 432
             K D++S G+ ++E+
Sbjct: 186 DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLV--RLI 299
           +G G +G V     T  G KVA+K++    +   + K  L E+K +    H N++  R I
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 300 GFCAEKSHNLLVYEYMP--NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
                 +    VY  M      L   +        L  +  +  +  + +GL Y+H    
Sbjct: 73  -LRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSAN- 127

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ---DQSQVVTTMRGTPGYLAPEWLSS 414
             ++H D+KP N+L++ +   ++ DFG+++ +     +    +T    T  Y APE L S
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185

Query: 415 I--ITEKVDIYSFGVVMLEILCGRKVF 439
           +   T  +D++S G +  E+L  R++F
Sbjct: 186 LPEYTTAIDMWSVGCIFAEMLGRRQLF 212

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)

Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIG--EINKSFLAEVKT 286
               +L+ + +     +G G  G V++   +  G  +AVK++   G  E NK  L ++  
Sbjct: 12  ADLNDLENLGE-----IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV 66

Query: 287 IGSIHH-QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           +   H    +V+  G+    S   +  E M    LD+ L +R    + +     K+ + I
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDK-LLKRIQGPIPE-DILGKMTVAI 123

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTP 404
            K L YL E  +  ++H D+KP NILLD + N K+ DFG+S +L+D   S+  T   G  
Sbjct: 124 VKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCA 178

Query: 405 GYLAPEWLS-SIITEKVDI----YSFGVVMLEILCGR 436
            Y+APE +       K DI    +S G+ ++E+  G+
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 48/233 (20%)

Query: 242 FRKMLGKGGFGSV-----------------FEGTQTDGTKVAVKRLEGIGEIN--KSFLA 282
           F++ LG+G FG V                 F   +     VAVK L      N    FL 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE------------ 330
           EVK +  +   N++RL+G C ++    ++ EYM NG L+++L     +            
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 331 ----FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
                 + +     + L IA G+ YL        +H D+  +N L+  N   K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 387 K-LIDQD----QSQVVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVMLEIL 433
           + L   D    Q + V  +R    ++A E  L    T   D+++FGV + EIL
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 38/108 (35%), Positives = 60/108 (55%), Gaps = 11/108 (10%)

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVT 398
           KI + I K L YLH   +  ++H D+KP N+L++ N   K+ DFG+S  L+D   S   T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKT 161

Query: 399 TMRGTPGYLAPEWLSSIITE-----KVDIYSFGVVMLEILCGRKVFDR 441
              G   Y+APE ++  + +     K D++S G+ M+E+  GR  +D 
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG V++G      +V   ++  + E     +    E+  +       + R  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 303 AEKSHNLLVYEYMPNGS-LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
            + +   ++ EY+  GS LD  L +      L+      I+ +I KGL YLH    ++ +
Sbjct: 72  LKGTKLWIIMEYLGGGSALD--LLKPGP---LEETYIATILREILKGLDYLHS---ERKI 123

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKV 420
           H DIK  N+LL    + K+ADFG++  +   Q +   T  GTP ++APE +  S    K 
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 421 DIYSFGVVMLEILCGRKVFDRSQP 444
           DI+S G+  +E+  G        P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHP 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 244 KMLGKGGFGSVF----EGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           ++LG G +G VF     G    G   A+K L+    + K+  AE  T         VR  
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLEAVRRC 64

Query: 300 GFCAE---------KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            F            K H  L+ +Y+  G L   L+QR + F     + +  I +I   L 
Sbjct: 65  PFLVTLHYAFQTDTKLH--LILDYVNGGELFTHLYQR-EHFTES--EVRVYIAEIVLALD 119

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +LH+     I++ DIK +NILLD   +  + DFGLSK    ++ +   +  GT  Y+APE
Sbjct: 120 HLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 411 WL---SSIITEKVDIYSFGVVMLEILCGRKVF 439
            +   S    + VD +S GV+  E+L G   F
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 12/212 (5%)

Query: 236 KVMTDNFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQ 293
           + + +N+ K +G+G  G V     +  G +VAVK ++   +  +  L  EV  +    HQ
Sbjct: 20  RSLLENYIK-IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQ 78

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V +           ++ E++  G+L   +     +  L+ +Q   +   + + L YLH
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLH 134

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               Q ++H DIK  +ILL  +   K++DFG    I +D  +   ++ GTP ++APE +S
Sbjct: 135 S---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVIS 190

Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            +    +VDI+S G++++E++ G   +    P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            + N ++L         ++L+ +Y+ +G L D  L ++  +  L   + KKII  + + L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGK--LSEAEVKKIIRQLVEAL 122

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
             LH   +  I+H DIK +N+L D       + D+GL K+I        +   GT  Y +
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFS 174

Query: 409 PEWLSSIITEKVDIYSF-----GVVMLEILCGRKVFDRSQPEE---EDM 449
           PE    I     D  SF     GV+  E+L G+  F   + EE   E +
Sbjct: 175 PE---KIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219

Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLE---GIGEINKSFLAEVKTIGSIHHQNLVR 297
           F +++GKG +G V     +TDG +  +K+L          K+   E + +  + H N+V 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 298 LI-GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
               +  E     +V  +   G L   L ++  + + +  Q  +  + IA  L YLHE  
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHE-- 120

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI- 415
            + ILH D+K QN+ L      KV D G+++++ ++Q  + +T+ GTP Y++PE  S+  
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKP 178

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFD 440
              K D+++ G  + E+   +  F+
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLI 299
           K +G G +G+V        G KVA+K+L    +     K    E++ +  + H+N++ L+
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 300 G-FCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
             F  + S +     Y  MP    D     + ++   D  Q   ++  + KGL Y+H   
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF--LVYQMLKGLKYIHA-- 136

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
              I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + +
Sbjct: 137 -AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----WYRAPEVILNWM 191

Query: 417 --TEKVDIYSFGVVMLEILCGRKVF 439
             T+ VDI+S G +M E+L G+ +F
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 24/243 (9%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G G +G+V++      G  VA+K +      +G+       +A +K + +  H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 299 IGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +  CA      ++   LV+E++ +  L  +L  +     L  +  K ++    +GL +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--QVVTTMRGTPGYLAPE- 410
            +C   I+H D+KP+NIL+      K+ADFGL+++     +   VV T+     Y APE 
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL----WYRAPEV 178

Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
            L S     VD++S G +  E+   + +F  +   ++   +  +     E+D   D+   
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238

Query: 471 HSN 473
              
Sbjct: 239 RGA 241

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 30/209 (14%)

Query: 246 LGKGGFGSVFEG---TQTDGTKVAVKRLE---GIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           +G G FG V      T T   +V VK L+      E N  FL +      + H N+++ +
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQCL 61

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQ 358
           G C E    LLV+EY   G L  +L Q             +++  +IA G+T++H   + 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGL------SKLIDQDQSQVVTTMRGTPGYLAPEW- 411
             LH D+  +N  L  +   KV D+G+         I+ +  + V  +R    +LAPE  
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLR----WLAPELV 173

Query: 412 -------LSSIITEKVDIYSFGVVMLEIL 433
                  +++  T+  ++++ GV + E+ 
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 34/227 (14%)

Query: 234 ELKVMTDNFRKMLGKGGFGSVFEG-----TQTDGTKVAVKRLEGIGEINK--SFLAEVKT 286
           EL +    F + LG+  FG +++G            VA+K L+ I    +   F  E   
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---------SDE-----FM 332
           +  +HH N+V L+G   ++    +++EY+  G L  +L  R         SDE       
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           LD      I + IA G+ YL        +H D+  +NIL+    + K++D GLS+ I   
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 393 -----QSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
                Q + +  +R  P    PE +     +   DI+SFGVV+ EI 
Sbjct: 178 DYYRVQPKSLLPIRWMP----PEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 39/278 (14%)

Query: 246 LGKGGFGSVFEGTQTDG--TKVAVKRL--------EGIGEINKSF---LAEVKTIG-SIH 291
           LG G FG V++  + +     +A+K +        +   E +KS    ++EV  I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK--KIILDIAKGL 349
           H N+VR      E     +V + +    L    F    E    + + +   I + +   L
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            YLH++  ++I+H D+ P NI+L  +    + DFGL+K   +     +T++ GT  Y  P
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCP 182

Query: 410 EWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV 468
           E + +    EK D+++FG ++ ++   +  F  +     +M  L+    +A  + L +  
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAVYEPLPE-- 235

Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
                 M S  E+V +++     CL  D   RP +  V
Sbjct: 236 -----GMYS--EDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 12/211 (5%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KVDI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 423 YSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           +S G++ +E++ G   +    P    +YL++
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRA-LYLIA 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 30/224 (13%)

Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLA--EVKTIGSIHHQNLVRLIG 300
           LG+G + +V++G ++  G  VA+K  RLE   E    F A  E   +  + H N+V L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQ 358
               K    LV+EY+     D  L Q  D+    L     +  +  + +GL Y H   ++
Sbjct: 71  IIHTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QR 122

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL-- 412
           ++LH D+KPQN+L+      K+ADFGL++          ++VVT       Y  P+ L  
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW-----YRPPDVLLG 177

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           S+  +  +D++  G +  E+  GR +F  S   E+   L  IF+
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 53/158 (33%), Positives = 74/158 (46%), Gaps = 20/158 (12%)

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVTTMRGTPGYL 407
           L  +H    + ++H DIK  NILL  N   K+ DFG SK+     S  V  T  GTP Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 408 APE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           APE W     ++K D++S GV++ E+L  ++ FD    EE           K    +   
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--------VMHKTLAGRYDP 264

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           L    S +MQ    E+V  +      L SD  +RPS S
Sbjct: 265 LPPSISPEMQ----EIVTAL------LSSDPKRRPSSS 292

Length = 496

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 72/250 (28%), Positives = 106/250 (42%), Gaps = 75/250 (30%)

Query: 241 NFRKMLGKGGFGSVF----EGT---------------QTDGTKVAV--KRLEGIGEINKS 279
           NF  +LGKG FG V     +GT               Q D  +  +  KR+  +      
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPP 61

Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
           FL ++ +      Q + RL            V EY+  G L           M   QQ  
Sbjct: 62  FLTQLHSC----FQTMDRL----------YFVMEYVNGGDL-----------MYHIQQVG 96

Query: 340 KI--------ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK--LI 389
           K           +IA GL +LH    + I++ D+K  N++LD   + K+ADFG+ K  + 
Sbjct: 97  KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153

Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIIT-----EKVDIYSFGVVMLEILCGRKVFDRSQP 444
               ++   T  GTP Y+APE    II      + VD ++FGV++ E+L G+  FD    
Sbjct: 154 GGKTTR---TFCGTPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD---G 203

Query: 445 EEEDMYLLSI 454
           E+ED    SI
Sbjct: 204 EDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 20/191 (10%)

Query: 261 DGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL----LVY 312
           +  +V ++  +    G   +      E+K +  I   N++++ GF  +   +L    L+ 
Sbjct: 42  NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101

Query: 313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
           EY   G L   L +  D   L ++ +  + +D  KGL  L++       + ++   + L+
Sbjct: 102 EYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLV 156

Query: 373 DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII---TEKVDIYSFGVVM 429
             N+  K+   GL K++     + V  M     Y + + L+ I    T K DIYS GVV+
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 430 LEILCGRKVFD 440
            EI  G+  F+
Sbjct: 213 WEIFTGKIPFE 223

Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.6 bits (168), Expect = 4e-12
 Identities = 67/256 (26%), Positives = 100/256 (39%), Gaps = 66/256 (25%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKR----LEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +++GKGG G V+         +VA+K+    L     + K FL E K    + H  +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 299 IGFCAEKSHNLLVYEYMP--NGSLDRWLFQRSDEFMLDWQQRK---------------KI 341
              C++      VY  MP   G   + L +        WQ+                  I
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSV------WQKESLSKELAEKTSVGAFLSI 118

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV-ADFGLSKLIDQ---DQSQVV 397
              I   + Y+H    + +LH D+KP NILL G F   V  D+G +        D   + 
Sbjct: 119 FHKICATIEYVHS---KGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 398 TTMR--------------GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILC-------- 434
              R              GTP Y+APE L  +  +E  DIY+ GV++ ++L         
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 435 -GRKVFDRSQ---PEE 446
            GRK+  R     P E
Sbjct: 235 KGRKISYRDVILSPIE 250

Length = 932

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 244 KMLGKGGFGSVFEGT--------QTDGTKVAVKRLE--GIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V                  VAVK L+     +     ++E++ +  I  H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C ++    ++ EY   G+L  +L  R               E  L ++   
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     ++ +H D+  +N+L+  +   K+ADFGL++ +   D  +  +
Sbjct: 138 SCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFG++M EI 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 234 ELKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKR----LEGIGEINKSFLAEVKTI 287
           ELK   D+F ++  LG G  G V    Q   + + + R    LE    I    + E++ +
Sbjct: 1   ELK--DDDFERISELGAGN-GGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDI 345
              +   +V   G         +  E+M  GSLD+ L   +R  E +L      K+ + +
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAV 112

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTP 404
            +GL YL E  + +I+H D+KP NIL++     K+ DFG+S +LID   +  V    GT 
Sbjct: 113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTR 166

Query: 405 GYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGR 436
            Y++PE L     + + DI+S G+ ++E+  GR
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 28/208 (13%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 301 -FCAEKS----HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
            F   +S    +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 138

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 192

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +    T  VDI+S G +M E+L GR +F
Sbjct: 193 MHYNQT--VDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGI--GEI-NKSFLAEVKTIGSIHHQNLVRLI 299
           K +G G +GSV     +  G KVA+K+L      EI  K    E+  +  + H+N++ L+
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 300 G-FCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
             F +  S +     Y  MP    D    Q+     L   + + ++  +  GL Y+H   
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WL 412
              I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W+
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----WYRAPEVILNWM 190

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVF 439
                + VDI+S G +M E+L G+ +F
Sbjct: 191 H--YNQTVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 66/222 (29%), Positives = 110/222 (49%), Gaps = 21/222 (9%)

Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQN--LVR 297
           ++LGKG FG V     +  G   AVK L+    + + +       K I S+   +  L +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 298 LIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L  +C  ++ + L  V E++  G L  +  Q+S  F  D  + +    +I   L +LH+ 
Sbjct: 61  L--YCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRF--DEARARFYAAEITSALMFLHD- 114

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
             + I++ D+K  N+LLD   + K+ADFG+ K    +  +  +T  GTP Y+APE L  +
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEM 171

Query: 416 I-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           +    VD ++ GV++ E+LCG   F   + E ED    +I  
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPF---EAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 244 KMLGKGGFGSVFE----GTQTD----GTKVAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V      G   D       VAVK L  +   +     ++E++ +  I  H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------------LDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R    M             L ++   
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  +   K+ADFGL++ +   D  +  T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV++ EI 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 16/214 (7%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEIN----KSFLAEVKTIG-SIHHQNLVR 297
           K+LGKG FG V         +V A+K L+    +        + E + +  +  H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L      K     V EY+  G L  +  QRS +F  D  + +    ++   L +LH   R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKF--DEPRSRFYAAEVTLALMFLH---R 114

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-I 416
             +++ D+K  NILLD   + K+ADFG+ K          TT  GTP Y+APE L  +  
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
              VD ++ GV+M E++ G+  F+     E+D++
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADN--EDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIGEINKSFLA-----EVKTIGSIH---H 292
           K LG+G +G V         +   VA+K++  +   +K  LA     E+K +   H   H
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILAKRALRELKLL--RHFRGH 61

Query: 293 QNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           +N+  L         N   +Y Y      D     RS + + D    +  I  I  GL Y
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTD-AHFQSFIYQILCGLKY 120

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG---TPGYLA 408
           +H      +LH D+KP N+L++ +   K+ DFGL++   ++  +    M     T  Y A
Sbjct: 121 IHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 409 PEWLSSI--ITEKVDIYSFGVVMLEILCGRKVF 439
           PE + S    T+ +D++S G ++ E+L  + VF
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 241 NFRKMLGKGGFG-SVFEGTQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           N  +++G+G FG ++         K A+K  RL       +    E   +  + H N+V 
Sbjct: 3   NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-----SDEFMLDWQQRKKIILDIAKGLTYL 352
                    H  +V EY   G L + +  +      ++ +L W       + +  G+ ++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHI 116

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           HE   +++LH DIK +NI L  N   K+ DFG ++L+    +   T + GTP Y+ PE W
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRK 437
            +     K DI+S G ++ E LC  K
Sbjct: 173 ENMPYNNKSDIWSLGCILYE-LCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 36/225 (16%)

Query: 246 LGKGGFGSVFEGTQTDGT---KVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG-F 301
           +G+G +G V++  + DG    + A+K++EG G I+ S   E+  +  + H N++ L   F
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67

Query: 302 CAEKSHNL-LVYEYMPNGSLDRW---LFQRSDE-----FMLDWQQRKKIILDIAKGLTYL 352
            +     + L+++Y  +   D W    F R+ +       L     K ++  I  G+ YL
Sbjct: 68  LSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 353 HEDCRQKILHLDIKPQNILLDGN----FNAKVADFGLSKLIDQ------DQSQVVTTMRG 402
           H +    +LH D+KP NIL+ G        K+AD G ++L +       D   VV T   
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF-- 179

Query: 403 TPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPE 445
              Y APE L  +   T+ +DI++ G +  E+L    +F   Q +
Sbjct: 180 --WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 14/207 (6%)

Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSFLA--EVKTIGSIHHQN 294
           D++ K+  LG+G + +V++G ++ +G  VA+K +    E    F A  E   +  + H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V L      K    LV+EY+ +  L +++ +       +    K  +  + +GL+Y+H+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE--NVKLFLFQLLRGLSYIHQ 121

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-- 412
              + ILH D+KPQN+L+      K+ADFGL++      S   +    T  Y  P+ L  
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVF 439
           S+  +  +D++  G + +E++ G   F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRL 298
           +++GKG +G V     T  G KVA+K++  + E + S     L E+K +  + H ++V +
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEI 64

Query: 299 IGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
                  S        +V+E M   S    + + +D+   +  Q    +  + + L Y+H
Sbjct: 65  KHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQF--FLYQLLRALKYIH 120

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--TTMRGTPGYLAPEW 411
                 + H D+KP+NIL + +   K+ DFGL+++   D    +  T    T  Y APE 
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 412 LSSII---TEKVDIYSFGVVMLEILCGRKVF 439
             S     T  +DI+S G +  E+L G+ +F
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 17/217 (7%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKT-----IGSIHHQNLVR 297
           K++GKG FG V     + +    AVK L+    + K     + +     + ++ H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLHEDC 356
           L            V +Y+  G L  +  QR   F+   + R +    +IA  L YLH   
Sbjct: 61  LHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIASALGYLHS-- 114

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
              I++ D+KP+NILLD   +  + DFGL K  + + +   +T  GTP YLAPE L    
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 417 TEK-VDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYL 451
            ++ VD +  G V+ E+L G   F  R+  E  D  L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 33/211 (15%)

Query: 245 MLGKGGFGSVFEGTQTDGTK-VAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           ++G+G +G V +    +  + VA+K+    E   E+ ++ L E+K + ++  +N+V L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 301 FCAEKSHNLLVYEY-----------MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
               +    LV+EY           MPNG                 ++ +  I  + K +
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP--------------EKVRSYIYQLIKAI 113

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            + H   +  I+H DIKP+N+L+  N   K+ DFG ++ + +  +   T    T  Y +P
Sbjct: 114 HWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 410 E-WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
           E  L +   + VD++S G ++ E+  G+ +F
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 21/227 (9%)

Query: 239 TDNFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQ 293
             NF  +LGKG FG V     +      A+K L+    I     +  + E + +      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 294 NLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
             +  +  C +    L  V EY+  G L  +  Q+  +F     Q      +I+ GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKF--KEPQAVFYAAEISVGLFFL 117

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPE 410
           H   R+ I++ D+K  N++LD   + K+ADFG+ K   +     VTT    GTP Y+APE
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171

Query: 411 WLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            ++     + VD +++GV++ E+L G+  FD    E+ED    SI +
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 23/245 (9%)

Query: 206 FRKKNGADEIEEDYLDQVPGLPK-RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK 264
            RK    D     Y D +  +   R   E+ +V+     K++G+G FG V         K
Sbjct: 15  LRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVV-----KVIGRGAFGEVQLVRHKSTRK 69

Query: 265 VAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGS 319
           V   +L    E I   + +F  E + I +  +   V  + +  +    L +V EYMP G 
Sbjct: 70  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129

Query: 320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK 379
           L   +      + +  +  +    ++   L  +H       +H D+KP N+LLD + + K
Sbjct: 130 LVNLM----SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLK 182

Query: 380 VADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILC 434
           +ADFG    ++++      T  GTP Y++PE L S         + D +S GV + E+L 
Sbjct: 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242

Query: 435 GRKVF 439
           G   F
Sbjct: 243 GDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 36/225 (16%)

Query: 246 LGKGGFGSVFEGTQTDGTK---VAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG-F 301
           +G+G +G V++  + DG      A+K++EG G I+ S   E+  +  + H N++ L   F
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67

Query: 302 CAEKSHNL-LVYEYMPNGSLDRW---LFQRSDE-----FMLDWQQRKKIILDIAKGLTYL 352
            +     + L+++Y  +   D W    F R+ +       L     K ++  I  G+ YL
Sbjct: 68  LSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 353 HEDCRQKILHLDIKPQNILLDGN----FNAKVADFGLSKLIDQ------DQSQVVTTMRG 402
           H +    +LH D+KP NIL+ G        K+AD G ++L +       D   VV T   
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF-- 179

Query: 403 TPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPE 445
              Y APE L  +   T+ +DI++ G +  E+L    +F   Q +
Sbjct: 180 --WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)

Query: 240 DNFRKM--LGKGGFGSVFEGT-QTDGTKVAVKRL----EGIGEINKSF----LAEVKTIG 288
           D + K+  + +G +G V+    +  G  VA+K+L    E  G     F    L E+  + 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILL 59

Query: 289 SIHHQNLVRL--IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
            + H N+V +  +   +      +V EY+ +  L   +      F+    + K ++L + 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ--SEVKCLMLQLL 116

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            G+ +LH++    ILH D+K  N+LL+     K+ DFGL++       +  T +  T  Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWY 172

Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            APE L  +   +  +D++S G +  E+L  + +F
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 59/227 (25%), Positives = 112/227 (49%), Gaps = 18/227 (7%)

Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQNLVR 297
           ++LGKGGFG V     +  G   A K+LE    I K       L E + +  ++ + +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHED 355
           L      K    LV   M  G L   ++   +     +++ + +    +I  GL  LH  
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLH-- 119

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SS 414
            +++I++ D+KP+NILLD + + +++D GL+  + + Q+  +    GT GY+APE + + 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 176

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
             T   D ++ G ++ E++ G+  F + + + +   +  + K+  EE
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 8/90 (8%)

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLH    + I++ D+KP+N+LLD   + KV DFG +K +         T+ GTP YLAPE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 411 WLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
            + S    K VD ++ GV++ E + G   F
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 65.1 bits (158), Expect = 7e-11
 Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 41/252 (16%)

Query: 226 LPKRFSFEELKVMTDNFRKMLGKGGFGSVF----EGTQTDGTKVAVKRLEGIGEINKSFL 281
           +P ++   E ++      K +G G FG VF    + TQ      A+    G+ E  KS L
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQL 59

Query: 282 A-EVKTIGSIHHQNLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             EV  +  + H+N+VR I     K++  L  + E+   G L R + Q+   + +  +  
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKC--YKMFGKIE 116

Query: 339 KKIILDIAKGLTYLHEDCR--------QKILHLDIKPQNILLD-------------GNFN 377
           +  I+DI + L +    C         +++LH D+KPQNI L               N N
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176

Query: 378 ----AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL---SSIITEKVDIYSFGVVML 430
               AK+ DFGLSK I  +   +  +  GTP Y +PE L   +    +K D+++ G ++ 
Sbjct: 177 GRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 431 EILCGRKVFDRS 442
           E+  G+  F ++
Sbjct: 235 ELCSGKTPFHKA 246

Length = 1021

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 241 NFR--KMLGKGGFGSVFEGTQTDGTKV----AVKRLEGIGEINKSFLAE-----VKTIGS 289
           NF   K+LG G +G VF   +  G       A+K L+    + K+   E      + +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           I     +  + +  +    L L+ +Y+  G L   L QR        Q+ +    +I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLA 117

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L +LH   +  I++ DIK +NILLD N +  + DFGLSK   +D+ +   +  GT  Y+A
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 409 PEWLSSIIT---EKVDIYSFGVVMLEILCGRKVF 439
           P+ +        + VD +S GV+M E+L G   F
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 37/226 (16%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIG----EINK 278
           P + + F  E+ + +  + R+ +G G FG+V+        +V A+K++   G    E  +
Sbjct: 12  PEIAELFFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 70

Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
             + EVK +  I H N +   G C  + H   LV EY    + D          +L+  +
Sbjct: 71  DIIKEVKFLQRIKHPNSIEYKG-CYLREHTAWLVMEYCLGSASD----------LLEVHK 119

Query: 338 RKKIILDIA-------KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           +    ++IA       +GL YLH      ++H DIK  NILL      K+ADFG + +  
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Query: 391 QDQSQVVTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEI 432
              S V     GTP ++APE + ++       KVD++S G+  +E+
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)

Query: 310 LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQN 369
            V E++  G L   +F    +  L  +  +    +I+  L +LHE   + I++ D+K  N
Sbjct: 73  FVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDN 126

Query: 370 ILLDGNFNAKVADFGLSK--LIDQDQSQVVTTMRGTPGYLAPEWLSSIITE-KVDIYSFG 426
           +LLD   + K+ D+G+ K  +   D +   +T  GTP Y+APE L        VD ++ G
Sbjct: 127 VLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALG 183

Query: 427 VVMLEILCGRKVFD----RSQPEE--EDMYLLSIFKKK 458
           V+M E++ GR  FD       P++  ED YL  +  +K
Sbjct: 184 VLMFEMMAGRSPFDIVGMSDNPDQNTED-YLFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 8/162 (4%)

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           +E+  + +  H  +V+           LL+ EY   G L++ + QR  E  L +Q+ +  
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVG 172

Query: 342 IL--DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVT 398
           +L   I   L  +H      ++H D+K  NI L      K+ DFG SK      S  V +
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 399 TMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  GTP YLAPE W     ++K D++S GV++ E+L   + F
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 8/137 (5%)

Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
            S   LV EY+  G L   +F    +  L  +  +    +I   L +LHE   + I++ D
Sbjct: 68  TSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRD 121

Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVDIY 423
           +K  N+LLD + + K+ D+G+ K          +T  GTP Y+APE L        VD +
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 424 SFGVVMLEILCGRKVFD 440
           + GV+M E++ GR  FD
Sbjct: 181 ALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 42/116 (36%), Positives = 68/116 (58%), Gaps = 12/116 (10%)

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR-- 401
           +IA GL +LH    + I++ D+K  N++LD   + K+ADFG+ K   ++    VTT    
Sbjct: 109 EIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFC 162

Query: 402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           GTP Y+APE ++     + VD ++FGV++ E+L G+  F+    E+ED    SI +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 11/142 (7%)

Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           ++++  LV +Y   G L   L +  D    D  +       IA+ +  +H   +   +H 
Sbjct: 72  DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYIAEMVLAIHSIHQLHYVHR 126

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI------IT 417
           DIKP N+LLD N + ++ADFG    ++QD +   +   GTP Y++PE L ++        
Sbjct: 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 186

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
            + D +S GV M E+L G   F
Sbjct: 187 PECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 53/248 (21%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKT----IGSIHHQNLVRL 298
           K++G+G FG V    + D   + A+K+L     + K  +A V+     +    +  +V+L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 299 IGFCA-EKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
             + + +  + L L+ EY+P G +   L  + D F  +  +       IA+ +  +    
Sbjct: 67  --YYSFQDENYLYLIMEYLPGGDM-MTLLMKKDTFTEEETR-----FYIAETILAIDSIH 118

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLS----KLIDQDQSQVV-------------TT 399
           +   +H DIKP N+LLD   + K++DFGL     K    +  +++               
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 400 MR--------------------GTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKV 438
           M                     GTP Y+APE +L +   ++ D +S GV+M E+L G   
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Query: 439 FDRSQPEE 446
           F    P+E
Sbjct: 239 FCSDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 12/153 (7%)

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           +H  LV L      +S    V EY+  G L   +F    +  L  +  +    +I+  L 
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQDQSQVVTTMRGTPGYLA 408
           YLHE   + I++ D+K  N+LLD   + K+ D+G+ K  L   D +       GTP Y+A
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIA 164

Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
           PE L        VD ++ GV+M E++ GR  FD
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)

Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQNLVR 297
           ++LGKGGFG V     +  G   A KRLE    I K       L E + +  ++ Q +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEK-KRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHED 355
           L      K    LV   M  G L   ++   +     +++ + +    +I  GL  LH  
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLH-- 119

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
            R+  ++ D+KP+NILLD   + +++D GL+  I + +S  +    GT GY+APE L++ 
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQ 176

Query: 416 -ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
             T   D +  G ++ E++ G+  F R + E+         K++  + ++ +  + +S  
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF-RGRKEK--------VKREEVDRRVLETEEVYSAK 227

Query: 475 MQSNGEEVVNMM 486
                + +  M+
Sbjct: 228 FSEEAKSICKML 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 244 KMLGKGGFGSVF---EGTQTDGTKV-AVKRLEGIGEINKSFLAE-VKTIGSIHHQNLVRL 298
           K+LG G +G VF   + T  D  K+ A+K L+    + K+   E  +T  ++     VR 
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LEHVRQ 63

Query: 299 IGFCAE---------KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
             F            K H  L+ +Y+  G +   L+QR D F  D  + +    +I   L
Sbjct: 64  SPFLVTLHYAFQTEAKLH--LILDYVSGGEMFTHLYQR-DNFSED--EVRFYSGEIILAL 118

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            +LH   +  I++ DIK +NILLD   +  + DFGLSK    ++ +   +  GT  Y+AP
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 410 EWLSSIITEK------VDIYSFGVVMLEILCGRKVF 439
           E    II  K      VD +S G+++ E+L G   F
Sbjct: 176 E----IIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 59/274 (21%), Positives = 128/274 (46%), Gaps = 28/274 (10%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEI-----NKSFLAEVKTIGSIHHQNLVR 297
           K +G+G F  V+  T   D   VA+K+++ I E+      +  + E+  +  ++H N+++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWL-FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            +    E +   +V E    G L + + + +  + ++  +   K  + +   + ++H   
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSI 415
            ++++H DIKP N+ +      K+ D GL +     ++    ++ GTP Y++PE +  + 
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM 475
              K DI+S G ++ E+   +  F       + M L S+ +K  + D      + +S  +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237

Query: 476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
           +    E+V+M      C+  D  +RP +  V ++
Sbjct: 238 R----ELVSM------CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 23/216 (10%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           K L  G  G VF  T+      V +K    IG+   + L E   + +++H +++R+    
Sbjct: 72  KTLTPGSEGRVFVATKPGQPDPVVLK----IGQ-KGTTLIEAMLLQNVNHPSVIRMKDTL 126

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +V   +P+ S D + +       L   Q   I   I +GL YLH    Q+I+H
Sbjct: 127 VSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIH 180

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM----RGTPGYLAPEWLS-SIIT 417
            D+K +NI ++      + D G +      Q  VV        GT    APE L+     
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAA------QFPVVAPAFLGLAGTVETNAPEVLARDKYN 234

Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
            K DI+S G+V+ E+L          P   + Y+ S
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270

Length = 357

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 48/235 (20%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV--AVKRLE--GIGEINKS--FLAEVKTIGSIHHQNLVR 297
           K+LGKG  G VF   +  GT    A+K L+   + + NK    L E + + ++ H  L  
Sbjct: 7   KLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L      +++  LV +Y P G L R L QR     L  +  +    ++   L YLH    
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLH---L 121

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR---------------- 401
             I++ D+KP+NILL  + +  ++DF LSK  D +   V   +R                
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 402 ------------GTPGYLAPEWLSSII-----TEKVDIYSFGVVMLEILCGRKVF 439
                       GT  Y+APE    +I        VD ++ G+++ E+L G   F
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPE----VISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 54/254 (21%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSI----HHQNLVRL 298
           K +G G FG V    + D   + A+K L     + ++  A VK    I     ++ +V+L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                +K +   V +Y+P G +   L +     + +    +  I ++   +  +H   + 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KM 120

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGL---------SKL------IDQD----------- 392
             +H DIKP NIL+D + + K+ DFGL         SK         QD           
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 393 --------------QSQVVT--TMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCG 435
                         Q Q     ++ GTP Y+APE L     T+  D +S GV++ E+L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 436 RKVFDRSQPEEEDM 449
           +  F    P E  +
Sbjct: 241 QPPFLADTPAETQL 254

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 56/296 (18%)

Query: 249 GGFGSVFEGTQTDGT-----KVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNLVRLIGF 301
           G FG +F G   D       +V VK + +   EI  +  L E   +  + HQN++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 302 CAEKSHNLLV-YEYMPNGSLDRWLFQRSD-----EFMLDWQQRKKIILDIAKGLTYLHED 355
           C E      V Y YM  G+L  +L Q           L  QQ   + + IA G++YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSK---------LIDQDQSQVVTTMRGTPGY 406
            ++ ++H DI  +N ++D     K+ D  LS+         L D +   V         +
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV--------KW 185

Query: 407 LAPEWL-SSIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           +A E L +   +   D++SFGV++ E++  G+  +    P E   YL   + + A+    
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLAQPINC 244

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
            D              E+  +M   A C   D  +RPS S +V+ L   T+F   L
Sbjct: 245 PD--------------ELFAVM---ACCWALDPEERPSFSQLVQCL---TDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 36/206 (17%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRL 298
           + +G G FG+V+       ++V A+K++   G    E  +  + EV+ +  + H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 299 IGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA-------KGLT 350
            G C  + H   LV EY    + D          +L+  ++    ++IA       +GL 
Sbjct: 81  RG-CYLREHTAWLVMEYCLGSASD----------LLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLH      ++H D+K  NILL      K+ DFG + ++      V     GTP ++APE
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPE 181

Query: 411 WLSSI----ITEKVDIYSFGVVMLEI 432
            + ++       KVD++S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 59/249 (23%), Positives = 108/249 (43%), Gaps = 48/249 (19%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN-- 294
           D+F   K++G+G FG V    + D G   A+K L     + K  +A ++    I  +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 295 --LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
             +V++     +K +  L+ E++P G +   L ++     L  +  +  I +    +  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAI 117

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGL--------------------------- 385
           H+      +H DIKP N+LLD   + K++DFGL                           
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 386 -------SKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRK 437
                  ++   +++ Q+  +  GTP Y+APE ++ +   +  D +S GV+M E+L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 438 VFDRSQPEE 446
            F    P+E
Sbjct: 235 PFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 71/250 (28%), Positives = 121/250 (48%), Gaps = 31/250 (12%)

Query: 242 FR--KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQ 293
           FR  ++LGKGGFG V     +  G   A K+LE    I K       L E + +  ++ +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKRILEKVNSR 60

Query: 294 NLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            +V L  +  E    L LV   M  G L   ++   +    D Q+      ++  GL  L
Sbjct: 61  FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDL 118

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
               R++I++ D+KP+NILLD   + +++D GL+  I + ++  V    GT GY+APE +
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVI 173

Query: 413 SS-IITEKVDIYSFGVVMLEILCGRKVF----DRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           ++   T   D +  G ++ E++ G+  F    +R + EE D        ++ +ED+  + 
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--------RRVKEDQ-EEY 224

Query: 468 VDKHSNDMQS 477
            +K S D +S
Sbjct: 225 SEKFSEDAKS 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 246 LGKGGFGSVFEGTQTD--------GTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLV 296
           LG+G F  +F+G + +         T+V +K L+      ++SF      +  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY-LHED 355
              G C     +++V EY+  GSLD +L +  +   + W+      L++AK L + LH  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT----MRGTPGYLAPEW 411
             + + H ++  +N+LL    + K  +    KL D   S  V      +   P ++ PE 
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPEC 175

Query: 412 LSS--IITEKVDIYSFGVVMLEILCG 435
           + +   ++   D +SFG  + EI  G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 242 FR--KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQ 293
           FR  ++LGKGGFG V     +  G   A K+LE    I K       L E + +  ++ +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKQILEKVNSR 60

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
            +V L      K    LV   M  G L   ++   +    D ++      +I  GL  LH
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH 119

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
              R++I++ D+KP+NILLD   + +++D GL+  I + ++  +    GT GY+APE + 
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVK 174

Query: 414 S-IITEKVDIYSFGVVMLEILCGRKVF 439
           +   T   D +  G ++ E++ G+  F
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 32/210 (15%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLI- 299
           +G G +GSV     T    KVAVK+L    + +    +++  E++ +  + H+N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81

Query: 300 ----GFCAEKSHNLLVYEYMPNGSLDRWL-FQR-SDEFMLDWQQRKKIILDIAKGLTYLH 353
                   E  + + +   +    L+  +  Q+ SDE +      + +I  + +GL Y+H
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV------QFLIYQLLRGLKYIH 135

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE--- 410
                 I+H D+KP N+ ++ +   ++ DFGL++  D + +  V T      Y APE   
Sbjct: 136 S---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR----WYRAPEIML 188

Query: 411 -WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
            W+     + VDI+S G +M E+L G+ +F
Sbjct: 189 NWMH--YNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 68/263 (25%), Positives = 104/263 (39%), Gaps = 64/263 (24%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSIHHQN-- 294
           ++F   K++GKG FG V    + D  K+ A+K L       K  LA VK    +  ++  
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 295 --LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ--RKKIILDIAKGLT 350
             +V L     +  +  L+ E++P G L   L  + D F  D  +    + +L I     
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEA--- 116

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-------------KLIDQD----- 392
            +H   +   +H DIKP NIL+D   + K++DFGLS             KL+        
Sbjct: 117 -VH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 393 ----QSQVVTTMR------------------------GTPGYLAPE-WLSSIITEKVDIY 423
                S  V ++                         GTP Y+APE +L     ++ D +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 424 SFGVVMLEILCGRKVFDRSQPEE 446
           S G +M E L G   F      E
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHE 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 59/260 (22%), Positives = 109/260 (41%), Gaps = 64/260 (24%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
           FE LKV        +G+G FG V    + D   V   ++     + K+ + E + +G I 
Sbjct: 3   FESLKV--------IGRGAFGEVRLVQKKDTGHVYAMKI-----LRKADMLEKEQVGHIR 49

Query: 292 HQN----------LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            +           +V++     +K +  L+ E++P G +   L ++     L  ++ +  
Sbjct: 50  AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFY 106

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL---------------- 385
           I +    +  +H+      +H DIKP N+LLD   + K++DFGL                
Sbjct: 107 IAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 386 ------------------SKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFG 426
                             ++   +++ Q+  +  GTP Y+APE ++ +   +  D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 427 VVMLEILCGRKVFDRSQPEE 446
           V+M E+L G   F    P+E
Sbjct: 224 VIMYEMLIGYPPFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 52/237 (21%)

Query: 246 LGKGGFGSVFEGT---QTDG--------TKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN 294
           LG+G F ++++G    Q+D           V +K L      + +F      +  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT---- 350
           LV+L G C  +  N++V EY+  G LD +L +  +   L W+      LD+AK L     
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWK------LDVAKQLASALH 115

Query: 351 YLHEDCRQKILHLDIKPQNILL-------DGNFNAKVADFG-----LSKLIDQDQSQVVT 398
           YL +   +K++H ++  +NIL+             K++D G     LS+    ++     
Sbjct: 116 YLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP--- 169

Query: 399 TMRGTPGYLAPEW---LSSIITEKVDIYSFGVVMLEILCGRK--VFDRSQPEEEDMY 450
                  ++APE      + +T   D +SFG  +LEI    +  +   S  E+E  Y
Sbjct: 170 -------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKT----IGSIHHQNLVRL 298
           K + +G FG V+ G + + +K+ AVK ++    INK+ + +V+     +       +V L
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
                  ++  LV EY+  G +   L  +   DE M       K I ++A  L YLH   
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM-----AVKYISEVALALDYLH--- 121

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKL 388
           R  I+H D+KP N+L+    + K+ DFGLSK+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           K++G+G FG V      +  KV   ++    E +     +   E + +        +  +
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 300 GFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLD----WQQRKKIILDIAKGLTYLHE 354
            +  +  +NL LV +Y   G L   L +  D    D    +     I +D    L Y+H 
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
           D         IKP NIL+D N + ++ADFG    + +D +   +   GTP Y++PE L +
Sbjct: 127 D---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 415 IITEK------VDIYSFGVVMLEILCGRKVF 439
           +   K       D +S GV M E+L G   F
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 34/227 (14%)

Query: 234 ELKVMTDNFRKMLGKGGFGSVFEG----------TQTDGTKVAVKRLEGIGE--INKSFL 281
           E+ + T  F + LG+  FG V++G          TQ     VA+K L+   E  + + F 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQA----VAIKTLKDKAEGPLREEFK 56

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQR 338
            E      + H N+V L+G   ++    +++ Y  +  L  +L  R   SD    D  + 
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 339 KK----------IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL-SK 387
            K          I+  IA G+ +L       ++H D+  +N+L+    N K++D GL  +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
           +   D  +++        +++PE +     +   DI+S+GVV+ E+ 
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 38/113 (33%), Positives = 57/113 (50%), Gaps = 18/113 (15%)

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL-------------IDQDQSQ 395
           L YLH      I+H D+KP N+L+    + K+ DFGLSK+             I++D  +
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 396 VV-TTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            +   + GTP Y+APE  L     + VD ++ G+++ E L G   F    PEE
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V     T  G  VAVK+L    +     K    E+  +  ++H+N++ L+
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +KS       Y+    +D  L Q      LD ++   ++  +  G+ +LH     
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELMDANLCQ-VIHMELDHERMSYLLYQMLCGIKHLHS---A 142

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-IT 417
            I+H D+KP NI++  +   K+ DFGL++    +   ++T    T  Y APE +  +   
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYK 200

Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
           E VDI+S G +M E++ G  +F
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 58/262 (22%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKT----IGSIHHQNLVRL 298
           K LG G FG V    + D     A+K L     +N++ +A VK     +    ++ +V+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                +K +   V +Y+P G +   L +     +      +  I ++   +  +H   + 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KM 120

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGL--------------------------SKLID-- 390
             +H DIKP NIL+D + + K+ DFGL                          S L D  
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 391 ------------------QDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLE 431
                             Q Q  +  ++ GTP Y+APE  L    T+  D +S GV++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 432 ILCGRKVFDRSQPEEEDMYLLS 453
           +L G+  F    P E  + +++
Sbjct: 241 MLVGQPPFLAPTPTETQLKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 58/261 (22%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKT----IGSIHHQNLVRL 298
           K LG G FG V    + D     A+K L     + ++ +A VK     +    ++ +VRL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                +K +   V +Y+P G +   L  R   F  D  +    I ++   +  +H   + 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDLARF--YIAELTCAVESVH---KM 120

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLS-------------------------------- 386
             +H DIKP NIL+D + + K+ DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 387 --------------KLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLE 431
                         +   Q Q  +  ++ GTP Y+APE  L +  T+  D +S GV++ E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 432 ILCGRKVFDRSQPEEEDMYLL 452
           +L G+  F    P E  M ++
Sbjct: 241 MLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 6/85 (7%)

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK- 419
           +H DIKP N+LLD N + ++ADFG    +  D +       GTP Y++PE L ++   K 
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 420 -----VDIYSFGVVMLEILCGRKVF 439
                 D +S GV M E+L G   F
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)

Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 131

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186

Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 57/230 (24%), Positives = 111/230 (48%), Gaps = 22/230 (9%)

Query: 245 MLGKGGFGSVFEGTQTDGT-KVAVKR-LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF- 301
           ++G G FG V+E    D + KVA+K+ L+     N+    E+  + +++H N++ L  + 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYY 128

Query: 302 ---CAEKSH-NL---LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              C +K+  N+   +V E++P            +   L     K     + + L Y+H 
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL- 412
              + I H D+KPQN+L+D N +  K+ DFG +K +   Q  V  +   +  Y APE + 
Sbjct: 189 ---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRFYRAPELML 243

Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
            ++  T  +D++S G ++ E++ G  +F      ++ + ++ +     E+
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293

Length = 440

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 17/195 (8%)

Query: 246 LGKGGFGSVFEGTQTDGTKVA---VKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G +G V++    +  ++A   V +LE  GE       E+  +    H N+V   G  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
             +    +  E+   GSL   ++  +    L   Q   +  +  +GL YLH   +   +H
Sbjct: 76  LRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK---MH 129

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-----IT 417
            DIK  NILL  N + K+ADFG+S  I    ++  + + GTP ++APE ++++       
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE-VAAVERKGGYN 187

Query: 418 EKVDIYSFGVVMLEI 432
           +  DI++ G+  +E+
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 38/160 (23%), Positives = 81/160 (50%), Gaps = 19/160 (11%)

Query: 283 EVKTIGSIHHQNLVRL--------IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD 334
           E+  +G ++H+N++++          +   + ++  +Y +M + + D W     D  +L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W----KDRPLL- 266

Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
            Q R  I+  +   + Y+H+   +K++H DIK +NI L+ +    + DFG +   ++++ 
Sbjct: 267 KQTRA-IMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 395 QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
                  GT    +PE L+     E  DI+S G+++L++L
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 18/225 (8%)

Query: 238 MTDNFRKMLGKGGFGSVFEGTQ---TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN 294
           M  N    L  G  G VF  T+       KV VK + G     K+   E+  + +I H+ 
Sbjct: 92  MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG----GKTPGREIDILKTISHRA 147

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF-QRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           ++ LI     KS    V   MP    D + +  RS    L  +Q   I   + + L YLH
Sbjct: 148 IINLIHAYRWKS---TVCMVMPKYKCDLFTYVDRSGPLPL--EQAITIQRRLLEALAYLH 202

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWL 412
               + I+H D+K +NI LD   NA + DFG + KL     +       GT    +PE L
Sbjct: 203 G---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259

Query: 413 S-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           +      K DI+S G+V+ E+          Q +     L SI +
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304

Length = 392

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 65/261 (24%), Positives = 103/261 (39%), Gaps = 74/261 (28%)

Query: 244 KMLGKGGFGSVFEGT------QTDGTKVAVKRL-EG-IGEINKSFLAEVKTIGSI-HHQN 294
           K+LG G FG V E +      ++    VAVK L EG     +K+ ++E+K +  I +H N
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72

Query: 295 LVRLIG--------------FC-------------------AEKSHNLLVY--------- 312
           +V L+G              FC                    EKS               
Sbjct: 73  VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 313 -EYMPNGSLDRWLFQR----------SDEFMLDWQQRKKIILD-------IAKGLTYLHE 354
            +          LF R            +   D  +    + D       +A+G+ +L  
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL-- 190

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWL- 412
              +K +H D+  +NILL  N   K+ DFGL++ I +D   V       P  ++APE + 
Sbjct: 191 -ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249

Query: 413 SSIITEKVDIYSFGVVMLEIL 433
             + T + D++SFGV++ EI 
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIF 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 23/186 (12%)

Query: 329 DEFMLDWQQRKKIILDIAKGLTYL-HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK 387
           DE  LD +        +AKG+++L  ++C    +H D+  +NILL      K+ DFGL++
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR 262

Query: 388 LIDQDQSQVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPE 445
            I  D + VV      P  ++APE + + + T + D++S+G+++ EI      F      
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI------FSLGSSP 316

Query: 446 EEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM 505
              M + S F K  +E             M S       M  +   C ++D  KRP+   
Sbjct: 317 YPGMPVDSKFYKMIKE----------GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366

Query: 506 VVRVLE 511
           +V+++E
Sbjct: 367 IVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 35/194 (18%)

Query: 275 EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD 334
           +I  +F      +  + H +L  + G C   S N++V E++ +G LD  L +      + 
Sbjct: 58  DIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVA 117

Query: 335 WQQRKKIIL--DIAKGLTYLHEDCRQKILHLDIKPQNILL------DGNFN-AKVADFGL 385
           W    KI +   +A  L+YL ED  + ++H ++  +NILL      +G     K++D G+
Sbjct: 118 W----KITVAQQLASALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170

Query: 386 SKLIDQDQSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFD--- 440
           S      + +V       P ++APE +     ++   D +SFG  +LEI C    FD   
Sbjct: 171 SFTALSREERV----ERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEI-C----FDGEV 220

Query: 441 ----RSQPEEEDMY 450
               R+  E+E  Y
Sbjct: 221 PLKERTPSEKERFY 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 22/222 (9%)

Query: 264 KVAVKRLE-GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
           KV +K L+    +I+ +F      +  + H+++V L G C     N++V E++  G LD 
Sbjct: 34  KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDL 93

Query: 323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-------DGN 375
           ++ ++SD     W  + K+   +A  L+YL ED  + ++H ++  +NILL       +  
Sbjct: 94  FMHRKSDVLTTPW--KFKVAKQLASALSYL-ED--KDLVHGNVCTKNILLAREGIDGECG 148

Query: 376 FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEIL 433
              K++D G+   +   Q  V       P ++APE +  S  ++   D +SFG  + EI 
Sbjct: 149 PFIKLSDPGIPITVLSRQECV----ERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEIC 203

Query: 434 CGRKV--FDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
              ++   D++  E+E  Y            +L+DL+    N
Sbjct: 204 YNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMN 245

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 21/197 (10%)

Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G +G V++      G   AVK  +LE  G+       E+  +    H N+V   G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
             +    +  EY   GSL   ++  +    L   Q   +  +  +GL YLH   +   +H
Sbjct: 76  LSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAYLHSKGK---MH 129

Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK--- 419
            DIK  NILL  N + K+ADFG++  I    ++  + + GTP ++APE  +    EK   
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAA---VEKNGG 185

Query: 420 ----VDIYSFGVVMLEI 432
                DI++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           +AKG+ +L     +K +H D+  +NILL  N   K+ DFGL++ I +D   V       P
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 405 -GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             ++APE +   + T + D++SFGV++ EI 
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 24/167 (14%)

Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKS-----HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
           E+  +  ++H+N++ L+  F  +KS        LV E M     D  L Q   +  LD +
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVI-QMDLDHE 118

Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ- 395
           +   ++  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++         
Sbjct: 119 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175

Query: 396 --VVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
             VVT       Y APE  L     E VDI+S G +M E++ G  +F
Sbjct: 176 PYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)

Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMELDHERMSYL 124

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 125 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 179

Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 31/164 (18%)

Query: 244 KMLGKGGFGSVFE---GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRL-- 298
           K++G GGFG V+E    +       AV ++E +   N++ + E     +I+  + + L  
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLE--NETIVMETLVYNNIYDIDKIALWK 75

Query: 299 -------IGF-----CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM---LDWQQR--KKI 341
                  +G      C       + Y ++    L++ L + + E         ++  K I
Sbjct: 76  NIHNIDHLGIPKYYGCGSFKRCRMYYRFI---LLEK-LVENTKEIFKRIKCKNKKLIKNI 131

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL 385
           + D+   L Y+HE     I H DIKP+NI++DGN    + D+G+
Sbjct: 132 MKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
             +A+G+ +L     +K +H D+  +NILL  N   K+ DFGL++ I +D   V      
Sbjct: 180 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 403 TP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI 432
            P  ++APE +   + T + D++SFGV++ EI
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 29/106 (27%), Positives = 57/106 (53%), Gaps = 8/106 (7%)

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
           +I  GL ++H    + +++ D+KP NILLD + + +++D GL+    + +        GT
Sbjct: 105 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 158

Query: 404 PGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
            GY+APE L   +      D +S G ++ ++L G   F + + +++
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 9/100 (9%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T      + +  +VAVK L+     ++  + ++E+K +  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM 332
           +N+V L+G C      L++ EY   G L  +L ++++ F+
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
           +I  GL ++H    + +++ D+KP NILLD + + +++D GL+    + +        GT
Sbjct: 105 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 158

Query: 404 PGYLAPEWLSSIIT--EKVDIYSFGVVMLEILCGRKVF 439
            GY+APE L   +      D +S G ++ ++L G   F
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 7/110 (6%)

Query: 326 QRSDEFMLDWQQRKKIILDIAKGLTYL-HEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
              D + LD     +    +A+G+ +L  ++C    +H D+  +N+LL     AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFG 257

Query: 385 LSKLIDQDQSQVVTTMRGTP-GYLAPE-WLSSIITEKVDIYSFGVVMLEI 432
           L++ I  D + VV      P  ++APE     + T + D++S+G+++ EI
Sbjct: 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 21/169 (12%)

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           +A G+ +L     +  +H D+  +N+L+      K+ DFGL++ I +D + +       P
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 405 -GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
             ++APE + +++ T   D++SFG+++ EI           P  E  Y  +  K+     
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY--NAIKRGYRMA 362

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           K +     H++D      E+  +M+    C E  F  RP  S +V ++ 
Sbjct: 363 KPA-----HASD------EIYEIMQK---CWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 9/100 (9%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     ++D    VAVK L+    + +  + ++E+K +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM 332
            N+V L+G C      L++ EY   G L  +L ++ D F+
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFI 138

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 40.7 bits (96), Expect = 7e-05
 Identities = 13/43 (30%), Positives = 19/43 (44%), Gaps = 3/43 (6%)

Query: 104 NTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYL-PSEIFSM 145
           +   + C+Q CL NCSC A  + Y        C +   E+  M
Sbjct: 26  SIGLKECEQRCLSNCSCTA--YAYADIRGGSGCLIWTGELVDM 66

Length = 66

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
             K LG+G FG V + +     K      VAVK L+     +  K+ + E+K +  I HH
Sbjct: 11  LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70

Query: 293 QNLVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML 333
            N+V L+G C +    L+V  EY   G+L  +L  + + F  
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 9/111 (8%)

Query: 244 KMLGKGGFGSVFEGTQTDGT------KVAVKRLEGIGEIN--KSFLAEVKTIGSI-HHQN 294
           ++LG G FG V EGT    +      KVAVK L+     +  ++ ++E+K +  +  H N
Sbjct: 43  RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           +V L+G C +     ++ EY   G L  +L +  D F+    ++ K  LDI
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDI 153

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           E   + +I+H ++++L G         L+        L R+   ++D +     +R   I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI--------LPRY---KTDLYCYLAAKRNIAI 181

Query: 343 LDIA-------KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL-IDQDQS 394
            DI        + + YLHE+   +I+H DIK +NI ++   +  + DFG +   +D + +
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 395 QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI-LCGRKVFDR 441
           +      GT    APE L+       VDI+S G+V+ E+  C   +F++
Sbjct: 239 KYY-GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 26/91 (28%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           +A+G+ +L     +  +H D+  +N+LL      K+ DFGL++ I  D + V       P
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 405 -GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             ++APE +  ++ T   D++S+G+++ EI 
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 12/100 (12%)

Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLEGIGEIN---KSFLAEVKTIGSI-HHQ 293
           K LG+G FG V E    G     T   VAVK L+  G  +   ++ ++E+K +  I HH 
Sbjct: 13  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHL 71

Query: 294 NLVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFM 332
           N+V L+G C +    L+V  E+   G+L  +L  +  EF+
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFV 111

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAP 409
           Y+H    + I+H DIK +N+L++G  +  + DFG +       S      + GT    AP
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 410 EWLS-SIITEKVDIYSFGVVMLE 431
           E L+    T  VDI+S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 37.2 bits (86), Expect = 0.002
 Identities = 18/61 (29%), Positives = 24/61 (39%), Gaps = 7/61 (11%)

Query: 79  SQDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLK-NCSCKAALFQYGLNSSAGDCY 137
             D  FV L +     FS     I+    E C   CL  NCSC++  +    N+    C 
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIV--ISVASLEECASKCLNSNCSCRSFTY----NNGTKGCL 54

Query: 138 L 138
           L
Sbjct: 55  L 55

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 16/154 (10%)

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V L  +   +    LV ++   G L   +   S    +  +  K+   ++   L  LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI---SKFLNIPEECVKRWAAEMVVALDALH 102

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFG-LSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
              R+ I+  D+ P NILLD   + ++  F   S++ D    + V  M     Y APE +
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPE-V 153

Query: 413 SSII--TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
             I   TE  D +S G ++ E+L G K      P
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	558
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
PRK10345	210	hypothetical protein; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.16
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.02
KOG3087	229	consensus Serine/threonine protein kinase [General	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.78
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
PRK09902	216	hypothetical protein; Provisional	98.49
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.07
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
PF01636	239	APH: Phosphotransferase enzyme family This family	98.02
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	97.95
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.86
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.78
PLN02876	822	acyl-CoA dehydrogenase	97.73
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.69
PRK10593	297	hypothetical protein; Provisional	97.69
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.69
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	97.45
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.4
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.33
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.31
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.24
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.15
PRK05231	319	homoserine kinase; Provisional	97.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.0
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.93
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.59
PLN02236	344	choline kinase	96.52
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.37
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.34
KOG2270	520	consensus Serine/threonine protein kinase involved	96.21
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.97
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.92
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.82
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.8
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.77
COG2334	331	Putative homoserine kinase type II (protein kinase	95.61
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.6
PRK11768	325	serine/threonine protein kinase; Provisional	95.49
PLN02756	418	S-methyl-5-thioribose kinase	95.3
PF14295	51	PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A.	95.19
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.13
PRK12396	409	5-methylribose kinase; Reviewed	94.69

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-57  Score=457.99  Aligned_cols=288  Identities=48%  Similarity=0.812  Sum_probs=252.7

Q ss_pred             CCCccCHHHHHHHHHHhh--hhcCccCceEEEEEEeCCCCEEEEEEecccccc-hHHHHHHHHHHhccCCcceeeeeeee
Q 043292          226 LPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI-NKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       226 ~~~~~~~~~l~~~t~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      ..+.|++.+|+.||++|.  ++||+|+||.||+|.+.++..||||++...... .++|.+|+.++++++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999997  699999999999999999999999998865544 67799999999999999999999999


Q ss_pred             ccCC-cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc
Q 043292          303 AEKS-HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA  381 (558)
Q Consensus       303 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~  381 (558)
                      .+.+ +++||||||++|+|.++|+..... .|+|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 499999999999999999976654 69999999999999999999999988899999999999999999999999


Q ss_pred             ccCCccccCCCCCceeecc-cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          382 DFGLSKLIDQDQSQVVTTM-RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       382 Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      |||+|+..... ....... .||.+|+|||++. +..++|+|||||||+|+||+||+++.+...+.. ...+..|.+..+
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~-~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG-ELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc-cccHHHHHHHHH
Confidence            99999765431 1112222 8999999999986 689999999999999999999999888655332 334788888888


Q ss_pred             hcccchhhccccCCCCCCCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          460 EEDKLSDLVDKHSNDMQSNG-EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ..+.+.+++|+.+....... +++.++..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            88899999999987444443 7899999999999999999999999999999665544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=380.64  Aligned_cols=250  Identities=34%  Similarity=0.518  Sum_probs=206.7

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccc---hHHHHHHHHHHhccCCcceeeeeeeeccCC-cceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI---NKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-HNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gs  319 (558)
                      +.||+|+||+||+|.+.....||||++......   .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+++|+
T Consensus        47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs  126 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS  126 (362)
T ss_pred             hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence            569999999999999875555999999754322   568999999999999999999999999988 7899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc-EEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCcee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK-ILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.++++.. ....+++..+++++.+||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus       127 L~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~  201 (362)
T KOG0192|consen  127 LSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM  201 (362)
T ss_pred             HHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence            99999875 23459999999999999999999999   67 99999999999999998 99999999998765432 234


Q ss_pred             ecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          398 TTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      +...||..|||||++.+   .++.|+|||||||++|||+||+.||.......       ........+...         
T Consensus       202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------~~~~v~~~~~Rp---------  265 (362)
T KOG0192|consen  202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------VASAVVVGGLRP---------  265 (362)
T ss_pred             cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcCCCC---------
Confidence            44789999999999984   49999999999999999999999998766421       111111111111         


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                       ..+......+..++.+||+.||..||++.+|+.+|+.+..
T Consensus       266 -~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  266 -PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence             1112255678889999999999999999999999987754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=382.20  Aligned_cols=262  Identities=29%  Similarity=0.477  Sum_probs=221.1

Q ss_pred             HHHHHHHHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          234 ELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       234 ~l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      ++......+.+.||+|.||.||.|.+.....||+|.++......+.|.+|+.+|.+|+|+|||+++|+|..++..+||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            33344445678999999999999999988899999999777777899999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      ||+.|+|.++|.... +..++..+.+.++.|||+||+||++   +++|||||.++|||++++..+||+|||||+...++.
T Consensus       282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            999999999998733 3359999999999999999999999   999999999999999999999999999999665555


Q ss_pred             CceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ........-+..|.|||.+. +.++.|||||||||+||||+| |+.||.+....+       .+ +.+..+.        
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~-~~le~Gy--------  421 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VL-ELLERGY--------  421 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HH-HHHhccC--------
Confidence            44444555678999999987 689999999999999999999 888987665443       11 1111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                        ..+.+..++..+.+|+..||..+|++|||++.+...|+.+....
T Consensus       422 --Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  422 --RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             --cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence              12334456778999999999999999999999999998876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=357.68  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=212.4

Q ss_pred             CccCHHHHHHHHHHhhhhcCccCceEEEEEEe-CCCCEEEEEEec--ccccchHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLE--GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       228 ~~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      ..++..||+..     +.||+|..|+|||+.+ .+++.+|+|.+.  ......++..+|++++...+||+||.++|.|..
T Consensus        74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            34677777765     7899999999999998 468899999994  334556789999999999999999999999999


Q ss_pred             CCc-ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEccc
Q 043292          305 KSH-NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADF  383 (558)
Q Consensus       305 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Df  383 (558)
                      ... ..|+||||.+|||++++....   .+++....+|+.+|++||.|||++  .+||||||||+|||++..|++||+||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence            884 999999999999999998653   389999999999999999999963  89999999999999999999999999


Q ss_pred             CCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          384 GLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       384 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                      |.+..+.+.   ...++.||..|||||.+++ .++.++||||||+.++|+.+|+.||....+..  ......        
T Consensus       224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~~~L--------  290 (364)
T KOG0581|consen  224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDIFEL--------  290 (364)
T ss_pred             cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCHHHH--------
Confidence            999977554   4567899999999999987 59999999999999999999999997652211  111111        


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       +..+++......+.. ....++..++..||+.||.+|||+.++++.
T Consensus       291 -l~~Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  291 -LCAIVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -HHHHhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             122233222222211 356789999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-45  Score=368.14  Aligned_cols=240  Identities=31%  Similarity=0.498  Sum_probs=205.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecc----cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG----IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+|+.+|+++. ..|+.||+|++.+    .....+...+|+++.+.|+|||||+++++|.+.++.|||.|+|++
T Consensus        23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~  102 (592)
T KOG0575|consen   23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR  102 (592)
T ss_pred             eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence            47899999999999998 7899999999975    344556789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..+++++.   .+++.+++.+++||+.||.|||+   .+|+|||||..|+||++++++||+|||||..+..+.. ..
T Consensus       103 ~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-rk  175 (592)
T KOG0575|consen  103 GSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-RK  175 (592)
T ss_pred             ccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc-cc
Confidence            99999998543   49999999999999999999999   9999999999999999999999999999998876544 35


Q ss_pred             ecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      .+.+||+.|+|||++.+. .+..+||||+||+||-|+.|++||+...-.+       .+.......            ..
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~------------Y~  236 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNE------------YS  236 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcC------------cc
Confidence            678999999999999864 8999999999999999999999998654332       121111111            11


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+........+||..+|+.||.+|||+++|+.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11123346778999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-45  Score=351.62  Aligned_cols=244  Identities=29%  Similarity=0.465  Sum_probs=198.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc--------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE--------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.||+|+||.|-+|.. .+++.||||.++....        ......+|+++|++++|||||++++++...+..|||+|
T Consensus       177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE  256 (475)
T KOG0615|consen  177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE  256 (475)
T ss_pred             eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence            57899999999999987 5799999999963211        12235799999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC---CCeEEcccCCccccC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFGLSKLID  390 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~---~~~ki~Dfgla~~~~  390 (558)
                      |++||+|.+++-.+.   .+.+..-..++.|++.|+.|||+   .||+||||||+|||+..+   ..+||+|||+|+...
T Consensus       257 ~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  257 YVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             EecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            999999999987654   37777788999999999999999   999999999999999766   679999999999875


Q ss_pred             CCCCceeecccCCCCcCChhhhcC---C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS---I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                        ....+.+.+||+.|.|||++.+   . +..|+|+||+||+||-+++|.+||........       ..++...+.+..
T Consensus       331 --~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI~~G~y~f  401 (475)
T KOG0615|consen  331 --EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQILKGRYAF  401 (475)
T ss_pred             --cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHHhcCcccc
Confidence              3446778999999999999864   2 44599999999999999999999975443221       111111222110


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                             .......-.++..+++.+||..||++|||+.|+++
T Consensus       402 -------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  402 -------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                   00112244568899999999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=377.10  Aligned_cols=272  Identities=27%  Similarity=0.509  Sum_probs=226.2

Q ss_pred             CccCHHHHHHHHHHhh-----------hhcCccCceEEEEEEeCC----CCEEEEEEeccc--ccchHHHHHHHHHHhcc
Q 043292          228 KRFSFEELKVMTDNFR-----------KMLGKGGFGSVFEGTQTD----GTKVAVKRLEGI--GEINKSFLAEVKTIGSI  290 (558)
Q Consensus       228 ~~~~~~~l~~~t~~~~-----------~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l  290 (558)
                      ..++|+|--.|...|.           ++||.|.||.|++|+++-    ...||||.|+..  .....+|+.|+.||+++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            4578887666666553           589999999999999852    346999999853  44467899999999999


Q ss_pred             CCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCE
Q 043292          291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNI  370 (558)
Q Consensus       291 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NI  370 (558)
                      +||||++|.|+.......+||+|||+||+|+.||.++..+  +++.++..++++||.||.||.+   .++|||||.++||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI  762 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI  762 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence            9999999999999999999999999999999999987765  9999999999999999999999   9999999999999


Q ss_pred             eecCCCCeEEcccCCccccCCCCCceeecccC--CCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 043292          371 LLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG--TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEE  446 (558)
Q Consensus       371 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~  446 (558)
                      |++.+...|++||||++.+.++.....++..|  +.+|.|||.+. +++|.+||||||||+|||.++ |.+||=.....+
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999999887665444444444  56999999987 679999999999999999998 999975443322


Q ss_pred             hhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccccccC
Q 043292          447 EDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHY  522 (558)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~~~  522 (558)
                             ..+.          ++... .++.+.+++..|.+|++.||++|-.+||.+.+|+.+|++++.-..++..
T Consensus       843 -------VIka----------Ie~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  843 -------VIKA----------IEQGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             -------HHHH----------HHhcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                   1111          11111 1345667888999999999999999999999999999998876655443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=343.07  Aligned_cols=196  Identities=32%  Similarity=0.617  Sum_probs=175.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||+||+|++ .++..||||.+...   .+..+.+..|+.+|+.++|||||.+++++..++..+||||||.+|
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG   94 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence            45699999999999998 46899999998644   344566889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC------CCeEEcccCCccccCCC
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN------FNAKVADFGLSKLIDQD  392 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~------~~~ki~Dfgla~~~~~~  392 (558)
                      +|.++++++..   +++.....++.|||.||++||+   .+||||||||+||||+..      -.+||+|||+|+.+.. 
T Consensus        95 DLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-  167 (429)
T KOG0595|consen   95 DLSDYIRRRGR---LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-  167 (429)
T ss_pred             CHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-
Confidence            99999987763   9999999999999999999999   999999999999999865      4689999999998764 


Q ss_pred             CCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE  446 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~  446 (558)
                       .....+.+|++-|||||++. .+|+.|+|+||.|++||++++|+.||+.....+
T Consensus       168 -~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  168 -GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             -hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence             33456789999999999985 679999999999999999999999998766554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-44  Score=375.38  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=212.0

Q ss_pred             HhhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          241 NFRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .|.+.||+|+||+||+|...      +..-||||.++...  +...+|.+|+++++.++|||||+|+|+|.+++..++|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            35688999999999999763      24569999998643  35678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc
Q 043292          313 EYMPNGSLDRWLFQRSD-----------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA  381 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~  381 (558)
                      |||..|+|.+||..+..           ...|+..+.+.||.|||.||+||.+   ..+|||||..+|+||.++..+||+
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIs  645 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKIS  645 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEec
Confidence            99999999999975321           1238999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHh
Q 043292          382 DFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKK  458 (558)
Q Consensus       382 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  458 (558)
                      ||||++..-..+.+. ...-.-.++|||||.+. ++||.+||||||||+||||++ |+.||.+....+..        +.
T Consensus       646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI--------e~  717 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI--------EC  717 (774)
T ss_pred             ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH--------HH
Confidence            999999654333322 22334477999999775 789999999999999999999 99999887765511        11


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ...+.+          .+.+..++..+..|+..||+.+|++||+++||-..|+...+.
T Consensus       718 i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 IRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            222221          344556778999999999999999999999999999876544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-44  Score=327.95  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=202.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecc---cccchHHHHHHHHHHhccCCcceeeeee-eeccCCc-ceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNLVRLIG-FCAEKSH-NLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e~~  315 (558)
                      +.++||+|.||+|||+.. .+|..+|.|.++-   ..+..++...|+.+|++|+|||||++++ .+.+++. .+||||++
T Consensus        23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c  102 (375)
T KOG0591|consen   23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC  102 (375)
T ss_pred             HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence            458899999999999976 6899999998872   2344567899999999999999999999 5555555 78999999


Q ss_pred             CCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          316 PNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       316 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      ..|+|...++.- ...+.+++..+++++.|++.||..+|+.... -|+||||||.||+|+.+|.+||+||||++.+....
T Consensus       103 ~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~  182 (375)
T KOG0591|consen  103 DAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT  182 (375)
T ss_pred             cccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh
Confidence            999999999753 3345699999999999999999999984322 38999999999999999999999999999886544


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . .....+|||.||+||.+.+ .++.||||||+||++|||..-+.||.+.+       +... .++...++...+     
T Consensus       183 t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L-~~KI~qgd~~~~-----  248 (375)
T KOG0591|consen  183 T-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSL-CKKIEQGDYPPL-----  248 (375)
T ss_pred             H-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHH-HHHHHcCCCCCC-----
Confidence            3 3567899999999999875 59999999999999999999999998653       2221 222333332211     


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                          ...-....+..|+..|+..||..||+.-.+++-+
T Consensus       249 ----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  249 ----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                1234566888999999999999999854444444

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=370.51  Aligned_cols=256  Identities=30%  Similarity=0.486  Sum_probs=210.6

Q ss_pred             hhhhcCccCceEEEEEEeCC--CC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD--GT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|.||.||.|...+  +.    .||||.++..  .+...+|++|..+|+.++|||||+++|+|.+....+|++|
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence            45789999999999998743  33    4899999854  4556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      ||++|+|..||++..    ....|+....+.++.+||+|+.||++   +++|||||.++|+||++...+||+|||||+.+
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            999999999998752    13459999999999999999999999   99999999999999999999999999999955


Q ss_pred             CCCCCceeecc-cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          390 DQDQSQVVTTM-RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       390 ~~~~~~~~~~~-~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                      .....+..... .-...|||||.+. +.++.|+|||||||+||||+| |..||...+..+    ++..+   ...+    
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~----v~~~~---~~gg----  921 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE----VLLDV---LEGG----  921 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----HHHHH---HhCC----
Confidence            44333332222 3457999999987 689999999999999999999 888997655432    11111   1111    


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                             .++.+..+++.+.+|+..||+.+|++||++..|++.++.+.....
T Consensus       922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                   223455677789999999999999999999999999888765543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-41  Score=334.20  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  317 (558)
                      ++||+|.||.||+++. .+|+.||+|++.-.   ........+|+.+|++|+||||++|.+...+.  ...|||+|||++
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh  202 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH  202 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence            6799999999999987 67999999998743   23345678999999999999999999988776  688999999976


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                       +|.-++....-  .++..++.-++.|++.||+|+|+   .+|+|||||.+|||||.+|.+||+|||||+++........
T Consensus       203 -DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~  276 (560)
T KOG0600|consen  203 -DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY  276 (560)
T ss_pred             -hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence             78887765432  39999999999999999999999   9999999999999999999999999999999888777777


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc----ch--hhcc
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK----LS--DLVD  469 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~d  469 (558)
                      +..+-|..|.|||++.|  .|+.++|+||.||||.||+.|+++|.+....++...+...........+    +.  ..+.
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k  356 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK  356 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence            88888999999999976  5999999999999999999999999988877655444333221111111    11  1111


Q ss_pred             ccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +.. ......     .-....++|+..+|..||.+|.|+.++++
T Consensus       357 p~~-~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  357 PQQ-PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCC-cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            100 000001     11246788999999999999999999884

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=330.90  Aligned_cols=269  Identities=25%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHh--ccCCcceeeeeeeeccCC----cceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG--SIHHQNLVRLIGFCAEKS----HNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~~  315 (558)
                      +.+++|+|.||.||||.+. ++.||||++....  .+.|.+|-++.+  .++|+||+++++.-..+.    +.+||++|.
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            4578999999999999987 4999999997433  345667666654  558999999999876665    789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC------CCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC------RQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      +.|+|.++|+.+.    ++|....+|+..+++||+|||++.      +++|+|||||++|||+.+|++..|+|||||..+
T Consensus       291 ~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  291 PKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             cCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999998765    899999999999999999999875      467999999999999999999999999999988


Q ss_pred             CCCCCce-eecccCCCCcCChhhhcCCC--C-----CccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          390 DQDQSQV-VTTMRGTPGYLAPEWLSSII--T-----EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       390 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~-----~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      ....... ....+||.+|||||++.+..  .     .+.||||+|.+||||++.-.-++.....+...-....+.....-
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            6443322 23478999999999998743  2     35899999999999999654333211111111000000000000


Q ss_pred             ccchhh-----ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          462 DKLSDL-----VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       462 ~~~~~~-----~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      +.+.++     ..+.+.+.-.....+..+.+.+..||..||+.|.|+.-|-+.+.++....
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            001110     11111111122255778999999999999999999999999988876655

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=335.95  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=212.5

Q ss_pred             HHHhhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchH--HHHHHHHHHhccC-CcceeeeeeeeccCC-cceEEEE
Q 043292          239 TDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINK--SFLAEVKTIGSIH-HQNLVRLIGFCAEKS-HNLLVYE  313 (558)
Q Consensus       239 t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~--~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e  313 (558)
                      .+...++||.|.||.||+|+- .++..||||++++.-..-+  .-++|++.|++++ ||||+++..++.+.+ ..++|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            345568999999999999987 5689999999986433333  3578999999998 999999999999888 8899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      || ..+|.++++++  ++.+++..+..|+.||++||+|+|+   .|+.|||+||+|||+..+..+||+|||+|+..... 
T Consensus        91 ~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   91 FM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             hh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC-
Confidence            99 46899999877  4579999999999999999999999   99999999999999999889999999999977543 


Q ss_pred             CceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch-----h
Q 043292          394 SQVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-----D  466 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  466 (558)
                       ...+..+.|..|.|||++.  +.|+.+.|||++||+++||.+-++.|.+.+..++...+..+........+..     .
T Consensus       164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence             3467788999999999875  5699999999999999999999999998887776665555443322221111     1


Q ss_pred             hccccCCCCCC------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          467 LVDKHSNDMQS------NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       467 ~~d~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+.-.+.....      -......+++++..|++.||.+|||+.+.+++
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111110000      11255688999999999999999999999976

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8e-42  Score=338.84  Aligned_cols=247  Identities=28%  Similarity=0.450  Sum_probs=207.0

Q ss_pred             cCHHHHHHHHHHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcce
Q 043292          230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       230 ~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  309 (558)
                      +.|++|...     +-||.|+.|.||+|++. ++.||||+++..+      ..+++-|++|+|+||+.|.|+|....-++
T Consensus       121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  121 IPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             CCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            556666554     56999999999999987 6889999887543      25788999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          310 LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      ||||||..|-|...|+...   .++......+..+||.||.|||.   ..|||||||.-||||+.+..+||+|||-++..
T Consensus       189 IiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhh
Confidence            9999999999999998654   38899999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ...  .....+.||..|||||++.+ ..++|+|||||||+||||+||..||..-....       ++|.          +
T Consensus       263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwG----------V  323 (904)
T KOG4721|consen  263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWG----------V  323 (904)
T ss_pred             hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEe----------c
Confidence            544  23456899999999999986 59999999999999999999999997443322       1111          1


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ..+...+..+..+++-+.-|++.||+-.|.+|||+++|+..|+-.
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            112223344556677888899999999999999999999998643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=325.05  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=204.0

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecc--cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||.|..++||+|+. +.+..||||++.-  .......+.+|+..++.++||||++.+..|..+...|+||.||.+|
T Consensus        30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G  109 (516)
T KOG0582|consen   30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG  109 (516)
T ss_pred             EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence            457899999999999987 6789999999973  3334578899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce--
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--  396 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--  396 (558)
                      |+.++++..-.. .+++..+..|++++++||.|||+   +|.||||||+.||||+++|.+||+|||.+..+.....+.  
T Consensus       110 S~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~  185 (516)
T KOG0582|consen  110 SLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT  185 (516)
T ss_pred             cHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence            999999864332 39999999999999999999999   999999999999999999999999999987654432221  


Q ss_pred             -eecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 -VTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 -~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       .....||+.|||||++..   -|+.|+||||||++..||.+|..||....+...  .++.     ++. ......- ..
T Consensus       186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~t-----Lqn-~pp~~~t-~~  256 (516)
T KOG0582|consen  186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLT-----LQN-DPPTLLT-SG  256 (516)
T ss_pred             eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHH-----hcC-CCCCccc-cc
Confidence             156789999999999542   399999999999999999999999987776441  1111     111 1111110 00


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+..........+.+++..||+.||.+|||++++++.
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0111112223478899999999999999999999853

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=345.63  Aligned_cols=255  Identities=31%  Similarity=0.453  Sum_probs=205.4

Q ss_pred             hhhhcCccCceEEEEEEeCC--C--CE-EEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD--G--TK-VAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||.||+|++..  +  .. ||||..+..    .....+|++|++++++++|||||+++|++......++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            34899999999999998842  2  23 899988742    344578999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      |++.||+|.++|++..+  .++..++.+++.+.|.||+|||+   .+++||||.++|+|++.++.+||+||||++.... 
T Consensus       241 El~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-  314 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-  314 (474)
T ss_pred             EecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc-
Confidence            99999999999998765  49999999999999999999999   9999999999999999999999999999886431 


Q ss_pred             CCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .........-+.+|+|||.+. +.++.++|||||||++||+++ |..||.+....+       ........+...     
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~~~r~-----  382 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKNGYRM-----  382 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhcCccC-----
Confidence            111111223567999999987 579999999999999999999 888997655432       111111111111     


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHN  519 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~  519 (558)
                           ..+...+..+..+...|+..+|++||||.+|.+.|+.+......
T Consensus       383 -----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  383 -----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                 11113445677788899999999999999999999988776554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=323.98  Aligned_cols=234  Identities=29%  Similarity=0.413  Sum_probs=193.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      -++||+|+||+||.++. ++++.+|+|++++..    ...+...+|..+|.+++||.||+++-.|++.+..|||+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            37899999999999987 468999999997542    2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.|..+|++...   +++..+.-++..|+.||.|||+   .+||||||||+|||||++|.++|+||||++...... ...
T Consensus       110 GeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t  182 (357)
T KOG0598|consen  110 GELFYHLQREGR---FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DAT  182 (357)
T ss_pred             ccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Ccc
Confidence            999999986653   8899899999999999999999   999999999999999999999999999999654332 335


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      .+++||+.|||||++.+ .++..+|.||+|+++|||++|.+||...+...       +..... .++        ..  .
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~-~~k--------~~--~  244 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKIL-KGK--------LP--L  244 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHh-cCc--------CC--C
Confidence            56899999999999876 59999999999999999999999998766433       111111 111        00  0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP  501 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP  501 (558)
                      .+.-......+++...|+.||++|-
T Consensus       245 ~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCccCCHHHHHHHHHHhccCHHHhc
Confidence            1111234677889999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=327.24  Aligned_cols=248  Identities=31%  Similarity=0.485  Sum_probs=197.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCC--cceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--HNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  317 (558)
                      ..+.||+|+||+||++... +|...|||.+.... ...+.+.+|+.+|.+++|||||+.+|.....+  ...+.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            4578999999999999985 48999999886432 12456899999999999999999999855555  58899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCC--CCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQ--DQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~--~~~  394 (558)
                      |+|.+++.+...  .|++..+.++.+||++||+|||+   ++|+||||||+|||++. ++.+||+|||+++....  ...
T Consensus       101 GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen  101 GSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            999999987664  39999999999999999999998   99999999999999999 79999999999987763  222


Q ss_pred             ceeecccCCCCcCChhhhc-CC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLS-SI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~-~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .......||+.|||||++. +. ...++|||||||+++||+||++||...  .+    ................      
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~----~~~~~~~ig~~~~~P~------  243 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE----EAEALLLIGREDSLPE------  243 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc----hHHHHHHHhccCCCCC------
Confidence            2344688999999999988 43 345999999999999999999999753  11    0111111111111111      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                          .+........+++..|++.||++|||+.++++..
T Consensus       244 ----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  244 ----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                1112345788899999999999999999999754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=338.35  Aligned_cols=241  Identities=29%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccch-HHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++||+|+.|.||.++. .+++.||||++....+.. +-.++|+.+|+..+|+|||+++..+..+++.|+|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            5799999999999987 578899999998665554 45789999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +.+....    +++.++..|+++++.||+|||.   .+|+|||||.+|||++.+|.+||+|||++..+..... ...+.+
T Consensus       359 DvVt~~~----~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV  430 (550)
T KOG0578|consen  359 DVVTKTR----MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV  430 (550)
T ss_pred             hhhhccc----ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence            9987544    9999999999999999999999   9999999999999999999999999999998876554 356789


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ||+.|||||+... .|.+|+||||||++++||+.|.+||-..++-. ..+      .....+         .........
T Consensus       431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-Aly------LIa~ng---------~P~lk~~~k  494 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALY------LIATNG---------TPKLKNPEK  494 (550)
T ss_pred             CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-HHH------HHhhcC---------CCCcCCccc
Confidence            9999999999875 69999999999999999999999997544321 111      111111         112223334


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+.+++.+||+.|+.+|||+.|+|+
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            4568899999999999999999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=338.55  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|.||+||+|++.  ..||||+++-.   .+..+.|.+|+..+++-+|.||+-+.|+|..... .||+.+|+|.+
T Consensus       397 ~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS  473 (678)
T KOG0193|consen  397 GERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS  473 (678)
T ss_pred             cceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence            478999999999999985  35999999733   3456789999999999999999999999998887 99999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC-CCceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-QSQVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~-~~~~~~  398 (558)
                      |+.+|+....  .++..+..+|++|||+|+.|||.   ++|||+|||..||+|.+++.|||+||||+..-..- ......
T Consensus       474 LY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~  548 (678)
T KOG0193|consen  474 LYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE  548 (678)
T ss_pred             hhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence            9999986553  38889999999999999999999   99999999999999999999999999998754322 122233


Q ss_pred             cccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc-hhhccccCC
Q 043292          399 TMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL-SDLVDKHSN  473 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~  473 (558)
                      ...|...|||||+++    ..|+..+||||||+++|||++|..||...+.+. ..      + .+..|.+ .+..     
T Consensus       549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-Ii------f-mVGrG~l~pd~s-----  615 (678)
T KOG0193|consen  549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-II------F-MVGRGYLMPDLS-----  615 (678)
T ss_pred             CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-eE------E-EecccccCccch-----
Confidence            456788999999986    259999999999999999999999998333221 10      0 0011110 1111     


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                        .........+.+|+..||..++++||.+.+|+.+|+.+..
T Consensus       616 --~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  616 --KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              1122345578889999999999999999999998888765

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.6e-41  Score=309.95  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++|+|++|.|||++.+ +|+.||||++..+.+   ..+-.++|+++|++++|+|+|.++.+|.......||+||++..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            46899999999999985 699999999975433   34568999999999999999999999999999999999998765


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+ |.....+  ++.....+++.|++.|+.|+|+   .++|||||||+||||+.++.+||+|||+|+.+.. .....+.
T Consensus        88 L~e-Le~~p~G--~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTD  160 (396)
T KOG0593|consen   88 LHE-LERYPNG--VPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTD  160 (396)
T ss_pred             HHH-HHhccCC--CCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhh
Confidence            554 4444433  8999999999999999999999   9999999999999999999999999999998864 2334567


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--------cccchhhcc
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--------EDKLSDLVD  469 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~d  469 (558)
                      .+-|..|.|||.+-+  +|...+||||.||++.||++|.+.|.+.+..++...+.........        ...+..+.-
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            788999999999876  5999999999999999999999999887765543332222211110        111111111


Q ss_pred             ccCCCCCCC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSN----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +.....+.-    .....-+++++..||+.||++|++-++++.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111111110    011236889999999999999999999884

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.5e-40  Score=301.30  Aligned_cols=260  Identities=26%  Similarity=0.398  Sum_probs=206.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|.||.||+|++ .+|+.||||+++...   .......+|++.|+.++|+||+.++++|.+.+..-||+|||+ .
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-t   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-T   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-c
Confidence            47899999999999998 579999999997432   235678999999999999999999999999999999999995 6


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|+..++++.  ..++..++..++.++++||+|+|+   ..|+||||||.|+|++++|.+||+|||+|+.+....... +
T Consensus        86 dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~  159 (318)
T KOG0659|consen   86 DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-T  159 (318)
T ss_pred             cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-c
Confidence            8999997654  359999999999999999999999   999999999999999999999999999999987655433 3


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc--cchhhccc---c
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDLVDK---H  471 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~---~  471 (558)
                      ..+-|..|.|||.+-|  .|+..+||||.||++.||+-|.+-|.+.+.-++...+.........+.  .+..+-|-   .
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            3367999999999865  599999999999999999999988887766554433333322111111  11111111   0


Q ss_pred             ----CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          472 ----SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       472 ----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          ......-......+++++..|+..||.+|+|++|++++
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                00000111234566999999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-40  Score=336.92  Aligned_cols=254  Identities=27%  Similarity=0.476  Sum_probs=197.8

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCC-cceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKS-HNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~lv  311 (558)
                      +.++||+|+||.||+|..      .++..||||+++...  .....+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI   90 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence            357899999999999974      235679999987432  2345689999999999 8999999999887644 57899


Q ss_pred             EEeCCCCCHHHHHhcCCC-----------------------------------------------------------CCC
Q 043292          312 YEYMPNGSLDRWLFQRSD-----------------------------------------------------------EFM  332 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~-----------------------------------------------------------~~~  332 (558)
                      |||+++|+|.+++.....                                                           ...
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            999999999999875321                                                           134


Q ss_pred             CCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhh
Q 043292          333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEW  411 (558)
Q Consensus       333 l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~  411 (558)
                      +++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||+
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence            8889999999999999999999   99999999999999999999999999999865432221 1223456788999998


Q ss_pred             hcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHH
Q 043292          412 LSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVA  489 (558)
Q Consensus       412 ~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  489 (558)
                      +.+ .++.++||||||+++|||++ |..||......+.   .    ......+....          ........+.+++
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~~----------~~~~~~~~l~~li  310 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---F----CQRLKDGTRMR----------APENATPEIYRIM  310 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---H----HHHHhcCCCCC----------CCCCCCHHHHHHH
Confidence            864 58999999999999999997 9999976543221   1    11111111100          0112234688999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          490 AWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       490 ~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .+|++.||.+|||+.+|+++|+.+..
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5e-40  Score=326.01  Aligned_cols=256  Identities=20%  Similarity=0.304  Sum_probs=201.6

Q ss_pred             ccCHHHHHHHHHHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccc----hHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          229 RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI----NKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       229 ~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      .++.+++...+   ...||+|++|.||+|.. +|+.||||+++.....    .+.|.+|+.++.+++||||++++|++.+
T Consensus        14 ~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         14 CIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             ecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            44555553221   14689999999999997 5889999999754332    3567899999999999999999999876


Q ss_pred             ----CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          305 ----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       305 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                          ....++||||+++|+|.+++....   .+++....+++.+++.||.|||+.  .+++||||||+|||+++++.+||
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEE
Confidence                346789999999999999997643   489999999999999999999972  47889999999999999999999


Q ss_pred             cccCCccccCCCCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH
Q 043292          381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      +|||+++......    ....++..|+|||++.+   .++.++||||||+++|||++|+.||......+    +..   .
T Consensus       165 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~---~  233 (283)
T PHA02988        165 ICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----IYD---L  233 (283)
T ss_pred             cccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----HHH---H
Confidence            9999998654321    23457899999999864   58999999999999999999999998654322    111   1


Q ss_pred             hhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       458 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ....+..          ...+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       234 i~~~~~~----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 IINKNNS----------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHhcCCC----------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1101000          0011123457889999999999999999999999998764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=326.22  Aligned_cols=243  Identities=25%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      |.+.||.|+|++|++++. .+++++|||++.+..    ...+-...|-..|.+| .||.|++|+-.|.+....|+|+||.
T Consensus        77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A  156 (604)
T KOG0592|consen   77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA  156 (604)
T ss_pred             hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence            568899999999999998 468999999997532    2234467788899999 8999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.++|++.+.   ++......++.+|+.||+|||+   .|||||||||+|||||+||.+||+|||.|+.+......
T Consensus       157 ~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  157 PNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             CCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            99999999987754   9999999999999999999999   99999999999999999999999999999988542211


Q ss_pred             ----------e--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          396 ----------V--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       396 ----------~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                                .  ...++||..|.+||++.. ..+..+|+|+|||+||.|+.|.+||.+.++--   ....+..      
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~------  301 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQA------  301 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHH------
Confidence                      1  145899999999999975 68999999999999999999999998665311   1111111      


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                           ++-     .++..-.+.+.+|+.+.|..||.+|+|.++|.+.
T Consensus       302 -----l~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 -----LDY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----hcc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                 011     1111122467788999999999999999888765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-39  Score=318.84  Aligned_cols=250  Identities=23%  Similarity=0.409  Sum_probs=198.5

Q ss_pred             HhhhhcCccCceEEEEEEeC----CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.+.||+|+||.||+|.+.    .+..||+|.++...  .....|.+|+..+.+++||||+++++++..++..++||||
T Consensus         8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   87 (266)
T cd05064           8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY   87 (266)
T ss_pred             EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence            34678999999999999763    35689999987542  2345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++.....  .+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+|++|||.+........
T Consensus        88 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          88 MSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             CCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            999999999976432  48999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             ceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .......++..|+|||.+. +.++.++||||||+++||+++ |..||......+    ....    ...+..        
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~~----~~~~~~--------  226 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIKA----VEDGFR--------  226 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH----HHCCCC--------
Confidence            1112234567899999886 468999999999999999875 999997544322    1111    111100        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        ..........+.+++..|++.+|.+|||+.+|++.|+++
T Consensus       227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              011122345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-39  Score=321.98  Aligned_cols=241  Identities=29%  Similarity=0.476  Sum_probs=203.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccch---HHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||||+-+ +.+.||+|.+.+.....   +.+.+|+++++.++|||||.++++|....+.++|.||+.+
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            3578999999999999874 68899999997654443   5588999999999999999999999999999999999976


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                       +|..+|.+...   |+++.+..|+.++..||.|||+   .+|+|||+||+||||+.++.+|++|||+|+.+... ....
T Consensus        86 -~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl  157 (808)
T KOG0597|consen   86 -DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL  157 (808)
T ss_pred             -hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence             99999987654   9999999999999999999999   99999999999999999999999999999987653 4456


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      +...||+-|||||+..+ .++..+|+||+||++||+++|++||....       +...++....+.         .   .
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~---------v---~  218 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDP---------V---K  218 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCC---------C---C
Confidence            77899999999999986 59999999999999999999999996322       222222222111         1   1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+......+..++...|+.||.+|.|+.+++..
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            222455678899999999999999999999853

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=316.05  Aligned_cols=252  Identities=28%  Similarity=0.413  Sum_probs=203.7

Q ss_pred             HHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          240 DNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      ..+.+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+++++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS   87 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence            34568999999999999998778899999998655556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++.............
T Consensus        88 L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05068          88 LLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG  163 (261)
T ss_pred             HHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence            999997654 2348999999999999999999999   899999999999999999999999999998765322211112


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...+..|+|||++.+ .++.++||||||++++||++ |+.||.......    +..   ........           ..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~---~~~~~~~~-----------~~  225 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQ---QVDQGYRM-----------PC  225 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH---HHHcCCCC-----------CC
Confidence            223458999998875 58999999999999999999 999986543221    111   11000000           01


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=321.93  Aligned_cols=241  Identities=26%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecc--cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.||+|.||.||||.+ ..++.||+|++.-  .....++..+|+.++..++++||.+.+|.+..+...+++|||+.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            6799999999999998 4688999999873  344567889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+.|+...   .+++....-|+++++.||.|||.   .+.+|||||+.|||+..+|.+|++|||++..+....... .++
T Consensus        99 ~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf  171 (467)
T KOG0201|consen   99 LDLLKSGN---ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF  171 (467)
T ss_pred             hhhhccCC---CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence            99997543   25778888899999999999999   999999999999999999999999999999887665544 789


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      +||+.|||||++.. .|+.|+||||||++.+||++|.+|+....++...                 -++.+..... ...
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-----------------flIpk~~PP~-L~~  233 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-----------------FLIPKSAPPR-LDG  233 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-----------------EeccCCCCCc-ccc
Confidence            99999999999986 5999999999999999999999999877664421                 1111111111 111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....+.+++..||+.||+.|||+.++++.
T Consensus       234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            344578899999999999999999999854

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.6e-39  Score=321.61  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=196.2

Q ss_pred             hhhhcCccCceEEEEEEeCC-----------------CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeee
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-----------------GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      +.++||+|+||.||++...+                 +..||+|.+...  .....+|.+|+.++.+++||||+++++++
T Consensus         9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   88 (304)
T cd05096           9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC   88 (304)
T ss_pred             eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            35789999999999997532                 336999998753  22345799999999999999999999999


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCC
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRS----------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIK  366 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk  366 (558)
                      .+.+..++||||+++++|.+++....                ....+++..+++++.||+.||.|||+   .+|+|||||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlk  165 (304)
T cd05096          89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA  165 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcc
Confidence            99999999999999999999986432                11347889999999999999999999   899999999


Q ss_pred             CCCEeecCCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh--CCCCCCCC
Q 043292          367 PQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC--GRKVFDRS  442 (558)
Q Consensus       367 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt--g~~p~~~~  442 (558)
                      |+|||++.++.+||+|||+++........ ......++..|+|||++. +.++.++||||||+++|||++  +..||...
T Consensus       166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            99999999999999999999865433221 122345578999999876 469999999999999999987  55677654


Q ss_pred             CCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          443 QPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ...+    .............. .....      ........+.+++.+|++.+|.+|||+.+|.++|++
T Consensus       246 ~~~~----~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         246 TDEQ----VIENAGEFFRDQGR-QVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CHHH----HHHHHHHHhhhccc-ccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            3322    11111111111000 00000      011223578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=325.45  Aligned_cols=239  Identities=29%  Similarity=0.529  Sum_probs=198.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc-----c-cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-----G-EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||+|+.|.. .++..||+|.+...     . ...+.+.+|+.++++++ ||||++++.++......++|||
T Consensus        21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE  100 (370)
T KOG0583|consen   21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME  100 (370)
T ss_pred             eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence            357899999999999977 57899999977543     1 23445668999999999 9999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-CCeEEcccCCccccCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQD  392 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~Dfgla~~~~~~  392 (558)
                      |+.+|+|.+++.+..   .+.+....++++|++.|++|+|+   .+|+||||||+|||++.+ +++||+|||++.... .
T Consensus       101 y~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~  173 (370)
T KOG0583|consen  101 YCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G  173 (370)
T ss_pred             ecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence            999999999998733   38899999999999999999999   999999999999999999 999999999999774 2


Q ss_pred             CCceeecccCCCCcCChhhhcCC--C-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc--cchhh
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSSI--I-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDL  467 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~~--~-~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  467 (558)
                      ......+..||+.|+|||++.+.  + ..++||||+||+||-|++|..||+..+..       ..... ...+  .+...
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~k-i~~~~~~~p~~  245 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRK-IRKGEFKIPSY  245 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHH-HhcCCccCCCC
Confidence            23346778999999999999863  4 47899999999999999999999863322       11111 1111  11111


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      ++            ...+..++.+|+..||.+|+|+.+|+
T Consensus       246 ~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  246 LL------------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cC------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11            44788999999999999999999999

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.7e-39  Score=313.72  Aligned_cols=249  Identities=25%  Similarity=0.427  Sum_probs=202.5

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .++||+|+||.||+|...++..||+|.+.......+.+..|+.+++.++|+||+++++.+..++..+++|||+++++|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD   90 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence            47899999999999998888899999987655556789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++..... ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++...............+
T Consensus        91 ~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  166 (261)
T cd05072          91 FLKSDEG-GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF  166 (261)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCcc
Confidence            9975432 248899999999999999999999   899999999999999999999999999998765433222223445


Q ss_pred             CCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      +..|+|||.+.+ .++.++||||||+++|||++ |+.||.......    .....    ......          +....
T Consensus       167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~----~~~~~~----------~~~~~  228 (261)
T cd05072         167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSAL----QRGYRM----------PRMEN  228 (261)
T ss_pred             ceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHH----HcCCCC----------CCCCC
Confidence            678999998864 58999999999999999998 999986543221    11111    111000          00111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ....+.+++.+|++.+|++|||+++++++|+.+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.9e-39  Score=313.16  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=199.9

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||.||++...++..+|+|.+........++..|+.++++++||||+++++++..+...++||||+++|+|.
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   87 (256)
T cd05114           8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL   87 (256)
T ss_pred             EeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            34789999999999999888889999998765555678999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++..............
T Consensus        88 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          88 NYLRQRQG--KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            99875433  38999999999999999999999   99999999999999999999999999999865433222222234


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||++.+ .++.++||||||+++|||++ |+.||......+    .   ..... .+..  ..        .+.
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~----~---~~~i~-~~~~--~~--------~~~  224 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE----V---VEMIS-RGFR--LY--------RPK  224 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH----H---HHHHH-CCCC--CC--------CCC
Confidence            5668999999874 58999999999999999999 899986543221    1   11111 1100  00        011


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .....+.+++.+|++.+|++|||+.++++.|.
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12346899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=364.24  Aligned_cols=257  Identities=28%  Similarity=0.524  Sum_probs=206.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .++||+|+||.||+|+. .++..||||+++.....   ...|++.+++++|||||++++++.++...++||||+++|+|.
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS  771 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence            46899999999999987 57899999998754332   235688999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      ++++.      ++|..+.+|+.||++||+|||+.+..+|+||||||+||+++.++.+++. ||.+......     ....
T Consensus       772 ~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~  839 (968)
T PLN00113        772 EVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF  839 (968)
T ss_pred             HHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence            99952      8999999999999999999996556899999999999999999988875 6665433221     2235


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC-CCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND-MQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~  479 (558)
                      ++..|+|||++.+ .++.++|||||||++|||++|+.||+.....  ...+..|.+..........++|+.+.. .....
T Consensus       840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            7899999999875 5999999999999999999999999643322  223444444443334445555555432 23345


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ++...+.+++.+|++.+|++||||.+|+++|+++...
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            6778899999999999999999999999999987653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.1e-39  Score=329.91  Aligned_cols=252  Identities=29%  Similarity=0.480  Sum_probs=198.0

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||.||+++.      .++..||||+++...  ...+.+.+|+.++..+ +||||+++++++..++..++||
T Consensus        39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~  118 (375)
T cd05104          39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT  118 (375)
T ss_pred             hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence            458899999999999963      245689999987432  2345688999999999 8999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------------------------------------------------------
Q 043292          313 EYMPNGSLDRWLFQRSD---------------------------------------------------------------  329 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  329 (558)
                      ||+++|+|.+++.....                                                               
T Consensus       119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (375)
T cd05104         119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD  198 (375)
T ss_pred             hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence            99999999999864321                                                               


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-eec
Q 043292          330 ---------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTT  399 (558)
Q Consensus       330 ---------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~  399 (558)
                               ...+++..+.+++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++......... ...
T Consensus       199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence                     1247899999999999999999999   999999999999999999999999999998664432211 122


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ..++..|+|||++.+ .++.++||||||+++|||++ |..||........   ....    ...+....     .     
T Consensus       276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~~----~~~~~~~~-----~-----  338 (375)
T cd05104         276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYKM----IKEGYRML-----S-----  338 (375)
T ss_pred             CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHHH----HHhCccCC-----C-----
Confidence            345678999999875 58999999999999999998 8888865433221   1111    11111000     0     


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .......+.+++.+|++.||++|||+.+|+++|++.
T Consensus       339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.3e-39  Score=314.34  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=201.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.++||+|+||.||++... .++.||+|.++.......++.+|++++.+++|+||+++++++..+...+++|||+++++|
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL   89 (263)
T ss_pred             EeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence            3578999999999999874 588999999886655567899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..............
T Consensus        90 ~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          90 LDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             HHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            999875432 348999999999999999999999   8999999999999999999999999999987654322211223


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+..|+|||.+.+ .++.++||||||+++|||++ |..||......+    ...    ......     ..     ...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~----~~~~~~-----~~-----~~~  227 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE----LLEKGY-----RM-----ERP  227 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH----HHHCCC-----CC-----CCC
Confidence            34668999998874 58999999999999999998 889986543221    111    111100     00     011


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ......+.+++.+|++.+|++|||+.+++++|+.+
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11235788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-39  Score=319.58  Aligned_cols=246  Identities=36%  Similarity=0.580  Sum_probs=190.2

Q ss_pred             hhhcCccCceEEEEEEeC-----CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-----DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||.|.||.||+|.+.     .+..|+||.++...  ...+.|.+|++.+.+++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999876     25679999996532  23578999999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.++|..... ..+++..++.|+.||++||.|||+   .+++|+||+++|||+++++.+||+|||++.........
T Consensus        84 ~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            99999999987622 248999999999999999999999   89999999999999999999999999999876332221


Q ss_pred             -eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 -VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 -~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ..........|+|||.+.. .++.++||||||+++|||++ |+.||......+       +.... ..+.....     
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~-~~~~~~~~-----  226 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKL-KQGQRLPI-----  226 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHH-HTTEETTS-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccc-ccccccee-----
Confidence             2233456779999999864 58999999999999999999 678886543211       11111 11111111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                           .......+.+++..||+.+|.+|||+.+|++.|
T Consensus       227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 111234688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.3e-38  Score=309.55  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=200.2

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||.||++...++..+|+|.++.......+|.+|+.++.+++||||+++++++......++||||+++++|.
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (256)
T cd05113           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL   87 (256)
T ss_pred             EeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence            45789999999999998877778999998865555678999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..++.++.||+.||.|||+   .+++|+||||+||++++++.+||+|||+++..............
T Consensus        88 ~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          88 NYLREHGK--RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            99976433  48999999999999999999999   99999999999999999999999999998865443222122234


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    .   .... ..+...     .     ...
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~---~~~~-~~~~~~-----~-----~~~  224 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----T---VEKV-SQGLRL-----Y-----RPH  224 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----H---HHHH-hcCCCC-----C-----CCC
Confidence            5678999999874 68999999999999999998 999987544322    1   1111 111100     0     011


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            12357899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.1e-39  Score=317.81  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=196.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||+++.. +++.||+|+++..   ....+.+.+|+.++..++|+||+++++++..++..++||||+++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07848           5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK   84 (287)
T ss_pred             EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence            3478999999999999985 6889999998743   22345688999999999999999999999999999999999998


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +.+..+....   ..+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++...........
T Consensus        85 ~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          85 NMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            8776554322   248999999999999999999999   9999999999999999999999999999987654333333


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH--------HHhhhcccchhhc
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF--------KKKAEEDKLSDLV  468 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  468 (558)
                      ....|+..|+|||++.+ .++.++|||||||++|||++|+.||......+....+....        .............
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            44678999999999875 58999999999999999999999997654332211111100        0000000000000


Q ss_pred             cccCCCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........     ........+.+++.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000     00012346899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-38  Score=316.04  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=195.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++.. .+++.||+|.+....    .....+.+|+.++.+++|+||+++++++.+++..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            46899999999999987 578999999886422    2234578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++..... ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++.......  ..
T Consensus        85 g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  158 (285)
T cd05631          85 GDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TV  158 (285)
T ss_pred             CcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--ee
Confidence            999988865332 248999999999999999999999   999999999999999999999999999998654322  23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ .++.++|||||||++|||++|+.||...........+.    ....... .          .
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~-~----------~  223 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----RRVKEDQ-E----------E  223 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----HHhhccc-c----------c
Confidence            34578999999999875 58999999999999999999999998654322111111    0000000 0          0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      ........+.+|+.+||+.||.+||+     ++++++
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11122346788999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.4e-38  Score=308.99  Aligned_cols=252  Identities=28%  Similarity=0.447  Sum_probs=203.4

Q ss_pred             HHHHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          238 MTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       238 ~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+..+.++||+|+||.||++...+++.||+|.+........++.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN   84 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence            344566899999999999999888999999999876666678999999999999999999999874 4568999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++...........
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          85 GSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence            999999875433 348999999999999999999999   8999999999999999999999999999987653322222


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....++..|+|||.+.. .++.++||||||++++||++ |+.||......+    ...   . ........         
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~---~-~~~~~~~~---------  223 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQ---N-LERGYRMP---------  223 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHH---H-HHcCCCCC---------
Confidence            23445778999999864 58899999999999999999 999997544322    111   1 00110000         


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                       ........+.+++.+|++.+|++|||+++++++|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             011123478999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=308.93  Aligned_cols=246  Identities=26%  Similarity=0.423  Sum_probs=199.0

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||.||++...++..+|+|.+.........|.+|+.++.+++|+||+++++++...+..++||||+++++|.
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL   87 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence            55789999999999998877778999998765555567899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..+..  .+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++..............
T Consensus        88 ~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          88 NYLRERKG--KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             HHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            99976443  48999999999999999999999   89999999999999999999999999999865432221112223


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+.    .   ... ...     ...     ....
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~---~~~-~~~-----~~~-----~~~~  224 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----V---ESV-SAG-----YRL-----YRPK  224 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----H---HHH-HcC-----CcC-----CCCC
Confidence            4468999999874 68999999999999999999 8889875433221    1   111 011     000     0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      .....+.+++.+|++.+|++|||+.+++++|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2345789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=321.64  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=206.1

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      -|.++||+|-||.|.+.....+..||||.++...  ....+|..|+++|.+++||||++++|+|..++..++|+|||++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            3568999999999999998888999999998543  34578999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-ee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~  397 (558)
                      +|.+||..+.... +.-....+|+.|||.||+||.+   .++|||||.++|+|++.++++||+|||+++.+-..... ..
T Consensus       621 DLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  621 DLNQFLSAHELPT-AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             cHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            9999998775332 4556677899999999999999   99999999999999999999999999999955433333 33


Q ss_pred             ecccCCCCcCChhhh-cCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC-
Q 043292          398 TTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILC--GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN-  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~-~~~~~~k~Dv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-  473 (558)
                      ...+-+.+|||||.+ .++++.++|||+||+++||+++  ..+||.....+..    ..-.         -++++.... 
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~---------~~~~~~~~~~  763 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENA---------GEFFRDQGRQ  763 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhh---------hhhcCCCCcc
Confidence            455667899999975 5899999999999999999866  7788865443221    1111         111111100 


Q ss_pred             -CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          474 -DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       474 -~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                       -...+.-+...+.+++++|+..+..+|||++++...|.+.
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             0112234556788999999999999999999999888653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-38  Score=327.03  Aligned_cols=253  Identities=25%  Similarity=0.472  Sum_probs=197.5

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.+.||+|+||.||+++.      .++..||+|+++...  .....+.+|+.+++.+ +|+||+++++++..+...++||
T Consensus        42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~  121 (374)
T cd05106          42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT  121 (374)
T ss_pred             ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence            458899999999999874      234579999997432  2345688999999999 8999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------------------------------------------------------
Q 043292          313 EYMPNGSLDRWLFQRSD---------------------------------------------------------------  329 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  329 (558)
                      ||+++|+|.+++.....                                                               
T Consensus       122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (374)
T cd05106         122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE  201 (374)
T ss_pred             hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence            99999999999864211                                                               


Q ss_pred             ----CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-eecccCCC
Q 043292          330 ----EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTP  404 (558)
Q Consensus       330 ----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~  404 (558)
                          ...+++.++++++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++......... .....++.
T Consensus       202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~  278 (374)
T cd05106         202 DTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV  278 (374)
T ss_pred             ccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence                1247889999999999999999999   999999999999999999999999999998654332211 12234567


Q ss_pred             CcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHH
Q 043292          405 GYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEV  482 (558)
Q Consensus       405 ~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  482 (558)
                      .|+|||++.+ .++.++||||||+++|||++ |+.||........   ....    ...+.     .....     ....
T Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~----~~~~~-----~~~~~-----~~~~  341 (374)
T cd05106         279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKM----VKRGY-----QMSRP-----DFAP  341 (374)
T ss_pred             ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHH----HHccc-----CccCC-----CCCC
Confidence            8999998864 69999999999999999997 9999975433221   1111    11100     00000     0113


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          483 VNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       483 ~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ..+.+++.+|++.||++|||+.+|+++|+++.
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            47889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-39  Score=308.33  Aligned_cols=243  Identities=25%  Similarity=0.448  Sum_probs=205.5

Q ss_pred             HHhhhhcCccCceEEEEEEe-CCCCEEEEEEecccccc----hHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          240 DNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEI----NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.|.+.||+|.||.|-++.. ..|+.||||.+++....    .-.+.+|+++|+.|+||||+.++.+|.+.+...|||||
T Consensus        55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY  134 (668)
T KOG0611|consen   55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY  134 (668)
T ss_pred             HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence            44568899999999999987 67999999999754332    23478899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ..+|.|.+++..+..   |++.+...+++||..|+.|+|+   .+++|||||.+|||||+++++||+||||+.++...  
T Consensus       135 aS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--  206 (668)
T KOG0611|consen  135 ASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--  206 (668)
T ss_pred             cCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence            999999999987664   9999999999999999999999   99999999999999999999999999999987553  


Q ss_pred             ceeecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ...++++|++-|.+||++.|.  -.+.+|-|||||+||-|+.|..||++.+...       .+++ ...+...       
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQ-Is~GaYr-------  271 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQ-ISRGAYR-------  271 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHH-hhccccc-------
Confidence            457789999999999999874  5689999999999999999999998765322       1111 1112111       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                           ..+.+....-||.|||..||++|.|+.+|....
T Consensus       272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                 112233566799999999999999999998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-38  Score=322.16  Aligned_cols=240  Identities=28%  Similarity=0.367  Sum_probs=194.1

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||+++. .+++.||+|+++..    ......+..|+.++.+++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999987 46899999998743    223356788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~  153 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence            9999987543   48999999999999999999999   99999999999999999999999999998753222 12233


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||++.+ .++.++|||||||++|||++|+.||.......    +...   .. ....           ..
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~---~~-~~~~-----------~~  214 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFEL---IL-MEEI-----------RF  214 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHH---HH-cCCC-----------CC
Confidence            4679999999999875 58999999999999999999999997543221    1111   00 0000           01


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      +......+.+++.+||+.||++||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            112234678899999999999999     79988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.6e-38  Score=312.00  Aligned_cols=250  Identities=27%  Similarity=0.487  Sum_probs=200.0

Q ss_pred             hhhhcCccCceEEEEEEeCC------CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+|....      ...|++|.+....  ....+|.+|+.++.+++||||+++++++......+++||
T Consensus         9 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   88 (283)
T cd05048           9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE   88 (283)
T ss_pred             hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence            35789999999999998643      2579999886432  234568999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          314 YMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                      |+++++|.+++.....             ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L  165 (283)
T cd05048          89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEE
Confidence            9999999999975421             1358899999999999999999999   89999999999999999999999


Q ss_pred             cccCCccccCCCCC-ceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHH
Q 043292          381 ADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       381 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      +|||+++....... .......++..|+|||.+. +.++.++||||||+++|||++ |..||......+    +..    
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----~~~----  237 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----VIE----  237 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH----
Confidence            99999986533221 1223345678899999876 468999999999999999998 999997654332    111    


Q ss_pred             hhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       458 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ....+...          .........+.+|+.+|++.||.+||++.+|++.|+.
T Consensus       238 ~i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111111          0112334688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=293.27  Aligned_cols=237  Identities=30%  Similarity=0.470  Sum_probs=196.3

Q ss_pred             cCHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       230 ~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      +++++.+.     .+.||.|+||.|.+++.+ +|..+|+|+++...    ...+...+|.++|+.+.||.++++.+.+.+
T Consensus        41 ~~l~dfe~-----~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFER-----LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhh-----eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            66666543     378999999999999984 68899999997532    223457889999999999999999999999


Q ss_pred             CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      .+..+|||||.+||.|..+|++...   ++.....-++.||+.||+|||+   .+|++|||||+|||||.+|.+||.|||
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEecc
Confidence            9999999999999999999987553   9999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      .|+.....    .-+.+||+.|+|||++.. .++..+|.|||||++|||+.|.+||...++..       ++. +..+++
T Consensus       190 FAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~-KI~~~~  257 (355)
T KOG0616|consen  190 FAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYE-KILEGK  257 (355)
T ss_pred             ceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHH-HHHhCc
Confidence            99976432    557899999999999875 59999999999999999999999998776532       111 111111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCC
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR  500 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  500 (558)
                      +           ..+.--...+.+|+...|+.|-.+|
T Consensus       258 v-----------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 V-----------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             c-----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1           1122222356778888889888888

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=319.66  Aligned_cols=237  Identities=26%  Similarity=0.344  Sum_probs=190.7

Q ss_pred             cCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||+|+||.||+++.. +++.||+|.++..    ......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999884 5889999998642    23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  153 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF  153 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence            99997643   38999999999999999999999   999999999999999999999999999998543222 123446


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .||+.|+|||++.+ .++.++|||||||+++||++|+.||......+       ....... ..        .   ....
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~~~-~~--------~---~~~~  214 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKILQ-EP--------L---RFPD  214 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHHHc-CC--------C---CCCC
Confidence            78999999999876 58999999999999999999999997543221       1111111 10        0   0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPS---MSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~  508 (558)
                      .....+.+++..||+.||.+||+   +.++++
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            22346788999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=322.73  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=215.8

Q ss_pred             HHHHHHHHhhhhcCccCceEEEEEEeCC-CCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          234 ELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       234 ~l~~~t~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      |++........+||.|.||.||.|.++. .-.||||.++...-..++|+.|..+|+.++|||+|+++|+|......|||+
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            4444333456899999999999999954 678999999988888899999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      |||.+|+|.++|.+.... .++.--++.++.||+.||+||..   .++|||||.++|.|+.++..+||+||||++++..+
T Consensus       343 EfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             ecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            999999999999875433 47778889999999999999998   99999999999999999999999999999999776


Q ss_pred             CCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .........-.+.|.|||-+. +.++.|+|||+|||+||||.| |-.||.+..       +...+          +++.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY----------~LLEk  481 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVY----------GLLEK  481 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHH----------HHHhc
Confidence            544444445578999999886 579999999999999999998 778886433       22211          12221


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ..+ ...+..++..+.+|++.||+.+|.+||++.|+-+.+|.+..
T Consensus       482 gyR-M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  482 GYR-MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ccc-ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            111 12233456789999999999999999999999999987644

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-38  Score=314.46  Aligned_cols=260  Identities=23%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||.|+||.||++... +++.||+|.++..  ......+.+|+.++++++||||+++++++......++||||++ +
T Consensus         9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (288)
T cd07871           9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-S   87 (288)
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-c
Confidence            3478999999999999874 6889999998643  2234567899999999999999999999999989999999997 4


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.....  .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        88 ~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~  161 (288)
T cd07871          88 DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYS  161 (288)
T ss_pred             CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-ccc
Confidence            89988865432  47899999999999999999999   9999999999999999999999999999976533221 223


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--------cccchhhc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--------EDKLSDLV  468 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~  468 (558)
                      ...+++.|+|||.+.+  .++.++||||+|+++|||++|+.||......+....+.........        ...+....
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4567899999998864  4899999999999999999999999765544322211111100000        00000000


Q ss_pred             cccCCCCC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQ---SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+......   ........+.+++.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000   00011246789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.2e-38  Score=306.77  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=203.8

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.++||.|+||.||+|...++..+++|.+..... ....+..|+.+++.++|+||+++++++......++||||+++++
T Consensus         9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (261)
T cd05148           9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS   88 (261)
T ss_pred             HHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence            44688999999999999998899999999875544 45678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++..... ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ ....
T Consensus        89 L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~  163 (261)
T cd05148          89 LLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSD  163 (261)
T ss_pred             HHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-cccC
Confidence            9999976443 348999999999999999999999   8999999999999999999999999999987643322 1223


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ..++..|+|||.+.+ .++.++||||||+++++|++ |+.||......+    ......    .+..          ...
T Consensus       164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----~~~~~~----~~~~----------~~~  225 (261)
T cd05148         164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQIT----AGYR----------MPC  225 (261)
T ss_pred             CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHH----hCCc----------CCC
Confidence            445678999998864 58999999999999999998 899996544221    111110    0000          011


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .......+.+++.+|++.||.+|||+.++++.|+.+
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-37  Score=305.47  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=199.9

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.++||+|+||.||++...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++++|
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L   87 (260)
T cd05070           9 QLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL   87 (260)
T ss_pred             hhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence            345789999999999999888889999999865555678999999999999999999999885 4567899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++.++..++.+++.||.|||+   .+++|+||||+||++++++.++|+|||++..+...........
T Consensus        88 ~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          88 LDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             HHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            999975432 248999999999999999999999   8999999999999999999999999999987644322222223


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      .++..|+|||.+.+ .++.++||||||++++||++ |..||......+    ...   ........           +..
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~---~~~~~~~~-----------~~~  225 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----VLE---QVERGYRM-----------PCP  225 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----HHH---HHHcCCCC-----------CCC
Confidence            45678999998764 58999999999999999999 888986543221    111   11100000           011


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ......+.+++.+|++.+|.+|||+.++++.|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=315.89  Aligned_cols=239  Identities=26%  Similarity=0.349  Sum_probs=194.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||++... +++.||+|++....    ...+.+.+|+.++.+++||||+++++++.++...++||||++
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   84 (291)
T cd05612           5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP   84 (291)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence            3478999999999999985 68999999986422    234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....    
T Consensus        85 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          85 GGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            999999997644   38999999999999999999999   99999999999999999999999999999865432    


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....|++.|+|||++.+ .++.++||||||+++|||++|+.||......+    +   .... ..+..           
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~---~~~i-~~~~~-----------  215 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----I---YEKI-LAGKL-----------  215 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHH-HhCCc-----------
Confidence            223568999999999875 48999999999999999999999997644322    1   1111 11110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  509 (558)
                      ..+......+.+++.+||+.||.+||+     +.++++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            001111346789999999999999995     7777743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-38  Score=293.27  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=200.7

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccc---hHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEI---NKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  317 (558)
                      ++|++|.||.||+|++ .+++.||+|+++-..+.   .-.-++|+.+|.+++|||||.+..+...  -+..||||||+++
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            6799999999999998 47889999999744322   2346899999999999999999887654  4568999999965


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                       +|..++.....  .+...+..-+..|+++|++|||.   ..|+|||||++|+|++..|.+||+|||||+.+.... ...
T Consensus       162 -DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~  234 (419)
T KOG0663|consen  162 -DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPY  234 (419)
T ss_pred             -hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-ccC
Confidence             89998887653  48899999999999999999999   999999999999999999999999999999987653 346


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc----cchhhcc-c
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED----KLSDLVD-K  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d-~  470 (558)
                      +..+-|..|.|||++.+  .++...|+||+|||+.|++++++.|.+....++...+...........    .....+. -
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            67778999999999875  599999999999999999999999998877665444443322111100    0000000 0


Q ss_pred             cCCCCCC-------CH-HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQS-------NG-EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~-------~~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.       .. ...+.-.+++...|..||.+|.|+.+.++
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0000000       00 02356678888899999999999999875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.8e-38  Score=306.18  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.++||+|+||.||+|+..+...||+|.++......+++.+|+.++.+++|+||+++++++.. ...++||||+++++|
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L   87 (262)
T cd05071           9 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL   87 (262)
T ss_pred             eEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcH
Confidence            3457899999999999998777789999998655556789999999999999999999998754 567999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..............
T Consensus        88 ~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          88 LDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             HHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            999975432 347999999999999999999999   9999999999999999999999999999986654332222234


Q ss_pred             cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      .++..|+|||+.. +.++.++||||||++++||++ |..||......+    .   ..... ...          .....
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~---~~~~~-~~~----------~~~~~  225 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----V---LDQVE-RGY----------RMPCP  225 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----H---HHHHh-cCC----------CCCCc
Confidence            4667899999876 468999999999999999999 888886543221    0   00100 000          00111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ......+.+++.+|++.+|++|||+.+++++|+..
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            23445788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7e-39  Score=305.57  Aligned_cols=283  Identities=23%  Similarity=0.335  Sum_probs=210.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCc-----ceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH-----NLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~~~~  317 (558)
                      +++|+|+||.||+|++. +++.||||+.-.....   -..|+.+|+++.|||||+++-+|.....     ..+|||||+.
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~  106 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE  106 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence            68999999999999984 5789999988654432   2378999999999999999988865332     3589999975


Q ss_pred             CCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-CCeEEcccCCccccCCCCCc
Q 043292          318 GSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       318 gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~~~  395 (558)
                       +|...++.. ..+..++...+.-+..||.+||.|||+   .+|+||||||.|+|+|.+ |.+||+|||.|+.+..... 
T Consensus       107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep-  181 (364)
T KOG0658|consen  107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP-  181 (364)
T ss_pred             -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC-
Confidence             788888742 112347778888899999999999999   999999999999999976 8999999999998865443 


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc------ccchhh
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE------DKLSDL  467 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  467 (558)
                       .....-|.-|.|||.+-|  .++.+.||||.||++.||+-|++.|.+.+..++...+.........+      ....+.
T Consensus       182 -niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 -NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             -ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence             345566889999999875  59999999999999999999999999876655443333332111000      000011


Q ss_pred             ccccCCCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhccccccccccCccCCCcHHhhhhc
Q 043292          468 VDKHSNDMQ----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGVTEFEHNLHYNLVHLPITAALAN  535 (558)
Q Consensus       468 ~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~~~~~~~~~~~~~~~p~~~~~~~  535 (558)
                      -.+......    ........+++++.++|+.+|.+|.++.+++.  .++++.+.+..++...+.+|..+..+.
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~  334 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRA  334 (364)
T ss_pred             cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHH
Confidence            111111111    12233457889999999999999999999994  477777766666666655555544443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=328.89  Aligned_cols=248  Identities=29%  Similarity=0.510  Sum_probs=206.0

Q ss_pred             hhhcCccCceEEEEEEe-CCC----CEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDG----TKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||+||+|.+ ++|    .+||+|++...  .+...++++|+.+|.+++||||++++|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            37899999999999987 444    36899988743  445788999999999999999999999998766 88999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +.|+|.++++.+...  +-....+.|..|||+||.|||+   ++++||||.++|||+.+-..+||.|||+++....+...
T Consensus       780 P~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             ccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            999999999876554  8889999999999999999998   99999999999999999999999999999988765544


Q ss_pred             eeec-ccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 VVTT-MRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~~~~-~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .... ..-.+.|||-|.+. ..++.++|||||||++||++| |..|+++....+                 +.+++..-.
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I~dlle~ge  917 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------IPDLLEKGE  917 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------hhHHHhccc
Confidence            3332 23356889999876 469999999999999999999 999999877655                 222222221


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      + ++.+.-....+..++..||..|+..||+++++...+.+..
T Consensus       918 R-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 R-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             c-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            1 2334456678899999999999999999999988776653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=319.66  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=211.8

Q ss_pred             HhhhhcCccCceEEEEEEeCC---CC--EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          241 NFRKMLGKGGFGSVFEGTQTD---GT--KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.++||.|-||.||+|+..+   |.  .||||.-+..  ....+.|+.|..+|++++||||++++|+|.+ ...|||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            346899999999999998732   33  4888877742  3446779999999999999999999999986 56799999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      .++-|.|..+|+.+...  |+......++.||..||+|||+   .++|||||..+|||+...-.+||+|||+++.+..+.
T Consensus       471 L~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             cccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999977653  8999999999999999999999   999999999999999999999999999999988777


Q ss_pred             CceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .+..+...-++.|||||.+. ++++.+||||.|||.+|||++ |..||.+-...+.                 ...+.. 
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~~iEn-  607 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IGHIEN-  607 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EEEecC-
Confidence            66666666678999999987 579999999999999999988 9999987554431                 111111 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      -...+.+..++..+..+..+||..+|.+||++.++...|+.+.+.
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            112234556777999999999999999999999999999887663

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-37  Score=308.01  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=202.0

Q ss_pred             HHHHhhhhcCccCceEEEEEEeCC------CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcce
Q 043292          238 MTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       238 ~t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  309 (558)
                      .+..+.+.||+|+||.||+|+..+      +..||+|.++....  ..+.+.+|++++..++|+||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            345567899999999999998633      47899999875433  3567999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          310 LVYEYMPNGSLDRWLFQRS-----------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      +||||+++++|.+++....           ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999997542           12348899999999999999999999   899999999999999999999


Q ss_pred             EEcccCCccccCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||+++....... .......++..|+|||++.+ .++.++||||||++++||++ |..||......+    .....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~~~  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIECI  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH
Confidence            9999999976433221 11223345788999999874 58999999999999999998 999986544322    11111


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                          ..+....          ........+.+++..||+.||++|||+.+|++.|++
T Consensus       238 ----~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 ----TQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----HcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                1111110          011233578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-38  Score=307.25  Aligned_cols=249  Identities=28%  Similarity=0.483  Sum_probs=199.1

Q ss_pred             hhhhcCccCceEEEEEEeCC----CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|....    ...||||.++..  .....+|..|+.++.+++|+||+++++++..++..++||||+
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   87 (266)
T cd05033           8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM   87 (266)
T ss_pred             eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence            35789999999999998742    457999988643  233457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.....  .+++..+.+++.|++.||.|||+   .+|+|+||||+||++++++.++|+|||+++........
T Consensus        88 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          88 ENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             CCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999999976443  48999999999999999999999   99999999999999999999999999999977522222


Q ss_pred             e-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 V-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . .....++..|+|||.+.+ .++.++||||||++++||++ |..||......+    ....    ...+...       
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~----~~~~~~~-------  227 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKA----VEDGYRL-------  227 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHH----HHcCCCC-------
Confidence            1 122334678999998874 58999999999999999998 999986433221    1111    1111000       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                         +........+.+++.+|++.+|++||++.+|+++|+++
T Consensus       228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               01112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-38  Score=303.58  Aligned_cols=262  Identities=27%  Similarity=0.412  Sum_probs=203.3

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHH--hccCCcceeeeeeeeccCC----cceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTI--GSIHHQNLVRLIGFCAEKS----HNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~----~~~lv~e~~  315 (558)
                      +.+.||+|.||.||+|.+. |+.||||++....+  +.+.+|.++.  -.|+|+||+.+++.-..++    ..+||++|.
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            3578999999999999987 88999999986543  3455555554  5569999999998766544    468999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc-----CCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED-----CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ++|||.|+|.+..    ++-...++++..+|.||++||.+     .++.|.|||||+.|||+..++...|+|+|||....
T Consensus       292 e~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  292 EHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             cCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            9999999998743    99999999999999999999964     35789999999999999999999999999998776


Q ss_pred             CCCCc---eeecccCCCCcCChhhhcCCCC-------CccchHHHHHHHHHHHhC----------CCCCCCCCCcchhhh
Q 043292          391 QDQSQ---VVTTMRGTPGYLAPEWLSSIIT-------EKVDIYSFGVVMLEILCG----------RKVFDRSQPEEEDMY  450 (558)
Q Consensus       391 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~-------~k~Dv~s~Gv~l~elltg----------~~p~~~~~~~~~~~~  450 (558)
                      .+...   .....+||.+|||||++....+       ..+||||||.++||+...          +.||....+.+-.+.
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            55332   2446789999999999975433       358999999999998752          356654433331111


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      -+   +..+    -.+-+.+.......+.+.+..+.++++.||..||.-|-|+-.|.+.|.++.+.+
T Consensus       448 eM---rkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  448 EM---RKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             HH---hcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            11   1111    112233334444556688999999999999999999999999999998887654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-38  Score=318.67  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=197.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+++.. ++..+|+|.+...  ......+.+|++++.+++||||+++++++..++..++||||+++++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence            468999999999999885 6888999988743  2334679999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++....   .+++..+..++.|++.||.|||+  ..+|+|+||||+|||++.++.+||+|||++......   ....
T Consensus        90 L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~  161 (331)
T cd06649          90 LDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS  161 (331)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---cccc
Confidence            999997644   38899999999999999999997  246999999999999999999999999999865432   1234


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc---c------------
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED---K------------  463 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------------  463 (558)
                      ..|+..|+|||++.+ .++.++||||||+++|||++|+.||......+    +..........+   .            
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCccccccc
Confidence            568999999999875 58999999999999999999999997544322    111111000000   0            


Q ss_pred             ---------------chhhcc---ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 ---------------LSDLVD---KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ---------------~~~~~d---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                                     ..++++   ...............+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                           000000   0000000011234578999999999999999999999865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.8e-38  Score=317.93  Aligned_cols=240  Identities=30%  Similarity=0.389  Sum_probs=194.1

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||++.. .+++.||+|++...    ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999987 46899999999743    223456888999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|..++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  153 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK  153 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence            9998886543   38999999999999999999999   999999999999999999999999999987543222 1233


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||++.+ .++.++|||||||++|||++|+.||......+    .   ...... ...           ..
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~---~~~~~~-~~~-----------~~  214 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----L---FELILM-EDI-----------KF  214 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----H---HHHhcc-CCc-----------cC
Confidence            4678999999999875 58999999999999999999999997543221    1   111100 000           00


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      +......+.+++.+||+.||.+||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            111234678899999999999997     89988864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-37  Score=304.36  Aligned_cols=248  Identities=28%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|++|.||++....+..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+++++|.
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   88 (260)
T cd05069          10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL   88 (260)
T ss_pred             eeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence            45789999999999999877778999998765555677899999999999999999999875 45678999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++...............
T Consensus        89 ~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05069          89 DFLKEGDG-KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK  164 (260)
T ss_pred             HHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCc
Confidence            99976432 348999999999999999999999   89999999999999999999999999999866433222222334


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||...+ ..+.++||||||+++|||++ |+.||......+    ....    .......          ....
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~----~~~~~~~----------~~~~  226 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQ----VERGYRM----------PCPQ  226 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHcCCCC----------CCCc
Confidence            5678999998864 68999999999999999999 899987543221    1111    1110000          0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      .....+.+++.+|++.||.+||++++|+++|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.4e-38  Score=317.55  Aligned_cols=239  Identities=28%  Similarity=0.369  Sum_probs=193.0

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||++.. .++..||+|.++..    ......+..|++++..++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999987 46899999998743    223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~  153 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence            9998887543   38999999999999999999999   999999999999999999999999999987542221 1233


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...|++.|+|||++.+ .++.++||||||+++|||++|+.||.......    ..   ..... ...           ..
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~---~~~~~-~~~-----------~~  214 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF---ELILM-EEI-----------RF  214 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HH---HHHhc-CCC-----------CC
Confidence            4678999999999865 58999999999999999999999997544322    11   11100 000           00


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      +......+.+++.+||+.||.+||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            111234678899999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-37  Score=321.97  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||.||+|+..      .+..||||+++...  ...+.+.+|++++.++. ||||+++++++.+....+|||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT  120 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence            3478999999999999852      13479999997432  23457899999999996 999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------------------------------------------------------
Q 043292          313 EYMPNGSLDRWLFQRSD---------------------------------------------------------------  329 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  329 (558)
                      ||+++|+|.++|.....                                                               
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (400)
T cd05105         121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY  200 (400)
T ss_pred             EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence            99999999999865310                                                               


Q ss_pred             ------------------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeE
Q 043292          330 ------------------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK  379 (558)
Q Consensus       330 ------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~k  379 (558)
                                                    ...+++..+..++.||+.||.|||+   .+++|+||||+|||+++++.+|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k  277 (400)
T cd05105         201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK  277 (400)
T ss_pred             hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence                                          1247888999999999999999999   9999999999999999999999


Q ss_pred             EcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHH
Q 043292          380 VADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFK  456 (558)
Q Consensus       380 i~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  456 (558)
                      |+|||+++........ ......++..|+|||.+.+ .++.++||||||+++|||++ |..||........   ..    
T Consensus       278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---~~----  350 (400)
T cd05105         278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---FY----  350 (400)
T ss_pred             EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---HH----
Confidence            9999999865433221 1223446788999998864 58999999999999999997 8899875432211   11    


Q ss_pred             HhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       457 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .....+..       .   .........+.+++.+||+.+|++|||+.+|.++|+.+.+
T Consensus       351 ~~~~~~~~-------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 NKIKSGYR-------M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHhcCCC-------C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111100       0   0111234578899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-37  Score=319.56  Aligned_cols=241  Identities=26%  Similarity=0.412  Sum_probs=189.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||.||+++.. +++.||||.+....  .....+.+|+++++.++|+||+++++++..++..++||||+++++
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  158 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS  158 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence            478999999999999874 68999999986432  234678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+..       ..++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++.+..... ....
T Consensus       159 L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  227 (353)
T PLN00034        159 LEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNS  227 (353)
T ss_pred             ccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccc
Confidence            86432       25677888999999999999999   9999999999999999999999999999987643221 2234


Q ss_pred             ccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          400 MRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ..|+..|+|||.+..      ..+.++|||||||++|||++|+.||......+.. .+..   ..... ..         
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~---~~~~~-~~---------  293 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA-SLMC---AICMS-QP---------  293 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH---HHhcc-CC---------
Confidence            578999999998742      2456899999999999999999999743322211 1110   00000 00         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ..........+.+++.+||+.||++|||+.++++.
T Consensus       294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00111233478899999999999999999999974

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.7e-38  Score=314.16  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||+++.. +++.||+|++....  .....+.+|+.+++.++||||+++++++.++...++||||++ +
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (303)
T cd07869           9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T   87 (303)
T ss_pred             EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence            3578999999999999985 68899999987432  223467889999999999999999999999999999999995 6


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||++....... ....
T Consensus        88 ~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  161 (303)
T cd07869          88 DLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYS  161 (303)
T ss_pred             CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCC
Confidence            88887765432  38899999999999999999999   999999999999999999999999999987543222 1223


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh-----ccc-
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL-----VDK-  470 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~d~-  470 (558)
                      ...+++.|+|||.+.+  .++.++||||||++++||++|..||............................     +++ 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            4567899999998864  47889999999999999999999998654322111111000000000000000     000 


Q ss_pred             cCCC-CCCCH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSND-MQSNG-------EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~-~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .... .....       .....+.+++..||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000 00000       01245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=321.11  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|+++...    .....+..|+.++..++||||+++++++.+++..++||||+++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g   85 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG   85 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence            478999999999999985 58899999997432    2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.....    ..
T Consensus        86 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~  155 (333)
T cd05600          86 GDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA  155 (333)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence            99999997543   38899999999999999999999   9999999999999999999999999999986543    23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|..||......+....+..+          ...+..... ..
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------~~~~~~~~~-~~  224 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW----------KETLQRPVY-DD  224 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc----------cccccCCCC-Cc
Confidence            45678999999999875 5899999999999999999999999765543311111110          000000000 00


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            001234577889999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-37  Score=303.58  Aligned_cols=245  Identities=26%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.||+|+||.||+++.. +++.+|+|.+...  ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999884 7899999987643  23356789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee-ec
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TT  399 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~~  399 (558)
                      .+++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........... ..
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999975432  48999999999999999999999   8999999999999999999999999999876432211111 11


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...+..|+|||.+.+ .++.++||||||++++||++ |..||.......    ....    .....     ..     ..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~~----~~~~~-----~~-----~~  217 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREA----IEQGV-----RL-----PC  217 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHHH----HHcCC-----CC-----CC
Confidence            123457999998864 58999999999999999998 888886433211    1110    00000     00     11


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .......+.+++.+|++.+|++|||+.+|.++|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1122457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-37  Score=301.66  Aligned_cols=245  Identities=29%  Similarity=0.454  Sum_probs=196.7

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++||+|+||.||+|...++..+|+|.+....  .....+.+|++++..++|+||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999998888999999987432  23446889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99875432  38999999999999999999999   99999999999999999999999999998754432221122234


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||++.+ .++.++||||||+++||+++ |..||.......    ...    ........          ....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~----~~~~~~~~----------~~~~  217 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----ARE----QVEKGYRM----------SCPQ  217 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHH----HHHcCCCC----------CCCC
Confidence            4678999999874 58999999999999999998 999986543221    100    11111000          0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .....+.+++.+|++.+|++|||+.+++++|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.3e-38  Score=316.25  Aligned_cols=250  Identities=27%  Similarity=0.464  Sum_probs=196.7

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||+|++. ++.    .||+|.++..  ....+++..|+.+++.++||||++++|++... ..++|+||+
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~   90 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   90 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence            478999999999999863 333    4899998743  23456789999999999999999999999864 567999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..+++++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus        91 ~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  165 (316)
T cd05108          91 PFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE  165 (316)
T ss_pred             CCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence            99999999986543  38899999999999999999999   99999999999999999999999999999876543322


Q ss_pred             ee-ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 VV-TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~~-~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .. ....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +..+    ...+..       .
T Consensus       166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~----~~~~~~-------~  230 (316)
T cd05108         166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI----LEKGER-------L  230 (316)
T ss_pred             eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----HhCCCC-------C
Confidence            11 22334678999999875 58999999999999999998 999987543221    1111    111100       0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                         .........+.+++.+|++.+|.+|||+.+++..|..+..-
T Consensus       231 ---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence               00111234678899999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=295.50  Aligned_cols=262  Identities=26%  Similarity=0.362  Sum_probs=203.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---chHHHHHHHHHHhccCCcc-eeeeeeeeccCC------cceEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQN-LVRLIGFCAEKS------HNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv  311 (558)
                      .++||+|.||+||+|+. .+|+.||+|++.-..+   ......+|+.++..++|+| |+++++++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            36799999999999988 5789999999874432   3455789999999999999 999999998877      67899


Q ss_pred             EEeCCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          312 YEYMPNGSLDRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      +||+ ..+|..++...... ..++...+..+++||+.||+|||+   .+|+||||||.||||+++|.+||+|||+|+.+.
T Consensus        96 fe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   96 FEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             EEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            9999 56999999875532 347778999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc--chh
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK--LSD  466 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  466 (558)
                      -.. ...+..++|..|.|||++.+  .++...||||+||++.||++++..|.+....++...+.........+.+  +..
T Consensus       172 ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  172 IPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             CCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            332 22556778999999999875  4999999999999999999999999887765544444333322211111  111


Q ss_pred             hcccc--CCCCC----CCHHH---HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          467 LVDKH--SNDMQ----SNGEE---VVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       467 ~~d~~--~~~~~----~~~~~---~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      +.+..  .....    .....   .....+++.+||+.+|.+|.|+..++++
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111  11111    00111   1368899999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-37  Score=302.67  Aligned_cols=244  Identities=27%  Similarity=0.462  Sum_probs=193.5

Q ss_pred             hcCccCceEEEEEEe---CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          245 MLGKGGFGSVFEGTQ---TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .||+|+||.||+|..   .++..+|+|+++...   ...+++..|+.++..++|+||+++++++. ++..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999965   357889999986432   23467899999999999999999999885 45678999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee-
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-  397 (558)
                      +|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999997543   38999999999999999999999   9999999999999999999999999999987654332211 


Q ss_pred             -ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          398 -TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       398 -~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                       ....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +...    ...+....        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~----i~~~~~~~--------  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQM----IESGERME--------  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHCCCCCC--------
Confidence             12234578999998864 58889999999999999998 999997543321    1111    11111111        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        .+......+.+++.+|++.||++||++.+|++.|++.
T Consensus       219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              1112335688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-37  Score=315.45  Aligned_cols=261  Identities=23%  Similarity=0.382  Sum_probs=192.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~  312 (558)
                      +.++||+|+||.||+|+.. ++..||||++...   ......+.+|++++++++||||+++++++....     ..++||
T Consensus         4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~   83 (338)
T cd07859           4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF   83 (338)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence            3578999999999999874 6899999998742   223356889999999999999999999875432     468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+. ++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          84 ELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             ecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9995 68998886543   38999999999999999999999   99999999999999999999999999999865332


Q ss_pred             CCc--eeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhh
Q 043292          393 QSQ--VVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAE  460 (558)
Q Consensus       393 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~  460 (558)
                      ...  ......|+..|+|||++.+   .++.++||||||++++||++|+.||...........+....       .....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            211  1234578999999999763   58999999999999999999999997654322111110000       00000


Q ss_pred             cccchhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          461 EDKLSDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+...........     .....+.+++.+||+.||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000111110000000000     112457899999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.3e-38  Score=318.44  Aligned_cols=239  Identities=25%  Similarity=0.360  Sum_probs=194.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||+++.. +++.||+|.+....    ...+.+.+|+.++.+++||||+++++++.+++..++||||++
T Consensus        22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  101 (329)
T PTZ00263         22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV  101 (329)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence            4578999999999999984 68899999986432    234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       102 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----  171 (329)
T PTZ00263        102 GGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----  171 (329)
T ss_pred             CChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence            999999997643   38899999999999999999999   99999999999999999999999999999866432    


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....|++.|+|||++.+ .++.++||||||+++|||++|..||.......    .   .. ....+..        .  
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~---~~-~i~~~~~--------~--  233 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----I---YE-KILAGRL--------K--  233 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----H---HH-HHhcCCc--------C--
Confidence            223568999999999875 48999999999999999999999997543211    1   11 1111111        0  


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  509 (558)
                       .+......+.+++..||+.||.+||+     +.++++.
T Consensus       234 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 -FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             00012236788999999999999996     6777643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-38  Score=319.00  Aligned_cols=248  Identities=28%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+-|.|-+|+. .+|+.+|||++....    .......+|+-+|+.++|||++++++++.+..+.|+|.||++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence            347799999999999988 689999999997542    223457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|-|.+++-.++.   |.+.+..++++||+.|+.|+|.   .+|+||||||+|+|||..+.+||+|||||.+-..  ...
T Consensus        96 gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl  167 (786)
T KOG0588|consen   96 GGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL  167 (786)
T ss_pred             CchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence            9999999987664   8999999999999999999999   9999999999999999999999999999986433  345


Q ss_pred             eecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ..+.+|++.|.+||++.|.  -..++||||.|||||.|++|+.||+..+       +.. ...+++.|.++-        
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~-LLlKV~~G~f~M--------  231 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRV-LLLKVQRGVFEM--------  231 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHH-HHHHHHcCcccC--------
Confidence            6778999999999999874  5679999999999999999999998322       222 222333333211        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhccccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTEF  516 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~~  516 (558)
                         +..-..++.+|+.+|+..||+.|.|+++|++.  |.+...+
T Consensus       232 ---Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  232 ---PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             ---CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence               11223477889999999999999999999975  4444433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=322.07  Aligned_cols=234  Identities=29%  Similarity=0.404  Sum_probs=195.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      |.++||+|+||+|+++.++ +++.+|||++++.    ....+..+.|.+++.... ||.|++++..|...++.++||||.
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~  451 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV  451 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence            4589999999999999984 6889999999864    344567888999988874 999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      .||++..+.+    ...+++....-++..|+.||.|||+   .+||+||||.+|||||.+|.+||+||||++.... ...
T Consensus       452 ~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g~  523 (694)
T KOG0694|consen  452 AGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QGD  523 (694)
T ss_pred             CCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC-CCC
Confidence            9999433322    1239999999999999999999999   9999999999999999999999999999996432 233


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC-
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN-  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-  473 (558)
                      ..++++||+.|||||++.+ .|+..+|.|||||+||||+.|..||.+.+.++.                    +|..+. 
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~--------------------FdsI~~d  583 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV--------------------FDSIVND  583 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--------------------HHHHhcC
Confidence            5678999999999999986 599999999999999999999999987665441                    111111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                      +..++.....+.+.|+.++|..||++|.-+
T Consensus       584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            112344455688899999999999999866

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-37  Score=312.37  Aligned_cols=238  Identities=29%  Similarity=0.398  Sum_probs=187.8

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhc-cCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGS-IHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+++.. +++.||+|.++...    ...+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999884 58899999987432    223445667777664 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            99999987543   38999999999999999999999   999999999999999999999999999998643322 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+    +   ...... ..  ..         
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~---~~~i~~-~~--~~---------  214 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----L---FDSILN-DR--PH---------  214 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----H---HHHHHc-CC--CC---------
Confidence            45678999999999875 58999999999999999999999997654321    1   111100 00  00         


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMS-MVV  507 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl  507 (558)
                      .+......+.+++.+||+.||.+||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0111234677899999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.1e-37  Score=314.62  Aligned_cols=247  Identities=24%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             hhhhcCccCceEEEEEEe----CCCCEEEEEEeccc-----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGI-----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      +.+.||+|+||.||+++.    .+++.||+|++...     ....+.+..|+.++..+ +|+||+++++++..++..++|
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (332)
T cd05614           4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI   83 (332)
T ss_pred             EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence            357899999999999875    35789999998642     12235678899999999 599999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||+++|+|.+++..+.   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          84 LDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999987543   38999999999999999999999   9999999999999999999999999999986544


Q ss_pred             CCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ..........||..|+|||++.+  .++.++||||||+++|||++|+.||...........+.   .... ..      +
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~~-~~------~  227 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS---RRIL-KC------D  227 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH---HHHh-cC------C
Confidence            33333345679999999999875  37889999999999999999999997543322111111   1110 00      0


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      ...     .......+.+++.+||+.||++||     +++++++.
T Consensus       228 ~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            001     111234678899999999999999     67777753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=294.83  Aligned_cols=271  Identities=25%  Similarity=0.392  Sum_probs=208.5

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecc---cccchHHHHHHHHHHhccCCcceeeeeeeecc-----CCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-----KSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~  314 (558)
                      +.||+|++|.|..+.. .+|..||+|++.+   .....++-.+|+++|+.++|+||+.+.+++..     -+..|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            6799999999999988 5789999999873   33445678999999999999999999998865     3456999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC-C
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-Q  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~-~  393 (558)
                      | ..+|...++....   |+......++.|+++||.|+|+   .+++||||||+|+|++.+..+||+|||+|+..... .
T Consensus       108 M-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  108 M-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             H-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            9 6799999976543   8999999999999999999999   99999999999999999999999999999977532 2


Q ss_pred             CceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEEDKL  464 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~  464 (558)
                      ....+..+-|..|.|||++.  ..++...||||.||++.||++|+..|.+.+..++...+......       .......
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            22356778899999999875  36999999999999999999999999887765543333222111       1111111


Q ss_pred             hhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccccccccc
Q 043292          465 SDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTEFEHNLH  521 (558)
Q Consensus       465 ~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~~~~~~~  521 (558)
                      ...+.........+     .......++++.+||..||.+|+|++|.++.  |+.....+..+.
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~  324 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV  324 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence            11111111100000     0122468899999999999999999999964  666655555443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.9e-38  Score=319.02  Aligned_cols=246  Identities=22%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||++... +++.||+|+++...    ...+.+..|+.++..++|+||+++++++.+++..++||||++
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (330)
T cd05601           5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP   84 (330)
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence            3578999999999999874 68999999997432    234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus        85 ~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          85 GGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999976532  48999999999999999999999   999999999999999999999999999998765443333


Q ss_pred             eecccCCCCcCChhhhc-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          397 VTTMRGTPGYLAPEWLS-------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .....||+.|+|||++.       ..++.++||||||+++|||++|+.||........       .............  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~--  230 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQRFLKF--  230 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHcCCCccCC--
Confidence            34457899999999875       2478899999999999999999999975443221       1111111000000  


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                            +........+.+++..|++ +|.+|||+.++++
T Consensus       231 ------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 ------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                  0011123467788899998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-38  Score=283.51  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             CccCHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeee
Q 043292          228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       228 ~~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      +.+++++++     ..+.||+|.||.||.|+.+ ++-.||+|++.++    .....++.+|+++-+.|+||||++++++|
T Consensus        17 ~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            345555443     3588999999999999984 5778999999753    23456899999999999999999999999


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      .+....||++||.++|+|...|+..... .++......++.|+|.||.|+|.   .+++||||||+|+|++.++.+||+|
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccC
Confidence            9999999999999999999999854432 38888999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      ||-+..-.   .....+.+||..|++||...+. .+.++|+|++|++.+|++.|.+||......+....+..        
T Consensus       168 fGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--------  236 (281)
T KOG0580|consen  168 FGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--------  236 (281)
T ss_pred             CCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--------
Confidence            99987543   2335678999999999999874 89999999999999999999999985553221111110        


Q ss_pred             ccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         .++.+        +......+.++|..|+..+|.+|.+..+|+..
T Consensus       237 ---~~~~~--------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 ---VDLKF--------PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---ccccC--------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               01111        11223467889999999999999999998864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-37  Score=307.51  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=197.1

Q ss_pred             hhhhcCccCceEEEEEEe-----CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+|..     ..+..+++|.++...  .....+.+|+.++++++|+||+++++++..+...++||||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   88 (283)
T cd05090           9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY   88 (283)
T ss_pred             eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence            457899999999999975     246789999987432  2335788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          315 MPNGSLDRWLFQRSD--------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                      +++++|.+++.....              ...+++.+...++.|++.||.|||+   .+++|+||||+|||+++++.+||
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEe
Confidence            999999999863321              2348899999999999999999999   89999999999999999999999


Q ss_pred             cccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHH
Q 043292          381 ADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      +|||+++........ ......++..|+|||++. +.++.++||||||++++||++ |..||......+    +..... 
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~----~~~~~~-  240 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----VIEMVR-  240 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH-
Confidence            999999865432211 122344567899999986 458999999999999999998 888986543221    111111 


Q ss_pred             hhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       458 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                         ......          ........+.+++.+|++.||++||++.+|.++|..
T Consensus       241 ---~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 ---KRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---cCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               111000          111123468889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-37  Score=311.98  Aligned_cols=194  Identities=29%  Similarity=0.435  Sum_probs=168.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||++... ++..+|+|.+...  ......+.+|++++.+++|+||+++++++.+++..++||||++++
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence            4578999999999999885 6888999988643  233467899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++.....++.+++.||.|||+  ..+++|+||||+|||+++++.+||+|||++......   ...
T Consensus        89 ~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~  160 (333)
T cd06650          89 SLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN  160 (333)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccc
Confidence            9999997643   38899999999999999999997  247999999999999999999999999999765332   123


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ  443 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~  443 (558)
                      ...|+..|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            4568999999999875 58999999999999999999999997544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-37  Score=311.98  Aligned_cols=234  Identities=26%  Similarity=0.398  Sum_probs=188.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||++... +++.||+|+++..    ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999884 6889999998742    22345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~  153 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT  153 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence            99999887654   38999999999999999999999   999999999999999999999999999987543221 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+    +   .... ..+..           .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~---~~~i-~~~~~-----------~  214 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----L---FEAI-LNDEV-----------V  214 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----H---HHHH-hcCCC-----------C
Confidence            44678999999999875 58999999999999999999999997554322    1   1111 11110           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                      ........+.+++.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            011123467889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-37  Score=307.37  Aligned_cols=260  Identities=26%  Similarity=0.380  Sum_probs=189.5

Q ss_pred             hhhhcCccCceEEEEEEeC--CCCEEEEEEecccc---cchHHHHHHHHHHhcc---CCcceeeeeeeec-----cCCcc
Q 043292          242 FRKMLGKGGFGSVFEGTQT--DGTKVAVKRLEGIG---EINKSFLAEVKTIGSI---HHQNLVRLIGFCA-----EKSHN  308 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~~~  308 (558)
                      +.+.||+|+||.||+++..  +++.||+|.++...   .....+.+|+.++..+   +||||+++++++.     .....
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~   84 (290)
T cd07862           5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   84 (290)
T ss_pred             eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence            3578999999999999873  46789999886432   2234566777776655   6999999999875     24457


Q ss_pred             eEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          85 TLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             EEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            89999996 689998875433 248999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc---
Q 043292          389 IDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL---  464 (558)
Q Consensus       389 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  464 (558)
                      ....  .......|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+.............   
T Consensus       160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            5433  22344568999999999864 58999999999999999999999998765433222221111000000000   


Q ss_pred             ---hhhccccCCCC--CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 ---SDLVDKHSNDM--QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ---~~~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ...+.......  .........+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence               00000000000  000012346779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-37  Score=301.90  Aligned_cols=249  Identities=30%  Similarity=0.473  Sum_probs=202.3

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.++||+|+||.||++...+++.+|||.+.......+++.+|+.++++++|+||+++++++..+...++||||+++++|.
T Consensus        10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   89 (261)
T cd05034          10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL   89 (261)
T ss_pred             eeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence            35789999999999999888889999999876666678999999999999999999999999988999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..+..++.+++.||.|||+   .+++|+||||+||++++++.+||+|||++..+............
T Consensus        90 ~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  165 (261)
T cd05034          90 DFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK  165 (261)
T ss_pred             HHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccC
Confidence            99976542 248999999999999999999999   89999999999999999999999999999876532222222333


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .+..|+|||.+.+ .++.++||||||++++|+++ |+.||.......    ...   ... .. .    .  .   ....
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~---~~~-~~-~----~--~---~~~~  227 (261)
T cd05034         166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLE---QVE-RG-Y----R--M---PRPP  227 (261)
T ss_pred             CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHH-cC-C----C--C---CCCC
Confidence            4678999999875 58999999999999999998 999986543221    111   110 00 0    0  0   0011


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      .....+.+++.+|++.+|++||++.++++.|+.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            123578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-37  Score=299.81  Aligned_cols=246  Identities=27%  Similarity=0.453  Sum_probs=195.3

Q ss_pred             hhcCccCceEEEEEEeC--C--CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT--D--GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~--~--~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+|+..  +  +..+|+|.+.....  ..+++..|+.+++.++|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999763  2  36899999875443  4567899999999999999999999876 4567999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999998654   48999999999999999999998   8999999999999999999999999999987644332211


Q ss_pred             e--cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 T--TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~--~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      .  ...++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +.....    .....        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~----~~~~~~----~~~~~--------  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----VIAMLE----SGERL--------  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHH----cCCcC--------
Confidence            1  1223568999998864 58999999999999999998 999997543221    111111    11100        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                        .........+.+++.+|++.+|.+|||+.+|++.|+++.
T Consensus       218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              011122357889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-37  Score=313.28  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=197.9

Q ss_pred             HhhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccC-CcceE
Q 043292          241 NFRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK-SHNLL  310 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~l  310 (558)
                      .+.++||+|+||.||+|...      +++.||+|+++...  ...+.+..|+.++.++ +|+||+++++++... ...++
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~   89 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence            34588999999999999642      24789999987432  2335678899999999 899999999987654 56789


Q ss_pred             EEEeCCCCCHHHHHhcCCC----------------------------------------------------------CCC
Q 043292          311 VYEYMPNGSLDRWLFQRSD----------------------------------------------------------EFM  332 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~----------------------------------------------------------~~~  332 (558)
                      ++||+++++|.+++.....                                                          ...
T Consensus        90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (337)
T cd05054          90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP  169 (337)
T ss_pred             EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence            9999999999999864321                                                          125


Q ss_pred             CCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-eecccCCCCcCChhh
Q 043292          333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEW  411 (558)
Q Consensus       333 l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~  411 (558)
                      ++|..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.+....... .....++..|+|||+
T Consensus       170 l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         170 LTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            8999999999999999999999   999999999999999999999999999998764332221 223456778999998


Q ss_pred             hcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHH
Q 043292          412 LSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVA  489 (558)
Q Consensus       412 ~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  489 (558)
                      +.+ .++.++|||||||+++||++ |..||......+.   +.    .....+....          ........+.+++
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~~~~----------~~~~~~~~~~~l~  309 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC----RRLKEGTRMR----------APEYATPEIYSIM  309 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH----HHHhccCCCC----------CCccCCHHHHHHH
Confidence            764 69999999999999999998 9999976443221   11    1111111100          0112235788999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          490 AWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       490 ~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .+|++.+|++||++.+|+++|+.+.+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-37  Score=313.69  Aligned_cols=239  Identities=28%  Similarity=0.371  Sum_probs=188.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHH---hccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTI---GSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||++... +++.||||+++...    ...+.+..|.+++   ..++||||+++++++..++..++||||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            468999999999999874 68999999997432    2234566666554   567899999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|..++...    .+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          84 AAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             CCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            9999999888542    38999999999999999999999   999999999999999999999999999987543222 


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      .......|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+.   ..    ... ....         
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~----~i~-~~~~---------  218 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FD----SIV-NDEV---------  218 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHH-hCCC---------
Confidence            22345678999999999875 589999999999999999999999975543221   00    100 0000         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                        ..+......+.+++.+||+.||.+||     ++.++++
T Consensus       219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 --RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              00111234678899999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.2e-37  Score=303.99  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=198.8

Q ss_pred             HHHhhhhcCccCceEEEEEEeCC------CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceE
Q 043292          239 TDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       239 t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  310 (558)
                      ...+.+.||+|+||.||+|+..+      ++.||+|+++....  ..+.+..|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            34456889999999999998632      47899999974432  24568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ++||+.+++|.+++....             ....+++..+.+++.|++.||.|||+   .+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            999999999999985321             12348899999999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++........ ......+++.|+|||.+. +.++.++||||||+++|||++ |..||......+    +.. 
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~-  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIE-  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH-
Confidence            999999998865432221 122344678999999876 568999999999999999998 888886543321    111 


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                         .........          ........+.+++..|++.+|.+||++.+|++.|+.
T Consensus       238 ---~i~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 ---MIRNRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHcCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               111111110          111234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-37  Score=313.53  Aligned_cols=239  Identities=28%  Similarity=0.359  Sum_probs=191.8

Q ss_pred             hhcCccCceEEEEEEe----CCCCEEEEEEecccc-----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      ++||+|+||.||+++.    .+++.||+|.++...     .....+..|+.++..++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    357899999987421     2234578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++....   .+.+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999987544   37888999999999999999999   9999999999999999999999999999875432221


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       ......|++.|+|||++.+ .++.++||||||+++|||++|+.||.......       ..... ..+.        ..
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~-~~~~--------~~  218 (323)
T cd05584         156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKI-LKGK--------LN  218 (323)
T ss_pred             -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHH-HcCC--------CC
Confidence             2334678999999999875 58899999999999999999999997544321       01111 0111        00


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                         .+......+.+++.+||+.+|++||     ++.++++
T Consensus       219 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 ---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               0111234678999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.6e-37  Score=303.98  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|...      .+..||+|.+....  ....++.+|+.++..++|+||+++++++..+...++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            578999999999998753      25679999886432  2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          315 MPNGSLDRWLFQRSD-------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      +++++|.+++.....       ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCcc
Confidence            999999999875321       2346889999999999999999999   899999999999999999999999999987


Q ss_pred             ccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          388 LIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       388 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ......... .....++..|+|||.+.+ .++.++||||||++++||++ |..||......+    ...    .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~----~~~~~~~  239 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLR----FVMEGGL  239 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH----HHHcCCc
Confidence            654322211 112345778999999874 58999999999999999999 788887544322    111    1111111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ...          .......+.+++.+|++.||++|||+.+++++|++
T Consensus       240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            110          11223478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=308.61  Aligned_cols=243  Identities=26%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ..||+|+||.||+++. .+|..+|+|+++++.    ...+....|-.+|...+++.||+++-.|++.+..||||||++||
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG  226 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG  226 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence            6799999999999987 569999999998653    33456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC-------
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-------  391 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~-------  391 (558)
                      ++..+|.+..   .|++......+.+.+-|+.-||+   .|+|||||||+|+|||..|++||+||||+.-+..       
T Consensus       227 D~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~  300 (550)
T KOG0605|consen  227 DMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY  300 (550)
T ss_pred             cHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence            9999998765   49999999999999999999999   9999999999999999999999999999853311       


Q ss_pred             ----------------CCC-----------------------ceeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHH
Q 043292          392 ----------------DQS-----------------------QVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLE  431 (558)
Q Consensus       392 ----------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~e  431 (558)
                                      +..                       ......+|||.|||||++.+. ++..+|.||+|||+||
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE  380 (550)
T KOG0605|consen  301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE  380 (550)
T ss_pred             cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence                            000                       001124699999999999864 8999999999999999


Q ss_pred             HHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 043292          432 ILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS---MSMVVR  508 (558)
Q Consensus       432 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~  508 (558)
                      |+.|.+||....+.+....+..|.......               .......+..++|.+|+- ||++|.-   +.||.+
T Consensus       381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  381 MLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            999999999888877665666553221110               111122577888899888 9999975   555554

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.2e-37  Score=302.19  Aligned_cols=249  Identities=25%  Similarity=0.433  Sum_probs=200.5

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.++||+|+||.||++...++..+++|.+.......+.+.+|+.++++++|+||+++.+++.. ...+++|||+++++|
T Consensus         9 ~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L   87 (260)
T cd05073           9 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL   87 (260)
T ss_pred             eEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence            3457899999999999998778889999988655556789999999999999999999999887 778999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..............
T Consensus        88 ~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          88 LDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             HHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            999976432 348899999999999999999999   8999999999999999999999999999986643322222233


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      .++..|+|||++.. .++.++|+||||++++++++ |+.||.......    +...    ...+...          ...
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~----~~~~~~~----------~~~  225 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRA----LERGYRM----------PRP  225 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHH----HhCCCCC----------CCc
Confidence            45678999999874 58999999999999999999 899987543221    1111    1111000          011


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ......+.+++.+|++.+|++||++.++.++|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1233578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.8e-37  Score=299.35  Aligned_cols=245  Identities=25%  Similarity=0.458  Sum_probs=192.7

Q ss_pred             hcCccCceEEEEEEeC---CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQT---DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .||+|+||.||+|...   .+..||+|.+....  ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999763   35579999987543  234568999999999999999999998854 56789999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee--
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~--  397 (558)
                      |.+++.....  .+++..+++++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999875432  48999999999999999999999   8999999999999999999999999999986544322211  


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....++..|+|||.+.+ .++.++||||||+++||+++ |..||......+    ...    ....+...          
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~----~~~~~~~~----------  217 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VMS----FIEQGKRL----------  217 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHH----HHHCCCCC----------
Confidence            11223578999998864 58999999999999999996 999997554322    111    11111100          


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ..+......+.+++..|++.+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11112345788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-37  Score=318.64  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=191.4

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.++||+|+||.||++.+ .+++.||+|....     ..+.+|++++++++||||+++++++..+...++|+|++. ++|
T Consensus        96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L  169 (391)
T PHA03212         96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL  169 (391)
T ss_pred             EEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence            347899999999999988 4688999996542     346789999999999999999999999999999999994 788


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      ..++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.............
T Consensus       170 ~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        170 YCYLAAKR---NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence            88886543   38999999999999999999999   8999999999999999999999999999975433222233456


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch----hhhHHHHHHHhhh---c------ccchh
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE----DMYLLSIFKKKAE---E------DKLSD  466 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~---~------~~~~~  466 (558)
                      .||+.|+|||++.+ .++.++||||||+++|||++|+.|+........    ...+..+......   +      ..+..
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~  323 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE  323 (391)
T ss_pred             cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence            79999999999875 589999999999999999999988754321110    0111111110000   0      00000


Q ss_pred             hc----cccC---CCCC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          467 LV----DKHS---NDMQ---SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       467 ~~----d~~~---~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+    ....   ....   ........+.+++.+||+.||.+|||+.++++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00    0000   0000   00122456889999999999999999999985

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-37  Score=312.95  Aligned_cols=240  Identities=25%  Similarity=0.344  Sum_probs=191.9

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+|+.. +++.||+|+++..    ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999884 5789999998743    22335577888888866 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            99999887543   38999999999999999999999   999999999999999999999999999987543222 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||++.+ .++.++||||||+++|||++|+.||...+..+.       ..... .+..           .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~-~~~~-----------~  214 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESIL-HDDV-----------L  214 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHH-cCCC-----------C
Confidence            44668999999999875 589999999999999999999999976543221       11111 1110           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-------SMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~~vl~~  509 (558)
                      .+......+.+++..||+.||++||       ++.++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0001224678899999999999999       77777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.5e-37  Score=303.40  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=192.6

Q ss_pred             cCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||+|+||+||++.. .+++.+|+|.+....    ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999987 468899999986432    2235678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          321 DRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       321 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      ..++.... ....+++..+..++.||+.||.|||+   .+|+||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            98885422 23458999999999999999999999   9999999999999999999999999999986543322 2234


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..|++.|+|||.+.+ .++.++||||||+++|||++|+.||............   ...         .+....   ...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~---------~~~~~~---~~~  221 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQR---------ILNDSV---TYP  221 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH---HHh---------hcccCC---CCc
Confidence            578999999999875 5889999999999999999999999754332111100   000         000000   111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      ......+.+++..||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            12345788999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.3e-37  Score=303.86  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=193.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||+|... +++    .+++|.+....  ....++..|+..+.+++||||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence            478999999999999873 444    47778775332  233567888889999999999999998764 5578999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..+..++.||+.||.|||+   .+++|+||||+|||+++++.+||+|||+++........
T Consensus        91 ~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          91 PLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            99999999976443  48999999999999999999999   89999999999999999999999999999865433221


Q ss_pred             -eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 -VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 -~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ......++..|+|||++. +.++.++||||||+++|||++ |..||.......    +..+.    ..+....  .   
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~~~~~~--~---  232 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLL----EKGERLA--Q---  232 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH----HCCCcCC--C---
Confidence             223455678999999986 469999999999999999998 999987544322    11111    1111100  0   


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                           .......+.+++.+|+..||++|||+.++++.|..+.
T Consensus       233 -----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 -----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 0012245778999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-37  Score=326.88  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             hhhhcCccCceEEEEEEeC-C-CCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-D-GTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|+||.||++... + +..||+|.+.... .....+..|+.+++.++||||+++++++..++..+|||||+++|
T Consensus        71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg  150 (478)
T PTZ00267         71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG  150 (478)
T ss_pred             EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence            4578999999999999763 3 6778888765333 23346788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-e
Q 043292          319 SLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-V  396 (558)
Q Consensus       319 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~  396 (558)
                      +|.+++.+.. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus       151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            9999886532 23358999999999999999999999   99999999999999999999999999999876543221 2


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+       ...... .+....         
T Consensus       228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~-~~~~~~---------  290 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVL-YGKYDP---------  290 (478)
T ss_pred             ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH-hCCCCC---------
Confidence            335669999999999875 58999999999999999999999997543221       111110 111100         


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       ........+.+++..||+.+|++||++.++++
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             01112346889999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.3e-37  Score=304.80  Aligned_cols=254  Identities=25%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||++...      ++..+|+|.+.... ...+.+.+|+.++.+++|+||+++++++..++..++||||
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY   88 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            3578999999999999742      34568999887543 3356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          315 MPNGSLDRWLFQRS----------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       315 ~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      +++++|.+++....          ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg  165 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG  165 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCC
Confidence            99999999987432          12348999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          385 LSKLIDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       385 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      +++....... .......++..|+|||.+.+ .++.++||||||++++||++ |..||......+    ..    .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~----~~i~~  237 (288)
T cd05093         166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VI----ECITQ  237 (288)
T ss_pred             ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH----HHHHc
Confidence            9986543221 11223345778999999875 58999999999999999998 899986544322    11    11111


Q ss_pred             ccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      +.....          .......+.+++.+|++.||.+|||+.+|++.|+.+...
T Consensus       238 ~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 GRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCcCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            111110          011234689999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6e-37  Score=301.29  Aligned_cols=253  Identities=20%  Similarity=0.387  Sum_probs=200.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||.||+|+. .+++.||||.++..    ......+.+|+.+++.++||||+++++++...+..++++||++
T Consensus         6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08228           6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD   85 (267)
T ss_pred             eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence            357899999999999987 47899999987532    2234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +++|.+++.... ....++...+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-  161 (267)
T cd08228          86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-
Confidence            999999886432 23348899999999999999999999   9999999999999999999999999999887643321 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......++..|+|||.+.+ .++.++||||||+++|||++|+.||.......     ..+... ........        
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~-~~~~~~~~--------  227 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLCQK-IEQCDYPP--------  227 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHHHH-HhcCCCCC--------
Confidence            1234568889999998865 58899999999999999999999986433211     111111 10000000        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                       .........+.+++.+|++.+|++|||+.+|++.|+.+
T Consensus       228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             01123345789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.6e-37  Score=302.02  Aligned_cols=246  Identities=25%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             cCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||+|+||.||++.. .+++.+|+|.+....    .....+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999987 468999999986321    1234466799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.||+.||+|||+   .+++||||||+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            988865432 248999999999999999999999   999999999999999999999999999998664322  23345


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .|+..|+|||++.+ .++.++|||||||++|||++|+.||.........   ........ ....    ...      ..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~-~~~~----~~~------~~  220 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRRTL-EDEV----KFE------HQ  220 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHHhh-cccc----ccc------cc
Confidence            68999999999864 5899999999999999999999999754322111   11111111 0010    000      01


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .....+.+++..||+.||++||++.++++.+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            12346789999999999999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.5e-37  Score=302.42  Aligned_cols=248  Identities=29%  Similarity=0.523  Sum_probs=197.0

Q ss_pred             hhhcCccCceEEEEEEeC-CC---CEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DG---TKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+|++. ++   ..+++|.++..  ....+++..|++++.+++|+|++++.+++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            578999999999999874 33   37999988643  2334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++.....  .+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..........
T Consensus        90 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          90 NGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            9999999975432  48999999999999999999999   899999999999999999999999999998664332221


Q ss_pred             ee--cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 VT--TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~~--~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ..  ....+..|+|||++.+ .++.++||||||+++|||++ |+.||......+    .   ..... ...         
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----~---~~~i~-~~~---------  227 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----V---MKAIN-DGF---------  227 (268)
T ss_pred             eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----H---HHHHh-cCC---------
Confidence            11  1223457999998864 58999999999999999997 999996543221    1   11111 110         


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                       ..+........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0011112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.6e-37  Score=311.57  Aligned_cols=247  Identities=24%  Similarity=0.308  Sum_probs=192.1

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||++... +++.||+|+++..    ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999884 6889999999743    22234578899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence            99998886543   39999999999999999999999   999999999999999999999999999987432211 123


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch-hhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE-DMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||..|+|||++.+ .++.++||||||+++|||++|+.||......+. ......+..+......        ..  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IR--  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CC--
Confidence            34678999999999875 589999999999999999999999974332210 0011111111111111        00  


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC------HHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS------MSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~~vl~  508 (558)
                       .+......+.+++.+||+.||.+|||      +.++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             01112346788999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.6e-37  Score=304.69  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=200.8

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||++...      +...+++|.+..... ..+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM   89 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence            478999999999999742      345689998875433 3457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          316 PNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       316 ~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      ++++|.+++.....             ...+++..++.++.||+.||+|||+   .+++|+||||+|||++.++.++|+|
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~d  166 (291)
T cd05094          90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGD  166 (291)
T ss_pred             CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECC
Confidence            99999999975421             2348999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          383 FGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       383 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ||++........ .......++..|+|||.+.+ .++.++||||||++++||++ |+.||......+    ..    ...
T Consensus       167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~----~~~  238 (291)
T cd05094         167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VI----ECI  238 (291)
T ss_pred             CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH----HHH
Confidence            999976543221 11223456788999998874 58999999999999999999 999986544322    11    111


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ..+.....          .......+.+++.+|++.+|.+|||+.+|+++|+.+..
T Consensus       239 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         239 TQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             hCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111110          11223578899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-37  Score=318.87  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||.||+++.. +++.||+|.+...    ....+.+..|+.+++.++||||+++++++.++...++||||++
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05596          47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence            3578999999999999884 6889999998642    1233457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++...    .++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus       127 gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         127 GGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999998653    27888899999999999999999   999999999999999999999999999998764433222


Q ss_pred             eecccCCCCcCChhhhcC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .....||+.|+|||++.+     .++.++|||||||++|||++|+.||.......       ...........       
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~-------  265 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKNS-------  265 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCCc-------
Confidence            345679999999998753     37899999999999999999999997544321       11111100000       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRV  509 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  509 (558)
                      . ..+........+.+++..||+.+|.+  |||+.++++.
T Consensus       266 ~-~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 L-TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C-CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0 00111122357788999999999987  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-36  Score=299.97  Aligned_cols=251  Identities=29%  Similarity=0.449  Sum_probs=193.7

Q ss_pred             hhhhcCccCceEEEEEEeCC-CC--EEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC------Ccce
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GT--KVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNL  309 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  309 (558)
                      +.++||+|+||.||+|...+ +.  .+|+|.++..   ....+.+..|+.++..++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            35789999999999998754 33  6899988643   23346788999999999999999999987432      2468


Q ss_pred             EEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          310 LVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      +++||+++|+|.+++....   ....+++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999999875321   22358999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +.+....... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +..   . ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~---~-~~~~~  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYD---Y-LRQGN  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH---H-HHcCC
Confidence            8764332211 122345678999999875 58999999999999999999 788886533211    111   1 11111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ...          ........+.+++.+|++.+|++|||+.+|++.|+.+
T Consensus       232 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            100          0112234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-37  Score=315.44  Aligned_cols=240  Identities=29%  Similarity=0.376  Sum_probs=193.9

Q ss_pred             HhhhhcCccCceEEEEEEeCC--CCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQTD--GTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.+.||+|+||.||+|....  +..||+|++...    ....+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus        33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey  112 (340)
T PTZ00426         33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF  112 (340)
T ss_pred             EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeC
Confidence            345889999999999998643  368999998642    22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++....   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......  
T Consensus       113 ~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        113 VIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            99999999997654   38999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.......    .   ... ...+..  .+     
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~---~~~-i~~~~~--~~-----  247 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I---YQK-ILEGII--YF-----  247 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H---HHH-HhcCCC--CC-----
Confidence              234578999999999875 48999999999999999999999997544321    0   111 111110  00     


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                          +......+.+++.+|++.+|.+|+     +++++++.
T Consensus       248 ----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        248 ----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                011123577899999999999995     88888764

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-37  Score=314.49  Aligned_cols=241  Identities=27%  Similarity=0.377  Sum_probs=193.0

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||++.. .+++.||+|.++..    ......+..|++++..++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999987 46899999998743    223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|..++....   .+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence            9999886543   389999999999999999999962  699999999999999999999999999987543222 1233


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||++.+ .++.++||||||+++|||++|+.||.......    +....   . ....           ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i---~-~~~~-----------~~  215 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI---L-MEEI-----------RF  215 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----HHHHH---h-cCCC-----------CC
Confidence            4569999999999875 58999999999999999999999997544321    11100   0 0000           00


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      +......+.+++.+||+.||++|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            111234678899999999999996     89998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.6e-37  Score=311.49  Aligned_cols=247  Identities=25%  Similarity=0.325  Sum_probs=190.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||++... +++.||+|.++..    ......+..|..++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999974 6889999998743    22334577888888776 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~  153 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence            99998886543   38999999999999999999999   999999999999999999999999999987532221 123


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch-hhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE-DMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||..|+|||++.+ .++.++||||||+++|||++|+.||........ ......+..........           
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----------  222 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----------  222 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------
Confidence            34678999999999875 589999999999999999999999964222110 00111111111111110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC------HHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS------MSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~~vl~  508 (558)
                      ..+......+.+++.+||+.||++||+      +.++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            011122346788999999999999998      466653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-37  Score=299.00  Aligned_cols=246  Identities=27%  Similarity=0.486  Sum_probs=198.8

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||.||++...++..+|+|.+........+|.+|++++++++|||++++++++......++|+||+++++|.
T Consensus         8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd05112           8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS   87 (256)
T ss_pred             EEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence            45789999999999998877889999998765555678999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..+..++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||++...............
T Consensus        88 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          88 DYLRAQRG--KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             HHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            99875433  38899999999999999999999   89999999999999999999999999998865433221122233


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++.+|+|||.+. +.++.++||||||+++|||++ |..||......+    ...   . ...+.  ....+        .
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~---~-~~~~~--~~~~~--------~  224 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----VVE---T-INAGF--RLYKP--------R  224 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHH---H-HhCCC--CCCCC--------C
Confidence            567899999887 468899999999999999998 899986543221    111   1 01100  00011        0


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      .....+.+++.+|++.+|++|||+.+++++|
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1235789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.2e-37  Score=309.27  Aligned_cols=239  Identities=28%  Similarity=0.372  Sum_probs=189.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhc-cCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGS-IHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||+|... +++.||+|.++..    ......+..|..++.. ++||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999985 5789999998743    2234456778888876 4999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            99999987543   38899999999999999999999   9999999999999999999999999999875322211 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||..|+|||++.+ .++.++||||||+++|||++|+.||......+    +..   .. ....      ..     
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~---~i-~~~~------~~-----  214 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQ---SI-RMDN------PC-----  214 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHH---HH-HhCC------CC-----
Confidence            34568999999999875 58999999999999999999999997544321    111   10 0000      00     


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  508 (558)
                      .+......+.+++.+||+.||.+||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            0111224678899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=283.08  Aligned_cols=256  Identities=25%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  314 (558)
                      +.+.||.|||+-||.+.. .++..+|+|++.-.. +..+..++|++..++++|||+++++++...+.     ..||+++|
T Consensus        25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py  104 (302)
T KOG2345|consen   25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY  104 (302)
T ss_pred             EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence            457899999999999985 678899999997443 56677899999999999999999999876544     37999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          315 MPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      ...|+|.+.+.... ++..+++.+.+.|+.+|.+||++||+. ..+++||||||.|||+++++.++|.|||.+....-.-
T Consensus       105 y~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i  183 (302)
T KOG2345|consen  105 YKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI  183 (302)
T ss_pred             hccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence            99999999997643 344699999999999999999999982 2349999999999999999999999999987653211


Q ss_pred             Cc--------eeecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          394 SQ--------VVTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       394 ~~--------~~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      ..        ......-|..|.|||.+.    ..+++++|||||||+||+|+.|..||+..-..               .
T Consensus       184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------------G  248 (302)
T KOG2345|consen  184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------------G  248 (302)
T ss_pred             echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------------C
Confidence            00        011234688999999986    24899999999999999999999999743221               1


Q ss_pred             ccchhhc-cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          462 DKLSDLV-DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       462 ~~~~~~~-d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      +.+.-.+ ..... .+......+.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       249 gSlaLAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 GSLALAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CeEEEeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1111111 11111 1112225678999999999999999999999999987753

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.1e-37  Score=304.59  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=197.6

Q ss_pred             hhhhcCccCceEEEEEEe-----CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  312 (558)
                      +.+.||+|+||+||++..     .++..||+|.++...  .....|.+|++++++++||||+++++++...  ...++||
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (283)
T cd05080           8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM   87 (283)
T ss_pred             eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence            347899999999987642     357889999987532  2456788999999999999999999987654  3578999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++|+||||+|||+++++.+||+|||+++.....
T Consensus        88 e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          88 EYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             cCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999653    28999999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 QSQV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ....  .....++..|+|||.+.+ .++.++||||||++++||++|..|+.........  .............+.+.++
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh--hhcccccccchhhhhhhhh
Confidence            2211  122345667999998864 5899999999999999999999998654321100  0000000000011111111


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .... ..........+.+++..|++.+|++|||+++|+++|+.+.
T Consensus       239 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111 1111223467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-36  Score=299.44  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=190.2

Q ss_pred             hcCccCceEEEEEEeC---CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQT---DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .||+|+||.||+|...   ++..+|+|.++...  .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            5899999999999864   34579999887543  233578899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC--CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          320 LDRWLFQRS--DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       320 L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      |.+++....  ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997532  22346788888999999999999999   999999999999999999999999999997543322211 


Q ss_pred             eecccCCCCcCChhhhcC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          397 VTTMRGTPGYLAPEWLSS--------IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~--------~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      .....++..|+|||++.+        .++.++||||||+++|||++ |+.||......+..    ..   .... .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~---~~~~-~~~~~  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TY---TVRE-QQLKL  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HH---Hhhc-ccCCC
Confidence            123456788999998753        25789999999999999996 99999754432211    10   0000 00111


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .++...     ......+.+++..|+ .+|++|||+.+|++.|+
T Consensus       231 ~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111     012235677888898 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.1e-37  Score=305.19  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=198.1

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+|+..      ....+++|.+....  ....++..|+.++..++||||+++++.+..++..++++|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            3478999999999999763      23568888886432  234578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee
Q 043292          314 YMPNGSLDRWLFQRS---------------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL  372 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll  372 (558)
                      |+.+++|.+++....                     ....+++..++.++.|++.||.|||+   .+++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence            999999999986421                     11348899999999999999999999   999999999999999


Q ss_pred             cCCCCeEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043292          373 DGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDM  449 (558)
Q Consensus       373 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~  449 (558)
                      ++++.+||+|||+++......... .....++..|+|||.+.+ .++.++||||||++++||++ |..||....+.+   
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---  237 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---  237 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            999999999999998654332211 122345678999998764 58999999999999999998 999996544322   


Q ss_pred             hHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                       +....    ....     ..     .........+.+++.+|++.+|++||++.++++.|+++.
T Consensus       238 -~~~~~----~~~~-----~~-----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 -LFNLL----KTGY-----RM-----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -HHHHH----hCCC-----CC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence             11111    1110     00     011122347889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.2e-37  Score=298.95  Aligned_cols=246  Identities=28%  Similarity=0.440  Sum_probs=196.5

Q ss_pred             hhcCccCceEEEEEEeCC--C--CEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTD--G--TKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|++|.||+|.+.+  +  ..||+|.+....  ...+.+..|+.++++++|+||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  369999987543  345679999999999999999999999988 888999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      ++|.+++.+... ..+++...+.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999986543 358999999999999999999999   999999999999999999999999999998764422211 


Q ss_pred             -eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          397 -VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       397 -~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       .....++..|+|||.+.+ .++.++||||||++++||++ |+.||......+    ...   .......       .  
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~---~~~~~~~-------~--  219 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILK---KIDKEGE-------R--  219 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHHhcCC-------c--
Confidence             123456789999999875 58999999999999999999 999996543322    111   1100000       0  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                       .......+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0011123457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-36  Score=299.20  Aligned_cols=254  Identities=22%  Similarity=0.403  Sum_probs=202.1

Q ss_pred             HhhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.+.||+|+||.||++.. .++..++||.+...    .....++.+|+.++..++|+||+++++++..++..+++|||+
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            3457899999999999997 57899999987642    223457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          316 PNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       316 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++++|.+++.... ....+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            9999999987422 23458999999999999999999999   9999999999999999999999999999886643322


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       ......++..|+|||++.+ .++.++||||||+++|||++|..||.......     ...... .....     .... 
T Consensus       162 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~-~~~~~-----~~~~-  228 (267)
T cd08229         162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKK-IEQCD-----YPPL-  228 (267)
T ss_pred             -ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhh-hhcCC-----CCCC-
Confidence             1234568899999999865 58899999999999999999999986433211     011100 00000     0000 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                         ........+.+++.+|++.+|.+||||.+|+++++++
T Consensus       229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence               1112345788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=302.81  Aligned_cols=249  Identities=29%  Similarity=0.414  Sum_probs=194.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---------------chHHHHHHHHHHhccCCcceeeeeeeeccC-
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---------------INKSFLAEVKTIGSIHHQNLVRLIGFCAEK-  305 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  305 (558)
                      .+.||+|.||.|-+++. .+++.||+|++.+...               ..+...+|+.+|++++|+|||+|+.+..+. 
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~  181 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE  181 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence            47899999999999988 5789999999963211               124688999999999999999999998764 


Q ss_pred             -CcceEEEEeCCCCCHHHHHhcCCCCCC-CCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEccc
Q 043292          306 -SHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADF  383 (558)
Q Consensus       306 -~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Df  383 (558)
                       +..|||+||+..|.+...    ..... |+..+.+++++++..||+|||.   ++||||||||+|+||+++|++||+||
T Consensus       182 s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  182 SDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeecc
Confidence             467999999998876432    22233 9999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCC----CCceeecccCCCCcCChhhhcC---C--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHH
Q 043292          384 GLSKLIDQD----QSQVVTTMRGTPGYLAPEWLSS---I--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       384 gla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~---~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  454 (558)
                      |.+..+...    .........||+.|+|||...+   .  .+.+.||||+||+||-|+.|+.||.....       ...
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------~~l  327 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------LEL  327 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-------HHH
Confidence            999876321    1122344789999999998754   2  46789999999999999999999974332       222


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ...         ++...+. .+...+..+.+.+|++++|..||+.|.+..+|....--...
T Consensus       328 ~~K---------Ivn~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  328 FDK---------IVNDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHH---------HhcCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            111         2222221 12223456788999999999999999999999876544333

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9e-37  Score=315.70  Aligned_cols=253  Identities=24%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||.||++++.      .+..||+|+++...  ...+.+..|++++.++. ||||+++++++...+..++|+
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            3588999999999999853      34689999997542  22356889999999997 999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------------------------------------------------------
Q 043292          313 EYMPNGSLDRWLFQRSD---------------------------------------------------------------  329 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  329 (558)
                      ||+++|+|.++++....                                                               
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            99999999999965321                                                               


Q ss_pred             --------------------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          330 --------------------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       330 --------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                                                      ...+++..++.++.|++.||.|||+   .+++||||||+|||+++++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCE
Confidence                                            1247888899999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++........ ......++..|+|||.+.+ .++.++||||||++++||++ |..||......+.   ..  
T Consensus       278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---~~--  352 (401)
T cd05107         278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---FY--  352 (401)
T ss_pred             EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---HH--
Confidence            999999999865332211 1223456788999998864 58999999999999999998 8889865433221   11  


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                        .....+..       .   ..+......+.+++..|++.+|.+||++++|++.|+.+.
T Consensus       353 --~~~~~~~~-------~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 --NAIKRGYR-------M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --HHHHcCCC-------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              11111100       0   001112357889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.9e-37  Score=299.04  Aligned_cols=238  Identities=23%  Similarity=0.385  Sum_probs=187.3

Q ss_pred             hhcCccCceEEEEEEeCC-------------CCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcce
Q 043292          244 KMLGKGGFGSVFEGTQTD-------------GTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  309 (558)
                      +.||+|+||.||+|+..+             ...|++|.+..... ....|.+|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             22588898765432 3456888999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC-------eEEcc
Q 043292          310 LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN-------AKVAD  382 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~-------~ki~D  382 (558)
                      +||||+++++|..++.....  .+++..+++++.||+.||+|||+   .+|+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999998865432  38999999999999999999999   99999999999999987664       89999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHH-hCCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ||++......     ....++..|+|||.+.  ..++.++||||||+++|||+ +|..|+......+.    ...     
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~-----  221 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERF-----  221 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHH-----
Confidence            9998755322     2345788999999885  35899999999999999998 58888764332210    000     


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      ....        ..   ........+.+++.+||+.||.+||++.+|++.|+
T Consensus       222 ~~~~--------~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 YEGQ--------CM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HhcC--------cc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0000        00   00112346789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.5e-37  Score=310.20  Aligned_cols=240  Identities=28%  Similarity=0.373  Sum_probs=191.9

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||++... +++.||+|+++..    ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999885 5789999999743    22345577888888877 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..++.+..   .+++..+..++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT  153 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence            99999887553   38999999999999999999999   999999999999999999999999999987532221 122


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ .++.++|||||||++|||++|+.||.......    ...   ... ....           .
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~~~---~i~-~~~~-----------~  214 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----LFQ---SIL-EDEV-----------R  214 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----HHH---HHH-cCCC-----------C
Confidence            34568999999999875 58999999999999999999999997544221    111   110 0000           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSM-----SMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~~  509 (558)
                      ........+.+++.+||+.||.+|||+     .++++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            011123467899999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8e-37  Score=315.25  Aligned_cols=260  Identities=27%  Similarity=0.385  Sum_probs=196.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  313 (558)
                      .++||+|+||.||++.. .+++.||+|++...   ....+++.+|+++++.++|+||+++++++....     ..++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            47899999999999997 47899999998643   223457889999999999999999999998776     7899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+. ++|.+++....   .+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          85 LMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             ccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            996 57887775433   48999999999999999999999   999999999999999999999999999998665443


Q ss_pred             CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc------ccch
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE------DKLS  465 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~  465 (558)
                      ........++..|+|||++.+  .++.++|||||||+++||++|+.||....+.+....+.........+      ....
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            333444567899999999875  37899999999999999999999998765443221111110000000      0000


Q ss_pred             hhccccCCCC-------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          466 DLVDKHSNDM-------QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       466 ~~~d~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..+.......       .........+.+++.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000000       0011123568899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=299.99  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=193.3

Q ss_pred             hhcCccCceEEEEEEeCC-CC--EEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTD-GT--KVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||+|++.+ +.  .+++|.++..  ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999853 43  4688888743  23446788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          318 GSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       318 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      ++|.+++....             ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997532             11248899999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                      ++.......  .......+..|+|||++.. .++.++||||||++++||++ |..||......+       ..... ..+
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~-~~~  227 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKL-PQG  227 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHH-hCC
Confidence            986322111  1112233567999999864 58999999999999999997 999996543221       11111 111


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ...   +       ........+.+++.+|++.||.+|||+.++++.|+.+.
T Consensus       228 ~~~---~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 YRL---E-------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC---C-------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000   0       01112346889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-37  Score=317.28  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=190.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||+||+++. .+++.||+|++....    .....+..|+.++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g   85 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            46899999999999987 468899999996432    2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC---
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS---  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~---  394 (558)
                      |+|.+++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....   
T Consensus        86 g~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          86 GDMMSLLIRME---VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            99999997644   38899999999999999999999   9999999999999999999999999999764321000   


Q ss_pred             -------------------------------------------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHH
Q 043292          395 -------------------------------------------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVML  430 (558)
Q Consensus       395 -------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~  430 (558)
                                                                 .......||+.|+|||.+.+ .++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                       00123569999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHH--ccCcCCCCCCCHHHHHH
Q 043292          431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW--CLESDFAKRPSMSMVVR  508 (558)
Q Consensus       431 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~~vl~  508 (558)
                      ||++|..||......+....+..+      ....      ...   ........+.+++.+  |+..+|..||++.++++
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINW------ENTL------HIP---PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHcc------cccc------CCC---CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999765543311111100      0000      000   000112345566665  55667777999999986


Q ss_pred             H
Q 043292          509 V  509 (558)
Q Consensus       509 ~  509 (558)
                      .
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=318.19  Aligned_cols=245  Identities=26%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|+++...    .....+..|+.++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            478999999999999985 68999999997432    3345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC----
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~----  393 (558)
                      ++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......    
T Consensus        86 ~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          86 GDLMNLLIRKD---VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99999998652   48999999999999999999999   999999999999999999999999999998665432    


Q ss_pred             ------------------------CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043292          394 ------------------------SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED  448 (558)
Q Consensus       394 ------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~  448 (558)
                                              ........||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                    112234568999999999875 5899999999999999999999999765532211


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS-MSMVVRV  509 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~~  509 (558)
                      ..+..+    .  ..   .   ..   +........+.+++..|++ +|.+||+ +.++++.
T Consensus       240 ~~i~~~----~--~~---~---~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         240 NKIINW----K--ES---L---RF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHhcc----C--Cc---c---cC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111110    0  00   0   00   0000123467889999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=310.18  Aligned_cols=245  Identities=26%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCc-ceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH-NLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~  316 (558)
                      +.+.+|+|+||.++..+. .++..+++|.+.-..   ...+....|+.++++++|||||.+.+.+.+++. .+|||+|++
T Consensus         8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence            457899999999999877 467899999886432   233467899999999999999999999999888 899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ||+|.+.+.+.. ...++++.+.+++.|++.|+.|||+   ..|+|||||+.||+++.+..+||+|||+|+.+..+.. .
T Consensus        88 Gg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~  162 (426)
T KOG0589|consen   88 GGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-L  162 (426)
T ss_pred             CCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh-h
Confidence            999999998765 3458999999999999999999998   9999999999999999999999999999999876652 3


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ..+..||+.||.||.+.+ .|+.|+|||||||++|||++-+++|...+...-..       +..     ...+.      
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~-------ki~-----~~~~~------  224 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL-------KIN-----RGLYS------  224 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH-------HHh-----hccCC------
Confidence            567889999999999987 59999999999999999999999998666433111       111     01111      


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      +.+..+...+..++..|++.+|..||++.+++.+
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2233455688899999999999999999999976

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-37  Score=303.61  Aligned_cols=252  Identities=25%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             hhhhcCccCceEEEEEEeCC-----CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-----GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  313 (558)
                      +.++||+|+||.||+|...+     +..|++|++...  ....+.+.+|+.++.+++|+||+++++++.. +...++++|
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   89 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP   89 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence            45789999999999998755     688999988743  2234668899999999999999999998766 567899999


Q ss_pred             eCCCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          314 YMPNGSLDRWLFQRSDE-----FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      |+++++|.+++......     ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            99999999999764321     458999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          389 IDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       389 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      +....... .....++..|+|||.+.+ .++.++||||||+++||+++ |+.||....+.+    +....    ..+.  
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~----~~~~--  236 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MAAYL----KDGY--  236 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----HHHHH----HcCC--
Confidence            64332221 123446778999998875 58999999999999999999 999997543322    11111    1110  


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                           ..   .........+.+++.+|++.+|++|||+.+++++|+.+.
T Consensus       237 -----~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         237 -----RL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -----CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                 00   001112346889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=303.88  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=195.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++.. .+++.||+|.+....    .....+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            46899999999999987 468999999986432    2234578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++........  .
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  158 (285)
T cd05605          85 GDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I  158 (285)
T ss_pred             CcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence            999988865432 348999999999999999999999   8999999999999999999999999999986543221  2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ .++.++||||+|+++|||++|+.||...........+    .......         ..  .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~~~~~~---------~~--~  223 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKED---------QE--E  223 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HHHhhhc---------cc--c
Confidence            34568999999999864 5899999999999999999999999754432211111    0100000         00  1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      ........+.+++..|++.||++||     ++.++++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1112345688999999999999999     78887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-37  Score=315.82  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++... +++.+|+|.+...    ....+.+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence            478999999999999984 5889999998642    12334578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++...    .++...+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||++...........
T Consensus       128 g~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~  200 (370)
T cd05621         128 GDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC  200 (370)
T ss_pred             CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence            9999998653    27889999999999999999999   9999999999999999999999999999987644332223


Q ss_pred             ecccCCCCcCChhhhcC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          398 TTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ....||+.|+|||++.+     .++.++||||||+++|||++|+.||........       ............      
T Consensus       201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~~------  267 (370)
T cd05621         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMDHKNSLN------  267 (370)
T ss_pred             ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCcccC------
Confidence            45679999999999863     278899999999999999999999975443221       111110000000      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  509 (558)
                        .+........+.+++..|++.++.+  |||+.++++.
T Consensus       268 --~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 --FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              0111122345677888889765543  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.5e-37  Score=308.20  Aligned_cols=238  Identities=28%  Similarity=0.397  Sum_probs=188.6

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+++.. ++..||+|.++..    ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999984 6889999998743    22334567788887654 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            99999987543   38899999999999999999999   999999999999999999999999999987432211 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||..|+|||++.+ .++.++||||||+++|||++|+.||......+    +..   .. ....      ...    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----~~~---~~-~~~~------~~~----  215 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----LFE---SI-RVDT------PHY----  215 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHH---HH-HhCC------CCC----
Confidence            45678999999999875 58999999999999999999999997543221    111   10 0000      000    


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMS-MVV  507 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl  507 (558)
                       +......+.+++.+||+.||.+||++. +++
T Consensus       216 -~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 -PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             011224677899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-37  Score=301.98  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=197.9

Q ss_pred             hhhcCccCceEEEEEEeCC------CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|....      +..||+|.+....  .....+.+|+.++..++|+||+++++++..+...++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            4789999999999998642      3689999987432  2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          315 MPNGSLDRWLFQRSD-------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      +++++|.+++.....       ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccch
Confidence            999999999975321       2247899999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          388 LIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       388 ~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ........ ......++..|+|||.+. +.++.++||||||+++||+++ |+.||......+    .....    ..+..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~~~~  239 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFV----IDGGH  239 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHHHH----hcCCC
Confidence            65433221 123345678999999886 468999999999999999998 899986544322    11111    11111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ..          .+......+.+++..|++.+|++|||+.++++.|+.
T Consensus       240 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         240 LD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            11          011124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.1e-37  Score=309.31  Aligned_cols=236  Identities=27%  Similarity=0.346  Sum_probs=190.1

Q ss_pred             hhcCccCceEEEEEEe----CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.||+|+||.||++..    .+++.+|+|++....   .....+..|++++.+++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999875    357899999997432   223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~  154 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK  154 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence            999999986543   38999999999999999999999   999999999999999999999999999998654332 22


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+    ...   ... ....           
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~---~i~-~~~~-----------  215 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----TMT---MIL-KAKL-----------  215 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----HHH---HHH-cCCC-----------
Confidence            335678999999999875 58899999999999999999999997544321    111   110 0000           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSM  505 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  505 (558)
                      ..+......+.+++.+||+.||.+||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            001112346788999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.8e-37  Score=305.78  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=198.3

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.||+|+||.||++...      ....+|+|.+....  ....++.+|+.++.++ +|+||+++++++..++..+++||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            478999999999999863      23579999887432  2335688999999999 89999999999999999999999


Q ss_pred             eCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          314 YMPNGSLDRWLFQR-------------SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       314 ~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                      |+++|+|..++...             .....+++..+++++.|++.||.|||+   .+|+|+||||+||++++++.+||
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEe
Confidence            99999999999643             123458999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHH
Q 043292          381 ADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      +|||+++......... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    ...    
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~----  245 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LFK----  245 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----HHH----
Confidence            9999998764432211 122335678999998764 58999999999999999998 999986544322    111    


Q ss_pred             hhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       458 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ....+...          .........+.+++.+|++.||++|||+.++++.|+.+.
T Consensus       246 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11111100          011123457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-36  Score=308.68  Aligned_cols=241  Identities=27%  Similarity=0.347  Sum_probs=187.8

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHH-HHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVK-TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||+++.. +++.||+|++....    .....+..|.. ++..++|+||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999884 57889999986432    22234444443 56788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .++......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~  153 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence            99999997543   37888889999999999999999   9999999999999999999999999999975432221 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.       ...... ..        ..   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~-~~--------~~---  214 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILN-KP--------LQ---  214 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHHHHh-CC--------cC---
Confidence            45679999999999875 589999999999999999999999975443221       111100 00        00   


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      ........+.+++.+|++.+|.+||++.+.+..+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            0011234678899999999999999987554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=299.22  Aligned_cols=245  Identities=25%  Similarity=0.425  Sum_probs=193.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccC------CcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK------SHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~e  313 (558)
                      +.+.||+|+||.||+|... +++.||+|.+.........+..|+.++.++ +|+||+++++++...      ...+++||
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e   89 (272)
T cd06637          10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME   89 (272)
T ss_pred             HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence            3578999999999999874 688999999976655667789999999998 799999999998653      35789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          90 FCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            9999999999876432 348999999999999999999999   899999999999999999999999999998654322


Q ss_pred             CceeecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          394 SQVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      . ......|+..|+|||++.      ..++.++||||||+++|||++|+.||..........       ... ...... 
T Consensus       166 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~~-~~~~~~-  235 (272)
T cd06637         166 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIP-RNPAPR-  235 (272)
T ss_pred             c-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHh-cCCCCC-
Confidence            1 233466889999999874      247889999999999999999999996433221100       000 000000 


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                          ..    .......+.+++.+||+.+|.+|||+.++++
T Consensus       236 ----~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 ----LK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ----CC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                00    1112346889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=296.39  Aligned_cols=245  Identities=32%  Similarity=0.507  Sum_probs=199.8

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||.|+||.||++... ++.||+|.++......+++.+|+.++..++|+||+++++++......++||||+++++|.
T Consensus        10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   88 (256)
T cd05039          10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV   88 (256)
T ss_pred             ceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence            4578999999999999865 789999999866555678999999999999999999999999989999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......    ....
T Consensus        89 ~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~~  160 (256)
T cd05039          89 DYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGK  160 (256)
T ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----ccCC
Confidence            99976543 248999999999999999999999   999999999999999999999999999998763221    1233


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .+..|+|||.+. +.++.++||||||++++|+++ |..||......+    +....    ..+....          ...
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~----------~~~  222 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHV----EKGYRME----------APE  222 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----hcCCCCC----------Ccc
Confidence            466899999886 468899999999999999997 999986443221    11111    1110000          011


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .....+.+++.+|++.+|++|||+.+++++|+.+
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            2235788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=300.29  Aligned_cols=237  Identities=24%  Similarity=0.396  Sum_probs=186.0

Q ss_pred             hcCccCceEEEEEEeCC-------------------------CCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeee
Q 043292          245 MLGKGGFGSVFEGTQTD-------------------------GTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRL  298 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l  298 (558)
                      .||+|+||.||+|++..                         ...|++|.+.... .....|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         1358899886433 234578889999999999999999


Q ss_pred             eeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC--
Q 043292          299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF--  376 (558)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~--  376 (558)
                      ++++.++...++||||+++|+|..++.....  .+++..+..++.||++||+|||+   .+|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999865432  48899999999999999999999   8999999999999997654  


Q ss_pred             -----CeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHH-hCCCCCCCCCCcchh
Q 043292          377 -----NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEED  448 (558)
Q Consensus       377 -----~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~ell-tg~~p~~~~~~~~~~  448 (558)
                           .+|++|||++......     ....++..|+|||.+.+  .++.++||||||+++|||+ +|+.||......+. 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                 3799999998644221     22346788999998864  4899999999999999994 68999875543321 


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                         .......           .....     .....+.+++.+|++.+|++|||+.+|++.|+
T Consensus       231 ---~~~~~~~-----------~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ---ERFYEKK-----------HRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HHHHHhc-----------cCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               1110000           00000     11236888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.7e-37  Score=300.96  Aligned_cols=250  Identities=27%  Similarity=0.502  Sum_probs=197.0

Q ss_pred             HhhhhcCccCceEEEEEEeC-CC---CEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQT-DG---TKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.+.||+|+||.||+|... ++   ..||+|.++..  .....+|..|+.+++.++||||+++++++..+...++||||
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   86 (269)
T cd05065           7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEF   86 (269)
T ss_pred             EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEec
Confidence            35678999999999999874 33   36999998743  33356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++.....  .+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          87 MENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             CCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999976433  48999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             ce--eeccc--CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          395 QV--VTTMR--GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       395 ~~--~~~~~--gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ..  .....  .+..|+|||.+.+ .++.++||||||++++|+++ |..||......+    .....    ....     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i----~~~~-----  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAI----EQDY-----  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHH----HcCC-----
Confidence            11  11111  2357999999874 58999999999999999886 999986543221    11111    0000     


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        ..   ....+.+..+.+++..|++.+|++||++.+|+++|+.+
T Consensus       229 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              00   11112335678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.8e-37  Score=308.82  Aligned_cols=235  Identities=29%  Similarity=0.396  Sum_probs=185.9

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHH-HHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVK-TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||+++.. +++.||+|++....    .....+..|.. ++..++||||+++++.+..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999984 68999999986421    22234455544 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT  153 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence            99999987543   38899999999999999999999   999999999999999999999999999987542221 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+       ...... ..        ...   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~-~~--------~~~---  214 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNIL-NK--------PLR---  214 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHH-cC--------CCC---
Confidence            44678999999999875 58999999999999999999999997543221       111111 00        000   


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMS  504 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  504 (558)
                      ........+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0011234688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=298.32  Aligned_cols=251  Identities=29%  Similarity=0.471  Sum_probs=196.0

Q ss_pred             hhhhcCccCceEEEEEEeC-C---CCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCc------c
Q 043292          242 FRKMLGKGGFGSVFEGTQT-D---GTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH------N  308 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  308 (558)
                      +.+.||+|+||.||+|... +   +..||+|+++...   .....+..|+..++.++|+||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            3478999999999999874 2   3679999987432   223578999999999999999999998876554      6


Q ss_pred             eEEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCC
Q 043292          309 LLVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL  385 (558)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgl  385 (558)
                      ++++||+++++|..++....   ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence            89999999999999986432   22358999999999999999999999   8999999999999999999999999999


Q ss_pred             ccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          386 SKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       386 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                      ++......... .....++..|+|||.+.+ .++.++||||||++++||++ |..||......+    +....    ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~----~~~  231 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYL----RHG  231 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcC
Confidence            98664332221 112334678999999864 58999999999999999999 888886543221    11111    111


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ...          .........+.+++.+|++.||++|||+.+|++.|+++
T Consensus       232 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100          01112345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-36  Score=298.74  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++.+++|+||+++++++..++..++|+||+++++
T Consensus        13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~   92 (267)
T cd06646          13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS   92 (267)
T ss_pred             hhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence            457899999999999997 568899999987432 334567889999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++....   .+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.+||+|||++........ ....
T Consensus        93 L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~  165 (267)
T cd06646          93 LQDIYHVTG---PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS  165 (267)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence            999987543   38999999999999999999999   8999999999999999999999999999986643221 1233


Q ss_pred             ccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          400 MRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       400 ~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ..++..|+|||.+.    ..++.++||||||++++||++|+.||....+.+.....        ....   ......   
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~---~~~~~~---  231 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSN---FQPPKL---  231 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCC---CCCCCC---
Confidence            56888999999874    24788999999999999999999998644322110000        0000   000001   


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      .........+.+++.+||+.+|++|||+++|++.|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            01112335788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.9e-37  Score=307.26  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=197.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCC--EEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGT--KVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|... ++.  .+++|.++..  ......+.+|+.++.++ +|+||+++++++..++..++|+||+
T Consensus        11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   90 (303)
T cd05088          11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   90 (303)
T ss_pred             eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence            4578999999999999874 444  4677777642  23445788999999999 8999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          316 PNGSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       316 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      ++++|.+++....             ....+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~d  167 (303)
T cd05088          91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  167 (303)
T ss_pred             CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCc
Confidence            9999999997542             12358899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhh
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ||++.......  .......+..|+|||++.+ .++.++||||||++++||++ |..||......+    .   .... .
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~---~~~~-~  237 (303)
T cd05088         168 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----L---YEKL-P  237 (303)
T ss_pred             cccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----H---HHHH-h
Confidence            99986432111  1112234568999998865 48899999999999999998 999996544322    1   1110 0


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                      ...     .  .   .........+.+++.+|++.+|++||++.+++++|+.+.+-+.
T Consensus       238 ~~~-----~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         238 QGY-----R--L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             cCC-----c--C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            000     0  0   0011123467899999999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=303.81  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=194.3

Q ss_pred             hhhhcCccCceEEEEEEeCC---------------CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          242 FRKMLGKGGFGSVFEGTQTD---------------GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      +.++||+|+||.||++....               ...||+|.++..  ......|.+|++++.+++|+|++++++++..
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   88 (295)
T cd05097           9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS   88 (295)
T ss_pred             ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence            45789999999999987532               234899988743  2234568999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCCHHHHHhcCCC---------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          305 KSHNLLVYEYMPNGSLDRWLFQRSD---------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      .+..++||||+++++|.+++.....         ...+++..++.++.|++.||.|||+   .+++|+||||+||+++++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~  165 (295)
T cd05097          89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNH  165 (295)
T ss_pred             CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCC
Confidence            9999999999999999999865321         1237899999999999999999999   999999999999999999


Q ss_pred             CCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh--CCCCCCCCCCcchhhhH
Q 043292          376 FNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC--GRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       376 ~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~~  451 (558)
                      +.+||+|||++......... ......++..|+|||.+. +.++.++||||||++++||++  +..||......+.....
T Consensus       166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~  245 (295)
T cd05097         166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT  245 (295)
T ss_pred             CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence            99999999999765332211 122334567899999876 468999999999999999998  56677654432211111


Q ss_pred             HHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       452 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .    .............       ........+.+++.+|++.||++|||+.+|+++|.
T Consensus       246 ~----~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         246 G----EFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H----HhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1    1010000000000       01112357999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=295.37  Aligned_cols=247  Identities=32%  Similarity=0.502  Sum_probs=200.6

Q ss_pred             hhcCccCceEEEEEEeCC----CCEEEEEEecccccc--hHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||++....    +..|++|.++.....  .+.+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998854    788999999754333  57789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          318 GSLDRWLFQRSD------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       318 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      ++|.+++.....      ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521      2459999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          392 DQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       392 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ... .......++..|+|||.+.. .++.++||||+|++++||++ |..||......+    +..    ....+...   
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~----~~~~~~~~---  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLE----YLRKGYRL---  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----HHH----HHHcCCCC---
Confidence            321 12234557889999998875 68999999999999999999 699997653221    111    11111000   


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                             .........+.+++.+|++.+|.+|||+.++++.|+
T Consensus       227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   111122457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-36  Score=299.21  Aligned_cols=249  Identities=28%  Similarity=0.491  Sum_probs=197.8

Q ss_pred             hhhhcCccCceEEEEEEeC-C---CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-D---GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|... +   ...+|+|.++..  ....+.+..|+.++.+++||||+++++++..++..++||||+
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (267)
T cd05066           8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM   87 (267)
T ss_pred             eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            4578999999999999863 2   337999988643  223467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.....  .+++.++..++.|++.||.|||+   .+++|+||||+|||++.++.++|+|||++.........
T Consensus        88 ~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          88 ENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999976543  48999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             eee--cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          396 VVT--TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       396 ~~~--~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ...  ...++..|+|||++.+ .++.++||||||++++|+++ |..||......+    .....    .++..       
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~----~~~~~-------  227 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAI----EEGYR-------  227 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHH----hCCCc-------
Confidence            222  1223568999999874 68999999999999999887 999987544322    11100    11100       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .   +.....+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0   01112235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-37  Score=298.68  Aligned_cols=248  Identities=32%  Similarity=0.546  Sum_probs=196.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchH---HHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||+||+++.. +++.+|+|.+........   ....|+.++.+++|+||+++++++.+....++||||+++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            3478999999999999985 466899999986543332   345699999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|+++||.+||+   .+++|+||||+||++++++.++|+|||.+.... ......
T Consensus        83 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   83 GSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             EBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             ccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence            99999998332   38999999999999999999999   899999999999999999999999999997642 222234


Q ss_pred             ecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....++..|+|||++.  ...+.++||||+|+++++|++|..||...........+..........    .     ... 
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~-----~~~-  225 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS----S-----SQQ-  225 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH----H-----TTS-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc----c-----ccc-
Confidence            5567899999999987  469999999999999999999999998652222111111111100000    0     000 


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .......+.+++..||+.||++|||+.++++
T Consensus       226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0001268899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=320.26  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             hhhcCccCceEEEEEEeCCC-CEEEEEEec-ccccchHHHHHHHHHHhccC-Ccceeeeeee-ecc------CCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQTDG-TKVAVKRLE-GIGEINKSFLAEVKTIGSIH-HQNLVRLIGF-CAE------KSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~~~lv~  312 (558)
                      .+.|.+|||+.||.+.+..+ .++|+|++- ......+...+|+.+|++|+ |+|||.+++. ...      .-+.+|+|
T Consensus        42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            47899999999999998665 999999885 34555677899999999997 9999999993 221      12568999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      |||++|+|-+++..+.... |++.++++|+.++++|+++||. +..+|||||||.+||||+.++..||+|||.|.-....
T Consensus       122 EyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~  199 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS  199 (738)
T ss_pred             hhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence            9999999999998766554 9999999999999999999997 5677999999999999999999999999998743222


Q ss_pred             CCce--------eecccCCCCcCChhhhc---C-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh
Q 043292          393 QSQV--------VTTMRGTPGYLAPEWLS---S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       393 ~~~~--------~~~~~gt~~y~aPE~~~---~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ....        .....-|+-|.|||.+.   + .+++|+|||+|||+||-|+....||+....-.              
T Consensus       200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------------  265 (738)
T KOG1989|consen  200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------------  265 (738)
T ss_pred             CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------------
Confidence            2100        11234689999999875   4 59999999999999999999999998553211              


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                            +++.... .+........+..||..||+.||.+||++-+|+..+-++...+-
T Consensus       266 ------Ilng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  266 ------ILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ------EEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                  2222111 12234677899999999999999999999999999877766543

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-36  Score=295.49  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=198.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|++|.||+++.. +++.|++|.+...   ......+..|+++++.++|||++++++++.+++..++||||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            3578999999999999884 6899999988632   23456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....... ..
T Consensus        84 ~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~  158 (256)
T cd08529          84 GDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA  158 (256)
T ss_pred             CcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence            999999976432 358999999999999999999999   8999999999999999999999999999886654322 22


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....++..|+|||++.+ .++.++||||||++++||++|+.||.......    ..   .. ...+....          
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~---~~-~~~~~~~~----------  220 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----LI---LK-IIRGVFPP----------  220 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HH---HH-HHcCCCCC----------
Confidence            34568889999999875 58899999999999999999999997544211    11   01 11111110          


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ........+.+++.+|++.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111234578999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-36  Score=302.41  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=198.5

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.+.||+|+||.||+++..      .+..||||.++...  ...+.+.+|+.+++++ +|+||+++++++...+..++||
T Consensus        39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  118 (302)
T cd05055          39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT  118 (302)
T ss_pred             EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence            3578999999999999742      34579999887532  2345789999999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++..... ..+++.++..++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||+++.....
T Consensus       119 e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  194 (302)
T cd05055         119 EYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND  194 (302)
T ss_pred             EcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence            99999999999975432 238999999999999999999999   89999999999999999999999999999866443


Q ss_pred             CCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 QSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ... ......++..|+|||.+.+ .++.++||||||+++|||++ |..||......+.   ...    ....+...    
T Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~----  263 (302)
T cd05055         195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYK----LIKEGYRM----  263 (302)
T ss_pred             CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHH----HHHcCCcC----
Confidence            221 1223345778999998764 58999999999999999998 9999875443221   111    11111000    


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                            .........+.+++.+|++.+|++|||+.+|++.|+..
T Consensus       264 ------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 ------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  00011234788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.6e-36  Score=295.57  Aligned_cols=254  Identities=24%  Similarity=0.425  Sum_probs=202.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||+|... +++.||+|.++..    ....+.+.+|++++++++|+|++++++++..++..++||||++
T Consensus         6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (267)
T cd08224           6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELAD   85 (267)
T ss_pred             eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCC
Confidence            4578999999999999985 7899999988632    2234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +++|.+++.... ....+++.++..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-  161 (267)
T cd08224          86 AGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             CCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-
Confidence            999999987532 23458999999999999999999999   9999999999999999999999999999886543321 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||......     ....... ...+....        
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~~~~--------  227 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKK-IEKCDYPP--------  227 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHHhh-hhcCCCCC--------
Confidence            1233567889999998865 5899999999999999999999998643321     1111111 00111100        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                       .........+.+++.+|++.+|++|||+.+|+++|+.+.
T Consensus       228 -~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 -LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             011133457889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9e-37  Score=306.13  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=201.4

Q ss_pred             hhhhcCccCceEEEEEEe--------CCCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQ--------TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+.||+|+||.||+++.        .++..||+|.+...  ....+++.+|+.++..+ +||||+++++++......++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   98 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   98 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence            457899999999999964        12457999988743  23346789999999999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ||||+++++|.+++.....             ...+++.++..++.||+.||.|||+   .+++|+||||+||++++++.
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~  175 (304)
T cd05101          99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNV  175 (304)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCc
Confidence            9999999999999976421             2348899999999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++......... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +   
T Consensus       176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~---  248 (304)
T cd05101         176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----L---  248 (304)
T ss_pred             EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----H---
Confidence            9999999998764332221 222345678999998865 58999999999999999998 788886543222    1   


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                      ... ...+...          .........+.+++.+|++.+|.+|||+.+|++.|+++..+..
T Consensus       249 ~~~-~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         249 FKL-LKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHH-HHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            111 1111100          0011234578889999999999999999999999999876653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-36  Score=307.28  Aligned_cols=241  Identities=24%  Similarity=0.290  Sum_probs=188.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||++... +++.||+|+++...    ...+.+..|..++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999884 67899999997432    2334578899998888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT  153 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence            99998886543   38999999999999999999999   999999999999999999999999999987532221 123


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||.......... ......+......        .   .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~--------~---~  221 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKP--------I---R  221 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCC--------C---C
Confidence            45679999999999875 58999999999999999999999996533221111 1111111111110        0   0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                      .+......+.+++.+||+.||.+||++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            111122467889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.3e-36  Score=298.99  Aligned_cols=248  Identities=28%  Similarity=0.426  Sum_probs=194.3

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|...      .+..|++|.+....  .....|..|+.++++++|+||+++++++.+....++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            478999999999999874      35678999886432  2345689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCcc
Q 043292          315 MPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSK  387 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~  387 (558)
                      +++++|.+++.....    ...+++..+.+++.||+.||+|||+   .+++|+||||+||+++.++   .+||+|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcccc
Confidence            999999999975432    1258999999999999999999999   8999999999999998765   59999999998


Q ss_pred             ccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          388 LIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       388 ~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ......... ......+..|+|||++. +.++.++|||||||+++||++ |..||......+    +....   ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~~---~~~~~~  240 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEFV---TGGGRL  240 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH---HcCCcC
Confidence            763322111 11223356899999986 469999999999999999997 999987544322    11111   000000


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                                 .........+.+++.+|++.+|++|||+.+|++.|+
T Consensus       241 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 -----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                       011122357889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-36  Score=294.96  Aligned_cols=237  Identities=24%  Similarity=0.428  Sum_probs=189.7

Q ss_pred             hhcCccCceEEEEEEeCCCC-----------EEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          244 KMLGKGGFGSVFEGTQTDGT-----------KVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.||+|+||.||+|.+.+..           .+++|.+.........|.+|+.++++++|+||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999985432           57888776544436789999999999999999999999988 7789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-------CeEEcccCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-------NAKVADFGL  385 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-------~~ki~Dfgl  385 (558)
                      ||+++|+|.+++.....  .+++..+..++.||+.||.|||+   .+|+|+||||+|||++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999986543  48999999999999999999998   9999999999999999888       799999999


Q ss_pred             ccccCCCCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          386 SKLIDQDQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       386 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      +.....     .....++..|+|||++.+   .++.++||||||+++|||++ |..|+......+..    ....    .
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~----~~~~----~  221 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE----RFYQ----D  221 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH----HHHh----c
Confidence            986543     123446778999999864   48899999999999999999 57777654322110    0000    0


Q ss_pred             ccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      ..       ....     .....+.+++..|++.+|.+|||+.+|++.|+
T Consensus       222 ~~-------~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH-------RLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC-------CCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00       0000     01157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-36  Score=303.82  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=196.7

Q ss_pred             hhhhcCccCceEEEEEEeCC-CC--EEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GT--KVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|.+.+ +.  .+++|.++..  ....+.+..|+.++.++ +||||+++++++......++++||+
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~   85 (297)
T cd05089           6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA   85 (297)
T ss_pred             eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence            45789999999999998743 33  4788888742  23345789999999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          316 PNGSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       316 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      ++++|.+++....             ....+++..+..++.|++.||+|||+   .+++|+||||+|||+++++.+||+|
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~d  162 (297)
T cd05089          86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIAD  162 (297)
T ss_pred             CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECC
Confidence            9999999996532             11248899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhh
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ||++.......  .......+..|+|||++.+ .++.++||||||++++||++ |..||......+    +.   .. ..
T Consensus       163 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~~---~~-~~  232 (297)
T cd05089         163 FGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----LY---EK-LP  232 (297)
T ss_pred             cCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HH---HH-Hh
Confidence            99986432111  1111223557999998865 58999999999999999998 999997554322    11   11 11


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .+...          .........+.+++..|++.+|.+|||+.++++.|+.+....
T Consensus       233 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         233 QGYRM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             cCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11000          001112346889999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=314.98  Aligned_cols=245  Identities=23%  Similarity=0.299  Sum_probs=189.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++.. .+++.||||++....    ...+.+.+|++++..++||||+++++++.++...++||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            47899999999999987 468999999986432    2335678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc--
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      |+|.+++....   .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+......  
T Consensus        86 g~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          86 GDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999997543   38899999999999999999999   99999999999999999999999999999643211000  


Q ss_pred             --------------------------------------------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHH
Q 043292          396 --------------------------------------------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVML  430 (558)
Q Consensus       396 --------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~  430 (558)
                                                                  ......||+.|+|||++.+ .++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        0012468999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCC---CCHHHHH
Q 043292          431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR---PSMSMVV  507 (558)
Q Consensus       431 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~vl  507 (558)
                      ||++|..||......+....+..       ......     ...   .......+.+++..|+. +|.+|   +|+.+++
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~-------~~~~~~-----~p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIIN-------WRETLY-----FPD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHc-------cCCccC-----CCC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            99999999975443221111110       000000     000   00122457788888997 66665   5999988


Q ss_pred             HH
Q 043292          508 RV  509 (558)
Q Consensus       508 ~~  509 (558)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.8e-36  Score=296.98  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=187.0

Q ss_pred             hcCccCceEEEEEEeCC---CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQTD---GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .||+|+||.||+|...+   ...+++|.+....  .....|.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643   3568888776432  234568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCC--CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          320 LDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       320 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      |.+++.....  ....++.....++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976432  2235688889999999999999999   899999999999999999999999999987543222111 


Q ss_pred             eecccCCCCcCChhhhc--------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          397 VTTMRGTPGYLAPEWLS--------SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~--------~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      .....++..|+|||++.        ..++.++||||||+++|||++ |..||......+   .    ......... ..+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~----~~~~~~~~~-~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V----LKQVVREQD-IKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H----HHHHhhccC-ccC
Confidence            12234567899999864        236789999999999999999 778886443221   1    111111111 111


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      .+...     .......+.+++..|+ .||++|||+++|+++|.
T Consensus       231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111     1122345566777787 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=316.45  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=192.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+++.. +++.||||++....    .....+..|+.++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            478999999999999984 68999999997432    2334578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc--
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      |+|.+++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+......  
T Consensus        86 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          86 GDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             cHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999997643   38999999999999999999999   99999999999999999999999999998754321100  


Q ss_pred             -----------------------------------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCC
Q 043292          396 -----------------------------------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF  439 (558)
Q Consensus       396 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~  439 (558)
                                                         ......||+.|+|||++.+ .++.++|||||||+++||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               0112468999999999875 5899999999999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 043292          440 DRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS---MSMVVRV  509 (558)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~  509 (558)
                      ......+....+.       ........     .   ........+.+++..|+. +|.+|++   +.++++.
T Consensus       240 ~~~~~~~~~~~i~-------~~~~~~~~-----~---~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         240 CSDNPQETYRKII-------NWKETLQF-----P---DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCHHHHHHHHH-------cCCCccCC-----C---CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            7554322111110       00000000     0   000112356778888886 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-36  Score=308.38  Aligned_cols=241  Identities=28%  Similarity=0.356  Sum_probs=188.7

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHH-HHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVK-TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||+++. .+++.+|+|++...    ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999987 46899999998643    122344555554 46789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  153 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT  153 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence            99998886543   38999999999999999999999   999999999999999999999999999987532221 123


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||++.+ .++.++||||||+++|||++|..||......+       ...... ..        ....  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~-~~--------~~~~--  215 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNIL-HK--------PLVL--  215 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHH-cC--------CccC--
Confidence            45678999999999875 58999999999999999999999997544222       111111 11        0000  


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                       .......+.+++..|++.+|.+||++.+.++.+
T Consensus       216 -~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         216 -RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence             011234677899999999999999986544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-36  Score=297.97  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=198.2

Q ss_pred             HhhhhcCccCceEEEEEEeCC----CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.++||+|+||.||+|...+    ...|++|......  ...+.+.+|+.++++++|+||+++++++.+ ...++||||
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~   87 (270)
T cd05056           9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMEL   87 (270)
T ss_pred             eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEc
Confidence            345789999999999998643    2468999886432  345679999999999999999999998875 557899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++.....  .+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||+++.......
T Consensus        88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          88 APLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             CCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            999999999976432  48999999999999999999999   9999999999999999999999999999986654432


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .......++..|+|||.+.+ .++.++||||||++++|+++ |..||......+..    ..    ...+...       
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~----~~~~~~~-------  227 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GR----IENGERL-------  227 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HH----HHcCCcC-------
Confidence            22223334568999998864 58999999999999999986 99999755432211    11    0111100       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         .........+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus       228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               0111223578899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-36  Score=299.25  Aligned_cols=250  Identities=27%  Similarity=0.458  Sum_probs=195.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|+. .++.    .||+|.++..  ....+++..|+.++..++|+||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence            47899999999999985 3444    4899998643  3335678899999999999999999999875 4578999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..++.++.||+.||.|||+   .+++|+||||+|||+++++.+||+|||+++........
T Consensus        91 ~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          91 PYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            99999999976433  48999999999999999999999   99999999999999999999999999999876533221


Q ss_pred             e-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 V-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . .....++..|+|||.+.+ .++.++||||||+++|||++ |..||.......    +.....    .+...       
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~----~~~~~-------  230 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----IPDLLE----KGERL-------  230 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH----CCCcC-------
Confidence            1 112334678999999864 58999999999999999998 889986443221    111111    11000       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                         .........+.+++..|++.||++||++.++++.|+.+...
T Consensus       231 ---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         231 ---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence               01112334688999999999999999999999999776443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-36  Score=307.80  Aligned_cols=235  Identities=29%  Similarity=0.398  Sum_probs=185.3

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHH-HHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVK-TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+++.. +++.||+|++....    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999984 68899999986422    22334555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..++....   .++...+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            99998886543   38889999999999999999999   999999999999999999999999999987532222 123


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||.+.+ .++.++||||||+++|||++|..||...+...       ......         ....   .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~---------~~~~---~  214 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNIL---------HKPL---Q  214 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHh---------cCCC---C
Confidence            44678999999999875 58999999999999999999999997543211       111111         1000   0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMS  504 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  504 (558)
                      .+......+.+++.+||+.+|.+||+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1112234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-36  Score=307.73  Aligned_cols=236  Identities=27%  Similarity=0.360  Sum_probs=187.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCc-ceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQ-NLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|... +++.||+|++...    ....+.+..|.+++..++|+ +|+++++++...+..++||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   83 (324)
T cd05587           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV   83 (324)
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence            4578999999999999875 5789999998743    23345678899999999765 6888999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... .
T Consensus        84 ~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~  156 (324)
T cd05587          84 NGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K  156 (324)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence            9999999987544   38899999999999999999999   999999999999999999999999999987532211 1


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+    +..   ... ...        .  
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~---~i~-~~~--------~--  218 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQ---SIM-EHN--------V--  218 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHH---HHH-cCC--------C--
Confidence            2334678999999999875 58999999999999999999999997544322    111   100 000        0  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                       ..+......+.+++.+||+.||.+||+.
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             0011123467889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-36  Score=304.95  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=194.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||.||+|+.. +++.||+|.++..  ......+.+|+.++++++|+||+++++++..++..++||||+++ +
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   89 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D   89 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence            478999999999999874 6788999998743  22345678899999999999999999999999999999999975 8


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus        90 l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  163 (309)
T cd07872          90 LKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSN  163 (309)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cccc
Confidence            8888765432  48899999999999999999999   9999999999999999999999999999976533221 1233


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc----c-cchhhccccC
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE----D-KLSDLVDKHS  472 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~d~~~  472 (558)
                      ..++..|+|||.+.+  .++.++||||||++++||++|+.||......+....+..........    . ......+...
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            457899999998854  48899999999999999999999997665433222111111000000    0 0000000000


Q ss_pred             CCCC------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQ------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....      ........+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000      00112345789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.3e-36  Score=300.70  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=197.8

Q ss_pred             hhhhcCccCceEEEEEEeCC-----------------CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeee
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-----------------GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      +.+.||+|+||.||++...+                 +..||+|.+....  ...+.+.+|++++.+++|+||+++++++
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   88 (296)
T cd05051           9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC   88 (296)
T ss_pred             ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            45789999999999987642                 2458999987432  3456789999999999999999999999


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRSD--------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      ..+...++++||+++++|.+++.+...        ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~  165 (296)
T cd05051          89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecC
Confidence            999999999999999999999976431        2258999999999999999999999   89999999999999999


Q ss_pred             CCCeEEcccCCccccCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh--CCCCCCCCCCcchhhh
Q 043292          375 NFNAKVADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC--GRKVFDRSQPEEEDMY  450 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~  450 (558)
                      ++.++|+|||+++....... .......++..|+|||.+.+ .++.++||||||+++|||++  +..||.......    
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~----  241 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ----  241 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH----
Confidence            99999999999986543221 12233456778999998864 69999999999999999998  667775443221    


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      ...................       ........+.+++.+|++.||.+|||+.+|++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1111111111111100000       11122357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-36  Score=299.97  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=196.1

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.++||+|+||.||++...      ++..+++|.+.... .....+.+|++++..++|+||+++++++..+...++++||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (280)
T cd05092           9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY   88 (280)
T ss_pred             eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence            3578999999999999642      35678999887443 3346799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          315 MPNGSLDRWLFQRSD------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      +++++|.+++.....            ...+++..++.++.|++.||+|||+   .+++|+||||+|||+++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECC
Confidence            999999999875431            1348899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          383 FGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       383 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ||++.......... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+.    ..   .. 
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~---~~-  237 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA----IE---CI-  237 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH----HH---HH-
Confidence            99997654322111 122335678999998864 58999999999999999998 8999864433221    00   00 


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ..+...          .........+.+++.+||+.||++||++.+|++.|++
T Consensus       238 ~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 TQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            000000          0011223468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=295.84  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=194.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|++|.||++.. .+++.+|+|.+....      .....+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            47899999999999987 468999999886321      12346888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++....   .+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++........
T Consensus        87 ~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          87 PGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             CCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999987643   38899999999999999999999   99999999999999999999999999999765432211


Q ss_pred             ee--ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 VV--TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~~--~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ..  ....++..|+|||++.+ .++.++||||||+++|||++|+.||......+..       .........        
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~--------  225 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-------FKIATQPTN--------  225 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------HHHhccCCC--------
Confidence            11  23457889999999875 4899999999999999999999999654322110       010000000        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        ..........+.+++..|++.+|.+|||+.++++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              01111233467889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.4e-36  Score=297.31  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=193.3

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||++.. .+++.||+|.+...  .....++.+|++++.+++||||+++++++...+..++||||++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            347899999999999987 56889999998643  233467899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|..+.       .+++..+..++.|++.||.|||+   .+++|+||||+|||++.++.++|+|||++.......   ..
T Consensus        85 ~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~  151 (279)
T cd06619          85 SLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AK  151 (279)
T ss_pred             ChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---cc
Confidence            997653       27888999999999999999999   999999999999999999999999999998654321   23


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||...................... .     ....    .
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~----~  221 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVL----P  221 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCC----C
Confidence            4578999999999875 58999999999999999999999997543322111111111110000 0     0000    0


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+|++.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11123467899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.8e-36  Score=292.18  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=198.2

Q ss_pred             hhhhcCccCceEEEEEEeCC-CCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.++||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++..+...++++||+++++|
T Consensus         7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   85 (256)
T cd06612           7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV   85 (256)
T ss_pred             hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence            45789999999999999854 78999999875443 67899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ .....
T Consensus        86 ~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  159 (256)
T cd06612          86 SDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV  159 (256)
T ss_pred             HHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence            99986543  248999999999999999999999   8999999999999999999999999999987654321 22334


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||.+.+ .++.++||||||+++++|++|+.||....+.....   .     ...        ..........
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---~-----~~~--------~~~~~~~~~~  223 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---M-----IPN--------KPPPTLSDPE  223 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---h-----hcc--------CCCCCCCchh
Confidence            57889999999875 58999999999999999999999997543322100   0     000        0000111112


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+++.+|++.||++|||+.+|++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            23356889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-36  Score=309.70  Aligned_cols=196  Identities=28%  Similarity=0.440  Sum_probs=168.7

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||+||++... +++.||+|++....    .....+..|+.++.+++|+||+++++.+.++...++||||+++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG   85 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence            478999999999999874 68899999997432    2235678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC---
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS---  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~---  394 (558)
                      |+|.+++.+..   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        86 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          86 GDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999997643   48999999999999999999999   9999999999999999999999999999875432110   


Q ss_pred             -------------------------------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043292          395 -------------------------------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRS  442 (558)
Q Consensus       395 -------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~  442 (558)
                                                     .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                           00123579999999999875 5899999999999999999999999765


Q ss_pred             CC
Q 043292          443 QP  444 (558)
Q Consensus       443 ~~  444 (558)
                      ..
T Consensus       240 ~~  241 (363)
T cd05628         240 TP  241 (363)
T ss_pred             CH
Confidence            43

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-36  Score=306.16  Aligned_cols=236  Identities=26%  Similarity=0.354  Sum_probs=187.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||++... +++.||+|.++...    ...+.+..|..++..+ +|++|+++++++...+..++||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   83 (323)
T cd05616           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV   83 (323)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence            3578999999999999875 57899999987432    2234567788888777 5899999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus        84 ~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~  156 (323)
T cd05616          84 NGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V  156 (323)
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence            9999999987543   38999999999999999999999   999999999999999999999999999997543221 1


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+    +..   ... ....          
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~---~i~-~~~~----------  218 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ---SIM-EHNV----------  218 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHH---HHH-hCCC----------
Confidence            2335678999999999875 58999999999999999999999997544322    111   110 1100          


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                       ..+......+.+++.+|++.+|.+|++.
T Consensus       219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             0111223467889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-36  Score=321.10  Aligned_cols=247  Identities=28%  Similarity=0.376  Sum_probs=194.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC--------cce
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--------HNL  309 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~  309 (558)
                      +.++||+|+||.||+++. .+++.||||++...   ......+.+|+..+..++|+|+++++..+....        ..+
T Consensus        36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~  115 (496)
T PTZ00283         36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA  115 (496)
T ss_pred             EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence            357899999999999987 57899999998643   223456888999999999999999988765432        257


Q ss_pred             EEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          310 LVYEYMPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      +||||+++|+|.+++..+. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~  192 (496)
T PTZ00283        116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKM  192 (496)
T ss_pred             EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence            9999999999999997532 23458999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          389 IDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       389 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                      +..... .......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+       ..... ..+....
T Consensus       193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~~~-~~~~~~~  264 (496)
T PTZ00283        193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMHKT-LAGRYDP  264 (496)
T ss_pred             ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH-hcCCCCC
Confidence            643221 12335679999999999875 58999999999999999999999997543221       11111 1111100


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                                ........+.+++..||+.||.+||++.+++++
T Consensus       265 ----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        265 ----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                      011223468899999999999999999999864

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-36  Score=293.85  Aligned_cols=244  Identities=32%  Similarity=0.484  Sum_probs=194.2

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeec-cCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA-EKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL  320 (558)
                      +.+.||+|+||.||++... +..+++|.++... ..+.+.+|+.++++++|+|++++++++. .++..++++||+++++|
T Consensus        10 ~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082          10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             eeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            4578999999999999765 7889999887543 3467899999999999999999999754 45678999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......    ...
T Consensus        88 ~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~  159 (256)
T cd05082          88 VDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTG  159 (256)
T ss_pred             HHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----CCC
Confidence            999976443 348899999999999999999999   899999999999999999999999999987543321    223


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+..|+|||++.+ .++.++||||||+++|||++ |+.||......+    +....    ..+....          ..
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~----------~~  221 (256)
T cd05082         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV----EKGYKMD----------AP  221 (256)
T ss_pred             ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----hcCCCCC----------CC
Confidence            34668999999875 58999999999999999998 999986433211    11111    1111000          01


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            12235788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.4e-36  Score=302.34  Aligned_cols=195  Identities=27%  Similarity=0.460  Sum_probs=160.1

Q ss_pred             hhcCccCceEEEEEEeC---CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  318 (558)
                      .+||+|+||.||+++..   +++.+|+|.++... ....+.+|+.++++++||||+++++++..  +...++++||+. +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            57999999999999864   46789999987543 23457889999999999999999998854  445789999985 5


Q ss_pred             CHHHHHhcCC------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee----cCCCCeEEcccCCccc
Q 043292          319 SLDRWLFQRS------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKL  388 (558)
Q Consensus       319 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll----~~~~~~ki~Dfgla~~  388 (558)
                      +|.+++....      ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            8888775321      12248899999999999999999999   999999999999999    4567899999999987


Q ss_pred             cCCCCCc--eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 043292          389 IDQDQSQ--VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQ  443 (558)
Q Consensus       389 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~  443 (558)
                      .......  ......+|+.|+|||++.+  .++.++||||+||+++||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            6433221  1234678999999999864  48899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-36  Score=291.30  Aligned_cols=246  Identities=27%  Similarity=0.448  Sum_probs=196.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++||.|+||.||++.+.+++.|++|.+.....  ....+..|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999987799999998874332  4567899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee-ecc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTM  400 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~~~  400 (558)
                      +++.....  .+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........... ...
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99975433  48899999999999999999999   8999999999999999999999999999986542221111 122


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+..|+|||.+.+ .++.++||||||++++||++ |..||.........    .    ......          .....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----~----~~~~~~----------~~~~~  217 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----E----RIESGY----------RMPAP  217 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----H----HHhcCC----------CCCCC
Confidence            33567999998764 68999999999999999999 78888654432210    0    000000          00011


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ......+.+++.+|++.+|.+|||+.+|++.|+.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            1234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-36  Score=312.55  Aligned_cols=246  Identities=23%  Similarity=0.321  Sum_probs=192.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.+|+|.+....    ...+.+.+|+.++..++||||+++++.+.++...++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  127 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            478999999999999885 68899999986421    2234578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++...    .++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...........
T Consensus       128 g~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~  200 (371)
T cd05622         128 GDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC  200 (371)
T ss_pred             CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence            9999998653    27888899999999999999999   9999999999999999999999999999987654333233


Q ss_pred             ecccCCCCcCChhhhcC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          398 TTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ....||+.|+|||++.+     .++.++|||||||++|||++|..||...+...       .............+     
T Consensus       201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~-----  268 (371)
T cd05622         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKNSLTF-----  268 (371)
T ss_pred             cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCcccC-----
Confidence            45679999999999863     27899999999999999999999997544321       11111111000000     


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L  510 (558)
                         +........+.+++..|++.++.+  ||++.++++..
T Consensus       269 ---~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         269 ---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               011122346778889999854443  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-36  Score=300.56  Aligned_cols=243  Identities=26%  Similarity=0.420  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L  104 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence            46799999999999987 468899999887432 3346788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.+.    .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ .....
T Consensus       105 ~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~  176 (296)
T cd06654         105 TDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (296)
T ss_pred             HHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence            9998643    38899999999999999999999   8999999999999999999999999999886543221 12335


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .+++.|+|||.+.+ ..+.++||||||+++++|++|+.||....+...   +...    ..... .     .   .....
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~~----~~~~~-~-----~---~~~~~  240 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLI----ATNGT-P-----E---LQNPE  240 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHHH----hcCCC-C-----C---CCCcc
Confidence            68899999998875 488999999999999999999999975443211   1100    00000 0     0   01111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....+.+++.+|++.+|++|||+.+|++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            233568889999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-36  Score=304.96  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=198.8

Q ss_pred             HhhhhcCccCceEEEEEEeC--------CCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcce
Q 043292          241 NFRKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  309 (558)
                      .+.+.||+|+||.||++...        +...+|+|.++..  .....++..|+.++.++ +|+||+++++++..++..+
T Consensus        21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (307)
T cd05098          21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  100 (307)
T ss_pred             EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            34588999999999999752        2357999998743  22345688899999999 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC
Q 043292          310 LVYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF  376 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~  376 (558)
                      +||||+++++|.+++.....             ...+++.++++++.|++.||+|||+   .+++|+||||+||+++.++
T Consensus       101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098         101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCC
Confidence            99999999999999976421             2348999999999999999999998   8999999999999999999


Q ss_pred             CeEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHH
Q 043292          377 NAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       377 ~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  453 (558)
                      .+||+|||++.......... .....++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+    +..
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----~~~  253 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFK  253 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHH
Confidence            99999999987654322111 112234568999998865 58999999999999999998 888886433211    111


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                          ........          .........+.+++..|++.+|.+|||+.+|++.|+.+...
T Consensus       254 ----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 ----LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                11111100          01112235788899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-36  Score=296.45  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=196.6

Q ss_pred             HhhhhcCccCceEEEEEEe-----CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEE
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLV  311 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  311 (558)
                      ...+.||+|+||.||+++.     .++..||+|.++..  ......+.+|+.+++.++|+|++++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            3457899999999999974     35788999998743  23346789999999999999999999998775  567899


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||+++++|.+++.+...  .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        87 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          87 MEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999865432  48999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CCCc--eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcc--------hhhhHHHHHHHhhh
Q 043292          392 DQSQ--VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEE--------EDMYLLSIFKKKAE  460 (558)
Q Consensus       392 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~  460 (558)
                      ....  ......++..|+|||.+.+ .++.++||||||++++||+++..|........        ......... ....
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHH
Confidence            3221  1223556778999998764 58999999999999999999876643211100        000000000 0000


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .+..          .+........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       241 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1100          001112345799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-36  Score=295.63  Aligned_cols=265  Identities=28%  Similarity=0.423  Sum_probs=193.8

Q ss_pred             hhhhcCccCceEEEEEEe-----CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  313 (558)
                      +.+.||+|+||.||++..     .++..||+|.+.... ...+.+.+|++++.+++||||+++++++..  ....++|+|
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   87 (284)
T cd05081           8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME   87 (284)
T ss_pred             eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence            347899999999999974     357899999987543 334678999999999999999999998754  346789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++.+...  .+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          88 YLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             ecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999975432  38999999999999999999999   899999999999999999999999999998764432


Q ss_pred             Ccee--ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 SQVV--TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~~~~--~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ....  ....++..|+|||.+.+ .++.++||||||++++||++|..++......... ..............+.+.+..
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR-MMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh-hcccccccccchHHHHHHHhc
Confidence            2111  12223456999999875 5899999999999999999988765432211000 000000000000000011111


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .. ...........+.+++.+|++.+|++|||+.+|++.|+.+
T Consensus       242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         242 NG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00 0011112235788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-37  Score=310.43  Aligned_cols=243  Identities=26%  Similarity=0.457  Sum_probs=198.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEec-----ccccchHHHHHHHHHHhccCCcceeeeeeeeccCCc--ceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLE-----GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH--NLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  313 (558)
                      |.++||+|+|-+||||.+. +|.+||--.++     +.....++|..|+++|+.|+|+||++++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4578999999999999984 57777743322     334445789999999999999999999999987666  678999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~~  392 (558)
                      .+..|+|..|+++...   ++...+..|++||++||.|||+ ..++|||||||-+||+|+. .|.+||+|+|||......
T Consensus       124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999987664   8889999999999999999998 3579999999999999975 578999999999987654


Q ss_pred             CCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ..   ....|||.|||||.....|++.+||||||+.++||+|+..||..-....      .+ .+++..|.-...+.+..
T Consensus       200 ~a---ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------QI-YKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  200 HA---KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------QI-YKKVTSGIKPAALSKVK  269 (632)
T ss_pred             cc---ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------HH-HHHHHcCCCHHHhhccC
Confidence            43   3478999999999999999999999999999999999999997443322      22 23333444444443322


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .         ..+.+||..||.. ..+|||+.|++.
T Consensus       270 d---------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 D---------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             C---------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1         3688899999998 999999999994

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.5e-36  Score=299.42  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=196.3

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.++||+|+||.||+|...      .+..||+|.+....  .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus        10 i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   89 (288)
T cd05061          10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME   89 (288)
T ss_pred             eeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            3578999999999999653      24579999886433  223468889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          314 YMPNGSLDRWLFQRSD-------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      |+++|+|.+++.....       ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++
T Consensus        90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~  166 (288)
T cd05061          90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT  166 (288)
T ss_pred             CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence            9999999999975321       2346788899999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +........ ......++..|+|||.+.+ .++.++||||||++++||++ |..||......+    ...   ... .+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~---~~~-~~~  238 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLK---FVM-DGG  238 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHH-cCC
Confidence            865332211 1122345678999999864 68999999999999999998 788886543222    111   110 111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ...          ........+.+++.+|++.+|++|||+.++++.|++..
T Consensus       239 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            000          01122357999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=310.09  Aligned_cols=244  Identities=25%  Similarity=0.431  Sum_probs=202.6

Q ss_pred             hhhcCccCceEEEEEEeC--CC--CEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT--DG--TKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|.||.|++|.+.  +|  ..||||.++....  ...+|++|+.+|-+|+|+|+++|+|+..+ ....||+|.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            488999999999999874  34  3689999985433  56789999999999999999999999987 77889999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      .|||.+.|.+ ..+..|-......++.|||.||.||.+   +++|||||.++|+||-..-.+||+||||.+.+.......
T Consensus       194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999987 334457788899999999999999999   999999999999999999999999999999876554432


Q ss_pred             -ee-cccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 -VT-TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 -~~-~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       +. ...-...|.|||.+. +.|+.++|||+|||++|||+| |..||.+.....                 +.+.+| .-
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL~~iD-~~  331 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------ILKNID-AG  331 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HHHhcc-cc
Confidence             22 233456899999997 579999999999999999999 788998765432                 112233 22


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..+.....+.+.++++++.||..+|++|||+..|.+.
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            2234455778899999999999999999999999743

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-36  Score=314.09  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=187.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+++. .+++.||+|.+....    .....+.+|+.++.+++|+||+++++.+.+++..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g   85 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG   85 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence            47899999999999987 468899999987432    2345688899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC----
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~----  393 (558)
                      |+|.+++.+..   .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....    
T Consensus        86 g~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          86 GDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            99999997643   38889999999999999999999   999999999999999999999999999975331100    


Q ss_pred             ------------------------------------------CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHH
Q 043292          394 ------------------------------------------SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVML  430 (558)
Q Consensus       394 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~  430 (558)
                                                                ........||+.|+|||++.+ .++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                      000123468999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHH
Q 043292          431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS---MSMVV  507 (558)
Q Consensus       431 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl  507 (558)
                      ||++|+.||....+.+....+..+      ....      ..   +........+.+++.+++ .+|.+|++   +.+++
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~---p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINW------QTSL------HI---PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcc------CCCc------CC---CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            999999999765443211111100      0000      00   000111234556666655 49999997   77776


Q ss_pred             H
Q 043292          508 R  508 (558)
Q Consensus       508 ~  508 (558)
                      +
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.1e-36  Score=295.81  Aligned_cols=261  Identities=24%  Similarity=0.356  Sum_probs=195.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|++|.||+|+.. +++.||+|.++..   ......+.+|+.++.+++||||+++++++.++...++||||++ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~   83 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M   83 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence            467999999999999884 6899999998643   2234568899999999999999999999999999999999997 6


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++........+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++....... ....
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  159 (285)
T cd07861          84 DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYT  159 (285)
T ss_pred             CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cccc
Confidence            898888765544568999999999999999999999   999999999999999999999999999997654322 1123


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh----hhc----ccchhhc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK----AEE----DKLSDLV  468 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~  468 (558)
                      ...++..|+|||.+.+  .++.++||||||++++||++|+.||...................    +..    ......+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            3456889999998864  47899999999999999999999997654322111111110000    000    0000000


Q ss_pred             cccCCCC--CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDM--QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......  .........+.+++.+||+.||.+|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000  000012346779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-36  Score=306.65  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=192.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||+++.. +++.||+|.+...    ......+.+|..++..++|+||+++++++.+++..++||||++
T Consensus         5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~   84 (331)
T cd05624           5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV   84 (331)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            3478999999999999884 6788999998642    1223457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.+...  .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus        85 gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          85 GGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            9999999976432  38899999999999999999999   999999999999999999999999999998765443333


Q ss_pred             eecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          397 VTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .....|++.|+|||++.+      .++.++||||||+++|||++|+.||......+.       ............ +..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~~-~p~  231 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHEERFQ-FPS  231 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-------HHHHHcCCCccc-CCC
Confidence            334679999999998863      478899999999999999999999975443221       111111100000 000


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRV  509 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  509 (558)
                      ..      ......+.+++.+|+..++.+  |++++++++.
T Consensus       232 ~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         232 HI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00      112346778888888765544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.6e-36  Score=295.65  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=194.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||.|+||.||++... ++..+++|.+... ....+.+.+|+.+++.++|+|++++++++..++..++|+||+++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            3577999999999999985 5778899988643 3345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |..++.+..  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus        89 l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~  162 (282)
T cd06643          89 VDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS  162 (282)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence            998876532  248999999999999999999999   9999999999999999999999999999876533221 2234


Q ss_pred             ccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          400 MRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       400 ~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ..++..|+|||++.      ..++.++|||||||++|||++|+.||......+.   .....    .. .....      
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----~~-~~~~~------  228 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV---LLKIA----KS-EPPTL------  228 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH---HHHHh----hc-CCCCC------
Confidence            56889999999873      2377899999999999999999999865432211   11110    00 00000      


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        .........+.+++.+|++.||.+|||+.++++.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0011123468899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=308.04  Aligned_cols=238  Identities=26%  Similarity=0.376  Sum_probs=198.0

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||.|+||.||.+++ .+.+.||||++.-+..    .-.+++.|+++|.+++|||.+.+.|++......||||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            4589999999999998 5688899999974332    2346899999999999999999999999999999999999 56


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      |-.+++.-..  ++|-..++..|..+.+.||+|||+   .+.||||||+.||||++.|.+||+|||.|.....     ..
T Consensus       111 SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----An  180 (948)
T KOG0577|consen  111 SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----AN  180 (948)
T ss_pred             cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-----hh
Confidence            8888886443  348899999999999999999999   9999999999999999999999999999987644     45


Q ss_pred             cccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          399 TMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .++||+.|||||++.    |.|+-|+||||||++..||...++|+...+...       .......++         .+.
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNe---------sPt  244 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNE---------SPT  244 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcC---------CCC
Confidence            688999999999873    689999999999999999999999987555432       211111111         111


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       -...+....+..++..||+.-|.+|||.+++++.
T Consensus       245 -Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 -LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence             1244667789999999999999999999988754

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.9e-36  Score=295.60  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=196.3

Q ss_pred             hhcCccCceEEEEEEeC------CCCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          244 KMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.||+|+||.||+++..      +.+.+++|.+.....  ...++..|++++++++|+||+++++++.+....++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT   90 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence            67999999999999863      346799998875433  3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          316 PNGSLDRWLFQRSDE------FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      ++++|.+++......      ..+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccccc
Confidence            999999999765422      148999999999999999999999   89999999999999999999999999998754


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      ............++..|+|||.+.+ ..+.++||||||+++++|++ |..||.......    ...    ....+.....
T Consensus       168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~----~~~~~~~~~~  239 (275)
T cd05046         168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLN----RLQAGKLELP  239 (275)
T ss_pred             CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----HHH----HHHcCCcCCC
Confidence            3322222233455778999998764 58899999999999999999 788886433211    111    1111111100


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                               ........+.+++.+|++.+|.+|||+.+++++|.+
T Consensus       240 ---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         240 ---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                     011223478899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.7e-36  Score=297.81  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=195.7

Q ss_pred             hhhhcCccCceEEEEEEeC-----------------CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeee
Q 043292          242 FRKMLGKGGFGSVFEGTQT-----------------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      +.++||+|+||.||++...                 +...+|+|++...  .....++.+|+.++..++|+||+++++++
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   88 (296)
T cd05095           9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC   88 (296)
T ss_pred             eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4578999999999998532                 2346899998743  22346789999999999999999999999


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRSD--------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      ..++..++||||+++++|.+++.....        ...+++.++..++.|++.||+|||+   .+++|+||||+|||+++
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~  165 (296)
T cd05095          89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcC
Confidence            999999999999999999999875321        1347889999999999999999999   89999999999999999


Q ss_pred             CCCeEEcccCCccccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh--CCCCCCCCCCcchhhh
Q 043292          375 NFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC--GRKVFDRSQPEEEDMY  450 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~  450 (558)
                      ++.++|+|||+++.+....... .....++..|+|||... +.++.++||||||+++|||++  |..||......+....
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN  245 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            9999999999998654322111 12233467899999765 569999999999999999998  6778865443221111


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ....    ..........       .........+.+++.+|++.||.+|||+.+|++.|+.
T Consensus       246 ~~~~----~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         246 TGEF----FRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHH----HhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1111    0000000000       0111233578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-36  Score=305.12  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=200.9

Q ss_pred             HHHhhhhcCccCceEEEEEEeC--------CCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCc
Q 043292          239 TDNFRKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSH  307 (558)
Q Consensus       239 t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  307 (558)
                      ...+.+.||+|+||.||++...        ....||+|.++..  ....+++.+|+.++.++ +|+||+++++++..++.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            3455688999999999999742        1236899988743  22346789999999999 89999999999999999


Q ss_pred             ceEEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          308 NLLVYEYMPNGSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      .++++||+++|+|.+++....             ....+++.++..++.|++.||.|||+   .+++||||||+|||++.
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~  169 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTE  169 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcC
Confidence            999999999999999997532             12348899999999999999999999   99999999999999999


Q ss_pred             CCCeEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhH
Q 043292          375 NFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~  451 (558)
                      ++.+||+|||+++......... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    .
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~  245 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----L  245 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----H
Confidence            9999999999998654322111 122334567999998865 58999999999999999998 888886543222    1


Q ss_pred             HHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       452 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                         .... .......          ........+.+++.+|++.+|.+|||+.++++.|+.+....
T Consensus       246 ---~~~~-~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         246 ---FKLL-KEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ---HHHH-HcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence               1111 1111000          01122347889999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-37  Score=298.41  Aligned_cols=238  Identities=22%  Similarity=0.425  Sum_probs=187.6

Q ss_pred             hhcCccCceEEEEEEeCC--------CCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTD--------GTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.||+|+||.||+|....        ..++++|.+.... ...+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997632        2348888876433 3345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC--------eEEcccCCc
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN--------AKVADFGLS  386 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~ki~Dfgla  386 (558)
                      +++|+|.+++.....  .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999976543  48999999999999999999999   99999999999999988765        599999988


Q ss_pred             cccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGR-KVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      .....     .....++..|+|||++.+  .++.++||||||+++|||++|. .|+.......    .......   .. 
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~---~~-  222 (258)
T cd05078         156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQFYED---RH-  222 (258)
T ss_pred             cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHHHHHc---cc-
Confidence            75432     223457889999999874  4799999999999999999985 5554322211    0000000   00 


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                             ..     +......+.+++..||+.+|++|||++++++.|+
T Consensus       223 -------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 -------QL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------cC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00     1112246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.1e-36  Score=294.94  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=195.0

Q ss_pred             HHHHHh--hhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          237 VMTDNF--RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       237 ~~t~~~--~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+++++  ..+||+|+||.||+|+.. ++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            344444  357999999999999874 67889999887443 34567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~  391 (558)
                      ||+++++|.+++.........++..+..++.||+.||+|||+   .+|+|+||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999764322113788899999999999999999   99999999999999976 67999999999876543


Q ss_pred             CCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ... ......++..|+|||++.+   .++.++||||||+++|+|++|+.||..........     ...... . .    
T Consensus       162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~~~~-~-~----  229 (268)
T cd06624         162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKVGMF-K-I----  229 (268)
T ss_pred             CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhhhhh-c-c----
Confidence            221 2233457899999999853   37899999999999999999999986433211110     000000 0 0    


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..     ..+......+.+++.+|++.+|.+|||+.++++
T Consensus       230 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 HP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CC-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00     011123346888999999999999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.7e-36  Score=294.48  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=195.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ..+.||+|+||.||+|.+. ++..||+|.+...  ....+.+.+|+.++++++|+||+++++++..+...++||||++++
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            3477999999999999874 5788999988733  233457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++...    .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........ ...
T Consensus        88 ~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~  159 (277)
T cd06642          88 SALDLLKPG----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN  159 (277)
T ss_pred             cHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence            999988642    38999999999999999999999   9999999999999999999999999999986543221 122


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ .++.++||||||++++||++|+.|+....+...    ..   . .....        ..  ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~---~-~~~~~--------~~--~~  221 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----LF---L-IPKNS--------PP--TL  221 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----Hh---h-hhcCC--------CC--CC
Confidence            3467889999999875 588999999999999999999999864432210    00   0 00000        00  01


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+|++.+|++|||+.+|++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11234568899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-36  Score=306.13  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=195.3

Q ss_pred             HhhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccC-CcceE
Q 043292          241 NFRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK-SHNLL  310 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~l  310 (558)
                      .+.+.||+|+||.||+|..      .+++.||||+++...  .....+..|+.++.++ +|+||+++++++... ...++
T Consensus        10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l   89 (343)
T cd05103          10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (343)
T ss_pred             cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence            3568899999999999963      346789999997432  2345688999999999 789999999987654 45689


Q ss_pred             EEEeCCCCCHHHHHhcCCC-------------------------------------------------------------
Q 043292          311 VYEYMPNGSLDRWLFQRSD-------------------------------------------------------------  329 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~-------------------------------------------------------------  329 (558)
                      ||||+++|+|.+++.....                                                             
T Consensus        90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T cd05103          90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE  169 (343)
T ss_pred             EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence            9999999999999864321                                                             


Q ss_pred             ---CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-eeecccCCCC
Q 043292          330 ---EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPG  405 (558)
Q Consensus       330 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~  405 (558)
                         ...+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||++......... ......++..
T Consensus       170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd05103         170 DLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  246 (343)
T ss_pred             hhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence               1237888999999999999999999   99999999999999999999999999999865332221 1122345678


Q ss_pred             cCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHH
Q 043292          406 YLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVV  483 (558)
Q Consensus       406 y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  483 (558)
                      |+|||.+.+ .++.++||||||+++|||++ |..||........   ..    .....+.....     .     .....
T Consensus       247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~~-----~-----~~~~~  309 (343)
T cd05103         247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC----RRLKEGTRMRA-----P-----DYTTP  309 (343)
T ss_pred             eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HH----HHHhccCCCCC-----C-----CCCCH
Confidence            999998764 58999999999999999997 8999865433221   11    11111111000     0     01123


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          484 NMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       484 ~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .+.+++..|++.+|++|||+.+|++.|+.+.+
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            67899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-36  Score=313.17  Aligned_cols=256  Identities=23%  Similarity=0.303  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||++... .++.||||...     ...+.+|++++++++|+||+++++++..++..++|||++ .++|.
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~  247 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLY  247 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHH
Confidence            468999999999999985 57889999533     234678999999999999999999999999999999999 47888


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-eeecc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTM  400 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~  400 (558)
                      .++.....  .+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       248 ~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  322 (461)
T PHA03211        248 TYLGARLR--PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI  322 (461)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence            88865432  49999999999999999999999   89999999999999999999999999999865433221 12345


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCC-Ccch---hhhHHHHHHHhhh-cccchh--------
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ-PEEE---DMYLLSIFKKKAE-EDKLSD--------  466 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~-~~~~---~~~~~~~~~~~~~-~~~~~~--------  466 (558)
                      .||..|+|||++.+ .++.++|||||||+||||++|..++.... ....   ...+..+...... ...+..        
T Consensus       323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~  402 (461)
T PHA03211        323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS  402 (461)
T ss_pred             CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence            69999999999875 58999999999999999999886653322 1110   1111111111100 000000        


Q ss_pred             hccc------cCCCCCCC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          467 LVDK------HSNDMQSN----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       467 ~~d~------~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+..      ........    ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000      00000000    0112357789999999999999999999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.4e-36  Score=302.62  Aligned_cols=255  Identities=19%  Similarity=0.227  Sum_probs=192.4

Q ss_pred             hhhhcCcc--CceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKG--GFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.++||+|  +|++||+++. .+++.||+|++....   ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999988 578999999987432   23345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++..+.. ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999975432 238999999999999999999999   99999999999999999999999999865433211110


Q ss_pred             ------eeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          396 ------VVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       396 ------~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                            ......++..|+|||++.+   .++.++||||||++++||++|+.||.........   ....     .+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~-----~~~~~~  229 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---LEKL-----NGTVPC  229 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH---HHHh-----cCCccc
Confidence                  0112346778999999864   4889999999999999999999999754322110   0000     000000


Q ss_pred             hcc-------------------ccC----------------CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          467 LVD-------------------KHS----------------NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       467 ~~d-------------------~~~----------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .++                   ...                ............+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000                   000                000011123457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.5e-36  Score=295.68  Aligned_cols=264  Identities=26%  Similarity=0.445  Sum_probs=200.0

Q ss_pred             hhhhcCccCceEEEEEEeC-----CCCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-----DGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  312 (558)
                      +.+.||+|+||.||+++..     ++..+|||.++....  ..+.|..|+++++.++|+||+++++++..  +...+++|
T Consensus         8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05038           8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM   87 (284)
T ss_pred             hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence            4578999999999999853     367899999986544  36789999999999999999999999877  55789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++.....  .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        88 e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          88 EYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             ecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            99999999999976543  38999999999999999999999   89999999999999999999999999999876533


Q ss_pred             CCce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 QSQV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ....  .....++..|+|||.+.+ .++.++||||||++++||++|..|+..............  ........+.+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  240 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIVTRLLELLK  240 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccHHHHHHHHH
Confidence            2211  112344567999998864 689999999999999999999998865332210000000  00000000001111


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .... ..........+.+++.+|++.+|++||||.+|+++|+.+
T Consensus       241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1000 011112335788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-35  Score=291.55  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=189.9

Q ss_pred             hhcCccCceEEEEEEeC----CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeec-cCCcceEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQT----DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCA-EKSHNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  316 (558)
                      +.||+|+||.||+|...    +...+|+|.+...  ....+.+..|+.+++.++||||+++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    2457999988643  233467889999999999999999999775 4556789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++.+...  .+++..+..++.|++.||.|||+   .+++|+||||+|||+++++.+||+|||+++.........
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999975433  36788889999999999999999   899999999999999999999999999998654322111


Q ss_pred             ---eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          397 ---VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCG-RKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       397 ---~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                         .....++..|+|||.+.+ .++.++||||||+++|||++| ..||......+    +..   ... .+..       
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~---~~~-~~~~-------  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITV---YLL-QGRR-------  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH---HHh-cCCC-------
Confidence               123345678999998864 589999999999999999995 55554332111    111   111 1100       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .   ......+..+.+++..|++.+|++||++.+|++.|+.+.
T Consensus       221 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 L---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0   001112346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.6e-36  Score=294.71  Aligned_cols=248  Identities=29%  Similarity=0.471  Sum_probs=194.6

Q ss_pred             hhcCccCceEEEEEEeCC-------CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTD-------GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.||+|+||.||+|+..+       +..+++|.+....  ....++.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       2578999876432  3456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-----CeEEcccCC
Q 043292          315 MPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-----NAKVADFGL  385 (558)
Q Consensus       315 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-----~~ki~Dfgl  385 (558)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532    22348899999999999999999998   8999999999999999887     899999999


Q ss_pred             ccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          386 SKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       386 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                      +......... ......++..|+|||++. +.++.++||||||+++|||++ |+.||......+    ....   . ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~---~-~~~  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----VLQH---V-TAG  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHH---H-hcC
Confidence            9765332211 112334567899999886 468999999999999999998 999986443221    1111   0 000


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ..       .   .........+.+++.+||+.+|.+||++.+|+++|++
T Consensus       230 ~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 GR-------L---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             Cc-------c---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00       0   1111234578899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.6e-36  Score=297.41  Aligned_cols=249  Identities=28%  Similarity=0.468  Sum_probs=196.0

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||++...      ++..||+|.+....  ....++.+|+.++++++||||+++++++..+...++|+||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY   89 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence            478999999999999863      46789999987432  3346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          315 MPNGSLDRWLFQRS-------------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       315 ~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      +++++|.+++....                   ....+++..++.++.|++.||.|||+   .+++|+||||+||+++++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~  166 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGEN  166 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCC
Confidence            99999999997432                   11247889999999999999999999   899999999999999999


Q ss_pred             CCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHH
Q 043292          376 FNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLL  452 (558)
Q Consensus       376 ~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~  452 (558)
                      +.++|+|||++......... .......+..|+|||.+.+ .++.++||||||+++|||++ |..||......+    ..
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~----~~  242 (288)
T cd05050         167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----VI  242 (288)
T ss_pred             CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HH
Confidence            99999999998765332211 1122334668999998764 68999999999999999998 888886443322    11


Q ss_pred             HHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       453 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                          .....+....          ........+.+++.+|++.+|.+|||+.|+++.|++
T Consensus       243 ----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         243 ----YYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                1111111110          011233578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-35  Score=292.53  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=195.2

Q ss_pred             HhhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.++||+|+||.||+++. .+++.||+|.++... .....+.+|+.++..++||||+++++.+..++..++|+||++++
T Consensus        12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~   91 (267)
T cd06645          12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG   91 (267)
T ss_pred             HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence            3457899999999999987 468899999987443 23456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....... ....
T Consensus        92 ~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  164 (267)
T cd06645          92 SLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK  164 (267)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence            9999987544   38999999999999999999999   899999999999999999999999999987654322 1223


Q ss_pred             cccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          399 TMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ...|+..|+|||++.    +.++.++||||||+++|||++|..||....+....   .....     ....   ..... 
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---~~~~~-----~~~~---~~~~~-  232 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMTK-----SNFQ---PPKLK-  232 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---Hhhhc-----cCCC---CCccc-
Confidence            456899999999873    34889999999999999999999998644332211   00000     0000   00000 


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ........+.+++.+|++.+|++|||+.+|++
T Consensus       233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              00012246789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.3e-36  Score=304.52  Aligned_cols=237  Identities=26%  Similarity=0.371  Sum_probs=188.1

Q ss_pred             HhhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      ++.+.||+|+||.||++... +++.||+|++...    ....+.+..|..++..+. |++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            35678999999999999874 6889999998743    223356778888888885 57788899999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++....   .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          83 VNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            99999999987543   38999999999999999999999   999999999999999999999999999987543222 


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      .......||+.|+|||++.+ .++.++||||||+++|||++|+.||.......    +.   .... ....         
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~---~~i~-~~~~---------  218 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LF---QSIM-EHNV---------  218 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HH---HHHH-hCCC---------
Confidence            12334568999999999875 58999999999999999999999997654321    11   1111 0000         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                        ..+......+.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0011123467889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.3e-36  Score=300.93  Aligned_cols=253  Identities=26%  Similarity=0.451  Sum_probs=197.3

Q ss_pred             hhhhcCccCceEEEEEEeC--------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.++||+|+||.||+++..        ....+|+|.++...  ....++..|+.++.++ +||||+++++++..+...++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            4578999999999999642        24568999887432  2345688999999999 69999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      +|||+++|+|.+++.....             ...+++.++.+++.|++.||.|||+   .+++|+||||+|||+++++.
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~  172 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNV  172 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCc
Confidence            9999999999999975321             2358999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++......... .....++..|+|||.+.+ .++.++||||||+++|||++ |..||......+    +...
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~  248 (314)
T cd05099         173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----LFKL  248 (314)
T ss_pred             EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Confidence            9999999998654322111 112234567999998864 58999999999999999999 888886543322    1111


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                          ...+...+          ........+.+++.+|++.+|++|||+.++++.|+++..
T Consensus       249 ----~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         249 ----LREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                11111000          111223467889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.5e-36  Score=293.12  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=187.0

Q ss_pred             hcCccCceEEEEEEeCCC---CEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQTDG---TKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .||+|+||.||++...++   ..+++|.++...  ...+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999976433   346677665332  345679999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCC-CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC-Ccee
Q 043292          320 LDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVV  397 (558)
Q Consensus       320 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~  397 (558)
                      |.+++.+... ...+++..+..++.||+.||.|||+   .+++|+||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976432 2346777888999999999999999   899999999999999999999999999986432211 1112


Q ss_pred             ecccCCCCcCChhhhcC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          398 TTMRGTPGYLAPEWLSS--------IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--------~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....++..|+|||++..        ..+.++||||||+++|||++ |..||......+       ....... +....+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~-~~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIK-DQQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh-hcccccC
Confidence            34567889999998742        35789999999999999997 566775433221       1111111 1112222


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      ++....     .....+.+++..|+ .+|++||++++|++.|.
T Consensus       231 ~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222211     12246777888899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.7e-36  Score=315.88  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=187.2

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccC--------CcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--------SHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~lv~  312 (558)
                      +.++||+|+||.||+|.. .+++.||||++.....   ...+|+.+++.++|+||+++++++...        ...++||
T Consensus        70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            357899999999999988 4688999998864322   345799999999999999999876432        1356899


Q ss_pred             EeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccC
Q 043292          313 EYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLID  390 (558)
Q Consensus       313 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~  390 (558)
                      ||+++ +|.+++... .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++.+.
T Consensus       147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            99974 777766532 223458999999999999999999999   9999999999999999665 79999999998664


Q ss_pred             CCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch---
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS---  465 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  465 (558)
                      ....  .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+....+....+....... ....+.   
T Consensus       223 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p-~~~~~~~~~  299 (440)
T PTZ00036        223 AGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP-TEDQLKEMN  299 (440)
T ss_pred             CCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-CHHHHHHhc
Confidence            3222  234568999999998764  58999999999999999999999998655433222111110000 000000   


Q ss_pred             -hhccccCCCCC-------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          466 -DLVDKHSNDMQ-------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       466 -~~~d~~~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ...+.......       .+......+.+++.+||+.||.+|||+.++++.
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence             00000000000       001123578899999999999999999999843

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-35  Score=292.42  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             hhhhcCccCceEEEEEEeCC--CCEEEEEEeccc-----------ccchHHHHHHHHHHhc-cCCcceeeeeeeeccCCc
Q 043292          242 FRKMLGKGGFGSVFEGTQTD--GTKVAVKRLEGI-----------GEINKSFLAEVKTIGS-IHHQNLVRLIGFCAEKSH  307 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~-----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~  307 (558)
                      +.+.||+|+||.||++....  ++.+|+|.+...           .....++..|+.++.+ ++|+||+++++++..++.
T Consensus         4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   83 (269)
T cd08528           4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR   83 (269)
T ss_pred             hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence            35789999999999999854  688999987521           1123457788888865 799999999999999999


Q ss_pred             ceEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          308 NLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      .+++|||+++++|.+++... .....+++..+++++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence            99999999999999988542 2223589999999999999999999952  68999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          387 KLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       387 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      .......  ......++..|+|||.+.+ .++.++||||||+++|||++|+.||.......       .... .......
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~  231 (269)
T cd08528         162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATK-IVEAVYE  231 (269)
T ss_pred             eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHH-HhhccCC
Confidence            8765433  2345668899999999875 58999999999999999999999986443221       1111 1111111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ...         .......+.+++.+|++.||++||++.+|..+++.
T Consensus       232 ~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         232 PLP---------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCC---------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            000         01123468899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=305.60  Aligned_cols=249  Identities=23%  Similarity=0.284  Sum_probs=190.9

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||+++.. +++.||+|.+...    ....+.+.+|..++..++|+||+++++++.+++..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597           5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence            3578999999999999974 6899999998642    2233558889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.+...  .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus        85 g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          85 GGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            9999999975332  38899999999999999999999   999999999999999999999999999987654433322


Q ss_pred             eecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          397 VTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .....||+.|+|||++.      +.++.++|||||||++|||++|+.||......+.       ............+ ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~-~~  231 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHKEHFQF-PP  231 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCcccC-CC
Confidence            33356899999999985      2478899999999999999999999975433221       1111111100000 00


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCc--CCCCCCCHHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLES--DFAKRPSMSMVVRV  509 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~vl~~  509 (558)
                            ........+.+++.+|+..  ++..||++.++++.
T Consensus       232 ------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         232 ------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                  0001233566677776644  44458899998866

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-36  Score=313.49  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=189.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++. .+++.||||.+....    .....+.+|++++.+++|+||+++++.+.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence            47899999999999987 468999999986432    2345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC----
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~----  393 (558)
                      |+|.+++.+..   .++......++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+....    
T Consensus        86 g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          86 GDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999997643   38889999999999999999999   999999999999999999999999999975331000    


Q ss_pred             --------------------------------------CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh
Q 043292          394 --------------------------------------SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC  434 (558)
Q Consensus       394 --------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt  434 (558)
                                                            ........||+.|+|||++.+ .++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                  000123468999999999875 58999999999999999999


Q ss_pred             CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC---CHHHHHHH
Q 043292          435 GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP---SMSMVVRV  509 (558)
Q Consensus       435 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~~vl~~  509 (558)
                      |+.||......+....+..+       ..  .. .  ..   ........+.+++.+|+ .+|.+|+   |+.++++.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~-------~~--~~-~--~~---~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVINW-------ET--TL-H--IP---SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhcc-------Cc--cc-c--CC---CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999865543311111000       00  00 0  00   00111234556666665 4999999   88988865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.1e-36  Score=298.48  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=196.8

Q ss_pred             HHHHHHHHHh--hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeec-----
Q 043292          233 EELKVMTDNF--RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCA-----  303 (558)
Q Consensus       233 ~~l~~~t~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----  303 (558)
                      +.+..++++|  .+.||+|+||.||++.. .+++.+|+|.+........++.+|+.++.++ +|+||+++++++.     
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            3333344444  47899999999999988 4688999998876544456788999999999 6999999999874     


Q ss_pred             cCCcceEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          304 EKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEcc
Confidence            345679999999999999988642 223358899999999999999999999   8999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK  456 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  456 (558)
                      ||+++....... ......|+..|+|||++.      ..++.++||||||+++|||++|+.||........   +..   
T Consensus       168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~---  240 (286)
T cd06638         168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFK---  240 (286)
T ss_pred             CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hhh---
Confidence            999886543221 223456899999999874      2378899999999999999999999975433211   000   


Q ss_pred             HhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       457 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        ..........+        .......+.+++.+|++.+|++|||+.+|++.
T Consensus       241 --~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 --IPRNPPPTLHQ--------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --ccccCCCcccC--------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              00000000000        01122468899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-35  Score=301.90  Aligned_cols=249  Identities=22%  Similarity=0.278  Sum_probs=191.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||.||+++.. +++.+|+|.+...    ......+..|+.++..++|+||+++++.+.+.+..++||||++
T Consensus         5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~   84 (332)
T cd05623           5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV   84 (332)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence            3478999999999999885 5788999998642    1223457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..........
T Consensus        85 ~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          85 GGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             CCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            9999999976432  38999999999999999999999   999999999999999999999999999997654433333


Q ss_pred             eecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          397 VTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .....||+.|+|||++.      +.++.++|||||||++|||++|+.||......+.       ............ +..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~~-~p~  231 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHKERFQ-FPA  231 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCCcccc-CCC
Confidence            33467999999999875      2478999999999999999999999975443221       111111100000 000


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcC--CCCCCCHHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESD--FAKRPSMSMVVRV  509 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~--p~~RPs~~~vl~~  509 (558)
                            ........+.+++.+|+..+  +..|+++.++++.
T Consensus       232 ------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         232 ------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                  00112345677778877554  4447899999866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-35  Score=293.83  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=199.4

Q ss_pred             HHhhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          240 DNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ..+.++||+|+||+||++... +++.||+|.+...  ....+.+.+|++++..++||||+++++++......++||||++
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD   86 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence            345588999999999999874 6889999987643  3345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .+++.....++.+++.||.|||+  ..+++|+||+|+||++++++.++|+|||++.......   
T Consensus        87 ~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          87 CGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            999999886543   38999999999999999999996  2589999999999999999999999999987543221   


Q ss_pred             eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh----hhHHHHHHHhhhcccchhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED----MYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .....|+..|+|||.+. +.++.++||||||+++++|++|+.||......+..    ..+........         ...
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  229 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------QEP  229 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh---------hcc
Confidence            22456899999999876 46889999999999999999999999865442111    11111111111         110


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      .... ........+.+++.+|++.||.+|||+.+|+++.
T Consensus       230 ~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 PPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000 0112345688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-35  Score=294.75  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=192.5

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||+||++.. .+++.+|+|.+....    .....+.+|++++..++|+|++++.+.+..++..++||||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            6799999999999988 468899999986432    22345788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++..... ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++.......  ...
T Consensus        86 ~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~  159 (285)
T cd05632          86 DLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIR  159 (285)
T ss_pred             cHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--ccc
Confidence            99988875432 248999999999999999999999   999999999999999999999999999997653322  123


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...|+..|+|||.+.+ .++.++|+||||++++||++|..||..........   .+ ........  ..         .
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~-~~~~~~~~--~~---------~  224 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EV-DRRVLETE--EV---------Y  224 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH-HHhhhccc--cc---------c
Confidence            4568999999999864 58999999999999999999999997544322111   11 11111110  00         0


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      .......+.+++..|++.||++||+     +.++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1112335788999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-36  Score=298.93  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=194.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||.|+||.||+++.. +++.||+|.++..  ......+.+|+.++..++|+||+++++++..+...++||||++ ++
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~   89 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   89 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence            468999999999999874 6889999998643  2234567889999999999999999999999999999999996 58


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+++|+||||+||++++++.+||+|||++........ ....
T Consensus        90 l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~  163 (301)
T cd07873          90 LKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSN  163 (301)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccc
Confidence            9888875433  38899999999999999999999   9999999999999999999999999999976533221 1223


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc------c
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK------H  471 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------~  471 (558)
                      ..++..|+|||.+.+  .++.++||||||++++||++|+.||......+............ .......++..      .
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFKSYN  242 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-Chhhchhhhccccccccc
Confidence            456889999998864  47889999999999999999999997655433211111110000 00000011000      0


Q ss_pred             CCCCC------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQ------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....      ........+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000      00012335788999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.9e-35  Score=294.72  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=193.9

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.++||+|+||.||+|... ++..+++|.+.... ...+.+..|+.+++.++|+|++++++.+..++..++||||+++++
T Consensus        16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            4578999999999999885 58899999987443 345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |..++.+...  .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus        96 l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~  169 (292)
T cd06644          96 VDAIMLELDR--GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RRDS  169 (292)
T ss_pred             HHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-ccce
Confidence            9988765432  38999999999999999999999   8999999999999999999999999999875432211 1234


Q ss_pred             ccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          400 MRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       400 ~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ..++..|+|||++.      ..++.++||||||+++|||++|..||........   ...    .. .....        
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~----~~-~~~~~--------  233 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLK----IA-KSEPP--------  233 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHH----Hh-cCCCc--------
Confidence            55788999999874      2368899999999999999999999865432210   111    00 00000        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...........+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00111122346788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-35  Score=298.96  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||.||++... ++..+|+|.++..  .....++.+|++++.+++||||+++++++..++..++||||+++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~   85 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   85 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence            478999999999999874 6788999988643  2234568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++....   .+++..+..++.|+++||.|||+  ..+++|+||||+|||++.++.+||+|||++.......   ...
T Consensus        86 L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~  157 (308)
T cd06615          86 LDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS  157 (308)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence            999997653   38899999999999999999997  2589999999999999999999999999987553221   234


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc---------------
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK---------------  463 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------  463 (558)
                      ..++..|+|||.+.+ .++.++||||||++++||++|+.||.......    .............               
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCCCc
Confidence            568899999999875 58899999999999999999999986543221    1111100000000               


Q ss_pred             -----chhhccccCCC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 -----LSDLVDKHSND---MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 -----~~~~~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                           ..+..+.....   ..........+.+++.+|++.+|++|||+.+|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000000000   00001123468899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-35  Score=304.65  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=189.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++.. .++..||+|.+...   ......+.+|+.++..++||||+++++++....      ..++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            47899999999999987 46899999998643   233456889999999999999999999886543      468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++ +|...+..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       106 e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876         106 ELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN  176 (359)
T ss_pred             eCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence            99965 56665532     27889999999999999999999   99999999999999999999999999999754322


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH---------------HHH
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS---------------IFK  456 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~---------------~~~  456 (558)
                      .  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...+..+.......               ...
T Consensus       177 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         177 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             c--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            1  2334578999999999875 589999999999999999999999986543221110000               000


Q ss_pred             Hhhhc-c-----cchhhccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          457 KKAEE-D-----KLSDLVDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       457 ~~~~~-~-----~~~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..... .     .+.+.+......  ..........+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000 0     000110000000  00011123467899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.5e-36  Score=295.82  Aligned_cols=245  Identities=24%  Similarity=0.348  Sum_probs=193.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++... +++.||+|.+....    .....+..|+.++.+++|+|++++++.+.+++..++||||+++
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            367999999999999884 68899999886432    2234577899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.++|+|||++........  .
T Consensus        85 ~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  158 (285)
T cd05630          85 GDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I  158 (285)
T ss_pred             CcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence            999999865432 248999999999999999999999   9999999999999999999999999999876543221  2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||.+.+ .++.++||||||+++|||++|+.||..................         ....      
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~------  223 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------VQEE------  223 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------hhhh------
Confidence            33568999999999875 5899999999999999999999999754332111111111000         0000      


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      ........+.+++..||+.||.+|||     +.++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            01112235788999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-36  Score=305.87  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=205.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-C-----cceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-H-----QNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|.||.|-++.+ .+++.||||++++......+-..|+++|..++ |     -|+|+++++|...++.+||+|.
T Consensus       190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL  269 (586)
T KOG0667|consen  190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL  269 (586)
T ss_pred             EEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence            358899999999999988 56999999999998888888899999999997 4     3899999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC--CeEEcccCCccccCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF--NAKVADFGLSKLIDQD  392 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~--~~ki~Dfgla~~~~~~  392 (558)
                      + ..+|.++|+.+.-+ .++...+..|+.||+.||.+||+   .+|||+||||+||||.+..  .+||+|||.|......
T Consensus       270 L-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~  344 (586)
T KOG0667|consen  270 L-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR  344 (586)
T ss_pred             h-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence            9 67999999976654 49999999999999999999999   9999999999999997544  6999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh----hhc-ccchh
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK----AEE-DKLSD  466 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~  466 (558)
                          ......+..|.|||++.| .|+.+.||||||||+.||++|.+.|.+.+..++...++......    +.. .+...
T Consensus       345 ----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  345 ----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             ----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence                236678899999999987 69999999999999999999999898877666433333222100    000 00000


Q ss_pred             hccc---------------------------------cCC-CCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          467 LVDK---------------------------------HSN-DMQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       467 ~~d~---------------------------------~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      +++.                                 ... ...     ....+-..+++++.+||..||.+|+|..+.+
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence            1111                                 000 000     0113345789999999999999999999998


Q ss_pred             HH
Q 043292          508 RV  509 (558)
Q Consensus       508 ~~  509 (558)
                      +.
T Consensus       501 ~H  502 (586)
T KOG0667|consen  501 NH  502 (586)
T ss_pred             cC
Confidence            64

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-35  Score=294.57  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=196.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||+++.. +++.||+|++....   ...+.+.+|+.++.+++|+|++++++++..+...++||||+++
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   84 (286)
T cd07847           5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH   84 (286)
T ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence            3467999999999999985 68999999886432   2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus        85 ~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  157 (286)
T cd07847          85 TVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY  157 (286)
T ss_pred             cHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence            98888765433   38999999999999999999999   9999999999999999999999999999987654322 12


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh-------cccc-hhh
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE-------EDKL-SDL  467 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~  467 (558)
                      ....++..|+|||.+.+  .++.++||||||++++||++|+.||......+....+.........       .... ...
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            33457889999998864  4789999999999999999999999865543322211111100000       0000 000


Q ss_pred             ccccCCCCCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQS----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..........    .......+.+++.+|++.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000    0011356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-35  Score=296.69  Aligned_cols=243  Identities=25%  Similarity=0.403  Sum_probs=195.7

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (297)
T cd06656          23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS  102 (297)
T ss_pred             eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence            347899999999999997 578999999987433 334568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.+.    .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ ....
T Consensus       103 L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~  174 (297)
T cd06656         103 LTDVVTET----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (297)
T ss_pred             HHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence            99998643    38899999999999999999999   8999999999999999999999999999876543322 1234


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+++.|+|||.+.+ .++.++||||||++++++++|..||....+.....   .             ............
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~-------------~~~~~~~~~~~~  238 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L-------------IATNGTPELQNP  238 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---e-------------eccCCCCCCCCc
Confidence            568889999999875 58899999999999999999999997544322100   0             000000000111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ......+.+++.+|++.+|++|||+.+|++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            123346788999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=293.18  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=196.2

Q ss_pred             HhhhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.+.||.|+||.||++... ++..+|+|.+.... ...+.|..|+.++++++|+||+++++++..+...++||||++++
T Consensus         8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (280)
T cd06611           8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG   87 (280)
T ss_pred             HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence            34578999999999999884 68899999987433 33457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.....  .+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++........ ...
T Consensus        88 ~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~  161 (280)
T cd06611          88 ALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD  161 (280)
T ss_pred             cHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence            99999875432  48999999999999999999999   8999999999999999999999999999876533221 223


Q ss_pred             cccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          399 TMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ...++..|+|||.+.      ..++.++||||||+++|||++|+.||........   +..+     .....        
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~--------  225 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---LLKI-----LKSEP--------  225 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---HHHH-----hcCCC--------
Confidence            456889999999874      2367899999999999999999999975433211   1110     01100        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ............+.+++..|++.+|.+||++.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000111223467889999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-35  Score=295.19  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=188.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhcc---CCcceeeeeeeeccC-----CcceE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSI---HHQNLVRLIGFCAEK-----SHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~~~l  310 (558)
                      .+.||+|+||.||++... +++.||+|.++...   .....+.+|+.++..+   +||||+++++++...     ...++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            467999999999999884 68899999886421   2234556677766655   799999999987642     34689


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+. ++|.+++..... ..+++..+..++.||+.||.|||+   .+++|+||||+|||+++++.+||+|||+++...
T Consensus        85 v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          85 VFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             EEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            999997 588888875432 248999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch----
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS----  465 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  465 (558)
                      ...  ......++..|+|||++.+ .++.++||||||++++||++|++||......+....+..............    
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         160 CQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             Ccc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            322  2234567899999999864 589999999999999999999999976544322211111110000000000    


Q ss_pred             --hhccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 --DLVDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 --~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ..+......  ..........+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              000000000  0000122346789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=315.58  Aligned_cols=256  Identities=18%  Similarity=0.291  Sum_probs=185.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCC------cceeeeeeeeccC-CcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH------QNLVRLIGFCAEK-SHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~lv~e~  314 (558)
                      .++||+|+||+||++.. ..++.||||+++.......++..|+.++..++|      .+++++++++... .+.++|||+
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~  213 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK  213 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence            47899999999999987 457889999997544444556667777766654      4588999888764 467899998


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----------------Ce
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----------------NA  378 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----------------~~  378 (558)
                      + +++|.+++.+..   .+++..+..|+.||+.||.|||+.  .+|+||||||+|||++.++                .+
T Consensus       214 ~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        214 Y-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             c-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            8 778988887543   389999999999999999999961  5999999999999998765                49


Q ss_pred             EEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-
Q 043292          379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-  456 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-  456 (558)
                      ||+|||++.....    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+..... 
T Consensus       288 kl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        288 RICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             EECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            9999998764322    2345679999999999876 599999999999999999999999986554332111111000 


Q ss_pred             ------HhhhcccchhhccccC---------------CCC-CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          457 ------KKAEEDKLSDLVDKHS---------------NDM-QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       457 ------~~~~~~~~~~~~d~~~---------------~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                            .........++++...               ... .........+.+|+.+||+.||.+|||+.|+++
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                  0000000000110000               000 000012346789999999999999999999996

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-35  Score=290.08  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||.|+||.||++... +++.+|+|.++..  ....+.+..|+.+++.++|+||+++++.+..+...+++|||++++
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (255)
T cd08219           4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG   83 (255)
T ss_pred             EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence            3578999999999999874 6889999988532  334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++..... ..++......++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++........ ...
T Consensus        84 ~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (255)
T cd08219          84 DLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC  158 (255)
T ss_pred             cHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence            99998865332 347899999999999999999999   9999999999999999999999999999986643221 223


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||++.+ ..+.++|+||||+++++|++|..||.......    .   ... ...+....+          
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~---~~~-~~~~~~~~~----------  220 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----L---ILK-VCQGSYKPL----------  220 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----H---HHH-HhcCCCCCC----------
Confidence            4568899999999875 58999999999999999999999997543221    0   111 111111110          


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+||+.||++|||+.+|+..
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11123467889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.1e-36  Score=326.76  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+|+.. +++.||+|++...    ....++|.+|++++++++||||+++++++.+++..++||||+++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG   86 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG   86 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence            478999999999999884 6899999998643    22345789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          318 GSLDRWLFQRS--------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       318 gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      ++|.+++....        ....+++..+++++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceec
Confidence            99999986421        11236778889999999999999999   89999999999999999999999999999866


Q ss_pred             CCCCC-----------------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH
Q 043292          390 DQDQS-----------------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       390 ~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  451 (558)
                      .....                 .......||+.|+|||.+.+ .++.++||||||++++||++|+.||.......    .
T Consensus       164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k----i  239 (932)
T PRK13184        164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK----I  239 (932)
T ss_pred             ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh----h
Confidence            21110                 01123468999999999875 58999999999999999999999997533211    0


Q ss_pred             HHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcccc
Q 043292          452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP-SMSMVVRVLEGVTE  515 (558)
Q Consensus       452 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~  515 (558)
                      ..  ...     .....+     ..........+.+++.+|++.||++|| +++++++.|+...+
T Consensus       240 ~~--~~~-----i~~P~~-----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        240 SY--RDV-----ILSPIE-----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh--hhh-----ccChhh-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00  000     000000     000112234678899999999999996 67778787776544

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=292.03  Aligned_cols=243  Identities=27%  Similarity=0.397  Sum_probs=197.0

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||.|+||.||+|+.. +++.||+|.+...  ......+.+|+.+++.++|+|++++++++.++...++|+||++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (274)
T cd06609           5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG   84 (274)
T ss_pred             hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence            4578999999999999984 6889999998643  233456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++...    .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++....... ...
T Consensus        85 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (274)
T cd06609          85 SCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN  156 (274)
T ss_pred             cHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence            999998754    48999999999999999999999   8999999999999999999999999999987654321 223


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||++.+ .++.++||||||+++|||++|+.||....+...   ..     .........+     ..   
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~-----~~~~~~~~~~-----~~---  220 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF-----LIPKNNPPSL-----EG---  220 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH-----HhhhcCCCCC-----cc---
Confidence            4567889999999875 589999999999999999999999975443211   00     0001111010     00   


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ......+.+++.+|+..+|++|||++++++.
T Consensus       221 -~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 -NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             0023468889999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8e-36  Score=297.29  Aligned_cols=258  Identities=28%  Similarity=0.419  Sum_probs=198.9

Q ss_pred             CHHHHHHHHHHh--hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccC-
Q 043292          231 SFEELKVMTDNF--RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK-  305 (558)
Q Consensus       231 ~~~~l~~~t~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  305 (558)
                      .+.++..++++|  .+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|+|++++++++... 
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            334444445555  46899999999999988 4688999999876555556788899999998 899999999998653 


Q ss_pred             ----CcceEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          306 ----SHNLLVYEYMPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       306 ----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                          ...++|+||+++++|.+++.... ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEE
Confidence                35789999999999999886421 22358999999999999999999999   89999999999999999999999


Q ss_pred             cccCCccccCCCCCceeecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHH
Q 043292          381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  454 (558)
                      +|||++........ ......++..|+|||.+..      .++.++||||||+++|||++|+.||........   +..+
T Consensus       170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~  245 (291)
T cd06639         170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKI  245 (291)
T ss_pred             eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHH
Confidence            99999886543221 1223467889999998753      268999999999999999999999975432211   1111


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           .......+        .........+.+++.+|++.+|++||++.++++
T Consensus       246 -----~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 -----PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----hcCCCCCC--------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 00111111        111123346889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-35  Score=296.37  Aligned_cols=242  Identities=26%  Similarity=0.424  Sum_probs=195.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||.|++|.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.++|+|++++++++..+...++|+||+++++|
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  103 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL  103 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence            36799999999999987 578999999886432 3356788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      ..++...    .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ .....
T Consensus       104 ~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~  175 (296)
T cd06655         104 TDVVTET----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTM  175 (296)
T ss_pred             HHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCc
Confidence            9988643    38999999999999999999999   9999999999999999999999999999886543322 12335


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||.+.+ .++.++||||||+++|+|++|+.||.........   ..+. .    .....        .....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~~-~----~~~~~--------~~~~~  239 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIA-T----NGTPE--------LQNPE  239 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-h----cCCcc--------cCCcc
Confidence            68889999998875 5899999999999999999999999765432211   1100 0    00000        00111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+++.+||..+|.+|||+.+|++
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            22346788999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-35  Score=296.69  Aligned_cols=249  Identities=27%  Similarity=0.490  Sum_probs=194.1

Q ss_pred             hhcCccCceEEEEEEeC-CCC----EEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.||+|+||.||+|... ++.    .+|+|.+....  ....++.+|+.+++.++|+||+++++++... ...+++||++
T Consensus        13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~   91 (303)
T cd05110          13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP   91 (303)
T ss_pred             cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence            67999999999999863 444    57888886432  2234688999999999999999999998754 4679999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.....  .+++..++.++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||+++.........
T Consensus        92 ~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          92 HGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            9999999876433  38899999999999999999999   899999999999999999999999999998764332211


Q ss_pred             -eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          397 -VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       397 -~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       .....++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+    ...+.    ..+..       . 
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~----~~~~~-------~-  230 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLL----EKGER-------L-  230 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HCCCC-------C-
Confidence             122345678999999875 58999999999999999998 899986543211    11111    11100       0 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        .........+.+++..|+..+|++||++.+++++|+.+.+-
T Consensus       231 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 --PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00111234688899999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-35  Score=297.09  Aligned_cols=195  Identities=27%  Similarity=0.464  Sum_probs=159.4

Q ss_pred             hhcCccCceEEEEEEeC---CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  318 (558)
                      .+||+|+||.||+++..   ++..||+|.+.... ....+.+|+.++.+++||||+++++++..  +...++|+||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            57999999999999864   45789999987543 23467889999999999999999998853  456789999986 4


Q ss_pred             CHHHHHhcC------CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee----cCCCCeEEcccCCccc
Q 043292          319 SLDRWLFQR------SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKL  388 (558)
Q Consensus       319 sL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll----~~~~~~ki~Dfgla~~  388 (558)
                      +|.+++...      .....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            777776432      112348899999999999999999999   999999999999999    5667899999999987


Q ss_pred             cCCCCCc--eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 043292          389 IDQDQSQ--VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQ  443 (558)
Q Consensus       389 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~  443 (558)
                      .......  ......+|..|+|||++.+  .++.++||||||+++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            6543221  1234568999999998864  48999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-35  Score=287.87  Aligned_cols=247  Identities=30%  Similarity=0.508  Sum_probs=197.5

Q ss_pred             hhhhcCccCceEEEEEEeCC-----CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-----GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||.|+||.||+++..+     +..||+|.+.....  ..+.+..|+..+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998853     37899999975443  456899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++...... .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       83 MEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             cCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999764432 28999999999999999999999   8999999999999999999999999999987654422


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .......++..|+|||.+.+ .++.++||||+|+++++|++ |..||.......    +...    .......       
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~----~~~~----~~~~~~~-------  223 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE----VLEY----LKKGYRL-------  223 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HhcCCCC-------
Confidence            22222336789999998864 58999999999999999998 788876532211    1111    1111110       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                         .........+.+++.+|++.+|++|||+.+++++|
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               00111345788899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-35  Score=293.52  Aligned_cols=244  Identities=25%  Similarity=0.415  Sum_probs=192.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeecc------CCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAE------KSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e~  314 (558)
                      .++||.|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+||+++++++..      +...+++|||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            47899999999999998 4688999999876555556788899999998 79999999999853      4567899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++..... ..+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~  176 (282)
T cd06636         101 CGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  176 (282)
T ss_pred             CCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence            999999999876433 248888999999999999999999   8999999999999999999999999999876532211


Q ss_pred             ceeecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          395 QVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                       ......|+..|+|||.+.      ..++.++||||||+++|||++|..||....+......        .....     
T Consensus       177 -~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--------~~~~~-----  242 (282)
T cd06636         177 -RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--------IPRNP-----  242 (282)
T ss_pred             -CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--------HhhCC-----
Confidence             123456889999999874      2478899999999999999999999965432221100        00000     


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....    ........+.+++..||+.||.+|||+.++++
T Consensus       243 ~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         243 PPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0000    01123357889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=308.77  Aligned_cols=259  Identities=25%  Similarity=0.258  Sum_probs=194.7

Q ss_pred             HHhhhhcCccCceEEEEEEeC---CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          240 DNFRKMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.+.||+|+||.||++...   .+..|++|.+...    ..+.+|++++.+++|+||+++++++......++|||++.
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            445678999999999999753   3578999988643    235689999999999999999999999999999999995


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-  395 (558)
                       ++|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus       170 -~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        170 -CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             -CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence             68888884332   48999999999999999999999   99999999999999999999999999999865443222 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc-c--------ch
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-K--------LS  465 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~  465 (558)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.........+..+........ .        +.
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            2234679999999999875 589999999999999999999999977654432222222221110000 0        00


Q ss_pred             hhc---cccCCC-CCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          466 DLV---DKHSND-MQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       466 ~~~---d~~~~~-~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..+   ...... ...+     ......+.+++.+||..||++|||+.+++..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000   000000 0000     0112457789999999999999999999965

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.8e-35  Score=290.51  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=194.3

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc-------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||+|...+++.+|+|.++...       .....+.+|+.+++.++|+||+++++++.+....++++||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            46799999999999998889999999886321       12345888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC---
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD---  392 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~---  392 (558)
                      ++++|.+++.+..   .+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......   
T Consensus        85 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          85 PGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999997643   37899999999999999999999   89999999999999999999999999998765321   


Q ss_pred             --CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 --QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 --~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                        .........++..|+|||.+.+ .++.++||||||+++++|++|..||........   ....   .........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~~~~~~~~---  229 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYI---GAHRGLMPR---  229 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHh---hhccCCCCC---
Confidence              1111234568899999999875 488999999999999999999999975432211   0000   000001101   


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                             ........+.+++.+|++.+|.+||++.++++
T Consensus       230 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 -------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   01123356789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=285.39  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=207.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +-++||+|++|.|||+.. ..|+.+|+|.+.-.. ..++...|+.++++.+.+++|+++|.+......|+|||||..|+.
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence            347899999999999988 469999999887433 356789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..+.  +.|++.++..+++..++||+|||.   ..-+|||||+.||||+-+|.+||+|||+|-.+.+...+ ..++
T Consensus       116 SDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNTV  189 (502)
T KOG0574|consen  116 SDIMRARR--KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNTV  189 (502)
T ss_pred             HHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCcc
Confidence            99997654  359999999999999999999999   88899999999999999999999999999887654433 4567


Q ss_pred             cCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .||+.|||||++... |+.++||||||++..||..|++||....+....+.+                -.........+.
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----------------PT~PPPTF~KPE  253 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----------------PTKPPPTFKKPE  253 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----------------cCCCCCCCCChH
Confidence            899999999999874 999999999999999999999999866554321111                111222233345


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      +-...+-+++..||-.+|++|-|+.++++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            567789999999999999999999998864

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-35  Score=288.73  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=197.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ..++||.|+||.||+|... ++..||+|.+...  ......+..|+.+++.++|+||+++++++.++...++||||++++
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            3477999999999999874 5889999988643  234567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++...    .+++.+...++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        88 ~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  159 (277)
T cd06640          88 SALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN  159 (277)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence            999998643    38899999999999999999999   9999999999999999999999999999976643321 123


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ .++.++||||||++++||++|..||....+.....       . .....          ....
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~-~~~~~----------~~~~  221 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------L-IPKNN----------PPTL  221 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------h-hhcCC----------CCCC
Confidence            3467889999999865 58999999999999999999999997544322100       0 00000          0112


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+|++.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            23455678899999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4e-35  Score=301.74  Aligned_cols=256  Identities=24%  Similarity=0.321  Sum_probs=190.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++... .++.||||++...   ......+.+|+.+++.++||||+++++++....      ..++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            478999999999999874 6889999998743   233456889999999999999999999875433      468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++ +|.+.+..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         109 ELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  179 (364)
T ss_pred             eCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence            99964 67777642     27889999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHh------
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKK------  458 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~------  458 (558)
                      .  ......+|..|+|||++.+ .++.++||||||+++|||++|+.||......+....+....       ...      
T Consensus       180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         180 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             C--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            1  2334578999999999875 58999999999999999999999997655332211111000       000      


Q ss_pred             --hh-ccc-----chhhccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          459 --AE-EDK-----LSDLVDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       459 --~~-~~~-----~~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        .. ...     ...++......  ..........+.+++.+||+.||.+|||+.++++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              00 000     00000000000  00011123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-36  Score=303.66  Aligned_cols=238  Identities=26%  Similarity=0.332  Sum_probs=185.1

Q ss_pred             cCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc---CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI---HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ||+|+||.||+++.. +++.||||++....    .....+..|..++...   +||||+++++.+..+...++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999874 68999999986421    1223455566666655   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~  153 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT  153 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence            99999987543   38999999999999999999999   999999999999999999999999999987543222 123


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||..|+|||++.+  .++.++|||||||++|||++|+.||......+       .... ...+..      .... 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~-i~~~~~------~~~~-  218 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRN-IAFGKV------RFPK-  218 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHH-HHcCCC------CCCC-
Confidence            35679999999999864  37999999999999999999999997543221       1111 111110      0000 


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC----CHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRP----SMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RP----s~~~vl~  508 (558)
                         ......+.+++.+||+.||.+||    ++.++++
T Consensus       219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               01234677899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-35  Score=304.79  Aligned_cols=196  Identities=28%  Similarity=0.440  Sum_probs=168.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|+++..    ......+..|+.++..++|+||+++++.+.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            478999999999999884 6899999998642    22345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC---
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS---  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~---  394 (558)
                      |+|.+++.+..   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........   
T Consensus        86 g~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          86 GDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999997543   38999999999999999999999   9999999999999999999999999999875432110   


Q ss_pred             -------------------------------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043292          395 -------------------------------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRS  442 (558)
Q Consensus       395 -------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~  442 (558)
                                                     .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                           00123568999999999875 5899999999999999999999999765


Q ss_pred             CC
Q 043292          443 QP  444 (558)
Q Consensus       443 ~~  444 (558)
                      ..
T Consensus       240 ~~  241 (360)
T cd05627         240 TP  241 (360)
T ss_pred             CH
Confidence            54

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=291.82  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=197.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCC----EEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+|... ++.    .+|+|.+....  ....++.+|+.++++++|+||+++++++.. ...++|+||
T Consensus        11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   89 (279)
T cd05057          11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL   89 (279)
T ss_pred             EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence            3478999999999999864 333    58999886543  234678899999999999999999999887 788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++.....  .+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.......
T Consensus        90 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          90 MPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             CCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            999999999976543  38999999999999999999999   9999999999999999999999999999987653322


Q ss_pred             cee-ecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          395 QVV-TTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       395 ~~~-~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ... ....++..|+|||.+. +.++.++|+||||++++|+++ |+.||......+    +...    ...+..       
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~~~-------  229 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDL----LEKGER-------  229 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHH----HhCCCC-------
Confidence            111 1222356899999886 468999999999999999998 999997654322    1111    111100       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .   .........+.+++..|+..+|.+|||+.++++.|+.+..
T Consensus       230 ~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0   0011122467889999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=325.59  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=192.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  315 (558)
                      +.++||+|+||.||++... ++..+|+|.+...   ......|..|+.++.+++|||||++++++..  ....+|||||+
T Consensus        17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~   96 (1021)
T PTZ00266         17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC   96 (1021)
T ss_pred             EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence            4578999999999999884 5778999988642   2234578999999999999999999998854  34678999999


Q ss_pred             CCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccC----CCcEEecCCCCCCEeecC----------------
Q 043292          316 PNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDC----RQKILHLDIKPQNILLDG----------------  374 (558)
Q Consensus       316 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~dlk~~NIll~~----------------  374 (558)
                      ++++|.++|.... ....+++..++.|+.||+.||.|||+..    ..+|+|+||||+||||+.                
T Consensus        97 ~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n  176 (1021)
T PTZ00266         97 DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN  176 (1021)
T ss_pred             CCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence            9999999997532 1235999999999999999999999832    135999999999999964                


Q ss_pred             -CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhh
Q 043292          375 -NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY  450 (558)
Q Consensus       375 -~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~  450 (558)
                       .+.+||+|||++..+....  ......||+.|+|||++.+   .++.++|||||||+||||++|..||.......   .
T Consensus       177 g~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~---q  251 (1021)
T PTZ00266        177 GRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS---Q  251 (1021)
T ss_pred             CCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH---H
Confidence             3348999999998664322  2234578999999998853   48899999999999999999999997543221   1


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH--HHHhcc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV--RVLEGV  513 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl--~~L~~~  513 (558)
                      +...    .....     ....      ......+.+|+..||+.+|.+||++.+++  +.+..+
T Consensus       252 li~~----lk~~p-----~lpi------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        252 LISE----LKRGP-----DLPI------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHH----HhcCC-----CCCc------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            1111    11100     0000      01234688999999999999999999998  445443

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=306.58  Aligned_cols=242  Identities=28%  Similarity=0.435  Sum_probs=198.9

Q ss_pred             hcCccCceEEEEEEeC-CCCEEEEEEecc-cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          245 MLGKGGFGSVFEGTQT-DGTKVAVKRLEG-IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      +||+|.+|+||.|++. +...+|||-+.. .....+-+.+|+.+.+.++|.|||+++|.+.+++..-|.||-.+||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999985 456799998864 34445568899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCC--CHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCCccccCCCCCceeec
Q 043292          323 WLFQRSDEFML--DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       323 ~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      +|...=+  +|  ++.+.-.+.+||++||.|||+   ..|||||||-+|||++ -.|.+||+|||-++.+..-+ ....+
T Consensus       662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET  735 (1226)
T KOG4279|consen  662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET  735 (1226)
T ss_pred             HHHhccC--CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence            9975322  24  788888899999999999999   9999999999999995 57899999999998775433 23557


Q ss_pred             ccCCCCcCChhhhc-C--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          400 MRGTPGYLAPEWLS-S--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       400 ~~gt~~y~aPE~~~-~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      +.||.-|||||++. |  -|..++|||||||++.||.||++||.........+.-+..             +.   ...+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-------------yK---vHP~  799 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-------------YK---VHPP  799 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-------------ee---cCCC
Confidence            88999999999997 3  3999999999999999999999999755443322211111             11   1122


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+.+-......++++|+.++|.+||++.++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            34455678899999999999999999999985

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-35  Score=287.75  Aligned_cols=243  Identities=30%  Similarity=0.496  Sum_probs=193.6

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++.+++|+|++++++++..+ ..++||||+++++|
T Consensus         9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L   85 (254)
T cd05083           9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL   85 (254)
T ss_pred             eeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence            3457899999999999974 57889999986532 345789999999999999999999998764 47999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......    ....
T Consensus        86 ~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~  157 (254)
T cd05083          86 VNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNS  157 (254)
T ss_pred             HHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc----CCCC
Confidence            999976543 248999999999999999999999   99999999999999999999999999998754322    1123


Q ss_pred             cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+..|+|||.+. +.++.++||||||++++||++ |+.||......+    ..    .....+...          ...
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~----~~~~~~~~~----------~~~  219 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VK----ECVEKGYRM----------EPP  219 (254)
T ss_pred             CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HH----HHHhCCCCC----------CCC
Confidence            3456899999886 468999999999999999998 999987544322    11    111111100          011


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ......+.+++.+|++.+|++||++.+|++.|++
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.8e-35  Score=301.92  Aligned_cols=256  Identities=24%  Similarity=0.316  Sum_probs=189.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++... .++.||||++...   ......+.+|+.+++.++|+||+++++++....      ..++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            478999999999999874 6889999998743   223456788999999999999999999876433      468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++ +|...+..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874         102 ELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             hhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            99965 67666642     27899999999999999999999   99999999999999999999999999999865332


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH---------------H
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF---------------K  456 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~---------------~  456 (558)
                        .......||..|+|||++.+ .++.++||||||++++||++|+.||......+.........               .
T Consensus       173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence              12334578999999999876 58999999999999999999999997654322111111000               0


Q ss_pred             Hhhhc-ccc-----hhhccccCC--CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          457 KKAEE-DKL-----SDLVDKHSN--DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       457 ~~~~~-~~~-----~~~~d~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..... ...     ...+.....  ...........+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000 000     000000000  000111223567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-35  Score=295.33  Aligned_cols=242  Identities=23%  Similarity=0.357  Sum_probs=194.0

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ..||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999999874 6899999998643 233456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      .++...    .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ......
T Consensus       107 ~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~  178 (297)
T cd06659         107 DIVSQT----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV  178 (297)
T ss_pred             HHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence            987542    38999999999999999999999   8999999999999999999999999999876543321 123456


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ++..|+|||++.+ .++.++||||||++++||++|+.||......+.    ....    .......     ..   ....
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~----~~~~~~~-----~~---~~~~  242 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKRL----RDSPPPK-----LK---NAHK  242 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHH----hccCCCC-----cc---ccCC
Confidence            8899999999875 589999999999999999999999975433221    1110    0000000     00   0011


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ....+.+++..|++.+|++||++.++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            23467889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-36  Score=273.81  Aligned_cols=243  Identities=27%  Similarity=0.477  Sum_probs=196.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-----cc----chHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-----GE----INKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      ++.||+|..++|-+... .+|++.|+|++...     .+    ..+.-..|+.+|+++ .||+|+++.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            47899999999998876 57899999998521     11    123457799999998 699999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      +|.|+.|.|.++|....   .+++....+|++|+.+|++|||.   .+||||||||+|||++++.++||+|||+|..+..
T Consensus       102 Fdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999997655   39999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCceeecccCCCCcCChhhhc-----C--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLS-----S--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~-----~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .  ......+||++|+|||.+.     +  -++..+|+|+.||++|-|+.|-+||-...    +    ....+...+++.
T Consensus       176 G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Q----mlMLR~ImeGky  245 (411)
T KOG0599|consen  176 G--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----Q----MLMLRMIMEGKY  245 (411)
T ss_pred             c--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----H----HHHHHHHHhccc
Confidence            4  3466789999999999875     2  37889999999999999999999984221    1    111222333332


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      . +-.+      .-.+......+++.+||+.||.+|.|++|+++
T Consensus       246 q-F~sp------eWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 Q-FRSP------EWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             c-cCCc------chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1 1111      11223446788999999999999999999985

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.3e-35  Score=286.98  Aligned_cols=246  Identities=25%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||.|+||.||.++. .+++.+++|.+...   .....++.+|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (256)
T cd08221           4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG   83 (256)
T ss_pred             EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence            347899999999999887 46889999987632   33456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ ..
T Consensus        84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~  158 (256)
T cd08221          84 GTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA  158 (256)
T ss_pred             CcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence            999999976532 348999999999999999999999   8999999999999999999999999999987644332 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....++..|+|||.+.+ ..+.++||||||++++||++|..||......+       ..... ..+....          
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~-~~~~~~~----------  220 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVVKI-VQGNYTP----------  220 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH-HcCCCCC----------
Confidence            34568999999999875 48899999999999999999999997544322       11111 1111111          


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      ........+.+++.+|++.+|.+|||+.++++.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            0112234688899999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-35  Score=291.23  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=196.5

Q ss_pred             HhhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++.+.||+|+||.||++... ++..||+|.++..  ......+.+|+.++.+++|+||+++++.+...+..++||||+++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (286)
T cd06622           4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA   83 (286)
T ss_pred             hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence            35578999999999999985 7899999988643  22346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..++........+++..+..++.+++.||.|||+  ..+++|+||||+||+++.++.+||+|||++..+....   .
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~  158 (286)
T cd06622          84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---A  158 (286)
T ss_pred             CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---c
Confidence            9999998764333358999999999999999999996  1589999999999999999999999999997653321   2


Q ss_pred             ecccCCCCcCChhhhcC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          398 TTMRGTPGYLAPEWLSS-------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ....++..|+|||.+.+       .++.++||||||++++||++|+.||........    .....         .+.+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~---------~~~~~  225 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI----FAQLS---------AIVDG  225 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH----HHHHH---------HHhhc
Confidence            33457889999998753       257899999999999999999999965432211    11000         01111


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...  .........+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         226 DPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            111  111224457889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.1e-36  Score=297.18  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=195.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||++... +++.||+|++....   ...+.+.+|++++..++|+||+++++++..+...++|+||+++
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (286)
T cd07846           5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH   84 (286)
T ss_pred             EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence            3478999999999999985 58999999886432   2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|..+.....   .+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++....... ...
T Consensus        85 ~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~  157 (286)
T cd07846          85 TVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY  157 (286)
T ss_pred             cHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence            99988765432   38999999999999999999999   899999999999999999999999999998654332 223


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc----cchhhccc-
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED----KLSDLVDK-  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~-  470 (558)
                      ....++..|+|||++.+  .++.++||||||++++||++|+.||......+....+...........    ....+++. 
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34567889999998864  478899999999999999999999875443221111111110000000    00000000 


Q ss_pred             ---cCCCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 ---HSNDMQ----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ---~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ......    ........+.+++.+|++.+|.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               000000    00112457889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-35  Score=288.66  Aligned_cols=243  Identities=28%  Similarity=0.491  Sum_probs=193.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccccc----------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE----------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+.||+|+||.||+|.. .+++.+|+|.+.....          ..+.+..|+.++.+++||||+++++++.+....++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            346899999999999987 4688999998863211          12467889999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      |+||+++++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          84 FLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999997643   38899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCc-----eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          391 QDQSQ-----VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       391 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .....     ......++..|+|||.+.+ .++.++||||||+++++|++|+.||........   ..    ... ..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~-~~--  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IF----KIG-EN--  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HH----HHh-cc--
Confidence            32111     1123457889999999865 588999999999999999999999975432110   00    000 00  


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ...     .........+.+++.+||+.+|.+||++.+|++
T Consensus       228 ---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ---ASP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---CCC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               000     011123457888999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-35  Score=295.28  Aligned_cols=242  Identities=23%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ..||+|+||.||++.. .++..||+|.+.... ...+.+.+|+.++..++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5699999999999987 468899999986432 33456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++...    .+++..+..++.||+.||.|||+   .+++|+||||+||++++++.+||+|||++........ ......
T Consensus       108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~  179 (292)
T cd06658         108 DIVTHT----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV  179 (292)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence            988543    38899999999999999999999   8999999999999999999999999999876543222 123356


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ++..|+|||.+.+ .++.++||||||++++||++|+.||.......    .......         .+.....   ....
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~---------~~~~~~~---~~~~  243 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRRIRD---------NLPPRVK---DSHK  243 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh---------cCCCccc---cccc
Confidence            8899999999875 58999999999999999999999997543321    1111000         0111111   1112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ....+..++..|+..||.+|||+.++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            23467788999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=296.33  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             HhhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc----chHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEe
Q 043292          241 NFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE----INKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.+.||+|.||.||+++.. +|+.+|+|.+.+...    ..+.+.+|+.+|+++. |||||.+.+.+.+....++|||+
T Consensus        38 ~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL  117 (382)
T KOG0032|consen   38 ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL  117 (382)
T ss_pred             EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence            34578999999999999985 499999999975432    3467899999999998 99999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC----CCeEEcccCCccccC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN----FNAKVADFGLSKLID  390 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla~~~~  390 (558)
                      +.||.|.+.+...  .  +++.....++.||+.++.|||+   .+++||||||+|+|+...    +.+|++|||++....
T Consensus       118 ~~GGeLfd~i~~~--~--~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  118 CEGGELFDRIVKK--H--YSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             cCCchHHHHHHHc--c--CCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            9999999999876  2  8999999999999999999999   999999999999999543    479999999999876


Q ss_pred             CCCCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .  .......+||+.|+|||++. ..++..+||||+|+++|.|++|..||..........        ....+.+ ++-+
T Consensus       191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~-~f~~  259 (382)
T KOG0032|consen  191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF-DFTS  259 (382)
T ss_pred             C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC-CCCC
Confidence            6  44577889999999999998 579999999999999999999999998766543221        1111111 1111


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .      .-......+-+++..++..||.+|+|+.++++.
T Consensus       260 ~------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  260 E------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C------CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1      112234578889999999999999999999984

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-35  Score=300.86  Aligned_cols=185  Identities=27%  Similarity=0.356  Sum_probs=157.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.+.||+|+||.||+++.. ++..||+|.....     ....|+.++.+++|+||+++++++..+...++|+|++ .++|
T Consensus        70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l  143 (357)
T PHA03209         70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDL  143 (357)
T ss_pred             EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcH
Confidence            3578999999999999985 5778999975432     2357899999999999999999999999999999999 4688


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.....  .+++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus       144 ~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~  216 (357)
T PHA03209        144 YTYLTKRSR--PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGL  216 (357)
T ss_pred             HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccc
Confidence            888865433  48999999999999999999999   899999999999999999999999999997533221  22345


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCC
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF  439 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~  439 (558)
                      .||..|+|||++.+ .++.++||||||+++|||+++..++
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            68999999999875 5899999999999999999866554

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=289.44  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=195.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCC------cceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKS------HNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~e~  314 (558)
                      .+.||+|+||.||++... +++.+++|.+.......+++..|+.++.++ +|+||+++++++....      ..++||||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            578999999999999984 578999999886665667899999999999 7999999999987644      47999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          315 MPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +++++|.+++.... ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  167 (275)
T cd06608          91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL  167 (275)
T ss_pred             CCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccch
Confidence            99999999987532 22358999999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                       .......++..|+|||.+..      .++.++||||||+++++|++|+.||.......   .+..+     ...     
T Consensus       168 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~-----~~~-----  233 (275)
T cd06608         168 -GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFKI-----PRN-----  233 (275)
T ss_pred             -hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHHh-----hcc-----
Confidence             12234568889999998742      36789999999999999999999996433221   11110     000     


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ..............+.+++.+||..||++|||+.++++
T Consensus       234 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 ---PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               01111112224457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=295.19  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||+++.. +++.|++|.++..   ....+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence            4578999999999999885 5889999988643   23346789999999999999999999999999999999999998


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +.+..+.....   .+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.+||+|||++...........
T Consensus        85 ~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          85 TLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            77766554332   38999999999999999999999   8999999999999999999999999999987655433233


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--------cccch--
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--------EDKLS--  465 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--  465 (558)
                      ....++..|+|||++.+  .++.++||||||+++++|++|+.||......+....+.........        .....  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            44667889999999864  5789999999999999999999999755433211111111100000        00000  


Q ss_pred             ---hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 ---DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ---~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         +..+...............+.+++..||+.+|++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               0000000000011112467899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.2e-35  Score=293.01  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=192.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||+++.. +|+.+|+|.++..   ......+.+|+.++++++|+||+++++++.+....++|+||++ 
T Consensus         4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   82 (284)
T cd07839           4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-   82 (284)
T ss_pred             eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence            3467999999999999984 6899999998642   2223567889999999999999999999999999999999996 


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++.....  .+++..+..++.||++||.|||+   .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        83 ~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (284)
T cd07839          83 QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY  156 (284)
T ss_pred             CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence            578887765332  38999999999999999999999   9999999999999999999999999999986543221 12


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cc---cchhhccc
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--ED---KLSDLVDK  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~d~  470 (558)
                      ....++..|+|||.+.+  .++.++||||||++++||++|..|+.........  +.........  ..   ......+.
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcccc
Confidence            33457889999998864  3789999999999999999999986543332211  1111000000  00   00000000


Q ss_pred             c-CCCC-------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 H-SNDM-------QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~-~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      . ....       .........+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 0000       001112357789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.5e-35  Score=287.04  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=199.2

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||.|+||.||+|.. .++..+++|++...  ......+.+|+..++.++|+|++++++.+..++..++|+|+++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (267)
T cd06610           5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG   84 (267)
T ss_pred             eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence            357899999999999987 46889999998643  234567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc---
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ---  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~---  395 (558)
                      +|.+++........+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..+......   
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          85 SLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             cHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            999999764433358999999999999999999999   99999999999999999999999999998866543322   


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......++..|+|||.+..  ..+.++|+||||++++||++|+.||........   ...    .....      .....
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~----~~~~~------~~~~~  228 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LML----TLQND------PPSLE  228 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HHH----HhcCC------CCCcC
Confidence            1234568899999998864  489999999999999999999999975543221   111    11100      00000


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...........+.+++..|++.||++|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00001123356789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=275.91  Aligned_cols=245  Identities=26%  Similarity=0.400  Sum_probs=194.7

Q ss_pred             HhhhhcCccCceEEEEEEe-CCCCEEEEEEecc---cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.+.||+|.|+.||+... .+|+.+|+|.+..   .....+++.+|+++-+.++||||+++.....+....+||+|+|.
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   93 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence            3458899999999999876 5799999998752   23356778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCC
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~  393 (558)
                      |++|..-+-.+   ..+++...-..++||+++|.|+|.   .+|||||+||.|+||..   .--+||+|||+|..++  .
T Consensus        94 G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~  165 (355)
T KOG0033|consen   94 GGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D  165 (355)
T ss_pred             chHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence            99997655433   347778888899999999999999   99999999999999953   3458999999999887  3


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ........||++|||||++++ .++..+|||+-||+|+-|+.|..||-+.....       ++.+. ..+    .+|-..
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I-~~g----~yd~~~  233 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQI-KAG----AYDYPS  233 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHH-hcc----ccCCCC
Confidence            334556889999999999986 69999999999999999999999997644322       11111 111    111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..   -....++..+++.+||..||++|.|+.|.+.
T Consensus       234 ~~---w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PE---WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cc---cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11   1122346778999999999999999998874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-35  Score=299.14  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC------CcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  312 (558)
                      .+.||+|+||.||++.. .+++.||||.+....   ...+.+.+|+.++++++|+||+++++++...      ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            47899999999999987 468899999987432   2335678899999999999999999987543      3458999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      +++ +++|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus       100 ~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  171 (343)
T cd07878         100 NLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE  171 (343)
T ss_pred             ecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence            988 78998887532    38999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  463 (558)
                          .....||..|+|||++.+  .++.++||||||++++||++|+.||......+....+.....       .......
T Consensus       172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence                234568999999999865  488999999999999999999999976443221111111000       0000000


Q ss_pred             chhhccccCCCCCCC------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 LSDLVDKHSNDMQSN------GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ....+.. +......      ......+.+++.+|++.||.+|||+.++++.
T Consensus       248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         248 ARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000 0000000      0012347799999999999999999999954

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-35  Score=293.50  Aligned_cols=262  Identities=27%  Similarity=0.381  Sum_probs=198.4

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||.|+||.||+|+. .+++.|++|++....   ...+.+.+|+.++++++|+||+++++++..+...++||||+ +
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~   82 (286)
T cd07832           4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P   82 (286)
T ss_pred             EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence            357799999999999997 468999999987432   23467899999999999999999999999999999999999 9


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....  ..+++.++..++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++...........
T Consensus        83 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          83 SDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            99999987544  348999999999999999999999   8999999999999999999999999999987654432223


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc--ccchhhcc---c
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE--DKLSDLVD---K  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d---~  470 (558)
                      ....++..|+|||.+.+  .++.++||||+|++++||++|.++|......+...............  ..+.++.+   .
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            34568899999998753  47899999999999999999988776544322111111110000000  00000000   0


Q ss_pred             cCCCCC------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          471 HSNDMQ------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       471 ~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ......      ...+....+.+++.+|++.+|.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000      001223688999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-35  Score=285.10  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=197.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||.|+||.||++... +++.+++|.+... ....+.+..|+.++++++||||+++++++..+...+++|||+++++
T Consensus         7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~   86 (262)
T cd06613           7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS   86 (262)
T ss_pred             EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence            3478999999999999874 5788999998743 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++....  ..++...+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ ....
T Consensus        87 l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~  160 (262)
T cd06613          87 LQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS  160 (262)
T ss_pred             HHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence            999987642  238999999999999999999999   8999999999999999999999999999986543221 2234


Q ss_pred             ccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          400 MRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ..++..|+|||.+.+    .++.++||||||++++||++|+.||.........   ....     ...+    ..  ...
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~---~~~~-----~~~~----~~--~~~  226 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL---FLIS-----KSNF----PP--PKL  226 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-----hccC----CC--ccc
Confidence            567889999998753    5888999999999999999999999754432211   0000     0000    00  000


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .........+.+++.+|++.+|.+|||+.+|+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112233457899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=288.02  Aligned_cols=242  Identities=24%  Similarity=0.397  Sum_probs=194.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|.. .+++.+|+|.+...  ....+++.+|+.++++++   |+|++++++++..+...++||||+
T Consensus         5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06917           5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA   84 (277)
T ss_pred             hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence            347899999999999997 57899999988643  334467888999999986   999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++...    .+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          85 EGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             CCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            999999998653    48999999999999999999999   9999999999999999999999999999987654332 


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......|+..|+|||.+.+  .++.++||||||+++|+|++|..||.........    .    .......     ..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~----~~~~~~~-----~~~~  223 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----M----LIPKSKP-----PRLE  223 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----h----ccccCCC-----CCCC
Confidence            2334568899999998864  3789999999999999999999999754322100    0    0000000     0111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .    ......+.+++.+|++.||++||++.++++
T Consensus       224 ~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 D----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             c----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0    013357889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-35  Score=281.45  Aligned_cols=245  Identities=24%  Similarity=0.290  Sum_probs=201.4

Q ss_pred             hhhcCccCceEEEEEEeCC-CCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||.|.-|+||++.+.+ +..+|+|++.+.    .....+...|-+||+.++||.++.|++.+..+...+++||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            3789999999999999964 689999999753    33445678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC------
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ------  391 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~------  391 (558)
                      |+|..+++++.. +.++...+.-++..|+-||+|||-   .|||.|||||+||||.++|.+-|+||.|+.....      
T Consensus       162 GdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  162 GDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             ccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence            999999887665 459999999999999999999999   9999999999999999999999999998754310      


Q ss_pred             ---------------------------CCC----------------------ceeecccCCCCcCChhhhcCC-CCCccc
Q 043292          392 ---------------------------DQS----------------------QVVTTMRGTPGYLAPEWLSSI-ITEKVD  421 (558)
Q Consensus       392 ---------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~-~~~k~D  421 (558)
                                                 ...                      .....++||-.|+|||++.|. .+.++|
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD  317 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD  317 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence                                       000                      012246789999999999985 889999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 043292          422 IYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP  501 (558)
Q Consensus       422 v~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  501 (558)
                      .|+|||++|||+.|..||.+.+..+...++                +.+.+. .+...+....+.+||...|..||.+|.
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----------------v~~~l~-Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNI----------------VGQPLK-FPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCchhhHHHH----------------hcCCCc-CCCCCcchhHHHHHHHHHhccChhhhh
Confidence            999999999999999999988876532222                111111 111224456889999999999999999


Q ss_pred             C----HHHHHH
Q 043292          502 S----MSMVVR  508 (558)
Q Consensus       502 s----~~~vl~  508 (558)
                      -    +.||.+
T Consensus       381 g~~rGA~eIK~  391 (459)
T KOG0610|consen  381 GSKRGAAEIKR  391 (459)
T ss_pred             ccccchHHhhc
Confidence            8    777765

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.4e-35  Score=284.26  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=194.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  316 (558)
                      +.+.||+|++|.||+++.. +++.+|+|.+...   ....+.+..|+.++++++|+|++++++.+.. +...+++|||++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (257)
T cd08223           4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE   83 (257)
T ss_pred             EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence            4578999999999999874 5788999998643   2234568899999999999999999988764 345789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++..... ..+++.++..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        84 ~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  158 (257)
T cd08223          84 GGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M  158 (257)
T ss_pred             CCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence            9999999976432 348999999999999999999999   8999999999999999999999999999986643322 2


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....+++.|+|||++.+ .++.++||||||++++||++|+.||.......       .... ...+....         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~~-~~~~~~~~---------  221 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------LVYR-IIEGKLPP---------  221 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH-HHhcCCCC---------
Confidence            334568899999999875 58899999999999999999999987443211       1111 11111100         


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ........+.+++.+|++.+|++|||+.++++.
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             111234578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-35  Score=286.28  Aligned_cols=241  Identities=28%  Similarity=0.439  Sum_probs=194.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||+|... ++..|++|.+....      ...+.+..|+.+++.++|+||+++++++..+...++++||+
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            467999999999999985 78999999886322      23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.+..   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        85 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          85 PGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            9999999997543   38899999999999999999999   899999999999999999999999999988654332  


Q ss_pred             eeecccCCCCcCChhhhcC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......++..|+|||.+.. . ++.++|+||||+++++|++|+.||.......   ....    .........       
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~----~~~~~~~~~-------  222 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFK----IGRSKELPP-------  222 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHH----HHhcccCCC-------
Confidence            2334568899999998864 3 7899999999999999999999997543211   1111    000001100       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ........+.+++.+|++.+|.+||++.++++
T Consensus       223 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               01112346788999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.5e-35  Score=292.85  Aligned_cols=261  Identities=26%  Similarity=0.354  Sum_probs=196.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+|... +++.|++|.++....      ....+..|+.++.+++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence            3467999999999999974 689999999874322      234577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      + +++|.+++....  ..+++..+..++.||++||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          84 M-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             c-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            9 999999997644  249999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh-----cccchhh
Q 043292          395 QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE-----EDKLSDL  467 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  467 (558)
                       ......++..|+|||.+.+  .++.++||||||++++||++|..+|......+..............     .......
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence             1233456788999998853  4789999999999999999998877654432211111110000000     0000000


Q ss_pred             ccccC-CC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          468 VDKHS-ND---MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       468 ~d~~~-~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..... ..   ..........+.+++.+|++.+|++|||+.+|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000 00   00001224578899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=288.10  Aligned_cols=244  Identities=27%  Similarity=0.433  Sum_probs=198.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|++|.||++... ++..+++|++.......+.+.+|++++..++|+|++++++.+......++|+||+++++|.
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT  103 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence            468999999999999985 6889999999755445667899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus       104 ~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  177 (286)
T cd06614         104 DIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV  177 (286)
T ss_pred             HHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence            9998754  249999999999999999999999   9999999999999999999999999999875543221 123345


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ++..|+|||.+.+ .++.++||||||+++|+|++|+.||....+...   ...+    . ..        ..........
T Consensus       178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~----~-~~--------~~~~~~~~~~  241 (286)
T cd06614         178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLI----T-TK--------GIPPLKNPEK  241 (286)
T ss_pred             CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----H-hc--------CCCCCcchhh
Confidence            7889999998875 589999999999999999999999975433221   0100    0 00        0001111111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+.+++.+|++.+|.+|||+.+|++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            3357889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-34  Score=283.09  Aligned_cols=244  Identities=23%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||+++. .+++.|++|.+...   ....+++.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus         4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08218           4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG   83 (256)
T ss_pred             EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence            347899999999999987 46889999998632   23345789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++..+.+++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        84 ~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~  158 (256)
T cd08218          84 GDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LA  158 (256)
T ss_pred             CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hh
Confidence            999999875432 237899999999999999999999   8999999999999999999999999999986543221 12


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ ..+.++||||||+++++|++|+.||......+       ...... .+...          .
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~~-~~~~~----------~  220 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVLKII-RGSYP----------P  220 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-------HHHHHh-cCCCC----------C
Confidence            23457889999999865 58899999999999999999999986433221       111111 11110          0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+|++.+|.+||++.+|++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11123457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.5e-34  Score=284.14  Aligned_cols=242  Identities=27%  Similarity=0.427  Sum_probs=185.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc------cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  313 (558)
                      .+.||+|+||.||++.. .++..|++|.+....      .....+.+|+.++++++|+||+++++++.+.  ...++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            47899999999999987 468899999886321      2234688899999999999999999988653  56689999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++....   .+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++......
T Consensus        87 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          87 YMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            999999999997543   38899999999999999999998   899999999999999999999999999998653211


Q ss_pred             C--ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 S--QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~--~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .  .......++..|+|||.+.+ .++.++||||||+++|||++|+.||........      .. .......     ..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~-~~~~~~~-----~~  228 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IF-KIATQPT-----NP  228 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HH-HHhcCCC-----CC
Confidence            1  11223457889999999875 489999999999999999999999974432110      00 0000000     00


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           .........+..++ .|+..+|++||++++|++
T Consensus       229 -----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 -----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                 01111223444455 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-34  Score=283.95  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=193.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-----------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-----------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  310 (558)
                      .+.||.|+||.||+|.. .+++.+|+|.++...           ...+.+..|+.++..++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            36899999999999987 468899999875211           012457889999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+++++|.+++.+..   .+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        86 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          86 FLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999997653   48999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCc-eeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          391 QDQSQ-VVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       391 ~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                      ..... ......++..|+|||.+..   .++.++||||||++++|+++|..||......+.   +..    ... .....
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~~-~~~~~  231 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFK----LGN-KRSAP  231 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHH----hhc-cccCC
Confidence            32211 1234568899999998764   278999999999999999999999964332110   110    000 00000


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+...     ........+.+++..|++.+|.+|||+.+|++.
T Consensus       232 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            01100     111234578889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-34  Score=286.36  Aligned_cols=250  Identities=29%  Similarity=0.472  Sum_probs=192.9

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cce
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNL  309 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  309 (558)
                      .+.||+|+||.||+|.+.    +++.||||++...   ....+++.+|+.++++++||||+++++++....      ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            468999999999999863    3688999998743   233457889999999999999999999886532      236


Q ss_pred             EEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          310 LVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      +++||+++|+|.+++....   ....+++....+++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccccc
Confidence            8899999999998875321   22348899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +........ ......++..|++||.+.+ .++.++||||||+++|||++ |+.||......+    +....   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~----~~~~~---~~~~~  233 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYL---IKGNR  233 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH----HHHHH---HcCCc
Confidence            866432211 1123345678999998864 58899999999999999999 888886443211    11111   10000


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .           .........+.+++.+|++.+|++|||+.++++.|+++
T Consensus       234 ~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 L-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0           00112335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-34  Score=287.72  Aligned_cols=241  Identities=23%  Similarity=0.387  Sum_probs=194.2

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            6899999999999987 468899999886433 23456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++...    .+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++........ ......
T Consensus       105 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  176 (285)
T cd06648         105 DIVTHT----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV  176 (285)
T ss_pred             HHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence            998762    38999999999999999999999   9999999999999999999999999998876543322 123356


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      |+..|+|||.+.+ .++.++||||||++++||++|+.||....+..    ...   . ......     ....   ....
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~----~~~---~-~~~~~~-----~~~~---~~~~  240 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ----AMK---R-IRDNLP-----PKLK---NLHK  240 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH----HHH---H-HHhcCC-----CCCc---cccc
Confidence            8899999999875 58999999999999999999999986543221    111   1 111100     0000   1111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+.+++.+|++.+|++|||+.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            3357899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-34  Score=284.08  Aligned_cols=245  Identities=29%  Similarity=0.462  Sum_probs=195.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... +++.|++|.++....   ..+.+..|+.+++.++|+||+++++++...+..++|+||++++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG   84 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence            478999999999999874 689999999875433   4567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee-
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-  397 (558)
                      +|.+++....   .+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++........... 
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          85 TLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             cHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            9999987543   37899999999999999999999   9999999999999999999999999999987654332211 


Q ss_pred             --ecccCCCCcCChhhhcC-C---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          398 --TTMRGTPGYLAPEWLSS-I---ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       398 --~~~~gt~~y~aPE~~~~-~---~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                        ....++..|+|||++.+ .   .+.++||||||++++|+++|+.||........   ...   .. ..+..     ..
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~---~~-~~~~~-----~~  226 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMF---HV-GAGHK-----PP  226 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHH---HH-hcCCC-----CC
Confidence              13567889999999864 3   78899999999999999999999975432110   000   00 00000     00


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .   +........+.+++.+|++.+|.+|||+.+++.
T Consensus       227 ~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 I---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0   111112346778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-34  Score=290.71  Aligned_cols=240  Identities=26%  Similarity=0.375  Sum_probs=191.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ..++||+|+||.||+|+.. +++.||+|.+....    ...+++.+|+.++..++||||+++++++.+++..++|+||+.
T Consensus        19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   98 (307)
T cd06607          19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL   98 (307)
T ss_pred             hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence            4478999999999999884 68999999886322    223568899999999999999999999999999999999996


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                       |+|.+++.....  .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......    
T Consensus        99 -g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          99 -GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             -CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence             677777654332  48999999999999999999999   89999999999999999999999999998765322    


Q ss_pred             eecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 VTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ....++..|+|||.+.    +.++.++||||||+++|||++|+.||........   +..    .. ....        
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~----~~-~~~~--------  231 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH----IA-QNDS--------  231 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHH----Hh-cCCC--------
Confidence             2345788999999873    3588999999999999999999999865432211   000    00 0000        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .. .........+.+++.+||+.+|++||++.+|++.
T Consensus       232 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PT-LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC-CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 0111234578999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=289.62  Aligned_cols=260  Identities=26%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  316 (558)
                      .+.||.|+||.||+++.. +++.+|+|++...   ......+.+|+.++.+++|+|++++++++...  +..++|+||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            467999999999999885 5889999999754   23345688999999999999999999999888  78999999997


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      + +|.+++....  ..+++..++.++.||++||+|||+   .+++|+||+|+||++++++.+||+|||++..........
T Consensus        84 ~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          84 H-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             c-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            4 8988886543  248999999999999999999999   899999999999999999999999999998765543322


Q ss_pred             eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc--ccchhh-----
Q 043292          397 VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE--DKLSDL-----  467 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----  467 (558)
                      .....++..|+|||.+.+  .++.++||||||++++||++|+.||...........+..........  .....+     
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            334556888999998754  47899999999999999999999997655433211111110000000  000000     


Q ss_pred             ccccCCC-----CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSND-----MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......     ......+...+.+++..|++.+|.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000     0000012457899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=290.34  Aligned_cols=260  Identities=22%  Similarity=0.348  Sum_probs=191.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|++|.||+++.. +++.||+|.+....  .....+.+|+.++++++|+||+++++++.+++..++||||+. +
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-T   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-C
Confidence            3478999999999999985 68999999986432  223457789999999999999999999999999999999997 4


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.+...  .+++.....++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... ...
T Consensus        88 ~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (291)
T cd07844          88 DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYS  161 (291)
T ss_pred             CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccc
Confidence            99998875443  48999999999999999999999   8999999999999999999999999999875432211 112


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh------cc-
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL------VD-  469 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~d-  469 (558)
                      ...++..|+|||.+.+  .++.++||||+|+++|||++|+.||............................      .. 
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            2346789999998764  47899999999999999999999997554221111110000000000000000      00 


Q ss_pred             -------ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 -------KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 -------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                             ...............+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                   000000000011246788999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-34  Score=288.35  Aligned_cols=259  Identities=22%  Similarity=0.287  Sum_probs=194.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  315 (558)
                      +.+.||.|+||.||+|+.. +++.+++|.++...   .....+.+|+.++.+++||||+++++++...  ...++||||+
T Consensus         9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~   88 (293)
T cd07843           9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV   88 (293)
T ss_pred             hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence            3578999999999999985 58899999987432   2234577899999999999999999998877  7889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      + ++|.+++.....  .+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus        89 ~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  161 (293)
T cd07843          89 E-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-  161 (293)
T ss_pred             C-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence            7 599988875443  48999999999999999999999   8999999999999999999999999999987654321 


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhc-----
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEE-----  461 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~-----  461 (558)
                      ......++..|+|||.+.+  .++.++|+||||++++||++|..||...........+......       ....     
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            1233457889999998864  3689999999999999999999999765543322221111100       0000     


Q ss_pred             -ccchhhccccCCCCCCCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          462 -DKLSDLVDKHSNDMQSNGE-EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       462 -~~~~~~~d~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       ..........+.. ..... ....+.+++..|++.+|++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0000000000000 00001 2456789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=289.11  Aligned_cols=244  Identities=26%  Similarity=0.415  Sum_probs=195.7

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||++.. .++..|++|.+... ....+.+.+|+.+++.++|||++++++++..++..++|+||+++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (293)
T cd06647          23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS  102 (293)
T ss_pred             eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence            347899999999999986 46889999998643 3334678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.+.    .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........ ....
T Consensus       103 L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~  174 (293)
T cd06647         103 LTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (293)
T ss_pred             HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence            99998653    37899999999999999999999   9999999999999999999999999999876543322 2233


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..+++.|+|||.+.+ .++.++||||||+++|++++|+.||............       ...+         .......
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~---------~~~~~~~  238 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG---------TPELQNP  238 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCC---------CCCCCCc
Confidence            568889999998864 5899999999999999999999999754432210000       0000         0001111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ......+.+++..|++.+|++||++.+++.+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223468889999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-34  Score=284.11  Aligned_cols=242  Identities=26%  Similarity=0.409  Sum_probs=194.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||+|.. .++..+|+|.+...  ......+.+|+.++.+++|+||+++++++..+...++||||++++
T Consensus         8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06641           8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG   87 (277)
T ss_pred             hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence            456899999999999987 46889999987643  233457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++...    .+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        88 ~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~  159 (277)
T cd06641          88 SALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN  159 (277)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence            999998643    38999999999999999999999   9999999999999999999999999999876543221 123


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ .++.++||||||+++++|++|..||.......    ...   . .......          ..
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~---~-~~~~~~~----------~~  221 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLF---L-IPKNNPP----------TL  221 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHH---H-HhcCCCC----------CC
Confidence            3567889999998865 58899999999999999999999986433211    000   0 0000000          01


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+|++.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11233567889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-34  Score=284.12  Aligned_cols=249  Identities=28%  Similarity=0.425  Sum_probs=195.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  315 (558)
                      +.+.||.|+||.||++.. .+++.+|+|.+...   ....+.+..|+.++++++|+||+++++++..  +...+++|||+
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217           4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence            346799999999999987 46889999998643   2234568889999999999999999997754  44578999999


Q ss_pred             CCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccC--CCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          316 PNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDC--RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       316 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ++++|.+++... .....+++..++.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~  163 (265)
T cd08217          84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD  163 (265)
T ss_pred             cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence            999999999753 22345899999999999999999999211  289999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .. ......++..|+|||.+.+ .++.++||||||+++++|++|+.||.......    +.    .....+...      
T Consensus       164 ~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~----~~~~~~~~~------  228 (265)
T cd08217         164 SS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LA----SKIKEGKFR------  228 (265)
T ss_pred             cc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----HH----HHHhcCCCC------
Confidence            32 1234568999999999875 58899999999999999999999997654211    11    111111110      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          .........+.+++.+|++.+|++|||+.+|+++
T Consensus       229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                1111234578899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-34  Score=282.38  Aligned_cols=242  Identities=27%  Similarity=0.378  Sum_probs=188.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc------cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  313 (558)
                      .++||+|+||.||++.. .++..||+|.+....      ...+.+.+|+.++.+++|+||+++++++.+.  ...+++||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            47899999999999987 458999999875221      1234688899999999999999999988764  45679999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++....   .+++....+++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          87 HMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            999999999987543   37889999999999999999999   899999999999999999999999999998653221


Q ss_pred             C--ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 S--QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~--~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .  .......++..|+|||.+.+ .++.++||||||+++|||++|+.||.......      ... ......        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~--------  225 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIF-KIATQP--------  225 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHH-HHhcCC--------
Confidence            1  11223458889999998865 58999999999999999999999996432211      100 000000        


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .....+......+..++..|+. +|++||++++|++
T Consensus       226 --~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 --TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              0011122334567788888885 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-34  Score=283.02  Aligned_cols=240  Identities=25%  Similarity=0.370  Sum_probs=193.0

Q ss_pred             cCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||.|+||.||+++.. +++.+++|.+....    ...+.+..|+.+++.++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999985 58899999986432    3346789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.+..   .+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            99997643   38999999999999999999999   999999999999999999999999999998765432  12335


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||.+.+ .++.++|+||||+++|+|++|..||.......     ............          ....+.
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~----------~~~~~~  217 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNG----------KLEFPN  217 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHhccCC----------CCCCCc
Confidence            67889999999864 58999999999999999999999997654311     111111110000          001111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      .....+.+++..||+.+|.+||+     +.|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            12457899999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.9e-35  Score=292.16  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... .++.|++|.+....    .....+.+|+.++..++|+||+++++.+..++..++||||+++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG   85 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            478999999999999884 57899999886432    2335688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC----
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~----  393 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......    
T Consensus        86 ~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          86 GDCATLLKNIG---ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999997543   38999999999999999999999   899999999999999999999999999987421100    


Q ss_pred             ----------CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          394 ----------SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       394 ----------~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                                ........++..|+|||.+.+ .++.++|+||||+++|||++|..||.+....+       +...... +
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~~~~-~  231 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVIS-D  231 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh-c
Confidence                      001112457889999998864 58999999999999999999999997543221       1111110 0


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ..   ....     ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       232 ~~---~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 DI---EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cc---CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00   0000     001123467899999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=286.60  Aligned_cols=244  Identities=26%  Similarity=0.402  Sum_probs=205.9

Q ss_pred             HHhhhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          240 DNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +++.+.||+|.|..|-+++. -+|..||||++.+.+   .....+..|++.|+.++|||||+++.+.......|||.|.=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            34557899999999999987 589999999997543   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee-cCCCCeEEcccCCccccCCCCC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-DGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll-~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      .+|+|.+|+.++...  +++....+++.||..|+.|+|+   ..+|||||||+||.+ ..-|-+||.|||++..+...  
T Consensus       100 D~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             CCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            999999999887654  9999999999999999999999   999999999999865 56788999999999877553  


Q ss_pred             ceeecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      +..++.+|+..|-|||++.|.  -.+++|||||||+||.|++|+.||+..+..+...                .++|-..
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------------mImDCKY  236 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------------MIMDCKY  236 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------------hhhcccc
Confidence            346788999999999998763  4578999999999999999999998777655221                2222211


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         ..+.-...++.++|..||..||++|.|.++|+..
T Consensus       237 ---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 ---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               2233456688999999999999999999998853

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-34  Score=280.45  Aligned_cols=244  Identities=25%  Similarity=0.415  Sum_probs=194.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||++.. .+++.+|+|.+...   ......+..|++++++++|+|++++++.+..++..++||||+++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08220           4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG   83 (256)
T ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence            347899999999999987 46889999998643   23356789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCce
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ++|.+++..... ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++ .+||+|||++........  
T Consensus        84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (256)
T cd08220          84 GTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--  157 (256)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence            999999976432 248999999999999999999999   9999999999999998654 589999999986643321  


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....++..|+|||.+.+ ..+.++||||||+++++|++|+.||........       ..... ......+        
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~--------  221 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-------VLKIM-SGTFAPI--------  221 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-------HHHHH-hcCCCCC--------
Confidence            223567889999999875 488999999999999999999999975443221       11110 0111111        


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        .......+.+++.+|++.+|.+|||+.++++.
T Consensus       222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              11123468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=299.34  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=198.1

Q ss_pred             HhhhhcCccCceEEEEEEeCC-CCEEEEEEec-ccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLE-GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ++...||-|+||.||++...+ +-..|.|++. ......++|+-|+++|...+||+||++++.|...+..+++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            345679999999999998764 3445677776 34556678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      -.+.++-.-.  ..|+..++.-++.|++.||.|||+   .+|||||||+.|||++-+|.++|+|||++...... .....
T Consensus       115 AVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD  188 (1187)
T KOG0579|consen  115 AVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD  188 (1187)
T ss_pred             hHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence            9998876543  249999999999999999999999   99999999999999999999999999998643221 12245


Q ss_pred             cccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          399 TMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .+.||+.|||||++.      ..|+.++||||||++|.||..+.+|....++..       ...... ..        ..
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKia-KS--------eP  252 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIA-KS--------EP  252 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHh-hc--------CC
Confidence            688999999999874      258999999999999999999999987555433       111111 11        11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..+..+......+.+++..||..||..||++.++++.
T Consensus       253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1111222344578899999999999999999999863

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=290.01  Aligned_cols=245  Identities=27%  Similarity=0.362  Sum_probs=193.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.+|+|.+....    ...+.+..|++++..++|+||+++++.+..+...++||||+.+
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG   85 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence            467999999999999885 58999999986432    2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc--
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      ++|.+++..... ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........  
T Consensus        86 ~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          86 GELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             CCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            999999875432 348999999999999999999999   89999999999999999999999999998755322110  


Q ss_pred             --------------------------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043292          396 --------------------------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED  448 (558)
Q Consensus       396 --------------------------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~  448 (558)
                                                ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........ 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-  240 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-  240 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-
Confidence                                      0112467889999999875 589999999999999999999999975543221 


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC----HHHHHH
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS----MSMVVR  508 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~vl~  508 (558)
                        ...             +.+.... ..........+.+++.+|++.+|++|||    +.++++
T Consensus       241 --~~~-------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 --FSN-------------ILKKEVT-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             --HHH-------------HhcCCcc-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence              111             0111100 0111113467899999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.2e-34  Score=285.71  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||.|++|.||+|+.. ++..||+|.++..  ......+.+|+.++++++|+||+++++++.+.+..++||||+++ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   83 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D   83 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence            478999999999999984 6889999998743  22345678899999999999999999999999999999999974 8


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++........+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++........ ....
T Consensus        84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~  159 (284)
T cd07836          84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSN  159 (284)
T ss_pred             HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cccc
Confidence            88888765544458999999999999999999999   8999999999999999999999999999976543221 1233


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc------hhhcccc
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL------SDLVDKH  471 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~d~~  471 (558)
                      ..++..|+|||.+.+  .++.++||||||+++++|++|+.||......+....+....... .....      ..+....
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP-TESTWPGISQLPEYKPTF  238 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC-ChhhHHHHhcCchhcccc
Confidence            456889999998754  37889999999999999999999998665443222221111000 00000      0000000


Q ss_pred             CCCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....     ........+.+++.+|++.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000     00112346789999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-34  Score=281.29  Aligned_cols=246  Identities=24%  Similarity=0.426  Sum_probs=194.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|++|.||++.. .+++.+|+|.+....       ...+.+..|++++++++|+||+++++++.+++..++|+||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            36799999999999987 568999999986322       1245789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~  393 (558)
                      +++++|.+++.+..   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          85 MAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             cCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999997543   48899999999999999999999   8999999999999998776 59999999998765331


Q ss_pred             Cc---eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          394 SQ---VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       394 ~~---~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ..   ......++..|+|||.+.+ .++.++||||+|+++++|++|..||..........    .........       
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~-------  227 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA----LIFKIASAT-------  227 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH----HHHHHhccC-------
Confidence            11   1223467889999998865 58899999999999999999999996443322111    110100000       


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ............+.+++.+|++.+|.+|||+.++++
T Consensus       228 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 ---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               000112233457888999999999999999999884

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-34  Score=283.20  Aligned_cols=252  Identities=28%  Similarity=0.358  Sum_probs=194.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  317 (558)
                      .++||.|++|.||++.+. +++.+|+|.+....  ....++.+|++++++++|+||+++++++.+.  ...++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            468999999999999984 68899999887432  3456789999999999999999999988653  367899999999


Q ss_pred             CCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          318 GSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       318 gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ++|.+++.... ....++...+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......   
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---  159 (287)
T cd06621          86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---  159 (287)
T ss_pred             CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc---
Confidence            99999876422 23348899999999999999999999   999999999999999999999999999987653322   


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcc-hhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEE-EDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....++..|+|||.+.+ .++.++||||||+++|+|++|..||....... ...........    .....+.+. .  
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~--  232 (287)
T cd06621         160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE-P--  232 (287)
T ss_pred             cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC-C--
Confidence            123457889999998875 58999999999999999999999997553211 11111111110    011111110 0  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .........+.+++.+|++.+|.+|||+.+|++
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             001123457889999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.5e-34  Score=286.56  Aligned_cols=257  Identities=24%  Similarity=0.314  Sum_probs=190.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+|.. .+++.||+|++....  .....+.+|+.++..++|+||+++++++..+...++|+||+. ++
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~   88 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD   88 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence            46899999999999987 468899999986432  233467889999999999999999999999999999999995 67


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... ....
T Consensus        89 l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~  162 (291)
T cd07870          89 LAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSS  162 (291)
T ss_pred             HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCC
Confidence            7777654432  37888999999999999999999   8999999999999999999999999999975432211 1223


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh--hc----------ccch
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA--EE----------DKLS  465 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~----------~~~~  465 (558)
                      ..++..|+|||++.+  .++.++||||||++++||++|..||........  .+...+....  ..          ....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            456889999999864  478899999999999999999999975543211  1111100000  00          0000


Q ss_pred             hhccccCC----CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 DLVDKHSN----DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~~~d~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........    ...........+.+++.+|++.||.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000    00000012346788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-34  Score=282.96  Aligned_cols=248  Identities=28%  Similarity=0.433  Sum_probs=197.0

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|+||.||++... +++.+++|.+...  ....+++.+|++++++++||||+++++.+..+...++++||++++
T Consensus         5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605           5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence            4578999999999999885 6899999998754  334567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....  ..++...+..++.|++.||+|||+  ..+++|+||||+||++++++.++|+|||.+........   .
T Consensus        85 ~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~  157 (265)
T cd06605          85 SLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---K  157 (265)
T ss_pred             cHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---h
Confidence            9999997653  348899999999999999999997  36999999999999999999999999999876543221   1


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ .++.++||||||+++++|++|+.||........  ..........         ....... .
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~---------~~~~~~~-~  225 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQYIV---------NEPPPRL-P  225 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHHHh---------cCCCCCC-C
Confidence            2668889999999875 589999999999999999999999965432111  1111111111         1110000 0


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......+.+++..|+..||.+|||+.++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1113456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=268.44  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             ccCHHHHHHHHHHhhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccC-Ccceeeeeeeecc
Q 043292          229 RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAE  304 (558)
Q Consensus       229 ~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  304 (558)
                      ...+.||+..     ..||.|..|.|++.+. .+|..+|||.+...  .+..++.+..+.++.+-+ .|.||+.+|+|..
T Consensus        88 ~~dindl~~l-----~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   88 QADINDLENL-----GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             ccChHHhhhH-----HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            3455566544     5699999999999988 46899999999754  344567888888887765 8999999999999


Q ss_pred             CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      +...++-||.| ...++.+|++-..  ++++.-+-++...+.+||.||.+  +++|+|||+||+|||+|+.|++|++|||
T Consensus       163 n~dV~IcMelM-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence            99999999998 4456666654332  37788888999999999999998  5899999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ++-.+.+.  ...+...|.+.|||||.+.-    .|+.++||||||+.|+||.||+.||.+...+-   ..+..+.    
T Consensus       238 IsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---e~ltkvl----  308 (391)
T KOG0983|consen  238 ISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---EVLTKVL----  308 (391)
T ss_pred             ccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---HHHHHHH----
Confidence            99877543  34566779999999999862    48899999999999999999999998755432   2222111    


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                              +.....++....-...+.+++..||+.|+.+||.+.++++.
T Consensus       309 --------n~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  309 --------NEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --------hcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                    11111111111234578899999999999999999998863

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-34  Score=285.41  Aligned_cols=258  Identities=24%  Similarity=0.293  Sum_probs=191.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc--cchHHHHHHHHHHhccC-CcceeeeeeeeccC--CcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEK--SHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~  315 (558)
                      +.++||+|+||.||+++. .+++.||+|.++...  ........|+..+.++. |+|++++++++.++  +..++|+||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            346799999999999987 468899999987532  22334567888888885 99999999999887  7889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      + ++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++. +.+||+|||+++....... 
T Consensus        83 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          83 D-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             C-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            6 58888876543  248999999999999999999999   89999999999999999 9999999999986643322 


Q ss_pred             eeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhcccchh
Q 043292          396 VVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEEDKLSD  466 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  466 (558)
                       .....++..|+|||.+.  +.++.++||||||++++||++|..||...+..+....+....       ...........
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence             23345788999999764  347899999999999999999999997655433211111110       00000000000


Q ss_pred             hccccCCC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          467 LVDKHSND---MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       467 ~~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........   ..........+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000   0001123568999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=287.05  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=194.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||.|++|.||+|.. .++..||+|++....   ...+.+.+|+.+++.++|+|++++++++.++...+++|||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            46899999999999987 479999999986432   233568899999999999999999999999999999999994 6


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++..... ..+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        83 ~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~  157 (283)
T cd07835          83 DLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT  157 (283)
T ss_pred             CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence            89999876542 248999999999999999999999   8999999999999999999999999999976543221 122


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc-----ccchhhcccc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE-----DKLSDLVDKH  471 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~d~~  471 (558)
                      ...++..|+|||++.+  .++.++||||||+++|||++|+.||......................     ....+.....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            3356889999998754  47899999999999999999999997654322211111110000000     0000000000


Q ss_pred             CCCC-----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDM-----QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....     .........+.+++.+|++.+|++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000     000112246889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.1e-34  Score=286.81  Aligned_cols=245  Identities=26%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ..+.||+|+||.||+++. .++..+|+|.+....    .....+..|+.+++.++|+|++++++++.++...++||||+.
T Consensus        29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  108 (317)
T cd06635          29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL  108 (317)
T ss_pred             hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence            346799999999999987 468899999986432    223468889999999999999999999999999999999996


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                       |+|.+.+.....  .+++.++..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.....     
T Consensus       109 -g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         109 -GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             -CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence             578777764332  48999999999999999999999   9999999999999999999999999999875432     


Q ss_pred             eecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 VTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .....++..|+|||++.    +.++.++||||||++++||++|+.||........   +..+.    ... .        
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----~~~-~--------  241 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA----QNE-S--------  241 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHH----hcc-C--------
Confidence            22346788999999863    3589999999999999999999999865432111   11110    000 0        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .. .........+.+++.+|++.+|.+||++.+|++.+-...
T Consensus       242 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 PT-LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CC-CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            00 011123346889999999999999999999998664443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-34  Score=285.90  Aligned_cols=258  Identities=22%  Similarity=0.353  Sum_probs=192.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||.|+||.||+++.. +++.||||.+....   .....+.+|++++++++||||+++++++.++...++||||+. +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~   83 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q   83 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence            467999999999999874 68999999886432   223568899999999999999999999999999999999995 6


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++..... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        84 ~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (284)
T cd07860          84 DLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT  158 (284)
T ss_pred             CHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence            89888865432 348999999999999999999999   8999999999999999999999999999876543221 122


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh------------cccc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE------------EDKL  464 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~  464 (558)
                      ...++..|+|||.+.+  .++.++||||||++++||++|+.||......+..............            ...+
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            3456889999998764  3688999999999999999999999754432211111110000000            0000


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...........  .......+.+++.+|++.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         239 PKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             ccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000000  0011245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.5e-34  Score=286.39  Aligned_cols=237  Identities=30%  Similarity=0.435  Sum_probs=192.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||++... +++.+|+|.+....    ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus         5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (290)
T cd05580           5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP   84 (290)
T ss_pred             EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence            3578999999999999884 68999999986432    234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......    
T Consensus        85 ~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          85 GGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999997653   38999999999999999999999   99999999999999999999999999999876443    


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....+++.|+|||.+.+ ..+.++||||||+++++|++|+.||.......    .   ..... .+..           
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~~~~-~~~~-----------  215 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----I---YEKIL-EGKV-----------  215 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHh-cCCc-----------
Confidence            234568899999998864 58899999999999999999999997544211    0   00000 1110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVV  507 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl  507 (558)
                      ..+......+.+++.+||+.||.+||     ++++++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            00111235788999999999999999     556655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.6e-34  Score=276.87  Aligned_cols=243  Identities=28%  Similarity=0.473  Sum_probs=198.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|++|.||++... ++..+++|++..... ....+.+|++.+++++|+|++++++++..+...++++||+++++|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            467999999999999985 688999999975543 557799999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.+........  ....
T Consensus        85 ~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~  157 (253)
T cd05122          85 KDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM  157 (253)
T ss_pred             HHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence            99987653  248999999999999999999999   9999999999999999999999999999987654332  3345


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||.+.+ ..+.++||||||+++++|++|+.||.........   ... .    .......        ....
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~-~----~~~~~~~--------~~~~  221 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FKI-A----TNGPPGL--------RNPE  221 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHH-H----hcCCCCc--------Cccc
Confidence            68899999999875 5889999999999999999999999754322211   000 0    0001111        1111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+++..|++.||++|||+.++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11357889999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-34  Score=284.95  Aligned_cols=241  Identities=23%  Similarity=0.381  Sum_probs=193.4

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+||+|+||.||++.. .++..||+|.+.... .....+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            6799999999999988 478999999886432 34456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++...    .+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........ ......
T Consensus       106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            987543    38899999999999999999999   8999999999999999999999999999876543221 123456


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ++..|+|||.+.+ .++.++|+||||++++||++|..||......+    ........         ......   ....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~----~~~~~~~~---------~~~~~~---~~~~  241 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDN---------LPPKLK---NLHK  241 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhh---------CCcccC---Cccc
Confidence            8899999998864 58999999999999999999999997543321    11111110         000110   0111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2346788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-34  Score=282.98  Aligned_cols=243  Identities=29%  Similarity=0.423  Sum_probs=194.1

Q ss_pred             cCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||.|+||.||++... +++.+++|.+....    ...+.+.+|++++.+++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985 58999999986432    2446788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC------
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS------  394 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~------  394 (558)
                      .+++.+..   .+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997644   48999999999999999999999   9999999999999999999999999999876533211      


Q ss_pred             -ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 -QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 -~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       .......++..|+|||.+.+ ..+.++||||||++++||++|..||......+.       ..... .+...      .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~-~~~~~------~  220 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-------FQNIL-NGKIE------W  220 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHh-cCCcC------C
Confidence             12234567889999998864 488999999999999999999999975443221       11110 00000      0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                         .........+.+++..|++.+|.+|||+..+.+.|+
T Consensus       221 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 ---PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence               000012457889999999999999999976666664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.4e-34  Score=284.25  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||.||++... +++.+|+|.+...  ......+..|+.++.++. |+||+++++++..+...+++|||+. +
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence            468999999999999874 6899999998643  233457889999999996 9999999999999889999999985 4


Q ss_pred             CHHHHHhc--CCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          319 SLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       319 sL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ++.++...  ......+++.....++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||++........  
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  163 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--  163 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--
Confidence            65554321  11123489999999999999999999972  5899999999999999999999999999976543221  


Q ss_pred             eecccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 VTTMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .....|+..|+|||.+.+    .++.++||||||+++|||++|+.||.....      ......+... +....     +
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~-----~  231 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVK-GDPPI-----L  231 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcC-CCCCc-----C
Confidence            233457889999999864    488999999999999999999999964331      1111111100 00000     0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .. .........+.+++.+|++.+|++|||+.+|++.
T Consensus       232 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 SN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 1111234578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.2e-34  Score=285.70  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=191.9

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC----------c
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS----------H  307 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------~  307 (558)
                      +.+.||.|+||.||+|+.. +++.||+|.++..   ......+.+|+.++++++||||+++++++.+..          .
T Consensus        11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   90 (302)
T cd07864          11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA   90 (302)
T ss_pred             eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence            3578999999999999985 5889999998643   223356788999999999999999999887654          7


Q ss_pred             ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          308 NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      .++|+||+++ ++...+....  ..+++..+..++.||+.||+|||+   .+|+|+||||+||++++++.+||+|||++.
T Consensus        91 ~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          91 FYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             EEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence            8899999976 7777776542  248999999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          388 LIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       388 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ..............++..|+|||.+.+  ..+.++||||||++++||++|+.||......+....+........ .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  243 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC-PAVWP  243 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhhcc
Confidence            765433222233446788999998754  478999999999999999999999975443221111111110000 00000


Q ss_pred             hhc--------cccCCCC----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 DLV--------DKHSNDM----QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~~~--------d~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+.        +......    .........+.+++..||+.+|.+|||+.+|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000        0000000    000012357899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.7e-34  Score=282.57  Aligned_cols=244  Identities=25%  Similarity=0.406  Sum_probs=188.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHH-HhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKT-IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... +++.||+|+++...  ....++..|+.+ ++.++|+||+++++++..++..+++|||++ +
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T   84 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence            467999999999999984 68999999987532  233456666665 566789999999999999999999999996 7


Q ss_pred             CHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          319 SLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       319 sL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|.+++... .....+++..++.++.||+.||.|||+   . +++|+||||+||+++.++.+||+|||++.......  .
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (283)
T cd06617          85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A  159 (283)
T ss_pred             cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence            888887652 223458999999999999999999998   5 89999999999999999999999999998654322  1


Q ss_pred             eecccCCCCcCChhhhcC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .....++..|+|||.+.+     .++.++|+||||++++||++|+.||.......  ..+..    ... +....     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~----~~~-~~~~~-----  227 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ----VVE-EPSPQ-----  227 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH----HHh-cCCCC-----
Confidence            233567889999998753     36889999999999999999999996432211  01111    000 00000     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..    .......+.+++..|++.+|.+||++.+|++
T Consensus       228 ~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 LP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00    0112346889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-34  Score=286.26  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=190.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccC-CcceeeeeeeeccCCc-----ceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSH-----NLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~  312 (558)
                      .+.||+|+||.||++... +++.||+|.++...   .....+.+|+.++..++ |+||+++++++.....     .++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            468999999999999984 68999999886432   22356888999999995 6999999999877665     79999


Q ss_pred             EeCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCcccc
Q 043292          313 EYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLI  389 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~  389 (558)
                      ||+++ +|.+++.....  ...+++..+..++.||+.||.|||+   .+++|+||+|+||+++. ++.+||+|||+++.+
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99985 78888765322  2458999999999999999999999   99999999999999998 889999999999865


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      ...... .....+++.|+|||++.+  .++.++||||||+++|||++|..||...........+...... .........
T Consensus       162 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (295)
T cd07837         162 SIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVWPGV  239 (295)
T ss_pred             CCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhCcch
Confidence            432211 122346788999998754  4789999999999999999999999765443322111111000 000000000


Q ss_pred             cccc----CCC-CC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKH----SND-MQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~----~~~-~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....    ... ..     ........+.+++..||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000    000 00     00112356889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-35  Score=310.83  Aligned_cols=265  Identities=19%  Similarity=0.280  Sum_probs=183.0

Q ss_pred             HhhhhcCccCceEEEEEEeCC--CCEEEE------------------EEecccccchHHHHHHHHHHhccCCcceeeeee
Q 043292          241 NFRKMLGKGGFGSVFEGTQTD--GTKVAV------------------KRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG  300 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~--~~~vav------------------K~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  300 (558)
                      .+.++||+|+||.||++....  +...++                  |.+.........+.+|+.++.+++|+||+++++
T Consensus       151 ~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  230 (501)
T PHA03210        151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEE  230 (501)
T ss_pred             EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence            345789999999999986532  222222                  222222233456889999999999999999999


Q ss_pred             eeccCCcceEEEEeCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      ++...+..++|+|++. ++|.+++.....  ...........++.||+.||.|||+   .+|+||||||+|||++.++.+
T Consensus       231 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~v  306 (501)
T PHA03210        231 ILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKI  306 (501)
T ss_pred             EEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence            9999999999999984 577777654321  1123456677899999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH
Q 043292          379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      ||+|||+++.+............||..|+|||++.+ .++.++|||||||++|||++|..++...........+......
T Consensus       307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~  386 (501)
T PHA03210        307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS  386 (501)
T ss_pred             EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence            999999998775443333345679999999999875 5899999999999999999987643322221111112111111


Q ss_pred             hh-hcc-------cchhhccccC-CCCCCC-H------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          458 KA-EED-------KLSDLVDKHS-NDMQSN-G------EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       458 ~~-~~~-------~~~~~~d~~~-~~~~~~-~------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .. ...       .+.+.++... ...... .      .....+.+++.+||+.||.+|||+.|+++.
T Consensus       387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00 000       0011111000 000000 0      011346778899999999999999999864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.6e-34  Score=281.24  Aligned_cols=240  Identities=22%  Similarity=0.334  Sum_probs=185.5

Q ss_pred             hcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHH---hccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTI---GSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +||+|+||.||++.. .+++.+|+|.+....    .....+..|..++   ...+|+|++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999988 468899999886432    1123344454433   34479999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999999887543   38999999999999999999999   899999999999999999999999999987553322   


Q ss_pred             eecccCCCCcCChhhhc-C-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLS-S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....|+..|+|||.+. + .++.++||||||++++||++|..||......... .+.    .....      ...    
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~----~~~~~------~~~----  216 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID----RMTLT------VNV----  216 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH----HHhhc------CCc----
Confidence            22346899999999885 3 4889999999999999999999999754432211 010    00000      000    


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                       .........+.+++..|++.||++||     |++++++.
T Consensus       217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             01112335788999999999999999     59988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-34  Score=283.38  Aligned_cols=242  Identities=29%  Similarity=0.389  Sum_probs=195.8

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||.|+||.||++... +++.+|+|.+....    ...+.+.+|++++++++||||+++++.+..+...++|+||++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (258)
T cd05578           4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL   83 (258)
T ss_pred             EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence            3578999999999999985 68999999986432    345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++....   .+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        84 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  155 (258)
T cd05578          84 GGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L  155 (258)
T ss_pred             CCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence            999999997652   48999999999999999999999   899999999999999999999999999988654332  2


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....++..|+|||.+.+ ..+.++|+||||+++++|++|..||......... .+.    ..... .          ..
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~----~~~~~-~----------~~  219 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-QIR----AKQET-A----------DV  219 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-HHH----HHhcc-c----------cc
Confidence            234568889999999875 4799999999999999999999999865542111 111    10000 0          00


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCH--HHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSM--SMVV  507 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~vl  507 (558)
                      ..+......+.+++.+|++.||.+||++  ++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1111223678899999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.2e-34  Score=281.11  Aligned_cols=242  Identities=27%  Similarity=0.383  Sum_probs=190.4

Q ss_pred             cCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||+|+||+||++.. .+++.+|+|.+...    ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999987 46889999998642    22344578899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence            999976543 348999999999999999999999   899999999999999999999999999988654321  22345


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+.    ..    ....    .   .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~----~~~~----~---~~~~~  219 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK----RR----TLEM----A---VEYPD  219 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH----hc----cccc----c---ccCCc
Confidence            67889999999864 58899999999999999999999997554321111110    00    0000    0   00111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      .....+.+++..||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1244788999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6e-34  Score=278.13  Aligned_cols=243  Identities=25%  Similarity=0.412  Sum_probs=194.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... ++..+|+|.+...   ....+.+.+|+.+++.++|+||+++++.+..+...++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            468999999999999985 5889999998643   233456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC-eEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN-AKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~-~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++. +||+|||.+........ ..
T Consensus        85 ~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~  159 (257)
T cd08225          85 DLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LA  159 (257)
T ss_pred             cHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cc
Confidence            99999875433 247999999999999999999999   89999999999999998864 69999999987653322 22


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ .++.++||||||++++||++|..||.......       ...... ....    ...     
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~----~~~-----  222 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLKIC-QGYF----API-----  222 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHh-cccC----CCC-----
Confidence            33468889999998864 58999999999999999999999986443221       111111 1111    100     


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .......+.+++.+|++.+|++|||+.+|++
T Consensus       223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 -SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             1112346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=297.50  Aligned_cols=267  Identities=26%  Similarity=0.365  Sum_probs=202.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e  313 (558)
                      .+.||+|+||.||+|+. .+|+.||||..+..  ....+....|++++++++|+|||+++++-....      ...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            47899999999999996 57999999998753  334566889999999999999999998765544      4589999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCC--CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNF--NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~--~~ki~Dfgla~~~  389 (558)
                      ||.+|||...|.+..+...|++.+.+.++..+..||.|||+   .+|+||||||.||++-  ++|  ..||+|||.|+.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999988877889999999999999999999999   9999999999999983  333  4799999999987


Q ss_pred             CCCCCceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      .++.  .....+||..|++||...  +.++..+|.|||||++|+.+||..||............+.........+.....
T Consensus       175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            6544  578899999999999987  469999999999999999999999997655443111111111111111110000


Q ss_pred             cc---------ccC-CCCCCCHHHHHHHHHHHHHccCcCCCCCC--CHHHHHHHHhccc
Q 043292          468 VD---------KHS-NDMQSNGEEVVNMMKVAAWCLESDFAKRP--SMSMVVRVLEGVT  514 (558)
Q Consensus       468 ~d---------~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--s~~~vl~~L~~~~  514 (558)
                      ..         ..+ ...........++-+.+..+|..+|.+|-  ...+....+..|.
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            00         000 01112334556778888889999999998  5555444444443

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-33  Score=287.45  Aligned_cols=260  Identities=23%  Similarity=0.391  Sum_probs=193.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhcc-CCcceeeeeeeeccC--CcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK--SHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+|.+. +++.+|+|++...   ......+..|+.++.++ +|+||+++++++...  ...++||||
T Consensus        11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~   90 (337)
T cd07852          11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY   90 (337)
T ss_pred             HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence            4578999999999999985 6889999988532   22345677899999999 999999999988653  357999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++ ++|..++...    .+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.+||+|||++........
T Consensus        91 ~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          91 ME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             cc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            96 5998888654    48899999999999999999999   9999999999999999999999999999986643322


Q ss_pred             ----ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhc
Q 043292          395 ----QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEE  461 (558)
Q Consensus       395 ----~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~  461 (558)
                          .......|+..|+|||.+.+  .++.++||||||+++|||++|+.||......+....+.....       .....
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                12234568899999998753  488999999999999999999999976544332111111100       00000


Q ss_pred             ccchhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          462 DKLSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....+++.........     ......+.+++.+|++.+|++|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00011111100000000     0124578899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=285.16  Aligned_cols=263  Identities=24%  Similarity=0.379  Sum_probs=192.9

Q ss_pred             hhhhcCccCceEEEEEEeC---CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  312 (558)
                      +.++||+|+||.||+|...   +++.||+|.+....    ...+.+.+|+.++..++||||+++++++.+.  ...++||
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence            3467999999999999984   47899999987532    2345678899999999999999999999888  7789999


Q ss_pred             EeCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC----CCCeEEcccCCc
Q 043292          313 EYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG----NFNAKVADFGLS  386 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~----~~~~ki~Dfgla  386 (558)
                      ||+++ +|.+++.....  ...++...++.++.||+.||.|||+   .+++|+||||+||+++.    ++.+||+|||++
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99975 67766653221  2258899999999999999999999   99999999999999999    999999999999


Q ss_pred             cccCCCCCc--eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch------hhhHHHHHH
Q 043292          387 KLIDQDQSQ--VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE------DMYLLSIFK  456 (558)
Q Consensus       387 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~------~~~~~~~~~  456 (558)
                      .........  ......++..|+|||.+.+  .++.++||||||++++||++|+.||........      ...+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            876433221  1223457889999998764  478999999999999999999999976544320      001111110


Q ss_pred             Hhh-----------hcccchhhccccCC-CCC--CCH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          457 KKA-----------EEDKLSDLVDKHSN-DMQ--SNG-------EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       457 ~~~-----------~~~~~~~~~d~~~~-~~~--~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...           .........+.... ...  ...       .....+.+++.+||+.||++|||+.++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000           00000000000000 000  000       22346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=278.94  Aligned_cols=241  Identities=27%  Similarity=0.326  Sum_probs=186.6

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccccc----chHHHHHHHHH-HhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE----INKSFLAEVKT-IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.||.|+||.||+++. .+++.||+|.++....    ....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999988 4689999999864321    12234455444 4455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.....     .
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            99999997543   38899999999999999999999   8999999999999999999999999999875432     2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....++..|+|||.+.+ .++.++||||||++++||++|..||.......    .   ... .......      .. ..
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~---~~~-~~~~~~~------~~-~~  215 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----V---FDN-ILSRRIN------WP-EE  215 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----H---HHH-HHhcccC------CC-Cc
Confidence            23457889999999875 47999999999999999999999997544321    1   101 0011000      00 00


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      ........+.+++.+|++.+|++||++.++.+.|
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0112235788999999999999999887666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-33  Score=283.94  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=190.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+|+.. ++..+++|.+...    .....++.+|+++++.++|+|++++++++......++||||+. 
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence            467999999999999974 6788999988632    2223568889999999999999999999999999999999996 


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++.....  .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......     
T Consensus        99 ~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          99 GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence            688877754332  38999999999999999999999   89999999999999999999999999998765432     


Q ss_pred             ecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....++..|+|||.+.    +..+.++||||||++++||++|..||......+.   ...+     .......       
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~-----~~~~~~~-------  233 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI-----AQNESPA-------  233 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHH-----hhcCCCC-------
Confidence            2345788999999874    3588899999999999999999999865432211   1100     0000000       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                        .........+.+++.+||+.+|.+||++.++++.-
T Consensus       234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              01112335688999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1e-33  Score=284.50  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCc--------ceE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH--------NLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------~~l  310 (558)
                      .++||+|+||.||+++.. +++.||||.+....   .....+.+|+.++++++||||+++++++.....        .++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            478999999999999884 68999999886322   223456789999999999999999998876543        489


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+. ++|.+++.....  .+++.++..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++..+.
T Consensus        97 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          97 VFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             EEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            999996 588888765432  48999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCc---eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          391 QDQSQ---VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       391 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      .....   ......++..|+|||.+.+  .++.++||||||++++||++|+.||...........+.... .........
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  249 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSITPEVWP  249 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhhcc
Confidence            32221   1223457889999998864  37889999999999999999999997654332111111110 000000000


Q ss_pred             -----hhcccc-CCCCC--------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 -----DLVDKH-SNDMQ--------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 -----~~~d~~-~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           +..+.. .....        ........+.+++.+||+.||.+|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 000000 00000        00011245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-33  Score=273.57  Aligned_cols=244  Identities=29%  Similarity=0.434  Sum_probs=198.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  316 (558)
                      .+.||+|++|.||+|... ++..|++|++....   ...+.+.+|+.++++++|+||+++++.+...  ...++++||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            367999999999999985 68999999987543   3456789999999999999999999999888  78899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-  395 (558)
                      +++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        85 ~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          85 GGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999997654   48999999999999999999999   99999999999999999999999999999876544321 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......++..|+|||.+.+ ..+.++||||||+++++|++|..||.......      ..............        
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~--------  224 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKIGSSGEPPE--------  224 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhccccCCCcC--------
Confidence            1234568889999999875 48999999999999999999999997655111      11111110001100        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ........+.+++.+|++.+|.+||++.++++
T Consensus       225 --~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 --IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              11122457899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-33  Score=286.09  Aligned_cols=257  Identities=22%  Similarity=0.268  Sum_probs=190.8

Q ss_pred             hhcCcc--CceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKG--GFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ..||+|  +||+||++.. .+++.||+|.+....   ...+.+.+|+.++..++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  8999999987 479999999986432   2345688899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      ++|.+++.+... ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999876433 238899999999999999999998   899999999999999999999999998654332211100 


Q ss_pred             -----eecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh---------
Q 043292          397 -----VTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA---------  459 (558)
Q Consensus       397 -----~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  459 (558)
                           .....++..|+|||++.+   .++.++||||||++++||++|+.||.........   ........         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML---LQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH---HHHhcCCCCCCcccccc
Confidence                 011234567999999864   3789999999999999999999999765432211   00000000         


Q ss_pred             --------------hcccch---------hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          460 --------------EEDKLS---------DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       460 --------------~~~~~~---------~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                                    ..+...         ...+... ...........+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                          000000         0000000 01112334567899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-33  Score=281.48  Aligned_cols=260  Identities=24%  Similarity=0.372  Sum_probs=191.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|++|.||+|+.. +++.||+|.+....   ...+.+.+|++++++++|+||+++++++..+...++||||++ +
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   85 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L   85 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence            468999999999999984 68899999886432   233568899999999999999999999999999999999995 5


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++..... ..+++.....++.||+.||+|||+   .+++|+||+|+||+++. ++.+||+|||++........ ..
T Consensus        86 ~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~  160 (294)
T PLN00009         86 DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TF  160 (294)
T ss_pred             cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-cc
Confidence            78887764432 236788889999999999999999   89999999999999985 55799999999976543211 12


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc-----cchhhccc
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-----KLSDLVDK  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~  470 (558)
                      ....++..|+|||++.+  .++.++||||||+++|+|++|..||......+................     .+.+....
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            33456889999998864  478999999999999999999999976543322211111110000000     00000000


Q ss_pred             cC--CCC---CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HS--NDM---QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~--~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..  ...   .........+.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  000   000112346789999999999999999999986

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-34  Score=281.59  Aligned_cols=260  Identities=28%  Similarity=0.397  Sum_probs=195.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc--chHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE--INKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||.|+||.||+|+.. +++.|++|++.....  ......+|+..+.+++ |+|++++++++..++..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            3578999999999999985 578899999875332  2234567999999999 999999999999999999999999 8


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++..... ..+++..+..++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        82 ~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~  155 (283)
T cd07830          82 GNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY  155 (283)
T ss_pred             CCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence            899988876542 348999999999999999999999   899999999999999999999999999998654322  12


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh----c-ccchhhccc
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE----E-DKLSDLVDK  470 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~d~  470 (558)
                      ....++..|+|||.+.+  .++.++|+||||++++||++|+.||......+..............    + ......++.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            34567889999998753  4799999999999999999999999766543322211111000000    0 000000000


Q ss_pred             cCCCCC-C-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQ-S-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~-~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...... .     .......+.+++.+|++.+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000 0     0011357889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-33  Score=283.81  Aligned_cols=259  Identities=25%  Similarity=0.320  Sum_probs=190.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||++... +++.||+|.++...   .....+.+|+.++.+++|+||+++++++...  +..++||||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            478999999999999984 68999999986332   1233567899999999999999999998755  45799999996


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                       ++|.+++....  ..+++.++..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++........ .
T Consensus        92 -~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~  164 (309)
T cd07845          92 -QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-P  164 (309)
T ss_pred             -CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-C
Confidence             58888887543  348999999999999999999999   8999999999999999999999999999987654321 1


Q ss_pred             eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh-------hhcccchhh
Q 043292          397 VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK-------AEEDKLSDL  467 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~  467 (558)
                      .....++..|+|||.+.+  .++.++||||||+++|||++|+.||......+....+.......       .........
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            223345788999998864  47899999999999999999999997654433211111110000       000000000


Q ss_pred             ccccCCCCCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQS----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +.........    .......+.+++.+|++.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000    0012356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-33  Score=283.34  Aligned_cols=258  Identities=22%  Similarity=0.240  Sum_probs=190.4

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.+|.|+++.||++.. +++.||||++...   ....+.+..|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            4455666666666654 6899999998643   33446789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-----
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-----  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-----  395 (558)
                      .+++..... ..+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||.+.........     
T Consensus        87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            999986432 238899999999999999999999   89999999999999999999999999998755322111     


Q ss_pred             -eeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh----hccc----
Q 043292          396 -VVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA----EEDK----  463 (558)
Q Consensus       396 -~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~----  463 (558)
                       ......++..|+|||++.+   .++.++||||||++++||++|+.||........   +........    ....    
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchhhh
Confidence             1123456778999999864   378999999999999999999999975432211   111000000    0000    


Q ss_pred             ---chh----hcccc---CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 ---LSD----LVDKH---SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ---~~~----~~d~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         ...    ..+..   .............+.+++.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               000    00000   00011122334578899999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=307.42  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             hhhhcCccCceEEEEEEeC----C----CCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQT----D----GTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+.||.|.||.|++|...    .    ...||||.++...  ...+.+..|+++++.+ +|+||+.++|.|..++..++
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~  379 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV  379 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence            4469999999999999753    1    3579999998543  3456799999999999 69999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCC-------C----C--CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRS-------D----E--FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      |+||++.|+|.++|..+.       .    .  ..|+....+.++.|||.|++||++   .++|||||.++|||++++..
T Consensus       380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCE
Confidence            999999999999998765       0    0  238899999999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCceeeccc--CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHH
Q 043292          378 AKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  453 (558)
                      +||+|||+|+............-.  -...|||||.+.. .++.|+|||||||+||||+| |..||.+....+.   +  
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~---l--  531 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE---L--  531 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH---H--
Confidence            999999999976554444333222  2457999999875 69999999999999999999 8889875332211   1  


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        .+....|..          ...+..+..++.++++.||+.+|++||++.++++.|+..
T Consensus       532 --~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  532 --LEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --HHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              112222221          112223456788999999999999999999999999884

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-34  Score=284.49  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=189.0

Q ss_pred             hhhhcCccCceEEEEEEeCC-CCEEEEEEecccc--cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIG--EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||++...+ ++.||||.++...  ....++..|+.++.+.. |+||+++++++..+...+++|||+. 
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   97 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-   97 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence            35789999999999999864 8999999987432  23455677887776675 9999999999999999999999985 


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++.....  .+++..+..++.|++.||.|||+  ..+++|+||+|+||++++++.+||+|||++..+.....  .
T Consensus        98 ~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~  171 (296)
T cd06618          98 TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--K  171 (296)
T ss_pred             cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--c
Confidence            577777655332  58999999999999999999996  15899999999999999999999999999986543222  2


Q ss_pred             ecccCCCCcCChhhhcCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          398 TTMRGTPGYLAPEWLSSI-----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~-----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ....++..|+|||.+.+.     ++.++||||||+++|||++|+.||.......      .........         ..
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~---------~~  236 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQE---------EP  236 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcC---------CC
Confidence            234578899999988632     7889999999999999999999996432211      011111111         00


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ............+.+++.+|++.||.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000111223468899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-33  Score=288.88  Aligned_cols=256  Identities=24%  Similarity=0.321  Sum_probs=190.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC------CcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  312 (558)
                      .+.||+|+||.||+++. .+++.||+|.+...   ......+.+|+.++.+++|+||+++++++...      ...++||
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            47899999999999987 47899999998642   22345677899999999999999999987643      3468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+. ++|.+.+...     ++...+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus       101 e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850         101 ELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             eccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            9995 5888877532     7889999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH---------------H
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF---------------K  456 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~---------------~  456 (558)
                      .  ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...+.......+....               .
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         172 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             C--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            2  1234567889999999875 58999999999999999999999997554322111111000               0


Q ss_pred             Hhhhc------ccchhhccccCCCC---CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          457 KKAEE------DKLSDLVDKHSNDM---QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       457 ~~~~~------~~~~~~~d~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....      ..+.+++.......   .........+.+++.+||+.||++|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000      00001111100000   0011235568899999999999999999999954

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-33  Score=275.81  Aligned_cols=247  Identities=30%  Similarity=0.436  Sum_probs=199.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|++|.||+++.. +++.|++|++....  .....+..|+..+.+++|+|++++++++..+...++|+||++++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            3478999999999999985 58999999987543  34567999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++..++.++.|+++||.|||+.  .+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus        85 ~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~  158 (264)
T cd06623          85 SLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CN  158 (264)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-cc
Confidence            9999997653   489999999999999999999973  79999999999999999999999999999876543322 22


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...++..|+|||.+.+ ..+.++||||||+++|+|++|+.||....... ......   ... ....        ..  .
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~---~~~-~~~~--------~~--~  223 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQ---AIC-DGPP--------PS--L  223 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHH---HHh-cCCC--------CC--C
Confidence            4567889999998865 58899999999999999999999997654311 111111   111 1100        00  1


Q ss_pred             CHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGE-EVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ... ....+.+++..|++.+|++|||+.++++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111 34578999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-33  Score=282.45  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=177.8

Q ss_pred             hhhhcCccCceEEEEEEeCC----CCEEEEEEecccccc------------hHHHHHHHHHHhccCCcceeeeeeeeccC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIGEI------------NKSFLAEVKTIGSIHHQNLVRLIGFCAEK  305 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~  305 (558)
                      +.++||+|+||.||+|...+    +..+++|........            ......+...+..++|+|++++++.+...
T Consensus        16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   95 (294)
T PHA02882         16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK   95 (294)
T ss_pred             EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence            45789999999999998754    345666654321111            01123344556677899999999876554


Q ss_pred             C----cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc
Q 043292          306 S----HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA  381 (558)
Q Consensus       306 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~  381 (558)
                      .    ..++++|++. .++.+.+....   ..++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+
T Consensus        96 ~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         96 RCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             cCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEE
Confidence            3    2367777763 46666665432   25788899999999999999999   899999999999999999999999


Q ss_pred             ccCCccccCCCCC------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH--H
Q 043292          382 DFGLSKLIDQDQS------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL--L  452 (558)
Q Consensus       382 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~--~  452 (558)
                      |||+++.+.....      .......||+.|+|||.+.+ .++.++||||||++++||++|+.||............  .
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            9999987643221      11223569999999999875 5899999999999999999999999866432211111  1


Q ss_pred             HHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       453 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                      ... .....+..      ..      ......+.+++..|++.+|++||++.++++.|+
T Consensus       249 ~~~-~~~~~~~~------~~------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        249 DFI-KRLHEGKI------KI------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHH-HHhhhhhh------cc------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111 11111110      00      011356889999999999999999999999874

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=290.51  Aligned_cols=262  Identities=24%  Similarity=0.407  Sum_probs=191.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  314 (558)
                      .++||+|+||.||+|+. .+++.||+|.+...  ......+..|+.++.+++|+||+++++++....     ..++|+||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            47899999999999987 46899999998632  233456888999999999999999998865543     46899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +. ++|...+...    .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        90 ~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          90 ME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             cc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            96 5887777543    38999999999999999999999   9999999999999999999999999999986543221


Q ss_pred             c--eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          395 Q--VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       395 ~--~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      .  ......|+..|+|||.+.+  .++.++||||||+++++|++|+.||................... .......+.+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  240 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDLNCIISL  240 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHHHHhhch
Confidence            1  1223567899999998653  58999999999999999999999997543222111110000000 00000000000


Q ss_pred             --------cCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcc
Q 043292          471 --------HSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGV  513 (558)
Q Consensus       471 --------~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~  513 (558)
                              ........     ......+.+++.+||+.+|.+|||+.++++.  ++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                    00000000     1123568899999999999999999999976  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-33  Score=276.42  Aligned_cols=239  Identities=22%  Similarity=0.327  Sum_probs=185.6

Q ss_pred             hcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHH---HHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVK---TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +||+|+||.||++.. .+++.||+|.+....    .....+..|..   .+...+|+||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999987 458899999886432    11223444443   3444579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|..++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999999886543   49999999999999999999999   899999999999999999999999999987654322   


Q ss_pred             eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....|+..|+|||.+.+  .++.++||||+|++++||++|+.||.........    ... .....      .....  
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~-~~~~~------~~~~~--  218 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EID-RMTLT------MAVEL--  218 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHH-HHhhc------cCCCC--
Confidence            223468999999999863  4899999999999999999999999765332211    000 00000      00001  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                         .......+.+++.+|++.+|.+||     ++.++++
T Consensus       219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               111235788999999999999999     9999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-33  Score=286.86  Aligned_cols=260  Identities=21%  Similarity=0.391  Sum_probs=193.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeecc----CCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAE----KSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++.. ++..||+|++....   .....+..|+.++.+++|+||+++++++..    ....++|+||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            468999999999999874 68999999987432   234567889999999999999999988753    3467899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +. ++|.+++....   .+++..+..++.||+.||.|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        90 ~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          90 ME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             hh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            95 68988886543   38999999999999999999999   8999999999999999999999999999986543222


Q ss_pred             c---eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhcc
Q 043292          395 Q---VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEED  462 (558)
Q Consensus       395 ~---~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~  462 (558)
                      .   ......++..|+|||.+.+  .++.++||||||+++|||++|+.||...........+.....       ......
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1   1234568889999998754  488999999999999999999999976544321111111000       000001


Q ss_pred             cchhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          463 KLSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+....+.........     ......+.+++..|++.+|.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111111111000110     1224678999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.9e-33  Score=286.06  Aligned_cols=258  Identities=25%  Similarity=0.340  Sum_probs=192.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccc---------------hHHHHHHHHHHhccCCcceeeeeeeeccCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEI---------------NKSFLAEVKTIGSIHHQNLVRLIGFCAEKS  306 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  306 (558)
                      .+.||.|+||.||++.+. +++.||||.++.....               ...+.+|+.++..++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            367999999999999974 6899999988643211               124778999999999999999999999999


Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      ..++||||+. ++|.+++....   .+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999996 68999886533   38999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCC-------------CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH
Q 043292          387 KLIDQDQ-------------SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       387 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  451 (558)
                      .......             ........++..|+|||.+.+  .++.++||||||++++||++|..||......+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8654111             111123346788999999864  3789999999999999999999999765543211111


Q ss_pred             HHHHHHhhhcccchhhcc-----ccCCCCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          452 LSIFKKKAEEDKLSDLVD-----KHSNDMQS-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       452 ~~~~~~~~~~~~~~~~~d-----~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....... ....+....+     ........     .......+.+++..|++.+|++|||+.+++.
T Consensus       247 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        247 FELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1111000 0000000000     00000000     0112356889999999999999999999996

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-33  Score=280.66  Aligned_cols=250  Identities=25%  Similarity=0.314  Sum_probs=195.8

Q ss_pred             hhhhcCccCceEEEEEEe----CCCCEEEEEEecccc-----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      +.+.||+|++|.||+++.    .++..||||.++...     ...+.+..|+.++.++ +|+||+++++.+..+...++|
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            347899999999999875    357889999986432     2335688999999999 699999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||+++++|.+++....   .+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          84 LDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999987543   38899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCcCChhhhcCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSSI---ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ..........++..|+|||.+.+.   .+.++||||||++++||++|..||........   ...+.....         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~---------  225 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRIL---------  225 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHH---------
Confidence            433223345688999999998642   68899999999999999999999864322111   111111110         


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                      ....   .........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       226 ~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         226 KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ccCC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0000   0111123467889999999999999999999887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-33  Score=275.22  Aligned_cols=242  Identities=28%  Similarity=0.415  Sum_probs=196.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||.|+||.||+++. .+++.+++|.+...   .....++..|+.+++.++|+||+++++++..+...++|+||++++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG   84 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence            47899999999999976 46889999998743   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++.+.. ....+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......   ..
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~  158 (256)
T cd08530          85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MA  158 (256)
T ss_pred             CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC---Cc
Confidence            9999987632 12358999999999999999999999   99999999999999999999999999999876543   12


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....++..|+|||.+.+ .++.++|+||||++++||++|+.||......+    +..    .........          
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~----------  220 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRY----KVQRGKYPP----------  220 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHhcCCCCC----------
Confidence            23457889999999875 48889999999999999999999997554322    111    111111111          


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+|++.+|++|||+.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11234457899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=279.86  Aligned_cols=258  Identities=25%  Similarity=0.370  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||.|++|.||++... +++.+++|.+.....   ....+..|+.++++++|+||+++++++..+...++|+||+++ 
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-   82 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-   82 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence            467999999999999884 688999999874322   346788899999999999999999999999999999999975 


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+....... ....
T Consensus        83 ~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~  156 (283)
T cd05118          83 DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT  156 (283)
T ss_pred             CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence            8888886643  248999999999999999999999   999999999999999999999999999998765443 1223


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc-------
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD-------  469 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-------  469 (558)
                      ...++..|+|||.+.+  ..+.++||||||+++++|++|+.||...+..+............ .......+.+       
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP-DPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-chHhcccchhhhhhhhh
Confidence            3457889999998764  58899999999999999999999997655433211111100000 0000000000       


Q ss_pred             ----ccCCC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 ----KHSND-MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ----~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                          ..... ..........+.+++..|++.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                00000 0001123567899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-33  Score=285.06  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=195.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  313 (558)
                      .+.||+|+||.||+++. .++..||||.+...   ......+..|+.++..++|+||+++++++...     ...++|+|
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            36799999999999987 46899999998642   22345678899999999999999999987654     34799999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+. ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          90 LMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             CCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            995 78988886543   38999999999999999999999   899999999999999999999999999998664332


Q ss_pred             CceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEEDKL  464 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~  464 (558)
                       .......++..|+|||.+.  ..++.++||||||+++++|++|+.||...........+......       .......
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             2233456788999999875  35899999999999999999999999765432211111111000       0000000


Q ss_pred             hhhccccCCCCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccc
Q 043292          465 SDLVDKHSNDMQS-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTE  515 (558)
Q Consensus       465 ~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~  515 (558)
                      ...++........     .......+.+++.+||+.+|++|||+.++++.  ++.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            0011000000000     01224568899999999999999999999976  655433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.6e-33  Score=279.00  Aligned_cols=245  Identities=27%  Similarity=0.333  Sum_probs=191.6

Q ss_pred             hhhcCccCceEEEEEEe----CCCCEEEEEEecccc-----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+.||.|+||.||++..    .++..||+|++....     ...+.+..|+.++.++ +|+||+++++.+..+...++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            46899999999999986    368899999987422     2345678899999999 5999999999999988999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+|||+++++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          85 DYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            9999999999997643   38899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .........|+..|+|||.+.+   ..+.++||||||+++++|++|..||.........   ..+.........      
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~------  229 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP------  229 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH---HHHHHHhhccCC------
Confidence            3322334568899999998863   3688999999999999999999999643322111   111111110000      


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                            ..+......+.+++..|++.+|++||     ++.+++.
T Consensus       230 ------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  01111234678999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.2e-33  Score=280.66  Aligned_cols=238  Identities=27%  Similarity=0.397  Sum_probs=188.6

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||.||+|+. .++..|++|.+....    .....+..|+.+++.++|+|++++++++.++...++||||+. +
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            5699999999999987 468899999986322    223467889999999999999999999999999999999995 5


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.....  .+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.....     ..
T Consensus       106 ~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~  175 (313)
T cd06633         106 SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN  175 (313)
T ss_pred             CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence            78777764332  48999999999999999999999   8999999999999999999999999999864322     22


Q ss_pred             cccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          399 TMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ...|+..|+|||++.    +.++.++||||||++++||++|..||.........   .    .... ......       
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~----~~~~-~~~~~~-------  240 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y----HIAQ-NDSPTL-------  240 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H----HHHh-cCCCCC-------
Confidence            456888999999873    35888999999999999999999998654332211   0    0000 000000       


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        ........+.+++.+|++.+|.+||++.++++.
T Consensus       241 --~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 --QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011122457889999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=276.93  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=190.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhcc---CCcceeeeeeeeccCCc-----ceE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSI---HHQNLVRLIGFCAEKSH-----NLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~~l  310 (558)
                      .++||+|+||.||+++.. +++.+|+|+++....   ....+.+|+.++.++   +|+|++++++++.....     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            467999999999999985 589999999973221   234466777766555   69999999999988776     899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      +|||+. ++|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++....
T Consensus        84 ~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          84 VFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             Eehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            999996 589888875433 248999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc-----
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL-----  464 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  464 (558)
                      ....  .....++..|+|||.+.+ ..+.++||||||++++||++|..||......+..................     
T Consensus       159 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            3321  223457889999999875 58999999999999999999999987655433211111110000000000     


Q ss_pred             -hhhccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 -SDLVDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 -~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       ...+......  ..........+.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence             0000000000  0001122456789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-33  Score=281.05  Aligned_cols=244  Identities=24%  Similarity=0.391  Sum_probs=192.8

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecc---cccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+||.+.||++...+.+.+|+|++..   ..+....|..|+.+|.+|+ |.+|+++++|-..++..||||||= .-
T Consensus       366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~  444 (677)
T KOG0596|consen  366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DI  444 (677)
T ss_pred             HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cc
Confidence            478999999999999988888999988753   3344567999999999994 999999999999999999999985 67


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-e
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-V  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~  397 (558)
                      +|..+|.+.... ...| .+..+..|++.++.++|+   .||||.||||.|+|+-. |.+||+|||+|..+..+.... .
T Consensus       445 DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k  518 (677)
T KOG0596|consen  445 DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK  518 (677)
T ss_pred             cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence            999999876543 2334 788899999999999999   99999999999998864 589999999999887665543 3


Q ss_pred             ecccCCCCcCChhhhcC------------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          398 TTMRGTPGYLAPEWLSS------------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~------------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ...+||+.||+||.+..            .+++++||||+||+||+|+.|+.||.....        .+       .++.
T Consensus       519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~-------aKl~  583 (677)
T KOG0596|consen  519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QI-------AKLH  583 (677)
T ss_pred             ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HH-------HHHH
Confidence            46789999999997641            267899999999999999999999962211        11       1123


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+.|+...-.-........++++++.||+.||.+|||..++++
T Consensus       584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            3344322110011111223899999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=271.81  Aligned_cols=242  Identities=26%  Similarity=0.454  Sum_probs=196.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|++|.||+++.. +++.|++|.+....   .....+.+|++++.+++|+|++++++++.+++..++++||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (254)
T cd06627           4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN   83 (254)
T ss_pred             eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence            3478999999999999874 67899999997544   3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus        84 ~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~  156 (254)
T cd06627          84 GSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D  156 (254)
T ss_pred             CcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence            99999987653   48999999999999999999999   89999999999999999999999999999876543321 2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....++..|+|||...+ ..+.++||||+|+++++|++|..||........   ..    ... .....          .
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~----~~~-~~~~~----------~  218 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LF----RIV-QDDHP----------P  218 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HH----HHh-ccCCC----------C
Confidence            34567889999998864 478999999999999999999999874432110   00    000 00000          0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+|++.+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11112357889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-33  Score=281.54  Aligned_cols=262  Identities=24%  Similarity=0.393  Sum_probs=190.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||+|+. .+++.||+|++...   ......+.+|+.++..++|+||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            36899999999999987 46899999998642   223356889999999999999999999886543      358999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+. .+|..++.     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus       100 e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879         100 PYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             cccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            9996 47766552     138899999999999999999999   89999999999999999999999999998864322


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~  463 (558)
                          .....++..|+|||.+.+  .++.++||||||++++||++|+.||...........+....       ........
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence                223457889999998864  48899999999999999999999997654322111111100       00000000


Q ss_pred             chhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccccc
Q 043292          464 LSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTEFE  517 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~~~  517 (558)
                      ....+..........     ......+.+++.+||+.||.+||++.++++.  ++.....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            000000000000000     0123467899999999999999999999954  77665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=271.95  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=189.4

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc------ccchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  312 (558)
                      +.+.||+|+||.||++.. .++..||+|.+...      ......+.+|+.++++++|+||+++++++.+.  ...++++
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            357899999999999987 46899999987421      22335788999999999999999999998664  4578999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++....   .+++....+++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        86 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          86 EYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            9999999999987543   37899999999999999999999   89999999999999999999999999999865321


Q ss_pred             C--CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 Q--SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .  ........++..|+|||++.+ .++.++||||||++++||++|+.||.......   ...    +...... ..   
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~-~~---  228 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIF----KIATQPT-KP---  228 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHH----HHHcCCC-CC---
Confidence            1  111223568899999999875 48899999999999999999999997433211   011    1110000 00   


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                            ..+......+.+++..|++ +|..||+..+++.
T Consensus       229 ------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 ------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  1112233568899999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-32  Score=270.20  Aligned_cols=233  Identities=24%  Similarity=0.338  Sum_probs=181.0

Q ss_pred             cCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCHHHH
Q 043292          246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW  323 (558)
Q Consensus       246 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  323 (558)
                      ||+|+||.||++.. .++..+|+|.+.......    .|+.....+ +|+|++++++.+...+..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            59999999999987 468889999886432211    122222222 799999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCceeecccC
Q 043292          324 LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       324 l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      +....   .+++..+..++.|+++||.|||+   .+++|+||||+||+++.++ .++|+|||++......     ....+
T Consensus       100 l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~  168 (267)
T PHA03390        100 LKKEG---KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDG  168 (267)
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCC
Confidence            97653   49999999999999999999999   8999999999999999998 9999999998765432     23457


Q ss_pred             CCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHH
Q 043292          403 TPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE  481 (558)
Q Consensus       403 t~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  481 (558)
                      +..|+|||++.+ .++.++||||||++++||++|+.||......+  .....+....  .        ...   ......
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~--------~~~---~~~~~~  233 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--Q--------KKL---PFIKNV  233 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--c--------ccC---Cccccc
Confidence            899999999875 58999999999999999999999997443322  1111111111  0        000   011123


Q ss_pred             HHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 043292          482 VVNMMKVAAWCLESDFAKRPS-MSMVVR  508 (558)
Q Consensus       482 ~~~l~~l~~~cl~~~p~~RPs-~~~vl~  508 (558)
                      ...+.+++..||+.+|.+||+ ++++++
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            457889999999999999995 688874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.9e-34  Score=304.48  Aligned_cols=250  Identities=29%  Similarity=0.485  Sum_probs=184.7

Q ss_pred             HHHHHhh--hhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccC------
Q 043292          237 VMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------  305 (558)
Q Consensus       237 ~~t~~~~--~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  305 (558)
                      +...+|.  +.||+||||.|||++.+ ||+.+|||++.-.  ........+|+.++++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4555665  57999999999999984 8999999999744  44456788999999999999999986421100      


Q ss_pred             --------------------------------------------------------------------------------
Q 043292          306 --------------------------------------------------------------------------------  305 (558)
Q Consensus       306 --------------------------------------------------------------------------------  305 (558)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 043292          306 ---------------------------------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL  352 (558)
Q Consensus       306 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL  352 (558)
                                                       ...||=||||+...|.+++.++.-..  .....++++++|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01256688888877777776544210  3667899999999999999


Q ss_pred             cccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC-----------------CCCCceeecccCCCCcCChhhhcC-
Q 043292          353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID-----------------QDQSQVVTTMRGTPGYLAPEWLSS-  414 (558)
Q Consensus       353 H~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~-  414 (558)
                      |+   .+||||||||.||+|+++..+||+|||+|....                 .......+..+||.-|+|||++.+ 
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   999999999999999999999999999998721                 011113456789999999999863 


Q ss_pred             ---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHH
Q 043292          415 ---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW  491 (558)
Q Consensus       415 ---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  491 (558)
                         .++.|+|+||+||+++||+.   ||.+  .++....+..     ++.+.+..-       .....++...-.+++.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~-----LR~g~iP~~-------~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTN-----LRKGSIPEP-------ADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHh-----cccCCCCCC-------cccccccchHHHHHHHH
Confidence               59999999999999999984   4542  2222222211     112222111       01122334455689999


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 043292          492 CLESDFAKRPSMSMVVR  508 (558)
Q Consensus       492 cl~~~p~~RPs~~~vl~  508 (558)
                      +++.||.+|||+.|++.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999985

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7e-33  Score=270.28  Aligned_cols=244  Identities=29%  Similarity=0.446  Sum_probs=198.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... ++..+++|++....   .....+..|+++++.++|+|++++++.+..+...++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~   84 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG   84 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence            467999999999999984 68899999987432   34567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++.... ....+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||++....... ...
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~  160 (258)
T cd08215          85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLA  160 (258)
T ss_pred             cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-cee
Confidence            9999997642 12459999999999999999999999   899999999999999999999999999998765433 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....+++.|+|||...+ .++.++||||+|+++++|++|+.||.......       ...... ......+         
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~---------  223 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKIL-KGQYPPI---------  223 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHh-cCCCCCC---------
Confidence            34568889999998765 58899999999999999999999996544221       111111 1111110         


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .......+.+++.+|++.+|++|||+.++++
T Consensus       224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             1122357889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-33  Score=282.38  Aligned_cols=269  Identities=23%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             ccCHHHHHHHHHHh--hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeee
Q 043292          229 RFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       229 ~~~~~~l~~~t~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      .....++..++++|  .+.||+|+||.||++.. .+++.||+|++....   ...+.+.+|+.++.+++|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            33445555566665  36899999999999987 568899999987432   2245688899999999999999999987


Q ss_pred             ccC------CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC
Q 043292          303 AEK------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF  376 (558)
Q Consensus       303 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~  376 (558)
                      ...      ...+++++++ +++|.+++...    .+++..+..++.|++.||.|||+   .+++|+||||+||++++++
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence            543      2357788876 78998887643    38999999999999999999999   9999999999999999999


Q ss_pred             CeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHH
Q 043292          377 NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       377 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  454 (558)
                      .+||+|||++......    .....++..|+|||.+.+  .++.++||||||++++||++|+.||...........+...
T Consensus       158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999998864322    234567889999998765  4789999999999999999999999654432211111110


Q ss_pred             H-------HHhhhcccchhhc---cccCCCC--CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          455 F-------KKKAEEDKLSDLV---DKHSNDM--QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       455 ~-------~~~~~~~~~~~~~---d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .       ............+   .......  .........+.+++.+|++.||.+||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0       0000000000000   0000000  0000123467899999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=262.90  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             CHHHHHHHHHHhhhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCc
Q 043292          231 SFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSH  307 (558)
Q Consensus       231 ~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  307 (558)
                      .++++-+.|.   +.||+|+++.|--++. .++.++|||++.+. .....+..+|++++... .|+||++++.+|.++..
T Consensus        74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            4667666664   7899999999998865 78999999999754 44567889999999888 59999999999999999


Q ss_pred             ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccC
Q 043292          308 NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFG  384 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfg  384 (558)
                      .|||||-|.||+|..+++++..   +++.+..++.+.|+.||.|||.   ++|.||||||+|||..+...   +||+||.
T Consensus       151 FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999999999987653   9999999999999999999999   99999999999999976554   8999999


Q ss_pred             CccccCCCC------CceeecccCCCCcCChhhhc---C---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhh--
Q 043292          385 LSKLIDQDQ------SQVVTTMRGTPGYLAPEWLS---S---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY--  450 (558)
Q Consensus       385 la~~~~~~~------~~~~~~~~gt~~y~aPE~~~---~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~--  450 (558)
                      |..-.....      .....+.+|+..|||||+..   +   .|+.+.|.|||||+||-|++|..||.+.-..+-++.  
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            876442211      11234577899999999864   3   388899999999999999999999987665442211  


Q ss_pred             -----HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          451 -----LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       451 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           -....-.-.+++.+ ++-|+.+.      .-.....+++...+..++.+|-++.++++
T Consensus       305 e~Cr~CQ~~LFesIQEGkY-eFPdkdWa------hIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKY-EFPDKDWA------HISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCC-cCChhhhH------HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                 01111111112211 12222111      12234566777778899999999999886

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.8e-33  Score=276.95  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=194.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+++.. +++.|++|++...    ....+.+..|..++.+++ |+||+++++++..++..++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            467999999999999984 6899999998642    233466888999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC--
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--  394 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~--  394 (558)
                      +++|.+++.+..   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        86 ~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          86 NGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999997654   49999999999999999999999   8999999999999999999999999999986644321  


Q ss_pred             -----------------ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH
Q 043292          395 -----------------QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK  456 (558)
Q Consensus       395 -----------------~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  456 (558)
                                       .......++..|+|||.+.. ..+.++||||||++++++++|+.||.......   ....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~---  233 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQK---  233 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHH---
Confidence                             12233557889999998764 58899999999999999999999997554211   1111   


Q ss_pred             HhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCH----HHHHH
Q 043292          457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM----SMVVR  508 (558)
Q Consensus       457 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~~vl~  508 (558)
                       ..         +..   ..........+.+++.+||+.+|.+|||+    +++++
T Consensus       234 -~~---------~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 -IL---------KLE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HH---------hcC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             00         000   00111224578899999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=274.66  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=196.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|++|.||+|+.. +++.+++|.+...   ....+.+..|+.++++++|+|++++++++.+....++|+||++ +
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            467999999999999985 5899999998753   3334678899999999999999999999999999999999997 5


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....  ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ ...
T Consensus        83 ~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (282)
T cd07829          83 DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT  156 (282)
T ss_pred             CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence            8999997653  248999999999999999999999   8999999999999999999999999999986644322 223


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc--cchhh--ccccC
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDL--VDKHS  472 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~d~~~  472 (558)
                      ...++..|+|||.+.+  .++.++||||||++++||++|+.||......+....+...........  ....+  .+...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            3445778999998753  589999999999999999999999976543322211111110000000  00000  00000


Q ss_pred             CCCCC------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQS------NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....      .......+.+++..|++.+|.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000      0011457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.9e-33  Score=278.23  Aligned_cols=260  Identities=28%  Similarity=0.363  Sum_probs=188.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCC--------cceE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--------HNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~l  310 (558)
                      .++||.|+||.||+++.. +++.+|+|++....   .....+.+|++++.+++|+||+++++++....        ..++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            478999999999999974 68999999886322   22346788999999999999999999875443        3589


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      |+||+.+ +|...+....  ..+++..+..++.|+++||.|||+   .+++|+||||+||++++++.+||+|||+++...
T Consensus        93 v~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          93 VTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             EEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            9999964 6777665433  249999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCc----------eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh
Q 043292          391 QDQSQ----------VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK  458 (558)
Q Consensus       391 ~~~~~----------~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  458 (558)
                      .....          ..+...++..|+|||.+.+  .++.++||||||++++||++|+.||...........+.......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            32211          1123456788999998754  48899999999999999999999997655433221111110000


Q ss_pred             hh-----cccchhhcc-ccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          459 AE-----EDKLSDLVD-KHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       459 ~~-----~~~~~~~~d-~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..     ...+....+ ..........     .....+.+++.+|++.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00     000000000 0000000000     11246889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=268.18  Aligned_cols=260  Identities=24%  Similarity=0.364  Sum_probs=198.4

Q ss_pred             CccCHHHHHHHHHHhhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeec
Q 043292          228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCA  303 (558)
Q Consensus       228 ~~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  303 (558)
                      ..|+-++|+..     ..||.|+||+|+|-.. ..|+..|||+++..  ....++++.|.....+- +.||||+++|.+.
T Consensus        59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            35666666654     5699999999999877 57999999999743  34566788888876555 7999999999999


Q ss_pred             cCCcceEEEEeCCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc
Q 043292          304 EKSHNLLVYEYMPNGSLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA  381 (558)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~  381 (558)
                      ..+..|+-||.| ..||+.+-+.  ...+..+++.-+-.|......||.||.++  ..|||||+||+||||+..|.+||+
T Consensus       134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence            999999999999 5677766542  12223488888888999999999999984  899999999999999999999999


Q ss_pred             ccCCccccCCCCCceeecccCCCCcCChhhhcC--C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh
Q 043292          382 DFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK  458 (558)
Q Consensus       382 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  458 (558)
                      |||++-.+....  ..+.-.|...|||||.+..  . ++.+|||||||++|+|+.||+.|+...+.      +.....+.
T Consensus       211 DFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~V  282 (361)
T KOG1006|consen  211 DFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQV  282 (361)
T ss_pred             cccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHH
Confidence            999987664432  2445678899999999863  3 89999999999999999999999975432      11111111


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      . .+....+.. .    ....+....+..++-.|+..|..+||.+.++.++
T Consensus       283 v-~gdpp~l~~-~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  283 V-IGDPPILLF-D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             H-cCCCCeecC-c----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1 111111111 0    1112345678999999999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.7e-33  Score=279.70  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=192.1

Q ss_pred             HHHHh--hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceE
Q 043292          238 MTDNF--RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLL  310 (558)
Q Consensus       238 ~t~~~--~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  310 (558)
                      ++++|  .+.||.|+||.||++... +++.||+|++...   ....+.+..|+.++..++||||+++++++.. +...++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            34444  478999999999999874 7899999987532   2234668899999999999999999998865 557889


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      |+||+ +++|..++...    .+++.....++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++....
T Consensus        88 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          88 VTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             Eeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            99998 56898888643    37888899999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEE  461 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~  461 (558)
                      ..    .....++..|+|||.+.+  .++.++||||||++++||++|+.||...........+....       ......
T Consensus       160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            21    233457889999998754  58999999999999999999999997554322111111110       000000


Q ss_pred             ccchhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          462 DKLSDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      +...+++...........     .....+.+++.+|++.+|++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            001111111000001111     123578899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-33  Score=284.05  Aligned_cols=240  Identities=28%  Similarity=0.426  Sum_probs=200.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|.|++|.+++. .++.+||+|.+.+...   ....+.+|+.+|..++|||||+++.+.......++||||..+|
T Consensus        61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g  140 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG  140 (596)
T ss_pred             eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence            47899999999999988 5699999999975432   2244889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      .+.++|.++..   +.......++.|+..|++|+|+   ..|+|||||++||||+.++++||+|||++..+..  .....
T Consensus       141 e~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~lq  212 (596)
T KOG0586|consen  141 ELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLMLQ  212 (596)
T ss_pred             hhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--ccccc
Confidence            99999987664   6668888999999999999999   9999999999999999999999999999998763  33467


Q ss_pred             cccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      +..|++.|.|||++.+.  ..+++|+||+|++||-|+.|..||++..-.+..        .....+++           .
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------~rvl~gk~-----------r  273 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------PRVLRGKY-----------R  273 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------chheeeee-----------c
Confidence            78999999999999863  789999999999999999999999876543311        00001110           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+..-...+-++++.+|-.+|.+|++++++.+.
T Consensus       274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            011112356678999999999999999999865

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-33  Score=268.36  Aligned_cols=234  Identities=30%  Similarity=0.401  Sum_probs=190.0

Q ss_pred             cCccCceEEEEEEeC-CCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ||.|+||.||+++.. +++.+++|.+.....    ....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999885 589999999874322    345788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            99997654   38999999999999999999999   999999999999999999999999999998764432 123445


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .++..|+|||...+ ..+.++|+||||++++++++|..||.......    .   ...... ..        .   ..+.
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~---~~~~~~-~~--------~---~~~~  214 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----I---YEKILK-DP--------L---RFPE  214 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----H---HHHHhc-CC--------C---CCCC
Confidence            67889999999875 48889999999999999999999996543211    1   111110 00        0   0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSM  505 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~  505 (558)
                      .....+.+++.+|+..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            11357789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-33  Score=280.75  Aligned_cols=267  Identities=25%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~  312 (558)
                      +.+.||.|+||.||+++.. +++.+++|++...   ....+.+.+|+.+++.++|+||+++++++....     ..+++|
T Consensus         4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~   83 (330)
T cd07834           4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT   83 (330)
T ss_pred             eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence            4578999999999999985 5899999998753   233467899999999999999999999988775     779999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||++ ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+|||++.++.++|+|||++......
T Consensus        84 e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          84 ELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             cchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9997 58888886543   49999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CC--ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh-------hhc
Q 043292          393 QS--QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK-------AEE  461 (558)
Q Consensus       393 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~  461 (558)
                      ..  .......++..|+|||.+.+  .++.++||||||+++++|++|+.||......+....+.......       ...
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            21  12334567889999999864  58899999999999999999999997665433211111110000       000


Q ss_pred             ccchhhccccCCCCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccc
Q 043292          462 DKLSDLVDKHSNDMQS-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTE  515 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~  515 (558)
                      ......+.........     .......+.+++.+||+.+|.+|||+.++++.  ++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            0011111100000000     01124568899999999999999999999974  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=281.13  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=191.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCc------ceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH------NLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~  312 (558)
                      .+.||+|+||.||+|+.. +++.||+|++...   ......+.+|+.++++++|+|++++++++...+.      .++|+
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            468999999999999984 5889999988642   2233567789999999999999999998766554      78999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+ +++|.+++...    .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus       100 e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851         100 HLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             ecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence            998 67999988652    38999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~  463 (558)
                          .....++..|+|||.+.+  ..+.++||||||++++|+++|+.||......+....+....       ........
T Consensus       172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence                234467889999998864  47899999999999999999999997654432111111110       00000000


Q ss_pred             chhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          464 LSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...++..........     ......+.+++.+|++.+|++|||+.+|++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            011111100000000     012457889999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-32  Score=278.15  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=191.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++.. .++..||||++...   ......+.+|+.++.+++|+||+++++++..+.      ..++||
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            36799999999999987 47899999998642   223356889999999999999999999887654      348999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+ +++|.+++...    .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus       100 e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  171 (343)
T cd07880         100 PFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE  171 (343)
T ss_pred             ecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence            998 77998887642    38999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHH-------HHHhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI-------FKKKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~  463 (558)
                          .....++..|+|||.+.+  .++.++|+||||++++++++|+.||...........+...       +........
T Consensus       172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence                223457889999998864  4889999999999999999999999755432211111110       000000000


Q ss_pred             chhhccccCCCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcc
Q 043292          464 LSDLVDKHSNDMQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGV  513 (558)
Q Consensus       464 ~~~~~d~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~  513 (558)
                      .............     ........+.+++.+|++.||++|||+.++++  .++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000000000     00112335889999999999999999999993  34443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-32  Score=276.75  Aligned_cols=260  Identities=24%  Similarity=0.348  Sum_probs=187.4

Q ss_pred             hhhhcCccCceEEEEEEeC-C--CCEEEEEEeccc---ccchHHHHHHHHHHhcc-CCcceeeeeeeeccC----CcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-D--GTKVAVKRLEGI---GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK----SHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~l  310 (558)
                      +.+.||+|+||.||++... .  +..||+|++...   ....+.+.+|+.++.++ +|+||+++++.+...    ...++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~   83 (332)
T cd07857           4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL   83 (332)
T ss_pred             EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence            3478999999999999974 3  778999998642   22345688899999999 599999999875432    34678


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ++||+. ++|.+++....   .+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          84 YEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            888885 68998886433   48999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCc---eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHh
Q 043292          391 QDQSQ---VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKK  458 (558)
Q Consensus       391 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~  458 (558)
                      .....   ......|+..|+|||++.+  .++.++||||||+++++|++|..||................       ...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211   1233568999999998754  48899999999999999999999997654322111100000       000


Q ss_pred             hhcccchhhccccCCCCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          459 AEEDKLSDLVDKHSNDMQS-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...................     .......+.+++.+|++.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000000000     0011347889999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-32  Score=269.72  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=189.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc------ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.++||+|+||.||+++.. .+..+++|.++..      .....++..|+.++..++||||+++++++.+....++||||
T Consensus         4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (260)
T cd08222           4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY   83 (260)
T ss_pred             eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence            4578999999999999874 3455666665531      12234567889999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          315 MPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +++++|.+++... .....+++..++.++.|++.||.|||+   .+++|+||+|+||++++ +.+||+|||++.......
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            9999999988642 223459999999999999999999999   99999999999999986 569999999998664332


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . ......++..|+|||.+.+ .++.++|+||||+++++|++|..||.......       ..... ..+.        .
T Consensus       160 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-------~~~~~-~~~~--------~  222 (260)
T cd08222         160 D-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-------VVLRI-VEGP--------T  222 (260)
T ss_pred             c-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHH-HcCC--------C
Confidence            2 2334567889999998865 48889999999999999999999986432211       11111 0111        0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .  .........+.+++.+|++.+|++||++.++++
T Consensus       223 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 P--SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C--CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            0  111233457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-33  Score=262.52  Aligned_cols=199  Identities=26%  Similarity=0.453  Sum_probs=165.4

Q ss_pred             hhhhcCccCceEEEEEEeCC-----CCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-----GTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  312 (558)
                      ....||+|.+|.||++.-.+     ...+|+|+++..+.   ......+|+.+++.++|+||+.+..++.. +...+|++
T Consensus        28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f  107 (438)
T KOG0666|consen   28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF  107 (438)
T ss_pred             ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence            35679999999999996532     23689999985532   24567899999999999999999999887 77789999


Q ss_pred             EeCCCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC----CCeEEcccCCc
Q 043292          313 EYMPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN----FNAKVADFGLS  386 (558)
Q Consensus       313 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla  386 (558)
                      ||.+. +|..+++-+  ...+.++...+..|+.||+.|+.|||+   .-|+||||||.|||+..+    |.+||+|||++
T Consensus       108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            99976 677777532  334579999999999999999999999   899999999999999888    89999999999


Q ss_pred             cccCCCCCce--eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 043292          387 KLIDQDQSQV--VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQP  444 (558)
Q Consensus       387 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~  444 (558)
                      +.+...-...  ...++-|..|.|||++.|  .+|.+.|||+.||++.||++-.+.|.+...
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            9886543221  234567899999999875  599999999999999999999998876443

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.5e-32  Score=278.41  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=186.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccC--------------C
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--------------S  306 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------~  306 (558)
                      .+.||.|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...              .
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN   89 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence            47899999999999988 468899999886433 3346688999999999999999999776543              2


Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCC
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGL  385 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgl  385 (558)
                      ..++|+||++ ++|.+++...    .+++.....++.||+.||.|||+   .+++|+||||+||+++ +++.+||+|||+
T Consensus        90 ~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          90 SVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             eEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            4689999996 5888887543    38899999999999999999999   8999999999999997 456789999999


Q ss_pred             ccccCCCCCc--eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh-
Q 043292          386 SKLIDQDQSQ--VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE-  460 (558)
Q Consensus       386 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  460 (558)
                      +.........  ......++..|+|||.+.+  .++.++||||||++++||++|+.||......+.............. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            9865432111  1123457889999998653  4888999999999999999999999765543321111110000000 


Q ss_pred             -c----ccchhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          461 -E----DKLSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       461 -~----~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .    .................     ......+.+++.+|++.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             0    00000000000000000     012346789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=309.58  Aligned_cols=243  Identities=29%  Similarity=0.406  Sum_probs=193.1

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecc---cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+||.|.||.||-+.. .+|...|+|-++-   .....+...+|+.++..++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            4799999999999987 5688899997752   23345667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC---ce
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS---QV  396 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~---~~  396 (558)
                      |.+.+.....   .++.....+..|++.|+.|||+   .+||||||||.||+|+.+|.+|++|||.|..+.....   ..
T Consensus      1321 La~ll~~gri---~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999975432   5555566778899999999999   9999999999999999999999999999987755421   12


Q ss_pred             eecccCCCCcCChhhhcCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 VTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .....||+.|||||++.+.    -..+.||||+||+++||+||++||...+.+-   .++-.+    ..+...+      
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V----~~gh~Pq------ 1461 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHV----AAGHKPQ------ 1461 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHH----hccCCCC------
Confidence            3357899999999999753    4568999999999999999999997554432   122111    1111111      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          .+......-.+++..||+.||++|-++.|+++.
T Consensus      1462 ----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                111234456789999999999999888877654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=271.94  Aligned_cols=238  Identities=25%  Similarity=0.371  Sum_probs=192.2

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecc----cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG----IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||.||-... .+|+-+|.|.+.+    ........++|-.+|.+++.+.||.+--.+...+..+||+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            6899999999999877 4688999998853    2344556789999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.-+|.+... ..+++....-++.+|+-||++||.   .+||.|||||+|||||+.|+++|+|+|||..+....  ...
T Consensus       271 DLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--~~~  344 (591)
T KOG0986|consen  271 DLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--PIR  344 (591)
T ss_pred             ceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC--ccc
Confidence            99999987654 459999999999999999999999   999999999999999999999999999999775543  345


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ..+||.+|||||++.+ .|+...|.||+||+||||+.|+.||........             ...+...+-...  ...
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-------------~eEvdrr~~~~~--~ey  409 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-------------REEVDRRTLEDP--EEY  409 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-------------HHHHHHHHhcch--hhc
Confidence            5689999999999975 599999999999999999999999974433221             111111111000  112


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCC
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPS  502 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs  502 (558)
                      +..-.+.+.+|....|+.||.+|.-
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhcc
Confidence            2233345666777789999999974

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-32  Score=260.40  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccC-CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEK-SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  313 (558)
                      ..++-+|.||.||.|.+.      +.+.|.||.+++...  ....++.|.-.+..+.|||+.++.+++.+. ...+.+|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            357899999999999653      345678888775432  345688999999999999999999998764 46789999


Q ss_pred             eCCCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          314 YMPNGSLDRWLF-----QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       314 ~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++.-|+|..||.     +......++..+...++.|++.|++|||.   .++||.||.++|.+||+...+||+|-.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999998     33334568888999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          389 IDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       389 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      +-..+. ......-.+..||+||.+.+ .++.++|||||||+||||+| |+.|+..-++.|-...+.             
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-------------  512 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-------------  512 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-------------
Confidence            543222 22223445779999999875 69999999999999999999 899997665544211111             


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                         |..  ....+.++++++..++.-||...|++||+++++++-|.+.
T Consensus       513 ---dGy--RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  513 ---DGY--RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---ccc--eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence               111  1123345778999999999999999999999999988653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=9.5e-32  Score=259.62  Aligned_cols=219  Identities=19%  Similarity=0.173  Sum_probs=174.5

Q ss_pred             cCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcC
Q 043292          249 GGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR  327 (558)
Q Consensus       249 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  327 (558)
                      |.+|.||++.. .+++.+|+|++....    .+..|...+....||||+++++++.+....++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            88999999998 468999999987543    2334555555667999999999999999999999999999999998754


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcC
Q 043292          328 SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL  407 (558)
Q Consensus       328 ~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~  407 (558)
                      .   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++++|||++......    .....++..|+
T Consensus        80 ~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          80 L---NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             c---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            3   38999999999999999999999   99999999999999999999999999988655432    22334577899


Q ss_pred             ChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHH
Q 043292          408 APEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMM  486 (558)
Q Consensus       408 aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  486 (558)
                      |||...+ .++.++||||+|++++||++|..|+.......                  ........     +......+.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~~~~~~-----~~~~~~~~~  206 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTHTTLNI-----PEWVSEEAR  206 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------ccccccCC-----cccCCHHHH
Confidence            9998864 58999999999999999999998875322110                  00000000     111234678


Q ss_pred             HHHHHccCcCCCCCCCHH
Q 043292          487 KVAAWCLESDFAKRPSMS  504 (558)
Q Consensus       487 ~l~~~cl~~~p~~RPs~~  504 (558)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=256.49  Aligned_cols=241  Identities=29%  Similarity=0.386  Sum_probs=193.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      |-++||+|.||.|-+++.+ +++.+|+|++++.-    .....-+.|-++|+..+||.+..+.-.|+..++.++||||..
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence            4589999999999999874 68999999998532    223345678999999999999999989999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ||.|.-+|.+..   .+++....-.-..|..||.|||+   .+||.||||.+|.|||.+|.+||+||||.+.-- .....
T Consensus       252 GGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t  324 (516)
T KOG0690|consen  252 GGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDT  324 (516)
T ss_pred             CceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-cccce
Confidence            999998887643   37777777888899999999999   999999999999999999999999999998543 23345


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ..+++||+.|+|||++.. .+...+|.|.+||++|||++|+.||.....+.    +......               .+.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----LFeLIl~---------------ed~  385 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----LFELILM---------------EDL  385 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----HHHHHHh---------------hhc
Confidence            678999999999999985 59999999999999999999999997544332    1111100               011


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      .++.....+...++...|..||.+|.     .+.||.+
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            12222333566777888999999995     3555554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2e-31  Score=285.85  Aligned_cols=256  Identities=19%  Similarity=0.244  Sum_probs=164.2

Q ss_pred             hhhcCccCceEEEEEEeC-C----CCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeee------eccCCcceEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-D----GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF------CAEKSHNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~~lv  311 (558)
                      .++||+|+||.||+|++. +    +..||||++...... +.+..|  .+....+.+++.++..      ...+...++|
T Consensus       137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV  213 (566)
T PLN03225        137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV  213 (566)
T ss_pred             eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence            478999999999999984 4    689999988643321 111111  1222222233222221      2456678999


Q ss_pred             EEeCCCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          312 YEYMPNGSLDRWLFQRSDE-----------------FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      |||+.+++|.+++......                 .......+..++.||+.||.|||+   .+|+||||||+|||+++
T Consensus       214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~~  290 (566)
T PLN03225        214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSE  290 (566)
T ss_pred             EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEeC
Confidence            9999999999998754210                 011233456799999999999999   89999999999999986


Q ss_pred             -CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-----------------------CCCCccchHHHHHHHH
Q 043292          375 -NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-----------------------IITEKVDIYSFGVVML  430 (558)
Q Consensus       375 -~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------------------~~~~k~Dv~s~Gv~l~  430 (558)
                       ++.+||+|||+|+.+............+++.|+|||.+..                       .++.++|||||||+||
T Consensus       291 ~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~  370 (566)
T PLN03225        291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL  370 (566)
T ss_pred             CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence             5799999999998665444344456778999999996521                       1345679999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhhHHHHHHHhhh-cccchhhccccCCC-----CCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 043292          431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAE-EDKLSDLVDKHSND-----MQSNGEEVVNMMKVAAWCLESDFAKRPSMS  504 (558)
Q Consensus       431 elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  504 (558)
                      ||+++..+++..     ...+......... ...+...+......     ............+|+.+||+.||.+|||+.
T Consensus       371 el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        371 QMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            999876654311     1111110000000 00000111111000     000001122455899999999999999999


Q ss_pred             HHHHH
Q 043292          505 MVVRV  509 (558)
Q Consensus       505 ~vl~~  509 (558)
                      ++++.
T Consensus       446 e~L~H  450 (566)
T PLN03225        446 AALAH  450 (566)
T ss_pred             HHhCC
Confidence            99974

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=230.49  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=191.6

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      ++||+|.+|+||+++.. +++.||+|+++-.   .......++|+-+++.++|.|||+++++...+...-+|+||+ ..+
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqd   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHH
Confidence            68999999999999884 5788999988632   222356789999999999999999999999999999999999 457


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |..+...-..  .++.+....++.|+++||.+.|+   .++.|||+||.|.||+.+|++|++|||+++.+.-... ..+.
T Consensus        87 lkkyfdslng--~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa  160 (292)
T KOG0662|consen   87 LKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA  160 (292)
T ss_pred             HHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence            8777765443  38999999999999999999999   9999999999999999999999999999998765432 2344


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHh--hhcccc---hhhcccc
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKK--AEEDKL---SDLVDKH  471 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~d~~  471 (558)
                      .+-|..|.+|.++-+  .++...|+||.||++.|+.. |++.|.+.+..+   .+..+++..  ..++..   ..+-|..
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHHHhCCCccccCCccccCCCCc
Confidence            556889999999865  49999999999999999998 555566555443   333333332  111211   1222211


Q ss_pred             CCC-CCCC---HH----HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SND-MQSN---GE----EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~-~~~~---~~----~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .-. .+..   .+    ....=.+++...+.-+|.+|.+++..++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            100 0000   01    1112356677778889999999998775

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.9e-31  Score=293.22  Aligned_cols=139  Identities=29%  Similarity=0.446  Sum_probs=125.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++... +++.||||+++...    .....+..|+.++..++|+||+++++++......++||||+.+
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            478999999999999985 68999999987432    2235688899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ++|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++
T Consensus        89 ~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999997543   38899999999999999999999   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=277.92  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeecc-----CCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAE-----KSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~  314 (558)
                      |.++||.|.+|.||+++. ++++..|||++.-.....++...|.+++... +|||++.++|++..     ++.+||||||
T Consensus        23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf  102 (953)
T KOG0587|consen   23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF  102 (953)
T ss_pred             EEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence            458899999999999987 5789999999988777888889999999988 79999999998864     5678999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |.+||..++++... ...+.|..+..|++.++.||.+||.   ..++|||||-.|||++.++.+|+.|||++..+.....
T Consensus       103 C~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             cCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence            99999999998765 4459999999999999999999999   8999999999999999999999999999987765433


Q ss_pred             ceeecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          395 QVVTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      + ..+..||+.|||||++..      .++..+|+||||++..||.-|.+|+-...+....+                .+.
T Consensus       179 r-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----------------~Ip  241 (953)
T KOG0587|consen  179 R-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----------------LIP  241 (953)
T ss_pred             c-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----------------cCC
Confidence            3 456789999999999852      37889999999999999999999987665543111                111


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .........+..-...+.++|..||..|..+||++.++++.
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            11111222344567789999999999999999999988753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=7.3e-31  Score=253.13  Aligned_cols=236  Identities=30%  Similarity=0.429  Sum_probs=190.5

Q ss_pred             CceEEEEEEeC-CCCEEEEEEecccccc--hHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhc
Q 043292          250 GFGSVFEGTQT-DGTKVAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ  326 (558)
Q Consensus       250 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  326 (558)
                      +||.||+++.. +++.+++|++......  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 5899999998754322  57899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCc
Q 043292          327 RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY  406 (558)
Q Consensus       327 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y  406 (558)
                      ...   +++..++.++.+++.++.|||+   .+++|+||+|+||++++++.++|+|||.+.......  ......++..|
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            443   8899999999999999999999   899999999999999999999999999998765432  23445678899


Q ss_pred             CChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHH
Q 043292          407 LAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNM  485 (558)
Q Consensus       407 ~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  485 (558)
                      ++||.+. ..++.++||||||+++++|++|..||......+   .+....    .......        ..........+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~~~~~~----~~~~~~~--------~~~~~~~~~~~  217 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---ELFKKI----GKPKPPF--------PPPEWKISPEA  217 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHH----hccCCCC--------ccccccCCHHH
Confidence            9999986 468899999999999999999999997532211   111111    0000000        00000033578


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 043292          486 MKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       486 ~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=266.54  Aligned_cols=241  Identities=26%  Similarity=0.440  Sum_probs=190.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|.||+||-|+. ++|+.||||++.+.   .....++.+|+.+|++++||.||.+.-.|...+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            37899999999999988 67999999998643   344578999999999999999999999999999999999999766


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC---CCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~---~~~ki~Dfgla~~~~~~~~~  395 (558)
                      -|+.+|.....  .|++..-..++.||+.||.|||.   ++|+|+||||+||||.+.   ..+||+|||.|+.+....  
T Consensus       649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            66666654443  38888888899999999999999   999999999999999654   369999999999886543  


Q ss_pred             eeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....+||+.|+|||++.++ |+..-|+||.||++|--++|.-||.......+   ...       +   ..++-+    
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---QIQ-------N---AaFMyP----  784 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---QIQ-------N---AAFMYP----  784 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---Hhh-------c---cccccC----
Confidence            34578899999999999865 89999999999999999999999963222111   100       0   001100    


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      ...-.+-....+++|...|+..-.+|.|...-+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            011123334667788888888888888877654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=260.42  Aligned_cols=269  Identities=21%  Similarity=0.357  Sum_probs=204.9

Q ss_pred             cCHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccC-C-c----ceeeeeeee
Q 043292          230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-H-Q----NLVRLIGFC  302 (558)
Q Consensus       230 ~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~  302 (558)
                      |...+.....+...+++|+|.||.|-...+. .+..||||+++....-.+..+-|+++++++. + |    -+|.+.++|
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            3444444444445578999999999999874 4789999999988777788889999999993 2 2    368888999


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC--------
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG--------  374 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~--------  374 (558)
                      .-.++.+||+|.+ |-|+.++|..+.- .+++..++..|+.|++++++|||+   .+++|-||||+|||+.+        
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence            9999999999998 7799999986543 358899999999999999999999   99999999999999831        


Q ss_pred             ------------CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCC
Q 043292          375 ------------NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDR  441 (558)
Q Consensus       375 ------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~  441 (558)
                                  +..+||.|||.|..-....    ...+.|..|.|||++.+. ++.++||||+||||.|+.+|...|.+
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                        3458999999998654332    567789999999999884 99999999999999999999999988


Q ss_pred             CCCcchhhhHHHHHHH---------h-----hhcccc-----------hhhcccc---CCCCCCCHHHHHHHHHHHHHcc
Q 043292          442 SQPEEEDMYLLSIFKK---------K-----AEEDKL-----------SDLVDKH---SNDMQSNGEEVVNMMKVAAWCL  493 (558)
Q Consensus       442 ~~~~~~~~~~~~~~~~---------~-----~~~~~~-----------~~~~d~~---~~~~~~~~~~~~~l~~l~~~cl  493 (558)
                      ....|.. ..+.-+..         .     ...+.+           ....+..   -.-......+...|++|+..||
T Consensus       312 Hen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  312 HENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             CCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            7754421 11111100         0     000000           0000000   0001123466778999999999


Q ss_pred             CcCCCCCCCHHHHHH
Q 043292          494 ESDFAKRPSMSMVVR  508 (558)
Q Consensus       494 ~~~p~~RPs~~~vl~  508 (558)
                      ..||.+|+|+.|+++
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=273.08  Aligned_cols=234  Identities=25%  Similarity=0.326  Sum_probs=188.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      |...+|.|+|+.|-++.. .+++..+||++.+..   .+-.+|+.++... +|+||+++.+.+.++.+.++|||.+.++-
T Consensus       326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e  402 (612)
T KOG0603|consen  326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE  402 (612)
T ss_pred             cccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence            346799999999999987 568899999997652   2234667666555 79999999999999999999999999988


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee-cCCCCeEEcccCCccccCCCCCceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-DGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll-~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      |.+.+.....   .. ..+..|+.+|+.|+.|||+   +++|||||||+|||+ ++.++++|+|||.++.....    ..
T Consensus       403 ll~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~  471 (612)
T KOG0603|consen  403 LLRRIRSKPE---FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD  471 (612)
T ss_pred             HHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence            8777754432   33 7788899999999999999   999999999999999 69999999999999977654    23


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      +.+-|..|.|||++.. .+++++|+||||++||+|++|+.||.......   .+    ......+.             .
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei----~~~i~~~~-------------~  531 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EI----HTRIQMPK-------------F  531 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HH----HHhhcCCc-------------c
Confidence            3456889999999986 49999999999999999999999998665541   11    11111121             1


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+|+.+||+.||.+||+|.++...
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            23344578889999999999999999998853

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=247.97  Aligned_cols=245  Identities=25%  Similarity=0.343  Sum_probs=190.5

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeecc----CCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAE----KSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~  317 (558)
                      ++||-|-.|.|-.... .+++++|+|++.+...    ..+|+++.-.. .|+|||.+++++.+    ....++|||+|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            7899999999999887 5789999999986654    35677765555 69999999998764    3345799999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |.|...++++... .+++.+...|+.||+.|+.|||+   .+|.||||||+|+|.+.   |-.+||+|||+|+.....  
T Consensus       144 GeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--  217 (400)
T KOG0604|consen  144 GELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--  217 (400)
T ss_pred             hHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC--
Confidence            9999999877654 59999999999999999999999   99999999999999964   446999999999975542  


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....+..-|+.|.|||++.. .++...|+||+||++|-|++|.+||.......    +..-.+.....+.+ ++-+    
T Consensus       218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy-~FP~----  288 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQY-EFPE----  288 (400)
T ss_pred             ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCc-cCCC----
Confidence            23556778999999999974 58888999999999999999999996433211    11111222211111 0000    


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        +.-....+...++++.+|..+|.+|.|+.+++..
T Consensus       289 --pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  289 --PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence              1112345677889999999999999999999854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=258.86  Aligned_cols=247  Identities=29%  Similarity=0.476  Sum_probs=190.0

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccc--------hHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEE
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEI--------NKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYE  313 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  313 (558)
                      .+||+|+|+.||++.+ ...+.||||+-.-.+..        .+...+|.++.+.|.||.||++++++.- .+..+-|.|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            6899999999999987 45778999975422111        1346789999999999999999999865 456789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec---CCCCeEEcccCCccccC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLID  390 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~---~~~~~ki~Dfgla~~~~  390 (558)
                      |++|.+|+-+|+.+.   .+++.+...|+.||..||.||.+ .+.+|||-||||.||||-   .-|.+||.||||++.+.
T Consensus       549 YceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd  624 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD  624 (775)
T ss_pred             ecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence            999999999998765   48999999999999999999986 468999999999999994   45789999999999886


Q ss_pred             CCCCc------eeecccCCCCcCChhhhc-C----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          391 QDQSQ------VVTTMRGTPGYLAPEWLS-S----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       391 ~~~~~------~~~~~~gt~~y~aPE~~~-~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      .+...      ......||..|++||.+- +    .++.|+||||.||++|..+.|+.||........   ++       
T Consensus       625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---IL-------  694 (775)
T KOG1151|consen  625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---IL-------  694 (775)
T ss_pred             CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---HH-------
Confidence            54332      234577999999999874 2    489999999999999999999999975443211   11       


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      .+..+   +...-...+...........+|.+||+..-++|....++.
T Consensus       695 qeNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 QENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11111   1111111122223344677899999999999998776654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=283.20  Aligned_cols=245  Identities=26%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecc---c-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG---I-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.|..++. .+++.+|+|++++   . .....-|..|-.+|..-+.+=|+.++-.|.+..+.|+|||||+|
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG  159 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG  159 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence            48899999999999998 4688999999975   2 23345688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|-.++.+..   .++..-...++..|..||.-||+   .|+|||||||+|||||..|++||+|||.+-.+..+..-..
T Consensus       160 GDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s  233 (1317)
T KOG0612|consen  160 GDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS  233 (1317)
T ss_pred             chHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence            99999998765   38888888999999999999999   9999999999999999999999999999988877666666


Q ss_pred             ecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          398 TTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ...+|||.|++||++.      +.|.+..|.||+||++|||+.|..||...+       ++..+...........+    
T Consensus       234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-------lveTY~KIm~hk~~l~F----  302 (1317)
T KOG0612|consen  234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-------LVETYGKIMNHKESLSF----  302 (1317)
T ss_pred             ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------HHHHHHHHhchhhhcCC----
Confidence            7789999999999984      358999999999999999999999997433       33333333222111111    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPS---MSMVVRV  509 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~  509 (558)
                          +...+......+||...+ -+|..|..   ++++...
T Consensus       303 ----P~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  303 ----PDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ----CcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence                111223345666666655 47888887   8777653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-32  Score=247.50  Aligned_cols=260  Identities=25%  Similarity=0.354  Sum_probs=190.2

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEec--ccccc-hHHHHHHHHHHhccCCcceeeeeeeeccC--------CcceEE
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLE--GIGEI-NKSFLAEVKTIGSIHHQNLVRLIGFCAEK--------SHNLLV  311 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~lv  311 (558)
                      .++|+|.||.||+++.. +++.||+|++-  +.+.+ -...++|+++|..++|+|++.++..|...        ...++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            57999999999999884 57888988653  33322 34578999999999999999999988643        246899


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      +++++. +|..+|.+...  .++..++.+++.++..||.|+|.   ..|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus       103 f~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             HHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            999965 78888876543  38999999999999999999998   8999999999999999999999999999987754


Q ss_pred             CCCc---eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh----hhc-
Q 043292          392 DQSQ---VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK----AEE-  461 (558)
Q Consensus       392 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~-  461 (558)
                      ....   ..+..+-|..|.+||.+.|  .++++.|||+.||++.||+++.+.+.+.....+...+.......    |.+ 
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            3221   1234456899999999875  59999999999999999999999987655433221111111110    000 


Q ss_pred             --ccchhhcccc-CCCCCC--CHHHH------HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          462 --DKLSDLVDKH-SNDMQS--NGEEV------VNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       462 --~~~~~~~d~~-~~~~~~--~~~~~------~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        -.+.+.+... +.....  ..+..      ...++++..++..||.+|+++.+++..
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              0111111000 000000  01111      267788899999999999999998853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=253.76  Aligned_cols=241  Identities=27%  Similarity=0.355  Sum_probs=191.7

Q ss_pred             HHHHHHHhhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcc
Q 043292          235 LKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHN  308 (558)
Q Consensus       235 l~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  308 (558)
                      ++...-||..+||+|+||.|-++..+ +.+.+|||++++.-    ...+--+.|-++|... +-|.+++++..++.-+..
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            44444578899999999999999764 46679999997532    2223356788888877 467889999999999999


Q ss_pred             eEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++||||+.+|+|--++++-..   +.+....-++..||-||-+||+   .+|+.||||.+||+||.+|.+||+|||+.+.
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999988887554   7778888999999999999999   9999999999999999999999999999985


Q ss_pred             cCCCCCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          389 IDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       389 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      ---+ .....++.||+.|+|||++. ..|...+|.|||||+||||+.|+.||++.+.++.-   ..+             
T Consensus       500 ni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~aI-------------  562 (683)
T KOG0696|consen  500 NIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QAI-------------  562 (683)
T ss_pred             cccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH-------------
Confidence            3222 22355789999999999987 46999999999999999999999999987655411   111             


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP  501 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  501 (558)
                      .+...   .++.....+.+.+....+..+|.+|.
T Consensus       563 ~ehnv---syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  563 MEHNV---SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHccC---cCcccccHHHHHHHHHHhhcCCcccc
Confidence            11111   12233345677788888899999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6.3e-30  Score=267.67  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=173.0

Q ss_pred             hhhcCccCceEEEEEEe-----------------CCCCEEEEEEecccccc-h--------------HHHHHHHHHHhcc
Q 043292          243 RKMLGKGGFGSVFEGTQ-----------------TDGTKVAVKRLEGIGEI-N--------------KSFLAEVKTIGSI  290 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~E~~~l~~l  290 (558)
                      .++||+|+||.||+|.+                 .+++.||||++...... .              +.+..|+..+.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            47899999999999964                 23567999998643221 1              2234577777777


Q ss_pred             CCcce-----eeeeeeecc--------CCcceEEEEeCCCCCHHHHHhcCCC---------------------CCCCCHH
Q 043292          291 HHQNL-----VRLIGFCAE--------KSHNLLVYEYMPNGSLDRWLFQRSD---------------------EFMLDWQ  336 (558)
Q Consensus       291 ~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~  336 (558)
                      +|.++     ++++++|..        .+..+|||||+++++|.++++....                     ...++|.
T Consensus       230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~  309 (507)
T PLN03224        230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN  309 (507)
T ss_pred             hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence            76654     677777753        3467999999999999999874211                     1235678


Q ss_pred             HHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCC-
Q 043292          337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-  415 (558)
Q Consensus       337 ~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-  415 (558)
                      .+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...............+++.|+|||.+... 
T Consensus       310 ~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             HHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            899999999999999999   8999999999999999999999999999976543222111223347899999987421 


Q ss_pred             ----------------------CCCccchHHHHHHHHHHHhCCC-CCCCCCCcchhh----hHHHHHHHhhhcccchhhc
Q 043292          416 ----------------------ITEKVDIYSFGVVMLEILCGRK-VFDRSQPEEEDM----YLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       416 ----------------------~~~k~Dv~s~Gv~l~elltg~~-p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  468 (558)
                                            ...+.||||+||++++|++|.. |+..........    ..... ++.......    
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~-~r~~~~~~~----  461 (507)
T PLN03224        387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR-WRMYKGQKY----  461 (507)
T ss_pred             CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-HHhhcccCC----
Confidence                                  1135799999999999999875 664321111000    00000 111111111    


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCC---CCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDF---AKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~~vl~  508 (558)
                      +     ............+++..+|..+|   .+|+|++++++
T Consensus       462 ~-----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        462 D-----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             C-----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0     00111123467788888888765   68999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=247.01  Aligned_cols=260  Identities=27%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCC-----cceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  314 (558)
                      +.||-|+||.||..++ .+|+.||+|++.+.-   ...+.+.+|+++|+.++|.|++..+++..-..     +.|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            5699999999999998 589999999987533   34578999999999999999999988765433     45788888


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      | ..+|..++-...   .|+...+.-++.||++||.|||+   .+|.||||||.|.|++.|..+||+|||+|+....++.
T Consensus       139 m-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  139 M-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             H-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            8 457777765433   38888899999999999999999   9999999999999999999999999999998877777


Q ss_pred             ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhcccch
Q 043292          395 QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEEDKLS  465 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~  465 (558)
                      ..++..+-|..|.|||++.|  .++.+.||||.||++.||+..+..|...++.++...+.+....       ...++--.
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            77777778999999999986  5999999999999999999999999887776644433332211       11111111


Q ss_pred             hhccccCCC--------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          466 DLVDKHSND--------MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       466 ~~~d~~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                      .++....+.        .......-...+.+...++..||.+|.+..+.+..+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            122211111        111111223455677778999999999999988765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-31  Score=272.41  Aligned_cols=284  Identities=28%  Similarity=0.347  Sum_probs=207.3

Q ss_pred             hhhcCccCceE-EEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGS-VFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+++|.|+.|+ ||+|... ++.||||++-...  ..-..+|+..|+.- +|||||++++.-.+....||..|.| ..+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            36899999985 7999875 7899999875322  23456899998877 6999999999999999999999999 5699


Q ss_pred             HHHHhcCCCC-CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---C--CCeEEcccCCccccCCCCC
Q 043292          321 DRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---N--FNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       321 ~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~--~~~ki~Dfgla~~~~~~~~  394 (558)
                      .+++...... ....-.....+..|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+++.+..+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999874111 111114457888999999999999   99999999999999976   2  4789999999998865544


Q ss_pred             ce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          395 QV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCG-RKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       395 ~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..  .....||-+|+|||.+.+ .-+.++||||+||++|+.++| ..||...-..+  .++..      .+..+      
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~------~~~~L------  732 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT------GNYTL------  732 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc------Cccce------
Confidence            32  346779999999999975 467789999999999999985 88997433221  11110      00000      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH---------HHhccccccccccCccCCCcH--Hhhhhccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR---------VLEGVTEFEHNLHYNLVHLPI--TAALANVDHR  539 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~---------~L~~~~~~~~~~~~~~~~~p~--~~~~~~~~~~  539 (558)
                        .......++  ...++|..|++++|..||++.+|+.         +|+-+.+.......+....|+  .+.+++-.-.
T Consensus       733 --~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le~~~~~  808 (903)
T KOG1027|consen  733 --VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALEAGARV  808 (903)
T ss_pred             --eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhccCCce
Confidence              011111112  7788999999999999999999984         355555555555555566666  6777765555


Q ss_pred             ccCCCCCccccc
Q 043292          540 EENDKPTTQLLP  551 (558)
Q Consensus       540 ~~~~~~~~~~~~  551 (558)
                      -..+.|.++..+
T Consensus       809 vv~~~W~~kl~~  820 (903)
T KOG1027|consen  809 VVSGDWTEKLDK  820 (903)
T ss_pred             EecCchhhhhCH
Confidence            556666555443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-30  Score=225.22  Aligned_cols=196  Identities=26%  Similarity=0.417  Sum_probs=162.9

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhc-cCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGS-IHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      ..||+|++|.|-+-++ .+|+..|||++...  .+..++.+.|+.+..+ ..+|.+|.++|........++.||.| ..|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence            5699999999988777 67999999999743  4455677888887654 47999999999999999999999999 568


Q ss_pred             HHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          320 LDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       320 L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      |+.+-.+- .....+++.-+-+|+..|.+||.|||+  +..++|||+||+||||+.+|.+||+|||.+-.+.+.-.  .+
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--kt  206 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--KT  206 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--HH
Confidence            88776531 122348888999999999999999999  58999999999999999999999999999987654322  33


Q ss_pred             cccCCCCcCChhhhcC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVFDRSQP  444 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~  444 (558)
                      .-.|...|||||.+..     .|+-|+||||||+.+.||.+++.||+....
T Consensus       207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            3568889999998862     488899999999999999999999975544

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9e-31  Score=257.55  Aligned_cols=241  Identities=23%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             hhcCccCceEEEEEEeCCCC-EEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGT-KVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ..||-|+||.|=+....... .+|+|.+++.    ....+....|-++|...+.|.||+++..|.+....|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            46999999999998875433 4888888743    223345788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      .|...|.++..   ++..+..-++..+.+|++|||.   .+||.|||||+|.+|+.+|-+||.|||+|+.+...  ...-
T Consensus       506 ElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTw  577 (732)
T KOG0614|consen  506 ELWTILRDRGS---FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTW  577 (732)
T ss_pred             hhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC--Ccee
Confidence            99999987664   8888888999999999999999   99999999999999999999999999999987543  3456


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      +++||+.|.|||++.+ -.+..+|.||||++++||++|.+||.+.++......+..-.       +..          ..
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------d~i----------~~  640 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------DKI----------EF  640 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------hhh----------hc
Confidence            7999999999998764 48899999999999999999999999887765332222111       111          11


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  509 (558)
                      +..-.....++++.....+|.+|.-     +.+|.+.
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            1222335677888888999999975     5555543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=235.58  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=186.1

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+||+|++.+|..+++ ++.+.+|+|++++.    .+...=...|-.+..+. +||.+|-+..+|......++|.||.++
T Consensus       256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g  335 (593)
T KOG0695|consen  256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG  335 (593)
T ss_pred             eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence            6899999999999988 46788999988742    22222345666666655 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|--++++..+   |+++...-+...|..||.|||+   .|||.||||.+|||||..|.+||.|+|+.+.--.+ ....
T Consensus       336 gdlmfhmqrqrk---lpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t  408 (593)
T KOG0695|consen  336 GDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT  408 (593)
T ss_pred             cceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence            999777765543   9999999999999999999999   99999999999999999999999999999864332 3346


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      +++.||+.|+|||++.+ .+...+|.|++||+++||+.|+.||+.-.....+.+..++.-+...+..        +   .
T Consensus       409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------i---r  477 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------I---R  477 (593)
T ss_pred             ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--------c---c
Confidence            68999999999999997 4999999999999999999999999743222212222222111111111        1   0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP  501 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP  501 (558)
                      .+.....+...+++.-|+.||.+|.
T Consensus       478 iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhc
Confidence            1112233566788888999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=6.1e-28  Score=227.04  Aligned_cols=208  Identities=39%  Similarity=0.658  Sum_probs=182.4

Q ss_pred             cCccCceEEEEEEeCC-CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      ||+|.+|.||++...+ ++.+++|++.....  ..+.+.+|+..+..++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999854 89999999986544  25679999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCCCCCceeeccc
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      ++....  ..+++..+..++.++++++.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            997653  238999999999999999999999   89999999999999999 89999999999986644321 123355


Q ss_pred             CCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      +...|++||....  ..+.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            7889999999875  688999999999999999                                               


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         ..+.+++..|++.||.+||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               367789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=238.86  Aligned_cols=154  Identities=24%  Similarity=0.330  Sum_probs=126.6

Q ss_pred             hhhhhhccCCCCCCccCHHHHHH-HHHHhhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-
Q 043292          215 IEEDYLDQVPGLPKRFSFEELKV-MTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-  291 (558)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~l~~-~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-  291 (558)
                      ..++..++..|..+...+.|... ..+-+.++||-|.|++||++-+ .+.+.||+|+.+....-.+..+.|+++|++++ 
T Consensus        54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~  133 (590)
T KOG1290|consen   54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE  133 (590)
T ss_pred             cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence            34445555666666666666655 5555678999999999999987 56789999999987777788899999999984 


Q ss_pred             ----C---cceeeeeeeecc----CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcE
Q 043292          292 ----H---QNLVRLIGFCAE----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI  360 (558)
Q Consensus       292 ----h---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i  360 (558)
                          |   ..||+|+++|..    +.+.+||+|++ |-+|..++....- +.++...+.+|++||+.||.|||.+  .+|
T Consensus       134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgI  209 (590)
T KOG1290|consen  134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGI  209 (590)
T ss_pred             cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCc
Confidence                2   369999999864    56889999999 7788888876443 3499999999999999999999995  699


Q ss_pred             EecCCCCCCEee
Q 043292          361 LHLDIKPQNILL  372 (558)
Q Consensus       361 vH~dlk~~NIll  372 (558)
                      ||-||||+|||+
T Consensus       210 IHTDlKPENvLl  221 (590)
T KOG1290|consen  210 IHTDLKPENVLL  221 (590)
T ss_pred             cccCCCcceeee
Confidence            999999999999

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.7e-28  Score=246.92  Aligned_cols=205  Identities=27%  Similarity=0.409  Sum_probs=171.2

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||-|+||.|.++.. ++...+|.|.|++...    .......|-.||...+.+=||+|+-.|.+++.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            5699999999999976 4466789998875432    2334677899999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC-------
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-------  391 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~-------  391 (558)
                      ++-.+|.+..-   +.+.....++..+..|+++.|.   .|+|||||||+|||||.+|.+||.||||..-+..       
T Consensus       715 DmMSLLIrmgI---FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  715 DMMSLLIRMGI---FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            99999987653   7777788888999999999999   9999999999999999999999999999754410       


Q ss_pred             --C----------------C----------------CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCC
Q 043292          392 --D----------------Q----------------SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGR  436 (558)
Q Consensus       392 --~----------------~----------------~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~  436 (558)
                        .                .                .......+||+.|+|||++.+ -++...|.||.||+|+||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence              0                0                001123579999999999976 4999999999999999999999


Q ss_pred             CCCCCCCCcchhhhHHHH
Q 043292          437 KVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       437 ~p~~~~~~~~~~~~~~~~  454 (558)
                      .||....+.+....+..|
T Consensus       869 ~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINW  886 (1034)
T ss_pred             CCccCCCCCcceeeeeeh
Confidence            999888877765555444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.4e-27  Score=213.38  Aligned_cols=255  Identities=19%  Similarity=0.384  Sum_probs=189.8

Q ss_pred             HhhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-CcceeeeeeeeccCC--cceEEEEeCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKS--HNLLVYEYMP  316 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~~  316 (558)
                      .+.+++|+|.++.||.|.. .+.++++||+++..+  .+...+|+.+|..+. ||||++++++..+..  ...||+||.+
T Consensus        41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             HHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            3457899999999999986 678899999998643  356789999999997 999999999987765  4579999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~  395 (558)
                      +.+...+..      .|+...+...+.++++||.|+|+   .||.|||+||.|++||... .++|+|+|+|.++......
T Consensus       119 n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY  189 (338)
T KOG0668|consen  119 NTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  189 (338)
T ss_pred             cccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence            988776653      27788889999999999999999   9999999999999998654 6999999999988655443


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcc-hhhhHHHHHHH-----------hhhc
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEE-EDMYLLSIFKK-----------KAEE  461 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~-----------~~~~  461 (558)
                        ...+-+.-|.-||.+-.  .++..-|+|||||+|.+|+..+.||-...... +...+......           ....
T Consensus       190 --nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  190 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             --eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence              23345667889999864  58889999999999999999999986544332 22222111100           0011


Q ss_pred             ccchhhccccCCC-------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          462 DKLSDLVDKHSND-------MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       462 ~~~~~~~d~~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..+.+++....+.       .....-...++++++...|..|-++|||+.|.+.
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1122222211110       0011112357788999999999999999999764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=7.7e-28  Score=240.45  Aligned_cols=188  Identities=24%  Similarity=0.406  Sum_probs=162.9

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccccch---------HHHHHHHHHHhccC---CcceeeeeeeeccCCcceE
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN---------KSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+|.|+||.|+.++++ +..+|+||.+.+.+-..         ...-.|+.+|..++   |+||++++++|.+++..+|
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            57999999999999985 56789999886543211         23456999999997   9999999999999999999


Q ss_pred             EEEeC-CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          311 VYEYM-PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       311 v~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      +||-. ++-+|.+++..+..   +++.+...|++||+.|+++||+   .+|||||||-+||.++.+|-+||+|||.|...
T Consensus       647 ~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             EecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99976 46788999976654   9999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCCceeecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCC
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFD  440 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~  440 (558)
                      ...   ....++||.+|.|||++.|.  ....-|||++|++||-++....||.
T Consensus       721 ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 KSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            432   35578899999999999874  6677899999999999998888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=3.1e-28  Score=240.32  Aligned_cols=273  Identities=22%  Similarity=0.292  Sum_probs=212.2

Q ss_pred             ccCHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccC------Ccceeeeeee
Q 043292          229 RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH------HQNLVRLIGF  301 (558)
Q Consensus       229 ~~~~~~l~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~  301 (558)
                      ++.+.|+....+.+....|+|-|++|.+|.+. -|+.||||++.+.....+.=+.|+++|.+|+      --+.++++-.
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            46677777776767778999999999999884 4889999999987766667788999999996      3478999999


Q ss_pred             eccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEE
Q 043292          302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKV  380 (558)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki  380 (558)
                      |...++++||+|-+ ..+|.++|++-+.+..|....+..++.|+.-||..|..   .+|+|.||||.|||+++.- .+||
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeee
Confidence            99999999999988 67999999988777779999999999999999999998   9999999999999998754 6899


Q ss_pred             cccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH----
Q 043292          381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF----  455 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~----  455 (558)
                      +|||.|.......   .+...-+..|.|||++.| .++...|+||.||+||||.||+..|.+.....-.-..+..-    
T Consensus       579 CDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  579 CDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             ccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            9999998765433   445556778999999987 59999999999999999999999998766543111111110    


Q ss_pred             HHhhhcccc-hhhccccCC---------------------------------CCCC---CHHHHHHHHHHHHHccCcCCC
Q 043292          456 KKKAEEDKL-SDLVDKHSN---------------------------------DMQS---NGEEVVNMMKVAAWCLESDFA  498 (558)
Q Consensus       456 ~~~~~~~~~-~~~~d~~~~---------------------------------~~~~---~~~~~~~l~~l~~~cl~~~p~  498 (558)
                      ...+..+.+ .+.+|..+.                                 ....   ....+..+.+|+..||..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            011111111 112221110                                 0001   123356788999999999999


Q ss_pred             CCCCHHHHHH
Q 043292          499 KRPSMSMVVR  508 (558)
Q Consensus       499 ~RPs~~~vl~  508 (558)
                      +|.|..+.+.
T Consensus       736 KRit~nqAL~  745 (752)
T KOG0670|consen  736 KRITVNQALK  745 (752)
T ss_pred             hcCCHHHHhc
Confidence            9999998875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.1e-26  Score=219.59  Aligned_cols=195  Identities=37%  Similarity=0.606  Sum_probs=168.7

Q ss_pred             hhhhcCccCceEEEEEEeCC-CCEEEEEEeccccc--chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||.|++|.||++...+ ++.+++|.+.....  ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            34679999999999999864 88999999975433  4567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++......  +++..+..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||++............
T Consensus        83 ~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       83 DLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            999999764432  7899999999999999999999   89999999999999999999999999999876544211223


Q ss_pred             cccCCCCcCChhhh-cC-CCCCccchHHHHHHHHHHHhCCCCCCC
Q 043292          399 TMRGTPGYLAPEWL-SS-IITEKVDIYSFGVVMLEILCGRKVFDR  441 (558)
Q Consensus       399 ~~~gt~~y~aPE~~-~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~  441 (558)
                      ...++..|++||.+ .. .++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            45678899999987 43 477899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-27  Score=220.92  Aligned_cols=253  Identities=26%  Similarity=0.339  Sum_probs=188.3

Q ss_pred             hcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEEEe
Q 043292          245 MLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVYEY  314 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~  314 (558)
                      .+|.|.- .|--+.+ -.+++||+|++...   ....++..+|..++..++|+|+++++.++.-..      +.++|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            4677776 4555544 35889999987532   334566789999999999999999999986543      45899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      | ..+|...+..     .++-.....|..|++.|+.|||+   .+|+||||||+||++..+..+||.|||+|+.-..+  
T Consensus       103 m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  103 M-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             h-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--
Confidence            9 5688888762     27778889999999999999999   99999999999999999999999999999854433  


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhh---------------HHHHHHHh
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY---------------LLSIFKKK  458 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~---------------~~~~~~~~  458 (558)
                      -.++..+.|..|.|||++-+ .+.+.+||||.||++.||++|...|.+...-++-..               +...++..
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y  251 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY  251 (369)
T ss_pred             cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence            34677888999999999875 499999999999999999999998876543332111               11111111


Q ss_pred             hh------cccchhhccc-cC-CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          459 AE------EDKLSDLVDK-HS-NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       459 ~~------~~~~~~~~d~-~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..      .-.+.+.+.. .. .....+.-....+.+++.+||-.||++|.|++++++.
T Consensus       252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            11      0111111111 11 1112223445678899999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.8e-27  Score=213.19  Aligned_cols=248  Identities=19%  Similarity=0.338  Sum_probs=185.0

Q ss_pred             HHhhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeee-eccCCcceEEEEeCC
Q 043292          240 DNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGF-CAEKSHNLLVYEYMP  316 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~~~  316 (558)
                      +++.+.||+|.||.+-++.. ...+.+++|.+.......++|.+|...--.| .|.||+.-++. |...+..++++||++
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            34568899999999999988 4678899999998877888999998876666 58999998865 555667789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCCCeEEcccCCccccCCCCC
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      .|+|.+-+...+    +.+....+++.|++.||.|+|+   .++||||||.+||||-  +...+||+|||+.+..+..  
T Consensus       106 ~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--  176 (378)
T KOG1345|consen  106 RGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--  176 (378)
T ss_pred             cchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence            999998876533    7788889999999999999999   9999999999999993  3347999999998754322  


Q ss_pred             ceeecccCCCCcCChhhhc----C--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          395 QVVTTMRGTPGYLAPEWLS----S--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~----~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                        .....-+..|.+||...    +  ...+.+|||.||++++.+++|+.||+.....+.    ..|-+..+..+....+-
T Consensus       177 --V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  177 --VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----PYWEWEQWLKRKNPALP  250 (378)
T ss_pred             --ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----hHHHHHHHhcccCccCc
Confidence              22233466799999764    2  367889999999999999999999985443331    12222223222222111


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      + ..+      .-...+.++..+-+.++|++|=-..++..+
T Consensus       251 ~-~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  251 K-KFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             h-hhc------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            1 111      112367778888899999999555555544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-27  Score=239.75  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=194.1

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .++|.|.+|.|||+++ ..++..|||+++-. .....-...|+-+++..+|+||+.++|.+......++.|||+.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            6799999999999998 46889999999843 333455678899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +.-+-..   .|++.++..+.+..++||+|||+   .+-+|||||-.|||+++.|.+|++|||.+..+...-. ....+.
T Consensus       101 diy~~Tg---plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krksfi  173 (829)
T KOG0576|consen  101 DIYHVTG---PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFI  173 (829)
T ss_pred             ceeeecc---cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh-hhhccc
Confidence            8876544   48899999999999999999999   8999999999999999999999999999887654322 244678


Q ss_pred             CCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          402 GTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       402 gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ||+.|||||+..    +.+..++|||+.|+...|+-.-+.|.....+.. ...++.           ...+++..  ...
T Consensus       174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmT-----------kS~~qpp~--lkD  239 (829)
T KOG0576|consen  174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMT-----------KSGFQPPT--LKD  239 (829)
T ss_pred             CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHhh-----------ccCCCCCc--ccC
Confidence            999999999863    469999999999999999988888765433322 111111           11111110  111


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...-...+-++++.++..||++|||++.+++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2233456788999999999999999987664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.2e-25  Score=218.39  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=190.5

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||.|.|++||++++.    ..+.||+|.+..... .....+|++.|..+ -+.||+++.+++..++...+|+||+++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            478999999999999874    467899998864332 34578999999999 599999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCCC----
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQD----  392 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~~----  392 (558)
                      ....+++..      ++...+...++.++.||.++|+   .|||||||||+|+|.+. .+.-.|.|||+|......    
T Consensus       120 ~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  120 DRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            999998864      7788999999999999999999   99999999999999974 456789999999722100    


Q ss_pred             -----------------------------CC----------ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHH
Q 043292          393 -----------------------------QS----------QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLE  431 (558)
Q Consensus       393 -----------------------------~~----------~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~e  431 (558)
                                                   ..          .......||++|.|||++.+  .-++++||||-||+++.
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                                         00          01123569999999999874  58899999999999999


Q ss_pred             HHhCCCCCCCCCCcchh-hhHHHHHHH------hhhccc--ch---------hhcc---cc------------CCCCCCC
Q 043292          432 ILCGRKVFDRSQPEEED-MYLLSIFKK------KAEEDK--LS---------DLVD---KH------------SNDMQSN  478 (558)
Q Consensus       432 lltg~~p~~~~~~~~~~-~~~~~~~~~------~~~~~~--~~---------~~~d---~~------------~~~~~~~  478 (558)
                      +++++.||-....+-.. ..+..+...      ....+.  +.         +...   ..            .......
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            99999999765443221 222221111      111111  10         0000   00            0001111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ......+++++.+|+..||.+|.|+++.++
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            122347899999999999999999999885

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=7.9e-26  Score=254.72  Aligned_cols=195  Identities=18%  Similarity=0.243  Sum_probs=137.6

Q ss_pred             ccCC-cceeeeeeee-------ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcE
Q 043292          289 SIHH-QNLVRLIGFC-------AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI  360 (558)
Q Consensus       289 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i  360 (558)
                      .++| .||+++++++       .+....++++||+ +++|.++|....  ..+++.+++.++.||++||.|||+   .+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHS---QGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            4456 6888888877       2334567888987 669999997532  349999999999999999999999   999


Q ss_pred             EecCCCCCCEeecC-------------------CCCeEEcccCCccccCCCCC---------------ceeecccCCCCc
Q 043292          361 LHLDIKPQNILLDG-------------------NFNAKVADFGLSKLIDQDQS---------------QVVTTMRGTPGY  406 (558)
Q Consensus       361 vH~dlk~~NIll~~-------------------~~~~ki~Dfgla~~~~~~~~---------------~~~~~~~gt~~y  406 (558)
                      +||||||+||||+.                   ++.+||+|||+++.......               .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566777777654211000               001124578889


Q ss_pred             CChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHH
Q 043292          407 LAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNM  485 (558)
Q Consensus       407 ~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  485 (558)
                      ||||++.+ .++.++|||||||+||||++|..|+....     .....+...         .+...      ........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~------~~~~~~~~  241 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQ------ILLNWPKE  241 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChh------hhhcCHHH
Confidence            99999865 58999999999999999999888764211     001111000         00000      01122345


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHH
Q 043292          486 MKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       486 ~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..++.+||+.+|.+||||.+|++.
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678889999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.3e-24  Score=199.67  Aligned_cols=166  Identities=22%  Similarity=0.228  Sum_probs=123.6

Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++..+..  .+++..++.|+.||+.||.|||+   .+      ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence            689999975432  49999999999999999999998   44      999999999999999  99988654322    


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                        ..|++.|+|||++.+ .++.++||||||+++|||++|+.||........  .+..+..... .        .......
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~-~--------~~~~~~~  130 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMP-A--------DDPRDRS  130 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhc-c--------CCccccc
Confidence              258899999999875 589999999999999999999999965432211  1111111100 0        0000001


Q ss_pred             CCHHHH--HHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          477 SNGEEV--VNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       477 ~~~~~~--~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ......  ..+.+++.+|++.+|.+|||+.++++.+..+
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            111112  2689999999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=199.13  Aligned_cols=246  Identities=25%  Similarity=0.438  Sum_probs=189.5

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecc---cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      |+..+|.....|..|+|+++ |..+++|++.-   .....++|..|.-.|+.+.||||++++|.|....+..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            45667899999999999987 45566677752   334557899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc--ccCCccccCCCCCc
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA--DFGLSKLIDQDQSQ  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~--Dfgla~~~~~~~~~  395 (558)
                      |||...|+...+ ...+-.+..+++..+|+|++|||+. .+-|.---|.+..+++|++.+++|+  |--++..       
T Consensus       272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-------  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------  342 (448)
T ss_pred             hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence            999999986543 4578889999999999999999983 2334455689999999999998884  2221111       


Q ss_pred             eeecccCCCCcCChhhhcCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          396 VVTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                       .....-.+.||+||.+++.    .-..+|+|||.+++|||.|...||....+.+..+.+.-       ++    + ...
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------eg----l-rv~  409 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------EG----L-RVH  409 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------cc----c-ccc
Confidence             1112236789999998742    34578999999999999999999998888775543321       11    1 111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      +     +..-...+.+++.-|++.||.+||.+..|+-+||++.
T Consensus       410 i-----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 I-----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             C-----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            1     1122346777888899999999999999999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.6e-22  Score=200.48  Aligned_cols=256  Identities=19%  Similarity=0.251  Sum_probs=189.0

Q ss_pred             hhhhcCccCceEEEEEEeCCC--CEEEEEEecccccc-hHHHHHHHHHHhccCC----cceeeeeeee-ccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTDG--TKVAVKRLEGIGEI-NKSFLAEVKTIGSIHH----QNLVRLIGFC-AEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~e  313 (558)
                      +.++||+|+||.||++.....  ..+|+|........ ...+..|..++..+..    +++..+++.. ..+...++||+
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~  101 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS  101 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence            457899999999999997553  47888877653222 2267788888888863    5888888888 47778899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-----CCeEEcccCCcc-
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-----FNAKVADFGLSK-  387 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~ki~Dfgla~-  387 (558)
                      .+ |.+|.++..... ...++..+.++|+.|++.+|.+||+   .|++||||||.|+++...     ..+.|.|||+++ 
T Consensus       102 l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  102 LL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             cc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            88 889999886655 4459999999999999999999999   999999999999999765     369999999999 


Q ss_pred             -ccCCCCCc------e-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh
Q 043292          388 -LIDQDQSQ------V-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK  458 (558)
Q Consensus       388 -~~~~~~~~------~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  458 (558)
                       .+......      . .....||.+|.++....+ ..+++.|+||++.++.|++.|..||...................
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence             43222211      1 234569999999999876 59999999999999999999999997655433211111111110


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                              ....   .....   ...+.++...+-..+..++|.+..+...|......
T Consensus       257 --------~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  257 --------LTDR---FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             --------cccc---ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence                    0110   01111   23445555555568999999999999998766443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6e-23  Score=206.41  Aligned_cols=166  Identities=20%  Similarity=0.199  Sum_probs=126.8

Q ss_pred             hhhhcCccCceEEEEEEeC--CCCEEEEEEeccc------ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT--DGTKVAVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||+||++...  +++.||||++...      ....+.|.+|++++.+++|+|+++.+..   .+..+||||
T Consensus        22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE   98 (365)
T PRK09188         22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRG   98 (365)
T ss_pred             EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEE
Confidence            3478999999999999874  5777899987532      1224568999999999999999853322   245799999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCC-CCCCEeecCCCCeEEcccCCccccCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI-KPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dl-k~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      |+++++|... .  .    ..   ...++.++++||.|||+   .+|+|||| ||+|||++.++.+||+|||+|+.+...
T Consensus        99 ~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188         99 WTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             ccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            9999999632 1  1    11   14678899999999999   99999999 999999999999999999999977543


Q ss_pred             CCce-------eecccCCCCcCChhhhcC-------CCCCccchH
Q 043292          393 QSQV-------VTTMRGTPGYLAPEWLSS-------IITEKVDIY  423 (558)
Q Consensus       393 ~~~~-------~~~~~gt~~y~aPE~~~~-------~~~~k~Dv~  423 (558)
                      ....       .+...+++.|+|||.+..       ..+..+|-|
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            2111       135668889999998862       133446766

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-21  Score=182.43  Aligned_cols=254  Identities=19%  Similarity=0.292  Sum_probs=190.3

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.++||.|+||.++.|+. -+++.||||.-.. +....++..|.+..+.| ..++|...+-|..++.+..||+|.+ |-|
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            358899999999999986 6799999996542 33345788899888888 4789999999999999999999998 889


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-----CCeEEcccCCccccCCCCC
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-----FNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~ki~Dfgla~~~~~~~~  394 (558)
                      |++++.-...  .++..++..||.|++.-++|+|+   ..+|.|||||+|+||...     ..+.|.|||+|+.+.+...
T Consensus       110 LEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  110 LEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             HHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            9998765443  38999999999999999999999   999999999999999643     3589999999998876554


Q ss_pred             ce------eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          395 QV------VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       395 ~~------~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      ..      .....||.+||+-....+ .-+.+.|+-|+|-+++..+-|..||.+............+- .....-.+.++
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG-e~Kr~T~i~~L  263 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG-ETKRSTPIEVL  263 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc-cccccCCHHHH
Confidence            43      335679999999887665 58999999999999999999999999876554222111110 00001111111


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      -.       .-.+   ++...+.-.-..+-.+-|.++-+...+..+
T Consensus       264 c~-------g~P~---efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  264 CE-------GFPE---EFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             Hh-------cCHH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            11       1123   344444445566778889887776665444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=3e-21  Score=174.26  Aligned_cols=254  Identities=20%  Similarity=0.292  Sum_probs=191.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCC-cceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.++||.|+||.+|.|.. .+|.+||+|.-+.. ....++.-|.++...+++ ..|..+.-|..++....+|||.+ +.|
T Consensus        19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs   96 (341)
T KOG1163|consen   19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS   96 (341)
T ss_pred             EEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence            458899999999999986 67999999976542 233567889999999975 67888888888999999999998 889


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC---CCeEEcccCCccccCCCCCce
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~---~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      |++++.-...  .++-.+.+-++-|++.-++|+|.   .+++||||||+|.|..-+   ..+.++|||+|+.+.+..+..
T Consensus        97 LEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   97 LEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            9998865443  38889999999999999999999   999999999999999643   468999999999876543322


Q ss_pred             ------eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          397 ------VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       397 ------~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                            .....||.+|.+-....+ .-+.+.|+-|+|.+|..+--|..||++..+.........+...     +..-.+.
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek-----K~s~~ie  246 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK-----KMSTPIE  246 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-----hcCCCHH
Confidence                  234668999998776654 4788999999999999999999999987765533332222211     1111111


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ....+      .+.++.-.+..|-..--++-|...-+-+++.-+
T Consensus       247 ~LC~G------~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  247 VLCKG------FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             HHhCC------CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            11111      123566667778888888889887777665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=5.7e-20  Score=185.04  Aligned_cols=256  Identities=31%  Similarity=0.435  Sum_probs=192.8

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccccc----chHHHHHHHHHHhccCCc-ceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQ-NLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||.|+||.||++...  ..+++|.+.....    ....+.+|+.++..+.|+ +++++.+++......+++++++.+
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~   82 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG   82 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence            467899999999999877  8889999874322    356799999999999988 799999999777778999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCc-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQ-  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~-  395 (558)
                      +++.+++........+.......++.|++.++.|+|+   .+++|||+||+||+++..+ .+++.|||+++........ 
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            9999776654311248899999999999999999999   8999999999999999998 7999999999865443322 


Q ss_pred             ----eeecccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          396 ----VVTTMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       396 ----~~~~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                          ......|+..|+|||.+.+    ..+...|+||+|++++++++|..||...................... .....
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  238 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASP  238 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccc
Confidence                2356789999999999875    58889999999999999999999976544310011111111111100 00000


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....     .......+.+++..++..+|..|.++.+....
T Consensus       239 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         239 LSPSN-----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCccc-----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000     01223567888999999999999998887754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=6.4e-21  Score=195.00  Aligned_cols=219  Identities=30%  Similarity=0.413  Sum_probs=165.9

Q ss_pred             HhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCC
Q 043292          287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIK  366 (558)
Q Consensus       287 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk  366 (558)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.....  .++|.....+++.|+.||.|||..  .-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            3568899999999999999999999999999999999987443  399999999999999999999982  333999999


Q ss_pred             CCCEeecCCCCeEEcccCCccccCCC-CCceeecccCCCCcCChhhhcCC--------CCCccchHHHHHHHHHHHhCCC
Q 043292          367 PQNILLDGNFNAKVADFGLSKLIDQD-QSQVVTTMRGTPGYLAPEWLSSI--------ITEKVDIYSFGVVMLEILCGRK  437 (558)
Q Consensus       367 ~~NIll~~~~~~ki~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~--------~~~k~Dv~s~Gv~l~elltg~~  437 (558)
                      ++|.++|..+.+||+|||+....... ............-|.|||.+.+.        .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876421 11112222345679999998642        5778999999999999999999


Q ss_pred             CCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          438 VFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       438 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ||......+....+...+..     .....+.+.+..   ..+....+..++..||..+|.+||++++|-..++.+....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            99875544432222222111     011111111111   1123337899999999999999999999999998876543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.8e-22  Score=211.27  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=182.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEec----cc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLE----GI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~----~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      ..++|.|++|.|+..... .....+.|...    ..   ......+..|+-+-..++|+|++..+....+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            357899999977776543 23333333221    11   11112256677788889999999988888777776666999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++ +|..++....   .++..++..++.|++.|+.|||+   .+|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus       403 ~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             ccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            999 9999987652   38888999999999999999999   9999999999999999999999999999987755444


Q ss_pred             c---eeecccCCCCcCChhhhcC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          395 Q---VVTTMRGTPGYLAPEWLSS-IITE-KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       395 ~---~~~~~~gt~~y~aPE~~~~-~~~~-k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .   ......|+..|+|||.+.+ .+.+ ..||||.|+++..|++|+.||......+....      ...    ......
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~----~~~~~~  545 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNN----YSDQRN  545 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhc----cccccc
Confidence            2   3456789999999999875 4554 68999999999999999999986655442210      000    000000


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..............+...++.+||+.||.+|.|+.+|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000112233456788999999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=8.5e-21  Score=175.59  Aligned_cols=138  Identities=15%  Similarity=0.197  Sum_probs=107.5

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc---c-------hHHH-----------------HHHHHHHhccCCccee
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---I-------NKSF-----------------LAEVKTIGSIHHQNLV  296 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~niv  296 (558)
                      ..||+|+||.||+|...+|+.||||+++....   .       ...|                 ..|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999988899999999864321   1       1122                 3499999999887764


Q ss_pred             eeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhc-cccCCCcEEecCCCCCCEeecCC
Q 043292          297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL-HEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       297 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      ....+..  ...+|||||++++++.......   ..++......++.|++.+|.|+ |+   .+|+||||||+|||++ +
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~  153 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence            4333222  2348999999988776543222   2488999999999999999999 67   8999999999999998 4


Q ss_pred             CCeEEcccCCccccC
Q 043292          376 FNAKVADFGLSKLID  390 (558)
Q Consensus       376 ~~~ki~Dfgla~~~~  390 (558)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=1.3e-20  Score=201.66  Aligned_cols=249  Identities=27%  Similarity=0.339  Sum_probs=181.3

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccc--cchHHH---HHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSF---LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||++.|=+|.+++..+|. |+||++-+..  -..+.|   +.|++ ...++|||.+++...-......|||-+|..
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk  104 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK  104 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence            3477999999999999988887 8899875332  222333   44444 566699999999988777777889988885


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC--CCCC
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID--QDQS  394 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~--~~~~  394 (558)
                      + +|.|.|..++   .|...+..-|+.|++.||.-+|.   .+|+|||||.+||||+.-.-+.|+||.-.+..-  .++.
T Consensus       105 h-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  105 H-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             h-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            4 7888776554   47888889999999999999999   999999999999999999999999998776431  2221


Q ss_pred             ----ceeecccCCCCcCChhhhcC------------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHH
Q 043292          395 ----QVVTTMRGTPGYLAPEWLSS------------IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       395 ----~~~~~~~gt~~y~aPE~~~~------------~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                          ....+...-..|+|||.+-.            ..+++.||||+||++.||++ |++||+-+       .+..+-  
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr--  248 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYR--  248 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHh--
Confidence                12223344558999997631            26788999999999999988 78888521       111110  


Q ss_pred             hhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       458 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .........++.+.-.         ..+..++..|++.||.+|.|+++.++.-.++.-.+
T Consensus       249 ~~~~~~~e~~Le~Ied---------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~  299 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIED---------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE  299 (1431)
T ss_pred             ccCccCHHHHHHhCcC---------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence            0001111112211111         15778999999999999999999999977775544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.5e-19  Score=167.83  Aligned_cols=139  Identities=16%  Similarity=0.190  Sum_probs=110.0

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccc---------------------------hHHHHHHHHHHhccCCccee
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI---------------------------NKSFLAEVKTIGSIHHQNLV  296 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~h~niv  296 (558)
                      +.||+|+||.||+|+..+|+.||||+++.....                           ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            579999999999999888999999998743210                           11235788999999999875


Q ss_pred             eeeeeeccCCcceEEEEeCCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          297 RLIGFCAEKSHNLLVYEYMPNGSLDRW-LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       297 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      ....+...  ..+|||||++++++... +..    ..++.....+++.|++.++.++|+.  .+|+||||||+|||++ +
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~  153 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-C
Confidence            54444332  34899999998865433 322    2378889999999999999999973  7999999999999999 7


Q ss_pred             CCeEEcccCCccccCC
Q 043292          376 FNAKVADFGLSKLIDQ  391 (558)
Q Consensus       376 ~~~ki~Dfgla~~~~~  391 (558)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.2e-19  Score=163.28  Aligned_cols=179  Identities=15%  Similarity=0.104  Sum_probs=138.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchH-----HHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK-----SFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ..|++|+||+||.+.. .+.+++.+.+.......+     .|.+|+++|.+++ |+++++++++    +..+++|||+.|
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            5799999999997765 688888888876555333     5789999999995 5789999886    446999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCC-CCCCEeecCCCCeEEcccCCccccCCCCCc-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI-KPQNILLDGNFNAKVADFGLSKLIDQDQSQ-  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dl-k~~NIll~~~~~~ki~Dfgla~~~~~~~~~-  395 (558)
                      .+|...+..          ....++.|++.+|.++|+   .+|+|||| ||.|||++.++.++|+|||+|......... 
T Consensus        83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         83 AAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            998654311          123577899999999999   99999999 799999999999999999999865432210 


Q ss_pred             ---e--------eecccCCCCcCChhhhc--CCCC-CccchHHHHHHHHHHHhCCCCCC
Q 043292          396 ---V--------VTTMRGTPGYLAPEWLS--SIIT-EKVDIYSFGVVMLEILCGRKVFD  440 (558)
Q Consensus       396 ---~--------~~~~~gt~~y~aPE~~~--~~~~-~k~Dv~s~Gv~l~elltg~~p~~  440 (558)
                         .        ......++.|++|+...  ...+ ...+.++-|.-+|.++|++.+.-
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence               0        01123578888888543  2333 56788899999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.6e-20  Score=171.13  Aligned_cols=162  Identities=15%  Similarity=0.115  Sum_probs=124.8

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchH----H------HHHHHHHHhccCCcceeeeeeeeccC-------
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK----S------FLAEVKTIGSIHHQNLVRLIGFCAEK-------  305 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----~------~~~E~~~l~~l~h~niv~l~~~~~~~-------  305 (558)
                      .++||.|+||.||.... ++..+|+|.+.......+    .      +.+|+..+.+++|++|..+..++...       
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~  114 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY  114 (232)
T ss_pred             EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence            47899999999999654 677899999974322222    2      57899999999999999998875533       


Q ss_pred             -CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          306 -SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       306 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                       +..+|||||++|.+|.++..       ++.    ....+++.+|..+|+   .+++|+|+||+||+++.++ ++|+|||
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEECC
Confidence             35789999999999988732       222    245689999999999   9999999999999999988 9999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhh-cCCCCCccchHHHHHHHHHHH
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL  433 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~k~Dv~s~Gv~l~ell  433 (558)
                      .......+...             ..+. ...+..++|+||||+++.-+.
T Consensus       180 ~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88755322111             0022 234667999999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=1.1e-18  Score=168.11  Aligned_cols=226  Identities=22%  Similarity=0.299  Sum_probs=145.6

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecc----cccchHHHHHHHHHHhccCC----------cceeeeeeee------
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEG----IGEINKSFLAEVKTIGSIHH----------QNLVRLIGFC------  302 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~------  302 (558)
                      +.||.|+++.||.+++. +++++|||+...    .....+++.+|.-.+..+.+          -.++..++..      
T Consensus        18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~   97 (288)
T PF14531_consen   18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP   97 (288)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred             cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence            67999999999999995 589999998742    22234567777666655432          2222222221      


Q ss_pred             ---ccCC--------cceEEEEeCCCCCHHHHHh---cCCC-CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCC
Q 043292          303 ---AEKS--------HNLLVYEYMPNGSLDRWLF---QRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKP  367 (558)
Q Consensus       303 ---~~~~--------~~~lv~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~  367 (558)
                         ....        +.+++|+-+ .++|.+++.   .... ...+....++.+..|+++.+++||.   .|++|+||+|
T Consensus        98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~  173 (288)
T PF14531_consen   98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIKP  173 (288)
T ss_dssp             SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-SG
T ss_pred             cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccce
Confidence               1111        235777777 678888754   2221 2234556667788999999999999   9999999999


Q ss_pred             CCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC---------CCCCccchHHHHHHHHHHHhCCCC
Q 043292          368 QNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---------IITEKVDIYSFGVVMLEILCGRKV  438 (558)
Q Consensus       368 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~k~Dv~s~Gv~l~elltg~~p  438 (558)
                      +|++++.+|.++|+||+.....+..    ......+..|.+||....         .++.+.|.|++|+++|.|+++..|
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            9999999999999999877654321    111345578999997632         378899999999999999999999


Q ss_pred             CCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCC
Q 043292          439 FDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR  500 (558)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  500 (558)
                      |+...+......                    ....   ..+-++.+..++..+|+.||.+|
T Consensus       250 f~~~~~~~~~~~--------------------~f~~---C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW--------------------DFSR---CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG--------------------GGTT---SS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc--------------------cchh---cCCcCHHHHHHHHHHccCCcccC
Confidence            986544321110                    1111   11455678889999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.8e-19  Score=184.25  Aligned_cols=224  Identities=25%  Similarity=0.284  Sum_probs=175.9

Q ss_pred             hcCccCceEEEEEEe----CCCCEEEEEEecccccc---hHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIGEI---NKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ++|.|.||.|++..-    ..+.-+|.|+++.....   ......|-.++...+ ||.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997643    34677888887643211   114456777888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|.|...+.+...   ++..........++-+++++|+   .+|+|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            9999888766543   6677777788899999999999   9999999999999999999999999999987644322  


Q ss_pred             eecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                         ..||..|||||++. .....+|-||||++++||++|..||..    +    .   .....         ..   ...
T Consensus       153 ---~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~----~---~~~Il---------~~---~~~  205 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----D----T---MKRIL---------KA---ELE  205 (612)
T ss_pred             ---cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----H----H---HHHHh---------hh---ccC
Confidence               17899999999988 457789999999999999999999975    1    1   11111         10   112


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                      .+.+....+.+++..++..+|.+|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            344555567778888999999999754

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=9.9e-18  Score=156.52  Aligned_cols=133  Identities=20%  Similarity=0.264  Sum_probs=103.2

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccc-ccchHHHHHHHHHHhcc-----CCcceeeeeeeeccCC---c-ceEEEE
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGI-GEINKSFLAEVKTIGSI-----HHQNLVRLIGFCAEKS---H-NLLVYE  313 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv~e  313 (558)
                      +.||+|+||.||. .-.++.. +||++... ....+.+.+|+.++..+     .||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            6799999999996 2234444 68887643 23456789999999999     5799999999998864   3 237899


Q ss_pred             e--CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhh-hhccccCCCcEEecCCCCCCEeecC----CCCeEEcccCCc
Q 043292          314 Y--MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL-TYLHEDCRQKILHLDIKPQNILLDG----NFNAKVADFGLS  386 (558)
Q Consensus       314 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~dlk~~NIll~~----~~~~ki~Dfgla  386 (558)
                      |  +.+++|.+++.+..    ++..  ..++.+++.++ +|||+   .+|+||||||+|||++.    +..++|+||+.+
T Consensus        86 ~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         86 FDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            9  55899999996532    5544  35677888777 99999   99999999999999974    347999995444


Q ss_pred             c
Q 043292          387 K  387 (558)
Q Consensus       387 ~  387 (558)
                      .
T Consensus       157 ~  157 (210)
T PRK10345        157 S  157 (210)
T ss_pred             c
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.7e-17  Score=157.43  Aligned_cols=138  Identities=17%  Similarity=0.212  Sum_probs=107.5

Q ss_pred             hhhhcCccCceEEEEEE--eCCCCEEEEEEeccccc-------------------------chHHHHHHHHHHhccCCcc
Q 043292          242 FRKMLGKGGFGSVFEGT--QTDGTKVAVKRLEGIGE-------------------------INKSFLAEVKTIGSIHHQN  294 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~-------------------------~~~~~~~E~~~l~~l~h~n  294 (558)
                      +.+.||+|+||.||+|+  ..+|+.||+|.++....                         ....+..|+..+.++.+..
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            45789999999999998  46899999998864311                         0123567999999997633


Q ss_pred             --eeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc-EEecCCCCCCEe
Q 043292          295 --LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK-ILHLDIKPQNIL  371 (558)
Q Consensus       295 --iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~dlk~~NIl  371 (558)
                        +.+++++    ...++||||+++.+|........   .+.......++.|++.++.+||+   .+ ++|+||||+||+
T Consensus       112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIl  181 (237)
T smart00090      112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNIL  181 (237)
T ss_pred             CCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEE
Confidence              3444443    23589999999988876543222   25566778999999999999999   88 999999999999


Q ss_pred             ecCCCCeEEcccCCccccC
Q 043292          372 LDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       372 l~~~~~~ki~Dfgla~~~~  390 (558)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=3.7e-17  Score=154.73  Aligned_cols=133  Identities=17%  Similarity=0.275  Sum_probs=113.1

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc---------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.||+|++|.||+|.. ++..+++|+......         ....+..|+.++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 677899997653211         123578899999999999998887777777888999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998642      22 788999999999999999   9999999999999999 78999999998874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.3e-17  Score=182.21  Aligned_cols=188  Identities=22%  Similarity=0.292  Sum_probs=148.6

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||+||+|+..+|+.||+|+-+.....  +|.--.+++.+|+   -+-|..+.......+..+||+||.+.|+
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            4689999999999999988999999987654332  2322233344444   2334444455556677899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-------CCCCeEEcccCCccccCC-
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-------GNFNAKVADFGLSKLIDQ-  391 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-------~~~~~ki~Dfgla~~~~~-  391 (558)
                      |.+++..   .+.++|.....++.|+++.++.||.   .+|||+||||+|.||.       ++..++|+|||-+-.+.- 
T Consensus       781 lld~~N~---~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  781 LLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             HHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            9999973   3459999999999999999999999   9999999999999994       234699999999875532 


Q ss_pred             CCCceeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCC
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKV  438 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p  438 (558)
                      ..........+|-.+--+|...|+ ++..+|.|.++-+++-|+.|+..
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            122345667789999999999875 99999999999999999999853

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=6.9e-17  Score=151.17  Aligned_cols=136  Identities=18%  Similarity=0.249  Sum_probs=107.3

Q ss_pred             HHhhhhcCccCceEEEEEEeCCCCEEEEEEeccccc-----------------------chHHHHHHHHHHhccCCcc--
Q 043292          240 DNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE-----------------------INKSFLAEVKTIGSIHHQN--  294 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~E~~~l~~l~h~n--  294 (558)
                      +.+.+.||+|+||.||++...+++.||||++.....                       ....+..|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            334578999999999999988899999998753211                       1123567888899888874  


Q ss_pred             eeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       295 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      +.+.++.    ...++||||+++++|......         .....++.+++.++.++|+   .+++|+||||+||++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence            4444432    345899999999998765421         2356788999999999999   99999999999999999


Q ss_pred             CCCeEEcccCCccccCC
Q 043292          375 NFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~  391 (558)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=7.7e-17  Score=151.05  Aligned_cols=129  Identities=19%  Similarity=0.308  Sum_probs=106.4

Q ss_pred             hcCccCceEEEEEEeCCCCEEEEEEecccc----c-----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIG----E-----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .||+|+||.||+|.. ++..+++|......    .     ...++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999984 57889999864321    1     1245778999999999887666555666667789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++++|.+++....    .      .++.+++.+|.+||+   .+++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875421    1      789999999999999   9999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.1e-17  Score=168.22  Aligned_cols=171  Identities=25%  Similarity=0.394  Sum_probs=129.4

Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      ..++.|+++...+|.+||.++......++...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999876655568899999999999999999      57899999999999999999999999998


Q ss_pred             cccCCCC-----CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          387 KLIDQDQ-----SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       387 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      .......     ....+...||..||+||.+.+ .++.|+||||||++|+|++. -...+......           ...
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-----------~d~  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-----------TDI  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-----------hhh
Confidence            7665443     234566789999999999986 59999999999999999987 33333211110           111


Q ss_pred             hcccch-hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 043292          460 EEDKLS-DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM  505 (558)
Q Consensus       460 ~~~~~~-~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  505 (558)
                      ..+.+. .+.           .....-..++.+++.+.|.+||++.+
T Consensus       473 r~g~ip~~~~-----------~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 RDGIIPPEFL-----------QDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hcCCCChHHh-----------hcCcHHHHHHHHhcCCCcccCchHHH
Confidence            112221 111           11113346889999999999994443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.5e-16  Score=171.21  Aligned_cols=132  Identities=18%  Similarity=0.268  Sum_probs=108.4

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---c-----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---G-----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .++||+|+||.||+|.+.....++.+++...   .     ...+.+.+|++++..++|++++....++......++||||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~  417 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY  417 (535)
T ss_pred             cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence            4789999999999998764443332222211   1     1134688999999999999999888888777788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      +++++|.+++.           ....++.+++.+|.|||+   .+++||||||+|||+ +++.++|+|||+++..
T Consensus       418 ~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        418 IGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             cCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999998874           356789999999999999   999999999999999 6779999999999753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=2.7e-16  Score=151.94  Aligned_cols=194  Identities=25%  Similarity=0.322  Sum_probs=135.8

Q ss_pred             CCcceeeeeeeeccC---------------------------CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHH
Q 043292          291 HHQNLVRLIGFCAEK---------------------------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL  343 (558)
Q Consensus       291 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  343 (558)
                      +|||||++.++|.+.                           ...|+||.-. ..+|..++..+.    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence            599999999877542                           2347888776 458999887654    66777888999


Q ss_pred             HHHHhhhhccccCCCcEEecCCCCCCEee--cCCC--CeEEcccCCccccCCC-----CCceeecccCCCCcCChhhhcC
Q 043292          344 DIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNF--NAKVADFGLSKLIDQD-----QSQVVTTMRGTPGYLAPEWLSS  414 (558)
Q Consensus       344 ~ia~~l~yLH~~~~~~ivH~dlk~~NIll--~~~~--~~ki~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~  414 (558)
                      |+++|..|||+   ++|.|||+|++|||+  |+|+  .+.|+|||.+-.-...     .....-...|....||||+...
T Consensus       349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999999   999999999999998  4444  4688999986532221     1111223567888999999862


Q ss_pred             ---C----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHH
Q 043292          415 ---I----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMK  487 (558)
Q Consensus       415 ---~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  487 (558)
                         .    -..|+|.|+.|-+.||+++...||.......    +..   +..++..+..+-+          .....+.+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L~~---r~Yqe~qLPalp~----------~vpp~~rq  488 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----LDT---RTYQESQLPALPS----------RVPPVARQ  488 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----ech---hhhhhhhCCCCcc----------cCChHHHH
Confidence               1    3569999999999999999999997522211    100   1112222222211          22346778


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 043292          488 VAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       488 l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ++...|+.||.+|++..-....
T Consensus       489 lV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhH
Confidence            8888999999999986544443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=1.3e-15  Score=141.14  Aligned_cols=136  Identities=21%  Similarity=0.258  Sum_probs=97.1

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccch---HHH----------------------HHHHHHHhccCCcc--ee
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN---KSF----------------------LAEVKTIGSIHHQN--LV  296 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--iv  296 (558)
                      +.||+|+||.||++...+++.||||++.......   ..+                      ..|...+..+.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            5799999999999998889999999886432111   111                      24555555554332  33


Q ss_pred             eeeeeeccCCcceEEEEeCCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          297 RLIGFCAEKSHNLLVYEYMPNGSLDRW-LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       297 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      +.++.    ...++||||++++.+... +....    .. .....++.+++.++.++|.+  .+|+|+||||+||+++ +
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-C
Confidence            44432    245899999998544221 11110    11 56788999999999999973  7899999999999999 8


Q ss_pred             CCeEEcccCCccccCC
Q 043292          376 FNAKVADFGLSKLIDQ  391 (558)
Q Consensus       376 ~~~ki~Dfgla~~~~~  391 (558)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=5e-16  Score=166.80  Aligned_cols=201  Identities=24%  Similarity=0.310  Sum_probs=135.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++.+..|++|.||..++. ..+++|.|. .+....    .+-  ++.....|.+|                     |+-.
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc--cccccCCccee---------------------chhh
Confidence            467889999999999875 466777743 221110    000  22222333333                     4555


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC--------
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ--------  393 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~--------  393 (558)
                      ..++....   ++..        .+.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+++......        
T Consensus       140 tllk~~g~---lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  140 TLLKNIGP---LPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhcccCCC---Ccch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            55544332   2222        2789999999   999999999999999999999999999987542111        


Q ss_pred             ----Cc--eeecccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          394 ----SQ--VVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       394 ----~~--~~~~~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                          ..  .....+||+.|+|||++..+ |...+|.|++|+++||.+-|..||.+..+++....++....         .
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i---------~  276 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---------E  276 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc---------c
Confidence                00  12346799999999998754 99999999999999999999999998877662211111100         0


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP  501 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  501 (558)
                      +.       +.......++.+++...|+.+|.+|-
T Consensus       277 wp-------E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  277 WP-------EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cc-------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            00       11112234677788889999999996

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=6e-15  Score=131.20  Aligned_cols=133  Identities=19%  Similarity=0.211  Sum_probs=113.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCC--cceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH--QNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.||.|.++.||+++..+ ..+++|....... ...+..|+..+..++|  .++.+++++...++..++++||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            568999999999999754 7899998865443 5678999999999976  58999999888888899999999887765


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      .+          +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            43          5567788899999999999984445799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=2.1e-14  Score=137.72  Aligned_cols=133  Identities=20%  Similarity=0.248  Sum_probs=104.2

Q ss_pred             hhcC-ccCceEEEEEEeCCCCEEEEEEecccc--------------cchHHHHHHHHHHhccCCcce--eeeeeeeccCC
Q 043292          244 KMLG-KGGFGSVFEGTQTDGTKVAVKRLEGIG--------------EINKSFLAEVKTIGSIHHQNL--VRLIGFCAEKS  306 (558)
Q Consensus       244 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  306 (558)
                      ..|| .|+.|+||+.... +..++||++....              .....+.+|++++..++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 8999999998775 7789999875211              123457889999999998875  67777644332


Q ss_pred             c----ceEEEEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEc
Q 043292          307 H----NLLVYEYMPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA  381 (558)
Q Consensus       307 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~  381 (558)
                      .    .++|+|++++ .+|.+++...    .++..    .+.+|+.+|.+||+   .+|+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 6999888643    24443    35689999999999   999999999999999999999999


Q ss_pred             ccCCccc
Q 043292          382 DFGLSKL  388 (558)
Q Consensus       382 Dfgla~~  388 (558)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.5e-15  Score=163.06  Aligned_cols=246  Identities=25%  Similarity=0.324  Sum_probs=180.2

Q ss_pred             hhhcCccCceEEEEEEeCC--CCEEEEEEeccccc---chHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQTD--GTKVAVKRLEGIGE---INKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+-||+|+|+.|-......  ...+|+|.+.....   ..+....|..+-..+. |+|++.+++...+.+..+++.+|..
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~  104 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD  104 (601)
T ss_pred             cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence            3558999999998876633  44566666653321   1223334666666665 9999999999999999999999999


Q ss_pred             CCCHHHHHh-cCCCCCCCCHHHHHHHHHHHHHhhhhcc-ccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCC--
Q 043292          317 NGSLDRWLF-QRSDEFMLDWQQRKKIILDIAKGLTYLH-EDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQ--  391 (558)
Q Consensus       317 ~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~--  391 (558)
                      ++++.+.+. ...  ...+....-..+.|+..++.|+| .   .++.|+|+||+|.+++..+ ..+++|||+|..+..  
T Consensus       105 g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  105 GGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             ccccccccccCCc--cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            999988873 222  13566677889999999999999 6   8999999999999999999 999999999998766  


Q ss_pred             CCCceeecccC-CCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          392 DQSQVVTTMRG-TPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       392 ~~~~~~~~~~g-t~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ..........| ++.|+|||...+  ...+..|+||.|+++.-+++|..|++........  ...|....   +....  
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~---~~~~~--  252 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK---GRFTQ--  252 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc---ccccc--
Confidence            33334445677 999999999876  4678899999999999999999999865544311  11110000   00000  


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                             .....-.....++...++..+|..|.+.+++.
T Consensus       253 -------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  253 -------LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -------CccccCChhhhhcccccccCCchhcccccccc
Confidence                   01111123566777888889999999988765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=9.1e-14  Score=131.68  Aligned_cols=203  Identities=23%  Similarity=0.346  Sum_probs=139.3

Q ss_pred             HHHHhccCCcceeeeeeeeccCC-----cceEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCC
Q 043292          284 VKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYEYMPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCR  357 (558)
Q Consensus       284 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  357 (558)
                      ..-|-.+.|.|||+++.|+.+..     ...++.|||+.|+|..+|++.. .+..+......+++.||+.||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            34556677999999999987644     4579999999999999998643 23457788888999999999999998 67


Q ss_pred             CcEEecCCCCCCEeecCCCCeEEcccCCcccc---CCCCCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHH
Q 043292          358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL  433 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~---~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ell  433 (558)
                      +.|+|+++..+-|++..++-+||+--.-....   ............+-++|.|||+=. -..+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999999998998532111100   000001112234678999999754 35778999999999999998


Q ss_pred             hCCCCCCCCCCc-chhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          434 CGRKVFDRSQPE-EEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       434 tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      -+..--..+... +....+             ...+-..-.+         .-..++..|++..|..||+|.+++..
T Consensus       277 ilEiq~tnseS~~~~ee~i-------------a~~i~~len~---------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENI-------------ANVIIGLENG---------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhh-------------hhheeeccCc---------cccCcCcccccCCCCCCcchhhhhcC
Confidence            876532221111 100000             0000000011         11236677999999999999998764

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.47  E-value=1.5e-14  Score=120.89  Aligned_cols=55  Identities=35%  Similarity=0.716  Sum_probs=49.0

Q ss_pred             CeeCCCCceEEEEec---cchhhhhhhcccCCCCCCCCccCCCCCCCC---CCCcCCCCCCccc
Q 043292            1 MRLWPDGHLRVYEWQ---RMWIVVADLLMSDLWDCDYPLVCGKYGICS---RGQCSCPATYFKL   58 (558)
Q Consensus         1 ~~l~~~G~l~~~~w~---~~w~~~~~~~~~~~~~c~~~~~Cg~~~~C~---~~~C~C~~g~~~~   58 (558)
                      ++||+||+||+|.|.   ..|..+|. .|.+  +||+|+.||+||+|+   .+.|+|++||.|.
T Consensus        49 ~~ld~~G~l~~~~w~~~~~~W~~~~~-~p~d--~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~  109 (110)
T PF00954_consen   49 LVLDSDGQLQRYIWNESTQSWSVFWS-APKD--QCDVYGFCGPNGICNSNNSPKCSCLPGFEPK  109 (110)
T ss_pred             EEEeeeeEEEEEEEecCCCcEEEEEE-eccc--CCCCccccCCccEeCCCCCCceECCCCcCCC
Confidence            579999999999997   56999988 8999  899999999999997   4689999999653

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=3.9e-13  Score=140.18  Aligned_cols=139  Identities=22%  Similarity=0.244  Sum_probs=99.0

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccc-----------------------------------------hHHHHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI-----------------------------------------NKSFLA  282 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~  282 (558)
                      +.||.|++|.||+|++.+|+.||||+.+.....                                         +-+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998532100                                         002444


Q ss_pred             HHHHHhccC----Ccceeeeeeee-ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-hhhhccccC
Q 043292          283 EVKTIGSIH----HQNLVRLIGFC-AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK-GLTYLHEDC  356 (558)
Q Consensus       283 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~~  356 (558)
                      |.+.+.++.    |.+-+.+-.++ ...+..+|||||++|++|.++.......  .   .+.+++..++. .+..+|.  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh--
Confidence            555554442    33333333333 2345679999999999998876532211  2   24456666665 4677887  


Q ss_pred             CCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       357 ~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                       .+++|+|+||.||+++.++.+++.|||++..+.
T Consensus       276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             899999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.42  E-value=1e-13  Score=103.76  Aligned_cols=59  Identities=29%  Similarity=0.571  Sum_probs=49.9

Q ss_pred             cCcceeeeccccccccCCCCCCCCCCChHHHHHHHhccCCceeecccccCcCCCCccccccc
Q 043292           80 QDHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSE  141 (558)
Q Consensus        80 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~  141 (558)
                      +.++|++|++|++|++.....+ .+++.++|+..||+||||+||+|.+..  ++++|++|.+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~-~~~s~~~C~~~Cl~nCsC~Ayay~~~~--~~~~C~lW~~   61 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVD-SSVSLEECEKACLSNCSCTAYAYSNLS--GGGGCLLWYG   61 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeee-cCCCHHHHHhhcCCCCCEeeEEeeccC--CCCEEEEEcC
Confidence            3478999999999998766544 569999999999999999999997532  5689999986

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.7e-12  Score=133.45  Aligned_cols=248  Identities=23%  Similarity=0.242  Sum_probs=175.9

Q ss_pred             HHHHHHhhhhcCc--cCceEEEEEEe---CCCCEEEEEEecc--c-ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCC
Q 043292          236 KVMTDNFRKMLGK--GGFGSVFEGTQ---TDGTKVAVKRLEG--I-GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKS  306 (558)
Q Consensus       236 ~~~t~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~--~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  306 (558)
                      ...+-++.+.+|.  |.+|.||.+..   .++..+|+|+-+.  . ......-.+|+....++ .|+|.++....+..++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3334455678999  99999999987   3577899997432  1 12222334566666666 4999999888889999


Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----hhhhccccCCCcEEecCCCCCCEeecCC-CCeEEc
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK----GLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVA  381 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~  381 (558)
                      ..++-+|.+ +.+|..+......  .++....+.+..+...    ||.++|+   ..++|-|+||.||++..+ ...+++
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence            999999998 4677777654332  3666677777777777    9999999   999999999999999999 889999


Q ss_pred             ccCCccccCCCCCc----eeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH
Q 043292          382 DFGLSKLIDQDQSQ----VVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK  457 (558)
Q Consensus       382 Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  457 (558)
                      |||+...+....-.    ......|...|++||...+.++..+|+|++|.++++...+..+....-...         |.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---------W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS---------WS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC---------cc
Confidence            99999877654311    122335788999999999999999999999999999988876553221110         00


Q ss_pred             hhhccc-chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          458 KAEEDK-LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       458 ~~~~~~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...... ..++.+          .-..++...+..|++.+|-.|++.+.+..
T Consensus       337 ~~r~~~ip~e~~~----------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 QLRQGYIPLEFCE----------GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccCchhhhc----------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            000000 011111          11124444888899999999998877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=4.1e-12  Score=115.61  Aligned_cols=130  Identities=19%  Similarity=0.147  Sum_probs=96.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCccee-eeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV-RLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      +.|+.|.++.||+.+.. +..+++|...........+..|+..+..+.+.+++ +++.+.  ....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            46789999999999865 77899998765433334567899999988766554 344443  334689999999988754


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC--CCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC--RQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      .    .    .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus        81 ~----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 E----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             c----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            2    0    1   11345678999999999822  12369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=5.5e-12  Score=133.05  Aligned_cols=138  Identities=18%  Similarity=0.217  Sum_probs=90.6

Q ss_pred             hhcCccCceEEEEEEeCC-CCEEEEEEeccccc-----------------------------------chH------HHH
Q 043292          244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGE-----------------------------------INK------SFL  281 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-----------------------------------~~~------~~~  281 (558)
                      +.||+|++|.||++++.+ |+.||||+++..-.                                   ..+      +|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            479999999999999977 99999999863210                                   001      234


Q ss_pred             HHHHHHhccC----Ccceeeeeeeecc-CCcceEEEEeCCCCCHHHHH--hcCC-CCCCCCHHHHHHHHHHHHHhhhhcc
Q 043292          282 AEVKTIGSIH----HQNLVRLIGFCAE-KSHNLLVYEYMPNGSLDRWL--FQRS-DEFMLDWQQRKKIILDIAKGLTYLH  353 (558)
Q Consensus       282 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH  353 (558)
                      .|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++-  .... ....+.......++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            4444444442    3333333333332 45678999999999998753  2211 001122223333344443       


Q ss_pred             ccCCCcEEecCCCCCCEeecCCC----CeEEcccCCccccCC
Q 043292          354 EDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLIDQ  391 (558)
Q Consensus       354 ~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~~~  391 (558)
                      .   .|++|+|+||.||+++.++    .+++.|||+...+..
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3   7999999999999999988    999999999987754

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.21  E-value=1.5e-11  Score=97.75  Aligned_cols=82  Identities=30%  Similarity=0.596  Sum_probs=58.7

Q ss_pred             CCcccCCc-CcceeeeccccccccCCCCCCCCCCChHHHHHHHhccCCceeecccccCcCCCCccccccccccccccccc
Q 043292           73 SLSCEASQ-DHRFVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKE  151 (558)
Q Consensus        73 ~l~C~~~~-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~~~~l~~~~~~  151 (558)
                      +++|.... .++|+.++++++|++....   ...+.++|++.|++||+|.||+|.++    +++|++|...+.  +... 
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~---~~~s~~~C~~~Cl~nCsC~a~~~~~~----~~~C~~~~~~~~--~~~~-   71 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI---TAISLEECREACLSNCSCTAYAYNNG----SGGCLLWNGLLN--NLRS-   71 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh---ccCCHHHHHHHHhcCCCcceeeecCC----CCeEEEEeceec--ceEe-
Confidence            56775332 4689999999999765432   66899999999999999999998753    678999976432  2222 


Q ss_pred             ccccCCccceecc
Q 043292          152 TTHYNSTAYIKVQ  164 (558)
Q Consensus       152 ~~~~~~~~ylkl~  164 (558)
                      ....+..+|+|++
T Consensus        72 ~~~~~~~~yiKv~   84 (84)
T cd01098          72 LSSGGGTLYLRLA   84 (84)
T ss_pred             ecCCCcEEEEEeC
Confidence            2222456888873

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=1.6e-10  Score=106.15  Aligned_cols=136  Identities=15%  Similarity=0.164  Sum_probs=98.9

Q ss_pred             hhcCccCceEEEEEEeCC-------CCEEEEEEecccc-----------------------cchHHH----HHHHHHHhc
Q 043292          244 KMLGKGGFGSVFEGTQTD-------GTKVAVKRLEGIG-----------------------EINKSF----LAEVKTIGS  289 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-----------------------~~~~~~----~~E~~~l~~  289 (558)
                      ..||.|.-+.||.|...+       +..+|||+.+...                       ...+.+    .+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       4799999764110                       001123    378999988


Q ss_pred             cCC--cceeeeeeeeccCCcceEEEEeCCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHhhhhc-cccCCCcEEecCC
Q 043292          290 IHH--QNLVRLIGFCAEKSHNLLVYEYMPNGSLDR-WLFQRSDEFMLDWQQRKKIILDIAKGLTYL-HEDCRQKILHLDI  365 (558)
Q Consensus       290 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~dl  365 (558)
                      +..  -++.+++++    ...+|||||+.+..+.. .+.+.    .++..+...+..+++.+|..| |+   .+++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            854  466666654    56789999997654422 22221    255566778889999999999 77   89999999


Q ss_pred             CCCCEeecCCCCeEEcccCCccccCC
Q 043292          366 KPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       366 k~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      ++.|||+++ +.+.|+|||.+....+
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCCC
Confidence            999999974 6899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.16  E-value=7.5e-10  Score=115.28  Aligned_cols=164  Identities=17%  Similarity=0.256  Sum_probs=123.8

Q ss_pred             CCCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHH
Q 043292          260 TDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR  338 (558)
Q Consensus       260 ~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~  338 (558)
                      .++.+|.|...+.... ......+-++.++.++||||++++......+..|||+|-+.  -|..++++      +.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            5688999998875544 23446677889999999999999999999999999999873  57777764      335566


Q ss_pred             HHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCCCCC
Q 043292          339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE  418 (558)
Q Consensus       339 ~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  418 (558)
                      .-.+.||+.||.|||+.  .+++|++|....|++++.|+.||++|.+......... ......--..|..|+.+... .-
T Consensus       107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s-~~  182 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS-EW  182 (690)
T ss_pred             HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc-cc
Confidence            67789999999999973  7899999999999999999999999988764332111 11111122345666644311 13


Q ss_pred             ccchHHHHHHHHHHHhC
Q 043292          419 KVDIYSFGVVMLEILCG  435 (558)
Q Consensus       419 k~Dv~s~Gv~l~elltg  435 (558)
                      ..|.|.||++++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            45999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=4.5e-10  Score=99.52  Aligned_cols=130  Identities=21%  Similarity=0.329  Sum_probs=100.9

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEE-eccc---cc-----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKR-LEGI---GE-----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~---~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      ..+++|+-+.+|.+.+. |.++++|. +++.   +.     ..++-.+|++++.+++--.|.-..-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999664 44466663 3221   11     124567899999999876666666667778888999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      +++..|.+.+...          +..++..|-.-+.-||.   .+|+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888643          35677778888888999   9999999999999998875 99999999984

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=3.1e-10  Score=107.94  Aligned_cols=141  Identities=19%  Similarity=0.261  Sum_probs=108.9

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc--chHHHHHHHHHHhccCC--cceeeeeeeeccCC---cceEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHH--QNLVRLIGFCAEKS---HNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  316 (558)
                      +.|+.|..+.||+++..+|..+++|.......  ....+..|.+++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45889999999999887778999998765432  35578899999999976  44577777766543   5689999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC----------------------------------------
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC----------------------------------------  356 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------  356 (558)
                      +.++.+.+..    ..++...+..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765431    12677777788888888888887521                                        


Q ss_pred             -------------CCcEEecCCCCCCEeecC--CCCeEEcccCCccc
Q 043292          357 -------------RQKILHLDIKPQNILLDG--NFNAKVADFGLSKL  388 (558)
Q Consensus       357 -------------~~~ivH~dlk~~NIll~~--~~~~ki~Dfgla~~  388 (558)
                                   ...++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         246799999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.02  E-value=2.7e-10  Score=88.04  Aligned_cols=68  Identities=18%  Similarity=0.162  Sum_probs=50.4

Q ss_pred             cceeeeccccccccCCCCCCCCCCChHHHHHHHhc---cCCceeecccccCcCCCCcccccccccccccccccccccCCc
Q 043292           82 HRFVELNDVAYFAFSSSSSDITNTDSETCKQACLK---NCSCKAALFQYGLNSSAGDCYLPSEIFSMMNNEKETTHYNST  158 (558)
Q Consensus        82 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~~C~~~~~~~~l~~~~~~~~~~~~~  158 (558)
                      .+|+++.++++|++.       ..+.++|++.|++   ||||+||+|.+.    +++|.+|.+.+. ++.+... ..+.+
T Consensus         9 g~fl~~~~~klpd~~-------~~s~~eC~~~Cl~~~~nCsC~Aya~~~~----~~gC~~W~~~l~-~d~~~~~-~~g~~   75 (80)
T cd00129           9 GTTLIKIALKIKTTK-------ANTADECANRCEKNGLPFSCKAFVFAKA----RKQCLWFPFNSM-SGVRKEF-SHGFD   75 (80)
T ss_pred             CeEEEeecccCCccc-------ccCHHHHHHHHhcCCCCCCceeeeccCC----CCCeEEecCcch-hhHHhcc-CCCce
Confidence            679999999988753       3689999999999   999999998753    358999997431 3333332 22566


Q ss_pred             ccee
Q 043292          159 AYIK  162 (558)
Q Consensus       159 ~ylk  162 (558)
                      +|+|
T Consensus        76 Ly~r   79 (80)
T cd00129          76 LYEN   79 (80)
T ss_pred             eEeE
Confidence            7776

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.00  E-value=2.8e-09  Score=93.97  Aligned_cols=140  Identities=16%  Similarity=0.247  Sum_probs=104.7

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEe-cc--------cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRL-EG--------IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l-~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      ..+-+|+-+.|+++... |+...||.- .+        ..-..++..+|++.+.+++--.|.-..-++.+.....|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            46778999999999866 666666632 21        112345678899999998766666666667777788899999


Q ss_pred             CCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCccc
Q 043292          315 MPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSKL  388 (558)
Q Consensus       315 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~~  388 (558)
                      +++ .++.+++...-... ........++..|-+.+.-||.   .+|+|+||..+||+|..++   .+.+.|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 47788876543321 2333347888999999999999   9999999999999996655   358999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.98  E-value=9.3e-09  Score=103.97  Aligned_cols=168  Identities=18%  Similarity=0.321  Sum_probs=128.8

Q ss_pred             ceEEEEEEe-CCCCEEEEEEecccccc-hHHHHHHHHHHhccCCcceeeeeeeec----cCCcceEEEEeCCC-CCHHHH
Q 043292          251 FGSVFEGTQ-TDGTKVAVKRLEGIGEI-NKSFLAEVKTIGSIHHQNLVRLIGFCA----EKSHNLLVYEYMPN-GSLDRW  323 (558)
Q Consensus       251 fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~  323 (558)
                      -.+.||+.. .||..|++|+++..+.. ...-..-++.++++.|.|+|++..++.    .+...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357889876 58999999999532211 112245578899999999999999886    34467899999885 678777


Q ss_pred             HhcCCC------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          324 LFQRSD------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       324 l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      .+....            +...++..+|.++.|+..||.++|+   .|+.-+-|.+++||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            654321            2346788999999999999999999   8999999999999999999999999998876654


Q ss_pred             CCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCC
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKV  438 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p  438 (558)
                      +.....               .  --.+-|.=.||.+++.|.+|...
T Consensus       446 d~~~~l---------------e--~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTEPL---------------E--SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCcch---------------h--HHhhhhHHHHHHHHHHHhhcccc
Confidence            431111               0  13467889999999999999653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=5.9e-10  Score=114.95  Aligned_cols=238  Identities=21%  Similarity=0.231  Sum_probs=164.4

Q ss_pred             hhhcCccCceEEEEEEe--CCCCEEEEEEecccccc---hHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQ--TDGTKVAVKRLEGIGEI---NKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ...||.|.|+.|++...  .++..+++|.+.+....   ...-..|+.+...+ .|.+++.....+....+.++=-||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            35799999999998754  35788999987643221   11124455555555 58888888777777777888899999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-CCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++...+.-.   ..++...++++..|++.++.++|+   ..++|+|++|+||++..+ +.-+++|||.+..+.-.   
T Consensus       350 ~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---  420 (524)
T KOG0601|consen  350 GGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---  420 (524)
T ss_pred             CcchhhhhHHH---HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee---
Confidence            99987666222   237788899999999999999999   999999999999999886 78899999998642211   


Q ss_pred             eeecccCCCCcC-Chhhhc-C-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 VVTTMRGTPGYL-APEWLS-S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~~~~~~gt~~y~-aPE~~~-~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ........++. .+|.+. . .+-.+.|++|||.-+.|.+++...-.....                   ...+.....
T Consensus       421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------------~~~i~~~~~  480 (524)
T KOG0601|consen  421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------------SLTIRSGDT  480 (524)
T ss_pred             -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------------ceeeecccc
Confidence             11222334444 255444 3 478899999999999999998753321110                   000111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                         .........+..++..++..++..||.+.+...+.+.
T Consensus       481 ---p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  481 ---PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ---cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence               1111222566677788999999999999887765543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=1.3e-08  Score=93.09  Aligned_cols=125  Identities=24%  Similarity=0.337  Sum_probs=82.8

Q ss_pred             EEEEEEeCCCCEEEEEEeccc--------------cc-------------chHHHHHHHHHHhccCCc--ceeeeeeeec
Q 043292          253 SVFEGTQTDGTKVAVKRLEGI--------------GE-------------INKSFLAEVKTIGSIHHQ--NLVRLIGFCA  303 (558)
Q Consensus       253 ~Vy~~~~~~~~~vavK~l~~~--------------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~  303 (558)
                      .||.|...++..+|||..+..              ..             ......+|.+.|.++..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999989999999976411              00             112357799999999765  55666655  


Q ss_pred             cCCcceEEEEeCC--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhh-ccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          304 EKSHNLLVYEYMP--NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY-LHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       304 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                        ....|||||++  +..+..+... .    ++......++.+++..+.. +|.   .+|+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence              24589999998  5555443321 1    1233456677777775555 467   899999999999999988 9999


Q ss_pred             cccCCccccC
Q 043292          381 ADFGLSKLID  390 (558)
Q Consensus       381 ~Dfgla~~~~  390 (558)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=1.1e-09  Score=118.83  Aligned_cols=239  Identities=22%  Similarity=0.265  Sum_probs=154.2

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +-+-+|.++.++...-. .|...+.|.......    ..+....+-.++-..++|-++...--+.-.....|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            35667888888766542 233333333321111    1111122222222234566665554455667789999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC-------
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-------  391 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~-------  391 (558)
                      +|...|+....   .+..-....+..+..+++|||.   ..+.|+|++|.|+|+..++..+++|||.......       
T Consensus       890 ~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  890 DLPSKLHNSGC---LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             CchhhhhcCCC---cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            99999876552   4444555566677889999998   6699999999999999999999999984332210       


Q ss_pred             -----------------------CCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch
Q 043292          392 -----------------------DQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE  447 (558)
Q Consensus       392 -----------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~  447 (558)
                                             +.........+|+.|.+||...+ .....+|.|++|++++|.++|..||....+...
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence                                   00011234568999999998875 578889999999999999999999986554331


Q ss_pred             hhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 043292          448 DMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS  504 (558)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  504 (558)
                                      +..+............+......+++...+..+|.+|-.|.
T Consensus      1044 ----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 ----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                            11111111111122223344566677777888999997766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=4.8e-08  Score=94.91  Aligned_cols=133  Identities=17%  Similarity=0.146  Sum_probs=97.2

Q ss_pred             ceEEEEEEeCCCCEEEEEEeccccc------------chHHHHHHHHHHhccCCcc--eeeeeeeecc-----CCcceEE
Q 043292          251 FGSVFEGTQTDGTKVAVKRLEGIGE------------INKSFLAEVKTIGSIHHQN--LVRLIGFCAE-----KSHNLLV  311 (558)
Q Consensus       251 fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv  311 (558)
                      ...|.+... +|+.+.||+......            ....+.+|.+.+.++...+  ..+++++...     ....+||
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            344666654 577899997753321            1114788999998885443  3455556543     2246899


Q ss_pred             EEeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-------CCCeEEccc
Q 043292          312 YEYMPNG-SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-------NFNAKVADF  383 (558)
Q Consensus       312 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-------~~~~ki~Df  383 (558)
                      +|++++. +|.+++..... ...+...+..++.+++..+.-||+   .||+|+|++++|||++.       +..+.++||
T Consensus       114 te~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999886 89998864322 225667788999999999999999   99999999999999975       467899999


Q ss_pred             CCccc
Q 043292          384 GLSKL  388 (558)
Q Consensus       384 gla~~  388 (558)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.78  E-value=2.7e-08  Score=93.63  Aligned_cols=134  Identities=22%  Similarity=0.242  Sum_probs=94.3

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEecc----------c-------c------cchHHHHHHHHHHhccCCc--ce
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEG----------I-------G------EINKSFLAEVKTIGSIHHQ--NL  295 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~----------~-------~------~~~~~~~~E~~~l~~l~h~--ni  295 (558)
                      .+.++||-|.-+.||.|..++|.++|||.=+-          .       .      .......+|.+.|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            34578999999999999999999999994320          0       0      0122457789999998755  66


Q ss_pred             eeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       296 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      .+.+++    +...+||||+++--|...-        ++....-.|+..|+.-+.-+-.   .|+||+|+++-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence            776654    5568999999886664321        1222233333333333333334   899999999999999999


Q ss_pred             CCeEEcccCCcccc
Q 043292          376 FNAKVADFGLSKLI  389 (558)
Q Consensus       376 ~~~ki~Dfgla~~~  389 (558)
                      |.+.++||--+...
T Consensus       239 g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 GDIVVIDWPQAVPI  252 (304)
T ss_pred             CCEEEEeCcccccC
Confidence            99999999766544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=4.7e-07  Score=89.65  Aligned_cols=258  Identities=12%  Similarity=0.162  Sum_probs=152.2

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccc-hHHHHHHHHHHhcc-CCcceeeeeee------eccCCc-ceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI-NKSFLAEVKTIGSI-HHQNLVRLIGF------CAEKSH-NLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~~-~~lv~e~  314 (558)
                      ..||+|+.+.+|-.-  .-..-+.|+....... ..+   .+..|... .||-+-.-+.+      .-+++. .-++|..
T Consensus        17 r~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          17 RPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             ccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            569999999999642  2222344666533221 111   12223333 45533221111      111222 3466666


Q ss_pred             CCCC-CHHHHHh---cCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          315 MPNG-SLDRWLF---QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       315 ~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      +.+. -...++.   ++..-...+|...+++++.+|.+.+-||.   .|.+-+|+.++|+|+.+++.+.|.|-...... 
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-  167 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-  167 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec-
Confidence            6543 2223332   12233457899999999999999999999   99999999999999999999999886554433 


Q ss_pred             CCCCceeecccCCCCcCChhhhc-----C-CCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLS-----S-IITEKVDIYSFGVVMLEILCG-RKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~k~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                       .+.......+|...|.+||.-.     + .-+..+|.|.+|+++++++.| +.||.+.......-.-.   ......+.
T Consensus       168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~---E~~Ia~g~  243 (637)
T COG4248         168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL---ETDIAHGR  243 (637)
T ss_pred             -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc---hhhhhcce
Confidence             3333455677899999999754     2 367889999999999999886 89997643221100000   00001111


Q ss_pred             chhhccccCC----CCC-CCHHHHHHHHHHHHHccCc--CCCCCCCHHHHHHHHhccc
Q 043292          464 LSDLVDKHSN----DMQ-SNGEEVVNMMKVAAWCLES--DFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       464 ~~~~~d~~~~----~~~-~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~vl~~L~~~~  514 (558)
                      +...-+....    ... .-.-....+.-+..+|+..  ++.-|||++..+..|..+.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            1111111100    000 0011123455566677755  5779999999998886653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=2.4e-07  Score=97.45  Aligned_cols=141  Identities=16%  Similarity=0.240  Sum_probs=90.6

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc-----------------------c--------chH----------HHHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-----------------------E--------INK----------SFLA  282 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------------~--------~~~----------~~~~  282 (558)
                      +.|+.++-|.||+|++.+|+.||||+.+..-                       .        ..+          ++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5789999999999999999999999874210                       0        000          1233


Q ss_pred             HHHHHhcc----C-CcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCC
Q 043292          283 EVKTIGSI----H-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR  357 (558)
Q Consensus       283 E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  357 (558)
                      |..-+.++    + .+++.-..=|..-.+...|+|||++|..+.+........  .+...   ++..++++  |+.+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~--f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRA--FLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHH--HHHHHHh
Confidence            44444333    2 233322222333456789999999999998885322221  44322   22222222  1111112


Q ss_pred             CcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      .+++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            6899999999999999999999999999887653

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=2e-06  Score=79.33  Aligned_cols=137  Identities=20%  Similarity=0.205  Sum_probs=102.7

Q ss_pred             cCccCceEEEEEEeCCCCEEEEEEeccc-------ccchHHHHHHHHHHhccCCc--ceeeeeeeeccC-----CcceEE
Q 043292          246 LGKGGFGSVFEGTQTDGTKVAVKRLEGI-------GEINKSFLAEVKTIGSIHHQ--NLVRLIGFCAEK-----SHNLLV  311 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~-----~~~~lv  311 (558)
                      -|+||-+.|++-.+. |..+-+|+-.+.       .-....|.+|...|.++...  ++.++. ++...     -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477999999997654 447889976521       33567899999999999643  344444 33211     124799


Q ss_pred             EEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC--eEEcccCCccc
Q 043292          312 YEYMPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN--AKVADFGLSKL  388 (558)
Q Consensus       312 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~--~ki~Dfgla~~  388 (558)
                      +|-+++ .+|.+++.+..-. ..+...+..++.+|+..+.-||+   .++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 6898888654322 36788889999999999999999   99999999999999986666  89999976653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=4.5e-08  Score=102.66  Aligned_cols=150  Identities=21%  Similarity=0.374  Sum_probs=100.3

Q ss_pred             HHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee--------ecccCCCCcCChhhhc
Q 043292          342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--------TTMRGTPGYLAPEWLS  413 (558)
Q Consensus       342 ~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~  413 (558)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+...........        .-......|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999998  48999999999999999999999999998765433211111        1123456899999987


Q ss_pred             C-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHH
Q 043292          414 S-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW  491 (558)
Q Consensus       414 ~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  491 (558)
                      + ..+.++|+||+|++++-+.. |+..+..........    ....         ..+  ........+.+.++.+=+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~~---------~~~--~~~~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSRN---------LLN--AGAFGYSNNLPSELRESLKK  247 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhhc---------ccc--cccccccccCcHHHHHHHHH
Confidence            6 48899999999999999995 444444332211100    0000         000  00111122334567777788


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 043292          492 CLESDFAKRPSMSMVVR  508 (558)
Q Consensus       492 cl~~~p~~RPs~~~vl~  508 (558)
                      ++..++.-||++.++..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            89999999997776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=8e-07  Score=83.44  Aligned_cols=107  Identities=21%  Similarity=0.332  Sum_probs=85.1

Q ss_pred             hHHHHHHHHHHhccCC--cceeeeeeeeccCC----cceEEEEeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhh
Q 043292          277 NKSFLAEVKTIGSIHH--QNLVRLIGFCAEKS----HNLLVYEYMPNG-SLDRWLFQRSDEFMLDWQQRKKIILDIAKGL  349 (558)
Q Consensus       277 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l  349 (558)
                      .....+|.+.+..+..  -...+.+++.....    ..+||+|++++. +|.+++.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            3467888888887753  34566666665532    347999999874 89999876433   56677889999999999


Q ss_pred             hhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCcccc
Q 043292          350 TYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSKLI  389 (558)
Q Consensus       350 ~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~~~  389 (558)
                      .-||+   .+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   9999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.27  E-value=8.6e-06  Score=77.51  Aligned_cols=139  Identities=17%  Similarity=0.158  Sum_probs=84.1

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcc--eeeeeeeeccCCcceEEEEeCCCCC-H
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN--LVRLIGFCAEKSHNLLVYEYMPNGS-L  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L  320 (558)
                      ..||+|..+.||+.   .+..+++|...... ......+|.+++..+..-.  +.+.+++...++...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   25567788776422 3345688999998886443  4667777777777789999998863 2


Q ss_pred             HHHHh--------------c-----CC-CCCCCCHHHHHH-HHHHH----------HH-hhhhccc-cCCCcEEecCCCC
Q 043292          321 DRWLF--------------Q-----RS-DEFMLDWQQRKK-IILDI----------AK-GLTYLHE-DCRQKILHLDIKP  367 (558)
Q Consensus       321 ~~~l~--------------~-----~~-~~~~l~~~~~~~-i~~~i----------a~-~l~yLH~-~~~~~ivH~dlk~  367 (558)
                      ...+.              +     +. .........+.. +..++          .. ...+|.. .....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            21111              0     00 000011111110 00000          00 1111111 1134678999999


Q ss_pred             CCEeecCCCCeEEcccCCcc
Q 043292          368 QNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       368 ~NIll~~~~~~ki~Dfgla~  387 (558)
                      .||++++++ +.|.||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999988 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.23  E-value=7.4e-06  Score=76.65  Aligned_cols=136  Identities=20%  Similarity=0.252  Sum_probs=90.0

Q ss_pred             hcCccCceEEEEEEeCCCCEEEEEEecccccc----------hHH---------------HHHHHHHHhccC--Ccceee
Q 043292          245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI----------NKS---------------FLAEVKTIGSIH--HQNLVR  297 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~---------------~~~E~~~l~~l~--h~niv~  297 (558)
                      .|.+|.-+.||+|.-.++..+|||+.+.....          ...               ...|+.-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            57788889999998888999999988532111          111               134555566553  344455


Q ss_pred             eeeeeccCCcceEEEEeCCCCC-HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC
Q 043292          298 LIGFCAEKSHNLLVYEYMPNGS-LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF  376 (558)
Q Consensus       298 l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~  376 (558)
                      .+++.    +..|||||+.... -.-.|++    ..+.......+..++++.+.-|-.  ..++||+||+.-|||+. ++
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence            55543    3479999995431 1111211    113333566666777777776655  27899999999999999 78


Q ss_pred             CeEEcccCCccccCC
Q 043292          377 NAKVADFGLSKLIDQ  391 (558)
Q Consensus       377 ~~ki~Dfgla~~~~~  391 (558)
                      .+.|+|||-|....+
T Consensus       204 ~p~iID~~QaV~~~h  218 (268)
T COG1718         204 EPYIIDVSQAVTIDH  218 (268)
T ss_pred             eEEEEECccccccCC
Confidence            999999998875543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.4e-05  Score=84.10  Aligned_cols=141  Identities=21%  Similarity=0.248  Sum_probs=89.4

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc--------------------------------chH------HHHHHHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE--------------------------------INK------SFLAEVK  285 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------------------------~~~------~~~~E~~  285 (558)
                      +.||.-+.|.||++++++|+.||||+-+..-+                                ..+      +|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            57999999999999999999999997642100                                001      2444444


Q ss_pred             HHhc----cCCcce---eeeeeee-ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCC
Q 043292          286 TIGS----IHHQNL---VRLIGFC-AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR  357 (558)
Q Consensus       286 ~l~~----l~h~ni---v~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  357 (558)
                      -..+    +.|-++   |.+=.++ .-...+.|+||||+|..+.+.-.-...  .++...+..-+.   ++  |++.-..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~---~~--~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLV---EA--YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHH---HH--HHHHHHh
Confidence            3322    335551   2222222 334578999999999888766432211  155554433333   32  2222122


Q ss_pred             CcEEecCCCCCCEeecC----CCCeEEcccCCccccCC
Q 043292          358 QKILHLDIKPQNILLDG----NFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~----~~~~ki~Dfgla~~~~~  391 (558)
                      .|++|+|-+|.||+++.    ++.+.+.|||+......
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68999999999999984    67899999999886654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=1.5e-06  Score=90.44  Aligned_cols=181  Identities=20%  Similarity=0.160  Sum_probs=129.8

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcc-eeeeeeeeccCCcceEEEEeCCCC-CHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN-LVRLIGFCAEKSHNLLVYEYMPNG-SLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~  321 (558)
                      +-+++|+.++++|.+....+...++.+...    ....-++++|.+++||| .+..++-+..+...+++++++..+ +-.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            347889999999988655555556665543    33456889999999999 666677677777788999998766 211


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      .-.  ......+...+...+.+.-+++++|||+   ..-+|+|    ||+..+ +..|.+||+....+....  ......
T Consensus       324 ~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~  391 (829)
T KOG0576|consen  324 LEM--TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI  391 (829)
T ss_pred             ccC--ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence            111  0111113333445566677789999998   4458888    877766 589999999988776543  345677


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFD  440 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~  440 (558)
                      +++.++|||+.. +.+..+.|+|++|+-..++.-|-+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            899999999765 579999999999988777777766643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.07  E-value=1.1e-05  Score=74.12  Aligned_cols=105  Identities=23%  Similarity=0.268  Sum_probs=82.2

Q ss_pred             HHHHHHHhccCC-cceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc
Q 043292          281 LAEVKTIGSIHH-QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK  359 (558)
Q Consensus       281 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  359 (558)
                      ..|.-++..+.+ +++.+++|+|-    .+++.||...+++...-..-..-..-+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357778888876 69999999994    4789999987765421000001112689999999999999999999866667


Q ss_pred             EEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          360 ILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       360 ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      +.-.|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=3.7e-05  Score=74.26  Aligned_cols=139  Identities=12%  Similarity=0.080  Sum_probs=84.1

Q ss_pred             cCccCc-eEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCCCHHHH
Q 043292          246 LGKGGF-GSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW  323 (558)
Q Consensus       246 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  323 (558)
                      |-.|.. ..||+.... +..+.||+.....  ..+...|++++..+. +-.+.+++++...++..++|||+++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            334444 789998764 4778888876543  345678888888874 44566777777766678999999999887644


Q ss_pred             Hh-------------------cCCC-CCCCC--HHHHHHHHH-H-------------------HHHhhhhcc----ccCC
Q 043292          324 LF-------------------QRSD-EFMLD--WQQRKKIIL-D-------------------IAKGLTYLH----EDCR  357 (558)
Q Consensus       324 l~-------------------~~~~-~~~l~--~~~~~~i~~-~-------------------ia~~l~yLH----~~~~  357 (558)
                      ..                   .... ...+.  ......... .                   +...+..|-    ....
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            21                   0000 00111  000110000 0                   011111111    0112


Q ss_pred             CcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          358 QKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ..++|+|+.|.|||++++..+.|.||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            569999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.02  E-value=3.2e-05  Score=73.88  Aligned_cols=142  Identities=20%  Similarity=0.247  Sum_probs=83.4

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc--ceeeeeeeeccC---CcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ--NLVRLIGFCAEK---SHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~g  318 (558)
                      +.|+.|..+.||+....+ ..+++|..... .....+..|..++..+...  .+.+++.+....   ...+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            458889999999999876 69999987655 4456677888888887533  345666644322   2357999999998


Q ss_pred             CHHH----------------HHh---cC-CCCCCCCHHHH---------HHH------------HHHHHH-hhhhccc--
Q 043292          319 SLDR----------------WLF---QR-SDEFMLDWQQR---------KKI------------ILDIAK-GLTYLHE--  354 (558)
Q Consensus       319 sL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~ia~-~l~yLH~--  354 (558)
                      .+..                .+.   .. .....+.+...         ...            ...+.. .+..+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8877                111   11 01111111110         000            011112 2233332  


Q ss_pred             --cCCCcEEecCCCCCCEeec-CCCCeEEcccCCcc
Q 043292          355 --DCRQKILHLDIKPQNILLD-GNFNAKVADFGLSK  387 (558)
Q Consensus       355 --~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgla~  387 (558)
                        .....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1346799999999999999 66666799998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=97.95  E-value=1.2e-05  Score=62.50  Aligned_cols=53  Identities=32%  Similarity=0.605  Sum_probs=43.4

Q ss_pred             cceeeeccccccccCCCCCCCCCCChHHHHHHHhc-cCCceeecccccCcCCCCcccccc
Q 043292           82 HRFVELNDVAYFAFSSSSSDITNTDSETCKQACLK-NCSCKAALFQYGLNSSAGDCYLPS  140 (558)
Q Consensus        82 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~~C~~~~  140 (558)
                      ..|+.++++.+++.....  ....+.++|++.|++ +|+|.||.|.+    +++.|++|.
T Consensus         4 ~~f~~~~~~~l~~~~~~~--~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~   57 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV--ISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWS   57 (78)
T ss_pred             ceeEEecCccCCCCccee--EcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEee
Confidence            569999999998554432  356799999999999 99999999864    467899998

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.86  E-value=8.1e-05  Score=69.06  Aligned_cols=68  Identities=24%  Similarity=0.353  Sum_probs=53.3

Q ss_pred             CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCC
Q 043292          306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL  385 (558)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgl  385 (558)
                      ...+|+|||++|..|.+...       ++.    .++..+.+++.-||+   .|+.|+|.+|.|++++++ .+++.||+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~  180 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQG  180 (229)
T ss_pred             eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECcc
Confidence            34569999999988866532       222    245567788899999   999999999999999966 499999986


Q ss_pred             ccc
Q 043292          386 SKL  388 (558)
Q Consensus       386 a~~  388 (558)
                      .+.
T Consensus       181 k~~  183 (229)
T PF06176_consen  181 KRM  183 (229)
T ss_pred             ccc
Confidence            653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.78  E-value=0.0003  Score=65.04  Aligned_cols=126  Identities=17%  Similarity=0.282  Sum_probs=88.9

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc-----------------cchHHHHHHHHHHhccC------Ccceeeeee
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-----------------EINKSFLAEVKTIGSIH------HQNLVRLIG  300 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~~  300 (558)
                      ..||+|+.-.||.-  ++.....||++....                 ...+++.+|+.....+.      +..|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            56999999999964  556667888876443                 23456677776655555      889999999


Q ss_pred             eeccCCcceEEEEeCC------CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC
Q 043292          301 FCAEKSHNLLVYEYMP------NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG  374 (558)
Q Consensus       301 ~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~  374 (558)
                      +...+...-+|+|.+.      .-+|.+++++..    ++. ...+.+.   +-..||-+   ..|+.+|++|.||++..
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEe
Confidence            9999999999999864      346777775432    554 3333333   44456666   78999999999999954


Q ss_pred             CC----CeEEcc
Q 043292          375 NF----NAKVAD  382 (558)
Q Consensus       375 ~~----~~ki~D  382 (558)
                      ..    .+.|.|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.73  E-value=0.00025  Score=80.68  Aligned_cols=77  Identities=12%  Similarity=0.295  Sum_probs=55.8

Q ss_pred             hhcCccCceEEEEEEeCCC---CEEEEEEecccc--cchHHHHHHHHHHhccC-Ccce--eeeeeeeccC---CcceEEE
Q 043292          244 KMLGKGGFGSVFEGTQTDG---TKVAVKRLEGIG--EINKSFLAEVKTIGSIH-HQNL--VRLIGFCAEK---SHNLLVY  312 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~  312 (558)
                      +.++.|.+..+|+....++   ..+++|+.....  .....+.+|.+++..+. |.++  .+++.++.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4578899999999876543   467777764322  23356889999999995 6654  7788887764   4578999


Q ss_pred             EeCCCCCH
Q 043292          313 EYMPNGSL  320 (558)
Q Consensus       313 e~~~~gsL  320 (558)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99987643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=0.00019  Score=63.65  Aligned_cols=128  Identities=19%  Similarity=0.263  Sum_probs=86.4

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceee-eeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR-LIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ..+.|++|.+|.||+|.+. |..+|+|+-.. ......+..|++++..+.--++.+ ++.|..    ..+.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            3467999999999999876 55888887653 234567889999999998776654 333322    2345999988888


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCC-CCCEeecCCCCeEEcccCCccc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIK-PQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk-~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      .++-..      .+..+    +..+++.---|-.   .||-|+.|. |..++|..+..+.|+||.-|..
T Consensus       100 ~~~~~~------~~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIG------GDRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhc------ccHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            665432      12222    2334444233333   788898887 5555555566999999998873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.69  E-value=0.00024  Score=68.12  Aligned_cols=73  Identities=19%  Similarity=0.246  Sum_probs=47.6

Q ss_pred             hhcCccCceEEEEEEeCC--CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQTD--GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.|..|-...+|+....+  +..+++|.........-....|+.++..+...++ .++++...    ..+||||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            346778888999987664  6788899775432222233478888888854444 34444332    2489999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.69  E-value=0.00045  Score=68.70  Aligned_cols=75  Identities=8%  Similarity=0.112  Sum_probs=55.6

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCC---cceeeeeeeeccC---CcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH---QNLVRLIGFCAEK---SHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~~~  317 (558)
                      +.||.|..+.||+....++ .+.+|..+. ......|..|.+.++.+..   ..+.++++++..+   +..+||||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4699999999999876655 466676443 2233578899999988853   4678888877543   567999999998


Q ss_pred             CCH
Q 043292          318 GSL  320 (558)
Q Consensus       318 gsL  320 (558)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.69  E-value=0.00021  Score=68.56  Aligned_cols=73  Identities=12%  Similarity=0.190  Sum_probs=45.4

Q ss_pred             hhcCccCce-EEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc---ceeeeeeeeccCC---cceEEEEeCC
Q 043292          244 KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ---NLVRLIGFCAEKS---HNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~~  316 (558)
                      +.|+.|+.. .||+.    +..+++|..+. ......+..|.+.+..+...   .+.++++.....+   ..+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            346767666 58875    23567776543 23345788899999887532   3444444433322   3478999999


Q ss_pred             CCCHH
Q 043292          317 NGSLD  321 (558)
Q Consensus       317 ~gsL~  321 (558)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=97.45  E-value=0.0001  Score=56.39  Aligned_cols=53  Identities=23%  Similarity=0.428  Sum_probs=40.3

Q ss_pred             eeeeccccccccCCCCCCCCCCChHHHHHHHhccCCceeecccccCcCCCCcccccccc
Q 043292           84 FVELNDVAYFAFSSSSSDITNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEI  142 (558)
Q Consensus        84 f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~~  142 (558)
                      |..++++.+++.+....  ...+.++|++.|+.+++|.||.|..    +.+.|+++...
T Consensus         6 ~~~~~~~~~~g~d~~~~--~~~s~~~Cq~~C~~~~~C~afT~~~----~~~~C~lk~~~   58 (73)
T cd01100           6 FRQGSNVDFRGGDLSTV--FASSAEQCQAACTADPGCLAFTYNT----KSKKCFLKSSE   58 (73)
T ss_pred             ccccCCCccccCCccee--ecCCHHHHHHHcCCCCCceEEEEEC----CCCeEEcccCC
Confidence            34446777777665433  3568999999999999999999864    36789998753

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.40  E-value=0.00065  Score=66.12  Aligned_cols=137  Identities=14%  Similarity=0.122  Sum_probs=77.9

Q ss_pred             cCccCceEEEEEEeCCCCEEEEEEecccccch-HHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeCCCCCHHHH
Q 043292          246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYMPNGSLDRW  323 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~  323 (558)
                      +..|-.+.+|+.. .++..+++|......... -...+|.+++..+....+ .+++....    ..+||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            4567778899887 456788888765332221 235778888888865444 33443322    3699999998765421


Q ss_pred             --------------H---hcCC-CCCCCCHHHHH-HHH------------HHHHHhhhhc--cccCCCcEEecCCCCCCE
Q 043292          324 --------------L---FQRS-DEFMLDWQQRK-KII------------LDIAKGLTYL--HEDCRQKILHLDIKPQNI  370 (558)
Q Consensus       324 --------------l---~~~~-~~~~l~~~~~~-~i~------------~~ia~~l~yL--H~~~~~~ivH~dlk~~NI  370 (558)
                                    +   +... ....++...+. ...            .++.+.+...  .......++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                          1   1111 11112222111 111            1111111111  011134689999999999


Q ss_pred             eecCCCCeEEcccCCccc
Q 043292          371 LLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       371 ll~~~~~~ki~Dfgla~~  388 (558)
                      ++++++ +.|.||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.33  E-value=0.0014  Score=60.25  Aligned_cols=121  Identities=26%  Similarity=0.452  Sum_probs=84.9

Q ss_pred             HhhhhcCccCc-eEEEEEEeCCCCEEEEEEecc------------cc----------cchHHHHHHHHHHhccC---Ccc
Q 043292          241 NFRKMLGKGGF-GSVFEGTQTDGTKVAVKRLEG------------IG----------EINKSFLAEVKTIGSIH---HQN  294 (558)
Q Consensus       241 ~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~------------~~----------~~~~~~~~E~~~l~~l~---h~n  294 (558)
                      .|.+.||.|.. |.||+.... |+.+|+|..+.            ..          .....|..|.+..++|+   +.+
T Consensus        40 ~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~  118 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG  118 (207)
T ss_pred             eeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence            45688999999 999999875 77999999321            00          11135888999888885   445


Q ss_pred             e--eeeeeeeccC------------------CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccc
Q 043292          295 L--VRLIGFCAEK------------------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE  354 (558)
Q Consensus       295 i--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~  354 (558)
                      +  |+.+||..-.                  ..+.||.||.+...            .++.    +-+.++.+-|.-+|.
T Consensus       119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKILHK  182 (207)
T ss_pred             ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHHHH
Confidence            5  9999987322                  11257888776543            1222    234556667778898


Q ss_pred             cCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       355 ~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                         .+|+-+|+++.|..     .-||.|||.+
T Consensus       183 ---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 ---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---CCeeeccCcccccc-----CCEEEecccC
Confidence               99999999999975     4579999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.31  E-value=0.001  Score=66.49  Aligned_cols=139  Identities=21%  Similarity=0.251  Sum_probs=81.9

Q ss_pred             hcCccCceEEEEEEeCC-------CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQTD-------GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .|..|-...+|+....+       ++.+++|+.........+...|.+++..+....+ .++++++..    .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            35556667899887654       5789999876543333456778888887754333 345555432    36899998


Q ss_pred             CCCHHHH--------------H---hcCCCCC------CC--CHHHHHH--------------------------HHHHH
Q 043292          317 NGSLDRW--------------L---FQRSDEF------ML--DWQQRKK--------------------------IILDI  345 (558)
Q Consensus       317 ~gsL~~~--------------l---~~~~~~~------~l--~~~~~~~--------------------------i~~~i  345 (558)
                      |..+...              |   +......      ..  -|....+                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            8766431              0   1111000      00  0111111                          11122


Q ss_pred             HHhhhhcc------ccCCCcEEecCCCCCCEeecCC----CCeEEcccCCcc
Q 043292          346 AKGLTYLH------EDCRQKILHLDIKPQNILLDGN----FNAKVADFGLSK  387 (558)
Q Consensus       346 a~~l~yLH------~~~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla~  387 (558)
                      ...+..|.      ......++|+|+.+.||+++++    +.++++||..+.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22233332      1234689999999999999985    789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.24  E-value=0.00094  Score=74.88  Aligned_cols=195  Identities=19%  Similarity=0.250  Sum_probs=131.8

Q ss_pred             HHHHHHHHhccCCcceeeeeeeeccCCcc----eEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc
Q 043292          280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED  355 (558)
Q Consensus       280 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  355 (558)
                      ...|+..+.++.|+|++.++.|.......    .+..+++..-++...++.-.   .++....+.+..++.+||.|+|+ 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHH-
Confidence            34567778888999999999987654433    24557788888887776544   37888899999999999999998 


Q ss_pred             CCCcEEecCCCCC---CEeecCCCCeEEc--ccCCccccCCCCCceeecccCCCCcCChhhhcCC---CCCccchHHHHH
Q 043292          356 CRQKILHLDIKPQ---NILLDGNFNAKVA--DFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI---ITEKVDIYSFGV  427 (558)
Q Consensus       356 ~~~~ivH~dlk~~---NIll~~~~~~ki~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~k~Dv~s~Gv  427 (558)
                        ....|.-+..+   +-..+.++.+.++  ||+..+.+......  ....-+..+.+||.....   .....|+|.+|.
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              44444444444   4445666777777  89888766543321  122334567777776543   344579999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          428 VMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       428 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      ++..+..|..+-......                   ..+++....         ..+......|+..++++|++..+++
T Consensus       381 l~~~~~~~~~i~~~~~~~-------------------~~~l~~~~~---------~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVP-------------------VSLLDVLST---------SELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHhhhhhcCcccccccch-------------------hhhhccccc---------hhhhhhhhhhcchhhhhccchhhhh
Confidence            999999987654322111                   111111000         0345677789999999999999998


Q ss_pred             HHH
Q 043292          508 RVL  510 (558)
Q Consensus       508 ~~L  510 (558)
                      ...
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.15  E-value=0.011  Score=60.87  Aligned_cols=73  Identities=16%  Similarity=0.215  Sum_probs=52.3

Q ss_pred             hhcCccCceEEEEEEeCCC-CEEEEEEecc------c--ccchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEE
Q 043292          244 KMLGKGGFGSVFEGTQTDG-TKVAVKRLEG------I--GEINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~------~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  311 (558)
                      +.||.|.+..||+....+| +.++||.-..      .  ....+++..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998877 4899997431      1  123456777888887763   2456667766  44567899


Q ss_pred             EEeCCCC
Q 043292          312 YEYMPNG  318 (558)
Q Consensus       312 ~e~~~~g  318 (558)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>PRK05231 homoserine kinase; Provisional

Probab=97.03  E-value=0.012  Score=59.28  Aligned_cols=141  Identities=15%  Similarity=0.196  Sum_probs=75.8

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc--ceeeeee------eeccCCcceEEEEeC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ--NLVRLIG------FCAEKSHNLLVYEYM  315 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~~  315 (558)
                      +.|+.|....+|+....++ .+++|+.+.  ...+....|+.++..+...  .+.+++.      +....+..+++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            3466777788999876555 688898762  1223334455555554321  2333332      112244568999999


Q ss_pred             CCCCHH-----------HHH---hcCCC--------CCCCCH-HHHHH------------HH-HHHHHhhhhccc----c
Q 043292          316 PNGSLD-----------RWL---FQRSD--------EFMLDW-QQRKK------------II-LDIAKGLTYLHE----D  355 (558)
Q Consensus       316 ~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~------------i~-~~ia~~l~yLH~----~  355 (558)
                      +|..+.           ..|   +....        ...+.| .....            .+ ..+...+..+.+    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            886431           111   11000        001112 11111            11 111112222221    1


Q ss_pred             CCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       356 ~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ...+++|+|+.+.||+++++...-|.||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            34689999999999999977556899999875

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.00  E-value=0.0056  Score=60.87  Aligned_cols=141  Identities=16%  Similarity=0.169  Sum_probs=83.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcc--eeeeeee------eccCCcceEEEEeC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN--LVRLIGF------CAEKSHNLLVYEYM  315 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~  315 (558)
                      +.|..|....+|+.... +..+++|+...  ........|++++..+.+.+  +.+++..      ...++..++|++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677777899988654 44688888764  23345667788777775432  4444432      12234568999999


Q ss_pred             CCCCHHH----H-------H---hcCCC--------CCCCCHHHHHH----------HHHHHHHhhhhccc----cCCCc
Q 043292          316 PNGSLDR----W-------L---FQRSD--------EFMLDWQQRKK----------IILDIAKGLTYLHE----DCRQK  359 (558)
Q Consensus       316 ~~gsL~~----~-------l---~~~~~--------~~~l~~~~~~~----------i~~~ia~~l~yLH~----~~~~~  359 (558)
                      +|..+..    .       |   +....        .....|.....          ....+..++.++.+    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9876532    0       1   10000        01122222210          11112333444432    12357


Q ss_pred             EEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          360 ILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       360 ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ++|+|+.|.||+++++..+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999998777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.93  E-value=0.019  Score=57.49  Aligned_cols=142  Identities=17%  Similarity=0.208  Sum_probs=79.9

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc--ceeeeeeee------ccCCcceEEEEeC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ--NLVRLIGFC------AEKSHNLLVYEYM  315 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~~  315 (558)
                      +.++.|....+|+....++ .+++|+..... ...+...|++++..+...  ++.+++...      ..++..+++++|+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            4567777788998765544 57788765421 223445666666666422  234444321      2234568999999


Q ss_pred             CCCCHH-----------HH---HhcCCCC---------CCCCHHHHHH------------HHHHHHHhhhhccc----cC
Q 043292          316 PNGSLD-----------RW---LFQRSDE---------FMLDWQQRKK------------IILDIAKGLTYLHE----DC  356 (558)
Q Consensus       316 ~~gsL~-----------~~---l~~~~~~---------~~l~~~~~~~------------i~~~ia~~l~yLH~----~~  356 (558)
                      +|..+.           ..   ++.....         ..-.|.....            ....+.+.++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            875432           11   1110010         0111221110            01122334444432    23


Q ss_pred             CCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          357 RQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       357 ~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ..+++|+|+++.||++++++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4789999999999999998777899999775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.59  E-value=0.019  Score=56.57  Aligned_cols=72  Identities=17%  Similarity=0.278  Sum_probs=47.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhcc---CCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI---HHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++.|....+|+.. .+++.+.||.-.  ......|..|.+-|+.|   .-..+.+++++...++..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            458889999999987 668889999876  33335678888877777   3456788888887777889999999866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.52  E-value=0.013  Score=59.54  Aligned_cols=138  Identities=19%  Similarity=0.225  Sum_probs=79.5

Q ss_pred             cCccCceEEEEEEeCC-----CCEEEEEEecccccchHHHHHHHHHHhccCCccee-eeeeeeccCCcceEEEEeCCCCC
Q 043292          246 LGKGGFGSVFEGTQTD-----GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV-RLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       246 lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      |-.|-...+|+....+     ++.+++|.........-....|..++..+...++. ++++.+..+    .|++|+++.+
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~  119 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART  119 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence            4446667889886532     36788887764433322346788888888655553 455655432    5899998766


Q ss_pred             HHHH-----------------HhcCC--CCC-CCCHHHHHHHHHHHH-----------------Hhhhh----ccc-cCC
Q 043292          320 LDRW-----------------LFQRS--DEF-MLDWQQRKKIILDIA-----------------KGLTY----LHE-DCR  357 (558)
Q Consensus       320 L~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~ia-----------------~~l~y----LH~-~~~  357 (558)
                      |...                 ++...  ... ..-|.+..++..++.                 ..+..    +.. ...
T Consensus       120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~  199 (344)
T PLN02236        120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE  199 (344)
T ss_pred             CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence            6421                 11110  001 112333333322211                 11111    111 123


Q ss_pred             CcEEecCCCCCCEeecC-CCCeEEcccCCcc
Q 043292          358 QKILHLDIKPQNILLDG-NFNAKVADFGLSK  387 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~  387 (558)
                      ..++|+|+++.||++++ ++.+.+.||..+.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            57899999999999986 4679999998876

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.37  E-value=0.023  Score=55.89  Aligned_cols=31  Identities=26%  Similarity=0.499  Sum_probs=26.0

Q ss_pred             CcEEecCCCCCCEeecCCCC-eEEcccCCccc
Q 043292          358 QKILHLDIKPQNILLDGNFN-AKVADFGLSKL  388 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~-~ki~Dfgla~~  388 (558)
                      ..++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            56899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.34  E-value=0.0028  Score=61.74  Aligned_cols=132  Identities=14%  Similarity=0.158  Sum_probs=88.1

Q ss_pred             HhhhhcCccCceEEEEEEeCCCCEEEEEEec----------c-------cccc------hHHHHHHHHHHhccCCc--ce
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLE----------G-------IGEI------NKSFLAEVKTIGSIHHQ--NL  295 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~----------~-------~~~~------~~~~~~E~~~l~~l~h~--ni  295 (558)
                      .+.+.||-|.-+.||.+...+|++.++|.-+          .       ....      .-....|+..|..+...  .+
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            3467899999999999999999999998321          0       0000      11245678888887532  23


Q ss_pred             eeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC
Q 043292          296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN  375 (558)
Q Consensus       296 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~  375 (558)
                      .+.++    .+..++|||++.+-.|...-+      ..+..++..-+.++   +.-|-.   .|+||+|..-=||+++++
T Consensus       175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  175 PKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHH---HHHHHH---cCceecccchheeEEecC
Confidence            34443    345689999998877754432      13334444333332   223334   899999999999999999


Q ss_pred             CCeEEcccCCccc
Q 043292          376 FNAKVADFGLSKL  388 (558)
Q Consensus       376 ~~~ki~Dfgla~~  388 (558)
                      +.++++||--...
T Consensus       239 ~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  239 DKIVVIDFPQMVS  251 (465)
T ss_pred             CCEEEeechHhhc
Confidence            9999999965443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.21  E-value=0.0065  Score=60.28  Aligned_cols=139  Identities=14%  Similarity=0.178  Sum_probs=91.0

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEeccccc----------chHH-----------------HHHHHHHHhccCCccee
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE----------INKS-----------------FLAEVKTIGSIHHQNLV  296 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------~~~~-----------------~~~E~~~l~~l~h~niv  296 (558)
                      ..|..|.-+.||.++-.+|..+|||+.+.+--          +.-+                 ...|++-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45788999999999999999999998753210          0000                 23466666666544322


Q ss_pred             eeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC
Q 043292          297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF  376 (558)
Q Consensus       297 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~  376 (558)
                      -.--+..  ....|||+|+.....   -.-.-....++...+...-++++.-|.-|.+.  .++||.||+--|+|+.+ |
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-C
Confidence            1111111  134799999853221   11111223477778888888888888888774  67999999999999875 5


Q ss_pred             CeEEcccCCccccC
Q 043292          377 NAKVADFGLSKLID  390 (558)
Q Consensus       377 ~~ki~Dfgla~~~~  390 (558)
                      .+.|+|.+-+....
T Consensus       302 ~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  302 KLYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEEccccccCC
Confidence            89999988776443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.97  E-value=0.011  Score=55.64  Aligned_cols=121  Identities=20%  Similarity=0.195  Sum_probs=61.8

Q ss_pred             CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeCCCCCHHH-------HH---------
Q 043292          262 GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYMPNGSLDR-------WL---------  324 (558)
Q Consensus       262 ~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~-------~l---------  324 (558)
                      .+.|+|++........-....|..+++.+...++ .++++++..+    +|++|+++..|..       .+         
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678888887665555566788888888865555 4556655432    6779997665432       11         


Q ss_pred             -hc--C--CCCCCCCHHHHHHH-----------------------------HHHHHHhhhhccccCCCcEEecCCCCCCE
Q 043292          325 -FQ--R--SDEFMLDWQQRKKI-----------------------------ILDIAKGLTYLHEDCRQKILHLDIKPQNI  370 (558)
Q Consensus       325 -~~--~--~~~~~l~~~~~~~i-----------------------------~~~ia~~l~yLH~~~~~~ivH~dlk~~NI  370 (558)
                       +.  .  .....--|.....+                             +..+-+.+.-..+  ...++|+|+.+.||
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~--~~v~cHnDl~~~Ni  155 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNS--PLVFCHNDLNPGNI  155 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCG--GEEEE-S--SGGGE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCC--CceEeeccCccccE
Confidence             00  0  00111112222222                             1111111111111  25789999999999


Q ss_pred             ee-cCCCCeEEcccCCccc
Q 043292          371 LL-DGNFNAKVADFGLSKL  388 (558)
Q Consensus       371 ll-~~~~~~ki~Dfgla~~  388 (558)
                      |+ +.++.++++||..|..
T Consensus       156 l~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  156 LINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EETSSSSCEEE--GTT-EE
T ss_pred             EeccCCCeEEEecHHHHhh
Confidence            99 8889999999988763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.92  E-value=0.033  Score=56.29  Aligned_cols=140  Identities=12%  Similarity=0.142  Sum_probs=78.2

Q ss_pred             hcCccCceEEEEEEeCC----CCEEEEEEecccccchHHHHHHHHHHhccCCccee-eeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQTD----GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV-RLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .|..|-...+|+....+    +..|++|+........-...+|..++..+..-++. ++++++..+    +|.+|+++..
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence            34446667788886543    23788888764333222346788888888765553 456555322    5899997765


Q ss_pred             HHH-------HH----------hcCC--CCC-CCCHHHHHHHHHHHH----------------------Hhhh----hcc
Q 043292          320 LDR-------WL----------FQRS--DEF-MLDWQQRKKIILDIA----------------------KGLT----YLH  353 (558)
Q Consensus       320 L~~-------~l----------~~~~--~~~-~l~~~~~~~i~~~ia----------------------~~l~----yLH  353 (558)
                      |..       .+          +...  ... .--|....++..++.                      .-+.    ++.
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            532       01          1110  001 112333322222211                      1111    111


Q ss_pred             c-cCCCcEEecCCCCCCEeecC-CCCeEEcccCCccc
Q 043292          354 E-DCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKL  388 (558)
Q Consensus       354 ~-~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~  388 (558)
                      . ....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 11235899999999999975 56899999998763

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.82  E-value=0.062  Score=53.39  Aligned_cols=140  Identities=19%  Similarity=0.322  Sum_probs=79.5

Q ss_pred             ccCce-EEEEEEeCCCCEEEEEEecc---cccchHHHHHHHHHHhccCC--cceeeeeeeeccCC--cceEEEEeCCCCC
Q 043292          248 KGGFG-SVFEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGSIHH--QNLVRLIGFCAEKS--HNLLVYEYMPNGS  319 (558)
Q Consensus       248 ~G~fg-~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gs  319 (558)
                      +|+++ .+|..... ++++++. ...   .........+|.++|+.+.-  ..+.+.++.|.++.  ..+.||+|.++..
T Consensus        34 ~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          34 SGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             cCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            34443 34444333 7778887 331   12233455678888877743  34555677777666  6689999998732


Q ss_pred             H------------------HHHHhc--C---------------CCCCCCCHHHHHHHHH--------HHHHhhhhcccc-
Q 043292          320 L------------------DRWLFQ--R---------------SDEFMLDWQQRKKIIL--------DIAKGLTYLHED-  355 (558)
Q Consensus       320 L------------------~~~l~~--~---------------~~~~~l~~~~~~~i~~--------~ia~~l~yLH~~-  355 (558)
                      +                  .++|..  +               ..+..-.|...++.+.        ....-..+|++. 
T Consensus       112 ~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~  191 (321)
T COG3173         112 VWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR  191 (321)
T ss_pred             ccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence            2                  222211  0               0001112222221111        111223344332 


Q ss_pred             ----CCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          356 ----CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       356 ----~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                          ....++|+|+++.||+++.+..+-|.||+++..-
T Consensus       192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                2367999999999999999988999999998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.80  E-value=0.0033  Score=72.38  Aligned_cols=159  Identities=15%  Similarity=0.058  Sum_probs=110.8

Q ss_pred             HHHHHHHHhccCCcceeeeeeeec--cCCcceEEEEeCCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHhhhhcccc-
Q 043292          280 FLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHED-  355 (558)
Q Consensus       280 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~-  355 (558)
                      ...|...++...|+++.....-..  +..+.+.+++|+..|.+.+.+-+...+ ..++..-......+......-.|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            444555666678998876554433  234567889999999999998764332 2344443333333334444444431 


Q ss_pred             -CCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHH
Q 043292          356 -CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEIL  433 (558)
Q Consensus       356 -~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ell  433 (558)
                       ...-.+|+++|+-|.+|..+..+|++++|+.+.... .........+++-|++|+.... .++.++|+|..|+.+++.-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             234478999999999999999999999999984332 2223445667888999998876 4788899999999999998


Q ss_pred             hCCCCC
Q 043292          434 CGRKVF  439 (558)
Q Consensus       434 tg~~p~  439 (558)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.77  E-value=0.12  Score=52.21  Aligned_cols=71  Identities=15%  Similarity=0.128  Sum_probs=45.4

Q ss_pred             hcCccCceEEEEEEeCCC-CEEEEEEec----c----cccchHHHHHHHHHHhccC--Ccc-eeeeeeeeccCCcceEEE
Q 043292          245 MLGKGGFGSVFEGTQTDG-TKVAVKRLE----G----IGEINKSFLAEVKTIGSIH--HQN-LVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~----~----~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  312 (558)
                      .||-|....||++...++ +.|+||.-.    .    -.-...+..-|.+.|....  -|. +.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            478999999999998654 589999542    1    1222344556777776553  343 444443  3555667999


Q ss_pred             EeCCC
Q 043292          313 EYMPN  317 (558)
Q Consensus       313 e~~~~  317 (558)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.61  E-value=0.098  Score=52.50  Aligned_cols=136  Identities=21%  Similarity=0.313  Sum_probs=79.7

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcce---ee---eee----eeccCCcceEEEEeCCCCC
Q 043292          250 GFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL---VR---LIG----FCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       250 ~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni---v~---l~~----~~~~~~~~~lv~e~~~~gs  319 (558)
                      .-..+|+....+++. ++|..+.. ....+...|+..+..+.-..+   ++   +=|    ....+...+-+++|++|..
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            445789888777776 88888776 556667777777777732221   22   111    1112236678999999888


Q ss_pred             HHH-H--------------Hhc--------CCC-CCCCCHH-----------------HHHHHHHHHHHhhhhccccCCC
Q 043292          320 LDR-W--------------LFQ--------RSD-EFMLDWQ-----------------QRKKIILDIAKGLTYLHEDCRQ  358 (558)
Q Consensus       320 L~~-~--------------l~~--------~~~-~~~l~~~-----------------~~~~i~~~ia~~l~yLH~~~~~  358 (558)
                      +.. .              |+.        +.. .....|.                 .+..+...+..-+..+-.....
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            772 1              110        111 1123443                 1222222222222222221122


Q ss_pred             c---EEecCCCCCCEeecCCCC-eEEcccCCcc
Q 043292          359 K---ILHLDIKPQNILLDGNFN-AKVADFGLSK  387 (558)
Q Consensus       359 ~---ivH~dlk~~NIll~~~~~-~ki~Dfgla~  387 (558)
                      .   +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3   999999999999999885 8899999775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.60  E-value=0.074  Score=53.28  Aligned_cols=31  Identities=16%  Similarity=0.254  Sum_probs=28.3

Q ss_pred             CCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          357 RQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       357 ~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ..+++|+|+.+.|||+++++.+.|.||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4689999999999999999999999998776

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.49  E-value=0.16  Score=51.33  Aligned_cols=70  Identities=13%  Similarity=0.105  Sum_probs=43.9

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCC--cceeeee---e--eeccCCcceEEEEeCCCCC
Q 043292          250 GFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH--QNLVRLI---G--FCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       250 ~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~---~--~~~~~~~~~lv~e~~~~gs  319 (558)
                      .-..||+....++..+++|+.+.......+...|++.+..+..  -.++...   |  +...++..+.++++++|..
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            3467899887788889999876443345566777777766632  1223222   1  1222345678999998754

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.30  E-value=0.25  Score=50.89  Aligned_cols=78  Identities=14%  Similarity=0.126  Sum_probs=50.3

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEec-----ccc---cchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEEE
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLE-----GIG---EINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~-----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.||.|....||+.... +..++||+-.     ...   ....+-..|.+.|..+.   ..++.+++.++.  +..+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            46899999999998764 5568899654     111   12333344566665553   347778888876  4568899


Q ss_pred             EeCCC--CCHHHHH
Q 043292          313 EYMPN--GSLDRWL  324 (558)
Q Consensus       313 e~~~~--gsL~~~l  324 (558)
                      |++++  ..+.+-+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3444433

>PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A

Probab=95.19  E-value=0.011  Score=41.28  Aligned_cols=37  Identities=38%  Similarity=0.717  Sum_probs=18.0

Q ss_pred             CCCChHHHHHHHhccCCceeeccccc-CcCCCCccccc
Q 043292          103 TNTDSETCKQACLKNCSCKAALFQYG-LNSSAGDCYLP  139 (558)
Q Consensus       103 ~~~~~~~C~~~Cl~nCsC~a~~~~~~-~~~~~~~C~~~  139 (558)
                      ...+.++|.+.|..+=.|.+|.|... .....+.|+++
T Consensus        14 ~~~s~~~C~~~C~~~~~C~~~~~~~~~~~~~~~~C~LK   51 (51)
T PF14295_consen   14 TASSPEECQAACAADPGCQAFTFNPPGCPSSSGRCYLK   51 (51)
T ss_dssp             ----HHHHHHHHHTSTT--EEEEETTEE----------
T ss_pred             cCCCHHHHHHHccCCCCCCEEEEECCCcccccccccCC
Confidence            56789999999999999999988651 12345678764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.13  E-value=0.24  Score=49.55  Aligned_cols=30  Identities=30%  Similarity=0.339  Sum_probs=25.9

Q ss_pred             CCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          357 RQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       357 ~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999998 578999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.69  E-value=0.17  Score=51.85  Aligned_cols=72  Identities=18%  Similarity=0.186  Sum_probs=46.8

Q ss_pred             hhcCccCceEEEEEEeCC-CCEEEEEEec----c---cccchHHHHHHHHHHhccC--Ccc-eeeeeeeeccCCcceEEE
Q 043292          244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLE----G---IGEINKSFLAEVKTIGSIH--HQN-LVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~----~---~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  312 (558)
                      +.||-|.-.-||++.+.+ ++.|+||.-.    .   -.-..++..-|.+.|+...  -|. +.+++.+  +.+...+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            468999999999999753 5679998532    1   1223455666777777653  343 4445543  455667888


Q ss_pred             EeCCC
Q 043292          313 EYMPN  317 (558)
Q Consensus       313 e~~~~  317 (558)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88853

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	558
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-61
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-59
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
3soa_A	444	Full-Length Human Camkii Length = 444		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  231 bits (589), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 140/312 (44%), Positives = 197/312 (63%), Gaps = 20/312 (6%)
Query: 212 ADEIEEDYLDQVPGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKR 269
           A+E  E +L Q+    KRFS  EL+V +DNF  + +LG+GGFG V++G   DGT VAVKR
Sbjct: 14  AEEDPEVHLGQL----KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 69
Query: 270 LE----GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF 325
           L+      GE+   F  EV+ I    H+NL+RL GFC   +  LLVY YM NGS+   L 
Sbjct: 70  LKEERXQGGELQ--FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 127
Query: 326 QRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
           +R + +  LDW +R++I L  A+GL YLH+ C  KI+H D+K  NILLD  F A V DFG
Sbjct: 128 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 187
Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           L+KL+D     V   +RGT G++APE+LS+   +EK D++ +GV++LE++ G++ FD ++
Sbjct: 188 LAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247
Query: 444 -PEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN--GEEVVNMMKVAAWCLESDFAKR 500
              ++D+ LL   K   +E KL  LVD    D+Q N   EEV  +++VA  C +S   +R
Sbjct: 248 LANDDDVMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMER 304
Query: 501 PSMSMVVRVLEG 512
           P MS VVR+LEG
Sbjct: 305 PKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 138/312 (44%), Positives = 195/312 (62%), Gaps = 20/312 (6%)
Query: 212 ADEIEEDYLDQVPGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKR 269
           A+E  E +L Q+    KRFS  EL+V +DNF  + +LG+GGFG V++G   DG  VAVKR
Sbjct: 6   AEEDPEVHLGQL----KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKR 61
Query: 270 LE----GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF 325
           L+      GE+   F  EV+ I    H+NL+RL GFC   +  LLVY YM NGS+   L 
Sbjct: 62  LKEERTQGGELQ--FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 326 QRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
           +R + +  LDW +R++I L  A+GL YLH+ C  KI+H D+K  NILLD  F A V DFG
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           L+KL+D     V   +RG  G++APE+LS+   +EK D++ +GV++LE++ G++ FD ++
Sbjct: 180 LAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 444 -PEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN--GEEVVNMMKVAAWCLESDFAKR 500
              ++D+ LL   K   +E KL  LVD    D+Q N   EEV  +++VA  C +S   +R
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMER 296
Query: 501 PSMSMVVRVLEG 512
           P MS VVR+LEG
Sbjct: 297 PKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 116/299 (38%), Positives = 163/299 (54%), Gaps = 22/299 (7%)
Query: 230 FSFEELKVMTDNFRKM--------LGKGGFGSVFEGTQTDGTKVAVKRLEGI-----GEI 276
           FSF ELK +T+NF +         +G+GGFG V++G   + T VAVK+L  +      E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 277 NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
            + F  E+K +    H+NLV L+GF ++     LVY YMPNGSL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQ 395
            R KI    A G+ +LHE+     +H DIK  NILLD  F AK++DFGL++  ++  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 396 VVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           + + + GT  Y+APE L   IT K DIYSFGVV+LEI+ G    D  +  E  + L    
Sbjct: 191 MXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDIKE 248
Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
           + + EE  + D +DK  ND  S   E   M  VA+ CL     KRP +  V ++L+ +T
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (434), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 116/299 (38%), Positives = 162/299 (54%), Gaps = 22/299 (7%)
Query: 230 FSFEELKVMTDNFRKM--------LGKGGFGSVFEGTQTDGTKVAVKRLEGI-----GEI 276
           FSF ELK +T+NF +         +G+GGFG V++G   + T VAVK+L  +      E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 277 NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
            + F  E+K +    H+NLV L+GF ++     LVY YMPNGSL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQ 395
            R KI    A G+ +LHE+     +H DIK  NILLD  F AK++DFGL++  ++  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 396 VVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           +   + GT  Y+APE L   IT K DIYSFGVV+LEI+ G    D  +  E  + L    
Sbjct: 191 MXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDIKE 248
Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
           + + EE  + D +DK  ND  S   E   M  VA+ CL     KRP +  V ++L+ +T
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 118/300 (39%), Positives = 161/300 (53%), Gaps = 24/300 (8%)
Query: 230 FSFEELKVMTDNFRKM--------LGKGGFGSVFEGTQTDGTKVAVKRLEGI-----GEI 276
           FSF ELK +T+NF +         +G+GGFG V++G   + T VAVK+L  +      E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 277 NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
            + F  E+K +    H+NLV L+GF ++     LVY YMPNGSL   L        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
            R KI    A G+ +LHE+     +H DIK  NILLD  F AK++DFGL++   +  +Q 
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQX 183
Query: 397 VTTMR--GTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V   R  GT  Y+APE L   IT K DIYSFGVV+LEI+ G    D  +  E  + L   
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDIK 241
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
            + + EE  + D +DK  ND  S   E   M  VA+ CL     KRP +  V ++L+ +T
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEA--MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 155/299 (51%), Gaps = 22/299 (7%)
Query: 230 FSFEELKVMTDNFRKM--------LGKGGFGSVFEGTQTDGTKVAVKRLEGI-----GEI 276
           FSF ELK +T+NF +          G+GGFG V++G   + T VAVK+L  +      E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 277 NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
            + F  E+K      H+NLV L+GF ++     LVY Y PNGSL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQ 395
            R KI    A G+ +LHE+     +H DIK  NILLD  F AK++DFGL++  ++  Q  
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 396 VVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
             + + GT  Y APE L   IT K DIYSFGVV+LEI+ G    D  +  E  + L    
Sbjct: 182 XXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDIKE 239
Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT 514
           + + EE  + D +DK  ND  S   E      VA+ CL     KRP +  V ++L+  T
Sbjct: 240 EIEDEEKTIEDYIDKKXNDADSTSVEA--XYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 114/306 (37%), Positives = 171/306 (55%), Gaps = 15/306 (4%)
Query: 213 DEIEEDYLDQVPGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKR- 269
           D +   YL  VP    R    +L+  T+NF  + ++G G FG V++G   DG KVA+KR 
Sbjct: 14  DALSSSYL--VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71
Query: 270 LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
                +  + F  E++T+    H +LV LIGFC E++  +L+Y+YM NG+L R L+    
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 330 EFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL 388
             M + W+QR +I +  A+GL YLH    + I+H D+K  NILLD NF  K+ DFG+SK 
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 389 -IDQDQSQVVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
             + DQ+ +   ++GT GY+ PE+ +   +TEK D+YSFGVV+ E+LC R    +S P E
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 447 EDMYLLSIFKKKAEED-KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM 505
             M  L+ +  ++  + +L  +VD +  D +   E +      A  CL      RPSM  
Sbjct: 249 --MVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 506 VVRVLE 511
           V+  LE
Sbjct: 306 VLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 113/306 (36%), Positives = 170/306 (55%), Gaps = 15/306 (4%)
Query: 213 DEIEEDYLDQVPGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKR- 269
           D +   YL  VP    R    +L+  T+NF  + ++G G FG V++G   DG KVA+KR 
Sbjct: 14  DALSSSYL--VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71
Query: 270 LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
                +  + F  E++T+    H +LV LIGFC E++  +L+Y+YM NG+L R L+    
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 330 EFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL 388
             M + W+QR +I +  A+GL YLH    + I+H D+K  NILLD NF  K+ DFG+SK 
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 389 -IDQDQSQVVTTMRGTPGYLAPEW-LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
             +  Q+ +   ++GT GY+ PE+ +   +TEK D+YSFGVV+ E+LC R    +S P E
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 447 EDMYLLSIFKKKAEED-KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM 505
             M  L+ +  ++  + +L  +VD +  D +   E +      A  CL      RPSM  
Sbjct: 249 --MVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 506 VVRVLE 511
           V+  LE
Sbjct: 306 VLWKLE 311

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           N ++ +G G FG+V    +  G+ VAVK L   +   E    FL EV  +  + H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
            +G   +  +  +V EY+  GSL R L +      LD ++R  +  D+AKG+ YLH +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT 417
             I+H D+K  N+L+D  +  KV DFGLS+L             GTP ++APE L    +
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 418 -EKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EK D+YSFGV++ E+   ++ +    P +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 7/210 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           N ++ +G G FG+V    +  G+ VAVK L   +   E    FL EV  +  + H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
            +G   +  +  +V EY+  GSL R L +      LD ++R  +  D+AKG+ YLH +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT 417
             I+H ++K  N+L+D  +  KV DFGLS+L          +  GTP ++APE L    +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 418 -EKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EK D+YSFGV++ E+   ++ +    P +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 243 RKMLGKGGFGSVFEGT--QTDGTK---VAVKRLE-GIGEINK-SFLAEVKTIGSIHHQNL 295
           +K++G G FG V++G    + G K   VA+K L+ G  E  +  FL E   +G   H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           +RL G  ++    +++ EYM NG+LD++L ++  EF +   Q   ++  IA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYL--- 163
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG--YLAPEWLS 413
                +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G     + APE +S
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 414 -SIITEKVDIYSFGVVMLEILC 434
               T   D++SFG+VM E++ 
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 30/223 (13%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V  G  +  G KVAVK         L+ +G+I +    E++ +    H +++
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHII 79
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +L    +  S   +V EY+  G L  ++ +      LD ++ +++   I  G+ Y H   
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH--- 133
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           R  ++H D+KP+N+LLD + NAK+ADFGLS ++     + +    G+P Y APE +S  +
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGSPNYAAPEVISGRL 191
Query: 417 TE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
               +VDI+S GV++  +LCG   FD       D ++ ++FKK
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFD-------DDHVPTLFKK 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 141/313 (45%), Gaps = 31/313 (9%)
Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLE- 271
           E +  + PG   R    E++    +  K++G G  G V  G  +  G +   VA+K L+ 
Sbjct: 28  EPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA 87
Query: 272 GIGEINKS-FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE 330
           G  E  +  FL+E   +G   H N++RL G        ++V EYM NGSLD +L     +
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           F +   Q   ++  +  G+ YL +      +H D+  +N+L+D N   KV+DFGLS++++
Sbjct: 148 FTI--MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202
Query: 391 QDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
            D     TT  G     + APE ++    +   D++SFGVVM E+L              
Sbjct: 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------- 249
Query: 448 DMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV 507
             Y    +      D +S + + +           ++ + +  W    D A+RP  S +V
Sbjct: 250 --YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCW--HKDRAQRPRFSQIV 305
Query: 508 RVLEGVTEFEHNL 520
            VL+ +     +L
Sbjct: 306 SVLDALIRSPESL 318

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 140/314 (44%), Gaps = 33/314 (10%)
Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-----QTDGTKVAVKRLE 271
           E +  + PG   R    E++    +  K++G G  G V  G      Q D   VA+K L+
Sbjct: 28  EPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRD-VPVAIKALK 86
Query: 272 -GIGEINKS-FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
            G  E  +  FL+E   +G   H N++RL G        ++V EYM NGSLD +L     
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI 389
           +F +   Q   ++  +  G+ YL +      +H D+  +N+L+D N   KV+DFGLS+++
Sbjct: 147 QFTI--MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 390 DQDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           + D     TT  G     + APE ++    +   D++SFGVVM E+L             
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------ 249
Query: 447 EDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
              Y    +      D +S + + +           ++ + +  W    D A+RP  S +
Sbjct: 250 ---YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCW--HKDRAQRPRFSQI 304
Query: 507 VRVLEGVTEFEHNL 520
           V VL+ +     +L
Sbjct: 305 VSVLDALIRSPESL 318

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L  +L  R+   +   +    + LD+ +G+ YL E C   +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 185 SDVWSFGVLMWEVFSEGKI 203

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L  +L  R+   +   +    + LD+ +G+ YL E C   +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 183 SDVWSFGVLMWEVFSEGKI 201

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L  +L  R+   +   +    + LD+ +G+ YL E C   +
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 188 SDVWSFGVLMWEVFSEGKI 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKR--LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           ++LGKG FG   + T  +  +V V +  +    E  ++FL EVK +  + H N+++ IG 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
             +      + EY+  G+L R + +  D     W QR     DIA G+ YLH      I+
Sbjct: 76  LYKDKRLNFITEYIKGGTL-RGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-------------VTTMRGTPGYLA 408
           H D+   N L+  N N  VADFGL++L+  +++Q                T+ G P ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 409 PEWLSS-IITEKVDIYSFGVVMLEIL 433
           PE ++     EKVD++SFG+V+ EI+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K ++        F+ E + +  + H  LV+L G
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L  +L  R+   +   +    + LD+ +G+ YL E C   +
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 205 SDVWSFGVLMWEVFSEGKI 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV E+M +G L  +L  R+   +   +    + LD+ +G+ YL E C   +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 186 SDVWSFGVLMWEVFSEGKI 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 119/227 (52%), Gaps = 22/227 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSF 280
           P++++ E+ ++      + LGKG FG+V+   +         KV  K +LE  G +    
Sbjct: 2   PRQWALEDFEIG-----RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQL 55
Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
             EV+    + H N++RL G+  + +   L+ EY P G++ R L Q+  +F  D Q+   
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTAT 112
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            I ++A  L+Y H    ++++H DIKP+N+LL      K+ADFG S       S   TT+
Sbjct: 113 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTL 166
Query: 401 RGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            GT  YL PE +   +  EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 127
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 136/301 (45%), Gaps = 44/301 (14%)
Query: 230 FSFEELKVMTDN---FRKMLGKGGFGSVFEGTQT-DGTKVAVKRL-----EGIGEI---N 277
           F    L  + DN   + K +GKGGFG V +G    D + VA+K L     EG  E+    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           + F  EV  + +++H N+V+L G         +V E++P G L   L  ++    + W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSV 123
Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-----DGNFNAKVADFGLSKLIDQD 392
           + +++LDIA G+ Y+ ++    I+H D++  NI L     +    AKVADFGLS    Q 
Sbjct: 124 KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQ 178
Query: 393 QSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM 449
               V+ + G   ++APE + +     TEK D YSF +++  IL G   FD      E  
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS 232
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
           Y    F     E+ L   + +       N         V   C   D  KRP  S +V+ 
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRN---------VIELCWSGDPKKRPHFSYIVKE 283
Query: 510 L 510
           L
Sbjct: 284 L 284

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 152
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G+  F+
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 89
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 90  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 143
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G+  F+
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 30/223 (13%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V  G  Q  G KVAVK         L+ +G+I +    E++ +    H +++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHII 74
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +L    +  +   +V EY+  G L  ++ +      ++  + +++   I   + Y H   
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCH--- 128
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           R  ++H D+KP+N+LLD + NAK+ADFGLS ++     + + T  G+P Y APE +S  +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 417 TE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
               +VDI+S GV++  +LCG   FD       D ++ ++FKK
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFD-------DEHVPTLFKK 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 6/199 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L  +L  R+   +   +    + LD+ +G+ YL E     +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S S  + K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 420 VDIYSFGVVMLEILCGRKV 438
            D++SFGV+M E+    K+
Sbjct: 185 SDVWSFGVLMWEVFSEGKI 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 131
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS---KR 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   +  E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILR 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+   F  D Q+    I ++A  L+Y H    
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSRF--DEQRTATYITELANALSYCHS--- 130
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL  N   K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G   F+
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 69
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 86
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 144
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 145 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 71
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 72  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 125
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 69
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 70  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 123
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 96
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 97  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 154
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 155 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
           K LG+G FG V      T G KVA+K       INK  LA          E+  +  + H
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKI------INKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            ++++L      K   ++V EY  N   D ++ QR     +  Q+ ++    I   + Y 
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYC 123
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H   R KI+H D+KP+N+LLD + N K+ADFGLS ++       + T  G+P Y APE +
Sbjct: 124 H---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVI 178
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
           S  +    +VD++S GV++  +LC R  FD
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
           K LG+G FG V      T G KVA+K       INK  LA          E+  +  + H
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKI------INKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            ++++L      K   ++V EY  N   D ++ QR     +  Q+ ++    I   + Y 
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYC 128
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H   R KI+H D+KP+N+LLD + N K+ADFGLS ++       + T  G+P Y APE +
Sbjct: 129 H---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVI 183
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
           S  +    +VD++S GV++  +LC R  FD
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
           K LG+G FG V      T G KVA+K       INK  LA          E+  +  + H
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKI------INKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            ++++L      K   ++V EY  N   D ++ QR     +  Q+ ++    I   + Y 
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYC 129
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H   R KI+H D+KP+N+LLD + N K+ADFGLS ++       + T  G+P Y APE +
Sbjct: 130 H---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVI 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
           S  +    +VD++S GV++  +LC R  FD
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS---KR 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   +  E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
           K LG+G FG V      T G KVA+K       INK  LA          E+  +  + H
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKI------INKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            ++++L      K   ++V EY  N   D ++ QR     +  Q+ ++    I   + Y 
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYC 119
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H   R KI+H D+KP+N+LLD + N K+ADFGLS ++       + T  G+P Y APE +
Sbjct: 120 H---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVI 174
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
           S  +    +VD++S GV++  +LC R  FD
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 130
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   + 
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G + + L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKEL-QKLSKF--DEQRTATYITELANALSYCHS---KR 133
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +   +  E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDE 190
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 22/227 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSF 280
           P++++ E+ ++      + LGKG FG+V+   +         KV  K +LE  G +    
Sbjct: 2   PRQWALEDFEIG-----RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQL 55
Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
             EV+    + H N++RL G+  + +   L+ EY P G++ R L Q+  +F  D Q+   
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTAT 112
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            I ++A  L+Y H    ++++H DIKP+N+LL      K+ADFG S       S   T +
Sbjct: 113 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTEL 166
Query: 401 RGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            GT  YL PE +   +  EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 135/301 (44%), Gaps = 44/301 (14%)
Query: 230 FSFEELKVMTDN---FRKMLGKGGFGSVFEGTQT-DGTKVAVKRL-----EGIGEI---N 277
           F    L  + DN   + K +GKGGFG V +G    D + VA+K L     EG  E+    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           + F  EV  + +++H N+V+L G         +V E++P G L   L  ++    + W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSV 123
Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-----DGNFNAKVADFGLSKLIDQD 392
           + +++LDIA G+ Y+ ++    I+H D++  NI L     +    AKVADFG S    Q 
Sbjct: 124 KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQ 178
Query: 393 QSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM 449
               V+ + G   ++APE + +     TEK D YSF +++  IL G   FD      E  
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS 232
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
           Y    F     E+ L   + +       N         V   C   D  KRP  S +V+ 
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRN---------VIELCWSGDPKKRPHFSYIVKE 283
Query: 510 L 510
           L
Sbjct: 284 L 284

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 131
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   TT+ GT  YL PE +     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGL+++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 128
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+A+FG S       S   TT+ GT  YL PE +   + 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS---KR 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+A+FG S       S   TT+ GT  YL PE +   +  E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDE 188
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 135/301 (44%), Gaps = 44/301 (14%)
Query: 230 FSFEELKVMTDN---FRKMLGKGGFGSVFEGTQT-DGTKVAVKRL-----EGIGEI---N 277
           F    L  + DN   + K +GKGGFG V +G    D + VA+K L     EG  E+    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           + F  EV  + +++H N+V+L G         +V E++P G L   L  ++    + W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSV 123
Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-----DGNFNAKVADFGLSKLIDQD 392
           + +++LDIA G+ Y+ ++    I+H D++  NI L     +    AKVADF LS    Q 
Sbjct: 124 KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQ 178
Query: 393 QSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM 449
               V+ + G   ++APE + +     TEK D YSF +++  IL G   FD      E  
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS 232
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
           Y    F     E+ L   + +       N         V   C   D  KRP  S +V+ 
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCPPRLRN---------VIELCWSGDPKKRPHFSYIVKE 283
Query: 510 L 510
           L
Sbjct: 284 L 284

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGL ++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   T + GT  YL PE +   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 116/223 (52%), Gaps = 30/223 (13%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V  G  Q  G KVAVK         L+ +G+I +    E++ +    H +++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHII 74
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +L    +  +   +V EY+  G L  ++ +      ++  + +++   I   + Y H   
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCH--- 128
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           R  ++H D+KP+N+LLD + NAK+ADFGLS ++     + +    G+P Y APE +S  +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSCGSPNYAAPEVISGRL 186
Query: 417 TE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
               +VDI+S GV++  +LCG   FD       D ++ ++FKK
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFD-------DEHVPTLFKK 222

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 127
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S    T+ GT  YL PE +   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 144
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 205 FGILLTEIVTHGRI 218

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 127
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   T + GT  YL PE +   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 141
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 202 FGILLTEIVTHGRI 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 83  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 137
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 198 FGILLTEIVTHGRI 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   + +       KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           +K++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G+  F+
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 196 FGILLTEIVTHGRI 209

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 143
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 204 FGILLTEIVTHGRI 217

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILR 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+   F  D Q+    I ++A  L+Y H    
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSRF--DEQRTATYITELANALSYCHS--- 130
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL  N   K+ADFG S       S    T+ GT  YL PE +   + 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G   F+
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 82  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 136
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 197 FGILLTEIVTHGRI 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   T + GT  YL PE +   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 76  PIX-IVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 191 FGILLTELTTKGRV 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 131
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   T + GT  YL PE +   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 196 FGILLTEIVTHGRI 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S   T + GT  YL PE +   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 86  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 201 FGILLTEIVTHGRI 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 141
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 202 FGILLTEIVTHGRI 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              ++  EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 91  PIYIIT-EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 145
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 206 FGILLTEIVTHGRI 219

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              ++  EYM NGSL  +L +      L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 81  PIYIIT-EYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 196 FGILLTEIVTHGRI 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              ++  EYM NGSL  +L +      L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 76  PIYIIT-EYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 130
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 191 FGILLTEIVTHGRI 204

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 194 FGILLTELTTKGRV 207

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 367 FGILLTELTTKGRV 380

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 69
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V E M NGSLD +L +   +F +   Q   ++  I
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 367 FGILLTELTTKGRV 380

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+ G   + TKVAVK L+      ++FL E   + ++ H  LVRL     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--------DIAKGLTYLHED 355
            +    ++ EYM  GSL  +L  +SDE         K++L         IA+G+ Y+   
Sbjct: 79  REEPIYIITEYMAKGSLLDFL--KSDE-------GGKVLLPKLIDFSAQIAEGMAYIE-- 127
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-S 414
            R+  +H D++  N+L+  +   K+ADFGL+++I+ ++       +    + APE ++  
Sbjct: 128 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 186
Query: 415 IITEKVDIYSFGVVMLEILCGRKV 438
             T K D++SFG+++ EI+   K+
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKI 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V E M NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  I H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 450 FGILLTELTTKGRV 463

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEGIGEINKS---FLAEVK 285
           +EL        +++G G FG V  G  +  G +   VA+K L+ +G   K    FL E  
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLK-VGYTEKQRRDFLCEAS 96
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N+V L G        ++V E+M NG+LD +L +   +F +   Q   ++  I
Sbjct: 97  IMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGI 154
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT-- 403
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++I+ D   V TT  G   
Sbjct: 155 AAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 404 PGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + APE +     T   D++S+G+VM E++
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINKS---FLAEVK 285
           +EL     +  K++G G FG V  G     +K    VA+K L+ +G   K    FL E  
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++RL G   +    ++V E M NGSLD +L +   +F +   Q   ++  I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + +PE ++    T   D++S+G+V+ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           +++G+G FG V +  +     VA+K++E   E  K+F+ E++ +  ++H N+V+L G C 
Sbjct: 14  EVVGRGAFGVVCKA-KWRAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 LV EY   GSL   L                  L  ++G+ YLH    + ++H 
Sbjct: 72  NPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 364 DIKPQNILL-DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVD 421
           D+KP N+LL  G    K+ DFG +     D    +T  +G+  ++APE +  S  +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 422 IYSFGVVMLEILCGRKVFDR-SQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE 480
           ++S+G+++ E++  RK FD    P    M+ +              L+      ++S   
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-------HNGTRPPLIKNLPKPIES--- 235
Query: 481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF 516
                  +   C   D ++RPSM  +V+++  +  +
Sbjct: 236 -------LMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G + + L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKEL-QKLSKF--DEQRTATYITELANALSYCHS---KR 133
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   +  E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLDYLPPEMIEGRMHDE 190
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              +++ EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  PIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEGIGEINKS---FLAEVK 285
           +E++       +++G G FG V  G  +  G +   VA+K L+ +G   K    FL E  
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK-VGYTEKQRRDFLGEAS 75
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            +G   H N++ L G   +    ++V EYM NGSLD +L +   +F +   Q   ++  I
Sbjct: 76  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGI 133
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           + G+ YL +      +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G   
Sbjct: 134 SAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 406 --YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
             + APE ++    T   D++S+G+VM E++
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           +++G+G FG V +  +     VA+K++E   E  K+F+ E++ +  ++H N+V+L G C 
Sbjct: 15  EVVGRGAFGVVCKA-KWRAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 LV EY   GSL   L                  L  ++G+ YLH    + ++H 
Sbjct: 73  NPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 364 DIKPQNILL-DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVD 421
           D+KP N+LL  G    K+ DFG +     D    +T  +G+  ++APE +  S  +EK D
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 422 IYSFGVVMLEILCGRKVFDR-SQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE 480
           ++S+G+++ E++  RK FD    P    M+ +              L+      ++S   
Sbjct: 187 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-------HNGTRPPLIKNLPKPIES--- 236
Query: 481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF 516
                  +   C   D ++RPSM  +V+++  +  +
Sbjct: 237 -------LMTRCWSKDPSQRPSMEEIVKIMTHLMRY 265

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 367 FGILLTELTTKGRV 380

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              +++ EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  PIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 198 FGILLTELTTKGRV 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 128
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 190 FGILLTELTTKGRV 203

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 192 FGILLTELTTKGRV 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 152
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
            EKVD++S GV+  E L G+  F+
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 21/228 (9%)
Query: 218 DYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFE-----GTQTDGTKVAVKRL 270
           D+L   PG+   F      + +D ++  ++LGKG FG V         Q    KV  KR 
Sbjct: 7   DHLHATPGM---FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 271 EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE 330
                  +S L EV+ +  + H N+++L  F  +K +  LV E    G L   +  R   
Sbjct: 64  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 123
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSK 387
             +D     +II  +  G+TY+H   + KI+H D+KP+N+LL+    + N ++ DFGLS 
Sbjct: 124 SEVD---AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
             +   S+ +    GT  Y+APE L     EK D++S GV++  +L G
Sbjct: 178 HFEA--SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 21/228 (9%)
Query: 218 DYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFE-----GTQTDGTKVAVKRL 270
           D+L   PG+   F      + +D ++  ++LGKG FG V         Q    KV  KR 
Sbjct: 30  DHLHATPGM---FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 86
Query: 271 EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE 330
                  +S L EV+ +  + H N+++L  F  +K +  LV E    G L   +  R   
Sbjct: 87  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 146
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSK 387
             +D     +II  +  G+TY+H   + KI+H D+KP+N+LL+    + N ++ DFGLS 
Sbjct: 147 SEVD---AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 200
Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
             +   S+ +    GT  Y+APE L     EK D++S GV++  +L G
Sbjct: 201 HFEA--SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L   + ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 198 FGILLTELTTKGRV 211

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 21/228 (9%)
Query: 218 DYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFE-----GTQTDGTKVAVKRL 270
           D+L   PG+   F      + +D ++  ++LGKG FG V         Q    KV  KR 
Sbjct: 31  DHLHATPGM---FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 87
Query: 271 EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE 330
                  +S L EV+ +  + H N+++L  F  +K +  LV E    G L   +  R   
Sbjct: 88  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 147
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSK 387
             +D     +II  +  G+TY+H   + KI+H D+KP+N+LL+    + N ++ DFGLS 
Sbjct: 148 SEVD---AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 201
Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
             +   S+ +    GT  Y+APE L     EK D++S GV++  +L G
Sbjct: 202 HFEA--SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               ++ EYM NGSL  +L +      L   +   +   IA+G+ ++ E   +  +H ++
Sbjct: 77  PI-YIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNL 131
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    T K D++S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 192 FGILLTEIVTHGRI 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 246 LGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++RL 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    ++
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS---KR 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-TE 418
           ++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   +  E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEMIEGRMHDE 188
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           KVD++S GV+  E L G+  F+ +  +E
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL +LI+ ++       +    + APE  L    T K D++S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 368 FGILLTELTTKGRV 381

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKG FG+V+   +         KV  K +LE  G +      EV+    + H N++R
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G+  + +   L+ EY P G++ R L Q+  +F  D Q+    I ++A  L+Y H    
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALSYCHS--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
           ++++H DIKP+N+LL      K+ADFG S       S     + GT  YL PE +   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            EKVD++S GV+  E L G+  F+ +  +E
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 132/290 (45%), Gaps = 39/290 (13%)
Query: 244 KMLGKGGFGSVFEGT--QTDGT--KVAVKRLEGIGEINKS---FLAEVKTIGSIHHQNLV 296
           K+LG+G FGSV EG   Q DGT  KVAVK ++      +    FL+E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 297 RLIGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEF---MLDWQQRKKIILDIAKG 348
           RL+G C E S       +++  +M  G L  +L     E     +  Q   K ++DIA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPGYL 407
           + YL     +  LH D+  +N +L  +    VADFGLSK I   D  +     +    ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 408 APEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           A E L+  + T K D+++FGV M EI   G   +   Q  E   YLL   + K  ED L 
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD 276
Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
           +L +                  +   C  +D   RP+ S++   LE + E
Sbjct: 277 ELYE------------------IMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  GSL  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
              NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKT 286
           +E+        K++G G FG V  G  +  G +   VA+K L+     +  + FL+E   
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++ L G   +    +++ EYM NGSLD +L +    F +   Q   ++  I 
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIG 126
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG- 405
            G+ YL +      +H D+  +NIL++ N   KV+DFG+S++++ D     TT  G    
Sbjct: 127 SGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 406 -YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            + APE ++    T   D++S+G+VM E++
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKT 286
           +E+        K++G G FG V  G  +  G +   VA+K L+     +  + FL+E   
Sbjct: 24  KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++ L G   +    +++ EYM NGSLD +L +    F +   Q   ++  I 
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIG 141
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG- 405
            G+ YL +      +H D+  +NIL++ N   KV+DFG+S++++ D     TT  G    
Sbjct: 142 SGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 406 -YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            + APE ++    T   D++S+G+VM E++
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKT 286
           +E+        K++G G FG V  G  +  G +   VA+K L+     +  + FL+E   
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++ L G   +    +++ EYM NGSLD +L +    F +   Q   ++  I 
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIG 120
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG- 405
            G+ YL +      +H D+  +NIL++ N   KV+DFG+S++++ D     TT  G    
Sbjct: 121 SGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 406 -YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            + APE ++    T   D++S+G+VM E++
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 32/215 (14%)
Query: 244 KMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIG-EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G      +T    VA+K L E  G + N  F+ E   + S+ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L V + MP+G L  ++ +  D    + +L+W       + IAKG+ YL
Sbjct: 81  RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
            E   ++++H D+  +N+L+    + K+ DFGL++L++ D+ +         G +  +W+
Sbjct: 134 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY----NADGGKMPIKWM 186
Query: 413 S------SIITEKVDIYSFGVVMLEILC-GRKVFD 440
           +         T + D++S+GV + E++  G K +D
Sbjct: 187 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 32/215 (14%)
Query: 244 KMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIG-EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G      +T    VA+K L E  G + N  F+ E   + S+ H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L V + MP+G L  ++ +  D    + +L+W       + IAKG+ YL
Sbjct: 104 RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
            E   ++++H D+  +N+L+    + K+ DFGL++L++ D+ +         G +  +W+
Sbjct: 157 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY----NADGGKMPIKWM 209
Query: 413 S------SIITEKVDIYSFGVVMLEILC-GRKVFD 440
           +         T + D++S+GV + E++  G K +D
Sbjct: 210 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKT 286
           +E+ V      +++G G FG V  G  +  G K   VA+K L+G       + FL+E   
Sbjct: 11  KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 70
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++RL G        +++ E+M NG+LD +L     +F +   Q   ++  IA
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIA 128
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM----RG 402
            G+ YL E      +H D+  +NIL++ N   KV+DFGLS+ ++++ S    T     + 
Sbjct: 129 SGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              + APE ++    T   D +S+G+VM E++
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 135/278 (48%), Gaps = 40/278 (14%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+ G   + TKVAVK L+      ++FL E   + ++ H  LVRL     
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--------DIAKGLTYLHED 355
           ++    ++ E+M  GSL  +L  +SDE         K++L         IA+G+ Y+   
Sbjct: 78  KEEPIYIITEFMAKGSLLDFL--KSDE-------GGKVLLPKLIDFSAQIAEGMAYIE-- 126
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-S 414
            R+  +H D++  N+L+  +   K+ADFGL+++I+ ++       +    + APE ++  
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS-N 473
             T K +++SFG+++ EI+   K+                +  +   D +S L   +   
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKI---------------PYPGRTNADVMSALSQGYRMP 230
Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
            M++  +E+ ++MK+   C +    +RP+   +  VL+
Sbjct: 231 RMENCPDELYDIMKM---CWKEKAEERPTFDYLQSVLD 265

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTK---VAVKRLEG--IGEINKSFLAEVKT 286
           +E+ V      +++G G FG V  G  +  G K   VA+K L+G       + FL+E   
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++RL G        +++ E+M NG+LD +L     +F +   Q   ++  IA
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIA 126
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM----RG 402
            G+ YL E      +H D+  +NIL++ N   KV+DFGLS+ ++++ S    T     + 
Sbjct: 127 SGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              + APE ++    T   D +S+G+VM E++
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  G L  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L    +E+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
               +V EYM  G L  +L     ++ L   Q   +   IA G+ Y+    R   +H D+
Sbjct: 86  P-IYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYS 424
           +  NIL+  N   KVADFGL++LI+ ++       +    + APE  L    T K D++S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 425 FGVVMLEILCGRKV 438
           FG+++ E+    +V
Sbjct: 201 FGILLTELTTKGRV 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 6/194 (3%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           LG G  G V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL     ++
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
              ++  EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   +  +H D+
Sbjct: 81  PIYIIT-EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYS 424
           +  NIL+    + K+ADFGL++LI+  +       +    + APE ++    T K D++S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 425 FGVVMLEILCGRKV 438
           FG+++ EI+   ++
Sbjct: 196 FGILLTEIVTHGRI 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 8   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 62
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 63  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 120
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 121 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 178 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 116
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 117 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G     + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 7   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 119
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 120 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 35  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 89
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 147
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 148 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 204
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 126
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP---GYLAPEWL-SSII 416
           LH D+  +N L++     KV+DFGLS+ +  D+    T+ RG+     +  PE L  S  
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 417 TEKVDIYSFGVVMLEILC-GRKVFDR 441
           + K DI++FGV+M EI   G+  ++R
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 3   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 57
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 58  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 115
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 116 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G     + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 173 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 24/220 (10%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV------FEGTQTDGTKVAVKRL--EGIGEINK 278
           P  F    LK + D     LG+G FG V       EG  T G +VAVK L  E  G    
Sbjct: 15  PTHFEKRFLKRIRD-----LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIA 68
Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
               E++ + +++H+N+V+  G C E   N   L+ E++P+GSL  +L +  ++  L  +
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--K 126
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-QSQ 395
           Q+ K  + I KG+ YL     ++ +H D+  +N+L++     K+ DFGL+K I+ D +  
Sbjct: 127 QQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 183
Query: 396 VVTTMRGTPGY-LAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            V   R +P +  APE L  S      D++SFGV + E+L
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 2   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 56
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 57  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 114
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 115 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G     + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 172 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 116
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 117 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G     + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 141
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 24/220 (10%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV------FEGTQTDGTKVAVKRL--EGIGEINK 278
           P  F    LK + D     LG+G FG V       EG  T G +VAVK L  E  G    
Sbjct: 3   PTHFEKRFLKRIRD-----LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIA 56
Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQ 336
               E++ + +++H+N+V+  G C E   N   L+ E++P+GSL  +L +  ++  L  +
Sbjct: 57  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--K 114
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-QSQ 395
           Q+ K  + I KG+ YL     ++ +H D+  +N+L++     K+ DFGL+K I+ D +  
Sbjct: 115 QQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 171
Query: 396 VVTTMRGTPGY-LAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            V   R +P +  APE L  S      D++SFGV + E+L
Sbjct: 172 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 10  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 64
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 65  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 122
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 123 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 179
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 180 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 125
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYER 208

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 21/229 (9%)
Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFE-----GTQTDGTKVAVKR 269
           E+   Q PG+   F      + +D ++  ++LGKG FG V         Q    KV  KR
Sbjct: 12  ENLYFQGPGM---FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 68
Query: 270 LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
                   +S L EV+ +  + H N+++L  F  +K +  LV E    G L   +  R  
Sbjct: 69  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 128
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLS 386
              +D     +II  +  G+TY+H++   KI+H D+KP+N+LL+    + N ++ DFGLS
Sbjct: 129 FSEVD---AARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 182
Query: 387 KLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
              +   S+ +    GT  Y+APE L     EK D++S GV++  +L G
Sbjct: 183 THFEA--SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 9   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 63
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 64  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 121
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 122 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 179 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 7   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L   ++   +D  + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKL 119
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 120 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G     + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 11  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 65
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 66  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 123
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 124 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 180
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 181 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 224 PGLPKRFSFEELKVMTDNFR-KMLGKGGFGSVFEGTQTDG-TKVAVKRLE---------- 271
           PG+  R   +E K+    F+ + LG G +G V    + +G ++ A+K ++          
Sbjct: 23  PGMYVRK--KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 272 ----GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR 327
                I + ++    E+  + S+ H N+++L     +K +  LV E+   G L   +  R
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140
Query: 328 SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFG 384
                 D      I+  I  G+ YLH   +  I+H DIKP+NILL+      N K+ DFG
Sbjct: 141 HK---FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
           LS    +D    +    GT  Y+APE L     EK D++S GV+M  +LCG
Sbjct: 195 LSSFFSKDYK--LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 121
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYER 204

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 221 DQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFE-----GTQTDGTKVAVKRLEGI 273
           D +   P  F      + +D ++  ++LGKG FG V         Q    KV  KR    
Sbjct: 7   DHLHATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66
Query: 274 GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML 333
               +S L EV+ +  + H N+ +L  F  +K +  LV E    G L   +  R     +
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLID 390
           D     +II  +  G+TY H   + KI+H D+KP+N+LL+    + N ++ DFGLS   +
Sbjct: 127 D---AARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 391 QDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
              S+      GT  Y+APE L     EK D++S GV++  +L G
Sbjct: 181 A--SKKXKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 141
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYER 224

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 6/196 (3%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+ GT    TKVA+K L+      +SFL E + +  + H  LV+L    +
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           E+    +V EYM  GSL  +L +  +   L       +   +A G+ Y+    R   +H 
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDI 422
           D++  NIL+      K+ADFGL++LI+ ++       +    + APE  L    T K D+
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 423 YSFGVVMLEILCGRKV 438
           +SFG+++ E++   +V
Sbjct: 190 WSFGILLTELVTKGRV 205

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 113/217 (52%), Gaps = 35/217 (16%)
Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKV--AVKRLEGIG--EINKSFLAEVKTIGSI-HHQNL 295
           F+ ++G+G FG V +   + DG ++  A+KR++     + ++ F  E++ +  + HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRKKII 342
           + L+G C  + +  L  EY P+G+L  +L                S    L  QQ     
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            D+A+G+ YL +   ++ +H D+  +NIL+  N+ AK+ADFGLS+       Q V  ++ 
Sbjct: 149 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEV-YVKK 198
Query: 403 TPGYLAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           T G L   W++      S+ T   D++S+GV++ EI+
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 113/217 (52%), Gaps = 35/217 (16%)
Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKV--AVKRLEGIG--EINKSFLAEVKTIGSI-HHQNL 295
           F+ ++G+G FG V +   + DG ++  A+KR++     + ++ F  E++ +  + HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRKKII 342
           + L+G C  + +  L  EY P+G+L  +L                S    L  QQ     
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            D+A+G+ YL +   ++ +H D+  +NIL+  N+ AK+ADFGLS+       Q V  ++ 
Sbjct: 139 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEV-YVKK 188
Query: 403 TPGYLAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           T G L   W++      S+ T   D++S+GV++ EI+
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 7   PTQFEERHLK-----FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ E++P GSL  +L +  +   +D  + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKL 119
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 120 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 126
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYER 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEG-TQTDGTK---VAVKRLE-GIGEINK-SFLAEVKT 286
           +E+ +      +++G G FG V  G  +  G +   VA+K L+ G  E  +  FL+E   
Sbjct: 28  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 87
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++ L G   + +  +++ E+M NGSLD +L Q   +F +   Q   ++  IA
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIA 145
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            G+ YL +      +H D+  +NIL++ N   KV+DFGLS+ ++ D S    T     G 
Sbjct: 146 AGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT-SALGGK 201
Query: 407 LAPEWLSS------IITEKVDIYSFGVVMLEIL 433
           +   W +         T   D++S+G+VM E++
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQF 132
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 420 VDIYSFGVVMLEILC-GRKVFDR 441
            DI++FGV+M EI   G+  ++R
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYER 215

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 89
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 202
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 116/218 (53%), Gaps = 21/218 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 116
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--QV 396
            +    I KG+ YL     ++ +H D+  +NIL++     K+ DFGL+K++ QD+   +V
Sbjct: 117 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
                    + APE L+ S  +   D++SFGVV+ E+ 
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 158/315 (50%), Gaps = 41/315 (13%)
Query: 220 LDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTDGTK--VAVKRLEG- 272
           L Q PG P  F    LK + D     LG+G FG V    ++ T  DGT   VAVK L+  
Sbjct: 18  LFQGPGDPTVFHKRYLKKIRD-----LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKAD 71
Query: 273 IGEINKS-FLAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRS- 328
            G  ++S +  E+  + +++H+++++  G C  A  +   LV EY+P GSL  +L + S 
Sbjct: 72  AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI 131
Query: 329 --DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
              + +L  QQ       I +G+ YLH    Q  +H D+  +N+LLD +   K+ DFGL+
Sbjct: 132 GLAQLLLFAQQ-------ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 387 KLIDQDQSQVVTTMRG-TPGY-LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           K + +          G +P +  APE L         D++SFGV + E+L      D SQ
Sbjct: 182 KAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH---CDSSQ 238
Query: 444 -PEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG--EEVVNMMKVAAWCLESDFAKR 500
            P  + + L+ I + +    +L++L+++     + +    EV ++MK    C E++ + R
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN---CWETEASFR 295
Query: 501 PSMSMVVRVLEGVTE 515
           P+   ++ +L+ V E
Sbjct: 296 PTFENLIPILKTVHE 310

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 90
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 203
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 91
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 90
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKLPVKWM 203
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 86
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 199
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 91
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 16/204 (7%)
Query: 242 FRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNL 295
           F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F  E++ + S+ H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 296 VRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  +  +    I KG+ YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL- 148
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG--YLAPEW 411
               ++ +H D+  +NIL++     K+ DFGL+K++ QD+        G     + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 412 LS-SIITEKVDIYSFGVVMLEILC 434
           L+ S  +   D++SFGVV+ E+  
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 109
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 168 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 222
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 16/204 (7%)
Query: 242 FRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNL 295
           F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F  E++ + S+ H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 296 VRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  +  +    I KG+ YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL- 148
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG--YLAPEW 411
               ++ +H D+  +NIL++     K+ DFGL+K++ QD+        G     + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 412 LS-SIITEKVDIYSFGVVMLEILC 434
           L+ S  +   D++SFGVV+ E+  
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 110
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 169 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 223
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 88
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 147 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 201
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 83
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ YL
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 142 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 196
Query: 413 ------SSIITEKVDIYSFGVVMLEIL 433
                 +   T K D++SFGV++ E++
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 23/223 (10%)
Query: 242 FRKMLGKGGFGSV-----FEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV 296
            R+ LG+G FG V     ++  Q    K   ++L    +++     E+  +  + H +++
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +L       +  ++V EY   G L  ++ ++     +   + ++    I   + Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCH--- 125
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           R KI+H D+KP+N+LLD N N K+ADFGLS ++       + T  G+P Y APE ++  +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 417 TE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
               +VD++S G+V+  +L GR  FD       D ++ ++FKK
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD-------DEFIPNLFKK 219

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K LG G FG V+  T    TKVAVK ++      ++FLAE   + ++ H  LV+L     
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII---LDIAKGLTYLHEDCRQKI 360
            K    ++ E+M  GSL  +L  +SDE     Q   K+I     IA+G+ ++ +   +  
Sbjct: 81  -KEPIYIITEFMAKGSLLDFL--KSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNY 132
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D++  NIL+  +   K+ADFGL+++I+ ++       +    + APE ++    T K
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 420 VDIYSFGVVMLEILC-GR 436
            D++SFG++++EI+  GR
Sbjct: 193 SDVWSFGILLMEIVTYGR 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 37/226 (16%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG-EINKS 279
           P  F    LK ++      LGKG FGSV E  + D      G  VAVK+L+  G +  + 
Sbjct: 1   PTIFEERHLKYISQ-----LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 54
Query: 280 FLAEVKTIGSIHHQNLV--RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           F  E++ + ++H   +V  R + +   +    LV EY+P+G L             D+ Q
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR------------DFLQ 102
Query: 338 RKKIILDIAKGLTYLHEDCR-------QKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           R +  LD ++ L Y  + C+       ++ +H D+  +NIL++   + K+ADFGL+KL+ 
Sbjct: 103 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 162
Query: 391 QDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            D+   V    G     + APE LS +I + + D++SFGVV+ E+ 
Sbjct: 163 LDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
              K LG G FG V+  T    TKVAVK ++      ++FLAE   + ++ H  LV+L  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII---LDIAKGLTYLHEDCR 357
               K    ++ E+M  GSL  +L  +SDE     Q   K+I     IA+G+ ++ +   
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFL--KSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ--- 302
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           +  +H D++  NIL+  +   K+ADFGL+++I+ ++       +    + APE ++    
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 417 TEKVDIYSFGVVMLEILC-GR 436
           T K D++SFG++++EI+  GR
Sbjct: 363 TIKSDVWSFGILLMEIVTYGR 383

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 115/229 (50%), Gaps = 37/229 (16%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG-EI 276
           P  P  F    LK ++      LGKG FGSV E  + D      G  VAVK+L+  G + 
Sbjct: 2   PQDPTIFEERHLKYISQ-----LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQHSGPDQ 55
Query: 277 NKSFLAEVKTIGSIHHQNLV--RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD 334
            + F  E++ + ++H   +V  R + +   +    LV EY+P+G L             D
Sbjct: 56  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR------------D 103
Query: 335 WQQRKKIILDIAKGLTYLHEDCR-------QKILHLDIKPQNILLDGNFNAKVADFGLSK 387
           + QR +  LD ++ L Y  + C+       ++ +H D+  +NIL++   + K+ADFGL+K
Sbjct: 104 FLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 163
Query: 388 LIDQDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
           L+  D+   V    G     + APE LS +I + + D++SFGVV+ E+ 
Sbjct: 164 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 113/217 (52%), Gaps = 35/217 (16%)
Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKV--AVKRLEGIG--EINKSFLAEVKTIGSI-HHQNL 295
           F+ ++G+G FG V +   + DG ++  A+KR++     + ++ F  E++ +  + HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRKKII 342
           + L+G C  + +  L  EY P+G+L  +L                S    L  QQ     
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            D+A+G+ YL +   ++ +H ++  +NIL+  N+ AK+ADFGLS+       Q V  ++ 
Sbjct: 146 ADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR------GQEV-YVKK 195
Query: 403 TPGYLAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           T G L   W++      S+ T   D++S+GV++ EI+
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 115/219 (52%), Gaps = 21/219 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTD-GTKVAVKRLEGIGEIN-KSF 280
           P +F    LK     F + LGKG FGSV    ++  Q + G  VAVK+L+   E + + F
Sbjct: 5   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 59
Query: 281 LAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + S+ H N+V+  G C  A + +  L+ EY+P GSL  +L +  +   +D  + 
Sbjct: 60  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKL 117
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +    I KG+ YL     ++ +H ++  +NIL++     K+ DFGL+K++ QD+     
Sbjct: 118 LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 399 TMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
              G     + APE L+ S  +   D++SFGVV+ E+  
Sbjct: 175 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 150
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 263
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 315
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 316 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 366
Query: 524 LVHLPI 529
             ++ +
Sbjct: 367 ATYVNV 372

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 37/226 (16%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG-EINKS 279
           P  F    LK ++      LGKG FGSV E  + D      G  VAVK+L+  G +  + 
Sbjct: 17  PTIFEERHLKYISQ-----LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 280 FLAEVKTIGSIHHQNLV--RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           F  E++ + ++H   +V  R + +   +    LV EY+P+G L             D+ Q
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR------------DFLQ 118
Query: 338 RKKIILDIAKGLTYLHEDCR-------QKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           R +  LD ++ L Y  + C+       ++ +H D+  +NIL++   + K+ADFGL+KL+ 
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 391 QDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            D+   V    G     + APE LS +I + + D++SFGVV+ E+ 
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 37/226 (16%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG-EINKS 279
           P  F    LK ++      LGKG FGSV E  + D      G  VAVK+L+  G +  + 
Sbjct: 4   PTIFEERHLKYISQ-----LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 57
Query: 280 FLAEVKTIGSIHHQNLV--RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
           F  E++ + ++H   +V  R + +   +    LV EY+P+G L             D+ Q
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR------------DFLQ 105
Query: 338 RKKIILDIAKGLTYLHEDCR-------QKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           R +  LD ++ L Y  + C+       ++ +H D+  +NIL++   + K+ADFGL+KL+ 
Sbjct: 106 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 165
Query: 391 QDQSQVVTTMRGTPG--YLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            D+   V    G     + APE LS +I + + D++SFGVV+ E+ 
Sbjct: 166 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 245 MLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIH----HQNLVRLI 299
           +LGKG F  V+       G +VA+K ++         +  V+    IH    H +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            +  + ++  LV E   NG ++R+L  R   F     + +  +  I  G+ YLH      
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF--SENEARHFMHQIITGMLYLHS---HG 132
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
           ILH D+   N+LL  N N K+ADFGL+  +     +   T+ GTP Y++PE  + S    
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-TLCGTPNYISPEIATRSAHGL 191
Query: 419 KVDIYSFGVVMLEILCGRKVFD 440
           + D++S G +   +L GR  FD
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLI 299
           F ++LG G F  VF   Q   G   A+K ++       S L  E+  +  I H+N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
                 +H  LV + +  G L   + +R    +   +    +I  +   + YLHE+    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---G 126
Query: 360 ILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-I 415
           I+H D+KP+N+L    + N    + DFGLSK+   +Q+ +++T  GTPGY+APE L+   
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
            ++ VD +S GV+   +LCG   F
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 89
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 202
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 254
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 255 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 305
Query: 524 LVHLPI 529
             ++ +
Sbjct: 306 ATYVNV 311

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 91
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 204
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 256
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 257 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 307
Query: 524 LVHLPI 529
             ++ +
Sbjct: 308 ATYVNV 313

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 96
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 155 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 209
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 261
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 262 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 312
Query: 524 LVHLPI 529
             ++ +
Sbjct: 313 ATYVNV 318

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 92
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 205
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 257
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 258 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 308
Query: 524 LVHLPI 529
             ++ +
Sbjct: 309 ATYVNV 314

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVFEG-TQTDGTK---VAVKRLE-GIGEINK-SFLAEVKT 286
           +E+ +      +++G G FG V  G  +  G +   VA+K L+ G  E  +  FL+E   
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +G   H N++ L G   + +  +++ E+M NGSLD +L Q   +F +   Q   ++  IA
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIA 119
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            G+ YL +      +H  +  +NIL++ N   KV+DFGLS+ ++ D S    T     G 
Sbjct: 120 AGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT-SALGGK 175
Query: 407 LAPEWLSS------IITEKVDIYSFGVVMLEIL 433
           +   W +         T   D++S+G+VM E++
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 91
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWM 204
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 256
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 257 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 307
Query: 524 LVHLPI 529
             ++ +
Sbjct: 308 ATYVNV 313

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 42/306 (13%)
Query: 241 NFRKMLGKGGFGSVFEGT--QTDGTKV--AVK---RLEGIGEINKSFLAEVKTIGSIHHQ 293
           +F +++G+G FG V+ GT    DG K+  AVK   R+  IGE+++ FL E   +    H 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHP 92
Query: 294 NLVRLIGFCAEKSHN-LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           N++ L+G C     + L+V  YM +G L    F R++      +      L +AKG+ +L
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                +K +H D+  +N +LD  F  KVADFGL++  D    +  +    T   L  +W+
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGAKLPVKWM 205
Query: 413 ------SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
                 +   T K D++SFGV++ E++       R  P   D+    I     +  +L  
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 257
Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVRVLEGVTEF--EHNLHYN 523
           L  ++  D          + +V   C       RPS S +V R+    + F  EH +H N
Sbjct: 258 LQPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 308
Query: 524 LVHLPI 529
             ++ +
Sbjct: 309 ATYVNV 314

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK-----SFLAEVKTIGSIHHQNLVRL 298
           + LGKG FG+V+   +     +   ++    +I K         E++    +HH N++RL
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             +  ++    L+ EY P G L + L Q+S  F  D Q+   I+ ++A  L Y H    +
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKEL-QKSCTF--DEQRTATIMEELADALMYCHG---K 142
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-T 417
           K++H DIKP+N+LL      K+ADFG S       S    TM GT  YL PE +   +  
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           EKVD++  GV+  E+L G   F+ +   E
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 18/215 (8%)
Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
            + +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  
Sbjct: 9   LNMKELKLL-----QTIGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQAFLAEASVMTQ 61
Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + H NLV+L+G   E+   L +V EYM  GSL  +L  R    +L      K  LD+ + 
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 120
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL  +     +H D+  +N+L+  +  AKV+DFGL+K    + S    T +    + A
Sbjct: 121 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA 173
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILC-GRKVFDR 441
           PE L  +  + K D++SFG+++ EI   GR  + R
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPR 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 245 MLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIG 300
           MLGKG FG V +   +    + AVK +      NK   + L EV+ +  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              + S   +V E    G L   + +R            +II  +  G+TY+H   +  I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 361 LHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPEWLSS 414
           +H D+KP+NILL+    + + K+ DFGLS    Q+     T M+   GT  Y+APE L  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEVLRG 197
Query: 415 IITEKVDIYSFGVVMLEILCGRKVF 439
              EK D++S GV++  +L G   F
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 236 KVMTDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIG 288
           K++ + ++ +  LG GG  +V+    T    KVA+K +        E  K F  EV    
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDI 345
            + HQN+V +I    E     LV EY+   +L  ++      S +  +++  +   ILD 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ---ILD- 122
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
             G+ + H+    +I+H DIKPQNIL+D N   K+ DFG++K + +        + GT  
Sbjct: 123 --GIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 406 YLAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVFD 440
           Y +PE      T++  DIYS G+V+ E+L G   F+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
            + +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  
Sbjct: 190 LNMKELKLL-----QTIGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQAFLAEASVMTQ 242
Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + H NLV+L+G   E+   L +V EYM  GSL  +L  R    +L      K  LD+ + 
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 301
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL  +     +H D+  +N+L+  +  AKV+DFGL+K    + S    T +    + A
Sbjct: 302 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA 354
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILC-GRKVFDR 441
           PE L     + K D++SFG+++ EI   GR  + R
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 16/220 (7%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK-VAVKRL--EGIGEINKSFLAE 283
           P+    E+++ + D FR +LG G F  V         K VA+K +  E +     S   E
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
           +  +  I H N+V L        H  L+ + +  G L   + ++        +   ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIF 123
Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNIL---LDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            +   + YLH+     I+H D+KP+N+L   LD +    ++DFGLSK+  +D   V++T 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
            GTPGY+APE L+    ++ VD +S GV+   +LCG   F
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 245 MLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIG 300
           MLGKG FG V +   +    + AVK +      NK   + L EV+ +  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              + S   +V E    G L   + +R            +II  +  G+TY+H   +  I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 361 LHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPEWLSS 414
           +H D+KP+NILL+    + + K+ DFGLS    Q+     T M+   GT  Y+APE L  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEVLRG 197
Query: 415 IITEKVDIYSFGVVMLEILCGRKVF 439
              EK D++S GV++  +L G   F
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL-----EGIGEINKSFLAEVKTIGSIHHQNL 295
              +++G GGFG V+      G +VAVK       E I +  ++   E K    + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYLH 353
           + L G C ++ +  LV E+   G L+R L  +    + +++W       + IA+G+ YLH
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARGMNYLH 122
Query: 354 EDCRQKILHLDIKPQNILL-----DGNFN---AKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           ++    I+H D+K  NIL+     +G+ +    K+ DFGL++   +       +  G   
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYA 179
Query: 406 YLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVF 439
           ++APE + +S+ ++  D++S+GV++ E+L G   F
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 245 MLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIG 300
           MLGKG FG V +   +    + AVK +      NK   + L EV+ +  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              + S   +V E    G L   + +R            +II  +  G+TY+H   +  I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 361 LHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPEWLSS 414
           +H D+KP+NILL+    + + K+ DFGLS    Q+     T M+   GT  Y+APE L  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEVLRG 197
Query: 415 IITEKVDIYSFGVVMLEILCGRKVF 439
              EK D++S GV++  +L G   F
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 52/236 (22%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI 290
           FEE+ V        LG+G FG V +     D    A+K++    E   + L+EV  + S+
Sbjct: 8   FEEIAV--------LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 291 HHQ-------------NLVRLIGFCAEKSHNLLVYEYMPNGSL-----DRWLFQRSDEFM 332
           +HQ             N V+ +    +KS   +  EY  NG+L        L Q+ DE+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY- 118
Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
             W+  ++I+    + L+Y+H    Q I+H D+KP NI +D + N K+ DFGL+K + + 
Sbjct: 119 --WRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 393 -------------QSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEIL 433
                         S  +T+  GT  Y+A E L       EK+D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINKSF 280
           P+    E+++ + D FR +LG G F  V         K      +A K LEG      S 
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK---EGSM 63
Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
             E+  +  I H N+V L        H  L+ + +  G L   + ++   F  + +   +
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTE-RDASR 120
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNIL---LDGNFNAKVADFGLSKLIDQDQSQVV 397
           +I  +   + YLH+     I+H D+KP+N+L   LD +    ++DFGLSK+  +D   V+
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVL 175
Query: 398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
           +T  GTPGY+APE L+    ++ VD +S GV+   +LCG   F
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK-VAVKRL--EGIGEINKSFLAE 283
           P+    E+++ + D FR +LG G F  V         K VA+K +  E +     S   E
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
           +  +  I H N+V L        H  L+ + +  G L   + ++   F  + +   ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTE-RDASRLIF 123
Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNIL---LDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            +   + YLH+     I+H D+KP+N+L   LD +    ++DFGLSK+  +D   V++T 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
            GTPGY+APE L+    ++ VD +S GV+   +LCG   F
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
            + +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  
Sbjct: 3   LNMKELKLL-----QTIGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQAFLAEASVMTQ 55
Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + H NLV+L+G   E+   L +V EYM  GSL  +L  R    +L      K  LD+ + 
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 114
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL  +     +H D+  +N+L+  +  AKV+DFGL+K    + S    T +    + A
Sbjct: 115 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA 167
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILC-GRKVFDR 441
           PE L     + K D++SFG+++ EI   GR  + R
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 7/209 (3%)
Query: 234 ELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ 293
           ELK       K LG G FG V  G       VAVK ++        F  E +T+  + H 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
            LV+  G C+++    +V EY+ NG L  +L  RS    L+  Q  ++  D+ +G+ +L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                + +H D+  +N L+D +   KV+DFG+++ +  DQ       +    + APE   
Sbjct: 122 S---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 414 SI-ITEKVDIYSFGVVMLEILC-GRKVFD 440
               + K D+++FG++M E+   G+  +D
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK-VAVKRL--EGIGEINKSFLAE 283
           P+    E+++ + D FR +LG G F  V         K VA+K +  E +     S   E
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
           +  +  I H N+V L        H  L+ + +  G L   + ++   F  + +   ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTE-RDASRLIF 123
Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNIL---LDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            +   + YLH+     I+H D+KP+N+L   LD +    ++DFGLSK+  +D   V++T 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
            GTPGY+APE L+    ++ VD +S GV+   +LCG   F
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
            + +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  
Sbjct: 18  LNMKELKLL-----QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQ 70
Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + H NLV+L+G   E+   L +V EYM  GSL  +L  R    +L      K  LD+ + 
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 129
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL  +     +H D+  +N+L+  +  AKV+DFGL+K    + S    T +    + A
Sbjct: 130 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA 182
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILC-GRKVFDR 441
           PE L     + K D++SFG+++ EI   GR  + R
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 122/260 (46%), Gaps = 29/260 (11%)
Query: 226 LPKR-FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEINK 278
           +PKR F+ ++  ++     + LGKG FG+V+   +         KV  K +LE  G +  
Sbjct: 6   MPKRKFTIDDFDIV-----RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEH 59
Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
               E++    + H N++R+  +  ++    L+ E+ P G L + L Q+   F  D Q+ 
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRF--DEQRS 116
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
              + ++A  L Y HE   +K++H DIKP+N+L+      K+ADFG S       S    
Sbjct: 117 ATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRR 170
Query: 399 TMRGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI--- 454
            M GT  YL PE +      EKVD++  GV+  E L G   FD     E    ++++   
Sbjct: 171 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
Query: 455 ---FKKKAEEDKLSDLVDKH 471
              F     +D +S L+  H
Sbjct: 231 FPPFLSDGSKDLISKLLRYH 250

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-H 291
           +F K LG G FG V E T     K      VAVK L+    + +  + ++E+K +  + +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD---------------WQ 336
           H N+V L+G C      L++ EY   G L  +L ++ D F+                  +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
                   +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V      P  ++APE + + + T + D++S+G+ + E+      F         M + S 
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSK 279
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           F K  +E     L  +H+        E+ ++MK    C ++D  KRP+   +V+++E
Sbjct: 280 FYKMIKEG-FRMLSPEHAP------AEMYDIMKT---CWDADPLKRPTFKQIVQLIE 326

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 226 LPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTD-----GTKVAVK-RLEGIGEIN 277
           +PKR      K   D+F   + LGKG FG+V+   +         KV  K +LE  G + 
Sbjct: 7   MPKR------KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VE 59
Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
                E++    + H N++R+  +  ++    L+ E+ P G L + L Q+   F  D Q+
Sbjct: 60  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRF--DEQR 116
Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV 397
               + ++A  L Y HE   +K++H DIKP+N+L+      K+ADFG S       S   
Sbjct: 117 SATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRR 170
Query: 398 TTMRGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI-- 454
             M GT  YL PE +      EKVD++  GV+  E L G   FD     E    ++++  
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 230
Query: 455 ----FKKKAEEDKLSDLVDKH 471
               F     +D +S L+  H
Sbjct: 231 KFPPFLSDGSKDLISKLLRYH 251

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 116/227 (51%), Gaps = 21/227 (9%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG G + +V++G  +T G  VA+K  +L+       + + E+  +  + H+N+VRL    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
             ++   LV+E+M N  L +++  R+       L+    K     + +GL + HE+   K
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL--S 413
           ILH D+KPQN+L++     K+ DFGL++     ++   S+VVT       Y AP+ L  S
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW-----YRAPDVLMGS 183
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE 460
              +  +DI+S G ++ E++ G+ +F  +  EE+   +  I     E
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 135 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 91  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 143
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 144 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-H 291
           +F K LG G FG V E T     K      VAVK L+    + +  + ++E+K +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD---------------WQ 336
           H N+V L+G C      L++ EY   G L  +L ++ D F+                  +
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
                   +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + V
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V      P  ++APE + + + T + D++S+G+ + E+      F         M + S 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSK 256
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           F K  +E     L  +H+        E+ ++MK    C ++D  KRP+   +V+++E
Sbjct: 257 FYKMIKEG-FRMLSPEHAP------AEMYDIMKT---CWDADPLKRPTFKQIVQLIE 303

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 135 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 136 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 75  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 127
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 84  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 137 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 87  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 139
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 140 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 138 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 137 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 106 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 158
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 159 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 241 NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
             +  LG G +G V+ G  +     VAVK L+      + FL E   +  I H NLV+L+
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G C  +    +V EYMP G+L  +L + + E     +    ++L +A  ++   E   +K
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-----EVTAVVLLYMATQISSAMEYLEKK 149
Query: 360 -ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIIT 417
             +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  +
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 418 EKVDIYSFGVVMLEI 432
            K D+++FGV++ EI
Sbjct: 210 IKSDVWAFGVLLWEI 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-H 291
           +F K LG G FG V E T     K      VAVK L+    + +  + ++E+K +  + +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD---------------WQ 336
           H N+V L+G C      L++ EY   G L  +L ++ D F+                  +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
                   +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V      P  ++APE + + + T + D++S+G+ + E+      F         M + S 
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSK 279
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           F K  +E     L  +H+        E+ ++MK    C ++D  KRP+   +V+++E
Sbjct: 280 FYKMIKEG-FRMLSPEHAP------AEMYDIMKT---CWDADPLKRPTFKQIVQLIE 326

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 136 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-H 291
           +F K LG G FG V E T     K      VAVK L+    + +  + ++E+K +  + +
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD---------------WQ 336
           H N+V L+G C      L++ EY   G L  +L ++ D F+                  +
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
                   +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + V
Sbjct: 164 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V      P  ++APE + + + T + D++S+G+ + E+      F         M + S 
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSK 274
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           F K  +E     L  +H+        E+ ++MK    C ++D  KRP+   +V+++E
Sbjct: 275 FYKMIKEG-FRMLSPEHA------PAEMYDIMKT---CWDADPLKRPTFKQIVQLIE 321

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 242 FRKMLGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
            ++ LG GGFG V      D G +VA+K  R E   +  + +  E++ +  ++H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 299 ------IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
                 +   A     LL  EY   G L ++L Q  +   L     + ++ DI+  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 353 HEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           HE+   +I+H D+KP+NI+L         K+ D G +K  + DQ ++ T   GT  YLAP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAP 192
Query: 410 EWL-SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L     T  VD +SFG +  E + G + F
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 137 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 137 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 141 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-H 291
           +F K LG G FG V E T     K      VAVK L+    + +  + ++E+K +  + +
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD---------------WQ 336
           H N+V L+G C      L++ EY   G L  +L ++ D F+                  +
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 337 QRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
                   +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + V
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           V      P  ++APE + + + T + D++S+G+ + E+      F         M + S 
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSK 272
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           F K  +E     L  +H+        E+ ++MK    C ++D  KRP+   +V+++E
Sbjct: 273 FYKMIKEG-FRMLSPEHA------PAEMYDIMKT---CWDADPLKRPTFKQIVQLIE 319

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 242 FRKMLGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
            ++ LG GGFG V      D G +VA+K  R E   +  + +  E++ +  ++H N+V  
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 299 ------IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
                 +   A     LL  EY   G L ++L Q  +   L     + ++ DI+  L YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 353 HEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           HE+   +I+H D+KP+NI+L         K+ D G +K  + DQ ++ T   GT  YLAP
Sbjct: 139 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAP 193
Query: 410 EWL-SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L     T  VD +SFG +  E + G + F
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 47/279 (16%)
Query: 245 MLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG--- 300
           ++G GGFG VF+   + DG    ++R   +   N+    EVK +  + H N+V   G   
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 301 -----------------FCAEKSHN---------LLVYEYMPNGSLDRWLFQRSDEFMLD 334
                            +  E S N          +  E+   G+L++W+ +R  E  LD
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLD 134
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
                ++   I KG+ Y+H    +K++H D+KP NI L      K+ DFGL   +  D  
Sbjct: 135 KVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 395 QVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEIL--CGRKVFDRSQ--PEEEDM 449
           +  T  +GT  Y++PE +SS    ++VD+Y+ G+++ E+L  C    F+ S+   +  D 
Sbjct: 192 R--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTDLRDG 248
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKV 488
            +  IF KK E+  L  L+ K   D + N  E++  + V
Sbjct: 249 IISDIFDKK-EKTLLQKLLSKKPED-RPNTSEILRTLTV 285

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 52/236 (22%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI 290
           FEE+ V        LG+G FG V +     D    A+K++    E   + L+EV  + S+
Sbjct: 8   FEEIAV--------LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 291 HHQ-------------NLVRLIGFCAEKSHNLLVYEYMPNGSL-----DRWLFQRSDEFM 332
           +HQ             N V+ +    +KS   +  EY  N +L        L Q+ DE+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY- 118
Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
             W+  ++I+    + L+Y+H    Q I+H D+KP NI +D + N K+ DFGL+K + + 
Sbjct: 119 --WRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 393 -------------QSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEIL 433
                         S  +T+  GT  Y+A E L       EK+D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVK------RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV +       R     + NK  L E   + S+ + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 115 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 167
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 168 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G FG V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 154/308 (50%), Gaps = 41/308 (13%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTDGTK--VAVKRLEG-IGEINKS 279
           P  F    LK + D     LG+G FG V    ++ T  DGT   VAVK L+   G  ++S
Sbjct: 8   PTVFHKRYLKKIRD-----LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRS 61
Query: 280 -FLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRS---DEFML 333
            +  E+  + +++H+++++  G C ++      LV EY+P GSL  +L + S    + +L
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL 121
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
             QQ       I +G+ YLH    Q  +H ++  +N+LLD +   K+ DFGL+K + +  
Sbjct: 122 FAQQ-------ICEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171
Query: 394 SQVVTTMRG-TPGY-LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQ-PEEEDM 449
                   G +P +  APE L         D++SFGV + E+L      D SQ P  + +
Sbjct: 172 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH---CDSSQSPPTKFL 228
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNG--EEVVNMMKVAAWCLESDFAKRPSMSMVV 507
            L+ I + +    +L++L+++     + +    EV ++MK    C E++ + RP+   ++
Sbjct: 229 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKN---CWETEASFRPTFENLI 285
Query: 508 RVLEGVTE 515
            +L+ V E
Sbjct: 286 PILKTVHE 293

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+GGFG VFE   + D    A+KR+         +  + EVK +  + H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDW-------QQRKK-----IILDIAKGLT 350
            EK+    +    P   L   +     E + DW       ++R++     I L IA+ + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--VVTTMR------- 401
           +LH    + ++H D+KP NI    +   KV DFGL   +DQD+ +  V+T M        
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 402 --GTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             GT  Y++PE +  +  + KVDI+S G+++ E+L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 154/308 (50%), Gaps = 41/308 (13%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTDGTK--VAVKRLEG-IGEINKS 279
           P  F    LK + D     LG+G FG V    ++ T  DGT   VAVK L+   G  ++S
Sbjct: 8   PTVFHKRYLKKIRD-----LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRS 61
Query: 280 -FLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRS---DEFML 333
            +  E+  + +++H+++++  G C ++      LV EY+P GSL  +L + S    + +L
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL 121
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
             QQ       I +G+ YLH    Q  +H ++  +N+LLD +   K+ DFGL+K + +  
Sbjct: 122 FAQQ-------ICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171
Query: 394 SQVVTTMRG-TPGY-LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQ-PEEEDM 449
                   G +P +  APE L         D++SFGV + E+L      D SQ P  + +
Sbjct: 172 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH---CDSSQSPPTKFL 228
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNG--EEVVNMMKVAAWCLESDFAKRPSMSMVV 507
            L+ I + +    +L++L+++     + +    EV ++MK    C E++ + RP+   ++
Sbjct: 229 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKN---CWETEASFRPTFENLI 285
Query: 508 RVLEGVTE 515
            +L+ V E
Sbjct: 286 PILKTVHE 293

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 225 GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAE 283
           G+   +   E++      +  LG G +G V+EG  +     VAVK L+      + FL E
Sbjct: 1   GMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 60
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
              +  I H NLV+L+G C  +    ++ E+M  G+L  +L +       + Q+   ++L
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVL 114
Query: 344 -----DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                 I+  + YL    ++  +H D+  +N L+  N   KVADFGLS+L+  D      
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPA 171
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
             +    + APE L+ +  + K D+++FGV++ EI
Sbjct: 172 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--------D 344
           +N+V L+G C      L++ EY   G L  +L +R  E  LD +  + + L         
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V      P
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 405 -GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             ++APE +   + T + D++S+G+++ EI 
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--------D 344
           +N+V L+G C      L++ EY   G L  +L +R  E  LD +  + + L         
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V      P
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 405 -GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             ++APE +   + T + D++S+G+++ EI 
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 245 MLGKGGFGSVFEGTQTD-GTKVAVKR-LEGIGE--INKSFLAEVKTIGSIHHQNLVRLIG 300
           ++G+G +G V +    D G  VA+K+ LE   +  + K  + E+K +  + H+NLV L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 301 FCAEKSHNLLVYEYMPNGSLDRW-LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            C +K    LV+E++ +  LD   LF       LD+Q  +K +  I  G+ + H      
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHS---HN 144
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT-- 417
           I+H DIKP+NIL+  +   K+ DFG ++ +     +V      T  Y APE L   +   
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
           + VD+++ G ++ E+  G  +F
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLF 225

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 138/300 (46%), Gaps = 43/300 (14%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK----VAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           +++GKG FG V+ G   D  +     A+K L  I E+ +  +FL E   +  ++H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 298 LIGFCAEK---SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           LIG         H LL   YM +G L +  F RS +     +      L +A+G+ YL E
Sbjct: 87  LIGIMLPPEGLPHVLL--PYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW--L 412
              QK +H D+  +N +LD +F  KVADFGL++ I   +   V   R     L  +W  L
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH--ARLPVKWTAL 197
Query: 413 SSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV 468
            S+     T K D++SFGV++ E+L       R  P    +    +    A+  +L    
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT------RGAPPYRHIDPFDLTHFLAQGRRLPQ-- 249
Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVHLP 528
            ++  D         ++ +V   C E+D A RP+  ++V  +E +       HY  V LP
Sbjct: 250 PEYCPD---------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY--VQLP 298

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           + +G+G FG VF G  + D T VAVK  R     ++   FL E + +    H N+VRLIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C +K    +V E +  G  D   F R++   L  +   +++ D A G+ YL   C    
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITE 418
           +H D+  +N L+      K++DFG+S+            +R  P  + APE L+    + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 419 KVDIYSFGVVMLE 431
           + D++SFG+++ E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IA+G+ YL
Sbjct: 78  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYL 130
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 131 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 193 KSDVWAFGVLLWEI 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 138 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 136 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 34/266 (12%)
Query: 245 MLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG--- 300
           ++G GGFG VF+   + DG    +KR++     N+    EVK +  + H N+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 301 ---FCAEKSHN----------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
              +  E S             +  E+   G+L++W+ +R  E  LD     ++   I K
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQITK 133
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           G+ Y+H    +K+++ D+KP NI L      K+ DFGL   +  D  +  +  +GT  Y+
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGTLRYM 188
Query: 408 APEWLSSI-ITEKVDIYSFGVVMLEIL--CGRKVFDRSQ--PEEEDMYLLSIFKKKAEED 462
           +PE +SS    ++VD+Y+ G+++ E+L  C    F+ S+   +  D  +  IF KK E+ 
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTDLRDGIISDIFDKK-EKT 246
Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKV 488
            L  L+ K   D + N  E++  + V
Sbjct: 247 LLQKLLSKKPED-RPNTSEILRTLTV 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 196 KSDVWAFGVLLWEI 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 136
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           + +G+G FG VF G  + D T VAVK  R     ++   FL E + +    H N+VRLIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C +K    +V E +  G  D   F R++   L  +   +++ D A G+ YL   C    
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS-SIITE 418
           +H D+  +N L+      K++DFG+S+            +R  P  + APE L+    + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 419 KVDIYSFGVVMLE 431
           + D++SFG+++ E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 136 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 136 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+L  G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 205 KSDVWAFGVLLWEI 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 82
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 138
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +   T+ GTP Y+APE LS 
Sbjct: 139 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVLSK 195
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 78
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 134
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +   T+ GTP Y+APE LS 
Sbjct: 135 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVLSK 191
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+L  G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L++ + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 88  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 141 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 241 NFRKMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-H 291
           N  K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 292 HQNLVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML---------DWQQRKKI 341
           H N+V L+G C +    L+V  E+   G+L  +L  + +EF+          D+   + +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 342 I---LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
           I     +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V  
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 399 TMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR---- 436
                P  ++APE +   + T + D++SFGV++ EI                 C R    
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 437 ---KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
              +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTK-VAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVR 297
            LG+G F +V++    +  + VA+K++      E    IN++ L E+K +  + H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L+     KS+  LV+++M     D  +  + +  +L     K  +L   +GL YLH+   
Sbjct: 77  LLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS----QVVTTMRGTPGYLAPEWL- 412
             ILH D+KP N+LLD N   K+ADFGL+K           QVVT       Y APE L 
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW-----YRAPELLF 185
Query: 413 -SSIITEKVDIYSFGVVMLEIL 433
            + +    VD+++ G ++ E+L
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 78
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 134
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +   T+ GTP Y+APE LS 
Sbjct: 135 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVLSK 191
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+L  G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E 
Sbjct: 141 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKV----AVKRLEGIG--EINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    +G KV    A+K L      + NK  L E   + S+ + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYL 352
           RL+G C   +  L+  + MP G L  ++ +  D    +++L+W       + IAKG+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE- 410
            +   ++++H D+  +N+L+    + K+ DFG +KL+  ++ +        P  ++A E 
Sbjct: 141 ED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 411 WLSSIITEKVDIYSFGVVMLEILC-GRKVFD 440
            L  I T + D++S+GV + E++  G K +D
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-----DIAKGLTYLHEDCRQK 359
           +    ++ E+M  G+L  +L +       + Q+   ++L      I+  + YL    ++ 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 419 KVDIYSFGVVMLEI 432
           K D+++FGV++ EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 26/215 (12%)
Query: 238 MTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHH 292
           + + ++K+  +G+G +G V++   + G  VA+KR+    E   I  + + E+  +  +HH
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ--QRKKIILDIAKGLT 350
            N+V LI     +    LV+E+M     ++ L +  DE     Q  Q K  +  + +G+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGY 406
           + H+    +ILH D+KPQN+L++ +   K+ADFGL++     +     +VVT       Y
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----Y 185
Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            AP+ L  S   +  VDI+S G +  E++ G+ +F
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 246 LGKGGFGSVFE-GTQTDGTKVAVKRLE--GIGEINKSFL-AEVKTIGSIHHQNLVRLIGF 301
           +G G +G   +   ++DG  +  K L+   + E  K  L +EV  +  + H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 302 CAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQ 358
             ++++  L  V EY   G L   + + + E   LD    ++ +L +   LT   ++C +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD----EEFVLRVMTQLTLALKECHR 129
Query: 359 K------ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           +      +LH D+KP N+ LDG  N K+ DFGL+++++ D S    T  GTP Y++PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQM 188
Query: 413 SSI-ITEKVDIYSFGVVMLEILCG 435
           + +   EK DI+S G ++ E LC 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 47/283 (16%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI--------NKSFLAEVKTIGSI-H 291
           N  K LG+G FG V E       K A  R   +  +        +++ ++E+K +  I H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 292 HQNLVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML------DWQQRKKII-- 342
           H N+V L+G C +    L+V  E+   G+L  +L  + +EF+       D+   + +I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 343 -LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 402 GTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------- 436
             P  ++APE +   + T + D++SFGV++ EI                 C R       
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 266
Query: 437 KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG 479
           +  D + PE     L     + ++    S+LV+   N +Q+N 
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 31/261 (11%)
Query: 264 KVAVKR--LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS-L 320
           KVA+KR  LE         L E++ +   HH N+V        K    LV + +  GS L
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 321 D--RWLFQRSDE--FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF 376
           D  + +  + +    +LD      I+ ++ +GL YLH++ +   +H D+K  NILL  + 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 377 NAKVADFGLSKLI----DQDQSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVML 430
           + ++ADFG+S  +    D  +++V  T  GTP ++APE +  +     K DI+SFG+  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAE---EDKLSDLVDKHSNDMQSNGEEVVNMMK 487
           E+  G   + +  P +  M  L       E   +DK  +++ K+    +          K
Sbjct: 214 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK--EMLKKYGKSFR----------K 261
Query: 488 VAAWCLESDFAKRPSMSMVVR 508
           + + CL+ D  KRP+ + ++R
Sbjct: 262 MISLCLQKDPEKRPTAAELLR 282

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG+G + +V++G ++     VA+K  RLE       + + EV  +  + H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             +    LV+EY     LD+ L Q  D+   +++    K  +  + +GL Y H   RQK+
Sbjct: 70  HTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           LH D+KPQN+L++     K+ADFGL++          ++VVT     P  L     S+  
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG---STDY 178
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
           + ++D++  G +  E+  GR +F  S  EE+  ++  I     EE
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 26/215 (12%)
Query: 238 MTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHH 292
           + + ++K+  +G+G +G V++   + G  VA+KR+    E   I  + + E+  +  +HH
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQ--QRKKIILDIAKGLT 350
            N+V LI     +    LV+E+M     ++ L +  DE     Q  Q K  +  + +G+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGY 406
           + H+    +ILH D+KPQN+L++ +   K+ADFGL++     +     +VVT       Y
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----Y 185
Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            AP+ L  S   +  VDI+S G +  E++ G+ +F
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 31/261 (11%)
Query: 264 KVAVKR--LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS-L 320
           KVA+KR  LE         L E++ +   HH N+V        K    LV + +  GS L
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 321 D--RWLFQRSDE--FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF 376
           D  + +  + +    +LD      I+ ++ +GL YLH++ +   +H D+K  NILL  + 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 377 NAKVADFGLSKLI----DQDQSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVML 430
           + ++ADFG+S  +    D  +++V  T  GTP ++APE +  +     K DI+SFG+  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 431 EILCGRKVFDRSQPEEEDMYLLSIFKKKAE---EDKLSDLVDKHSNDMQSNGEEVVNMMK 487
           E+  G   + +  P +  M  L       E   +DK  +++ K+    +          K
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK--EMLKKYGKSFR----------K 266
Query: 488 VAAWCLESDFAKRPSMSMVVR 508
           + + CL+ D  KRP+ + ++R
Sbjct: 267 MISLCLQKDPEKRPTAAELLR 287

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           F++ LG G F  V     +  G   AVK +  + +     S   E+  +  I H+N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                  +H  LV + +  G L   + ++   F  + +    +I  +   + YLH   R 
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTE-KDASTLIRQVLDAVYYLH---RM 139
Query: 359 KILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
            I+H D+KP+N+L    D      ++DFGLSK+  + +  V++T  GTPGY+APE L+  
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQK 197
Query: 416 -ITEKVDIYSFGVVMLEILCGRKVF 439
             ++ VD +S GV+   +LCG   F
Sbjct: 198 PYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 244 KMLGKGGFGSVF----EGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           K LG G +G V     + T  +     +++       N   L EV  +  + H N+++L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F  +K +  LV E    G L   +  R     +D      II  +  G+TYLH   +  
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVTYLH---KHN 156
Query: 360 ILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           I+H D+KP+N+LL+        K+ DFGLS +  ++Q ++   + GT  Y+APE L    
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAPEVLRKKY 214
Query: 417 TEKVDIYSFGVVMLEILCGRKVF 439
            EK D++S GV++  +L G   F
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPF 237

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLPVR 197
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 194
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 16/229 (6%)
Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGS 289
           +++  D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           PE L     + + DI+S G+ ++E+  GR        +E+    ++IF+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFE 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 49/284 (17%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI--------NKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E       K A  R   +  +        +++ ++E+K +  I HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFM-----------LDWQQRKKII 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           L  +      
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
             +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V      
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 403 TP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR-------K 437
            P  ++APE +   + T + D++SFGV++ EI                 C R       +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 438 VFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
             D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 16/217 (7%)
Query: 223 VPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL 281
           V G+   +   E++      +  LG G +G V+EG  +     VAVK L+      + FL
Sbjct: 244 VYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 303
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            E   +  I H NLV+L+G C  +    ++ E+M  G+L  +L +       + Q+   +
Sbjct: 304 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVNAV 357
Query: 342 IL-----DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
           +L      I+  + YL    ++  +H ++  +N L+  N   KVADFGLS+L+  D    
Sbjct: 358 VLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 414
Query: 397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
               +    + APE L+ +  + K D+++FGV++ EI
Sbjct: 415 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 52/236 (22%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI 290
           FEE+ V        LG+G FG V +     D    A+K++    E   + L+EV  + S+
Sbjct: 8   FEEIAV--------LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASL 59
Query: 291 HHQNLVRLIGFCAE-------------KSHNLLVYEYMPNGSL-----DRWLFQRSDEFM 332
           +HQ +VR      E             KS   +  EY  N +L        L Q+ DE+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY- 118
Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
             W+  ++I+    + L+Y+H    Q I+H ++KP NI +D + N K+ DFGL+K + + 
Sbjct: 119 --WRLFRQIL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 393 -------------QSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEIL 433
                         S  +T+  GT  Y+A E L       EK+D YS G++  E +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 150/308 (48%), Gaps = 41/308 (13%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTDGTK--VAVKRL-EGIG-EINK 278
           P  F    LK + D     LG+G FG V    ++ T  DGT   VAVK L EG G ++  
Sbjct: 3   PTVFHKRYLKKIRD-----LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRS 56
Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRS---DEFML 333
            +  E++ + +++H+++V+  G C ++      LV EY+P GSL  +L +      + +L
Sbjct: 57  GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL 116
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
             QQ       I +G+ YLH    Q  +H  +  +N+LLD +   K+ DFGL+K + +  
Sbjct: 117 FAQQ-------ICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166
Query: 394 SQVVTTMRG-TPGY-LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQ-PEEEDM 449
                   G +P +  APE L         D++SFGV + E+L      D +Q P  +  
Sbjct: 167 EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL---TYCDSNQSPHTKFT 223
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSN--GEEVVNMMKVAAWCLESDFAKRPSMSMVV 507
            L+   + +    +L++L+++     + +    E+ ++MK    C E++ + RP+   +V
Sbjct: 224 ELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKN---CWETEASFRPTFQNLV 280
Query: 508 RVLEGVTE 515
            +L+   E
Sbjct: 281 PILQTAQE 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 150/308 (48%), Gaps = 41/308 (13%)
Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSV----FEGTQTDGTK--VAVKRL-EGIG-EINK 278
           P  F    LK + D     LG+G FG V    ++ T  DGT   VAVK L EG G ++  
Sbjct: 2   PTVFHKRYLKKIRD-----LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRS 55
Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRS---DEFML 333
            +  E++ + +++H+++V+  G C ++      LV EY+P GSL  +L +      + +L
Sbjct: 56  GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL 115
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
             QQ       I +G+ YLH    Q  +H  +  +N+LLD +   K+ DFGL+K + +  
Sbjct: 116 FAQQ-------ICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165
Query: 394 SQVVTTMRG-TPGY-LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQ-PEEEDM 449
                   G +P +  APE L         D++SFGV + E+L      D +Q P  +  
Sbjct: 166 EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL---TYCDSNQSPHTKFT 222
Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSN--GEEVVNMMKVAAWCLESDFAKRPSMSMVV 507
            L+   + +    +L++L+++     + +    E+ ++MK    C E++ + RP+   +V
Sbjct: 223 ELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKN---CWETEASFRPTFQNLV 279
Query: 508 RVLEGVTE 515
            +L+   E
Sbjct: 280 PILQTAQE 287

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 225 GLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAE 283
           G+   +   E++      +  LG G +G V+EG  +     VAVK L+      + FL E
Sbjct: 207 GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 266
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
              +  I H NLV+L+G C  +    ++ E+M  G+L  +L +       + Q+   ++L
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVL 320
Query: 344 -----DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                 I+  + YL    ++  +H ++  +N L+  N   KVADFGLS+L+  D      
Sbjct: 321 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
             +    + APE L+ +  + K D+++FGV++ EI
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI--------NKSFLAEVKTIGSI-H 291
           N  K LG+G FG V E       K A  R   +  +        +++ ++E+K +  I H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 292 HQNLVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFM---------LDWQQRKKI 341
           H N+V L+G C +    L+V  E+   G+L  +L  + +EF+         L  +     
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 402 GTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             P  ++APE +   + T + D++SFGV++ EI 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 158
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +    + GTP Y+APE LS 
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSK 215
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 132
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +    + GTP Y+APE LS 
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSK 189
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQN 294
            LGKGGF   FE +  D  +V   ++     + KS L           E+    S+ HQ+
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKI-----VPKSLLLKPHQREKMSMEISIHRSLAHQH 100
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   GF  +     +V E     SL     +R     L   + +  +  I  G  YLH 
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH- 156
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
             R +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +    + GTP Y+APE LS 
Sbjct: 157 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSK 213
Query: 415 I-ITEKVDIYSFGVVMLEILCGRKVFDRS 442
              + +VD++S G +M  +L G+  F+ S
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRL-EGIGEI-NKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L EG     +++ ++E+K +  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 295 LVRLIGFCAEKSHNLLVY-EYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 99/186 (53%), Gaps = 18/186 (9%)
Query: 264 KVAVKRL--EGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSL 320
           +V  +RL  E + E+ ++   E   +  +  H +++ LI      S   LV++ M  G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV 380
             +L   +++  L  ++ + I+  + + +++LH +    I+H D+KP+NILLD N   ++
Sbjct: 188 FDYL---TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241
Query: 381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE-------KVDIYSFGVVMLEIL 433
           +DFG S  ++  +   +  + GTPGYLAPE L   + E       +VD+++ GV++  +L
Sbjct: 242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 434 CGRKVF 439
            G   F
Sbjct: 300 AGSPPF 305

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
              K LG G FG V+  T    TKVAVK ++      ++FLAE   + ++ H  LV+L  
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 244
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII---LDIAKGLTYLHEDCR 357
               K    ++ E+M  GSL  +L  +SDE     Q   K+I     IA+G+ ++ +   
Sbjct: 245 VVT-KEPIYIITEFMAKGSLLDFL--KSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ--- 296
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           +  +H D++  NIL+  +   K+ADFGL+++            +    + APE ++    
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSF 346
Query: 417 TEKVDIYSFGVVMLEILC-GR 436
           T K D++SFG++++EI+  GR
Sbjct: 347 TIKSDVWSFGILLMEIVTYGR 367

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 246 LGKGGFGSVFE-GTQTDGTKVAVKRLE--GIGEINKSFL-AEVKTIGSIHHQNLVRLIGF 301
           +G G +G   +   ++DG  +  K L+   + E  K  L +EV  +  + H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 302 CAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQ 358
             ++++  L  V EY   G L   + + + E   LD    ++ +L +   LT   ++C +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD----EEFVLRVMTQLTLALKECHR 129
Query: 359 K------ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           +      +LH D+KP N+ LDG  N K+ DFGL+++++ D S       GTP Y++PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQM 188
Query: 413 SSI-ITEKVDIYSFGVVMLEILCG 435
           + +   EK DI+S G ++ E LC 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 244 KMLGKGGFGSVFEGT-----QTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIHHQNL 295
           K+LG G FG+V +G      ++    V +K +E      +SF A    +  IGS+ H ++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHI 95
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR----SDEFMLDWQQRKKIILDIAKGLTY 351
           VRL+G C   S  L V +Y+P GSL   + Q       + +L+W       + IAKG+ Y
Sbjct: 96  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYY 148
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPE 410
           L E     ++H ++  +N+LL      +VADFG++ L+  D  Q++ +   TP  ++A E
Sbjct: 149 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 411 WLS-SIITEKVDIYSFGVVMLEILC 434
            +     T + D++S+GV + E++ 
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 197
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 196
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 32/221 (14%)
Query: 235 LKVMTDNFR-------KMLGKGGFGSVFEGT-----QTDGTKVAVKRLEGIGEINKSFLA 282
           +KV+   F+       K+LG G FG+V +G      ++    V +K +E      +SF A
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQA 61
Query: 283 ---EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR----SDEFMLDW 335
               +  IGS+ H ++VRL+G C   S  L V +Y+P GSL   + Q       + +L+W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
                  + IAKG+ YL E     ++H ++  +N+LL      +VADFG++ L+  D  Q
Sbjct: 121 G------VQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 396 VVTTMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEILC 434
           ++ +   TP  ++A E +     T + D++S+GV + E++ 
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQN 294
           D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +   +   
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGLTYL E
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 184
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS 413
             + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++PE L 
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 238
Query: 414 SI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
               + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 276

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 126/302 (41%), Gaps = 53/302 (17%)
Query: 246 LGKGGFGSVFEGTQT------DGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G FG VF+            T VAVK L  E   ++   F  E   +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML-----DWQQRKK------------ 340
           L+G CA      L++EYM  G L+ +L   S   +      D   R +            
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 341 ----IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
               I   +A G+ YL E   +K +H D+  +N L+  N   K+ADFGLS+ I       
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 397 VTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
                  P  ++ PE +  +  T + D++++GVV+ EI                 Y L  
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------------YGLQP 276
Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGE-EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
           +   A E+ +  + D +      N   E+ N+M++   C     A RPS   + R+L+ +
Sbjct: 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL---CWSKLPADRPSFCSIHRILQRM 333
Query: 514 TE 515
            E
Sbjct: 334 CE 335

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 95/177 (53%), Gaps = 16/177 (9%)
Query: 271 EGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
           E + E+ ++ L EV  +  +  H N+++L       +   LV++ M  G L  +L   ++
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TE 117
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI 389
           +  L  ++ +KI+  + + +  LH   +  I+H D+KP+NILLD + N K+ DFG S  +
Sbjct: 118 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIITE-------KVDIYSFGVVMLEILCGRKVF 439
           D  +   + ++ GTP YLAPE +   + +       +VD++S GV+M  +L G   F
Sbjct: 175 DPGEK--LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N + L     EV+ +  ++H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKT-QLNPTSLQKLFREVRIMKILNHP 74
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQYCH 131
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +   + I+H D+K +N+LLDG+ N K+ADFG S   +      + T  G+P Y APE   
Sbjct: 132 Q---KYIVHRDLKAENLLLDGDMNIKIADFGFSN--EFTVGNKLDTFCGSPPYAAPELFQ 186
Query: 414 SIITE--KVDIYSFGVVMLEILCGRKVFD 440
               +  +VD++S GV++  ++ G   FD
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQN 294
           D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +   +   
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGLTYL E
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS 413
             + KI+H D+KP NIL++     K+ DFG+S +LID+  ++ V    GT  Y++PE L 
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV----GTRSYMSPERLQ 179
Query: 414 SI-ITEKVDIYSFGVVMLEILCGR 436
               + + DI+S G+ ++E+  GR
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 190
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRL-EGIGEI-NKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L EG     +++ ++E+K +  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 295 LVRLIGFCAEKSHNLLVY-EYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 199
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 18/225 (8%)
Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGS 289
           +++  D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           PE L     + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 242 FRKMLGKGGFGSVFEG------TQTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQN 294
            ++ LG+G FG VF           D   VAVK L +      K F  E + + ++ H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML--DWQQRKK-----------I 341
           +V+  G C +    ++V+EYM +G L+++L     + M+  D Q R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTM 400
              IA G+ YL     Q  +H D+  +N L+  N   K+ DFG+S+ +   D  +V    
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 401 RGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
                ++ PE  +    T + D++SFGV++ EI 
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------------LDWQQRKK 340
           +N+V L+G C      L++ EY   G L  +L ++++  +            LD +  + 
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 341 IIL--------DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           + L         +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 393 QSQVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            + +V      P  ++APE +   + T + D++S+G+++ EI 
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 271
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 272 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 317

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 18/225 (8%)
Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGS 289
           +++  D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           PE L     + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 242 FRKMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQN 294
            ++ LG+G FG VF         + D   VAVK L+   +   K F  E + + ++ H++
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM----------LDWQQRKKIILD 344
           +V+  G C E    ++V+EYM +G L+++L     + +          L   Q   I   
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGT 403
           IA G+ YL     Q  +H D+  +N L+  N   K+ DFG+S+ +   D  +V       
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 404 PGYLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
             ++ PE  +    T + D++S GVV+ EI 
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 137/312 (43%), Gaps = 46/312 (14%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 267
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 268 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 313
Query: 518 HNLHYNLVHLPI 529
            N  Y  + +P+
Sbjct: 314 SNQEYLDLSMPL 325

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRLE--GIGEINKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L+       +++ ++E+K +  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 295 LVRLIGFCAEKSHNLLVY-EYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   + T + D++SFGV+M EI           P EE   L  + K+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKE 274
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK ++  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 275 GHRMDKPANCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 518 HNLHY 522
            N  Y
Sbjct: 321 TNEEY 325

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVK------RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G    DG  V +       R     + NK  L E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           RL+G C   +  L V + MP G L   +  R +   L  Q      + IAKG++YL ED 
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHV--RENRGRLGSQDLLNWCMQIAKGMSYL-EDV 138
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW--LSS 414
           R  ++H D+  +N+L+    + K+ DFGL++L+D D+    T      G +  +W  L S
Sbjct: 139 R--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKWMALES 192
Query: 415 II----TEKVDIYSFGVVMLEILC-GRKVFD 440
           I+    T + D++S+GV + E++  G K +D
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   + T + D++SFGV+M EI           P EE   L  + K+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKE 274
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK ++  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 275 GHRMDKPANCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 518 HNLHY 522
            N  Y
Sbjct: 321 TNEEY 325

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   E     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 41/250 (16%)
Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRL----EGIGEINKSFLAEVKTIGSIH-HQNLVR 297
           K LGKG +G V++   +  G  VAVK++    +   +  ++F  E+  +  +  H+N+V 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVN 73
Query: 298 LIGFC-AEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L+    A+   ++ LV++YM     D     R++  +L+   ++ ++  + K + YLH  
Sbjct: 74  LLNVLRADNDRDVYLVFDYM---ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKL---------------------IDQDQS 394
               +LH D+KP NILL+   + KVADFGLS+                       D DQ 
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 395 QVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            ++T    T  Y APE L  S+  T+ +D++S G ++ EILCG+ +F  S    +   ++
Sbjct: 186 -ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 453 SIFKKKAEED 462
            +    + ED
Sbjct: 245 GVIDFPSNED 254

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 18/225 (8%)
Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGS 289
           +++  D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           PE L     + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 18/225 (8%)
Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGS 289
           +++  D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLA 408
           TYL E  + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           PE L     + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 51/286 (17%)
Query: 244 KMLGKGGFGSVFE----GTQTDGT--KVAVKRL-EGIGEI-NKSFLAEVKTIGSI-HHQN 294
           K LG+G FG V E    G     T   VAVK L EG     +++ ++E+K +  I HH N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 295 LVRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFML----------DWQQRKKII- 342
           +V L+G C +    L+V  E+   G+L  +L  + +EF+           D+   + +I 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 343 --LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
               +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V    
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 401 RGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEI----------------LCGR------ 436
              P  ++APE +   + T + D++SFGV++ EI                 C R      
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 306
Query: 437 -KVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEE 481
            +  D + PE     L     + ++    S+LV+   N +Q+N ++
Sbjct: 307 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 246 LGKGGFGSVFE-GTQTDGTKVAVKRLE--GIGEINKSFL-AEVKTIGSIHHQNLVRLIGF 301
           +G G +G   +   ++DG  +  K L+   + E  K  L +EV  +  + H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 302 CAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQ 358
             ++++  L  V EY   G L   + + + E   LD    ++ +L +   LT   ++C +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD----EEFVLRVMTQLTLALKECHR 129
Query: 359 K------ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           +      +LH D+KP N+ LDG  N K+ DFGL+++++ D+        GTP Y++PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYMSPEQM 188
Query: 413 SSI-ITEKVDIYSFGVVMLEILCG 435
           + +   EK DI+S G ++ E LC 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 94/177 (53%), Gaps = 16/177 (9%)
Query: 271 EGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
           E + E+ ++ L EV  +  +  H N+++L       +   LV++ M  G L  +L   ++
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TE 117
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI 389
           +  L  ++ +KI+  + + +  LH   +  I+H D+KP+NILLD + N K+ DFG S  +
Sbjct: 118 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIITE-------KVDIYSFGVVMLEILCGRKVF 439
           D  +   +  + GTP YLAPE +   + +       +VD++S GV+M  +L G   F
Sbjct: 175 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF-----------MLDWQQRKKI 341
           +N+V L+G C      L++ EY   G L  +L ++S               L  +     
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 402 GTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             P  ++APE +   + T + D++S+G+++ EI 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 94/177 (53%), Gaps = 16/177 (9%)
Query: 271 EGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD 329
           E + E+ ++ L EV  +  +  H N+++L       +   LV++ M  G L  +L   ++
Sbjct: 48  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TE 104
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI 389
           +  L  ++ +KI+  + + +  LH   +  I+H D+KP+NILLD + N K+ DFG S  +
Sbjct: 105 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 161
Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIITE-------KVDIYSFGVVMLEILCGRKVF 439
           D  +   +  + GTP YLAPE +   + +       +VD++S GV+M  +L G   F
Sbjct: 162 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQN 294
           D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +   +   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGLTYL E
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 149
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS 413
             + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++PE L 
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 203
Query: 414 SI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
               + + DI+S G+ ++E+  GR  +    P+ +++ L+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELM 241

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N S L     EV+ +  ++H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKT-QLNSSSLQKLFREVRIMKVLNHP 66
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L      +M + + R K    I   + Y  
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--WMKEKEARAKF-RQIVSAVQY-- 121
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      + T  G+P Y APE  
Sbjct: 122 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELF 177
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQT------DGTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 240 DNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           DN +  +++G+G +G+V++G+  D   VAVK        N      +  +  + H N+ R
Sbjct: 13  DNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 298 LI----GFCAE-KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            I       A+ +   LLV EY PNGSL ++L   +     DW    ++   + +GL YL
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 353 HEDC------RQKILHLDIKPQNILLDGNFNAKVADFGLS------KLIDQ-DQSQVVTT 399
           H +       +  I H D+  +N+L+  +    ++DFGLS      +L+   ++     +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 400 MRGTPGYLAPEWLSSIIT--------EKVDIYSFGVVMLEIL 433
             GT  Y+APE L   +         ++VD+Y+ G++  EI 
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 246 LGKGGFGSVFEGT--QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G +G VF+    +  G  VA+KR+      EG+       +A ++ + +  H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 298 LIGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           L   C       ++   LV+E++ +  L  +L  +  E  +  +  K ++  + +GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H     +++H D+KPQNIL+  +   K+ADFGL+++     +  +T++  T  Y APE  
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 191
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           L S     VD++S G +  E+   + +F  S   ++   +L +     EED
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H ++  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 197
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 227
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIIL-- 343
           +N+V L+G C      L++ EY   G L  +L ++S     D            + +L  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 344 --DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 402 GTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             P  ++APE +   + T + D++S+G+++ EI 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 144 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 196
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 199
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 192
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N S L     EV+ +  ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKT-QLNSSSLQKLFREVRIMKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      + T  G+P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N S L     EV+ +  ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKT-QLNSSSLQKLFREVRIMKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      + T  G+P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG   D       T+VAVK +     + +   FL E   +      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLD-------WQQRKKIILDIAKGLT 350
           L+G  ++    L+V E M +G L  +L     E   +        Q+  ++  +IA G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+    +K +H ++  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W++       + T   D++SFGVV+ EI
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K + +  H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 149
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 246 LGKGGFGSVFEGT--QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G +G VF+    +  G  VA+KR+      EG+       +A ++ + +  H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 298 LIGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           L   C       ++   LV+E++ +  L  +L  +  E  +  +  K ++  + +GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H     +++H D+KPQNIL+  +   K+ADFGL+++     +  +T++  T  Y APE  
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 191
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           L S     VD++S G +  E+   + +F  S   ++   +L +     EED
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 136/285 (47%), Gaps = 41/285 (14%)
Query: 246 LGKGGFGSVFEGT--QTDGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +G+G +G VF+    +  G  VA+KR+      EG+       +A ++ + +  H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 298 LIGFCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           L   C       ++   LV+E++ +  L  +L  +  E  +  +  K ++  + +GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H     +++H D+KPQNIL+  +   K+ADFGL+++     +  +T++  T  Y APE  
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 191
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFDRSQ--------------PEEEDMYLLSIFKK 457
           L S     VD++S G +  E+   + +F  S               P EED        +
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           +A   K +  ++K   D+   G+++  ++K    CL  + AKR S
Sbjct: 252 QAFHSKSAQPIEKFVTDIDELGKDL--LLK----CLTFNPAKRIS 290

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K + +  H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 149
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 242 FRKMLGKGGFGSVFEGT-----QTDGT-KVAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K LG G FG V E T     + D   KVAVK L+     ++  + ++E+K +  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N+V L+G C      L++ EY   G L  +L ++             + E  L  +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
                +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V  
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 400 MRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
               P  ++APE +   + T + D++S+G+++ EI 
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRL 298
           ++LG+GGFG VF    +  G   A K+L           +  + E K +  +H + +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDC 356
             +  E   +L +   + NG   R+     DE    +Q+ + I     I  GL +LH+  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSI 415
            + I++ D+KP+N+LLD + N +++D GL+  +   Q++      GTPG++APE  L   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD ++ GV + E++  R  F
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEG------TQTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRL 298
           LG+G FG VF         + D   VAVK L+   E   + F  E + +  + HQ++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------------LDWQQRKKIILDIA 346
            G C E    L+V+EYM +G L+R+L     +              L   Q   +   +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPG 405
            G+ YL        +H D+  +N L+      K+ DFG+S+ +   D  +V         
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 406 YLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
           ++ PE  L    T + D++SFGVV+ EI 
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 229 RFSFEELKVMTDNFRKMLGKGGFGSV-FEGTQTDGTKVAVK--------RLEGIGEINKS 279
           ++S ++ +++     + LG G FG V    ++ +G   A+K        RL+ +   N  
Sbjct: 2   KYSLQDFQIL-----RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
            L     +  + H  ++R+ G   +     ++ +Y+  G L   L ++S  F       K
Sbjct: 57  RLM----LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRF--PNPVAK 109
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
               ++   L YLH    + I++ D+KP+NILLD N + K+ DFG +K +      V   
Sbjct: 110 FYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYX 162
Query: 400 MRGTPGYLAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
           + GTP Y+APE +S+    K +D +SFG+++ E+L G   F
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRL 298
           ++LG+GGFG VF    +  G   A K+L           +  + E K +  +H + +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDC 356
             +  E   +L +   + NG   R+     DE    +Q+ + I     I  GL +LH+  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSI 415
            + I++ D+KP+N+LLD + N +++D GL+  +   Q++      GTPG++APE  L   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD ++ GV + E++  R  F
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRL 298
           ++LG+GGFG VF    +  G   A K+L           +  + E K +  +H + +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDC 356
             +  E   +L +   + NG   R+     DE    +Q+ + I     I  GL +LH+  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSI 415
            + I++ D+KP+N+LLD + N +++D GL+  +   Q++      GTPG++APE  L   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD ++ GV + E++  R  F
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEG------TQTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRL 298
           LG+G FG VF         + D   VAVK L+   E   + F  E + +  + HQ++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------------LDWQQRKKIILDIA 346
            G C E    L+V+EYM +G L+R+L     +              L   Q   +   +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPG 405
            G+ YL        +H D+  +N L+      K+ DFG+S+ +   D  +V         
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 406 YLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
           ++ PE  L    T + D++SFGVV+ EI 
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 244 KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRL 298
           ++LG+GGFG VF    +  G   A K+L           +  + E K +  +H + +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDC 356
             +  E   +L +   + NG   R+     DE    +Q+ + I     I  GL +LH+  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSI 415
            + I++ D+KP+N+LLD + N +++D GL+  +   Q++      GTPG++APE  L   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD ++ GV + E++  R  F
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 28/241 (11%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEI 276
           QVPG+    +  E     + F K+  +GKG FG VF+G      +V   +   LE   + 
Sbjct: 10  QVPGMQNNIADPE-----ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE 64
Query: 277 NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS-LDRWLFQRSDEFMLDW 335
            +    E+  +       + +  G   + S   ++ EY+  GS LD       DEF    
Sbjct: 65  IEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF---- 120
Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
            Q   ++ +I KGL YLH    +K +H DIK  N+LL    + K+ADFG++  +   Q +
Sbjct: 121 -QIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 176
Query: 396 VVTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
              T  GTP ++APE +  S    K DI+S G+  +E+  G       +P   DM+ + +
Sbjct: 177 -RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-------EPPNSDMHPMRV 228
Query: 455 F 455
Sbjct: 229 L 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           R +LGKG +G V+ G   ++  ++A+K + E     ++    E+     + H+N+V+ +G
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             +E     +  E +P GSL   L  +      + Q        I +GL YLH++   +I
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 361 LHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---II 416
           +H DIK  N+L++      K++DFG SK +    +    T  GT  Y+APE +       
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE 460
            +  DI+S G  ++E+  G+  F      +  M+ + +FK   E
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQN 294
           D+F K+  LG G  G VF+ +      V  ++L   E    I    + E++ +   +   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGLTYL E
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEWLS 413
             + KI+H D+KP NIL++     K+ DFG+S +LID     +  +  GT  Y++PE L 
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 195
Query: 414 SI-ITEKVDIYSFGVVMLEILCGR 436
               + + DI+S G+ ++E+  GR
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           R +LGKG +G V+ G   ++  ++A+K + E     ++    E+     + H+N+V+ +G
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             +E     +  E +P GSL   L  +      + Q        I +GL YLH++   +I
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 129
Query: 361 LHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---II 416
           +H DIK  N+L++      K++DFG SK +    +    T  GT  Y+APE +       
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE 460
            +  DI+S G  ++E+  G+  F      +  M+ + +FK   E
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 238 MTDNFRKM--LGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSI 290
           ++D ++++  LG G +G V     +  G + A+K ++       S     L EV  +  +
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            H N+++L  F  +K +  LV E    G L   +  R     +D      I+  +  G T
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTT 135
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTTMR---GTP 404
           YLH   +  I+H D+KP+N+LL+        K+ DFGLS        +V   M+   GT 
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGKMKERLGTA 187
Query: 405 GYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            Y+APE L     EK D++S GV++  +LCG   F     +E
Sbjct: 188 YYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQT------DGTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQ----RSDEFMLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L       ++  +L      K+I    +IA G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAV+ ++   ++N S L     EV+ +  ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKT-QLNSSSLQKLFREVRIMKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      + T  G+P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 241 NFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           NFR  K +G+G F  V+      DG  VA+K+++    ++    A    E+  +  ++H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLD---WQQRKKIILDIAKG 348
           N+++      E +   +V E    G L R +  F++    + +   W    K  + +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSA 148
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L ++H    ++++H DIKP N+ +      K+ D GL +     ++    ++ GTP Y++
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 204
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           PE +  +    K DI+S G ++ E+   +  F       + M L S+ KK  + D     
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCDYPPLP 259
Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV 509
            D +S +++    ++VNM      C+  D  KRP ++ V  V
Sbjct: 260 SDHYSEELR----QLVNM------CINPDPEKRPDVTYVYDV 291

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 11  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 71  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               + +++ DIK +N++LD + + K+ DFGL K    D +  + T  GTP YLAPE L 
Sbjct: 126 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLE 181
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            +     VD +  GVVM E++CGR  F
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEG------TQTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRL 298
           LG+G FG VF         + D   VAVK L+   E   + F  E + +  + HQ++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------------LDWQQRKKIILDIA 346
            G C E    L+V+EYM +G L+R+L     +              L   Q   +   +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPG 405
            G+ YL        +H D+  +N L+      K+ DFG+S+ +   D  +V         
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 406 YLAPE-WLSSIITEKVDIYSFGVVMLEIL 433
           ++ PE  L    T + D++SFGVV+ EI 
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 238 MTDNFR--KMLGKGGFGSVFE-GTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSI 290
           ++D ++  K LG G +G V     +  G + A+K ++       S     L EV  +  +
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            H N+++L  F  +K +  LV E    G L   +  R     +D      I+  +  G T
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTT 118
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTTMR---GTP 404
           YLH   +  I+H D+KP+N+LL+        K+ DFGLS        +V   M+   GT 
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGKMKERLGTA 170
Query: 405 GYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
            Y+APE L     EK D++S GV++  +LCG   F     +E
Sbjct: 171 YYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 212

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 68  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               + +++ DIK +N++LD + + K+ DFGL K    D +  + T  GTP YLAPE L 
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLE 178
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            +     VD +  GVVM E++CGR  F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 149
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 167
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 68  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               + +++ DIK +N++LD + + K+ DFGL K    D +  + T  GTP YLAPE L 
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLE 178
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            +     VD +  GVVM E++CGR  F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 155
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 259

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 112/241 (46%), Gaps = 10/241 (4%)
Query: 244 KMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + +G+G +G V         T+VA+K++         +  L E++ +    H+N++ +  
Sbjct: 49  QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
                +   +   Y+    ++  L++      L        +  I +GL Y+H      +
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS---ANV 165
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLID--QDQSQVVTTMRGTPGYLAPEWL--SSII 416
           LH D+KP N+L++   + K+ DFGL+++ D   D +  +T    T  Y APE +  S   
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ 476
           T+ +DI+S G ++ E+L  R +F      ++  ++L I    ++ED    +  K  N +Q
Sbjct: 226 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQ 285
Query: 477 S 477
           S
Sbjct: 286 S 286

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQ----RSDEFMLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L       ++  +L      K+I    +IA G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N ++  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 195
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD------GTKVAVKRLEGIGEINK--SFLAEVKTIGSIHHQNLVR 297
           LG+G FG V+EG           T+VA+K +     + +   FL E   +   +  ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF----MLDWQQRKKIIL---DIAKGLT 350
           L+G  ++    L++ E M  G L  +L     E     +L      K+I    +IA G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YL+ +   K +H D+  +N  +  +F  K+ DFG+++    D  +     +G  G L   
Sbjct: 140 YLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 192
Query: 411 WLS------SIITEKVDIYSFGVVMLEI 432
           W+S       + T   D++SFGVV+ EI
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 39  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 154
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG++    QD  +     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----QDIYRASYYRKGGCAM 207
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTK------VAVKRLEGIGEINK--SFLAEVKTIGSI-HH 292
           F K+LG G FG V   T    +K      VAVK L+   + ++  + ++E+K +  +  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM---LDWQQRKKI-------- 341
           +N+V L+G C       L++EY   G L  +L  + ++F    ++++ +K++        
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 342 ---------ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
                       +AKG+ +L     +  +H D+  +N+L+      K+ DFGL++ I  D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 393 QSQVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
            + VV      P  ++APE L   I T K D++S+G+++ EI 
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 145
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 249

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKV-AVKRL--EGIGEIN--KSFLAEVKTIGSIHHQNLVRL 298
           + +GKG FG V    + D  K+ A+K +  +   E N  ++   E++ +  + H  LV L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                ++    +V + +  G L R+  Q++  F    +  K  I ++   L YL     Q
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHF--KEETVKLFICELVMALDYLQ---NQ 134
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI--- 415
           +I+H D+KP NILLD + +  + DF ++ ++ ++    +TTM GT  Y+APE  SS    
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKGA 192
Query: 416 -ITEKVDIYSFGVVMLEILCGRKVF 439
             +  VD +S GV   E+L GR+ +
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V++     G   A+K  RLE   E I  + + E+  +  + H N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             K   +LV+E+     LD+ L +  D  E  L+    K  +L +  G+ Y H+   +++
Sbjct: 70  HTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL--SS 414
           LH D+KPQN+L++     K+ADFGL++     + +   +VVT       Y AP+ L  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMGSK 176
Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
             +  +DI+S G +  E++ G  +F      ++ M +  I 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 152
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 153
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 257

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 144
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 248

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V++     G   A+K  RLE   E I  + + E+  +  + H N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             K   +LV+E+     LD+ L +  D  E  L+    K  +L +  G+ Y H+   +++
Sbjct: 70  HTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL--SS 414
           LH D+KPQN+L++     K+ADFGL++     + +   +VVT       Y AP+ L  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMGSK 176
Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
             +  +DI+S G +  E++ G  +F      ++ M +  I 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRIL 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   ++ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VA+K ++   ++N + L     EV+ +  ++H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT-QLNPTSLQKLFREVRIMKILNHP 71
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    L+ EY   G +  +L       M + + R K    I   + Y H
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKF-RQIVSAVQYCH 128
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +   ++I+H D+K +N+LLD + N K+ADFG S   +      + T  G+P Y APE   
Sbjct: 129 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQ 183
Query: 414 SIITE--KVDIYSFGVVMLEILCGRKVFD 440
               +  +VD++S GV++  ++ G   FD
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    +   L++      L        +  I +GL Y+H      +LH
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 167
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I  ++HQN+V
Sbjct: 53  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 168
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 267
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 268 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 313
Query: 518 HN 519
            N
Sbjct: 314 SN 315

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I  ++HQN+V
Sbjct: 39  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 154
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 207
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 252
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 253 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 298
Query: 518 HN 519
            N
Sbjct: 299 SN 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L               R  E  + ++   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V++     G   A+K  RLE   E I  + + E+  +  + H N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSD--EFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             K   +LV+E+     LD+ L +  D  E  L+    K  +L +  G+ Y H+   +++
Sbjct: 70  HTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWL--SS 414
           LH D+KPQN+L++     K+ADFGL++     + +   ++VT       Y AP+ L  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-----YRAPDVLMGSK 176
Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
             +  +DI+S G +  E++ G  +F      ++ M +  I 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 71  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 242 FRKMLGKGGFGSV-------------FEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           F++ LG G FG V              +    D ++V ++++E          AE++ + 
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE----------AEIEVLK 75
Query: 289 SIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIA 346
           S+ H N++++     E  HN+ +V E    G L +R +  ++    L      +++  + 
Sbjct: 76  SLDHPNIIKIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
             L Y H    Q ++H D+KP+NIL      +   K+ DFGL++L   D+    T   GT
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGT 189
Query: 404 PGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
             Y+APE     +T K DI+S GVVM  +L G   F  +  EE
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 244 KMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNL 295
           K LG+G FG V + T      +   T VAVK L+     +  +  L+E   +  ++H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL---------------------FQRSDEFMLD 334
           ++L G C++    LL+ EY   GSL  +L                         DE  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
                     I++G+ YL E    K++H D+  +NIL+      K++DFGLS+ + ++ S
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 395 QVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILC 434
            V  +    P  ++A E L   I T + D++SFGV++ EI+ 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G +G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 125
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 259
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 260 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 305
Query: 518 HN 519
            N
Sbjct: 306 SN 307

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 256
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 257 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 302
Query: 518 HN 519
            N
Sbjct: 303 SN 304

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 38  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 153
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 244 KMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNL 295
           K LG+G FG V + T      +   T VAVK L+     +  +  L+E   +  ++H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL---------------------FQRSDEFMLD 334
           ++L G C++    LL+ EY   GSL  +L                         DE  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
                     I++G+ YL E    K++H D+  +NIL+      K++DFGLS+ + ++ S
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 395 QVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILC 434
            V  +    P  ++A E L   I T + D++SFGV++ EI+ 
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 38  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 153
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA++++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 145
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +T    T  Y APE +  S   T+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I     +ED
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQED 249

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 260
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 261 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 306
Query: 518 HN 519
            N
Sbjct: 307 SN 308

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 65  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 180
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 233
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGIGEINKS--FLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +        FL E   I   +HQN+V
Sbjct: 30  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 145
Query: 350 TYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 198
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 308
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 309 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 354
Query: 518 HN 519
            N
Sbjct: 355 SN 356

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 55  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 170
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 223
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N S L     EV+ +  ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKT-QLNSSSLQKLFREVRIMKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      +    G P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 267
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 268 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 313
Query: 518 HN 519
            N
Sbjct: 314 SN 315

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 45  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 160
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 213
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 244 KMLGKGGFGSVF--EGTQTDG------TKVAVKRLEGIGEIN--KSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D       TKVAVK L+           ++E++ +  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQRK 339
           +N++ L+G C +     ++ EY   G+L  +L  R             + E  L  +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I   D  +  T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             R    ++APE L   I T + D++SFGV++ EI           P EE   L  + K+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE 267
Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
               DK S+  +           E+  MM+    C  +  ++RP+   +V  L+ +    
Sbjct: 268 GHRMDKPSNCTN-----------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIVALT 313
Query: 518 HN 519
            N
Sbjct: 314 SN 315

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 39  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 154
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 207
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 53  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 168
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIH 291
            +DN+  ++ LGKG F  V     +T G + A K +       + F     E +    + 
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+VRL     E+S + LV++ +  G L   +  R  EF  +       I  I + + Y
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSE-ADASHCIQQILESIAY 119
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
            H +    I+H ++KP+N+LL         K+ADFGL+  I+ + S+      GTPGYL+
Sbjct: 120 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 174
Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
           PE L     ++ VDI++ GV++  +L G   F
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIH 291
            +DN+  ++ LGKG F  V     +T G + A K +       + F     E +    + 
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+VRL     E+S + LV++ +  G L   +  R  EF  +       I  I + + Y
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSE-ADASHCIQQILESIAY 120
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
            H +    I+H ++KP+N+LL         K+ADFGL+  I+ + S+      GTPGYL+
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
           PE L     ++ VDI++ GV++  +L G   F
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 79  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 194
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +   +    FL E   I   +HQN+V
Sbjct: 53  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD     +   DIA G 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR---DIACGC 168
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++  Y   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 130/281 (46%), Gaps = 28/281 (9%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAV-KRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           +G G FG+V++G       V + K ++   E  ++F  EV  +    H N++  +G+   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT- 102
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
           K +  +V ++    SL + L  +  +F +   Q   I    A+G+ YLH    + I+H D
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHA---KNIIHRD 157
Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIITEK 419
           +K  NI L      K+ DFGL+ +  +   SQ V    G+  ++APE +    ++  + +
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG 479
            D+YS+G+V+ E++ G   +  S     D  +  + +  A  D LS L       M+   
Sbjct: 218 SDVYSYGIVLYELMTGELPY--SHINNRDQIIFMVGRGYASPD-LSKLYKNCPKAMK--- 271
Query: 480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
                  ++ A C++    +RP   +  ++L  +   +H+L
Sbjct: 272 -------RLVADCVKKVKEERP---LFPQILSSIELLQHSL 302

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGF 301
           +++G G +G V++G     G   A+K ++  G+  +    E+  +    HH+N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 302 CAEKS------HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
             +K+         LV E+   GS+   L + +    L  +    I  +I +GL++LH+ 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 147
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-- 413
              K++H DIK QN+LL  N   K+ DFG+S  +D+   +   T  GTP ++APE ++  
Sbjct: 148 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACD 204
Query: 414 ----SIITEKVDIYSFGVVMLEILCG 435
               +    K D++S G+  +E+  G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 13  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 73  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               + +++ DIK +N++LD + + K+ DFGL K    D +  +    GTP YLAPE L 
Sbjct: 128 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLE 183
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            +     VD +  GVVM E++CGR  F
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 68  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPE 410
               + +++ DIK +N++LD + + K+ DFGL K    D +    TM+   GTP YLAPE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKXFCGTPEYLAPE 175
Query: 411 WLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            L  +     VD +  GVVM E++CGR  F
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIH 291
            +DN+  ++ LGKG F  V     +T G + A K +       + F     E +    + 
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+VRL     E+S + LV++ +  G L   +  R  EF  +       I  I + + Y
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSE-ADASHCIQQILESIAY 120
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
            H +    I+H ++KP+N+LL         K+ADFGL+  I+ + S+      GTPGYL+
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
           PE L     ++ VDI++ GV++  +L G   F
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 246 LGKGGFGSVFEGTQTDGT-------KVAVKRLEGIGEINKS--FLAEVKTIGSIHHQNLV 296
           LG G FG V+EG Q  G        +VAVK L  +        FL E   I   +HQN+V
Sbjct: 56  LGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWL-------FQRSDEFMLDWQQRKKIILDIAKGL 349
           R IG   +     ++ E M  G L  +L        Q S   MLD      +  DIA G 
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIACGC 171
Query: 350 TYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E+     +H DI  +N LL        AK+ DFG+++    D  +     +G    
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 224
Query: 407 LAPEWLS------SIITEKVDIYSFGVVMLEIL 433
           L  +W+        I T K D +SFGV++ EI 
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 68  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               + +++ DIK +N++LD + + K+ DFGL K    D +  +    GTP YLAPE L 
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLE 178
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
            +     VD +  GVVM E++CGR  F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAV+ ++   ++N S L     EV+ +  ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKT-QLNSSSLQKLFREVRIMKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L       M + + R K    I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKF-RQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      +    G+P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGSPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 111/250 (44%), Gaps = 36/250 (14%)
Query: 210 NGADEIEEDYLDQV------PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGT 263
           N  D    D LD         GLP  F  +          + +GKG +G V+ G+   G 
Sbjct: 5   NVGDSTLADLLDHSCTSGSGSGLP--FLVQRTVARQITLLECVGKGRYGEVWRGSW-QGE 61
Query: 264 KVAVKRLEGIGEINKSFLAEVKTIGSI--HHQNLVRLIGFCAEKSHN----LLVYEYMPN 317
            VAVK      E  KS+  E +   ++   H+N++  I       H+     L+  Y   
Sbjct: 62  NVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 119
Query: 318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-----RQKILHLDIKPQNILL 372
           GSL  +L   +    LD     +I+L IA GL +LH +      +  I H D+K +NIL+
Sbjct: 120 GSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 175
Query: 373 DGNFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPEWLSSIIT-------EKVDI 422
             N    +AD GL+ +  Q  +Q+        GT  Y+APE L   I        ++VDI
Sbjct: 176 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 235
Query: 423 YSFGVVMLEI 432
           ++FG+V+ E+
Sbjct: 236 WAFGLVLWEV 245

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 241 NFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNL 295
           ++ K+LGKG FG V     +  G   A+K L     I K  +A    E + + +  H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 296 VRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
             L    A ++H+ L  V EY   G L    F  S E +   ++ +    +I   L YLH
Sbjct: 68  TALK--YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR---GTPGYLAPE 410
               + +++ DIK +N++LD + + K+ DFGL K    D +    TM+   GTP YLAPE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKXFCGTPEYLAPE 175
Query: 411 WLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            L  +     VD +  GVVM E++CGR  F
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 120/247 (48%), Gaps = 35/247 (14%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +          NF K +G+G  G V   T+   G +VAVK+++   +  +  L 
Sbjct: 40  PGDPREY--------LANFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF 90
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +   HH N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAT 145
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+YLH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 146 VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXL 201
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCG-------------RKVFDRSQPEE 446
            GTP ++APE +S +    +VDI+S G++++E++ G             R++ D   P  
Sbjct: 202 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRV 261
Query: 447 EDMYLLS 453
           +D++ +S
Sbjct: 262 KDLHKVS 268

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTK---VAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRLIG 300
           LG G FGSV +G      K   VA+K L+   E    +  + E + +  + +  +VRLIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C  ++  +LV E    G L ++L  + +E  +      +++  ++ G+ YL E   +  
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KNF 131
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWLS-SIIT 417
           +H D+  +N+LL     AK++DFGLSK +  D S       G     + APE ++    +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 418 EKVDIYSFGVVMLEILC-GRKVFDRSQPEE 446
            + D++S+GV M E L  G+K + + +  E
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI--HHQNLVRLIGFCA 303
           +GKG +G V+ G+   G  VAVK      E  KS+  E +   ++   H+N++  I    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDM 72
Query: 304 EKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC--- 356
              H+     L+  Y   GSL  +L   +    LD     +I+L IA GL +LH +    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 357 --RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--VVTTMR-GTPGYLAPEW 411
             +  I H D+K +NIL+  N    +AD GL+ +  Q  +Q  V    R GT  Y+APE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 412 LSSIIT-------EKVDIYSFGVVMLEI 432
           L   I        ++VDI++FG+V+ E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI--HHQNLVRLIGFCA 303
           +GKG +G V+ G+   G  VAVK      E  KS+  E +   ++   H+N++  I    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDM 72
Query: 304 EKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC--- 356
              H+     L+  Y   GSL  +L   +    LD     +I+L IA GL +LH +    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 357 --RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--VVTTMR-GTPGYLAPEW 411
             +  I H D+K +NIL+  N    +AD GL+ +  Q  +Q  V    R GT  Y+APE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 412 LSSIIT-------EKVDIYSFGVVMLEI 432
           L   I        ++VDI++FG+V+ E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           + K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L 
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L            V EY   G L    F  S E +    + +    +I   L YLH + 
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 267
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ D+K +N++LD + + K+ DFGL K   +D +  + T  GTP YLAPE L  + 
Sbjct: 268 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDND 325
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G G +G+V++      G  VA+K +      EG+       +A ++ + +  H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 299 IGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +  CA    +      LV+E++ +  L  +L  ++    L  +  K ++    +GL +LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ--SQVVTTMRGTPGYLAPE- 410
            +C   I+H D+KP+NIL+      K+ADFGL+++       + VV T+     Y APE 
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTL----WYRAPEV 182
Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
            L S     VD++S G +  E+   + +F
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G G +G+V++      G  VA+K +      EG+       +A ++ + +  H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 299 IGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +  CA    +      LV+E++ +  L  +L  ++    L  +  K ++    +GL +LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--QVVTTMRGTPGYLAPE- 410
            +C   I+H D+KP+NIL+      K+ADFGL+++     +   VV T+     Y APE 
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTL----WYRAPEV 182
Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
            L S     VD++S G +  E+   + +F
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 151
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +     T  Y APE +  S   T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           + K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L 
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 214
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L            V EY   G L    F  S E +    + +    +I   L YLH + 
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 270
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ D+K +N++LD + + K+ DFGL K   +D +  + T  GTP YLAPE L  + 
Sbjct: 271 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDND 328
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G G +G+V++      G  VA+K +      EG+       +A ++ + +  H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 299 IGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +  CA    +      LV+E++ +  L  +L  ++    L  +  K ++    +GL +LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--QVVTTMRGTPGYLAPE- 410
            +C   I+H D+KP+NIL+      K+ADFGL+++     +   VV T+     Y APE 
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTL----WYRAPEV 182
Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
            L S     VD++S G +  E+   + +F
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VA+K ++   ++N + L     EV+ +  ++H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT-QLNPTSLQKLFREVRIMKILNHP 74
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    L+ EY   G +  +L       M + + R K    I   + Y H
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKF-RQIVSAVQYCH 131
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +   ++I+H D+K +N+LLD + N K+ADFG S   +      +    G P Y APE   
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 414 SIITE--KVDIYSFGVVMLEILCGRKVFD 440
               +  +VD++S GV++  ++ G   FD
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
              +   +   Y+    ++  L++      L        +  I +GL Y+H      +LH
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLH 152
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLI--DQDQSQVVTTMRGTPGYLAPEWL--SSIITE 418
            D+KP N+LL+   + K+ DFGL+++   D D +  +     T  Y APE +  S   T+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +DI+S G ++ E+L  R +F      ++  ++L I    ++ED
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 226 LPKRFSFEELKVMTD-NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE--INKSFL 281
           +PKR  +    + +D   + +LG+G +G V   T +  G  VA+K++E   +       L
Sbjct: 1   MPKRIVY---NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            E+K +    H+N++ +       S       Y+    +   L +     ML     +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ---DQSQVVT 398
           I    + +  LH      ++H D+KP N+L++ N + KV DFGL+++ID+   D S+   
Sbjct: 118 IYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 399 TMRGTPGYLAPEWL--------SSIITEKVDIYSFGVVMLEILCGRKVF 439
              G   Y+A  W         S+  +  +D++S G ++ E+   R +F
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA---EVKTIGSIH 291
            +DN+  ++ LGKG F  V     +T G + A K +       + F     E +    + 
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+VRL     E+S + LV++ +  G L   +  R  EF  +       I  I + + Y
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSE-ADASHCIQQILESIAY 143
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
            H +    I+H ++KP+N+LL         K+ADFGL+  I+ + S+      GTPGYL+
Sbjct: 144 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 198
Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVF 439
           PE L     ++ VDI++ GV++  +L G   F
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 244 KMLGKGGFGSVF--EGTQTDGTK------VAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           K LG+G FG V   E    D  K      VAVK L  +   +     ++E++ +  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-------------FQRSDEFMLDWQQRK 339
           +N++ L+G C +     ++  Y   G+L  +L               R  E  + ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVT 398
                +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+  D  +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEIL 433
             R    ++APE L   + T + D++SFGV+M EI 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 234 ELKVMTDNFRKMLGKGGFGSVF-----EGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           +LK+      KMLGKG FG VF     +  Q    K   K +  + +  +  + E + + 
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 289 -SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
            +  H  L  +      K +   V EY+  G L  +  Q   +F  D  +      +I  
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKF--DLSRATFYAAEIIL 130
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTP 404
           GL +LH    + I++ D+K  NILLD + + K+ADFG+ K   L D   ++      GTP
Sbjct: 131 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC----GTP 183
Query: 405 GYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
            Y+APE  L       VD +SFGV++ E+L G+  F   Q EEE
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE 226

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 113/244 (46%), Gaps = 43/244 (17%)
Query: 234 ELKVMTDNFR----KMLGKGGFG--SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTI 287
           +L +M D+ R    K +G G FG   +    Q +   VAVK +E   +I+++   E+   
Sbjct: 11  DLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANEL-VAVKYIERGEKIDENVKREIINH 69
Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--------SDEFMLDWQQRK 339
            S+ H N+VR        +H  +V EY   G     LF+R         DE    +QQ  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQ-- 123
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQS 394
                +  G++Y H     ++ H D+K +N LLDG+     K+ADFG SK   L  Q +S
Sbjct: 124 -----LISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS 175
Query: 395 QVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            V     GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   +  
Sbjct: 176 AV-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEPKNFRK 228
Query: 453 SIFK 456
           +I +
Sbjct: 229 TIHR 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+G  G V     +     VAVK ++    ++  ++   E+     ++H+N+V+  G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
              E +   L  EY   G L    F R + +  +     ++    +  G+ YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 124
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLID-QDQSQVVTTMRGTPGYLAPEWLS--SII 416
           I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDR 441
            E VD++S G+V+  +L G   +D+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 244 KMLGKGGFGSVFEG--TQTDGT--KVAVKRLEG--IGEIN-KSFLAEVKTIGSIHHQNLV 296
           +MLGKG FGSV E    Q DG+  KVAVK L+   I   + + FL E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 297 RLIGFCAEKSHN------LLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAK 347
           +L+G              +++  +M +G L  +L       + F L  Q   + ++DIA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGY 406
           G+ YL     +  +H D+  +N +L  +    VADFGLS K+   D  +     +    +
Sbjct: 149 GMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 407 LAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           LA E L+ ++ T   D+++FGV M EI+  G+  +   +  E   YL+   + K   + +
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECM 265
Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
                          EEV ++M     C  +D  +RPS + +   LE +
Sbjct: 266 ---------------EEVYDLMY---QCWSADPKQRPSFTCLRMELENI 296

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 244 KMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNL 295
           K LG+G FG V + T      +   T VAVK L+     +  +  L+E   +  ++H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWL---------------------FQRSDEFMLD 334
           ++L G C++    LL+ EY   GSL  +L                         DE  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
                     I++G+ YL E     ++H D+  +NIL+      K++DFGLS+ + ++ S
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 395 QVVTTMRGTP-GYLAPEWL-SSIITEKVDIYSFGVVMLEILC 434
            V  +    P  ++A E L   I T + D++SFGV++ EI+ 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG VF+G      KV   +   LE   +  +    E+  +       + +  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            + +   ++ EY+  GS    L    +   LD  Q   I+ +I KGL YLH    +K +H
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 127
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVD 421
            DIK  N+LL  +   K+ADFG++  +   Q +   T  GTP ++APE +  S    K D
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 422 IYSFGVVMLEILCGRKVFDRSQP 444
           I+S G+  +E+  G        P
Sbjct: 187 IWSLGITAIELARGEPPHSELHP 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 114/261 (43%), Gaps = 43/261 (16%)
Query: 247 GKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS 306
            +G FG V++  Q     VAVK      + +     EV ++  + H+N+++ IG  AEK 
Sbjct: 33  ARGRFGCVWK-AQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG--AEKR 89
Query: 307 HN------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC---- 356
                    L+  +   GSL  +L       ++ W +   I   +A+GL YLHED     
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 357 ---RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR-GTPGYLAPEWL 412
              +  I H DIK +N+LL  N  A +ADFGL+   +  +S   T  + GT  Y+APE L
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 413 SSIIT------EKVDIYSFGVVMLEILCGRKVFD--------------RSQPEEEDMYLL 452
              I        ++D+Y+ G+V+ E+       D                 P  EDM  +
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV 265
Query: 453 SIFKKKAEEDKLSDLVDKHSN 473
            + KKK     L D   KH+ 
Sbjct: 266 VVHKKK--RPVLRDYWQKHAG 284

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTK---VAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRLIG 300
           LG G FGSV +G      K   VA+K L+   E    +  + E + +  + +  +VRLIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C  ++  +LV E    G L ++L  + +E  +      +++  ++ G+ YL E   +  
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KNF 457
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT-P-GYLAPEWLS-SIIT 417
           +H ++  +N+LL     AK++DFGLSK +  D S       G  P  + APE ++    +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 418 EKVDIYSFGVVMLEILC-GRKVFDRSQPEE 446
            + D++S+GV M E L  G+K + + +  E
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 109/238 (45%), Gaps = 35/238 (14%)
Query: 234 ELKVMTD----NFRKMLGKGGFGSVFEGTQTDGTK--VAVKRLEGIGEINKSFLAEVKTI 287
           ++ +M D    +F K +G G FG V    +   TK  VAVK +E    I+++   E+   
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAAIDENVQREIINH 70
Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ----RSDEFMLDWQQRKKIIL 343
            S+ H N+VR        +H  ++ EY   G L   +        DE    +QQ      
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ------ 124
Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQSQVVT 398
            +  G++Y H     +I H D+K +N LLDG+     K+ DFG SK   L  Q +S V  
Sbjct: 125 -LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 178
Query: 399 TMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
              GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   Y  +I
Sbjct: 179 ---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPEEPRDYRKTI 231

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 245 MLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA-------EVKTIGSIHHQNLV 296
           +LG+G   +VF G  +  G   A+K    I     SFL        E + +  ++H+N+V
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNI-----SFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 297 RLIGFCAEKS--HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +L     E +  H +L+ E+ P GSL   L + S+ + L   +   ++ D+  G+ +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 355 DCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +    I+H +IKP NI+     DG    K+ DFG ++ ++ D+  V  ++ GT  YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLYGTEEYLHPD 185
Query: 411 WLSSIITEK---------VDIYSFGVVMLEILCGR---KVFDRSQPEEEDMY 450
                +  K         VD++S GV       G    + F+  +  +E MY
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG VF+G      KV   +   LE   +  +    E+  +       + +  G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            + +   ++ EY+  GS    L    +   LD  Q   I+ +I KGL YLH    +K +H
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVD 421
            DIK  N+LL  +   K+ADFG++  +   Q +   T  GTP ++APE +  S    K D
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDSKAD 206
Query: 422 IYSFGVVMLEILCGRKVFDRSQP 444
           I+S G+  +E+  G        P
Sbjct: 207 IWSLGITAIELARGEPPHSELHP 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 30/252 (11%)
Query: 238 MTDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRL---EGIGEINKSFLAEVKTIGSIH 291
           M + + K+  +G+G +G VF+    D G  VA+K+    E    I K  L E++ +  + 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNG---SLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           H NLV L+     K    LV+EY  +     LDR  +QR     L     K I     + 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHL----VKSITWQTLQA 114
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + + H   +   +H D+KP+NIL+  +   K+ DFG ++L+    S        T  Y +
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRS 170
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           PE L   +     VD+++ G V  E+L G  ++    P + D+  L + +K      L D
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW----PGKSDVDQLYLIRK-----TLGD 221
Query: 467 LVDKHSNDMQSN 478
           L+ +H     +N
Sbjct: 222 LIPRHQQVFSTN 233

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINK-SFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V   T+   G   A K +    E +K +   E++T+  + H  LV L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           + +  +++YE+M  G L   +    ++   D  +  + +  + KGL ++HE+     +HL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN---NYVHL 173
Query: 364 DIKPQNILLDGNFNA--KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKV 420
           D+KP+NI+     +   K+ DFGL+  +D  QS  VTT  GT  + APE      +    
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYT 231
Query: 421 DIYSFGVVMLEILCGRKVF 439
           D++S GV+   +L G   F
Sbjct: 232 DMWSVGVLSYILLSGLSPF 250

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGF 301
           ++LG G FG V +  +T  G K+A K ++  G  +K  +  E+  +  + H NL++L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDCRQK 359
              K+  +LV EY+  G     LF R  +   +  +   I+    I +G+ ++H+     
Sbjct: 155 FESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MY 207
Query: 360 ILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
           ILHLD+KP+NIL   N +A   K+ DFGL++     +   V    GTP +LAPE ++   
Sbjct: 208 ILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYDF 264
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
           ++   D++S GV+   +L G   F
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINK-SFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V   T+   G   A K +    E +K +   E++T+  + H  LV L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
           + +  +++YE+M  G L   +    ++   D  +  + +  + KGL ++HE+     +HL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN---NYVHL 279
Query: 364 DIKPQNILLDGNFNA--KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKV 420
           D+KP+NI+     +   K+ DFGL+  +D  QS  VTT  GT  + APE      +    
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYT 337
Query: 421 DIYSFGVVMLEILCGRKVF 439
           D++S GV+   +L G   F
Sbjct: 338 DMWSVGVLSYILLSGLSPF 356

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 226 LPKRFSFEELKVMTD-NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE--INKSFL 281
           +PKR  +    + +D   + +LG+G +G V   T +  G  VA+K++E   +       L
Sbjct: 1   MPKRIVY---NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            E+K +    H+N++ +       S       Y+    +   L +     ML     +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD--------- 392
           I    + +  LH      ++H D+KP N+L++ N + KV DFGL+++ID+          
Sbjct: 118 IYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           Q   +T    T  Y APE +  S+  +  +D++S G ++ E+   R +F
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 21/235 (8%)
Query: 224 PGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVF-----EGTQTDGTKVAVKRLEGIGEI 276
           P L K     ++K+  ++F   KMLGKG FG VF     +  Q    K   K +  + + 
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 277 NKSFLAEVKTIG-SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDW 335
            +  + E + +  +  H  L  +      K +   V EY+  G L  +  Q   +F  D 
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKF--DL 117
Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQDQ 393
            +      +I  GL +LH    + I++ D+K  NILLD + + K+ADFG+ K  ++   +
Sbjct: 118 SRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 394 SQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
           +       GTP Y+APE  L       VD +SFGV++ E+L G+  F   Q EEE
Sbjct: 175 TNXFC---GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE 225

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           + K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L 
Sbjct: 14  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 73
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L            V EY   G L    F  S E +    + +    +I   L YLH + 
Sbjct: 74  ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 129
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ D+K +N++LD + + K+ DFGL K   +D +  +    GTP YLAPE L  + 
Sbjct: 130 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDND 187
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           + K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L 
Sbjct: 13  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 72
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L            V EY   G L    F  S E +    + +    +I   L YLH + 
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 128
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ D+K +N++LD + + K+ DFGL K   +D +  +    GTP YLAPE L  + 
Sbjct: 129 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDND 186
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQN 294
           K+LG+G FG VF   +  G+    ++L  +  + K+ L          E   +  ++H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDA--RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V+L      +    L+ +++  G L    F R S E M   +  K  + ++A  L +LH
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                 I++ D+KP+NILLD   + K+ DFGLSK    D  +   +  GT  Y+APE ++
Sbjct: 144 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 414 SI-ITEKVDIYSFGVVMLEILCG 435
               T+  D +SFGV+M E+L G
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 117/238 (49%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++   S+D   F  +     +     K  +  + +GL + 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRA 174
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           PE L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 245 MLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA-------EVKTIGSIHHQNLV 296
           +LG+G   +VF G  +  G   A+K    I     SFL        E + +  ++H+N+V
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNI-----SFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 297 RLIGFCAEKS--HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +L     E +  H +L+ E+ P GSL   L + S+ + L   +   ++ D+  G+ +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 355 DCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +    I+H +IKP NI+     DG    K+ DFG ++ ++ D+  V   + GT  YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--XLYGTEEYLHPD 185
Query: 411 WLSSIITEK---------VDIYSFGVVMLEILCGR---KVFDRSQPEEEDMY 450
                +  K         VD++S GV       G    + F+  +  +E MY
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 19/234 (8%)
Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL----EG 272
           +++L++   + K+    ++K    +  K++G+G FG V         KV   +L    E 
Sbjct: 54  DNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEM 113
Query: 273 IGEINKSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDE 330
           I   + +F  E + I +  +   V  + FCA  +  +  +V EYMP G L   +      
Sbjct: 114 IKRSDSAFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLM----SN 168
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
           + +  +  K    ++   L  +H      ++H D+KP N+LLD + + K+ADFG    +D
Sbjct: 169 YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 225
Query: 391 QDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCGRKVF 439
           +       T  GTP Y++PE L S         + D +S GV + E+L G   F
Sbjct: 226 ETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KVDI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 423 YSFGVVMLEILCGRKVFDRSQP 444
           +S G++ +E++ G   +    P
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENP 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 242 FRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLV 296
           + K+LGKG FG V     +  G   A+K L+    + K      L E + + +  H  L 
Sbjct: 12  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 71
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L            V EY   G L    F  S E +    + +    +I   L YLH + 
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 127
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
            + +++ D+K +N++LD + + K+ DFGL K   +D +  +    GTP YLAPE L  + 
Sbjct: 128 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDND 185
Query: 416 ITEKVDIYSFGVVMLEILCGRKVF 439
               VD +  GVVM E++CGR  F
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 111/243 (45%), Gaps = 41/243 (16%)
Query: 234 ELKVMTDNFR----KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           +L +M D+ R    K +G G FG +     +     VAVK +E   +I+++   E+    
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR 69
Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--------SDEFMLDWQQRKK 340
           S+ H N+VR        +H  +V EY   G     LF+R         DE    +QQ   
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQ--- 122
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQSQ 395
               +  G++Y H     ++ H D+K +N LLDG+     K+ DFG SK   L  Q +S 
Sbjct: 123 ----LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 175
Query: 396 VVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           V     GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   +  +
Sbjct: 176 V-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEPKNFRKT 228
Query: 454 IFK 456
           I +
Sbjct: 229 IHR 231

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 119/239 (49%), Gaps = 29/239 (12%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++   S+D   F  +     +     K  +  + +GL + 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRA 173
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKKKAEEDKL 464
           PE L      +  VDI+S G +  E++  R +F    P + ++  L  IF+     D++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF----PGDSEIDQLFRIFRTLGTPDEV 228

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQ 293
           + LGKGGF   +E T  D  +V   ++     + KS L           E+    S+ + 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKV-----VPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD--------- 344
           ++V   GF  +     +V E     SL            L+  +R+K + +         
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSL------------LELHKRRKAVTEPEARYFMRQ 150
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
             +G+ YLH +   +++H D+K  N+ L+ + + K+ DFGL+  I+ D  +   T+ GTP
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKTLCGTP 206
Query: 405 GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRS 442
            Y+APE L     + +VDI+S G ++  +L G+  F+ S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQN 294
           K+LG+G FG VF   +  G+    ++L  +  + K+ L          E   +  ++H  
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDA--RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 88
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V+L      +    L+ +++  G L    F R S E M   +  K  + ++A  L +LH
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                 I++ D+KP+NILLD   + K+ DFGLSK    D  +   +  GT  Y+APE ++
Sbjct: 145 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 414 SI-ITEKVDIYSFGVVMLEILCG 435
               T+  D +SFGV+M E+L G
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG+G    V+   Q    K  A+K L+   +  K    E+  +  + H N+++L      
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
            +   LV E +  G L   + ++      D     K IL+    + YLHE+    I+H D
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAYLHEN---GIVHRD 173
Query: 365 IKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKV 420
           +KP+N+L      +   K+ADFGLSK+++     ++ T+ GTPGY APE L       +V
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCAYGPEV 231
Query: 421 DIYSFGVVMLEILCGRKVF 439
           D++S G++   +LCG + F
Sbjct: 232 DMWSVGIITYILLCGFEPF 250

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 226 LPKRFSFEELKVMTD-NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE--INKSFL 281
           +PKR  +    + +D   + +LG+G +G V   T +  G  VA+K++E   +       L
Sbjct: 1   MPKRIVY---NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            E+K +    H+N++ +       S       Y+    +   L +     ML     +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ---DQSQVVT 398
           I    + +  LH      ++H D+KP N+L++ N + KV DFGL+++ID+   D S+   
Sbjct: 118 IYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 399 TMRGTPGYLAPEWL--------SSIITEKVDIYSFGVVMLEILCGRKVF 439
              G   ++A  W         S+  +  +D++S G ++ E+   R +F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQN 294
           K+LG+G FG VF   +  G+    ++L  +  + K+ L          E   +  ++H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDA--RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V+L      +    L+ +++  G L    F R S E M   +  K  + ++A  L +LH
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                 I++ D+KP+NILLD   + K+ DFGLSK    D  +   +  GT  Y+APE ++
Sbjct: 144 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 414 SI-ITEKVDIYSFGVVMLEILCG 435
               T+  D +SFGV+M E+L G
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 241 NFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQ 293
           N+R  K +GKG F  V        G +VAVK ++   ++N S L     EV+    ++H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKT-QLNSSSLQKLFREVRIXKVLNHP 73
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L      +    LV EY   G +  +L           ++ +     I   + Y  
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG---RXKEKEARAKFRQIVSAVQY-- 128
Query: 354 EDCRQK-ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
             C QK I+H D+K +N+LLD + N K+ADFG S   +      +    G P Y APE  
Sbjct: 129 --CHQKFIVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELF 184
Query: 413 SSIITE--KVDIYSFGVVMLEILCGRKVFD 440
                +  +VD++S GV++  ++ G   FD
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 244 KMLGKGGFGSVFEGTQTD--GTK--VAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVR 297
           ++LG+G FG V+EG  T+  G K  VAVK  +    ++  + F++E   + ++ H ++V+
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE-DC 356
           LIG   E+    ++ E  P G L  +L +  +   +         L I K + YL   +C
Sbjct: 74  LIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINC 130
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SI 415
               +H DI  +NIL+      K+ DFGLS+ I+ +     +  R    +++PE ++   
Sbjct: 131 ----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 416 ITEKVDIYSFGVVMLEILC-GRKVF 439
            T   D++ F V M EIL  G++ F
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 242 FRKMLGKGGFGSVFEGTQTD--GTK--VAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNL 295
             ++LG+G FG V+EG  T+  G K  VAVK  +    ++  + F++E   + ++ H ++
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE- 354
           V+LIG   E+    ++ E  P G L  +L +  +   L         L I K + YL   
Sbjct: 88  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESI 144
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS- 413
           +C    +H DI  +NIL+      K+ DFGLS+ I+ +     +  R    +++PE ++ 
Sbjct: 145 NC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 414 SIITEKVDIYSFGVVMLEILC-GRKVF 439
              T   D++ F V M EIL  G++ F
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG VF+G      KV   +   LE   +  +    E+  +       + +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            + +   ++ EY+  GS    L    +   LD  Q   I+ +I KGL YLH    +K +H
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 142
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVD 421
            DIK  N+LL  +   K+ADFG++  +   Q +      GTP ++APE +  S    K D
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 422 IYSFGVVMLEILCGRKVFDRSQP 444
           I+S G+  +E+  G        P
Sbjct: 202 IWSLGITAIELARGEPPHSELHP 224

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL-----------AEVKTIGSIHH 292
           ++LGKGG+G VF+  +  G      ++  +  + K+ +           AE   +  + H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTG--KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
             +V LI          L+ EY+  G L   L +R   FM D       + +I+  L +L
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACF--YLAEISMALGHL 137
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H+   + I++ D+KP+NI+L+   + K+ DFGL K    D + V  T  GT  Y+APE L
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEIL 193
Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVF 439
             S     VD +S G +M ++L G   F
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++   S+D   F  +     +     K  +  + +GL + 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KP+N+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 123 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRA 174
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           PE L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 242 FRKMLGKGGFGSVFEGTQTD--GTK--VAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNL 295
             ++LG+G FG V+EG  T+  G K  VAVK  +    ++  + F++E   + ++ H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE- 354
           V+LIG   E+    ++ E  P G L  +L +  +   +         L I K + YL   
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESI 132
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS- 413
           +C    +H DI  +NIL+      K+ DFGLS+ I+ +     +  R    +++PE ++ 
Sbjct: 133 NC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 414 SIITEKVDIYSFGVVMLEILC-GRKVF 439
              T   D++ F V M EIL  G++ F
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +     L     + +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK----LTDDHVQFLIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG VF+G      KV   +   LE   +  +    E+  +       + +  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
            + +   ++ EY+  GS    L    +   LD  Q   I+ +I KGL YLH    +K +H
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKIH 127
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVD 421
            DIK  N+LL  +   K+ADFG++  +   Q +      GTP ++APE +  S    K D
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 422 IYSFGVVMLEILCGRKVFDRSQP 444
           I+S G+  +E+  G        P
Sbjct: 187 IWSLGITAIELARGEPPHSELHP 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 24/213 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++   S+D   F  +     +     K  +  + +GL + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KP+N+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRA 172
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           PE L      +  VDI+S G +  E++  R +F
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +S +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KSQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL +  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNA 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 148
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 202
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 203 MH--YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 93  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 145
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 146 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 93  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 145
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 146 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 110/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
           E+  +  + H N+V+L+    +  + H  +V+E +  G +      +     L   Q + 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP----LSEDQARF 141
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
              D+ KG+ YLH    QKI+H DIKP N+L+  + + K+ADFG+S       + +  T+
Sbjct: 142 YFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 401 RGTPGYLAPEWLS---SIITEK-VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            GTP ++APE LS    I + K +D+++ GV +   + G+  F     +E  M L S  K
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF----MDERIMCLHSKIK 253
Query: 457 KKAEE-----DKLSDLVDKHSNDMQSNGEE--VVNMMKVAAWC 492
            +A E     D   DL D  +  +  N E   VV  +K+  W 
Sbjct: 254 SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE 304
           LG+G +GSV++    + G  VA+K++    ++ +  + E+  +      ++V+  G   +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLD 364
            +   +V EY   GS+   +  R+     D  +   I+    KGL YLH     + +H D
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGLEYLH---FMRKIHRD 150
Query: 365 IKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKV-DIY 423
           IK  NILL+   +AK+ADFG++  +  D       + GTP ++APE +  I    V DI+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 424 SFGVVMLEILCGRKVFDRSQP 444
           S G+  +E+  G+  +    P
Sbjct: 210 SLGITAIEMAEGKPPYADIHP 230

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLI- 299
           +G G +GSV        G K+AVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 300 ----GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 172
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 173 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 226
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +   +T  VDI+S G +M E+L GR +F
Sbjct: 227 MHYNMT--VDIWSVGCIMAELLTGRTLF 252

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 190 TFSHASDTWMFGVTLWEMF 208

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 109/243 (44%), Gaps = 41/243 (16%)
Query: 234 ELKVMTDNFR----KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           +L +M D+ R    K +G G FG +     +     VAVK +E   +I  +   E+    
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHR 70
Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--------SDEFMLDWQQRKK 340
           S+ H N+VR        +H  +V EY   G     LF+R         DE    +QQ   
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQ--- 123
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQSQ 395
               +  G++Y H     ++ H D+K +N LLDG+     K+ DFG SK   L  Q +S 
Sbjct: 124 ----LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 176
Query: 396 VVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           V     GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   +  +
Sbjct: 177 V-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEPKNFRKT 229
Query: 454 IFK 456
           I +
Sbjct: 230 IHR 232

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 139
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 128 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 233

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 128 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 233

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 148
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 202
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 203 MH--YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 123 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 174
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 228

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +     L     + +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK----LTDDHVQFLIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 19  PGDPRSY--------LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 69
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 70  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 124
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+ LH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 125 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXL 180
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 15  PGDPRSY--------LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 65
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 120
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+ LH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 121 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXL 176
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F    P + ++  L  IF+     D++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF----PGDSEIDQLFRIFRTLGTPDEV 226

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 124 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 175
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 123 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 174
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 228

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 171
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 132/296 (44%), Gaps = 52/296 (17%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVRLIGFC 302
           K+LG G  G+V       G  VAVKR+  + +     L E+K +  S  H N++R   +C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YC 76
Query: 303 AEKSHNLL-VYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIIL--DIAKGLTYLHEDCR 357
           +E +   L +   + N +L   +  +  SDE +   ++   I L   IA G+ +LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 358 QKILHLDIKPQNILLDG-------------NFNAKVADFGLSKLIDQDQSQVVTTMR--- 401
            KI+H D+KPQNIL+               N    ++DFGL K +D  QS   T +    
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 402 GTPGYLAPEWLSSI--------ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLL 452
           GT G+ APE L           +T  +DI+S G V   IL  G+  F      E ++ + 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IR 252
Query: 453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
            IF        L ++   H   + +   ++++ M      ++ D  KRP+   V+R
Sbjct: 253 GIF-------SLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTAMKVLR 295

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF
Sbjct: 8   LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 63
Query: 302 CAEKSHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
            A  + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 355 DC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGY 406
           +      +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 407 LAPEWLSSIIT-------EKVDIYSFGVVMLEI 432
           +APE L   I        ++ DIY+ G+V  EI
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 203
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 204 MH--YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 190 TFSHASDTWMFGVTLWEMF 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 171
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 125 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 176
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 91  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 143
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 144 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 133
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 194 TFSHASDTWMFGVTLWEMF 212

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 226

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI---------HHQNL 295
           +G G +G+V++      G  VA+K +             + T+  +          H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 296 VRLIGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           VRL+  CA    +      LV+E++ +  L  +L  ++    L  +  K ++    +GL 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +LH +C   I+H D+KP+NIL+      K+ADFGL+++     +  +T +  T  Y APE
Sbjct: 135 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAPE 189
Query: 411 -WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
             L S     VD++S G +  E+   + +F
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 154
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 155 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 208
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 209 MH--YNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 171
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 150 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 203
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 204 MH--YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 122 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 173
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 133
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 194 TFSHASDTWMFGVTLWEMF 212

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 139
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 122 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 173
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK 305
           +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF A  
Sbjct: 11  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGFIAAD 66
Query: 306 SHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-- 356
           + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH +   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 357 ---RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGYLAPE 410
              +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 411 WLSSIIT-------EKVDIYSFGVVMLEI 432
            L   I        ++ DIY+ G+V  EI
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 171
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 122 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 173
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 24  PGDPRSY--------LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 74
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 75  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 129
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+ LH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 130 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXL 185
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 125 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 176
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 246 LGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNLVR 297
           LG G FG V  G           VAVK L+       E    F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L G        + V E  P GSL   L +    F+L    R  +   +A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTP-GYLAPEWLSS- 414
           ++ +H D+  +N+LL      K+ DFGL + + Q D   V+   R  P  + APE L + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 415 IITEKVDIYSFGVVMLEIL 433
             +   D + FGV + E+ 
Sbjct: 190 TFSHASDTWMFGVTLWEMF 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 124 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 175
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR----WYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 26  PGDPRSY--------LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 76
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 77  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 131
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+ LH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 132 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXL 187
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 232

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF
Sbjct: 46  LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 101
Query: 302 CAEKSHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
            A  + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 355 DC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGY 406
           +      +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 407 LAPEWLSSIIT-------EKVDIYSFGVVMLEI 432
           +APE L   I        ++ DIY+ G+V  EI
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 145
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 199
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 200 MH--YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 140
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 194
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 203
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 204 MH--YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 203
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 204 MH--YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 141
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           +IK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KVDI
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 423 YSFGVVMLEILCGRKVFDRSQP 444
           +S G++ +E++ G   +    P
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENP 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 204
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 205 MH--YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF
Sbjct: 13  LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 68
Query: 302 CAEKSHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
            A  + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 124
Query: 355 DC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGY 406
           +      +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 407 LAPEWLSSIIT-------EKVDIYSFGVVMLEI 432
           +APE L   I        ++ DIY+ G+V  EI
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 145
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 199
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 145
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 146 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 199
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 200 MH--YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 145
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 199
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 200 MH--YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 148
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 202
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 203 MH--YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 155
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 209
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 210 MH--YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 155
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 209
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 210 MH--YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 155
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 209
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 210 MH--YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 122/255 (47%), Gaps = 26/255 (10%)
Query: 246 LGKGGFGSVFEGTQTDGTK-VAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G+G +G+VF+    +  + VA+KR+      EG+     S L E+  +  + H+N+VRL
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRL 66
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                      LV+E+  +  L ++    + +  LD +  K  +  + KGL + H    +
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD----QSQVVTTMRGTPGYLAPEWLSS 414
            +LH D+KPQN+L++ N   K+A+FGL++          ++VVT     P  L   + + 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL---FGAK 177
Query: 415 IITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDLVDKH 471
           + +  +D++S G +  E+   GR +F  +  +++   +  +     EE    ++ L D  
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 472 SNDMQSNGEEVVNMM 486
              M      +VN++
Sbjct: 238 PYPMYPATTSLVNVV 252

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF
Sbjct: 10  LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 65
Query: 302 CAEKSHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
            A  + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 121
Query: 355 DC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGY 406
           +      +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 407 LAPEWLSSIIT-------EKVDIYSFGVVMLEI 432
           +APE L   I        ++ DIY+ G+V  EI
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 41/219 (18%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQ 293
           + LGKGGF   +E T  D  +V   ++     + KS L           E+    S+ + 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKV-----VPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD--------- 344
           ++V   GF  +     +V E     SL            L+  +R+K + +         
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSL------------LELHKRRKAVTEPEARYFMRQ 150
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
             +G+ YLH +   +++H D+K  N+ L+ + + K+ DFGL+  I+ D  +    + GTP
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTP 206
Query: 405 GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRS 442
            Y+APE L     + +VDI+S G ++  +L G+  F+ S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 141
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  + M GTP ++APE ++      KVDI
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 423 YSFGVVMLEILCGRKVFDRSQP 444
           +S G++ +E++ G   +    P
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENP 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 148
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 202
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 203 MH--YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 142
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 143 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 196
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 197 MH--YNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 77  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 129
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 154
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 155 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 208
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 77  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 129
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 163
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 217
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G +  G +VAVK      E +    AE+     + H+N+   +GF
Sbjct: 33  LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 88
Query: 302 CAEKSHN-------LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
            A  + +        LV +Y  +GSL    F   + + +  +   K+ L  A GL +LH 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 355 DC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGY 406
           +      +  I H D+K +NIL+  N    +AD GL+   D   D   +    R GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 407 LAPEWLSSIIT-------EKVDIYSFGVVMLEI 432
           +APE L   I        ++ DIY+ G+V  EI
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 153
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 154 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 207
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 208 MH--YNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 140
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 194
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 116/228 (50%), Gaps = 26/228 (11%)
Query: 236 KVMTDNFR--KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG---IGEINKSFLAEVKTIGS 289
           ++  DNF   ++LGKG FG V     +  G   AVK L+    + + +       K I S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 290 I--HHQNLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           +  +H  L +L  FC  ++ + L  V E++  G L  +  Q+S  F  D  + +    +I
Sbjct: 79  LARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRF--DEARARFYAAEI 133
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GT 403
              L +LH+   + I++ D+K  N+LLD   + K+ADFG+ K   +     VTT    GT
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGT 187
Query: 404 PGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           P Y+APE L  ++    VD ++ GV++ E+LCG   F+     E+D++
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLF 233

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 86
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 141
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 142 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 195
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 196 MH--YNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  + M GTP ++APE ++      KVDI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 423 YSFGVVMLEILCGRKVFDRSQP 444
           +S G++ +E++ G   +    P
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENP 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 162
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 216
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 217 MH--YNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK----GLTYLHEDCRQ 358
             K    +V ++    SL   L     +F +      K ++DIA+    G+ YLH    +
Sbjct: 78  T-KPQLAIVTQWCEGSSLYHHLHASETKFEM------KKLIDIARQTARGMDYLHA---K 127
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----S 413
            I+H D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +    S
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
           +  + + D+Y+FG+V+ E++ G+  +      ++   ++ +  + +    LS +      
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSKV------ 238
Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
             +SN  +   M ++ A CL+    +RPS     R+L  + E    L
Sbjct: 239 --RSNCPK--RMKRLMAECLKKKRDERPSFP---RILAEIEELAREL 278

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 135
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 139
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 193
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 125
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 139
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 193
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 194 MH--YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQNLVRLIGFCA 303
           +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 +V EY+  GSL   +     E  +D  Q   +  +  + L +LH +   +++H 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDI 422
           DIK  NILL  + + K+ DFG    I  +QS+  + M GTP ++APE ++      KVDI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 423 YSFGVVMLEILCGRKVFDRSQP 444
           +S G++ +E++ G   +    P
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENP 221

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 139
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR----WYRAPEIMLNW 193
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 194 MH--YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 163
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 217
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 218 MH--YNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 166
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + + 
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 220
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 41/219 (18%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL----------AEVKTIGSIHHQ 293
           + LGKGGF   +E T  D  +V   ++     + KS L           E+    S+ + 
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKV-----VPKSMLLKPHQKEKMSTEIAIHKSLDNP 86
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD--------- 344
           ++V   GF  +     +V E     SL            L+  +R+K + +         
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSL------------LELHKRRKAVTEPEARYFMRQ 134
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
             +G+ YLH +   +++H D+K  N+ L+ + + K+ DFGL+  I+ D  +    + GTP
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTP 190
Query: 405 GYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRS 442
            Y+APE L     + +VDI+S G ++  +L G+  F+ S
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 71  MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 123
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 124 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 435 MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 487
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 488 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 244 KMLGKGGFGSVFEG------TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G               +K       +    LAE   +  + +  +VR
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +IG C  +S  +LV E    G L+++L Q     D+ +++      ++  ++ G+ YL E
Sbjct: 436 MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEE 488
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--PGYLAPEWL 412
                 +H D+  +N+LL     AK++DFGLSK +  D++       G     + APE +
Sbjct: 489 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 413 SSI-ITEKVDIYSFGVVMLEILC-GRKVF 439
           +    + K D++SFGV+M E    G+K +
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 32/210 (15%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
                   E+ +++ +  ++    L+  +   + +D+ +      + +I  I +GL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHV------QFLIYQILRGLKYIH 138
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE--- 410
                 I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE   
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIML 191
Query: 411 -WLSSIITEKVDIYSFGVVMLEILCGRKVF 439
            W+     + VDI+S G +M E+L GR +F
Sbjct: 192 NWMH--YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 162
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE    W
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 216
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 217 MH--YNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++     D   F  +     +     K  +  + +GL + 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRA 174
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           PE L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKR-LEGIGEINKS 279
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K+ L+G    N+ 
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR- 62
Query: 280 FLAEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 63  ---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V  +   +  Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 122/255 (47%), Gaps = 26/255 (10%)
Query: 246 LGKGGFGSVFEGTQTDGTK-VAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           +G+G +G+VF+    +  + VA+KR+      EG+     S L E+  +  + H+N+VRL
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRL 66
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                      LV+E+  +  L ++    + +  LD +  K  +  + KGL + H    +
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAPEWLSS 414
            +LH D+KPQN+L++ N   K+ADFGL++     +    ++VVT     P  L   + + 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL---FGAK 177
Query: 415 IITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFKKKAEED--KLSDLVDKH 471
           + +  +D++S G +  E+    R +F  +  +++   +  +     EE    ++ L D  
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 472 SNDMQSNGEEVVNMM 486
              M      +VN++
Sbjct: 238 PYPMYPATTSLVNVV 252

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 244 KMLGKGGFGSVFEGTQTD-----GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           + LGKGGF   +E T  D       KV  K +       +    E+    S+ + ++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD---------IAKGL 349
            GF  +     +V E     SL            L+  +R+K + +           +G+
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSL------------LELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            YLH +   +++H D+K  N+ L+ + + K+ DFGL+  I+ D  +    + GTP Y+AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 211
Query: 410 EWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRS 442
           E L     + +VDI+S G ++  +L G+  F+ S
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  +F LD          ++  L YL     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQN 294
           K+LG+G FG VF   +   T+     L  +  + K+ L          E   +  ++H  
Sbjct: 34  KVLGQGSFGKVFLVRKV--TRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V+L      +    L+ +++  G L    F R S E M   +  K  + ++A GL +LH
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPGYLAPEWL 412
                 I++ D+KP+NILLD   + K+ DFGLSK  ID ++     +  GT  Y+APE +
Sbjct: 148 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK--AYSFCGTVEYMAPEVV 202
Query: 413 SSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           +    +   D +S+GV+M E+L G   F + +  +E M L+
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPF-QGKDRKETMTLI 242

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G G +GSV     +  G KVA+K+L    +     K    E+  +  + H+N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 302 CAEKSHNLLVYEY---MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
               S     Y++   MP    D    Q+        ++ + ++  + KGL Y+H     
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---A 145
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-- 416
            ++H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + S +  
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----WYRAPEVILSWMHY 201
Query: 417 TEKVDIYSFGVVMLEILCGRKVF 439
            + VDI+S G +M E+L G+ +F
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKR-LEGIGEINKS 279
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K+ L+G    N+ 
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR- 62
Query: 280 FLAEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 63  ---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKR-LEGIGEINKS 279
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K+ L+G    N+ 
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR- 62
Query: 280 FLAEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 63  ---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V  +   +  Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 246 LGKGGFG------SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG F        V  G +     +  K+L      ++    E +    + H N+VRL 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLH 87
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ- 358
              +E+ H+ L+++ +  G L   +  R      D     + IL+       LH  C Q 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-----AVLH--CHQM 140
Query: 359 KILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
            ++H D+KP+N+LL         K+ADFGL+  ++ +Q Q      GTPGYL+PE L   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKD 199
Query: 416 ITEK-VDIYSFGVVMLEILCGRKVF 439
              K VD+++ GV++  +L G   F
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 124 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 175
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 229

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL- 281
           PG P+ +         DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L 
Sbjct: 69  PGDPRSY--------LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 119
Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKK 340
            EV  +    H+N+V +           +V E++  G+L D     R +E     +Q   
Sbjct: 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAA 174
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           + L + + L+ LH    Q ++H DIK  +ILL  +   K++DFG    + ++  +    +
Sbjct: 175 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXL 230
Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            GTP ++APE +S +    +VDI+S G++++E++ G   +    P
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQN 294
           D+F ++  LG G  G V +        +  ++L   E    I    + E++ +   +   
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +V   G         +  E+M  GSLD+ L   +R  E +L      K+ + + +GL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRGTPGYLAPEW 411
            E  + +I+H D+KP NIL++     K+ DFG+S +LID   +  V    GT  Y+APE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMAPER 184
Query: 412 LSSI-ITEKVDIYSFGVVMLEILCGR 436
           L     + + DI+S G+ ++E+  GR
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 166
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++  D +    V T      Y APE    W
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR----WYRAPEIMLNW 220
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 221 MH--YNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 240 DNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQNLVR 297
           DNF K +G+G  G V   T ++ G  VAVK+++   +  +  L  EV  +    H+N+V 
Sbjct: 154 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 298 LIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           +           +V E++  G+L D     R +E     +Q   + L + + L+ LH   
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHA-- 265
Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI- 415
            Q ++H DIK  +ILL  +   K++DFG    + ++  +    + GTP ++APE +S + 
Sbjct: 266 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLP 323
Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
              +VDI+S G++++E++ G   +    P
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 110/243 (45%), Gaps = 41/243 (16%)
Query: 234 ELKVMTDNFR----KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           +L +M D+ R    K +G G FG +     +     VAVK +E   +I+++   E+    
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR 70
Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--------SDEFMLDWQQRKK 340
           S+ H N+VR        +H  +V EY   G     LF+R         DE    +QQ   
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQ--- 123
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQSQ 395
               +  G++Y H     ++ H D+K +N LLDG+     K+  FG SK   L  Q +S 
Sbjct: 124 ----LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST 176
Query: 396 VVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           V     GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   +  +
Sbjct: 177 V-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEPKNFRKT 229
Query: 454 IFK 456
           I +
Sbjct: 230 IHR 232

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL-----------AEVKTIGSIHH 292
           ++LGKGG+G VF+  +  G      ++  +  + K+ +           AE   +  + H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTG--KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
             +V LI          L+ EY+  G L   L +R   FM D       + +I+  L +L
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACF--YLAEISMALGHL 137
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H+   + I++ D+KP+NI+L+   + K+ DFGL K    D + V     GT  Y+APE L
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEIL 193
Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVF 439
             S     VD +S G +M ++L G   F
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + + +A  ++      E  + ++ E+  + S  H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
            +++  ++ E+   G++D  + +   E  L   Q + +       L YLH++   KI+H 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE----- 418
           D+K  NIL   + + K+ADFG+S   +    Q   +  GTP ++APE +    ++     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 419 -KVDIYSFGVVMLEI 432
            K D++S G+ ++E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G G +GSV     +  G KVA+K+L    +     K    E+  +  + H+N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 302 CAEKSHNLLVYEY---MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
               S     Y++   MP    D    Q+        ++ + ++  + KGL Y+H     
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---A 163
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-- 416
            ++H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE + S +  
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----WYRAPEVILSWMHY 219
Query: 417 TEKVDIYSFGVVMLEILCGRKVF 439
            + VDI+S G +M E+L G+ +F
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KP+N+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 123 S---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 174
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 163
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ DFGL++  D +    V T      Y APE + + 
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR----WYRAPEIMLNW 217
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + + +A  ++      E  + ++ E+  + S  H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
            +++  ++ E+   G++D  + +   E  L   Q + +       L YLH++   KI+H 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE----- 418
           D+K  NIL   + + K+ADFG+S   +    Q   +  GTP ++APE +    ++     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 419 -KVDIYSFGVVMLEI 432
            K D++S G+ ++E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++     D      S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KP+N+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KP+N+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 122 S---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAP 173
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E L      +  VDI+S G +  E++  R +F
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+K++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
           N+V+L+     ++   LV+E++     D   F  +     +     K  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLA 408
           H     ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y A
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRA 170
Query: 409 PEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           PE L      +  VDI+S G +  E++  R +F     + E   L  IF+     D++
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 36/213 (16%)
Query: 246 LGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIHHQNL 295
           +G+G FG ++   +  DG +  +K      EIN S ++         EV  + ++ H N+
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIK------EINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRW-------LFQRSDEFMLDWQQRKKIILDIAKG 348
           V+      E     +V +Y   G L +        LFQ  ++ +LDW       + I   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ--EDQILDW------FVQICLA 137
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L ++H+   +KILH DIK QNI L  +   ++ DFG++++++    ++     GTP YL+
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLS 193
Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
           PE   +     K DI++ G V+ E+   +  F+
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ D+GL++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 258 TQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN 317
           T+++  K+++K           F  E++ I  I ++  +   G         ++YEYM N
Sbjct: 74  TKSNNDKISIKSKYD------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEN 127
Query: 318 GSL---DRWLFQRSDEF--MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
            S+   D + F     +   +  Q  K II  +    +Y+H +  + I H D+KP NIL+
Sbjct: 128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILM 185
Query: 373 DGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPGYLAPEWL---SSIITEKVDIYSFGVV 428
           D N   K++DFG S+ ++D+     +   RGT  ++ PE+    SS    KVDI+S G+ 
Sbjct: 186 DKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 429 M 429
           +
Sbjct: 242 L 242

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 119/238 (50%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+ ++    E   +  + + E+  +  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 121 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 172
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F    P + ++  L  IF+     D++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF----PGDSEIDQLFRIFRTLGTPDEV 226

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 119/238 (50%), Gaps = 27/238 (11%)
Query: 240 DNFRKM--LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           +NF+K+  +G+G +G V++   +  G  VA+ ++    E   +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++ +  L +++   S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL----IDQDQSQVVTTMRGTPGYLAP 409
                ++LH D+KPQN+L++     K+ADFGL++     +     +VVT       Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 171
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKKKAEEDKL 464
           E L      +  VDI+S G +  E++  R +F    P + ++  L  IF+     D++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF----PGDSEIDQLFRIFRTLGTPDEV 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + + +A  ++      E  + ++ E+  + S  H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
            +++  ++ E+   G++D  + +   E  L   Q + +       L YLH++   KI+H 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE----- 418
           D+K  NIL   + + K+ADFG+S   +    Q      GTP ++APE +    ++     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 419 -KVDIYSFGVVMLEI 432
            K D++S G+ ++E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 238 MTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI----NKSFLAEVKTIGSIH 291
            TD+++  + LGKG F  V    +   T+    ++    ++    ++    E +    + 
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+VRL    +E+  + LV++ +  G L   +  R      D       I  I + + +
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIHQILESVNH 145
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           +H+     I+H D+KP+N+LL         K+ADFGL+  + Q + Q      GTPGYL+
Sbjct: 146 IHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFGFAGTPGYLS 201
Query: 409 PEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
           PE L      K VDI++ GV++  +L G   F
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 119/290 (41%), Gaps = 45/290 (15%)
Query: 170 GASPGGKETSHRKRIMGFILESXXXXXXXXXXXXXXXRKKNGADEIEE-DYLDQVPGLPK 228
           G  P G   S R R   F                   R K+G+          Q P  P+
Sbjct: 38  GLVPRGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ 97
Query: 229 RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFL-AEVKT 286
             S+ + KV        +G G FG V++    D G  VA+K++      +K F   E++ 
Sbjct: 98  EVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQI 145
Query: 287 IGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
           +  + H N+VRL  F     EK   +   LV +Y+P             +  L     K 
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 205
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTT 399
            +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +          
Sbjct: 206 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---------- 252
Query: 400 MRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTKV--AVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G +G V    Q  GT++  A K++    + ++++ F  E++ + S+ H N++RL   
Sbjct: 17  IGRGSWGEVKIAVQ-KGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYET 74
Query: 302 CAEKSHNLLVYEYMPNGSL-----DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
             + +   LV E    G L      + +F+ SD          +I+ D+   + Y H   
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSAVAYCH--- 123
Query: 357 RQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +  + H D+KP+N L      +   K+ DFGL+        +++ T  GTP Y++P+ L 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLE 181
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL 451
            +   + D +S GV+M  +LCG   F  S P + ++ L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPF--SAPTDXEVML 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIG- 300
           +G G +G+V        G KVA+K+L    +     K    E++ +  + H+N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 301 FCAEKSHNLLV--YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           F  +++ +     Y  MP    D     + ++   D  Q   ++  + KGL Y+H     
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF--LVYQMLKGLRYIHA---A 147
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WLSS 414
            I+H D+KP N+ ++ +   K+ DFGL++  D +    V T      Y APE    W+  
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR----WYRAPEVILNWMR- 202
Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRS 442
             T+ VDI+S G +M E++ G+ +F  S
Sbjct: 203 -YTQTVDIWSVGCIMAEMITGKTLFKGS 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 130/292 (44%), Gaps = 50/292 (17%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK----GLTYLHEDCRQ 358
             K    +V ++    SL   L     +F +      K ++DIA+    G+ YLH    +
Sbjct: 90  T-KPQLAIVTQWCEGSSLYHHLHASETKFEM------KKLIDIARQTARGMDYLHA---K 139
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----S 413
            I+H D+K  NI L  +   K+ DFGL+    +   S     + G+  ++APE +    S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS- 472
           +  + + D+Y+FG+V+ E++ G+  +                      D++ ++V + S 
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN----------------NRDQIIEMVGRGSL 243
Query: 473 ----NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
               + ++SN  +   M ++ A CL+    +RPS     R+L  + E    L
Sbjct: 244 SPDLSKVRSNCPK--RMKRLMAECLKKKRDERPSFP---RILAEIEELAREL 290

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTKV--AVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G +G V    Q  GT++  A K++    + ++++ F  E++ + S+ H N++RL   
Sbjct: 34  IGRGSWGEVKIAVQ-KGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYET 91
Query: 302 CAEKSHNLLVYEYMPNGSL-----DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
             + +   LV E    G L      + +F+ SD          +I+ D+   + Y H   
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSAVAYCH--- 140
Query: 357 RQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +  + H D+KP+N L      +   K+ DFGL+        +++ T  GTP Y++P+ L 
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLE 198
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL 451
            +   + D +S GV+M  +LCG   F  S P + ++ L
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPF--SAPTDXEVML 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 236 KVMTDNFRKMLGKGGFGSV-FEGTQTDGTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQ 293
           +++ D++ K +G+G  G V     +  G +VAVK ++   +  +  L  EV  +    H 
Sbjct: 44  RLLLDSYVK-IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V +           ++ E++  G+L   + Q      L+ +Q   +   + + L YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH 158
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               Q ++H DIK  +ILL  +   K++DFG    I +D  +    + GTP ++APE +S
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVIS 214
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            S+   +VDI+S G++++E++ G   +    P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFL----AEVKTIGSIHHQNLVRL 298
           ++LG GG   V       D   VAVK L      + SF      E +   +++H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 299 --IGFCAEKSHNL--LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              G     +  L  +V EY+   +L   +     E  +  ++  ++I D  + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWL 412
           +    I+H D+KP NIL+      KV DFG+++ I    + V  T    GT  YL+PE  
Sbjct: 135 N---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
               +  + D+YS G V+ E+L G   F    P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  +F LD          ++  L YL     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES--- 509
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 241 NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKT-----IGSIHHQN 294
           +F K++GKG FG V     + +    AVK L+    + K     + +     + ++ H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 295 LVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL-DIAKGLTYL 352
           LV L  F  + +  L  V +Y+  G L  +  QR   F+   + R +    +IA  L YL
Sbjct: 101 LVGL-HFSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIASALGYL 155
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      I++ D+KP+NILLD   +  + DFGL K  + + +   +T  GTP YLAPE L
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVL 211
Query: 413 SSIITEK-VDIYSFGVVMLEILCGRKVF 439
                ++ VD +  G V+ E+L G   F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 238 MTDNFR--KMLGKGGFGSVFE------GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
           MTD ++  + +GKG F  V        G +     +  K+L      ++    E +    
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA--RDHQKLEREARICRL 59
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           + H N+VRL    +E+  + LV++ +  G L   +  R      D       I  I + +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAV 116
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            + H+     ++H D+KP+N+LL         K+ADFGL+  +  DQ Q      GTPGY
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 407 LAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
           L+PE L      K VDI++ GV++  +L G   F
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEI--NKSFLAEVKT 286
           F+ E+LK + +     +G+G +GSV +   +  G  +AVKR+    +    K  L ++  
Sbjct: 19  FTAEDLKDLGE-----IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 287 I-GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR---WLFQRSDEFMLDWQQRKKII 342
           +  S     +V+  G    +    +  E M + S D+   +++   D+ + + +   KI 
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPE-EILGKIT 131
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMR 401
           L   K L +L E+   KI+H DIKP NILLD + N K+ DFG+S +L+D   S   T   
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDA 186
Query: 402 GTPGYLAPEWLSSIITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           G   Y+APE +    +      + D++S G+ + E+  GR  + +           S+F 
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN---------SVF- 236
Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEE---VVNMMKVAAWCLESDFAKRP 501
                D+L+ +V K      SN EE     + +     CL  D +KRP
Sbjct: 237 -----DQLTQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + G   A K +E   E   + ++ E++ + +  H  +V+L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 ++ E+ P G++D  + +   +  L   Q + +   + + L +LH    ++I+H 
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHR 141
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL------SSIIT 417
           D+K  N+L+    + ++ADFG+S   +    Q   +  GTP ++APE +       +   
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 418 EKVDIYSFGVVMLEI 432
            K DI+S G+ ++E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFL----AEVKTIGSIHHQNLVRL 298
           ++LG GG   V       D   VAVK L      + SF      E +   +++H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 299 --IGFCAEKSHNL--LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              G     +  L  +V EY+   +L   +     E  +  ++  ++I D  + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWL 412
           +    I+H D+KP NI++      KV DFG+++ I    + V  T    GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPE 445
               +  + D+YS G V+ E+L G   F    P+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 130/292 (44%), Gaps = 48/292 (16%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVRLIGFC 302
           K+LG G  G+V       G  VAVKR+  + +     L E+K +  S  H N++R   +C
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YC 94
Query: 303 AEKSHNLL-VYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIIL--DIAKGLTYLHEDCR 357
           +E +   L +   + N +L   +  +  SDE +   ++   I L   IA G+ +LH    
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 358 QKILHLDIKPQNILLDG-------------NFNAKVADFGLSKLIDQDQSQVVTTMR--- 401
            KI+H D+KPQNIL+               N    ++DFGL K +D  Q      +    
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 402 GTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFK 456
           GT G+ APE L       +T  +DI+S G V   IL  G+  F      E ++ +  IF 
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IRGIF- 269
Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                  L ++   H   + +   ++++ M      ++ D  KRP+   V+R
Sbjct: 270 ------SLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTAMKVLR 309

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 130/292 (44%), Gaps = 48/292 (16%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVRLIGFC 302
           K+LG G  G+V       G  VAVKR+  + +     L E+K +  S  H N++R   +C
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YC 94
Query: 303 AEKSHNLL-VYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIIL--DIAKGLTYLHEDCR 357
           +E +   L +   + N +L   +  +  SDE +   ++   I L   IA G+ +LH    
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 358 QKILHLDIKPQNILLDG-------------NFNAKVADFGLSKLIDQDQSQVVTTMR--- 401
            KI+H D+KPQNIL+               N    ++DFGL K +D  Q      +    
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 402 GTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFK 456
           GT G+ APE L       +T  +DI+S G V   IL  G+  F      E ++ +  IF 
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IRGIF- 269
Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                  L ++   H   + +   ++++ M      ++ D  KRP+   V+R
Sbjct: 270 ------SLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTAMKVLR 309

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 231 SFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEIN----KSFLAEVK 285
           + + +K+   NF  +LGKG FG V    +    ++ A+K L+    I     +  + E +
Sbjct: 12  NLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
            +  +     +  +  C +    L  V EY+  G L  +  Q+  +F     Q      +
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKF--KEPQAVFYAAE 128
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--G 402
           I+ GL +LH   ++ I++ D+K  N++LD   + K+ADFG+ K   +     VTT    G
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCG 182
Query: 403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           TP Y+APE ++     + VD +++GV++ E+L G+  FD    E+ED    SI
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSI 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 246 LGKGGFG------SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           LGKG F        V  G +     +  K+L      ++    E +    + H N+VRL 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLH 76
Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ- 358
              +E+ H+ L+++ +  G L   +  R      D     + IL+       LH  C Q 
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-----AVLH--CHQM 129
Query: 359 KILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
            ++H ++KP+N+LL         K+ADFGL+  ++ +Q Q      GTPGYL+PE L   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKD 188
Query: 416 ITEK-VDIYSFGVVMLEILCGRKVF 439
              K VD+++ GV++  +L G   F
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 126
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIGFCA 303
           LG G FG V++    + G   A K +E   E   + ++ E++ + +  H  +V+L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 304 EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
                 ++ E+ P G++D  + +   +  L   Q + +   + + L +LH    ++I+H 
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHR 133
Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL------SSIIT 417
           D+K  N+L+    + ++ADFG+S   +    Q   +  GTP ++APE +       +   
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 418 EKVDIYSFGVVMLEI 432
            K DI+S G+ ++E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 78  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 131
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 29/241 (12%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRL--- 298
           K LG GG G VF     D  K VA+K++      + K  L E+K I  + H N+V++   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 299 -----------IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
                      +G   E +   +V EYM        L    ++  L  +  +  +  + +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLR 131
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVTTMRG--TP 404
           GL Y+H      +LH D+KP N+ ++  +   K+ DFGL++++D   S       G  T 
Sbjct: 132 GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 405 GYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            Y +P  L S    T+ +D+++ G +  E+L G+ +F  +   E+   +L       EED
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 463 K 463
           +
Sbjct: 249 R 249

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 79  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 132
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 41/243 (16%)
Query: 234 ELKVMTDNFR----KMLGKGGFG-SVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG 288
           +L +M D+ R    K +G G FG +     +     VAVK +E   +I+++   E+    
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR 70
Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--------SDEFMLDWQQRKK 340
           S+ H N+VR        +H  +V EY   G     LF+R         DE    +QQ   
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQ--- 123
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFGLSK---LIDQDQSQ 395
               +  G++Y H     ++ H D+K +N LLDG+     K+  FG SK   L  Q +  
Sbjct: 124 ----LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT 176
Query: 396 VVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
           V     GTP Y+APE L       +  D++S GV +  +L G   F+   PEE   +  +
Sbjct: 177 V-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEPKNFRKT 229
Query: 454 IFK 456
           I +
Sbjct: 230 IHR 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 134
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++    + +  V     T  Y APE    W
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 205 MH--YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL     
Sbjct: 104 LIGVITENP-VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 157
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K +GKG +G V+ G +  G KVAVK      E +     E+     + H+N+   +GF A
Sbjct: 43  KQIGKGRYGEVWMG-KWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENI---LGFIA 98
Query: 304 EK-------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
                    +   L+ +Y  NGSL  +L   +    LD +   K+      GL +LH + 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 357 -----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV---VTTMRGTPGYLA 408
                +  I H D+K +NIL+  N    +AD GL+     D ++V     T  GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 409 PEWLSSIITEK-------VDIYSFGVVMLEI 432
           PE L   +           D+YSFG+++ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++    + +  V     T  Y APE    W
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 205 MH--YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DFGL++    + +  V     T  Y APE    W
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNW 204
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 205 MH--YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFL----AEVKTIGSIHHQNLVRL 298
           ++LG GG   V       D   VAVK L      + SF      E +   +++H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 299 --IGFCAEKSHNL--LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              G     +  L  +V EY+   +L   +     E  +  ++  ++I D  + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWL 412
           +    I+H D+KP NI++      KV DFG+++ I    + V  T    GT  YL+PE  
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
               +  + D+YS G V+ E+L G   F    P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+  FGL++  D + +  V T      Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 112/237 (47%), Gaps = 32/237 (13%)
Query: 221 DQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG-IGEINK 278
           D +PG      FE++  +T    ++LG+G +  V       +G + AVK +E   G    
Sbjct: 4   DSLPG-----KFEDMYKLTS---ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 279 SFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
               EV+T+     ++N++ LI F  + +   LV+E +  GS+   L     +   + ++
Sbjct: 56  RVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNERE 112
Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQS 394
             +++ D+A  L +LH    + I H D+KP+NIL +        K+ DF L   +  + S
Sbjct: 113 ASRVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNS 169
Query: 395 QV------VTTMRGTPGYLAPEWL------SSIITEKVDIYSFGVVMLEILCGRKVF 439
                   +TT  G+  Y+APE +      ++   ++ D++S GVV+  +L G   F
Sbjct: 170 CTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 40  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 87
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 88  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 147
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +   
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--- 201
Query: 393 QSQVVTTMRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 202 -------VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 46  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 93
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 211 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 46  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 93
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +   
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--- 207
Query: 393 QSQVVTTMRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 208 -------VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 24  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 71
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 72  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 189 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  +F LD          ++  L YL     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES--- 129
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+      K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 20  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 67
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 68  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 127
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 185 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 31  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 78
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 79  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 138
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 196 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    K+  KR   IG   ++  A     E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 175
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ DF L++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    K+  KR   IG   ++  A     E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 175
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 48  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 95
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 96  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 155
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +   
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--- 209
Query: 393 QSQVVTTMRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 210 -------VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    K+  KR   IG   ++  A     E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 175
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    K+  KR   IG   ++  A     E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 126
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 127 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 181
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    K+  KR   IG   ++  A     E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 119
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 120 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 174
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 75/260 (28%)
Query: 246 LGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +G+GGFG VFE   + D    A+KR+         +  + EVK +  + H  +VR     
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 303 ----AEKSHNLLVYEYMPNGSLDRWL------------FQRSDEF--------------- 331
                EK    +   ++ + S D  L             +R D F               
Sbjct: 74  LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 332 --------------MLDWQQRK------------KIILDIAKGLTYLHEDCRQKILHLDI 365
                         + DW  R+             I + IA+ + +LH    + ++H D+
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDL 190
Query: 366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQ--VVTTMR---------GTPGYLAPEWL-S 413
           KP NI    +   KV DFGL   +DQD+ +  V+T M          GT  Y++PE +  
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHG 250
Query: 414 SIITEKVDIYSFGVVMLEIL 433
           +  + KVDI+S G+++ E+L
Sbjct: 251 NNYSHKVDIFSLGLILFELL 270

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 17  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 64
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 65  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 124
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +   
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--- 178
Query: 393 QSQVVTTMRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 179 -------VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 23/244 (9%)
Query: 207 RKKNGADEIEEDYLDQVPGLPK-RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKV 265
           RK    D     Y D +  +   R   E+ +V+     K++G+G FG V         KV
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVV-----KVIGRGAFGEVQLVRHKSTRKV 96
Query: 266 AVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSL 320
              +L    E I   + +F  E + I +  +   V  + +  +    L +V EYMP G L
Sbjct: 97  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156
Query: 321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV 380
              +      + +  +  +    ++   L  +H       +H D+KP N+LLD + + K+
Sbjct: 157 VNLM----SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 209
Query: 381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCG 435
           ADFG    ++++      T  GTP Y++PE L S         + D +S GV + E+L G
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 436 RKVF 439
              F
Sbjct: 270 DTPF 273

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 238 MTDNFR--KMLGKGGFGSVFE------GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
           MTD ++  + LGKG F  V        G +     +  K+L      ++    E +    
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA--RDHQKLEREARICRL 59
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           + H N+VRL    +E+  + LV++ +  G L   +  R      D       I  I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            + H +    I+H D+KP+N+LL         K+ADFGL+  +  DQ Q      GTPGY
Sbjct: 117 NHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 407 LAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
           L+PE L      K VD+++ GV++  +L G   F
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 24  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 71
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 72  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 189 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----W 411
               I+H D+KP N+ ++ +   K+ D GL++  D + +  V     T  Y APE    W
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           +     + VDI+S G +M E+L GR +F
Sbjct: 198 MH--YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 25  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 72
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 73  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 132
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V  +   +  Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 190 EPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 50  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 97
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 98  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 157
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K +   
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--- 211
Query: 393 QSQVVTTMRGTPG--------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  +RG P         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 212 -------VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 247 GKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS 306
            +G FG V++  Q     VAVK      + +     E+ +   + H+NL++ I    ++ 
Sbjct: 24  ARGRFGCVWK-AQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIA-AEKRG 81
Query: 307 HNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED---CRQ 358
            NL     L+  +   GSL  +L       ++ W +   +   +++GL+YLHED   CR 
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 359 K-----ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR-GTPGYLAPEWL 412
           +     I H D K +N+LL  +  A +ADFGL+   +  +    T  + GT  Y+APE L
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 413 SSIIT------EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
              I        ++D+Y+ G+V+ E++   K  D       D Y+L   ++  +   L +
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPV----DEYMLPFEEEIGQHPSLEE 253
Query: 467 L 467
           L
Sbjct: 254 L 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 59
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 23/244 (9%)
Query: 207 RKKNGADEIEEDYLDQVPGLPK-RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKV 265
           RK    D     Y D +  +   R   E+ +V+     K++G+G FG V         KV
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVV-----KVIGRGAFGEVQLVRHKSTRKV 101
Query: 266 AVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSL 320
              +L    E I   + +F  E + I +  +   V  + +  +    L +V EYMP G L
Sbjct: 102 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 161
Query: 321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV 380
              +      + +  +  +    ++   L  +H       +H D+KP N+LLD + + K+
Sbjct: 162 VNLM----SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 214
Query: 381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEILCG 435
           ADFG    ++++      T  GTP Y++PE L S         + D +S GV + E+L G
Sbjct: 215 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274
Query: 436 RKVF 439
              F
Sbjct: 275 DTPF 278

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ D GL++  D + +  V     T  Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV----ATRWYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 59
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 13  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 60
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 61  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 120
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 178 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 136/306 (44%), Gaps = 43/306 (14%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSI 290
           FE+L++      +++GKG FG V+ G       + +  +E   E   K+F  EV      
Sbjct: 32  FEQLEI-----GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            H+N+V  +G C    H  ++       +L  +   R  + +LD  + ++I  +I KG+ 
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTL--YSVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS----QVVTTMRGTPGY 406
           YLH    + ILH D+K +N+  D N    + DFGL  +    Q+      +    G   +
Sbjct: 145 YLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 407 LAPEWLSSI----------ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           LAPE +  +           ++  D+++ G +  E L  R+   ++QP E  ++ +    
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPAEAIIWQMGTGM 259
Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF 516
           K      LS +           G+E+ +++ +  W  E +  +RP+ + ++ +LE + + 
Sbjct: 260 K----PNLSQI---------GMGKEISDIL-LFCWAFEQE--ERPTFTKLMDMLEKLPKR 303
Query: 517 EHNLHY 522
              L +
Sbjct: 304 NRRLSH 309

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 59
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V  +   +  Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 52/296 (17%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVRLIGFC 302
           K+LG G  G+V       G  VAVKR+  + +     L E+K +  S  H N++R   +C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YC 76
Query: 303 AEKSHNLL-VYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIIL--DIAKGLTYLHEDCR 357
           +E +   L +   + N +L   +  +  SDE +   ++   I L   IA G+ +LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 358 QKILHLDIKPQNILLDG-------------NFNAKVADFGLSKLIDQDQSQVVTTMR--- 401
            KI+H D+KPQNIL+               N    ++DFGL K +D  Q      +    
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 193
Query: 402 GTPGYLAPEWLSSI--------ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLL 452
           GT G+ APE L           +T  +DI+S G V   IL  G+  F      E ++ + 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IR 252
Query: 453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
            IF        L ++   H   + +   ++++ M      ++ D  KRP+   V+R
Sbjct: 253 GIF-------SLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTAMKVLR 295

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 16  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 63
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 64  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 123
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 181 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 238 MTDNFR--KMLGKGGFGSVFE------GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
           MTD ++  + LGKG F  V        G +     +  K+L      ++    E +    
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA--RDHQKLEREARICRL 59
Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           + H N+VRL    +E+  + LV++ +  G L   +  R      D       I  I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            + H +    I+H D+KP+N+LL         K+ADFGL+  +  DQ Q      GTPGY
Sbjct: 117 NHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 407 LAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
           L+PE L      K VD+++ GV++  +L G   F
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQNLVRLIGFC 302
           K++G G FG VF+    +  +VA+K++      +K F   E++ +  + H N+V L  F 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQ----DKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 303 ---AEKSHNL---LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL------DIAKGLT 350
               +K   +   LV EY+P          R+       +Q   ++L       + + L 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPET------VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           Y+H      I H DIKPQN+LLD      K+ DFG +K++   +  V         Y AP
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAP 210
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E +  ++  T  +DI+S G VM E++ G+ +F
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 106/246 (43%), Gaps = 27/246 (10%)
Query: 207 RKKNGADEIEEDYLDQVPGLPK-RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKV 265
           RK    D     Y D +  +   R   E+ +V+     K++G+G FG V         KV
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVV-----KVIGRGAFGEVQLVRHKSTRKV 101
Query: 266 AVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSL 320
              +L    E I   + +F  E + I +  +   V  + +  +    L +V EYMP G L
Sbjct: 102 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 161
Query: 321 DRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA 378
              +  +   +++   +     + LD    + ++H D         +KP N+LLD + + 
Sbjct: 162 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD---------VKPDNMLLDKSGHL 212
Query: 379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-----IITEKVDIYSFGVVMLEIL 433
           K+ADFG    ++++      T  GTP Y++PE L S         + D +S GV + E+L
Sbjct: 213 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272
Query: 434 CGRKVF 439
            G   F
Sbjct: 273 VGDTPF 278

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV     T  G +VAVK+L    + I    +++  E++ +  + H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 301 FCA-----EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
                   E+ +++ +  ++    L+  +  +  +   D  Q   +I  I +GL Y+H  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF--LIYQILRGLKYIHS- 143
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I+H D+KP N+ ++ +   K+ D GL++  D + +  V T      Y APE + + 
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR----WYRAPEIMLNW 197
Query: 416 I--TEKVDIYSFGVVMLEILCGRKVF 439
           +   + VDI+S G +M E+L GR +F
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEV------KTIGSIHH 292
           +LGKGGFG+VF G + TD  +VA+K     R+ G   ++ S    +      K      H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 293 QNLVRLIGFCAEKSHNLLVYEY-MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
             ++RL+ +   +   +LV E  +P   L  ++ ++     L     +     +   + +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQH 154
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFN-AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
            H    + ++H DIK +NIL+D     AK+ DFG   L+     +  T   GT  Y  PE
Sbjct: 155 CHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPE 208
Query: 411 WLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           W+S          ++S G+++ +++CG   F+R Q
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 47/283 (16%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK----GLTYLHEDCRQ 358
                  +V ++    SL   L     +F +      K ++DIA+    G+ YLH    +
Sbjct: 90  TA-PQLAIVTQWCEGSSLYHHLHASETKFEM------KKLIDIARQTARGMDYLHA---K 139
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----S 413
            I+H D+K  NI L  +   K+ DFGL+    +   S     + G+  ++APE +    S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS- 472
           +  + + D+Y+FG+V+ E++ G+  +                      D++ ++V + S 
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN----------------NRDQIIEMVGRGSL 243
Query: 473 ----NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
               + ++SN  +   M ++ A CL+    +RPS   ++  +E
Sbjct: 244 SPDLSKVRSNCPK--RMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 244 KMLGKGGFGSVFEGT----QTDGTKVAVKRLEGIGE--INKSFLAEVKTIGSIHHQNLVR 297
           + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG   E     ++ E    G L  +L  R  +F LD          ++  L YL     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES--- 509
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
           ++ +H DI  +N+L+      K+ DFGLS+ ++       +  +    ++APE ++    
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 417 TEKVDIYSFGVVMLEIL 433
           T   D++ FGV M EIL
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 246 LGKGGFGSVFEGTQTDGT-KVAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRLI- 299
           +G+G F +V++G  T+ T +VA   L+   ++ KS    F  E + +  + H N+VR   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 300 ---GFCAEKSHNLLVYEYMPNGSLDRWLFQ---RSDEFMLDWQQRKKIILDIAKGLTYLH 353
                   K   +LV E   +G+L  +L +      + +  W ++      I KGL +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFLH 146
Query: 354 EDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                 I+H D+K  NI + G   + K+ D GL+ L    ++     + GTP + APE  
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXY 202
Query: 413 SSIITEKVDIYSFGVVMLE 431
                E VD+Y+FG   LE
Sbjct: 203 EEKYDESVDVYAFGXCXLE 221

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K +G G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EYMP G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     KVADFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K +G G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EYMP G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     KVADFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++      +K F
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRF 59
Query: 281 L-AEVKTIGSIHHQNLVRLIGF---CAEKSHNL---LVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H N+VRL  F     EK   +   LV +Y+P             +  L
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQD 392
                K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           +  V         Y APE +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 177 EPNVSXICSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 234 ELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKRL-------EGIGEINKSFLA-- 282
           EL  M   +  ++ +  G +G+V  G  ++G  VA+KR+         +  ++ SFL   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 283 ---EVKTIGSIHHQNLVRL----IGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLD 334
              E++ +   HH N++ L    + F     H L LV E M     D          ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM---RTDLAQVIHDQRIVIS 132
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQD 392
            Q  +  +  I  GL  LHE     ++H D+ P NILL  N +  + DF L++    D +
Sbjct: 133 PQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 393 QSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVF 439
           ++  VT       Y APE +      T+ VD++S G VM E+   + +F
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 234 ELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKRL-------EGIGEINKSFLA-- 282
           EL  M   +  ++ +  G +G+V  G  ++G  VA+KR+         +  ++ SFL   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 283 ---EVKTIGSIHHQNLVRL----IGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLD 334
              E++ +   HH N++ L    + F     H L LV E M     D          ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM---RTDLAQVIHDQRIVIS 132
Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK--LIDQD 392
            Q  +  +  I  GL  LHE     ++H D+ P NILL  N +  + DF L++    D +
Sbjct: 133 PQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 393 QSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVF 439
           ++  VT       Y APE +      T+ VD++S G VM E+   + +F
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    ++  KR   IG   ++  A     E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 245
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 246 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 300
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 296 VRLIGFCAEKSHNLLV-YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           V+L  FC +    L     Y  NG L +++ +       D    +    +I   L YLH 
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH- 154
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS 413
              + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 414 -SIITEKVDIYSFGVVMLEILCGRKVF 439
                +  D+++ G ++ +++ G   F
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 280 FLAEVKTIGSIHHQNLVRLIGFC-AEKSHNLLVY---EYMPNGSLDRWLFQRSDEFMLDW 335
           F  E +   +++H  +V +     AE     L Y   EY+   +L   +     E  +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTP 115
Query: 336 QQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
           ++  ++I D  + L + H++    I+H D+KP NI++      KV DFG+++ I    + 
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 396 VVTTMR--GTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
           V  T    GT  YL+PE      +  + D+YS G V+ E+L G   F    P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 236 KVMTDNF--RKMLGKGGFGSV---FE--GTQTDGTKVAVKRLEGIGEINKSFLA-----E 283
           K + D +   K LG G  G V   FE    +    ++  KR   IG   ++  A     E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKII 342
           ++ +  ++H  ++++  F   + +  +V E M  G L D+ +  +     L     K   
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYF 259
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTT 399
             +   + YLHE+    I+H D+KP+N+LL         K+ DFG SK++ +  + ++ T
Sbjct: 260 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT 314
Query: 400 MRGTPGYLAPEWLSSIIT----EKVDIYSFGVVMLEILCGRKVF 439
           + GTP YLAPE L S+ T      VD +S GV++   L G   F
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
           ++I D  + L + H++    I+H D+KP NI++      KV DFG+++ I    + V  T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 400 MR--GTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
               GT  YL+PE      +  + D+YS G V+ E+L G   F    P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           NF   L +   G +++G +  G  + VK L   +     ++ F  E   +    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 298 LIGFC--AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           ++G C      H  L+  +MP GSL   L + ++ F++D  Q  K  LD+A+G+ +LH  
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT- 129
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               I    +  +++++D +  A+++      + D   S         P ++APE L   
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKK 183
Query: 416 ITE----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
             +      D++SF V++ E++     F        D+  + I  K A E     +    
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPF-------ADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
           S         V  +MK+   C+  D AKRP   M+V +LE + +
Sbjct: 237 S-------PHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 10/138 (7%)
Query: 306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDI 365
           S  +L+ EY   G +         E M+      ++I  I +G+ YLH++    I+HLD+
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAE-MVSENDVIRLIKQILEGVYYLHQN---NIVHLDL 157
Query: 366 KPQNILLDGNF---NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVD 421
           KPQNILL   +   + K+ DFG+S+ I    +  +  + GTP YLAPE L+   IT   D
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDPITTATD 215
Query: 422 IYSFGVVMLEILCGRKVF 439
           +++ G++   +L     F
Sbjct: 216 MWNIGIIAYMLLTHTSPF 233

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 129
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            + D+Y+FG+V+ E++ G+  +      ++ ++++
Sbjct: 190 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 240
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 241 A-------MKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
           ++I D  + L + H++    I+H D+KP NI++      KV DFG+++ I    + V  T
Sbjct: 137 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 400 MR--GTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
               GT  YL+PE      +  + D+YS G V+ E+L G   F    P       +S+  
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAY 246
Query: 457 KKAEEDKL 464
           +   ED +
Sbjct: 247 QHVREDPI 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKR---LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +GKG FG V++G      +V   +   LE   +  +    E+  +       + R  G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 303 AEKSHNLLVYEYMPNGS-LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
            + +   ++ EY+  GS LD  L +      L+      I+ +I KGL YLH + +   +
Sbjct: 87  LKSTKLWIIMEYLGGGSALD--LLKPGP---LEETYIATILREILKGLDYLHSERK---I 138
Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKV 420
           H DIK  N+LL    + K+ADFG++  +   Q +      GTP ++APE +  S    K 
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 421 DIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           DI+S G+  +E+  G       +P   D++ + + 
Sbjct: 198 DIWSLGITAIELAKG-------EPPNSDLHPMRVL 225

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 132
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 245
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 246 A-------MKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 99
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 154
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            + D+Y+FG+V+ E++ G+  +      ++ ++++
Sbjct: 215 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 132
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            + D+Y+FG+V+ E++ G+  +      ++ ++++
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 236 KVMTDNFR--KMLGKGGFGSVF-----EGTQTDGTKVAVKRLEGIGEINKS-----FLAE 283
           KV  +NF   K+LG G +G VF      G  T G   A+K L+    + K+        E
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDT-GKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
            + +  I     +  + +  +    L L+ +Y+  G L   L QR         + +  +
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYV 165
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            +I   L +LH   +  I++ DIK +NILLD N +  + DFGLSK    D+++      G
Sbjct: 166 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 403 TPGYLAPEWL---SSIITEKVDIYSFGVVMLEILCGRKVF 439
           T  Y+AP+ +    S   + VD +S GV+M E+L G   F
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 155
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
            + D+Y+FG+V+ E++ G+  +      ++ ++++
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           +H  LV L      +S    V EY+  G L   +F    +  L  +  +    +I+  L 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +T  GTP Y+APE
Sbjct: 168 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPE 223
Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
            L        VD ++ GV+M E++ GR  FD
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + EI  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFGL+K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 227 PKRFSFEELKVMTDNF---RKMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSFLA 282
           PK+++      +TD++   +++LG G  G V E   +  G K A+K L    +  +    
Sbjct: 2   PKKYA------VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH 55
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             +  G  H   +V ++       H     L++ E M  G L   + +R D+   + ++ 
Sbjct: 56  HWQASGGPH---IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-REA 111
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQ 395
            +I+ DI   + +LH      I H D+KP+N+L    + +   K+ DFG +K   Q+  Q
Sbjct: 112 AEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 168
Query: 396 VVTTMRGTPGYLAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
              T   TP Y+APE L     +K  D++S GV+M  +LCG   F
Sbjct: 169 ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 105/251 (41%), Gaps = 55/251 (21%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEIN----KSFLAEVKTIGSIHHQ 293
           + +  +G+G +G V    +     +   ++     I +IN    +    EV+ +  +HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM--------------------- 332
           N+ RL     ++ +  LV E    G L   L    D+                       
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 333 ------------LDWQQRKKIILDIAK----GLTYLHEDCRQKILHLDIKPQNILLDGN- 375
                       LD+ QR+K+I +I +     L YLH    Q I H DIKP+N L   N 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNK 205
Query: 376 -FNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPEWLSSI---ITEKVDIYSFGVV 428
            F  K+ DFGLSK    ++  +   +TT  GTP ++APE L++       K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 429 MLEILCGRKVF 439
           +  +L G   F
Sbjct: 266 LHLLLMGAVPF 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  + H N++ L      ++  +L+ E +  G L  +L Q+     L  ++    I
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFI 121
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH    +KI H D+KP+NI LLD N    + K+ DFGL+  I+        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 91
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 145
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +         T+ GTP YLAPE  LS   
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGY 201
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +         T+ GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K +G G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     KVADFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA-------EVKTIGSIHHQNLVRL 298
           LG G FG V    +    +V V +      IN  +         E+  +  +HH  L+ L
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-----INTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
                +K   +L+ E++  G L    F R  ++++ +   +    +    +GL ++HE  
Sbjct: 114 HDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-- 167
Query: 357 RQKILHLDIKPQNILLDGN--FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS- 413
              I+HLDIKP+NI+ +     + K+ DFGL+  ++ D+   VTT   T  + APE +  
Sbjct: 168 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDR 224
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
             +    D+++ GV+   +L G   F
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 227 PKRFSFEELKVMTDNF---RKMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGEINKSFLA 282
           PK+++      +TD++   +++LG G  G V E   +  G K A+K L    +  +    
Sbjct: 21  PKKYA------VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH 74
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             +  G  H   +V ++       H     L++ E M  G L   + +R D+   + ++ 
Sbjct: 75  HWQASGGPH---IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-REA 130
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQ 395
            +I+ DI   + +LH      I H D+KP+N+L    + +   K+ DFG +K   Q+  Q
Sbjct: 131 AEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 396 VVTTMRGTPGYLAPEWLSSIITEK-VDIYSFGVVMLEILCGRKVF 439
              T   TP Y+APE L     +K  D++S GV+M  +LCG   F
Sbjct: 188 ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEG--------TQTDGTKVAVKRLEGIGEINKS 279
           K+   +E+ +    F + LG+  FG V++G         QT    +   + +  G + + 
Sbjct: 16  KQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE 75
Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD---------- 329
           F  E      + H N+V L+G   +     +++ Y  +G L  +L  RS           
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 330 ---EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
              +  L+      ++  IA G+ YL       ++H D+  +N+L+    N K++D GL 
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 387 K-LIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKV----DIYSFGVVMLEIL 433
           + +   D  +++        ++APE   +I+  K     DI+S+GVV+ E+ 
Sbjct: 193 REVYAADYYKLLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 119
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 174
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 119
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 174
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS 414
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q    +  GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 415 IITEK-VDIYSFGVVMLEILCGRKVF 439
               K  D+++ G ++ +++ G   F
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 147
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+    +   S     + G+  ++APE +     +  +
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 260
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 261 A-------MKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+    +   S     + G+  ++APE +     +  +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 240
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 241 A-------MKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           + K    +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 155
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+    +   S     + G+  ++APE +     +  +
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 268
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 269 A-------MKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
           D    L +LH    Q ++HLD+KP NI L      K+ DFGL  L++   +       G 
Sbjct: 165 DTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGD 219
Query: 404 PGYLAPEWLSSIITEKVDIYSFGVVMLEILC 434
           P Y+APE L        D++S G+ +LE+ C
Sbjct: 220 PRYMAPELLQGSYGTAADVFSLGLTILEVAC 250

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEI---NKSFLAEVKTIGSIHHQNLVRL--- 298
           +G G +G V    +   G +VA+K++    ++    K  L E+K +    H N++ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 299 ----IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
               + +   KS    VY  +     D      S +  L  +  +  +  + +GL Y+H 
Sbjct: 123 LRPTVPYGEFKS----VYVVLDLMESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHS 177
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYLAPEW 411
               +++H D+KP N+L++ N   K+ DFG+++ +     +    +T    T  Y APE 
Sbjct: 178 ---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 412 LSSI--ITEKVDIYSFGVVMLEILCGRKVF 439
           + S+   T+ +D++S G +  E+L  R++F
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++      +  Q  K I
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
           LD   G+ YLH    ++I H D+KP+NI LLD N      K+ DFG++  I+        
Sbjct: 125 LD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FK 176
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + EI  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     +V DFGL+K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK---SFLAEVKTIGSIHHQNLVRLIGFC 302
           +G G FG+V++G       VAVK L       +   +F  EV  +    H N++  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH 362
           +      +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I+H
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 363 LDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWL----SSIIT 417
            D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     +  +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSNDMQ 476
            + D+Y+FG+V+ E++ G+  +      ++ ++++           LS DL    SN  +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPK 240
Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +       M ++ A CL+    +RP    ++  +E
Sbjct: 241 A-------MKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++      +  Q  K I
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
           LD   G+ YLH    ++I H D+KP+NI LLD N      K+ DFG++  I+        
Sbjct: 118 LD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FK 169
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++     L  ++  + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFL 120
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
             I  G+ YLH     +I H D+KP+NI LLD N      K+ DFGL+  ID        
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q    +  GT  Y++PE L+ 
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEI---NKSFLAEVKTIGSIHHQNLVRL--- 298
           +G G +G V    +   G +VA+K++    ++    K  L E+K +    H N++ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 299 ----IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
               + +   KS    VY  +     D      S +  L  +  +  +  + +GL Y+H 
Sbjct: 122 LRPTVPYGEFKS----VYVVLDLMESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHS 176
Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYLAPEW 411
               +++H D+KP N+L++ N   K+ DFG+++ +     +    +T    T  Y APE 
Sbjct: 177 ---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 412 LSSI--ITEKVDIYSFGVVMLEILCGRKVF 439
           + S+   T+ +D++S G +  E+L  R++F
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS 414
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 415 IITEK-VDIYSFGVVMLEILCGRKVF 439
               K  D+++ G ++ +++ G   F
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKS 279
           P  P++   E+ K     F K+LG+G F +V    +   ++  A+K LE    I E    
Sbjct: 1   PPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 55
Query: 280 FLAEVKTIGS-IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
           ++   + + S + H   V+L     +         Y  NG L +++ +       D    
Sbjct: 56  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCT 112
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-V 397
           +    +I   L YLH    + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q   
Sbjct: 113 RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 169
Query: 398 TTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
               GT  Y++PE L+     +  D+++ G ++ +++ G   F
Sbjct: 170 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G FG VF+   +  G KVA+K++    E      + L E+K +  + H+N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 302 CAEKSHNL--------LVYEYMPN---GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           C  K+           LV+++  +   G L   L +    F L   + K+++  +  GL 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS--EIKRVMQMLLNGLY 139
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYL 407
           Y+H   R KILH D+K  N+L+  +   K+ADFGL++   L    Q         T  Y 
Sbjct: 140 YIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 408 APEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
            PE L         +D++  G +M E+   R    +   E+  + L+S
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV  +  I H N++ L      K+  +L+ E +  G L  +L ++      +  Q  K I
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNI-LLDGNF---NAKVADFGLSKLIDQDQSQVVT 398
           LD   G+ YLH    ++I H D+KP+NI LLD N      K+ DFG++  I+        
Sbjct: 139 LD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FK 190
Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF 439
            + GTP ++APE ++   +  + D++S GV+   +L G   F
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G FG VF+   +  G KVA+K++    E      + L E+K +  + H+N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 302 CAEKSHNL--------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           C  K+           LV+++  +  L   L     +F L   + K+++  +  GL Y+H
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTL--SEIKRVMQMLLNGLYYIH 142
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPE 410
              R KILH D+K  N+L+  +   K+ADFGL++   L    Q         T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
            L         +D++  G +M E+   R    +   E+  + L+S
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQ 293
           D +R++  LG+G +G V++   T     VA+KR+    E   +  + + EV  +  + H+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N++ L           L++EY  N  L +++ +  D  M   +  K  +  +  G+ + H
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM---RVIKSFLYQLINGVNFCH 149
Query: 354 EDCRQKILHLDIKPQNILLDGNFNA-----KVADFGLSKL----IDQDQSQVVTTMRGTP 404
               ++ LH D+KPQN+LL  +  +     K+ DFGL++     I Q   +++T      
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW---- 202
Query: 405 GYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            Y  PE L  S   +  VDI+S   +  E+L    +F
Sbjct: 203 -YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G FG VF+   +  G KVA+K++    E      + L E+K +  + H+N+V LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 302 CAEKSHNL--------LVYEYMPN---GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           C  K+           LV+++  +   G L   L +    F L   + K+++  +  GL 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTL--SEIKRVMQMLLNGLY 138
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYL 407
           Y+H   R KILH D+K  N+L+  +   K+ADFGL++   L    Q         T  Y 
Sbjct: 139 YIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 408 APEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
            PE L         +D++  G +M E+   R    +   E+  + L+S
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 242

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV          KVAVK+L    + +    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 94
Query: 301 -FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F    S       Y+    +   L        L  +  + ++  + +GL Y+H      
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS---AG 151
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WLSSI 415
           I+H D+KP N+ ++ +   ++ DFGL++  D++ +  V T      Y APE    W+   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR----WYRAPEIMLNWMH-- 205
Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRS 442
             + VDI+S G +M E+L G+ +F  S
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEG--------TQTDGTKVAVKRLEGIGEINKSFLAE 283
            +E+ +    F + LG+  FG V++G         QT    +   + +  G + + F  E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSD-------------E 330
                 + H N+V L+G   +     +++ Y  +G L  +L  RS              +
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK-LI 389
             L+      ++  IA G+ YL       ++H D+  +N+L+    N K++D GL + + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIITEKV----DIYSFGVVMLEIL 433
             D  +++        ++APE   +I+  K     DI+S+GVV+ E+ 
Sbjct: 180 AADYYKLLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 146
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q    +  GT  Y++PE L+ 
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGF 301
           +G+G FG VF+   +  G KVA+K++    E      + L E+K +  + H+N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 302 CAEKSHNL--------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           C  K+           LV+++  +  L   L     +F L   + K+++  +  GL Y+H
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL--SEIKRVMQMLLNGLYYIH 142
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK---LIDQDQSQVVTTMRGTPGYLAPE 410
              R KILH D+K  N+L+  +   K+ADFGL++   L    Q         T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS 453
            L         +D++  G +M E+   R    +   E+  + L+S
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 147
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           +H  LV L      +S    V EY+  G L   +F    +  L  +  +    +I+  L 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +   GTP Y+APE
Sbjct: 136 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPE 191
Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
            L        VD ++ GV+M E++ GR  FD
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 233 EELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKS-----FLAEVK 285
           +E+++  ++F   K++G+G FG V      +  ++   ++    E+ K      F  E  
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            + +   Q +  L     +++H  LV +Y   G L   L +  D+   D    +  I ++
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED--MARFYIGEM 184
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
              +  +H+      +H DIKP N+LLD N + ++ADFG    ++ D +   +   GTP 
Sbjct: 185 VLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD 241
Query: 406 YLAPEWLSSI------ITEKVDIYSFGVVMLEILCGRKVF 439
           Y++PE L ++         + D +S GV M E+L G   F
Sbjct: 242 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXE--PHARFYAAQIVLTFEYLHS--- 152
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 208
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 147
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG- 127
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 128 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 147
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 150
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 98
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 152
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 208
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG- 125
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 126 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG- 126
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 131
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 132 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 152
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 153 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 233 EELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKS-----FLAEVK 285
           +E+++  ++F   K++G+G FG V      +  ++   ++    E+ K      F  E  
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 286 TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
            + +   Q +  L     +++H  LV +Y   G L   L +  D+   D    +  I ++
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED--MARFYIGEM 200
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
              +  +H+      +H DIKP N+LLD N + ++ADFG    ++ D +   +   GTP 
Sbjct: 201 VLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD 257
Query: 406 YLAPEWLSSI------ITEKVDIYSFGVVMLEILCGRKVF 439
           Y++PE L ++         + D +S GV M E+L G   F
Sbjct: 258 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           +H  LV L      +S    V EY+  G L   +F    +  L  +  +    +I+  L 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +   GTP Y+APE
Sbjct: 125 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPE 180
Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
            L        VD ++ GV+M E++ GR  FD
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           +H  LV L      +S    V EY+  G L   +F    +  L  +  +    +I+  L 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +   GTP Y+APE
Sbjct: 121 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPE 176
Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFD 440
            L        VD ++ GV+M E++ GR  FD
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 295 LVRLIGFCAEKSHNLLVYEYM-PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           ++RL+ +       +L+ E M P   L  ++ +R     L  +  +     + + + + H
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 131
Query: 354 EDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
            +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+
Sbjct: 132 -NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 413 S--SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                      ++S G+++ +++CG   F+  +
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 218

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 149
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +V    +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 146
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIH 291
           D F ++  LG G FG V      + G   A+K L+      + +I  + L E +   +++
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRIQQAVN 100
Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
              LV+L     + S+  +V EY P G +   L +R   F       +     I     Y
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEY 157
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE- 410
           LH      +++ D+KP+N+L+D     KVADFG +K +          + GTP YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            LS    + VD ++ GV++ E+  G   F   QP
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV          KVAVK+L    + +    +++  E++ +  + H+N++ L+ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 86
Query: 301 -FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F    S       Y+    +   L        L  +  + ++  + +GL Y+H      
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS---AG 143
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WLSSI 415
           I+H D+KP N+ ++ +   ++ DFGL++  D++ +  V T      Y APE    W+   
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR----WYRAPEIMLNWMH-- 197
Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRS 442
             + VDI+S G +M E+L G+ +F  S
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGS 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 126
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+P G +   L +R   F       +     I     YLH    
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 180
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 236
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 25/256 (9%)
Query: 210 NGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVF--EGTQTD---GTK 264
            G    EE   + +       + + +K+   NF  +LGKG FG V   E   TD     K
Sbjct: 313 QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 265 VAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRW 323
           +  K +    +  +  + E + +        +  +  C +    L  V EY+  G L  +
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-MY 431
Query: 324 LFQRSDEFMLDWQQRKKIIL--DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVA 381
             Q+   F    ++   +    +IA GL +L     + I++ D+K  N++LD   + K+A
Sbjct: 432 HIQQVGRF----KEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIA 484
Query: 382 DFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKV 438
           DFG+ K   ++    VTT    GTP Y+APE ++     + VD ++FGV++ E+L G+  
Sbjct: 485 DFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
Query: 439 FDRSQPEEEDMYLLSI 454
           F+    E+ED    SI
Sbjct: 542 FEG---EDEDELFQSI 554

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLE------GIGEINKSFLAEVKTIGSIHHQNLV 296
           +++GKG F  V      + G + AVK ++        G   +    E      + H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHED 355
            L+   +      +V+E+M    L   + +R+D  F+         +  I + L Y H++
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 356 CRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMR-GTPGYLAPEW 411
               I+H D+KP+N+LL    N+   K+ DFG++  I   +S +V   R GTP ++APE 
Sbjct: 150 ---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPEV 204
Query: 412 LS-SIITEKVDIYSFGVVMLEILCG 435
           +      + VD++  GV++  +L G
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRL----EGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G +GSV          KVAVK+L    + +    +++  E++ +  + H+N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 94
Query: 301 -FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F    S       Y+    +   L        L  +  + ++  + +GL Y+H      
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS---AG 151
Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE----WLSSI 415
           I+H D+KP N+ ++ +   ++ DFGL++  D++ +  V T      Y APE    W+   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR----WYRAPEIMLNWMH-- 205
Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRS 442
             + VDI+S G +M E+L G+ +F  S
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIG-SIHHQNLVRLIGF 301
           + +LG G  G++      D   VAVKR+  + E       EV+ +  S  H N++R   F
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHPNVIRY--F 84
Query: 302 CAEKSHNLLVYEYMP----NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           C EK      ++Y+       +L  ++ Q+  +F     +   ++     GL +LH    
Sbjct: 85  CTEKDRQ---FQYIAIELCAATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 358 QKILHLDIKPQNILLD-----GNFNAKVADFGLSK--LIDQDQSQVVTTMRGTPGYLAPE 410
             I+H D+KP NIL+      G   A ++DFGL K   + +      + + GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 411 WLSSIITEK----VDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYL 451
            LS    E     VDI+S G V   ++  G   F +S   + ++ L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 246 LGKGGFGSVFE--GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN------LVR 297
           LG+G FG V E    +  G  VAVK ++ +    ++  +E++ +  ++  +       V+
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDC 356
           ++ +     H  +V+E +   + D   F + + F+       +K+   I K + +LH + 
Sbjct: 82  MLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQICKSVNFLHSN- 137
Query: 357 RQKILHLDIKPQNILLDG-------------------NFNAKVADFGLSKLIDQDQSQVV 397
             K+ H D+KP+NIL                      N + KV DFG +   D+  S +V
Sbjct: 138 --KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLV 195
Query: 398 TTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
           +T      Y APE + ++  ++  D++S G +++E   G  VF     +E 
Sbjct: 196 STRH----YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 246 LGKGGFGSVFEGTQTDGTK---VAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG-F 301
           +G+G +G V++  + DG      A+K++EG G I+ S   E+  +  + H N++ L   F
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 87
Query: 302 CAEKSHNL-LVYEYMPNGSLDRWLFQRSDE-----FMLDWQQRKKIILDIAKGLTYLHED 355
            +     + L+++Y  +       F R+ +       L     K ++  I  G+ YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 356 CRQKILHLDIKPQNILLDG----NFNAKVADFGLSKLIDQ------DQSQVVTTMRGTPG 405
               +LH D+KP NIL+ G        K+AD G ++L +       D   VV T      
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF----W 200
Query: 406 YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           Y APE L  +   T+ +DI++ G +  E+L    +F
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 233 EELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRL----EGIGEINKSFLAEVKT 286
           +++++  ++F   K++G+G FG V      +  KV   ++    E +     +   E + 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 287 IGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           +        +  + +  +  +NL LV +Y   G L   L +  D   L  +  +  + ++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMARFYLAEM 184
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
              +  +H+      +H DIKP NIL+D N + ++ADFG    + +D +   +   GTP 
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 406 YLAPEWLSSIITEK------VDIYSFGVVMLEILCGRKVF 439
           Y++PE L ++   K       D +S GV M E+L G   F
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 126
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 180
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +         T+ GTP YLAPE  LS   
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEIILSKGY 236
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 218 DYLDQVPGLPKRFS----FEELKVMTDNFR--KMLGKGGFGSVFE-GTQTDGTKVAVKRL 270
           DYLD +     RF      E   V  + FR  ++LGKGGFG V     +  G   A K+L
Sbjct: 160 DYLDSI--YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL 217
Query: 271 EGIGEINKS----FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ 326
           E      +      L E + +  ++ + +V L      K    LV   M  G L   ++ 
Sbjct: 218 EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277
Query: 327 RSDEFMLDWQQRKKIIL--DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
                   + + + +    +I  GL  LH   R++I++ D+KP+NILLD + + +++D G
Sbjct: 278 MGQA---GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           L+  +   + Q +    GT GY+APE + +   T   D ++ G ++ E++ G+  F + +
Sbjct: 332 LA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 233 EELKVMTDNFRKMLGKGGFGSVF--EGTQTD---GTKVAVKRLEGIGEINKSFLAEVKTI 287
           + +K+   NF  +LGKG FG V   E   TD     K+  K +    +  +  + E + +
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 288 GSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL--D 344
                   +  +  C +    L  V EY+  G L  +  Q+   F    ++   +    +
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRF----KEPHAVFYAAE 129
Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--G 402
           IA GL +L     + I++ D+K  N++LD   + K+ADFG+ K   ++    VTT    G
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCG 183
Query: 403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           TP Y+APE ++     + VD ++FGV++ E+L G+  F   + E+ED    SI
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSI 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 241 NFRKMLGKGGFGSVFEGTQTDGTK-VAVKRLEG---IGEINKSFLAEVKTIGS-IHHQNL 295
            F K+LG+G F +     +   ++  A+K LE    I E    ++   + + S + H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+L     +         Y  NG L +++ +       D    +    +I   L YLH  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-- 147
Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS- 413
             + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q       GT  Y++PE L+ 
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
               +  D+++ G ++ +++ G   F
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   L +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   L +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   L +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY P G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     KV DFG +K +      +     GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 218 DYLDQVPGLPKRFS----FEELKVMTDNFR--KMLGKGGFGSVFE-GTQTDGTKVAVKRL 270
           DYLD +     RF      E   V  + FR  ++LGKGGFG V     +  G   A K+L
Sbjct: 160 DYLDSI--YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL 217
Query: 271 EGIGEINKS----FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQ 326
           E      +      L E + +  ++ + +V L      K    LV   M  G L   ++ 
Sbjct: 218 EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277
Query: 327 RSDEFMLDWQQRKKIIL--DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
                   + + + +    +I  GL  LH   R++I++ D+KP+NILLD + + +++D G
Sbjct: 278 MGQA---GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           L+  +   + Q +    GT GY+APE + +   T   D ++ G ++ E++ G+  F + +
Sbjct: 332 LA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 246 LGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE- 304
           +GKG +G V+ G    G  VAVK      E +     E+     + H N+   +GF A  
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIASD 71
Query: 305 -KSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-- 356
             S N      L+  Y  +GSL  +L +++ E  L      ++ +  A GL +LH +   
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFG 127
Query: 357 ---RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ--DQSQVVTTMR-GTPGYLAPE 410
              +  I H D K +N+L+  N    +AD GL+ +  Q  D   +    R GT  Y+APE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 411 WLSSIIT-------EKVDIYSFGVVMLEI 432
            L   I        +  DI++FG+V+ EI
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 17/248 (6%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVK-TIGSIHHQNLVRLIGF 301
           LG+G +G V +      G  +AVKR+      +  K  L ++  ++ ++     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              +    +  E M + SLD++  Q  D+   +      KI + I K L +LH   +  +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE-- 418
           +H D+KP N+L++     K+ DFG+S  +  D ++ +    G   Y+APE ++  + +  
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPELNQKG 189
Query: 419 ---KVDIYSFGVVMLEILCGRKVFDR-SQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHSN 473
              K DI+S G+ M+E+   R  +D    P ++   ++     +   DK S + VD  S 
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 249
Query: 474 DMQSNGEE 481
            ++ N +E
Sbjct: 250 CLKKNSKE 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 146
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 147 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 201
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 147
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 202
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 146
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 147 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 201
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 233

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 147
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 202
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 116/249 (46%), Gaps = 19/249 (7%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVK-TIGSIHHQNLVRLIGF 301
           LG+G +G V +      G  +AVKR+      +  K  L ++  ++ ++     V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKI 360
              +    +  E M + SLD++  Q  D+   +      KI + I K L +LH   +  +
Sbjct: 119 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 175
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSK-LIDQDQSQVVTTMRGTPGYLAPEWLSSIITE- 418
           +H D+KP N+L++     K+ DFG+S  L+D   S   T   G   Y+APE ++  + + 
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQK 232
Query: 419 ----KVDIYSFGVVMLEILCGRKVFDR-SQPEEEDMYLLSIFKKKAEEDKLS-DLVDKHS 472
               K DI+S G+ M+E+   R  +D    P ++   ++     +   DK S + VD  S
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 292
Query: 473 NDMQSNGEE 481
             ++ N +E
Sbjct: 293 QCLKKNSKE 301

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 147
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 202
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 159
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 160 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 214
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 160
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 219 LGVIMYILLCGYPPF 233

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 160
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 161 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 215
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 159
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 160 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 214
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 132
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 187
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 110 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 166
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 167 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 221
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 160
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 161 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 215
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 174
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 175 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 229
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 160
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 161 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 215
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 159
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 160 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 214
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 159
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 160 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 214
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 152
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 211 LGVIMYILLCGYPPF 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 132
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 187
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 132
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 187
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 145
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 204 LGVIMYILLCGYPPF 218

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 150
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 209 LGVIMYILLCGYPPF 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 203 LGVIMYILLCGYPPF 217

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 160
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 161 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 215
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 151
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 210 LGVIMYILLCGYPPF 224

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 75  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 131
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 132 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 186
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 218

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 174
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 175 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 229
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 123 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 179
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 180 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 234
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 266

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 196
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 255 LGVIMYILLCGYPPF 269

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 74  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 130
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 131 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 185
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 242 FRKMLGKGGFGSVFEG-TQTDGTKVAVKRLEGIGE--IN-KSFLAEVKTIGSIHHQNLVR 297
            R ++G G +G V E   + +   VA+K++  + E  I+ K  L E+  +  ++H ++V+
Sbjct: 57  IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 298 LIGFC----AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           ++        EK   L V   + +    + LF R+  ++ +    K ++ ++  G+ Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKK-LF-RTPVYLTELHI-KTLLYNLLVGVKYVH 173
Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID--------------QDQSQVVT- 398
                 ILH D+KP N L++ + + KV DFGL++ +D              +D   +VT 
Sbjct: 174 S---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 399 -----TMRGTPGYLAPEW--------LSSIITEKVDIYSFGVVMLEIL 433
                  R   G++   W        L    TE +D++S G +  E+L
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 205 LGVIMYILLCGYPPF 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 205 LGVIMYILLCGYPPF 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 249 LGVIMYILLCGYPPF 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 127
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 98  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 154
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 155 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 209
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 241

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH- 127
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
           +C   +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 48/243 (19%)
Query: 232 FEELKVMTDN----FRKMLGKGGFGSV--FEGTQTDGTKVAVKRLEGIGEINKSFLAEVK 285
           F+   V+ DN    F + LG+GGF  V   EG   DG   A+KR+    + ++    E +
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHEQQDRE---EAQ 74
Query: 286 TIGSIH----HQNLVRLIGFC----AEKSHNLLVYEYMPNGSL--------DRWLFQRSD 329
               +H    H N++RL+ +C      K    L+  +   G+L        D+  F   D
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL--SK 387
           + +  W     ++L I +GL  +H    +   H D+KP NILL       + D G     
Sbjct: 135 QIL--W-----LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 388 LIDQDQSQVVTTM------RGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRK 437
            I  + S+   T+      R T  Y APE  S     +I E+ D++S G V+  ++ G  
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 438 VFD 440
            +D
Sbjct: 245 PYD 247

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 39/231 (16%)
Query: 246 LGKGGFGSVFE--GTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN------LVR 297
           LG+G FG V E    +  G  VAVK ++ +    ++  +E++ +  ++  +       V+
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDC 356
           ++ +     H  +V+E +   + D   F + + F+       +K+   I K + +LH + 
Sbjct: 82  MLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQICKSVNFLHSN- 137
Query: 357 RQKILHLDIKPQNILLDG-------------------NFNAKVADFGLSKLIDQDQSQVV 397
             K+ H D+KP+NIL                      N + KV DFG +   D+  S +V
Sbjct: 138 --KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLV 195
Query: 398 TTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
                   Y APE + ++  ++  D++S G +++E   G  VF     +E 
Sbjct: 196 XXRH----YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 92
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 146
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 147 LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 202
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 100
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 154
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 155 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 210
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEP--HARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 245 MLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTI----GSIHHQN 294
           +LG GGFGSV+ G + +D   VA+K     R+   GE+       ++ +     S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL+ +       +L+ E  P    D + F  ++   L  +  +     + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                +LH DIK +NIL+D N    K+ DFG   L+   +  V T   GT  Y  PEW+ 
Sbjct: 129 ---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 414 --SIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
                     ++S G+++ +++CG   F+  +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V      + G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +      +     GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 126
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEP--HARFYAAQIVLTFEYLHS--- 180
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 236
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 244 KMLGKGGFGSVFE-----GTQTDGTKVAVKRLEG--IGEINKSFLAEVKTIGSIHHQNLV 296
           K LG+G F    +       Q    K+  KR+E     EI    L E        H N+V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIV 69
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHED 355
           +L     ++ H  LV E +  G L    F+R   +      +   I+  +   ++++H+ 
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD- 124
Query: 356 CRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
               ++H D+KP+N+L    + N   K+ DFG ++L   D +Q + T   T  Y APE L
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPELL 181
Query: 413 S-SIITEKVDIYSFGVVMLEILCGRKVF---DRS 442
           + +   E  D++S GV++  +L G+  F   DRS
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V     T  G  VAVK+L    +     K    E+  +  ++H+N++ L+
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +K+       Y+    +D  L Q      LD ++   ++  +  G+ +LH     
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQ-VIHMELDHERMSYLLYQMLCGIKHLHS---A 143
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-IT 417
            I+H D+KP NI++  +   K+ DFGL++      + ++T    T  Y APE +  +   
Sbjct: 144 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
           E VDI+S G +M E++ G  +F
Sbjct: 202 ENVDIWSVGCIMGELVKGSVIF 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 106
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 160
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 216
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 56/264 (21%)
Query: 214 EIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT----DGTKVAVKR 269
           +IE+ Y + VP L   F  E+           +G+G F SV+  T         K+A+K 
Sbjct: 8   DIEKLY-EAVPQLSNVFKIED----------KIGEGTFSSVYLATAQLQVGPEEKIALKH 56
Query: 270 LEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-HNLLVYEYMPNGSLDRWLFQRS 328
           L       +   AE++ +     Q+ V  + +C  K+ H ++   Y+ + S    L    
Sbjct: 57  LIPTSHPIR-IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-- 113
Query: 329 DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVADFGLSK 387
               L +Q+ ++ +L++ K L  +H+     I+H D+KP N L +       + DFGL++
Sbjct: 114 ----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166
Query: 388 --------LIDQDQS-------------------QVVTTMRGTPGYLAPEWLSSII--TE 418
                   L+   QS                   Q V    GTPG+ APE L+     T 
Sbjct: 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTT 226
Query: 419 KVDIYSFGVVMLEILCGRKVFDRS 442
            +D++S GV+ L +L GR  F ++
Sbjct: 227 AIDMWSAGVIFLSLLSGRYPFYKA 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 36/204 (17%)
Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIG 300
           +G G FG+V+       ++V A+K++   G    E  +  + EV+ +  + H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 301 FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA-------KGLTYL 352
            C  + H   LV EY    + D          +L+  ++    ++IA       +GL YL
Sbjct: 83  -CYLREHTAWLVMEYCLGSASD----------LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      ++H D+K  NILL      K+ DFG + ++      V     GTP ++APE +
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 413 SSI----ITEKVDIYSFGVVMLEI 432
            ++       KVD++S G+  +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 36/204 (17%)
Query: 246 LGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRLIG 300
           +G G FG+V+       ++V A+K++   G+ +    +  + EV+ +  + H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 301 FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA-------KGLTYL 352
            C  + H   LV EY    + D          +L+  ++    ++IA       +GL YL
Sbjct: 122 -CYLREHTAWLVMEYCLGSASD----------LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      ++H D+K  NILL      K+ DFG + ++      V     GTP ++APE +
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 222
Query: 413 SSI----ITEKVDIYSFGVVMLEI 432
            ++       KVD++S G+  +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHH-QNLVRLIGF 301
           +G G  G V++   +  G  +AVK  R  G  E NK  L ++  +   H    +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
               +   +  E M  G+    L +R  +  +  +   K+ + I K L YL E  +  ++
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE--KHGVI 147
Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-- 419
           H D+KP NILLD     K+ DFG+S  +  D+++  +   G   Y+APE +      K  
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPD 205
Query: 420 ----VDIYSFGVVMLEILCGR 436
                D++S G+ ++E+  G+
Sbjct: 206 YDIRADVWSLGISLVELATGQ 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF- 301
           +M G+G FG+V  G + + G  VA+K++          L  ++ +  +HH N+V+L  + 
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 302 --CAEKSHNLL----VYEYMPNGSLDR-----WLFQRSDEFMLDWQQRKKIILDIAKGLT 350
               E+    +    V EY+P+ +L R     +  Q +   +L     K  +  + + + 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILI----KVFLFQLIRSIG 143
Query: 351 YLHEDCRQKILHLDIKPQNILL-DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            LH      + H DIKP N+L+ + +   K+ DFG +K +   +  V      +  Y AP
Sbjct: 144 CLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAP 200
Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           E +  +   T  VDI+S G +  E++ G  +F
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHH 292
           F + LG+G F  +F+G         Q   T+V +K L+      ++SF      +  + H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY- 351
           ++LV   G C     N+LV E++  GSLD +L +  +   + W+      L++AK L + 
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK------LEVAKQLAWA 125
Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT---TMRGTPGYLA 408
           +H      ++H ++  +NILL    + K  +    KL D   S  V     ++    ++ 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 409 PEWLSSI--ITEKVDIYSFGVVMLEILCG 435
           PE + +   +    D +SFG  + EI  G
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHH 292
           F + LG+G F  +F+G         Q   T+V +K L+      ++SF      +  + H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           ++LV   G C     N+LV E++  GSLD +L +  +   + W  + ++   +A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT---TMRGTPGYLAP 409
            E+    ++H ++  +NILL    + K  +    KL D   S  V     ++    ++ P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 410 EWLSSI--ITEKVDIYSFGVVMLEILCG 435
           E + +   +    D +SFG  + EI  G
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 37/234 (15%)
Query: 234 ELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRL-EGIGEINKSFLAEVKTIGSIH 291
           EL  +    R++L +GGF  V+E      G + A+KRL     E N++ + EV  +  + 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 292 -HQNLVRLIGFCAEKS----------HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
            H N+V+   FC+  S             L+   +  G L  +L +      L      K
Sbjct: 84  GHPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 341 IILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ------- 391
           I     + + ++H   RQK  I+H D+K +N+LL      K+ DFG +  I         
Sbjct: 141 IFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 392 DQSQVVT----TMRGTPGYLAPE----WLSSIITEKVDIYSFGVVMLEILCGRK 437
            Q + +     T   TP Y  PE    + +  I EK DI++ G + L +LC R+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI-LYLLCFRQ 250

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 283 EVKTIGSIHHQNLVRLIG--FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
           E++ +  + H+N+++L+   +  EK    +V EY   G  +  +     E      Q   
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHG 113
Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVTT 399
               +  GL YLH    Q I+H DIKP N+LL      K++  G+++ +    +     T
Sbjct: 114 YFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 400 MRGTPGYLAPEWLSSIIT---EKVDIYSFGVVMLEILCGRKVFD 440
            +G+P +  PE  + + T    KVDI+S GV +  I  G   F+
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 107/237 (45%), Gaps = 29/237 (12%)
Query: 210 NGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVK 268
           NG  + ++    QVP     + +E LKV        +GKG FG V +         VA+K
Sbjct: 77  NGGYDDDQGSYVQVPHDHVAYRYEVLKV--------IGKGSFGQVVKAYDHKVHQHVALK 128
Query: 269 RLEGIGEINKSFLAEVKTIGSIHHQ------NLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
            +      ++    E++ +  +  Q      N++ ++     ++H  + +E +   S++ 
Sbjct: 129 MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL---SMNL 185
Query: 323 WLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNFNAK 379
           +   + ++F        +K    I + L  LH++   +I+H D+KP+NILL   G    K
Sbjct: 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242
Query: 380 VADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCG 435
           V DFG S      + Q V T   +  Y APE  L +     +D++S G ++ E+L G
Sbjct: 243 VIDFGSSCY----EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I+  I + + YLH      I H D+KP+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +T    TP Y+APE L     +K  D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 425 FGVVMLEILCGRKVF 439
            GV+M  +LCG   F
Sbjct: 203 LGVIMYILLCGYPPF 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ ++  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 107/237 (45%), Gaps = 29/237 (12%)
Query: 210 NGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVK 268
           NG  + ++    QVP     + +E LKV        +GKG FG V +         VA+K
Sbjct: 77  NGGYDDDQGSYVQVPHDHVAYRYEVLKV--------IGKGSFGQVVKAYDHKVHQHVALK 128
Query: 269 RLEGIGEINKSFLAEVKTIGSIHHQ------NLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
            +      ++    E++ +  +  Q      N++ ++     ++H  + +E +   S++ 
Sbjct: 129 MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL---SMNL 185
Query: 323 WLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNFNAK 379
           +   + ++F        +K    I + L  LH++   +I+H D+KP+NILL   G    K
Sbjct: 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242
Query: 380 VADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCG 435
           V DFG S      + Q V T   +  Y APE  L +     +D++S G ++ E+L G
Sbjct: 243 VIDFGSSCY----EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   +P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S GV+M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            H N++ L     +  H  LV E M  G L D+ L Q+        ++   ++  I K +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 350 TYLHEDCRQKILHLDIKPQNIL-LDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPG 405
            YLH    Q ++H D+KP NIL +D + N    ++ DFG +K +  +   ++T    T  
Sbjct: 135 EYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 406 YLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRS---QPEE 446
           ++APE L      E  DI+S G+++  +L G   F       PEE
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 42/232 (18%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGE--IN-KSFLAEVKTIGSIH 291
           + DN+  + ++G+G +G V+     +  K VA+K++  + E  I+ K  L E+  +  + 
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLK 85
Query: 292 HQNLVRLIGFCAE----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
              ++RL          K   L +   + +  L + LF+      L  Q  K I+ ++  
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK-LFKTP--IFLTEQHVKTILYNLLL 142
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-------------- 393
           G  ++HE     I+H D+KP N LL+ + + K+ DFGL++ I+ D+              
Sbjct: 143 GEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 394 ----------SQVVTTMRGTPGYLAPE--WLSSIITEKVDIYSFGVVMLEIL 433
                      + +T+   T  Y APE   L    T  +DI+S G +  E+L
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V         + VA+K+L    +     K    E+  +  ++H+N++ L+
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +KS       Y+    +D  L Q   +  LD ++   ++  +  G+ +LH     
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYLLYQMLVGIKHLHSAG-- 146
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-IT 417
            I+H D+KP NI++  +   K+ DFGL++      S ++T    T  Y APE +  +   
Sbjct: 147 -IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
           E VDI+S GV+M E++ G  +F
Sbjct: 204 ENVDIWSVGVIMGEMIKGGVLF 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 23/191 (12%)
Query: 266 AVKRLEG-IGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW 323
           AVK +E   G I      EV+ +     H+N++ LI F  E+    LV+E M  GS+   
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 324 LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKV 380
           + +R      +  +   ++ D+A  L +LH    + I H D+KP+NIL +        K+
Sbjct: 102 IHKRRH---FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 381 ADFGLSKLI--DQDQSQVVT----TMRGTPGYLAPEWL------SSIITEKVDIYSFGVV 428
            DFGL   I  + D S + T    T  G+  Y+APE +      +SI  ++ D++S GV+
Sbjct: 156 CDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 429 MLEILCGRKVF 439
           +  +L G   F
Sbjct: 216 LYILLSGYPPF 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 251 FGSVFEGTQTDGTKVAVKRLEGIGEINKSF---------LAEVKTIGSIHHQNLVRLIG- 300
            GS  +G         ++R   I ++++ F           E+  +  ++H+N++ L+  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
           F  +KS       Y+    +D  L Q   +  LD ++   ++  +  G+ +LH      I
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYLLYQMLCGIKHLHS---AGI 152
Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-ITEK 419
           +H D+KP NI++  +   K+ DFGL++      S ++T    T  Y APE +  +   E 
Sbjct: 153 IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 420 VDIYSFGVVMLEILCGRKVF 439
           VD++S G +M E++C + +F
Sbjct: 211 VDLWSVGCIMGEMVCHKILF 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+++D     +V DFG +K +          + GTP YLAPE  +S   
Sbjct: 160 LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIISKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V         + VA+K+L    +     K    E+  +  ++H+N++ L+
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +KS       Y+    +D  L Q   +  LD ++   ++  +  G+ +LH     
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYLLYQMLCGIKHLHS---A 139
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-IT 417
            I+H D+KP NI++  +   K+ DFGL++      S ++T    T  Y APE +  +   
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
           E VD++S G +M E++C + +F
Sbjct: 198 ENVDLWSVGCIMGEMVCHKILF 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            H N++ L     +  H  LV E M  G L D+ L Q+        ++   ++  I K +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 350 TYLHEDCRQKILHLDIKPQNIL-LDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPG 405
            YLH    Q ++H D+KP NIL +D + N    ++ DFG +K +  +   ++T    T  
Sbjct: 135 EYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 406 YLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRS---QPEE 446
           ++APE L      E  DI+S G+++  +L G   F       PEE
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP YLAP   LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 39/229 (17%)
Query: 238 MTDNF--RKMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGE--IN-KSFLAEVKTIGSIH 291
           + DN+  + ++G+G +G V+     +  K VA+K++  + E  I+ K  L E+  +  + 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 292 HQNLVRLIGFCAE----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
              ++RL          K   L +   + +  L + LF+      L  +  K I+ ++  
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTP--IFLTEEHIKTILYNLLL 140
Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVVTTMRGT--P 404
           G  ++HE     I+H D+KP N LL+ + + KV DFGL++ I+ ++ + +V  +     P
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 405 G------------------YLAPE--WLSSIITEKVDIYSFGVVMLEIL 433
           G                  Y APE   L    T+ +DI+S G +  E+L
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V         + VA+K+L    +     K    E+  +  ++H+N++ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +KS       Y+    +D  L Q   +  LD ++   ++  +  G+ +LH     
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYLLYQMLCGIKHLHS---A 145
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD---QSQVVTTMRGTPGYLAPEWLSSI 415
            I+H D+KP NI++  +   K+ DFGL++        + +VVT       Y APE +  +
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEVILGM 200
Query: 416 -ITEKVDIYSFGVVMLEILCGRKVF 439
              E VDI+S G +M E++C + +F
Sbjct: 201 GYKENVDIWSVGCIMGEMVCHKILF 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 65/135 (48%), Gaps = 10/135 (7%)
Query: 309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
           L+V E +  G L   +  R D+   + ++  +I   I + + YLH      I H D+KP+
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTE-REASEIXKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 369 NILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-VDIYS 424
           N+L      N   K+ DFG +K      S  +TT   TP Y+APE L     +K  D +S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 425 FGVVMLEILCGRKVF 439
            GV+   +LCG   F
Sbjct: 249 LGVIXYILLCGYPPF 263

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 244 KMLGKGGFGSV-FEGTQTDGTKVAVKRLEG-----IGEINKSFLAEVKTIGSIHHQNLVR 297
           K LG G FG V     +  G   A+K L+      + +I  + L E + + +++   LV+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVK 105
Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     + S+  +V EY+  G +   L +R   F       +     I     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRF--SEPHARFYAAQIVLTFEYLHS--- 159
Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
             +++ D+KP+N+L+D     +V DFG +K +          + GTP  LAPE  LS   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEIILSKGY 215
Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQP 444
            + VD ++ GV++ E+  G   F   QP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V     T  G  VAVK+L    +     K    E+  +  ++H+N++ L+
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +K+       Y+    +D  L Q      LD ++   ++  +  G+ +LH     
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQ-VIHMELDHERMSYLLYQMLCGIKHLHS---A 145
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI-IT 417
            I+H D+KP NI++  +   K+ DFGL++      + ++T    T  Y APE +  +   
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 418 EKVDIYSFGVVMLEILCGRKVF 439
             VDI+S G +M E++ G  +F
Sbjct: 204 ANVDIWSVGCIMGELVKGCVIF 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 21/227 (9%)
Query: 225 GLPKRFSFEELKVMTDNFRKM---LGKGGFGSVFEGTQTD-GTKVAVKRLE------GIG 274
           GL  R S  +  V+ ++  ++   +GKG F  V      + G + AVK ++        G
Sbjct: 10  GLVPRGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG 69
Query: 275 EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE-FML 333
              +    E      + H ++V L+   +      +V+E+M    L   + +R+D  F+ 
Sbjct: 70  LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 129
Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLID 390
                   +  I + L Y H++    I+H D+KP  +LL    N+   K+  FG++  I 
Sbjct: 130 SEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQ 184
Query: 391 QDQSQVVTTMR-GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCG 435
             +S +V   R GTP ++APE +      + VD++  GV++  +L G
Sbjct: 185 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVKRLEGIGEIN---KSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V         + VA+K+L    +     K    E+  +  ++H+N++ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 300 G-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             F  +KS       Y+    +D  L Q   +  LD ++   ++  +  G+ +LH     
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYLLYQMLCGIKHLHS---A 145
Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD---QSQVVTTMRGTPGYLAPEWLSSI 415
            I+H D+KP NI++  +   K+ DFGL++        + +VVT       Y APE +  +
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEVILGM 200
Query: 416 -ITEKVDIYSFGVVMLEILCGRKVF 439
              E VD++S G +M E++C + +F
Sbjct: 201 GYKENVDLWSVGCIMGEMVCHKILF 225

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 210 NGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVK 268
           NG  + ++    QVP     + +E LKV        +GKG FG V +         VA+K
Sbjct: 77  NGGYDDDQGSYVQVPHDHVAYRYEVLKV--------IGKGXFGQVVKAYDHKVHQHVALK 128
Query: 269 RLEGIGEINKSFLAEVKTIGSIHHQ------NLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
            +      ++    E++ +  +  Q      N++ ++     ++H  + +E +   S++ 
Sbjct: 129 MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL---SMNL 185
Query: 323 WLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNFNAK 379
           +   + ++F        +K    I + L  LH++   +I+H D+KP+NILL   G    K
Sbjct: 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242
Query: 380 VADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCG 435
           V DFG S      + Q V     +  Y APE  L +     +D++S G ++ E+L G
Sbjct: 243 VIDFGSSCY----EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLE------GIGEINKSFLAEVKTIGSIHHQNLV 296
           +++GKG F  V      + G + AVK ++        G   +    E      + H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHED 355
            L+   +      +V+E+M    L   + +R+D  F+         +  I + L Y H++
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 356 CRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMR-GTPGYLAPEW 411
               I+H D+KP  +LL    N+   K+  FG++  I   +S +V   R GTP ++APE 
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPEV 204
Query: 412 LS-SIITEKVDIYSFGVVMLEILCG 435
           +      + VD++  GV++  +L G
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 19/263 (7%)
Query: 233 EELKVMTDNFRKM--LGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVK-T 286
           E  +V  D+   +  LG+G +G V +      G   AVKR+      +  K  L ++  +
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS 86
Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDI 345
             ++     V   G    +    +  E + + SLD++  Q  D+   +      KI + I
Sbjct: 87  XRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
            K L +LH   +  ++H D+KP N+L++     K  DFG+S  +  D ++ +    G   
Sbjct: 146 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA--GCKP 201
Query: 406 YLAPEWLSSIITE-----KVDIYSFGVVMLEILCGRKVFDR-SQPEEEDMYLLSIFKKKA 459
           Y APE ++  + +     K DI+S G+  +E+   R  +D    P ++   ++     + 
Sbjct: 202 YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 261
Query: 460 EEDKLS-DLVDKHSNDMQSNGEE 481
             DK S + VD  S  ++ N +E
Sbjct: 262 PADKFSAEFVDFTSQCLKKNSKE 284

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 132
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 133 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 187
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +K+       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +K+       Y+    +D  L Q   +  LD ++   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ-VIQMELDHERMSYL 124
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 125 LYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYV 179
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +K+       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG-IGEINKSFLAEVKTIGS 289
           FE++  + ++   +LG+G    V          + AVK +E   G I      EV+ +  
Sbjct: 10  FEDVYQLQED---VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 290 IH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
              H+N++ LI F  E+    LV+E M  GS+   + +R      +  +   ++ D+A  
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASA 123
Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLI--DQDQSQVVT----T 399
           L +LH    + I H D+KP+NIL +        K+ DF L   I  + D S + T    T
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 400 MRGTPGYLAPEWL------SSIITEKVDIYSFGVVMLEILCGRKVF 439
             G+  Y+APE +      +SI  ++ D++S GV++  +L G   F
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            H N++ L     +  +  +V E M  G L D+ L Q+        ++   ++  I K +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTV 129
Query: 350 TYLHEDCRQKILHLDIKPQNILL---DGNFNA-KVADFGLSKLIDQDQSQVVTTMRGTPG 405
            YLH    Q ++H D+KP NIL     GN  + ++ DFG +K +  +   ++T    T  
Sbjct: 130 EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TAN 185
Query: 406 YLAPEWLSSIITEKV-DIYSFGVVMLEILCGRKVFDRS---QPEE 446
           ++APE L     +   DI+S GV++  +L G   F       PEE
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSI--HHQNLVRL 298
           K +G GG   VF+         A+K +   E   +   S+  E+  +  +  H   ++RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             +     +  +V E   N  L+ WL ++     +D  +RK    ++ + +  +H+    
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 359 KILHLDIKPQNILL-DGNFNAKVADFGLSKLIDQDQSQVVT-TMRGTPGYLAPEWLSSII 416
            I+H D+KP N L+ DG    K+ DFG++  +  D + VV  +  GT  Y+ PE +  + 
Sbjct: 175 GIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 417 TEK------------VDIYSFGVVMLEILCGRKVFDR 441
           + +             D++S G ++  +  G+  F +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +K+       Y+    +D  L Q   +  LD ++   +
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ-VIQMELDHERMSYL 131
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 227 PKRFSFEELKVMTDNFR--KMLGKGGFG--SVFEGTQTDGTKVAVKRLEGIGEINKS--- 279
           P     +E+++  D+F   K++G+G F   +V +  QT G   A+K +     + +    
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDMLKRGEVS 106
Query: 280 -FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
            F  E   + +   + + +L     ++++  LV EY   G L   L +  +   +  +  
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER--IPAEMA 164
Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
           +  + +I   +  +H   R   +H DIKP NILLD   + ++ADFG    +  D +    
Sbjct: 165 RFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 399 TMRGTPGYLAPEWLSSI--------ITEKVDIYSFGVVMLEILCGRKVF 439
              GTP YL+PE L ++           + D ++ GV   E+  G+  F
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +K+       Y+    +D  L Q   +  LD ++   +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYL 169
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++T   
Sbjct: 170 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 224
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++  + +F
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 15/136 (11%)
Query: 246 LGKGGFGSVFEGTQT-DGTKVAVKRLEG--IGEIN-KSFLAEVKTIGSI-HHQNLVRLIG 300
           +G G FGSVF+  +  DG   A+KR +    G ++ ++ L EV     +  H ++VR   
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML----DWQQRKKIILDIAKGLTYLHEDC 356
             AE  H L+  EY   GSL   +   S+ + +       + K ++L + +GL Y+H   
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVGRGLRYIHS-- 131
Query: 357 RQKILHLDIKPQNILL 372
              ++H+DIKP NI +
Sbjct: 132 -MSLVHMDIKPSNIFI 146

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 8/159 (5%)
Query: 283 EVKTIGSIHHQNLVRLIG-FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E+  +  ++H+N++ L+  F  +KS       Y+    +D  L Q   +  LD ++   +
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYL 133
Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +  +  G+ +LH      I+H D+KP NI++  +   K+ DFGL++      S ++    
Sbjct: 134 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFV 188
Query: 402 GTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVF 439
            T  Y APE +  +   E VDI+S G +M E++ G  +F
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	558
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-137
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-128
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-78
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-57
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-54
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-46
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-45
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-44
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-43
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-42
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-42
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-40
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-40
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-40
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-35
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-34
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-33
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-33
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-33
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-33
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-33
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-32
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-32
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-32
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-32
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-31
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-31
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-30
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-29
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-29
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-27
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-25
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  400 bits (1031), Expect = e-137
 Identities = 137/312 (43%), Positives = 190/312 (60%), Gaps = 12/312 (3%)

Query: 216 EEDYLDQVPGLPKRFSFEELKVMTDNFRK--MLGKGGFGSVFEGTQTDGTKVAVKRL--E 271
            E+  +   G  KRFS  EL+V +DNF    +LG+GGFG V++G   DGT VAVKRL  E
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65

Query: 272 GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF-QRSDE 330
                   F  EV+ I    H+NL+RL GFC   +  LLVY YM NGS+   L  +   +
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
             LDW +R++I L  A+GL YLH+ C  KI+H D+K  NILLD  F A V DFGL+KL+D
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 391 QDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQP-EEED 448
              + V T +RGT G++APE+LS+   +EK D++ +GV++LE++ G++ FD ++   ++D
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSN--GEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           + LL   K   +E KL  LVD    D+Q N   EEV  +++VA  C +S   +RP MS V
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 507 VRVLEGVTEFEH 518
           VR+LEG    E 
Sbjct: 303 VRMLEGDGLAER 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  375 bits (965), Expect = e-128
 Identities = 119/314 (37%), Positives = 167/314 (53%), Gaps = 24/314 (7%)

Query: 216 EEDYLDQVPGLPKRFSFEELKVMTDNFRK--------MLGKGGFGSVFEGTQTDGTKVAV 267
           E   L+        FSF ELK +T+NF +         +G+GGFG V++G   + T VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGY-VNNTTVAV 59

Query: 268 KRLEGIGEI-----NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
           K+L  + +I      + F  E+K +    H+NLV L+GF ++     LVY YMPNGSL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD 382
            L        L W  R KI    A G+ +LHE+     +H DIK  NILLD  F AK++D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 383 FGLSKLIDQDQSQVVTTM-RGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDR 441
           FGL++  ++    V+T+   GT  Y+APE L   IT K DIYSFGVV+LEI+ G    D 
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 442 SQPEEEDMYLLSIFKKK-AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR 500
            +  +    LL I ++   EE  + D +DK  ND  ++   V  M  VA+ CL     KR
Sbjct: 237 HREPQ---LLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKR 291

Query: 501 PSMSMVVRVLEGVT 514
           P +  V ++L+ +T
Sbjct: 292 PDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  355 bits (913), Expect = e-119
 Identities = 110/301 (36%), Positives = 162/301 (53%), Gaps = 11/301 (3%)

Query: 223 VPGLPKRFSFEELKVMTDNFRK--MLGKGGFGSVFEGTQTDGTKVAVKRL-EGIGEINKS 279
           VP    R    +L+  T+NF    ++G G FG V++G   DG KVA+KR      +  + 
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81

Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS-DEFMLDWQQR 338
           F  E++T+    H +LV LIGFC E++  +L+Y+YM NG+L R L+        + W+QR
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVV 397
            +I +  A+GL YLH      I+H D+K  NILLD NF  K+ DFG+SK   + DQ+ + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 398 TTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           T ++GT GY+ PE ++   +TEK D+YSFGVV+ E+LC R    +S P E  + L     
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAV 257

Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF 516
           +     +L  +VD +  D +   E +      A  CL      RPSM  V+  LE     
Sbjct: 258 ESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

Query: 517 E 517
           +
Sbjct: 317 Q 317

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  249 bits (638), Expect = 1e-78
 Identities = 72/314 (22%), Positives = 125/314 (39%), Gaps = 31/314 (9%)

Query: 230 FSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTI 287
              E L   +   +  ++  +G FG V++        VAVK      + +     EV ++
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 288 GSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
             + H+N+++ IG     +       L+  +   GSL  +L        + W +   I  
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAE 128

Query: 344 DIAKGLTYLHED-------CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
            +A+GL YLHED        +  I H DIK +N+LL  N  A +ADFGL+   +  +S  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 397 VTTMR-GTPGYLAPEWLSSII------TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM 449
            T  + GT  Y+APE L   I        ++D+Y+ G+V+ E+       D    E    
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 450 YLLSIFKKKAEEDKLSDLVDKHSNDMQ-----SNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           +   I +  + ED + ++V                  +  + +    C + D   R S  
Sbjct: 249 FEEEIGQHPSLED-MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 505 MVVRVLEGVTEFEH 518
            V   +  +    +
Sbjct: 308 CVGERITQMQRLTN 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (551), Expect = 7e-66
 Identities = 77/287 (26%), Positives = 133/287 (46%), Gaps = 35/287 (12%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIG 288
           + +L       ++ +G G FG+V       G+ VAVK L   +   E    FL EV  + 
Sbjct: 36  WCDLN-----IKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
            + H N+V  +G   +  +  +V EY+  GSL R L +      LD ++R  +  D+AKG
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YLH      I+H ++K  N+L+D  +  KV DFGLS+L          +  GTP ++A
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMA 207

Query: 409 PEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK---L 464
           PE L      EK D+YSFGV++ E+   ++ +        ++    +      + K   +
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKCKRLEI 260

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
              ++           +V  +++    C  ++  KRPS + ++ +L 
Sbjct: 261 PRNLN----------PQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  213 bits (544), Expect = 6e-65
 Identities = 68/287 (23%), Positives = 132/287 (45%), Gaps = 41/287 (14%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
           ++E++       +++G+G FG V +        VA+K++E      K+F+ E++ +  ++
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAK-WRAKDVAIKQIES-ESERKAFIVELRQLSRVN 59

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+V+L G C   +   LV EY   GSL   L                  L  ++G+ Y
Sbjct: 60  HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFN-AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           LH    + ++H D+KP N+LL       K+ DFG +     D    +T  +G+  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173

Query: 411 WL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD 469
               S  +EK D++S+G+++ E++  RK F       +++   +         ++   V 
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-------DEIGGPAF--------RIMWAVH 218

Query: 470 KH-----SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                    ++    + + ++M     C   D ++RPSM  +V+++ 
Sbjct: 219 NGTRPPLIKNLP---KPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  210 bits (537), Expect = 1e-63
 Identities = 69/321 (21%), Positives = 129/321 (40%), Gaps = 48/321 (14%)

Query: 230 FSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVK-- 285
            +  E  +  DN +  +++G+G +G+V++G+  D   VAVK         ++F+ E    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANR--QNFINEKNIY 59

Query: 286 TIGSIHHQNLVRLIGFCAEKSHN-----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
            +  + H N+ R I      + +     LLV EY PNGSL ++L   +     DW    +
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115

Query: 341 IILDIAKGLTYLHED------CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-- 392
           +   + +GL YLH +       +  I H D+  +N+L+  +    ++DFGLS  +  +  
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 393 -----QSQVVTTMRGTPGYLAPEWLSSII--------TEKVDIYSFGVVMLEILCGRKVF 439
                +     +  GT  Y+APE L   +         ++VD+Y+ G++  EI       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 440 DRSQPEEEDMYLLSIFKKKAEEDKLSDLVD---------KHSNDMQSNGEEVVNMMKVAA 490
              +   E  Y ++   +        D+           K     + N   V ++ +   
Sbjct: 236 FPGESVPE--YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 491 WCLESDFAKRPSMSMVVRVLE 511
            C + D   R +       + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  205 bits (524), Expect = 3e-62
 Identities = 78/306 (25%), Positives = 131/306 (42%), Gaps = 56/306 (18%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRL--------EGIGEINK 278
              +  E++     + K +GKGGFG V +G    D + VA+K L          + E  +
Sbjct: 14  PTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
            F  EV  + +++H N+V+L G         +V E++P G L   L  ++    + W  +
Sbjct: 69  EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVK 124

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-----GNFNAKVADFGLSKLIDQDQ 393
            +++LDIA G+ Y+  +    I+H D++  NI L          AKVADFGLS+      
Sbjct: 125 LRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QS 179

Query: 394 SQVVTTMRGTPGYLAPEWL---SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
              V+ + G   ++APE +       TEK D YSF +++  IL G   F       ++  
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-------DEYS 232

Query: 451 LLSIFKKKAEEDK-----LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM 505
              I       ++     + +               + N+++    C   D  KRP  S 
Sbjct: 233 YGKIKFINMIREEGLRPTIPEDCP----------PRLRNVIE---LCWSGDPKKRPHFSY 279

Query: 506 VVRVLE 511
           +V+ L 
Sbjct: 280 IVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  203 bits (518), Expect = 1e-61
 Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 44/294 (14%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL-----EGIGEINKSFLAEVKT 286
           F EL        +++G GGFG V+      G +VAVK       E I +  ++   E K 
Sbjct: 6   FAELT-----LEEIIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
              + H N++ L G C ++ +  LV E+   G L+R L  +     +         + IA
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIA 115

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLD--------GNFNAKVADFGLSKLIDQDQSQVVT 398
           +G+ YLH++    I+H D+K  NIL+          N   K+ DFGL++   +       
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KM 172

Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           +  G   ++APE + +S+ ++  D++S+GV++ E+L G   F         +  L++   
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-------RGIDGLAVAYG 225

Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
            A       +         +  E    +M+    C   D   RPS + ++  L 
Sbjct: 226 VAMNKLALPI-------PSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (516), Expect = 3e-61
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 46/292 (15%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIG 288
           F++L      F   L +   G +++G    G  + VK L   +     ++ F  E   + 
Sbjct: 9   FKQLN-----FLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62

Query: 289 SIHHQNLVRLIGFCAE--KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
              H N++ ++G C      H  L+  +MP GSL   L      F++D  Q  K  LD+A
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           +G+ +LH      I    +  +++++D +  A+++   +        S         P +
Sbjct: 122 RGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAW 174

Query: 407 LAPEWL----SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           +APE L            D++SF V++ E++     F        D+  + I  K A E 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-------ADLSNMEIGMKVALEG 227

Query: 463 K---LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
               +   +  H          V  +MK    C+  D AKRP   M+V +LE
Sbjct: 228 LRPTIPPGISPH----------VSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  194 bits (495), Expect = 1e-57
 Identities = 82/303 (27%), Positives = 128/303 (42%), Gaps = 43/303 (14%)

Query: 226 LPKR-FSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEIN-KSFLA 282
           +P R F   +L        ++LGKG FG   + T +  G  + +K L    E   ++FL 
Sbjct: 2   MPHRIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK 56

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EVK +  + H N+++ IG   +      + EY+  G+L   +  +S +    W QR    
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFA 114

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ------- 395
            DIA G+ YLH      I+H D+   N L+  N N  VADFGL++L+  +++Q       
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 396 ------VVTTMRGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEED 448
                    T+ G P ++APE ++     EKVD++SFG+V+ EI+          P   D
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231

Query: 449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
             L            L      +             +      C + D  KRPS   +  
Sbjct: 232 FGL-------NVRGFLDRYCPPNCP------PSFFPITV---RCCDLDPEKRPSFVKLEH 275

Query: 509 VLE 511
            LE
Sbjct: 276 WLE 278

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  192 bits (490), Expect = 3e-57
 Identities = 62/289 (21%), Positives = 123/289 (42%), Gaps = 36/289 (12%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN----KSFLAEVKTI 287
             ++        + +G G FG+V++G       VAVK L  +        ++F  EV  +
Sbjct: 23  DGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLN-VTAPTPQQLQAFKNEVGVL 74

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
               H N++  +G+        +V ++    SL   L   + E   + ++   I    A+
Sbjct: 75  RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTAR 131

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVVTTMRGTPGY 406
           G+ YLH    + I+H D+K  NI L  +   K+ DFGL+    +   S     + G+  +
Sbjct: 132 GMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 407 LAPEWL----SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           +APE +    S+  + + D+Y+FG+V+ E++ G+  +      ++ + ++       +  
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           K+     K           +  +M     CL+    +RPS   ++  +E
Sbjct: 249 KVRSNCPK----------RMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  192 bits (490), Expect = 1e-56
 Identities = 75/339 (22%), Positives = 133/339 (39%), Gaps = 47/339 (13%)

Query: 207 RKKNGADEIEEDYLDQV---------PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEG 257
           R         +D +  +         P L +R     +       ++ +GKG FG V+ G
Sbjct: 7   RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIV-----LQESIGKGRFGEVWRG 61

Query: 258 TQTDGTKVAVKRLEGIGEINKSFLAE--VKTIGSIHHQNLVRLIGFCAEKSHN----LLV 311
               G +VAVK      E  +S+  E  +     + H+N++  I    + +       LV
Sbjct: 62  K-WRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118

Query: 312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED-----CRQKILHLDIK 366
            +Y  +GSL  +L + +    +  +   K+ L  A GL +LH +      +  I H D+K
Sbjct: 119 SDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 367 PQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM---RGTPGYLAPEWLSSII------- 416
            +NIL+  N    +AD GL+   D     +        GT  Y+APE L   I       
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS---- 472
            ++ DIY+ G+V  EI   R        + +  Y   +    + E+    + ++      
Sbjct: 235 FKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
            +   + E +  M K+   C  ++ A R +   + + L 
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (488), Expect = 1e-56
 Identities = 63/297 (21%), Positives = 123/297 (41%), Gaps = 47/297 (15%)

Query: 232 FEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRL---EGIGEINKSFLAEVKTIG 288
           FE+L+       +++GKG FG V+ G    G  VA++ +       +  K+F  EV    
Sbjct: 32  FEQLE-----IGELIGKGRFGQVYHGR-WHGE-VAIRLIDIERDNEDQLKAFKREVMAYR 84

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
              H+N+V  +G C    H  ++       +L   +  R  + +LD  + ++I  +I KG
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKG 142

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID----QDQSQVVTTMRGTP 404
           + YLH    + ILH D+K +N+  D N    + DFGL  +        +   +    G  
Sbjct: 143 MGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 405 GYLAPEWLSSII----------TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
            +LAPE +  +           ++  D+++ G +  E+      F       +     +I
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-------KTQPAEAI 251

Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
             +     K +              +E+ +++    +C   +  +RP+ + ++ +LE
Sbjct: 252 IWQMGTGMKPNLSQIGMG-------KEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  190 bits (485), Expect = 6e-56
 Identities = 74/320 (23%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAE 283
           P L +R   ++++       K +GKG +G V+ G    G KVAVK      E +     E
Sbjct: 28  PLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGK-WRGEKVAVKVFFTTEEASWFRETE 81

Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
           +     + H+N++  I    + + +     L+ +Y  NGSL  +L   +    LD +   
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSML 137

Query: 340 KIILDIAKGLTYLHED-----CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS 394
           K+      GL +LH +      +  I H D+K +NIL+  N    +AD GL+     D +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 395 QVVTTM---RGTPGYLAPEWLSSII-------TEKVDIYSFGVVMLEILCGRKVFDR--- 441
           +V        GT  Y+ PE L   +           D+YSFG+++ E+            
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

Query: 442 ----------SQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW 491
                     S P  EDM  +   KK        +              ++  +M     
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPS--FPNRWSSDECL-----RQMGKLMT---E 307

Query: 492 CLESDFAKRPSMSMVVRVLE 511
           C   + A R +   V + L 
Sbjct: 308 CWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (468), Expect = 5e-54
 Identities = 74/318 (23%), Positives = 126/318 (39%), Gaps = 56/318 (17%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVK-- 285
           +R    ++        + +GKG +G V+ G+   G  VAVK      E  KS+  E +  
Sbjct: 3   QRTVARDIT-----LLECVGKGRYGEVWRGS-WQGENVAVKIFSSRDE--KSWFRETELY 54

Query: 286 TIGSIHHQNLVRLIGFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
               + H+N++  I       H+     L+  Y   GSL  +L   +    LD     +I
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRI 110

Query: 342 ILDIAKGLTYLHED-----CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
           +L IA GL +LH +      +  I H D+K +NIL+  N    +AD GL+ +  Q  +Q+
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170

Query: 397 VTTM---RGTPGYLAPEWLSSII-------TEKVDIYSFGVVMLEILCGRKVFDR----- 441
                   GT  Y+APE L   I        ++VDI++FG+V+ E+              
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230

Query: 442 --------SQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCL 493
                   + P  EDM  +    ++     + +               +  +MK    C 
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPN--IPNRWFSDPTL-----TSLAKLMK---ECW 280

Query: 494 ESDFAKRPSMSMVVRVLE 511
             + + R +   + + L 
Sbjct: 281 YQNPSARLTALRIKKTLT 298

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  163 bits (414), Expect = 3e-46
 Identities = 69/288 (23%), Positives = 106/288 (36%), Gaps = 50/288 (17%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           + LG+GGFG VFE     D    A+K  RL       +  + EVK +  + H  +VR   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 301 FCAEK---------SHNLLVY---EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
              EK         S  + +Y   +     +L  W+  R      +      I L IA+ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-----------QVV 397
           + +LH    + ++H D+KP NI    +   KV DFGL   +DQD+               
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 398 TTMRGTPGYLAPE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           T   GT  Y++PE    +  + KVDI+S G+++ E+L          P    M  +    
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQMERVRTL- 237

Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                 K   L  +                 +    L     +RP   
Sbjct: 238 TDVRNLKFPPLFTQKYPCEY----------VMVQDMLSPSPMERPEAI 275

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  161 bits (408), Expect = 4e-45
 Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 30/289 (10%)

Query: 241 NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLE--GIGEINKSFLAEVKTIGSIHHQNLVR 297
               +LG+G   +VF G  +  G   A+K              + E + +  ++H+N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 298 LIGF--CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L          H +L+ E+ P GSL   L + S+ + L   +   ++ D+  G+ +L E 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130

Query: 356 CRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
               I+H +IKP NI+     DG    K+ DFG ++ ++ D  +   ++ GT  YL P+ 
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186

Query: 412 LSSII---------TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
               +            VD++S GV       G   F   +    +  ++  +K    + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM--YKIITGKP 244

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                    S   ++    +     +   C  S   +     ++  +LE
Sbjct: 245 S-----GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  159 bits (403), Expect = 1e-44
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 55/294 (18%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
              +LG+G FG V +     D    A+K++    E   + L+EV  + S++HQ +VR   
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 301 FCAEKSHNL-------------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
              E+ + +             +  EY  NG+L   +   +        +  ++   I +
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILE 127

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV---------- 397
            L+Y+H    Q I+H D+KP NI +D + N K+ DFGL+K + +    +           
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 398 ---TTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
              T+  GT  Y+A E L       EK+D+YS G++  E++          P    M  +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---------PFSTGMERV 235

Query: 453 SIFKK--KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           +I KK      +   D  D      +          K+    ++ D  KRP   
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEK----------KIIRLLIDHDPNKRPGAR 279

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  162 bits (411), Expect = 2e-44
 Identities = 65/288 (22%), Positives = 105/288 (36%), Gaps = 55/288 (19%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKT-IGSIHHQNL 295
             + +LG G  G++      D   VAVKR      I     +    EV+    S  H N+
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKR------ILPECFSFADREVQLLRESDEHPNV 80

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           +R      ++    +  E     +L  ++ Q+  +F     +   ++     GL +LH  
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 356 CRQKILHLDIKPQNILL-----DGNFNAKVADFGLSKLIDQDQS--QVVTTMRGTPGYLA 408
               I+H D+KP NIL+      G   A ++DFGL K +   +      + + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 409 PEWLSSII----TEKVDIYSFGVVMLEILCGRKVF--DRSQPEEEDMYLLSIFKKKAEED 462
           PE LS       T  VDI+S G V   ++           Q +   +           E 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254

Query: 463 KLS----DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
                  +L++K                      +  D  KRPS   V
Sbjct: 255 HEDVIARELIEK---------------------MIAMDPQKRPSAKHV 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  158 bits (401), Expect = 3e-44
 Identities = 67/277 (24%), Positives = 102/277 (36%), Gaps = 41/277 (14%)

Query: 231 SFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVK--RLEGIGEINK-SFLAEVKT 286
           SF+ L          LG G +G VF+     DG   AVK       G  ++   LAEV +
Sbjct: 58  SFQRLSR--------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 287 IGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
              +  H   VRL     E     L  E     SL +              Q    + D 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASL--PEAQVWGYLRDT 166

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
              L +LH    Q ++HLD+KP NI L      K+ DFGL   +    +       G P 
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPR 221

Query: 406 YLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           Y+APE L        D++S G+ +LE+ C  ++    +  ++      + +         
Sbjct: 222 YMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ------LRQGYLPP---- 271

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           +     S++++S          V    LE D   R +
Sbjct: 272 EFTAGLSSELRS----------VLVMMLEPDPKLRAT 298

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  155 bits (393), Expect = 2e-43
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 52/280 (18%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           +++G GGFG VF+   + DG    +KR   +   N+    EVK +  + H N+V   G  
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCW 73

Query: 303 AEKSHNL----------------LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
               ++                 +  E+   G+L++W+ +R  E  LD     ++   I 
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           KG+ Y+H    +K+++ D+KP NI L      K+ DFGL   +  D  +  T  +GT  Y
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 187

Query: 407 LAPEWLSSI-ITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           ++PE +SS    ++VD+Y+ G+++ E+L      F+ S+           F     +  +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----------FFTDLRDGII 236

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           SD+        ++          +    L      RP+ S
Sbjct: 237 SDIF---DKKEKT----------LLQKLLSKKPEDRPNTS 263

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  157 bits (399), Expect = 3e-43
 Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 30/289 (10%)

Query: 241 NFRKMLGKGGFGSVFEGT-QTDGTKVAVKRLE--GIGEINKSFLAEVKTIGSIHHQNLVR 297
               +LG+G   +VF G  +  G   A+K              + E + +  ++H+N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 298 LIGF--CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L          H +L+ E+ P GSL   L + S+ + L   +   ++ D+  G+ +L E 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130

Query: 356 CRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
               I+H +IKP NI+     DG    K+ DFG ++ ++ D  +   ++ GT  YL P+ 
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186

Query: 412 LSSII---------TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
               +            VD++S GV       G   F   +    +  ++  +K    + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM--YKIITGKP 244

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                    S   ++    +     +   C  S   +     ++  +LE
Sbjct: 245 S-----GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  153 bits (389), Expect = 2e-42
 Identities = 62/307 (20%), Positives = 122/307 (39%), Gaps = 50/307 (16%)

Query: 221 DQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKR--LEGIGEI 276
             V    +   F+ + V    +   K +G GG   VF+         A+K   LE     
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ 68

Query: 277 N-KSFLAEVKTIGSIHHQNL--VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFML 333
              S+  E+  +  +   +   +RL  +     +  +V E   N  L+ WL ++     +
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SI 124

Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
           D  +RK    ++ + +  +H+     I+H D+KP N L+      K+ DFG++  +  D 
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180

Query: 394 SQVV-TTMRGTPGYLAPEWLSSI------------ITEKVDIYSFGVVMLEILCGRKVFD 440
           + VV  +  GT  Y+ PE +  +            I+ K D++S G ++  +  G+  F 
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

Query: 441 RSQPEEEDMYLLSIFKKKAE---EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDF 497
           +   +   ++  +I     E    D                 +++ +++K    CL+ D 
Sbjct: 241 QIINQISKLH--AIIDPNHEIEFPDIPE--------------KDLQDVLK---CCLKRDP 281

Query: 498 AKRPSMS 504
            +R S+ 
Sbjct: 282 KQRISIP 288

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  156 bits (396), Expect = 2e-42
 Identities = 75/300 (25%), Positives = 114/300 (38%), Gaps = 58/300 (19%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLA----EVKT-IGSIHHQNL 295
              K+LG G  G+V       G  VAVKR      +   F      E+K    S  H N+
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGRPVAVKR------MLIDFCDIALMEIKLLTESDDHPNV 71

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKGLTY 351
           +R            +  E   N +L   +  ++    +  +        ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 352 LHEDCRQKILHLDIKPQNILLD-------------GNFNAKVADFGLSKLIDQDQSQVVT 398
           LH     KI+H D+KPQNIL+               N    ++DFGL K +D  QS   T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 399 TMR---GTPGYLAPEWLSSII--------TEKVDIYSFGVVMLEILC-GRKVFDRSQPEE 446
            +    GT G+ APE L            T  +DI+S G V   IL  G+  F      E
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 447 EDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
            +     I +     D++  L D+          E  +++      ++ D  KRP+   V
Sbjct: 248 SN-----IIRGIFSLDEMKCLHDRS------LIAEATDLIS---QMIDHDPLKRPTAMKV 293

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  151 bits (382), Expect = 3e-41
 Identities = 60/282 (21%), Positives = 115/282 (40%), Gaps = 48/282 (17%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKR--LEGIGEIN-KSFLAEVKTIGSIHHQNL--VRL 298
           K +G GG   VF+         A+K   LE        S+  E+  +  +   +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             +     +  +V E   N  L+ WL ++     +D  +RK    ++ + +  +H+    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTMRGTPGYLAPE------- 410
            I+H D+KP N L+  +   K+ DFG++  +  D + VV  +  GT  Y+ PE       
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 411 -----WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE---ED 462
                   S I+ K D++S G ++  +  G+  F +   +   ++  +I     E    D
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AIIDPNHEIEFPD 244

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                            +++ +++K    CL+ D  +R S+ 
Sbjct: 245 IPE--------------KDLQDVLK---CCLKRDPKQRISIP 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (378), Expect = 4e-41
 Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 44/307 (14%)

Query: 207 RKKNGADEIEEDYLDQVPGLPK-RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTK 264
            +    D+IEE     V      RF           F   +G+G F +V++G  T+   +
Sbjct: 3   ERNQQQDDIEELETKAVGMSNDGRFL---------KFDIEIGRGSFKTVYKGLDTETTVE 53

Query: 265 VAVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRLIGFC---AEKSHNLLVY-EYMP 316
           VA   L+   ++ KS    F  E + +  + H N+VR         +    +++  E M 
Sbjct: 54  VAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112

Query: 317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-N 375
           +G+L  +L +R        +  +     I KGL +LH      I+H D+K  NI + G  
Sbjct: 113 SGTLKTYL-KRFKVM--KIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPT 168

Query: 376 FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCG 435
            + K+ D GL+ L     ++    + GTP ++APE       E VD+Y+FG+ MLE+   
Sbjct: 169 GSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 225

Query: 436 RKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLES 495
              +   Q          I+++     K +        +++    E++        C+  
Sbjct: 226 EYPYSECQN------AAQIYRRVTSGVKPASFDKVAIPEVK----EIIEG------CIRQ 269

Query: 496 DFAKRPS 502
           +  +R S
Sbjct: 270 NKDERYS 276

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  151 bits (383), Expect = 6e-41
 Identities = 59/279 (21%), Positives = 118/279 (42%), Gaps = 42/279 (15%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKR--LEGIGEIN-KSFLAEVKTIGSIHHQNL--VRL 298
           K +G GG   VF+         A+K   LE        S+  E+  +  +   +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
             +     +  +V E   N  L+ WL ++     +D  +RK    ++ + +  +H+    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTMRGTPGYLAPEWLSSI-- 415
            I+H D+KP N L+  +   K+ DFG++  +  D + VV  +  G   Y+ PE +  +  
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 416 ----------ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
                     I+ K D++S G ++  +  G+  F +   +   ++  +I      E +  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AIIDPN-HEIEFP 290

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
           D+ +K          ++ +++K    CL+ D  +R S+ 
Sbjct: 291 DIPEK----------DLQDVLK---CCLKRDPKQRISIP 316

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 1e-40
 Identities = 59/266 (22%), Positives = 109/266 (40%), Gaps = 28/266 (10%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINK-SFLAEVKTIGSIHHQNLVRLI 299
           + +G+G FG         DG +  +K   +  +    +     EV  + ++ H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
               E     +V +Y   G L + +       +    Q     + I   L ++H+   +K
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---RK 145

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIITE 418
           ILH DIK QNI L  +   ++ DFG++++++     +     GTP YL+PE   +     
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICENKPYNN 204

Query: 419 KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN 478
           K DI++ G V+ E+   +  F     E   M  L     K        +   +S D++S 
Sbjct: 205 KSDIWALGCVLYELCTLKHAF-----EAGSMKNLV---LKIISGSFPPVSLHYSYDLRS- 255

Query: 479 GEEVVNMMKVAAWCLESDFAKRPSMS 504
                    + +   + +   RPS++
Sbjct: 256 ---------LVSQLFKRNPRDRPSVN 272

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (381), Expect = 1e-40
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVKRL-EGIG-EINKSFLAEVKTIGSIHHQNLVRL 298
             + +G+G FG VF G  + D T VAVK   E +  ++   FL E + +    H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           IG C +K    +V E +  G    +L  R++   L  +   +++ D A G+ YL     +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---K 232

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APE-WL 412
             +H D+  +N L+      K++DFG+S+              G    +     APE   
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPEALN 288

Query: 413 SSIITEKVDIYSFGVVMLEIL 433
               + + D++SFG+++ E  
Sbjct: 289 YGRYSSESDVWSFGILLWETF 309

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  148 bits (375), Expect = 2e-40
 Identities = 58/268 (21%), Positives = 117/268 (43%), Gaps = 26/268 (9%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRL 298
           K +G+G F  V+      DG  VA+K+++    ++       + E+  +  ++H N+++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWL-FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
                E +   +V E    G L R +   +  + ++  +   K  + +   L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSII 416
           ++++H DIKP N+ +      K+ D GL +      +    ++ GTP Y++PE    +  
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGY 213

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ 476
             K DI+S G ++ E+   +  F       + M L S+ KK  + D      D +S +++
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268

Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                      +   C+  D  KRP ++
Sbjct: 269 Q----------LVNMCINPDPEKRPDVT 286

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (371), Expect = 3e-40
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 29/275 (10%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINK-SFLAEVKTIGSIHHQNLVRLI 299
             +G G +G   +   ++DG  +  K      + E  K   ++EV  +  + H N+VR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 300 GFCAEKSHNLL--VYEYMPNGSLDRWL-FQRSDEFMLDWQQRKKIILDIAKGLTYLHE-- 354
               ++++  L  V EY   G L   +     +   LD +   +++  +   L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
           D    +LH D+KP N+ LDG  N K+ DFGL+++++ D S    T  GTP Y++PE ++ 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNR 190

Query: 415 II-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
           +   EK DI+S G ++ E+      F            L+    K  E K   +  ++S+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELA---GKIREGKFRRIPYRYSD 242

Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
           ++            +    L      RPS+  ++ 
Sbjct: 243 ELNE----------IITRMLNLKDYHRPSVEEILE 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  146 bits (371), Expect = 5e-40
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 30/225 (13%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKGGF   FE +  D     A K      L    +  K    E+    S+ HQ++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 79

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
             GF  +     +V E     SL     +R     L   + +  +  I  G  YLH   R
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---R 133

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT 417
            +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +    + GTP Y+APE    +++
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE----VLS 188

Query: 418 EK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           +K     VD++S G +M  +L G+  F+          L   + +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLR 226

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  147 bits (372), Expect = 6e-40
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 30/225 (13%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           + LGKGGF   FE +  D     A K      L    +  K    E+    S+ HQ++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 105

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
             GF  +     +V E     SL     +R     L   + +  +  I  G  YLH   R
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---R 159

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIIT 417
            +++H D+K  N+ L+ +   K+ DFGL+  ++ D  +    + GTP Y+APE    +++
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE----VLS 214

Query: 418 EK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           +K     VD++S G +M  +L G+  F+          L   + +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLR 252

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  144 bits (365), Expect = 2e-39
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
            +LGKG F  V+       G +VA+K      +   G + +    EVK    + H +++ 
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILE 75

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L  +  + ++  LV E   NG ++R+L  R   F  + + R   +  I  G+ YLH    
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARH-FMHQIITGMLYLH---S 130

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII- 416
             ILH D+   N+LL  N N K+ADFGL+  +     +   T+ GTP Y++PE  +    
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTLCGTPNYISPEIATRSAH 189

Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
             + D++S G +   +L GR  FD
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFD 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (365), Expect = 7e-39
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQN 294
             K+LG G FG+V++G      +     VA+K L E          L E   + S+ + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           + RL+G C   S   L+ + MP G L  ++ +  D      Q      + IAKG+ YL +
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLED 135

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS 413
              ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E + 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 414 -SIITEKVDIYSFGVVMLEIL 433
             I T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  142 bits (361), Expect = 8e-39
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 73/319 (22%)

Query: 211 GADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKR 269
           GA  ++  Y  +         F EL+         +G G FGSVF+  +  DG   A+KR
Sbjct: 1   GAMGMKSRYTTE---------FHELEK--------IGSGEFGSVFKCVKRLDGCIYAIKR 43

Query: 270 --LEGIGEINK-SFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF 325
                 G +++ + L EV     +  H ++VR     AE  H L+  EY   GSL   + 
Sbjct: 44  SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103

Query: 326 QRSDEF-MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN--------- 375
           +           + K ++L + +GL Y+H      ++H+DIKP NI +            
Sbjct: 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEE 160

Query: 376 ----------FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII--TEKVDIY 423
                        K+ D G    I   Q +      G   +LA E L        K DI+
Sbjct: 161 GDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIF 215

Query: 424 SFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVV 483
           +  + ++       +     P   D +       +  + +L  +    S +         
Sbjct: 216 ALALTVVCAAGAEPL-----PRNGDQW------HEIRQGRLPRIPQVLSQEFTE------ 258

Query: 484 NMMKVAAWCLESDFAKRPS 502
               +    +  D  +RPS
Sbjct: 259 ----LLKVMIHPDPERRPS 273

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  142 bits (361), Expect = 9e-39
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNL 295
           F + LGKG FGSV            G  VAVK+L     E  + F  E++ + S+ H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 296 VRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           V+  G C         L+ EY+P GSL  +L  +  +  +D  +  +    I KG+ YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----A 408
               ++ +H D+  +NIL++     K+ DFGL+K++ QD+          PG       A
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK---EPGESPIFWYA 185

Query: 409 PEWLS-SIITEKVDIYSFGVVMLEIL 433
           PE L+ S  +   D++SFGVV+ E+ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (372), Expect = 1e-38
 Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 6/194 (3%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            +  LG G +G V+EG  +     VAVK L+      + FL E   +  I H NLV+L+G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C  +    ++ E+M  G+L  +L +  +   +       +   I+  + YL +   +  
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H ++  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 420 VDIYSFGVVMLEIL 433
            D+++FGV++ EI 
Sbjct: 400 SDVWAFGVLLWEIA 413

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  142 bits (360), Expect = 1e-38
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 243 RKMLGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
           R +LGKG +G V+ G       ++A+K           +    E+     + H+N+V+ +
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYL 85

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G  +E     +  E +P GSL   L  +      + Q        I +GL YLH+    +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142

Query: 360 ILHLDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-- 416
           I+H DIK  N+L++  +   K++DFG SK +    +    T  GT  Y+APE    II  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE----IIDK 197

Query: 417 -----TEKVDIYSFGVVMLEILCGR 436
                 +  DI+S G  ++E+  G+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  149 bits (377), Expect = 2e-38
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 23/235 (9%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRL 298
            ++ LG GGFG V     Q  G +VA+K  R E   +  + +  E++ +  ++H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 299 IGFCAEKSH------NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
                           LL  EY   G L ++L Q  +   L     + ++ DI+  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNA---KVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           HE    +I+H D+KP+NI+L         K+ D G +K +DQ   ++ T   GT  YLAP
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAP 192

Query: 410 EWLSSII-TEKVDIYSFGVVMLEILCGRK-VFDRSQPEEEDMYLLSIFKKKAEED 462
           E L     T  VD +SFG +  E + G +      QP +         ++K+ E 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ----WHGKVREKSNEH 243

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 3e-38
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNL 295
           F + LGKG FGSV            G  VAVK+L     E  + F  E++ + S+ H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 296 VRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           V+  G C         L+ EY+P GSL  +L  +  +  +D  +  +    I KG+ YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----A 408
               ++ +H D+  +NIL++     K+ DFGL+K++ QD+          PG       A
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK---EPGESPIFWYA 216

Query: 409 PEWLS-SIITEKVDIYSFGVVMLEIL 433
           PE L+ S  +   D++SFGVV+ E+ 
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELF 242

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (360), Expect = 3e-38
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 46/307 (14%)

Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKSF 280
           P  F    LK     +   LGKG FGSV            G  VAVK+L     +  + F
Sbjct: 17  PTIFEERHLK-----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF 71

Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             E++ + ++H   +V+  G           LV EY+P+G L  +L  +     LD  + 
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRL 129

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VV 397
                 I KG+ YL     ++ +H D+  +NIL++   + K+ADFGL+KL+  D+   VV
Sbjct: 130 LLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186

Query: 398 TTMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSI 454
                +P  + APE LS +I + + D++SFGVV+ E+     K              L +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK------SCSPSAEFLRM 240

Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGE----------EVVNMMKVAAWCLESDFAKRPSMS 504
              + +   LS L+     ++   G+          EV  +MK    C       RPS S
Sbjct: 241 MGCERDVPALSRLL-----ELLEEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFS 292

Query: 505 MVVRVLE 511
            +   L+
Sbjct: 293 ALGPQLD 299

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (360), Expect = 3e-38
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 242 FRKMLGKGGFGSVFEGT----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             K++G G  G V  G           VA+K L  G  E  +  FL+E   +G   H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           +RL G        ++V EYM NGSLD +L  R+ +      Q   ++  +  G+ YL + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSD- 169

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG------TPGYLAP 409
                +H D+  +N+L+D N   KV+DFGLS++++ D     TT  G      T    AP
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223

Query: 410 EWLS-SIITEKVDIYSFGVVMLEIL 433
           E ++    +   D++SFGVVM E+L
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVL 248

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (358), Expect = 3e-38
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 17/204 (8%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQN 294
             + LG+G FG V            G +VAVK L    G  + +    E++ + +++H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 295 LVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +V+  G C E   N   L+ E++P+GSL  +L    ++  ++ +Q+ K  + I KG+ YL
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTP-GYLAPE 410
                ++ +H D+  +N+L++     K+ DFGL+K I+ D+    V   R +P  + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 411 WLS-SIITEKVDIYSFGVVMLEIL 433
            L  S      D++SFGV + E+L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELL 223

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (358), Expect = 4e-38
 Identities = 64/299 (21%), Positives = 114/299 (38%), Gaps = 38/299 (12%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLI 299
           F + LG+GGF  V       DG   A+KR+     +  +    E       +H N++RL+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 300 GFCAEKSHN----LLVYEYMPNGSLDRWLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHE 354
            +C  +        L+  +   G+L   + +  D+   L   Q   ++L I +GL  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD--------QSQVVTTMRGTPGY 406
              +   H D+KP NILL       + D G                  Q     R T  Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 407 LAPE----WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            APE        +I E+ D++S G V+  ++ G   +D    ++ D   L++  + +   
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-MVFQKGDSVALAVQNQLSIPQ 268

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLH 521
                  +HS+ +            +    +  D  +RP + +++  LE +       H
Sbjct: 269 S-----PRHSSALWQ----------LLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  144 bits (364), Expect = 9e-38
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
               LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
            +E+    +V EYM  GSL  +L +      L   Q   +   IA G+ Y+        +
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H D++  NIL+  N   KVADFGL++LI+ ++       +    + APE       T K 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 421 DIYSFGVVMLEIL 433
           D++SFG+++ E+ 
Sbjct: 363 DVWSFGILLTELT 375

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (354), Expect = 1e-37
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 25/233 (10%)

Query: 214 EIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDG----TKVAVKR 269
            +  + +  V  +    S   +      F +++G+G FG V+ GT  D        AVK 
Sbjct: 6   ALNPELVQAVQHVVIGPSSLIVH-----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 270 L-EGIGEINKS-FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL-VYEYMPNGSLDRWLFQ 326
           L         S FL E   +    H N++ L+G C     + L V  YM +G L  ++  
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-- 118

Query: 327 RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
           R++      +      L +AKG+ YL     +K +H D+  +N +LD  F  KVADFGL+
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 175

Query: 387 KLIDQDQSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           + +   +   V    G    L     A E L     T K D++SFGV++ E++
Sbjct: 176 RDMYDKEYYSVHNKTG--AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 1e-37
 Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C E++   LV E+M +G L  +L  R+   +   +    + LD+ +G+ YL E     ++
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 126

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--P-GYLAPEWLS-SIIT 417
           H D+  +N L+  N   KV+DFG+++ +  DQ    T+  GT  P  + +PE  S S  +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 418 EKVDIYSFGVVMLEIL 433
            K D++SFGV+M E+ 
Sbjct: 184 SKSDVWSFGVLMWEVF 199

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (365), Expect = 2e-37
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
               LG+G FG V+ GT    T+VA+K L+      ++FL E + +  + H+ LV+L   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
            +E+    +V EYM  GSL  +L +      L   Q   +   IA G+ Y+        +
Sbjct: 331 VSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H D++  NIL+  N   KVADFGL++LI+ ++       +    + APE       T K 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 421 DIYSFGVVMLEIL 433
           D++SFG+++ E+ 
Sbjct: 446 DVWSFGILLTELT 458

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  141 bits (356), Expect = 2e-37
 Identities = 46/278 (16%), Positives = 100/278 (35%), Gaps = 29/278 (10%)

Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG 274
            +  +    LP      E ++ +       +LG+G F  V+E TQ D      K+   + 
Sbjct: 42  PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101

Query: 275 EINKSFLAEVKT-------IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DR-WLF 325
               +   E          +        ++       ++ ++LV E    G+L +   L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 326 QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-----------DG 374
           + + E ++         + +   +  +H+    +I+H DIKP N +L           D 
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218

Query: 375 NFNAKVADFGLSK-LIDQDQSQVVTTMRGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEI 432
           +    + D G S  +    +  + T    T G+   E LS+     ++D +     +  +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278

Query: 433 LCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
           L G  +  +++  E       +F++    D  ++    
Sbjct: 279 LFGTYMKVKNEGGE--CKPEGLFRRLPHLDMWNEFFHV 314

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  140 bits (355), Expect = 2e-37
 Identities = 53/250 (21%), Positives = 102/250 (40%), Gaps = 40/250 (16%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVK--------RLEGIGEINKSFLA--- 282
               +++R  + L +G F  +    +      A+K        +     + N   ++   
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85

Query: 283 -------EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL-----FQRSDE 330
                  E++ I  I ++  +   G         ++YEYM N S+ ++        ++  
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
             +  Q  K II  +    +Y+H    + I H D+KP NIL+D N   K++DFG S+ + 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202

Query: 391 QDQSQVVTTMRGTPGYLAPEWLSSIIT---EKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
               + +   RGT  ++ PE+ S+  +    KVDI+S G+ +  +      F        
Sbjct: 203 --VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS------L 254

Query: 448 DMYLLSIFKK 457
            + L+ +F  
Sbjct: 255 KISLVELFNN 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  139 bits (353), Expect = 2e-37
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQN 294
             K+LG G FG+V +G      ++    V +K + +  G  +       +  IGS+ H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +VRL+G C   S   LV +Y+P GSL   + Q         Q      + IAKG+ YL E
Sbjct: 77  IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEE 133

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS 413
                ++H ++  +N+LL      +VADFG++ L+  D  Q++ +   TP  ++A E + 
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 414 -SIITEKVDIYSFGVVMLEIL 433
               T + D++S+GV + E++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELM 211

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (350), Expect = 3e-37
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 243 RKMLGKGGFGSVFEGT---QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNLVR 297
              LG G FGSV +G    +     VA+K L +G  + +    + E + +  + +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           LIG C  ++  +LV E    G L ++L        +      +++  ++ G+ YL E   
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE--- 128

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG------TPGYLAPEW 411
           +  +H D+  +N+LL     AK++DFGLSK +  D S       G           APE 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APEC 184

Query: 412 LS-SIITEKVDIYSFGVVMLEIL 433
           ++    + + D++S+GV M E L
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEAL 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (352), Expect = 3e-37
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 30/229 (13%)

Query: 220 LDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGI 273
           L Q PG P  F    LK       + LG+G FG V            G  VAVK L    
Sbjct: 18  LFQGPGDPTVFHKRYLK-----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA 72

Query: 274 GEINKS-FLAEVKTIGSIHHQNLVRLIGFCAEKSHN--LLVYEYMPNGSLDRWLFQRSDE 330
           G  ++S +  E+  + +++H+++++  G C +       LV EY+P GSL  +L + S  
Sbjct: 73  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-- 130

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
             +   Q       I +G+ YLH    Q  +H D+  +N+LLD +   K+ DFGL+K + 
Sbjct: 131 --IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185

Query: 391 QDQSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           +             G       APE L         D++SFGV + E+L
Sbjct: 186 EGHEYYRVR---EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (353), Expect = 3e-37
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 23/206 (11%)

Query: 242 FRKMLGKGGFGSVFEG-----TQTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQN 294
            +K++G G FG V++G     +      VA+K L  G  E  +  FL E   +G   H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           ++RL G  ++    +++ EYM NG+LD++L  R  +      Q   ++  IA G+ YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG------TPGYLA 408
                 +H D+  +NIL++ N   KV+DFGLS++++ D     TT  G      T    A
Sbjct: 166 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218

Query: 409 PEWLS-SIITEKVDIYSFGVVMLEIL 433
           PE +S    T   D++SFG+VM E++
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVM 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 6e-37
 Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C ++    ++ EYM NG L  +L  R        QQ  ++  D+ + + YL     ++ L
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 142

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--P-GYLAPEWLS-SIIT 417
           H D+  +N L++     KV+DFGLS+ +  D+    T+  G+  P  +  PE L  S  +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 418 EKVDIYSFGVVMLEIL 433
            K DI++FGV+M EI 
Sbjct: 200 SKSDIWAFGVLMWEIY 215

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (346), Expect = 6e-37
 Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 12/196 (6%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             K LG G FG V  G       VAVK ++        F  E +T+  + H  LV+  G 
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
           C+++    +V EY+ NG L  +L  RS    L+  Q  ++  D+ +G+ +L      + +
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFI 126

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT--P-GYLAPEWLS-SIIT 417
           H D+  +N L+D +   KV+DFG+++ +  DQ     +  GT  P  + APE       +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 418 EKVDIYSFGVVMLEIL 433
            K D+++FG++M E+ 
Sbjct: 184 SKSDVWAFGILMWEVF 199

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  138 bits (350), Expect = 7e-37
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 242 FRKMLGKGGFGSVFEGT-----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQN 294
             K+LG G FG+V++G      +     VA+K L E          L E   + S+ + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           + RL+G C   S   L+ + MP G L  ++ +  D      Q      + IAKG+ YL +
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLED 135

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP-GYLAPEWLS 413
              ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +        P  ++A E + 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 414 -SIITEKVDIYSFGVVMLEIL 433
             I T + D++S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (353), Expect = 7e-37
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 25/233 (10%)

Query: 214 EIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDG----TKVAVKR 269
            +  + +  V  +    S   +      F +++G+G FG V+ GT  D        AVK 
Sbjct: 70  ALNPELVQAVQHVVIGPSSLIVH-----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124

Query: 270 LEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL-VYEYMPNGSLDRWLFQ 326
           L  I +I     FL E   +    H N++ L+G C     + L V  YM +G L  ++  
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-- 182

Query: 327 RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
           R++      +      L +AKG+ +L     +K +H D+  +N +LD  F  KVADFGL+
Sbjct: 183 RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 387 KLIDQDQSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           + +   +   V    G    L     A E L     T K D++SFGV++ E++
Sbjct: 240 RDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 7e-37
 Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 45/273 (16%)

Query: 243 RKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
           +  +G+G FG V        G + AVK++     +    + E+     +    +V L G 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 302 CAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
             E     +  E +  GSL + +       E      +    +    +GL YLH    ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQALEGLEYLHT---RR 170

Query: 360 ILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQVVT----TMRGTPGYLAPEWLSS 414
           ILH D+K  N+LL  +   A + DFG +  +  D           + GT  ++APE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE---- 226

Query: 415 IITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD 469
           ++       KVDI+S   +ML +L G   +     +     L    K  +E   + ++  
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPW----TQYFRGPL--CLKIASEPPPIREIPP 280

Query: 470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
             +        + +         L  +   R S
Sbjct: 281 SCAPLTA----QAIQE------GLRKEPVHRAS 303

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (352), Expect = 1e-36
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 242 FRKMLGKGGFGSVFEGT----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             K++G G FG V  G           VA+K L  G  E  +  FL E   +G   H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           +RL G   +    ++V EYM NGSLD +L  R  +      Q   ++  IA G+ YL + 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSD- 165

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG------TPGYLAP 409
                +H D+  +NIL++ N   KV+DFGL ++++ D     TT  G      T    +P
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219

Query: 410 EWLS-SIITEKVDIYSFGVVMLEIL 433
           E ++    T   D++S+G+V+ E++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVM 244

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (345), Expect = 1e-36
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 25/226 (11%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA-----EVKTI 287
           +   ++F   + LGKG FG+V+   +      +A+K L    ++ K+ +      EV+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRREVEIQ 63

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDI 345
             + H N++RL G+  + +   L+ EY P G++ R L    + DE     Q+    I ++
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITEL 118

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A  L+Y H    ++++H DIKP+N+LL      K+ADFG S      +      + GT  
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLCGTLD 172

Query: 406 YLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           YL PE +   +  EKVD++S GV+  E L G+  F+ +  +E   Y
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TY 216

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (343), Expect = 3e-36
 Identities = 57/203 (28%), Positives = 86/203 (42%), Gaps = 17/203 (8%)

Query: 242 FRKMLGKGGFGSVFEGT----QTDGTKVAVKRL-EGI---GEINKSFLAEVKTIGSIHHQ 293
             + LG G FG V  G           VAVK L   +    E    F+ EV  + S+ H+
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           NL+RL G         +V E  P GSL   L  R  +         +  + +A+G+ YL 
Sbjct: 82  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLE 138

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG-TP-GYLAPEW 411
               ++ +H D+  +N+LL      K+ DFGL + + Q+    V       P  + APE 
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 412 LS-SIITEKVDIYSFGVVMLEIL 433
           L     +   D + FGV + E+ 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMF 218

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (351), Expect = 5e-36
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             K LG G FG V+  T    TKVAVK ++      ++FLAE   + ++ H  LV+L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
              K    ++ E+M  GSL  +L            +       IA+G+ ++ +   +  +
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ---RNYI 306

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H D++  NIL+  +   K+ADFGL+++I+ ++       +    + APE ++    T K 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 421 DIYSFGVVMLEIL 433
           D++SFG++++EI+
Sbjct: 367 DVWSFGILLMEIV 379

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (340), Expect = 8e-36
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 8/195 (4%)

Query: 242 FRKMLGKGGFGSVFEGT-QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
            +  LG G +G V+EG  +     VAVK L E   E+ + FL E   +  I H NLV+L+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLL 75

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
           G C  +    ++ E+M  G+L  +L +  +   +       +   I+  + YL +   + 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KN 131

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITE 418
            +H D+  +N L+  N   KVADFGLS+L+  D        +    + APE L+ +  + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 419 KVDIYSFGVVMLEIL 433
           K D+++FGV++ EI 
Sbjct: 192 KSDVWAFGVLLWEIA 206

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  133 bits (338), Expect = 1e-35
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 25/226 (11%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA-----EVKTI 287
           K   D+F   + LGKG FG+V+   +      +A+K L    ++ K  +      E++  
Sbjct: 10  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQ 68

Query: 288 GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDI 345
             + H N++R+  +  ++    L+ E+ P G L + L    R DE     Q+    + ++
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATFMEEL 123

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A  L Y H    +K++H DIKP+N+L+      K+ADFG S      + +   TM GT  
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTLD 177

Query: 406 YLAPEWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           YL PE +      EKVD++  GV+  E L G   FD     E   +
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--TH 221

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (338), Expect = 1e-35
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 244 KMLGKGGFGSVFEGT---QTDGTKVAVKRL-EGIGEINKS--FLAEVKTIGSIHHQNLVR 297
           K LG G FG+V +G    +     VAVK L     +       LAE   +  + +  +VR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           +IG C  +S  +LV E    G L+++L Q      +  +   +++  ++ G+ YL E   
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE--- 135

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG------TPGYLAPEW 411
              +H D+  +N+LL     AK++DFGLSK +  D++       G           APE 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191

Query: 412 LS-SIITEKVDIYSFGVVMLEIL 433
           ++    + K D++SFGV+M E  
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAF 214

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (346), Expect = 3e-35
 Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 12/194 (6%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             + +GKG FG V  G    G KVAVK ++      ++FLAE   +  + H NLV+L+G 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 302 CAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             E+   L +V EYM  GSL  +L +     +L      K  LD+ + + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N+L+  +  AKV+DFGL+K     Q      ++ T    APE L     + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366

Query: 420 VDIYSFGVVMLEIL 433
            D++SFG+++ EI 
Sbjct: 367 SDVWSFGILLWEIY 380

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  134 bits (339), Expect = 4e-35
 Identities = 27/305 (8%), Positives = 69/305 (22%), Gaps = 56/305 (18%)

Query: 242 FRKMLGKGGFGSVFEGTQTD-GTKVAVK----RLEGIGEINKSFLAEVKTIGSIHHQNLV 296
             + L  G    VF     +     A+K      E      +           +  ++  
Sbjct: 66  LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125

Query: 297 RLIGFC--------------------------AEKSHNLLVYEYMPNGSL----DRWLFQ 326
                                              ++ LL+     +  L        F 
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFV 184

Query: 327 RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS 386
                         +   + +    L     + ++H    P N+ +  +    + D    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 387 KLIDQDQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
             +                Y   E+L++     T  ++ +  G+ +  + C    F    
Sbjct: 242 WKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 444 PEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
           P  +  +     +    +           + ++     ++         L  D  +R   
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK----TLIGRF------LNFDRRRRLLP 347

Query: 504 SMVVR 508
              + 
Sbjct: 348 LEAME 352

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (335), Expect = 4e-35
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 242 FRKMLGKGGFGSVFEGTQTDG----TKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             +++GKG FG V+ G   D      + A+K L           FL E   +  ++H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 296 VRLIGFC-AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           + LIG     +    ++  YM +G L +++  RS +     +      L +A+G+ YL E
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----AP 409
              QK +H D+  +N +LD +F  KVADFGL++ I     +  +  +     L     A 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRHARLPVKWTAL 197

Query: 410 EWLS-SIITEKVDIYSFGVVMLEIL 433
           E L     T K D++SFGV++ E+L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELL 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  132 bits (334), Expect = 5e-35
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 25/219 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA--------EVKTIGSIH 291
            F++ LG G FG V    + + G +  +K       INK            E++ + S+ 
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKT------INKDRSQVPMEQIEAEIEVLKSLD 78

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           H N++++     +  +  +V E    G L +R +  ++    L      +++  +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 351 YLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           Y H    Q ++H D+KP+NIL      +   K+ DFGL++L   D+    T   GT  Y+
Sbjct: 139 YFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYM 193

Query: 408 APEWLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPE 445
           APE     +T K DI+S GVVM  +L G   F   S  E
Sbjct: 194 APEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (333), Expect = 6e-35
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 16/198 (8%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             + LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVRL   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
              +    ++ EYM NGSL  +L +      L   +   +   IA+G+ ++ E   +  +
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APEWLS-SI 415
           H D++  NIL+    + K+ADFGL++LI+ ++    T   G          APE ++   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG--AKFPIKWTAPEAINYGT 186

Query: 416 ITEKVDIYSFGVVMLEIL 433
            T K D++SFG+++ EI+
Sbjct: 187 FTIKSDVWSFGILLTEIV 204

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (332), Expect = 9e-35
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)

Query: 242 FRKMLGKGGFGSVFEGT----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             ++LG+G FG V+EG     + +   VAVK   +     NK  F++E   + ++ H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+LIG   E+    ++ E  P G L  +L    ++  L         L I K + YL   
Sbjct: 76  VKLIGIIEEEPT-WIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES- 131

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APE 410
                +H DI  +NIL+      K+ DFGLS+ I+ +        + +   L     +PE
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKWMSPE 184

Query: 411 WLS-SIITEKVDIYSFGVVMLEIL 433
            ++    T   D++ F V M EIL
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEIL 208

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  137 bits (347), Expect = 9e-35
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 22/222 (9%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT---QTDGTKVAVKRL-EGIGEINKS 279
           P   K       +         LG G FGSV +G    +     VA+K L +G  + +  
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381

Query: 280 -FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             + E + +  + +  +VRLIG C  ++  +LV E    G L ++L        +     
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNV 438

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
            +++  ++ G+ YL E   +  +H ++  +N+LL     AK++DFGLSK +  D S    
Sbjct: 439 AELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495

Query: 399 TMRG------TPGYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
              G           APE ++    + + D++S+GV M E L
Sbjct: 496 RSAGKWPLKWY----APECINFRKFSSRSDVWSYGVTMWEAL 533

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  131 bits (331), Expect = 1e-34
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 242 FRKMLGKGGFGSVFEGT----QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             + +G+G FG V +G     +     VA+K       +  +  FL E  T+    H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+LIG    ++   ++ E    G L  +L  +  ++ LD          ++  L YL   
Sbjct: 79  VKLIGVI-TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES- 134

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APE 410
             ++ +H DI  +N+L+  N   K+ DFGLS+ ++       T  + + G L     APE
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPE 187

Query: 411 WLS-SIITEKVDIYSFGVVMLEIL 433
            ++    T   D++ FGV M EIL
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEIL 211

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  130 bits (330), Expect = 2e-34
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLE---GIGEINKSFLAEVKTIGSIHHQNLV 296
           N   MLGKG FG V +        + AVK +       +   + L EV+ +  + H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAKGLTYLH 353
           +L     + S   +V E    G L D  + +R    E         +II  +  G+TY+H
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDE-IIKRKRFSE-----HDAARIIKQVFSGITYMH 138

Query: 354 EDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +     I+H D+KP+NILL   + + + K+ DFGLS    Q+    +    GT  Y+APE
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPE 193

Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPE 445
            L     EK D++S GV++  +L G   F  +++ +
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  134 bits (338), Expect = 2e-34
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 28/225 (12%)

Query: 241 NFRKMLGKGGFGSVFEGTQTD-GTKVAVK---------RLEGIGEINKSFLAEVKTIGSI 290
              K LG G  G V    +     KVA++               +   +   E++ +  +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGL 349
           +H  ++++  F   + + + V E M  G L    F +      L     K     +   +
Sbjct: 198 NHPCIIKIKNFFDAEDYYI-VLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 350 TYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YLHE     I+H D+KP+N+LL   + +   K+ DFG SK++ +    ++ T+ GTP Y
Sbjct: 253 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTY 307

Query: 407 LAPEWLSSII----TEKVDIYSFGVVMLEILCGRKVFDRSQPEEE 447
           LAPE L S+        VD +S GV++   L G   F   + +  
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (328), Expect = 3e-34
 Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 12/194 (6%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
             + +GKG FG V  G    G KVAVK ++      ++FLAE   +  + H NLV+L+G 
Sbjct: 25  LLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 302 CAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
             E+   L +V EYM  GSL  +L +     +L      K  LD+ + + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 138

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEK 419
           +H D+  +N+L+  +  AKV+DFGL+K     Q      ++ T    APE L     + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 194

Query: 420 VDIYSFGVVMLEIL 433
            D++SFG+++ EI 
Sbjct: 195 SDVWSFGILLWEIY 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 4e-34
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 242 FRKMLGKGGFGSVFEGTQTDG----TKVAVKRL--EGIGEINKS-FLAEVKTIGSIHHQN 294
             K+LG+G FGSV EG          KVAVK +  +   +     FL+E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 295 LVRLIGFCAEK-----SHNLLVYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIA 346
           ++RL+G C E         +++  +M  G L  +L      +    +  Q   K ++DIA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            G+ YL     +  LH D+  +N +L  +    VADFGLSK I           +G    
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD----YYRQGRIAK 210

Query: 407 L-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           +     A E L+  + T K D+++FGV M EI 
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (330), Expect = 4e-34
 Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 47/294 (15%)

Query: 243 RKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSI-HHQNLVRLI 299
           R++L +GGF  V+E      G + A+KRL    E   ++ + EV  +  +  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 300 GFCA-------EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
              +             L+   +  G L  +L +      L      KI     + + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-----------TMR 401
           H   +  I+H D+K +N+LL      K+ DFG +  I        +           T  
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 402 GTPGYLAPE----WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
            TP Y  PE    + +  I EK DI++ G ++  +   +  F       ED   L I   
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------EDGAKLRIVNG 264

Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           K              +D Q           +    L+ +  +R S++ VV  L+
Sbjct: 265 K---------YSIPPHDTQYT-----VFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (326), Expect = 6e-34
 Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 41/217 (18%)

Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHH 292
           F + LG+G F  +F+G         Q   T+V +K L +     ++SF      +  + H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           ++LV   G C     N+LV E++  GSLD +L  + ++  ++   + ++   +A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 353 HEDCRQKILHLDIKPQNILLDGNFN--------AKVADFGLSKLIDQDQSQVVTTMRGTP 404
            E     ++H ++  +NILL    +         K++D G+S  +               
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------- 175

Query: 405 GY------LAPEWLS--SIITEKVDIYSFGVVMLEIL 433
                   + PE +     +    D +SFG  + EI 
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  133 bits (337), Expect = 6e-34
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 47/282 (16%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHHQNL 295
             +++LGKG FG V        G + AVK +           +S L EV+ +  + H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLH 353
           ++L  F  +K +  LV E    G L D  + ++   E         +II  +  G+TY+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-----VDAARIIRQVLSGITYMH 143

Query: 354 EDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +    KI+H D+KP+N+LL     + N ++ DFGLS   +  +   +    GT  Y+APE
Sbjct: 144 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE 198

Query: 411 WLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKKAEE-DKLS--- 465
            L     EK D++S GV++  +L G   F   ++ +         +  +  +  K+S   
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 466 -DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
            DL+ K                      L    + R S    
Sbjct: 259 KDLIRK---------------------MLTYVPSMRISARDA 279

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  131 bits (331), Expect = 6e-34
 Identities = 38/271 (14%), Positives = 76/271 (28%), Gaps = 56/271 (20%)

Query: 224 PGLPKRF-SFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVK------------- 268
            G P R  S    +  T     +LG+    +  E T Q  G    V              
Sbjct: 58  TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 117

Query: 269 ----------------RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG-FCAEKSHNLLV 311
                           + +   +++  F+     +     + ++R+          +   
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177

Query: 312 YEYMPNGSLDR---WLFQRSDE-FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKP 367
                  +L      L   S     L    R ++ L + + L  LH      ++H  ++P
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRP 234

Query: 368 QNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS------------I 415
            +I+LD      +  F                   + G+  PE  +             +
Sbjct: 235 VDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVSRGFEPPELEARRATISYHRDRRTL 289

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           +T   D ++ G+V+  I C      +     
Sbjct: 290 MTFSFDAWALGLVIYWIWCADLPITKDAALG 320

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (328), Expect = 6e-34
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
             + LG+G FG V+EG           T+VA+K + E      +  FL E   +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------LDWQQRKKIILDIA 346
           ++VRL+G  ++    L++ E M  G L  +L                   +  ++  +IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            G+ YL+     K +H D+  +N ++  +F  K+ DFG+++ I +         +G  G 
Sbjct: 149 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGL 201

Query: 407 L-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           L     +PE L   + T   D++SFGVV+ EI 
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  129 bits (326), Expect = 7e-34
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 39/257 (15%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVK----------RLEGIGEINKSFLAEVKTIGSI 290
            +++LG+G    V          + AVK            E + E+ ++ L EV  +  +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 291 -HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIA 346
             H N+++L       +   LV++ M  G L D  L ++    E     ++ +KI+  + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSE-----KETRKIMRALL 134

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           + +  LH+     I+H D+KP+NILLD + N K+ DFG S  +D    + +  + GTP Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSY 189

Query: 407 LAPEWLSSII-------TEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKK 458
           LAPE +   +        ++VD++S GV+M  +L G   F  R Q     M +   ++  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249

Query: 459 AEE-DKLS----DLVDK 470
           + E D  S    DLV +
Sbjct: 250 SPEWDDYSDTVKDLVSR 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (327), Expect = 1e-33
 Identities = 65/212 (30%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
             + LG G FG V+EG            +VAVK L E   E ++  FL E   I   +HQ
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM----LDWQQRKKIILDIAKGL 349
           N+VR IG   +     ++ E M  G L  +L +          L       +  DIA G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 350 TYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E      +H DI  +N LL        AK+ DFG+++ I +         +G    
Sbjct: 154 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAM 206

Query: 407 L-----APEWLS-SIITEKVDIYSFGVVMLEI 432
           L      PE     I T K D +SFGV++ EI
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (335), Expect = 1e-33
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 50/282 (17%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIH 291
             K LG G +G V          + A+K       I K+ ++         EV  +  + 
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKI------IRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS-DEFMLDWQQRKKIILDIAKGL 349
           H N+++L  F  +K +  LV E    G L D  + +   +E          II  +  G+
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-----VDAAVIIKQVLSGV 149

Query: 350 TYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
           TYLH+     I+H D+KP+N+LL   + +   K+ DFGLS + +  +   +    GT  Y
Sbjct: 150 TYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYY 204

Query: 407 LAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK--KKAEEDKL 464
           +APE L     EK D++S GV++  +L G   F     +E       I +  +K +    
Sbjct: 205 IAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTFD 257

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           S      S   +    +++  M      L+ D  +R S    
Sbjct: 258 SPEWKNVSEGAK----DLIKQM------LQFDSQRRISAQQA 289

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  132 bits (335), Expect = 1e-33
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 58/287 (20%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSI 290
           N   MLGKG FG V +        + AVK       INK+            EV+ +  +
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKV------INKASAKNKDTSTILREVELLKKL 78

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS-DEFMLDWQQRKKIILDIAKG 348
            H N+++L     + S   +V E    G L D  + ++   E         +II  +  G
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSG 133

Query: 349 LTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           +TY+H+     I+H D+KP+NILL   + + + K+ DFGLS    Q+    +    GT  
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188

Query: 406 YLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKKAEE-DK 463
           Y+APE L     EK D++S GV++  +L G   F  +++ +         +     +   
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248

Query: 464 LS----DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           +S    DL+ K                      L    + R + +  
Sbjct: 249 ISDDAKDLIRK---------------------MLTFHPSLRITATQC 274

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  129 bits (327), Expect = 1e-33
 Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 32/217 (14%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQN 294
            +  LG+G FG VF         + D   VAVK L E      + F  E + +  + HQ+
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK------------KII 342
           +VR  G C E    L+V+EYM +G L+R+L     +  L                   + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
             +A G+ YL        +H D+  +N L+      K+ DFG+S+ I            G
Sbjct: 165 SQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVG 217

Query: 403 TPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
               L      PE +     T + D++SFGVV+ EI 
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  129 bits (326), Expect = 1e-33
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 34/235 (14%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKS----FLAEVKTIGSI 290
              K LG G  G V    +     KVA+K     +                 E++ +  +
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGL 349
           +H  ++++  F   + + + V E M  G L    F +      L     K     +   +
Sbjct: 73  NHPCIIKIKNFFDAEDYYI-VLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 350 TYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YLHE     I+H D+KP+N+LL   + +   K+ DFG SK++ +    ++ T+ GTP Y
Sbjct: 128 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTY 182

Query: 407 LAPEWLSSII----TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           LAPE L S+        VD +S GV++   L G   F   + +        +  +
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 231

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  130 bits (329), Expect = 1e-33
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 24/238 (10%)

Query: 213 DEIEEDYLDQVPGLPKRFSFEELKVMTDNFRK--------MLGKGGFGSVFEGTQ-TDGT 263
            +        +P  P  F    +                 +LG G FG V +  +   G 
Sbjct: 56  SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115

Query: 264 KVAVKRLEGIGEINK-SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR 322
           K+A K ++  G  +K     E+  +  + H NL++L      K+  +LV EY+  G L  
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL-- 173

Query: 323 WLFQR--SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-- 378
             F R   + + L        +  I +G+ ++H+     ILHLD+KP+NIL         
Sbjct: 174 --FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQI 228

Query: 379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCG 435
           K+ DFGL++       + +    GTP +LAPE ++   ++   D++S GV+   +L G
Sbjct: 229 KIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  129 bits (326), Expect = 2e-33
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 36/244 (14%)

Query: 215 IEEDYLD-QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT---QTDGTKVAVKRL 270
           +++ +        P    +  L      F+ ++G+G FG V +            A+KR+
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 271 -EGIGEINKS-FLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--- 324
            E   + +   F  E++ +  + HH N++ L+G C  + +  L  EY P+G+L  +L   
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120

Query: 325 ----------FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG 374
                        S    L  QQ      D+A+G+ YL +   ++ +H D+  +NIL+  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 177

Query: 375 NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVV 428
           N+ AK+ADFGLS+   Q+       ++ T G L     A E L+ S+ T   D++S+GV+
Sbjct: 178 NYVAKIADFGLSR--GQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230

Query: 429 MLEI 432
           + EI
Sbjct: 231 LWEI 234

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (324), Expect = 2e-33
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKSFLAEVKTIGSIHHQN 294
            ++ LG+G FG VF           D   VAVK L +      K F  E + + ++ H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK-------------I 341
           +V+  G C +    ++V+EYM +G L+++L     + M+    + +             I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
              IA G+ YL     Q  +H D+  +N L+  N   K+ DFG+S+ +            
Sbjct: 139 ASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYRV 191

Query: 402 GTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
           G    L      PE +     T + D++SFGV++ EI 
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  128 bits (324), Expect = 2e-33
 Identities = 64/333 (19%), Positives = 109/333 (32%), Gaps = 95/333 (28%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKR--LEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
           + +G+GGFG VFE   + D    A+KR  L       +  + EVK +  + H  +VR   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 301 FCAEKSHNLLVYE-----------------------------------------YMPNGS 319
              E        E                                          +   S
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131

Query: 320 LDRWLF----------------QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHL 363
              +L+                +R      +      I + IA+ + +LH    + ++H 
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHR 188

Query: 364 DIKPQNILLDGNFNAKVADFGLSKLIDQDQS-----------QVVTTMRGTPGYLAPEWL 412
           D+KP NI    +   KV DFGL   +DQD+               T   GT  Y++PE +
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248

Query: 413 SSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
                + KVDI+S G+++ E+L           + E + +++  +      K   L  + 
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSF------STQMERVRIITDVRNL----KFPLLFTQK 298

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                           +    L     +RP  +
Sbjct: 299 YPQEH----------MMVQDMLSPSPTERPEAT 321

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  130 bits (328), Expect = 2e-33
 Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 22/232 (9%)

Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFR------KMLGKGGFGSVFEGTQ-TDGTKVAVKR 269
            DY      + K++  + ++V   +        + LG G FG V    +   G     K 
Sbjct: 24  NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83

Query: 270 LEGIGEINK-SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR- 327
           +     ++K +   E+  +  +HH  L+ L     +K   +L+ E++  G L    F R 
Sbjct: 84  INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRI 139

Query: 328 -SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA--KVADFG 384
            ++++ +   +    +    +GL ++HE     I+HLDIKP+NI+ +    +  K+ DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFG 196

Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCG 435
           L+  ++ D  ++V     T  + APE +    +    D+++ GV+   +L G
Sbjct: 197 LATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  127 bits (321), Expect = 3e-33
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 36/230 (15%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQN 294
                +G+G +G V    Q     + A K      +E +      F  E++ + S+ H N
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV----DRFKQEIEIMKSLDHPN 67

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAKGLTY 351
           ++RL     + +   LV E    G L +R +  +    E         +I+ D+   + Y
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFER-VVHKRVFRE-----SDAARIMKDVLSAVAY 121

Query: 352 LHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
            H+     + H D+KP+N L      +   K+ DFGL+      +  ++ T  GTP Y++
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVS 176

Query: 409 PEWLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKK 457
           P+ L  +   + D +S GV+M  +LCG   F   +  E        +  K
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VMLK 218

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (323), Expect = 4e-33
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 21/210 (10%)

Query: 242 FRKMLGKGGFGSVFEGTQTDG----TKVAVKRL-EGIGEIN--KSFLAEVKTIGSIHHQN 294
             +MLGKG FGSV E           KVAVK L   I   +  + FL E   +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 295 LVRLIGFCAEK------SHNLLVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDI 345
           + +L+G              +++  +M +G L  +L       + F L  Q   + ++DI
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP- 404
           A G+ YL     +  +H D+  +N +L  +    VADFGLS+ I              P 
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 405 GYLAPEWLS-SIITEKVDIYSFGVVMLEIL 433
            +LA E L+ ++ T   D+++FGV M EI+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 4e-33
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 242 FRKMLGKGGFGSVFEGTQTDG----TKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQNL 295
             + +G+G FG V +G           VA+K       +  +  FL E  T+    H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+LIG    ++   ++ E    G L  +L  R     L           ++  L YL   
Sbjct: 454 VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES- 509

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL-----APE 410
             ++ +H DI  +N+L+  N   K+ DFGLS+ ++       T  + + G L     APE
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPE 562

Query: 411 WLS-SIITEKVDIYSFGVVMLEIL 433
            ++    T   D++ FGV M EIL
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (335), Expect = 4e-33
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 23/205 (11%)

Query: 245 MLGKGGFGSVFEGTQT--DGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            +  GG G ++       +G  V +K     G  E     +AE + +  + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 301 FCAEKSHNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           F      +      +V EY+   SL R   Q+     L   +    +L+I   L+YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI 415
               +++ D+KP+NI+L      K+ D G    I+     +     GTPG+ APE + + 
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-GYLY----GTPGFQAPEIVRTG 252

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFD 440
            T   DIY+ G  +  +       +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  131 bits (331), Expect = 6e-33
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 49/287 (17%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRL--------------EGIGEINKSFLAEVKT 286
             + LG G +G V    +    ++ A+K +              + I + ++    E+  
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF-MLDWQQRKKIILDI 345
           + S+ H N+++L     +K +  LV E+   G L    F++       D      I+  I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQI 155

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
             G+ YLH+     I+H DIKP+NILL   +   N K+ DFGLS    +D    +    G
Sbjct: 156 LSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLG 210

Query: 403 TPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFK--KKA 459
           T  Y+APE L     EK D++S GV+M  +LCG   F  ++  +        I K  +K 
Sbjct: 211 TAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--------IIKKVEKG 262

Query: 460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           +     +     S++ +    E++ +M      L  D+ KR +    
Sbjct: 263 KYYFDFNDWKNISDEAK----ELIKLM------LTYDYNKRCTAEEA 299

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  126 bits (320), Expect = 8e-33
 Identities = 40/201 (19%), Positives = 86/201 (42%), Gaps = 15/201 (7%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
              + LG+G FG V    + +       K ++  G        E+  +    H+N++ L 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
                    ++++E++        +F+R  +  F L+ ++    +  + + L +LH    
Sbjct: 68  ESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 358 QKILHLDIKPQNILLDGNFNA--KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-S 414
             I H DI+P+NI+     ++  K+ +FG ++ +          +   P Y APE     
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHD 178

Query: 415 IITEKVDIYSFGVVMLEILCG 435
           +++   D++S G ++  +L G
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG 199

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (322), Expect = 9e-33
 Identities = 65/212 (30%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
             + LG G FG V+EG            +VAVK L E   E ++  FL E   I   +HQ
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM----LDWQQRKKIILDIAKGL 349
           N+VR IG   +     ++ E M  G L  +L +          L       +  DIA G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 350 TYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
            YL E      +H DI  +N LL        AK+ DFG+++ I +         +G    
Sbjct: 195 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAM 247

Query: 407 L-----APEWLS-SIITEKVDIYSFGVVMLEI 432
           L      PE     I T K D +SFGV++ EI
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  127 bits (322), Expect = 1e-32
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 38/256 (14%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRL---------EGIGEINKSFLAEVKTIGSIH 291
            + ++G+G    V        G + AVK +         E + E+ ++   E   +  + 
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 292 -HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAK 347
            H +++ LI      S   LV++ M  G L D  L ++    E     ++ + I+  + +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSE-----KETRSIMRSLLE 211

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
            +++LH      I+H D+KP+NILLD N   +++DFG S  ++    + +  + GTPGYL
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYL 266

Query: 408 APEWLSSII-------TEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKKA 459
           APE L   +        ++VD+++ GV++  +L G   F  R Q     M +   ++  +
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326

Query: 460 EE-DKLS----DLVDK 470
            E D  S    DL+ +
Sbjct: 327 PEWDDRSSTVKDLISR 342

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  125 bits (316), Expect = 1e-32
 Identities = 67/253 (26%), Positives = 107/253 (42%), Gaps = 40/253 (15%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSI 290
           + ++ LGKG F  V      T G + A K       IN   L+         E +    +
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKI------INTKKLSARDFQKLEREARICRKL 62

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAK 347
            H N+VRL     E+S + LV++ +  G L +  +  R    E           I  I +
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFED-IVAREFYSE-----ADASHCIQQILE 116

Query: 348 GLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
            + Y H      I+H ++KP+N+LL         K+ADFGL+  ++  +        GTP
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTP 171

Query: 405 GYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKKAEE- 461
           GYL+PE L     ++ VDI++ GV++  +L G   F D  Q           +   + E 
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 231

Query: 462 DKLS----DLVDK 470
           D ++     L+D 
Sbjct: 232 DTVTPEAKSLIDS 244

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  128 bits (322), Expect = 2e-32
 Identities = 40/309 (12%), Positives = 85/309 (27%), Gaps = 71/309 (22%)

Query: 206 FRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDN------------------------ 241
           FR  +  D + E+  +++P    R + E ++   D+                        
Sbjct: 19  FRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 78

Query: 242 ---FRKMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVK------------ 285
                 +LG+    +  E T Q  G    V           + + ++K            
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 286 --------------TIGSIHHQNLVRLIGFCAEKSHNLLVYEY--MP-----NGSLDRWL 324
                             +      ++I    ++    ++  +   P       +    L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 325 FQRSDEF-MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADF 383
              S     L    R ++ L + + L  LH      ++H  ++P +I+LD      +  F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 384 GLSKLIDQDQSQVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRK 437
                        +      P   A   L       +++T   D ++ G+ +  I C   
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 438 VFDRSQPEE 446
                    
Sbjct: 316 PNTDDAALG 324

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  126 bits (319), Expect = 2e-32
 Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 16/216 (7%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINK-SFLAEVKTIGSIHHQN 294
             +++GKG F  V        G + AVK     +      ++      E      + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V L+   +      +V+E+M    L    + +    F+         +  I + L Y H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 354 EDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           +     I+H D+KP  +LL   + +   K+  FG++  + +    V     GTP ++APE
Sbjct: 148 D---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPE 203

Query: 411 WLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPE 445
            +      + VD++  GV++  +L G   F  ++  
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  125 bits (315), Expect = 3e-32
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
            +LG+G +G V E   ++   + AVK     +L  I     +   E++ +  + H+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 298 L--IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           L  + +  EK    +V EY   G  +  +     E      Q       +  GL YLH  
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLH-- 126

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWLSS 414
             Q I+H DIKP N+LL      K++  G+++ +          T +G+P +  PE  + 
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 415 IIT---EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           + T    KVDI+S GV +  I  G   F+      +++Y L  F+ 
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFE-----GDNIYKL--FEN 224

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  125 bits (316), Expect = 3e-32
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-------RLEGIGEINKSFLAEVKTIGSIHH 292
           +  + LG G F  V +  + + G + A K       R    G   +    EV  +  + H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTY 351
            N++ L      ++  +L+ E +  G L    F   + +  L  ++    I  I  G+ Y
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 352 LHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           LH    +KI H D+KP+NI+L        + K+ DFGL+  I+         + GTP ++
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFV 185

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCG 435
           APE ++   +  + D++S GV+   +L G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (315), Expect = 4e-32
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEV---KTIGSI 290
           F K LG G FG V E T            VAVK L        +   ++E+     +G  
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-- 84

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK----------- 339
           +H N+V L+G C      L++ EY   G L  +L ++ D F+                  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 340 ----KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
                    +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + 
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 396 VVTTMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
           VV      P  ++APE +   + T + D++S+G+ + E+
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  125 bits (315), Expect = 5e-32
 Identities = 63/257 (24%), Positives = 102/257 (39%), Gaps = 56/257 (21%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEINK-SFLAEVKTIGSIHHQN 294
            +  +G+G +G V    +       A+K     ++  I   +      EV+ +  +HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSL-DR------------------------------- 322
           + RL     ++ +  LV E    G L D+                               
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 323 -----WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGN 375
                  F+ S +F+   +    I+  I   L YLH    Q I H DIKP+N L   + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKS 206

Query: 376 FNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYLAPEWLSSI---ITEKVDIYSFGVVM 429
           F  K+ DFGLSK     +  +   +TT  GTP ++APE L++       K D +S GV++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 430 LEILCGRKVF-DRSQPE 445
             +L G   F   +  +
Sbjct: 267 HLLLMGAVPFPGVNDAD 283

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  124 bits (313), Expect = 6e-32
 Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 43/215 (20%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKS-------FLAEVKTIGSIHH 292
            F ++LG G F  VF   Q   G   A+K       I KS          E+  +  I H
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKC------IKKSPAFRDSSLENEIAVLKKIKH 65

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK--------IILD 344
           +N+V L       +H  LV + +  G L    F R  E       R          +I  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILE-------RGVYTEKDASLVIQQ 114

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           +   + YLHE     I+H D+KP+N+L    + N    + DFGLSK+       +++T  
Sbjct: 115 VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTAC 168

Query: 402 GTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCG 435
           GTPGY+APE L+    ++ VD +S GV+   +LCG
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (312), Expect = 7e-32
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 40/222 (18%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
           F + LG+  FG V++G             VA+K L +      +  F  E      + H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK------------- 340
           N+V L+G   +     +++ Y  +G L  +L  RS    +      +             
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
           ++  IA G+ YL       ++H D+  +N+L+    N K++D GL + +           
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYK 185

Query: 401 RGTPGYL-----APEWLSSII----TEKVDIYSFGVVMLEIL 433
                 L     APE   +I+    +   DI+S+GVV+ E+ 
Sbjct: 186 LLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVF 224

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  125 bits (315), Expect = 1e-31
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-------RLEGIGEINKSFLAEVKTIGSIHH 292
           +  + LG G F  V +  + + G + A K       R    G   +    EV  +  + H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTY 351
            N++ L      ++  +L+ E +  G L    F   + +  L  ++    I  I  G+ Y
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 352 LHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           LH    +KI H D+KP+NI+L        + K+ DFGL+  I+         + GTP ++
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFV 185

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCG 435
           APE ++   +  + D++S GV+   +L G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  122 bits (309), Expect = 1e-31
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-----RLEGIGEIN--KSFLAEVKTIGSIHH 292
              + LG G F  V +  Q   G + A K     RL         +    EV  +  I H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTY 351
            N++ L      K+  +L+ E +  G L    F   +++  L   +  + +  I  G+ Y
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 352 LHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           LH    ++I H D+KP+NI+L      N   K+ DFG++  I+         + GTP ++
Sbjct: 124 LHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFV 178

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCG 435
           APE ++   +  + D++S GV+   +L G
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  123 bits (312), Expect = 1e-31
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSI-HH 292
           K LG+G F  V +    + G + A K       + K             E+  +      
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKF------LKKRRRGQDCRAEILHEIAVLELAKSC 88

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
             ++ L       S  +L+ EY   G +          E + +     ++I  I +G+ Y
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSL-CLPELAEMVSE-NDVIRLIKQILEGVYY 146

Query: 352 LHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           LH+     I+HLD+KPQNILL       + K+ DFG+S+ I       +  + GTP YLA
Sbjct: 147 LHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLA 201

Query: 409 PEWLS-SIITEKVDIYSFGVVMLEILCG 435
           PE L+   IT   D+++ G++   +L  
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (311), Expect = 1e-31
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 34/222 (15%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
             K LG+G FG V + T      +   T VAVK L E          L+E   +  ++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM--------------------- 332
           ++++L G C++    LL+ EY   GSL  +L +                           
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           L           I++G+ YL E    K++H D+  +NIL+      K++DFGLS+ + ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 393 QSQVVTTMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
            S V  +    P  ++A E L   I T + D++SFGV++ EI
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (312), Expect = 1e-31
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 33/219 (15%)

Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRL-EGIGEINKS-FLAEV---KTIG 288
             K LG+G FG V              +   VAVK L +   E + S  ++E+   K IG
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK--------- 339
              H+N++ L+G C +     ++ EY   G+L  +L  R    M                
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 340 ----KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
                    +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+     
Sbjct: 157 KDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213

Query: 396 VVTTMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
             TT    P  ++APE L   + T + D++SFGV+M EI
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  123 bits (312), Expect = 2e-31
 Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---EVKTIG-SIHHQNL 295
             ++ +G G +             + AVK       I+KS      E++ +     H N+
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKI------IDKSKRDPTEEIEILLRYGQHPNI 78

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLH 353
           + L     +  +  +V E M  G L D+ L Q+   E     ++   ++  I K + YLH
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-----REASAVLFTITKTVEYLH 133

Query: 354 EDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
               Q ++H D+KP NIL         + ++ DFG +K +  +   ++ T   T  ++AP
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAP 189

Query: 410 EWLSSII-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           E L         DI+S GV++  +L G   F     +  +     I  +
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILAR 234

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (312), Expect = 2e-31
 Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 42/227 (18%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSIHHQ 293
           + + +G+G FG VF+            T VAVK L E      ++ F  E   +    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK-------------- 339
           N+V+L+G CA      L++EYM  G L+ +L   S   +                     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 340 -------KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
                   I   +A G+ YL E   +K +H D+  +N L+  N   K+ADFGLS+ I   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 393 QSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEIL 433
                         +      PE +  +  T + D++++GVV+ EI 
Sbjct: 228 D----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  127 bits (321), Expect = 2e-31
 Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 30/246 (12%)

Query: 207 RKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFR------KMLGKGGFGSVFEGTQ- 259
           +   G   +  +Y + V  + K++  + +++  D+        + LG G FG V   T+ 
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 260 TDGTKVAVK-----RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY 314
             G   A K            + K    E++T+  + H  LV L     + +  +++YE+
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRK----EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235

Query: 315 MPNGSLDRWLFQR--SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
           M  G L    F++   +   +   +  + +  + KGL ++HE      +HLD+KP+NI+ 
Sbjct: 236 MSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 288

Query: 373 DGNFNA--KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVM 429
               +   K+ DFGL+  +D    Q V    GT  + APE      +    D++S GV+ 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

Query: 430 LEILCG 435
             +L G
Sbjct: 347 YILLSG 352

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (313), Expect = 2e-31
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 47/226 (20%)

Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRL-EGIGEINKS-FLAEV---KTIG 288
             K LG+G FG V              +   VAVK L +   E + S  ++E+   K IG
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK--------- 339
              H+N++ L+G C +     ++ EY   G+L  +L  R    M                
Sbjct: 145 --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 340 ----KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
                    +A+G+ YL     QK +H D+  +N+L+  N   K+ADFGL++ I+     
Sbjct: 203 KDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259

Query: 396 VVTT--------MRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
             TT        M       APE L   + T + D++SFGV+M EI
Sbjct: 260 KKTTNGRLPVKWM-------APEALFDRVYTHQSDVWSFGVLMWEI 298

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  123 bits (311), Expect = 2e-31
 Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 28/242 (11%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKT 286
           K   F +   + D   K LG+G F    +          AVK       I+K   A  + 
Sbjct: 2   KDSPFYQHYDL-DLKDKPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQK 54

Query: 287 IGSIH-----HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS-DEFMLDWQQRK 339
             +       H N+V+L     ++ H  LV E +  G L +R   ++   E      +  
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE-----TEAS 109

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQV 396
            I+  +   ++++H+     ++H D+KP+N+L    + N   K+ DFG ++L   D  Q 
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165

Query: 397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           + T   T  Y APE L+ +   E  D++S GV++  +L G+  F            + I 
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225

Query: 456 KK 457
           KK
Sbjct: 226 KK 227

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (308), Expect = 2e-31
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 12/203 (5%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRL 298
             LG GG  +V+    T    KVA+K +       +  L     EV     + HQN+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
           I    E     LV EY+   +L  ++        L           I  G+ + H     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DM 130

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIIT 417
           +I+H DIKPQNIL+D N   K+ DFG++K + +        + GT  Y +PE        
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 418 EKVDIYSFGVVMLEILCGRKVFD 440
           E  DIYS G+V+ E+L G   F+
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN 213

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  121 bits (305), Expect = 4e-31
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 36/232 (15%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA--------EVKTIGSIHHQN 294
           + LG+G +G V           VAVK    I  ++             E+     ++H+N
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK----I--VDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKK---IILDIAKGL 349
           +V+  G   E +   L  EY   G L    F R   D  M +   ++    ++     G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA----GV 118

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPGYLA 408
            YLH      I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 409 PEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
           PE L       E VD++S G+V+  +L G   +D  QP +         +KK
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (307), Expect = 6e-31
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 39/220 (17%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSI-HH 292
           F K LG G FG V E T      +    KVAVK L        K   ++E+K +  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK-----------KI 341
           +N+V L+G C      L++ EY   G L  +L ++S     D                  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT-- 399
              +A+G+ +L     +  +H D+  +N+LL     AK+ DFGL++ I  D + +V    
Sbjct: 170 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 400 ------MRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
                 M       APE +   + T + D++S+G+++ EI
Sbjct: 227 RLPVKWM-------APESIFDCVYTVQSDVWSYGILLWEI 259

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  122 bits (308), Expect = 8e-31
 Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 40/252 (15%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIH 291
            ++ LGKG F  V      T G + A K       IN   L+         E +    + 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKI------INTKKLSARDFQKLEREARICRKLQ 86

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAKG 348
           H N+VRL     E+S + LV++ +  G L +  +  R    E           I  I + 
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFED-IVAREFYSE-----ADASHCIQQILES 140

Query: 349 LTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           + Y H      I+H ++KP+N+LL         K+ADFGL+  ++  +        GTPG
Sbjct: 141 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPG 195

Query: 406 YLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVF-DRSQPEEEDMYLLSIFKKKAEE-D 462
           YL+PE L     ++ VDI++ GV++  +L G   F D  Q           +   + E D
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255

Query: 463 KLS----DLVDK 470
            ++     L+D 
Sbjct: 256 TVTPEAKSLIDS 267

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (304), Expect = 1e-30
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEVKTIGSI-HH 292
             K LG+G FG V E              VAVK L EG         ++E+K +  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 293 QNLVRLIGFC-AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK------------ 339
            N+V L+G C       +++ E+   G+L  +L  + +EF+      +            
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 340 -KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                 +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V  
Sbjct: 151 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 399 TMRGTP-GYLAPEWLS-SIITEKVDIYSFGVVMLEI 432
                P  ++APE +   + T + D++SFGV++ EI
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  120 bits (303), Expect = 2e-30
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 36/232 (15%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA--------EVKTIGSIHHQN 294
           + LG+G +G V           VAVK    I  ++             E+     ++H+N
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK----I--VDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR--SDEFMLDWQQRKK---IILDIAKGL 349
           +V+  G   E +   L  EY   G L    F R   D  M +   ++    ++     G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA----GV 118

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPGYLA 408
            YLH      I H DIKP+N+LLD   N K++DFGL+ +    ++ +++  M GT  Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 409 PEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
           PE L       E VD++S G+V+  +L G   +D  QP +         +KK
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 3e-30
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVK-------RLEGIGEINKSFLAEVKTIGSIHH 292
           +  + LG G F  V +  + + G + A K       +    G   +    EV  +  I H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTY 351
            N++ L      K+  +L+ E +  G L    F   +++  L  ++  + +  I  G+ Y
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 352 LHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
           LH     +I H D+KP+NI+L          K+ DFGL+  ID         + GTP ++
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFV 184

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCG 435
           APE ++   +  + D++S GV+   +L G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (303), Expect = 3e-30
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL-EGIGEINKS-FLAEV---KTIGSI 290
           F K+LG G FG V   T           +VAVK L E      +   ++E+     +G  
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-- 106

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK----------- 339
            H+N+V L+G C       L++EY   G L  +L  + ++F  D  + +           
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 340 ---------KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
                         +AKG+ +L     +  +H D+  +N+L+      K+ DFGL++ I 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 391 QDQSQVVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEI 432
            D + V          L     APE L   I T K D++S+G+++ EI
Sbjct: 224 SDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  119 bits (301), Expect = 5e-30
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKS-----FLAEVKTIGSIHHQNL 295
               LG+G    V+   Q       A+K       + K+        E+  +  + H N+
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKV------LKKTVDKKIVRTEIGVLLRLSHPNI 110

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAKGLTYL 352
           ++L       +   LV E +  G L DR + ++    E     +     +  I + + YL
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDR-IVEKGYYSE-----RDAADAVKQILEAVAYL 164

Query: 353 HEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           HE     I+H D+KP+N+L      +   K+ADFGLSK+++     ++ T+ GTPGY AP
Sbjct: 165 HE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAP 219

Query: 410 EWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           E L       +VD++S G++   +LCG + F   +  ++ M+
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPF-YDERGDQFMF 260

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 8e-30
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 12/204 (5%)

Query: 243 RKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVR 297
           R+++G+GG G V+E   T     VA+K +      +  F      E +T G +   ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           +  F        +    +    L   L     +  L   +   I+  I   L   H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---A 152

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SII 416
               H D+KP+NIL+  +  A + DFG++     ++   +    GT  Y+APE  S S  
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 417 TEKVDIYSFGVVMLEILCGRKVFD 440
           T + DIY+   V+ E L G   + 
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQ 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (302), Expect = 8e-30
 Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 41/223 (18%)

Query: 242 FRKMLGKGGFGSVFEGT--------QTDGTKVAVKRL-EGIGEINKS-FLAEV---KTIG 288
             K LG+G FG V                TKVAVK L     E + S  ++E+   K IG
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK--------- 339
              H+N++ L+G C +     ++ EY   G+L  +L  R    +                
Sbjct: 133 --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 340 ----KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
                    +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I      
Sbjct: 191 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-- 245

Query: 396 VVTTMRGTPGYL-----APEWLS-SIITEKVDIYSFGVVMLEI 432
                + T G L     APE L   I T + D++SFGV++ EI
Sbjct: 246 --YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (298), Expect = 8e-30
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 18/209 (8%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRL 298
           ++LG GG   V           VAVK L      + SF      E +   +++H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 299 --IGFCAEKSHNL--LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
              G     +  L  +V EY+   +L   +     E  +  ++  ++I D  + L + H 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH- 133

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT--MRGTPGYLAPE-W 411
             +  I+H D+KP NI++      KV DFG+++ I    + V  T  + GT  YL+PE  
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVFD 440
               +  + D+YS G V+ E+L G   F 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  120 bits (304), Expect = 1e-29
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 33/211 (15%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA---------EVKTIGSIH 291
             + LGKG F  V    +   G + A         IN   L+         E +    + 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMI------INTKKLSARDHQKLEREARICRLLK 68

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSL-DRWLFQRS--DEFMLDWQQRKKIILDIAKG 348
           H N+VRL    +E+ H+ L+++ +  G L +  +  R    E           I  I + 
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFED-IVAREYYSE-----ADASHCIQQILEA 122

Query: 349 LTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           + + H+     ++H ++KP+N+LL         K+ADFGL+  ++ +Q Q      GTPG
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPG 178

Query: 406 YLAPEWLS-SIITEKVDIYSFGVVMLEILCG 435
           YL+PE L      + VD+++ GV++  +L G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  118 bits (297), Expect = 1e-29
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA-------------EVKTIGS 289
            +LG GGFGSV+ G   +D   VA+K       + K  ++             EV  +  
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKH------VEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 290 IHHQ--NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF------QRSDEFMLDWQQRKKI 341
           +      ++RL+ +       +L+ E  P    D  LF          E     +  +  
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQE-----ELARSF 154

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQVVTTM 400
              + + + + H      +LH DIK +NIL+D N    K+ DFG   L+   +  V T  
Sbjct: 155 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 208

Query: 401 RGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
            GT  Y  PEW+           ++S G+++ +++CG   F+  +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  116 bits (294), Expect = 2e-29
 Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 61/254 (24%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA-------------------- 282
             +GKG +G V     + D T  A+K       ++K  L                     
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMK------VLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 283 -------------EVKTIGSIHHQNLVRL--IGFCAEKSHNLLVYEYMPNGSLDRWLFQR 327
                        E+  +  + H N+V+L  +     + H  +V+E +  G +     + 
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEV 128

Query: 328 SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK 387
                L   Q +    D+ KG+ YLH    QKI+H DIKP N+L+  + + K+ADFG+S 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWLSSIITE----KVDIYSFGVVMLEILCGRKVFDRSQ 443
              +    +++   GTP ++APE LS          +D+++ GV +   + G+  F    
Sbjct: 186 EF-KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM--- 241

Query: 444 PEEEDMYLLSIFKK 457
               D  ++ +  K
Sbjct: 242 ----DERIMCLHSK 251

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 3e-29
 Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 48/289 (16%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKR--LEGIGEINKSFLAEVKTIGSIHHQN 294
           D++     +G G    V          KVA+KR  LE         L E++ +   HH N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 295 LVRLIGFCAEKSHNL-LVYEYMPNGSL-----DRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           +V            L LV + +  GS+                +LD      I+ ++ +G
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG----LSKLIDQDQSQVVTTMRGTP 404
           L YLH   +   +H D+K  NILL  + + ++ADFG    L+   D  +++V  T  GTP
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 405 GYLAPEWLSSIITE------KVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKK 457
            ++APE    ++ +      K DI+SFG+  +E+  G   + +  P    M  L+   + 
Sbjct: 191 CWMAPE----VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKVLMLTLQN 242

Query: 458 KA----EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
                    +  +++ K+    +    +++      + CL+ D  KRP+
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFR----KMI------SLCLQKDPEKRPT 281

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  117 bits (295), Expect = 3e-29
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 31/215 (14%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK-----RLEGIGEINKSFLA----EVKTIGSIHHQ 293
             LG G FG V+    +    +V VK     ++     I    L     E+  +  + H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF------QRSDEFMLDWQQRKKIILDIAK 347
           N+++++     +    LV E   +G LD  LF       R DE          I   +  
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDE-----PLASYIFRQLVS 141

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYL 407
            + YL     + I+H DIK +NI++  +F  K+ DFG +  +++   ++  T  GT  Y 
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196

Query: 408 APEWLSSIITE--KVDIYSFGVVMLEILCGRKVFD 440
           APE L        +++++S GV +  ++     F 
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  117 bits (294), Expect = 3e-29
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRL 298
           K +GKG F  V        G +VA+K ++   ++N + L     EV+ +  ++H N+V+L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                 +    L+ EY   G +  +L        +  ++ +     I   + Y H   ++
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QK 133

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE 418
           +I+H D+K +N+LLD + N K+ADFG S          +    G P Y APE       +
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYD 191

Query: 419 --KVDIYSFGVVMLEILCGRKVFD 440
             +VD++S GV++  ++ G   FD
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  117 bits (294), Expect = 4e-29
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA--E 283
           PK+++  +   ++   +++LG G  G V E      G K A+K       +  S  A  E
Sbjct: 21  PKKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKL------LYDSPKARQE 71

Query: 284 VKTIGSI-HHQNLVRLIGFCAEKSHN----LLVYEYMPNGSL-DRWLFQRSDEFMLDWQQ 337
           V          ++V ++       H     L++ E M  G L  R + +R D+   + ++
Sbjct: 72  VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR-IQERGDQAFTE-RE 129

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQS 394
             +I+ DI   + +LH      I H D+KP+N+L    + +   K+ DFG +K   Q   
Sbjct: 130 AAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--- 183

Query: 395 QVVTTMRGTPGYLAPEWLSSII-TEKVDIYSFGVVMLEILCG 435
             + T   TP Y+APE L      +  D++S GV+M  +LCG
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  115 bits (291), Expect = 6e-29
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 47/227 (20%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTI--------------- 287
            +LGKGGFG+VF G   TD  +VA+K       I ++ +     +               
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKV------IPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 288 --GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLF------QRSDEFMLDWQQRK 339
                 H  ++RL+ +   +   +LV E        + LF          E        +
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGE-----GPSR 142

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVT 398
                +   + + H    + ++H DIK +NIL+D     AK+ DFG   L+     +  T
Sbjct: 143 CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYT 196

Query: 399 TMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
              GT  Y  PEW+S          ++S G+++ +++CG   F+R Q
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (287), Expect = 2e-28
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 52/225 (23%)

Query: 243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA-------EVKTIGSI-HHQ 293
             +LG+G    V          + AVK       I K           EV+ +     H+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKI------IEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK--------KIILDI 345
           N++ LI F  E+    LV+E M  GS    +            +R+         ++ D+
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGS----ILSHI-------HKRRHFNELEASVVVQDV 120

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQ------SQV 396
           A  L +LH    + I H D+KP+NIL    +     K+ DF L   I  +       +  
Sbjct: 121 ASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 397 VTTMRGTPGYLAPEWLSSIIT------EKVDIYSFGVVMLEILCG 435
           + T  G+  Y+APE + +         ++ D++S GV++  +L G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  115 bits (290), Expect = 3e-28
 Identities = 64/239 (26%), Positives = 112/239 (46%), Gaps = 44/239 (18%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSF----------LA 282
            V  D+F   + +GKG FG V    + D  K+ A+K       +NK              
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK------YMNKQKCVERNEVRNVFK 64

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
           E++ +  + H  LV L  +  +   ++ +V + +  G L R+  Q++  F  +     K+
Sbjct: 65  ELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEE---TVKL 119

Query: 342 -ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM 400
            I ++   L YL     Q+I+H D+KP NILLD + +  + DF ++ ++ ++     TTM
Sbjct: 120 FICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTM 174

Query: 401 RGTPGYLAPEWLSSIITEK--------VDIYSFGVVMLEILCGRKVFD-RSQPEEEDMY 450
            GT  Y+APE    + + +        VD +S GV   E+L GR+ +  RS    +++ 
Sbjct: 175 AGTKPYMAPE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  113 bits (284), Expect = 3e-28
 Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 42/231 (18%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
             LG G FG V  G     G KVAVK    I  +N+  +           E++ +    H
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVK----I--LNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKG 348
            ++++L    +  +   +V EY+  G L  ++ +       E    +QQ       I   
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ-------ILSA 123

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + Y H   R  ++H D+KP+N+LLD + NAK+ADFGLS ++     + + T  G+P Y A
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAA 178

Query: 409 PEWLSSIITE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
           PE +S  +    +VDI+S GV++  +LCG   FD       D ++ ++FKK
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-------DEHVPTLFKK 222

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (286), Expect = 3e-28
 Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 29/241 (12%)

Query: 207 RKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDN------FRKM--LGKGGFGSVFEGT 258
              +G D   E+   Q   +        L+++ D             +G+G  G V    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 259 QTD-GTKVAVKRLEGIGEINKSFL-AEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYM 315
           +   G +VAVK ++   +  +  L  EV  +    H N+V +          L ++ E++
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFL 124

Query: 316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN 375
             G+L   +     +  L+ +Q   +   + + L YLH    Q ++H DIK  +ILL  +
Sbjct: 125 QGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177

Query: 376 FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITE-----KVDIYSFGVVML 430
              K++DFG    I +D  +   ++ GTP ++APE    +I+      +VDI+S G++++
Sbjct: 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPE----VISRSLYATEVDIWSLGIMVI 232

Query: 431 E 431
           E
Sbjct: 233 E 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (282), Expect = 7e-28
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA-EVKTIGSIHHQN 294
              + +   +G+G  G+V+       G +VA++++    +  K  +  E+  +    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 295 LVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V  +         L +V EY+  GSL   +     E  +D  Q   +  +  + L +LH
Sbjct: 79  IVNYLD-SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH 133

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                +++H DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE   
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPE--- 186

Query: 414 SIITE-----KVDIYSFGVVMLE 431
            ++T      KVDI+S G++ +E
Sbjct: 187 -VVTRKAYGPKVDIWSLGIMAIE 208

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 8e-28
 Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 50/279 (17%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKR--LEGIGEINKSFLAEVKTIGSIHHQ 293
            + F K+  +GKG FG VF+G        VA+K   LE   +  +    E+  +      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 294 NLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
            + +  G    K   L ++ EY+  GS    L        LD  Q   I+ +I KGL YL
Sbjct: 81  YVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYL 135

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H    +K +H DIK  N+LL  +   K+ADFG++  +   Q +   T  GTP ++APE  
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPE-- 189

Query: 413 SSIITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKAEEDK 463
             +I +     K DI+S G+  +E+  G       +P   +++    L  I K       
Sbjct: 190 --VIKQSAYDSKADIWSLGITAIELARG-------EPPHSELHPMKVLFLIPKNNPPT-- 238

Query: 464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
              L   +S  ++    E V        CL  + + RP+
Sbjct: 239 ---LEGNYSKPLK----EFV------EACLNKEPSFRPT 264

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (281), Expect = 1e-27
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 33/213 (15%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKV-AVKRL--EGIGEINKS--FLAEVKTIGSIHHQNL 295
            F K+LG+G F +V    +   ++  A+K L    I + NK      E   +  + H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 296 VRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK-----IILDIAKGL 349
           V+L  F  +    L     Y  NG L +++ ++   F        +     I+      L
Sbjct: 93  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDET---CTRFYTAEIVS----AL 143

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT-TMRGTPGYLA 408
            YLH    + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q    +  GT  Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 409 PEWLSSIITEK-----VDIYSFGVVMLEILCGR 436
           PE    ++TEK      D+++ G ++ +++ G 
Sbjct: 201 PE----LLTEKSACKSSDLWALGCIIYQLVAGL 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (281), Expect = 2e-27
 Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 26/244 (10%)

Query: 224 PGLPKRFSFEELKVMTDNFRKM--LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGE-INK 278
                R +     +M + ++K+  +G+G +G V++   + G  VA+K  RL+   E I  
Sbjct: 6   HHSSGRENLYFQGLM-EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS 64

Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
           + + E+  +  +HH N+V LI     +    LV+E+M     D       ++  L   Q 
Sbjct: 65  TAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQI 121

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----S 394
           K  +  + +G+ + H   + +ILH D+KPQN+L++ +   K+ADFGL++           
Sbjct: 122 KIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 395 QVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL 452
           +VVT       Y AP+ L  S   +  VDI+S G +  E++ G+ +F       +D  L 
Sbjct: 179 EVVTLW-----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF---PGVTDDDQLP 230

Query: 453 SIFK 456
            IF 
Sbjct: 231 KIFS 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  113 bits (285), Expect = 2e-27
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 28/224 (12%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA--EVKTIGSI-HHQNLVR 297
             ++LG G  G V +        K A+K       +     A  EV+         ++VR
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKM------LQDCPKARREVELHWRASQCPHIVR 119

Query: 298 LIGFC----AEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           ++       A +   L+V E +  G L  R   +    F    ++  +I+  I + + YL
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYL 177

Query: 353 HEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           H      I H D+KP+N+L      N   K+ DFG +K         +TT   TP Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAP 232

Query: 410 EWLSSII-TEKVDIYSFGVVMLEILCGRKVF--DRSQPEEEDMY 450
           E L      +  D++S GV+M  +LCG   F  +        M 
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 2e-27
 Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 36/298 (12%)

Query: 217 EDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGT-QTDGTKVAVK--RLEGI 273
              L   P     F+ E+LK +       +G+G +GSV +   +  G  +AVK  R    
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60

Query: 274 GEINKSFLAEVKTI-GSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL--FQRSDE 330
            +  K  L ++  +  S     +V+  G    +    +  E M + S D++        +
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD 119

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLI 389
            ++  +   KI L   K L +L E+   KI+H DIKP NILLD + N K+ DFG+S +L+
Sbjct: 120 DVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

Query: 390 DQDQSQVVTTMRGTPGYLAPEWLSSIITE-----KVDIYSFGVVMLEILCGRKVFDRSQP 444
           D   S   T   G   Y+APE +    +      + D++S G+ + E+  GR  + +   
Sbjct: 178 D---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

Query: 445 EEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
             + +    + K    +   +    + S    +     VN+      CL  D +KRP 
Sbjct: 235 VFDQLTQ--VVKGDPPQLS-NSEEREFSPSFIN----FVNL------CLTKDESKRPK 279

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (280), Expect = 2e-27
 Identities = 75/304 (24%), Positives = 123/304 (40%), Gaps = 46/304 (15%)

Query: 221 DQVPGLPKRFSFEELKVMTDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN 277
           D             L+     F  +  +G G +G V++G     G   A+K ++  G+  
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64

Query: 278 KSFLAEVKTIGSI-HHQNLVRLIG-----FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDE 330
           +    E+  +    HH+N+    G             L LV E+   GS+   L + +  
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKG 123

Query: 331 FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID 390
             L  +    I  +I +GL++LH+    K++H DIK QN+LL  N   K+ DFG+S  +D
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180

Query: 391 QDQSQVVTTMRGTPGYLAPE------WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQP 444
           +   +   T  GTP ++APE         +    K D++S G+  +E+  G        P
Sbjct: 181 RTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------AP 232

Query: 445 EEEDMY----LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR 500
              DM+    L  I +  A   +L     K S   QS              CL  + ++R
Sbjct: 233 PLCDMHPMRALFLIPRNPAP--RLKS--KKWSKKFQS----------FIESCLVKNHSQR 278

Query: 501 PSMS 504
           P+  
Sbjct: 279 PATE 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (279), Expect = 3e-27
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 45/277 (16%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL 295
            + F  +  LG+G +GSV++    + G  VA+K++    ++ +  + E+  +      ++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHV 86

Query: 296 VRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           V+  G    K+ +L +V EY   GS+   +  R+    L   +   I+    KGL YLH 
Sbjct: 87  VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF 143

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
               + +H DIK  NILL+   +AK+ADFG++  +    ++   T+ GTP ++APE    
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPE---- 195

Query: 415 IITE-----KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKAEEDKLS 465
           +I E       DI+S G+  +E+  G       +P   D++    +  I           
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEG-------KPPYADIHPMRAIFMIPTNPPP--TFR 246

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
              +  S++                 CL     +R +
Sbjct: 247 K-PELWSDNFTD----------FVKQCLVKSPEQRAT 272

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (281), Expect = 3e-27
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 26/251 (10%)

Query: 246 LGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           LG G  G VF+ + +  G  +A K   LE    I    + E++ +   +   +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 303 AEKSHNLLVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
                  +  E+M  GSLD+ L    R  E +L      K+ + + KGLTYL E    KI
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLREK--HKI 153

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR----GTPGYLAPEWLSSII 416
           +H D+KP NIL++     K+ DFG+S        Q++ +M     GT  Y++PE L    
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGTH 206

Query: 417 -TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM 475
            + + DI+S G+ ++E+  GR  +    P+ +++ L+   + + +  +           +
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 476 QSNGEEVVNMM 486
              G +    M
Sbjct: 265 NKFGMDSRPPM 275

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  111 bits (280), Expect = 4e-27
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 28/223 (12%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           K +G G FG       +     VAVK +E    I+++   E+    S+ H N+VR     
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 303 AEKSHNLLVYEYMPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
              +H  ++ EY   G L   +        DE    +QQ       +  G++Y H     
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-------LLSGVSYCH---SM 135

Query: 359 KILHLDIKPQNILLDGNF--NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII 416
           +I H D+K +N LLDG+     K+ DFG SK           +  GTP Y+APE L    
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQE 193

Query: 417 TE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
            +    D++S GV +  +L G   F+    + E+      ++K
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE----DPEEPRD---YRK 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  112 bits (283), Expect = 7e-27
 Identities = 75/241 (31%), Positives = 113/241 (46%), Gaps = 62/241 (25%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
             LG G FG V  G  +  G KVAVK    I  +N+  +           E++ +    H
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVK----I--LNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSL-D-------------RWLFQRSDEFMLDWQQR 338
            ++++L    +  S   +V EY+  G L D             R LFQ          Q 
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ----------Q- 124

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                 I  G+ Y H   R  ++H D+KP+N+LLD + NAK+ADFGLS ++     + + 
Sbjct: 125 ------ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 173

Query: 399 TMRGTPGYLAPEWLSSIITE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           T  G+P Y APE +S  +    +VDI+S GV++  +LCG   FD       D ++ ++FK
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-------DDHVPTLFK 226

Query: 457 K 457
           K
Sbjct: 227 K 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (273), Expect = 1e-26
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)

Query: 235 LKVMTDNFRKM--LGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTI-G 288
           ++V  D+   +  LG+G +G V +      G  +AVK  R     +  K  L ++     
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWL------FQRSDEFMLDWQQRKKII 342
           ++     V   G    +    +  E M + SLD++        Q   E +L      KI 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDIL-----GKIA 115

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMR 401
           + I K L +LH      ++H D+KP N+L++     K+ DFG+S  L+D           
Sbjct: 116 VSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDA 170

Query: 402 GTPGYLAPEWLSSIITE-----KVDIYSFGVVMLEILCGR 436
           G   Y+APE ++  + +     K DI+S G+ M+E+   R
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  110 bits (276), Expect = 1e-26
 Identities = 67/240 (27%), Positives = 107/240 (44%), Gaps = 61/240 (25%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----------EVKTIGSIHH 292
           + LG+G FG V   T      KVA+K       I++  L           E+  +  + H
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALK----F--ISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 293 QNLVRLIGFCAEKSHNLLVYEY---------MPNGSLD----RWLFQRSDEFMLDWQQRK 339
            ++++L       +  ++V EY         +    +     R  FQ          Q  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ----------Q-- 116

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT 399
                I   + Y H   R KI+H D+KP+N+LLD N N K+ADFGLS ++       + T
Sbjct: 117 -----IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKT 166

Query: 400 MRGTPGYLAPEWLSSIITE--KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             G+P Y APE ++  +    +VD++S G+V+  +L GR  FD       D ++ ++FKK
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-------DEFIPNLFKK 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (274), Expect = 1e-26
 Identities = 61/279 (21%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKS-FLAEVKTIGSIHHQN 294
            + +  +  LG G FG V++      G   A K +E   E     ++ E++ + +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 295 LVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +V+L+G        L ++ E+ P G++D  +     +  L   Q + +   + + L +LH
Sbjct: 78  IVKLLG-AYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               ++I+H D+K  N+L+    + ++ADFG+S    +   +   +  GTP ++APE + 
Sbjct: 135 S---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSFIGTPYWMAPEVVM 190

Query: 414 SIIT------EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKAEEDK 463
                      K DI+S G+ ++E+          +P   ++     LL I K       
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI-------EPPHHELNPMRVLLKIAKSDPP--T 241

Query: 464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
           L     K S + +                L+ +   RPS
Sbjct: 242 LLT-PSKWSVEFRD----------FLKIALDKNPETRPS 269

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  111 bits (280), Expect = 1e-26
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 26/234 (11%)

Query: 233 EELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS----FLAEVK 285
           +++++  ++F   K++G+G FG V      +  KV A+K L     + ++    F  E  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQ--RKKII 342
            + +   + +  L  +  +  +NL LV +Y   G L   L +  D    +  +    +++
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
           +     +  +H+      +H DIKP NIL+D N + ++ADFG    + +D +   +   G
Sbjct: 186 I----AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238

Query: 403 TPGYLAPEWLSSIITEK------VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           TP Y++PE L ++   K       D +S GV M E+L G   F      E   Y
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TY 290

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (271), Expect = 2e-26
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 25/228 (10%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQN 294
           + +  +  +G+G +G V++     G   A+K  RLE   E I  + + E+  +  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L      K   +LV+E++     D        E  L+    K  +L +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGYLAPE 410
              +++LH D+KPQN+L++     K+ADFGL++           ++VT       Y AP+
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-----YRAPD 170

Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            L  S   +  +DI+S G +  E++ G  +F       E   L+ IF+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF---PGVSEADQLMRIFR 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  111 bits (280), Expect = 3e-26
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 26/233 (11%)

Query: 233 EELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINK----SFLAEVK 285
           E   V  + FR  ++LGKGGFG V         K+ A K+LE      +      L E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
            +  ++ + +V L  +  E    L LV   M  G L ++      +      +      +
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL-KFHIYHMGQAGFPEARAVFYAAE 294

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           I  GL  LH    ++I++ D+KP+NILLD + + +++D GL+  + + Q+  +    GT 
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349

Query: 405 GYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVF--DRSQPEEEDMY 450
           GY+APE    ++  +      D ++ G ++ E++ G+  F   + + + E++ 
Sbjct: 350 GYMAPE----VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (273), Expect = 4e-26
 Identities = 45/300 (15%), Positives = 87/300 (29%), Gaps = 52/300 (17%)

Query: 247 GKGGFGSVFEGTQTD-GTKVAVKRL-------EGIGEINKSFLAEVKTIGSIHHQNLVRL 298
           G     +V        G  V V+R+       E +  +      E+      +H N+V  
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG----ELHVSKLFNHPNIVPY 91

Query: 299 IGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ 358
                  +   +V  +M  GS  + L        ++      I+  + K L Y+H     
Sbjct: 92  RATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIH---HM 147

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR------GTPGYLAPEWL 412
             +H  +K  +IL+  +    ++    +  +     +                +L+PE L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 413 SSII---TEKVDIYSFGVVMLEILCGR---------KVF----DRSQPEEEDMYLLSIFK 456
              +     K DIYS G+   E+  G          ++     + + P   D   +   +
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267

Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVA--------------AWCLESDFAKRPS 502
                 +         +   S                            CL+ +   RPS
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  107 bits (269), Expect = 6e-26
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 26/231 (11%)

Query: 238 MTDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGE-INKSFLAEVKTIGSIH 291
           M + + K+  +G+G +G VF+    D G  VA+K          I K  L E++ +  + 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H NLV L+     K    LV+EY  + ++   L +            K I     + + +
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGV--PEHLVKSITWQTLQAVNF 117

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGYL 407
            H   +   +H D+KP+NIL+  +   K+ DFG ++L+         +V T       Y 
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-----YR 169

Query: 408 APEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
           +PE L   +     VD+++ G V  E+L G  ++     + +   L  I K
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW---PGKSDVDQLYLIRK 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  106 bits (267), Expect = 1e-25
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 233 EELKVMTDNFRKM--LGKGGFGSVFEGT-QTDGTKVAVK--RLEGIGEINKSFLAEVKTI 287
           +  +   ++   +  +G G  G V++   +  G  +AVK  R  G  E NK  L ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 288 -GSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLD--RWLFQRSDEFMLDWQQRKKIIL 343
             S     +V+  G     + ++ +  E M   +    + +     E +L      K+ +
Sbjct: 78  LKSHDCPYIVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTV 131

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS-KLIDQDQSQVVTTMRG 402
            I K L YL E     ++H D+KP NILLD     K+ DFG+S +L+D    +      G
Sbjct: 132 AIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAG 186

Query: 403 TPGYLAPEWLSSII------TEKVDIYSFGVVMLEILCGR 436
              Y+APE +            + D++S G+ ++E+  G+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  110 bits (276), Expect = 1e-25
 Identities = 55/266 (20%), Positives = 107/266 (40%), Gaps = 38/266 (14%)

Query: 205 FFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDG 262
             R       IE D   +     K        +  ++F   +++G+GGFG V+   + D 
Sbjct: 156 NLRGDVFQKFIESDKFTR-FCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADT 213

Query: 263 TKV-AVKRLE------------GIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL 309
            K+ A+K L+             + E  +  L+ V    +     +V +  +       L
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLALNE--RIMLSLVS---TGDCPFIVCMS-YAFHTPDKL 267

Query: 310 -LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLHEDCRQKILHLDIKP 367
             + + M  G L  +   +   F        +    +I  GL ++H    + +++ D+KP
Sbjct: 268 SFILDLMNGGDL-HYHLSQHGVFSEA---DMRFYAAEIILGLEHMHN---RFVVYRDLKP 320

Query: 368 QNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSII--TEKVDIYSF 425
            NILLD + + +++D GL+    + +        GT GY+APE L   +      D +S 
Sbjct: 321 ANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377

Query: 426 GVVMLEILCGRKVF-DRSQPEEEDMY 450
           G ++ ++L G   F      ++ ++ 
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEID 403

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  109 bits (274), Expect = 2e-25
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 34/265 (12%)

Query: 205 FFRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDG 262
              +    + ++  Y  +     +    E   +  D F   ++LG+GGFG VF       
Sbjct: 153 HLGQAPFQEFLDSLYFLR---FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT 209

Query: 263 TKV-AVKRLEGIGEINK----SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMP 316
            K+ A K+L       +      + E K +  +H + +V L  +  E   +L LV   M 
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMN 268

Query: 317 NGSLDRWLF---QRSDEFMLDWQQRKKI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILL 372
            G +   ++   + +  F      R       I  GL +LH+   + I++ D+KP+N+LL
Sbjct: 269 GGDIRYHIYNVDEDNPGFQEP---RAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLL 322

Query: 373 DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-----VDIYSFGV 427
           D + N +++D GL+  +   Q++      GTPG++APE    ++  +     VD ++ GV
Sbjct: 323 DDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPE----LLLGEEYDFSVDYFALGV 377

Query: 428 VMLEILCGRKVF--DRSQPEEEDMY 450
            + E++  R  F     + E +++ 
Sbjct: 378 TLYEMIAARGPFRARGEKVENKELK 402

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  107 bits (270), Expect = 2e-25
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 28/236 (11%)

Query: 233 EELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS----FLAEVK 285
           +E+++  D+F   K++G+G F  V         +V A+K +     + +     F  E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQ--RKKII 342
            + +   + + +L  F  +  + L LV EY   G L   L +  +    +  +    +I+
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV 172

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
           +     +  +H       +H DIKP NILLD   + ++ADFG    +  D +       G
Sbjct: 173 M----AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225

Query: 403 TPGYLAPEWLSSIITEK--------VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           TP YL+PE L ++             D ++ GV   E+  G+  F      E   Y
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TY 279

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (263), Expect = 2e-25
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQ 293
             + K+  +G+G +G+VF+    +    VA+K  RL+   E +  S L E+  +  + H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+VRL           LV+E+     L ++    + +   +    K  +  + KGL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCH 118

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGYLAP 409
               + +LH D+KPQN+L++ N   K+A+FGL++          ++VVT       Y  P
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW-----YRPP 170

Query: 410 EWL--SSIITEKVDIYSFGVVMLEILCGRK 437
           + L  + + +  +D++S G +  E+    +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  105 bits (265), Expect = 3e-25
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 31/230 (13%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRL--EGIGEIN--KSFLAEVKTIG 288
           KV  ++F   K+LGKG FG V    +    +  A+K L  E I   +     + E + + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 289 SIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDI 345
           +  H  L  L    A         V EY   G L   L  R   F  +   R +    +I
Sbjct: 61  NTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEE---RARFYGAEI 114

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
              L YLH    + +++ DIK +N++LD + + K+ DFGL K         + T  GTP 
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPE 170

Query: 406 YLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           YLAPE    ++ +      VD +  GVVM E++CGR  F     + E ++
Sbjct: 171 YLAPE----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLF 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (263), Expect = 4e-25
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 48/231 (20%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSF----------LAEVKTIGS 289
              + LG G FG V         +  A+K L       K              E   +  
Sbjct: 9   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERLMLSI 62

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK-----IILD 344
           + H  ++R+ G   +     ++ +Y+  G L   L ++S  F        K     + L 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNP---VAKFYAAEVCL- 117

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
               L YLH    + I++ D+KP+NILLD N + K+ DFG +K +      V  T+ GTP
Sbjct: 118 ---ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTP 167

Query: 405 GYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
            Y+APE    +++ K     +D +SFG+++ E+L G   F  S   +   Y
Sbjct: 168 DYIAPE----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY 212

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  105 bits (265), Expect = 4e-25
 Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 32/243 (13%)

Query: 224 PGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRL--EGIGEIN- 277
           P L K     ++K+  ++F   KMLGKG FG VF        +  A+K L  + +   + 
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60

Query: 278 -KSFLAEVKTI--GSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFM 332
            +  + E K +   +  H  L  +  FC    K +   V EY+  G L  +  Q   +F 
Sbjct: 61  VECTMVE-KRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFD 116

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           L   +      +I  GL +LH    + I++ D+K  NILLD + + K+ADFG+ K  +  
Sbjct: 117 LS--RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NML 170

Query: 393 QSQVVTTMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEE 447
                 T  GTP Y+APE    I+  +     VD +SFGV++ E+L G+  F     +EE
Sbjct: 171 GDAKTNTFCGTPDYIAPE----ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH--GQDEE 224

Query: 448 DMY 450
           +++
Sbjct: 225 ELF 227

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (262), Expect = 6e-25
 Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 31/231 (13%)

Query: 240 DNFRKM--LGKGGFGSVFEGT-QTDGTKVAVKRL-----EGIGEINKSFLAEVKTIGSIH 291
           + + K+  LG+G + +V++G  +     VA+K +     EG      + + EV  +  + 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA---PCTAIREVSLLKDLK 58

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H N+V L      +    LV+EY+     D   +      +++    K  +  + +GL Y
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGYL 407
            H   RQK+LH D+KPQN+L++     K+ADFGL++          ++VVT       Y 
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW-----YR 167

Query: 408 APEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            P+ L  S+  + ++D++  G +  E+  GR +F        +  L  IF+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF---PGSTVEEQLHFIFR 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (263), Expect = 6e-25
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQT-DGTKVAVK--RLEGIGEINKSF----LAEVKTIGSI 290
             + K+  LG+G F +V++         VA+K  +L    E         L E+K +  +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
            H N++ L+     KS+  LV+++M     D  +  + +  +L     K  +L   +GL 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTPGY 406
           YLH   +  ILH D+KP N+LLD N   K+ADFGL+K           QVVT       Y
Sbjct: 127 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW-----Y 178

Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            APE L  + +    VD+++ G ++ E+L      
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  104 bits (262), Expect = 9e-25
 Identities = 67/257 (26%), Positives = 108/257 (42%), Gaps = 30/257 (11%)

Query: 208 KKNGADEIEEDYLDQVPG--LPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGT 263
           KK    E  +++L +     L K  +  +     D F   K LG G FG V      +  
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 264 KV-AVKRLEGIGEINKS----FLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG 318
              A+K L+    +        L E + + +++   LV+L     + S+  +V EY+  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA 378
            +   L +R   F       +     I     YLH      +++ D+KP+N+L+D     
Sbjct: 127 EMFSHL-RRIGRFSEP--HARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180

Query: 379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEIL 433
           +V DFG +K +         T+ GTP  LAPE    II  K     VD ++ GV++ E+ 
Sbjct: 181 QVTDFGFAKRVK----GRTWTLCGTPEALAPE----IILSKGYNKAVDWWALGVLIYEMA 232

Query: 434 CGRKVFDRSQPEEEDMY 450
            G   F   QP +  +Y
Sbjct: 233 AGYPPFFADQPIQ--IY 247

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (262), Expect = 9e-25
 Identities = 61/280 (21%), Positives = 104/280 (37%), Gaps = 49/280 (17%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK----RLEGIGEINKSFLAEVKTIGSIH 291
              F  +  +G G FG+V+          VA+K      +   E  +  + EV+ +  + 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 292 HQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           H N ++  G C  + H   LV EY    + D        +  L   +   +     +GL 
Sbjct: 113 HPNTIQYRG-CYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLA 168

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE 410
           YLH      ++H D+K  NILL      K+ DFG + ++         +  GTP ++APE
Sbjct: 169 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPE 220

Query: 411 ----WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY----LLSIFKKKAEED 462
                       KVD++S G+  +E+          +P   +M     L  I + ++   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAMSALYHIAQNESP-- 271

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS 502
            L       S   ++              CL+     RP+
Sbjct: 272 ALQS--GHWSEYFRN----------FVDSCLQKIPQDRPT 299

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (260), Expect = 1e-24
 Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 32/234 (13%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRL-----EGIGEINKSFLAEVKTIGSIH 291
             F+++  LG G + +V++G     G  VA+K +     EG      + + E+  +  + 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT---PSTAIREISLMKELK 61

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM---LDWQQRKKIILDIAKG 348
           H+N+VRL      ++   LV+E+M N  L +++  R+       L+    K     + +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQVVTTMRGTP 404
           L + H     KILH D+KPQN+L++     K+ DFGL++          S+VVT      
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW---- 173

Query: 405 GYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
            Y AP+ L  S   +  +DI+S G ++ E++ G+ +F       ++  L  IF 
Sbjct: 174 -YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF---PGTNDEEQLKLIFD 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (260), Expect = 1e-24
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 18/225 (8%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGE-INKSFLAEVKTIGSIHHQ 293
           + +  +  +G+G +G V +    D G  VA+K        + + K  + E+K +  + H+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           NLV L+  C +K    LV+E++ + ++   L    +    D+Q  +K +  I  G+ + H
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGL--DYQVVQKYLFQIINGIGFCH 141

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL- 412
                 I+H DIKP+NIL+  +   K+ DFG ++ +     +V      T  Y APE L 
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLV 197

Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
                 + VD+++ G ++ E+  G  +F     + +   L  I  
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLF---PGDSDIDQLYHIMM 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  105 bits (264), Expect = 2e-24
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 36/260 (13%)

Query: 206 FRKKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGT 263
           FR  + +D    + ++     PK       +V  + F   K+LGKG FG V    +    
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKH------RVTMNEFEYLKLLGKGTFGKVILVKEKATG 173

Query: 264 KV-AVKRL--EGIGEIN--KSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMP 316
           +  A+K L  E I   +     L E + + +  H  L  L    +         V EY  
Sbjct: 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCFVMEYAN 231

Query: 317 NGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN 375
            G L   L  R   F  D   R +    +I   L YLH +  + +++ D+K +N++LD +
Sbjct: 232 GGELFFHL-SRERVFSED---RARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKD 285

Query: 376 FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVML 430
            + K+ DFGL K         + T  GTP YLAPE    ++ +      VD +  GVVM 
Sbjct: 286 GHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPE----VLEDNDYGRAVDWWGLGVVMY 340

Query: 431 EILCGRKVFDRSQPEEEDMY 450
           E++CGR  F     + E ++
Sbjct: 341 EMMCGRLPFY--NQDHEKLF 358

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  104 bits (261), Expect = 2e-24
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA 303
           K++G G FG VF+    +  +VA+K+   + +  +    E++ +  + H N+V L  F  
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 304 EKSHNL------LVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHEDC 356
                       LV EY+P  ++ R     +     +     K  +  + + L Y+H   
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--- 158

Query: 357 RQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQ---SQVVTTMRGTPGYLAPEWL 412
              I H DIKPQN+LLD      K+ DFG +K++   +   S + +  R    Y APE +
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS--R---YYRAPELI 213

Query: 413 --SSIITEKVDIYSFGVVMLEILCGRKVF 439
             ++  T  +DI+S G VM E++ G+ +F
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (261), Expect = 3e-24
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           K++G G FG V++    D G  VA+K+   + +  +    E++ +  + H N+VRL  F 
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 303 AEKSHNL------LVYEYMPNGSLDRWL--FQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
                        LV +Y+P  ++ R    + R+ + +      K  +  + + L Y+H 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIH- 173

Query: 355 DCRQKILHLDIKPQNILLDGNFNA-KVADFGLSKLIDQDQ---SQVVTTMRGTPGYLAPE 410
                I H DIKPQN+LLD +    K+ DFG +K + + +   S + +  R    Y APE
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--R---YYRAPE 226

Query: 411 WL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            +  ++  T  +D++S G V+ E+L G+ +F
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  102 bits (256), Expect = 3e-24
 Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 36/239 (15%)

Query: 240 DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVKRL------EGIGEINKSFLAEV---KTI 287
             +  +  +G G +G+V++      G  VA+K +       G G +  S + EV   + +
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 288 GSIHHQNLVRLIGFCAEKSHNL-----LVYEYMPNGSLD-RWLFQRSDEFMLDWQQRKKI 341
            +  H N+VRL+  CA    +      LV+E++     D R    ++    L  +  K +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDL 125

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ---SQVVT 398
           +    +GL +LH      I+H D+KP+NIL+      K+ADFGL+++          VVT
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 399 TMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
                  Y APE L  S     VD++S G +  E+   + +F       E   L  IF 
Sbjct: 183 LW-----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF---CGNSEADQLGKIFD 233

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  104 bits (260), Expect = 3e-24
 Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 39/239 (16%)

Query: 233 EELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKS----FLAEVK 285
            +L++  +++   K++G+G FG V         KV A+K L     I +S    F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 286 TIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
            +   +   +V+L  +  +    L +V EYMP G L            L       +   
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL----------VNL--MSNYDVPEK 168

Query: 345 IAK--------GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV 396
            A+         L  +H       +H D+KP N+LLD + + K+ADFG    ++++    
Sbjct: 169 WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 397 VTTMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
             T  GTP Y++PE L S   +       D +S GV + E+L G   F          Y
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TY 282

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  102 bits (256), Expect = 4e-24
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 43/224 (19%)

Query: 236 KVMTDNFR--KMLGKGGFGSVF---EGTQTDGTKV-AVKRLEGIGEINKSFLA---EVKT 286
           K     F   K+LG+G FG VF   + + +D  ++ A+K L       K+ L     V+T
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL------KKATLKVRDRVRT 73

Query: 287 IG------SIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
                    ++H  +V+L    A   +    L+ +++  G L   L  +   F  +    
Sbjct: 74  KMERDILVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEE---D 127

Query: 339 KKI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV 397
            K  + ++A  L +LH      I++ D+KP+NILLD   + K+ DFGLSK    D  +  
Sbjct: 128 VKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKA 183

Query: 398 TTMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGR 436
            +  GT  Y+APE    ++  +      D +SFGV+M E+L G 
Sbjct: 184 YSFCGTVEYMAPE----VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  102 bits (256), Expect = 4e-24
 Identities = 64/256 (25%), Positives = 112/256 (43%), Gaps = 34/256 (13%)

Query: 220 LDQVPGLPKRFSFEELKVMT--DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK--RLEG 272
           L+     P   S       T  D +R++  LG+G +G V++   T     VA+K  RLE 
Sbjct: 12  LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71

Query: 273 IGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEF 331
             E +  + + EV  +  + H+N++ L           L++EY  N  L +++ +  D  
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD-- 128

Query: 332 MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-----KVADFGLS 386
            +  +  K  +  +  G+ + H    ++ LH D+KPQN+LL  +  +     K+ DFGL+
Sbjct: 129 -VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

Query: 387 KLIDQDQ----SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFD 440
           +           +++T       Y  PE L  S   +  VDI+S   +  E+L    +F 
Sbjct: 185 RAFGIPIRQFTHEIITLW-----YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF- 238

Query: 441 RSQPEEEDMYLLSIFK 456
               + E   L  IF+
Sbjct: 239 --PGDSEIDQLFKIFE 252

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  102 bits (256), Expect = 4e-24
 Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 236 KVMTDNFR--KMLGKGGFGSVF----EGTQTDGTKVAVKRL--EGIGEINK---SFLAEV 284
           K+  + F   ++LGKGG+G VF          G   A+K L    I    K      AE 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72

Query: 285 KTIGSIHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-I 342
             +  + H  +V LI +  +    L L+ EY+  G L   L +R   FM D        +
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFMED---TACFYL 127

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            +I+  L +LH+   + I++ D+KP+NI+L+   + K+ DFGL K        V  T  G
Sbjct: 128 AEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCG 183

Query: 403 TPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGR 436
           T  Y+APE    I+        VD +S G +M ++L G 
Sbjct: 184 TIEYMAPE----ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  102 bits (256), Expect = 6e-24
 Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 44/237 (18%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSI-- 290
           ++   +F    +LGKG FG V    +    ++ AVK L       K  + +   +     
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL------KKDVVIQDDDVECTMV 69

Query: 291 ---------HHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
                        L +L              V EY+  G L   + Q+   F        
Sbjct: 70  EKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEP---HA 123

Query: 340 KI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                +IA GL +L     + I++ D+K  N++LD   + K+ADFG+ K  +        
Sbjct: 124 VFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTK 179

Query: 399 TMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           T  GTP Y+APE    II  +     VD ++FGV++ E+L G+  F+    +E++++
Sbjct: 180 TFCGTPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELF 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  102 bits (256), Expect = 6e-24
 Identities = 68/269 (25%), Positives = 110/269 (40%), Gaps = 45/269 (16%)

Query: 210 NGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVF----EGTQTDGT 263
           +G D  E+    +        +    KV  +NF   K+LG G +G VF          G 
Sbjct: 24  DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83

Query: 264 KVAVKRL--EGIGEIN---------KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL-LV 311
             A+K L    I +           +  L  ++         LV L  +  +    L L+
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLH-YAFQTETKLHLI 137

Query: 312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDIAKGLTYLHEDCRQKILHLDIKPQNI 370
            +Y+  G L      + + F        +I + +I   L +LH+     I++ DIK +NI
Sbjct: 138 LDYINGGEL-FTHLSQRERFTEH---EVQIYVGEIVLALEHLHK---LGIIYRDIKLENI 190

Query: 371 LLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEK-------VDIY 423
           LLD N +  + DFGLSK    D+++      GT  Y+AP+    I+          VD +
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD----IVRGGDSGHDKAVDWW 246

Query: 424 SFGVVMLEILCGRKVF--DRSQPEEEDMY 450
           S GV+M E+L G   F  D  +  + ++ 
Sbjct: 247 SLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (255), Expect = 9e-24
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 40/257 (15%)

Query: 226 LPKRFSFEELKVMT--DNFRKM--LGKGGFGSVFEGTQTD-GTKVAVK--RLEGIGE-IN 277
           + K++   E         + K+  +G+G FG VF+      G KVA+K   +E   E   
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 60

Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL--------LVYEYMPNGSLDRWLFQRSD 329
            + L E+K +  + H+N+V LI  C  K+           LV+++      D      + 
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNV 117

Query: 330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI 389
                  + K+++  +  GL Y+H   R KILH D+K  N+L+  +   K+ADFGL++  
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 390 DQDQ--------SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
              +        ++VVT       Y  PE L         +D++  G +M E+     + 
Sbjct: 175 SLAKNSQPNRYTNRVVTLW-----YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

Query: 440 DRSQPEEEDMYLLSIFK 456
              Q   E   L  I +
Sbjct: 230 ---QGNTEQHQLALISQ 243

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 2e-23
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 44/237 (18%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSI-- 290
           ++  DNF   ++LGKG FG V      +   + AVK L       K  + +   +     
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL------KKDVILQDDDVECTMT 72

Query: 291 ---------HHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
                    +H  L +L  FC          V E++  G L   + Q+S  F      R 
Sbjct: 73  EKRILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEA---RA 126

Query: 340 KI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
           +    +I   L +LH+   + I++ D+K  N+LLD   + K+ADFG+ K           
Sbjct: 127 RFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTA 182

Query: 399 TMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           T  GTP Y+APE    I+ E      VD ++ GV++ E+LCG   F+     E+D++
Sbjct: 183 TFCGTPDYIAPE----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE--AENEDDLF 233

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  100 bits (252), Expect = 2e-23
 Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 42/230 (18%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGS---------- 289
           +F K++GKG FG V            AVK L       K  + + K              
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVL------QKKAILKKKEEKHIMSERNVLLK 94

Query: 290 -IHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI-ILDI 345
            + H  LV L    +         V +Y+  G L   L QR   F+     R +    +I
Sbjct: 95  NVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP---RARFYAAEI 148

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
           A  L YLH      I++ D+KP+NILLD   +  + DFGL K  + + +   +T  GTP 
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPE 204

Query: 406 YLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
           YLAPE    ++ ++     VD +  G V+ E+L G   F      E  MY
Sbjct: 205 YLAPE----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MY 248

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (250), Expect = 4e-23
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKR-LEGIGEINKSF----LAEVKTIGSIHHQNLVR 297
           +M G+G FG+V  G +   G  VA+K+ ++     +  F    L  ++ +  +HH N+V+
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVLHHPNIVQ 83

Query: 298 LI-GFCAEKSHNL------LVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGL 349
           L   F      +       +V EY+P+ +L R         +       K  +  + + +
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142

Query: 350 TYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQ---SQVVTTMRGTPG 405
             LH      + H DIKP N+L++  +   K+ DFG +K +   +   + + +       
Sbjct: 143 GCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY----- 196

Query: 406 YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           Y APE +  +   T  VDI+S G +  E++ G  +F
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  102 bits (255), Expect = 5e-23
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRL--EGIGEIN--KSFLAEVKTI- 287
           ++   +F    +LGKG FG V    +    ++ AVK L  + + + +  +  + E K + 
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KRVL 395

Query: 288 -GSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
                   L +L              V EY+  G L   + Q+   F            +
Sbjct: 396 ALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEP--HAVFYAAE 450

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTP 404
           IA GL +L     + I++ D+K  N++LD   + K+ADFG+ K  +        T  GTP
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTP 506

Query: 405 GYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
            Y+APE    II  +     VD ++FGV++ E+L G+  F+    +E++++
Sbjct: 507 DYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELF 551

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 98.8 bits (247), Expect = 6e-23
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 42/241 (17%)

Query: 240 DNFRKM--LGKGGFGSVFEG--TQTDGTKVAVKRL------EG-----IGEINKSFLAEV 284
             +  +  +G+G +G VF+    +  G  VA+KR+      EG     I E+  + L  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--AVLRHL 68

Query: 285 KTIGSIHHQNLVRLI----GFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
           +   +  H N+VRL         ++   L LV+E++    L  +L +  +   +  +  K
Sbjct: 69  E---TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIK 123

Query: 340 KIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ---SQV 396
            ++  + +GL +LH     +++H D+KPQNIL+  +   K+ADFGL+++        S V
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180

Query: 397 VTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           VT       Y APE L  S     VD++S G +  E+   + +F   +   +   L  I 
Sbjct: 181 VTLW-----YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF---RGSSDVDQLGKIL 232

Query: 456 K 456
            
Sbjct: 233 D 233

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (250), Expect = 6e-23
 Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 43/252 (17%)

Query: 238 MTDNFRKM---LGKGGFGSVFEGTQTD---GTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
           + D F      +G+G +G V++  + D       A+K++EG G I+ S   E+  +  + 
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELK 76

Query: 292 HQNLVRLIGFCAEKSHNL--LVYEYMPN---GSLD--RWLFQRSDEFMLDWQQRKKIILD 344
           H N++ L       +     L+++Y  +     +   R          L     K ++  
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA----KVADFGLSKLID-------QDQ 393
           I  G+ YLH      +LH D+KP NIL+ G        K+AD G ++L +          
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 394 SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF-------DRSQP 444
             VVT       Y APE L  +   T+ +DI++ G +  E+L    +F         S P
Sbjct: 194 PVVVTF-----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248

Query: 445 EEEDMYLLSIFK 456
              D  L  IF 
Sbjct: 249 YHHDQ-LDRIFN 259

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 57/244 (23%), Positives = 102/244 (41%), Gaps = 49/244 (20%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSI-- 290
            +   +F   +++G+G +  V         ++ A+K +       K  + + + I  +  
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV------KKELVNDDEDIDWVQT 58

Query: 291 ---------HHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
                    +H  LV L        +S    V EY+  G L   + QR  +   +     
Sbjct: 59  EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEE---HA 112

Query: 340 KI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
           +    +I+  L YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +
Sbjct: 113 RFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 168

Query: 399 TMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPE-------E 446
           T  GTP Y+APE    I+  +     VD ++ GV+M E++ GR  FD            E
Sbjct: 169 TFCGTPNYIAPE----ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 224

Query: 447 EDMY 450
           + ++
Sbjct: 225 DYLF 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 39/244 (15%)

Query: 225 GLPKRFSFEELKVMTDNFR--------KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI 276
           G+  +       ++ +           + +  G +G+V  G  ++G  VA+KR+      
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60

Query: 277 NKSF------------LAEVKTIGSIHHQNLVRLIG-FCAEKSHNL----LVYEYMPNGS 319
            ++             L E++ +   HH N++ L   F   +   +    LV E M    
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119

Query: 320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK 379
           L + +       ++  Q  +  +  I  GL  LHE     ++H D+ P NILL  N +  
Sbjct: 120 LAQVI--HDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDIT 174

Query: 380 VADFGLSKLIDQDQ--SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCG 435
           + DF L++    D   +  VT       Y APE +      T+ VD++S G VM E+   
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRW----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

Query: 436 RKVF 439
           + +F
Sbjct: 231 KALF 234

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 49/244 (20%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQTDGTKV-AVKRLEGIGEINKSFLAEVKTIGSI-- 290
            +   +F   +++G+G +  V         ++ A++ +       K  + + + I  +  
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV------KKELVNDDEDIDWVQT 101

Query: 291 ---------HHQNLVRLIGFCA--EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK 339
                    +H  LV L        +S    V EY+  G L   + QR  +   +     
Sbjct: 102 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEE---HA 155

Query: 340 KI-ILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
           +    +I+  L YLHE   + I++ D+K  N+LLD   + K+ D+G+ K          +
Sbjct: 156 RFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 211

Query: 399 TMRGTPGYLAPEWLSSIITEK-----VDIYSFGVVMLEILCGRKVFDRSQPE-------E 446
           T  GTP Y+APE    I+  +     VD ++ GV+M E++ GR  FD            E
Sbjct: 212 TFCGTPNYIAPE----ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267

Query: 447 EDMY 450
           + ++
Sbjct: 268 DYLF 271

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 25/206 (12%), Positives = 55/206 (26%), Gaps = 40/206 (19%)

Query: 246 LGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA----EVKTIGSIHHQNLVRLIG 300
            G       ++   T    +VA+  ++  G +    L         +  I    + R++ 
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
               ++  L+V E++  GSL                   + +  +A      H   R  +
Sbjct: 99  VVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGV 150

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKV 420
                 P  + +  + +  +A                      P  +           + 
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA------NPQD 183

Query: 421 DIYSFGVVMLEILCGRKVFDRSQPEE 446
           DI   G  +  +L  R     +    
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRS 209

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 27/209 (12%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
             +G G +GSV        G KVA+K+L    + ++ F      E+  +  + H+N++ L
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 299 IG-FCAEKSHNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +  F    S        LV  +M    L + +  +        ++ + ++  + KGL Y+
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSEEKIQYLVYQMLKGLKYI 142

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      ++H D+KP N+ ++ +   K+ DFGL++  D + +  V T      Y APE +
Sbjct: 143 HS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVI 195

Query: 413 --SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  + VDI+S G +M E+L G+ +F
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 58/234 (24%), Positives = 112/234 (47%), Gaps = 34/234 (14%)

Query: 227 PKRFSFEELKVMTDNFR--------KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN 277
           P R  F   +V    +         + +G G +G+V        G KVA+K+L    + +
Sbjct: 6   PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-S 64

Query: 278 KSF----LAEVKTIGSIHHQNLVRLIG-FCAEKSHNL-----LVYEYMPNGSLDRWLFQR 327
           + F      E++ +  + H+N++ L+  F  +++ +      LV  +M    L + +  +
Sbjct: 65  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--K 121

Query: 328 SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK 387
            ++  L   + + ++  + KGL Y+H      I+H D+KP N+ ++ +   K+ DFGL++
Sbjct: 122 HEK--LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

Query: 388 LIDQDQSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
             D + +  V T      Y APE +      T+ VDI+S G +M E++ G+ +F
Sbjct: 177 QADSEMTGYVVTRW----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 7e-20
 Identities = 52/243 (21%), Positives = 99/243 (40%), Gaps = 60/243 (24%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           K LG G FG V E    + G + A+K+   + +  +    E+  +  + H N+++L+ + 
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKNRELDIMKVLDHVNIIKLVDYF 69

Query: 303 AEKSHNL--------------------------------------LVYEYMPNGSLDRWL 324
                                                        ++ EY+P+ +L + L
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVL 128

Query: 325 --FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA-KVA 381
             F RS   +         I  + + + ++H      I H DIKPQN+L++   N  K+ 
Sbjct: 129 KSFIRSGRSIPM-NLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 382 DFGLSKLIDQDQ---SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGR 436
           DFG +K +   +   + + +       Y APE +  ++  T  +D++S G V  E++ G+
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 437 KVF 439
            +F
Sbjct: 240 PLF 242

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 50/223 (22%), Positives = 80/223 (35%), Gaps = 47/223 (21%)

Query: 242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLA--EVKTIGSI-HHQNLVR 297
             ++LG G  G V +        K A+K       +     A  EV+         ++VR
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKM------LQDCPKARREVELHWRASQCPHIVR 75

Query: 298 LIGFC----AEKSHNLLVYEYMPNGSL-DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           ++       A +   L+V E +  G L  R   +    F    ++  +I+  I + + YL
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYL 133

Query: 353 HEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           H      I H D+KP+N+L      N   K+ DFG                       A 
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAK 168

Query: 410 EWLSSIITEKVDIYSFGVVMLEILCGRKVF--DRSQPEEEDMY 450
           E       +  D++S GV+M  +LCG   F  +        M 
Sbjct: 169 ETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
           K +G G  G V           VA+K+L    + N++       E+  +  ++H+N++ L
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 299 IG-FCAEKSHNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +  F  +KS        +V E M   +L + +        LD ++   ++  +  G+ +L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHL 143

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H      I+H D+KP NI++  +   K+ DFGL++        ++T    T  Y APE  
Sbjct: 144 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           L     E VDI+S G +M E++ G  +F
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLA-----EVKTIGSIHHQNLVR 297
             +G+G +G V          +VA+K+   I              E+K +    H+N++ 
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKK---ISPFEHQTYCQRTLREIKILLRFRHENIIG 89

Query: 298 LIG-FCAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +     A     +    +V + M    L + L  ++    L        +  I +GL Y+
Sbjct: 90  INDIIRAPTIEQMKDVYIVQDLMET-DLYKLL--KTQH--LSNDHICYFLYQILRGLKYI 144

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-------VVTTMRGTPG 405
           H      +LH D+KP N+LL+   + K+ DFGL+++ D D          V T  R    
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT--R---W 196

Query: 406 YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
           Y APE +  S   T+ +DI+S G ++ E+L  R +F
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN--KSFLAEVKTIGSIHHQNLVRLIG 300
            +LG+G +G V   T    G  VA+K++E   +       L E+K +    H+N++ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76

Query: 301 -FCAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
               +   N     ++ E M    L R +   +    L     +  I    + +  LH  
Sbjct: 77  IQRPDSFENFNEVYIIQELMQT-DLHRVI--STQM--LSDDHIQYFIYQTLRAVKVLHG- 130

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG---------Y 406
               ++H D+KP N+L++ N + KV DFGL+++ID+  +          G         Y
Sbjct: 131 --SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 407 LAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
            APE +  S+  +  +D++S G ++ E+   R +F
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIG- 300
           + LG+G +  VFE    T+  KV VK L+ + +  K    E+K + ++    N++ L   
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADI 99

Query: 301 FCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
                S    LV+E++ N    +     +D  +      +  + +I K L Y H      
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI------RFYMYEILKALDYCH---SMG 150

Query: 360 ILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQS---QVVTTMRGTPGYLAPEWL--S 413
           I+H D+KP N+++D  +   ++ D+GL++     Q    +V +       +  PE L   
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDY 205

Query: 414 SIITEKVDIYSFGVVMLEILCGRKVF 439
            +    +D++S G ++  ++  ++ F
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
           K +G G  G V           VA+K+L    + N++       E+  +  ++H+N++ L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 299 IG-FCAEKSHNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +  F  +K+        LV E M   +L + +        LD ++   ++  +  G+ +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHL 180

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-W 411
           H      I+H D+KP NI++  +   K+ DFGL++        ++T    T  Y APE  
Sbjct: 181 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235

Query: 412 LSSIITEKVDIYSFGVVMLEILCGRKVF 439
           L     E VDI+S G +M E++  + +F
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
             +G G +GSV        G +VAVK+L    + +         E++ +  + H+N++ L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGL 93

Query: 299 IG-FCAEKSHNL-----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
           +  F   +S        LV   M    L+  +  +  +  L     + +I  I +GL Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV--KCQK--LTDDHVQFLIYQILRGLKYI 148

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H      I+H D+KP N+ ++ +   K+ DFGL++    + +  V T      Y APE +
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----YRAPEIM 201

Query: 413 --SSIITEKVDIYSFGVVMLEILCGRKVF 439
                  + VDI+S G +M E+L GR +F
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 45/229 (19%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
            ++G+G +G V+     +    VA+K++  + E +       L E+  +  +    ++RL
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRL 90

Query: 299 IG-FCAEKSHNL----LVYEYMPNGSLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGLTY 351
                 +         +V E       D  L +  ++  F+ + +  K I+ ++  G  +
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTE-EHIKTILYNLLLGENF 144

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG------ 405
           +HE     I+H D+KP N LL+ + + KV DFGL++ I+ ++   +              
Sbjct: 145 IHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 406 ---------------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRK 437
                          Y APE +      T+ +DI+S G +  E+L   +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 51/228 (22%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF---------LAEVKTIGSIHHQ 293
           K LG GG G VF     D   +VA+K++                   L E+K I  + H 
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKI--------VLTDPQSVKHALREIKIIRRLDHD 68

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM------------LDWQQRKKI 341
           N+V++          L             ++ Q   E+M            L  +  +  
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQ---EYMETDLANVLEQGPLLEEHARLF 125

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQ----- 395
           +  + +GL Y+H      +LH D+KP N+ ++  +   K+ DFGL++++D   S      
Sbjct: 126 MYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 396 --VVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
             +VT       Y +P  L   +  T+ +D+++ G +  E+L G+ +F
Sbjct: 183 EGLVTKW-----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.1 bits (195), Expect = 8e-16
 Identities = 46/228 (20%), Positives = 93/228 (40%), Gaps = 46/228 (20%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIHHQNLVRL 298
            ++G G +G V E         VA+K++  + E +       L E+  +  ++H ++V++
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKV 117

Query: 299 IG-FCAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           +     +         +V E   +    +    R+  ++ +    K ++ ++  G+ Y+H
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTE-LHIKTLLYNLLVGVKYVH 173

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG-------- 405
                 ILH D+KP N L++ + + KV DFGL++ +D  ++                   
Sbjct: 174 S---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 406 ------------------YLAPEWL--SSIITEKVDIYSFGVVMLEIL 433
                             Y APE +      TE +D++S G +  E+L
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 47/224 (20%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH----------- 291
           + LG G F +V+      + T VA+K + G     ++   E+K +  ++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 292 HQNLVRLIGF----CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
             ++++L+           H ++V+E +   +L   + ++ +   +     K+I   +  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI-KKYEHRGIPLIYVKQISKQLLL 142

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLD------GNFNAKVADFGLSKLIDQDQSQVVTTMR 401
           GL Y+H  C   I+H DIKP+N+L++           K+AD G +   D+  +  +    
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ--- 197

Query: 402 GTPGYLAPEWLSSII-----TEKVDIYSFGVVMLEILCGRKVFD 440
            T  Y +PE    ++         DI+S   ++ E++ G  +F+
Sbjct: 198 -TREYRSPE----VLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 43/228 (18%)

Query: 244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF----LAEVKTIGSIH-HQNLVR 297
           K LGKG +G V++      G  VAVK++    + N +       E+  +  +  H+N+V 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVN 73

Query: 298 LIG-FCAEKSHNL-LVYEYMPNGSLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGLTYLH 353
           L+    A+   ++ LV++YM     D  L    R++   L+   ++ ++  + K + YLH
Sbjct: 74  LLNVLRADNDRDVYLVFDYMET---D--LHAVIRANI--LEPVHKQYVVYQLIKVIKYLH 126

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG-------- 405
                 +LH D+KP NILL+   + KVADFGLS+     +                    
Sbjct: 127 S---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 406 ------------YLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVF 439
                       Y APE L  S+  T+ +D++S G ++ EILCG+ +F
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 29/211 (13%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ------NLV 296
           K++GKG FG V +         VA+K +      ++    E++ +  +  Q      N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLHED 355
            ++     ++H  + +E +   S++ +   + ++F        +K    I + L  LH  
Sbjct: 163 HMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH-- 217

Query: 356 CRQKILHLDIKPQNILL--DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
            + +I+H D+KP+NILL   G    KV DFG S    Q     + +      Y APE   
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----YRAPE--- 269

Query: 414 SII-----TEKVDIYSFGVVMLEILCGRKVF 439
            +I        +D++S G ++ E+L G  + 
Sbjct: 270 -VILGARYGMPIDMWSLGCILAELLTGYPLL 299

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 5/109 (4%)

Query: 326 QRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL 385
           +   +  L  +        +AKG+ +L     +K +H D+  +NILL      K+ DFGL
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 239

Query: 386 SKLIDQDQSQVVTTMRGTPG-YLAPEWLS-SIITEKVDIYSFGVVMLEI 432
           ++ I +D   V       P  ++APE +   + T + D++SFGV++ EI
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 27/183 (14%)

Query: 217 EDYLDQVPGLPKRFSF--EELKVMTDNFRKMLGKGGFGSVFEGT------QTDGTKVAVK 268
           +++ +++P    ++ F  + LK       K LG+G FG V E              VAVK
Sbjct: 4   DEHCERLPYDASKWEFPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 58

Query: 269 RL-EGIGEI-NKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSH-NLLVYEYMPNGSLDRWL 324
            L EG     +++ ++E+K +  I HH N+V L+G C +     +++ E+   G+L  +L
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

Query: 325 FQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
                       +R + +    KG  +         + +D+K +   +  + ++  + F 
Sbjct: 119 ----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168

Query: 385 LSK 387
             K
Sbjct: 169 EEK 171

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 61/271 (22%), Positives = 98/271 (36%), Gaps = 77/271 (28%)

Query: 244 KMLGKGGFGSVFEGTQTDGTK-VAVK--------RLEGIGEINKSFLAEVKTIGSIH--H 292
           + LG G F +V+      G K VA+K            + EI    L  V+         
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR--LLKSVRNSDPNDPNR 100

Query: 293 QNLVRLIG-FC---AEKSHNLLVYEYMPNG-SLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
           + +V+L+  F       +H  +V+E +  G  L +W+  +S+   L     KKII  + +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI-IKSNYQGLPLPCVKKIIQQVLQ 157

Query: 348 GLTYLHEDCRQKILHLDIKPQNILL----------------------------------- 372
           GL YLH  C  +I+H DIKP+NILL                                   
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 373 --------------DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE-WLSSIIT 417
                               K+AD G +  + +  ++ +     T  Y + E  + S   
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYN 271

Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEED 448
              DI+S   +  E+  G  +F+    EE  
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYT 302

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 31/213 (14%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQN 294
            ++GKG FG V +   + +   VA+K          +   E+    L  +    +     
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR--LLELMNKHDTEMKYY 117

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYLH 353
           +V L      ++H  LV+E +   S + +   R+  F  +     +K    +   L +L 
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 354 EDCRQKILHLDIKPQNILL--DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
                 I+H D+KP+NILL        K+ DFG S  + Q   Q + + R    Y +PE 
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-R---FYRSPE- 228

Query: 412 LSSII-----TEKVDIYSFGVVMLEILCGRKVF 439
              ++        +D++S G +++E+  G  +F
Sbjct: 229 ---VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 28/158 (17%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNLVRLIGF 301
           K +G G FG +  G        VA+K LE +         E +    +     + ++  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK---KIILDIAK----GLTYLHE 354
                +N +V E          L   S E + D   R    K +L IA      + Y+H 
Sbjct: 74  GPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH- 122

Query: 355 DCRQKILHLDIKPQNILL--DGNFNAKVA---DFGLSK 387
              + +++ D+KP+N L+   GN   +V    DF L+K
Sbjct: 123 --SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 30/164 (18%)

Query: 240 DNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNL 295
            +++  + +G+G FG +FEGT   +  +VA+K  E           E +T   +     +
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK---KIILDIAK----G 348
             +  F  E  HN+LV +          L   S E +LD   RK   K +   AK     
Sbjct: 69  PNVYYFGQEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAK-----VADFGLSK 387
           +  +HE   + +++ DIKP N L+    +       V DFG+ K
Sbjct: 119 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 51/231 (22%)

Query: 244 KMLGKGGFGSVFEG--TQTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQ 293
             LG+G FG V E    +  G  VAVK              EI    L  + T       
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ--VLEHLNTTDPNSTF 77

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
             V+++ +     H  +V+E +    L  + F + + F+       +K+   I K + +L
Sbjct: 78  RCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNA-------------------KVADFGLSKLIDQDQ 393
           H     K+ H D+KP+NIL   +                      KV DFG +   D+  
Sbjct: 135 HS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191

Query: 394 SQVVTTMRGTPGYLAPEWLSSII-----TEKVDIYSFGVVMLEILCGRKVF 439
           S +V+T R    Y APE    +I     ++  D++S G +++E   G  VF
Sbjct: 192 STLVST-R---HYRAPE----VILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 32/190 (16%), Positives = 69/190 (36%), Gaps = 52/190 (27%)

Query: 236 KVMTD----NFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKS---------- 279
           +++TD     ++    +G+GGFG ++         V       + ++  S          
Sbjct: 27  EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVV-KVEPSDNGPLFTELK 85

Query: 280 ---FLAEVKTIGSIHHQNLVRLIGFC----------AEKSHNLLVYEYMPNGSLDRWLFQ 326
                A+ + I        ++ +G              KS+  ++ +           F 
Sbjct: 86  FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD----------RFG 135

Query: 327 RSDEFMLDWQQRK---KIILDIA----KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK 379
              + + +   ++   K +L ++      L Y+HE    + +H DIK  N+LL+     +
Sbjct: 136 SDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQ 192

Query: 380 V--ADFGLSK 387
           V   D+GL+ 
Sbjct: 193 VYLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 34/187 (18%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           + FR  + +G G FG ++ GT      +VA+K  E +   +   L E K    +     +
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 297 -RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK---KIILDIAK----G 348
             +  F  E  +N+LV +          L   S E + ++  RK   K +L +A      
Sbjct: 66  PNVRWFGVEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAK---VADFGLSKL-IDQDQSQVV-----TT 399
           + ++H    +  LH DIKP N L+     A    + DFGL+K   D    Q +       
Sbjct: 116 VEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 400 MRGTPGY 406
           + GT  Y
Sbjct: 173 LTGTARY 179

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 51/231 (22%)

Query: 244 KMLGKGGFGSVFEG--TQTDGTKVAVK--------RLEGIGEINKSFLAEVKTIGSIHHQ 293
             LG+G FG V E        ++VA+K        R     EIN   L ++K     +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN--VLKKIKEKDKENKF 82

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLTYL 352
             V +  +     H  + +E +     + + F + + F        + +   +   L +L
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNA-------------------KVADFGLSKLIDQDQ 393
           HE    ++ H D+KP+NIL   +                      +VADFG +    +  
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196

Query: 394 SQVVTTMRGTPGYLAPEWLSSII-----TEKVDIYSFGVVMLEILCGRKVF 439
           + +V T R    Y  PE    +I      +  D++S G ++ E   G  +F
Sbjct: 197 TTIVAT-R---HYRPPE----VILELGWAQPCDVWSIGCILFEYYRGFTLF 239

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 32/176 (18%), Positives = 62/176 (35%), Gaps = 46/176 (26%)

Query: 244 KMLGKGGFGSVFEGTQT---------DGTKVAVKRLE-----GIGEIN-------KSFLA 282
               +   G ++E   T            K ++K L+        E N          + 
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 283 EVKTIGSIHHQNLVRLIGF-CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK-- 339
           + K + S     +   +GF   +  +  LV   +P          RS +  LD   +   
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LP-------SLGRSLQSALDVSPKHVL 156

Query: 340 --KIILDIAK----GLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV--ADFGLSK 387
             + +L +A      L +LHE    + +H ++  +NI +D    ++V  A +G + 
Sbjct: 157 SERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.5 bits (143), Expect = 8e-10
 Identities = 35/202 (17%), Positives = 61/202 (30%), Gaps = 57/202 (28%)

Query: 239 TDNFRKM--LGKGGFGSVFEGTQTDGTKVAVK--RLEGIGEIN-------KSFLAEV--- 284
           T+  ++   +G+G FG VF+    D T VA+K   +EG   +N       +  L E+   
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 285 KTIGSIHHQNLVRLIGFCAEKSHNL----------------------------------- 309
           K +  +  +   R  GF    S +                                    
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 310 -LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQ 368
            +V E+   G     +  +    +      K I+  +   L         +  H D+   
Sbjct: 138 FIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWG 191

Query: 369 NILLDGNFNAKVADFGLSKLID 390
           N+LL      K+      K   
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 28/162 (17%)

Query: 240 DNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNL 295
           + +R  + +G G FG ++ GT    G +VA+K  E +   +     E K    +     +
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRK---KIILDIAKGLT-- 350
             +    AE  +N++V E          L   S E + ++  RK   K +L +A  +   
Sbjct: 68  PTIRWCGAEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117

Query: 351 --YLHEDCRQKILHLDIKPQNILLDGNFNAK---VADFGLSK 387
             Y+H    +  +H D+KP N L+          + DFGL+K
Sbjct: 118 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 63/239 (26%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-----HHQNLVR 297
           + +G G FG V       +    AVK +  I +  +S   E   +  I     ++ N+V+
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------LDWQQRKKIILDIAKGLT 350
             G      H  L++E      L   L+    E +          +  K   ++I K L 
Sbjct: 101 YHGKFMYYDHMCLIFE-----PLGPSLY----EIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNA-------------------------KVADFGL 385
           YL +     + H D+KP+NILLD  +                           K+ DFG 
Sbjct: 152 YLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 386 SKLIDQDQSQVVTTMRGTPGYLAPEWLSSII-----TEKVDIYSFGVVMLEILCGRKVF 439
           +         ++ T R    Y APE    +I         D++SFG V+ E+  G  +F
Sbjct: 209 ATFKSDYHGSIINT-R---QYRAPE----VILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 41/195 (21%), Positives = 67/195 (34%), Gaps = 55/195 (28%)

Query: 231 SFEELKVMTD----NFR--KMLGKGGFGSVFEGT-QTDGTKVAV---------------- 267
            F E KV+ D     +   K +G GGFG ++         K A                 
Sbjct: 24  PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE 83

Query: 268 ----KRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF----CAEKSHNLLVYEYMPNG- 318
               +R+     I K           + +  +    G        +S+  +V E +  G 
Sbjct: 84  LKFYQRVAKKDCIKKW-----IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GI 136

Query: 319 SLDRWLFQRSDEFMLDWQQRKKIILDIA----KGLTYLHEDCRQKILHLDIKPQNILLDG 374
            L + +  ++  F          +L +       L Y+HE    + +H DIK  N+LL  
Sbjct: 137 DLQK-ISGQNGTFKK------STVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186

Query: 375 NFNAKV--ADFGLSK 387
               +V  AD+GLS 
Sbjct: 187 KNPDQVYLADYGLSY 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 2e-06
 Identities = 64/392 (16%), Positives = 120/392 (30%), Gaps = 118/392 (30%)

Query: 201 ILIFF---FRKKNGADEIEEDYLDQVPGLPKRFSFEELK--VMTDN----FRKMLGKGGF 251
           IL  F   F       +++ D    +       S EE+   +M+ +      ++      
Sbjct: 21  ILSVFEDAFVDNFDCKDVQ-DMPKSI------LSKEEIDHIIMSKDAVSGTLRLFW---- 69

Query: 252 GSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLV 311
                  Q +  +  V   E +  IN  FL        I  +          + S    +
Sbjct: 70  --TLLSKQEEMVQKFV---EEVLRINYKFLMS-----PIKTE--------QRQPSMMTRM 111

Query: 312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKP-QNI 370
           Y        DR L+  +  F      R +  L + + L             L+++P +N+
Sbjct: 112 YIE----QRDR-LYNDNQVFAKYNVSRLQPYLKLRQAL-------------LELRPAKNV 153

Query: 371 LLDGNFNAKVADFGLSKL-IDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVV 428
           L+DG     V   G + + +D   S  V        +    WL+         +    + 
Sbjct: 154 LIDG-----VLGSGKTWVALDVCLSYKVQCKMDFKIF----WLNLKNCNSPETV----LE 200

Query: 429 MLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD--KHSN------DMQSNGE 480
           ML+ L  +   D +     D       +  + + +L  L+    + N      ++Q+   
Sbjct: 201 MLQKLLYQ--IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN--A 256

Query: 481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVL-----EGVTEF---EHNLHYNLVHLPIT-- 530
           +  N   ++  C               ++L     + VT+F       H +L H  +T  
Sbjct: 257 KAWNAFNLS--C---------------KILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 531 -----AALANVDHREENDKP--TTQLLPSVLS 555
                + L         D P       P  LS
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 63/489 (12%), Positives = 140/489 (28%), Gaps = 141/489 (28%)

Query: 111 KQACLKNCSCKAALFQYGLNS-----SAGDCYLPSEIFSMMNNEKETTHYNSTAYIK-VQ 164
           K   +    C +   Q  ++      +  +C  P  +  M+         N T+      
Sbjct: 163 KT-WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221

Query: 165 NLPMPGASPGGKETSHRKRIMGFILESFF--GLLVL-------------IG--ILIFFFR 207
           N+ +          S +  +   +    +   LLVL             +   IL+   R
Sbjct: 222 NIKLR-------IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-TTR 273

Query: 208 KKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAV 267
            K   D +       +       +    +V      K L         E   T+  ++++
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPRRLSI 332

Query: 268 KRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLL-------VYEYM----- 315
                I E  +  LA       ++   L  +I    E S N+L       +++ +     
Sbjct: 333 -----IAESIRDGLATWDNWKHVNCDKLTTII----ESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 316 ----PNGSLDR-W--LFQRSDEFMLDWQQRKKIIL-DIAKGLTYLHEDCRQKILHLDIKP 367
               P   L   W  + +     +++   +  ++     +    +        ++L++K 
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKV 437

Query: 368 QNILLDGNFNAKVADFGL-SKLIDQDQSQVVTTMRG-TPGYLAPEWLSSIITEKVDIYSF 425
           +             ++ L   ++D          +      L P +L        D Y +
Sbjct: 438 KL----------ENEYALHRSIVDHYNIP-----KTFDSDDLIPPYL--------DQYFY 474

Query: 426 GVVMLEILCGRKVFDRSQPEEEDM----YL-LSIFKKK---------AEEDKLSDLVD-- 469
             +      G  + +   PE   +    +L     ++K         A    L+ L    
Sbjct: 475 SHI------GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528

Query: 470 ---KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNLHYNLVH 526
               +  D     E +VN +         DF  +   +++            + + +L+ 
Sbjct: 529 FYKPYICDNDPKYERLVNAIL--------DFLPKIEENLI-----------CSKYTDLLR 569

Query: 527 LPITAALAN 535
           +    AL  
Sbjct: 570 I----ALMA 574

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	558
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.08
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.86
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.83
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.6
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.4
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.37
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.2
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.81
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.75
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.3
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.09
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	93.56
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.05
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	90.43
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.96
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.8
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.36
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.14
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	87.51
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.19

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.2e-55  Score=433.21  Aligned_cols=257  Identities=21%  Similarity=0.390  Sum_probs=209.3

Q ss_pred             HHHHhhhhcCccCceEEEEEEeC------CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcce
Q 043292          238 MTDNFRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       238 ~t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  309 (558)
                      .+..|.++||+|+||+||+|++.      +++.||||+++..  ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34456789999999999999862      4678999999743  334578999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC
Q 043292          310 LVYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF  376 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~  376 (558)
                      |||||+++|+|.++|..+..             ...++|..+++|+.|||.||+|||+   .+||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence            99999999999999975421             2359999999999999999999999   9999999999999999999


Q ss_pred             CeEEcccCCccccCCCCC-ceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHH
Q 043292          377 NAKVADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       377 ~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  453 (558)
                      .+||+|||+|+....... ...+...||+.|||||++. +.++.++|||||||+||||+| |..||.+....+    +..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~----~~~  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VVE  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----HHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence            999999999987644332 2344567999999999886 579999999999999999999 899997654322    111


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .    ...+...          +.+...+..+.+|+.+||+.||++||||.+|++.|+....
T Consensus       259 ~----i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          259 M----IRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             H----HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             H----HHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            1    1111111          1112334578899999999999999999999999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-53  Score=419.52  Aligned_cols=252  Identities=24%  Similarity=0.424  Sum_probs=198.4

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||+||+|++.+  .||||+++..   ....++|.+|+.++++++|||||+++|++.+ +..+|||||+++|
T Consensus        40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG  116 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS  116 (307)
T ss_dssp             EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred             EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence            45789999999999998753  6999998743   2345679999999999999999999999865 5689999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC-Ccee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~  397 (558)
                      +|.++|.....  .++|.++++|+.|||.||+|||+   .+||||||||+||||++++.+||+|||+|+...... ....
T Consensus       117 sL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          117 SLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             BHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             CHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            99999976543  49999999999999999999999   999999999999999999999999999998765432 2234


Q ss_pred             ecccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....||+.|||||++.+    .++.++|||||||+||||+||+.||...+....   +.....    .+..    .+...
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~----~~~~----~p~~~  260 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVG----RGYA----SPDLS  260 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHH----TTCC----CCCST
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHh----cCCC----CCCcc
Confidence            56789999999999853    489999999999999999999999986554321   111111    1111    11111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .  ........+.+|+.+||+.||++||||.+|++.|+.+.
T Consensus       261 ~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          261 K--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             T--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             c--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            0  11123457889999999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=426.13  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=200.7

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.++||+|+||.||+|++.      +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..+|||||
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey  124 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY  124 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3478999999999999863      47789999998543 3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          315 MPNGSLDRWLFQRSD------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      +++|+|.++|+....            ...++|.++++|+.|||.||.|||+   .+||||||||+||||++++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcc
Confidence            999999999976432            2359999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          383 FGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       383 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ||+|+........ ......||+.|||||++.+ .++.++|||||||+||||+| |+.||......+    +...+    
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~i----  273 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCI----  273 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----HHHHH----
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----HHHHH----
Confidence            9999876443322 2345679999999999875 59999999999999999999 899997654322    11111    


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ..+..       +   ..+......+.+|+.+||+.||++||||.+|+++|+.+.+.
T Consensus       274 ~~g~~-------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 TQGRE-------L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHTCC-------C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcCCC-------C---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11110       0   11112345788999999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-53  Score=420.75  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=205.7

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.++||+|+||+||+|++.      ++..||||+++... ...++|.+|++++++++|||||+++|++.+++..+|||||
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey   96 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY   96 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence            3578999999999999863      46789999998543 3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          315 MPNGSLDRWLFQRS----------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       315 ~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      +++|+|.++|....          ....++|.++++|+.|||.||.|||+   .+|+||||||+||||++++.+||+|||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFG  173 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG  173 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcc
Confidence            99999999997642          23459999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhc
Q 043292          385 LSKLIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEE  461 (558)
Q Consensus       385 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  461 (558)
                      +|+......... .....||+.|||||++. +.++.++|||||||+||||+| |+.||...+..+    +...    ...
T Consensus       174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~----i~~  245 (299)
T 4asz_A          174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIEC----ITQ  245 (299)
T ss_dssp             CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHH----HHH
T ss_pred             cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----HHc
Confidence            998765433322 22356899999999986 579999999999999999999 899997654322    1111    111


Q ss_pred             ccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       462 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      +...          ..+...+..+.+|+.+||+.||++||||++|+++|+.+.+
T Consensus       246 ~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          246 GRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111          0111234578899999999999999999999999988754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-52  Score=418.53  Aligned_cols=264  Identities=26%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCC----cceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS----HNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g  318 (558)
                      .++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||++++++.+++    ..+|||||+++|
T Consensus         8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g   86 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence            47899999999999997 5899999999765443344456677778899999999999998754    468999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC-----CCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +|.++|+...    ++|..+.+++.|++.||+|||+.+     ..+|+||||||+||||+.++.+||+|||+|+......
T Consensus        87 sL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  162 (303)
T 3hmm_A           87 SLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             BHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             cHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence            9999997643    899999999999999999999831     2499999999999999999999999999998765443


Q ss_pred             Cce---eecccCCCCcCChhhhcCC-------CCCccchHHHHHHHHHHHhCCCCCCCCCCcchh--------hhHHHHH
Q 043292          394 SQV---VTTMRGTPGYLAPEWLSSI-------ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED--------MYLLSIF  455 (558)
Q Consensus       394 ~~~---~~~~~gt~~y~aPE~~~~~-------~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~--------~~~~~~~  455 (558)
                      ...   .....||+.|||||++.+.       ++.++|||||||+||||+||..|+.........        ..... .
T Consensus       163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-~  241 (303)
T 3hmm_A          163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-M  241 (303)
T ss_dssp             TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-H
T ss_pred             CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH-H
Confidence            221   2346799999999998653       567999999999999999998876543221100        00111 1


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ......    ..+++.+.......+....+.+|+.+||+.||++||||.+|+++|+.+.+-
T Consensus       242 ~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          242 RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            111111    112222222222345677899999999999999999999999999887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-51  Score=402.15  Aligned_cols=242  Identities=26%  Similarity=0.464  Sum_probs=196.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc----CCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE----KSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  313 (558)
                      |.++||+|+||+||+|.. .++..||+|++...   ....+.|.+|++++++++|||||++++++.+    +...+||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            346799999999999998 46899999999643   2234679999999999999999999999865    345789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeecC-CCCeEEcccCCccccC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDG-NFNAKVADFGLSKLID  390 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~  390 (558)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+   .+  |+||||||+||||+. ++.+||+|||+|+...
T Consensus       110 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          110 LMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999998654   39999999999999999999998   66  999999999999984 7899999999998643


Q ss_pred             CCCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..   ......||+.|||||++.+.++.++|||||||++|||++|+.||........   +   . .....+.....++.
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~---~-~~i~~~~~~~~~~~  253 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I---Y-RRVTSGVKPASFDK  253 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H---H-HHHTTTCCCGGGGG
T ss_pred             CC---ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---H---H-HHHHcCCCCCCCCc
Confidence            32   2456789999999999998899999999999999999999999975443221   1   1 11111111111111


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .         ....+.+|+.+||+.||++|||++++++
T Consensus       254 ~---------~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 V---------AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C---------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c---------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1         1235788999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-51  Score=409.84  Aligned_cols=242  Identities=23%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+++..+|||||+++|+|
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  158 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  158 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            36799999999999998 47999999999643 23345689999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.+.    .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus       159 ~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~  230 (346)
T 4fih_A          159 TDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  230 (346)
T ss_dssp             HHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred             HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccc
Confidence            9999753    39999999999999999999999   9999999999999999999999999999997754432 34567


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .||+.|||||++.+ .++.++|||||||++|||++|+.||...+..+    +......    ..     ....   ....
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~----~~-----~~~~---~~~~  294 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRD----NL-----PPRL---KNLH  294 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHH----SS-----CCCC---SCGG
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHc----CC-----CCCC---Cccc
Confidence            89999999999975 59999999999999999999999997644322    1111111    00     0000   1111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+|+.+||+.||++|||+.|+++
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22347889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-51  Score=407.97  Aligned_cols=248  Identities=23%  Similarity=0.265  Sum_probs=200.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .++||+|+||.||+++. .+|+.||||+++....    +.+|+.++++++|||||++++++.+++..+|||||+++|+|.
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  138 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG  138 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence            36799999999999998 5699999999975332    247999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCc----e
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQ----V  396 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~----~  396 (558)
                      ++|.+..   .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++ .+||+|||+|+.+..+...    .
T Consensus       139 ~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          139 QLIKQMG---CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             HHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             HHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            9998654   39999999999999999999999   9999999999999999988 5999999999977543221    1


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|||||++.+ .++.++|||||||++|||++|+.||......+...   .+....   ....+         
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~---~~~~~---------  277 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEP---PPIRE---------  277 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSC---CGGGG---------
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCC---CCchh---------
Confidence            234679999999999986 59999999999999999999999998765543211   111110   00001         


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                       ........+.+++.+||+.||.+|||+.|+++.|.....-
T Consensus       278 -~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          278 -IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence             0112234788899999999999999999999988766543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.8e-51  Score=407.84  Aligned_cols=243  Identities=22%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||+||+++. .+++.||||+++...   ...+.|.+|++++++++|||||++++++.+++..+|||||+++|
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            47899999999999997 579999999996432   23467999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.++|..... ..+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+|+.+.... ....
T Consensus       109 ~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~  183 (350)
T 4b9d_A          109 DLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELAR  183 (350)
T ss_dssp             BHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHH
T ss_pred             cHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-cccc
Confidence            99999975432 347899999999999999999999   999999999999999999999999999999764322 1234


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|||||++.+ .++.++|||||||+||||++|+.||...+..+       ...... .+....          .
T Consensus       184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~-~~~~~~----------~  245 (350)
T 4b9d_A          184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKII-SGSFPP----------V  245 (350)
T ss_dssp             HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHH-HTCCCC----------C
T ss_pred             ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHH-cCCCCC----------C
Confidence            5679999999999986 59999999999999999999999997654322       111111 111110          0


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112346889999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-50  Score=410.21  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=205.4

Q ss_pred             hhhhcCccCceEEEEEEeCC------CCEEEEEEecccc--cchHHHHHHHHHHhccCC-cceeeeeeeeccC-CcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHH-QNLVRLIGFCAEK-SHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~~lv  311 (558)
                      +.++||+|+||.||+|+...      ++.||||+++...  ...++|.+|++++.+++| ||||+++|+|.+. +..+||
T Consensus        68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV  147 (353)
T 4ase_A           68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI  147 (353)
T ss_dssp             EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred             EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence            35789999999999998632      3579999997543  334679999999999965 8999999998764 568999


Q ss_pred             EEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          312 YEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      ||||++|+|.++|+....             ...++|.++..++.|||.||+|||+   .+||||||||+|||+++++.+
T Consensus       148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~v  224 (353)
T 4ase_A          148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV  224 (353)
T ss_dssp             EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCE
Confidence            999999999999975321             2458999999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||+|+.+..+... ......||+.|||||++. +.++.++|||||||+||||+| |+.||.+....+.   +..  
T Consensus       225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---~~~--  299 (353)
T 4ase_A          225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR--  299 (353)
T ss_dssp             EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHH--
T ss_pred             EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---HHH--
Confidence            99999999977554433 234567899999999986 569999999999999999998 8999987654331   111  


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        ....+....          .+......+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       300 --~i~~g~~~~----------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          300 --RLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             --HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHcCCCCC----------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence              111111111          1112234788999999999999999999999999887653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=410.49  Aligned_cols=242  Identities=23%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.+|+.++|||||++++++.+++..+|||||+++|+|
T Consensus       156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L  235 (423)
T 4fie_A          156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  235 (423)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence            36899999999999998 469999999997433 3345689999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....    +++..+..++.||+.||+|||+   .+||||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus       236 ~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~  307 (423)
T 4fie_A          236 TDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  307 (423)
T ss_dssp             HHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCC
T ss_pred             HHHHhccC----CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccccc
Confidence            99997543    9999999999999999999999   9999999999999999999999999999997754432 34567


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      +||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+    +......    ..     ...+.   ...
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~----~~-----~~~~~---~~~  371 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRD----NL-----PPRLK---NLH  371 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHH----SC-----CCCCS---CTT
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHc----CC-----CCCCc---ccc
Confidence            89999999999975 59999999999999999999999997544322    1111111    00     00111   111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+|+.+||+.||++|||+.|+++
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12346889999999999999999999886

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-50  Score=396.16  Aligned_cols=241  Identities=22%  Similarity=0.367  Sum_probs=200.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||+||+++. .+++.||||++...    ....+.+.+|++++++++|||||++++++.+++..+|||||++
T Consensus        36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~  115 (311)
T 4aw0_A           36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK  115 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence            458899999999999998 57999999999742    2345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-c
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-Q  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~  395 (558)
                      +|+|.+++.+..   .+++.....++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus       116 gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          116 NGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999998654   39999999999999999999999   9999999999999999999999999999998754332 2


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....+||+.|||||++.+ .++.++||||+||++|||++|+.||...+..+    +   ..... .+.+      ..  
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~---~~~i~-~~~~------~~--  253 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----I---FAKII-KLEY------DF--  253 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHHH-HTCC------CC--
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHH-cCCC------CC--
Confidence            3456789999999999975 58999999999999999999999997644322    1   11111 1111      00  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                         +......+.+|+.+||+.||++|||++|++
T Consensus       254 ---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 ---PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               011224678899999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-49  Score=384.90  Aligned_cols=239  Identities=28%  Similarity=0.466  Sum_probs=185.0

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||+||+++. .+++.||||+++..    ....+.+.+|++++++++|||||++++++.+++..++||||+ 
T Consensus        17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-   95 (275)
T 3hyh_A           17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-   95 (275)
T ss_dssp             EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence            357899999999999987 57999999999643    233467899999999999999999999999999999999999 


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.++.   .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+......  .
T Consensus        96 ~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~  167 (275)
T 3hyh_A           96 GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F  167 (275)
T ss_dssp             CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence            689999997654   39999999999999999999999   999999999999999999999999999998764332  2


Q ss_pred             eecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....||+.|||||++.+.  .+.++||||+||++|||++|+.||...+..+    +..   . ...+...      .  
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~---~-i~~~~~~------~--  231 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFK---N-ISNGVYT------L--  231 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-HHHTCCC------C--
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH---H-HHcCCCC------C--
Confidence            4467899999999999864  4689999999999999999999997543221    111   1 1111110      0  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         +......+.+++.+||+.||++|||++|+++
T Consensus       232 ---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          232 ---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               0112246788999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-49  Score=389.64  Aligned_cols=241  Identities=27%  Similarity=0.335  Sum_probs=189.8

Q ss_pred             hhhhcCccCceEEEEEEeC----CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||+||+++..    +++.||||+++...   .....+.+|++++++++|||||++++++.+++..+|||||
T Consensus        28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy  107 (304)
T 3ubd_A           28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF  107 (304)
T ss_dssp             EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred             EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence            4588999999999999762    47899999997432   2334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++.+..   .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+...... 
T Consensus       108 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  180 (304)
T 3ubd_A          108 LRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-  180 (304)
T ss_dssp             CTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence            99999999998654   39999999999999999999999   999999999999999999999999999998654332 


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      .......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+    +..   ... ....         
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~---~i~-~~~~---------  243 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMT---MIL-KAKL---------  243 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHH-HCCC---------
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHH---HHH-cCCC---------
Confidence            23456789999999999975 59999999999999999999999997654322    111   111 1111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSM-----SMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~  508 (558)
                        ..+......+.+++.+||+.||++|||+     +|+++
T Consensus       244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 --GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              0011123468899999999999999984     56553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-47  Score=380.48  Aligned_cols=243  Identities=28%  Similarity=0.435  Sum_probs=183.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------------c
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------------H  307 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------~  307 (558)
                      .+.||+|+||.||+++. .+++.||||+++..  ....+.+.+|++++++++|||||++++++.+.+            .
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            47899999999999987 57999999998643  233467899999999999999999999987544            3


Q ss_pred             ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          308 NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      .++||||+++|+|.+++..+......++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+|+
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGla~  166 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  166 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCccce
Confidence            58999999999999999876554456788899999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCCc-----------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH
Q 043292          388 LIDQDQSQ-----------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       388 ~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  455 (558)
                      .+......           ..+...||+.|||||++.+ .++.++|||||||++|||++   ||...   ........  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~~~~~--  238 (299)
T 4g31_A          167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERVRTLT--  238 (299)
T ss_dssp             -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHHHHH--
T ss_pred             ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHHHHHH--
Confidence            77543221           1234579999999999986 59999999999999999996   66421   11111111  


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ...........          ......+.+++.+||+.||++|||+.++++
T Consensus       239 --~~~~~~~p~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 --DVRNLKFPPLF----------TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHHTTCCCHHH----------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHhcCCCCCCC----------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11111111111          122345678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=377.34  Aligned_cols=265  Identities=20%  Similarity=0.357  Sum_probs=198.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeecc------CCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAE------KSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv  311 (558)
                      +.++||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+++|+.++|||||++++++..      .+..+||
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence            347899999999999998 579999999997543   234568899999999999999999998754      3567999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||++ |+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       138 mE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          138 LDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            99995 78999997643   49999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CC---CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh------
Q 043292          392 DQ---SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE------  460 (558)
Q Consensus       392 ~~---~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  460 (558)
                      ..   ........||+.|||||++.+  .++.++||||+||++|||++|+.||.+.+..+....+.........      
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            21   223456789999999999865  4799999999999999999999999876543322211111100000      


Q ss_pred             -cccchhhccccCCCCCCCHH-----HHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcc
Q 043292          461 -EDKLSDLVDKHSNDMQSNGE-----EVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGV  513 (558)
Q Consensus       461 -~~~~~~~~d~~~~~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~  513 (558)
                       .......+............     ....+.+|+.+||+.||.+|||+.|+++.  +.+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence             00000011111111111111     12467899999999999999999999863  5443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.6e-45  Score=369.24  Aligned_cols=291  Identities=45%  Similarity=0.748  Sum_probs=239.5

Q ss_pred             CCCccCHHHHHHHHHHhh--hhcCccCceEEEEEEeCCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeee
Q 043292          226 LPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGF  301 (558)
Q Consensus       226 ~~~~~~~~~l~~~t~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~  301 (558)
                      ..+.|++.++...+++|.  +.||+|+||.||++...+++.||||++....  .....+.+|+.++..++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            346789999999888874  7899999999999998889999999987532  223468999999999999999999999


Q ss_pred             eccCCcceEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEE
Q 043292          302 CAEKSHNLLVYEYMPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKV  380 (558)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki  380 (558)
                      +...+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998654 3345999999999999999999999932239999999999999999999999


Q ss_pred             cccCCccccCCCCCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCC-cchhhhHHHHHHHh
Q 043292          381 ADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQP-EEEDMYLLSIFKKK  458 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~  458 (558)
                      +|||+++..............||+.|+|||.+. +.++.++||||||+++|||++|+.||..... .........+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999999987655555556677999999999986 4589999999999999999999999963211 11122344444444


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ........+.+..... .........+.+++.+||+.||.+|||+.+|+++|++....+
T Consensus       256 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          256 LKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TSSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             hhchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            4555555555555443 456788899999999999999999999999999999865544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-44  Score=366.61  Aligned_cols=192  Identities=28%  Similarity=0.449  Sum_probs=164.5

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||+||+|+..    +++.||+|++.... ...++.+|++++..+ +||||+++++++.+.++.++||||+++
T Consensus        26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g  104 (361)
T 4f9c_A           26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH  104 (361)
T ss_dssp             EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred             EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence            478999999999999752    46789999987543 345688999999988 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-CCeEEcccCCccccCCCCC--
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQS--  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~~--  394 (558)
                      |+|.+++.      .+++.++..++.||+.||+|||+   .+|+||||||+|||++.+ +.+||+|||+|+.......  
T Consensus       105 ~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          105 ESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             CCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred             ccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence            99999984      28999999999999999999999   999999999999999877 7999999999986543211  


Q ss_pred             -------------------------ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 043292          395 -------------------------QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQP  444 (558)
Q Consensus       395 -------------------------~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~  444 (558)
                                               ...+...||+.|+|||++.+  .++.++||||+||+++||++|+.||.....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                     11234679999999999865  489999999999999999999999975544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-43  Score=352.04  Aligned_cols=280  Identities=40%  Similarity=0.637  Sum_probs=231.1

Q ss_pred             CCccCHHHHHHHHHHhh--------hhcCccCceEEEEEEeCCCCEEEEEEeccc-----ccchHHHHHHHHHHhccCCc
Q 043292          227 PKRFSFEELKVMTDNFR--------KMLGKGGFGSVFEGTQTDGTKVAVKRLEGI-----GEINKSFLAEVKTIGSIHHQ  293 (558)
Q Consensus       227 ~~~~~~~~l~~~t~~~~--------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~  293 (558)
                      ...|++.++..++++|.        ++||+|+||.||+|.. +++.||||++...     ....+.+.+|+.++.+++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            46799999999999986        4699999999999986 5889999998642     22356789999999999999


Q ss_pred             ceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       294 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      ||+++++++.+++..++||||+++++|.+++........+++..++.++.|++.||.|||+   .+++|+||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999999765444569999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHH
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL  452 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~  452 (558)
                      .++.+||+|||++......... ......||+.|+|||.+.+.++.++||||||+++|||++|..||...........+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            9999999999999876543322 233467899999999998889999999999999999999999998665443222222


Q ss_pred             HHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       453 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ...  ......+.+.++..+.  .........+.+++..||+.||.+|||+.+|+++|+++.
T Consensus       248 ~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          248 EEI--EDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHH--HTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHh--hhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            111  1112233444554443  245667788999999999999999999999999998864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-43  Score=356.03  Aligned_cols=271  Identities=37%  Similarity=0.640  Sum_probs=224.4

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||+|+..+++.||||++... ....+.+.+|+.++..++||||+++++++.+++..++||||+++|+|.
T Consensus        44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (321)
T 2qkw_B           44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK  123 (321)
T ss_dssp             CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred             cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence            3689999999999999888999999998754 334567999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCC-CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC-Cceeec
Q 043292          322 RWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVVTT  399 (558)
Q Consensus       322 ~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~~~  399 (558)
                      +++..... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus       124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  200 (321)
T 2qkw_B          124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV  200 (321)
T ss_dssp             GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred             HHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence            99975432 2358999999999999999999999   999999999999999999999999999998654322 222334


Q ss_pred             ccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..||+.|+|||++. +.++.++||||||+++|||++|+.||....+.+ ......+.......+.+...++..... ...
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  278 (321)
T 2qkw_B          201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLAD-KIR  278 (321)
T ss_dssp             CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCTT-CSC
T ss_pred             cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhhcc-ccC
Confidence            56899999999885 569999999999999999999999998765543 223333333344445555555554433 345


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                      ......+.+++.+||+.||++|||+.+|++.|+.+.+..+
T Consensus       279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            6788899999999999999999999999999998876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-43  Score=380.29  Aligned_cols=241  Identities=21%  Similarity=0.330  Sum_probs=193.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHH---HHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLA---EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .++||+|+||.||+++. .+|+.||||+++..    ......+.+   ++.++..++|||||++++++.+.+..+|||||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            47899999999999998 46999999999632    122223333   46677888999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++||+|.++|.+..   .+++..+..++.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+|+.+.... 
T Consensus       274 ~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-  346 (689)
T 3v5w_A          274 MNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  346 (689)
T ss_dssp             CCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence            99999999998654   39999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             ceeecccCCCCcCChhhhc-C-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLS-S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~-~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                        ..+.+||+.|||||++. + .++.++||||+||+||||++|+.||......+..    .+...... ...        
T Consensus       347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~----~i~~~i~~-~~~--------  411 (689)
T 3v5w_A          347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT-MAV--------  411 (689)
T ss_dssp             --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH----HHHHHHHH-CCC--------
T ss_pred             --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhhcC-CCC--------
Confidence              34578999999999986 4 4899999999999999999999999764433211    11111111 000        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                         ..+......+.+|+.+||+.||.+|++     +++|++
T Consensus       412 ---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               001112346889999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-43  Score=379.76  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=200.6

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||+++. .+|+.||+|.+..... ..+.+.+|+.+|+.++|||||++++++.+++..+|||||+++|+
T Consensus       161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~  240 (573)
T 3uto_A          161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE  240 (573)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence            457899999999999998 5799999999875433 34568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC--CCeEEcccCCccccCCCCCcee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN--FNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~--~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.++|.....  .+++.++..++.||+.||.|||+   .+|+||||||+|||++.+  +.+||+|||+|+.+....  ..
T Consensus       241 L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~  313 (573)
T 3uto_A          241 LFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SV  313 (573)
T ss_dssp             HHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EE
T ss_pred             HHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--ce
Confidence            9999965432  49999999999999999999999   999999999999999854  899999999999875433  34


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+..+.    ..   .. ..... .+-+....   
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~---~i-~~~~~-~~~~~~~~---  381 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LR---NV-KSCDW-NMDDSAFS---  381 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HH---HH-HTTCC-CCCSGGGT---
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HH---HH-HhCCC-CCCccccc---
Confidence            56789999999999986 489999999999999999999999976543321    11   11 11110 00000001   


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       382 ---~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          382 ---GISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               112467889999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-43  Score=354.39  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=205.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCc----ceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH----NLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~~~~g  318 (558)
                      .++||+|+||.||+|+.. ++.||||++.........+..|+.++.+++||||+++++++.....    .++||||+++|
T Consensus        29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g  107 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG  107 (322)
T ss_dssp             EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence            478999999999999876 7899999998665555667789999999999999999999987554    58999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC----------cEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ----------KILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~----------~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      +|.+++....    +++..++.++.|++.||.|||+   .          +|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~  180 (322)
T 3soc_A          108 SLSDFLKANV----VSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK  180 (322)
T ss_dssp             BHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence            9999997643    8999999999999999999998   7          999999999999999999999999999987


Q ss_pred             cCCCCCc-eeecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH---------H
Q 043292          389 IDQDQSQ-VVTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL---------L  452 (558)
Q Consensus       389 ~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~---------~  452 (558)
                      ....... ......||+.|+|||++.+      .++.++||||||+++|||++|+.||............         .
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (322)
T 3soc_A          181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE  260 (322)
T ss_dssp             ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred             cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence            6543322 2334678999999999875      2556889999999999999999999865443211110         1


Q ss_pred             HHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       453 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .+. .......    ....+............+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       261 ~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          261 DMQ-EVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHH-HHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhh-hhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111 1111111    1111111112234566799999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-43  Score=350.42  Aligned_cols=253  Identities=30%  Similarity=0.498  Sum_probs=196.4

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+++. +++.||||++....   ...+++.+|++++.+++||||+++++++.+....++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            47899999999999986 58899999987543   234578999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.+++........+++..++.++.||+.||.|||+   .+  |+||||||+|||++.++.+||+|||+++...... ...
T Consensus       121 L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  196 (309)
T 3p86_A          121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSS  196 (309)
T ss_dssp             HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-ccc
Confidence            99999865443448999999999999999999999   78  9999999999999999999999999998654322 223


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+    .......   ....          ..
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~~~~---~~~~----------~~  259 (309)
T 3p86_A          197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGF---KCKR----------LE  259 (309)
T ss_dssp             -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHHH---SCCC----------CC
T ss_pred             ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh---cCCC----------CC
Confidence            45678999999999875 58999999999999999999999997654322    1111100   0000          01


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ........+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            11122346889999999999999999999999999887654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-42  Score=339.48  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||++...++..||+|+++......+++.+|+.++.+++||||+++++++.++...++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (268)
T 3sxs_A           13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN   92 (268)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred             eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence            47899999999999998888899999998776667889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...............+
T Consensus        93 ~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  167 (268)
T 3sxs_A           93 YLRSHGK--GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF  167 (268)
T ss_dssp             HHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCC
T ss_pred             HHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCc
Confidence            9976532  38999999999999999999999   999999999999999999999999999998765544333344556


Q ss_pred             CCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      |+.|+|||.+.+ .++.++||||||++++||++ |+.||......+.    .   ... ..+..  ..        .+..
T Consensus       168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~---~~~-~~~~~--~~--------~~~~  229 (268)
T 3sxs_A          168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV----V---LKV-SQGHR--LY--------RPHL  229 (268)
T ss_dssp             CGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----H---HHH-HTTCC--CC--------CCTT
T ss_pred             CcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH----H---HHH-HcCCC--CC--------CCCc
Confidence            778999999875 58999999999999999999 9999975543221    1   011 11100  00        0111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ....+.+++..||+.||.+|||+.++++.|+.+.+.+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            2346889999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-42  Score=345.98  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=209.7

Q ss_pred             CccCHHHHHHHHHHh------------hhhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCc
Q 043292          228 KRFSFEELKVMTDNF------------RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQ  293 (558)
Q Consensus       228 ~~~~~~~l~~~t~~~------------~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~  293 (558)
                      ..|++++++.+++..            .++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++.+++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            468999999988752            257999999999999985 7999999999743 33456789999999999999


Q ss_pred             ceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       294 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      ||+++++++..++..++||||+++++|.+++...    .+++..+..++.|++.||.|||+   .+|+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence            9999999999999999999999999999998643    39999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHH
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLL  452 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~  452 (558)
                      .++.+||+|||++........ ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.......    ..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence            999999999999987654322 2345679999999999875 58999999999999999999999997543221    11


Q ss_pred             HHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          453 SIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       453 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ...    .....     ...   .........+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~----~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 KRL----RDSPP-----PKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHH----HHSSC-----CCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHH----hcCCC-----CCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111    01000     000   0111123468899999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-42  Score=340.99  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=208.1

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||++...+++.||+|++.......+++.+|++++.+++||||+++++++.++...++||||+++++|.+
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD   94 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence            47899999999999999888999999998776677889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...............+
T Consensus        95 ~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  169 (269)
T 4hcu_A           95 YLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF  169 (269)
T ss_dssp             HHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTC
T ss_pred             HHHhcCc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccccCccc
Confidence            9976443  48999999999999999999999   999999999999999999999999999998765433223334556


Q ss_pred             CCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ++.|+|||.+. ..++.++||||||++++||++ |+.||......+    ...   .. ..+.     ...     ....
T Consensus       170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----~~~---~~-~~~~-----~~~-----~~~~  231 (269)
T 4hcu_A          170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVE---DI-STGF-----RLY-----KPRL  231 (269)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---HH-HTTC-----CCC-----CCTT
T ss_pred             ccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----HHH---HH-hcCc-----cCC-----CCCc
Confidence            77899999987 569999999999999999999 999997544322    111   11 0100     000     0111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++..|++.||.+|||+.++++.|+++.+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            23468899999999999999999999999988764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=349.09  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=201.8

Q ss_pred             hhcCccCceEEEEEEeC----CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT----DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+|.+.    .+..||||+++..  ....+.|.+|+.++.+++||||+++++++.+++..++||||+++
T Consensus        55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  134 (325)
T 3kul_A           55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN  134 (325)
T ss_dssp             EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred             eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence            67999999999999884    3446999999753  33456799999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      ++|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......... 
T Consensus       135 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  209 (325)
T 3kul_A          135 GSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY  209 (325)
T ss_dssp             CBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCE
T ss_pred             CcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcccee
Confidence            999999975533  39999999999999999999999   999999999999999999999999999998765433222 


Q ss_pred             -eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          397 -VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       397 -~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       .....+|+.|+|||++. +.++.++||||||+++|||++ |..||......+    +..   .. ..+..         
T Consensus       210 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~---~~-~~~~~---------  272 (325)
T 3kul_A          210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----VIS---SV-EEGYR---------  272 (325)
T ss_dssp             ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHH---HH-HTTCC---------
T ss_pred             eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----HHH---HH-HcCCC---------
Confidence             22344677899999987 458999999999999999999 999997544322    111   11 11100         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                       ..........+.+++..||+.||.+|||+.+|+++|+.+.....
T Consensus       273 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          273 -LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence             01111233578899999999999999999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=344.26  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=204.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||++.. .+++.||+|++... ....+.|.+|++++.+++||||+++++++.+++..++||||+++++|
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            47899999999999998 46899999988653 34456799999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce----
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV----  396 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~----  396 (558)
                      .+++.....  .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.........    
T Consensus        95 ~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  169 (310)
T 3s95_A           95 RGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR  169 (310)
T ss_dssp             HHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred             HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence            999987443  39999999999999999999999   999999999999999999999999999998764432211    


Q ss_pred             ---------eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh
Q 043292          397 ---------VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD  466 (558)
Q Consensus       397 ---------~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (558)
                               .....||+.|+|||.+.+ .++.++||||||+++|||++|..|+.............           ...
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-----------~~~  238 (310)
T 3s95_A          170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----------VRG  238 (310)
T ss_dssp             ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-----------HHH
T ss_pred             cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-----------hhc
Confidence                     114579999999999875 58999999999999999999999987654433211000           000


Q ss_pred             hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       467 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ..+.....     .....+.+++.+|++.||++|||+.++++.|+.+...
T Consensus       239 ~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          239 FLDRYCPP-----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHHTCCT-----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccccCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            01110000     1123678899999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-42  Score=341.86  Aligned_cols=242  Identities=26%  Similarity=0.420  Sum_probs=199.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||++.. .+++.||||++... ....+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus        25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (297)
T 3fxz_A           25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (297)
T ss_dssp             CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence            36899999999999987 57899999998643 33456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++....    +++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........ .....
T Consensus       105 ~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  176 (297)
T 3fxz_A          105 TDVVTETC----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (297)
T ss_dssp             HHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred             HHHHhhcC----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence            99997653    8999999999999999999999   8999999999999999999999999999987654332 24456


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .||+.|+|||.+.+ .++.++||||||+++|||++|+.||........   .......    ...         ......
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~----~~~---------~~~~~~  240 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATN----GTP---------ELQNPE  240 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHH----CSC---------CCSCGG
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC----CCC---------CCCCcc
Confidence            79999999999875 589999999999999999999999975443221   1111100    000         001111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            22346889999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=339.19  Aligned_cols=270  Identities=24%  Similarity=0.358  Sum_probs=212.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCC--cceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--HNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++... +++.||||+++...  ...+.+.+|++++.+++||||+++++++....  ..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence            478999999999999985 58999999997533  34567889999999999999999999987655  67899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee----cCCCCeEEcccCCccccCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll----~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      ++|.+++........+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++......
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~  170 (319)
T 4euu_A           94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE  170 (319)
T ss_dssp             CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred             CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence            9999999876554559999999999999999999999   999999999999999    788889999999998765433


Q ss_pred             CceeecccCCCCcCChhhhc---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLS---------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~---------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .  .....||+.|+|||++.         ..++.++||||||+++|||++|+.||.........................
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (319)
T 4euu_A          171 Q--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (319)
T ss_dssp             C--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred             c--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence            2  34567999999999874         458999999999999999999999997655444332222222221111111


Q ss_pred             hhh----------ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          465 SDL----------VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       465 ~~~----------~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ..+          .................+.+++.+||+.||++|||++|+++...+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~  311 (319)
T 4euu_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG  311 (319)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred             hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence            100          00111122345677788999999999999999999999999987765544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-42  Score=367.43  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=209.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.++||+|+||.||+|+.. ++..||||.++......++|.+|+.++.+++||||+++++++......++||||+++|+|
T Consensus       224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L  303 (495)
T 1opk_A          224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL  303 (495)
T ss_dssp             EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence            4578999999999999985 488999999987666678899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.............
T Consensus       304 ~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  379 (495)
T 1opk_A          304 LDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  379 (495)
T ss_dssp             HHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred             HHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence            999986433 348999999999999999999999   9999999999999999999999999999987654332223344


Q ss_pred             cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      .++..|+|||.+. +.++.++||||||+++|||++ |..||......+    +....    ..+.       .+   ...
T Consensus       380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~~~~~----~~~~-------~~---~~~  441 (495)
T 1opk_A          380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL----EKDY-------RM---ERP  441 (495)
T ss_dssp             CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHH----HTTC-------CC---CCC
T ss_pred             cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcCC-------CC---CCC
Confidence            5678999999987 458999999999999999999 999997655332    11111    1110       00   111


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ......+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            1233578899999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-42  Score=364.85  Aligned_cols=252  Identities=25%  Similarity=0.429  Sum_probs=206.6

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.++||+|+||.||+|...++..||||+++......+.|.+|+.++++++||||+++++++. .+..++||||+++|+|.
T Consensus       192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~  270 (454)
T 1qcf_A          192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL  270 (454)
T ss_dssp             EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred             EEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence            35789999999999999988899999999876666788999999999999999999999987 56789999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..............
T Consensus       271 ~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  346 (454)
T 1qcf_A          271 DFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK  346 (454)
T ss_dssp             HHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSS
T ss_pred             HHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCc
Confidence            99975421 238899999999999999999999   89999999999999999999999999999876433222223345


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+. +.++.++||||||+++|||++ |+.||......+    +.....    .+..       +   ....
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i~----~~~~-------~---~~~~  408 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALE----RGYR-------M---PRPE  408 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHH----HTCC-------C---CCCT
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----cCCC-------C---CCCC
Confidence            678899999987 579999999999999999999 999997654322    111111    1100       0   0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .....+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            2345788999999999999999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.7e-42  Score=351.81  Aligned_cols=254  Identities=27%  Similarity=0.450  Sum_probs=205.1

Q ss_pred             hhhcCccCceEEEEEEeC--------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          243 RKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      .+.||+|+||.||++...        ++..||||+++...  ...+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  165 (370)
T 2psq_A           86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  165 (370)
T ss_dssp             EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence            478999999999999752        34579999997542  2346799999999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          312 YEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      |||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  242 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM  242 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCE
Confidence            999999999999986432             2348999999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||+++........ ......+|+.|+|||++.+ .++.++||||||+++|||++ |+.||......+    +....
T Consensus       243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----~~~~~  318 (370)
T 2psq_A          243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL  318 (370)
T ss_dssp             EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHH
T ss_pred             EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH
Confidence            99999999866543221 2233557789999998865 59999999999999999999 999997654332    11111


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                          ..+...          .........+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus       319 ----~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          319 ----KEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             ----HTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----hcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                111100          011123347889999999999999999999999999886543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.3e-41  Score=335.16  Aligned_cols=255  Identities=28%  Similarity=0.391  Sum_probs=200.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++.. .+++.||+|.+...    ....+.+.+|+.++.+++||||+++++++.+++..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g   95 (294)
T 4eqm_A           16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG   95 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence            47899999999999987 46899999998532    22346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...........
T Consensus        96 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  169 (294)
T 4eqm_A           96 PTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT  169 (294)
T ss_dssp             CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence            99999997654   38999999999999999999999   9999999999999999999999999999987655443334


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........       ...... ...........    
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~-~~~~~~~~~~~----  237 (294)
T 4eqm_A          170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHIQ-DSVPNVTTDVR----  237 (294)
T ss_dssp             -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHHS-SCCCCHHHHSC----
T ss_pred             CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhh-ccCCCcchhcc----
Confidence            45679999999999875 589999999999999999999999976543221       111111 11111100000    


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcccccc
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-SMSMVVRVLEGVTEFE  517 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~~~  517 (558)
                        ......+.+++.+|++.||.+|| +++++.+.|+.+....
T Consensus       238 --~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          238 --KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             --cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence              11234788999999999999999 9999999998876544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.1e-42  Score=338.93  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||++...++..||+|+++......+++.+|++++.+++|+||+++++++.+++..++||||+++++|.+
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN  108 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence            47899999999999999888899999998776667889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++.....  .+++..++.++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++...............+
T Consensus       109 ~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  183 (283)
T 3gen_A          109 YLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF  183 (283)
T ss_dssp             HHHCGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTS
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCcc
Confidence            9976332  39999999999999999999999   999999999999999999999999999998765433222334456


Q ss_pred             CCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      |+.|+|||.+. ..++.++||||||+++|||++ |+.||......+..    .   .. ..+.     ....     ...
T Consensus       184 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~----~---~~-~~~~-----~~~~-----~~~  245 (283)
T 3gen_A          184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----E---HI-AQGL-----RLYR-----PHL  245 (283)
T ss_dssp             CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----H---HH-HTTC-----CCCC-----CTT
T ss_pred             CcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----H---HH-hccc-----CCCC-----CCc
Confidence            78899999987 568999999999999999998 99999765432211    1   11 0110     0000     111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            13478899999999999999999999999988754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-41  Score=337.92  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=195.5

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhc--cCCcceeeeeeeecc----CCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS--IHHQNLVRLIGFCAE----KSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+|+. +++.||||++....  ...+..|.+++..  ++||||+++++++..    ....++||||++
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~   89 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE   89 (301)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred             EEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence            47899999999999987 58899999987543  3445566666655  899999999998654    345789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcc--------ccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH--------EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      +|+|.+++...    .+++..++.++.|++.||.|||        +   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  162 (301)
T 3q4u_A           90 MGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLAVM  162 (301)
T ss_dssp             TCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence            99999999643    3999999999999999999999        6   8999999999999999999999999999986


Q ss_pred             cCCCCCce---eecccCCCCcCChhhhcCC-------CCCccchHHHHHHHHHHHhC----------CCCCCCCCCcchh
Q 043292          389 IDQDQSQV---VTTMRGTPGYLAPEWLSSI-------ITEKVDIYSFGVVMLEILCG----------RKVFDRSQPEEED  448 (558)
Q Consensus       389 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-------~~~k~Dv~s~Gv~l~elltg----------~~p~~~~~~~~~~  448 (558)
                      ........   .....||+.|+|||.+.+.       ++.++||||||+++|||++|          +.||.........
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~  242 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS  242 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence            65433322   2235799999999998753       34689999999999999999          7888654433322


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .....  ........     ................+.+++.+||+.||++|||+.+|+++|+++
T Consensus       243 ~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          243 FEDMR--KVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             HHHHH--HHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhh--HHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11111  11111110     111111111235667899999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.3e-42  Score=353.00  Aligned_cols=252  Identities=26%  Similarity=0.471  Sum_probs=192.6

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+|+..    ++..||||+++..  ....++|.+|+.++.+++||||+++++++.++...++||||++
T Consensus        50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (373)
T 2qol_A           50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME  129 (373)
T ss_dssp             CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence            478999999999999874    4678999999743  2345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       130 ~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  204 (373)
T 2qol_A          130 NGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA  204 (373)
T ss_dssp             TCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence            9999999976532  48999999999999999999999   899999999999999999999999999998765433221


Q ss_pred             e--ecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          397 V--TTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       397 ~--~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      .  ....++..|+|||++. +.++.++||||||+++|||++ |+.||......+    +....    ..+..       .
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----~~~~i----~~~~~-------~  269 (373)
T 2qol_A          205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAV----DEGYR-------L  269 (373)
T ss_dssp             ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----HHHHH----HTTEE-------C
T ss_pred             eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcCCC-------C
Confidence            1  1233577899999987 569999999999999999998 999997544221    11111    11100       0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                         .........+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus       270 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          270 ---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence               011123457889999999999999999999999999886543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-41  Score=341.70  Aligned_cols=240  Identities=25%  Similarity=0.423  Sum_probs=198.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++.. .+++.||||++....   ...+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus        20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~   99 (328)
T 3fe3_A           20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG   99 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence            47899999999999998 679999999997432   23456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++.....   +++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ...
T Consensus       100 ~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~  171 (328)
T 3fe3_A          100 EVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLD  171 (328)
T ss_dssp             BHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGG
T ss_pred             cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccc
Confidence            99999976543   8999999999999999999999   999999999999999999999999999998765432  245


Q ss_pred             cccCCCCcCChhhhcCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSSI-I-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~~-~-~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...||+.|+|||++.+. + +.++||||||++++||++|+.||...+..+    +..    ....+..           .
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~----~i~~~~~-----------~  232 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRE----RVLRGKY-----------R  232 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCCC-----------C
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhCCC-----------C
Confidence            67799999999998753 4 579999999999999999999997654322    111    1111111           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+......+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            011123467889999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.9e-42  Score=355.06  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=201.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+|+.. +++.||||.++...  ...++|.+|++++.+++||||+++++++..++..++||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            478999999999999985 78999999987532  233568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee-e
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-T  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~  398 (558)
                      |.+++.....  .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......... .
T Consensus       199 L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~  273 (377)
T 3cbl_A          199 FLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG  273 (377)
T ss_dssp             HHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence            9999976432  38999999999999999999999   9999999999999999999999999999986543211111 1


Q ss_pred             cccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...++..|+|||.+. +.++.++||||||+++|||++ |..||......+    ....    ...+..       +   .
T Consensus       274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----~~~~----~~~~~~-------~---~  335 (377)
T 3cbl_A          274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREF----VEKGGR-------L---P  335 (377)
T ss_dssp             CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----HHHH----HHTTCC-------C---C
T ss_pred             CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHcCCC-------C---C
Confidence            123467899999986 568999999999999999998 999997554322    1111    111110       0   1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .+......+.+++..||+.||++|||+.+|++.|+.+..
T Consensus       336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            111223478899999999999999999999999988753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.5e-42  Score=359.46  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.++||+|+||.||+|...++..||||.++......++|.+|+.++.+++||||+++++++.+ +..++||||+++|+|.
T Consensus       188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~  266 (452)
T 1fmk_A          188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL  266 (452)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred             eeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence            357899999999999999888889999998665566789999999999999999999999876 6789999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus       267 ~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  342 (452)
T 1fmk_A          267 DFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  342 (452)
T ss_dssp             HHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCc
Confidence            99975321 248999999999999999999999   99999999999999999999999999999876543322233455


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+. +.++.++||||||+++|||++ |+.||......+    ...   . ...+..       +   ..+.
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~---~-i~~~~~-------~---~~~~  404 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLD---Q-VERGYR-------M---PCPP  404 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHH---H-HHTTCC-------C---CCCT
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----HHH---H-HHcCCC-------C---CCCC
Confidence            778999999886 579999999999999999999 999997554322    111   1 111100       0   1111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .....+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            2345788999999999999999999999999987644

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-41  Score=332.21  Aligned_cols=250  Identities=26%  Similarity=0.453  Sum_probs=207.0

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||++...+++.||+|.+.......+.+.+|++++.+++||||+++++++.+++..++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD   92 (267)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred             eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence            47899999999999999888899999998776667889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...............+
T Consensus        93 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  167 (267)
T 3t9t_A           93 YLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF  167 (267)
T ss_dssp             HHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTC
T ss_pred             HHhhCcc--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccccccccc
Confidence            9976543  48999999999999999999999   999999999999999999999999999998764332222234556


Q ss_pred             CCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      +..|+|||.+. ..++.++||||||++++||++ |+.||......+    ...   . ...+.     ...     ....
T Consensus       168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~-i~~~~-----~~~-----~~~~  229 (267)
T 3t9t_A          168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVE---D-ISTGF-----RLY-----KPRL  229 (267)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---H-HHTTC-----CCC-----CCTT
T ss_pred             cccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH----HHH---H-HhcCC-----cCC-----CCcc
Confidence            78899999987 568999999999999999999 899997544222    111   1 11110     000     0111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++.+|++.||.+|||+.++++.|+++.+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            23468899999999999999999999999988754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8e-42  Score=356.70  Aligned_cols=258  Identities=22%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             HHHHHHHHHh--hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccC
Q 043292          233 EELKVMTDNF--RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK  305 (558)
Q Consensus       233 ~~l~~~t~~~--~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  305 (558)
                      .+++..+++|  .++||+|+||.||+++.. +++.||+|+++...    .....+.+|..++..++||||+++++++.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            3333334444  378999999999999985 57889999997421    2233488999999999999999999999999


Q ss_pred             CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCC
Q 043292          306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL  385 (558)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgl  385 (558)
                      +..++||||+++|+|.+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999986432  39999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          386 SKLIDQDQSQVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       386 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ++..............||+.|+|||++.      +.++.++|||||||++|||++|+.||...+..+....+....    
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----  297 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK----  297 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----
Confidence            9877655444445578999999999985      348999999999999999999999998654333111111100    


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRV  509 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  509 (558)
                      ....+..    ...      .....+.+++.+||..+|++  ||+++++++.
T Consensus       298 ~~~~~p~----~~~------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          298 ERFQFPT----QVT------DVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHCCCCS----SCC------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccccCCc----ccc------cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            0000100    000      12246788999999888888  9999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.8e-41  Score=338.17  Aligned_cols=254  Identities=17%  Similarity=0.242  Sum_probs=203.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+|+. .+++.||||++.... ..+.+..|+.++.++ +||||+++++++..+...++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL   91 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence            47899999999999997 578999999987432 234688999999999 9999999999999999999999999 9999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC-----eEEcccCCccccCCCCCc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN-----AKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~ki~Dfgla~~~~~~~~~  395 (558)
                      .+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.     +||+|||+++.+......
T Consensus        92 ~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           92 EDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             HHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             HHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence            99998653  249999999999999999999999   89999999999999999887     999999999876543321


Q ss_pred             ------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          396 ------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       396 ------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                            ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.......+...... ... +.+
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~-~~~  244 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPI-EVL  244 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCH-HHH
T ss_pred             ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCH-HHH
Confidence                  1245679999999999876 5899999999999999999999999876544322222221111110 000 000


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         ..      ... .+.+++..|++.||.+||++.+|++.|+.+.+
T Consensus       245 ---~~------~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          245 ---CE------NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             ---TT------TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---hc------cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence               00      012 78899999999999999999999999987654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.8e-41  Score=352.73  Aligned_cols=247  Identities=31%  Similarity=0.467  Sum_probs=201.3

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCC-cceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS-HNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~  321 (558)
                      .++||+|+||.||+|... ++.||||+++... ..+.|.+|+.++.+++||||+++++++.... ..++||||+++|+|.
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~  275 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  275 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence            478999999999999876 7799999998644 4578999999999999999999999987655 689999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       276 ~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~  347 (450)
T 1k9a_A          276 DYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGK  347 (450)
T ss_dssp             HHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------C
T ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCC
Confidence            99986543 247999999999999999999999   99999999999999999999999999999854322    22335


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+.    ..    ....+..       +   ..+.
T Consensus       348 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----~~----~i~~~~~-------~---~~p~  409 (450)
T 1k9a_A          348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----VP----RVEKGYK-------M---DAPD  409 (450)
T ss_dssp             CCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----HH----HHHTTCC-------C---CCCT
T ss_pred             CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HH----HHHcCCC-------C---CCCC
Confidence            7889999999864 69999999999999999998 9999986554331    11    1111110       0   1111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .....+.+++..||+.||.+|||+.+|++.|+.+...+
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            23457889999999999999999999999999876443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=335.76  Aligned_cols=245  Identities=18%  Similarity=0.324  Sum_probs=200.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||+++.. +++.+|+|.+.........+.+|+.++..++||||+++++++.+.+..++||||+++++|.
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~   89 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence            478999999999999984 6889999999866556677899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC--CCCeEEcccCCccccCCCCCceeec
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG--NFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      +++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||++.......  ....
T Consensus        90 ~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~  162 (321)
T 1tki_A           90 ERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRL  162 (321)
T ss_dssp             HHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEE
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--cccc
Confidence            9997543  248999999999999999999999   99999999999999987  7899999999998765432  2445


Q ss_pred             ccCCCCcCChhhhcCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..||+.|+|||++.+. ++.++||||||+++|||++|..||......+    ...   ... ..... .......     
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~---~i~-~~~~~-~~~~~~~-----  228 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIE---NIM-NAEYT-FDEEAFK-----  228 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---HHH-HTCCC-CCHHHHT-----
T ss_pred             ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHH---HHH-cCCCC-CChhhhc-----
Confidence            6789999999998765 7999999999999999999999997644322    111   111 00000 0000000     


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       .....+.+++.+||+.||.+|||+.++++.
T Consensus       229 -~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          229 -EISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             113468899999999999999999999973

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-41  Score=340.70  Aligned_cols=249  Identities=26%  Similarity=0.481  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|+.. +++    +||+|.+...  ....++|.+|+.++.+++||||+++++++..+. .++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~   98 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM   98 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence            478999999999999863 444    3688887532  344578999999999999999999999998754 78999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        99 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           99 PFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             TTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence            99999999987543  39999999999999999999999   89999999999999999999999999999876543322


Q ss_pred             e-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 V-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . .....+|..|+|||.+. +.++.++||||||+++|||++ |+.||......+    +.....    .+..        
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~----~~~~--------  237 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE----KGER--------  237 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH----TTCC--------
T ss_pred             ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHH----cCCC--------
Confidence            2 23445688999999886 469999999999999999999 999998655433    111111    1100        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                        ..........+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       238 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              01111233478899999999999999999999999988754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4e-40  Score=330.05  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||.||+++..+++.||+|++....   .....+.+|+.++.+++||||+++++++.++...++||||++ ++
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~  104 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD  104 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence            47899999999999999889999999997432   224678899999999999999999999999999999999997 58


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       105 l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~  178 (311)
T 3niz_A          105 LKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTH  178 (311)
T ss_dssp             HHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----C
T ss_pred             HHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccC
Confidence            8888875443  48999999999999999999999   9999999999999999999999999999987643322 2344


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc-----cchhhccccC
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-----KLSDLVDKHS  472 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~  472 (558)
                      ..||+.|+|||++.+  .++.++||||||++++||++|+.||......+....+...........     ......+...
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            678999999999864  489999999999999999999999987665543222222111100000     0000000000


Q ss_pred             CCCC-CC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQ-SN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~-~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .... ..     ......+.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000 00     011246789999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=346.53  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             hhhcCccCceEEEEEEeC--------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          243 RKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      .++||+|+||.||+++..        .+..||||+++...  ...+++.+|++++.++ +||||+++++++..++..++|
T Consensus        74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  153 (382)
T 3tt0_A           74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  153 (382)
T ss_dssp             EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence            478999999999999852        23579999997542  2346789999999999 999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          312 YEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      |||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~  230 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM  230 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcE
Confidence            999999999999986532             2359999999999999999999999   899999999999999999999


Q ss_pred             EEcccCCccccCCCCC-ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||+++....... .......+|+.|+|||++.+ .++.++||||||++++||++ |..||......+    +... 
T Consensus       231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----~~~~-  305 (382)
T 3tt0_A          231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKL-  305 (382)
T ss_dssp             EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH-
T ss_pred             EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-
Confidence            9999999987654322 22334567889999999875 58999999999999999999 999997554222    1111 


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                         ...+....          ........+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus       306 ---~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          306 ---LKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             ---HHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             ---HHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence               11111000          011223478899999999999999999999999999876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.9e-41  Score=332.65  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=209.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||++... ++..||+|.+.......+.+.+|+.++++++||||+++++++.++...++||||+++++|.
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   97 (288)
T 3kfa_A           18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL   97 (288)
T ss_dssp             EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred             EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            478999999999999985 5889999999877666788999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++...............
T Consensus        98 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  173 (288)
T 3kfa_A           98 DYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK  173 (288)
T ss_dssp             HHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEE
T ss_pred             HHHHhccc-CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCc
Confidence            99976443 348999999999999999999999   89999999999999999999999999999877655444444556


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      +++.|+|||.+. ..++.++||||||+++++|++ |..||.......    .......    ..     ..     ....
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~~~~~----~~-----~~-----~~~~  235 (288)
T 3kfa_A          174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEK----DY-----RM-----ERPE  235 (288)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHHHT----TC-----CC-----CCCT
T ss_pred             cccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhc----cC-----CC-----CCCC
Confidence            788999999986 568999999999999999999 999997654332    1111111    00     00     0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .....+.+++..|++.||.+|||+.+++++|+.+..
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            223578899999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-40  Score=336.93  Aligned_cols=244  Identities=25%  Similarity=0.385  Sum_probs=198.0

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc-------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE-------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+++.. +++.||+|.++....       ..+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e   95 (361)
T 2yab_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE   95 (361)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence            3478999999999999984 689999999974321       24678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~  389 (558)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||++...
T Consensus        96 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           96 LVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             CCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999997543   49999999999999999999999   9999999999999998877    7999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.   +..+. .  ....+..-.
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~~i~-~--~~~~~~~~~  241 (361)
T 2yab_A          170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANIT-A--VSYDFDEEF  241 (361)
T ss_dssp             CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH-T--TCCCCCHHH
T ss_pred             CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH-h--cCCCCCchh
Confidence            5432  2345679999999999875 589999999999999999999999976443221   11110 0  000000000


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ..      .....+.+++..||+.||.+|||+.++++
T Consensus       242 ---~~------~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          242 ---FS------QTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ---HT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---cc------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00      11246789999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.7e-41  Score=333.53  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=196.8

Q ss_pred             hhhhcCccCceEEEEEEe-----CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  313 (558)
                      +.++||+|+||.||+++.     .+++.||||++.... ...+.+.+|+.++.+++||||+++++++...  ...++|||
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   93 (295)
T 3ugc_A           14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME   93 (295)
T ss_dssp             EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred             hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence            347899999999999983     368899999997543 3346789999999999999999999998653  45799999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++.....  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        94 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           94 YLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             CCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             eCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            9999999999976543  38999999999999999999999   999999999999999999999999999998765433


Q ss_pred             Cc--eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcch--------hhhHHHHHHHhhhcc
Q 043292          394 SQ--VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE--------DMYLLSIFKKKAEED  462 (558)
Q Consensus       394 ~~--~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  462 (558)
                      ..  ......++..|+|||.+. ..++.++||||||+++|||++|..|+........        ...............
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            21  223345677899999986 4689999999999999999999998864221100        000000000111110


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .          ...........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       249 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          249 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            0          00112233457889999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.9e-40  Score=335.64  Aligned_cols=241  Identities=28%  Similarity=0.359  Sum_probs=198.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|+++..    ......+.+|+.++..++||||+++++++...+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g   89 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            478999999999999884 6899999999743    33456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        90 g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~  162 (337)
T 1o6l_A           90 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  162 (337)
T ss_dssp             CBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCB
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Ccc
Confidence            99999997644   38999999999999999999999   999999999999999999999999999998643322 224


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||.......    +.   ..... ...           .
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~---~~i~~-~~~-----------~  223 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF---ELILM-EEI-----------R  223 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHH-CCC-----------C
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----HH---HHHHc-CCC-----------C
Confidence            45679999999999875 58999999999999999999999997543221    11   11111 110           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      .+......+.+++.+||+.||.+||     ++.+|++.
T Consensus       224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1111234688999999999999999     89999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=331.53  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=195.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||+++.. ++.||||.+... ...+.|.+|++++.+++||||+++++++.+  ..++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~   88 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYN   88 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHH
Confidence            478999999999999875 788999998753 345679999999999999999999998874  5899999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC-eEEcccCCccccCCCCCceeeccc
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN-AKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~-~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      ++........+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||++......    .....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~  164 (307)
T 2eva_A           89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNK  164 (307)
T ss_dssp             HHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------
T ss_pred             HHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCC
Confidence            9987654445889999999999999999999854468999999999999998887 799999999765432    23446


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ||+.|+|||.+.+ .++.++||||||++++||++|+.||........  ..   .+.. ..+.....          ...
T Consensus       165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~---~~~~-~~~~~~~~----------~~~  228 (307)
T 2eva_A          165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RI---MWAV-HNGTRPPL----------IKN  228 (307)
T ss_dssp             CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HH---HHHH-HTTCCCCC----------BTT
T ss_pred             CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HH---HHHH-hcCCCCCc----------ccc
Confidence            8999999999876 589999999999999999999999975443221  11   1111 11111111          011


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ....+.+++.+||+.||++|||+.+++++|+.+.+.-
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            2346889999999999999999999999999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=336.12  Aligned_cols=262  Identities=27%  Similarity=0.382  Sum_probs=196.0

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhc--cCCcceeeeeeeeccC----CcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS--IHHQNLVRLIGFCAEK----SHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~  315 (558)
                      +.++||+|+||.||+|+.. ++.||||++.....  ..+..|.+++..  ++||||+++++++...    ...++||||+
T Consensus        41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~  117 (337)
T 3mdy_A           41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH  117 (337)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred             EEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence            3589999999999999876 89999999865433  344555555554  4999999999998877    6789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC-----CCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ++|+|.+++...    .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       118 ~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          118 ENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI  193 (337)
T ss_dssp             TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence            999999999764    3899999999999999999999810     1299999999999999999999999999998664


Q ss_pred             CCCCce---eecccCCCCcCChhhhcCC-CCCc------cchHHHHHHHHHHHhC----------CCCCCCCCCcchhhh
Q 043292          391 QDQSQV---VTTMRGTPGYLAPEWLSSI-ITEK------VDIYSFGVVMLEILCG----------RKVFDRSQPEEEDMY  450 (558)
Q Consensus       391 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~k------~Dv~s~Gv~l~elltg----------~~p~~~~~~~~~~~~  450 (558)
                      ......   .....||+.|+|||++.+. .+.+      +||||||+++|||++|          +.||...........
T Consensus       194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  273 (337)
T 3mdy_A          194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE  273 (337)
T ss_dssp             ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             cccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence            433221   2245799999999998753 4443      8999999999999999          666654433221111


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ...   .......    .................+.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus       274 ~~~---~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          274 DMR---EIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             HHH---HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhH---HHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            111   1111111    11111111112356778999999999999999999999999999876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.3e-41  Score=344.86  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             hhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCc-ceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSH-NLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~  312 (558)
                      .+.||+|+||.||+++.      .+++.||||+++...  ...+.+.+|++++.++ +||||+++++++.+.+. .++||
T Consensus        27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~  106 (359)
T 3vhe_A           27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  106 (359)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence            47899999999999973      346789999997532  2345799999999999 89999999999887654 89999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------------------------------------------------------
Q 043292          313 EYMPNGSLDRWLFQRSD---------------------------------------------------------------  329 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  329 (558)
                      ||+++|+|.+++.....                                                               
T Consensus       107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3vhe_A          107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY  186 (359)
T ss_dssp             ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred             EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence            99999999999986532                                                               


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-eeecccCCCCcCC
Q 043292          330 EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLA  408 (558)
Q Consensus       330 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~a  408 (558)
                      ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  263 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  263 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence            1228999999999999999999999   89999999999999999999999999999866443322 2345668899999


Q ss_pred             hhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHH
Q 043292          409 PEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMM  486 (558)
Q Consensus       409 PE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  486 (558)
                      ||++. ..++.++||||||+++|||++ |..||......+..   ...    ...+....          ........+.
T Consensus       264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~----~~~~~~~~----------~~~~~~~~l~  326 (359)
T 3vhe_A          264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRR----LKEGTRMR----------APDYTTPEMY  326 (359)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH---HHH----HHHTCCCC----------CCTTCCHHHH
T ss_pred             hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH---HHH----HHcCCCCC----------CCCCCCHHHH
Confidence            99886 468999999999999999998 99999765543311   111    11111000          0111234688


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          487 KVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       487 ~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      +++..||+.||.+|||+.+|+++|+.+.+
T Consensus       327 ~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          327 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            99999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.3e-41  Score=330.37  Aligned_cols=250  Identities=29%  Similarity=0.459  Sum_probs=204.5

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      .+.||+|+||.||+|...++..||||.+.......+.+.+|++++.+++||||+++++++.+ +..++||||+++++|.+
T Consensus        18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~   96 (279)
T 1qpc_A           18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD   96 (279)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred             eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHH
Confidence            47899999999999998888899999998766667789999999999999999999999874 56899999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecccC
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG  402 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g  402 (558)
                      ++..... ..+++..++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++...............+
T Consensus        97 ~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  172 (279)
T 1qpc_A           97 FLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF  172 (279)
T ss_dssp             HTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCC
T ss_pred             HHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCC
Confidence            9975321 238999999999999999999999   999999999999999999999999999998775443333334557


Q ss_pred             CCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       403 t~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      +..|+|||.+. +.++.++||||||++++||++ |+.||......+    +...    ...+.     ..     .....
T Consensus       173 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~----~~~~~-----~~-----~~~~~  234 (279)
T 1qpc_A          173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQN----LERGY-----RM-----VRPDN  234 (279)
T ss_dssp             CTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----HHTTC-----CC-----CCCTT
T ss_pred             ccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----HHHH----Hhccc-----CC-----CCccc
Confidence            88999999987 458999999999999999999 899997544322    1111    11110     00     00112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++..|++.||++|||+.++++.|+.+..
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            23578899999999999999999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.4e-41  Score=328.80  Aligned_cols=243  Identities=27%  Similarity=0.444  Sum_probs=187.2

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc-----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++... ++.||||+++...     ...+.+.+|+.++..++||||+++++++.+++..++||||+++
T Consensus        12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG   90 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred             eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence            478999999999999975 8899999986432     2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc---EEecCCCCCCEeecC--------CCCeEEcccCCc
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK---ILHLDIKPQNILLDG--------NFNAKVADFGLS  386 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~---ivH~dlk~~NIll~~--------~~~~ki~Dfgla  386 (558)
                      ++|.+++...    .+++..++.++.|++.||.|||+   .+   |+||||||+|||++.        ++.+||+|||++
T Consensus        91 ~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           91 GPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             CCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            9999998643    38999999999999999999999   66   999999999999986        778999999999


Q ss_pred             cccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          387 KLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       387 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      .......   .....||+.|+|||.+.+ .++.++||||||++++||++|+.||........       ....... ...
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~-~~~  232 (271)
T 3dtc_A          164 REWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AYGVAMN-KLA  232 (271)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHTS-CCC
T ss_pred             ccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHhhhcC-CCC
Confidence            8654332   234568999999999864 589999999999999999999999975442211       0011100 000


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                               ..........+.+++.+|++.||.+|||+.++++.|+.+
T Consensus       233 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 ---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     001112235788999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-40  Score=331.01  Aligned_cols=245  Identities=25%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc-------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+++.. +++.||+|.+....       ...+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   94 (326)
T 2y0a_A           15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE   94 (326)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence            3578999999999999984 68999999986432       135679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~  389 (558)
                      |+++++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+++..
T Consensus        95 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           95 LVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             CCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             cCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999997543   49999999999999999999999   9999999999999999887    7999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....  ......||+.|+|||++.+ .++.++||||||+++|||++|..||......+.   +..+. ..  ....... 
T Consensus       169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~-~~--~~~~~~~-  239 (326)
T 2y0a_A          169 DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVS-AV--NYEFEDE-  239 (326)
T ss_dssp             CTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH-HT--CCCCCHH-
T ss_pred             CCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHH-hc--CCCcCcc-
Confidence            5332  2345679999999999875 589999999999999999999999975443221   11110 00  0000000 


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        ...      .....+.+++.+||+.||.+|||+.++++.
T Consensus       240 --~~~------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          240 --YFS------NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --HHT------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --ccc------cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              000      112467899999999999999999999973

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=346.56  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=203.0

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.++||+|+||.||+|+..      ++..||||+++..  .....++.+|+.++.+++||||+++++++.++...++|||
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  154 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE  154 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence            3578999999999999843      4668999999743  3344578999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCc
Q 043292          314 YMPNGSLDRWLFQRS----DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLS  386 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla  386 (558)
                      |+++|+|.+++....    ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||++
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a  231 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  231 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence            999999999998643    12358999999999999999999999   9999999999999999555   5999999999


Q ss_pred             cccCCCC-CceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQ-SQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +...... ........+|+.|+|||.+. +.++.++||||||+++|||++ |..||......+    +...   . ..+.
T Consensus       232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----~~~~---i-~~~~  303 (367)
T 3l9p_A          232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF---V-TSGG  303 (367)
T ss_dssp             HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH---H-HTTC
T ss_pred             cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH---H-HcCC
Confidence            8553221 12233456789999999885 569999999999999999998 999997554322    1111   1 1111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ..          .........+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       304 ~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          304 RM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            00          011122346889999999999999999999999998876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=333.92  Aligned_cols=241  Identities=26%  Similarity=0.389  Sum_probs=189.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---------------------------chHHHHHHHHHHhccCCcc
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---------------------------INKSFLAEVKTIGSIHHQN  294 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~l~h~n  294 (558)
                      .+.||+|+||.||+++. .+++.||||++.....                           ..+.+.+|++++.+++|||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   97 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN   97 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence            47899999999999987 4688999999864321                           1246889999999999999


Q ss_pred             eeeeeeeecc--CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee
Q 043292          295 LVRLIGFCAE--KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL  372 (558)
Q Consensus       295 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll  372 (558)
                      |+++++++.+  +...++||||+++++|.+++..    ..+++..+..++.||+.||.|||+   .+|+||||||+|||+
T Consensus        98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLV  170 (298)
T ss_dssp             BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred             CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEE
Confidence            9999999886  5678999999999999876543    249999999999999999999999   899999999999999


Q ss_pred             cCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043292          373 DGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED  448 (558)
Q Consensus       373 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~  448 (558)
                      +.++.+||+|||+++....... ......||+.|+|||.+.+.    .+.++||||||+++|||++|+.||.......  
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--  247 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC--  247 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             CCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH--
Confidence            9999999999999987654332 23456799999999998753    3778999999999999999999997543211  


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        +..   . .......      .   .........+.+++.+||+.||++|||+.++++
T Consensus       248 --~~~---~-~~~~~~~------~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 --LHS---K-IKSQALE------F---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             --HHH---H-HHHCCCC------C---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HHH---H-HhcccCC------C---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence              111   1 1111100      0   000112346889999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-40  Score=326.39  Aligned_cols=245  Identities=32%  Similarity=0.539  Sum_probs=196.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc--------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE--------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.||+|+||.||+++. .+++.||+|++.....        ..+.+.+|+.++.+++||||+++++++.+..  ++|||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e  101 (287)
T 4f0f_A           24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME  101 (287)
T ss_dssp             EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred             hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence            47899999999999998 5789999999863221        1167899999999999999999999987654  79999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeecCCCC-----eEEcccCCc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDGNFN-----AKVADFGLS  386 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~~~~~-----~ki~Dfgla  386 (558)
                      |+++++|.+++.....  .+++..++.++.|++.||.|||+   .+  |+|+||||+|||++.++.     +||+|||++
T Consensus       102 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A          102 FVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             CCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             ecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            9999999998876443  49999999999999999999999   78  999999999999988876     999999999


Q ss_pred             cccCCCCCceeecccCCCCcCChhhhc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQVVTTMRGTPGYLAPEWLS---SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +....    ......||+.|+|||.+.   ..++.++||||||+++|||++|+.||.........  .......    ..
T Consensus       177 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~----~~  246 (287)
T 4f0f_A          177 QQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIRE----EG  246 (287)
T ss_dssp             BCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHH----SC
T ss_pred             ccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhc----cC
Confidence            85433    244567999999999984   24789999999999999999999999765543311  1111110    11


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ...         .........+.+++..||+.||.+|||+.++++.|+++
T Consensus       247 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            100         01112235788999999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-41  Score=362.86  Aligned_cols=252  Identities=28%  Similarity=0.421  Sum_probs=205.7

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.++||+|+||.||+|.+.++..||||+++......++|.+|++++.+++|+||+++++++.+ +..+|||||+++|+|.
T Consensus       271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~  349 (535)
T 2h8h_A          271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL  349 (535)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred             hheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence            357899999999999999888889999998765566789999999999999999999999876 6789999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      ++|..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus       350 ~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  425 (535)
T 2h8h_A          350 DFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  425 (535)
T ss_dssp             HHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTT
T ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCc
Confidence            99975321 238999999999999999999999   99999999999999999999999999999876532222223345


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+. +.++.++||||||++||||++ |+.||......+    +...    ...+..       +   ....
T Consensus       426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----~~~~----i~~~~~-------~---~~~~  487 (535)
T 2h8h_A          426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ----VERGYR-------M---PCPP  487 (535)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----HHHH----HHTTCC-------C---CCCT
T ss_pred             CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHcCCC-------C---CCCC
Confidence            678999999886 569999999999999999999 999997544322    1111    111110       0   0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .....+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            2335788999999999999999999999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=338.21  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=203.1

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++..      +++.||||+++...  ...+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus        52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  131 (343)
T 1luf_A           52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY  131 (343)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence            478999999999999874      34789999997532  3356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          315 MPNGSLDRWLFQRSD---------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      +++++|.+++.....                     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~  208 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG  208 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEC
Confidence            999999999986421                     1459999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCC-ceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 043292          374 GNFNAKVADFGLSKLIDQDQS-QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMY  450 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~  450 (558)
                      .++.+||+|||+++....... .......+|+.|+|||.+. +.++.++||||||+++|||++ |..||......+    
T Consensus       209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  284 (343)
T 1luf_A          209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----  284 (343)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----
T ss_pred             CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH----
Confidence            999999999999986543322 1233456788999999886 469999999999999999999 999997544322    


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      +..    ....+....          ........+.+++.+||+.||.+|||+.+|+++|+.+.+-
T Consensus       285 ~~~----~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          285 VIY----YVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHH----HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HHH----HHhCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            111    111111110          1112234788999999999999999999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.7e-40  Score=326.56  Aligned_cols=255  Identities=21%  Similarity=0.283  Sum_probs=205.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||++.. .+++.||||++.... ..+.+.+|+.++..+ +|+|++++++++.++...++||||+ +++|
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   92 (298)
T 1csn_A           15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   92 (298)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence            47899999999999997 578999999986432 334688999999999 8999999999999999999999999 9999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC-----eEEcccCCccccCCCCCc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN-----AKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~ki~Dfgla~~~~~~~~~  395 (558)
                      .+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.     +||+|||+++........
T Consensus        93 ~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           93 EDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             HHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence            999986543  38999999999999999999999   99999999999999987776     999999999876543321


Q ss_pred             ------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          396 ------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       396 ------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                            ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+..+.... .........
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  246 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLRELC  246 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHHHHT
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-cCccHHHHH
Confidence                  2345679999999999875 58999999999999999999999998765443222222211111 111111111


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .          .....+.+++..|++.||++|||+.+|++.|+.+.+
T Consensus       247 ~----------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          247 A----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             T----------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             h----------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            0          112478899999999999999999999999988764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-40  Score=328.23  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=194.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||++...+++.||+|++....   ...+.+.+|+.++.+++||||+++++++..++..++||||+++ +
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   85 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D   85 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence            47899999999999999889999999986432   2346788999999999999999999999999999999999975 9


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus        86 l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  159 (288)
T 1ob3_A           86 LKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH  159 (288)
T ss_dssp             HHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cccc
Confidence            9998876433  38999999999999999999999   8999999999999999999999999999986643221 2334


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cccchh-----hccc
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--EDKLSD-----LVDK  470 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~d~  470 (558)
                      ..||+.|+|||++.+  .++.++||||||++++||++|+.||......+.   +..+......  ......     ..+.
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhccccccc
Confidence            568999999999864  489999999999999999999999976543321   1111111000  000000     0010


Q ss_pred             cCCCC------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDM------QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....      .........+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000      000112356789999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.9e-41  Score=330.17  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=190.3

Q ss_pred             hhhhcCccCceEEEEEEeCC----CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|....    +..||+|.++..  ....+.+.+|+.++.+++||||+++++++. ++..++||||+
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~   97 (281)
T 1mp8_A           19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC   97 (281)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence            34789999999999998743    456999998753  233467899999999999999999999985 46789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.....  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           98 TLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             TTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            99999999976542  48999999999999999999999   99999999999999999999999999999876544333


Q ss_pred             eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......+++.|+|||.+. ..++.++||||||+++|||++ |..||......+.    ....    ..+...        
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~----~~~i----~~~~~~--------  236 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGRI----ENGERL--------  236 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----HHHH----HTTCCC--------
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH----HHHH----HcCCCC--------
Confidence            334455778999999986 468999999999999999997 9999976554321    1111    111100        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        .........+.+++.+|++.||++|||+.++++.|+.+.+.
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              01112235788999999999999999999999999887643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-40  Score=334.09  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=203.9

Q ss_pred             hhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++.      .++..||||+++...  ...+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  107 (314)
T 2ivs_A           28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY  107 (314)
T ss_dssp             EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence            47899999999999986      235789999997532  3346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          315 MPNGSLDRWLFQRSD---------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      +++++|.+++.....                     ...+++..++.++.||+.||.|||+   .+|+|+||||+|||++
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~  184 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVA  184 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEE
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEc
Confidence            999999999986432                     2348999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCce-eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMY  450 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~  450 (558)
                      .++.+||+|||+++......... .....+++.|+|||.+.+ .++.++||||||++++||++ |..||.......    
T Consensus       185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  260 (314)
T 2ivs_A          185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER----  260 (314)
T ss_dssp             TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999999998765433221 233457788999998864 58999999999999999999 999997655432    


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      +....    ..+...          .........+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       261 ~~~~~----~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          261 LFNLL----KTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HHHHH----HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHh----hcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11111    111100          0111223578899999999999999999999999988653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-40  Score=339.29  Aligned_cols=259  Identities=16%  Similarity=0.214  Sum_probs=199.3

Q ss_pred             hhhcCccCceEEEEEEeCC------CCEEEEEEeccccc------------chHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          243 RKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIGE------------INKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      .++||+|+||.||+|.+..      ++.||||++.....            ....+..|+..+..++|+||+++++++..
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  119 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH  119 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence            4789999999999998754      47899999864321            11234556677788899999999999876


Q ss_pred             C----CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCCCe
Q 043292          305 K----SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNFNA  378 (558)
Q Consensus       305 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~~~  378 (558)
                      .    ...++||||+ +++|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++  .++.+
T Consensus       120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          120 DKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTTCE
T ss_pred             ccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCCeE
Confidence            5    4479999999 9999999986532  49999999999999999999999   8999999999999999  88999


Q ss_pred             EEcccCCccccCCCCCc------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH
Q 043292          379 KVADFGLSKLIDQDQSQ------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  451 (558)
                      ||+|||+++.+......      ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........  
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~--  271 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV--  271 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH--
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH--
Confidence            99999999876533211      1133559999999999876 49999999999999999999999998543332111  


Q ss_pred             HHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          452 LSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       452 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                       ...... ....+.++++..+....    ....+.+++..|++.||.+||++.+|+++|+.+.+
T Consensus       272 -~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          272 -RDSKIR-YRENIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             -HHHHHH-HHHCHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -HHHHHH-hhhhHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence             111111 11223344443332111    23478899999999999999999999999988765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=336.56  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             hhhcCccCceEEEEEEe------CCCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.||+|+||.||+++.      .++..||||.+...  ....+.+.+|+.++.++ +||||+++++++..++..++|||
T Consensus        50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  129 (344)
T 1rjb_A           50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  129 (344)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence            47899999999999986      24568999999743  23456799999999999 89999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          314 YMPNGSLDRWLFQRSDE--------------------FMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      |+++|+|.+++......                    ..+++..++.++.||+.||.|||+   .+|+||||||+|||++
T Consensus       130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~  206 (344)
T 1rjb_A          130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT  206 (344)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEc
Confidence            99999999999865321                    248999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMY  450 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~  450 (558)
                      .++.+||+|||++......... ......+|+.|+|||.+. +.++.++||||||+++|||++ |..||........   
T Consensus       207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---  283 (344)
T 1rjb_A          207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---  283 (344)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred             CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH---
Confidence            9999999999999876544332 233456788999999886 569999999999999999998 9999976654331   


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .....    ..+..     .     .........+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       284 ~~~~~----~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          284 FYKLI----QNGFK-----M-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             HHHHH----HTTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHH----hcCCC-----C-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11111    11100     0     01112235788999999999999999999999999887654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.4e-40  Score=332.36  Aligned_cols=243  Identities=26%  Similarity=0.415  Sum_probs=192.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCc------------
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH------------  307 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------------  307 (558)
                      .+.||+|+||.||+++.. +++.||||+++..  ....+.+.+|+.++++++||||+++++++.+...            
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            478999999999999985 7999999998733  3345679999999999999999999998865432            


Q ss_pred             ---------------------------------------------ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHH
Q 043292          308 ---------------------------------------------NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII  342 (558)
Q Consensus       308 ---------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~  342 (558)
                                                                   .++||||+++++|.+++.........++..++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~  170 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF  170 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHH
Confidence                                                         68999999999999999877665567888899999


Q ss_pred             HHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-----------ceeecccCCCCcCChhh
Q 043292          343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-----------QVVTTMRGTPGYLAPEW  411 (558)
Q Consensus       343 ~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~aPE~  411 (558)
                      .||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......           .......||+.|+|||.
T Consensus       171 ~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  247 (332)
T 3qd2_B          171 IQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ  247 (332)
T ss_dssp             HHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHH
T ss_pred             HHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHH
Confidence            999999999999   9999999999999999999999999999987754321           12234569999999999


Q ss_pred             hcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHH
Q 043292          412 LSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAA  490 (558)
Q Consensus       412 ~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  490 (558)
                      +.+ .++.++||||||++++||++|..|+.      .......    ..........          .......+.+++.
T Consensus       248 ~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~----~~~~~~~~~~----------~~~~~~~~~~li~  307 (332)
T 3qd2_B          248 IHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIIT----DVRNLKFPLL----------FTQKYPQEHMMVQ  307 (332)
T ss_dssp             HHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHH----HHHTTCCCHH----------HHHHCHHHHHHHH
T ss_pred             hcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHH----HhhccCCCcc----------cccCChhHHHHHH
Confidence            875 58999999999999999999876542      0111111    1111111110          1123346788999


Q ss_pred             HccCcCCCCCCCHHHHHH
Q 043292          491 WCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       491 ~cl~~~p~~RPs~~~vl~  508 (558)
                      +||+.||.+|||+.++++
T Consensus       308 ~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          308 DMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHCSSGGGSCCHHHHHH
T ss_pred             HHccCCCCcCCCHHHHhh
Confidence            999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=343.35  Aligned_cols=269  Identities=24%  Similarity=0.354  Sum_probs=210.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCC--cceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--HNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+|... +++.||||+++...  ...+.+.+|++++.+++||||+++++++....  ..++||||+++
T Consensus        14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~   93 (396)
T 4eut_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred             EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence            478999999999999985 58999999997532  33567889999999999999999999987655  67999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee----cCCCCeEEcccCCccccCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll----~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+|.+++........+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++......
T Consensus        94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~  170 (396)
T 4eut_A           94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE  170 (396)
T ss_dssp             EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG
T ss_pred             CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC
Confidence            9999999875544459999999999999999999999   899999999999999    778889999999998764432


Q ss_pred             CceeecccCCCCcCChhhhcC---------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS---------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~---------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                        ......||+.|+|||++.+         .++.++||||||+++|||++|+.||.........................
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (396)
T 4eut_A          171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (396)
T ss_dssp             --GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred             --ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence              2345679999999998752         46789999999999999999999997654433222222211111111110


Q ss_pred             hh----------hccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          465 SD----------LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       465 ~~----------~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ..          +.................+.+++..||+.||++|||+.++++.++.+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            00          00011112233466778899999999999999999999999999887654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=330.23  Aligned_cols=238  Identities=27%  Similarity=0.317  Sum_probs=188.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||+||+|++. +++.||||++....   .....+..|+..+.++ +|+||+++++++.+++..++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            478999999999999985 79999999986432   2233455666666555 8999999999999999999999999 7


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ..
T Consensus       141 ~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~  213 (311)
T 3p1a_A          141 PSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AG  213 (311)
T ss_dssp             CBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred             CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CC
Confidence            799998876543  49999999999999999999999   899999999999999999999999999998764332  23


Q ss_pred             ecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ....||+.|+|||++.+.++.++||||||+++|||++|..|+.....           ......+.....+..       
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~~~~~-------  275 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPPEFTA-------  275 (311)
T ss_dssp             -CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCHHHHT-------
T ss_pred             cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCccccc-------
Confidence            45669999999999998999999999999999999999776642110           011111111111111       


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .....+.+++.+||+.||++|||+.++++
T Consensus       276 --~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          276 --GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              11347889999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9e-41  Score=338.42  Aligned_cols=263  Identities=24%  Similarity=0.399  Sum_probs=192.3

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeec-----cCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA-----EKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+|+. +++.||||++............|+..+..++|+||+++++.+.     .....++||||+++
T Consensus        18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~   96 (336)
T 3g2f_A           18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN   96 (336)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred             eeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence            47899999999999986 5899999999754332222233444455689999999997543     23356899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC---------cEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ---------KILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~---------~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      |+|.+++....    .++..+..++.||+.||.|||+   .         +|+||||||+|||++.++.+||+|||+++.
T Consensus        97 g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           97 GSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            99999997654    6899999999999999999998   6         999999999999999999999999999987


Q ss_pred             cCCCC-------CceeecccCCCCcCChhhhcC--------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch-hhhHH
Q 043292          389 IDQDQ-------SQVVTTMRGTPGYLAPEWLSS--------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE-DMYLL  452 (558)
Q Consensus       389 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~--------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~  452 (558)
                      +....       ........||+.|+|||++.+        .++.++||||||+++|||++|..|+........ .....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            65322       112234569999999999875        256789999999999999999777643322111 11100


Q ss_pred             H---------HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          453 S---------IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       453 ~---------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .         ..............+   .............+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          250 TEVGNHPTFEDMQVLVSREKQRPKF---PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCC---CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccCCCchHHHHHhhhcccccCCCC---CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            0         000000001100000   111112334667899999999999999999999999999988654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-40  Score=337.07  Aligned_cols=247  Identities=25%  Similarity=0.340  Sum_probs=189.5

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.+.||+|+||.||+++.. +++.||||++.......+.+.+|+.+++.++||||+++++++.+....++||||+++|+|
T Consensus        24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L  103 (361)
T 3uc3_A           24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL  103 (361)
T ss_dssp             EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence            3478999999999999985 789999999987666667899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC--eEEcccCCccccCCCCCceee
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN--AKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~--~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      .+++....   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.  +||+|||+++......  ...
T Consensus       104 ~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~  175 (361)
T 3uc3_A          104 YERICNAG---RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPK  175 (361)
T ss_dssp             HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCC
Confidence            99997644   39999999999999999999999   99999999999999987776  9999999998543221  234


Q ss_pred             cccCCCCcCChhhhcC-CCCCc-cchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEK-VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k-~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...||+.|+|||++.+ .++.+ +||||||+++|||++|+.||..............   .... ...      ...   
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~-~~~------~~~---  242 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILS-VKY------SIP---  242 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHT-TCC------CCC---
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhc-CCC------CCC---
Confidence            4579999999999865 45444 8999999999999999999986554332211111   1110 000      000   


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ........+.+++.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000122467899999999999999999999964

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.7e-40  Score=326.78  Aligned_cols=253  Identities=25%  Similarity=0.449  Sum_probs=190.8

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||+++..  ..||||+++...   ...+.|.+|+.++++++||||++++++. .....++||||++++
T Consensus        28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~  104 (289)
T 3og7_A           28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS  104 (289)
T ss_dssp             EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred             eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence            3478999999999999864  369999997432   3346789999999999999999999975 456689999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC-Ccee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~  397 (558)
                      +|.+++.....  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus       105 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          105 SLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             EHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             cHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            99999965443  48999999999999999999999   999999999999999999999999999998654322 2223


Q ss_pred             ecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....||+.|+|||.+.    ..++.++||||||++++||++|+.||......+.   +.....    .+.....+..   
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~----~~~~~~~~~~---  249 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG----RGSLSPDLSK---  249 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHH----HTSCCCCTTS---
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhc----ccccCcchhh---
Confidence            4567899999999985    3578899999999999999999999976554331   111111    1111111111   


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         ........+.+++..||+.||.+|||+.+++++|+++.+
T Consensus       250 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          250 ---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence               011233578999999999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=339.21  Aligned_cols=240  Identities=25%  Similarity=0.389  Sum_probs=192.7

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|+||.||+++.. +++.||||+++..    ....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            478999999999999884 6899999999743    23345688899999988 79999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus       108 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~  180 (353)
T 3txo_A          108 GGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVT  180 (353)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC-Ccc
Confidence            999999997654   39999999999999999999999   99999999999999999999999999999854322 223


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+..+    +   ..... .+..           
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~---~~~i~-~~~~-----------  241 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----L---FEAIL-NDEV-----------  241 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHHH-HCCC-----------
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----H---HHHHH-cCCC-----------
Confidence            445779999999999875 48999999999999999999999997654322    1   11111 1110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSM------SMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~vl~  508 (558)
                      ..+......+.+++..||+.||.+||++      .++++
T Consensus       242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            0111123468889999999999999998      77765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-40  Score=334.34  Aligned_cols=245  Identities=24%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||++... +++.||||++....  ...+.+.+|+.++..++||||+++++++.+++..++||||+++++
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~   91 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence            478999999999999885 78999999986432  234678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-ceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~  398 (558)
                      |.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..... ....
T Consensus        92 L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (323)
T 3tki_A           92 LFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (323)
T ss_dssp             GGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence            999986543   39999999999999999999999   9999999999999999999999999999986643322 2234


Q ss_pred             cccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...||+.|+|||++.+.  .+.++||||||+++|||++|+.||.........  ...+.    .....   ..       
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~----~~~~~---~~-------  229 (323)
T 3tki_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWK----EKKTY---LN-------  229 (323)
T ss_dssp             SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHH----TTCTT---ST-------
T ss_pred             CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHh----ccccc---CC-------
Confidence            56799999999998753  477999999999999999999999765543211  11110    00000   00       


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ........+.+++.+||+.||.+|||+.++++.
T Consensus       230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            001123467889999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-39  Score=331.09  Aligned_cols=260  Identities=27%  Similarity=0.372  Sum_probs=203.6

Q ss_pred             HHhhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhc--cCCcceeeeeeeeccCC----cceEEEE
Q 043292          240 DNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS--IHHQNLVRLIGFCAEKS----HNLLVYE  313 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e  313 (558)
                      ..+.+.||+|+||.||+++. +++.||||++...  ....+..|.+++..  ++||||+++++++....    ..++|||
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           44 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             EEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            34468999999999999987 4899999999743  34567888888877  79999999999998776    7899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcc--------ccCCCcEEecCCCCCCEeecCCCCeEEcccCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH--------EDCRQKILHLDIKPQNILLDGNFNAKVADFGL  385 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgl  385 (558)
                      |+++|+|.+++.+.    .+++..++.++.|++.||.|||        +   .+|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            99999999999764    3899999999999999999999        6   8999999999999999999999999999


Q ss_pred             ccccCCCCCc---eeecccCCCCcCChhhhcCC-------CCCccchHHHHHHHHHHHhC----------CCCCCCCCCc
Q 043292          386 SKLIDQDQSQ---VVTTMRGTPGYLAPEWLSSI-------ITEKVDIYSFGVVMLEILCG----------RKVFDRSQPE  445 (558)
Q Consensus       386 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-------~~~k~Dv~s~Gv~l~elltg----------~~p~~~~~~~  445 (558)
                      +.........   ......||+.|+|||++.+.       ++.++||||||+++|||++|          ..||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            9876544322   12345789999999998753       23689999999999999999          7787654432


Q ss_pred             chhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          446 EEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ....  ..+. .......    ............+....+.+++.+||+.||++|||+.+|++.|+.+.+-
T Consensus       274 ~~~~--~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          274 DPSV--EEMR-KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             SCCH--HHHH-HHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccH--HHHH-HHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            2111  1111 1111111    1111111112336677899999999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.1e-40  Score=325.18  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=194.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||+||++... +++.||||++....   .....+.+|+.++.+++||||+++++++.+++..++||||+++ 
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence            478999999999999984 68999999997432   2346788999999999999999999999999999999999975 


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+.+.....  .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        86 ~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  159 (292)
T 3o0g_A           86 DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS  159 (292)
T ss_dssp             EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred             CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence            56665554332  39999999999999999999999   899999999999999999999999999998764332 2234


Q ss_pred             cccCCCCcCChhhhcC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhh--hcccchhhc---cc-
Q 043292          399 TMRGTPGYLAPEWLSS-I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA--EEDKLSDLV---DK-  470 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---d~-  470 (558)
                      ...||+.|+|||.+.+ . ++.++||||||++++||++|..|+........  .+..+.....  .........   +. 
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccccccc
Confidence            5678999999999864 3 79999999999999999999888654333221  1111111110  000000000   00 


Q ss_pred             -------cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 -------HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 -------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                             ..............+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   00000011123357789999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.5e-40  Score=328.64  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=190.5

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|+||.||+|... +++.||+|+++..  ....+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~   87 (317)
T 2pmi_A            9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N   87 (317)
T ss_dssp             ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred             EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence            3578999999999999874 6899999998643  2334678999999999999999999999999999999999997 6


Q ss_pred             CHHHHHhcCC---CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++....   ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  163 (317)
T 2pmi_A           88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-  163 (317)
T ss_dssp             BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-
T ss_pred             CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-
Confidence            9999887532   12348999999999999999999999   9999999999999999999999999999987643322 


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh-----c
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL-----V  468 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  468 (558)
                      ......||+.|+|||++.+  .++.++||||||+++|||++|+.||......+....+...... .........     .
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT-PNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCTTTCGGGGGCTTC
T ss_pred             cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChhHhhhhhhhhhc
Confidence            2345578999999999864  4899999999999999999999999865543321111111100 000000000     0


Q ss_pred             cccCCCC--C---------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDM--Q---------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~--~---------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......  .         ........+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000000  0         00012346889999999999999999999885

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=337.16  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|++...    ....+.+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   99 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG   99 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            478999999999999874 6889999998643    23446788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus       100 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~  171 (384)
T 4fr4_A          100 GDLRYHLQQNV---HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQI  171 (384)
T ss_dssp             EEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CCB
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cce
Confidence            99999998643   39999999999999999999999   99999999999999999999999999999876433  234


Q ss_pred             ecccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....||+.|+|||++.+    .++.++||||||+++|||++|+.||..............+ ..    ...         
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~----~~~---------  237 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ET----TVV---------  237 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HH----CCC---------
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hh----ccc---------
Confidence            56789999999999853    3889999999999999999999999765443321111111 00    000         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPS-MSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~  508 (558)
                        ..+......+.+++.+||+.||.+||+ +++|++
T Consensus       238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              011122347889999999999999998 777664

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=338.69  Aligned_cols=243  Identities=27%  Similarity=0.398  Sum_probs=192.9

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.||+|+||.||++.. .+++.||+|+++... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            5799999999999987 568999999997543 34567999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee--cCCCCeEEcccCCccccCCCCCceeec
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll--~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      +++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++......  ....
T Consensus       175 ~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~  247 (373)
T 2x4f_A          175 DRIIDESY--NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV  247 (373)
T ss_dssp             HHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence            98875432  38999999999999999999999   999999999999999  667889999999998765432  2334


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..||+.|+|||++.+ .++.++||||||+++|||++|+.||......+   .+..+.....   .   .......     
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~~---~---~~~~~~~-----  313 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNILACRW---D---LEDEEFQ-----  313 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCC---C---SCSGGGT-----
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccC---C---CChhhhc-----
Confidence            569999999999875 58999999999999999999999997654322   1111111100   0   0000001     


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .....+.+++.+||+.||.+|||+.++++
T Consensus       314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 -DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             12347889999999999999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-40  Score=344.57  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+++.. +++.||+|+++..    ....+.+.+|..++..++||||+++++++.++...++||||+++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  153 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  153 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            378999999999999985 6889999999642    22334588999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....    +++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       154 g~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~  226 (410)
T 3v8s_A          154 GDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC  226 (410)
T ss_dssp             EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred             CcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence            99999997542    8999999999999999999999   9999999999999999999999999999987765443344


Q ss_pred             ecccCCCCcCChhhhcCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          398 TTMRGTPGYLAPEWLSSI-----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~-----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      ....||+.|+|||++.+.     ++.++||||||+++|||++|+.||...+..+....+..   ... ...+        
T Consensus       227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---~~~-~~~~--------  294 (410)
T 3v8s_A          227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN---HKN-SLTF--------  294 (410)
T ss_dssp             CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---HHH-HCCC--------
T ss_pred             cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh---ccc-cccC--------
Confidence            567899999999998642     77899999999999999999999976543221111111   000 0000        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAK--RPSMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  509 (558)
                      ..   .......+.+++.+||+.+|.+  ||++++|++.
T Consensus       295 p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          295 PD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00   0012246788999999999988  9999999965

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-40  Score=336.06  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=204.4

Q ss_pred             hhhhcCccCceEEEEEEeC--------CCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQT--------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+.||+|+||.||++...        ++..||||+++...  ...+.+.+|+.++.++ +||||+++++++...+..++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  118 (334)
T 2pvf_A           39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  118 (334)
T ss_dssp             EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred             EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence            3478999999999999863        46789999997532  3346789999999999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ||||+++++|.+++.....             ...+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~  195 (334)
T 2pvf_A          119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNV  195 (334)
T ss_dssp             EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCC
T ss_pred             EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCC
Confidence            9999999999999986432             2248999999999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++........ ......+++.|+|||.+.+ .++.++||||||+++|||++ |+.||......+    +...
T Consensus       196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~  271 (334)
T 2pvf_A          196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKL  271 (334)
T ss_dssp             EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH
T ss_pred             EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH----HHHH
Confidence            999999999876543322 1233456789999998864 58999999999999999999 999997554322    1111


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                      .    ..+....          ........+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       272 ~----~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          272 L----KEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H----HHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H----hcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1    1111000          111223478899999999999999999999999999876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-40  Score=331.77  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=205.4

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.+.||+|+||.||+++.      .+++.||||+++...  ...+.+.+|+.++.++ +||||+++++++..++..++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  106 (313)
T 1t46_A           27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT  106 (313)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence            347899999999999974      346789999997543  2346789999999999 9999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          313 EYMPNGSLDRWLFQRSD---------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ||+++|+|.+++.....               ...+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  183 (313)
T 1t46_A          107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRI  183 (313)
T ss_dssp             ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTE
T ss_pred             ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCC
Confidence            99999999999986542               1248999999999999999999999   89999999999999999999


Q ss_pred             eEEcccCCccccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||++.......... .....+|+.|+|||.+. ..++.++||||||++++||++ |+.||.........   ...
T Consensus       184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~  260 (313)
T 1t46_A          184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF---YKM  260 (313)
T ss_dssp             EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH---HHH
T ss_pred             EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH---HHH
Confidence            9999999998765543322 23455778999999876 468999999999999999999 99999765543311   111


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ...    .     ....     ........+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       261 ~~~----~-----~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          261 IKE----G-----FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             HHH----T-----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcc----C-----CCCC-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            111    0     0000     011223478899999999999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-40  Score=323.37  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=197.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+|+.. ++.||||+++...   ...+.+.+|+.++.+++||||+++++++.+.  ...++||||+++
T Consensus        15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY   93 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred             HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence            478999999999999975 8899999997532   3346799999999999999999999999887  678999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      |+|.+++..... ..+++..++.++.||+.||.|||+   .+  ++|+||||+|||++.++.++|.|||++.....    
T Consensus        94 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----  165 (271)
T 3kmu_A           94 GSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----  165 (271)
T ss_dssp             CBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred             CcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence            999999986442 358999999999999999999998   78  99999999999999999999999988764322    


Q ss_pred             eeecccCCCCcCChhhhcCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          396 VVTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                        ....||+.|+|||.+.+.    .+.++||||||+++|||++|+.||......+.       .......+...     .
T Consensus       166 --~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~  231 (271)
T 3kmu_A          166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------GMKVALEGLRP-----T  231 (271)
T ss_dssp             --TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------HHHHHHSCCCC-----C
T ss_pred             --cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------HHHHHhcCCCC-----C
Confidence              234689999999998753    33479999999999999999999975443221       11111111100     0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                           ........+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       232 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          232 -----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                 111223468899999999999999999999999988753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=334.27  Aligned_cols=260  Identities=19%  Similarity=0.253  Sum_probs=195.0

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEeccccc------------chHHHHHHHHHHhccCCcceeeeeeeecc--
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIGE------------INKSFLAEVKTIGSIHHQNLVRLIGFCAE--  304 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  304 (558)
                      .+.||+|+||.||++...    ++..+|||++.....            ....+.+|+..+..++||||+++++++..  
T Consensus        42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~  121 (345)
T 2v62_A           42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF  121 (345)
T ss_dssp             EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred             EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence            478999999999999985    578899999864321            12346788899999999999999999887  


Q ss_pred             --CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC--CeEE
Q 043292          305 --KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF--NAKV  380 (558)
Q Consensus       305 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~--~~ki  380 (558)
                        +...++||||+ +++|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++  .+||
T Consensus       122 ~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          122 KGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             SSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             CCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEEE
Confidence              67889999999 999999997654   49999999999999999999999   8999999999999999887  9999


Q ss_pred             cccCCccccCCCCCc------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          381 ADFGLSKLIDQDQSQ------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       381 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                      +|||+++.+......      ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........  ..
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~  272 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV--QT  272 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH--HH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH--HH
Confidence            999999876432211      1234679999999999876 48999999999999999999999996433222111  11


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                       ...... ..+...+......    ......+.+++..||+.||++|||+.+|++.|+.+....
T Consensus       273 -~~~~~~-~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          273 -AKTNLL-DELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             -HHHHHH-HTTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             -HHHhhc-ccccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence             111111 1111111111110    012347889999999999999999999999998865433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=335.18  Aligned_cols=251  Identities=26%  Similarity=0.467  Sum_probs=194.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEecc--cccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEG--IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|... +++    +||+|.+..  .....+.+.+|+.++.+++||||+++++++..+. .++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~   98 (327)
T 3lzb_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM   98 (327)
T ss_dssp             EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred             EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence            478999999999999873 444    357777753  2345678999999999999999999999998754 78999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      .+|+|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        99 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           99 PFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             SSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence            99999999986543  38999999999999999999999   99999999999999999999999999999876443222


Q ss_pred             -eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 -VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 -~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ......+|+.|+|||.+.+ .++.++||||||+++|||++ |..||......+    +.....    .+..        
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~----~~~~--------  237 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE----KGER--------  237 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH----TTCC--------
T ss_pred             ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH----cCCC--------
Confidence             2233456788999998864 68999999999999999999 999998655433    111111    1100        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                        ..........+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       238 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          238 --LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence              0011123346889999999999999999999999999887543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=327.56  Aligned_cols=237  Identities=26%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|+++..    ....+.+.+|..++..++||||+++++++.+....++||||+++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g   90 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   90 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence            478999999999999884 6899999999743    23346688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    .
T Consensus        91 g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~  160 (318)
T 1fot_A           91 GELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T  160 (318)
T ss_dssp             CBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence            99999998654   38999999999999999999999   99999999999999999999999999999865432    3


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+..+       ....... ...           .
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~-~~~-----------~  221 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILN-AEL-----------R  221 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHH-CCC-----------C
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh-CCC-----------C
Confidence            35679999999999875 58999999999999999999999997544222       1111111 110           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      .+......+.+++.+||+.||++||     ++++|++
T Consensus       222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            0111234688999999999999999     8898885

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.9e-40  Score=333.90  Aligned_cols=239  Identities=26%  Similarity=0.438  Sum_probs=196.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++.. .+++.||||++...    ......+.+|+.+++.++||||+++++++...+..++||||+ +
T Consensus        14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~   92 (336)
T 3h4j_B           14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G   92 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence            47899999999999997 57899999998642    233467899999999999999999999999999999999999 7


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||++.......  ..
T Consensus        93 g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~  164 (336)
T 3h4j_B           93 GELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FL  164 (336)
T ss_dssp             EEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TT
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--cc
Confidence            89999887654   39999999999999999999999   899999999999999999999999999998765432  23


Q ss_pred             ecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||+.|+|||.+.+.  .++++||||||+++|+|++|+.||........                ...+....   .
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~---~  225 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCV---Y  225 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSC---C
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCC---C
Confidence            456799999999999764  37899999999999999999999975443221                00000000   0


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0111223467899999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=342.02  Aligned_cols=245  Identities=23%  Similarity=0.341  Sum_probs=197.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++.. .+++.+|+|++....   ...+.+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   95 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG   95 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence            57899999999999987 578999999987433   23456899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec---CCCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+.+....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++........ 
T Consensus        96 ~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-  168 (444)
T 3soa_A           96 ELFEDIVARE---YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-  168 (444)
T ss_dssp             BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence            9999998654   39999999999999999999999   9999999999999998   567899999999987654332 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+    +...    ...+... ......  
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~----i~~~~~~-~~~~~~--  237 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQ----IKAGAYD-FPSPEW--  237 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH----HHHTCCC-CCTTTT--
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHHH----HHhCCCC-CCcccc--
Confidence            2345679999999999976 59999999999999999999999997543221    1111    1111110 000000  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          ......+.+++..||+.||.+|||+.++++.
T Consensus       238 ----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          238 ----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                1123468899999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=344.73  Aligned_cols=247  Identities=23%  Similarity=0.253  Sum_probs=197.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+++. .+++.||+|+++...    ...+.+.+|..++..++||||+++++++.+.+..++||||+++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g  145 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG  145 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence            37899999999999998 479999999997422    2234588999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       146 g~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          146 GDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             CBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            999999976432  38999999999999999999999   9999999999999999999999999999987755443334


Q ss_pred             ecccCCCCcCChhhhc--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          398 TTMRGTPGYLAPEWLS--------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~--------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ....||+.|+|||++.        +.++.++||||||+++|||++|+.||...+..+....+...   . ....+.. + 
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---~-~~~~~p~-~-  294 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY---K-EHLSLPL-V-  294 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH---H-HHCCCC----
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c-cCcCCCc-c-
Confidence            4568999999999986        24899999999999999999999999765433211111110   0 0000000 0 


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCC---CCHHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKR---PSMSMVVRV  509 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~vl~~  509 (558)
                              .......+.+++.+||. +|.+|   |++++|++.
T Consensus       295 --------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          295 --------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                    01123478899999999 99998   689998853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-40  Score=332.81  Aligned_cols=252  Identities=27%  Similarity=0.485  Sum_probs=195.7

Q ss_pred             hhhcCccCceEEEEEEeCC-----CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQTD-----GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .+.||+|+||.||+|....     +..||||.++...  .....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            3689999999999998742     2359999997532  23456899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       129 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          129 ENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             TTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            99999999976533  48999999999999999999999   89999999999999999999999999999876543222


Q ss_pred             e--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          396 V--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       396 ~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .  .....++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+    +...    ...+..       
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~----~~~~~~-------  268 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKA----INDGFR-------  268 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH----HHTTCC-------
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----HHHH----HHCCCc-------
Confidence            1  223345778999999874 68999999999999999999 999997543221    1111    111100       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .   .........+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus       269 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          269 L---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             C---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0   011123357889999999999999999999999998876543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.5e-40  Score=325.94  Aligned_cols=249  Identities=23%  Similarity=0.429  Sum_probs=196.3

Q ss_pred             hhhhcCccCceEEEEEEeCC-C-------CEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-G-------TKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.+.||+|+||.||++.... +       ..||+|.+.... ...+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence            34789999999999998743 3       479999997543 44567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC--------eEEcccC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN--------AKVADFG  384 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~ki~Dfg  384 (558)
                      ||+++++|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.        +||+|||
T Consensus        92 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             ECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             ECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            99999999999986542  38999999999999999999999   99999999999999998887        9999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  462 (558)
                      ++......     ....++..|+|||.+.+  .++.++||||||+++|||++|..|+........   ......   ...
T Consensus       167 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~---~~~  235 (289)
T 4fvq_A          167 ISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQFYE---DRH  235 (289)
T ss_dssp             SCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH---TTC
T ss_pred             ccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHHHhh---ccC
Confidence            99755322     23457889999999875  489999999999999999996555433222111   111110   000


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccccc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHN  519 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~  519 (558)
                      ...    ..         ....+.+++..||+.||.+|||+.++++.|+.+......
T Consensus       236 ~~~----~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          236 QLP----AP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             CCC----CC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             CCC----CC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            000    00         122577899999999999999999999999998765543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.4e-40  Score=335.40  Aligned_cols=244  Identities=25%  Similarity=0.389  Sum_probs=197.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++.. .+++.||+|++....   ...+.+.+|+.++..++||||+++++++.+++..++||||+++|
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg  113 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG  113 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            57899999999999988 468999999997432   23456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||++.......  
T Consensus       114 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--  185 (362)
T 2bdw_A          114 ELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--  185 (362)
T ss_dssp             BHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence            9999987543   48999999999999999999999   8999999999999998654   59999999998765332  


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++||||||+++|||++|..||......+    +....    ..+... ......  
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i----~~~~~~-~~~~~~--  254 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQI----KAGAYD-YPSPEW--  254 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHTCCC-CCTTGG--
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH----HhCCCC-CCcccc--
Confidence            2345679999999999876 59999999999999999999999997543221    11111    111100 000000  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          ......+.+++.+||+.||.+|||+.++++.
T Consensus       255 ----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          255 ----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                1123468899999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-40  Score=333.60  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=190.6

Q ss_pred             hhhcCccCceEEEEEEeCC-C---CEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcc------e
Q 043292          243 RKMLGKGGFGSVFEGTQTD-G---TKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN------L  309 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~  309 (558)
                      .+.||+|+||.||+++... +   ..||||+++..   ....+.+.+|+.++++++||||+++++++......      +
T Consensus        28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  107 (323)
T 3qup_A           28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM  107 (323)
T ss_dssp             EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred             eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence            4789999999999998754 3   27999998743   33456799999999999999999999999877665      8


Q ss_pred             EEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          310 LVYEYMPNGSLDRWLFQRS---DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      +||||+++|+|.+++....   ....+++..++.++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus       108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a  184 (323)
T 3qup_A          108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS  184 (323)
T ss_dssp             EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeecccc
Confidence            9999999999999997532   12248999999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +........ ......+++.|+|||.+.+ .++.++||||||+++|||++ |..||......+.    ....   . .+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----~~~~---~-~~~  256 (323)
T 3qup_A          185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI----YNYL---I-GGN  256 (323)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----HHHH---H-TTC
T ss_pred             ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH----HHHH---h-cCC
Confidence            876443221 2234456789999999864 58999999999999999999 8999976554331    1110   0 000


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .          ..........+.+++.+||+.||.+|||+.++++.|+++..-.
T Consensus       257 ~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 R----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             C----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             C----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            0          0011123357889999999999999999999999999886543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.6e-40  Score=336.64  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=194.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|+||.||+++.. +++.||+|+++...    ...+.+..|..++.++ +||||+++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            478999999999999985 57889999997432    2234578899999877 89999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|..++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       137 gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~  209 (396)
T 4dc2_A          137 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  209 (396)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-Cc
Confidence            999999998654   39999999999999999999999   999999999999999999999999999998633222 23


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-hhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED-MYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.. ........+.......          
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  279 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  279 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----------
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----------
Confidence            456789999999999876 5899999999999999999999999754332211 0001111111111110          


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSM------SMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~vl~  508 (558)
                       ..+......+.+++..||+.||.+||++      .+|++
T Consensus       280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          280 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence             0111123468899999999999999985      56654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.3e-40  Score=323.21  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=193.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.++||+|+||.||++.. .++..+|+|++....  ...+.+.+|++++.+++||||+++++++.+....++||||++++
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  105 (285)
T 3is5_A           26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG  105 (285)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred             ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence            358899999999999988 468999999987533  34578999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCC
Q 043292          319 SLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       319 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +|.+++.... ....+++..++.++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||++....... 
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-  181 (285)
T 3is5_A          106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-  181 (285)
T ss_dssp             BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             cHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-
Confidence            9999986431 12349999999999999999999999   999999999999999   556789999999998764432 


Q ss_pred             ceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                       ......||+.|+|||.+.+.++.++||||||++++||++|+.||......+.    ....  .......    .  ...
T Consensus       182 -~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----~~~~--~~~~~~~----~--~~~  248 (285)
T 3is5_A          182 -HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----QQKA--TYKEPNY----A--VEC  248 (285)
T ss_dssp             ------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHH--HHCCCCC----C--C--
T ss_pred             -cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH----Hhhh--ccCCccc----c--ccc
Confidence             2345678999999999988899999999999999999999999976543221    1100  0000000    0  000


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .    .....+.+++.+||+.||.+|||+.++++
T Consensus       249 ~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          249 R----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             C----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0    01246788999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-40  Score=325.21  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=202.2

Q ss_pred             hhcCccCceEEEEEEeC---CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||+|...   ++..||||+++..  ....+.+.+|++++.+++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999863   5778999999853  33456799999999999999999999999 556789999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce--
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--  396 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--  396 (558)
                      +|.+++....  ..+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++..........  
T Consensus        95 ~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  169 (287)
T 1u59_A           95 PLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  169 (287)
T ss_dssp             EHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             CHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence            9999997543  249999999999999999999999   899999999999999999999999999998765433322  


Q ss_pred             eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....+|+.|+|||.+. ..++.++||||||++++||++ |+.||......+    +...    ...+...         
T Consensus       170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~----i~~~~~~---------  232 (287)
T 1u59_A          170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF----IEQGKRM---------  232 (287)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHH----HHTTCCC---------
T ss_pred             cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHH----HhcCCcC---------
Confidence            22345688999999987 458999999999999999998 999997655432    1111    1111100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                       .........+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             011123357889999999999999999999999998876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.4e-40  Score=327.50  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=199.0

Q ss_pred             hhhcCccCceEEEEEEe-----CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  313 (558)
                      .+.||+|+||.||+++.     .+++.||||++...  ....+.+.+|+.++.+++||||+++++++...  ...++|||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  105 (302)
T 4e5w_A           26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME  105 (302)
T ss_dssp             EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred             hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence            47899999999999983     46889999999743  23457799999999999999999999999876  56789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++.....  .+++..++.++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++.......
T Consensus       106 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          106 FLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             CCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             eCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence            9999999999965443  38999999999999999999999   999999999999999999999999999998775543


Q ss_pred             Cc--eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCC--------cchhhhHHHHHHHhhhcc
Q 043292          394 SQ--VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQP--------EEEDMYLLSIFKKKAEED  462 (558)
Q Consensus       394 ~~--~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  462 (558)
                      ..  ......+|..|+|||.+.+ .++.++||||||++++||++|..|+.....        ........... .....+
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  259 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLKEG  259 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHHTT
T ss_pred             cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHhcc
Confidence            32  2334567888999998864 588999999999999999999988642110        00000011110 111000


Q ss_pred             cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       463 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .          ...........+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       260 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 K----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0          00111223457889999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-39  Score=321.19  Aligned_cols=243  Identities=23%  Similarity=0.387  Sum_probs=199.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||++... ++..||+|++... ....+.+.+|++++.+++||||+++++++.++...++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL   93 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence            478999999999999984 5789999998753 34457799999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCCcee
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      .+++....   .+++..++.++.|++.||.|||+   .+|+|+||||+|||+   +.++.+||+|||++.......  ..
T Consensus        94 ~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~  165 (277)
T 3f3z_A           94 FERVVHKR---VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM  165 (277)
T ss_dssp             HHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CB
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--ch
Confidence            99987654   38999999999999999999999   999999999999999   888999999999998765432  23


Q ss_pred             ecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ....||+.|+|||.+.+.++.++||||||++++||++|+.||......+.   ...     ...+... .......    
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~-----~~~~~~~-~~~~~~~----  232 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---MLK-----IREGTFT-FPEKDWL----  232 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-----HHHCCCC-CCHHHHT----
T ss_pred             hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---HHH-----HHhCCCC-CCchhhh----
Confidence            45679999999999988899999999999999999999999976443221   111     1111100 0000000    


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .....+.+++.+||+.||.+|||+.++++
T Consensus       233 --~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 --NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11347889999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=323.36  Aligned_cols=251  Identities=28%  Similarity=0.408  Sum_probs=198.0

Q ss_pred             hhcCccCceEEEEEEeC-CC---CEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcc-eEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DG---TKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN-LLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~~  316 (558)
                      ++||+|+||.||+|... ++   ..+|+|.+....  ...+.+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus        27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~  106 (298)
T 3pls_A           27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC  106 (298)
T ss_dssp             EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred             ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence            68999999999999863 22   379999997533  2346789999999999999999999999876665 89999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC--
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--  394 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~--  394 (558)
                      +++|.+++.....  .+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......  
T Consensus       107 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          107 HGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             TCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             CCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            9999999976433  48999999999999999999999   8999999999999999999999999999986543221  


Q ss_pred             -ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 -QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 -~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       .......++..|+|||.+.+ .++.++||||||++++||++|..|+........   +......    ...        
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~----~~~--------  246 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQ----GRR--------  246 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHT----TCC--------
T ss_pred             cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhc----CCC--------
Confidence             12234567889999999876 589999999999999999996665543322221   1111111    000        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        ..........+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus       247 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 --LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              001111234788999999999999999999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-39  Score=330.77  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc------ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+++. .+++.||||++...      ....+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus        28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  107 (351)
T 3c0i_A           28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF  107 (351)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            457899999999999987 46899999998632      12356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccCCccccC
Q 043292          315 MPNGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLID  390 (558)
Q Consensus       315 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfgla~~~~  390 (558)
                      +++++|.+++.... ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||++....
T Consensus       108 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             CSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            99999988886532 23358999999999999999999999   99999999999999987655   9999999998765


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ... .......||+.|+|||++.+ .++.++||||||+++|||++|..||.....     .+..   .. ..+.... ..
T Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~---~i-~~~~~~~-~~  253 (351)
T 3c0i_A          185 ESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFE---GI-IKGKYKM-NP  253 (351)
T ss_dssp             TTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHH---HH-HHTCCCC-CH
T ss_pred             CCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHH---HH-HcCCCCC-Cc
Confidence            432 22345679999999999875 589999999999999999999999975321     1111   11 0111000 00


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....      .....+.+++.+||+.||++|||+.++++
T Consensus       254 ~~~~------~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 RQWS------HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccc------cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0000      11246889999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-39  Score=320.60  Aligned_cols=241  Identities=25%  Similarity=0.442  Sum_probs=194.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc----CCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE----KSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|.. .++..||+|.+...   ....+.+.+|+.++.+++||||+++++++..    +...++||||
T Consensus        31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~  110 (290)
T 1t4h_A           31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL  110 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred             eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence            36799999999999988 46889999998743   2334668999999999999999999998765    3457899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeec-CCCCeEEcccCCccccCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLD-GNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~-~~~~~ki~Dfgla~~~~~  391 (558)
                      +++++|.+++....   .+++..++.++.||+.||.|||+   .+  |+|+||||+|||++ .++.+||+|||++.....
T Consensus       111 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          111 MTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             cCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            99999999997643   38999999999999999999999   77  99999999999998 789999999999975543


Q ss_pred             CCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ..   .....||+.|+|||.+.+.++.++||||||+++++|++|+.||........   .   .. ....+.....++. 
T Consensus       185 ~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~---~~-~~~~~~~~~~~~~-  253 (290)
T 1t4h_A          185 SF---AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I---YR-RVTSGVKPASFDK-  253 (290)
T ss_dssp             TS---BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H---HH-HHTTTCCCGGGGG-
T ss_pred             cc---cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---H---HH-HHhccCCccccCC-
Confidence            22   345678999999999988899999999999999999999999975443221   1   11 1111111111111 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                              .....+.+++..||+.||.+|||+.++++
T Consensus       254 --------~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          254 --------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                    11236889999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6e-40  Score=330.95  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|+.. +++    +||+|.+...  ......+.+|+.++.+++||||+++++++. +...++||||+
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   96 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL   96 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence            478999999999999874 444    3888887533  233456789999999999999999999986 56688999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        97 ~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           97 PLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             TTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             CCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            9999999997643  248999999999999999999999   89999999999999999999999999999977544322


Q ss_pred             -eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 -VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 -~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       ......++..|+|||.+. +.++.++||||||+++|||++ |+.||......+.    ....    ..+.....     
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~----~~~~~~~~-----  238 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----PDLL----EKGERLAQ-----  238 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----HHHH----HTTCBCCC-----
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----HHHH----HcCCCCCC-----
Confidence             234566788999999987 569999999999999999999 9999986554331    1111    11110000     


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                           .......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       239 -----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 -----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 00112246789999999999999999999999988754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=335.11  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++..++||||+++++++.+....++||||+++|+|
T Consensus        56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L  135 (387)
T 1kob_A           56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  135 (387)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence            478999999999999884 68999999987543 2345789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC--CCCeEEcccCCccccCCCCCceee
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG--NFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      .+++....  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||+++.......  ..
T Consensus       136 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~  208 (387)
T 1kob_A          136 FDRIAAED--YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VK  208 (387)
T ss_dssp             HHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EE
T ss_pred             HHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--ee
Confidence            99987543  248999999999999999999999   99999999999999974  56799999999987654332  34


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||++.+ .++.++||||||+++|||++|..||......+    ......    .....  ++..     .
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~----~~~~~--~~~~-----~  273 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVK----RCDWE--FDED-----A  273 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH----HCCCC--CCSS-----T
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHHHHH----hCCCC--CCcc-----c
Confidence            4579999999999875 58999999999999999999999997643221    111111    00000  0000     0


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+||+.||.+|||+.++++.
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            01123478899999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-40  Score=330.76  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=177.6

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ++||+|+||.||++... +++.||||++...  ....+.+|+.++..+. ||||+++++++.++...++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            57999999999999984 6899999998643  3456789999999997 999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCccccCCCCCceee
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||+++...... ....
T Consensus        95 ~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~  167 (325)
T 3kn6_A           95 ERIKKKK---HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK  167 (325)
T ss_dssp             HHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence            9998654   39999999999999999999999   9999999999999998766   79999999998654432 2234


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||.+.+ .++.++||||||+++|||++|+.||................... ..+...      ... ..
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~-~~  239 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEG-EA  239 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCS-HH
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCc-cc
Confidence            5678999999999875 58999999999999999999999997654322111111111111 111110      000 00


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0112357889999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-39  Score=323.48  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=193.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.++.+++||||+++++++..++..++||||+++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING  118 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence            478999999999999984 688999999975422    236788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..++.++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++...........
T Consensus       119 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  192 (309)
T 2h34_A          119 VDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL  192 (309)
T ss_dssp             EEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence            99999998653   38999999999999999999999   8999999999999999999999999999987654433334


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc-chhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK-LSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~  475 (558)
                      ....|++.|+|||.+.+ .++.++||||||+++|||++|+.||......    .+.    ....... .......     
T Consensus       193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~----~~~~~~~~~~~~~~~-----  259 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMG----AHINQAIPRPSTVRP-----  259 (309)
T ss_dssp             ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHH----HHHHSCCCCGGGTST-----
T ss_pred             cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHH----HHhccCCCCccccCC-----
Confidence            45678999999999875 5899999999999999999999999743221    111    1111110 0000111     


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcccccc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRP-SMSMVVRVLEGVTEFE  517 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~~~  517 (558)
                          .....+.+++.+||+.||.+|| |++++++.|+......
T Consensus       260 ----~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          260 ----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                1123688899999999999999 9999999998875543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=357.54  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=196.7

Q ss_pred             hcCccCceEEEEEEeC---CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQT---DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .||+|+||.||+|...   ++..||||+++..  ....++|.+|++++.+++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999763   4567999999753  3345789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce--e
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--V  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--~  397 (558)
                      |.+++....  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.........  .
T Consensus       422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            999997543  349999999999999999999999   999999999999999999999999999998765433221  1


Q ss_pred             ecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....+++.|+|||++. +.++.++||||||+++|||++ |+.||......+    +..    ....+...          
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~----~i~~~~~~----------  558 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMA----FIEQGKRM----------  558 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHH----HHHTTCCC----------
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHH----HHHcCCCC----------
Confidence            2234568999999986 579999999999999999998 999998665433    111    11111100          


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      .........+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111123457889999999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4e-40  Score=334.17  Aligned_cols=239  Identities=28%  Similarity=0.371  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+++.. +++.||+|+++..    ....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            478999999999999984 6889999999743    23445678899999877 99999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       102 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~  174 (345)
T 1xjd_A          102 GGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AK  174 (345)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-Cc
Confidence            999999997643   38999999999999999999999   999999999999999999999999999998643222 22


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+..+    +.   .... ....      ..   
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~---~~i~-~~~~------~~---  237 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LF---HSIR-MDNP------FY---  237 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHH-HCCC------CC---
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HH---HHHH-hCCC------CC---
Confidence            456789999999999875 58999999999999999999999997544322    11   1111 1100      00   


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVV  507 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl  507 (558)
                        +......+.+++.+||+.||.+||++. +|+
T Consensus       238 --p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          238 --PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              111234688999999999999999997 554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-39  Score=331.35  Aligned_cols=237  Identities=26%  Similarity=0.359  Sum_probs=196.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|++...    ....+.+.+|+.++..++||||+++++++.+....++||||+++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  125 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            478999999999999984 6899999999643    23446788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    .
T Consensus       126 g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~  195 (350)
T 1rdq_E          126 GEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             CBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence            99999998654   38999999999999999999999   99999999999999999999999999999876432    2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+    +   .... ..+..           .
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~---~~~i-~~~~~-----------~  256 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----I---YEKI-VSGKV-----------R  256 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHH-HHCCC-----------C
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----H---HHHH-HcCCC-----------C
Confidence            34678999999999875 58999999999999999999999997544221    1   1111 11111           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      .+......+.+++.+||+.||.+||+     +.+|++
T Consensus       257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            01112346889999999999999998     888875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.6e-40  Score=332.61  Aligned_cols=239  Identities=25%  Similarity=0.400  Sum_probs=193.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+|+. .+++.||||++....    ...+++.+|++++.+++||||+++++++..++..++||||+. 
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence            36899999999999997 578999999986432    223568999999999999999999999999999999999996 


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++.....  .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......     
T Consensus       138 g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----  207 (348)
T 1u5q_A          138 GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  207 (348)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence            688888864332  48999999999999999999999   89999999999999999999999999999865432     


Q ss_pred             ecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....||+.|+|||++.    +.++.++||||||++++||++|+.||........   +.    ..... .....     .
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~----~~~~~-~~~~~-----~  274 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY----HIAQN-ESPAL-----Q  274 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----HHHHS-CCCCC-----C
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HH----HHHhc-CCCCC-----C
Confidence            3457899999999873    4689999999999999999999999975442221   11    11111 10000     0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          .......+.+++.+||+.||++|||+.++++.
T Consensus       275 ----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                01123467889999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=326.52  Aligned_cols=260  Identities=22%  Similarity=0.343  Sum_probs=194.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||.||++... +++.||||++.....   ..+.+.+|+.++.+++||||+++++++.+++..++||||++++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT   87 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence            478999999999999984 589999999864432   2456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++........ ...
T Consensus        88 ~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  160 (311)
T 4agu_A           88 VLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD  160 (311)
T ss_dssp             HHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             hHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence            9999887543   38999999999999999999999   9999999999999999999999999999987653322 234


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhcccchhhcc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEEDKLSDLVD  469 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d  469 (558)
                      ...||..|+|||.+.+  .++.++||||||++++||++|+.||......+....+......       ............
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            5578999999999864  5899999999999999999999999765543322111111000       000000000000


Q ss_pred             -ccCCCCCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          470 -KHSNDMQS----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       470 -~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ........    .......+.+++..||+.||.+|||++++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             00000000    01123468899999999999999999999964

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-39  Score=334.87  Aligned_cols=267  Identities=19%  Similarity=0.218  Sum_probs=199.5

Q ss_pred             hhhcCcc--CceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKG--GFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|  +||.||+++.. +++.||||++....   ...+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus        30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  109 (389)
T 3gni_B           30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA  109 (389)
T ss_dssp             EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence            4789999  99999999985 79999999997432   234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC--
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS--  394 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~--  394 (558)
                      +|+|.+++...... .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  
T Consensus       110 ~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~  185 (389)
T 3gni_B          110 YGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ  185 (389)
T ss_dssp             TCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred             CCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence            99999999865322 38999999999999999999999   9999999999999999999999999999875432211  


Q ss_pred             ----ceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-hhh------
Q 043292          395 ----QVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-KAE------  460 (558)
Q Consensus       395 ----~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~------  460 (558)
                          .......||+.|+|||++.+   .++.++||||||+++|||++|+.||.................. ...      
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (389)
T 3gni_B          186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA  265 (389)
T ss_dssp             SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred             cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence                11223468899999999875   4899999999999999999999999865543321111000000 000      


Q ss_pred             ------------cccchhhccc--------cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcc
Q 043292          461 ------------EDKLSDLVDK--------HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGV  513 (558)
Q Consensus       461 ------------~~~~~~~~d~--------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~  513 (558)
                                  .....+.+..        ..............+.+|+.+||+.||++|||+.++++.  ++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                        0000000000        000000111223568999999999999999999999864  4444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-40  Score=332.18  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             hhhcCccCceEEEEEEe-----CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccC--CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK--SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  313 (558)
                      .++||+|+||.||++..     .+++.||||+++...  ...+.+.+|++++++++||||+++++++.+.  ...++|||
T Consensus        36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  115 (318)
T 3lxp_A           36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME  115 (318)
T ss_dssp             EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred             hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence            47899999999988754     257889999997543  3356789999999999999999999999874  56789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++....    +++..++.++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++.......
T Consensus       116 ~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          116 YVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             CCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             cccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            999999999997653    8999999999999999999999   999999999999999999999999999998775443


Q ss_pred             Cc--eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 SQ--VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~~--~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..  ......++..|+|||.+.+ .++.++||||||++++||++|..||........  ....+.........+.+.+..
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHHHHhc
Confidence            22  2234567888999999875 588999999999999999999999864221100  000000000000001111111


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ... ..........+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus       267 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          267 GER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            110 111223345789999999999999999999999999887543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.5e-40  Score=324.05  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=198.2

Q ss_pred             hhhcCccCceEEEEEEeCC----CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+|+..+    +..||+|.+...  ....+.+.+|+.++.+++||||+++++++.+ +..++||||++
T Consensus        17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   95 (281)
T 3cc6_A           17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP   95 (281)
T ss_dssp             EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence            4789999999999998632    336999998754  2345679999999999999999999999875 45689999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +++|.+++.....  .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus        96 ~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  170 (281)
T 3cc6_A           96 YGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK  170 (281)
T ss_dssp             TCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred             CCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence            9999999976543  38999999999999999999999   999999999999999999999999999998765543333


Q ss_pred             eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....+++.|+|||.+. ..++.++||||||+++|||++ |+.||......+.    ......    +...         
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~----~~~~~~----~~~~---------  233 (281)
T 3cc6_A          171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV----IGVLEK----GDRL---------  233 (281)
T ss_dssp             --CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH----HHHHHH----TCCC---------
T ss_pred             cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH----HHHHhc----CCCC---------
Confidence            34456788999999986 468999999999999999998 9999975543321    111110    1000         


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                       .........+.+++.+||+.||.+|||+.++++.|+.+.+.+
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence             001112346889999999999999999999999999876554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-40  Score=332.36  Aligned_cols=257  Identities=25%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             HHHHHHHHh--hhhcCccCceEEEEEEe-CCCCEEEEEEeccc------ccchHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          234 ELKVMTDNF--RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       234 ~l~~~t~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      ++....++|  .+.||+|+||.||++.. .++..||+|++...      ....+.+.+|++++.+++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            344445555  57899999999999988 56889999998642      2345679999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCCHHHHHhcCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 043292          305 KSHNLLVYEYMPNGSLDRWLFQRS-------------------------------------DEFMLDWQQRKKIILDIAK  347 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  347 (558)
                      .+..++||||+++|+|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999985210                                     0112467788899999999


Q ss_pred             hhhhccccCCCcEEecCCCCCCEeecCCC--CeEEcccCCccccCCCCC---ceeecccCCCCcCChhhhc---CCCCCc
Q 043292          348 GLTYLHEDCRQKILHLDIKPQNILLDGNF--NAKVADFGLSKLIDQDQS---QVVTTMRGTPGYLAPEWLS---SIITEK  419 (558)
Q Consensus       348 ~l~yLH~~~~~~ivH~dlk~~NIll~~~~--~~ki~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~k  419 (558)
                      ||.|||+   .+|+||||||+|||++.++  .+||+|||+++.+.....   .......||+.|+|||.+.   ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  899999999986643221   1234567999999999986   358999


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCC
Q 043292          420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAK  499 (558)
Q Consensus       420 ~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  499 (558)
                      +||||||+++|||++|+.||......+.   ...    .......  .....      .......+.+++..||+.||.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~---~~~----~~~~~~~--~~~~~------~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT---ISQ----VLNKKLC--FENPN------YNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HHHCCCC--TTSGG------GGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH---HHH----HHhcccc--cCCcc------cccCCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999976543221   111    1111000  00000      0012346889999999999999


Q ss_pred             CCCHHHHHH
Q 043292          500 RPSMSMVVR  508 (558)
Q Consensus       500 RPs~~~vl~  508 (558)
                      |||+.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=332.60  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=182.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||+++.. +++.||||+++... ..+.+.+|+.++.+++||||+++++++..++..++||||+++++|.
T Consensus        58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  136 (349)
T 2w4o_A           58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF  136 (349)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence            478999999999999985 58899999997543 3456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCCceee
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++......  ...
T Consensus       137 ~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  208 (349)
T 2w4o_A          137 DRIVEKG---YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMK  208 (349)
T ss_dssp             HHHTTCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccc
Confidence            9997543   38999999999999999999999   89999999999999975   8899999999998664322  234


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...||+.|+|||++.+ .++.++||||||+++|||++|..||........   +..   .. ..... ......      
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~---~i-~~~~~-~~~~~~------  274 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFR---RI-LNCEY-YFISPW------  274 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHH---HH-HTTCC-CCCTTT------
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHH---HH-HhCCC-ccCCch------
Confidence            5678999999999876 589999999999999999999999975543321   111   11 11110 000000      


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......+.+++.+||+.||++|||+.++++.
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11223478899999999999999999999873

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.9e-40  Score=327.56  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcc----eEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN----LLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e  313 (558)
                      .+.||+|+||.||+++. .+++.||||+++...    .....+.+|+.++.+++||||+++++++......    ++|||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e   96 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   96 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence            47899999999999997 578999999997532    2235688999999999999999999998776554    99999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        97 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A           97 YVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  170 (311)
T ss_dssp             CCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred             cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence            999999999997654   38999999999999999999999   899999999999999999999999999998765432


Q ss_pred             Cc--eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 SQ--VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~~--~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.       ............... 
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~-  242 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPIPPSAR-  242 (311)
T ss_dssp             -----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCCCHHHH-
T ss_pred             cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCCCcccc-
Confidence            21  2234568999999999875 589999999999999999999999976543221       111111111100000 


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH-HHHhcc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV-RVLEGV  513 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl-~~L~~~  513 (558)
                       .      ......+.+++.+||+.||.+||+..+++ +.|..+
T Consensus       243 -~------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          243 -H------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -S------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -c------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence             0      01224688999999999999999655544 555544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-39  Score=324.16  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEeCC----CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeec-cCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCA-EKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|+..+    ...+|+|.+....  ...+.+.+|+.++++++||||+++++++. .++..++||||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            4789999999999998643    2358999987533  33467899999999999999999999864 456789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++++|.+++.....  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       110 ~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          110 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             TTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            99999999976433  48999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             ---eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 ---VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ---~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                         ......+|+.|+|||.+. ..++.++||||||++++||++ |.+||......+..    ...    ..+.. .    
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~----~~~----~~~~~-~----  251 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----VYL----LQGRR-L----  251 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH----HHH----HTTCC-C----
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH----HHH----hcCCC-C----
Confidence               123456778999999986 468999999999999999999 55566544433211    100    00000 0    


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                           .........+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 0011123468899999999999999999999999988765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-39  Score=329.81  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-----CcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-----HQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|+||.||+++. .+++.||||+++........+..|+.++..+.     ||||+++++++...+..++||||+ 
T Consensus        40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-  118 (360)
T 3llt_A           40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-  118 (360)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred             EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence            47899999999999998 56899999999876666677888999999986     999999999999999999999999 


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC----------------------
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG----------------------  374 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~----------------------  374 (558)
                      +++|.+++...... .+++..+..++.||+.||.|||+   .+|+||||||+|||++.                      
T Consensus       119 ~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~  194 (360)
T 3llt_A          119 GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY  194 (360)
T ss_dssp             CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred             CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccccccc
Confidence            99999999865432 48999999999999999999999   99999999999999975                      


Q ss_pred             ---CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhh
Q 043292          375 ---NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY  450 (558)
Q Consensus       375 ---~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~  450 (558)
                         ++.+||+|||++......    .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....
T Consensus       195 ~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  270 (360)
T 3llt_A          195 RTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM  270 (360)
T ss_dssp             EESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence               789999999999865432    235678999999999875 599999999999999999999999976543321111


Q ss_pred             HHHHHH-------Hhhhcccchhhccc-----cCCCCCCCHHH---------------HHHHHHHHHHccCcCCCCCCCH
Q 043292          451 LLSIFK-------KKAEEDKLSDLVDK-----HSNDMQSNGEE---------------VVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       451 ~~~~~~-------~~~~~~~~~~~~d~-----~~~~~~~~~~~---------------~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                      +.....       ...........++.     ...........               ...+.+++.+||+.||++|||+
T Consensus       271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta  350 (360)
T 3llt_A          271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP  350 (360)
T ss_dssp             HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence            111000       00000000000000     00000111110               1467799999999999999999


Q ss_pred             HHHHH
Q 043292          504 SMVVR  508 (558)
Q Consensus       504 ~~vl~  508 (558)
                      .++++
T Consensus       351 ~elL~  355 (360)
T 3llt_A          351 AELLK  355 (360)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-39  Score=327.17  Aligned_cols=241  Identities=27%  Similarity=0.347  Sum_probs=187.6

Q ss_pred             hhhcCccCceEEEEEEe----CCCCEEEEEEecccc-----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .++||+|+||.||+++.    .+++.||+|+++...     .....+.+|+.++..++||||+++++++..++..++|||
T Consensus        22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  101 (327)
T 3a62_A           22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE  101 (327)
T ss_dssp             EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence            47899999999999987    468999999997532     233567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       102 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  175 (327)
T 3a62_A          102 YLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG  175 (327)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence            999999999997644   38999999999999999999999   899999999999999999999999999998643322


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                       .......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.   ...+.     ....      . 
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~-----~~~~------~-  239 (327)
T 3a62_A          176 -TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKIL-----KCKL------N-  239 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH-----HTCC------C-
T ss_pred             -ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHH-----hCCC------C-
Confidence             22345679999999999875 589999999999999999999999975443221   11111     0000      0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                          .+......+.+++.+||+.||.+||     ++.++++.
T Consensus       240 ----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          240 ----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                0111234688999999999999999     77888763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-40  Score=336.73  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=189.6

Q ss_pred             hhhcCccCceEEEEEEeC--CC--CEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT--DG--TKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|+..  ++  ..||||.++...  ...++|.+|+.++++++||||+++++++.. ++..++||||+
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            478999999999999873  22  368999987432  345679999999999999999999998754 55779999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       174 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          174 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999976443  38899999999999999999999   99999999999999999999999999999866433211


Q ss_pred             ---eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 ---VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ---~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                         ......+++.|+|||.+. +.++.++||||||+++|||++ |..||......+..    ...    ..+..      
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~----~~~----~~~~~------  314 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----VYL----LQGRR------  314 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH----HHH----HTTCC------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH----HHH----HcCCC------
Confidence               123345778999999986 468999999999999999999 67777655443311    111    11110      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                       .   ..+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       315 -~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 -L---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             -C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             0   00112234788999999999999999999999999887543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.6e-40  Score=358.83  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=195.0

Q ss_pred             hhcCccCceEEEEEEe---CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ---TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||+|.+   ..++.||||+++...   ...+++.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965   246789999997532   235789999999999999999999999964 567899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc--
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      |+|.+++....   .+++..++.|+.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999997643   38999999999999999999999   99999999999999999999999999999876543321  


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......+|+.|+|||++.+ .++.++||||||+++|||++ |+.||......+    +..    ....+...        
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~----~i~~~~~~--------  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTA----MLEKGERM--------  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHH----HHHTTCCC--------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----HHHcCCCC--------
Confidence            2233456789999999874 69999999999999999998 999997654322    111    11111110        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        .........+.+++..||+.||++|||+.+|++.|+.+
T Consensus       592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              01112335788999999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-40  Score=331.12  Aligned_cols=234  Identities=22%  Similarity=0.339  Sum_probs=194.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+.||+|+||.||++.. .+++.||||+++....         ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  108 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM  108 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence            36899999999999987 5688999999875321         2345788999999999999999999999999999999


Q ss_pred             EeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          313 EYMPNG-SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       313 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      ||+.+| +|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       109 e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          109 EKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             ECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999777 9999997654   39999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ..  ......||+.|+|||++.+.  .+.++||||||+++|||++|+.||......                      ..
T Consensus       183 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------~~  238 (335)
T 3dls_A          183 GK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------VE  238 (335)
T ss_dssp             TC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------TT
T ss_pred             CC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------Hh
Confidence            33  23456799999999998753  478999999999999999999999642110                      00


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....   .......+.+++..||+.||.+|||+.++++.
T Consensus       239 ~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 AAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000   00123468899999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=319.12  Aligned_cols=241  Identities=27%  Similarity=0.443  Sum_probs=178.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++. .+++.||||.+....    ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN   95 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence            47899999999999987 578999999996432    2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus        96 ~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  169 (278)
T 3cok_A           96 GEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KH  169 (278)
T ss_dssp             EEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             CcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cc
Confidence            999999976432  48999999999999999999999   8999999999999999999999999999987643322 22


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||.+.+ .++.++||||||++++||++|+.||......+..                ........   .
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~---~  230 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NKVVLADY---E  230 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCC---C
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HHHhhccc---C
Confidence            34568999999999875 5889999999999999999999999765433210                00000000   0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+......+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11122347889999999999999999999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-39  Score=330.82  Aligned_cols=240  Identities=25%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|+||.||+++.. +++.||+|+++..    ....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  104 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  104 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence            478999999999999985 4789999999743    23456688999999988 89999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       105 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~  177 (353)
T 2i0e_A          105 GGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT  177 (353)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cc
Confidence            999999998644   38999999999999999999999   999999999999999999999999999998643222 22


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+..+    +   ..... ....           
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~---~~~i~-~~~~-----------  238 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----L---FQSIM-EHNV-----------  238 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHHH-HCCC-----------
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----H---HHHHH-hCCC-----------
Confidence            445779999999999875 58999999999999999999999997544322    1   11111 1110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      ..+......+.+++.+||+.||.+||+     +.+|++
T Consensus       239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            011112347889999999999999995     567664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-40  Score=327.93  Aligned_cols=259  Identities=25%  Similarity=0.324  Sum_probs=194.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc------cchHHHHHHHHHHhccC---CcceeeeeeeeccCC-----
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG------EINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKS-----  306 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~-----  306 (558)
                      +.++||+|+||.||+++. .+++.||||++....      .....+.+|+.++.+++   ||||+++++++....     
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~   92 (308)
T 3g33_A           13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI   92 (308)
T ss_dssp             EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence            357899999999999997 578999999986321      22346677777777664   999999999987755     


Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  167 (308)
T 3g33_A           93 KVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLA  167 (308)
T ss_dssp             EEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred             eEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence            4689999996 699999986543 238999999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          387 KLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       387 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      +......  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+....... ......
T Consensus       168 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~  244 (308)
T 3g33_A          168 RIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP-PEDDWP  244 (308)
T ss_dssp             TTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSC
T ss_pred             cccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-Chhhcc
Confidence            8664332  2345678999999999864 69999999999999999999999997655433211111111000 000000


Q ss_pred             hhc---cccCC-CCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 DLV---DKHSN-DMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~~~---d~~~~-~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...   ..... ......     +....+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000   00000 000000     12357889999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-39  Score=327.83  Aligned_cols=243  Identities=25%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+++.. +++.||+|+++...    ...+.+..|..++.++ +||||+++++++.+.+..++||||++
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            478999999999999984 68899999997432    2235578899999887 89999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        94 gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~  166 (345)
T 3a8x_A           94 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  166 (345)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence            999999997643   38999999999999999999999   999999999999999999999999999998643222 22


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh-hHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-YLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.......... ...............          
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  236 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  236 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----------
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----------
Confidence            455789999999999875 58999999999999999999999997533221100 000111111111110          


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSM  503 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  503 (558)
                       ..+......+.+++.+||+.||.+||++
T Consensus       237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             0111123468899999999999999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.7e-39  Score=322.68  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=197.9

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc-------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE-------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+++.. +++.||+|.+.....       ..+.+.+|+.++.+++||||+++++++.++...++|||
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (321)
T 2a2a_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE   95 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence            3578999999999999984 689999999864321       35679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~  389 (558)
                      |+++++|.+++....   .+++..++.++.|++.||.|||+   .+|+|+||||+|||++.++    .+||+|||++...
T Consensus        96 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           96 LVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             CCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999997643   38999999999999999999999   9999999999999999888    7999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....  ......||+.|+|||.+.+ .++.++||||||++++||++|..||......+.   +..+ ..  ........+
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i-~~--~~~~~~~~~  241 (321)
T 2a2a_A          170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI-TS--VSYDFDEEF  241 (321)
T ss_dssp             CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-HT--TCCCCCHHH
T ss_pred             Cccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH-Hh--cccccChhh
Confidence            5432  2345678999999999875 589999999999999999999999975443221   1110 00  000000000


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .   .      .....+.+++.+||+.||.+|||+.++++
T Consensus       242 ~---~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          242 F---S------HTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             H---T------TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             h---c------ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0   0      11246889999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.4e-39  Score=318.09  Aligned_cols=239  Identities=29%  Similarity=0.453  Sum_probs=193.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... ++..||||++...    ......+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   93 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence            478999999999999874 5789999998642    22346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++......   ..
T Consensus        94 ~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~  164 (279)
T 3fdn_A           94 GTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR  164 (279)
T ss_dssp             EEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence            99999997654   38999999999999999999999   99999999999999999999999999998654332   23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||.+.+ .++.++||||||+++++|++|..||......+.    ..   .. ....      ..     
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~---~~-~~~~------~~-----  225 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----YK---RI-SRVE------FT-----  225 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HH---HH-HHTC------CC-----
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH----HH---HH-HhCC------CC-----
Confidence            44678999999999875 588999999999999999999999975443221    10   00 0000      00     


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+......+.+++..||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            011123467899999999999999999999964

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.4e-40  Score=332.97  Aligned_cols=267  Identities=27%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             hhhcCccCceEEEEEEe-----CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeec--cCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++.     .+++.||||++.... ...+.+.+|++++.+++|+||+++++++.  +....++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  107 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY  107 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence            47899999999999983     468899999997543 33466899999999999999999999886  45567899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++.....  .+++..++.++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++........
T Consensus       108 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  182 (327)
T 3lxl_A          108 LPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD  182 (327)
T ss_dssp             CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence            999999999976432  38999999999999999999999   9999999999999999999999999999987654333


Q ss_pred             c--eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          395 Q--VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       395 ~--~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .  ......+|..|+|||.+.+ .++.++||||||++++||++|..||..........  ............+.+.+...
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHHHHHTT
T ss_pred             cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHHHhhcc
Confidence            2  1234567888999999875 58999999999999999999999986322110000  00000000000000111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .. ..........+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       261 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          261 QR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00 1112233457889999999999999999999999999886543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.3e-40  Score=331.37  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=202.2

Q ss_pred             hhhcCccCceEEEEEEeCC------CCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQTD------GTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .+.||+|+||.||++....      ...||+|.+....  ...+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus        51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  130 (333)
T 2i1m_A           51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE  130 (333)
T ss_dssp             EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence            4789999999999998742      2479999997543  3346789999999999 89999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          314 YMPNGSLDRWLFQRS-----------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      |+++|+|.+++....           ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~D  207 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGD  207 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECc
Confidence            999999999997532           12348999999999999999999999   8999999999999999999999999


Q ss_pred             cCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhh
Q 043292          383 FGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKA  459 (558)
Q Consensus       383 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  459 (558)
                      ||++......... ......+|+.|+|||.+. ..++.++||||||+++|||++ |..||.........   ......  
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~~--  282 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---YKLVKD--  282 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---HHHHHH--
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---HHHHhc--
Confidence            9999866443322 223455688999999876 468999999999999999998 99999765543311   111111  


Q ss_pred             hcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       460 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                        ..     ...     ........+.+++..||+.||.+|||+.+|+++|+.+..
T Consensus       283 --~~-----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          283 --GY-----QMA-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             --TC-----CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CC-----CCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence              00     000     011123478899999999999999999999999987653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-39  Score=336.25  Aligned_cols=243  Identities=22%  Similarity=0.375  Sum_probs=191.2

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccC--CcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIH--HQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++...+++.||||++...   ....+.+.+|+.++.+++  |+||+++++++..++..++||| +.+
T Consensus        61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~  139 (390)
T 2zmd_A           61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  139 (390)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred             EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence            4789999999999999888999999998643   233467899999999996  5999999999999999999999 568


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-e
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-V  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~  396 (558)
                      ++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+...... .
T Consensus       140 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  212 (390)
T 2zmd_A          140 IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  212 (390)
T ss_dssp             EEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence            99999998654   48999999999999999999999   8999999999999996 579999999999876543322 2


Q ss_pred             eecccCCCCcCChhhhcC------------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLSS------------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~------------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .....||+.|+|||++.+            .++.++|||||||++|||++|+.||.......  ..+    ..       
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~----~~-------  279 (390)
T 2zmd_A          213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKL----HA-------  279 (390)
T ss_dssp             -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HH-------
T ss_pred             CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHH----HH-------
Confidence            345679999999999864            58889999999999999999999997543221  011    11       


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        +++..... ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       280 --~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 --IIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             --HHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HhCccccC-CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence              11111000 0000113468899999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=330.54  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=189.3

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---cchHHHHHHHHHHhccCC--cceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHH--QNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++...+++.||||++....   ...+.+.+|+.++.+++|  +||+++++++..+...++||| +.+
T Consensus        14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~   92 (343)
T 3dbq_A           14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN   92 (343)
T ss_dssp             EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence            47899999999999999889999999986432   234678999999999976  999999999999999999999 468


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-e
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-V  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~  396 (558)
                      ++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++........ .
T Consensus        93 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  165 (343)
T 3dbq_A           93 IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  165 (343)
T ss_dssp             EEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence            89999998754   38999999999999999999999   8999999999999997 578999999999876543322 2


Q ss_pred             eecccCCCCcCChhhhc------------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLS------------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~------------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .....||+.|+|||++.            +.++.++||||||+++|||++|+.||.......      .....       
T Consensus       166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~-------  232 (343)
T 3dbq_A          166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHA-------  232 (343)
T ss_dssp             ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHH-------
T ss_pred             CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------HHHHH-------
Confidence            33567999999999874            358889999999999999999999997543211      00111       


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        .++..... ..+......+.+++..||+.||.+|||+.++++.
T Consensus       233 --~~~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 --IIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --HHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HhcCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence              11111000 0111112467899999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-39  Score=333.56  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=186.0

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHH-hccCCcceeeeeeeecc----CCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTI-GSIHHQNLVRLIGFCAE----KSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  317 (558)
                      ++||+|+||.||++... +++.||||+++..    ..+.+|+.++ ...+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999884 6899999998643    4567788877 44589999999998865    5678999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |+|.+++..... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++...... 
T Consensus       144 g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-  218 (400)
T 1nxk_A          144 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  218 (400)
T ss_dssp             EEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             CcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence            999999986432 349999999999999999999999   99999999999999998   7899999999998654322 


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.................    .+... +....  
T Consensus       219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~-~~~~~--  290 (400)
T 1nxk_A          219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE-FPNPE--  290 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC-CCTTT--
T ss_pred             -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc-CCCcc--
Confidence             2345678999999999875 599999999999999999999999976554321111111111    11100 00000  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                          .......+.+++..||+.||.+|||+.++++.
T Consensus       291 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          291 ----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                01123468899999999999999999999974

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-39  Score=322.96  Aligned_cols=246  Identities=28%  Similarity=0.444  Sum_probs=196.9

Q ss_pred             hcCccCceEEEEEEe---CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          245 MLGKGGFGSVFEGTQ---TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .||+|+||.||++..   .+++.||||+++...   ...+++.+|+.++..++||||+++++++ ..+..++||||++++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            899999999999954   346789999997532   2356799999999999999999999999 567789999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce--
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--  396 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--  396 (558)
                      +|.+++....   .+++..++.++.||+.||.|||+   .+|+|+||||+||+++.++.+||+|||++..........  
T Consensus       103 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  176 (291)
T 1xbb_A          103 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  176 (291)
T ss_dssp             EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence            9999998654   38999999999999999999999   899999999999999999999999999998765443322  


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....++..|+|||.+.+ .++.++||||||+++|||++ |+.||......+    +..    ....+...         
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~----~~~~~~~~---------  239 (291)
T 1xbb_A          177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTA----MLEKGERM---------  239 (291)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHH----HHHTTCCC---------
T ss_pred             cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH----HHHcCCCC---------
Confidence            223446788999999864 58899999999999999999 999997644322    111    11111100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                       .........+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus       240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             0111233578899999999999999999999999988754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-39  Score=340.03  Aligned_cols=239  Identities=31%  Similarity=0.529  Sum_probs=198.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+|+.. +++.||||++....    .....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g  100 (476)
T 2y94_A           21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG  100 (476)
T ss_dssp             EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            478999999999999984 79999999996432    2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ..
T Consensus       101 g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~  172 (476)
T 2y94_A          101 GELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL  172 (476)
T ss_dssp             EEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CB
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc--cc
Confidence            99999997543   49999999999999999999999   999999999999999999999999999998765432  23


Q ss_pred             ecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||+.|+|||++.+.  .+.++||||||+++|||++|+.||.......    +   ... ...+..        .  
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~---~~~-i~~~~~--------~--  234 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----L---FKK-ICDGIF--------Y--  234 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----H---HHH-HHTTCC--------C--
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----H---HHH-HhcCCc--------C--
Confidence            456799999999998864  4789999999999999999999997654322    1   111 111110        0  


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .+......+.+++.+||+.||.+|||+.++++
T Consensus       235 -~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 -TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             00112246889999999999999999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=332.81  Aligned_cols=247  Identities=26%  Similarity=0.318  Sum_probs=199.0

Q ss_pred             hhhcCccCceEEEEEEe----CCCCEEEEEEecccc-----cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGIG-----EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .++||+|+||.||+++.    .+++.||||+++...     ...+.+..|+.++..+ +||||+++++++......++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            47899999999999987    368999999987432     2345678899999999 6999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       139 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  212 (355)
T 1vzo_A          139 DYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  212 (355)
T ss_dssp             CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence            9999999999998654   38999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .........||+.|+|||++.+   .++.++||||||+++|||++|+.||...........+..   .....        
T Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~--------  281 (355)
T 1vzo_A          213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS--------  281 (355)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---HHHHC--------
T ss_pred             CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---HHhcc--------
Confidence            4434445679999999999874   378999999999999999999999976543332221111   11100        


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRVL  510 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~L  510 (558)
                       ..   .........+.+++.+||+.||.+||     |+.++++..
T Consensus       282 -~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -CC---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             00   01112234678899999999999999     999988653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.3e-39  Score=319.79  Aligned_cols=255  Identities=20%  Similarity=0.302  Sum_probs=200.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeee-ccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC-AEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+++. .+++.||||++.... ....+..|+.++..++|++++..+..+ ..+...++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence            57899999999999997 578899999875432 224588999999999988877777665 5666779999999 9999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCCc--
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      .+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++........  
T Consensus        92 ~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           92 EDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             HHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence            999975433  39999999999999999999999   999999999999999   78999999999999876543321  


Q ss_pred             ----eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 ----VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ----~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                          ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...................... ..... ..
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~  244 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEVL-CK  244 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHHHH-TT
T ss_pred             CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hhhhh-hc
Confidence                2235678999999999875 58999999999999999999999998765544332222222111110 00000 00


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                               .....+.+++..|++.||++|||+.+|++.|+.+.+
T Consensus       245 ---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          245 ---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             ---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence                     012478899999999999999999999999988765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-39  Score=337.54  Aligned_cols=263  Identities=25%  Similarity=0.419  Sum_probs=187.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccC-CcceeeeeeeeccCC--cceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKS--HNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~  315 (558)
                      .++||+|+||.||++.. .+++.||||++...   ......+.+|+.++..+. ||||+++++++...+  ..++||||+
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            47899999999999987 57899999998643   233456889999999997 999999999987544  679999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC---
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD---  392 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~---  392 (558)
                      + ++|..++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...   
T Consensus        94 ~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           94 E-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             S-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             C-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence            7 6899998763    38999999999999999999999   99999999999999999999999999999865321   


Q ss_pred             -----------------CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          393 -----------------QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       393 -----------------~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                                       .....+...||+.|+|||++.+  .++.++|||||||+++||++|+.||.+....+....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                             1112345679999999999864  589999999999999999999999987654332221111


Q ss_pred             HHHHhh-------hcccchhhccc-------cCCCCCC--------------CHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 043292          454 IFKKKA-------EEDKLSDLVDK-------HSNDMQS--------------NGEEVVNMMKVAAWCLESDFAKRPSMSM  505 (558)
Q Consensus       454 ~~~~~~-------~~~~~~~~~d~-------~~~~~~~--------------~~~~~~~l~~l~~~cl~~~p~~RPs~~~  505 (558)
                      ......       ........+..       .......              .......+.+++.+||+.||.+|||+.+
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            100000       00000000000       0000000              0011346889999999999999999999


Q ss_pred             HHHH--Hhcc
Q 043292          506 VVRV--LEGV  513 (558)
Q Consensus       506 vl~~--L~~~  513 (558)
                      +++.  +...
T Consensus       326 ~l~Hp~~~~~  335 (388)
T 3oz6_A          326 ALKHPFVSIF  335 (388)
T ss_dssp             HTTSTTTTTT
T ss_pred             HhCCHHHHHh
Confidence            9875  4443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-39  Score=327.95  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|+..      +++.||||.+....  .....+.+|+.++..++||||+++++++.+++..++||||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  109 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  109 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence            478999999999999764      36789999997543  2345689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          315 MPNGSLDRWLFQRS-------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       315 ~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      +++++|.+++....       ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~  186 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR  186 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCcccc
Confidence            99999999997532       12347999999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          388 LIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       388 ~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ........ ......+|+.|+|||.+. +.++.++||||||+++|||++ |..||......+    ...    ....+..
T Consensus       187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~----~~~~~~~  258 (322)
T 1p4o_A          187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLR----FVMEGGL  258 (322)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHH----HHHTTCC
T ss_pred             ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH----HHH----HHHcCCc
Confidence            66433221 122345688999999986 468999999999999999999 889987544221    111    1111111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ..          ........+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       259 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          259 LD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            00          111223468899999999999999999999999988755

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-38  Score=316.80  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeee-ccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC-AEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+++. .+++.||||++..... .+++.+|+.++..++|++++..+.++ ..+...++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence            47899999999999997 6789999999865432 34688999999999998877766655 5566779999999 9999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCCc--
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      .+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||++.........  
T Consensus        92 ~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           92 EDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             HHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             HHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence            999975433  49999999999999999999999   999999999999999   48889999999999876543321  


Q ss_pred             ----eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 ----VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ----~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                          ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+..+....... .... +..
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~  244 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEV-LCK  244 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHHH-HTT
T ss_pred             cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-chHH-HHh
Confidence                1245679999999999876 58999999999999999999999998755443222222222111110 0000 000


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                               .....+.+++.+||+.||.+|||+.+|++.|+.+..-
T Consensus       245 ---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          245 ---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                     1124688999999999999999999999999887543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-39  Score=322.77  Aligned_cols=258  Identities=22%  Similarity=0.401  Sum_probs=193.6

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||.||++.. .+++.||||++...    ......+.+|+.++.+++||||+++++++..++..++||||++
T Consensus        36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  115 (310)
T 2wqm_A           36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD  115 (310)
T ss_dssp             EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence            347899999999999987 57899999999742    2334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +++|.+++.... ....+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  191 (310)
T 2wqm_A          116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  191 (310)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-
Confidence            999999987521 22348999999999999999999999   9999999999999999999999999999986643322 


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......|++.|+|||.+.+ .++.++||||||++++||++|+.||.......     ..... ...........      
T Consensus       192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~~~~~~------  259 (310)
T 2wqm_A          192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCK-KIEQCDYPPLP------  259 (310)
T ss_dssp             -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HHHHH-HHHTTCSCCCC------
T ss_pred             cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HHHHH-HhhcccCCCCc------
Confidence            2334568999999999875 58999999999999999999999997543221     11111 11111111110      


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEH  518 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  518 (558)
                         .......+.+++.+||+.||.+|||+.+|+++|+.+.....
T Consensus       260 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          260 ---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             ---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence               01123468899999999999999999999999999876554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=332.88  Aligned_cols=257  Identities=18%  Similarity=0.234  Sum_probs=198.9

Q ss_pred             hhhcCccCceEEEEEEeCC---------CCEEEEEEecccccchHHHHHHHHHHhccCCcceee---------------e
Q 043292          243 RKMLGKGGFGSVFEGTQTD---------GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR---------------L  298 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~---------------l  298 (558)
                      .+.||+|+||.||+++...         ++.||||.+...    +.+.+|++++.+++||||++               +
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~  122 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC  122 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence            4789999999999998853         789999998754    35889999999999999998               5


Q ss_pred             eeeecc-CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-
Q 043292          299 IGFCAE-KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-  376 (558)
Q Consensus       299 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-  376 (558)
                      ++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++ 
T Consensus       123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETTEE
T ss_pred             hhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCCCC
Confidence            666665 67789999999 999999998652 2349999999999999999999999   8999999999999999998 


Q ss_pred             -CeEEcccCCccccCCCCCc------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043292          377 -NAKVADFGLSKLIDQDQSQ------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED  448 (558)
Q Consensus       377 -~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~  448 (558)
                       .+||+|||+++.+......      ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  277 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED  277 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence             8999999999876543221      1234579999999999876 5899999999999999999999999865432211


Q ss_pred             hhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          449 MYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        +.......  ......+.+.....    ......+.+++.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       278 --~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          278 --IMKQKQKF--VDKPGPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             --HHHHHHHH--HHSCCCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHhc--cCChhhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence              11111110  01111111111100    01124788999999999999999999999999887654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9e-40  Score=329.49  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=190.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccc--hHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEI--NKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||.||+++.. +++.||||++......  ...+.+|+.++.+++||||+++++++..++..++||||++ ++
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   85 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence            478999999999999985 7899999998743321  2245679999999999999999999999999999999997 68


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        86 l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  159 (324)
T 3mtl_A           86 LKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDN  159 (324)
T ss_dssp             HHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccccc
Confidence            9998876543  48999999999999999999999   999999999999999999999999999998654322 22334


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc------c
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK------H  471 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------~  471 (558)
                      ..||+.|+|||++.+  .++.++||||||++++||++|+.||......+....+....... ...........      .
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHHHHTC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhhcccc
Confidence            568999999999864  48999999999999999999999998765433222221111100 00001111000      0


Q ss_pred             CCCCC-C-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQ-S-----NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~-~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..... .     .......+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000 0     0011246789999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-39  Score=327.34  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=202.6

Q ss_pred             hhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCC-cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKS-HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  312 (558)
                      .+.||+|+||.||+++.      .+++.||||+++...  ...+.+.+|+.++.++ +||||+++++++...+ ..++||
T Consensus        32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~  111 (316)
T 2xir_A           32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  111 (316)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence            47899999999999974      346789999997543  2345789999999999 7999999999987755 489999


Q ss_pred             EeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeE
Q 043292          313 EYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK  379 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~k  379 (558)
                      ||+++++|.+++.....             ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~k  188 (316)
T 2xir_A          112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK  188 (316)
T ss_dssp             ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEE
Confidence            99999999999986543             1238899999999999999999999   8999999999999999999999


Q ss_pred             EcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHH
Q 043292          380 VADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFK  456 (558)
Q Consensus       380 i~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  456 (558)
                      |+|||+++........ ......+|+.|+|||.+. ..++.++||||||+++|||++ |..||......+.   ....  
T Consensus       189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~--  263 (316)
T 2xir_A          189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR--  263 (316)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---HHHH--
T ss_pred             ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH---HHHH--
Confidence            9999999876543322 233456788999999886 468999999999999999998 9999976554331   1111  


Q ss_pred             HhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       457 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                        ...+....          ........+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       264 --~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          264 --LKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             --HHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --hccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence              11111000          0111234688999999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9e-39  Score=320.82  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=191.8

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      ++||+|+||.||+++. .+++.||||++.... .....+.+|+.++.++ +||||+++++++.+++..++||||+++++|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            5799999999999987 478999999997543 3456789999999885 799999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccCCccccCCCCC---
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQS---  394 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfgla~~~~~~~~---  394 (558)
                      .+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||++........   
T Consensus        99 ~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (316)
T 2ac3_A           99 LSHIHKRR---HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP  172 (316)
T ss_dssp             HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred             HHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence            99997653   38999999999999999999999   89999999999999998776   99999999986542211   


Q ss_pred             ---ceeecccCCCCcCChhhhcC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH-------HHHHHHh
Q 043292          395 ---QVVTTMRGTPGYLAPEWLSS------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL-------LSIFKKK  458 (558)
Q Consensus       395 ---~~~~~~~gt~~y~aPE~~~~------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-------~~~~~~~  458 (558)
                         .......||+.|+|||++.+      .++.++||||||+++|||++|+.||......+.....       .......
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (316)
T 2ac3_A          173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES  252 (316)
T ss_dssp             ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred             ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence               11224568999999999852      4789999999999999999999999865543211100       0001111


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...+.. .+......      .....+.+++.+||+.||.+|||+.++++
T Consensus       253 i~~~~~-~~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          253 IQEGKY-EFPDKDWA------HISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHCCC-CCCHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhccCc-ccCchhcc------cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            111110 00000000      11346889999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.9e-39  Score=337.70  Aligned_cols=256  Identities=24%  Similarity=0.300  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .++||+|+||.||++.. .+++.||||++...   ....+++.+|+.+++.++||||+++++++....      ..++||
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  146 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  146 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence            47899999999999987 46889999999753   233567889999999999999999999986653      459999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++ +|.+.+..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       147 E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          147 ELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             ECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             eCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            99975 46666642     28999999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hh-----
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KA-----  459 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~-----  459 (558)
                        ...+...||+.|+|||++.+ .++.++|||||||+++||++|+.||.+.+..+....+......       ..     
T Consensus       218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          218 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             --CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             --cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence              22455789999999999875 5999999999999999999999999876543322211111000       00     


Q ss_pred             ---hc------ccchhhccccCCCCC--CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          460 ---EE------DKLSDLVDKHSNDMQ--SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       460 ---~~------~~~~~~~d~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                         ..      ..+...+........  ........+.+|+.+||+.||++|||++|+++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00      000011110000000  011225678999999999999999999999964

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-39  Score=343.66  Aligned_cols=246  Identities=25%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||+++.. +++.||+|++...    ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g  268 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence            368999999999999884 7999999999642    23446688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++..... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus       269 g~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~~  342 (576)
T 2acx_A          269 GDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI  342 (576)
T ss_dssp             CBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CE
T ss_pred             CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc--cc
Confidence            999999976442 348999999999999999999999   899999999999999999999999999998765432  23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+......    ..      .     .
T Consensus       343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~------~-----~  407 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VP------E-----E  407 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CC------C-----C
T ss_pred             cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----cc------c-----c
Confidence            45689999999999876 4899999999999999999999999865443222112111111    00      0     0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      ........+.+++..||+.||.+||     ++.+|++.
T Consensus       408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0111234788999999999999999     78888753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-39  Score=341.59  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=188.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .++||+|+||.||++.. .+++.||||+++..    ......+.+|+.++..++||||+++++++...+..++||||+++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  232 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG  232 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence            47899999999999987 56899999999742    23345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|.+++....   .+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       233 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~  306 (446)
T 4ejn_A          233 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM  306 (446)
T ss_dssp             CBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-ccc
Confidence            99999997654   389999999999999999999952  689999999999999999999999999998643322 234


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++||||||+++|||++|+.||.......    +..   .... ...           .
T Consensus       307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~---~i~~-~~~-----------~  367 (446)
T 4ejn_A          307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFE---LILM-EEI-----------R  367 (446)
T ss_dssp             CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHHH-CCC-----------C
T ss_pred             ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHH---HHHh-CCC-----------C
Confidence            55789999999999875 59999999999999999999999997544322    111   1110 000           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      .+......+.+++..||+.||.+||     |+.++++
T Consensus       368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1111234688999999999999999     9999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.3e-39  Score=315.96  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++.. .+++.||+|++....   ...+.+.+|+.++.+++||||+++++++.+++..++||||++++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   90 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG   90 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence            47899999999999987 468999999986433   23456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+.+....   .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++.......  
T Consensus        91 ~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~--  162 (284)
T 3kk8_A           91 ELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--  162 (284)
T ss_dssp             BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence            9999887654   38999999999999999999999   99999999999999987665   9999999998665432  


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||.+.+ .++.++||||||+++++|++|+.||.......    .....    ..+... .....   
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~----~~~~~~-~~~~~---  230 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQI----KAGAYD-YPSPE---  230 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHTCCC-CCTTT---
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHH----Hhcccc-CCchh---
Confidence            2345678999999999875 58999999999999999999999997543222    11111    111100 00000   


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         .......+.+++.+||+.||.+|||+.++++
T Consensus       231 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          231 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               0112346889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=324.89  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             hhhcCccCceEEEEEEe-----CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCC--cceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-----TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS--HNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  314 (558)
                      .+.||+|+||.||+++.     .+++.||||++.... ...+.+.+|+.++.+++||||+++++++...+  ..++||||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  125 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY  125 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence            47899999999999983     468899999997543 34567999999999999999999999987654  67899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++.....  .+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++........
T Consensus       126 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~  200 (326)
T 2w1i_A          126 LPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE  200 (326)
T ss_dssp             CTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred             CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence            999999999986543  38999999999999999999999   9999999999999999999999999999987754433


Q ss_pred             ce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcc--------hhhhHHHHHHHhhhccc
Q 043292          395 QV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEE--------EDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       395 ~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~  463 (558)
                      ..  .....++..|+|||.+.+ .++.++||||||++++||++|..|+.......        ........         
T Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  271 (326)
T 2w1i_A          201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH---------  271 (326)
T ss_dssp             EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH---------
T ss_pred             ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH---------
Confidence            21  223456778999999864 58899999999999999999998875321000        00000000         


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      +.+.+..... ..........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       272 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          272 LIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0111111000 01112234578899999999999999999999999988643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-39  Score=336.22  Aligned_cols=258  Identities=25%  Similarity=0.343  Sum_probs=198.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC--------Ccceeeeeeeec----cCCcc
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH--------HQNLVRLIGFCA----EKSHN  308 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~----~~~~~  308 (558)
                      +.++||+|+||.||+++. .+++.||||+++......+.+.+|++++..++        |+||+++++++.    .+...
T Consensus        41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~  120 (397)
T 1wak_A           41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI  120 (397)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred             EEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence            457899999999999987 56889999999876666678899999999985        888999999987    56678


Q ss_pred             eEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCC-----------
Q 043292          309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNF-----------  376 (558)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~-----------  376 (558)
                      ++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+   . +|+||||||+|||++.++           
T Consensus       121 ~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          121 CMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             EEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            9999999 6666666654432 249999999999999999999999   7 999999999999999775           


Q ss_pred             --------------------------------------CeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCC
Q 043292          377 --------------------------------------NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IIT  417 (558)
Q Consensus       377 --------------------------------------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  417 (558)
                                                            .+||+|||++......    .....||+.|+|||++.+ .++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCC
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCC
Confidence                                                  7999999999876432    334578999999999875 599


Q ss_pred             CccchHHHHHHHHHHHhCCCCCCCCCCcchhh--hHHHHHHHhhhc--------ccc-hhhcccc---------------
Q 043292          418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM--YLLSIFKKKAEE--------DKL-SDLVDKH---------------  471 (558)
Q Consensus       418 ~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~--------~~~-~~~~d~~---------------  471 (558)
                      .++||||||+++|||++|+.||......+...  ............        +.. ...+...               
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            99999999999999999999998765433211  111111110000        000 0011000               


Q ss_pred             ---CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 ---SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         .............+.+|+.+||+.||++|||+.++++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence               0011234567788999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-39  Score=316.49  Aligned_cols=242  Identities=27%  Similarity=0.434  Sum_probs=196.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc----------------C
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE----------------K  305 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------------~  305 (558)
                      .+.||+|+||.||+++.. +++.||+|.+....   +.+.+|++++.+++||||+++++++..                .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT   92 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence            478999999999999985 79999999997543   356789999999999999999998754                4


Q ss_pred             CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCC
Q 043292          306 SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGL  385 (558)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgl  385 (558)
                      ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  168 (284)
T 2a19_B           93 KCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGL  168 (284)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcchh
Confidence            457899999999999999975432 248999999999999999999999   8999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          386 SKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       386 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      +.......  ......|++.|+|||.+.+ .++.++||||||++++||++|..|+...      .   .. ........+
T Consensus       169 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~---~~-~~~~~~~~~  236 (284)
T 2a19_B          169 VTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------S---KF-FTDLRDGII  236 (284)
T ss_dssp             CEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------H---HH-HHHHHTTCC
T ss_pred             heeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------H---HH-HHHhhcccc
Confidence            98765432  2334568999999999875 5899999999999999999999876310      0   01 111111111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      ..             .....+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       237 ~~-------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          237 SD-------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             CT-------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cc-------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            11             1123578899999999999999999999999877543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=318.62  Aligned_cols=245  Identities=25%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999997 568899999987543 34567999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccCCCCCceeecc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      +++........+++..+..++.|++.||.|||+   .+++|+||||+||+++. ++.+||+|||++....... ......
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  183 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETF  183 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccccc
Confidence            999876554457899999999999999999999   89999999999999987 8999999999998764322 123456


Q ss_pred             cCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          401 RGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       401 ~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      .|++.|+|||.+.+   .++.++||||||+++|||++|+.||.........  ...   ... ..     .....     
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~---~~~-~~-----~~~~~-----  247 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFK---VGM-FK-----VHPEI-----  247 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHH---HHH-HC-----CCCCC-----
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHh---hcc-cc-----ccccc-----
Confidence            78999999999863   2789999999999999999999999643322211  000   000 00     00001     


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......+.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1122347889999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-38  Score=340.71  Aligned_cols=243  Identities=28%  Similarity=0.463  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--------------cchHHHHHHHHHHhccCCcceeeeeeeeccCCc
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--------------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH  307 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  307 (558)
                      .++||+|+||.||+++.. +++.||+|++....              ...+.+.+|+.++.+++||||+++++++.++..
T Consensus        41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  120 (504)
T 3q5i_A           41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY  120 (504)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            478999999999999984 68899999986432              234678999999999999999999999999999


Q ss_pred             ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccC
Q 043292          308 NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFG  384 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfg  384 (558)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||
T Consensus       121 ~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          121 FYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            999999999999999987654   39999999999999999999999   9999999999999998776   69999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ++.......  ......||+.|+|||++.+.++.++||||+|+++|+|++|..||......+    +...    ...+..
T Consensus       195 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~----i~~~~~  264 (504)
T 3q5i_A          195 LSSFFSKDY--KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKK----VEKGKY  264 (504)
T ss_dssp             TCEECCTTS--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCC
T ss_pred             CCEEcCCCC--ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHcCCC
Confidence            998765432  234567999999999999889999999999999999999999997654322    1111    111111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..... ...      .....+.+++.+||+.||.+|||+.++++
T Consensus       265 ~~~~~-~~~------~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          265 YFDFN-DWK------NISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CCCHH-HHT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCcc-ccC------CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000 000      11246889999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=328.31  Aligned_cols=246  Identities=18%  Similarity=0.224  Sum_probs=198.1

Q ss_pred             hhhcCccCceEEEEEE------eCCCCEEEEEEecccccchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGT------QTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .++||+|+||.||+|.      ..+++.||||+++..  ...++..|+.++..++   |+||+++++++..++..++|||
T Consensus        70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e  147 (365)
T 3e7e_A           70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE  147 (365)
T ss_dssp             EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred             EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence            4689999999999994      356889999999754  3456778888888876   9999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-----------CCCeEE
Q 043292          314 YMPNGSLDRWLFQRS--DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-----------NFNAKV  380 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-----------~~~~ki  380 (558)
                      |+++|+|.+++....  ....+++..++.|+.||+.||+|||+   .+|+||||||+|||++.           ++.+||
T Consensus       148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence            999999999997521  23459999999999999999999999   99999999999999998           899999


Q ss_pred             cccCCccccCC-CCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh
Q 043292          381 ADFGLSKLIDQ-DQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK  458 (558)
Q Consensus       381 ~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  458 (558)
                      +|||+++.+.. ..........||+.|+|||++.+ .++.++||||||+++|||++|+.||.......            
T Consensus       225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------  292 (365)
T 3e7e_A          225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------------  292 (365)
T ss_dssp             CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------------
T ss_pred             eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc------------
Confidence            99999976542 22334456789999999999876 48999999999999999999999985332211            


Q ss_pred             hhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHhccccc
Q 043292          459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKR-PSMSMVVRVLEGVTEF  516 (558)
Q Consensus       459 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~~vl~~L~~~~~~  516 (558)
                         ..    +.......    .....+.+++..|++.+|.+| |+++++.+.|+...+.
T Consensus       293 ---~~----~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 ---CK----PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ---EE----ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---ee----echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence               00    11111111    123456788889999999999 5889999988877543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.9e-39  Score=340.47  Aligned_cols=244  Identities=28%  Similarity=0.433  Sum_probs=195.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||+++.. ++..||+|++...   ......+.+|+.++..++||||+++++++.+....++||||+++
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  120 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG  120 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            3578999999999999984 6889999998743   23456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC---CCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~---~~~ki~Dfgla~~~~~~~~  394 (558)
                      |+|.+.+....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++..   +.+||+|||++....... 
T Consensus       121 g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          121 GELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            99999887654   38999999999999999999999   999999999999999764   459999999998765432 


Q ss_pred             ceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                       ......||+.|+|||++.+.++.++||||||+++|+|++|..||......+    +...    ...+... ....... 
T Consensus       194 -~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~----i~~~~~~-~~~~~~~-  262 (494)
T 3lij_A          194 -KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRK----VEKGKYT-FDSPEWK-  262 (494)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHTCCC-CCSGGGT-
T ss_pred             -cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHhCCCC-CCchhcc-
Confidence             244567999999999998889999999999999999999999997654322    1111    1111110 0000001 


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           .....+.+++.+||+.||.+|||+.++++
T Consensus       263 -----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          263 -----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                 12246889999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-39  Score=331.61  Aligned_cols=243  Identities=28%  Similarity=0.367  Sum_probs=187.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHH-HhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKT-IGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+++.. +++.||+|+++...    .....+..|..+ +..++||||+++++++.+.+..++||||+
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~  121 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI  121 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence            3578999999999999984 58899999997532    223456667776 57789999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       122 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~  194 (373)
T 2r5t_A          122 NGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S  194 (373)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence            9999999997644   38899999999999999999999   999999999999999999999999999998643322 2


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++||||||+++|||++|..||...+..+       ....... ...        . 
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~-~~~--------~-  257 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILN-KPL--------Q-  257 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHH-SCC--------C-
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHh-ccc--------C-
Confidence            3456789999999999876 58999999999999999999999997544322       1111111 100        0 


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVL  510 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  510 (558)
                        ........+.+++..||+.||.+||++.+.++.+
T Consensus       258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             --CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence              0011224688899999999999999986444333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.5e-39  Score=322.03  Aligned_cols=252  Identities=30%  Similarity=0.468  Sum_probs=189.4

Q ss_pred             hhhcCccCceEEEEEEeC----CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCc-----ceE
Q 043292          243 RKMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH-----NLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~l  310 (558)
                      .+.||+|+||.||+|...    ++..||+|.++...   ...+.+.+|+.++.+++||||+++++++.+...     .++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  118 (313)
T 3brb_A           39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV  118 (313)
T ss_dssp             EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred             ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence            478999999999999763    34589999987432   234578999999999999999999999887653     489


Q ss_pred             EEEeCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          311 VYEYMPNGSLDRWLFQR---SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ||||+++++|.+++...   .....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~  195 (313)
T 3brb_A          119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSK  195 (313)
T ss_dssp             EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred             EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcce
Confidence            99999999999998542   223459999999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          388 LIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       388 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ........ ......+++.|+|||.+.+ .++.++||||||+++|||++ |..||......+    .....    ..+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~----~~~~~  267 (313)
T 3brb_A          196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MYDYL----LHGHR  267 (313)
T ss_dssp             ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHH----HTTCC
T ss_pred             ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHHH----HcCCC
Confidence            76443221 2234557889999999875 58999999999999999999 888987654432    11111    01100


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .          .........+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       268 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          268 L----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             C----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0          0111223478899999999999999999999999988753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=323.22  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeec----cCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCA----EKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++..++||||+++++++.    .....++||||++
T Consensus        34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~  113 (317)
T 2buj_A           34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK  113 (317)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred             EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence            47899999999999998 57899999988643 334567899999999999999999999986    3446789999999


Q ss_pred             CCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +++|.+++... .....+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++.........
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~  190 (317)
T 2buj_A          114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG  190 (317)
T ss_dssp             TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred             CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence            99999999752 123459999999999999999999999   89999999999999999999999999998765321110


Q ss_pred             --------eeecccCCCCcCChhhhcCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          396 --------VVTTMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       396 --------~~~~~~gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                              ......||+.|+|||.+.+.    ++.++||||||+++|||++|+.||........  ......    .. .
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~-~  263 (317)
T 2buj_A          191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV----QN-Q  263 (317)
T ss_dssp             HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH----HC-C
T ss_pred             ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh----hc-c
Confidence                    01234579999999998642    68999999999999999999999853111000  000000    00 0


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .    .     ..........+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       264 ~----~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          264 L----S-----IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             C----C-----CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            0    0     001112234788999999999999999999999999887543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-38  Score=335.46  Aligned_cols=255  Identities=21%  Similarity=0.311  Sum_probs=201.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCC-cceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||.||+++. .+++.||||++..... ..++..|++++..++| +++..+..++......+|||||+ +++|
T Consensus        12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            47899999999999997 5789999998764332 3458899999999987 55566666677778889999999 9999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCCc--
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQ--  395 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~~--  395 (558)
                      .+++.....  .+++..++.|+.||+.||.|||+   .+|+||||||+||||   +.++.+||+|||+++.+......  
T Consensus        90 ~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           90 EDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             HHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence            999975433  39999999999999999999999   999999999999999   68899999999999876543321  


Q ss_pred             ----eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 ----VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ----~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                          ......||..|+|||.+.+ .++.++||||||++||||++|+.||...........+..+..... ...+..+.. 
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l~~-  242 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEALCR-  242 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHHHHT-
T ss_pred             cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHHHhc-
Confidence                1235679999999999875 589999999999999999999999987665443322222222111 111111111 


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         .      ....+.+++..||+.+|++||++.+|+++|+.+..
T Consensus       243 ---~------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          243 ---G------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             ---T------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---C------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               1      12478899999999999999999999999988754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=329.80  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=181.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccC-Ccceeeeeeeec--------cCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIH-HQNLVRLIGFCA--------EKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~~~l  310 (558)
                      +.++||+|+||.||+++. .+++.||||++... ....+.+.+|+.++.++. ||||+++++++.        .....++
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l  111 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL  111 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence            347899999999999997 47899999988643 334567899999999996 999999999983        3445789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ||||+. |+|.+++........+++..++.++.||+.||.|||+   .+  |+|+||||+|||++.++.+||+|||++..
T Consensus       112 v~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  187 (337)
T 3ll6_A          112 LTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT  187 (337)
T ss_dssp             EEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred             EEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence            999995 7999998764334459999999999999999999999   77  99999999999999999999999999987


Q ss_pred             cCCCCCce-----------eecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          389 IDQDQSQV-----------VTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       389 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                      ........           .....||+.|+|||++.    ..++.++||||||+++|||++|+.||.......       
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------  260 (337)
T 3ll6_A          188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-------  260 (337)
T ss_dssp             CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-------
Confidence            65432211           11345899999999973    348899999999999999999999996433211       


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ....     ..    ....     .......+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       261 ~~~~-----~~----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 IVNG-----KY----SIPP-----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----------C----CCCT-----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hhcC-----cc----cCCc-----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            0000     00    0000     0011124778999999999999999999999999886543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-38  Score=322.21  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=193.6

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.||+|+||.||++... +++.||+|+++..   ......+.+|+.++..+ +||||+++++++.+....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            78999999999999884 6899999998743   23356789999999999 5699999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++..... ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++......  
T Consensus       115 ~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--  188 (327)
T 3lm5_A          115 EIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--  188 (327)
T ss_dssp             EGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred             cHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--
Confidence            99999865432 349999999999999999999999   89999999999999998   7899999999998764332  


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.   ...+. ..  ....   ..     
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~-~~--~~~~---~~-----  254 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNIS-QV--NVDY---SE-----  254 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-HT--CCCC---CT-----
T ss_pred             ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHH-hc--cccc---Cc-----
Confidence            2344679999999999875 589999999999999999999999976543221   11110 00  0000   00     


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       .........+.+++.+||+.||.+|||+.++++.
T Consensus       255 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          255 -ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             0011223468899999999999999999999853

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-39  Score=326.75  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=199.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCE--EEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTK--VAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+++.. ++..  +|+|.++..  ....+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  108 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA  108 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence            3578999999999999874 4554  499988742  23345689999999999 9999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          316 PNGSLDRWLFQRS-------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       316 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      ++++|.+++....             ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcc
Confidence            9999999997643             22359999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhh
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ||+++......  ......+++.|+|||.+.+ .++.++||||||+++|||++ |+.||......+       ... ...
T Consensus       186 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~-~~~  255 (327)
T 1fvr_A          186 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE-KLP  255 (327)
T ss_dssp             TTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH-HGG
T ss_pred             cCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH-Hhh
Confidence            99997433211  1233456889999999875 58999999999999999998 999997554321       111 111


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .+..     .     .........+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       256 ~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          256 QGYR-----L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GTCC-----C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cCCC-----C-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            1100     0     011122357889999999999999999999999998876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-38  Score=312.60  Aligned_cols=244  Identities=24%  Similarity=0.379  Sum_probs=194.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc-------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+++.. +++.||+|.++...       ...+.+.+|+.++.+++||||+++++++.++...++|||
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   88 (283)
T 3bhy_A            9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE   88 (283)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence            3578999999999999985 68999999986432       135679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~  389 (558)
                      |+++++|.+++....   .+++..+..++.||+.||.|||+   .+++|+||||+||+++.++    .+||+|||++...
T Consensus        89 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           89 LVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999997643   38999999999999999999999   9999999999999999887    8999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....  ......|++.|+|||.+.+ .++.++||||||+++++|++|..||......+    .......  .........
T Consensus       163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~--~~~~~~~~~  234 (283)
T 3bhy_A          163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTNISA--VNYDFDEEY  234 (283)
T ss_dssp             C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHT--TCCCCCHHH
T ss_pred             cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHhHh--cccCCcchh
Confidence            4432  2334568999999999874 58999999999999999999999997544221    1110000  000000000


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         ..      .....+.+++.+||+.||.+|||+.++++
T Consensus       235 ---~~------~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          235 ---FS------NTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ---HT------TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cc------cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence               00      11246889999999999999999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.1e-39  Score=326.74  Aligned_cols=244  Identities=22%  Similarity=0.361  Sum_probs=192.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||++... +++.||||+++....   .+.+|++++.++ +||||+++++++.++...++||||+++|+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            478999999999999984 688999999975433   235688888887 799999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC----CCeEEcccCCccccCCCCCce
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN----FNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      .+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||+.++    +.+||+|||+++....... .
T Consensus       104 ~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~  176 (342)
T 2qr7_A          104 LDKILRQK---FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-L  176 (342)
T ss_dssp             HHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-C
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-c
Confidence            99997643   38999999999999999999999   999999999999998543    2499999999987654332 2


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|..||.......... +..    ....+... +...     
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~~~----~i~~~~~~-~~~~-----  245 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-ILA----RIGSGKFS-LSGG-----  245 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH-HHH----HHHHCCCC-CCST-----
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH-HHH----HHccCCcc-cCcc-----
Confidence            345678999999999875 48899999999999999999999997543322111 111    11111110 0000     


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       ........+.+++.+||+.||++|||+.++++
T Consensus       246 -~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          246 -YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             00112346889999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-38  Score=323.29  Aligned_cols=240  Identities=26%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|++....    ...+.+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  125 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR  125 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence            478999999999999985 58899999986432    3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++........ ..
T Consensus       126 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~  198 (335)
T 2owb_A          126 RSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK  198 (335)
T ss_dssp             CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cc
Confidence            99999987643   38999999999999999999999   8999999999999999999999999999987643322 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|+..|+|||++.+ .++.++||||||+++|||++|+.||......+.   ...    .. ....      ..    
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~----~~-~~~~------~~----  260 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YLR----IK-KNEY------SI----  260 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH----HH-HTCC------CC----
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH----Hh-cCCC------CC----
Confidence            45678999999999875 589999999999999999999999975442221   111    10 0100      00    


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .......+.+++.+||+.||++|||+.++++
T Consensus       261 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 -PKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0112246788999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-39  Score=319.61  Aligned_cols=247  Identities=31%  Similarity=0.473  Sum_probs=192.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccC-CcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-SHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||++... ++.||||.++... ..+.+.+|+.++.+++||||+++++++.+. +..++||||+++++|.
T Consensus        26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  103 (278)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence            478999999999999875 8899999997543 456789999999999999999999987554 4789999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......    .....
T Consensus       104 ~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~  175 (278)
T 1byg_A          104 DYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGK  175 (278)
T ss_dssp             HHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred             HHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCC
Confidence            99975432 237899999999999999999999   99999999999999999999999999999865432    22345


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ++..|+|||.+. ..++.++||||||++++||++ |+.||......+    ...    ....+..     .     ....
T Consensus       176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~----~~~~~~~-----~-----~~~~  237 (278)
T 1byg_A          176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP----RVEKGYK-----M-----DAPD  237 (278)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHH----HHTTTCC-----C-----CCCT
T ss_pred             ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----HHhcCCC-----C-----CCcc
Confidence            788999999986 468999999999999999998 999997654322    111    1111100     0     0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .....+.+++..||+.||.+|||+.++++.|+.+...+
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            22357889999999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-38  Score=339.82  Aligned_cols=245  Identities=27%  Similarity=0.400  Sum_probs=198.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.++||+|+||.||+++.. +++.||||++...   ......+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus        26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  105 (486)
T 3mwu_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG  105 (486)
T ss_dssp             EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence            4578999999999999984 7899999998632   33456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec---CCCCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++|.+.+....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||+++...... 
T Consensus       106 ~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-  178 (486)
T 3mwu_A          106 GELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (486)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence            99999887654   38999999999999999999999   9999999999999995   55679999999998764432 


Q ss_pred             ceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                       ......||+.|+|||++.+.++.++||||||+++|+|++|..||......+    +...    ...+......      
T Consensus       179 -~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~----i~~~~~~~~~------  243 (486)
T 3mwu_A          179 -KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKR----VETGKYAFDL------  243 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHTCCCSCS------
T ss_pred             -ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHhCCCCCCC------
Confidence             234567999999999999889999999999999999999999997654322    1111    1111110000      


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       +........+.+++.+||+.||.+|||+.++++.
T Consensus       244 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 -PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0001123468899999999999999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-38  Score=339.10  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=198.5

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||.||+++.. +++.||+|++...    ......+..|+.++.+++||||+++++++......++||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            57999999999999984 6999999999643    233467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC-CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++..... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus       271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~  346 (543)
T 3c4z_A          271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KT  346 (543)
T ss_dssp             BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-CB
T ss_pred             CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-cc
Confidence            99999976432 3459999999999999999999999   9999999999999999999999999999987654332 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+..   .... ...           .
T Consensus       347 ~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~-~~~-----------~  411 (543)
T 3c4z_A          347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLE-QAV-----------T  411 (543)
T ss_dssp             CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHH-CCC-----------C
T ss_pred             ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhh-ccc-----------C
Confidence            44689999999999876 589999999999999999999999986543221111111   1111 100           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSM-----SMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~  508 (558)
                      .+......+.+++.+||+.||.+||++     .+|++
T Consensus       412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            111223477889999999999999975     55553

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-38  Score=322.40  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=194.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc--------CCcceE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--------KSHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~l  310 (558)
                      .++||+|+||.||+++. .+++.||||++...   ......+.+|+.++..++||||+++++++..        ++..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l  101 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL  101 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence            47899999999999998 57899999998643   2234678899999999999999999999876        345789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+++ +|.+.+.....  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       102 v~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A          102 VFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             EEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            9999975 77777765433  39999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCC---CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          391 QDQ---SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       391 ~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ...   ........||+.|+|||++.+  .++.++||||||++++||++|+.||......+....+...... .......
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~  254 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVWP  254 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTST
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChhhcc
Confidence            322   122345678999999998864  4899999999999999999999999865533321111111100 0000000


Q ss_pred             h-----hcccc--CCCCCCCH-HH------HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 D-----LVDKH--SNDMQSNG-EE------VVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~-----~~d~~--~~~~~~~~-~~------~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .     ..+..  ........ ..      ...+.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0     00000  00000111 11      235789999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-39  Score=341.87  Aligned_cols=244  Identities=28%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||.||+++.. +++.||||++...    ....+.+.+|+.++.+++||||+++++++.+.+..++||||+.
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3578999999999999985 7899999998632    3345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCC
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||++..+....
T Consensus       110 ~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          110 GGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             SCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            999999987644   38999999999999999999999   899999999999999   567899999999998765432


Q ss_pred             CceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                        ......||+.|+|||++.+.++.++||||||+++|+|++|..||......+    +...    ...+......     
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~----i~~~~~~~~~-----  248 (484)
T 3nyv_A          184 --KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD----ILKK----VEKGKYTFEL-----  248 (484)
T ss_dssp             --SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCCCCCS-----
T ss_pred             --ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHcCCCCCCC-----
Confidence              234567999999999999899999999999999999999999997654322    1111    1111110000     


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        +........+.+++.+||+.||.+|||+.++++
T Consensus       249 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 --PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence              000112346889999999999999999999995

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-39  Score=334.28  Aligned_cols=234  Identities=16%  Similarity=0.179  Sum_probs=182.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecc----cccchHHHHHHH---HHHhccCCcceeeee-------eeeccCC-
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEG----IGEINKSFLAEV---KTIGSIHHQNLVRLI-------GFCAEKS-  306 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~~-  306 (558)
                      .+.||+|+||.||+|+. .+++.||||++..    .....+.+.+|+   +++++++||||++++       +++...+ 
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            47899999999999997 5699999999863    223456788999   556666899999998       5554443 


Q ss_pred             ----------------cceEEEEeCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCC
Q 043292          307 ----------------HNLLVYEYMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIK  366 (558)
Q Consensus       307 ----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk  366 (558)
                                      ..++||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||+   .+|+|||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDik  233 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR  233 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence                            268999999 6899999975321    1235568899999999999999999   899999999


Q ss_pred             CCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC------------CCCCccchHHHHHHHHHHHh
Q 043292          367 PQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS------------IITEKVDIYSFGVVMLEILC  434 (558)
Q Consensus       367 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~k~Dv~s~Gv~l~ellt  434 (558)
                      |+|||++.++.+||+|||+++....    ......| +.|+|||++.+            .++.++||||||+++|||++
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            9999999999999999999985332    3445667 99999999863            58999999999999999999


Q ss_pred             CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          435 GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       435 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      |+.||........                ...+... ..      .....+.+++.+||+.||++|||+.++++
T Consensus       309 g~~Pf~~~~~~~~----------------~~~~~~~-~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          309 ADLPITKDAALGG----------------SEWIFRS-CK------NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             SSCCC------CC----------------SGGGGSS-CC------CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             CCCCCcccccccc----------------hhhhhhh-cc------CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999975443221                1111110 11      11246889999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.3e-39  Score=314.49  Aligned_cols=244  Identities=25%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||++... +++.||||++...  ....+.+.+|+.++..++||||+++++++.+++..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            478999999999999984 7899999998643  2335678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-ceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~  398 (558)
                      |.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus        92 L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  165 (276)
T 2yex_A           92 LFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (276)
T ss_dssp             GGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             HHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence            999986543   48999999999999999999999   9999999999999999999999999999986543221 1234


Q ss_pred             cccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...|++.|+|||.+.+.  .+.++||||||++++||++|+.||.........  ...+.    .....   ..       
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~----~~~~~---~~-------  229 (276)
T 2yex_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWK----EKKTY---LN-------  229 (276)
T ss_dssp             CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHH----TTCTT---ST-------
T ss_pred             CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhh----hcccc---cC-------
Confidence            56789999999998753  477999999999999999999999865543211  11110    00000   00       


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00112346788999999999999999999885

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.2e-38  Score=321.78  Aligned_cols=243  Identities=25%  Similarity=0.460  Sum_probs=195.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---------cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---------EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  311 (558)
                      .+.||+|+||.||++++. +|+.||||++....         ...+.+.+|+.++.++ +||||+++++++......++|
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            378999999999999985 79999999986432         1135678899999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++.....
T Consensus       179 ~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999997643   38999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCcCChhhhcC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSS-------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ..  ......||+.|+|||++.+       .++.++||||||+++|||++|+.||.......    .....    ..+..
T Consensus       253 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i----~~~~~  322 (365)
T 2y7j_A          253 GE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMI----MEGQY  322 (365)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHTCC
T ss_pred             Cc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHH----HhCCC
Confidence            32  2345679999999998752       47889999999999999999999997543211    11111    11110


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      . .......      .....+.+++.+||+.||.+|||+.++++
T Consensus       323 ~-~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          323 Q-FSSPEWD------DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             C-CCHHHHS------SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C-CCCcccc------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 0000000      11246889999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=325.53  Aligned_cols=260  Identities=23%  Similarity=0.384  Sum_probs=192.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++.. .+++.||||++....   ...+.+.+|+++++.++||||+++++++....      ..++||
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  109 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  109 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence            47899999999999998 579999999996432   23457889999999999999999999987764      359999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+ +++|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       110 e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  181 (367)
T 1cm8_A          110 PFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  181 (367)
T ss_dssp             ECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             ecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence            999 88999999763    38999999999999999999999   99999999999999999999999999999875432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  463 (558)
                          .....+|+.|+|||++.+  .++.++||||+|++++||++|+.||.+....+....+.....       .......
T Consensus       182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  257 (367)
T 1cm8_A          182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  257 (367)
T ss_dssp             ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence                345678999999998865  589999999999999999999999986554332111111100       0000000


Q ss_pred             chhhccccCC----CC-CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhccc
Q 043292          464 LSDLVDKHSN----DM-QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVT  514 (558)
Q Consensus       464 ~~~~~d~~~~----~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~  514 (558)
                      ....+.....    .. .........+.+++.+||+.||.+|||+.++++.  ++.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0000000000    00 0001123468899999999999999999999973  55543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.5e-39  Score=335.70  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=184.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+.||+|+||.||+|.. .+++.||||++....         .....+.+|+.++.+++||||+++++++.. +..++||
T Consensus       140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  218 (419)
T 3i6u_A          140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVL  218 (419)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEE
T ss_pred             EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEE
Confidence            47899999999999988 468999999986432         112358899999999999999999999754 5579999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC---CeEEcccCCcccc
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF---NAKVADFGLSKLI  389 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~---~~ki~Dfgla~~~  389 (558)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++   .+||+|||+++..
T Consensus       219 e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          219 ELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             ECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            9999999999887543   49999999999999999999999   8999999999999997544   5999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ...  .......||+.|+|||++.    ..++.++||||||+++|||++|+.||.........   ....    ..+...
T Consensus       293 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~---~~~i----~~~~~~  363 (419)
T 3i6u_A          293 GET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQI----TSGKYN  363 (419)
T ss_dssp             C-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH---HHHH----HTTCCC
T ss_pred             CCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH---HHHH----hcCCCC
Confidence            532  2234567999999999974    35788999999999999999999999765433211   1111    111100


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .......      .....+.+++.+||+.||.+|||+.++++
T Consensus       364 -~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 -FIPEVWA------EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -CCHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCchhhc------ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             0000000      11347889999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-38  Score=316.78  Aligned_cols=240  Identities=26%  Similarity=0.415  Sum_probs=197.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|.+....    ...+.+.+|+.+++.++|+||+++++++.+++..++||||+++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR   99 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence            478999999999999985 58899999986432    2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus       100 ~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  172 (294)
T 2rku_A          100 RSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK  172 (294)
T ss_dssp             CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-cc
Confidence            99999987644   38999999999999999999999   8999999999999999999999999999987643322 23


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||.+.+ .++.++||||||++++||++|+.||......+.       .... .....           .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~-~~~~~-----------~  233 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRI-KKNEY-----------S  233 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHH-HTTCC-----------C
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHH-hhccC-----------C
Confidence            44678999999999875 589999999999999999999999975443221       1111 01100           0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          234 IPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            01112246888999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-39  Score=339.00  Aligned_cols=185  Identities=27%  Similarity=0.478  Sum_probs=147.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  313 (558)
                      .++||+|+||.||++... +++.||||++...   ....+.+.+|+.++..++||||+++++++...     ...++|||
T Consensus        58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  137 (458)
T 3rp9_A           58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE  137 (458)
T ss_dssp             CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred             eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence            478999999999999874 7899999999643   22346789999999999999999999998443     56799999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+ +++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++......
T Consensus       138 ~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          138 IA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE  210 (458)
T ss_dssp             CC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred             cc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence            98 579999987543   49999999999999999999999   899999999999999999999999999998764322


Q ss_pred             C--------------------------ceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHh
Q 043292          394 S--------------------------QVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILC  434 (558)
Q Consensus       394 ~--------------------------~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~ellt  434 (558)
                      .                          ...+...||+.|+|||++.  ..++.++|||||||++|||++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            1                          1234567899999999763  359999999999999999999

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-39  Score=326.22  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=196.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      +.+.||+|+||.||+++.. +++.||||++.....      ..+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   93 (346)
T 1ua2_A           14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   93 (346)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence            3578999999999999984 689999999864221      134688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++ +|..++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        94 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  166 (346)
T 1ua2_A           94 MET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  166 (346)
T ss_dssp             CSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             CCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence            975 8988887543  248899999999999999999999   999999999999999999999999999998764332 


Q ss_pred             ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cccchhh---
Q 043292          395 QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--EDKLSDL---  467 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---  467 (558)
                      .......||+.|+|||.+.+  .++.++||||||+++|||++|..||......+.   +..+......  .....+.   
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhhhccC
Confidence            22345678999999999864  488999999999999999999999976543221   1221111100  0000000   


Q ss_pred             cccc-CCCC-CCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          468 VDKH-SNDM-QSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       468 ~d~~-~~~~-~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .+.. .... ...     ......+.+++.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000 0000 000     1123578999999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-39  Score=326.42  Aligned_cols=259  Identities=24%  Similarity=0.417  Sum_probs=193.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||+++.. +++.||||++.....   ..+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  109 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT  109 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence            368999999999999985 589999999864322   2456789999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|.+++....   .+++..+..++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++........ ...
T Consensus       110 ~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  182 (331)
T 4aaa_A          110 ILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYD  182 (331)
T ss_dssp             HHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred             hHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccC
Confidence            9988876443   38999999999999999999999   8999999999999999999999999999986644322 234


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhc-ccchhhc
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEE-DKLSDLV  468 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~  468 (558)
                      ...|++.|+|||.+.+  .++.++||||||+++|||++|+.||......+....+.....       ..... .......
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            5678999999999875  589999999999999999999999976554332211111100       00000 0001110


Q ss_pred             cccCCCCCCC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSN----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..........    ......+.+++.+||+.||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0111100000    012457899999999999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.8e-39  Score=325.62  Aligned_cols=255  Identities=24%  Similarity=0.354  Sum_probs=187.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||.||++.. .+++.||||+++....   ..+.+.+|+.++++++||||+++++++.++...++||||++ +
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence            47899999999999987 4788999999974322   23567899999999999999999999999999999999997 5


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-----CCCCeEEcccCCccccCCCC
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-----GNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-----~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +|.+++.....   +++..+..++.||+.||.|||+   .+|+||||||+|||++     +++.+||+|||+++......
T Consensus       118 ~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          118 DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99999976543   8999999999999999999999   8999999999999994     55569999999998764332


Q ss_pred             CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cccch----
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--EDKLS----  465 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~----  465 (558)
                      . ......||+.|+|||++.+  .++.++||||||++++||++|+.||......+.   +..+......  .....    
T Consensus       192 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          192 R-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhhhhh
Confidence            2 2344568999999999865  489999999999999999999999976543321   1111111100  00000    


Q ss_pred             --hhccccCCCCCCCHH------HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          466 --DLVDKHSNDMQSNGE------EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       466 --~~~d~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ...............      ....+.+++.+||+.||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence              000000000000111      2256789999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.1e-39  Score=326.99  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=196.3

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||++... +++.||+|++...  ....+.+.+|+.++.+++||||+++++++.+++..++||||+++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  117 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS  117 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence            368999999999999985 6899999998753  3334678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      |.+++....   .+++..+..++.|++.||.|||+   . +|+|+||||+|||++.++.+||+|||++......   ...
T Consensus       118 L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~  188 (360)
T 3eqc_A          118 LDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN  188 (360)
T ss_dssp             HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence            999997654   38999999999999999999998   5 8999999999999999999999999999755322   233


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH---------------------
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK---------------------  456 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~---------------------  456 (558)
                      ...||+.|+|||++.+ .++.++||||||++++||++|+.||......+..........                     
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG  268 (360)
T ss_dssp             --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred             CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence            4678999999999875 589999999999999999999999976543321110000000                     


Q ss_pred             -Hhhhcccchhhcc----ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          457 -KKAEEDKLSDLVD----KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       457 -~~~~~~~~~~~~d----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .........+.++    ..... .........+.+++.+||+.||++|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          269 MDSRPPMAIFELLDYIVNEPPPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----CCCHHHHHHHHHHSCCCC-CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccchhhhhHHhccCCCC-CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             0000000000000    00000 011112346889999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-39  Score=320.09  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=190.6

Q ss_pred             hhhcCccCceEEEEEEeC--CCC--EEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT--DGT--KVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++..  +++  .||||+++..    ....+.+.+|++++.+++||||+++++++..+. .++|+||
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~  101 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL  101 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence            478999999999999853  333  6899988643    234567899999999999999999999998765 8899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++.....  .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  176 (291)
T 1u46_A          102 APLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  176 (291)
T ss_dssp             CTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             ccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence            999999999976432  38999999999999999999999   8999999999999999999999999999987654332


Q ss_pred             ce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          395 QV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       395 ~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..  .....++..|+|||.+.+ .++.++||||||++++||++ |+.||......+    +   ..........      
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~---~~~~~~~~~~------  243 (291)
T 1u46_A          177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----I---LHKIDKEGER------  243 (291)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----H---HHHHHTSCCC------
T ss_pred             chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----H---HHHHHccCCC------
Confidence            21  223557788999999864 58899999999999999999 999997554321    1   1111111100      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                          ..........+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       244 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 ----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                011112335788999999999999999999999999887543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-38  Score=314.06  Aligned_cols=238  Identities=27%  Similarity=0.408  Sum_probs=196.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||+|.+...    ......+.+|+.++.+++||||+++++++.+++..++||||+++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   98 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR   98 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence            478999999999999985 5788999998642    22346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......   .
T Consensus        99 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~  169 (284)
T 2vgo_A           99 GELYKELQKHG---RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---R  169 (284)
T ss_dssp             EEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---B
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc---c
Confidence            99999997654   38999999999999999999999   999999999999999999999999999997654322   2


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....|++.|+|||.+.+ .++.++||||||++++||++|..||......+.       ..... ....      .     
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~-~~~~------~-----  230 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIV-NVDL------K-----  230 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH-TTCC------C-----
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHh-cccc------C-----
Confidence            34678999999999875 589999999999999999999999975442221       11110 0000      0     


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            01112346789999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-38  Score=315.81  Aligned_cols=241  Identities=27%  Similarity=0.424  Sum_probs=198.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+|+. .+++.||||++...  ....+.+.+|+.++..++||||+++++++.+....++||||+++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  106 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS  106 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence            47899999999999987 46899999998643  3345779999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++...    .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++........ ....
T Consensus       107 L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  178 (303)
T 3a7i_A          107 ALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT  178 (303)
T ss_dssp             HHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence            99998643    38999999999999999999999   8999999999999999999999999999987654322 2345


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      ..|++.|+|||.+.+ .++.++||||||++++||++|+.||.......    .....    ......     ...     
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~----~~~~~~-----~~~-----  240 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLI----PKNNPP-----TLE-----  240 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHH----HHSCCC-----CCC-----
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH----HHHHh----hcCCCC-----CCc-----
Confidence            678999999999875 58999999999999999999999997543221    11111    011100     010     


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ......+.+++..||+.||.+|||+.++++.
T Consensus       241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1123468899999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-38  Score=332.28  Aligned_cols=194  Identities=25%  Similarity=0.374  Sum_probs=169.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhcc------CCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI------HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||++... +++.||||+++.......++..|++++..+      +|+||+++++++......++||||+
T Consensus       102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  181 (429)
T 3kvw_A          102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL  181 (429)
T ss_dssp             EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence            478999999999999874 588999999987666667788888888777      5779999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC--eEEcccCCccccCCCC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN--AKVADFGLSKLIDQDQ  393 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~--~ki~Dfgla~~~~~~~  393 (558)
                      . ++|.+++...... .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.  +||+|||++...... 
T Consensus       182 ~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-  255 (429)
T 3kvw_A          182 S-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-  255 (429)
T ss_dssp             C-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred             C-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-
Confidence            5 6999998765432 38999999999999999999999   89999999999999999987  999999999754332 


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCc
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPE  445 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~  445 (558)
                         .....||+.|+|||++.+ .++.++|||||||++|||++|..||......
T Consensus       256 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          256 ---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             ---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence               335678999999999875 5999999999999999999999999866543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-39  Score=324.69  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=198.6

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+|+.      .++..||||.+...  .....++.+|+.++.+++||||+++++++.+....++|||
T Consensus        34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (327)
T 2yfx_A           34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME  113 (327)
T ss_dssp             EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence            347899999999999984      34778999999643  3345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCc
Q 043292          314 YMPNGSLDRWLFQRSD----EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLS  386 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla  386 (558)
                      |+++++|.+++.....    ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.   +..+||+|||++
T Consensus       114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~  190 (327)
T 2yfx_A          114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  190 (327)
T ss_dssp             CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccc
Confidence            9999999999986532    1348999999999999999999999   89999999999999994   446999999999


Q ss_pred             cccCCCCC-ceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQS-QVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      ........ .......+++.|+|||.+. +.++.++||||||+++|||++ |..||......+    +...    ...+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~----~~~~~  262 (327)
T 2yfx_A          191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF----VTSGG  262 (327)
T ss_dssp             HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHH----HHTTC
T ss_pred             cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHH----HhcCC
Confidence            86533221 1233456788999999886 568999999999999999998 999997543221    1111    11111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ..          .........+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       263 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 RM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            00          011122347889999999999999999999999998876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.6e-38  Score=316.51  Aligned_cols=250  Identities=22%  Similarity=0.381  Sum_probs=194.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-Ccceeeeeeeecc--CCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAE--KSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||.||+++. .+++.||||+++..  ..+.+.+|+.++.+++ ||||+++++++.+  ....++||||++++
T Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~  118 (330)
T 3nsz_A           41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  118 (330)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence            47899999999999987 57899999999743  3467899999999997 9999999999987  56779999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|.+++..      +++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++.......  .
T Consensus       119 ~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~  187 (330)
T 3nsz_A          119 DFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y  187 (330)
T ss_dssp             CHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--C
T ss_pred             hHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--c
Confidence            99998853      8899999999999999999999   9999999999999999777 899999999987654332  3


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc------
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD------  469 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------  469 (558)
                      ....++..|+|||.+.+  .++.++||||||++++||++|+.||..........  ...... .......+.++      
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l--~~~~~~-~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKV-LGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHH-HCHHHHHHHHHHTTCCC
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH--HHHHHh-cCCchhhhHHHHhcccc
Confidence            45678999999999864  58999999999999999999999996544332111  111100 00000000000      


Q ss_pred             ---------ccC-------CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 ---------KHS-------NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ---------~~~-------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                               ...       ............+.+++.+||+.||.+|||++++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     000       000011112457899999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=317.26  Aligned_cols=243  Identities=24%  Similarity=0.383  Sum_probs=193.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .+.||+|+||.||++... +++.||+|.+.... ..+.+.+|+.++.+++||||+++++++...+..++||||+++++|.
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  112 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS  112 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence            478999999999999885 58999999997543 3467899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++........ ......
T Consensus       113 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~  186 (314)
T 3com_A          113 DIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVI  186 (314)
T ss_dssp             HHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCC
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccC
Confidence            99974332  38999999999999999999999   9999999999999999999999999999987644322 234457


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      |++.|+|||.+.+ .++.++||||||+++++|++|+.||........   ...    .. ......+        .....
T Consensus       187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~-~~~~~~~--------~~~~~  250 (314)
T 3com_A          187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---IFM----IP-TNPPPTF--------RKPEL  250 (314)
T ss_dssp             SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----HH-HSCCCCC--------SSGGG
T ss_pred             CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---HHH----Hh-cCCCccc--------CCccc
Confidence            8999999999875 589999999999999999999999975442211   000    00 0000000        00111


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            2347889999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.4e-39  Score=317.07  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeec--cCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||++... +++.||+|.+...   ....+.+.+|+.++.+++||||+++++++.  .+...++||||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            478999999999999884 6899999999743   233467899999999999999999999874  4567899999999


Q ss_pred             CCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccCCCc-----EEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          317 NGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDCRQK-----ILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       317 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      +++|.+++.... ....+++..++.++.|++.||.|||+   .+     ++|+||||+||+++.++.+||+|||++....
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~  167 (279)
T 2w5a_A           91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  167 (279)
T ss_dssp             TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred             CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence            999999997532 23348999999999999999999999   67     9999999999999999999999999998764


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .... ......|+..|+|||.+.+ .++.++||||||+++|||++|+.||......+    +.    .....+....+  
T Consensus       168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~----~~i~~~~~~~~--  236 (279)
T 2w5a_A          168 HDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LA----GKIREGKFRRI--  236 (279)
T ss_dssp             --CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH----HHHHHTCCCCC--
T ss_pred             cccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH----HH----HHHhhcccccC--
Confidence            3321 1234568999999999875 58999999999999999999999997654221    11    11111111110  


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG  512 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  512 (558)
                              .......+.+++.+||+.||.+|||+.+|++.+..
T Consensus       237 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          237 --------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                    11123478899999999999999999999987644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=319.00  Aligned_cols=244  Identities=25%  Similarity=0.436  Sum_probs=191.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeecc------CCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAE------KSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e~  314 (558)
                      .+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++.++ +||||+++++++..      ....++||||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~  108 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF  108 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence            47899999999999998 5789999999986666678899999999999 89999999999876      4578999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++++|.+++..... ..+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++........
T Consensus       109 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  184 (326)
T 2x7f_A          109 CGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  184 (326)
T ss_dssp             CTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred             CCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence            999999999986432 348999999999999999999999   8999999999999999999999999999986643221


Q ss_pred             ceeecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          395 QVVTTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                       ......|++.|+|||++.      ..++.++||||||+++|||++|..||........   +..    .. ........
T Consensus       185 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~-~~~~~~~~  255 (326)
T 2x7f_A          185 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFL----IP-RNPAPRLK  255 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----HH-HSCCCCCS
T ss_pred             -ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHH----hh-cCccccCC
Confidence             233456899999999985      3589999999999999999999999975442221   111    00 01111110


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .         ......+.+++.+||+.||.+|||+.++++
T Consensus       256 ~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          256 S---------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             C---------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0         111247889999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-38  Score=348.47  Aligned_cols=240  Identities=25%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .++||+|+||.||+++.. +++.||||+++..    ....+.+..|..++..+ +|+||+++++++.+.+..+|||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            368999999999999984 6889999999742    23456788899999988 79999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|..++....   .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++...... ..
T Consensus       426 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~  498 (674)
T 3pfq_A          426 GGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT  498 (674)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CC
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cc
Confidence            999999998654   39999999999999999999999   999999999999999999999999999998643322 23


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+..+    +   ..... ....           
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~---~~~i~-~~~~-----------  559 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----L---FQSIM-EHNV-----------  559 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHHH-SSCC-----------
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----H---HHHHH-hCCC-----------
Confidence            456789999999999875 59999999999999999999999997644322    1   11111 1110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSM-----SMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~  508 (558)
                      ..+......+.+|+..||+.||++||++     ++|++
T Consensus       560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            0111223478899999999999999997     66664

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-39  Score=320.14  Aligned_cols=244  Identities=24%  Similarity=0.396  Sum_probs=191.5

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l  103 (302)
T 2j7t_A           24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV  103 (302)
T ss_dssp             EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred             cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence            478999999999999985 5899999998744 33457899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.....  .+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++....... ......
T Consensus       104 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  177 (302)
T 2j7t_A          104 DAIMLELDR--GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSF  177 (302)
T ss_dssp             HHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC----
T ss_pred             HHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccc
Confidence            999876433  38999999999999999999999   899999999999999999999999999976432111 112345


Q ss_pred             cCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          401 RGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       401 ~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .|++.|+|||++.      ..++.++||||||++++||++|..||........   ...    ... ......       
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~-~~~~~~-------  242 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLK----IAK-SDPPTL-------  242 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----HHH-SCCCCC-------
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH----Hhc-cCCccc-------
Confidence            6899999999873      3588999999999999999999999975543221   111    111 110000       


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .........+.+++.+||+.||.+|||+.++++
T Consensus       243 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             011122346889999999999999999999885

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-38  Score=316.33  Aligned_cols=248  Identities=28%  Similarity=0.460  Sum_probs=197.3

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||+++.. +++.||+|.++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (304)
T 2jam_A           13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE   92 (304)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence            3578999999999999984 789999999975432 34568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee---cCCCCeEEcccCCccccCCCCCce
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL---DGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      |.+++....   .+++..+..++.|++.||.|||+   .+|+|+||||+||++   +.++.+||+|||++......   .
T Consensus        93 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~  163 (304)
T 2jam_A           93 LFDRILERG---VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---I  163 (304)
T ss_dssp             HHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---T
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---c
Confidence            999987644   38999999999999999999999   899999999999999   78899999999999764332   1


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....|++.|+|||.+.+ .++.++||||||++++||++|..||.......    +...    ...+.. ....      
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~----i~~~~~-~~~~------  228 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LFEK----IKEGYY-EFES------  228 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH----HHHCCC-CCCT------
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHcCCC-CCCc------
Confidence            234568999999999875 58999999999999999999999997543221    1111    111110 0000      


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGV  513 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~  513 (558)
                      .........+.+++.+||+.||.+|||+.++++  .+.+.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            001122347889999999999999999999996  45443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-38  Score=321.79  Aligned_cols=266  Identities=21%  Similarity=0.317  Sum_probs=186.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCc-------ceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH-------NLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~e~  314 (558)
                      .++||+|+||.||+++. .+++.||||++.........+..+++.+..++||||+++++++.....       .++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~  107 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY  107 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence            47899999999999998 468999999987655555667888999999999999999999865443       6899999


Q ss_pred             CCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHhhhhcc--ccCCCcEEecCCCCCCEeecC-CCCeEEcccCCccccC
Q 043292          315 MPNGSLDRWLFQ-RSDEFMLDWQQRKKIILDIAKGLTYLH--EDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLID  390 (558)
Q Consensus       315 ~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~~  390 (558)
                      +++ +|...+.. ......+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||+++...
T Consensus       108 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~  183 (360)
T 3e3p_A          108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS  183 (360)
T ss_dssp             CSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred             ccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence            976 55444432 223345899999999999999999999  7   99999999999999997 8999999999998765


Q ss_pred             CCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhh-h
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKA-E  460 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~-~  460 (558)
                      ...  ......||+.|+|||++.+  .++.++||||||+++|||++|+.||...........+.....       ... .
T Consensus       184 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3e3p_A          184 PSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP  261 (360)
T ss_dssp             TTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred             CCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence            433  2345678999999999854  389999999999999999999999986554332211111100       000 0


Q ss_pred             cccchhhccccCCC-----CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhccc
Q 043292          461 EDKLSDLVDKHSND-----MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVT  514 (558)
Q Consensus       461 ~~~~~~~~d~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~  514 (558)
                      ........+.....     ..........+.+++.+||+.||.+|||+.++++.  +.++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            00000000000000     00111235678999999999999999999999964  44443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-38  Score=318.72  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=200.4

Q ss_pred             hhhhcCccCceEEEEEEe--CCCCEEEEEEecccccchHHHHHHHHHHhccCCcc------eeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ--TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN------LVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||++..  .+++.||||+++......+.+.+|+.++..++|+|      ++++++++...+..++|||
T Consensus        18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   97 (339)
T 1z57_A           18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE   97 (339)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence            347899999999999986  36889999999876666678899999999997765      9999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-------------------
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-------------------  374 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-------------------  374 (558)
                      |+ +++|.+++..... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.                   
T Consensus        98 ~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           98 LL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             CC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            99 8999999976543 248999999999999999999999   89999999999999987                   


Q ss_pred             CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          375 NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                      ++.+||+|||++......    .....||+.|+|||.+.+ .++.++||||||+++|||++|..||......+....+..
T Consensus       173 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  248 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER  248 (339)
T ss_dssp             CCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred             CCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            678999999999864432    234678999999999875 589999999999999999999999986554332111111


Q ss_pred             HHH-------Hhhhcccc------------------hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          454 IFK-------KKAEEDKL------------------SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       454 ~~~-------~~~~~~~~------------------~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...       ........                  ....................+.+++.+||+.||.+|||+.++++
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            100       00000000                  00000000111123355678999999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-38  Score=319.15  Aligned_cols=244  Identities=25%  Similarity=0.378  Sum_probs=190.6

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  311 (558)
                      +.+.||+|+||.||++... +++.||||.+....         .....+.+|+.++.+++||||+++++++..+. .++|
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv   92 (322)
T 2ycf_A           14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV   92 (322)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred             EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence            3578999999999999884 68899999986432         12245889999999999999999999987654 8999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccCCccc
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKL  388 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfgla~~  388 (558)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||++..
T Consensus        93 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           93 LELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            99999999999987543   48999999999999999999999   99999999999999987665   99999999987


Q ss_pred             cCCCCCceeecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          389 IDQDQSQVVTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       389 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      ....  .......||+.|+|||++.    ..++.++||||||+++|||++|..||.........   .....    .+..
T Consensus       167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~----~~~~  237 (322)
T 2ycf_A          167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQIT----SGKY  237 (322)
T ss_dssp             CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH---HHHHH----HTCC
T ss_pred             cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH---HHHHH----hCcc
Confidence            6432  1233456899999999873    35899999999999999999999999765443211   11111    1110


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      . .......      .....+.+++.+||+.||.+|||+.++++
T Consensus       238 ~-~~~~~~~------~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 N-FIPEVWA------EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             C-CCHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c-cCchhhh------hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0 0000000      11347889999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.6e-39  Score=320.08  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=180.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||++.. .+++.||||++...  ....+++.+|+.++.+++||||+++++++...+..++||||+++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   99 (303)
T 2vwi_A           20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS   99 (303)
T ss_dssp             EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred             hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence            47899999999999987 46899999988643  3345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-----CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          320 LDRWLFQR-----SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       320 L~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |.+++...     .....+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  176 (303)
T 2vwi_A          100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD  176 (303)
T ss_dssp             HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred             hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence            99998741     123358999999999999999999999   8999999999999999999999999999976543221


Q ss_pred             ----ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh-h
Q 043292          395 ----QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD-L  467 (558)
Q Consensus       395 ----~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  467 (558)
                          .......||+.|+|||.+.+  .++.++||||||++++||++|+.||.........   .... ... ...... .
T Consensus       177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~-~~~-~~~~~~~~  251 (303)
T 2vwi_A          177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTL-QND-PPSLETGV  251 (303)
T ss_dssp             -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHH-TSS-CCCTTC--
T ss_pred             ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHh-ccC-CCcccccc
Confidence                11234578999999999863  5899999999999999999999999765543211   1100 000 000000 0


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+...     .......+.+++.+||+.||.+|||+.++++
T Consensus       252 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          252 QDKEM-----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             ---CC-----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccchh-----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000     0112346889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-38  Score=323.20  Aligned_cols=269  Identities=24%  Similarity=0.352  Sum_probs=192.1

Q ss_pred             HHHHHHHHHh--hhhcCccCceEEEEEEeCCCCEEEEEEeccccc------------chHHHHHHHHHHhccCCcceeee
Q 043292          233 EELKVMTDNF--RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE------------INKSFLAEVKTIGSIHHQNLVRL  298 (558)
Q Consensus       233 ~~l~~~t~~~--~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l  298 (558)
                      .++.....+|  .+.||+|+||.||++...+++.||||++.....            ..+.+.+|++++.+++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            3444444444  478999999999999998899999999863211            12678999999999999999999


Q ss_pred             eeeecc-----CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          299 IGFCAE-----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       299 ~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      ++++..     ....++||||++ |+|.+++....  ..+++..+..++.||+.||.|||+   .+|+|+||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA  168 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence            999843     335799999997 68888887543  349999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL  451 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  451 (558)
                      .++.+||+|||++.......  ......||+.|+|||.+.+  .++.++||||||++++||++|+.||......+....+
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998544322  2344678999999998864  5899999999999999999999999865533321111


Q ss_pred             HHHHHHh-------hhcccchhhccccCCCCCC-C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          452 LSIFKKK-------AEEDKLSDLVDKHSNDMQS-N-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       452 ~~~~~~~-------~~~~~~~~~~d~~~~~~~~-~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .......       .......+.+......... .     ......+.+++.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            1110000       0000011111111111000 0     0113468899999999999999999999863

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-38  Score=310.59  Aligned_cols=240  Identities=28%  Similarity=0.480  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||||.+...    ....+.+.+|+.++..++||||+++++++...+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG   95 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence            478999999999999985 7999999998643    23346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......  ..
T Consensus        96 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  167 (276)
T 2h6d_A           96 GELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL  167 (276)
T ss_dssp             CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred             CcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc--ce
Confidence            99999997654   38999999999999999999999   899999999999999999999999999998764432  23


Q ss_pred             ecccCCCCcCChhhhcCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~--~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....+++.|+|||.+.+.  .+.++||||||+++++|++|+.||.......    +..   . ...+..      ..   
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~---~-~~~~~~------~~---  230 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFK---K-IRGGVF------YI---  230 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-HHHCCC------CC---
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHH---H-hhcCcc------cC---
Confidence            345689999999998764  3689999999999999999999997543211    111   1 111100      00   


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        +......+.+++.+||+.||.+|||+.++++.
T Consensus       231 --~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          231 --PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              01122468899999999999999999999973

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-37  Score=318.57  Aligned_cols=259  Identities=22%  Similarity=0.367  Sum_probs=196.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  314 (558)
                      .++||+|+||.||++... +++.||||++....  ...+.+.+|++++.+++||||+++++++...     ...++||||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            478999999999999874 68899999997432  2346789999999999999999999998765     357899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++ ++|.+++....    +++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus       112 ~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          112 ME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             CS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             cC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            96 59999987543    8999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ce--eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh-------ccc
Q 043292          395 QV--VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE-------EDK  463 (558)
Q Consensus       395 ~~--~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~  463 (558)
                      ..  .....||+.|+|||++.+  .++.++||||||++++||++|+.||......+....+.........       ...
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence            21  244679999999998643  4899999999999999999999999876654432222211100000       000


Q ss_pred             chhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 LSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ...............     ......+.+++.+||+.||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000000     0113468899999999999999999999963

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-38  Score=327.47  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=193.1

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCc------ceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH------NLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~~~  316 (558)
                      .++||+|+||.||+++...+..||+|++......   ..+|+.+++.++||||+++++++.....      .++||||++
T Consensus        45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~  121 (394)
T 4e7w_A           45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP  121 (394)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred             eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence            4789999999999999977777999988643322   2369999999999999999999865443      679999998


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCCccccCCCCCc
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++.+............+++..+..++.||+.||.|||+   .+|+||||||+|||++ .++.+||+|||+++......  
T Consensus       122 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--  196 (394)
T 4e7w_A          122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--  196 (394)
T ss_dssp             EEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             ccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--
Confidence            75544443322223359999999999999999999999   9999999999999999 79999999999998764432  


Q ss_pred             eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhc---ccchhhccc
Q 043292          396 VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE---DKLSDLVDK  470 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~  470 (558)
                      ......+|+.|+|||++.+  .++.++||||||+++|||++|+.||.+....+....+.........+   .........
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  276 (394)
T 4e7w_A          197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH  276 (394)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred             CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence            2345678999999999864  48999999999999999999999998765433222221111000000   000000000


Q ss_pred             cCCCCC-C------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccc
Q 043292          471 HSNDMQ-S------NGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTE  515 (558)
Q Consensus       471 ~~~~~~-~------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~  515 (558)
                      ...... .      .......+.+++.+||+.||.+|||+.++++.  ++++..
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            000000 0      01123478999999999999999999999964  555443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.6e-39  Score=321.35  Aligned_cols=250  Identities=23%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||.||+|....  .+|+|.++..   ....+.+.+|+.++.+++|+||+++++++.+....++||||+++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~  115 (319)
T 2y4i_B           38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT  115 (319)
T ss_dssp             CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred             eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence            4789999999999998753  4999998643   2233567889999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC----Cc
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ----SQ  395 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~----~~  395 (558)
                      |.+++....  ..+++..++.++.||+.||.|||+   .+++|+||||+|||++ ++.+||+|||++.......    ..
T Consensus       116 L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~  189 (319)
T 2y4i_B          116 LYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED  189 (319)
T ss_dssp             HHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence            999997643  248999999999999999999999   8999999999999998 6799999999987653211    11


Q ss_pred             eeecccCCCCcCChhhhcC----------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          396 VVTTMRGTPGYLAPEWLSS----------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~----------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ......|++.|+|||.+.+          .++.++||||||+++|||++|+.||.......    .   ... ...+...
T Consensus       190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~---~~~-~~~~~~~  261 (319)
T 2y4i_B          190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----I---IWQ-MGTGMKP  261 (319)
T ss_dssp             SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----H---HHH-HHTTCCC
T ss_pred             ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHH-hccCCCC
Confidence            2234558899999998863          37889999999999999999999997544322    1   111 1111111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      .....         .....+.+++..||+.||.+|||+.+++++|+.+.+..
T Consensus       262 ~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          262 NLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11110         11235789999999999999999999999999987654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-38  Score=323.17  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=177.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC------CcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  312 (558)
                      .+.||+|+||.||+|.. .+++.||||++....   ...+.+.+|+.+++.++||||+++++++...      ...++|+
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            47899999999999987 568999999996432   2346788999999999999999999998654      4578999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      |++ +++|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~  185 (367)
T 2fst_X          114 HLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE  185 (367)
T ss_dssp             ECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             ccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence            999 78999888652    39999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH-------hhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK-------KAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~  463 (558)
                          .....||+.|+|||++.+  .++.++||||||++++||++|+.||.+....+....+......       ......
T Consensus       186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence                345678999999999865  5899999999999999999999999865543322111111100       000000


Q ss_pred             chhhccccCCCCCCCHH-----HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 LSDLVDKHSNDMQSNGE-----EVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ....+............     ....+.+|+.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            01111110000001111     12468899999999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-38  Score=312.03  Aligned_cols=243  Identities=26%  Similarity=0.419  Sum_probs=195.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----------cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----------EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  310 (558)
                      .+.||+|+||.||++... +++.||||.+....          ...+.+.+|+.++.++. ||||+++++++..+...++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            478999999999999984 68899999986432          22356889999999995 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+++++|.+++....   .+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus       102 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A          102 VFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            999999999999997643   38999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCcCChhhhc-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLS-------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      ...  ......|++.|+|||++.       ..++.++||||||++++||++|+.||.......    ....    ...+.
T Consensus       176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~~~~~  245 (298)
T 1phk_A          176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRM----IMSGN  245 (298)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHTC
T ss_pred             CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHHH----HhcCC
Confidence            432  234567899999999874       347899999999999999999999997543221    1111    11111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .. ...      .........+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 YQ-FGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC-CCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cc-cCc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00 000      000122357889999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.6e-38  Score=311.60  Aligned_cols=237  Identities=25%  Similarity=0.388  Sum_probs=190.6

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++... +++.||+|+++..   .....++.+|+..+..+ +||||+++++++.+++..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            478999999999999985 7999999998743   33456788999999999 999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-------------------CC
Q 043292          318 GSLDRWLFQRSD-EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-------------------FN  377 (558)
Q Consensus       318 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-------------------~~  377 (558)
                      ++|.+++..... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.+                   ..
T Consensus        96 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~  172 (289)
T 1x8b_A           96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM  172 (289)
T ss_dssp             CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CCC
T ss_pred             CcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence            999999976421 1348999999999999999999999   999999999999999844                   47


Q ss_pred             eEEcccCCccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  455 (558)
                      +||+|||++.......     ...||+.|+|||.+.+  .++.++||||||++++||++|..++....      ..    
T Consensus       173 ~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~----  237 (289)
T 1x8b_A          173 FKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------QW----  237 (289)
T ss_dssp             EEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------HH----
T ss_pred             EEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------HH----
Confidence            9999999998765432     2458999999999875  35679999999999999999988764221      00    


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .....+....+          .......+.+++.+||+.||++|||+.++++
T Consensus       238 -~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 -HEIRQGRLPRI----------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HHHHTTCCCCC----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHcCCCCCC----------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             11111111111          0112347889999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.6e-39  Score=328.95  Aligned_cols=246  Identities=12%  Similarity=0.058  Sum_probs=174.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc----cchHHHHHHHHHHhcc--CCcceeeee-------eeeccC---
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLAEVKTIGSI--HHQNLVRLI-------GFCAEK---  305 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~---  305 (558)
                      .++||+|+||.||+++.. +++.||||++....    ...+.+.+|+.++..+  +||||++++       +++...   
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence            478999999999999974 78999999998633    2345677785444444  699988755       333222   


Q ss_pred             --------------CcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHH------HHHHHHHHHhhhhccccCCCcEEecCC
Q 043292          306 --------------SHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR------KKIILDIAKGLTYLHEDCRQKILHLDI  365 (558)
Q Consensus       306 --------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~ivH~dl  365 (558)
                                    ...++||||++ |+|.+++.....  .+.+..+      +.++.||+.||+|||+   .+|+||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDi  220 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF  220 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcC
Confidence                          33799999998 899999986422  2455566      7888999999999999   99999999


Q ss_pred             CCCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043292          366 KPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRS  442 (558)
Q Consensus       366 k~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~  442 (558)
                      ||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+   .++.++||||||+++|||++|+.||...
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999986542    1224556799999999875   4899999999999999999999999866


Q ss_pred             CCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          443 QPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .......         ............... ..........+.+++.+||+.||++|||+.++++
T Consensus       297 ~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          297 TPGIKGS---------WKRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CTTCTTC---------CCBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             Ccccccc---------hhhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4432110         000000000000000 0001122457889999999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.8e-38  Score=320.58  Aligned_cols=256  Identities=23%  Similarity=0.308  Sum_probs=185.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .+.||+|+||.||++.. .+++.||||++...   ....+.+.+|+.+++.++||||+++++++....      ..++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            47899999999999987 46889999999743   223456889999999999999999999987665      679999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||++ ++|.+++..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       110 e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          110 ELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             ECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             EcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            9996 578888752     28899999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHH--------H-------H
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI--------F-------K  456 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~-------~  456 (558)
                      .  ......||+.|+|||++.+ .++.++||||||++++||++|+.||.+.+..+....+...        .       .
T Consensus       181 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          181 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             c--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            1  2345678999999999875 5899999999999999999999999765432211111000        0       0


Q ss_pred             Hhhhc------ccchhhccccCCCCC--CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          457 KKAEE------DKLSDLVDKHSNDMQ--SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       457 ~~~~~------~~~~~~~d~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .....      ..+...+........  ........+.+++.+||+.||.+|||++++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00000      000000100000000  011235678999999999999999999999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=328.70  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=179.5

Q ss_pred             hhcCccCceEEEEEEeC---CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeec--cCCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCA--EKSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||.||+++..   +++.||||++.... ....+.+|+.++.+++||||+++++++.  .+...++||||++ +
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~  104 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H  104 (405)
T ss_dssp             CCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-E
T ss_pred             cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-C
Confidence            57999999999999864   57889999997543 3456889999999999999999999994  4677899999996 5


Q ss_pred             CHHHHHhcCC------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee----cCCCCeEEcccCCccc
Q 043292          319 SLDRWLFQRS------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL----DGNFNAKVADFGLSKL  388 (558)
Q Consensus       319 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll----~~~~~~ki~Dfgla~~  388 (558)
                      +|.+++....      ....+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus       105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence            7887775321      12248999999999999999999999   999999999999999    7788999999999987


Q ss_pred             cCCCCC--ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch------hhhHHHHHHHh
Q 043292          389 IDQDQS--QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE------DMYLLSIFKKK  458 (558)
Q Consensus       389 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~------~~~~~~~~~~~  458 (558)
                      +.....  .......||+.|+|||++.+  .++.++|||||||++|||++|+.||........      ...+..+....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            654321  22345678999999999875  489999999999999999999999976543210      01111111110


Q ss_pred             hh--cccchhh------------c-cccCCCCC-------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          459 AE--EDKLSDL------------V-DKHSNDMQ-------SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       459 ~~--~~~~~~~------------~-d~~~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..  ...+..+            + ........       ........+.+|+.+||+.||.+|||+.++++.
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00  0000000            0 00000000       000012367899999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-38  Score=312.81  Aligned_cols=244  Identities=24%  Similarity=0.356  Sum_probs=180.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc---chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++.. .+++.||||+++....   ..+.+.++...++.++||||+++++++.+++..++||||++ |
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~   90 (290)
T 3fme_A           12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T   90 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred             HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence            47899999999999998 5789999999974322   22334555566888999999999999999999999999997 5


Q ss_pred             CHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          319 SLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       319 sL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|.+++... .....+++..++.++.|++.||.|||+   . +|+||||||+||+++.++.+||+|||++........  
T Consensus        91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  165 (290)
T 3fme_A           91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--  165 (290)
T ss_dssp             EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc--
Confidence            888887642 122359999999999999999999999   7 999999999999999999999999999987644322  


Q ss_pred             eecccCCCCcCChhhhc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLS-----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      .....||+.|+|||.+.     ..++.++||||||++++||++|+.||.........  +..    ...... ..     
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~~~~-~~-----  233 (290)
T 3fme_A          166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQ----VVEEPS-PQ-----  233 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHH----HHHSCC-CC-----
T ss_pred             ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHH----HhccCC-CC-----
Confidence            23456899999999962     34889999999999999999999999754332211  111    111110 00     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .    ........+.+++.+||+.||++|||+.++++
T Consensus       234 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 L----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             c----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0    01112346889999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-38  Score=348.53  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             hhhcCccCceEEEEEEeCC----CCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+|....    +..||+|.++...  ...+.|.+|+.++.+++||||+++++++. ++..++||||++
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~  473 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT  473 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence            4679999999999998742    4579999987432  33467999999999999999999999985 456899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.....  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       474 ~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  548 (656)
T 2j0j_A          474 LGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  548 (656)
T ss_dssp             TCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred             CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCccee
Confidence            9999999986532  48999999999999999999999   899999999999999999999999999998775544333


Q ss_pred             eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          397 VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .....+++.|+|||.+. ..++.++||||||+++|||++ |..||......+    .....    ..+...         
T Consensus       549 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~~~i----~~~~~~---------  611 (656)
T 2j0j_A          549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI----ENGERL---------  611 (656)
T ss_dssp             -----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHH----HHTCCC---------
T ss_pred             ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHH----HcCCCC---------
Confidence            34456778999999986 469999999999999999997 999997654322    11111    111100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                       .........+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       612 -~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          612 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             0111223578899999999999999999999999988754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.5e-38  Score=322.59  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-----------CcceeeeeeeeccCC---
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-----------HQNLVRLIGFCAEKS---  306 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~~---  306 (558)
                      +.+.||+|+||.||+++. .+++.||||++.......+.+.+|+.++.+++           |+||+++++++...+   
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  102 (373)
T 1q8y_A           23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG  102 (373)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred             EEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence            357899999999999997 57899999999866656677889999998886           899999999987654   


Q ss_pred             -cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeec------CCCCe
Q 043292          307 -HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLD------GNFNA  378 (558)
Q Consensus       307 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~------~~~~~  378 (558)
                       ..++||||+ +++|.+++...... .+++..+..++.||+.||.|||+   . +|+||||||+|||++      ..+.+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A          103 VHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             EEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcceE
Confidence             678999999 89999999864432 38999999999999999999999   7 999999999999994      44579


Q ss_pred             EEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch---hhhHHHH
Q 043292          379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEE---DMYLLSI  454 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~---~~~~~~~  454 (558)
                      ||+|||++......    .....||+.|+|||++.+ .++.++||||||+++|||++|+.||........   ...+..+
T Consensus       178 kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          178 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             EEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            99999999876432    334578999999999875 589999999999999999999999986543221   1111111


Q ss_pred             HHHhhh-------cccc-hhhccc------------------cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          455 FKKKAE-------EDKL-SDLVDK------------------HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       455 ~~~~~~-------~~~~-~~~~d~------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ......       .... ...+..                  ..............+.+++.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            110000       0000 000000                  00111234567788999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-37  Score=324.49  Aligned_cols=190  Identities=26%  Similarity=0.448  Sum_probs=159.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  313 (558)
                      .+.||+|+||.||+++. .+++.||||++....   ...+.+.+|++++..++|+||+++++++...     ...++|||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  110 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE  110 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence            47899999999999988 468899999997532   2346789999999999999999999999776     56899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |++ ++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       111 ~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          111 IAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             CCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             cCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            986 69999997543   39999999999999999999999   899999999999999999999999999998765432


Q ss_pred             C---------------------ceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCC
Q 043292          394 S---------------------QVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVF  439 (558)
Q Consensus       394 ~---------------------~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~  439 (558)
                      .                     ...+...||+.|+|||++.  ..++.++|||||||+++||++|..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            1                     1235678999999999863  35999999999999999999855444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=311.22  Aligned_cols=243  Identities=26%  Similarity=0.358  Sum_probs=192.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-----ccchHHHHHHHHHHhccCCcceeeeeeee--ccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-----GEINKSFLAEVKTIGSIHHQNLVRLIGFC--AEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~lv~e~  314 (558)
                      .+.||+|+||.||++.. .+++.||+|++...     ....+.+.+|+.++.+++||||+++++++  .+....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY   89 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence            47899999999999998 46889999999743     23456799999999999999999999998  445678999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC-
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-  393 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-  393 (558)
                      ++++ |.+++..... ..+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           90 CVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA  164 (305)
T ss_dssp             CSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred             ccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence            9876 7777765432 349999999999999999999999   899999999999999999999999999998764322 


Q ss_pred             CceeecccCCCCcCChhhhcCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLSSI---ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~~---~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ........|++.|+|||.+.+.   .+.++||||||++++||++|+.||......+    ...    ....+..      
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----~i~~~~~------  230 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFE----NIGKGSY------  230 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH----HHHHCCC------
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHH----HHhcCCC------
Confidence            2223456789999999998752   4779999999999999999999997543211    111    1111110      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ..     .......+.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 AI-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CC-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CC-----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00     11123467899999999999999999999964

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.6e-38  Score=310.72  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=197.1

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      +.+.||+|+||.||+++.. +++.||+|++...   ....+.+.+|+.++.+++||||+++++++.+....++|+||+++
T Consensus        26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  105 (287)
T 2wei_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG  105 (287)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence            3578999999999999985 7899999998643   23456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC---CCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN---FNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~---~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++|.+++....   .+++..++.++.||+.||.|||+   .+++|+||||+||+++.+   +.+||+|||++........
T Consensus       106 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          106 GELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            99999887543   38999999999999999999999   899999999999999764   4699999999986644322


Q ss_pred             ceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                        .....+++.|+|||.+.+.++.++||||||+++++|++|..||......+    +..    ....+....... ..  
T Consensus       180 --~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~~~~-~~--  246 (287)
T 2wei_A          180 --MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----RVETGKYAFDLP-QW--  246 (287)
T ss_dssp             --CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCCCCCCSG-GG--
T ss_pred             --cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHcCCCCCCch-hh--
Confidence              23345788999999998889999999999999999999999997644221    111    111111100000 00  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                          ......+.+++.+||+.||.+|||+.++++
T Consensus       247 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          247 ----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                012346889999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.5e-37  Score=317.76  Aligned_cols=259  Identities=20%  Similarity=0.299  Sum_probs=197.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccC-Cc-----ceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQ-----NLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|... +++.||||+++.......++..|++++..++ |+     +|+++++++...+..++||||+
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  138 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML  138 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence            478999999999999874 6889999999866555667888888888875 44     4999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCCCeEEcccCCccccCCCC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~  393 (558)
                      + ++|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||+++..... 
T Consensus       139 ~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-  214 (382)
T 2vx3_A          139 S-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-  214 (382)
T ss_dssp             C-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred             C-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-
Confidence            5 599999986542 2389999999999999999999941 27899999999999994  5778999999999876432 


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH----hh-hcccchhh
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK----KA-EEDKLSDL  467 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~  467 (558)
                         .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+......    .. ........
T Consensus       215 ---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  291 (382)
T 2vx3_A          215 ---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF  291 (382)
T ss_dssp             ---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHH
T ss_pred             ---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHH
Confidence               335678999999999876 5999999999999999999999999865543321111111000    00 00000001


Q ss_pred             cccc----------------------------------------CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 043292          468 VDKH----------------------------------------SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       468 ~d~~----------------------------------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  507 (558)
                      ++..                                        .........+...+.+|+.+||+.||++|||+.+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L  371 (382)
T 2vx3_A          292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYAL  371 (382)
T ss_dssp             EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHh
Confidence            1000                                        000111234556899999999999999999999998


Q ss_pred             H
Q 043292          508 R  508 (558)
Q Consensus       508 ~  508 (558)
                      +
T Consensus       372 ~  372 (382)
T 2vx3_A          372 Q  372 (382)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-38  Score=323.61  Aligned_cols=257  Identities=20%  Similarity=0.284  Sum_probs=189.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccC----------------
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK----------------  305 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------------  305 (558)
                      .++||+|+||.||+++. .+++.||||++.....   ...+|+.+++.++||||+++++++...                
T Consensus        12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~   88 (383)
T 3eb0_A           12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK   88 (383)
T ss_dssp             EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence            47899999999999987 5799999999865432   234799999999999999999998432                


Q ss_pred             ----------------------CcceEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEe
Q 043292          306 ----------------------SHNLLVYEYMPNGSLDRWLFQR-SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILH  362 (558)
Q Consensus       306 ----------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH  362 (558)
                                            ...++||||++ ++|.+.+... .....+++..+..++.||+.||.|||+   .+|+|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~H  164 (383)
T 3eb0_A           89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICH  164 (383)
T ss_dssp             ---------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEEC
T ss_pred             ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CcCcc
Confidence                                  33789999997 5888777641 122359999999999999999999999   99999


Q ss_pred             cCCCCCCEeec-CCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCC
Q 043292          363 LDIKPQNILLD-GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVF  439 (558)
Q Consensus       363 ~dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~  439 (558)
                      |||||+|||++ .++.+||+|||+++......  ......+|+.|+|||.+.+  .++.++||||+|++++||++|+.||
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            99999999997 68899999999998764433  2345678999999998865  4899999999999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHhhh------cccchhhccccCCCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          440 DRSQPEEEDMYLLSIFKKKAE------EDKLSDLVDKHSNDMQ----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .+....+....+.........      .....+..-+......    ........+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            865543322222111100000      0000000000000000    01112346889999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.3e-38  Score=329.29  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=190.0

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccC------CcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~  315 (558)
                      .++||+|+||.||+++.. +++.||||++.....   .+.+|+++++.++|+||+++++++...      ...++||||+
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  135 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  135 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence            478999999999999984 689999999865332   234799999999999999999988542      2356999999


Q ss_pred             CCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-CCeEEcccCCccccCCCC
Q 043292          316 PNGSLDRWLFQ-RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       316 ~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~  393 (558)
                      ++ +|.+.+.. ......+++..+..++.||+.||.|||+   .+|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus       136 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~  211 (420)
T 1j1b_A          136 PE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  211 (420)
T ss_dssp             CE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             cc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence            75 66665543 1122359999999999999999999999   999999999999999965 568999999998764432


Q ss_pred             CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHH----hhh--cccch
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK----KAE--EDKLS  465 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~--~~~~~  465 (558)
                        ......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+....+......    .+.  .....
T Consensus       212 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          212 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             --CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence              2345678999999999864  5899999999999999999999999865533322111111000    000  00000


Q ss_pred             hhccccCCCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcc
Q 043292          466 DLVDKHSNDMQ----SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGV  513 (558)
Q Consensus       466 ~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~  513 (558)
                      +..-+......    ........+.+|+.+||+.||.+|||+.++++  .++++
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            00000000000    00112357889999999999999999999985  34444

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-37  Score=319.03  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=190.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcc------eEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHN------LLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv~  312 (558)
                      .+.||+|+||.||++.. .+++.||||++....   ...+.+.+|+.++..++||||+++++++...+..      ++||
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            46899999999999987 468999999997532   2346788999999999999999999999887765      9999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+. ++|.+++..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       127 e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          127 PFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             ECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             cccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence            9996 688887732     28999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  463 (558)
                          .....||+.|+|||.+.+  .++.++||||||++++||++|+.||......+....+.....       .......
T Consensus       198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  273 (371)
T 4exu_A          198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  273 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred             ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence                345678999999999875  589999999999999999999999986553322111111000       0000000


Q ss_pred             chhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 LSDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ....+...........     .....+.+++.+||+.||.+|||+.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000000000000000     123578899999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-37  Score=314.49  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=192.7

Q ss_pred             hhhcCccCceEEEEEEe--CCCCEEEEEEecccc---cchHHHHHHHHHHhcc---CCcceeeeeeeec-----cCCcce
Q 043292          243 RKMLGKGGFGSVFEGTQ--TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSI---HHQNLVRLIGFCA-----EKSHNL  309 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~~~~  309 (558)
                      .+.||+|+||.||++..  .+++.||+|+++...   .....+.+|+.++..+   +||||+++++++.     .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            47899999999999997  457889999986322   2233566777777666   8999999999987     556789


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          310 LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      +||||++ |+|.+++..... ..+++..++.++.||+.||.|||+   .+|+|+||||+|||++.++.+||+|||++...
T Consensus        96 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             EEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            9999997 699999986543 248999999999999999999999   89999999999999999999999999999866


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchh--
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD--  466 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  466 (558)
                      ....  ......|+..|+|||.+.+ .++.++||||||+++|||++|+.||......+....+...... ........  
T Consensus       171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~  247 (326)
T 1blx_A          171 SFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPRDV  247 (326)
T ss_dssp             CGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCGGGSCTTC
T ss_pred             cCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC-CCcccCcccc
Confidence            4322  2345678999999999875 5899999999999999999999999865433211111111000 00000000  


Q ss_pred             -----hccccC-C-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          467 -----LVDKHS-N-DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       467 -----~~d~~~-~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           .+.... . ...........+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 000000 0 00001122356789999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-37  Score=307.78  Aligned_cols=244  Identities=29%  Similarity=0.459  Sum_probs=186.9

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc-------------CCcc
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-------------KSHN  308 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------~~~~  308 (558)
                      .+.||+|+||.||+++. .+++.||||.+.......+.+.+|+.++.+++||||+++++++.+             ....
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL   90 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence            47899999999999997 478999999997665566789999999999999999999998754             3567


Q ss_pred             eEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          309 LLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  165 (303)
T 1zy4_A           91 FIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN  165 (303)
T ss_dssp             EEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred             EEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence            899999999999999986432  47899999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCC-------------CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          389 IDQDQ-------------SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       389 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                      .....             ........|++.|+|||.+.+  .++.++||||||+++|||++   ||...   ........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~~~~  239 (303)
T 1zy4_A          166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVNILK  239 (303)
T ss_dssp             TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHHHHH
T ss_pred             cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHHHHH
Confidence            64321             112234568999999999874  58999999999999999998   44311   11111111


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         . ......  .+..     .........+.+++.+||+.||.+|||+.++++
T Consensus       240 ---~-~~~~~~--~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 ---K-LRSVSI--EFPP-----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---H-HHSTTC--CCCT-----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---h-cccccc--ccCc-----cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               1 111000  0000     111223456889999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-37  Score=316.52  Aligned_cols=263  Identities=22%  Similarity=0.385  Sum_probs=194.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~  314 (558)
                      .+.||+|+||.||+++.. +++.||||++....  .....+.+|+.++.+++||||+++++++...     ...++||||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            478999999999999984 68899999997432  2345688999999999999999999987764     567999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +. ++|.+++...    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        96 ~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           96 MQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             CS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             cC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            96 6899998763    38999999999999999999999   8999999999999999999999999999987653221


Q ss_pred             c---------eeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc-
Q 043292          395 Q---------VVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-  462 (558)
Q Consensus       395 ~---------~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  462 (558)
                      .         ......||+.|+|||++.  ..++.++||||||++++||++|+.||......+....+........... 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence            1         122356899999999875  4589999999999999999999999986553221111111100000000 


Q ss_pred             -------cchhhccccCCCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcc
Q 043292          463 -------KLSDLVDKHSNDMQSN-----GEEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGV  513 (558)
Q Consensus       463 -------~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~  513 (558)
                             ...+.+..........     ......+.+++.+||+.||++|||+.++++  .+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                   0000000000000000     012346789999999999999999999997  34443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.9e-38  Score=318.35  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccc------------------hHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEI------------------NKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      .+.||+|+||.||++.. +++.||||.+......                  .+.+.+|+.++.+++||||+++++++.+
T Consensus        36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  114 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN  114 (348)
T ss_dssp             EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred             EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence            47899999999999998 8999999998633211                  1789999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCCHHHH------HhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          305 KSHNLLVYEYMPNGSLDRW------LFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      .+..++||||+++++|.++      +.... ...+++..++.++.||+.||.|||+  ..+++|+||||+||+++.++.+
T Consensus       115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~  191 (348)
T 2pml_X          115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRV  191 (348)
T ss_dssp             SSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCE
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcE
Confidence            9999999999999999998      54321 3459999999999999999999996  3799999999999999999999


Q ss_pred             EEcccCCccccCCCCCceeecccCCCCcCChhhhcCC--CCC-ccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI--ITE-KVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||++......   ......|+..|+|||.+.+.  ++. ++||||||++++||++|+.||........   +..  
T Consensus       192 kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~--  263 (348)
T 2pml_X          192 KLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---LFN--  263 (348)
T ss_dssp             EECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---HHH--
T ss_pred             EEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHH--
Confidence            99999999876433   34556789999999998753  555 99999999999999999999986554221   111  


Q ss_pred             HHhhhcccchhh------ccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          456 KKKAEEDKLSDL------VDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       456 ~~~~~~~~~~~~------~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        ....+.....      .......  ..........+.+++.+||+.||.+|||+.++++
T Consensus       264 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          264 --NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1111111000      0000000  0000123357889999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.3e-37  Score=314.33  Aligned_cols=258  Identities=22%  Similarity=0.365  Sum_probs=196.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CC-CEEEEEEecccccchHHHHHHHHHHhccCCcc------eeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DG-TKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN------LVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||++... ++ +.||+|+++......+.+..|+.++.+++|++      ++.+++++...+..++|||
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e  102 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE  102 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence            3478999999999999874 34 68999999876666677889999999998776      8999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee-------------------cC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL-------------------DG  374 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll-------------------~~  374 (558)
                      |+ +++|.+++..... ..+++..+..++.||+.||.|||+   .+|+||||||+|||+                   +.
T Consensus       103 ~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          103 LL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             cc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            99 6677777765432 248999999999999999999999   899999999999999                   66


Q ss_pred             CCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHH
Q 043292          375 NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       375 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  453 (558)
                      ++.+||+|||+++.....    .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+..
T Consensus       178 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             CCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            889999999999864332    234678999999999875 589999999999999999999999986543321111111


Q ss_pred             HHH-------Hhhhcccc------------------hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          454 IFK-------KKAEEDKL------------------SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       454 ~~~-------~~~~~~~~------------------~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...       ........                  .+..............+...+.+++.+||+.||++|||+.++++
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            100       00000000                  00000000001122344568899999999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=309.86  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=185.9

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeec--------------cCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCA--------------EKS  306 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------------~~~  306 (558)
                      .+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.              +..
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            368999999999999985 58999999987443 34567899999999999999999999874              345


Q ss_pred             cceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCC
Q 043292          307 HNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGL  385 (558)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgl  385 (558)
                      ..++||||++ |+|.+++...    .+++..+..++.|++.||.|||+   .+|+|+||||+|||++ +++.+||+|||+
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence            6789999997 6999998643    38999999999999999999999   9999999999999997 567999999999


Q ss_pred             ccccCCCCC--ceeecccCCCCcCChhhhc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH------
Q 043292          386 SKLIDQDQS--QVVTTMRGTPGYLAPEWLS--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF------  455 (558)
Q Consensus       386 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~--~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~------  455 (558)
                      ++.......  .......++..|+|||.+.  ..++.++||||||++++||++|+.||......+....+....      
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            987643221  1223456789999999875  458999999999999999999999998655332111111000      


Q ss_pred             -HHhhhcccchhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          456 -KKKAEEDKLSDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       456 -~~~~~~~~~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       +... ...+...+...........     .....+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          248 DRQEL-LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHH-HTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhh-hhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence             0000 0000000011110000010     12357889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-37  Score=325.33  Aligned_cols=245  Identities=28%  Similarity=0.383  Sum_probs=183.7

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      ++||+|+||+||.+...+|+.||||++...  ..+.+.+|+.++.++ +||||+++++++.++...++||||+. |+|.+
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~   97 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD   97 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence            679999999998776678999999998643  235678999999876 89999999999999999999999995 69999


Q ss_pred             HHhcCCCCC----CCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC-------------CCeEEcccCC
Q 043292          323 WLFQRSDEF----MLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-------------FNAKVADFGL  385 (558)
Q Consensus       323 ~l~~~~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~-------------~~~ki~Dfgl  385 (558)
                      ++.......    ..++..++.++.||+.||.|||+   .+|+||||||+|||++.+             +.+||+|||+
T Consensus        98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence            997643211    12334567899999999999999   999999999999999754             4899999999


Q ss_pred             ccccCCCCCc---eeecccCCCCcCChhhhcC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHH
Q 043292          386 SKLIDQDQSQ---VVTTMRGTPGYLAPEWLSS--------IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLS  453 (558)
Q Consensus       386 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  453 (558)
                      ++........   ......||+.|+|||++.+        .++.++|||||||++|||++ |..||......+     ..
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~  249 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----SN  249 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----HH
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----HH
Confidence            9877543322   1234679999999999853        48899999999999999999 999996543322     11


Q ss_pred             HHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       454 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +....         .................+.+++.+||+.||.+|||+.+|++
T Consensus       250 i~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          250 IIRGI---------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHTC---------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhcCC---------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11110         00000011123455678999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-37  Score=311.09  Aligned_cols=242  Identities=22%  Similarity=0.362  Sum_probs=187.9

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccC--CcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIH--HQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||++...+++.||||++...   ....+.+.+|+.++.+++  |+||+++++++..++..++||| +.+
T Consensus        33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~  111 (313)
T 3cek_A           33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  111 (313)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence            4689999999999999988999999998643   233467899999999997  5999999999999999999999 568


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc-e
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ-V  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~  396 (558)
                      ++|.+++....   .+++..++.++.|++.||.|||+   .+|+|+||||+|||+++ +.+||+|||++......... .
T Consensus       112 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~  184 (313)
T 3cek_A          112 IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV  184 (313)
T ss_dssp             EEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence            99999998654   48999999999999999999999   89999999999999975 79999999999876543322 1


Q ss_pred             eecccCCCCcCChhhhcC------------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc
Q 043292          397 VTTMRGTPGYLAPEWLSS------------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL  464 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~------------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (558)
                      .....|++.|+|||.+.+            .++.++||||||++++||++|+.||........  .    ..........
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~----~~~~~~~~~~  258 (313)
T 3cek_A          185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K----LHAIIDPNHE  258 (313)
T ss_dssp             -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H----HHHHHCTTSC
T ss_pred             ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--H----HHHHHhcccc
Confidence            234568999999999864            578899999999999999999999975433211  0    1111110000


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           ....     ......+.+++.+||+.||.+|||+.++++
T Consensus       259 -----~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          259 -----IEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -----CCCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----cCCc-----ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                 0000     011346889999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.2e-37  Score=312.35  Aligned_cols=244  Identities=24%  Similarity=0.355  Sum_probs=166.4

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc----CCcceEEEEeCCCC
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE----KSHNLLVYEYMPNG  318 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g  318 (558)
                      ++||+|+||.||++... +++.||||++.......   ......+..++||||+++++++..    +...++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999985 68999999997543322   222334566799999999999876    44578999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++.....   
T Consensus       112 ~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---  184 (336)
T 3fhr_A          112 ELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---  184 (336)
T ss_dssp             EHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---
Confidence            99999986543 359999999999999999999999   89999999999999986   455999999999865432   


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||.............    ........ ....     
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~-~~~~-----  254 (336)
T 3fhr_A          185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIRLGQY-GFPN-----  254 (336)
T ss_dssp             -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCCT-----
T ss_pred             ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhhcccc-ccCc-----
Confidence            2334568999999999865 48899999999999999999999997544322110000    00000000 0000     


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .........+.+++.+||+.||.+|||+.++++
T Consensus       255 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          255 -PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             000122347889999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=312.37  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=189.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCc------ceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH------NLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~  312 (558)
                      .+.||+|+||.||+++. .+++.||||++....   ...+.+.+|+.++..++||||+++++++.....      .++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            46899999999999998 468999999997532   234578899999999999999999999987664      39999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+. ++|.+++..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          109 PFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             ECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             cccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence            9997 688777642     38999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~  463 (558)
                          .....+|+.|+|||.+.+  .++.++||||||++++||++|+.||......+....+....       ........
T Consensus       180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence                334578999999999865  58999999999999999999999998655322111111100       00000000


Q ss_pred             chhhccccC----CC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          464 LSDLVDKHS----ND-MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       464 ~~~~~d~~~----~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....+....    .. ..........+.+++.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000    00 0011123457889999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.1e-37  Score=311.31  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=172.8

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc--cchHHHHHHHH-HHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVK-TIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... +++.||||++....  ....++..|+. +++.++||||+++++++...+..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            368999999999999984 68999999997532  23345566665 77888999999999999999999999999975 


Q ss_pred             CHHHHHhc--CCCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQ--RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++..  ......+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++......  
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  180 (327)
T 3aln_A          106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--  180 (327)
T ss_dssp             EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred             ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc--
Confidence            88887763  1112358999999999999999999999   7 99999999999999999999999999998764332  


Q ss_pred             eeecccCCCCcCChhhhc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          396 VVTTMRGTPGYLAPEWLS-----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~-----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ......||+.|+|||.+.     ..++.++||||||+++|||++|+.||.........               +...+..
T Consensus       181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~~  245 (327)
T 3aln_A          181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------------LTQVVKG  245 (327)
T ss_dssp             -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------CCCCCS
T ss_pred             ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------------HHHHhcC
Confidence            223346899999999983     34899999999999999999999999754321100               0111111


Q ss_pred             cCCCCC--CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQ--SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ......  ........+.+++.+||+.||.+|||+.+|++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            100000  00122347889999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=307.66  Aligned_cols=243  Identities=23%  Similarity=0.359  Sum_probs=173.7

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc--ch-HHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE--IN-KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||++... +++.||||++.....  .. +.+.++..++..++||||+++++++.+++..++||||+ ++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~  108 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT  108 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence            368999999999999984 789999999975432  22 33445556788889999999999999999999999999 55


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCC-cEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQ-KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      .+..+.....  ..+++..+..++.|++.||.|||+   . +++|+||||+||+++.++.+||+|||++.......  ..
T Consensus       109 ~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~  181 (318)
T 2dyl_A          109 CAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AK  181 (318)
T ss_dssp             EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             cHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cc
Confidence            6665554322  248999999999999999999998   5 99999999999999999999999999997654332  23


Q ss_pred             ecccCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcccc
Q 043292          398 TTMRGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH  471 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  471 (558)
                      ....+++.|+|||++.      ..++.++||||||+++|||++|+.||........   ..   ...... ...     .
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~~~-~~~-----~  249 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VL---TKVLQE-EPP-----L  249 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HH---HHHHHS-CCC-----C
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---HH---HHHhcc-CCC-----C
Confidence            3456899999999984      3488999999999999999999999975433211   11   111111 000     0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       472 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..   ........+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LP---GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC---ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00   00012346889999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.7e-37  Score=310.76  Aligned_cols=232  Identities=24%  Similarity=0.472  Sum_probs=190.2

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccccc-------chHHHHHHHHHHhccC--CcceeeeeeeeccCCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE-------INKSFLAEVKTIGSIH--HQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+.||+|+||.||+|+. .+++.||||.+.....       ....+..|+.++.+++  |+||+++++++...+..++|+
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~  127 (320)
T 3a99_A           48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL  127 (320)
T ss_dssp             EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence            47899999999999987 5688999999864321       2245778999999996  599999999999999999999


Q ss_pred             EeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCCccccC
Q 043292          313 EYMPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGLSKLID  390 (558)
Q Consensus       313 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgla~~~~  390 (558)
                      |++.+ ++|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++ +++.+||+|||+++...
T Consensus       128 e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          128 ERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             ECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            99976 89999997643   38999999999999999999999   9999999999999999 78899999999998765


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ...   .....||+.|+|||++.+ . .+.++||||||+++|||++|+.||....         ....     ...  .+
T Consensus       202 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~-----~~~--~~  262 (320)
T 3a99_A          202 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR-----GQV--FF  262 (320)
T ss_dssp             SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH-----CCC--CC
T ss_pred             ccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc-----ccc--cc
Confidence            332   334668999999998864 3 4788999999999999999999996321         0000     000  00


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..         .....+.+++.+||+.||++|||+.+|++
T Consensus       263 ~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          263 RQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             SS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00         12246889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=318.33  Aligned_cols=242  Identities=26%  Similarity=0.347  Sum_probs=182.5

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .++||+|+||+||.....+++.||||++.....  ..+.+|+.++..+ +||||+++++++.+....++||||+. |+|.
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~  105 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ  105 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence            368999999997655556799999999964322  2356899999999 79999999999999999999999995 6999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-----CCCeEEcccCCccccCCCCC--
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-----NFNAKVADFGLSKLIDQDQS--  394 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~ki~Dfgla~~~~~~~~--  394 (558)
                      +++......  +.+..+..++.||+.||.|||+   .+|+||||||+|||++.     ...+||+|||+++.......  
T Consensus       106 ~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          106 EYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             HHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             HHHHhcCCC--ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence            999765432  4455678999999999999999   99999999999999953     33688999999987653321  


Q ss_pred             ceeecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          395 QVVTTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      .......||+.|+|||++.    ..++.++|||||||+++||++ |..||........     .   .......      
T Consensus       181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-----~---~~~~~~~------  246 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-----N---ILLGACS------  246 (432)
T ss_dssp             -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-----H---HHTTCCC------
T ss_pred             eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-----H---HHhccCC------
Confidence            1234567999999999986    347889999999999999999 8999864332210     0   0000000      


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .............+.+++.+||+.||.+|||+.+|++
T Consensus       247 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 --LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence              0111112234556789999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=309.63  Aligned_cols=234  Identities=26%  Similarity=0.467  Sum_probs=186.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccccc-------chHHHHHHHHHHhcc----CCcceeeeeeeeccCCcce
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE-------INKSFLAEVKTIGSI----HHQNLVRLIGFCAEKSHNL  309 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~  309 (558)
                      +.+.||+|+||.||+++. .+++.||||++.....       ....+..|+.++.++    +|+||+++++++...+..+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~  114 (312)
T 2iwi_A           35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM  114 (312)
T ss_dssp             EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred             EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence            357899999999999987 5688999999964321       223456788888888    8999999999999999999


Q ss_pred             EEEEe-CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec-CCCCeEEcccCCcc
Q 043292          310 LVYEY-MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD-GNFNAKVADFGLSK  387 (558)
Q Consensus       310 lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~-~~~~~ki~Dfgla~  387 (558)
                      +|+|+ +.+++|.+++....   .+++..++.++.||+.||.|||+   .+|+|+||||+||+++ .++.+||+|||++.
T Consensus       115 ~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          115 LVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             EEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99999 78999999998654   38999999999999999999999   8999999999999999 88999999999998


Q ss_pred             ccCCCCCceeecccCCCCcCChhhhcC-CC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch
Q 043292          388 LIDQDQSQVVTTMRGTPGYLAPEWLSS-II-TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS  465 (558)
Q Consensus       388 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (558)
                      ......   .....|+..|+|||++.+ .+ +.++||||||+++|||++|+.||....         ....     ..  
T Consensus       189 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~-----~~--  249 (312)
T 2iwi_A          189 LLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILE-----AE--  249 (312)
T ss_dssp             ECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH-----TC--
T ss_pred             hcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHhh-----hc--
Confidence            765432   345668999999998864 33 458999999999999999999996321         0000     00  


Q ss_pred             hhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       466 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                            .   .........+.+++.+||+.||++|||+.++++.
T Consensus       250 ------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          250 ------L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0   0011123468899999999999999999999973

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-36  Score=326.46  Aligned_cols=272  Identities=25%  Similarity=0.359  Sum_probs=201.3

Q ss_pred             HhhhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeecc------CCcceEE
Q 043292          241 NFRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE------KSHNLLV  311 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv  311 (558)
                      .+.++||+|+||.||++.. .+++.||||+++..  ....+.+.+|++++.+++||||+++++++..      ++..++|
T Consensus        17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV   96 (676)
T 3qa8_A           17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA   96 (676)
T ss_dssp             CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence            3458899999999999988 46899999998743  3335678999999999999999999998765      6677999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC---eEEcccCCccc
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKL  388 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~---~ki~Dfgla~~  388 (558)
                      |||+++|+|.+++........+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++..
T Consensus        97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            9999999999999876555569999999999999999999999   99999999999999997765   99999999987


Q ss_pred             cCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhh-HHH-HHHHhhhcccch
Q 043292          389 IDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY-LLS-IFKKKAEEDKLS  465 (558)
Q Consensus       389 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~  465 (558)
                      .....  ......||+.|+|||.+.+ .++.++||||||+++|||++|..||........... ... ............
T Consensus       174 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          174 LDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             TTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            65432  2345679999999999875 699999999999999999999999975421110000 000 000000000000


Q ss_pred             hh--cccc-CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH-----HHHHHhcccccc
Q 043292          466 DL--VDKH-SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSM-----VVRVLEGVTEFE  517 (558)
Q Consensus       466 ~~--~d~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~-----vl~~L~~~~~~~  517 (558)
                      ..  +... .............+.+++..||+.||++|||+.+     ..+.++.+....
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            00  0000 0111123345678999999999999999999977     445555554433

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-35  Score=291.76  Aligned_cols=226  Identities=14%  Similarity=0.115  Sum_probs=178.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEeccccc----chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGE----INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++.. +++.||||++.....    ..+.+.+|+.++.+++||||+++++++.+++..++||||+++
T Consensus        36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  115 (286)
T 3uqc_A           36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG  115 (286)
T ss_dssp             EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred             EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence            478999999999999985 589999999975432    236799999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      ++|.+++...     ....+..+++.|++.||.|||+   .+|+||||||+|||++.++.+||++++             
T Consensus       116 ~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          116 GSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             CCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            9999999532     3566789999999999999999   999999999999999999999998543             


Q ss_pred             ecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC-CC
Q 043292          398 TTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND-MQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~  476 (558)
                              |++|      ++.++||||||+++|||++|+.||......+....             ....+...... ..
T Consensus       175 --------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------~~~~~~~~~~~~~~  227 (286)
T 3uqc_A          175 --------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------AERDTAGQPIEPAD  227 (286)
T ss_dssp             --------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------------CCBCTTSCBCCHHH
T ss_pred             --------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------------HHHHhccCCCChhh
Confidence                    3333      58899999999999999999999986554221000             00000000000 00


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                      ........+.+++.+||+.||.+| |+.++++.|+.+....
T Consensus       228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            001123468899999999999999 9999999999876554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-36  Score=332.09  Aligned_cols=232  Identities=24%  Similarity=0.360  Sum_probs=188.2

Q ss_pred             hhhcCccCceEEEEEEeC--CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCc-----ceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT--DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH-----NLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e  313 (558)
                      .+.||+|+||.||++.+.  +++.||||++....  .....+.+|+.++.+++||||+++++++...+.     .+||||
T Consensus        85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E  164 (681)
T 2pzi_A           85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME  164 (681)
T ss_dssp             EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence            478999999999999984  68999999986432  334578999999999999999999999987765     699999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++..     .+++..++.++.||+.||.|||+   .+|+||||||+|||++.+ .+||+|||+++..... 
T Consensus       165 ~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          165 YVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             CCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred             eCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence            9999999887754     38999999999999999999999   999999999999999986 8999999999876432 


Q ss_pred             CceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                          ....||+.|+|||++.+..+.++||||||++++||++|..||.......                 +        .
T Consensus       235 ----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~--------~  285 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------L--------P  285 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------C--------C
T ss_pred             ----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc-----------------c--------c
Confidence                3457999999999988767999999999999999999998876421110                 0        0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRP-SMSMVVRVLEGV  513 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~  513 (558)
                      ...........+.+++.+||+.||.+|| +++++.+.|.++
T Consensus       286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            0001112235688999999999999999 567777776654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.4e-35  Score=291.09  Aligned_cols=220  Identities=23%  Similarity=0.331  Sum_probs=173.5

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHH-hccCCcceeeeeeeecc----CCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTI-GSIHHQNLVRLIGFCAE----KSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~  317 (558)
                      +.||+|+||.||++.. .+++.||+|+++..    ..+.+|+.++ ...+||||+++++++..    +...++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            5799999999999988 56899999998643    4567888887 66699999999999876    6678999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~  394 (558)
                      ++|.+++..... ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||++.....   
T Consensus       100 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---  172 (299)
T 3m2w_A          100 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---  172 (299)
T ss_dssp             CBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---
T ss_pred             CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---
Confidence            999999987543 249999999999999999999999   99999999999999998   78899999999875431   


Q ss_pred             ceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                                         ..++.++||||||+++|||++|+.||.........            ......+...   .
T Consensus       173 -------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~---~  218 (299)
T 3m2w_A          173 -------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMG---Q  218 (299)
T ss_dssp             -------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTT---C
T ss_pred             -------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhc---c
Confidence                               23578999999999999999999999754332100            0000000000   0


Q ss_pred             CCCCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNG----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....    .....+.+++.+||+.||.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            01111    12357889999999999999999999996

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-35  Score=304.97  Aligned_cols=234  Identities=16%  Similarity=0.150  Sum_probs=174.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCC-ccee---------------ee---
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHH-QNLV---------------RL---  298 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h-~niv---------------~l---  298 (558)
                      .++||+|+||.||+|++ .+++.||||++...    ....+.|.+|+.++..++| +|..               .+   
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            36899999999999996 57999999998732    2235679999999999977 2211               11   


Q ss_pred             ---eeeecc-----CCcceEEEEeCCCCCHHHHHhc----CCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCC
Q 043292          299 ---IGFCAE-----KSHNLLVYEYMPNGSLDRWLFQ----RSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIK  366 (558)
Q Consensus       299 ---~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk  366 (558)
                         ..+...     ....+++|+++ +++|.+++..    ......+++..++.++.||+.||.|||+   .+|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence               111111     12345666655 7899998852    1223358899999999999999999999   999999999


Q ss_pred             CCCEeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhh----------cC-CCCCccchHHHHHHHHHHHhC
Q 043292          367 PQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL----------SS-IITEKVDIYSFGVVMLEILCG  435 (558)
Q Consensus       367 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~k~Dv~s~Gv~l~elltg  435 (558)
                      |+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+ .++.++|||||||++|||++|
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999999999865432    445667 999999998          33 378899999999999999999


Q ss_pred             CCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          436 RKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       436 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +.||......+.                ....+....       .....+.+++..||+.||.+|||+.++++
T Consensus       314 ~~Pf~~~~~~~~----------------~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          314 DLPNTDDAALGG----------------SEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SCCCCTTGGGSC----------------SGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcchhhh----------------HHHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999975443221                111111111       11246889999999999999999887754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.5e-35  Score=296.64  Aligned_cols=238  Identities=16%  Similarity=0.167  Sum_probs=176.5

Q ss_pred             HHhhhhcCccCceEEEEEEeCCCCEEEEEEecccc---------cchHHHHHHHHHHhccC---------Ccceeee---
Q 043292          240 DNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---------EINKSFLAEVKTIGSIH---------HQNLVRL---  298 (558)
Q Consensus       240 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~---------h~niv~l---  298 (558)
                      +.+.++||+|+||.||+++. +++.||||++....         ...+.+.+|+.+++.++         |+||+++   
T Consensus        22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~  100 (336)
T 2vuw_A           22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV  100 (336)
T ss_dssp             HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred             chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence            34568999999999999997 68999999997432         22367889999988886         5555554   


Q ss_pred             --------------eeeecc-------------CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhh
Q 043292          299 --------------IGFCAE-------------KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY  351 (558)
Q Consensus       299 --------------~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y  351 (558)
                                    ++++.+             ....++||||+++|++.+.+.+    ..+++..+..++.||+.||.|
T Consensus       101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHH
T ss_pred             eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHH
Confidence                          444443             6788999999999977666643    238999999999999999999


Q ss_pred             cc-ccCCCcEEecCCCCCCEeecCCC--------------------CeEEcccCCccccCCCCCceeecccCCCCcCChh
Q 043292          352 LH-EDCRQKILHLDIKPQNILLDGNF--------------------NAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPE  410 (558)
Q Consensus       352 LH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE  410 (558)
                      || +   .+|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|+|||
T Consensus       177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            99 8   8999999999999999887                    8999999999876432      346899999999


Q ss_pred             hhcCCCCCccchHHHHHH-HHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHH
Q 043292          411 WLSSIITEKVDIYSFGVV-MLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVA  489 (558)
Q Consensus       411 ~~~~~~~~k~Dv~s~Gv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  489 (558)
                      ++.+..+.++||||+|.+ .+++++|..||...      ................     ...............+.+++
T Consensus       248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF-----KTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC-----SSCCCSHHHHHHHHHHHHHH
T ss_pred             hhcCCCccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc-----CcccchhhhhhcCHHHHHHH
Confidence            998877899999998777 77788898887310      0000010010000000     00000011224567899999


Q ss_pred             HHccCcCCCCCCCHHHHH
Q 043292          490 AWCLESDFAKRPSMSMVV  507 (558)
Q Consensus       490 ~~cl~~~p~~RPs~~~vl  507 (558)
                      .+||+.|     |+.+++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999976     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=5.2e-30  Score=276.08  Aligned_cols=182  Identities=18%  Similarity=0.113  Sum_probs=128.8

Q ss_pred             cCccCceEEEEEEe-CCCCEEEEEEeccc-----------ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          246 LGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-----------GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       246 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      .+.|++|.+..++- .-|+.+++|.+...           ....++|.+|+++|+++ +|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45666665555432 34888999998632           12235699999999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||++|++|.+.|.+...   ++..   +|+.||+.||+|+|+   .+||||||||+||||++++.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999986543   6553   589999999999999   99999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCC
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRK  437 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~  437 (558)
                      .. ......||+.|||||++.+....++|+||+|++++++.++..
T Consensus       393 ~~-~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          393 CS-WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -C-CSHHHHHHHHHHHHHHC-----------------CCCCTTHH
T ss_pred             Cc-cccCceechhhccHHHhCCCCCCcccccccccchhhhccccc
Confidence            32 234577999999999999988899999999999888765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.6e-26  Score=244.80  Aligned_cols=181  Identities=15%  Similarity=0.190  Sum_probs=145.6

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccc---------cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG---------EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      .++||+|+||.||++. ..+..+++|+.....         ...+++.+|++++.+++||||+++..++...+..+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            4689999999999995 447889999864321         113458999999999999999977777777888899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++++|.+++..           +..++.|++.||.|||+   .+|+||||||+|||++.  .+||+|||+++......
T Consensus       420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            9999999999864           46899999999999999   99999999999999999  99999999999875432


Q ss_pred             Cce------eecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCC
Q 043292          394 SQV------VTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFD  440 (558)
Q Consensus       394 ~~~------~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~  440 (558)
                      ...      .....||+.|||||++..   .++..+|+|+..+-.++-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            221      235679999999999874   37888999999999999888877663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.9e-22  Score=198.06  Aligned_cols=138  Identities=18%  Similarity=0.145  Sum_probs=113.8

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc-------------------cchHHHHHHHHHHhccCCcceeeeeeeecc
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-------------------EINKSFLAEVKTIGSIHHQNLVRLIGFCAE  304 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  304 (558)
                      +.||+|+||.||+|...+++.||||.++...                   .....+.+|+.++.+++  | +++.+++. 
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~-  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA-  171 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence            7899999999999999779999999986321                   12356899999999999  4 66666543 


Q ss_pred             CCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          305 KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      .+..++||||+++++|.+ +..         .....++.|++.||.|||+   .+|+||||||+|||++ ++.+||+|||
T Consensus       172 ~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          172 WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            356799999999999988 421         1245799999999999999   9999999999999999 9999999999


Q ss_pred             CccccCCCCCceeecccCCCCcCChhhhc
Q 043292          385 LSKLIDQDQSQVVTTMRGTPGYLAPEWLS  413 (558)
Q Consensus       385 la~~~~~~~~~~~~~~~gt~~y~aPE~~~  413 (558)
                      +++.              +..++|||++.
T Consensus       238 ~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TCEE--------------TTSTTHHHHHH
T ss_pred             CCeE--------------CCCCCHHHHHH
Confidence            9973              34578999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=4.2e-19  Score=172.09  Aligned_cols=132  Identities=18%  Similarity=0.207  Sum_probs=104.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCE--EEEEEecccccc-------------------------hHHHHHHHHHHhccCCcc
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTK--VAVKRLEGIGEI-------------------------NKSFLAEVKTIGSIHHQN  294 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~h~n  294 (558)
                      .+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..+.+++|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            36799999999999998 67888  999987532111                         135788999999998886


Q ss_pred             e--eeeeeeeccCCcceEEEEeCCC-C----CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcc-ccCCCcEEecCCC
Q 043292          295 L--VRLIGFCAEKSHNLLVYEYMPN-G----SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH-EDCRQKILHLDIK  366 (558)
Q Consensus       295 i--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~dlk  366 (558)
                      +  ..++.+    ...+|||||+.+ |    +|.++...      .++.....++.|++.||.||| +   .+|+|||||
T Consensus       132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlk  198 (258)
T 1zth_A          132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADLS  198 (258)
T ss_dssp             CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCS
T ss_pred             CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCC
Confidence            4  334432    367899999942 4    67666432      234467889999999999999 8   899999999


Q ss_pred             CCCEeecCCCCeEEcccCCcccc
Q 043292          367 PQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       367 ~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=9.7e-17  Score=161.79  Aligned_cols=135  Identities=12%  Similarity=0.066  Sum_probs=94.2

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccccc---------------chHHHHHHHHHHhccCCcceeeeeeeec----
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---------------INKSFLAEVKTIGSIHHQNLVRLIGFCA----  303 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~~~----  303 (558)
                      .+.||+|+||.||+|...+|+.||||+++....               .......+.++.....|+|+.+++....    
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~  179 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE  179 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            467999999999999998999999998753210               0112222333333333444444332111    


Q ss_pred             --cCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC----
Q 043292          304 --EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN----  377 (558)
Q Consensus       304 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~----  377 (558)
                        .....+|||||+++++|..+..         ......++.||+.+|.|||+   .+||||||||.|||+++++.    
T Consensus       180 p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          180 PIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             EEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSSCT
T ss_pred             eeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCcccc
Confidence              1123479999999988865432         12245688999999999999   89999999999999988773    


Q ss_pred             ------eEEcccCCcccc
Q 043292          378 ------AKVADFGLSKLI  389 (558)
Q Consensus       378 ------~ki~Dfgla~~~  389 (558)
                            +.|+||+-+...
T Consensus       248 ~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECCCTTCEET
T ss_pred             cccccceEEEEeCCcccC
Confidence                  899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=5.4e-11  Score=115.05  Aligned_cols=135  Identities=15%  Similarity=0.044  Sum_probs=105.6

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc-cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      ..++.|+.+.||+.... ++.+++|+..... .....+.+|++++..+. +.++.+++++..+.+..++||||++|.+|.
T Consensus        20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            45777888999998754 6899999987421 22346889999999884 677889999998888899999999999998


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc----------------------------------------------
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED----------------------------------------------  355 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------------  355 (558)
                      +.+.        +......++.+++++|..||+.                                              
T Consensus        99 ~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           99 EEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             hccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            7632        1122347888899999999971                                              


Q ss_pred             ----------CCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          356 ----------CRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       356 ----------~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                                ....++|+|+++.||+++++..+.|.||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                      01459999999999999876566799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=1.4e-10  Score=111.70  Aligned_cols=130  Identities=15%  Similarity=0.088  Sum_probs=96.7

Q ss_pred             cC-ccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcc--eeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          246 LG-KGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN--LVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       246 lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      ++ .|..+.||+....+|..+++|.....  ....+..|+.++..+.+.+  +.+++++...++..++||||++|.+|. 
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            44 55569999998777888999987653  2345788999998886544  456888888777889999999998884 


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC----------------------------------------------
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC----------------------------------------------  356 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------------  356 (558)
                       ...      .+   ...++.++++.|..||+..                                              
T Consensus       104 -~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 -SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             -TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             -cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence             211      11   2356677777777777621                                              


Q ss_pred             ---------CCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          357 ---------RQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       357 ---------~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                               ...++|+|++|.||+++++..+.|.||+.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     12399999999999998876677999998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=1.3e-09  Score=110.44  Aligned_cols=139  Identities=14%  Similarity=0.206  Sum_probs=105.0

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEec--ccc--cchHHHHHHHHHHhccC--CcceeeeeeeeccC---CcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLE--GIG--EINKSFLAEVKTIGSIH--HQNLVRLIGFCAEK---SHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~  314 (558)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|+.++..+.  +.++.+++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            46889999999998865 4678888775  322  22356888999999886  45678889888776   447899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC--------------------------------------
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC--------------------------------------  356 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------  356 (558)
                      +++..+.+..     ...++...+..++.++++.|..||+..                                      
T Consensus       123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9988774311     112778889999999999999999721                                      


Q ss_pred             -----------------CCcEEecCCCCCCEeecCCCC--eEEcccCCccc
Q 043292          357 -----------------RQKILHLDIKPQNILLDGNFN--AKVADFGLSKL  388 (558)
Q Consensus       357 -----------------~~~ivH~dlk~~NIll~~~~~--~ki~Dfgla~~  388 (558)
                                       ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             257999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=3.9e-09  Score=104.28  Aligned_cols=181  Identities=18%  Similarity=0.198  Sum_probs=119.8

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhcc-CCcc--eeeeeeeeccCC---cceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQN--LVRLIGFCAEKS---HNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~~~  317 (558)
                      +.++.|....||+..    ..+++|+.... .....+..|.+++..+ .+..  +.+++.....++   ..++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            457889999999863    56888886533 3346788999999887 3332  345555544333   34789999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc------------------------------------------
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED------------------------------------------  355 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------  355 (558)
                      .+|......     .++..++..++.++++.|..||+.                                          
T Consensus       101 ~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          101 VPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             EECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             eECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            888654321     266777777888888887777751                                          


Q ss_pred             -------------CCCcEEecCCCCCCEeecC--CCCeEEcccCCccccCCCCCceeecccCCCCc---CChhhhc----
Q 043292          356 -------------CRQKILHLDIKPQNILLDG--NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY---LAPEWLS----  413 (558)
Q Consensus       356 -------------~~~~ivH~dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~----  413 (558)
                                   ....++|+|+++.||++++  +..+.|.||+.+........  ..   .....   ..|+...    
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~---~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--FI---SLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--HH---TTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--HH---HHHhhccccCHHHHHHHHH
Confidence                         1146899999999999998  45678999998865322110  00   01111   2333221    


Q ss_pred             --CCC---------CCccchHHHHHHHHHHHhCCCCC
Q 043292          414 --SII---------TEKVDIYSFGVVMLEILCGRKVF  439 (558)
Q Consensus       414 --~~~---------~~k~Dv~s~Gv~l~elltg~~p~  439 (558)
                        +..         .-..+.|+++.+++++.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              111         11258899999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=1.8e-06  Score=85.19  Aligned_cols=135  Identities=13%  Similarity=0.156  Sum_probs=91.1

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc---ceeeeeeeec-cCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ---NLVRLIGFCA-EKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs  319 (558)
                      +.++.|....||+.    +..++||+-.. ......+..|.+++..+.+.   .+.+++.+.. ..+..++||||++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            35788888899987    56788887532 23346788999999998652   3556666663 4456789999999988


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc--------------------------------------------
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED--------------------------------------------  355 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------------------------------------------  355 (558)
                      +......     .++...+..++.++++.|..||+.                                            
T Consensus       100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A          100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            8763211     133444444444444444444431                                            


Q ss_pred             -------------CCCcEEecCCCCCCEeecC---CCCe-EEcccCCccc
Q 043292          356 -------------CRQKILHLDIKPQNILLDG---NFNA-KVADFGLSKL  388 (558)
Q Consensus       356 -------------~~~~ivH~dlk~~NIll~~---~~~~-ki~Dfgla~~  388 (558)
                                   ....++|+|+++.||+++.   ++.+ .|.||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1246799999999999997   4554 8999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.27  E-value=2.8e-06  Score=81.94  Aligned_cols=134  Identities=16%  Similarity=0.169  Sum_probs=90.3

Q ss_pred             cCccCce-EEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCCCHHH
Q 043292          246 LGKGGFG-SVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDR  322 (558)
Q Consensus       246 lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  322 (558)
                      +..|..| .||+.... ++..++||+-...  ....+..|...|..+. +-.+.++++++.+++..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445554 68987764 4677899976532  2356788999888774 4457788899888889999999999988776


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHhhhhcccc-----------------------------------------------
Q 043292          323 WLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED-----------------------------------------------  355 (558)
Q Consensus       323 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----------------------------------------------  355 (558)
                      ......       .....+..+++..|.-||..                                               
T Consensus       110 ~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          110 VLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            543211       11122333333333333321                                               


Q ss_pred             --------CCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          356 --------CRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       356 --------~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                              ....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    113489999999999999887777999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=4.1e-06  Score=84.36  Aligned_cols=78  Identities=8%  Similarity=-0.016  Sum_probs=54.8

Q ss_pred             hhc-CccCceEEEEEEeC-------CCCEEEEEEecccc---c-chHHHHHHHHHHhccCC---cceeeeeeeeccC---
Q 043292          244 KML-GKGGFGSVFEGTQT-------DGTKVAVKRLEGIG---E-INKSFLAEVKTIGSIHH---QNLVRLIGFCAEK---  305 (558)
Q Consensus       244 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---  305 (558)
                      +.| +.|....+|+....       ++..+++|+.....   . ....+..|+.++..+..   ..+.+++.++.++   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999988654       26678888765432   1 12457788888888843   3567788877665   


Q ss_pred             CcceEEEEeCCCCCHH
Q 043292          306 SHNLLVYEYMPNGSLD  321 (558)
Q Consensus       306 ~~~~lv~e~~~~gsL~  321 (558)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.86  E-value=5.8e-05  Score=77.11  Aligned_cols=73  Identities=12%  Similarity=0.079  Sum_probs=48.7

Q ss_pred             hhcCccCceEEEEEEeC-CCCEEEEEEecccc--------cchHHHHHHHHHHhccCC--c-ceeeeeeeeccCCcceEE
Q 043292          244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--------EINKSFLAEVKTIGSIHH--Q-NLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lv  311 (558)
                      +.||.|.++.||+++.. +++.++||......        .....+..|.+++..+..  + .+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999764 46889999764211        123456778888887742  3 34455544  34567899


Q ss_pred             EEeCCCC
Q 043292          312 YEYMPNG  318 (558)
Q Consensus       312 ~e~~~~g  318 (558)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.83  E-value=8.2e-05  Score=74.06  Aligned_cols=139  Identities=17%  Similarity=0.221  Sum_probs=78.6

Q ss_pred             hcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCC--cceeeeee------eeccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH--QNLVRLIG------FCAEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~~  316 (558)
                      .|+.|..+.||+....++ .+++|+.....   .++..|..++..+..  -++.+++.      +...++..+++|+|++
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            456677889999876554 58899887532   333445555554432  12334443      1123556789999999


Q ss_pred             CCCHH-----------HH---Hhc--C----CCC-----CCCCHHHHH-------------------------------H
Q 043292          317 NGSLD-----------RW---LFQ--R----SDE-----FMLDWQQRK-------------------------------K  340 (558)
Q Consensus       317 ~gsL~-----------~~---l~~--~----~~~-----~~l~~~~~~-------------------------------~  340 (558)
                      |..+.           ..   ++.  .    ...     ..-.|...+                               .
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86542           11   111  0    100     112343211                               1


Q ss_pred             HHHHHHHhhhhccc----------cCCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          341 IILDIAKGLTYLHE----------DCRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       341 i~~~ia~~l~yLH~----------~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      +...+..++.+|++          .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11123345666653          124789999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.60  E-value=0.0002  Score=70.36  Aligned_cols=137  Identities=18%  Similarity=0.181  Sum_probs=90.4

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccC---CcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH---HQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.|+.|....+|+... ++..++||+....  ....+..|...|+.+.   ...+.+++++....+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4588899999999875 4678889987543  3456888998888874   36788888888877889999999998764


Q ss_pred             H--------HH---HhcCCC--C-----------------CCCCHHHHH---HHHH----------------HHHHh-hh
Q 043292          321 D--------RW---LFQRSD--E-----------------FMLDWQQRK---KIIL----------------DIAKG-LT  350 (558)
Q Consensus       321 ~--------~~---l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~ia~~-l~  350 (558)
                      .        ..   |+....  .                 ..-+|....   ++..                .+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2        11   222111  0                 012455332   1111                11111 12


Q ss_pred             hccc-cCCCcEEecCCCCCCEeecCCCCeEEcccC
Q 043292          351 YLHE-DCRQKILHLDIKPQNILLDGNFNAKVADFG  384 (558)
Q Consensus       351 yLH~-~~~~~ivH~dlk~~NIll~~~~~~ki~Dfg  384 (558)
                      .|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 1247899999999999999887 8898973

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.49  E-value=0.00048  Score=66.84  Aligned_cols=73  Identities=18%  Similarity=0.228  Sum_probs=53.5

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccc-cchHHHHHHHHHHhccCC---cceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHH---QNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+|.|..+.||+.++.+|+.++||+-.... .....|..|.+.|+.+..   -.+.+++++    +..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            4589999999999999999999999876432 233457889998888742   234555554    23579999998765


Q ss_pred             H
Q 043292          320 L  320 (558)
Q Consensus       320 L  320 (558)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.40  E-value=0.00031  Score=68.71  Aligned_cols=135  Identities=13%  Similarity=0.054  Sum_probs=74.4

Q ss_pred             hhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeC-CCCCHH
Q 043292          244 KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYM-PNGSLD  321 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL~  321 (558)
                      +.|+.|....+|+.     ..+++|+.............|+.++..+...++ .+++++.  .+..++|+||+ ++.++.
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEECC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccCC
Confidence            56788889999998     568888776432222223567777777643333 3555543  34457999999 654442


Q ss_pred             HH------------------HhcCCCC--CCCCH-HHHHHH---------------------HHHHHHhhhhccccCCCc
Q 043292          322 RW------------------LFQRSDE--FMLDW-QQRKKI---------------------ILDIAKGLTYLHEDCRQK  359 (558)
Q Consensus       322 ~~------------------l~~~~~~--~~l~~-~~~~~i---------------------~~~ia~~l~yLH~~~~~~  359 (558)
                      ..                  ++.....  ...+. .....+                     +..+...+.-.  .....
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~--~~~~~  174 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH--PLPLA  174 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS--CCCCE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc--CCCce
Confidence            10                  1111100  00111 111111                     11111111111  12356


Q ss_pred             EEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          360 ILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       360 ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ++|+|+.+.||+ ..++.+.|.||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5666789999988764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.37  E-value=0.00062  Score=69.97  Aligned_cols=75  Identities=12%  Similarity=0.017  Sum_probs=44.7

Q ss_pred             CcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc--CCCCcCChhhhcCC----CCCccchHHHHHHHHH
Q 043292          358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR--GTPGYLAPEWLSSI----ITEKVDIYSFGVVMLE  431 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~----~~~k~Dv~s~Gv~l~e  431 (558)
                      ..++|+|+++.|||++.++ ++|.||+.+..-.....-  ....  -...|.+|+.....    -....++.+....+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            7899999999999999876 999999988743211100  0000  01234555543211    1112445577777777


Q ss_pred             HHhC
Q 043292          432 ILCG  435 (558)
Q Consensus       432 lltg  435 (558)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.20  E-value=0.00057  Score=70.38  Aligned_cols=72  Identities=19%  Similarity=0.246  Sum_probs=49.4

Q ss_pred             hhcCccCceEEEEEEeCC--------CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTD--------GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  314 (558)
                      +.|+.|....+|+....+        +..+++|+.... .....+..|..++..+...++ .++++.+.+    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            457778889999998653        578999987432 112456689988888854444 566766543    389999


Q ss_pred             CCCCCH
Q 043292          315 MPNGSL  320 (558)
Q Consensus       315 ~~~gsL  320 (558)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.13  E-value=0.0045  Score=60.98  Aligned_cols=141  Identities=15%  Similarity=0.143  Sum_probs=80.5

Q ss_pred             hcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCc--ceeeeeee-----eccCCcceEEEEeCCC
Q 043292          245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQ--NLVRLIGF-----CAEKSHNLLVYEYMPN  317 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~  317 (558)
                      .++ |....||+....+|+.+++|...........+..|..++..+...  .+.+++..     ...++..+++|+|++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            355 777889998777777899999874333445667788887777432  24445443     1113345789999987


Q ss_pred             CCHH-----H------H---Hhc----CC--CCCCCCHHHH----------------------HHHHHHHHHhhhhcc-c
Q 043292          318 GSLD-----R------W---LFQ----RS--DEFMLDWQQR----------------------KKIILDIAKGLTYLH-E  354 (558)
Q Consensus       318 gsL~-----~------~---l~~----~~--~~~~l~~~~~----------------------~~i~~~ia~~l~yLH-~  354 (558)
                      ..+.     .      .   ++.    ..  ....+++...                      ...+..++..+.-+. .
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            5432     1      1   111    00  0111232211                      011111111121111 1


Q ss_pred             cCCCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       355 ~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1236789999999999999 4 899999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0035  Score=61.99  Aligned_cols=140  Identities=14%  Similarity=0.052  Sum_probs=71.7

Q ss_pred             hcCccCceE-EEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCC--cceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          245 MLGKGGFGS-VFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH--QNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       245 ~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      .|+.|.... +|+....++..+++|......  ...+..|+.++..+..  -.+.+++.+....  .+++||++.+..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence            354454443 667765446777777654322  0233456666665532  3355666664333  37899999877765


Q ss_pred             HHHhcCC---------------------C--CCCCCHHHHH-------H-------------HHHHHHHhhhhcc---cc
Q 043292          322 RWLFQRS---------------------D--EFMLDWQQRK-------K-------------IILDIAKGLTYLH---ED  355 (558)
Q Consensus       322 ~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~l~yLH---~~  355 (558)
                      +++....                     .  ...++.....       .             ....+...+..+.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            4442110                     0  0011111100       0             0001111122221   11


Q ss_pred             CCCcEEecCCCCCCEeecCC----CCeEEcccCCccc
Q 043292          356 CRQKILHLDIKPQNILLDGN----FNAKVADFGLSKL  388 (558)
Q Consensus       356 ~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla~~  388 (558)
                      ....++|+|+.+.||+++.+    ..+.|.||+.+..
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            23689999999999999875    6789999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.01  E-value=0.0014  Score=67.91  Aligned_cols=73  Identities=12%  Similarity=0.084  Sum_probs=46.9

Q ss_pred             hhcCccCceEEEEEEeCC-CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeCCCCCH
Q 043292          244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.|+.|-...+|+....+ +..+++|+........-....|..++..+...++ .++++.+..    .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            457778889999998765 4778888775322211122578888888865555 467776632    359999987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.81  E-value=0.0019  Score=64.95  Aligned_cols=73  Identities=14%  Similarity=0.132  Sum_probs=43.6

Q ss_pred             hhcCccCceEEEEEEeCC---------CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEE
Q 043292          244 KMLGKGGFGSVFEGTQTD---------GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  313 (558)
                      +.|+.|....+|+....+         +..+++|+.............|..++..+...++ .++++..    ..++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence            346777788999987653         2688888775432222234578888877754343 4566544    2378999


Q ss_pred             eCCCCCH
Q 043292          314 YMPNGSL  320 (558)
Q Consensus       314 ~~~~gsL  320 (558)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.75  E-value=0.004  Score=62.75  Aligned_cols=140  Identities=18%  Similarity=0.182  Sum_probs=82.5

Q ss_pred             hcCccCceEEEEEEeC--------CCCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEeC
Q 043292          245 MLGKGGFGSVFEGTQT--------DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  315 (558)
                      .|..|-...+|+....        +++.+++|+..........+.+|.++++.+...++ .++++++.++    +||||+
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i  132 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYI  132 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEe
Confidence            4556777789998764        25789999864433344566789999888753333 5666666542    999999


Q ss_pred             CCCCHHH--------------HH---hcCC--CCCCCC--HHHHHHHHHHHHHh-------------------hhhcc--
Q 043292          316 PNGSLDR--------------WL---FQRS--DEFMLD--WQQRKKIILDIAKG-------------------LTYLH--  353 (558)
Q Consensus       316 ~~gsL~~--------------~l---~~~~--~~~~l~--~~~~~~i~~~ia~~-------------------l~yLH--  353 (558)
                      +|..|..              .|   +...  -.....  |.++.++..++...                   +..|.  
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            8765431              11   1110  011122  45555555444321                   12221  


Q ss_pred             --c-cCCCcEEecCCCCCCEeecCC----CCeEEcccCCccc
Q 043292          354 --E-DCRQKILHLDIKPQNILLDGN----FNAKVADFGLSKL  388 (558)
Q Consensus       354 --~-~~~~~ivH~dlk~~NIll~~~----~~~ki~Dfgla~~  388 (558)
                        . .....++|+|+.+.||+++.+    +.+.|.||..+..
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              1 123579999999999999876    7899999988763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.75  E-value=0.0053  Score=60.32  Aligned_cols=141  Identities=13%  Similarity=0.101  Sum_probs=76.6

Q ss_pred             hcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcc--eeeeeeee------ccCCcceEEEEeCC
Q 043292          245 MLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQN--LVRLIGFC------AEKSHNLLVYEYMP  316 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~e~~~  316 (558)
                      .|+.|....+|+....++ .+++|..... .....+..|+.++..+...+  +.+++...      ...+..+++++|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            466687889999876655 6888987652 12234556777776664322  23333211      12345689999998


Q ss_pred             CCCHHH-----------H---HhcCCC----C-----CCCCHHHHHHH------------HHHHHHhhhhccc----cCC
Q 043292          317 NGSLDR-----------W---LFQRSD----E-----FMLDWQQRKKI------------ILDIAKGLTYLHE----DCR  357 (558)
Q Consensus       317 ~gsL~~-----------~---l~~~~~----~-----~~l~~~~~~~i------------~~~ia~~l~yLH~----~~~  357 (558)
                      |..+..           .   ++....    .     ....|...+.-            ...+...+..+++    ...
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            765321           0   111100    0     00123321110            0012333344432    123


Q ss_pred             CcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          358 QKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       358 ~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ..++|+|+++.|||++++..+.|.||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            689999999999999987656899998775

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.56  E-value=0.014  Score=53.14  Aligned_cols=104  Identities=16%  Similarity=0.046  Sum_probs=68.1

Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      .-||.++|.....  +++++++|.++.|.+.+|.-+-..  ..-..+=+.|..|+|..+|.+.+.+ ..+.         
T Consensus        32 ~vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            3479999986553  599999999999999998766210  0111233457899999999988764 1111         


Q ss_pred             eecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKV  438 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p  438 (558)
                          .....+.|||......+.+.=|||+|+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                12234668887655567888999999999999875443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.30  E-value=0.0084  Score=59.49  Aligned_cols=32  Identities=22%  Similarity=0.337  Sum_probs=28.2

Q ss_pred             CCcEEecCCCCCCEeecCCCCeEEcccCCccc
Q 043292          357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKL  388 (558)
Q Consensus       357 ~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~  388 (558)
                      ...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            36799999999999999888899999987763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.09  E-value=0.072  Score=54.32  Aligned_cols=73  Identities=11%  Similarity=0.058  Sum_probs=46.4

Q ss_pred             hhcCccCceEEEEEEeCC--------CCEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTD--------GTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  314 (558)
                      +.|..|-...+|+....+        +..+++++........-+..+|.+++..+...++ .++++.+.    .++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            346667778899987653        5788998865432222234578888877753333 44555432    3789999


Q ss_pred             CCCCCH
Q 043292          315 MPNGSL  320 (558)
Q Consensus       315 ~~~gsL  320 (558)
                      ++|..|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=93.56  E-value=0.028  Score=35.47  Aligned_cols=29  Identities=31%  Similarity=0.576  Sum_probs=19.0

Q ss_pred             cceEEehhHHHHHHHHHHHHHhhhhhccc
Q 043292          181 RKRIMGFILESFFGLLVLIGILIFFFRKK  209 (558)
Q Consensus       181 ~~~~~~~v~~~~~~~~~l~~~~~~~~~~~  209 (558)
                      ...|.++++++++++++++++.+|++|||
T Consensus        10 ~GaIAGiVvG~v~gv~li~~l~~~~~rrr   38 (38)
T 2k1k_A           10 GGEIVAVIFGLLLGAALLLGILVFRSRRA   38 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence            45567777777777766666666665553

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.05  E-value=0.08  Score=34.50  Aligned_cols=29  Identities=21%  Similarity=0.278  Sum_probs=14.3

Q ss_pred             ceEEehhHHHHHHHHHHHHHhhhhhcccC
Q 043292          182 KRIMGFILESFFGLLVLIGILIFFFRKKN  210 (558)
Q Consensus       182 ~~~~~~v~~~~~~~~~l~~~~~~~~~~~~  210 (558)
                      ..|++.+++++++++++++.+++++||++
T Consensus        11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            34455555555555544444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=90.43  E-value=0.11  Score=33.81  Aligned_cols=27  Identities=19%  Similarity=0.306  Sum_probs=13.0

Q ss_pred             eEEehhHHHHHHHHHHHHHhhhhhccc
Q 043292          183 RIMGFILESFFGLLVLIGILIFFFRKK  209 (558)
Q Consensus       183 ~~~~~v~~~~~~~~~l~~~~~~~~~~~  209 (558)
                      .|++.+++++++++++++.+++++||+
T Consensus        11 aIA~gVVgGv~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence            344455555555544444444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.96  E-value=1.2  Score=40.39  Aligned_cols=115  Identities=11%  Similarity=0.204  Sum_probs=77.4

Q ss_pred             CCcceeeeeeeeccCCcceEEEEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCC
Q 043292          291 HHQNLVRLIGFCAEKSHNLLVYEYMPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQN  369 (558)
Q Consensus       291 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~N  369 (558)
                      .||++++. .+-.+.+...+.|+.-++ .++.. +.      .++...+++++.+|+....+++.     -+|--|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            57888866 455555665566655432 22222 22      27889999999999998877764     3788999999


Q ss_pred             EeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCC
Q 043292          370 ILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFD  440 (558)
Q Consensus       370 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~  440 (558)
                      |+++.++.++|.=.|+-..+                  +|.    ..++..=.-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l------------------~P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV------------------DPL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB------------------SCC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC------------------CCC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999877754322                  121    01111123357888999999988774

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.80  E-value=0.53  Score=47.53  Aligned_cols=31  Identities=29%  Similarity=0.313  Sum_probs=25.6

Q ss_pred             CcEEecCCCCCCEee------cCCCCeEEcccCCccc
Q 043292          358 QKILHLDIKPQNILL------DGNFNAKVADFGLSKL  388 (558)
Q Consensus       358 ~~ivH~dlk~~NIll------~~~~~~ki~Dfgla~~  388 (558)
                      ..++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            346899999999999      4567799999988763

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.36  E-value=0.18  Score=32.70  Aligned_cols=8  Identities=13%  Similarity=0.355  Sum_probs=4.0

Q ss_pred             eEEehhHH
Q 043292          183 RIMGFILE  190 (558)
Q Consensus       183 ~~~~~v~~  190 (558)
                      .+++.+++
T Consensus        13 ~Ia~~vVG   20 (44)
T 2jwa_A           13 SIISAVVG   20 (44)
T ss_dssp             HHHHHHHH
T ss_pred             chHHHHHH
Confidence            34445555

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.14  E-value=1.5  Score=39.76  Aligned_cols=114  Identities=10%  Similarity=0.100  Sum_probs=76.4

Q ss_pred             CCcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhh-hccccCCCcEEecCCCCCC
Q 043292          291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT-YLHEDCRQKILHLDIKPQN  369 (558)
Q Consensus       291 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~ivH~dlk~~N  369 (558)
                      .||.+  -..+-.+.+...+.|+.-+++.=...+.      .++...+++++.+|+.... +++.     -+|--|+|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57777  3444466667677777653332222332      2788999999999999887 6664     4788899999


Q ss_pred             EeecCCCCeEEcccCCccccCCCCCceeecccCCCCcCChhhhcCCCCCccchH-HHHHHHHHHHhCCCCCC
Q 043292          370 ILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIY-SFGVVMLEILCGRKVFD  440 (558)
Q Consensus       370 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~-s~Gv~l~elltg~~p~~  440 (558)
                      |++|.++.++|.-.|+-..+                  +|.-     ....|.+ ++=+++..++.++..|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999877754322                  2221     1112333 57778888888877663

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=87.51  E-value=0.25  Score=37.11  Aligned_cols=36  Identities=17%  Similarity=0.462  Sum_probs=30.1

Q ss_pred             CCCChHHHHHHHhccCCceeecccccCcCCCCcccccccc
Q 043292          103 TNTDSETCKQACLKNCSCKAALFQYGLNSSAGDCYLPSEI  142 (558)
Q Consensus       103 ~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~~~~~  142 (558)
                      ...++++|++.|+.+=.|.||.|.-    ....|+++.+.
T Consensus        28 ~~~sl~~Cq~aC~a~~~C~aFTyN~----~s~~CflKs~~   63 (82)
T 2ll3_A           28 RASSLSECRARCQAEKECSHYTYNV----KSGLCYPKRGK   63 (82)
T ss_dssp             ECSSHHHHHHHHHHCTTEEEEEEET----TTTEEEEEESS
T ss_pred             cCCCHHHHHHHhhccCCCCeEEecc----CCCceEcccCC
Confidence            4578999999999999999999854    36679998753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.19  E-value=0.17  Score=52.35  Aligned_cols=59  Identities=7%  Similarity=0.013  Sum_probs=17.8

Q ss_pred             hhhhcCccCceEEEEEEeCC-CCEEEE------EEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeec
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-GTKVAV------KRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCA  303 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  303 (558)
                      +.++||   ||.||+|.+.. ..+|||      |..+..   .+....|.+|..++..++|+|+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            346676   99999998854 467888      766532   222346888999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	558
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-47
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 8e-69
 Identities = 57/276 (20%), Positives = 118/276 (42%), Gaps = 25/276 (9%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQNLVRLIG 300
             + +G G FG+V++G       V +  +        ++F  EV  +    H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
           +        +V ++    SL   L     +F  +  +   I    A+G+ YLH    + I
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLH---AKSI 125

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ-SQVVTTMRGTPGYLAPEWL----SSI 415
           +H D+K  NI L  +   K+ DFGL+ +  +   S     + G+  ++APE +     + 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 416 ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM 475
            + + D+Y+FG+V+ E++ G+  +      ++   ++ +  +      LS +       M
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           +          ++ A CL+    +RP    ++  +E
Sbjct: 243 K----------RLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 7e-67
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 25/275 (9%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVR 297
           +  +  + LG G FG V+ G     TKVAVK L+       +FLAE   +  + HQ LVR
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 298 LIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCR 357
           L     ++    ++ EYM NGSL  +L   S    L   +   +   IA+G+ ++ E   
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 358 QKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-II 416
           +  +H D++  NIL+    + K+ADFGL++LI+ ++       +    + APE ++    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ 476
           T K D++SFG+++ EI+   ++        E +  L    +    D   +          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------- 237

Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                   + ++   C +     RP+   +  VLE
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-66
 Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 23/276 (8%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F + +G G FG V  G   +  KVA+K +       + F+ E + +  + H  LV+L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C E++   LV+E+M +G L    + R+   +   +    + LD+ +G   +       +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEK 419
           +H D+  +N L+  N   KV+DFG+++ +  DQ    T  +    + +PE  S    + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 420 VDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG 479
            D++SFGV+M E+    K+   ++   E +  +S   +  +    S              
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229

Query: 480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
               ++ ++   C +     RP+ S ++R L  + E
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 3e-64
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 31/294 (10%)

Query: 222 QVPGLPK---RFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINK 278
           Q  GL K       E L+         LG+G FG V+ GT    T+VA+K L+      +
Sbjct: 3   QTQGLAKDAWEIPRESLR-----LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 57

Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
           +FL E + +  + H+ LV+L      +    +V EYM  GSL  +L   + +++    Q 
Sbjct: 58  AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQL 115

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
             +   IA G+ Y+    R   +H D++  NIL+  N   KVADFGL++LI+ ++     
Sbjct: 116 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

Query: 399 TMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             +    + APE       T K D++SFG+++ E+    +V        E +  +    +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232

Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                +  +                 ++  +   C   +  +RP+   +   LE
Sbjct: 233 MPCPPECPE-----------------SLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 3e-64
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 27/298 (9%)

Query: 242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGF 301
            ++ +GKG FG V+ G    G +VAVK      E +    AE+     + H+N++  I  
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 302 CAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC- 356
             + +       LV +Y  +GSL  +L + +    +  +   K+ L  A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 357 ----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV---VTTMRGTPGYLAP 409
               +  I H D+K +NIL+  N    +AD GL+   D     +        GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 410 EWLSSII-------TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
           E L   I        ++ DIY+ G+V  EI     +    +  +   Y L       EE 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 463 K---LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
           +       +  +  +   + E +  M K+   C  ++ A R +   + + L  +++ E
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 8e-63
 Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 39/305 (12%)

Query: 235 LKVMTDNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGS 289
           +++  D+F     LG G  G VF+ + +  G  +A K +  E    I    + E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
            +   +V   G         +  E+M  GSLD+ L +      +  Q   K+ + + KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
           TYL E  + KI+H D+KP NIL++     K+ DFG+S  +    +    +  GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 410 EWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED------ 462
           E L     + + DI+S G+ ++E+  GR        +E ++      +  A E       
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 463 -------------------KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
                              +L D +         +G   +        CL  + A+R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 504 SMVVR 508
             ++ 
Sbjct: 293 KQLMV 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 5e-62
 Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 34/286 (11%)

Query: 230 FSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGS 289
            + +ELK++     + +GKG FG V  G    G KVAVK ++      ++FLAE   +  
Sbjct: 4   LNMKELKLL-----QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQ 56

Query: 290 IHHQNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + H NLV+L+G   E+   L +V EYM  GSL  +L  R     L      K  LD+ + 
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 115

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           + YL        +H D+  +N+L+  +  AKV+DFGL+K     Q     T +    + A
Sbjct: 116 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 168

Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           PE L     + K D++SFG+++ EI    +V     P ++ +        + E+    D 
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYKMDA 221

Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
            D     +           +V   C   D A RPS   +   LE +
Sbjct: 222 PDGCPPAVY----------EVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 7e-62
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 25/273 (9%)

Query: 241 NFRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIG 300
            F K LG G FG V  G       VA+K ++        F+ E K + ++ H+ LV+L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
            C ++    ++ EYM NG L  +L +    F    QQ  ++  D+ + + YL     ++ 
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---SKQF 121

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEK 419
           LH D+  +N L++     KV+DFGLS+ +  D+       +    +  PE L  S  + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 420 VDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN 478
            DI++FGV+M EI   G+  ++R    E   ++    +          +           
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT--------- 232

Query: 479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                    +   C      +RP+  +++  + 
Sbjct: 233 ---------IMYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  200 bits (509), Expect = 9e-61
 Identities = 65/291 (22%), Positives = 125/291 (42%), Gaps = 25/291 (8%)

Query: 227 PKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSFLAE 283
           P   ++++ ++   +      LG G +G V+EG        VAVK L+      + FL E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 284 VKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
              +  I H NLV+L+G C  +    ++ E+M  G+L  +L +  +   +       +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 122

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
            I+  + YL    ++  +H D+  +N L+  N   KVADFGLS+L+  D        +  
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 404 PGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
             + APE L+    + K D+++FGV++ EI              +   +  + +K    +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYRME 236

Query: 463 KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
           +     +K              + ++   C + + + RPS + + +  E +
Sbjct: 237 RPEGCPEK--------------VYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-60
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 32/276 (11%)

Query: 242 FRKMLGKGGFGSVFEGTQTD-GTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVR 297
           F   +G+G F +V++G  T+   +VA   L   +      + F  E + +  + H N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 298 LIGFCAE----KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
                      K   +LV E M +G+L  +L +     ++  +  +     I KGL +LH
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 129

Query: 354 EDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                 I+H D+K  NI + G   + K+ D GL+ L     +     + GTP ++APE  
Sbjct: 130 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS 472
                E VD+Y+FG+ MLE+      +   Q   +      I+++     K +       
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAI 239

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
            +++           +   C+  +  +R S+  ++ 
Sbjct: 240 PEVKE----------IIEGCIRQNKDERYSIKDLLN 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (505), Expect = 6e-60
 Identities = 75/314 (23%), Positives = 130/314 (41%), Gaps = 46/314 (14%)

Query: 230 FSFEELKVMTDNFR-----------KMLGKGGFGSVFEG----TQTDGTKVAVKRL--EG 272
           F+FE+       F            +++G G FG V  G           VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 273 IGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM 332
             +  + FL+E   +G   H N++ L G   + +  +++ E+M NGSLD +L Q   +F 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
               Q   ++  IA G+ YL        +H D+  +NIL++ N   KV+DFGLS+ ++ D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 393 QSQVVTT----MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEE 446
            S    T     +    + APE +     T   D++S+G+VM E++  G + +     ++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 447 EDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
               +   ++     D  S L                    +   C + D   RP    +
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQ------------------LMLDCWQKDRNHRPKFGQI 283

Query: 507 VRVLEGVTEFEHNL 520
           V  L+ +    ++L
Sbjct: 284 VNTLDKMIRNPNSL 297

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (505), Expect = 9e-60
 Identities = 58/294 (19%), Positives = 117/294 (39%), Gaps = 38/294 (12%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN----K 278
           P + + F  ++ + +  + R+ +G G FG+V+      +   VA+K++   G+ +    +
Sbjct: 2   PDVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60

Query: 279 SFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQR 338
             + EV+ +  + H N ++  G    +    LV EY    + D     +     L   + 
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEI 117

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
             +     +GL YLH      ++H D+K  NILL      K+ DFG + ++         
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169

Query: 399 TMRGTPGYLAPEWLSSI----ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
           +  GTP ++APE + ++       KVD++S G+  +E+   +             ++   
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229

Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                +    S              E   N +     CL+     RP+  ++++
Sbjct: 230 ESPALQSGHWS--------------EYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-59
 Identities = 65/281 (23%), Positives = 121/281 (43%), Gaps = 31/281 (11%)

Query: 240 DNFR--KMLGKGGFGSVFEGT-QTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQ 293
           +++     +G G +G   +   ++DG  +  K L          +  ++EV  +  + H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 294 NLVRLIGFCAEKSHNLL--VYEYMPNGSLDRWLFQRSDEFM-LDWQQRKKIILDIAKGLT 350
           N+VR      ++++  L  V EY   G L   + + + E   LD +   +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 351 YLHE--DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
             H   D    +LH D+KP N+ LDG  N K+ DFGL+++++ D S       GTP Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMS 182

Query: 409 PEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           PE ++     EK DI+S G ++ E+      F     +E           K  E K   +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRI 234

Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
             ++S+++           ++    L      RPS+  ++ 
Sbjct: 235 PYRYSDELN----------EIITRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 3e-59
 Identities = 73/318 (22%), Positives = 124/318 (38%), Gaps = 53/318 (16%)

Query: 231 SFEELKVMTDNFR--KMLGKGGFGSVFEGTQT------DGTKVAVKRL--EGIGEINKSF 280
               L+   +N    + +G+G FG VF+            T VAVK L  E   ++   F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------- 332
             E   +    + N+V+L+G CA      L++EYM  G L+ +L   S   +        
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 333 -------------LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAK 379
                        L   ++  I   +A G+ YL E   +K +H D+  +N L+  N   K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 380 VADFGLSKLI-DQDQSQVVTTMRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRK 437
           +ADFGLS+ I   D  +          ++ PE +     T + D++++GVV+ EI     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 438 VFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDF 497
                   EE +Y +        +  +    +    ++            +   C     
Sbjct: 241 QPYYGMAHEEVIYYV-------RDGNILACPENCPLELY----------NLMRLCWSKLP 283

Query: 498 AKRPSMSMVVRVLEGVTE 515
           A RPS   + R+L+ + E
Sbjct: 284 ADRPSFCSIHRILQRMCE 301

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-58
 Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 30/277 (10%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQN 294
           +++   + LG+G +G V           VAVK +  +   +  ++   E+     ++H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+  G   E +   L  EY   G L   +        +     ++    +  G+ YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD-QSQVVTTMRGTPGYLAPEWLS 413
                I H DIKP+N+LLD   N K++DFGL+ +   + + +++  M GT  Y+APE L 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 414 S--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKH 471
                 E VD++S G+V+  +L G   +D+     +     S +K+K         +D  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPWKKID-- 233

Query: 472 SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                      + ++      L  + + R ++  + +
Sbjct: 234 --------SAPLALLH---KILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 4e-58
 Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 39/287 (13%)

Query: 228 KRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG----EINKSFLA 282
           ++++ E+ ++      + LGKG FG+V+   +      +A+K L         +      
Sbjct: 1   RQWALEDFEIG-----RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55

Query: 283 EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKII 342
           EV+    + H N++RL G+  + +   L+ EY P G++ R L + S     D Q+    I
Sbjct: 56  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYI 112

Query: 343 LDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRG 402
            ++A  L+Y H    ++++H DIKP+N+LL      K+ADFG S      +     T+ G
Sbjct: 113 TELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCG 166

Query: 403 TPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
           T  YL PE +   +  EKVD++S GV+  E L G+  F+ +  +E      +  +    E
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE 220

Query: 462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
               D V           E   +++      L+ + ++RP +  V+ 
Sbjct: 221 FTFPDFVT----------EGARDLIS---RLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 7e-58
 Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 32/280 (11%)

Query: 239 TDNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEIN-KSFLAEVKTIGSIHHQN 294
            D +     LG G FG V++    +     A K ++   E   + ++ E+  + S  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L+     +++  ++ E+   G++D  + +   E  L   Q + +       L YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-- 412
               KI+H D+K  NIL   + + K+ADFG+S    +   +   +  GTP ++APE +  
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMC 184

Query: 413 ----SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV 468
                     K D++S G+ ++E+           P      LL I K +          
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKSEPPTLAQPSRW 241

Query: 469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                          + +K    CLE +   R + S +++
Sbjct: 242 S----------SNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 9e-58
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
           F K LG G FG V E T            VAVK L         ++ ++E+K +  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM---------------LDWQQ 337
            N+V L+G C      L++ EY   G L  +L ++ D F+               LD + 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV 397
                  +AKG+ +L     +  +H D+  +NILL      K+ DFGL++ I  D + VV
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 398 TTM-RGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
               R    ++APE + + + T + D++S+G+ + E+           P +   Y +   
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 261

Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEG 512
                         K    M S       M  +   C ++D  KRP+   +V+++E 
Sbjct: 262 --------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-57
 Identities = 66/291 (22%), Positives = 124/291 (42%), Gaps = 36/291 (12%)

Query: 233 EELKVMTDNFR---KMLGKGGFGSVFEGT---QTDGTKVAVKRL--EGIGEINKSFLAEV 284
           ++L +  DN       LG G FGSV +G    +     VA+K L         +  + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 285 KTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
           + +  + +  +VRLIG C +    +LV E    G L ++L  + +E  +      +++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--TTMRG 402
           ++ G+ YL     +  +H D+  +N+LL     AK++DFGLSK +  D S     +  + 
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 403 TPGYLAPEWLSS-IITEKVDIYSFGVVMLEIL-CGRKVFDRSQPEEEDMYLLSIFKKKAE 460
              + APE ++    + + D++S+GV M E L  G+K + + +  E             E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIE 226

Query: 461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
           + K  +   +   ++            + + C    +  RP    V + + 
Sbjct: 227 QGKRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-56
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 36/300 (12%)

Query: 238 MTDNFRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGIGEIN--KSFLAEVKTIGSIH 291
           +  +F +++G+G FG V+ GT  D        AVK L  I +I     FL E   +    
Sbjct: 27  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86

Query: 292 HQNLVRLIGFCAE-KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLT 350
           H N++ L+G C   +   L+V  YM +G L  ++   +       +      L +AKG+ 
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGM- 143

Query: 351 YLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI---DQDQSQVVTTMRGTPGYL 407
                  +K +H D+  +N +LD  F  KVADFGL++ +   + D     T  +    ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 408 APEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           A E L +   T K D++SFGV++ E++             +    L   ++  + +   D
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE---FEHNLHYN 523
                             + +V   C       RPS S +V  +  +      EH +H N
Sbjct: 262 -----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-56
 Identities = 75/335 (22%), Positives = 134/335 (40%), Gaps = 55/335 (16%)

Query: 208 KKNGADEIEEDYLDQVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD------ 261
             +  +    D+ +    L   F  E L+     F K+LG G FG V   T         
Sbjct: 12  GSSDNEYFYVDFREYEYDLKWEFPRENLE-----FGKVLGSGAFGKVMNATAYGISKTGV 66

Query: 262 GTKVAVKRL--EGIGEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNG 318
             +VAVK L  +      ++ ++E+K +  +  H+N+V L+G C       L++EY   G
Sbjct: 67  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126

Query: 319 SLDRWLFQRSDEF--------------------MLDWQQRKKIILDIAKGLTYLHEDCRQ 358
            L  +L  + ++F                    +L ++        +AKG+ +L     +
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---K 183

Query: 359 KILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTMRGTPGYLAPEWL-SSII 416
             +H D+  +N+L+      K+ DFGL++ I  D + VV    R    ++APE L   I 
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ 476
           T K D++S+G+++ EI           P + + Y   + +   + D+     ++      
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--KLIQNGFKMDQPFYATEE------ 295

Query: 477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                   +  +   C   D  KRPS   +   L 
Sbjct: 296 --------IYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 8e-56
 Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 32/287 (11%)

Query: 244 KMLGKGGFGSVFEGTQTDGT-----KVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLV 296
           K++G G FG V++G     +      VA+K L      +    FL E   +G   H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           RL G  ++    +++ EYM NG+LD++   R  +      Q   ++  IA G+ YL    
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMKYLA--- 127

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT--MRGTPGYLAPEWLSS 414
               +H D+  +NIL++ N   KV+DFGLS++++ D     TT   +    + APE +S 
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187

Query: 415 -IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
              T   D++SFG+VM E++   +         E M  +                     
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-----------------NDGF 230

Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFEHNL 520
            + +  +    + ++   C + + A+RP  + +V +L+ +     +L
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-55
 Identities = 69/294 (23%), Positives = 115/294 (39%), Gaps = 42/294 (14%)

Query: 227 PKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD---GTKVAVKRLE---GIGEINKSF 280
            K  + E+         K LG G FG+V +G          VAVK L+       +    
Sbjct: 5   RKLLTLED---------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55

Query: 281 LAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKK 340
           LAE   +  + +  +VR+IG C E    +LV E    G L+++L Q      +  +   +
Sbjct: 56  LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIE 111

Query: 341 IILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT- 399
           ++  ++ G+ YL        +H D+  +N+LL     AK++DFGLSK +  D++      
Sbjct: 112 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168

Query: 400 -MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKK 457
             +    + APE ++    + K D++SFGV+M E     +   R     E   +L   ++
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228

Query: 458 KAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                                      M  +   C   D   RP  + V   L 
Sbjct: 229 MGCPAGCPR-----------------EMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-54
 Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 27/268 (10%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKS-FLAEVKTIGSIHHQNLVRLIGF 301
           + +G+G  G+V+       G +VA++++    +  K   + E+  +    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 302 CAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKIL 361
                   +V EY+  GSL   + +       D  Q   +  +  + L +LH     +++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS---NQVI 138

Query: 362 HLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKV 420
           H DIK  NILL  + + K+ DFG    I  +QS+  +TM GTP ++APE ++      KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 421 DIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE 480
           DI+S G++ +E++ G   +    P      L  I      E +  + +            
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATNGTPELQNPEKLS----------A 244

Query: 481 EVVNMMKVAAWCLESDFAKRPSMSMVVR 508
              + +     CL+ D  KR S   +++
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-54
 Identities = 74/312 (23%), Positives = 136/312 (43%), Gaps = 47/312 (15%)

Query: 224 PGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTDG---TKVAVKRLEGIG--EINK 278
           P +     + ++K     F+ ++G+G FG V +            A+KR++     + ++
Sbjct: 1   PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 279 SFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR---------- 327
            F  E++ +  + HH N++ L+G C  + +  L  EY P+G+L  +L +           
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 328 ---SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFG 384
              S    L  QQ      D+A+G+ YL +   ++ +H D+  +NIL+  N+ AK+ADFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172

Query: 385 LSKLIDQDQSQVVTTMRGTPGYLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQ 443
           LS+  +    +  T  R    ++A E L  S+ T   D++S+GV++ EI+          
Sbjct: 173 LSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230

Query: 444 PEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
              E    L    +  +     D              EV ++M+    C      +RPS 
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDD--------------EVYDLMR---QCWREKPYERPSF 273

Query: 504 SMVVRVLEGVTE 515
           + ++  L  + E
Sbjct: 274 AQILVSLNRMLE 285

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-53
 Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 30/283 (10%)

Query: 242 FRKMLGKGGFGSVFEG----TQTDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNL 295
             + +G+G FG V +G     +     VA+K  +      + + FL E  T+    H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           V+LIG   E     ++ E    G L  +L  R  ++ LD          ++  L YL   
Sbjct: 71  VKLIGVITEN-PVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES- 126

Query: 356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS- 414
             ++ +H DI  +N+L+  N   K+ DFGLS+ ++       +  +    ++APE ++  
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
             T   D++ FGV M EIL       +     + +  +   ++                 
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP-------- 236

Query: 475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE 517
                     +  +   C   D ++RP  + +   L  + E E
Sbjct: 237 ---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-52
 Identities = 63/277 (22%), Positives = 117/277 (42%), Gaps = 32/277 (11%)

Query: 244 KMLGKGGFGSVFEGT-----QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQNLV 296
           K+LG G FG+V++G      +     VA+K L      + NK  L E   + S+ + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
           RL+G C   +   L+ + MP G L  ++ +  D      Q      + IAKG+ YL    
Sbjct: 75  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL---E 128

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT-MRGTPGYLAPEWLSS- 414
            ++++H D+  +N+L+    + K+ DFGL+KL+  ++ +      +    ++A E +   
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 415 IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
           I T + D++S+GV + E++          P  E   + SI +K     +           
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLPQPPICTID---- 241

Query: 475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                     +  +   C   D   RP    ++    
Sbjct: 242 ----------VYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 5e-52
 Identities = 67/285 (23%), Positives = 108/285 (37%), Gaps = 35/285 (12%)

Query: 240 DNFR--KMLGKGGFGSVFEG----TQTDGTKVAVKRLE----GIGEINKSFLAEVKTIGS 289
            + R  + LG G FG V  G           VAVK L+       E    F+ EV  + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           + H+NL+RL G         +V E  P GSL   L +    F+L      +  + +A+G+
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGM 124

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--TTMRGTPGYL 407
            YL     ++ +H D+  +N+LL      K+ DFGL + + Q+    V     +    + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 408 APEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSD 466
           APE L +   +   D + FGV + E+    +         +      I  K  +E +   
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLP 235

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
             +    D+            V   C       RP+   +   L 
Sbjct: 236 RPEDCPQDIY----------NVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-50
 Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 46/298 (15%)

Query: 242 FRKMLGKGGFGSVFEGTQT--------DGTKVAVKRL--EGIGEINKSFLAEVKTIGSI- 290
             K LG+G FG V                TKVAVK L  +   +     ++E++ +  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 291 HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR-------------SDEFMLDWQQ 337
            H+N++ L+G C +     ++ EY   G+L  +L  R             + E  L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV 397
                  +A+G+ YL     +K +H D+  +N+L+  +   K+ADFGL++ I        
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 398 T-TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF 455
           T   R    ++APE L   I T + D++SFGV++ EI           P EE   L  + 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLL 250

Query: 456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV 513
           K+    DK S+  ++              +  +   C  +  ++RP+   +V  L+ +
Sbjct: 251 KEGHRMDKPSNCTNE--------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  173 bits (440), Expect = 7e-50
 Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 30/288 (10%)

Query: 226 LPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINK-SFL 281
            P+    +   V+ D++   + LG G FG V   T+   G   A K +    E +K +  
Sbjct: 13  YPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR 71

Query: 282 AEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKI 341
            E++T+  + H  LV L     + +  +++YE+M  G L   +    ++  +   +  + 
Sbjct: 72  KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEY 129

Query: 342 ILDIAKGLTYLHEDCRQKILHLDIKPQNILL--DGNFNAKVADFGLSKLIDQDQSQVVTT 399
           +  + KGL ++HE      +HLD+KP+NI+     +   K+ DFGL+  +D  QS     
Sbjct: 130 MRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KV 184

Query: 400 MRGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
             GT  + APE      +    D++S GV+   +L G   F     +E      ++   K
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVK 238

Query: 459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
           + +  + D      +      E+  + ++     L +D   R ++   
Sbjct: 239 SCDWNMDDSAFSGIS------EDGKDFIR---KLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-49
 Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 36/279 (12%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN----KSFLAEVKTIG 288
           K   ++F+  K+LG+G F +V    +     + A+K LE    I          E   + 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
            + H   V+L     +         Y  NG L +++ +       D    +    +I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV-TTMRGTPGYL 407
           L YLH    + I+H D+KP+NILL+ + + ++ DFG +K++  +  Q    +  GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE-EDKLS 465
           +PE L+     +  D+++ G ++ +++ G   F              I K + +  +K  
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYDFPEKFF 234

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                          +  ++++     L  D  KR    
Sbjct: 235 --------------PKARDLVE---KLLVLDATKRLGCE 256

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-49
 Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 37/291 (12%)

Query: 242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRL--EGIGEINKSFLAEVKTIGSIHHQ 293
             + LG+G FG V+EG           T+VA+K +           FL E   +   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFM-------LDWQQRKKIILDIA 346
           ++VRL+G  ++    L++ E M  G L  +L                   +  ++  +IA
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI-DQDQSQVVTTMRGTPG 405
            G+ YL+     K +H D+  +N ++  +F  K+ DFG+++ I + D  +          
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 406 YLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           +++PE L   + T   D++SFGVV+ EI    +   +    E+ +       +   E  L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFVMEGGL 253

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
            D  D   + +           ++   C + +   RPS   ++  ++   E
Sbjct: 254 LDKPDNCPDMLF----------ELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-49
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 44/299 (14%)

Query: 242 FRKMLGKGGFGSVFEGT------QTDGTKVAVKRL--EGIGEINKSFLAEVKTIGSI-HH 292
             K LG+G FG V E              VAVK L        +++ ++E+K +  I HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 293 QNLVRLIGFCAEKSHNL-LVYEYMPNGSLDRWLFQRSDEFM-------------LDWQQR 338
            N+V L+G C +    L ++ E+   G+L  +L  + +EF+             L  +  
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 339 KKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT 398
                 +AKG+ +L     +K +H D+  +NILL      K+ DFGL++ I +D   V  
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 399 T-MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK 456
              R    ++APE +   + T + D++SFGV++ EI                + +   F 
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFC 247

Query: 457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE 515
           ++ +E       D  + +M           +    C   + ++RP+ S +V  L  + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 7e-49
 Identities = 45/275 (16%), Positives = 105/275 (38%), Gaps = 28/275 (10%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLV 296
           + +   + LG+G FG V    +T        K ++  G        E+  +    H+N++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L          ++++E++    +   +   +  F L+ ++    +  + + L +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 357 RQKILHLDIKPQNILLD--GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS 414
              I H DI+P+NI+     +   K+ +FG ++ +    +     +   P Y APE    
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQH 177

Query: 415 -IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN 473
            +++   D++S G ++  +L G   F     ++    + +I   +               
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAE---------YTFDEE 225

Query: 474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
             +    E ++ +      L  +   R + S  ++
Sbjct: 226 AFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  166 bits (421), Expect = 4e-48
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 44/288 (15%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL----------EGIGEINKSFLAEVKT 286
           +N+   ++LG+G    V          + AVK +          E + E+ ++ L EV  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 287 IGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDI 345
           +  +  H N+++L       +   LV++ M  G L  +L ++     L  ++ +KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
            + +  LH+     I+H D+KP+NILLD + N K+ DFG S  +D  +   +  + GTP 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174

Query: 406 YLAPEWLSS-------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK 458
           YLAPE +            ++VD++S GV+M  +L G   F   +       L  I    
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMSGN 231

Query: 459 AEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
            +    S   D +S+ ++           + +  L     KR +    
Sbjct: 232 YQFG--SPEWDDYSDTVKD----------LVSRFLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (420), Expect = 1e-47
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 26/283 (9%)

Query: 232 FEELKVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL--EGIGEINKSFLAEVKT 286
           +++ + + D +    +LG G F  V           VA+K +  + +     S   E+  
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 287 IGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIA 346
           +  I H N+V L        H  L+ + +  G L   + ++        +   ++I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117

Query: 347 KGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGY 406
             + YLH+                 LD +    ++DFGLSK+ D     V++T  GTPGY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175

Query: 407 LAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS 465
           +APE L+    ++ VD +S GV+   +LCG   F      +       I K + E D  S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAEYEFD--S 230

Query: 466 DLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
              D  S       +   + ++     +E D  KR +    ++
Sbjct: 231 PYWDDIS-------DSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-47
 Identities = 80/358 (22%), Positives = 137/358 (38%), Gaps = 52/358 (14%)

Query: 222 QVPGLPKRFSFEELKVMTDNFRKMLGKGGFGSVFEGTQTD-GTKVAVKRLEGIGEINKSF 280
           Q P  P+  S+ + KV        +G G FG V++    D G  VA+K++    +  +  
Sbjct: 12  QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK 60

Query: 281 LAEVKTIGSIHHQNLVRLIGFCAE------KSHNLLVYEYMPNGSLDRWLFQRSDEFMLD 334
             E++ +  + H N+VRL  F         + +  LV +Y+P             +  L 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120

Query: 335 WQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQ 393
               K  +  + + L Y+H      I H DIKPQN+LLD +    K+ DFG +K + + +
Sbjct: 121 VIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

Query: 394 SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL 451
                +   +  Y APE +  ++  T  +D++S G V+ E+L G+ +F      ++ + +
Sbjct: 178 PN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

Query: 452 LSIFKKKAEEDKLSDLVDKHSNDMQSNG-------------EEVVNMMKVAAWCLESDFA 498
           + +      E       +                        E + +       LE    
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPT 292

Query: 499 KRPSMSMVVRVLEGVTEFEHNLHYNLVHLPI---TAALANVDHREENDKP--TTQLLP 551
            R +             F   L    V LP    T AL N   +E +  P   T L+P
Sbjct: 293 ARLTPLEACA-----HSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-46
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 22/280 (7%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIG 300
             +G+G +G V       +  +VA+K++         +  L E+K +    H+N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 301 FCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKI 360
                +   +   Y+    +   L++      L        +  I +GL Y+H      +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANV 130

Query: 361 LHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ--VVTTMRGTPGYLAPEWL--SSII 416
           LH D+KP N+LL+   + K+ DFGL+++ D D      +T    T  Y APE +  S   
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 417 TEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ 476
           T+ +DI+S G ++ E+L  R +F      ++  ++L I    ++ED    +  K  N + 
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 477 SNGEEVVNMMK------------VAAWCLESDFAKRPSMS 504
           S   +                  +    L  +  KR  + 
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (416), Expect = 2e-46
 Identities = 61/276 (22%), Positives = 115/276 (41%), Gaps = 29/276 (10%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINK-SFLAEVKTIGSIHHQNL 295
           D +   + LG G FG V    +   G     K +     ++K +   E+  +  +HH  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           + L     +K   +L+ E++  G L   +     ++ +   +    +    +GL ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 356 CRQKILHLDIKPQNILLDGNFNA--KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
               I+HLDIKP+NI+ +    +  K+ DFGL+  ++ D  ++V     T  + APE + 
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 201

Query: 414 S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS 472
              +    D+++ GV+   +L G   F      E    L ++ +   E D   D     S
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCDWEFD--EDAFSSVS 256

Query: 473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                   E  + +K     L+ +  KR ++   + 
Sbjct: 257 -------PEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-46
 Identities = 65/282 (23%), Positives = 116/282 (41%), Gaps = 31/282 (10%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRL------EGIGEINKSFLAEVKTIGSIHHQNLV 296
             LG+G F +V++         VA+K++      E    IN++ L E+K +  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 297 RLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC 356
            L+     KS+  LV+++M           + +  +L     K  +L   +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 357 RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSSI- 415
              ILH D+KP N+LLD N   K+ADFGL+K       +  T    T  Y APE L    
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGAR 176

Query: 416 -ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND 474
                VD+++ G ++ E+L            ++   +        EE             
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 475 MQSN------------GEEVVNMMKVAAWCLESDFAKRPSMS 504
            +S             G++++++++        +   R + +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITAT 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 7e-46
 Identities = 61/296 (20%), Positives = 112/296 (37%), Gaps = 40/296 (13%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL----EGIGEINKSFLAEVKTIG 288
             ++D +   ++LG GG   V           VAVK L             F  E +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 289 SIHHQNLVRLIGFCAEKSHNL----LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILD 344
           +++H  +V +      ++       +V EY+   +L   +        +  ++  ++I D
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIAD 119

Query: 345 IAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV--TTMRG 402
             + L +     +  I+H D+KP NI++      KV DFG+++ I    + V     + G
Sbjct: 120 ACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 403 TPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE 461
           T  YL+PE      +  + D+YS G V+ E+L G   F    P         +  +   E
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVRE 229

Query: 462 DKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVRVLEG 512
           D +       S   +    ++  ++      L  +   R        + +VRV  G
Sbjct: 230 DPIPP-----SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (407), Expect = 4e-45
 Identities = 54/277 (19%), Positives = 109/277 (39%), Gaps = 39/277 (14%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTD-GTKVAVKRL-------EGIGEINKSFLAEVKTIGS 289
           ++F   +++G+GGFG V+   + D G   A+K L       +    +  +    +  + +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 290 IHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
                +V +            + + M  G L   L Q     +      +    +I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAP 409
            ++H    + +++ D+KP NILLD + + +++D GL+    + +        GT GY+AP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAP 174

Query: 410 EWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEE-DKLSD 466
           E L          D +S G ++ ++L G   F + + +++            E  D  S 
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS- 233

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
                         E+ ++++     L+ D  +R   
Sbjct: 234 -------------PELRSLLE---GLLQRDVNRRLGC 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 27/290 (9%)

Query: 239 TDNFR--KMLGKGGFGSVFEGT--QTDGTKVAVKRL------EGIGEINKSFLAEVKTIG 288
              +     +G+G +G VF+    +  G  VA+KR+      EG+       +A ++ + 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRW---LFQRSDEFMLDWQQRKKIILDI 345
           +  H N+VRL   C     +      +    +D+       +  E  +  +  K ++  +
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 346 AKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPG 405
            +GL +LH     +++H D+KPQNIL+  +   K+ADFGL+++     +   T++  T  
Sbjct: 126 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 180

Query: 406 YLAPEWL-SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL 464
           Y APE L  S     VD++S G +  E+   + +F  S   ++   +L +     EED  
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 465 SDLVDKHSNDMQSNGEEVVNMMKVA--------AWCLESDFAKRPSMSMV 506
            D+          + + +   +             CL  + AKR S    
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 3e-44
 Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 33/292 (11%)

Query: 234 ELKVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI 290
           EL+V  + +R  + +G G FG ++ GT    G +VA+K    +   +     E K    +
Sbjct: 2   ELRV-GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMM 59

Query: 291 HHQNLVRLIGFC-AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
                +  I +C AE  +N++V E +     D + F          +    +   +   +
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRI 116

Query: 350 TYLHEDCRQKILHLDIKPQNIL---LDGNFNAKVADFGLSKLIDQDQSQVV------TTM 400
            Y+H    +  +H D+KP N L           + DFGL+K     ++           +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 401 RGTPGYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKA 459
            GT  Y +      I  + + D+ S G V++    G   +   +   +         ++ 
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERI 228

Query: 460 EEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
            E K+S  ++           E    +    +C    F  +P  S + ++  
Sbjct: 229 SEKKMSTPIEVLCKGYP---SEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 61/281 (21%), Positives = 117/281 (41%), Gaps = 32/281 (11%)

Query: 236 KVMTDNFR---KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIH 291
             + D+++   ++LG G  G V +        K A+K L+   +  +      +   +  
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR---ASQ 63

Query: 292 HQNLVRLIGFC----AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAK 347
             ++VR++       A +   L+V E +  G L   +  R D+     ++  +I+  I +
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGE 122

Query: 348 GLTYLHEDCRQKILHLDIKPQNILLDGNFN---AKVADFGLSKLIDQDQSQVVTTMRGTP 404
            + YLH      I H D+KP+N+L          K+ DFG +K      S   TT   TP
Sbjct: 123 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTP 177

Query: 405 GYLAPEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK 463
            Y+APE L      +  D++S GV+M  +LCG   F  +        + +  +       
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---- 233

Query: 464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                +  + +     EEV  +++     L+++  +R +++
Sbjct: 234 ----YEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTIT 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-43
 Identities = 56/278 (20%), Positives = 100/278 (35%), Gaps = 46/278 (16%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRL-------EGIGEINKSFLAEVKTIGSIH--HQ 293
            +LG GGFGSV+ G +  D   VA+K +        G          EV  +  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
            ++RL+ +       +L+ E                   L  +  +     + + + + H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH 127

Query: 354 EDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
                 +LH DIK +NIL+D N    K+ DFG   L+        T   GT  Y  PEW+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181

Query: 413 S--SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
                      ++S G+++ +++CG   F+  +                   ++S     
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------RQRVS----- 228

Query: 471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                     E  ++++   WCL    + RP+   +  
Sbjct: 229 ---------SECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  152 bits (384), Expect = 1e-42
 Identities = 58/286 (20%), Positives = 119/286 (41%), Gaps = 24/286 (8%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE---INKSFLAEVKTIGSIHHQN 294
           + +   + +G+G +G V++     G   A+K++    E   I  + + E+  +  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 295 LVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHE 354
           +V+L      K   +LV+E++                 L+    K  +L +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118

Query: 355 DCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL-- 412
              +++LH D+KPQN+L++     K+ADFGL++       +    +  T  Y AP+ L  
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMG 174

Query: 413 SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-----KLSDL 467
           S   +  +DI+S G +  E++ G  +F      ++ M +  I      ++     +L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 468 VDKHSNDMQSNGEEVVNMMKVAA-----WCLESDFAKRPSMSMVVR 508
               +       E  +  +  +        L+ D  +R +    + 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLE----GIGEINKSFLAEVKTIGSIHH 292
            +F+  + LG G FG V       +G   A+K L+       +  +    E   +  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 293 QNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYL 352
             ++R+ G   +     ++ +Y+  G L   L +            K    ++   L YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120

Query: 353 HEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL 412
           H    + I++ D+KP+NILLD N + K+ DFG +K +         T+ GTP Y+APE +
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVV 173

Query: 413 SS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEE 446
           S+    + +D +SFG+++ E+L G   F  S   +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 68/273 (24%), Positives = 109/273 (39%), Gaps = 35/273 (12%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEIN----KSFLAEVKTIG-SIH 291
           ++F   KMLGKG FG VF           A+K L+    +     +  + E + +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
           H  L  +      K +   V EY+  G L   +         D  +      +I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
           LH    + I++ D+K  NILLD + + K+ADFG+ K      ++   T  GTP Y+APE 
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEI 174

Query: 412 LS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
           L        VD +SFGV++ E+L G+  F     EE  ++             L      
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNPFYPRWLE----- 227

Query: 471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
                    +E  +++         +  KR  +
Sbjct: 228 ---------KEAKDLLV---KLFVREPEKRLGV 248

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 3e-41
 Identities = 52/284 (18%), Positives = 94/284 (33%), Gaps = 32/284 (11%)

Query: 242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSI-HHQNLVRLI 299
             + +G+G FG +FEGT   +  +VA+K              E +T   +     +  + 
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
            F  E  HN+LV + +     D              +        +   +  +HE   + 
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 360 ILHLDIKPQNILLD-----GNFNAKVADFGLSKLIDQDQSQVV------TTMRGTPGYLA 408
           +++ DIKP N L+            V DFG+ K      ++          + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 409 PE-WLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
               L    + + D+ + G V +  L G   +   +          I +KK +   L +L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLREL 240

Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE 511
                       EE    M    +     F   P    +  +  
Sbjct: 241 CAGFP-------EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 5e-41
 Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 24/285 (8%)

Query: 240 DNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQ 293
           +NF+  + +G+G +G V++      G  VA+K++        +  + + E+  +  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 294 NLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
           N+V+L+     ++   LV+E++            S    +     K  +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL- 412
                ++LH D+KPQN+L++     K+ADFGL++       +  T    T  Y APE L 
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILL 175

Query: 413 -SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-----KLSD 466
                +  VDI+S G +  E++  R +F      ++   +        E        + D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 467 LVDKHSNDMQSNGEEVVNMMKVAA-----WCLESDFAKRPSMSMV 506
                    + +  +VV  +           L  D  KR S    
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-40
 Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 36/278 (12%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRL-------EGIGEINKSFLAEVKTIGSIHHQNL 295
           + LG G F  V +  +   G + A K +          G   +    EV  +  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 296 VRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHED 355
           + L      K+  +L+ E +  G L  +L ++     L  ++  + +  I  G   ++  
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNG---VYYL 129

Query: 356 CRQKILHLDIKPQNILLD----GNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEW 411
              +I H D+KP+NI+L          K+ DFGL+  ID         + GTP ++APE 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187

Query: 412 LSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK 470
           ++   +  + D++S GV+   +L G   F     ++E +  +S    + E++  S+    
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNT--- 243

Query: 471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR 508
                        + ++     L  D  KR ++   ++
Sbjct: 244 --------SALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 58/293 (19%), Positives = 108/293 (36%), Gaps = 36/293 (12%)

Query: 244 KMLGKGGFGSVFEGT-QTDGTKVAVKRL---EGIGEINKSFLAEVKTIGSIHHQNLVRLI 299
             +G+G FG VF+   +  G KVA+K++           + L E+K +  + H+N+V LI
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 300 GFCAE--------KSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTY 351
             C          K    LV+++  +                   + K+++  +   L  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML---LNG 129

Query: 352 LHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS---QVVTTMRGTPGYLA 408
           L+   R KILH D+K  N+L+  +   K+ADFGL++     ++      T    T  Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 409 PEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEE-------------EDMYLLS 453
           PE L         +D++  G +M E+     +   +  +               +++   
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 454 IFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMV 506
              +  E+ +L     +   D           + +    L  D A+R      
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-38
 Identities = 71/276 (25%), Positives = 111/276 (40%), Gaps = 34/276 (12%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKS----FLAEVKTIG 288
           KV  ++F   K+LGKG FG V    +   G   A+K L     I K      + E + + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 289 SIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           +  H  L  L            V EY   G L   L +     +   ++ +    +I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSA 117

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLA 408
           L        + +++ DIK +N++LD + + K+ DFGL K    D + + T   GTP YLA
Sbjct: 118 L---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173

Query: 409 PEWLSSI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL 467
           PE L        VD +  GVVM E++CGR  F     E   ++ L + ++      LS  
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEIRFPRTLS-- 229

Query: 468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSM 503
                        E  +++      L+ D  +R   
Sbjct: 230 ------------PEAKSLLA---GLLKKDPKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-37
 Identities = 54/282 (19%), Positives = 112/282 (39%), Gaps = 24/282 (8%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLI 299
           + +G+G +G+VF+         VA+KR+        +  S L E+  +  + H+N+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 300 GFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK 359
                     LV+E+        +         LD +  K  +  + KGL + H    + 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 360 ILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWL--SSIIT 417
           +LH D+KPQN+L++ N   K+A+FGL++       +  +    T  Y  P+ L  + + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 418 EKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS 477
             +D++S G +  E+    +        ++ +  +        E++   +          
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 478 NGEEVVNMMKVA-----------AWCLESDFAKRPSMSMVVR 508
                 +++ V               L+ +  +R S    ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 62/307 (20%), Positives = 122/307 (39%), Gaps = 42/307 (13%)

Query: 230 FSFEELKVMTDNFR------KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKS 279
           F  +E+       R      + +G G +G+V        G KVA+K+L          K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 280 FLAEVKTIGSIHHQNLVRLIGFCAEKSHN------LLVYEYMPNGSLDRWLFQRSDEFML 333
              E++ +  + H+N++ L+                LV  +M          ++     L
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----L 118

Query: 334 DWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ 393
              + + ++  + KGL Y+H      I+H D+KP N+ ++ +   K+ DFGL++  D + 
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175

Query: 394 SQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL 451
               T    T  Y APE +      T+ VDI+S G +M E++ G+ +F  S   ++   +
Sbjct: 176 ----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231

Query: 452 LSI-------FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAA-----WCLESDFAK 499
           + +       F ++ + D+  + +       + +   ++      A       L  D  +
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291

Query: 500 RPSMSMV 506
           R +    
Sbjct: 292 RVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (342), Expect = 3e-36
 Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 19/249 (7%)

Query: 207 RKKNGADEIEEDYLDQVPGLPKRFSFEELKVMT-DNFR--KMLGKGGFGSVFEGTQT-DG 262
           +K +  + ++E          K++          D F   K LG G FG V        G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 263 TKVAVKRLEGIGEIN----KSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG 318
              A+K L+    +     +  L E + + +++   LV+L     + S+  +V EY+  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA 378
            +   L +            +     I     YLH      +++ D+KP+N+L+D     
Sbjct: 127 EMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180

Query: 379 KVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRK 437
           +V DFG +K +         T+ GTP  LAPE + S    + VD ++ GV++ E+  G  
Sbjct: 181 QVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 438 VFDRSQPEE 446
            F   QP +
Sbjct: 237 PFFADQPIQ 245

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 57/314 (18%), Positives = 120/314 (38%), Gaps = 50/314 (15%)

Query: 227 PKRFSFEELKVMT---DNFR--KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSF 280
            + + +E   V     D+++  + LG+G +  VFE    T+  KV VK L+ + +  K  
Sbjct: 19  REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKI 76

Query: 281 LAEVKTIGSI-HHQNLVRLIGFCAEKSHNL--LVYEYMPNGSLDRWLFQRSDEFMLDWQQ 337
             E+K + ++    N++ L     +       LV+E++ N    +          L    
Sbjct: 77  KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYD 130

Query: 338 RKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLIDQDQSQV 396
            +  + +I K L Y H      I+H D+KP N+++D  +   ++ D+GL++     Q   
Sbjct: 131 IRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 397 VTTMRGTPGYLAPEWLSSI--ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSI 454
                 +  +  PE L         +D++S G ++  ++  ++ F       + +  ++ 
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA- 244

Query: 455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAW----------------------C 492
             K    + L D +DK++ ++     +++       W                       
Sbjct: 245 --KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

Query: 493 LESDFAKRPSMSMV 506
           L  D   R +    
Sbjct: 303 LRYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 36/284 (12%)

Query: 236 KVMTDNFR--KMLGKGGFGSVFEGTQT----DGTKVAVKRLEGIGEINKS-----FLAEV 284
           KV  +NF   K+LG G +G VF   +      G   A+K L+    + K+        E 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 285 KTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIIL 343
           + +  I     LV L      ++   L+ +Y+  G L   L QR         + +  + 
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVG 136

Query: 344 DIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGT 403
           +I   L +LH+     I++ DIK +NILLD N +  + DFGLSK    D+++      GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 404 PGYLAPEWLS---SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE 460
             Y+AP+ +    S   + VD +S GV+M E+L G   F     +        I ++  +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILK 250

Query: 461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
            +       + S           ++++     L  D  KR    
Sbjct: 251 SE--PPYPQEMS-------ALAKDLIQ---RLLMKDPKKRLGCG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 1e-31
 Identities = 65/306 (21%), Positives = 126/306 (41%), Gaps = 36/306 (11%)

Query: 224 PGLPKRFSFEELKVMTDNFR--KMLGKGGFGSVFEGTQT-DGTKVAVKRL---EGIGEIN 277
           P   ++   + +  + + ++    +G G +GSV     T  G +VAVK+L          
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 278 KSFLAEVKTIGSIHHQNLVRLIGFCAEKS-----HNLLVYEYMPNGSLDRWLFQRSDEFM 332
           K    E++ +  + H+N++ L+            +++ +  ++    L+  +  +     
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----K 117

Query: 333 LDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD 392
           L     + +I  I +GL Y+H      I+H D+KP N+ ++ +   K+ DFGL++  D +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 393 QSQVVTTMRGTPGYLAPEWL--SSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMY 450
                T    T  Y APE +       + VDI+S G +M E+L GR +F  +   ++   
Sbjct: 175 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 451 LLSI-------FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAA-----WCLESDFA 498
           +L +         KK   +   + +   +   + N   V       A       L  D  
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 499 KRPSMS 504
           KR + +
Sbjct: 291 KRITAA 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (300), Expect = 2e-30
 Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 22/230 (9%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLI 299
           K +G G  G V           VA+K+L          K    E+  +  ++H+N++ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 300 GFCA------EKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLH 353
                     E     LV E M          +       D ++   ++  +  G+ +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLH 136

Query: 354 EDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS 413
                   H D+KP NI++  +   K+ DFGL++          T    T  Y APE + 
Sbjct: 137 SAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVIL 191

Query: 414 SI-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED 462
            +   E VDI+S G +M E++  + +F      ++   ++        E 
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 8e-28
 Identities = 55/281 (19%), Positives = 112/281 (39%), Gaps = 22/281 (7%)

Query: 244 KMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFC 302
           + LG G F +V+      + T VA+K + G     ++   E+K +  ++  +  +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 303 AEKSHNLLVY-------------EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGL 349
           A     LL +              +   G     L ++ +   +     K+I   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 350 TYLHEDCRQKILHLDIKPQNILLDGN-FNAKVADFGLSKLIDQDQS-QVVTTMRGTPGYL 407
            Y+H   R  I+H DIKP+N+L++       +    ++ L +     +  T    T  Y 
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 408 APEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPE---EEDMYLLSIFKKKAEEDK 463
           +PE L  +      DI+S   ++ E++ G  +F+  +     ++D ++  I +   E   
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMS 504
                 K++    ++   + N+ K+  W LE    ++   S
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.4 bits (208), Expect = 2e-19
 Identities = 25/167 (14%), Positives = 54/167 (32%), Gaps = 29/167 (17%)

Query: 244 KMLGKGGFGSVFEGTQTDGTKVAVKRLE-----------GIGEINKSFLAEVKTIGSIHH 292
           K++G+G   +VF        +  VK  +                +  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 293 QNLVRLIGFCAEKSH----NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKG 348
           + L +L G    K +    N ++ E +    L R             +   +++  I + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMILEE 115

Query: 349 LTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ 395
           +   +      I+H D+   N+L+       + DF  S  + ++  +
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	558
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.63
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.15
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.55
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.76
d2qj2a1	91	Hepatocyte growth factor {Human (Homo sapiens) [Ta	85.09

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=404.58  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=197.1

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|++.+++..++||||+++|+|.
T Consensus         9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~   88 (263)
T d1sm2a_           9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   88 (263)
T ss_dssp             EEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence            45789999999999999988889999999877777788999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++.....  .+++..++.++.|||.||.|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus        89 ~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          89 DYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             HHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             HHhhcccc--CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            99876443  48999999999999999999999   99999999999999999999999999999877655444444567


Q ss_pred             CCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ||+.|+|||++.+ .++.++|||||||++|||+|+..|+.......   .+.....    .+..  .        ..+..
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~----~~~~--~--------~~p~~  226 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS----TGFR--L--------YKPRL  226 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHH----HTCC--C--------CCCTT
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----hcCC--C--------CCccc
Confidence            8999999999875 69999999999999999999654443322221   1111111    1100  0        01112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++.+||+.||++||||++|++.|+++.+
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            23478899999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-52  Score=408.55  Aligned_cols=265  Identities=27%  Similarity=0.486  Sum_probs=203.8

Q ss_pred             ccCHHHHHHHHHHhh-----------hhcCccCceEEEEEEeC-CCC---EEEEEEeccc--ccchHHHHHHHHHHhccC
Q 043292          229 RFSFEELKVMTDNFR-----------KMLGKGGFGSVFEGTQT-DGT---KVAVKRLEGI--GEINKSFLAEVKTIGSIH  291 (558)
Q Consensus       229 ~~~~~~l~~~t~~~~-----------~~lG~G~fg~Vy~~~~~-~~~---~vavK~l~~~--~~~~~~~~~E~~~l~~l~  291 (558)
                      .++|+++..++.+|.           ++||+|+||+||+|++. +++   .||||.+...  ....++|.+|++++++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            577888888888874           47999999999999874 332   5889988643  334567999999999999


Q ss_pred             CcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEe
Q 043292          292 HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNIL  371 (558)
Q Consensus       292 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIl  371 (558)
                      |||||+++|++.+++..++||||+++|+|.+++.....  .++|.+++.++.|||+||.|||+   .+|+||||||+|||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL  160 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence            99999999999999999999999999999999876443  49999999999999999999999   99999999999999


Q ss_pred             ecCCCCeEEcccCCccccCCCCCce----eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 043292          372 LDGNFNAKVADFGLSKLIDQDQSQV----VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPE  445 (558)
Q Consensus       372 l~~~~~~ki~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~  445 (558)
                      |+.++.+||+|||+++.........    .....||+.|||||.+. +.++.++|||||||++|||+| |+.||......
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999998765433221    12245789999999986 469999999999999999998 89999765432


Q ss_pred             chhhhHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          446 EEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      +    +...+    ..+..       +   +.+......+.+++.+||+.||.+||||.+|++.|+.+.+-
T Consensus       241 ~----~~~~i----~~~~~-------~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         241 D----VINAI----EQDYR-------L---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             H----HHHHH----HTTCC-------C---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H----HHHHH----HcCCC-------C---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            2    11111    11110       0   11223345788999999999999999999999999987543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=399.35  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=204.5

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.++||+|+||.||+|++.+++.||||+++......++|.+|+.++++++|||||+++|++.+ +..++||||+++|+|.
T Consensus        17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~   95 (272)
T d1qpca_          17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV   95 (272)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred             EeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence            357899999999999999888899999998776677889999999999999999999998865 5679999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      +++..... ..+++..+++|+.||++||.|||+   .+|+||||||+||||++++.+||+|||+|+..............
T Consensus        96 ~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (272)
T d1qpca_          96 DFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (272)
T ss_dssp             HHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence            98765432 238999999999999999999999   99999999999999999999999999999987655444445677


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ||+.|+|||++. +.++.++|||||||++|||+||..|+.......   .+...    ...+..     ..     .+..
T Consensus       172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~----i~~~~~-----~~-----~p~~  234 (272)
T d1qpca_         172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LERGYR-----MV-----RPDN  234 (272)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCC-----CC-----CCTT
T ss_pred             CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHhcCC-----CC-----Cccc
Confidence            899999999987 569999999999999999999766654333221   11111    111110     00     1112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      ....+.+|+.+||+.||++||||++|+++|+..
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            234688999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-51  Score=400.12  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=210.2

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.++||+|+||+||+|++. +++.||||+++......++|.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l  100 (287)
T d1opja_          21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL  100 (287)
T ss_dssp             EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence            3578999999999999985 588999999987766778899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++..... ..+++..++.|+.||+.||+|||+   .+|+||||||+||||++++.+||+|||+|+.............
T Consensus       101 ~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_         101 LDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             HHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             HHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            999976543 359999999999999999999999   8999999999999999999999999999998766555445556


Q ss_pred             cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .|++.|+|||++. +.++.++|||||||++|||++|..|+........   +....    ..+...          ..+.
T Consensus       177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---~~~~i----~~~~~~----------~~~~  239 (287)
T d1opja_         177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDYRM----------ERPE  239 (287)
T ss_dssp             EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----HTTCCC----------CCCT
T ss_pred             cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---HHHHH----hcCCCC----------CCCc
Confidence            6899999999876 5799999999999999999998777654333221   11111    111100          1111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .....+.+|+..||+.||++||||++|++.|+.+.+
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            223578899999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=391.21  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=210.3

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      |.++||+|+||+||+|+..+++.||||+++......++|.+|+.++++++||||++++|++.+++..++||||+++|+|.
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            45789999999999999988889999999877777789999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      .++.....  .+++..+.+++.||++||.|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus        88 ~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          88 NYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             HHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             Hhhhcccc--CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            99875443  38999999999999999999999   99999999999999999999999999999877655444445577


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      ||+.|+|||.+. +.++.++||||||+++|||+| |+.||......+    +..    ....+...          ..+.
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~~----~i~~~~~~----------~~p~  224 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAE----HIAQGLRL----------YRPH  224 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHH----HHHTTCCC----------CCCT
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HHH----HHHhCCCC----------CCcc
Confidence            899999999986 569999999999999999998 899997665332    111    11111100          0111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                      .....+.+++.+||+.||++|||+++|++.|.++
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            2235788999999999999999999999998654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=394.76  Aligned_cols=252  Identities=23%  Similarity=0.427  Sum_probs=197.8

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||+||+|+..  ..||||+++..   ....+.|.+|+.++++++|||||++++++.+ +..++||||+++|+
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            478999999999999864  36999998643   3345789999999999999999999999765 56899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-ceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~  398 (558)
                      |.+++.....  .+++..+..|+.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+|+....... ....
T Consensus        90 L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~  164 (276)
T d1uwha_          90 LYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE  164 (276)
T ss_dssp             HHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred             HHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence            9999975543  39999999999999999999999   8999999999999999999999999999987654332 2344


Q ss_pred             cccCCCCcCChhhhcC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          399 TMRGTPGYLAPEWLSS----IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~----~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ...||+.|||||++.+    .++.++|||||||++|||+||+.||........   +...............        
T Consensus       165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~--------  233 (276)
T d1uwha_         165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSK--------  233 (276)
T ss_dssp             -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCCCCGGG--------
T ss_pred             ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCcchh--------
Confidence            6789999999999852    478999999999999999999999986554331   1111111111111111        


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                        ........+.+++.+||+.||++||||++|++.|+.+.+
T Consensus       234 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         234 --VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             --SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              111223578899999999999999999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=383.49  Aligned_cols=242  Identities=26%  Similarity=0.450  Sum_probs=195.5

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeecc----CCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAE----KSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  313 (558)
                      |.++||+|+||+||+|+.. +++.||+|.+....   ...+.|.+|++++++++|||||++++++.+    +...++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3467999999999999984 68899999986432   234578999999999999999999999864    345689999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCc--EEecCCCCCCEeec-CCCCeEEcccCCccccC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQK--ILHLDIKPQNILLD-GNFNAKVADFGLSKLID  390 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~dlk~~NIll~-~~~~~ki~Dfgla~~~~  390 (558)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+   .+  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        93 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999997654   38999999999999999999998   66  99999999999996 57899999999998654


Q ss_pred             CCCCceeecccCCCCcCChhhhcCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSSIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDK  470 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  470 (558)
                      ..   ......||+.|||||++.+.++.++|||||||++|||++|+.||........   +.    +....+.....++.
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~~----~~i~~~~~~~~~~~  236 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IY----RRVTSGVKPASFDK  236 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HH----HHHTTTCCCGGGGG
T ss_pred             CC---ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---HH----HHHHcCCCCcccCc
Confidence            32   2345789999999999998899999999999999999999999975443221   11    11111111111111


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                               .....+.+++.+||+.||++|||+.|+++
T Consensus       237 ---------~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         237 ---------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     11235788999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-50  Score=388.01  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .+.||+|+||+||+|+. .+++.||||++...  ....+.+.+|++++++++|||||++++++.+++..+|||||+++|+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~   89 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   89 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence            47899999999999998 57899999998643  2334678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-ceee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-QVVT  398 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~  398 (558)
                      |.+++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+....... ....
T Consensus        90 L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~  163 (271)
T d1nvra_          90 LFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  163 (271)
T ss_dssp             GGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence            999996543   49999999999999999999999   9999999999999999999999999999997654332 2245


Q ss_pred             cccCCCCcCChhhhcC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ...||+.|||||++.+ . .+.++|||||||++|||++|+.||..........  .. ..   .......          
T Consensus       164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~-~~---~~~~~~~----------  227 (271)
T d1nvra_         164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-WK---EKKTYLN----------  227 (271)
T ss_dssp             CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH-HH---TTCTTST----------
T ss_pred             ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH-Hh---cCCCCCC----------
Confidence            6789999999999875 3 4678999999999999999999997655432111  11 10   0000000          


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00111246778999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=388.32  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=199.4

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCHH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSLD  321 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  321 (558)
                      +.+.||+|+||.||+|++.+++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|+|.
T Consensus        21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~   99 (285)
T d1fmka3          21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL   99 (285)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred             EeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchh
Confidence            457899999999999999888899999998777677889999999999999999999999865 5679999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeeccc
Q 043292          322 RWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTMR  401 (558)
Q Consensus       322 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~  401 (558)
                      .++..... ..++|.+++.++.||+.||+|||+   .+|+||||||+||||+.++++||+|||+++..............
T Consensus       100 ~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  175 (285)
T d1fmka3         100 DFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  175 (285)
T ss_dssp             HHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             hhhhhccc-ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceeecccc
Confidence            99875432 249999999999999999999999   89999999999999999999999999999877655444445577


Q ss_pred             CCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCHH
Q 043292          402 GTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNGE  480 (558)
Q Consensus       402 gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  480 (558)
                      ||+.|+|||++. +.++.++||||||+++|||++|..|+........   +...+.    .+...          +....
T Consensus       176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---~~~~i~----~~~~~----------~~~~~  238 (285)
T d1fmka3         176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE----RGYRM----------PCPPE  238 (285)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTCCC----------CCCTT
T ss_pred             ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHH----hcCCC----------CCCcc
Confidence            899999999986 5799999999999999999997766654333221   111111    11100          11112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          481 EVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       481 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ....+.+++.+||+.||++||||++|+++|+....
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            23478899999999999999999999999988654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=387.68  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=195.9

Q ss_pred             hhhcCccCceEEEEEEeCCC-----CEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQTDG-----TKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||.||+|.+...     ..||||+++..  .....+|.+|+.++++++|||||+++|++.+.+..++||||+
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~   91 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM   91 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence            47899999999999987532     36999999643  233457999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      .++++.+++.....  .++|.++++++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++........
T Consensus        92 ~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          92 ENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             TTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             ccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            99999998876543  49999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             --eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 --VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 --~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+........   +...    ...+..        
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~----i~~~~~--------  231 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKA----INDGFR--------  231 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHTTCC--------
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---HHHH----HhccCC--------
Confidence              2234568999999998874 699999999999999999997666544332221   1111    111110        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEFE  517 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  517 (558)
                        .+.+......+.+|+.+||+.||++||||.+|+++|+.+.+..
T Consensus       232 --~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         232 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence              0111223457899999999999999999999999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=387.62  Aligned_cols=242  Identities=26%  Similarity=0.424  Sum_probs=200.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++|||||++++++.+++..++||||+++|+|
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L  104 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence            47899999999999987 579999999987433 3456799999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.+.    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+..... .....
T Consensus       105 ~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~  176 (293)
T d1yhwa1         105 TDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (293)
T ss_dssp             HHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred             HHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccccc
Confidence            9988754    39999999999999999999999   9999999999999999999999999999997654332 34567


Q ss_pred             cCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCCH
Q 043292          401 RGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSNG  479 (558)
Q Consensus       401 ~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  479 (558)
                      .||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+.   +...    ...... .        .....
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~----~~~~~~-~--------~~~~~  240 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLI----ATNGTP-E--------LQNPE  240 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHHCSC-C--------CSSGG
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---HHHH----HhCCCC-C--------CCCcc
Confidence            79999999999976 589999999999999999999999975443221   1111    111110 0        01111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          480 EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       480 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .....+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22346889999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=382.92  Aligned_cols=239  Identities=30%  Similarity=0.484  Sum_probs=199.5

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||+||+++. .+++.||+|++...    ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~   89 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   89 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            357899999999999998 46899999998632    3345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+......   
T Consensus        90 ~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---  160 (263)
T d2j4za1          90 LGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  160 (263)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred             CCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence            999999998654   39999999999999999999999   999999999999999999999999999998654332   


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+    +   ... ......      .    
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~---~~~-i~~~~~------~----  222 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----T---YKR-ISRVEF------T----  222 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HHH-HHTTCC------C----
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----H---HHH-HHcCCC------C----
Confidence            345679999999999986 48999999999999999999999997644322    1   111 111110      0    


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                       .+......+.+++.+||+.||++|||++|+++
T Consensus       223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             01112346788999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=386.47  Aligned_cols=245  Identities=28%  Similarity=0.454  Sum_probs=196.2

Q ss_pred             hhcCccCceEEEEEEeC---CCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQT---DGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      ++||+|+||+||+|.+.   .++.||||+++..   ....++|.+|++++++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999863   3568999999643   2234679999999999999999999999865 567899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce-
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV-  396 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-  396 (558)
                      |+|.+++....   .+++..+++++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998654   39999999999999999999999   899999999999999999999999999998765443332 


Q ss_pred             -eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          397 -VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       397 -~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       .....||+.|+|||.+. +.++.++|||||||++|||++ |+.||......+    +...    ...+...        
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~----i~~~~~~--------  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM----LEKGERM--------  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----HHTTCCC--------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----HHHH----HHcCCCC--------
Confidence             23467899999999886 468999999999999999998 899997654322    1111    1111110        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                        ..+......+.+|+.+||+.||++|||+++|+++|+..
T Consensus       230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              11112235788999999999999999999999988653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=386.33  Aligned_cols=245  Identities=26%  Similarity=0.453  Sum_probs=199.2

Q ss_pred             hcCccCceEEEEEEeC---CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          245 MLGKGGFGSVFEGTQT---DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       245 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +||+|+||.||+|...   ++..||||+++..  ....++|.+|++++++++|||||+++|++.+ +..+|||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999763   3457999999743  2335679999999999999999999999865 56899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce--e
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV--V  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--~  397 (558)
                      |.+++.....  .+++..+++++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.......  .
T Consensus        95 L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          95 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             HHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            9999865433  49999999999999999999999   999999999999999999999999999999775543322  2


Q ss_pred             ecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          398 TTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      ....||+.|+|||++. +.++.++|||||||++|||+| |+.||......+    +..    ....+...+         
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~----~i~~~~~~~---------  232 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMA----FIEQGKRME---------  232 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHH----HHHTTCCCC---------
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----HHH----HHHcCCCCC---------
Confidence            3456899999999986 569999999999999999998 899998655432    111    111111111         


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                       .+......+.+|+.+||+.||++||||.+|++.|+..
T Consensus       233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1112335788999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=387.80  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=199.5

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc-ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      .+.||+|+||.||+|+. .+++.||||+++.. ....+.|.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L   96 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence            46899999999999998 56899999999743 34457799999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+...... ......
T Consensus        97 ~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~  170 (288)
T d2jfla1          97 DAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF  170 (288)
T ss_dssp             HHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence            999875432  49999999999999999999999   999999999999999999999999999997654321 123456


Q ss_pred             cCCCCcCChhhhc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          401 RGTPGYLAPEWLS------SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       401 ~gt~~y~aPE~~~------~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      .||+.|+|||++.      ..++.++|||||||++|||++|+.||...+..+.   +..+..     +...        .
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~-----~~~~--------~  234 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAK-----SEPP--------T  234 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHH-----SCCC--------C
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHc-----CCCC--------C
Confidence            7999999999873      2478999999999999999999999986654331   111111     1100        0


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0111122347889999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=388.75  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=200.5

Q ss_pred             hhhhcCccCceEEEEEEeCC-C-----CEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD-G-----TKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||+||+|+... +     ..||||.+...  ......+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus        41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (325)
T d1rjba_          41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF  120 (325)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence            45789999999999998632 2     36999998643  33456799999999998 8999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEee
Q 043292          313 EYMPNGSLDRWLFQRSD--------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILL  372 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll  372 (558)
                      ||+++|+|.++|..+..                    ...+++..++.++.||+.||+|||+   .+|+||||||+|||+
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill  197 (325)
T d1rjba_         121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV  197 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred             EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcccc
Confidence            99999999999976432                    1348999999999999999999999   999999999999999


Q ss_pred             cCCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043292          373 DGNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDM  449 (558)
Q Consensus       373 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~  449 (558)
                      +.++.+||+|||+|+........ ......||+.|||||++. +.++.++|||||||++|||+| |+.||.+......  
T Consensus       198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--  275 (325)
T d1rjba_         198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--  275 (325)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred             ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999876554433 233566899999999886 579999999999999999998 8999986554331  


Q ss_pred             hHHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 043292          450 YLLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLE  511 (558)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  511 (558)
                       +.....    .+..       +   ..+......+.+|+.+||+.||++|||+++|+++|.
T Consensus       276 -~~~~~~----~~~~-------~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         276 -FYKLIQ----NGFK-------M---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -HHHHHH----TTCC-------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHh----cCCC-------C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence             111111    1110       0   111122357889999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=381.47  Aligned_cols=247  Identities=25%  Similarity=0.415  Sum_probs=185.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeecc--CCcceEEEEeCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAE--KSHNLLVYEYMP  316 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  316 (558)
                      .+.||+|+||.||+++. .+|+.||||.+....   ...+.+.+|++++++++|||||++++++.+  ++..++||||++
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~   88 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   88 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence            47899999999999987 578999999997432   234568999999999999999999998865  455789999999


Q ss_pred             CCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHhhhhccccC--CCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          317 NGSLDRWLFQRS-DEFMLDWQQRKKIILDIAKGLTYLHEDC--RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       317 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +|+|.+++.+.. ....+++..++.++.||+.||.|||+..  ..+|+||||||+||||+.++.+||+|||+|+.+....
T Consensus        89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            999999987532 2335999999999999999999999821  1249999999999999999999999999999775433


Q ss_pred             CceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . ......||+.|||||++.+ .++.++|||||||++|||++|+.||...+..+    +.    .....+....+     
T Consensus       169 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~----~~i~~~~~~~~-----  234 (269)
T d2java1         169 S-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LA----GKIREGKFRRI-----  234 (269)
T ss_dssp             --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH----HHHHHTCCCCC-----
T ss_pred             C-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HH----HHHHcCCCCCC-----
Confidence            2 2445789999999999875 59999999999999999999999997544322    11    11111111111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           +......+.+++.+||+.||.+|||+.|+++
T Consensus       235 -----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 -----PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 1112346889999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=390.34  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||+||+|+. .+++.||+|+++..  .....++.+|+.++++++|||||++++++.+.++.++||||+++|+
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~   90 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   90 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence            47899999999999997 56899999998743  3335678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      |.+++.+..   .+++..+..++.|++.||.|||+  +.+|+||||||+||||++++.+||+|||+|+......   ...
T Consensus        91 L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~  162 (322)
T d1s9ja_          91 LDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS  162 (322)
T ss_dssp             HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C--
T ss_pred             HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---ccc
Confidence            999998654   39999999999999999999997  1489999999999999999999999999998764322   345


Q ss_pred             ccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh------------------
Q 043292          400 MRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE------------------  460 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------------  460 (558)
                      ..||+.|+|||++.+ .++.++||||+||+++||++|+.||...+..+..............                  
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM  242 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred             ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence            689999999999976 6999999999999999999999999875543321110000000000                  


Q ss_pred             ----cccchhhc----cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          461 ----EDKLSDLV----DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       461 ----~~~~~~~~----d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                          .....+..    ...... .........+.+++.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         243 DSRPPMAIFELLDYIVNEPPPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---CCCCHHHHHHHHHTSCCCC-CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccchhHHHHHhhhhccCCcc-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                00000000    000000 000112346888999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-48  Score=383.63  Aligned_cols=238  Identities=24%  Similarity=0.398  Sum_probs=195.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||+||+|+. .+++.||||+++...    ...+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            46799999999999987 568899999987432    2335689999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++..+.   .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+|+....     .
T Consensus       100 g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~  168 (309)
T d1u5ra_         100 SASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A  168 (309)
T ss_dssp             EHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred             CchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence            99987766543   39999999999999999999999   9999999999999999999999999999986543     2


Q ss_pred             ecccCCCCcCChhhhc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          398 TTMRGTPGYLAPEWLS----SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~----~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ....||+.|||||++.    +.++.++|||||||++|||++|+.||......+.   +.    .... ........    
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~~----~i~~-~~~~~~~~----  236 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY----HIAQ-NESPALQS----  236 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----HHHH-SCCCCCSC----
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---HH----HHHh-CCCCCCCC----
Confidence            3467999999999985    3489999999999999999999999975443221   11    1111 11111111    


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                           ......+.+++.+||+.||.+|||++++++
T Consensus       237 -----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 -----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                 112347889999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=380.42  Aligned_cols=242  Identities=22%  Similarity=0.361  Sum_probs=196.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||+||+|+. .+++.||||++...    ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~   91 (288)
T d1uu3a_          12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK   91 (288)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence            457899999999999998 57899999998632    2344679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC-c
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS-Q  395 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~  395 (558)
                      +|+|.+++....   .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus        92 gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          92 NGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999987654   39999999999999999999999   9999999999999999999999999999997754332 2


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+    +   .... .....      ..  
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~---~~~i-~~~~~------~~--  229 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----I---FQKI-IKLEY------DF--  229 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHH-HTTCC------CC--
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----H---HHHH-HcCCC------CC--
Confidence            3345779999999999976 58999999999999999999999998654322    1   1111 11111      00  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                         +......+.+++.+||+.||.+|||++|+++
T Consensus       230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               1112346789999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=383.39  Aligned_cols=264  Identities=26%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCC----cceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS----HNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g  318 (558)
                      .+.||+|+||.||+|++ +|+.||||+++........+..|+..+.+++|||||++++++.+.+    ..++||||+++|
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g   86 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence            47899999999999996 5889999999755433333445566667889999999999997654    468999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccC-----CCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDC-----RQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      +|.++|++..    ++|..+++++.|+|.||.|||+..     .++|+||||||+||||+.++.+||+|||+++......
T Consensus        87 ~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~  162 (303)
T d1vjya_          87 SLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             BHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             CHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence            9999998643    999999999999999999999631     3699999999999999999999999999998775433


Q ss_pred             Cc---eeecccCCCCcCChhhhcCC-------CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh-------hHHHHHH
Q 043292          394 SQ---VVTTMRGTPGYLAPEWLSSI-------ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDM-------YLLSIFK  456 (558)
Q Consensus       394 ~~---~~~~~~gt~~y~aPE~~~~~-------~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~-------~~~~~~~  456 (558)
                      ..   ......||+.|+|||++.+.       ++.++|||||||+||||+||..|+..........       .......
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T d1vjya_         163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR  242 (303)
T ss_dssp             TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred             cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence            22   23356799999999998743       5678999999999999999988875433221100       0011111


Q ss_pred             HhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          457 KKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       457 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      .....    ..+++.+.......+....+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus       243 ~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         243 KVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            11111    11122222222233456779999999999999999999999999988754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-47  Score=380.28  Aligned_cols=245  Identities=27%  Similarity=0.437  Sum_probs=183.7

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      +.+.||+|+||+||+++.. +++.||||++...  ....+.+.+|+.++++++|||||++++++.+++..+|||||+++|
T Consensus        13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg   92 (307)
T d1a06a_          13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG   92 (307)
T ss_dssp             EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            4578999999999999984 6899999998643  233456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec---CCCCeEEcccCCccccCCCCCc
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      +|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++   +++.+||+|||+|+......  
T Consensus        93 ~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--  164 (307)
T d1a06a_          93 ELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--  164 (307)
T ss_dssp             BHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             cHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence            9999997643   49999999999999999999999   9999999999999994   57899999999998664332  


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|||||++.+ .++.++|||||||++|||++|+.||......+    +..   ... .....  +..    
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~---~i~-~~~~~--~~~----  230 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFE---QIL-KAEYE--FDS----  230 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH---HHH-TTCCC--CCT----
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHH---HHh-ccCCC--CCC----
Confidence            2345679999999999876 58999999999999999999999997544322    111   111 11100  000    


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       .........+.+++.+||+.||++|||++|+++.
T Consensus       231 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         231 -PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             0111223468899999999999999999999973

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-47  Score=379.93  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=202.6

Q ss_pred             hhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .+.||+|+||+||+|+..      +++.||||+++...  ...++|.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~   97 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY   97 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence            578999999999999863      35789999997432  3356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec
Q 043292          315 MPNGSLDRWLFQRSD---------------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD  373 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~  373 (558)
                      +++|+|.+++.....                     ...+++..++.|+.||+.||+|||+   .+|+||||||+||||+
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld  174 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG  174 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEEC
Confidence            999999999975321                     2348999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEcccCCccccCCCCCc-eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhh
Q 043292          374 GNFNAKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGR-KVFDRSQPEEEDMY  450 (558)
Q Consensus       374 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~  450 (558)
                      .++.+||+|||+++........ ..+...|++.|+|||.+.+ .++.++|||||||++|||++|. .||......+    
T Consensus       175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e----  250 (301)
T d1lufa_         175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----  250 (301)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----
T ss_pred             CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH----
Confidence            9999999999999866443322 2345678899999998874 6999999999999999999986 5666543322    


Q ss_pred             HHHHHHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          451 LLSIFKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      +..    ....+.....          +...+..+.+|+.+||+.||++||||.+|+++|+++.+
T Consensus       251 ~~~----~v~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         251 VIY----YVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHH----HHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHH----HHHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111    1112221111          11223478899999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=370.60  Aligned_cols=245  Identities=32%  Similarity=0.475  Sum_probs=192.5

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL  320 (558)
                      |.++||+|+||.||+|++. |..||||+++... ..++|.+|++++++++||||++++|++.+ .+..++||||+++|+|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L   88 (262)
T d1byga_          11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   88 (262)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence            4578999999999999985 7889999997543 45779999999999999999999999865 4567999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeecc
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTTM  400 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~  400 (558)
                      .++|..+.. ..++|..+++|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    ....
T Consensus        89 ~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~  160 (262)
T d1byga_          89 VDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTG  160 (262)
T ss_dssp             HHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHhcCC-CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----Cccc
Confidence            999975432 238999999999999999999999   99999999999999999999999999999865432    2345


Q ss_pred             cCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCCC
Q 043292          401 RGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQSN  478 (558)
Q Consensus       401 ~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  478 (558)
                      .++..|+|||++. +.+++++||||||+++|||+| |+.||......+    +...    ...+...+          .+
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~----i~~~~~~~----------~~  222 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR----VEKGYKMD----------AP  222 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHH----HTTTCCCC----------CC
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHH----HHcCCCCC----------CC
Confidence            6789999999886 579999999999999999998 677776554332    1111    11111111          11


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          479 GEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       479 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ......+.+++.+||+.||++||||.+|+++|+.+.
T Consensus       223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            122347889999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=372.22  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=191.0

Q ss_pred             hhhhcCccCceEEEEEEeCC----CCEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQTD----GTKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||.||+|++..    +..||||.++..  ....+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus        11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~   89 (273)
T d1mp8a_          11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC   89 (273)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence            35789999999999998742    346899988643  333467999999999999999999999986 46789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....  .+++..++.++.||+.||.|||+   .+|+||||||+||++++++.+||+|||+|+........
T Consensus        90 ~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          90 TLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             TTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             cCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            99999998875443  48999999999999999999999   99999999999999999999999999999977655444


Q ss_pred             eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          396 VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                      ......||+.|+|||++. +.++.++|||||||++|||++ |..||......+    +...    ...+....       
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~----i~~~~~~~-------  229 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGR----IENGERLP-------  229 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH----HHTTCCCC-------
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHH----HHcCCCCC-------
Confidence            455677899999999986 569999999999999999998 889997665443    1111    11111111       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          474 DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       474 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         .+......+.+|+..||+.||++|||+.+|++.|+.+.+
T Consensus       230 ---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         230 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               111223578899999999999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=376.90  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             HhhhhcCccCceEEEEEEeCCC----CEEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeecc-CCcceEEEE
Q 043292          241 NFRKMLGKGGFGSVFEGTQTDG----TKVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE-KSHNLLVYE  313 (558)
Q Consensus       241 ~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  313 (558)
                      +|.++||+|+||+||+|++.+.    ..||||+++..  ....++|.+|++++++++||||++++|++.. +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999987432    25899999743  3345679999999999999999999999875 457899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++|+|.+++.....  .+++..+++++.|++.||.|||+   .+|+||||||+||||++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999876543  37899999999999999999999   999999999999999999999999999998765433


Q ss_pred             Cc---eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          394 SQ---VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       394 ~~---~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ..   ......||+.|+|||.+. +.++.++||||||+++|||++|..||........   +...    ...+...    
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~----i~~g~~~----  253 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRRL----  253 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH----HHTTCCC----
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC----
Confidence            22   123456899999999876 5799999999999999999998888764332111   1111    1111110    


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         .   .+......+.+++.+||+.||++||||.||++.|+.+.+
T Consensus       254 ---~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 ---L---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ---C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---C---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               0   011123478899999999999999999999999998864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-46  Score=378.81  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccccc-chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE-INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||+++. .+|+.||||++..... ..+.+.+|+.++.+++|||||++++++.+++..+|||||+++|+
T Consensus        30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~  109 (350)
T d1koaa2          30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE  109 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence            457899999999999997 5789999999975433 34678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCCCeEEcccCCccccCCCCCcee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.+++.+...  .+++..+..++.||+.||.|||+   .+|+||||||+|||++  .++.+||+|||+++.+....  ..
T Consensus       110 L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~  182 (350)
T d1koaa2         110 LFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SV  182 (350)
T ss_dssp             HHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--CE
T ss_pred             HHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--cc
Confidence            9999965432  49999999999999999999999   9999999999999996  46789999999998765433  24


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+.   +..+...   ........   .    
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~---~~~~~~~~---~----  249 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSC---DWNMDDSA---F----  249 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT---CCCSCCGG---G----
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhC---CCCCCccc---c----
Confidence            55789999999999876 589999999999999999999999976543221   1111110   00000000   0    


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                        ......+.+++.+||+.||++|||++|+++.
T Consensus       250 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         250 --SGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0112467889999999999999999999984

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-46  Score=379.17  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.++||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+.++++++|||||++++++.+++..+|||||+++|+
T Consensus        33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~  112 (352)
T d1koba_          33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE  112 (352)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence            357899999999999997 579999999987543 334568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec--CCCCeEEcccCCccccCCCCCcee
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD--GNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |.+++.....  .+++..+..|+.||+.||.|||+   .+|+||||||+||||+  .++.+||+|||+|+.+....  ..
T Consensus       113 L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~  185 (352)
T d1koba_         113 LFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV  185 (352)
T ss_dssp             HHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CE
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC--ce
Confidence            9988765432  49999999999999999999999   9999999999999998  67899999999999876543  34


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+    +..   .. ...... . ..     .
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~---~i-~~~~~~-~-~~-----~  250 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQ---NV-KRCDWE-F-DE-----D  250 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---HH-HHCCCC-C-CS-----S
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHH---HH-HhCCCC-C-Cc-----c
Confidence            55679999999999976 49999999999999999999999997554322    111   11 111100 0 00     0


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            001123467899999999999999999999873

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=368.91  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=198.7

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc-------ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI-------GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||+||+|+. .+|+.||||+++..       ....+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus        14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (293)
T d1jksa_          14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE   93 (293)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            347899999999999998 57999999998632       1235679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC----CeEEcccCCcccc
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF----NAKVADFGLSKLI  389 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~----~~ki~Dfgla~~~  389 (558)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++    .+||+|||+|...
T Consensus        94 ~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          94 LVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             cCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999997654   39999999999999999999999   9999999999999998877    4999999999876


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.   +..+. .  .........
T Consensus       168 ~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~-~--~~~~~~~~~  239 (293)
T d1jksa_         168 DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVS-A--VNYEFEDEY  239 (293)
T ss_dssp             TTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-T--TCCCCCHHH
T ss_pred             CCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHHHH-h--cCCCCCchh
Confidence            5432  2345678999999999986 599999999999999999999999986543221   11110 0  000011100


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..         .....+.+++.+||+.||++|||++++++
T Consensus       240 ~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         240 FS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC---------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00         11246788999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=376.33  Aligned_cols=248  Identities=27%  Similarity=0.476  Sum_probs=196.2

Q ss_pred             hhhcCccCceEEEEEEeC-CCC----EEEEEEeccc--ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGT----KVAVKRLEGI--GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      .++||+|+||+||+|+.. +|+    +||+|+++..  ....++|.+|++++++++|||||+++|++.++ ..++++||+
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~   92 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   92 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence            478999999999999874 444    6899988643  34567899999999999999999999999864 567889999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      .+|+|.+++.....  .+++..+++++.|||.||.|||+   .+|+||||||+|||++.++.+||+|||+|+........
T Consensus        93 ~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~  167 (317)
T d1xkka_          93 PFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  167 (317)
T ss_dssp             TTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred             cCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence            99999998876543  49999999999999999999999   89999999999999999999999999999977554333


Q ss_pred             e-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          396 V-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       396 ~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                      . .....||+.|+|||++. +.++.++|||||||++|||+| |..||......+    +......    +..       +
T Consensus       168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~~i~~----~~~-------~  232 (317)
T d1xkka_         168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEK----GER-------L  232 (317)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHHHHHH----TCC-------C
T ss_pred             ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHc----CCC-------C
Confidence            2 33456899999999876 569999999999999999998 788887655433    1111111    110       0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                         ..+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       233 ---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         233 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence               111123357889999999999999999999999988764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=370.96  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=190.5

Q ss_pred             hhhhcCccCceEEEEEEeC--CC--CEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT--DG--TKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.+.||+|+||.||+|+..  ++  ..||||+++..    ....++|.+|++++++++||||++++|++.+ ...++|||
T Consensus        12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e   90 (273)
T d1u46a_          12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE   90 (273)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence            3478999999999999863  23  36899988642    3334679999999999999999999999976 46789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+++|++.+.+..+..  .+++..+++++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++......
T Consensus        91 ~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          91 LAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             CCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            9999999998876543  39999999999999999999999   999999999999999999999999999999875543


Q ss_pred             Cce--eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          394 SQV--VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       394 ~~~--~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                      ...  .....|+..|+|||.+.+ .++.++||||||+++|||+| |+.||...+..+       ........+...+   
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~---  235 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERLP---  235 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCCCC---
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-------HHHHHHhCCCCCC---
Confidence            322  234567889999999874 58999999999999999998 899997554332       1111111111111   


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGV  513 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  513 (558)
                             .....+..+.+++.+||+.||++||||.+|+++|++.
T Consensus       236 -------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 -------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   1112234788999999999999999999999999763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=371.60  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=192.5

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccC-CcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEK-SHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~lv  311 (558)
                      +.++||+|+||.||+|+..      +++.||||+++..  ....+.+..|...+.++ +|+||+.+++++... ...++|
T Consensus        17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv   96 (299)
T d1ywna1          17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   96 (299)
T ss_dssp             EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred             EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence            3578999999999999853      3468999998743  23345688888888777 689999999987664 467899


Q ss_pred             EEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCe
Q 043292          312 YEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNA  378 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~  378 (558)
                      |||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+||||++++.+
T Consensus        97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~  173 (299)
T d1ywna1          97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV  173 (299)
T ss_dssp             EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcE
Confidence            999999999999975421             2358999999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhhHHHHH
Q 043292          379 KVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGR-KVFDRSQPEEEDMYLLSIF  455 (558)
Q Consensus       379 ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~  455 (558)
                      ||+|||+|+........ ......||+.|+|||.+. +.++.++|||||||++|||++|. .||......+.   +... 
T Consensus       174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---~~~~-  249 (299)
T d1ywna1         174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR-  249 (299)
T ss_dssp             EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---HHHH-
T ss_pred             EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---HHHH-
Confidence            99999999876543332 234567999999999886 46999999999999999999975 57765544331   1111 


Q ss_pred             HHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          456 KKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       456 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                         ...+.....          +......+.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus       250 ---~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         250 ---LKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ---HHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               111111111          111234688999999999999999999999999987643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-45  Score=367.49  Aligned_cols=239  Identities=26%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.+.||+|+||+||+++. .+|+.||||+++..    ....+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~   87 (316)
T d1fota_           8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   87 (316)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence            357899999999999998 56999999999632    2345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|..++.....   +++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+|+.....    
T Consensus        88 gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          88 GGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             SCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             Ccccccccccccc---ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence            9999999876553   8899999999999999999999   99999999999999999999999999999876432    


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|||||++.+ .++.++|||||||++|||++|+.||...+..+.       ..... .+..           
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~-~~~~-----------  218 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKIL-NAEL-----------  218 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH-HCCC-----------
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHH-cCCC-----------
Confidence            345789999999999986 489999999999999999999999976543221       11111 1110           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVRV  509 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  509 (558)
                      ..+......+.+++.+||+.||.+||     |++++++.
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            00111224678899999999999996     89999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=370.18  Aligned_cols=241  Identities=28%  Similarity=0.361  Sum_probs=199.8

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      +.++||+|+||.||+++. .+++.||||+++..    ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~   88 (337)
T d1o6la_           9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence            357899999999999998 57999999999742    2345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      +|+|.+++.....   +++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        89 gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~  161 (337)
T d1o6la_          89 GGELFFHLSRERV---FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT  161 (337)
T ss_dssp             TCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred             CCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence            9999999986543   8999999999999999999999   999999999999999999999999999998664332 23


Q ss_pred             eecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCC
Q 043292          397 VTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDM  475 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  475 (558)
                      .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...+..+    +.   ... ..+..           
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~---~~i-~~~~~-----------  222 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF---ELI-LMEEI-----------  222 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHH-HHCCC-----------
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HH---HHH-hcCCC-----------
Confidence            456789999999999975 59999999999999999999999998654322    11   111 11111           


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          476 QSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       476 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                      ..+......+.+++.+||+.||.+||+     ++++++
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            001112346788999999999999995     788875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=371.60  Aligned_cols=252  Identities=28%  Similarity=0.461  Sum_probs=198.4

Q ss_pred             hhhhcCccCceEEEEEEeC-CCC--EEEEEEeccc--ccchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGT--KVAVKRLEGI--GEINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.++||+|+||.||+|++. ++.  .||||+++..  ....+.|.+|++++.++ +|||||+++|++.+++..++||||+
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~   93 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   93 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence            3578999999999999884 344  4788887532  33455799999999998 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          316 PNGSLDRWLFQR-------------SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       316 ~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                      ++|+|.++|+..             .....+++..++.++.|||.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcc
Confidence            999999999754             223459999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCCC-CCCCCCCcchhhhHHHHHHHhhh
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGRK-VFDRSQPEEEDMYLLSIFKKKAE  460 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~  460 (558)
                      ||+++.......  .....||..|+|||.+. +.++.++||||||+++|||++|.. ||...+..+    +   ... ..
T Consensus       171 fG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~---~~~-i~  240 (309)
T d1fvra_         171 FGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----L---YEK-LP  240 (309)
T ss_dssp             TTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----H---HHH-GG
T ss_pred             cccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----H---HHH-HH
Confidence            999986543222  23456899999999986 469999999999999999999765 565443222    1   111 11


Q ss_pred             cccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccccc
Q 043292          461 EDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTEF  516 (558)
Q Consensus       461 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  516 (558)
                      .+...          ..+......+.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       241 ~~~~~----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         241 QGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GTCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11100          11112335788999999999999999999999999988653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-46  Score=369.07  Aligned_cols=253  Identities=28%  Similarity=0.485  Sum_probs=203.1

Q ss_pred             hhhhcCccCceEEEEEEe------CCCCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ------TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  312 (558)
                      +.++||+|+||.||+|++      .+++.||||+++...  ....+|.+|+.++.++ +|||||++++++.++...++||
T Consensus        27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm  106 (311)
T d1t46a_          27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT  106 (311)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence            457899999999999975      245689999997433  3345789999999999 6999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          313 EYMPNGSLDRWLFQRS---------------DEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ||+++|+|.+++....               ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.
T Consensus       107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~  183 (311)
T d1t46a_         107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRI  183 (311)
T ss_dssp             ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTE
T ss_pred             EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCc
Confidence            9999999999997643               12358999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++........ ......||+.|+|||.+. +.++.++||||||+++|||+| |.+|+......+.   +..+
T Consensus       184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---~~~~  260 (311)
T d1t46a_         184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FYKM  260 (311)
T ss_dssp             EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HHHH
T ss_pred             ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---HHHH
Confidence            999999999977554332 334567899999999886 569999999999999999999 5555554443321   1111


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                      ...    +..     .     ..+......+.+|+.+||+.||.+||||.+|+++|+++.
T Consensus       261 i~~----~~~-----~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         261 IKE----GFR-----M-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHH----TCC-----C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhc----CCC-----C-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            111    110     0     011122357899999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-45  Score=360.14  Aligned_cols=243  Identities=26%  Similarity=0.406  Sum_probs=197.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc----------cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----------EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  310 (558)
                      .+.||+|+||+||+++. .+++.||||+++...          ...+.+.+|+.++++++ ||||+++++++.+++..+|
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            57899999999999997 578999999986432          12246889999999997 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||+++|+|.+++..+.   .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        88 vmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          88 VFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            999999999999997654   39999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCcCChhhhcC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          391 QDQSQVVTTMRGTPGYLAPEWLSS-------IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       391 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      ...  ......||+.|+|||++.+       .++.++||||+||+++||++|+.||...+..+.    ..   . ...+.
T Consensus       162 ~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~----~~---~-i~~~~  231 (277)
T d1phka_         162 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LR---M-IMSGN  231 (277)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH---H-HHHTC
T ss_pred             CCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH----HH---H-HHhCC
Confidence            432  2355779999999998751       368899999999999999999999986543221    11   1 11111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      .. ....      ........+.+++.+||+.||++|||+.||++
T Consensus       232 ~~-~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 YQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CC-CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            10 0000      01112347889999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-45  Score=360.77  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc----cchHHHHHHHHHHhccCCcceeeeeeeeccCCc----ceEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG----EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSH----NLLVY  312 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~  312 (558)
                      +.+.||+|+||.||+++. .+++.||||+++...    ...+.|.+|+++++.++||||+++++++...+.    .++||
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence            357899999999999997 579999999997432    234568999999999999999999999876543    68999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+++++|.+++....   .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++..+|+|||.+......
T Consensus        91 E~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             ECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             ECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            9999999999987654   39999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CC--ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch-hhc
Q 043292          393 QS--QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS-DLV  468 (558)
Q Consensus       393 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  468 (558)
                      ..  .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+       ............ ...
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~  237 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPPSAR  237 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCCGGGT
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCCCCCchh
Confidence            22  22345679999999999876 58999999999999999999999997654322       111122111111 111


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcc
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRP-SMSMVVRVLEGV  513 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~  513 (558)
                      ..         .....+.+++.+||+.||.+|| |++++++.|.++
T Consensus       238 ~~---------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         238 HE---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             SS---------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cc---------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            11         1224788999999999999999 899999888765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=365.29  Aligned_cols=245  Identities=19%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             hhhhcCccCceEEEEEEeC-CCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          242 FRKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +.+.||+|+||+||+|... +++.||||.++........+.+|++++..++|||||++++++.+++..++||||+++|+|
T Consensus         9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L   88 (321)
T d1tkia_           9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI   88 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence            3478999999999999984 688999999987665566789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCC--CCeEEcccCCccccCCCCCceee
Q 043292          321 DRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGN--FNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       321 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~--~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      .+++.....  .+++.++..++.||+.||.|||+   .+|+||||||+|||++.+  ..+||+|||+++......  ...
T Consensus        89 ~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~  161 (321)
T d1tkia_          89 FERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFR  161 (321)
T ss_dssp             HHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEE
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC--ccc
Confidence            999976542  38999999999999999999999   999999999999999854  479999999998764432  344


Q ss_pred             cccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCCC
Q 043292          399 TMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQS  477 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  477 (558)
                      ...+|+.|+|||.+.+ .++.++||||+||++|||++|+.||......+.   +..+...   ...+......       
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~~i~~~---~~~~~~~~~~-------  228 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNA---EYTFDEEAFK-------  228 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT---CCCCCHHHHT-------
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC---CCCCChhhcc-------
Confidence            5678999999999876 489999999999999999999999976543221   1111100   0001000000       


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          478 NGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       478 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                        .....+.+++.+||+.||.+|||+.|+++
T Consensus       229 --~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         229 --EISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              01236789999999999999999999997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=368.43  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=198.9

Q ss_pred             hhhhcCccCceEEEEEEeCC--------CCEEEEEEecccc--cchHHHHHHHHHHhcc-CCcceeeeeeeeccCCcceE
Q 043292          242 FRKMLGKGGFGSVFEGTQTD--------GTKVAVKRLEGIG--EINKSFLAEVKTIGSI-HHQNLVRLIGFCAEKSHNLL  310 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  310 (558)
                      +.+.||+|+||.||+|+...        +..||||+++...  ....++.+|...+.++ +|||||++++++.++...++
T Consensus        17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~   96 (299)
T d1fgka_          17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV   96 (299)
T ss_dssp             EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence            34789999999999997632        2479999997533  3346788999999888 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC
Q 043292          311 VYEYMPNGSLDRWLFQRSD-------------EFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN  377 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~  377 (558)
                      ||||+++|+|.+++..+..             ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.
T Consensus        97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~  173 (299)
T d1fgka_          97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNV  173 (299)
T ss_dssp             EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCC
T ss_pred             EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCC
Confidence            9999999999999975431             2458999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCc-eeecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhhHHHH
Q 043292          378 AKVADFGLSKLIDQDQSQ-VVTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILC-GRKVFDRSQPEEEDMYLLSI  454 (558)
Q Consensus       378 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  454 (558)
                      +||+|||+++........ ......+++.|+|||.+. +.++.++||||||+++|||++ |..||.......    +.. 
T Consensus       174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----~~~-  248 (299)
T d1fgka_         174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFK-  248 (299)
T ss_dssp             EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHH-
T ss_pred             eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----HHH-
Confidence            999999999977544332 234567899999999886 579999999999999999998 688886544321    111 


Q ss_pred             HHHhhhcccchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          455 FKKKAEEDKLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       455 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                         ....+....          .+......+.+|+.+||+.||.+|||+.+|+++|+++..
T Consensus       249 ---~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         249 ---LLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ---HHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence               111111111          111123468899999999999999999999999988754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=367.08  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=194.0

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEeccccc------chHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGE------INKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMP  316 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  316 (558)
                      ++||+|+||+||+|+. .+++.||||+++....      ..+.+.+|+.++++++|||||++++++.++++.++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999998 4689999999864321      13468899999999999999999999999999999999998


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCce
Q 043292          317 NGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQV  396 (558)
Q Consensus       317 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~  396 (558)
                      ++++..+....   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus        84 ~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~  156 (299)
T d1ua2a_          84 TDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A  156 (299)
T ss_dssp             EEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred             chHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence            88776665432   248899999999999999999999   9999999999999999999999999999987654432 2


Q ss_pred             eecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc----c
Q 043292          397 VTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD----K  470 (558)
Q Consensus       397 ~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----~  470 (558)
                      .....||+.|+|||++.+  .++.++|||||||++|||++|..||......+....+........ .........    .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTSSTTCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhccchhh
Confidence            345679999999998863  479999999999999999999999976553331111111100000 000000000    0


Q ss_pred             cCCCCC-CCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSNDMQ-SNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~~~-~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ...... ...     .....+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000 011     11346889999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=364.38  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=202.7

Q ss_pred             hhhhcCccCceEEEEEEeC------CCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEE
Q 043292          242 FRKMLGKGGFGSVFEGTQT------DGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYE  313 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  313 (558)
                      +.++||+|+||+||+|.+.      +++.||||+++...  .....|.+|+.++++++||||+++++++...+..++|||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e  103 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME  103 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence            3478999999999999763      25789999997533  233568999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcC-------CCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCc
Q 043292          314 YMPNGSLDRWLFQR-------SDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLS  386 (558)
Q Consensus       314 ~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla  386 (558)
                      |+++|+|.+++...       .....+++..+.+++.|+|+||.|||+   .+|+||||||+|||+++++.+||+|||+|
T Consensus       104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla  180 (308)
T d1p4oa_         104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT  180 (308)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccc
Confidence            99999999998642       222347999999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCce-eecccCCCCcCChhhhc-CCCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhhHHHHHHHhhhccc
Q 043292          387 KLIDQDQSQV-VTTMRGTPGYLAPEWLS-SIITEKVDIYSFGVVMLEILCGR-KVFDRSQPEEEDMYLLSIFKKKAEEDK  463 (558)
Q Consensus       387 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~k~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  463 (558)
                      +......... .....||+.|+|||.+. +.++.++||||||+++|||+||. .||...+..+       +.... ..+.
T Consensus       181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i-~~~~  252 (308)
T d1p4oa_         181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFV-MEGG  252 (308)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHH-HTTC
T ss_pred             eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH-HhCC
Confidence            8765433322 23456899999999886 56899999999999999999985 6665433222       11111 1111


Q ss_pred             chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          464 LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       464 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ...          .+......+.+++.+||+.||.+||||.+|+++|++..+
T Consensus       253 ~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         253 LLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111          111223579999999999999999999999999988755

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.1e-45  Score=369.34  Aligned_cols=241  Identities=21%  Similarity=0.326  Sum_probs=193.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHH---HHHHHhccCCcceeeeeeeeccCCcceEEEEe
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLA---EVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  314 (558)
                      .++||+|+||.||+|+. .+|+.||||++...    ......+.+   |+.+++.++|||||++++++.+.+..++||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            47899999999999998 46999999998632    122233444   47778888999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCC
Q 043292          315 MPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~  394 (558)
                      +++|+|.+++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        89 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-  161 (364)
T d1omwa3          89 MNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  161 (364)
T ss_dssp             CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred             cCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence            99999999997654   38899999999999999999999   999999999999999999999999999998765432 


Q ss_pred             ceeecccCCCCcCChhhhc-C-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccC
Q 043292          395 QVVTTMRGTPGYLAPEWLS-S-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHS  472 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~-~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  472 (558)
                        .....||+.|+|||++. + .++.++|||||||++|||++|+.||......+..    ....... ..        ..
T Consensus       162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~-~~--------~~  226 (364)
T d1omwa3         162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL-TM--------AV  226 (364)
T ss_dssp             --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSS-SC--------CC
T ss_pred             --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcc-cC--------CC
Confidence              34567999999999986 4 4899999999999999999999999865544311    1111110 00        00


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          473 NDMQSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       473 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                         .........+.+++.+||+.||.+|||     ++++++
T Consensus       227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               001112346889999999999999999     688875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-45  Score=366.27  Aligned_cols=237  Identities=26%  Similarity=0.353  Sum_probs=197.6

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPN  317 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  317 (558)
                      .+.||+|+||.||+++. .+|+.||||++...    ....+.+.+|+++++.++|||||++++++.+....++||||+.+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~  125 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence            47899999999999998 57999999998632    23346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCcee
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      |+|..++.+..   .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+|+.....    .
T Consensus       126 g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~  195 (350)
T d1rdqe_         126 GEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             CBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             cchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----c
Confidence            99999997654   39999999999999999999999   99999999999999999999999999999876532    3


Q ss_pred             ecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCCCC
Q 043292          398 TTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSNDMQ  476 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  476 (558)
                      ....||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+...    +.   .... .+..        .   
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~---~~i~-~~~~--------~---  256 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IY---EKIV-SGKV--------R---  256 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHH-HCCC--------C---
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HH---HHHh-cCCC--------C---
Confidence            35679999999999876 48999999999999999999999997543221    11   1111 1110        0   


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 043292          477 SNGEEVVNMMKVAAWCLESDFAKRP-----SMSMVVR  508 (558)
Q Consensus       477 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  508 (558)
                      .+......+.+++.+||+.||.+|+     |++++++
T Consensus       257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            0111234688999999999999994     8999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=364.42  Aligned_cols=242  Identities=25%  Similarity=0.353  Sum_probs=191.9

Q ss_pred             hhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhc-cCCcceeeeeeeecc----CCcceEEEEeCCC
Q 043292          244 KMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGS-IHHQNLVRLIGFCAE----KSHNLLVYEYMPN  317 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~~~  317 (558)
                      ++||+|+||+||+|+. .+++.||||+++..    ..+.+|+.++.+ .+|||||++++++.+    +...++||||+++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999987 57899999998753    456789988655 489999999998865    4567999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC---CCCeEEcccCCccccCCCCC
Q 043292          318 GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG---NFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       318 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |+|.+++.++.. ..+++.++..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+|+...... 
T Consensus        94 g~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-  168 (335)
T d2ozaa1          94 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  168 (335)
T ss_dssp             EEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred             CcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCC-
Confidence            999999986433 349999999999999999999999   99999999999999985   5579999999998765433 


Q ss_pred             ceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCC
Q 043292          395 QVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSN  473 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  473 (558)
                       ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+.......+    ......+.        . 
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~--------~-  234 (335)
T d2ozaa1         169 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQ--------Y-  234 (335)
T ss_dssp             -CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS--------S-
T ss_pred             -ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCC--------C-
Confidence             2455779999999999876 5999999999999999999999999765443211100    00000000        0 


Q ss_pred             CCCCC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          474 DMQSN--GEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       474 ~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ..+..  ......+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00111  123457899999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=363.36  Aligned_cols=241  Identities=28%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEeccc----ccchHHHHHHHHHHh-ccCCcceeeeeeeeccCCcceEEEEeC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI----GEINKSFLAEVKTIG-SIHHQNLVRLIGFCAEKSHNLLVYEYM  315 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~  315 (558)
                      +.+.||+|+||+||+|+. .+++.||||+++..    ....+.+..|..++. .++|||||++++++.+++..++||||+
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~   85 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL   85 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence            457899999999999998 46899999999642    233456777777765 689999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      ++|+|.+++.....   +++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus        86 ~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~  158 (320)
T d1xjda_          86 NGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A  158 (320)
T ss_dssp             TTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred             CCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence            99999999986543   8999999999999999999999   999999999999999999999999999998665433 2


Q ss_pred             eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhccccCCC
Q 043292          396 VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVDKHSND  474 (558)
Q Consensus       396 ~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  474 (558)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+    +..   .. ..+..      .   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~---~i-~~~~~------~---  221 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFH---SI-RMDNP------F---  221 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HH-HHCCC------C---
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----HHH---HH-HcCCC------C---
Confidence            3455789999999999876 59999999999999999999999998654322    111   11 11110      0   


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 043292          475 MQSNGEEVVNMMKVAAWCLESDFAKRPSMS-MVVR  508 (558)
Q Consensus       475 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  508 (558)
                        .+......+.+|+.+||+.||++|||+. ++++
T Consensus       222 --~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              0111234688999999999999999995 6754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=355.17  Aligned_cols=258  Identities=23%  Similarity=0.372  Sum_probs=195.0

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .+.||+|+||+||+|+. .+++.||||+++...   ...+++.+|++++++++|||||++++++.++++.++||||+.++
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~   86 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD   86 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence            37899999999999997 579999999996432   23567999999999999999999999999999999999999654


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                       +..++.... ...+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||+|+...... ....
T Consensus        87 -~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~  160 (298)
T d1gz8a_          87 -LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT  160 (298)
T ss_dssp             -HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTT
T ss_pred             -hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-ccce
Confidence             444444332 2349999999999999999999999   999999999999999999999999999998765433 2344


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cccchhhc---c--
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--EDKLSDLV---D--  469 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---d--  469 (558)
                      ...||+.|+|||.+..  ..+.++|||||||++|||++|+.||...+..+.   +.........  +.......   +  
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccccccccc
Confidence            5679999999998764  368999999999999999999999986543221   1111111110  00000000   0  


Q ss_pred             -ccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          470 -KHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       470 -~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                       ..........     .....+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             0000000000     112467889999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.4e-44  Score=352.72  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             hhhcCccCceEEEEEEeCCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQTDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      .++||+|+||+||+|+..+++.||||+++..   ....+++.+|+.++++++||||+++++++.+++..++++||+.++.
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~   86 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL   86 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence            4789999999999999999999999999643   2335789999999999999999999999999999999999998777


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceeec
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVTT  399 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~  399 (558)
                      +..+.....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus        87 ~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  159 (286)
T d1ob3a_          87 KKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH  159 (286)
T ss_dssp             HHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             HHHHHhhcC---CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccce
Confidence            766655432   49999999999999999999999   9999999999999999999999999999987654322 2344


Q ss_pred             ccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhh--cccchhhc-----cc
Q 043292          400 MRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAE--EDKLSDLV-----DK  470 (558)
Q Consensus       400 ~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----d~  470 (558)
                      ..+++.|+|||.+.+  .++.++|||||||+++||++|+.||...+..+.   +..+......  ........     +.
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhhhhccc
Confidence            568999999999864  479999999999999999999999976543321   1111111100  00000000     00


Q ss_pred             cCCC------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          471 HSND------MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       471 ~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ....      ..........+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000      0001112346789999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=349.40  Aligned_cols=233  Identities=24%  Similarity=0.470  Sum_probs=189.2

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccc-------cchHHHHHHHHHHhccC--CcceeeeeeeeccCCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG-------EINKSFLAEVKTIGSIH--HQNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  311 (558)
                      +.++||+|+||+||+|+. .+++.||||+++...       ....++.+|+.++++++  |||||++++++.+++..++|
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv   87 (273)
T d1xwsa_           8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI   87 (273)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence            347899999999999998 578999999986421       11234678999999986  89999999999999999999


Q ss_pred             EEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-CCCeEEcccCCcccc
Q 043292          312 YEYMPN-GSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-NFNAKVADFGLSKLI  389 (558)
Q Consensus       312 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-~~~~ki~Dfgla~~~  389 (558)
                      |||+.+ +++.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++. ++.+||+|||+|+..
T Consensus        88 ~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          88 LERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceec
Confidence            999975 67888876544   39999999999999999999999   99999999999999985 478999999999865


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-I-ITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      ...   ..+...||+.|+|||++.+ . .+.++|||||||++|||++|+.||....         .+.     .+..  .
T Consensus       162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~-----~~~~--~  222 (273)
T d1xwsa_         162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EII-----RGQV--F  222 (273)
T ss_dssp             CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH-----HCCC--C
T ss_pred             ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHh-----hccc--C
Confidence            432   2446789999999999864 3 4677999999999999999999996321         000     0000  0


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      +..         .....+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         223 FRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC---------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111         11246889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=351.28  Aligned_cols=260  Identities=26%  Similarity=0.353  Sum_probs=189.4

Q ss_pred             hhhcCccCceEEEEEEe-CC-CCEEEEEEeccc---ccchHHHHHHHHHHhcc---CCcceeeeeeeecc-----CCcce
Q 043292          243 RKMLGKGGFGSVFEGTQ-TD-GTKVAVKRLEGI---GEINKSFLAEVKTIGSI---HHQNLVRLIGFCAE-----KSHNL  309 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~~~  309 (558)
                      .++||+|+||+||++++ .+ ++.||||+++..   ......+.+|+.+++.+   +||||+++++++..     ....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            47899999999999987 34 567999998632   22233566777776665   79999999998853     34678


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCcccc
Q 043292          310 LVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLI  389 (558)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~  389 (558)
                      ++|||+.++++........  ..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        92 ~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             EEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            9999998887765544333  348999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhccc-----
Q 043292          390 DQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDK-----  463 (558)
Q Consensus       390 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  463 (558)
                      ...  .......||+.|+|||++.+ .++.++||||+||++|||++|+.||...+..+....+............     
T Consensus       167 ~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         167 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             ccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            433  23456789999999999865 6999999999999999999999999866543321111111100000000     


Q ss_pred             c-hhhccccC-C-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          464 L-SDLVDKHS-N-DMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       464 ~-~~~~d~~~-~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      . ...+.... . ...........+.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0 00000000 0 000011123467889999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=354.38  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=192.7

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeeeeeeeccC------CcceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRLIGFCAEK------SHNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~  315 (558)
                      .++||+|+||+||+|++ .+++.||||++.....   .+.+|++++++++|+||+++++++...      .+.+|||||+
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~  101 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  101 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence            36799999999999998 4699999999975432   234799999999999999999998543      2468999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCC
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~  394 (558)
                      +++.+..+.........+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||+++...... 
T Consensus       102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-  177 (350)
T d1q5ka_         102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-  177 (350)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-
T ss_pred             CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCc-
Confidence            876554444332333459999999999999999999999   9999999999999999775 89999999998765433 


Q ss_pred             ceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHH-------HHhhhcc---
Q 043292          395 QVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIF-------KKKAEED---  462 (558)
Q Consensus       395 ~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~---  462 (558)
                       ......||..|+|||.+.+  .++.++||||+||++|||++|+.||......+....+....       .......   
T Consensus       178 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         178 -PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             -CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             -ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence             2345679999999998753  58999999999999999999999997655333211111110       0000000   


Q ss_pred             -cchhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcccc
Q 043292          463 -KLSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVTE  515 (558)
Q Consensus       463 -~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~~  515 (558)
                       .+.......... .........+.+|+.+||+.||++|||+.|+++.  ++++.+
T Consensus       257 ~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         257 FKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence             000000000000 0011123468899999999999999999999963  555544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-42  Score=342.34  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEeccc---ccchHHHHHHHHHHhccCCcceeeeeeeecc--------CCcceE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGI---GEINKSFLAEVKTIGSIHHQNLVRLIGFCAE--------KSHNLL  310 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~l  310 (558)
                      .++||+|+||+||+|+. .+|+.||||++...   .....++.+|+.++++++|||++++++++..        ....++
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i   94 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL   94 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence            47899999999999998 57999999998532   2345678999999999999999999998755        345789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccC
Q 043292          311 VYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLID  390 (558)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~  390 (558)
                      ||||++++.+..+....   ..++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 v~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          95 VFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             EEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            99999887766554332   248899999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCCc---eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccc-
Q 043292          391 QDQSQ---VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKL-  464 (558)
Q Consensus       391 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  464 (558)
                      .....   ......||+.|+|||.+.+  .++.++|||||||+++||++|+.||.+....+....+...... ...... 
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~  247 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVWP  247 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTST
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CChhhcc
Confidence            33221   2234579999999999864  4899999999999999999999999765433221111111100 000000 


Q ss_pred             -------hhhccccCCCCCCCHHH-------HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          465 -------SDLVDKHSNDMQSNGEE-------VVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       465 -------~~~~d~~~~~~~~~~~~-------~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                             ...+.... ........       ...+.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                   00000000 00111111       235678999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=345.94  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=190.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCC------cceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS------HNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  312 (558)
                      .++||+|+||+||+|+. .+++.||||+++...   ...+.+.+|+.+|+.++|||||++++++...+      +.++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            36899999999999997 569999999997432   23457889999999999999999999997655      468999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+ +.+|..+.+..    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       103 e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_         103 PFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             ECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             ecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCCc
Confidence            999 66788777543    39999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CCceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH-------Hhhhccc
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK-------KKAEEDK  463 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  463 (558)
                          .+...||+.|+|||.+.+  .++.++||||+||+++||++|+.||...+.............       .......
T Consensus       175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence                345679999999998864  478999999999999999999999976543321111111000       0000000


Q ss_pred             -------chhhccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhccc
Q 043292          464 -------LSDLVDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGVT  514 (558)
Q Consensus       464 -------~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~~  514 (558)
                             +.+.....+..  ........+.+|+.+||+.||.+|||+.|+++.  |+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                   00000000000  001112367889999999999999999999974  65544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=343.06  Aligned_cols=264  Identities=23%  Similarity=0.373  Sum_probs=193.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc--cchHHHHHHHHHHhccCCcceeeeeeeeccCC----cceEEEEeC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG--EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKS----HNLLVYEYM  315 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~  315 (558)
                      .++||+|+||+||+|+. .+++.||||+++...  ...+.+.+|+.+|++++||||+++++++....    ..+++++|+
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            47899999999999987 579999999997433  33457899999999999999999999987654    235566777


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCc
Q 043292          316 PNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQ  395 (558)
Q Consensus       316 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  395 (558)
                      .+|+|.+++...    .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus        93 ~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          93 MGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             CCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             cCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            799999999754    39999999999999999999999   99999999999999999999999999999876443222


Q ss_pred             --eeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcc-------cc
Q 043292          396 --VVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEED-------KL  464 (558)
Q Consensus       396 --~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~  464 (558)
                        ......||+.|+|||++..  .++.++||||+||+++||++|+.||......+................       ..
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              2345678999999998753  478999999999999999999999976554332111111000000000       00


Q ss_pred             hhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhcc
Q 043292          465 SDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVRV--LEGV  513 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~--L~~~  513 (558)
                      ...............     .....+.+++.+||+.||.+|||+.++++.  |+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            000000000000000     011367899999999999999999999974  5443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-41  Score=334.85  Aligned_cols=256  Identities=21%  Similarity=0.280  Sum_probs=201.9

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCC-cceeeeeeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHH-QNLVRLIGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.++||+|+||+||+|+. .+++.||||+++... ....+.+|++.+..++| +|++.+++++..+...++||||+ +++
T Consensus         9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~   86 (293)
T d1csna_           9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS   86 (293)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence            357899999999999997 468999999886432 23457889999999965 89999999999999999999999 789


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecC-----CCCeEEcccCCccccCCCCC
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDG-----NFNAKVADFGLSKLIDQDQS  394 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~ki~Dfgla~~~~~~~~  394 (558)
                      |.+++.....  .+++..+..++.|++.||+|||+   .+|+||||||+|||++.     ++.+||+|||+|+.+.....
T Consensus        87 l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          87 LEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             HHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9999876543  48999999999999999999999   99999999999999974     56899999999987654322


Q ss_pred             c------eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhh
Q 043292          395 Q------VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDL  467 (558)
Q Consensus       395 ~------~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (558)
                      .      ......||+.|||||.+.+ .++.++||||||+++|||++|+.||.+............+.... ......++
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~l  240 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLREL  240 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHHHH
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChHHh
Confidence            1      2335679999999999876 49999999999999999999999998766554332222211111 11111111


Q ss_pred             ccccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcccc
Q 043292          468 VDKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVTE  515 (558)
Q Consensus       468 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  515 (558)
                      ..    .      .+..+.+++..|++.+|++||+++.+.+.|+++.+
T Consensus       241 ~~----~------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         241 CA----G------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             TT----T------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cC----C------CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            11    1      12367889999999999999999999998877643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=336.99  Aligned_cols=255  Identities=19%  Similarity=0.269  Sum_probs=192.6

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccCCcceeee-eeeeccCCcceEEEEeCCCCC
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNLVRL-IGFCAEKSHNLLVYEYMPNGS  319 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~~~~gs  319 (558)
                      +.+.||+|+||.||+|++ .+++.||||++.... ...++..|+++++.++|+|++.. .++..+++..++||||+ +++
T Consensus        11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~   88 (299)
T d1ckia_          11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   88 (299)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence            357899999999999987 568999999886532 23468899999999987765554 55567777888999999 566


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeec---CCCCeEEcccCCccccCCCCCc-
Q 043292          320 LDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLD---GNFNAKVADFGLSKLIDQDQSQ-  395 (558)
Q Consensus       320 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~~~-  395 (558)
                      |...+.....  .+++..+..++.|++.||+|||+   .+|+||||||+|||++   .+..+||+|||+|+.+...... 
T Consensus        89 l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          89 LEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             HHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             hhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            7666654433  39999999999999999999999   9999999999999975   4557999999999977543321 


Q ss_pred             -----eeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhcc
Q 043292          396 -----VVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLVD  469 (558)
Q Consensus       396 -----~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  469 (558)
                           ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..................... .......+
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  242 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEVLCK  242 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHHHHTT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChhHhcc
Confidence                 2345679999999999886 5999999999999999999999999876554432222221111110 11111111


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhccc
Q 043292          470 KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRVLEGVT  514 (558)
Q Consensus       470 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  514 (558)
                                ..+..+.+++..|++.||++||+++++.+.|+.+.
T Consensus       243 ----------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         243 ----------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ----------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ----------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                      11246888999999999999999999999888764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=335.51  Aligned_cols=259  Identities=21%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccCCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEKSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||+||+|++ .+++.||||+++...   ....++.+|+.+++.++||||+++++++.+....++|+|++.++
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~   86 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD   86 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence            47899999999999998 578999999986432   33567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCCCceee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQSQVVT  398 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~  398 (558)
                      +|..++....   .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.++....... ...
T Consensus        87 ~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~  159 (292)
T d1unla_          87 LKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS  159 (292)
T ss_dssp             HHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred             cccccccccc---ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence            9988876543   38899999999999999999999   9999999999999999999999999999987654332 234


Q ss_pred             cccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccch---hhcc----
Q 043292          399 TMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLS---DLVD----  469 (558)
Q Consensus       399 ~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d----  469 (558)
                      ...++..|+|||.+.+  .++.++|||||||+++||++|+.||..........................   ...+    
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            4567889999998864  379999999999999999999999765443332211111111100000000   0000    


Q ss_pred             ----ccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          470 ----KHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       470 ----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                          ...............+.+|+.+||+.||.+|||++||++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000000011122346788999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-42  Score=341.57  Aligned_cols=246  Identities=26%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             hhhhcCccCceEEEEEEe----CCCCEEEEEEeccc-----ccchHHHHHHHHHHhccCC-cceeeeeeeeccCCcceEE
Q 043292          242 FRKMLGKGGFGSVFEGTQ----TDGTKVAVKRLEGI-----GEINKSFLAEVKTIGSIHH-QNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  311 (558)
                      +.++||+|+||+||+++.    .+|+.||||.++..     ....+.+.+|++++.+++| |||+++++++.+....+++
T Consensus        28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v  107 (322)
T d1vzoa_          28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI  107 (322)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence            458999999999999975    24789999998632     2234568899999999976 8999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCC
Q 043292          312 YEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQ  391 (558)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~  391 (558)
                      |||+.+|+|.+++.....   ++......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       108 ~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         108 LDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             ECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            999999999999976553   7889999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCCceeecccCCCCcCChhhhcC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHhhhcccchhhc
Q 043292          392 DQSQVVTTMRGTPGYLAPEWLSS---IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKKAEEDKLSDLV  468 (558)
Q Consensus       392 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (558)
                      ..........|++.|+|||.+.+   .++.++|||||||+||||++|+.||......+....+....   .. ..     
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---~~-~~-----  252 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LK-SE-----  252 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HH-CC-----
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc---cc-CC-----
Confidence            55444556789999999999863   37889999999999999999999998766544322222111   10 00     


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 043292          469 DKHSNDMQSNGEEVVNMMKVAAWCLESDFAKRPS-----MSMVVR  508 (558)
Q Consensus       469 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  508 (558)
                         .   .........+.+++.+||+.||++|||     ++|+++
T Consensus       253 ---~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ---P---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---C---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence               0   011123457889999999999999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.7e-41  Score=334.57  Aligned_cols=253  Identities=20%  Similarity=0.363  Sum_probs=191.8

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-Ccceeeeeeeecc--CCcceEEEEeCCCC
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-HQNLVRLIGFCAE--KSHNLLVYEYMPNG  318 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~g  318 (558)
                      .++||+|+||+||+|+. .+++.||||+++..  ..+++.+|+.++.+++ ||||+++++++..  ....++||||+.++
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~  117 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  117 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence            47899999999999998 57899999999753  3467889999999995 9999999999874  34678999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCC-CeEEcccCCccccCCCCCcee
Q 043292          319 SLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNF-NAKVADFGLSKLIDQDQSQVV  397 (558)
Q Consensus       319 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~~  397 (558)
                      +|..+..      .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+|+......  ..
T Consensus       118 ~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~  186 (328)
T d3bqca1         118 DFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EY  186 (328)
T ss_dssp             BGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CC
T ss_pred             cHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC--cc
Confidence            9976542      38999999999999999999999   9999999999999998655 58999999998765432  24


Q ss_pred             ecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhH-HHHH-----HHhhhc---c---c
Q 043292          398 TTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYL-LSIF-----KKKAEE---D---K  463 (558)
Q Consensus       398 ~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-~~~~-----~~~~~~---~---~  463 (558)
                      ....+|+.|+|||.+.+  .++.++||||+|++++||++|+.||............ ....     ......   .   .
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            45678999999999764  4799999999999999999999999765543321111 1100     000000   0   0


Q ss_pred             chhhcccc-------CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 043292          464 LSDLVDKH-------SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVR  508 (558)
Q Consensus       464 ~~~~~d~~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  508 (558)
                      ........       .............+.+|+.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000       0000011112346789999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-40  Score=332.94  Aligned_cols=256  Identities=23%  Similarity=0.280  Sum_probs=182.4

Q ss_pred             hhhcCccCceEEEEEEeC-CCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeecc------CCcceEEE
Q 043292          243 RKMLGKGGFGSVFEGTQT-DGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAE------KSHNLLVY  312 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~  312 (558)
                      .++||+|+||+||+|.+. +|+.||||++....   ....++.+|+.++++++||||+++++++..      ..+.++||
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            368999999999999984 69999999997432   234568899999999999999999999864      35779999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCC
Q 043292          313 EYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQD  392 (558)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~  392 (558)
                      ||+.++.+ +.+..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|++|||+++.....
T Consensus       102 Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1         102 ELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             ECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccc
Confidence            99976544 44432     38999999999999999999999   99999999999999999999999999998865443


Q ss_pred             CCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHH----Hhhh--cccch
Q 043292          393 QSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFK----KKAE--EDKLS  465 (558)
Q Consensus       393 ~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~--~~~~~  465 (558)
                      .  ......+|+.|+|||++.+ .+++++||||+||+++||++|+.||.+.+.......+.....    ..+.  .....
T Consensus       173 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             c--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            2  3455678999999999875 599999999999999999999999976543221111110000    0000  00000


Q ss_pred             h---------------hccccCCC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          466 D---------------LVDKHSND--MQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       466 ~---------------~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .               .+......  ..........+.+|+.+||+.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1               11111100  01112345678999999999999999999999854

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-40  Score=330.99  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=191.1

Q ss_pred             hhhcCccCceEEEEEEe-CCCCEEEEEEecccc---cchHHHHHHHHHHhccCCcceeeeeeeeccC-----CcceEEEE
Q 043292          243 RKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIG---EINKSFLAEVKTIGSIHHQNLVRLIGFCAEK-----SHNLLVYE  313 (558)
Q Consensus       243 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  313 (558)
                      .++||+|+||+||+|+. .+++.||||+++...   ...+++.+|+.++++++|||+|++++++...     ...+++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            47899999999999997 579999999997432   2345688999999999999999999998643     34467788


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcccCCccccCCCC
Q 043292          314 YMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVADFGLSKLIDQDQ  393 (558)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~~~~~~~  393 (558)
                      |+.+|+|.+++..+    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||++.....  
T Consensus       103 ~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--  173 (348)
T d2gfsa1         103 HLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--  173 (348)
T ss_dssp             ECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred             eecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc--
Confidence            88899999999643    39999999999999999999999   9999999999999999999999999999976533  


Q ss_pred             CceeecccCCCCcCChhhhcC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhhHHHHHHHh-------hhcccc
Q 043292          394 SQVVTTMRGTPGYLAPEWLSS--IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEEDMYLLSIFKKK-------AEEDKL  464 (558)
Q Consensus       394 ~~~~~~~~gt~~y~aPE~~~~--~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~  464 (558)
                        ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+.......+.......       ......
T Consensus       174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence              2345678999999998764  47899999999999999999999997654332111111110000       000000


Q ss_pred             hhhccccCCCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcc
Q 043292          465 SDLVDKHSNDMQSNG-----EEVVNMMKVAAWCLESDFAKRPSMSMVVR--VLEGV  513 (558)
Q Consensus       465 ~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~--~L~~~  513 (558)
                      ...............     .....+.+|+.+||+.||.+|||+.|+++  .+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            000000000000000     11246788999999999999999999997  35544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-36  Score=306.74  Aligned_cols=262  Identities=22%  Similarity=0.288  Sum_probs=188.2

Q ss_pred             hhhhcCccCceEEEEEEe-CCCCEEEEEEecccccchHHHHHHHHHHhccC-----------CcceeeeeeeeccC--Cc
Q 043292          242 FRKMLGKGGFGSVFEGTQ-TDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH-----------HQNLVRLIGFCAEK--SH  307 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~--~~  307 (558)
                      +.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.+++.++           |+||+++++++...  ..
T Consensus        17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~   96 (362)
T d1q8ya_          17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG   96 (362)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence            458899999999999998 57999999999876555667888999888875           57899999887654  34


Q ss_pred             ceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCC------eEEc
Q 043292          308 NLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFN------AKVA  381 (558)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~------~ki~  381 (558)
                      .++++++...+..............+++..+..++.||+.||.|||+  ..+|+||||||+||||+.++.      ++++
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~  174 (362)
T d1q8ya_          97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIA  174 (362)
T ss_dssp             EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEe
Confidence            55666666555444433333344458999999999999999999996  378999999999999987654      9999


Q ss_pred             ccCCccccCCCCCceeecccCCCCcCChhhhcC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh---hhHHHHHHH
Q 043292          382 DFGLSKLIDQDQSQVVTTMRGTPGYLAPEWLSS-IITEKVDIYSFGVVMLEILCGRKVFDRSQPEEED---MYLLSIFKK  457 (558)
Q Consensus       382 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~k~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~  457 (558)
                      |||.+......    .....||+.|+|||.+.+ .++.++||||+|++++||++|+.||.........   ..+......
T Consensus       175 dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         175 DLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             CCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             ecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            99999865432    345679999999998764 5899999999999999999999999754332111   111111110


Q ss_pred             h-------hhccc-chhhccc-----c-------------CCCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 043292          458 K-------AEEDK-LSDLVDK-----H-------------SNDMQSNGEEVVNMMKVAAWCLESDFAKRPSMSMVVRV  509 (558)
Q Consensus       458 ~-------~~~~~-~~~~~d~-----~-------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  509 (558)
                      .       ..... ....++.     .             .............+.+|+.+||..||.+|||++|+++.
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0       00000 0000100     0             01122345667889999999999999999999999863

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.9e-23  Score=190.95  Aligned_cols=162  Identities=17%  Similarity=0.193  Sum_probs=121.7

Q ss_pred             hhhhcCccCceEEEEEEeCCCCEEEEEEeccccc-------------------chHHHHHHHHHHhccCCcceeeeeeee
Q 043292          242 FRKMLGKGGFGSVFEGTQTDGTKVAVKRLEGIGE-------------------INKSFLAEVKTIGSIHHQNLVRLIGFC  302 (558)
Q Consensus       242 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~  302 (558)
                      +.++||+|+||+||+|++.+|+.||||+++....                   .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            3578999999999999998899999998752110                   112345688889999999999888663


Q ss_pred             ccCCcceEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHhhhhccccCCCcEEecCCCCCCEeecCCCCeEEcc
Q 043292          303 AEKSHNLLVYEYMPNGSLDRWLFQRSDEFMLDWQQRKKIILDIAKGLTYLHEDCRQKILHLDIKPQNILLDGNFNAKVAD  382 (558)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dlk~~NIll~~~~~~ki~D  382 (558)
                          ..+++|||+++..+..          ++......++.|++.+|.|||+   .+|+||||||+|||++++ .++|+|
T Consensus        84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence                3479999998765432          3444567899999999999999   999999999999999976 589999


Q ss_pred             cCCccccCCCCCceeecccCCCCcCC------hhhhcCCCCCccchHHHHHHHH
Q 043292          383 FGLSKLIDQDQSQVVTTMRGTPGYLA------PEWLSSIITEKVDIYSFGVVML  430 (558)
Q Consensus       383 fgla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~k~Dv~s~Gv~l~  430 (558)
                      ||+|.........         .|..      .+.+.+.++.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            9999866433221         1111      1334456789999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.16  E-value=3.2e-06  Score=78.79  Aligned_cols=129  Identities=13%  Similarity=0.067  Sum_probs=84.0

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccc-cchHHHHHHHHHHhccC-CcceeeeeeeeccCCcceEEEEeCCCCCHHHHHhcC
Q 043292          250 GFGSVFEGTQTDGTKVAVKRLEGIG-EINKSFLAEVKTIGSIH-HQNLVRLIGFCAEKSHNLLVYEYMPNGSLDRWLFQR  327 (558)
Q Consensus       250 ~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  327 (558)
                      +.+.||+.. .+++.+.||+..... .....+.+|...+..+. +-.+.+++.+..+++..++||+++++.++.+.....
T Consensus        26 s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~  104 (263)
T d1j7la_          26 SPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE  104 (263)
T ss_dssp             SSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred             CCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence            346899876 456677888876432 23345778888877664 445677888888888889999999998876543211


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhhcccc----------------------------------------------------
Q 043292          328 SDEFMLDWQQRKKIILDIAKGLTYLHED----------------------------------------------------  355 (558)
Q Consensus       328 ~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------------------  355 (558)
                      .     .   ...++.++++.+..||+.                                                    
T Consensus       105 ~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  176 (263)
T d1j7la_         105 Q-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT  176 (263)
T ss_dssp             S-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred             c-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence            1     1   111222222222222210                                                    


Q ss_pred             ----CCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          356 ----CRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       356 ----~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                          ....++|+|+.|.|||+++++..-|.||+.+.
T Consensus       177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                01348999999999999987666799998776

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.63  E-value=9.2e-05  Score=68.08  Aligned_cols=73  Identities=14%  Similarity=0.108  Sum_probs=52.0

Q ss_pred             cCccCc-eEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccC--CcceeeeeeeeccCCcceEEEEeCCCCCH
Q 043292          246 LGKGGF-GSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIH--HQNLVRLIGFCAEKSHNLLVYEYMPNGSL  320 (558)
Q Consensus       246 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  320 (558)
                      +..|.. +.||+....++..+++|.-....  ...+..|...+..+.  ...+.+++.+..+++..++||+++++.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344443 67999988888888999765432  234667777777663  33466778888888888999999987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.47  E-value=0.00031  Score=69.09  Aligned_cols=74  Identities=14%  Similarity=0.127  Sum_probs=47.2

Q ss_pred             hhcCccCceEEEEEEeCC-CCEEEEEEecc----c----ccchHHHHHHHHHHhccC-C--cceeeeeeeeccCCcceEE
Q 043292          244 KMLGKGGFGSVFEGTQTD-GTKVAVKRLEG----I----GEINKSFLAEVKTIGSIH-H--QNLVRLIGFCAEKSHNLLV  311 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~----~----~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  311 (558)
                      +.||.|....||+....+ ++.++||.-..    .    .....+...|.+.+..+. +  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            458999999999998754 67899996431    1    112234456777776662 2  345556554  45567899


Q ss_pred             EEeCCCCC
Q 043292          312 YEYMPNGS  319 (558)
Q Consensus       312 ~e~~~~gs  319 (558)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.15  E-value=0.0011  Score=63.24  Aligned_cols=134  Identities=15%  Similarity=0.152  Sum_probs=79.3

Q ss_pred             eEEEEEEeCCCCEEEEEEecccccchHHHHHHHHHHhccCCcce--eeeee-----eeccCCcceEEEEeCCCCCHH---
Q 043292          252 GSVFEGTQTDGTKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL--VRLIG-----FCAEKSHNLLVYEYMPNGSLD---  321 (558)
Q Consensus       252 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~---  321 (558)
                      -.||+.+..+|+.+++|+.+......+++..|...+..|...++  +..+.     ....++..+.++++++|..+.   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            47999999999999999987665566778889988888753332  22221     122344567889998753321   


Q ss_pred             --HH------H---hc----C--CCCCCCCHHH----------------------HHHHHHHHHHhhh-hccccCCCcEE
Q 043292          322 --RW------L---FQ----R--SDEFMLDWQQ----------------------RKKIILDIAKGLT-YLHEDCRQKIL  361 (558)
Q Consensus       322 --~~------l---~~----~--~~~~~l~~~~----------------------~~~i~~~ia~~l~-yLH~~~~~~iv  361 (558)
                        .+      +   +.    .  .....+++..                      ....+..+...+. ++.+....+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence              11      0   00    0  0111122211                      1122222222222 12233346899


Q ss_pred             ecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          362 HLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       362 H~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      |+|+.+.|||++++  ..+.||+-+.
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             cCCCCcccEEEeCC--ceEEechhcc
Confidence            99999999999754  4689999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.55  E-value=0.0023  Score=62.66  Aligned_cols=72  Identities=19%  Similarity=0.243  Sum_probs=48.4

Q ss_pred             hhcCccCceEEEEEEeCCC--------CEEEEEEecccccchHHHHHHHHHHhccCCcce-eeeeeeeccCCcceEEEEe
Q 043292          244 KMLGKGGFGSVFEGTQTDG--------TKVAVKRLEGIGEINKSFLAEVKTIGSIHHQNL-VRLIGFCAEKSHNLLVYEY  314 (558)
Q Consensus       244 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  314 (558)
                      +.|+.|-.-.+|+....++        +.|.+++... ........+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            4577788889999886542        4566666553 3333456688888888854455 467777653    689999


Q ss_pred             CCCCCH
Q 043292          315 MPNGSL  320 (558)
Q Consensus       315 ~~~gsL  320 (558)
                      +++..|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            986544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.76  E-value=0.018  Score=54.01  Aligned_cols=32  Identities=19%  Similarity=0.311  Sum_probs=28.3

Q ss_pred             CCCcEEecCCCCCCEeecCCCCeEEcccCCcc
Q 043292          356 CRQKILHLDIKPQNILLDGNFNAKVADFGLSK  387 (558)
Q Consensus       356 ~~~~ivH~dlk~~NIll~~~~~~ki~Dfgla~  387 (558)
                      ...++||+|+.+.||+++.+...-|.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            35789999999999999998777899999875

>d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Hairpin loop containing domain-like
superfamily: Hairpin loop containing domain-like
family: Hairpin loop containing domain
domain: Hepatocyte growth factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.09  E-value=0.31  Score=35.75  Aligned_cols=55  Identities=16%  Similarity=0.409  Sum_probs=37.1

Q ss_pred             cceeeeccccccccCCCCC--CCCCCChHHHHHHHhc----cCCceeecccccCcCCCCcccccc
Q 043292           82 HRFVELNDVAYFAFSSSSS--DITNTDSETCKQACLK----NCSCKAALFQYGLNSSAGDCYLPS  140 (558)
Q Consensus        82 ~~f~~~~~~~~~~~~~~~~--~~~~~~~~~C~~~Cl~----nCsC~a~~~~~~~~~~~~~C~~~~  140 (558)
                      +.|.+..++.+...+....  .....+.++|...|++    +-.|.+|.|..    ..+.|.+-.
T Consensus         5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~----~~~~C~Ls~   65 (91)
T d2qj2a1           5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK----ARKQCLWFP   65 (91)
T ss_dssp             GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET----TTTEEEEES
T ss_pred             HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC----CCCeEEEcc
Confidence            4577777777765443211  1123589999999987    45799998854    366898743